PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Smardon, AM; Nasab, ND; Tarsio, M; Diakov, TT; Kane, PM				Smardon, Anne M.; Nasab, Negin Dehdar; Tarsio, Maureen; Diakov, Theodore T.; Kane, Patricia M.			Molecular Interactions and Cellular Itinerary of the Yeast RAVE (Regulator of the H+-ATPase of Vacuolar and Endosomal Membranes) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; SACCHAROMYCES-CEREVISIAE; SUBUNIT-C; CRYSTAL-STRUCTURE; IN-VIVO; PROTEIN; DOMAIN; RABCONNECTIN-3; PURIFICATION; PREDICTION	The RAVE complex (regulator of the H+-ATPase of vacuolar and endosomal membranes) is required for biosynthetic assembly and glucose-stimulated reassembly of the yeast vacuolar H+-ATPase (V-ATPase). Yeast RAVE contains three subunits: Rav1, Rav2, and Skp1. Rav1 is the largest subunit, and it binds Rav2 and Skp1 of RAVE; the E, G, and C subunits of the V-TPase peripheral V-1 sector; and Vph1 of the membrane Vo sector. We identified Rav1 regions required for interaction with its binding partners through deletion analysis, co-immunoprecipitation, two-hybrid assay, and pulldown assays with expressed proteins. We find that Skp1 binding requires sequences near the C terminus of Rav1, V-1 subunits E and C bind to a conserved region in the C-terminal half of Rav1, and the cytosolic domain of Vph1 binds near the junction of the Rav1 N- and C-terminal halves. In contrast, Rav2 binds to the N-terminal domain of Rav1, which can be modeled as a double beta-propeller. Only the V-1 C subunit binds to both Rav1 and Rav2. Using GFP-tagged RAVE subunits in vivo, we demonstrate glucose-dependent association of RAVE with the vacuolar membrane, consistent with its role in glucose-dependent V-ATPase assembly. It is known that V-1 subunit C localizes to the V-1-V-o interface in assembled V-ATPase complexes and is important in regulated disassembly of V-ATPases. We propose that RAVE cycles between cytosol and vacuolar membrane in a glucose-dependent manner, positioning V-1 and V-0 subcomplexes and orienting the V-1 C subunit to promote assembly.	[Smardon, Anne M.; Nasab, Negin Dehdar; Tarsio, Maureen; Diakov, Theodore T.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM50322, R01 GM63742]; American Heart Association postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063742, R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM50322 and R01 GM63742 (to P. M. K.) and an American Heart Association postdoctoral fellowship (to A. M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai C, 1997, METHOD ENZYMOL, V283, P141; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Brace EJ, 2006, EUKARYOT CELL, V5, P2104, DOI 10.1128/EC.00347-05; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Einhorn Z, 2012, J NEUROSCI, V32, P11144, DOI 10.1523/JNEUROSCI.1705-12.2012; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HO MN, 1993, J BIOL CHEM, V268, P221; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; James P, 1996, GENETICS, V144, P1425; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Li KW, 2012, PROTEOMICS, V12, P2428, DOI 10.1002/pmic.201100675; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; Sakisaka T, 2005, METHOD ENZYMOL, V403, P401, DOI 10.1016/S0076-6879(05)03035-1; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Sethi N, 2010, J BIOL CHEM, V285, P34757, DOI 10.1074/jbc.M110.158634; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	49	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27511	27523		10.1074/jbc.M115.667634	http://dx.doi.org/10.1074/jbc.M115.667634			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405040	Green Published, hybrid			2022-12-26	WOS:000365757500007
J	Zhao, X; Zhang, LL; Zhao, ZT; Wang, WC; Leavitt, SD; Lumbsch, HT				Zhao, Xin; Zhang, Lu Lu; Zhao, Zun Tian; Wang, Wei Cheng; Leavitt, Steven D.; Lumbsch, Helge Thorsten			A Molecular Phylogeny of the Lichen Genus Lecidella Focusing on Species from Mainland China	PLOS ONE			English	Article							GRAPHIDACEAE ASCOMYCOTA; RIBOSOMAL DNA; CHARACTER EVOLUTION; PARALLEL EVOLUTION; PCR PRIMERS; SSU RDNA; LECANORACEAE; FUNGI; IDENTIFICATION; AMPLIFICATION	The phylogeny of Lecidella species is studied, based on a 7-locus data set using ML and Bayesian analyses. Phylogenetic relationships among 43 individuals representing 11 Lecidella species, mainly from mainland China, were included in the analyses and phenotypical characters studied and mapped onto the phylogeny. The Lecidella species fall into three major clades, which are proposed here as three informal groups-Lecidella stigmatea group, L. elaeochroma group and L. enteroleucella group, each of them strongly supported. Our phylogenetic analyses support traditional species delimitation based on morphological and chemical traits in most but not all cases. Individuals considered as belonging to the same species based on phenotypic characters were found to be paraphyletic, indicating that cryptic species might be hidden under these names (e.g. L. carpathica and L. effugiens). Potentially undescribed species were found within the phenotypically circumscribed species L. elaeochroma and L. stigmatea. Additional sampling across a broader taxonomic and geographic scale will be crucial to fully resolving the taxonomy in this cosmopolitan genus.	[Zhao, Xin; Zhang, Lu Lu; Zhao, Zun Tian; Wang, Wei Cheng] Shandong Normal Univ, Coll Life Sci, Jinan 250014, Peoples R China; [Leavitt, Steven D.; Lumbsch, Helge Thorsten] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA; [Leavitt, Steven D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	Shandong Normal University; Field Museum of Natural History (Chicago); University of Chicago	Lumbsch, HT (corresponding author), Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA.	tlumbsch@fieldmuseum.org	Leavitt, Steven D./AAC-6462-2021	Leavitt, Steven D./0000-0002-5034-9724; Lumbsch, Thorsten/0000-0003-1512-835X	China Scholorship Council [201408370093]; National Natural Science Foundation of China [31170187, 31270059]	China Scholorship Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Scholorship Council (www.csc.edu.cn) 201408370093 to XZ, National Natural Science Foundation of China (www.nsfc.gov.cn) 31170187 to ZTZ and the National Natural Science Foundation of China (www.nsfc.gov.cn) 31270059 to LLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Abdulla, 2001, Harvard Papers in Botany, V5, P359; de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; Divakar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083115; Doring H, 2000, LICHENOLOGIST, V32, P200, DOI 10.1006/lich.1999.0250; Ekman S, 2000, PLANT BIOLOGY, V2, P350, DOI 10.1055/s-2000-3703; ELIX JA, 1992, BRYOLOGIST, V95, P52, DOI 10.2307/3243785; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grube M, 2004, MYCOL RES, V108, P1111, DOI 10.1017/S0953756204000826; Grube M, 2004, MYCOL RES, V108, P506, DOI 10.1017/S0953756204009888; Grube Martin, 2002, Mycologist, V16, P67, DOI 10.1017/S0269915X02002069; Gueidan C, 2007, MYCOL RES, V111, P1145, DOI 10.1016/j.mycres.2007.08.010; Hafellner J, 1984, MITT BOT TAG WIEN 19, P116; Hafellner J., 1984, NOVA HEDWIGIA S, V79, P241; Hertel H, 1984, NOVA HEDWIGIA S, V79, P399; Hertel H, 1967, NOVA HEDWIGIA S, V24, P1; INOUE M, 1991, Antarctic Record, V35, P271; Jaklitsch WM, 2015, SYLLABUS PLANT FAMIL, V1/2, P150; Kalb K, 2008, NOVA HEDWIGIA, V86, P23, DOI 10.1127/0029-5035/2008/0086-0023; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirk PM, 2008, AINSWORTH BISBYS DIC; KNOPH J.-G., 1997, BIBLIOTHECA LICHENOL, V68, P129; Knoph J. G., 1990, BIBLIOTHECA LICHENOL, V36, P1; KNOPH JG, 1994, NOVA HEDWIGIA, V59, P455; Knoph Johannes-Guenther, 2000, Herzogia, V14, P1; Knoph Johannes-Guenther, 1995, Cryptogamic Botany, V5, P45; Koerber GW., 1855, SYSTEMA LICHENUM GER; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; LEUCKERT C, 1992, Herzogia, V9, P1; LEUCKERT C, 1992, LICHENOLOGIST, V24, P383, DOI 10.1017/S0024282992000501; LEUCKERT C, 1990, Herzogia, V8, P265; LEUCKERT C., 1967, NOVA HEDWIGIA, V14, P291; Leuckert C, 1993, BIBLIOTHECA LICHENOL, V53, P161; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lucking R, 2014, P NATL ACAD SCI USA, V111, P11091, DOI 10.1073/pnas.1403517111; Lumbsch H.T., 2009, MYCONET, V14, P1, DOI DOI 10.3158/1557.1; LUMBSCH H. T., 2006, FUNGI MULTIFACETED M, P153; Lumbsch HT, 2014, SYST BIODIVERS, V12, P271, DOI 10.1080/14772000.2014.905506; Lumbsch H. Thorsten, 2002, P281; Lumbsch HT, 2000, NATURWISSENSCHAFTEN, V87, P335, DOI 10.1007/s001140050736; Mangold A, 2008, TAXON, V57, P476, DOI 10.2307/25066016; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miadlikowska J, 2006, MYCOLOGIA, V98, P1088, DOI 10.3852/mycologia.98.6.1088; Miadlikowska J, 2014, MOL PHYLOGENET EVOL, V79, P132, DOI 10.1016/j.ympev.2014.04.003; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Orange A., 2001, MICROCHEMICAL METHOD; Otalora MAG, 2013, MOL PHYLOGENET EVOL, V68, P185, DOI 10.1016/j.ympev.2013.04.004; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Printzen C, PROGR BOT, V712010, P233; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruprecht U, 2012, NOVA HEDWIGIA, V94, P287, DOI 10.1127/0029-5035/2012/0017; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schmitt I, 2009, MOL PHYLOGENET EVOL, V52, P34, DOI 10.1016/j.ympev.2009.03.017; Schmull M, 2011, MYCOLOGIA, V103, P983, DOI 10.3852/10-234; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Tehler A, 2007, CLADISTICS, V23, P432, DOI 10.1111/j.1096-0031.2007.00156.x; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Wedin M, 2009, MOL PHYLOGENET EVOL, V53, P862, DOI 10.1016/j.ympev.2009.08.013; Wei J.C., 1991, ENUMERATION LICHENS; Zhang LL, 2012, BRYOLOGIST, V115, P329, DOI 10.1639/0007-2745-115.2.329; Zhang LL, 2012, MYCOTAXON, V119, P445, DOI 10.5248/119.445; Zhao X, 2015, MYCOTAXON IN PRESS; Zhao X, 2015, FUNGAL DIVERSITY, Vxx; Zhou SG, 2001, MYCOL RES, V105, P1033, DOI 10.1016/S0953-7562(08)61965-6; Zoller S, 1999, LICHENOLOGIST, V31, P511	73	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139405	10.1371/journal.pone.0139405	http://dx.doi.org/10.1371/journal.pone.0139405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414323	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700056
J	Deng, K; Liu, RY; Rao, HY; Jiang, D; Wang, JH; Xie, XW; Wei, L				Deng, Kai; Liu, Ruyu; Rao, Huiying; Jiang, Dong; Wang, Jianghua; Xie, Xingwang; Wei, Lai			Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; E2 GLYCOPROTEIN; IMMUNE-RESPONSES; ENVELOPE; PARTICLES; IMMUNIZATION; CHIMPANZEES; PROTEIN; SERUM	Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partly due to our insufficient understanding of the virus glycoprotein immunology. Most neutralizing antibodies (nAbs) were identified using glycoprotein immunogens, such as recombinant E1E2, HCV pseudoparticles or cell culture derived HCV. However, the fact that in the HCV acute infection phase, only a small proportion of patients are self-resolved accompanied with the emergence of nAbs, indicates the limited immunogenicity of glycoprotein itself to induce effective antibodies against a highly evolved virus. Secondly, in previous reports, the immunogen sequence was mostly the genotype of the 1a H77 strain. Rarely, other genotypes/subtypes have been studied, although theoretically one genotype/subtype immunogen is able to induce cross-genotype neutralizing antibodies. To overcome these drawbacks and find potential novel neutralizing epitopes, 57 overlapping peptides encompassing the full-length glycoprotein E1E2 of subtype 1b were synthesized to immunize BALB/c mice, and the neutralizing reactive of the induced antisera against HCVpp genotypes 1-6 was determined. We defined a domain comprising amino acids (aa) 192-221, 232-251, 262-281 and 292-331 of E1, and 421-543, 564-583, 594-618 and 634-673 of E2, as the neutralizing regions of HCV glycoprotein. Peptides PUHI26 (aa 444-463) and PUHI45 (aa 604-618)-induced antisera displayed the most potent broad neutralizing reactive. Two monoclonal antibodies recognizing the PUHI26 and PUHI45 epitopes efficiently precluded genotype 2 viral (HCVcc JFH and J6 strains) infection, but they did not neutralize other genotypes. Our study mapped a neutralizing epitope region of HCV glycoprotein using a novel immunization strategy, and identified two monoclonal antibodies effective in preventing genotype 2 virus infection.	[Deng, Kai; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China; [Liu, Ruyu] Capital Med Univ, Liver Dis Ctr, Beijing Ditan Hosp, Beijing, Peoples R China; [Jiang, Dong] Capital Med Univ, Inst Infect Dis, Beijing Ditan Hosp, Beijing Key Lab Emerging Infect Dis, Beijing, Peoples R China	Peking University; Capital Medical University; Capital Medical University	Wei, L (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China.	weelai@163.com			National Science and Technology Major Project [2012ZX10002003]	National Science and Technology Major Project	The work was sponsored by National Science and Technology Major Project (2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2013, GASTROENTEROLOGY, V145, P447, DOI 10.1053/j.gastro.2013.05.007; Alexander J, 2014, J VIROL, V88, P14278, DOI 10.1128/JVI.01911-14; Carlsen THR, 2014, HEPATOLOGY, V60, P1551, DOI 10.1002/hep.27298; Cashman SB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00550; Claassen MAA, 2013, CURR OPIN VIROL, V3, P461, DOI 10.1016/j.coviro.2013.05.006; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062684; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Ishii K, 1998, HEPATOLOGY, V28, P1117, DOI 10.1002/hep.510280429; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Liu RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066872; Mathiesen CK, 2014, VIROLOGY, V458, P190, DOI 10.1016/j.virol.2014.03.021; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Meyer K, 2008, J VIROL, V82, P2140, DOI 10.1128/JVI.01867-07; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Ndongo N, 2010, HEPATOLOGY, V52, P1531, DOI 10.1002/hep.23862; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Pedersen J, 2013, HEPATOLOGY, V58, P1587, DOI 10.1002/hep.26524; Puig M, 2004, VACCINE, V22, P991, DOI 10.1016/j.vaccine.2003.09.010; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Ruwona TB, 2014, J VIROL, V88, P10459, DOI 10.1128/JVI.01584-14; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tarr AW, 2007, J GEN VIROL, V88, P2991, DOI 10.1099/vir.0.83065-0; Torresi J, 2007, IMMUNOL CELL BIOL, V85, P169, DOI 10.1038/sj.icb.7100021; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7	32	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138756	10.1371/journal.pone.0138756	http://dx.doi.org/10.1371/journal.pone.0138756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406225	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700088
J	Guy, F; Lazzari, V; Gilissen, E; Thiery, G				Guy, Franck; Lazzari, Vincent; Gilissen, Emmanuel; Thiery, Ghislain			To What Extent is Primate Second Molar Enamel Occlusal Morphology Shaped by the Enamel-Dentine Junction?	PLOS ONE			English	Article							BRIEF COMMUNICATION; THICKNESS; TOOTH; SURFACE; MODEL; EXPRESSION; DENTITIONS; EVOLUTION; MICROWEAR; PATTERNS	The form of two hard tissues of the mammalian tooth, dentine and enamel, is the result of a combination of the phylogenetic inheritance of dental traits and the adaptive selection of these traits during evolution. Recent decades have been significant in unveiling developmental processes controlling tooth morphogenesis, dental variation and the origination of dental novelties. The enamel-dentine junction constitutes a precursor for the morphology of the outer enamel surface through growth of the enamel cap which may go along with the addition of original features. The relative contribution of these two tooth components to morphological variation and their respective response to natural selection is a major issue in paleoanthropology. This study will determine how much enamel morphology relies on the form of the enamel-dentine junction. The outer occlusal enamel surface and the enamel-dentine junction surface of 76 primate second upper molars are represented by polygonal meshes and investigated using tridimensional topometrical analysis. Quantitative criteria (elevation, inclination, orientation, curvature and occlusal patch count) are introduced to show that the enamel-dentine junction significantly constrains the topographical properties of the outer enamel surface. Our results show a significant correlation for elevation, orientation, inclination, curvature and occlusal complexity between the outer enamel surface and the enamel dentine junction for all studied primate taxa with the exception of four modern humans for curvature (p<0.05). Moreover, we show that, for all selected topometrical parameters apart from occlusal patch count, the recorded correlations significantly decrease along with enamel thickening in our sample. While preserving tooth integrity by providing resistance to wear and fractures, the variation of enamel thickness may modify the curvature present at the occlusal enamel surface in relation to enamel-dentine junction, potentially modifying dental functionalities such as blunt versus sharp dental tools. In terms of natural selection, there is a balance between increasing tooth resistance and maintaining efficient dental tools. In this sense the enamel cap acts as a functional buffer for the molar occlusal pattern. In primates, results suggest a primary emergence of dental novelties on the enamel-dentine junction and a secondary transposition of these novelties with no or minor modifications of dental functionalities by the enamel cap. Whereas enamel crenations have been reported by previous studies, our analysis do not support the presence of enamel tubercles without dentine relief nuclei. As is, the enamel cap is, at most, a secondary source of morphological novelty.	[Guy, Franck; Lazzari, Vincent; Thiery, Ghislain] Univ Poitiers, Fac Sci, CNRS INEE UMR 7262, IPHEP, F-86073 Poitiers 9, France; [Gilissen, Emmanuel] Royal Museum Cent Afr, Dept African Zool, B-3080 Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, B-1070 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Royal Museum for Central Africa; Universite Libre de Bruxelles	Guy, F (corresponding author), Univ Poitiers, Fac Sci, CNRS INEE UMR 7262, IPHEP, Bat B35-TSA 51106,6 rue Michel Brunet, F-86073 Poitiers 9, France.	franck.guy@univ-poitiers.fr	Thiery, Ghislain/ABI-7588-2020	Thiery, Ghislain/0000-0003-4789-7372; GUY, Franck/0000-0001-7032-7963; Lazzari, Vincent/0000-0002-8210-2646	Centre National de la Recherche Scientifique (CNRS, INEE); University of Poitiers; Region Poitou-Charentes [07/RPC-R-100, 12/RPC-013]	Centre National de la Recherche Scientifique (CNRS, INEE); University of Poitiers; Region Poitou-Charentes(Region Nouvelle-Aquitaine)	Funding: This work was supported by the Centre National de la Recherche Scientifique (CNRS, INEE); the University of Poitiers and the Region Poitou-Charentes (Conventions #07/RPC-R-100 & #12/RPC-013).	Adloff P., 1938, Z MORPHOL ANTHROPOL, P490; Anderson PSL, 2009, J EXP BIOL, V212, P3627, DOI 10.1242/jeb.033712; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Boyer DM, 2010, AM J PHYS ANTHROPOL, V142, P194, DOI 10.1002/ajpa.21211; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Cuozzo FP, 2012, AM J PHYS ANTHROPOL, V148, P163, DOI 10.1002/ajpa.21656; Cuvier G., 1817, REGNE ANIMAL APRES S; Dean C, 2004, J HUM EVOL, V46, P633, DOI 10.1016/j.jhevol.2004.03.001; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 2005, ANN ZOOL FENN, V42, P603; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; Gregory WK, 1926, ANTHROPOL PAP AM MUS, V27, P3; Guy F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066142; Harjunmaa E, 2014, NATURE, V512, P44, DOI 10.1038/nature13613; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jones D, 2012, P ROY SOC B-BIOL SCI, V279, P2849, DOI 10.1098/rspb.2012.0147; Kato A, 2014, AM J PHYS ANTHROPOL, V155, P447, DOI 10.1002/ajpa.22593; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; Korenhof C.A.W., 1982, EVOLUTIONARY TRENDS, P350; Korenhof CAW, 1961, KONINKL NEDERL AKA B, V64, P639; Kraus BS, 1965, HUMAN DENTITION BIRT; LIEM KF, 1980, AM ZOOL, V20, P295; Lucas P.W., 2000, P282, DOI 10.1017/CBO9780511542626.020; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; MAAS MC, 1991, AM J PHYS ANTHROPOL, V85, P31, DOI 10.1002/ajpa.1330850106; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Morita W, 2014, J ANAT, V224, P669, DOI 10.1111/joa.12180; NAGER GOTTFRIED, 1960, ACTA ANAT, V42, P226; Norconk MA, 2011, ANAT REC, V294, P2092, DOI 10.1002/ar.21506; Olejniczak AJ, 2008, AM J PHYS ANTHROPOL, V135, P85, DOI 10.1002/ajpa.20711; Olejniczak AJ, 2004, ANN ANAT, V186, P479, DOI 10.1016/S0940-9602(04)80087-6; Ortiz A, 2012, J HUM EVOL, V63, P586, DOI 10.1016/j.jhevol.2012.06.003; Osborn JW, 2008, J THEOR BIOL, V255, P338, DOI 10.1016/j.jtbi.2008.09.008; OSBORN JW, 1993, J THEOR BIOL, V165, P429, DOI 10.1006/jtbi.1993.1199; Pampush JD, 2013, J HUM EVOL, V64, P216, DOI 10.1016/j.jhevol.2013.01.009; Schwartz GT, 2000, ARCH ORAL BIOL, V45, P401, DOI 10.1016/S0003-9969(00)00007-8; Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239; Shellis RP, 1998, J HUM EVOL, V35, P507, DOI 10.1006/jhev.1998.0238; Shimizu D, 2002, J HUM EVOL, V43, P605, DOI 10.1006/jhev.2002.0593; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2010, J ANAT, V217, P245, DOI 10.1111/j.1469-7580.2010.01265.x; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Skinner MM, 2009, J HUM EVOL, V56, P76, DOI 10.1016/j.jhevol.2008.08.021; Smith TM, 2008, AM J PHYS ANTHROPOL, V136, P237, DOI 10.1002/ajpa.20796; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; Tiphaine C, 2013, EVOLUTION, V67, P3323, DOI 10.1111/evo.12172; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; VONKOENIGSWALD W, 1994, ZOOL J LINN SOC-LOND, V110, P141, DOI 10.1006/zjls.1994.1008; Walkhoff O., 1925, Z STOMATOL, V23, P93; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Wright BW, 2012, AM J PHYS ANTHROPOL, V148, P262, DOI 10.1002/ajpa.22081	58	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138802	10.1371/journal.pone.0138802	http://dx.doi.org/10.1371/journal.pone.0138802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406597	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700101
J	Meijer, M; Cijsouw, T; Toonen, RF; Verhage, M				Meijer, Marieke; Cijsouw, Tony; Toonen, Ruud F.; Verhage, Matthijs			Synaptic Effects of Munc18-1 Alternative Splicing in Excitatory Hippocampal Neurons	PLOS ONE			English	Article							READILY RELEASABLE POOL; PROTEIN-PHOSPHORYLATION; NERVOUS-SYSTEM; CALYX; COMPLEX; EXPRESSION; PREDICTION; SNAP-25	The munc18-1 gene encodes two splice-variants that vary at the C-terminus of the protein and are expressed at different levels in different regions of the adult mammalian brain. Here, we investigated the expression pattern of these splice variants within the brainstem and tested whether they are functionally different. Munc18-1a is expressed in specific nuclei of the brainstem including the LRN, VII and SOC, while Munc18-1b expression is relatively low/absent in these regions. Furthermore, Munc18-1a is the major splice variant in the Calyx of Held. Synaptic transmission was analyzed in autaptic hippocampal munc18-1 KO neurons re-expressing either Munc18-1a or Munc18-1b. The two splice variants supported synaptic transmission to a similar extent, but Munc18-1b was slightly more potent in sustaining synchronous release during high frequency stimulation. Our data suggest that alternative splicing of Munc18-1 support synaptic transmission to a similar extent, but could modulate presynaptic short-term plasticity.	[Verhage, Matthijs] Vrije Univ Amsterdam, NCA, CNCR, Dept Funct Genom, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Verhage, M (corresponding author), Vrije Univ Amsterdam, NCA, CNCR, Dept Funct Genom, Amsterdam, Netherlands.	m.verhage@vu.nl	Cijsouw, Anthony/B-8309-2008; Toonen, Rob/V-6230-2019	Cijsouw, Anthony/0000-0002-3670-7863; Toonen, Rob/0000-0001-6339-4340; verhage, matthijs/0000-0002-6085-7503; Toonen, Ruud/0000-0002-9900-4233	EU (EUROSPIN) [HEALTH-F2-2009-241498, HEALTH-F2-2009-242167]; Netherlands Organization for Scientific Research, NWO (ZonMW-TOP) [91208017]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]	EU (EUROSPIN); Netherlands Organization for Scientific Research, NWO (ZonMW-TOP)(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium	Funding: This work was supported by the EU (EUROSPIN project HEALTH-F2-2009-241498, and HEALTH-F2-2009-242167 SynSys project to MV), the Netherlands Organization for Scientific Research, NWO (ZonMW-TOP 91208017 to RFT) and the NeuroBsik Mouse Phenomics Consortium (BSIK03053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awatramani GB, 2005, J NEUROPHYSIOL, V93, P819, DOI 10.1152/jn.00798.2004; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Broeke JHP, 2010, BIOL CELL, V102, P479, DOI 10.1042/BC20100036; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Cijsouw T, 2014, J CELL BIOL, V204, P759, DOI 10.1083/jcb.201308026; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Han SH, 1999, NEUROSCIENCE, V94, P955, DOI 10.1016/S0306-4522(99)00372-3; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KELLY PT, 1985, DEV BRAIN RES, V18, P211, DOI 10.1016/0165-3806(85)90265-2; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Lipstein N, 2013, NEURON, V79, P82, DOI 10.1016/j.neuron.2013.05.011; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wierda KDB, 2014, J NEUROSCI, V34, P2100, DOI 10.1523/JNEUROSCI.3934-13.2014; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; Xiao L, 2010, MOL CELL NEUROSCI, V44, P374, DOI 10.1016/j.mcn.2010.05.002	43	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138950	10.1371/journal.pone.0138950	http://dx.doi.org/10.1371/journal.pone.0138950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407320	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700126
J	Turner, LM; Croft, RJ; Churchyard, A; Looi, JCL; Apthorp, D; Georgiou-Karistianis, N				Turner, Lauren M.; Croft, Rodney J.; Churchyard, Andrew; Looi, Jeffrey C. L.; Apthorp, Deborah; Georgiou-Karistianis, Nellie			Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation	PLOS ONE			English	Article							MOVEMENT-RELATED POTENTIALS; CONTINGENT NEGATIVE-VARIATION; FUNCTIONAL COMPENSATION; WORKING-MEMORY; BASAL GANGLIA; CONNECTIVITY; ONSET; INHIBITION; PATHOLOGY; NETWORKS	Background Huntington's disease (HD) causes progressive motor dysfunction through characteristic atrophy. Changes to neural structure begin in premanifest stages yet individuals are able to maintain a high degree of function, suggesting involvement of supportive processing during motor performance. Electroencephalography (EEG) enables the investigation of subtle impairments at the neuronal level, and possible compensatory strategies, by examining differential activation patterns. We aimed to use EEG to investigate neural motor processing (via the Readiness Potential; RP), premotor processing and sensorimotor integration (Contingent Negative Variation; CNV) during simple motor performance in HD. Methods We assessed neural activity associated with motor preparation and processing in 20 premanifest (pre-HD), 14 symptomatic HD (symp-HD), and 17 healthy controls. Participants performed sequential tapping within two experimental paradigms (simple tapping; Go/NoGo). RP and CNV potentials were calculated separately for each group. Results Motor components and behavioural measures did not distinguish pre-HD from controls. Compared to controls and pre-HD, symp-HD demonstrated significantly reduced relative amplitude and latency of the RP, whereas controls and pre-HD did not differ. However, early CNV was found to significantly differ between control and pre-HD groups, due to enhanced early CNV in pre-HD. Conclusions For the first time, we provide evidence of atypical activation during preparatory processing in pre-HD. The increased activation during this early stage of the disease may reflect ancillary processing in the form of recruitment of additional neural resources for adequate motor preparation, despite atrophic disruption to structure and circuitry. We propose an early adaptive compensation mechanism in pre-HD during motor preparation.	[Turner, Lauren M.; Apthorp, Deborah] Australian Natl Univ, Res Sch Psychol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Croft, Rodney J.; Apthorp, Deborah] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Croft, Rodney J.; Apthorp, Deborah] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Churchyard, Andrew; Georgiou-Karistianis, Nellie] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Churchyard, Andrew] Calvary Hlth Care Bethlehem Hosp, Caulfield, Vic, Australia; [Looi, Jeffrey C. L.] Australian Natl Univ, Sch Med, Canberra Hosp, Res Ctr Neurosci Ageing,Acad Unit Psychiat & Med, Canberra, ACT, Australia; [Looi, Jeffrey C. L.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia	Australian National University; University of Wollongong; University of Wollongong; Monash University; Australian National University; Canberra Hospital; University of Melbourne	Turner, LM (corresponding author), Australian Natl Univ, Res Sch Psychol, Coll Med Biol & Environm, Canberra, ACT, Australia.	lauren.turner@anu.edu.au	Georgiou-Karistianis, Nellie/ABC-5623-2020; Apthorp, Deborah/N-5623-2014	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Apthorp, Deborah/0000-0001-5785-024X; Looi, Jeffrey/0000-0003-3351-6911; Croft, Rodney/0000-0002-5986-9136				Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; Bartenstein P, 1997, BRAIN, V120, P1553, DOI 10.1093/brain/120.9.1553; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beste C, 2008, NEUROPSYCHOLOGIA, V46, P1290, DOI 10.1016/j.neuropsychologia.2007.12.008; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Beste C, 2011, NEUROPSYCHOLOGIA, V49, P3484, DOI 10.1016/j.neuropsychologia.2011.08.024; Beste C, 2009, EXP NEUROL, V216, P148, DOI 10.1016/j.expneurol.2008.11.018; Brandt J., 1992, CLIN NEUROPSYCHOL, V5, P125; Campodonico JR, 1996, J NEUROL NEUROSUR PS, V61, P621, DOI 10.1136/jnnp.61.6.621; Croft RJ, 2000, CLIN NEUROPHYSIOL, V111, P444, DOI 10.1016/S1388-2457(99)00296-5; Cunnington R, 1999, MOVEMENT DISORD, V14, P63; de Tommaso M, 2007, J NEUROL SCI, V254, P84, DOI 10.1016/j.jns.2007.01.011; Dominguez D JF, 2013, PLOS ONE, V8, P1; Farrow M, 2006, COGN BEHAV NEUROL, V19, P208, DOI 10.1097/01.wnn.0000213914.64772.b6; Feigin A, 2006, ANN NEUROL, V59, P53, DOI 10.1002/ana.20684; FEVE A, 1994, J NEUROL NEUROSUR PS, V57, P100, DOI 10.1136/jnnp.57.1.100; Gavazzi C, 2007, J COMPUT ASSIST TOMO, V31, P574, DOI 10.1097/01.rct.0000284390.53202.2e; Georgiou-Karistianis N, 2013, NEUROBIOL DIS, V51, P82, DOI 10.1016/j.nbd.2012.10.001; Georgiou-Karistianis N, 2014, HUM BRAIN MAPP, V35, P1847, DOI 10.1002/hbm.22296; Georgiou-Karistianis N, 2013, BRAIN COGNITION, V83, P80, DOI 10.1016/j.bandc.2013.07.004; GIORDANI B, 1995, ARCH NEUROL-CHICAGO, V52, P59, DOI 10.1001/archneur.1995.00540250063014; Gordon AM, 2000, EXP NEUROL, V163, P136, DOI 10.1006/exnr.2000.7348; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Ikeda A, 1997, ELECTROEN CLIN NEURO, V102, P142, DOI 10.1016/S0921-884X(96)95067-5; Johnson KA, 2001, EXP BRAIN RES, V138, P492, DOI 10.1007/s002210100733; Johnson KA, 2002, MOVEMENT DISORD, V17, P998, DOI 10.1002/mds.10204; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kloppel S, 2009, BRAIN, V132, P1624, DOI 10.1093/brain/awp081; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Papoutsi M, 2014, MOVEMENT DISORD, V29, P673, DOI 10.1002/mds.25864; Poudel GR, 2015, BRAIN STRUCT FUNCT, V220, P501, DOI 10.1007/s00429-013-0670-z; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Quinn L, 2001, MOVEMENT DISORD, V16, P469, DOI 10.1002/mds.1108; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Weeks RA, 1997, BRAIN, V120, P1569, DOI 10.1093/brain/120.9.1569; Wolf RC, 2008, EXP NEUROL, V213, P137, DOI 10.1016/j.expneurol.2008.05.017	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138563	10.1371/journal.pone.0138563	http://dx.doi.org/10.1371/journal.pone.0138563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406226	Green Published, gold			2022-12-26	WOS:000361800700058
J	Visweswaran, GRR; Gholizadeh, S; Ruiters, MHJ; Molema, G; Kok, RJ; Kamps, JAAM				Visweswaran, Ganesh Ram R.; Gholizadeh, Shima; Ruiters, Marcel H. J.; Molema, Grietje; Kok, Robbert J.; Kamps, Jan. A. A. M.			Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VIVO; O-SOMES; EXPRESSION; DELIVERY; SIRNA; CYTOSKELETON; INFLAMMATION; ANTI-VCAM-1; INHIBITION	Together with mesangial cells, glomerular endothelial cells and the basement membrane, podocytes constitute the glomerular filtration barrier (GFB) of the kidney. Podocytes play a pivotal role in the progression of various kidney-related diseases such as glomerular sclerosis and glomerulonephritis that finally lead to chronic end-stage renal disease. During podocytopathies, the slit-diaphragm connecting the adjacent podocytes are detached leading to severe loss of proteins in the urine. The pathophysiology of podocytopathies makes podocytes a potential and challenging target for nanomedicine development, though there is a lack of known molecular targets for cell selective drug delivery. To identify VCAM-1 as a cell-surface receptor that is suitable for binding and internalization of nanomedicine carrier systems by podocytes, we investigated its expression in the immortalized podocyte cell lines AB8/13 and MPC-5, and in primary podocytes. Gene and protein expression analyses revealed that VCAM-1 expression is increased by podocytes upon TNF alpha-activation for up to 24 h. This was paralleled by anti-VCAM-1 antibody binding to the TNF alpha-activated cells, which can be employed as a ligand to facilitate the uptake of nanocarriers under inflammatory conditions. Hence, we next explored the possibilities of using VCAM-1 as a cell-surface receptor to deliver the potent immunosuppressant rapamycin to TNF alpha-activated podocytes using the lipid-based nanocarrier system Saint-O-Somes. Anti-VCAM-1-rapamycin-SAINT-O-Somes more effectively inhibited the cell migration of AB8/13 cells than free rapamycin and non-targeted rapamycin-SAINT-O-Somes indicating the potential of VCAM-1 targeted drug delivery to podocytes.	[Visweswaran, Ganesh Ram R.; Ruiters, Marcel H. J.; Molema, Grietje; Kamps, Jan. A. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands; [Gholizadeh, Shima; Kok, Robbert J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands	University of Groningen; Utrecht University	Kamps, JAAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands.	j.a.a.m.kamps@umcg.nl	Kok, Robbert/I-9579-2016; Kok, Robbert/AAX-9863-2020	Kok, Robbert/0000-0003-4933-3968; Kok, Robbert/0000-0003-4933-3968; Molema, Grietje/0000-0002-4147-6676	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands;  [03D.07]	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 	Funding: This work is supported by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners (Grant number: project 03D.07), http://www.nanonextnl.nl/.	Adrian JE, 2010, J CONTROL RELEASE, V144, P341, DOI 10.1016/j.jconrel.2010.03.003; Asgeirdottir SA, 2008, AM J PHYSIOL-RENAL, V294, pF554, DOI 10.1152/ajprenal.00391.2007; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Chiang WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011837; Fogo AB, 2011, J CLIN INVEST, V121, P2142, DOI 10.1172/JCI57935; Gao HX, 2009, CYTOKINE, V46, P24, DOI 10.1016/j.cyto.2008.12.001; Haraldsson B, 2009, CURR OPIN NEPHROL HY, V18, P331, DOI 10.1097/MNH.0b013e32832c9dba; Hauser PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009463; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kowalski PS, 2014, J CONTROL RELEASE, V176, P64, DOI 10.1016/j.jconrel.2013.12.029; Kowalski PS, 2013, MOL PHARMACEUT, V10, P3033, DOI 10.1021/mp4001124; Kuldo JM, 2013, J CONTROL RELEASE, V166, P57, DOI 10.1016/j.jconrel.2012.12.016; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ricard I, 1998, EUR J IMMUNOL, V28, P1708, DOI 10.1002/(SICI)1521-4141(199805)28:05<1708::AID-IMMU1708>3.0.CO;2-Y; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sapra P, 2002, CANCER RES, V62, P7190; Siddiqi FS, 2013, DIABETES, V62, P3647, DOI 10.2337/db13-0795; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008	24	23	23	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138870	10.1371/journal.pone.0138870	http://dx.doi.org/10.1371/journal.pone.0138870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407295	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700106
J	Wu, PP; Zheng, J; Huang, TM; Li, DM; Hu, QQ; Cheng, AM; Jiang, ZY; Jiao, LY; Zhao, SQ; Zhang, K				Wu, Panpan; Zheng, Jie; Huang, Tianming; Li, Dianmeng; Hu, Qingqing; Cheng, Anming; Jiang, Zhengyun; Jiao, Luoying; Zhao, Suqing; Zhang, Kun			Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent	PLOS ONE			English	Article							IN-VITRO; CYTOTOXIC ACTIVITY; CONJUGATE APPROACH; DERIVATIVES; DESIGN; MECHANISM; APOPTOSIS; OBESITY	Ursolic acid (UA) is a naturally bioactive compound that possesses potential anti-diabetic activity. The relatively safe and effective molecule intrigued us to further explore and to improve its anti-diabetic activity. In the present study, a series of novel UA analogues was synthesized and their structures were characterized. Their bioactivities against the alpha-glucosidase from baker's yeast were determined in vitro. The results suggested that most of the analogues exhibited significant inhibitory activity, especially analogues 8b and 9b with the IC50 values of 1.27 +/- 0.27 mu M (8b) and 1.28 +/- 0.27 mu M (9b), which were lower than the other analogues and the positive control. The molecular docking and 2D-QSAR studies were carried out to prove that the C-3 hydroxyl could interact with the hydrophobic region of the active pocket and form hydrogen bonds to increase the binding affinity of ligand and the homology modelling protein. Thus, these results will be helpful for understanding the relationship between binding mode and bioactivity and for designing better inhibitors from UA analogues.	[Wu, Panpan; Zheng, Jie; Huang, Tianming; Hu, Qingqing; Cheng, Anming; Jiang, Zhengyun; Jiao, Luoying; Zhao, Suqing; Zhang, Kun] Guangdong Univ Technol, Fac Chem Engn & Light Ind, Dept Pharmaceut Engn, Guangzhou, Peoples R China; [Li, Dianmeng] Guangxi Zhuang Autonomous Reg, Guangxi Inst Bot, Guilin, Peoples R China; [Li, Dianmeng] Chinese Acad Sci, Guilin, Peoples R China	Guangdong University of Technology; Chinese Academy of Sciences	Wu, PP (corresponding author), Guangdong Univ Technol, Fac Chem Engn & Light Ind, Dept Pharmaceut Engn, Guangzhou, Peoples R China.	sqzhao@gdut.edu.cn; kzhang@gdut.edu.cn		Wu, Panpan/0000-0002-6515-0726	National Natural Science Foundation of China [21172046]; Guangdong Province; Ministry of Education [2011B090600033]; Guangzhou Science and Technology Plan [2013Y2-00081]; Guangdong Province Higher Education "Qianbaishi Engineering"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province; Ministry of Education; Guangzhou Science and Technology Plan; Guangdong Province Higher Education "Qianbaishi Engineering"	This study was supported by National Natural Science Foundation of China (Grant No. 21172046). The authors are also grateful to the combination research projects of Guangdong Province and Ministry of Education for financial support (Grant No. 2011B090600033), Guangdong Province Higher Education "Qianbaishi Engineering", and Guangzhou Science and Technology Plan (Grant No. 2013Y2-00081).	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Ali H, 2006, J ETHNOPHARMACOL, V107, P449, DOI 10.1016/j.jep.2006.04.004; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; Bai KK, 2012, BIOORG MED CHEM LETT, V22, P2488, DOI 10.1016/j.bmcl.2012.02.009; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Dong HY, 2015, BIOCHEM PHARMACOL, V93, P151, DOI 10.1016/j.bcp.2014.11.014; Castro AJG, 2015, BBA-GEN SUBJECTS, V1850, P51, DOI 10.1016/j.bbagen.2014.10.001; Gu W, 2015, BIOORG MED CHEM LETT, V25, P554, DOI 10.1016/j.bmcl.2014.12.021; Hua SX, 2015, EUR J MED CHEM, V95, P435, DOI 10.1016/j.ejmech.2015.03.051; Huang TM, 2015, RSC ADV, V5, P44234, DOI 10.1039/c5ra05450h; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Ramirez-Espinosa JJ, 2011, EUR J MED CHEM, V46, P2243, DOI 10.1016/j.ejmech.2011.03.005; Kalani K, 2015, RSC ADV, V5, P32133, DOI 10.1039/c4ra13709d; Kashiwada Y, 2000, J NAT PROD, V63, P1619, DOI 10.1021/np990633v; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085827; Liu Y, 2011, CHEMMEDCHEM, V6, P1654, DOI 10.1002/cmdc.201100149; Ma CM, 2005, EUR J MED CHEM, V40, P582, DOI 10.1016/j.ejmech.2005.01.001; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meng YQ, 2009, BIOORGAN MED CHEM, V17, P848, DOI 10.1016/j.bmc.2008.11.036; Saravanan R, 2006, PHARMACOL REP, V58, P41; Schafer A, 2007, DIABETES RES CLIN PR, V77, P41, DOI 10.1016/j.diabres.2006.10.011; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Song GP, 2015, EUR J MED CHEM, V93, P431, DOI 10.1016/j.ejmech.2015.02.029; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05006; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Worawalai W, 2012, MEDCHEMCOMM, V3, P1466, DOI 10.1039/c2md20227a; Wu PP, 2014, EUR J MED CHEM, V80, P502, DOI 10.1016/j.ejmech.2014.04.073; Wu PP, 2014, MOLECULES, V19, P12559, DOI 10.3390/molecules190812559	33	16	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138767	10.1371/journal.pone.0138767	http://dx.doi.org/10.1371/journal.pone.0138767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406581	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700091
J	Shen, Y; Ding, FH; Zhang, RY; Zhang, Q; Lu, L; Shen, WF				Shen, Ying; Ding, Feng Hua; Zhang, Rui Yan; Zhang, Qi; Lu, Lin; Shen, Wei Feng			Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TYPE-2 DIABETIC-PATIENTS; ANGINA PATIENTS; CATHEPSIN-L; CIRCULATION; ASSOCIATION; LEVEL	Objective We investigated whether and to what extent cystatin C was associated with angiographic coronary collateralization in patients with stable coronary artery disease and chronic total occlusion. Methods Serum levels of cystatin C and high-sensitive C-reactive protein (hsCRP) and glomerular filtration rate (GFR) were determined in 866 patients with stable angina and angiographic total occlusion of at least one major coronary artery. The degree of collaterals supplying the distal aspect of a total occlusion from the contra-lateral vessel was graded as poor (Rentrop score of 0 or 1) or good coronary collateralization (Rentrop score of 2 or 3). Results In total, serum cystatin C was higher in patients with poor collateralization than in those with good collateralization (1.08 +/- 0.32 mg/L vs. 0.90 +/- 0.34 mg/L, P < 0.001), and correlated inversely with Rentrop score (adjusted Spearmen's r = -0.145, P < 0.001). The prevalence of poor coronary collateralization increased stepwise with increasing cystatin C quartiles (P for trend < 0.001). After adjusting for age, gender, risk factors for coronary artery disease, GFR and hsCRP, serum cystatin C >= 0.97 mg/L remained independently associated with poor collateralization (OR 2.374, 95% CI 1.660 similar to 3.396, P < 0.001). The diagnostic value of cystatin C levels for detecting poor coronary collateralization persisted regardless of age, gender, presence or absence of diabetes, hypertension or renal dysfunction. Conclusions Serum cystatin C reflects angiographic coronary collateralization in patients with stable coronary artery disease, and cystatin C >= 0.97 mg/L indicates a great risk of poor coronary collaterals.	[Shen, Ying; Ding, Feng Hua; Zhang, Rui Yan; Zhang, Qi; Lu, Lin; Shen, Wei Feng] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Cardiol, Sch Med, Shanghai 200025, Peoples R China; [Lu, Lin; Shen, Wei Feng] Shanghai Jiao Tong Univ, Inst Cardiovasc Dis, Sch Med, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, WF (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Cardiol, Sch Med, Shanghai 200025, Peoples R China.	rjshenweifeng@126.com	Zhang, Ruiyan/HHC-5329-2022		National Natural Science Foundation of China [81400327]; Science Technology Committee of Shanghai Municipal Government [14ZR1425800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Committee of Shanghai Municipal Government(Science & Technology Commission of Shanghai Municipality (STCSM))	The present work is supported by the National Natural Science Foundation of China (81400327) and Science Technology Committee of Shanghai Municipal Government (14ZR1425800). These funders support the basic and clinical researches in the field of cardiovascular diseases. However, no author received a salary from any of these funders, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Akboga MK, 2014, ATHEROSCLEROSIS, V235, P289, DOI 10.1016/j.atherosclerosis.2014.04.029; Akin F, 2015, ANATOL J CARDIOL, V15, P218, DOI 10.5152/akd.2014.5263; Altin T, 2007, INT HEART J, V48, P435, DOI 10.1536/ihj.48.435; Angelidis C, 2013, CURR TOP MED CHEM, V13, P164, DOI 10.2174/1568026611313020006; Celik T, 2010, INT J CARDIOL, V138, P101, DOI 10.1016/j.ijcard.2008.06.012; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dincer I, 2006, CORONARY ARTERY DIS, V17, P561; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Feng JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057240; Ferraro S, 2011, CLIN CHEM LAB MED, V49, P1397, DOI 10.1515/CCLM.2011.607; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Gavin JR, 1999, DIABETES CARE, V22, pS5; Guray U, 2004, CORONARY ARTERY DIS, V15, P413, DOI 10.1097/00019501-200411000-00008; Hsu PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087001; Hsu PC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-98; Kadi H, 2011, CLIN CARDIOL, V34, P617, DOI 10.1002/clc.20951; Keeley EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021174; Kerner A, 2007, AM J CARDIOL, V99, P509, DOI 10.1016/j.amjcard.2006.08.062; Kobayashi S, 2005, AM J KIDNEY DIS, V45, P275, DOI 10.1053/j.ajkd.2004.09.034; LEVIN DC, 1974, CIRCULATION, V50, P831, DOI 10.1161/01.CIR.50.4.831; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Liu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066907; Lv BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041813; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Meier P, 2012, EUR HEART J, V33, P614, DOI 10.1093/eurheartj/ehr308; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rocic P, 2012, VASC PHARMACOL, V57, P179, DOI 10.1016/j.vph.2012.02.001; Sahinarslan A, 2010, CORONARY ARTERY DIS, V21, P455, DOI 10.1097/MCA.0b013e32833fd29b; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Seiler C, 2003, HEART, V89, P96, DOI 10.1136/heart.89.1.96; Seiler C, 2013, EUR HEART J, V34, P2674, DOI 10.1093/eurheartj/eht195; Shen Y, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000453; Shen Y, 2015, J HYPERTENS, V33, P621, DOI 10.1097/HJH.0000000000000455; Shen Y, 2014, INT J CARDIOL, V174, P203, DOI 10.1016/j.ijcard.2014.03.205; Shen Y, 2014, CHINESE MED J-PEKING, V127, P66, DOI 10.3760/cma.j.issn.0366-6999.20132070; Shen Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-165; Sun Z, 2013, J ZHEJIANG UNIV-SC B, V14, P705, DOI 10.1631/jzus.BQICC704; Taglieri N, 2009, CLIN CHEM, V55, P1932, DOI 10.1373/clinchem.2009.128397; Traupe T, 2010, CIRCULATION, V122, P1210, DOI 10.1161/CIRCULATIONAHA.109.930651; van den Hengel LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061923; van der Hoeven NW, 2013, HEART, V99, P1100, DOI 10.1136/heartjnl-2013-304006; Xie SL, 2011, CLIN RES CARDIOL, V100, P227, DOI 10.1007/s00392-010-0233-8; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; Zhang J, 2010, J INT MED RES, V38, P1389, DOI 10.1177/147323001003800421	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137253	10.1371/journal.pone.0137253	http://dx.doi.org/10.1371/journal.pone.0137253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402227	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100010
J	Wittenbecher, C; di Giuseppe, R; Biemann, R; Menzel, J; Arregui, M; Hoffmann, J; Aleksandrova, K; Boeing, H; Isermann, B; Schulze, MB; Weikert, C				Wittenbecher, Clemens; di Giuseppe, Romina; Biemann, Ronald; Menzel, Juliane; Arregui, Maria; Hoffmann, Juliane; Aleksandrova, Krasimira; Boeing, Heiner; Isermann, Berend; Schulze, Matthias B.; Weikert, Cornelia			Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants	PLOS ONE			English	Article							ADIPOSE-TISSUE; RBP4; RETINOL-BINDING-PROTEIN-4; RISK; DISEASE; KIDNEY; ASSOCIATION; ADIPOKINE; OBESITY	The reliability of single time point measurements of the novel adipokines retinol-binding protein 4 and omentin-1 in the blood has not been evaluated in large samples yet. The present study aimed to assess the amount of biological variation of these two adipokines within individuals. The study sample comprised 207 participants (124 women and 83 men) from Potsdam (Germany) and surrounding areas, with an average age of 56.5 years (SD 4.2). Blood samples were collected from each participant twice, approximately four months apart. Using enzyme linked immunosorbent assays, the concentrations of retinol-binding protein 4 and omentin-1 were determined in EDTA plasma. As indicators of reliability, intraclass correlation coefficients (ICCs) were calculated from the repeated biomarker measurements. The ICCs for repeated retinol-binding protein 4 and omentin-1 measurements were 0.77 (95% CI 0.71, 0.82) and 0.83 (95% CI 0.78, 0.87), respectively, indicating for both adipokines excellent reliability. ICCs were stable across strata according to sex, age, BMI, and blood pressure. Thus, for epidemiological studies it seems reasonable to rely on concentrations of retinol-binding protein 4 and omentin-1 in samples from a single time point if repeated measurements are not available.	[Wittenbecher, Clemens; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Wittenbecher, Clemens; Schulze, Matthias B.] German Ctr Diabet Res DZD, Neuherberg, Germany; [di Giuseppe, Romina; Menzel, Juliane; Arregui, Maria; Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Biemann, Ronald; Hoffmann, Juliane; Isermann, Berend] Univ Magdeburg, Dept Clin Chem & Pathobiochem, D-39106 Magdeburg, Germany; [Aleksandrova, Krasimira; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Weikert, Cornelia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Otto von Guericke University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weikert, C (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany.	Weikert@dife.de	Schulze, Matthias B/AAH-6906-2021	Schulze, Matthias B/0000-0002-0830-5277; Menzel, Juliane/0000-0001-7938-4251; Aleksandrova, Krasimira/0000-0002-1275-1827; Wittenbecher, Clemens/0000-0001-7792-877X; di Giuseppe, Romina/0000-0002-5214-8897	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD, http://www.dzd-ev.de).	Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Chiba M, 2010, ENDOCR J, V57, P811, DOI 10.1507/endocrj.K10E-054; di Giuseppe R, 2012, ANN CLIN BIOCHEM, V49, P542, DOI 10.1258/acb.2012.011273; Frey SK, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-29; Gallo V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001117; Gavi S, 2008, OBESITY, V16, P893, DOI 10.1038/oby.2007.138; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Greulich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059697; Henze A, 2010, BIOCHEM BIOPH RES CO, V393, P79, DOI 10.1016/j.bbrc.2010.01.082; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Hermsdorff HHM, 2011, INFLAMMATION, V34, P161, DOI 10.1007/s10753-010-9219-y; Kelly KR, 2010, OBESITY, V18, P663, DOI 10.1038/oby.2009.328; Lin CJ, 2013, CLIN PEDIATR, V52, P16, DOI 10.1177/0009922812459948; Luft Vivian C., 2013, Rev. bras. epidemiol., V16, P388, DOI 10.1590/S1415-790X2013000200014; Luque-Ramirez M, 2013, HUM REPROD, V28, P1908, DOI 10.1093/humrep/det097; Onur I, 2014, ANGIOLOGY, V65, P896, DOI 10.1177/0003319713511322; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Rocha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078670; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Rosner B., 2010, CENGAGE LEARNING; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Sun L, 2014, J NUTR, V144, P722, DOI 10.3945/jn.113.189860; Sun Q, 2013, CIRCULATION, V127, P1938, DOI 10.1161/CIRCULATIONAHA.113.002073; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004	28	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138480	10.1371/journal.pone.0138480	http://dx.doi.org/10.1371/journal.pone.0138480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402656	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100025
J	Dufeau, DL; Witmer, LM				Dufeau, David L.; Witmer, Lawrence M.			Ontogeny of the Middle-Ear Air-Sinus System in Alligator mississippiensis (Archosauria: Crocodylia)	PLOS ONE			English	Article							AUDITORY RESPONSES; EVOLUTION; INSIGHTS; REGION	Modern crocodylians, including Alligator mississippiensis, have a greatly elaborated system of pneumatic sinuses invading the cranium. These sinuses invade nearly all the bones of the chondrocranium and several bony elements of the splanchnocranium, but patterns of postnatal paratympanic sinus development are poorly understood and documented. Much of crocodylomorph-indeed archosaurian-evolution is characterized by the evolution of various paratympanic air sinuses, the homologies of which are poorly understood due in large part to the fact that individual sinuses tend to become confluent in adults, obscuring underlying patterns. This study seeks to explore the ontogeny of these sinuses primarily to clarify the anatomical relations of the individual sinuses before they become confluent and thus to provide the foundation for later studies testing hypotheses of homology across extant and extinct Archosauria. Ontogeny was assessed using computed tomography in a sample of 13 specimens covering an almost 19-fold increase in head size. The paratympanic sinus system comprises two major inflations of evaginated pharyngeal epithelium: the pharyngotympanic sinus, which communicates with the pharynx via the lateral (true) Eustachian tubes and forms the cavum tympanicum proprium, and the median pharyngeal sinus, which communicates with the pharynx via the median pharyngeal tube. Each of these primary inflations gives rise to a number of secondary inflations that further invade the bones of the skull. The primary sinuses and secondary diverticula are well developed in perinatal individuals of Alligator, but during ontogeny the number and relative volumes of the secondary diverticula are reduced. In addition to describing the morphological ontogeny of this sinus system, we provide some preliminary exploratory analyses of sinus function and allometry, rejecting the hypothesis that changes in the volume of the paratympanic sinuses are simply an allometric function of braincase volume, but instead support the hypothesis that these changes may be a function of the acoustic properties of the middle ear.	[Dufeau, David L.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Dufeau, DL (corresponding author), Marian Univ, Dept Biomed Sci, Coll Osteopath Med, Indianapolis, IN 46222 USA.	ddufeau@marian.edu		Witmer, Lawrence/0000-0002-7610-0118	Sigma Xi; Ohio Center for Ecology and Evolutionary Studies, Ohio University; Jurassic Foundation; United States National Science Foundation [IBN-0343744, IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center	Sigma Xi; Ohio Center for Ecology and Evolutionary Studies, Ohio University; Jurassic Foundation; United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center	DLD acknowledges grants from Sigma Xi, the Ohio Center for Ecology and Evolutionary Studies, Ohio University, and the Jurassic Foundation. LMW acknowledges funding support from the United States National Science Foundation (IBN-0343744, IOB-0517257, IOS-1050154) and the Ohio University Heritage College of Osteopathic Medicine. The Ohio Supercomputing Center also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierman HS, 2014, J EXP BIOL, V217, P1094, DOI 10.1242/jeb.092866; Bierman HS, 2015, HEAR RES; Britton ARC, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P364; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P610, DOI 10.1671/0272-4634(2004)024[0610:ANLCGC]2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Carr CE, 2009, J NEUROSCI, V29, P7978, DOI 10.1523/JNEUROSCI.6154-08.2009; Chapman H. C., 1894, Proceedings of the Academy Philadelphia, P32; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; COLBERT EH, 1946, COPEIA, P12; COLBERT EH, 1946, B AM MUS NAT HIST, V87, P223; Crompton A.W., 1980, P193; Cuvier G., 1824, RECHERCHES OSSEMENTS, P143; Dufeau D, 2009, J VERTEBR PALEONTOL, V29, p90A; Dufeau DL, 2010, J VERTEBR PALEONT S3, V30, p83A; Dufeau DL., 2011, THESIS U MICROFILMS; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Gold MEL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105793; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hasse C., 1873, ANAT STUD HASSE, P17; Helmholz H., 1885, SENSATIONS TONE; Henson V.W. Jr., 1974, P39; HERZOG HA, 1977, Z TIERPSYCHOL, V44, P294; Higgs DM, 2002, J COMP PHYSIOL A, V188, P217, DOI 10.1007/s00359-002-0296-8; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; M?ller H.J., 1963, Z WISS ZOOL, V168, P35; Mechel F.P., 2008, FORMULAS ACOUSTICS; Miall L.C., 1878, SKULL CROCODILE; MULLER FABIOLA, 1967, REV SUISSE ZOOL, V74, P189; Owen R., 1850, PHILOS T ROY SOC LON, V140, P521, DOI [10.1098/rstl.1850.0028, DOI 10.1098/RSTL.1850.0028]; Parker W. K., 1883, Transactions of the Zoological Society, Vxi, P263; Reber SA, 2015, J EXP BIOL, V218, P2442, DOI 10.1242/jeb.119552; Rowe T, 1999, J VERTEBR PALEONTOL, V19, P1, DOI 10.1080/02724634.1999.10011200; Senter P, 2008, J HERPETOL, V42, P354, DOI 10.1670/07-150.1; Simonetta A., 1956, Archivio Italiano di Anatomia e di Embriologia, V61, P335; Simonetta A., 1954, MONIT ZOOL ITAL, V62, P85; Smith TD, 2005, ANAT REC PART A, V285A, P677, DOI 10.1002/ar.a.20209; Stanton MA., 1977, AM NAT, V112, P327; Tarsitano S.F., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V170, P27; TARSITANO SF, 1989, AM ZOOL, V29, P843; Van Beneden E., 1880, ARCH BIOL, V3, P497; WALKER AD, 1990, PHILOS T ROY SOC B, V330, P1, DOI 10.1098/rstb.1990.0185; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Watanabe ME., 1980, THESIS U MICROFILMS; Wever E. G., 1978, THE REPTILE EAR; WEVER EG, 1957, J CELL COMPAR PHYSL, V50, P333, DOI 10.1002/jcp.1030500213; WHETSTONE KN, 1979, NATURE, V279, P234, DOI 10.1038/279234a0; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027	52	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137060	10.1371/journal.pone.0137060	http://dx.doi.org/10.1371/journal.pone.0137060			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398659	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500017
J	Linsley, PS; Chaussabel, D; Speake, C				Linsley, Peter S.; Chaussabel, Damien; Speake, Cate			The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types	PLOS ONE			English	Article							REGULATORY T-CELLS; CLINICAL ACTIVITY; PROGNOSTIC-FACTOR; CANCER; MELANOMA; IPILIMUMAB; LANDSCAPE; MPDL3280A; MODELS	Enhancing pre-existing anti-tumor immunity leads to therapeutic benefit for some patients, but why some tumors are more immunogenic than others remains unresolved. We took a unique systems approach to relate patient survival to immune gene expression in >3,500 tumor RNAseq profiles from a dozen tumor types. We found significant links between immune gene expression and patient survival in 8/12 tumor types, with tumors partitioned by gene expression comprising distinct molecular subtypes. T/NK cell genes were most clearly survival-related for melanoma, head and neck, and bladder tumors, whereas myeloid cell genes were most clearly survival-related with kidney and breast tumors. T/NK or myeloid cell gene expression was linked to poor prognosis in bladder and kidney tumors, respectively, suggesting tumor-specific immunosuppressive checkpoints. Our results suggest new biomarkers for existing cancer immunotherapies and identify targets for new immunotherapies.	[Linsley, Peter S.; Chaussabel, Damien; Speake, Cate] Benaroya Res Inst, Dept Syst Immunol, 1201 Ninth Ave, Seattle, WA 98101 USA	Benaroya Research Institute	Linsley, PS (corresponding author), Benaroya Res Inst, Dept Syst Immunol, 1201 Ninth Ave, Seattle, WA 98101 USA.	plinsley@benaroyaresearch.org	Chaussabel, Damien/AAX-1909-2020	Chaussabel, Damien/0000-0002-6131-7242; Speake, Cate/0000-0003-1480-4272				Abhijit Thomas G, 2011, ENHANCED KAPLAN MEIE; Acharya UH, 2013, CLIN PHARMACOL-ADV A, V5, P21, DOI 10.2147/CPAA.S45884; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Beck AH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002875; Benz CC, 2014, CELL, V158, P929, DOI [10.1016/j.cell.2014.06.049, DOI 10.1016/J.CELL.2014.06.049]; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Galluzzi L, 2014, ONCOTARGET, V5, P12472, DOI 10.18632/oncotarget.2998; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; Keskin S, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-95; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Linsley PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109760; Loskog A, 2007, J UROLOGY, V177, P353, DOI 10.1016/j.juro.2006.08.078; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Minarik I, 2013, IMMUNOL LETT, V152, P144, DOI 10.1016/j.imlet.2013.05.010; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Montojo Jason, 2014, F1000Res, V3, P153, DOI 10.12688/f1000research.4572.1; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Quaglino P, 2010, ANN ONCOL, V21, P409, DOI 10.1093/annonc/mdp325; R Core Team, 2013, LANG ENV STAT COMP; Rotondo R, 2011, J LEUKOCYTE BIOL, V89, P721, DOI 10.1189/jlb.1109737; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Terry M, 2000, MODELING SURVIVAL DA; Therneau T, PACKAGE SURVIVAL ANA; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Wolchok JD, 2014, NATURE, V515, P496, DOI 10.1038/515496a; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	51	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138726	10.1371/journal.pone.0138726	http://dx.doi.org/10.1371/journal.pone.0138726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398410	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500099
J	Ma, XD; Ma, J; Zhai, HH; Xin, PY; Chu, JF; Qiao, YL; Han, LZ				Ma, Xiaoding; Ma, Jian; Zhai, Honghong; Xin, Peiyong; Chu, Jinfang; Qiao, Yongli; Han, Longzhi			CHR729 Is a CHD3 Protein That Controls Seedling Development in Rice	PLOS ONE			English	Article							CHROMATIN-REMODELING FACTOR; SSR MARKERS; GIBBERELLIN; ETHYLENE; GENE; PICKLE; EIN2; TRIMETHYLATION; INVOLVEMENT; EFFICIENT	CHD3 is one of the chromatin-remodeling factors that contribute to controlling the expression of genes associated with plant development. Loss-of-function mutants display morphological and growth defects. However, the molecular mechanisms underlying CHD3 regulation of plant development remain unclear. In this study, a rice CHD3 protein, CHR729, was identified. The corresponding mutant line (t483) exhibited late seed germination, low germination rate, dwarfism, low tiller number, root growth inhibition, adaxial albino leaves, and short and narrow leaves. CHR729 encoded a nuclear protein and was expressed in almost all organs. RNA-sequencing analysis showed that several plant hormone-related genes were up- or down-regulated in t483 compared to wild type. In particular, expression of the gibberellin synthetase gibberellin 20 oxidase 4 gene was elevated in the mutant. Endogenous gibberellin assays demonstrated that the content of bioactive GA(3) was reduced in t483 compared to wild type. Moreover, the seedling dwarfism, late seed germination, and short root length phenotypes of t483 were partially rescued by treatment with exogenous GA3. These results suggest that the rice CHD3 protein CHR729 plays an important role in many aspects of seedling development and controls this development via the gibberellin pathway.	[Ma, Xiaoding; Qiao, Yongli; Han, Longzhi] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhai, Honghong] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Ma, Jian] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Minist Agr, Key Lab Biol & Genet Improvement Hort Crops North, Beijing, Peoples R China; [Xin, Peiyong; Chu, Jinfang] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Han, LZ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	hanlongzhi@caas.cn			National Key Technology Research and Development Program of China [2013BAD01B02-2, 2013BAD01B0101-02]; CAAS Science and Technology Innovation Program; Platform of National Crop Germplasm Resources; Protective Program of Crop Germplasm of China [2014NWB030-01]; International Cooperation Project from National Institute of Crop Science, RDA [PJ008685]; CAS Key Technology Talent Program	National Key Technology Research and Development Program of China(National Key Technology R&D Program); CAAS Science and Technology Innovation Program; Platform of National Crop Germplasm Resources; Protective Program of Crop Germplasm of China; International Cooperation Project from National Institute of Crop Science, RDA; CAS Key Technology Talent Program	This work was supported by National Key Technology Research and Development Program of China (2013BAD01B02-2, 2013BAD01B0101-02), CAAS Science and Technology Innovation Program, Platform of National Crop Germplasm Resources, Protective Program of Crop Germplasm of China (2014NWB030-01), International Cooperation Project from National Institute of Crop Science, RDA (PJ008685), and CAS Key Technology Talent Program.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Aichinger E, 2011, PLANT CELL, V23, P1047, DOI 10.1105/tpc.111.083352; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Han MJ, 2011, MOL CELLS, V31, P523, DOI 10.1007/s10059-011-2321-7; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirose F, 2012, PLANT CELL PHYSIOL, V53, P1570, DOI 10.1093/pcp/pcs097; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hu YF, 2012, P NATL ACAD SCI USA, V109, P5773, DOI 10.1073/pnas.1203148109; Hubbard L, 2002, GENETICS, V162, P1927; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kang HG, 1998, PLANT MOL BIOL, V38, P1021, DOI 10.1023/A:1006051911291; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Mao BG, 2012, PLANTA, V235, P39, DOI 10.1007/s00425-011-1481-1; Matilla AJ, 2008, PLANT SCI, V175, P87, DOI 10.1016/j.plantsci.2008.01.014; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; McCouch SR, 2002, DNA RES, V9, P257, DOI 10.1093/dnares/9.6.257; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Murawska M, 2008, MOL CELL BIOL, V28, P2745, DOI 10.1128/MCB.01839-07; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oikawa T, 2004, PLANT MOL BIOL, V55, P687, DOI 10.1007/s11103-004-1692-y; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qin X, 2013, MOL PLANT MICROBE IN, V26, P227, DOI 10.1094/MPMI-05-12-0138-R; Rentzsch S, 2012, PLANTA, V235, P137, DOI 10.1007/s00425-011-1501-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Shimono Y, 2003, J BIOL CHEM, V278, P51638, DOI 10.1074/jbc.M309198200; Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713; Stoutjesdijk PA, 2002, PLANT PHYSIOL, V129, P1723, DOI 10.1104/pp.006353; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Vandenbussche F, 2007, J PLANT GROWTH REGUL, V26, P178, DOI 10.1007/s00344-007-9001-z; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zhang H, 2012, PLANT PHYSIOL, V159, P418, DOI 10.1104/pp.112.194878; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhao CF, 2012, PLANTA, V236, P1165, DOI 10.1007/s00425-012-1667-1	52	25	31	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138934	10.1371/journal.pone.0138934	http://dx.doi.org/10.1371/journal.pone.0138934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398683	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500129
J	Molnar, B; Fattebert, J; Palme, R; Ciucci, P; Betschart, B; Smith, DW; Diehl, PA				Molnar, Barbara; Fattebert, Julien; Palme, Rupert; Ciucci, Paolo; Betschart, Bruno; Smith, Douglas W.; Diehl, Peter-Allan			Environmental and Intrinsic Correlates of Stress in Free-Ranging Wolves	PLOS ONE			English	Article							PITUITARY-ADRENAL RESPONSES; FECAL GLUCOCORTICOID LEVELS; CORTISOL METABOLITES; REPRODUCTIVE OUTPUT; URINARY CORTISOL; SOCIAL-BEHAVIOR; WILD POPULATION; ECOLOGY; MAMMALS; CANIS	Background When confronted with a stressor, animals react with several physiological and behavioral responses. Although sustained or repeated stress can result in severe deleterious physiological effects, the causes of stress in free-ranging animals are yet poorly documented. In our study, we aimed at identifying the main factors affecting stress levels in free-ranging wolves (Canis lupus). Methodology/Principal Findings We used fecal cortisol metabolites (FCM) as an index of stress, after validating the method for its application in wolves. We analyzed a total of 450 fecal samples from eleven wolf packs belonging to three protected populations, in Italy (Abruzzo), France (Mercantour), and the United States (Yellowstone). We collected samples during two consecutive winters in each study area. We found no relationship between FCM concentrations and age, sex or social status of individuals. At the group level, our results suggest that breeding pair permanency and the loss of pack members through processes different from dispersal may importantly impact stress levels in wolves. We measured higher FCM levels in comparatively small packs living in sympatry with a population of free-ranging dogs. Lastly, our results indicate that FCM concentrations are associated with endoparasitic infections of individuals. Conclusions/Significance In social mammals sharing strong bonds among group members, the death of one or several members of the group most likely induces important stress in the remainder of the social unit. The potential impact of social and territorial stability on stress levels should be further investigated in free-ranging populations, especially in highly social and in territorial species. As persistent or repeated stressors may facilitate or induce pathologies and physiological alterations that can affect survival and fitness, we advocate considering the potential impact of anthropogenic causes of stress in management and conservation programs regarding wolves and other wildlife.	[Molnar, Barbara; Betschart, Bruno; Diehl, Peter-Allan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Fattebert, Julien] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Palme, Rupert] Vetmeduni, Unit Physiol Pathophysiol & Expt Endocrinol, Dept Biomed Sci, Vienna, Austria; [Ciucci, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol, I-00185 Rome, Italy; [Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA	University of Neuchatel; University of Kwazulu Natal; Sapienza University Rome; United States Department of the Interior	Molnar, B (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	bmolnar17@gmail.com	Ciucci, Paolo/C-7677-2009; Palme, Rupert/A-3499-2008; Fattebert, Julien/I-8126-2019	Ciucci, Paolo/0000-0002-0994-3422; Palme, Rupert/0000-0001-9466-3662; Fattebert, Julien/0000-0001-5510-6804; BETSCHART, Bruno/0000-0001-6057-9374	Institute of Biology of the University of Neuchatel, Switzerland; Fondation Gerard Pierre; Fondation Pierre Mercier pour la Science; Fond Wuthrich et Mathey-Dupraz	Institute of Biology of the University of Neuchatel, Switzerland; Fondation Gerard Pierre; Fondation Pierre Mercier pour la Science; Fond Wuthrich et Mathey-Dupraz	Funding was provided by the Institute of Biology of the University of Neuchatel, Switzerland, the Fondation Gerard Pierre, the Fondation Pierre Mercier pour la Science (to R. Bshary) and the Fond Wuthrich et Mathey-Dupraz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Anestis SF, 2005, BEHAVIOUR, V142, P1245, DOI 10.1163/156853905774539418; [Anonymous], 2014, R LANG ENV STAT COMP; Aureli Filippo, 2000, P199; Baan C, 2014, ANIM BEHAV, V90, P327, DOI 10.1016/j.anbehav.2014.01.033; Bailenger J., 1982, COPROLOGIE PARASITAI; Bangs EE, 2005, CONSERV BIOL SER, V9, P340; Barja I, 2008, J CHEM ECOL, V34, P697, DOI 10.1007/s10886-008-9460-0; Barton K., 2013, MUMIN MULTIMODEL INF; Berger Joel, 2005, P100; Boggiano F, 2013, MAMM BIOL, V78, P374, DOI 10.1016/j.mambio.2013.06.001; Boitani L., 1995, P217; Boitani L, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P147, DOI 10.1079/9781845931872.0147; Boitani Luigi, 2003, P317; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Bowman D. D., 2000, COMPANION EXOTIC ANI, P1; Bowman DD., 2009, GEORGISPARASITOLOGY, V10th; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL BG, 1991, COMP CONT EDUC PRACT, V13, P769; Ciucci P, 2007, J ZOOL, V273, P125, DOI 10.1111/j.1469-7998.2007.00379.x; Ciucci P., 1994, THESIS U ROME; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot021; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dantzer B, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou023; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; DeVries AC, 2003, PHYSIOL BEHAV, V79, P399, DOI 10.1016/S0031-9384(03)00152-5; Duchamp C, 2012, HYSTRIX, V23, P14, DOI 10.4404/hystrix-23.1-4559; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Ewing S.A., 1986, VET CLIN PATHOL, P374; Foreyt W.J, 2001, VET PARASITOLOGY REF, V5th; Fuller Todd K., 2003, P161; Ganong WF, 1995, REV MED PHYSL, P327; Garcia LS, 1979, DIAGNOSITC PARASITOL; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Grottoli L., 2011, THESIS U ROME; Hennessy MB, 1997, NEUROSCI BIOBEHAV R, V21, P11, DOI 10.1016/S0149-7634(96)00013-9; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Houard Thierry, 1994, Riviera Scientifique, V1993, P61; Jachowski DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031818; Kersey DC, 2014, GEN COMP ENDOCR, V203, P296, DOI 10.1016/j.ygcen.2014.04.022; Kreeger Terry J., 2003, P192; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Maiorano L, 2015, EUR J WILDLIFE RES, V61, P241, DOI 10.1007/s10344-014-0894-0; Mason WA, 1998, PSYCHONEUROENDOCRINO, V23, P765; McLeod PJ, 1996, CAN J ZOOL, V74, P209, DOI 10.1139/z96-026; Mech L. David, 2003, P1; Mech LD, 1970, WOLF ECOLOGY BEHAV E, P304; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Metz MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017332; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Molinari-Jobin A, 2012, ANIM CONSERV, V15, P266, DOI 10.1111/j.1469-1795.2011.00511.x; Molnar B, 2014, EUR J WILDLIFE RES, V60, P613, DOI 10.1007/s10344-014-0825-0; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Nowak RM, 2005, WALKERS CARNIVORES W, P70; Olsson K, 2003, ACTA PHYSIOL SCAND, V179, P281, DOI 10.1046/j.0001-6772.2003.01178.x; [ONCFS Reseau Loup/Lynx ONCFS Reseau grands carnivores loup-lynx], B INF RESEAU LOUP, V15, P13; ONCFS Reseau Loup/Lynx, 2006, B INF RESEAU LOUP, V16, P12; ONCFS Reseau Loup/Lynx, 2007, B INF RESEAU LOUP, V17, P10; ONCFS Reseau Loup/Lynx, 2004, B INF RESEAU LOUP, V12, P9; Orihel, 1987, PARASITES GUIDE LAB; Packard Jane M., 2003, P35; Packard Jane M., 2012, P1; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Palme R, 1997, Z SAUGETIERKD, V62, P192; Palme R, 2001, DEUT TIERARZTL WOCH, V108, P23; Paquet PC, 2010, ANIM WELFARE, V19, P177; Patt A, 2013, APPL ANIM BEHAV SCI, V144, P63, DOI 10.1016/j.applanim.2012.11.009; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pence D. B., 1981, Worldwide furbearer conference proceedings, 3-11 August, 1980, Frostburg, Maryland, USA. Volume II., P760; Pratelli A, 2008, VET J, V177, P71, DOI 10.1016/j.tvjl.2007.03.019; Pride E, 2005, BEHAV ECOL, V16, P550, DOI 10.1093/beheco/ari025; Pride RE, 2005, BIOL LETT-UK, V1, P60, DOI 10.1098/rsbl.2004.0245; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Rehnus M, 2014, J APPL ECOL, V51, P6, DOI 10.1111/1365-2664.12174; Reimers TJ, 1984, BIOL REPROD; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; Sapolsky R. M., 2004, WHY ZEBRAS DONT GET, P1; SAPOLSKY RM, 1993, RECENT PROG HORM RES, V48, P437; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Sapolsky RM, 2004, WHY ZEBRAS DONT GET, P144; Sapolsky RM, 2004, WHY ZEBRAS DONT GET, P353; Sapolsky RM, 2004, WHY ZEBRAS DONT GET, P309; Schatz S, 2001, VET RES COMMUN, V25, P271, DOI 10.1023/A:1010626608498; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Seal U.S., 1987, Perspectives in Vertebrate Science, V4, P109; SELYE H, 1973, AM SCI, V61, P692; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Smith D, 1997, BEHAV ECOL, V8, P384, DOI 10.1093/beheco/8.4.384; Smith Douglas W., 2009, P92, DOI 10.1002/9781444312034.ch5; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Smith DW, YELLOWSTONE WOLF PRO; Stahler DR, 2002, CAN J ZOOL, V80, P360, DOI 10.1139/Z01-223; Thienpont D., 1979, DIAGNOSTIC VERMINOSE; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-62; TRUANT AL, 1981, J CLIN MICROBIOL, V13, P882, DOI 10.1128/JCM.13.5.882-884.1981; Uga S, 2000, VET PARASITOL, V92, P287, DOI 10.1016/S0304-4017(00)00323-X; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vandel JM, 2005, MAMMALIA, V69, P145, DOI 10.1515/mamm.2005.013; Viau V, 1996, J NEUROSCI, V16, P1866; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.3.CO;2-T; von der Ohe CG, 2002, WILDLIFE SOC B, V30, P1215; Vonholdt BM, 2007, MOL ECOL, DOI [10.1111/j.1365-294X.2007, DOI 10.1111/J.1365-294X.2007]; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; Wey TW, 2015, ACTA ETHOL, V18, P181, DOI 10.1007/s10211-014-0204-6; Wielebnowski N, 2013, ISR J ECOL EVOL, V53, P439; Wingfield JC, 1997, ARDEA, V85, P155; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; YANG J, 1977, AM J CLIN PATHOL, V67, P300	127	19	19	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137378	10.1371/journal.pone.0137378	http://dx.doi.org/10.1371/journal.pone.0137378			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398784	gold, Green Published			2022-12-26	WOS:000361797500032
J	Cho, SM; Jeoung, SC; Song, JY; Kupriyanova, EV; Pronina, NA; Lee, BW; Jo, SW; Park, BS; Choi, SB; Song, JJ; Park, YI				Cho, Sung Mi; Jeoung, Sae Chae; Song, Ji-Young; Kupriyanova, Elena V.; Pronina, Natalia A.; Lee, Bong-Woo; Jo, Seong-Whan; Park, Beom-Seok; Choi, Sang-Bong; Song, Ji-Joon; Park, Youn-Il			Genomic Survey and Biochemical Analysis of Recombinant Candidate Cyanobacteriochromes Reveals Enrichment for Near UV/Violet Sensors in the Halotolerant and Alkaliphilic Cyanobacterium Microcoleus IPPAS B353	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAF DOMAIN; LIGHT RECEPTOR; PHYTOCHROME; BLUE; PHOTOCONVERSION; CHROMOPHORE; PHOTOTAXIS; TEPIXJ; MULTICELLULARITY	Cyanobacteriochromes (CBCRs), which are exclusive to and widespread among cyanobacteria, are photoproteins that sense the entire range of near-UV and visible light. CBCRs are related to the red/far-red phytochromes that utilize linear tetrapyrrole (bilin) chromophores. Best characterized from the unicellular cyanobacterium Synechocystis sp. PCC 6803 and the multicellular heterocyst forming filamentous cyanobacteria Nostoc punctiforme ATCC 29133 and Anabaena sp. PCC 7120, CBCRs have been poorly investigated in mat-forming, nonheterocystous cyanobacteria. In this study, we sequenced the genome of one of such species, Microcoleus IPPAS B353 (Microcoleus B353), and identified two phytochromes and seven CBCRs with one or more bilin-binding cGMP-specific phosphodiesterase, adenylyl cyclase and FhlA (GAF) domains. Biochemical and spectroscopic measurements of 23 purified GAF proteins from phycocyanobilin (PCB) producing recombinant Escherichia coli indicated that 13 of these proteins formed near-UV and visible light-absorbing covalent adducts: 10 GAFs containedPCBchromophores, whereas three contained the PCB isomer, phycoviolobilin (PVB). Furthermore, the complement of Microcoleus B353 CBCRs is enriched in near-UV and violet sensors, but lacks red/green and green/red CBCRs that are widely distributed in other cyanobacteria. We hypothesize that enrichment in short wavelength-absorbing CBCRs is critical for acclimation to highlight environments where this organism is found.	[Cho, Sung Mi; Song, Ji-Young; Park, Youn-Il] Chungnam Natl Univ, Dept Biol Sci, Daejeon 305764, South Korea; [Jeoung, Sae Chae] Korea Res Inst Stand & Sci, Ctr Adv Measurement & Instrumentat, Daejeon 305340, South Korea; [Kupriyanova, Elena V.; Pronina, Natalia A.] Russian Acad Sci, Inst Plant Physiol, Moscow 127276, Russia; [Lee, Bong-Woo; Jo, Seong-Whan] Seeders Inc, Daejeon 305509, South Korea; [Park, Beom-Seok] Rural Dev Adm, Natl Acad Agr Sci, Agr Genome Ctr, Wonju 565851, South Korea; [Choi, Sang-Bong] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin 449728, South Korea; [Song, Ji-Joon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea	Chungnam National University; Korea Research Institute of Standards & Science (KRISS); Russian Academy of Sciences; Timiryazev Institute of Plant Physiology; Rural Development Administration (RDA); Myongji University; Korea Advanced Institute of Science & Technology (KAIST)	Park, YI (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Daejeon 305764, South Korea.	yipark@cnu.ac.kr	Park, Youn-Il/S-2997-2019; Song, Ji-Joon/C-1721-2011	Park, Youn-Il/0000-0003-2912-2821; Song, Ji-Young/0000-0003-3964-1094; Jeoung, Sae Chae/0000-0001-5978-9286; Cho, Sung Mi/0000-0001-5414-7727	Next-Generation BioGreen 21 Program, Rural Development Administration [PJ011659]; Advanced Biomass R&D Center (ABC) of Korea - Ministry of Science, ICT, and Future Planning, Korea [NRF-2011-0031344]; Russian Science Foundation [14-24-00020] Funding Source: Russian Science Foundation	Next-Generation BioGreen 21 Program, Rural Development Administration; Advanced Biomass R&D Center (ABC) of Korea - Ministry of Science, ICT, and Future Planning, Korea; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by grants from the Next-Generation BioGreen 21 Program, Rural Development Administration Grant PJ011659, and the Advanced Biomass R&D Center (ABC) of Korea Grant NRF-2011-0031344, funded by the Ministry of Science, ICT, and Future Planning, Korea (to Y-I. P.). The authors declare that they have no conflicts of interest related to the contents of this article.	Anders K, 2014, J BIOL CHEM, V289, P25590, DOI 10.1074/jbc.M114.562082; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Campbell EL, 2015, J BACTERIOL, V197, P782, DOI 10.1128/JB.02374-14; Castenholz R. W., 1989, BERGEYS MANUAL SYSTE, V3, P1710; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Enomoto G, 2012, BIOCHEMISTRY-US, V51, P3050, DOI 10.1021/bi300020u; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hirose Y, 2008, P NATL ACAD SCI USA, V105, P9528, DOI 10.1073/pnas.0801826105; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Hirose Y, 2010, P NATL ACAD SCI USA, V107, P8854, DOI 10.1073/pnas.1000177107; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kompantseva E I, 2005, Mikrobiologiia, V74, P410; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lim S, 2014, PHOTOCH PHOTOBIO SCI, V13, P951, DOI 10.1039/c3pp50442e; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2013, PLANT CELL PHYSIOL, V54, P171, DOI 10.1093/pcp/pcs173; MYERS J, 1980, PLANT PHYSIOL, V66, P1144, DOI 10.1104/pp.66.6.1144; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Narikawa R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07950; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Raffelberg S, 2013, BIOCHEM J, V455, P359, DOI 10.1042/BJ20130637; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2015, BIOCHEMISTRY-US, V54, P3772, DOI 10.1021/acs.biochem.5b00438; Rockwell NC, 2015, PHOTOCH PHOTOBIO SCI, V14, P929, DOI 10.1039/c4pp00486h; Rockwell NC, 2015, BIOCHEMISTRY-US, V54, P2581, DOI 10.1021/bi501548t; Rockwell NC, 2015, PHOTOCH PHOTOBIO SCI, V14, P258, DOI 10.1039/c4pp00336e; Rockwell NC, 2014, BIOCHEMISTRY-US, V53, P3118, DOI 10.1021/bi500037a; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Ryu JY, 2010, PLANT BIOTECHNOL REP, V4, P149, DOI 10.1007/s11816-010-0130-7; Ryu JY, 2004, J BIOL CHEM, V279, P25320, DOI 10.1074/jbc.M402541200; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Sergeev V. N., 2002, Mikrobiologiya, V71, P725; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Sun YF, 2014, PHOTOCH PHOTOBIO SCI, V13, P757, DOI 10.1039/c3pp50411e; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xu XL, 2014, CHEMBIOCHEM, V15, P1190, DOI 10.1002/cbic.201400053; Yang EC, 2012, PROTIST, V163, P217, DOI 10.1016/j.protis.2011.08.001; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Yoshihara S, 2002, PLANT CELL PHYSIOL, V43, P513, DOI 10.1093/pcp/pcf061; Zavarzin GA, 2003, MICROBIOLOGY+, V72, P80, DOI 10.1023/A:1022234208175; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548	67	28	28	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28502	28514		10.1074/jbc.M115.669150	http://dx.doi.org/10.1074/jbc.M115.669150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405033	hybrid, Green Published			2022-12-26	WOS:000365761900043
J	Jiang, H; Wang, WW; Zhang, Y; Yao, WW; Jiang, JY; Qin, B; Yao, WY; Liu, FS; Wu, HH; Ward, TL; Chen, CW; Liu, LF; Ding, X; Liu, X; Yao, XB				Jiang, Hao; Wang, Wenwen; Zhang, Yin; Yao, William W.; Jiang, Jiying; Qin, Bo; Yao, Wendy Y.; Liu, Fusheng; Wu, Huihui; Ward, Tarsha L.; Chen, Chun Wei; Liu, Lifang; Ding, Xia; Liu, Xing; Yao, Xuebiao			Cell Polarity Kinase MST4 Cooperates with cAMP-dependent Kinase to Orchestrate Histamine-stimulated Acid Secretion in Gastric Parietal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE; 80-KDA PHOSPHOPROTEIN; ERM PROTEINS; SYNTAXIN 3; EZRIN; PHOSPHORYLATION; ACTIVATION; LOCALIZATION; AURORA; CORTEX	The digestive function of the stomach depends on acidification of the gastric lumen. Acid secretion into the lumen is triggered by activation of the PKA cascade, which ultimately results in the insertion of gastric H,K-ATPases into the apical plasma membranes of parietal cells. A coupling protein is ezrin, whose phosphorylation at Ser-66 by PKA is required for parietal cell activation. However, little is known regarding the molecular mechanism(s) by which this signaling pathway operates in gastric acid secretion. Here we show that PKA cooperates with MST4 to orchestrate histamine-elicited acid secretion by phosphorylating ezrin at Ser-66 and Thr-567. Histamine stimulation activates PICA, which phosphorylates msT4 at Thr-178 and then promotes MST4 kinase activity. Interestingly, activated MST4 then phosphorylates ezrin prephosphorylated by PKA. Importantly, MST4 is important for acid secretion in parietal cells because either suppression of MST4 or overexpression of non-phosphorylatable MST4 prevents the apical membrane reorganization and proton pump translocation elicited by histamine stimulation. In addition, overexpressing MST4 phosphorylation-deficient ezrin results in an inhibition of gastric acid secretion. Taken together, these results define a novel molecular mechanism linking the PKA-MST4-ezrin signaling cascade to polarized epithelial secretion in gastric parietal cells.	[Jiang, Hao; Wang, Wenwen; Zhang, Yin; Jiang, Jiying; Qin, Bo; Liu, Fusheng; Wu, Huihui; Chen, Chun Wei; Ding, Xia; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam, Hefei 230027, Peoples R China; [Jiang, Hao; Wang, Wenwen; Zhang, Yin; Jiang, Jiying; Qin, Bo; Liu, Fusheng; Wu, Huihui; Chen, Chun Wei; Ding, Xia; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Zhang, Yin; Liu, Fusheng; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wang, Wenwen; Yao, William W.; Qin, Bo; Yao, Wendy Y.; Wu, Huihui; Ward, Tarsha L.; Liu, Xing] Atlanta Clin & Translat Sci Inst, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Liu, Fusheng; Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine	Ding, X (corresponding author), Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam, Hefei 230027, Peoples R China.	dingx@bucm.edu.cn; xing1017@ustc.edu.cn; xyao@msm.edu	Regan, Clinton/E-6250-2012; liu, li/HGC-0900-2022; Yao, Xuebiao/P-5771-2014; WANG, WENWEN/AAF-1080-2020	WANG, WENWEN/0000-0002-1545-4369	Chinese 973 Project [2013CB911203]; Ministry of Education [20113402130010]; Anhui Project Grant [08040102005]; Chinese Natural Science Foundation [31430054, 31271518, 31301105, 31501095, 90508002, 90913016]; National Institutes of Health [CA164133, DK56292]; China Postdoctoral Science Foundation [2014M560517]; Central University [WK2340000032, WK2340000021]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	Chinese 973 Project(National Basic Research Program of China); Ministry of Education; Anhui Project Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Central University; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Chinese 973 Project Grant 2013CB911203; Ministry of Education Grant 20113402130010; Anhui Project Grant 08040102005; Chinese Natural Science Foundation Grants 31430054, 31271518, 31301105, 31501095, 90508002, and 90913016; National Institutes of Health Grants CA164133 and DK56292; China Postdoctoral Science Foundation Grant 2014M560517; and Central University Grants WK2340000032 and WK2340000021. The authors declare that they have no conflicts of interest with the contents of this article.; Visiting scholar sponsored by the China Scholarship Council.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Karvar S, 2002, J BIOL CHEM, V277, P50030, DOI 10.1074/jbc.M207694200; Karvar S, 2002, GASTROENTEROLOGY, V123, P281, DOI 10.1053/gast.2002.34217; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Peng XR, 1997, MOL BIOL CELL, V8, P399, DOI 10.1091/mbc.8.3.399; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; URUSHIDANI T, 1989, AM J PHYSIOL, V256, pG1070, DOI 10.1152/ajpgi.1989.256.6.G1070; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yu HJ, 2014, J BIOL CHEM, V289, P33333, DOI 10.1074/jbc.M114.581280; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	28	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28272	28285		10.1074/jbc.M115.668855	http://dx.doi.org/10.1074/jbc.M115.668855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405038	Green Published, hybrid			2022-12-26	WOS:000365761900020
J	Jiang, PS; Yu, CF; Yen, CY; Woo, CW; Lo, SH; Huang, YK; Hong, JH; Chiang, CS				Jiang, Pei-Shin; Yu, Ching-Fang; Yen, Chia-Yi; Woo, Christopher William; Lo, Shao-Hua; Huang, Yu-Kuan; Hong, Ji-Hong; Chiang, Chi-Shiun			Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ANTIRETROVIRAL DRUG; DELIVERY; HYPOXIA; TISSUES; EXPRESSION; RADIATION; MODEL	The tumor-homing ability of monocytes renders them a potential cellular delivery system for alternative cancer therapies, although their migratory ability can be impaired following reagent uptake. Approaches that enhance monocyte tumor homing and promote their migration will improve the clinical value of these cells as cellular carriers. Previous studies have shown that irradiation (IR) can promote macrophage aggregation in hypoxic regions. To investigate whether IR enhances the infiltration of bone marrow-derived monocytes (BMDMs) into tumors, the infiltration of BMDMs from GFP-transgenic mice in a murine prostate adenocarcinoma TRAMP-C1 model was examined by fluorescence microscopy. IR did not increase the number of BMDMs that infiltrated initially, but did increase monocyte retention within IR-treated tumors for up to 2 weeks. We also showed that BMDMs can take up various imaging and therapeutic agents, although the mobility of BMDMs decreased with increasing load. When BMDMs were differentiated in IR-treated tumor-conditioned medium (IR-CM) in vitro, the nanoparticle load-mediated inhibition of migration was attenuated. These IR-CM-differentiated BMDMs delivered polymer vesicles encapsulating doxorubicin to radiation therapy (RT)-induced hypoxic tumor regions, and enhanced the efficacy of RT. The prolonged retention of monocytes within irradiated tumor tissues and the ability of IRCM to enhance the migratory ability of cargo-laden BMDMs suggest that monocytes preconditioned by IR-CM can potentially act as cellular carriers for targeted therapy following conventional RT.	[Jiang, Pei-Shin; Yen, Chia-Yi; Woo, Christopher William; Lo, Shao-Hua; Huang, Yu-Kuan; Chiang, Chi-Shiun] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Yu, Ching-Fang; Hong, Ji-Hong] Chang Gung Mem Hosp Linkou, Dept Radiat Oncol, Taoyuan, Taiwan; [Yu, Ching-Fang; Hong, Ji-Hong] Chang Gung Univ, Inst Radiol Res, Radiat Biol Res Ctr, Chang Gung Mem Hosp, Taoyuan, Taiwan; [Hong, Ji-Hong] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chiang, CS (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cschiang@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129; HUANG, Yu-Kuan (Tony)/0000-0003-2262-7069	National Science Council, Taiwan [NSC 101-2627-N-007-001]; National Health Research Institute, Taiwan [NHRI-EX100-9827BI]; National Tsing Hua University, Taiwan [102N2767E1]; Chang-Gung Memorial Hospital [CIRPG3D0141, CMRPG3E1301]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Tsing Hua University, Taiwan; Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work is supported by NSC 101-2627-N-007-001, NHRI-EX100-9827BI, and 102N2767E1 from the National Science Council, National Health Research Institute, and National Tsing Hua University, respectively, Taiwan, to Chi-Shiun Chiang, and CIRPG3D0141 and CMRPG3E1301 from Chang-Gung Memorial Hospital to Ji-Hong Hong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2010, NANOMED-NANOTECHNOL, V6, P382, DOI 10.1016/j.nano.2009.10.001; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chen FH, 2011, INT J RADIAT ONCOL, V80, P1512, DOI 10.1016/j.ijrobp.2011.02.055; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; Chen JJ, 2012, MED PHYS, V39, P7490, DOI 10.1118/1.4762683; Chiang CS, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00089; Chiang WH, 2013, J CONTROL RELEASE, V168, P280, DOI 10.1016/j.jconrel.2013.03.029; Choi J, 2012, BIOMATERIALS, V33, P4195, DOI 10.1016/j.biomaterials.2012.02.022; Choi MR, 2007, NANO LETT, V7, P3759, DOI 10.1021/nl072209h; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; FIDLER IJ, 1974, CANCER RES, V34, P1074; GORDON S, 1992, CURR OPIN IMMUNOL, V4, P25, DOI 10.1016/0952-7915(92)90119-Y; Griffiths L, 2000, GENE THER, V7, P255, DOI 10.1038/sj.gt.3301058; Huang WC, 2011, J DRUG TARGET, V19, P944, DOI 10.3109/1061186X.2011.632012; Kang ST, 2011, LANGMUIR, V27, P13183, DOI 10.1021/la203212p; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; MANTOVANI A, 1986, BIOCHIM BIOPHYS ACTA, V865, P59, DOI 10.1016/0304-419X(86)90013-2; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; MEHTA K, 1982, J RETICULOENDOTH SOC, V32, P155; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Muthana M, 2013, CANCER RES, V73, P490, DOI 10.1158/0008-5472.CAN-12-3056; Muthana M, 2011, CANCER RES, V71, P1805, DOI 10.1158/0008-5472.CAN-10-2349; Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; YU CP, 1989, FUND APPL TOXICOL, V13, P452, DOI 10.1016/0272-0590(89)90282-0	29	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139043	10.1371/journal.pone.0139043	http://dx.doi.org/10.1371/journal.pone.0139043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418962	Green Published, gold			2022-12-26	WOS:000362171400037
J	Lambertini, L; Chen, J; Nomura, Y				Lambertini, Luca; Chen, Jia; Nomura, Yoko			Mitochondrial Gene Expression Profiles Are Associated with Maternal Psychosocial Stress in Pregnancy and Infant Temperament	PLOS ONE			English	Article							CHAIN COMPLEX-I; PARENTAL PSYCHOPATHOLOGY; ENDOPLASMIC-RETICULUM; UNCOUPLING PROTEINS; BRAIN-DEVELOPMENT; ANXIETY; DEPRESSION; BEHAVIOR; HEALTH; ROLES	Background Gene-environment interactions mediate through the placenta and shape the fetal brain development. Between the environmental determinants of the fetal brain, maternal psychosocial stress in pregnancy has been shown to negatively influence the infant temperament development. This in turn may have adverse consequences on the infant neurodevelopment extending throughout the entire life-span. However little is known about the underlying biological mechanisms of the effects of maternal psychosocial stress in pregnancy on infant temperament. Environmental stressors such as maternal psychosocial stress in pregnancy activate the stress response cascade that in turn drives the increase in the cellular energy demand of vital organs with high metabolic rates such as, in pregnancy, the placenta. Key players of the stress response cascade are the mitochondria. Results Here, we tested the expression of all 13 protein-coding genes encoded by the mitochondria in 108 placenta samples from the Stress in Pregnancy birth cohort, a study that aims at determining the influence of in utero exposure to maternal psychosocial stress in pregnancy on infant temperament. We showed that the expression of the protein-coding mitochondrial-encoded gene MT-ND2 was positively associated with indices of maternal psychosocial stress in pregnancy including Prenatal Perceived Stress (beta = 0.259; p-regression = 0.004; r(2)-regression = 0.120), State Anxiety (beta = 0.218; p-regression = 0.003; r(2)-regression = 0.153), Trait Anxiety (beta = 0.262; p-regression = 0.003; r(2)-regression = 0.129) and Pregnancy Anxiety Total (beta = 0.208; p-regression = 0.010; r(2)-regression = 0.103). In the meantime MT-ND2 was negatively associated with the infant temperament indices of Activity Level (beta = -0.257; p-regression = 0.008; r(2)-regression = 0.165) and Smile and Laughter (beta = -0.286; p-regression = 0.036; r(2)-regression = 0.082). Additionally, MT-ND6 was associated with the maternal psychosocial stress in pregnancy index of Prenatal Perceived Stress (beta = -0.231; p-regression = 0.004; r(2)-regression = 0.120), while MT-CO2 was associated with the maternal psychosocial stress in pregnancy indices of State Anxiety (beta = 0.206; p-regression = 0.003; r(2)-regression = 0.153) and Trait Anxiety (beta = 0.205; p-regression = 0.003; r(2)-regression = 0.129). Conclusions Our data support the role of mitochondria in responding to maternal psychosocial stress in pregnancy, as assessed in placenta, while also suggesting an important role for the mitochondria in the infant temperament development.	[Lambertini, Luca; Chen, Jia; Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Lambertini, Luca] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Nomura, Yoko] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai	Lambertini, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.	luca.lambertini@mssm.edu		Lambertini, Luca/0000-0003-3326-219X	Venture Capital Research Funding Program of the Mount Sinai Children's Environmental Health Center; Queens College; CUNY Research Enhancement Grant; NIMH [K01 MH080062]; ARRA [K01 MH080062S]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102729, K01MH080062] Funding Source: NIH RePORTER	Venture Capital Research Funding Program of the Mount Sinai Children's Environmental Health Center; Queens College; CUNY Research Enhancement Grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ARRA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Venture Capital Research Funding Program of the Mount Sinai Children's Environmental Health Center, the Queens College, CUNY Research Enhancement Grant, and NIMH grants K01 MH080062 and ARRA supplement K01 MH080062S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton QA, 2012, ADV OVERWEIGHT RES T; Adzic M, 2009, INT J BIOCHEM CELL B, V41, P2181, DOI 10.1016/j.biocel.2009.04.001; ALDORETTA PW, 1995, CLIN PERINATOL, V22, P15; [Anonymous], 2014, J DEPRESS ANXIETY, DOI DOI 10.1186/2193-2697-3-13; Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Belkacemi L, 2011, AM J PHYSIOL-REG I, V301, pR1599, DOI 10.1152/ajpregu.00100.2011; Berdanier CD, 2006, EXP BIOL MED, V231, P1593; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brand SR, 2006, ANN NY ACAD SCI, V1071, P454, DOI 10.1196/annals.1364.041; Buss KA, 2011, DEV COGN NEUROS-NETH, V1, P131, DOI 10.1016/j.dcn.2010.12.003; Callahan Jennifer L, 2002, J Perinatol, V22, P448, DOI 10.1038/sj.jp.7210783; Choe DE, 2013, DEV PSYCHOL, V49, P2245, DOI 10.1037/a0032293; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Dalwadi DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-413; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; Del Giudice M, 2012, PSYCHONEUROENDOCRINO, V37, P1614, DOI 10.1016/j.psyneuen.2012.05.014; DeMier RL, 2000, J CLIN PSYCHOL, V56, P89, DOI 10.1002/(SICI)1097-4679(200001)56:1<89::AID-JCLP8>3.0.CO;2-6; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Ferguson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088606; First M. B., 2007, STRUCTURED CLIN INTE; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; GOLDSMITH HH, 1990, CHILD DEV, V61, P1944, DOI 10.2307/1130849; Gureje O, 2011, MOL PSYCHIATR, V16, P1221, DOI 10.1038/mp.2010.111; Hagekull Berit, 2003, Attach Hum Dev, V5, P2, DOI 10.1080/1461673031000078643; Heininger K, 2002, INT REV NEUROBIOL, V51, P103, DOI 10.1016/S0074-7742(02)51004-7; Hirshfeld-Becker DR, 2012, AM J PSYCHIAT, V169, P1175, DOI 10.1176/appi.ajp.2012.11101514; Holmboe K, 2010, DEV PSYCHOL, V46, P404, DOI 10.1037/a0018180; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; King JE, 2007, STANDARDIZED COEFFIC; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kubera B, 2012, OBESITY FACTS, V5, P384, DOI 10.1159/000339958; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Martinez F, 2012, RECENT ADV RES HUMAN, P397; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mayeur S, 2012, AM J PHYSL ENDOCRINO; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Minamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086036; MOLINA RD, 1990, P SOC EXP BIOL MED, V195, P379, DOI 10.3181/00379727-195-43158AA; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nicholls TJ, 2013, INT J BIOCH CELL BIO; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Nomura Y, 2008, J CHILD PSYCHOL PSYC, V49, P1108, DOI 10.1111/j.1469-7610.2008.01939.x; Nomura Y, 2009, J PEDIATR PSYCHOL, V34, P406, DOI 10.1093/jpepsy/jsn092; Oliva K, 2012, J MOL ENDOCRINOL, V48, P139, DOI 10.1530/JME-11-0123; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Peters A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00074; Petruzzella V, 2012, ADV EXP MED BIOL, V942, P371, DOI 10.1007/978-94-007-2869-1_17; Picard M, 2014, NAT REV ENDOCRINOL, V10, P303, DOI 10.1038/nrendo.2014.22; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Scatena R, 2012, ADV EXP MED BIOL, V942, P1, DOI 10.1007/978-94-007-2869-1; Sluse FE, 2012, ADV EXP MED BIOL, V942, P137, DOI 10.1007/978-94-007-2869-1_6; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Turlejski K, 1996, ACTA NEUROBIOL EXP, V56, P619; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Van Den Bergh BRH, 2006, PEDIATR RES, V59, P78, DOI 10.1203/01.pdr.0000191143.75673.52; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010; Van Den Bergh BRH., 1990, PREPERINAT PSYCHOL J, V5, P119; Vera J, 2012, CHILD PSYCHIAT HUM D, V43, P376, DOI 10.1007/s10578-011-0272-z; Vidair HB, 2012, CHILD ADOL PSYCH CL, V21, P669, DOI 10.1016/j.chc.2012.05.007; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weissman MM, 2000, ARCH GEN PSYCHIAT, V57, P675, DOI 10.1001/archpsyc.57.7.675; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolpert L, 2010, PRINCIPLES DEV; Wright RJ, 2013, CURR OPIN PEDIATR, V25, P232, DOI 10.1097/MOP.0b013e32835e78cc; Zeltser LM, 2011, P NATL ACAD SCI USA, V108, P15667, DOI 10.1073/pnas.1112239108; Zhu P, 2014, DEV MED CHILD NEUROL, V56, P283, DOI 10.1111/dmcn.12378	91	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138929	10.1371/journal.pone.0138929	http://dx.doi.org/10.1371/journal.pone.0138929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418562	Green Published, gold			2022-12-26	WOS:000362171400027
J	Penna, A; Stutzin, A				Penna, Antonello; Stutzin, Andres			K(Ca)3.1-Dependent Hyperpolarization Enhances Intracellular Ca2+ Signaling Induced by fMLF in Differentiated U937 Cells	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNEL; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; METHIONYL-LEUCYL-PHENYLALANINE; HUMAN MACROPHAGES; CHEMOTACTIC FACTORS; MOLECULAR-CLONING; EXTRACELLULAR ATP; CALCIUM; CONDUCTANCE	Formylated peptides are chemotactic agents generated by pathogens. The most relevant peptide is fMLF (formyl-Met-Leu-Phe) which participates in several immune functions, such as chemotaxis, phagocytosis, cytokine release and generation of reactive oxygen species. In macrophages fMLF-dependent responses are dependent on both, an increase in intracellular calcium concentration and on a hyperpolarization of the membrane potential. However, the molecular entity underlying this hyperpolarization remains unknown and it is not clear whether changes in membrane potential are linked to the increase in intracellular Ca2+. In this study, differentiated U937 cells, as a macrophage-like cell model, was used to characterize the fMLF response using electrophysiological and Ca2+ imaging techniques. We demonstrate by means of pharmacological and molecular biology tools that fMLF induces a Ca2+-dependent hyperpolarization via activation of the K+ channel K(Ca)3.1 and thus, enhancing fMLF-induced intracellular Ca2+ increase through an amplification of the driving force for Ca2+ entry. Consequently, enhanced Ca2+ influx would in turn lengthen the hyperpolarization, operating as a positive feedback mechanism for fMLF-induced Ca2+ signaling.	[Penna, Antonello; Stutzin, Andres] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 7, Chile	Universidad de Chile	Stutzin, A (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Independencia 838-0453, Santiago 7, Chile.	astutzin@bitmed.med.uchile.cl	Stutzin, Andrés/I-7605-2013; Penna, Antonello/O-6694-2019	Stutzin, Andrés/0000-0002-7264-066X; Penna, Antonello/0000-0002-8626-4415	Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias) (Chile) [15010006]	Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias) (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP)	This work was funded by Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias) (Chile) Grant Number 15010006, http://www.conicyt.cl/fondap/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechard S, 2008, J LEUKOCYTE BIOL, V84, P1223, DOI 10.1189/jlb.0807553; Bylund J, 2003, EXP CELL RES, V282, P70, DOI 10.1016/S0014-4827(02)00010-1; CASSATELLA MA, 1992, J IMMUNOL, V148, P3216; Desai R, 2000, J BIOL CHEM, V275, P39954, DOI 10.1074/jbc.M001562200; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fay AJ, 2006, P NATL ACAD SCI USA, V103, P17548, DOI 10.1073/pnas.0607914103; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; GALLIN EK, 1977, J CELL BIOL, V75, P277, DOI 10.1083/jcb.75.1.277; Gao YD, 2010, CELL CALCIUM, V48, P19, DOI 10.1016/j.ceca.2010.06.002; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; INCE C, 1988, J CELL BIOL, V106, P1873, DOI 10.1083/jcb.106.6.1873; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; KAY GE, 1983, INFECT IMMUN, V41, P1166, DOI 10.1128/IAI.41.3.1166-1174.1983; LAZZARI KG, 1990, J BIOL CHEM, V265, P10959; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Schlichter LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-4; Schmid-Antomarchi H, 1997, J IMMUNOL, V159, P6209; SELIGMANN BE, 1980, J MEMBRANE BIOL, V52, P257, DOI 10.1007/BF01869194; Shao ZF, 2011, AM J RESP CELL MOL, V45, P962, DOI 10.1165/rcmb.2010-0514OC; SHETH B, 1988, IMMUNOLOGY, V63, P483; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139243	10.1371/journal.pone.0139243	http://dx.doi.org/10.1371/journal.pone.0139243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418693	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400066
J	Zhang, WJ; Li, N; Wang, XY; Wang, SP				Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping			Integration of Sentence-Level Semantic Information in Parafovea: Evidence from the RSVP-Flanker Paradigm	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; E-Z-READER; PREVIEW BENEFIT; SACCADE GENERATION; DYNAMICAL MODEL; WORD; COMPREHENSION; FIXATIONS; N400; POTENTIALS	During text reading, the parafoveal word was usually presented between 2 degrees and 5 degrees from the point of fixation. Whether semantic information of parafoveal words can be processed during sentence reading is a critical and long-standing issue. Recently, studies using the RSVP-flanker paradigm have shown that the incongruent parafoveal word, presented as right flanker, elicited a more negative N400 compared with the congruent parafoveal word. This suggests that the semantic information of parafoveal words can be extracted and integrated during sentence reading, because the N400 effect is a classical index of semantic integration. However, as most previous studies did not control the word-pair congruency of the parafoveal and the foveal words that were presented in the critical triad, it is still unclear whether such integration happened at the sentence level or just at the word-pair level. The present study addressed this question by manipulating verbs in Chinese sentences to yield either a semantically congruent or semantically incongruent context for the critical noun. In particular, the interval between the critical nouns and verbs was controlled to be 4 or 5 characters. Thus, to detect the incongruence of the parafoveal noun, participants had to integrate it with the global sentential context. The results revealed that the N400 time-locked to the critical triads was more negative in incongruent than in congruent sentences, suggesting that parafoveal semantic information can be integrated at the sentence level during Chinese reading.	[Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping] S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; South China Normal University	Wang, SP (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	suiping@scnu.edu.cn		Wang, Suiping/0000-0001-8726-169X; WANG, Xiaoyue/0000-0002-3809-1310	Natural Science Foundation of China [NSF 31271086]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This work was funded by grants from the Natural Science Foundation of China (NSF 31271086) and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS 2011) to Suiping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altarriba J, 2001, PERCEPT PSYCHOPHYS, V63, P875, DOI 10.3758/BF03194444; Baccino T, 2005, J PSYCHOPHYSIOL, V19, P204, DOI 10.1027/0269-8803.19.3.204; Barber HA, 2013, PSYCHOPHYSIOLOGY, V50, P48, DOI 10.1111/j.1469-8986.2012.01489.x; Barber HA, 2011, PSYCHOPHYSIOLOGY, V48, P523, DOI 10.1111/j.1469-8986.2010.01082.x; Barber HA, 2010, NEUROSCI LETT, V479, P152, DOI 10.1016/j.neulet.2010.05.053; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; Chace KH, 2005, CAN J EXP PSYCHOL, V59, P209, DOI 10.1037/h0087476; Chwilla DJ, 2005, COGNITIVE BRAIN RES, V25, P589, DOI 10.1016/j.cogbrainres.2005.08.011; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Dimigen O, 2012, NEUROIMAGE, V62, P381, DOI 10.1016/j.neuroimage.2012.04.006; Drieghe D, 2008, Q J EXP PSYCHOL, V61, P1239, DOI 10.1080/17470210701467953; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Engbert R, 2002, VISION RES, V42, P621, DOI 10.1016/S0042-6989(01)00301-7; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; Hyona J, 2005, SCAND J PSYCHOL, V46, P475, DOI 10.1111/j.1467-9450.2005.00479.x; Juhasz BJ, 2008, J EXP PSYCHOL HUMAN, V34, P1560, DOI 10.1037/a0012319; Miellet S, 2004, BRAIN LANG, V90, P299, DOI 10.1016/S0093-934X(03)00442-5; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Paterson KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088358; Rayner K, 2006, VISION RES, V46, P310, DOI 10.1016/j.visres.2005.06.018; RAYNER K, 1986, CAN J PSYCHOL, V40, P473, DOI 10.1037/h0080111; RAYNER K, 1992, J EXP PSYCHOL HUMAN, V18, P163, DOI 10.1037/0096-1523.18.1.163; Rayner K, 2007, COGNITIVE SCI, V31, P1021, DOI 10.1080/03640210701703824; Rayner K, 2007, J EXP PSYCHOL HUMAN, V33, P230, DOI 10.1037/0096-1523.33.1.230; Rayner K, 2009, J EYE MOVEMENT RES, V2; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reichle ED, 2009, PSYCHON B REV, V16, P1, DOI 10.3758/PBR.16.1.1; Simola J, 2009, BRAIN LANG, V111, P101, DOI 10.1016/j.bandl.2009.08.004; Starr MS, 2004, EUR J COGN PSYCHOL, V16, P203, DOI 10.1080/09541440340000150; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; Wang SP, 2008, LANG COGNITIVE PROC, V23, P241, DOI 10.1080/01690960701437061; Yan M, 2012, J EXP PSYCHOL LEARN, V38, P1069, DOI 10.1037/a0026935; Yan M, 2009, PSYCHON B REV, V16, P561, DOI 10.3758/PBR.16.3.561; Yang JM, 2014, VIS COGN, V22, P193, DOI 10.1080/13506285.2014.890689; Yang JM, 2012, READ WRIT, V25, P1031, DOI 10.1007/s11145-010-9281-8; Zhou W, 2013, J RES READ, V36, pS51, DOI 10.1111/j.1467-9817.2013.01556.x; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001	38	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139016	10.1371/journal.pone.0139016	http://dx.doi.org/10.1371/journal.pone.0139016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418230	Green Submitted, gold, Green Published			2022-12-26	WOS:000362171400033
J	Svirskis, G; Baranauskas, G; Svirskiene, N; Tkatch, T				Svirskis, Gytis; Baranauskas, Gytis; Svirskiene, Natasa; Tkatch, Tatiana			Visual Stimuli Evoked Action Potentials Trigger Rapidly Propagating Dendritic Calcium Transients in the Frog Optic Tectum Layer 6 Neurons	PLOS ONE			English	Article							RETINAL GANGLION-CELL; MAMMALIAN SUPERIOR COLLICULUS; IN-VITRO; SUPRATHRESHOLD EXCITATION; RANA-PIPIENS; MECHANISMS; DRIVEN; ACTIVATION; ATTENTION; NETWORK	The superior colliculus in mammals or the optic tectum in amphibians is a major visual information processing center responsible for generation of orientating responses such as saccades in monkeys or prey catching avoidance behavior in frogs. The conserved structure function of the superior colliculus the optic tectum across distant species such as frogs, birds monkeys permits to draw rather general conclusions after studying a single species. We chose the frog optic tectum because we are able to perform whole-cell voltage-clamp recordings fluorescence imaging of tectal neurons while they respond to a visual stimulus. In the optic tectum of amphibians most visual information is processed by pear-shaped neurons possessing long dendritic branches, which receive the majority of synapses originating from the retinal ganglion cells. Since the first step of the retinal input integration is performed on these dendrites, it is important to know whether this integration is enhanced by active dendritic properties. We demonstrate that rapid calcium transients coinciding with the visual stimulus evoked action potentials in the somatic recordings can be readily detected up to the fine branches of these dendrites. These transients were blocked by calcium channel blockers nifedipine CdCl2 indicating that calcium entered dendrites via voltage-activated L-type calcium channels. The high speed of calcium transient propagation, > 300 mu m in < 10 ms, is consistent with the notion that action potentials, actively propagating along dendrites, open voltage-gated L-type calcium channels causing rapid calcium concentration transients in the dendrites. We conclude that such activation by somatic action potentials of the dendritic voltage gated calcium channels in the close vicinity to the synapses formed by axons of the retinal ganglion cells may facilitate visual information processing in the principal neurons of the frog optic tectum.	[Svirskis, Gytis; Baranauskas, Gytis; Svirskiene, Natasa; Tkatch, Tatiana] Lithuanian Univ Hlth Sci, Neurosci Inst, Neurophysiol Lab, Kaunas, Lithuania	Lithuanian University of Health Sciences	Baranauskas, G (corresponding author), Lithuanian Univ Hlth Sci, Neurosci Inst, Neurophysiol Lab, Kaunas, Lithuania.	gytis11@yahoo.com		Tkatch, Tatiana/0000-0001-6626-7435	Lithuanian Research Council [VP1-3.1-SMM-07-K-02-059]	Lithuanian Research Council(Research Council of Lithuania (LMTLT))	This work was supported by the Lithuanian Research Council grant No. VP1-3.1-SMM-07-K-02-059 to TT that is a part of the Global Grant measure of the European Social Fund.	ANTAL M, 1986, J COMP NEUROL, V246, P238, DOI 10.1002/cne.902460208; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; BACKSTROM AC, 1975, J PHYSIOL-LONDON, V246, P79; Baginskas A, 2008, NEUROSCI RES, V60, P412, DOI 10.1016/j.neures.2007.12.010; Baranauskas G, 2012, NEUROSCI LETT, V528, P196, DOI 10.1016/j.neulet.2012.09.009; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Cakir Y, 2005, PHARMACOL REP, V57, P467; COMER C, 1978, BRAIN RES, V153, P217, DOI 10.1016/0006-8993(78)91148-4; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Delvendahl I, 2015, P NATL ACAD SCI USA, V112, pE3075, DOI 10.1073/pnas.1508419112; Dutta A, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00001; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Gutmaniene N, 2003, BRAIN RES, V981, P213, DOI 10.1016/S0006-8993(03)03038-5; Gutmaniene N, 2006, NEUROSCI LETT, V406, P142, DOI 10.1016/j.neulet.2006.07.035; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; JACKSON MB, 1992, BIOPHYS J, V61, P756, DOI 10.1016/S0006-3495(92)81880-5; Kuras A, 2006, NEUROSCI RES, V54, P328, DOI 10.1016/j.neures.2005.12.014; Kuras A, 2004, EXP BRAIN RES, V159, P509, DOI 10.1007/s00221-004-1976-0; Leopold DA, 2012, ANNU REV NEUROSCI, V35, P91, DOI 10.1146/annurev-neuro-062111-150356; Lettvin Jerome Y., 1968, MIND BIOL APPROACHES, P233; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Maximino C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003582; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Mysore SP, 2014, NEURON, V84, P214, DOI 10.1016/j.neuron.2014.08.019; Narayanan R, 2012, J NEUROPHYSIOL, V108, P2343, DOI 10.1152/jn.00530.2012; Nikolakopoulou AM, 2010, J COMP NEUROL, V518, P972, DOI 10.1002/cne.22258; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; POTTER HD, 1969, J COMP NEUROL, V136, P203, DOI 10.1002/cne.901360207; REH TA, 1984, J NEUROSCI, V4, P442; Safronov BV, 2007, J NEUROSCI METH, V164, P292, DOI 10.1016/j.jneumeth.2007.05.010; SPARKS DL, 1987, TRENDS NEUROSCI, V10, P312, DOI 10.1016/0166-2236(87)90085-3; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Svirskis G, 2009, J NEUROSCI METH, V180, P22, DOI 10.1016/j.jneumeth.2009.02.012; Szekely G, 1973, J Hirnforsch, V14, P189; Thier P, 2002, CURR BIOL, V12, pR158, DOI 10.1016/S0960-9822(02)00730-3; Wurtz Robert H., 1994, Current Opinion in Neurobiology, V4, P857, DOI 10.1016/0959-4388(94)90134-1; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186	45	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139472	10.1371/journal.pone.0139472	http://dx.doi.org/10.1371/journal.pone.0139472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414356	gold, Green Published, Green Submitted			2022-12-26	WOS:000362170700058
J	Prehn-Kristensen, A; Lotzkat, K; Bauhofer, E; Wiesner, CD; Baving, L				Prehn-Kristensen, Alexander; Lotzkat, Kristin; Bauhofer, Eva; Wiesner, Christian D.; Baving, Lioba			Sleep Supports Memory of Odors in Adults but Not in Children	PLOS ONE			English	Article							SLOW-WAVE SLEEP; SMELL IDENTIFICATION TEST; RECOGNITION MEMORY; ENHANCES MEMORY; CONSOLIDATION; REM; CONSISTENCY; FAMILIARITY; INSTRUMENT; INTENSITY	Sleep supports the consolidation of declarative memory in children and adults. However, it is unclear whether sleep improves odor memory in children as well as adults. Thirty healthy children (mean age of 10.6, ranging from 8-12 yrs.) and 30 healthy adults (mean age of 25.4, ranging from 20-30 yrs.) participated in an incidental odor recognition paradigm. While learning of 10 target odorants took place in the evening and retrieval (10 target and 10 distractor odorants) the next morning in the sleep groups (adults: n = 15, children: n = 15), the time schedule was vice versa in the wake groups (n = 15 each). During encoding, adults rated odors as being more familiar. After the retention interval, adult participants of the sleep group recognized odors better than adults in the wake group. While children in the wake group showed memory performance comparable to the adult wake group, the children sleep group performed worse than adult and children wake groups. Correlations between memory performance and familiarity ratings during encoding indicate that pre-experiences might be critical in determining whether sleep improves or worsens memory consolidation.	[Prehn-Kristensen, Alexander; Bauhofer, Eva; Wiesner, Christian D.; Baving, Lioba] Univ Kiel, Sch Med, Ctr Integrat Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany; [Lotzkat, Kristin] Univ Kiel, Dept Psychol, Kiel, Germany	University of Kiel; University of Kiel	Prehn-Kristensen, A (corresponding author), Univ Kiel, Sch Med, Ctr Integrat Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany.	a.prehn@zip-kiel.de	Prehn-Kristensen, Alexander/A-3234-2019	Prehn-Kristensen, Alexander/0000-0002-3510-9888; Wiesner, Christian/0000-0003-1287-4955	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Sonderforschungsbereich (SFB) 654]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This study was supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) Sonderforschungsbereich (SFB) 654 "Plasticity and Sleep" [http://www.sfb654.uni-luebeck.de/].	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; [Anonymous], 1991, MANUAL CHILD BEHAV C; Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Barnes DC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00134; Barnes DC, 2014, J NEUROSCI, V34, P5134, DOI 10.1523/JNEUROSCI.5274-13.2014; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cairney SA, 2011, EXP BRAIN RES, V214, P83, DOI 10.1007/s00221-011-2808-7; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Chalouhi C, 2005, PEDIATRICS, V116, pE81, DOI 10.1542/peds.2004-1970; Cleland TA, 2003, HDB OLFACTION GUSTAT, P165, DOI DOI 10.1201/9780203911457.CH8; Cox R, 2014, NEUROIMAGE, V99, P103, DOI 10.1016/j.neuroimage.2014.05.028; Crabtree VM, 2009, CHILD ADOL PSYCH CL, V18, P799, DOI 10.1016/j.chc.2009.04.013; Diekelmann S, 2012, NEUROBIOL LEARN MEM, V98, P103, DOI 10.1016/j.nlm.2012.07.002; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Distel H, 1999, CHEM SENSES, V24, P191, DOI 10.1093/chemse/24.2.191; Distel H, 2001, CHEM SENSES, V26, P247, DOI 10.1093/chemse/26.3.247; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 1986, ONTOGENY OLFACTION, P3; Durrant SJ, 2015, NEUROBIOL LEARN MEM, V122, P41, DOI 10.1016/j.nlm.2015.02.011; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Fischer S, 2007, J COGNITIVE NEUROSCI, V19, P214, DOI 10.1162/jocn.2007.19.2.214; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Frank RA, 2011, CHEM SENSES, V36, P29, DOI 10.1093/chemse/bjq095; Franke G, 1995, QUAL LIFE RES, V9, P185; Gais S, 2011, J COGNITIVE NEUROSCI, V23, P2582, DOI 10.1162/jocn.2011.21622; German Sleep Society, AB MORG; Goel N, 2004, CHRONOBIOL INT, V21, P691, DOI 10.1081/CBI-200025989; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Herz RS, 2012, ADV CONSC RES, V85, P95; Herz RS, 1996, PSYCHON B REV, V3, P300, DOI 10.3758/BF03210754; Hugh SC, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0061-y; Jehl C, 1998, ANN NY ACAD SCI, V855, P632, DOI 10.1111/j.1749-6632.1998.tb10635.x; Larsson M, 1997, MEMORY, V5, P361; Larsson M, 2009, ANN NY ACAD SCI, V1170, P318, DOI 10.1111/j.1749-6632.2009.03934.x; Larsson M, 2009, EXP PSYCHOL, V56, P375, DOI 10.1027/1618-3169.56.6.375; Lehrner J, 2002, OLFACTION, TASTE, AND COGNITION, P278, DOI 10.1017/CBO9780511546389.024; LEHRNER JP, 1993, CHEM SENSES, V18, P17, DOI 10.1093/chemse/18.1.17; Lehrner JP, 1999, CHEM SENSES, V24, P337, DOI 10.1093/chemse/24.3.337; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Nordin S, 2003, PSYCHOPHYSIOLOGY, V40, P612, DOI 10.1111/1469-8986.00062; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Owens JA, 2000, J DEV BEHAV PEDIATR, V21, P27, DOI 10.1097/00004703-200002000-00005; Owens JA, 2000, SLEEP, V23, P1043; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Prehn-Kristensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065098; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Price JL, 2004, HUMAN NERVOUS SYSTEM; RABIN MD, 1984, J EXP PSYCHOL LEARN, V10, P316, DOI 10.1037/0278-7393.10.2.316; Rasch B, 2012, PHYSIOL REV, DOI [10.1152/physrev.00007.2012, DOI 10.1152/PHYSREV.00007.2012]; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rihm JS, 2014, J COGNITIVE NEUROSCI, V26, P1806, DOI 10.1162/jocn_a_00579; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; Schaal B, 2015, PRENATAL POSTNATAL H; Scholle S, 2007, CLIN NEUROPHYSIOL, V118, P1525, DOI 10.1016/j.clinph.2007.03.007; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; Watzlawik M, 2009, DIAGNOSTICA, V55, P55, DOI 10.1026/0012-1924.55.1.55; Wilhelm I, 2012, NEUROSCI BIOBEHAV R, V36, P1718, DOI 10.1016/j.neubiorev.2012.03.002; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Wright KP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00050; Zucco GM, 2007, CONV EVI LANG COMMUN, V8, P155	69	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139069	10.1371/journal.pone.0139069	http://dx.doi.org/10.1371/journal.pone.0139069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406604	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700161
J	Shcherbik, S; Pearce, N; Balish, A; Jones, J; Thor, S; Davis, CT; Pearce, M; Tumpey, T; Cureton, D; Chen, LM; Villanueva, J; Bousse, TL				Shcherbik, Svetlana; Pearce, Nicholas; Balish, Amanda; Jones, Joyce; Thor, Sharmi; Davis, Charles Todd; Pearce, Melissa; Tumpey, Terrence; Cureton, David; Chen, Li-Mei; Villanueva, Julie; Bousse, Tatiana L.			Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation	PLOS ONE			English	Article							H7N9; PROTECTION; TECHNOLOGY; STABILITY; INFECTION; YIELD; MICE	Background Avian influenza A (H7N9) virus has emerged recently and continues to cause severe disease with a high mortality rate in humans prompting the development of candidate vaccine viruses. Live attenuated influenza vaccines (LAIV) are 6: 2 reassortant viruses containing the HA and NA gene segments from wild type influenza viruses to induce protective immune responses and the six internal genes from Master Donor Viruses (MDV) to provide temperature sensitive, cold-adapted and attenuated phenotypes. Methodology/Principal Findings LAIV candidate A/Anhui/1/2013(H7N9)-CDC-LV7A (abbreviated as CDC-LV7A), based on the Russian MDV, A/Leningrad/134/17/57 (H2N2), was generated by classical reassortment in eggs and retained MDV temperature-sensitive and cold-adapted phenotypes. CDC-LV7A had two amino acid substitutions N123D and N149D (H7 numbering) in HA and one substitution T10I in NA. To evaluate the role of these mutations on the replication capacity of the reassortants in eggs, the recombinant viruses A(H7N9) RG-LV1 and A (H7N9) RG-LV2 were generated by reverse genetics. These changes did not alter virus antigenicity as ferret antiserum to CDC-LV7A vaccine candidate inhibited hemagglutination by homologous A(H7N9) virus efficiently. Safety studies in ferrets confirmed that CDC-LV7A was attenuated compared to wild-type A/Anhui/1/2013. In addition, the genetic stability of this vaccine candidate was examined in eggs and ferrets by monitoring sequence changes acquired during virus replication in the two host models. No changes in the viral genome were detected after five passages in eggs. However, after ten passages additional mutations were detected in the HA gene. The vaccine candidate was shown to be stable in the ferret model; post-vaccination sequence data analysis showed no changes in viruses collected in nasal washes present at day 5 or day 7. Conclusions/Significance Our data indicate that the A/Anhui/1/2013(H7N9)-CDC-LV7A reassortant virus is a safe and genetically stable candidate vaccine virus that is now available for distribution by WHO to vaccine manufacturers.	[Shcherbik, Svetlana; Pearce, Nicholas; Balish, Amanda; Jones, Joyce; Thor, Sharmi; Davis, Charles Todd; Pearce, Melissa; Tumpey, Terrence; Cureton, David; Chen, Li-Mei; Villanueva, Julie; Bousse, Tatiana L.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Shcherbik, Svetlana; Pearce, Nicholas] Battelle Mem Inst, Atlanta, GA USA; [Cureton, David] Atlanta Res & Educ Fdn, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Bousse, TL (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA.	tbousse@cdc.gov			WHO; BARDA	WHO(World Health Organization); BARDA	We thank the Chinese Center for Disease Control and Prevention, Beijing, China; Centre for Health Protection, Hong Kong, SAR; Centers for Disease Control, Taiwan; and the National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada for providing wild type A(H7N9) viruses used in this study. We thank IEM, St Petersburg, Russia and Bio-Diem (Australia) for providing MDV and serum to MDV. We thank WHO and BARDA for special contribution funds to support LAIV seed strains generation and quality control at CDC. We thank Nancy Cox for support of LAIV development at CDC and David Wentworth for constructive suggestions for the paper. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	ALEKSANDROVA GI, 1977, VOP VIRUSOL+, P387; [Anonymous], 2005, WHOCDSCSRGIP20056; [Anonymous], 2013, WHO REC ASS QUAL SAF; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Blanchfield K, 2014, INFLUENZA OTHER RESP, V8, P628, DOI 10.1111/irv.12285; Buonagurio DA, 2006, VACCINE, V24, P2151, DOI 10.1016/j.vaccine.2005.11.007; Chen ZY, 2014, J VIROL, V88, P7016, DOI 10.1128/JVI.00100-14; Chia MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120793; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Dong J, 2009, INFLUENZA OTHER RESP, V3, P287, DOI 10.1111/j.1750-2659.2009.00104.x; Duan YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099322; Friede M, 2011, VACCINE, V29, pA2, DOI 10.1016/j.vaccine.2011.02.079; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GHENDON YZ, 1984, INFECT IMMUN, V44, P730, DOI 10.1128/IAI.44.3.730-733.1984; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; Guo Wanshen, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P949; Halliley JL, 2015, J INFECT DIS, V212, P1270, DOI 10.1093/infdis/jiv210; Isakova-Sivak I, 2011, VIROLOGY, V412, P297, DOI 10.1016/j.virol.2011.01.004; Jernigan DB, 2015, ANNU REV MED, V66, P361, DOI 10.1146/annurev-med-010714-112311; Jin H, 2014, CURR OPIN VIROL, V6, P34, DOI 10.1016/j.coviro.2014.02.008; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Kendal AP, 1997, EUR J EPIDEMIOL, V13, P591, DOI 10.1023/A:1007327505862; KLIMOV AI, 1992, VIROLOGY, V186, P795, DOI 10.1016/0042-6822(92)90050-Y; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Krammer F, 2014, J VIROL, V88, P3976, DOI 10.1128/JVI.03095-13; Liu YV, 2015, VACCINE, V33, P2152, DOI 10.1016/j.vaccine.2015.03.009; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Neuzil KM, 2012, EXPERT REV VACCINES, V11, P939, DOI [10.1586/ERV.12.76, 10.1586/erv.12.76]; Reed L. J., 1938, AM J HYG, V27, P5; Ridenour C, 2015, INFLUENZA OTHER RESP, V9, P263, DOI 10.1111/irv.12322; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Rudenko LG, 1996, B WORLD HEALTH ORGAN, V74, P77; Shcherbik S, 2014, J VIROL METHODS, V195, P18, DOI 10.1016/j.jviromet.2013.09.003; Shcherbik SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092580; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; SMORODINTSEN AA, 1965, IND MED SURG, V34, P53; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wareing MD, 2002, VACCINE, V20, P2082, DOI 10.1016/S0264-410X(02)00056-7; Wodal W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113963; Wong SS, 2015, J INFECT DIS, V212, P542, DOI 10.1093/infdis/jiv099; Wong SS, 2014, VACCINE, V32, P4571, DOI 10.1016/j.vaccine.2014.06.016; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123659	46	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138951	10.1371/journal.pone.0138951	http://dx.doi.org/10.1371/journal.pone.0138951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405798	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700127
J	Mulry, KR; Hanson, BA; Dudle, DA				Mulry, Kristina R.; Hanson, Bryan A.; Dudle, Dana A.			Alternative Strategies in Response to Saline Stress in Two Varieties of Portulaca oleracea (Purslane)	PLOS ONE			English	Article							SALT STRESS; PHENOTYPIC PLASTICITY; FATTY-ACIDS; ANTIOXIDANT ACTIVITY; COMMON PURSLANE; CLIMATE-CHANGE; L.; PROLINE; PLANTS; ACCUMULATION	Purslane (Portulaca oleracea) is a globally-distributed plant with a long history of use in folk medicine and cooking. We have developed purslane as a model system for exploring plant responses to stress. We exposed two varieties of purslane to saline stress with the objective of identifying differences between the varieties in the plasticity of morphological and physiological traits. The varieties responded to saline stress with significantly different changes in the measured traits, which included inter alia biomass, flower counts, proline concentrations and betalain pigment concentrations. The alternative responses of the two varieties consisted of complex, simultaneous changes in multiple traits. In particular, we observed that while both varieties increased production of betalain pigments and proline under saline stress, one variety invested more in betalain pigments while the other invested more in proline. Proline and betalain pigments undoubtedly play multiple roles in plant tissues, but in this case their role as antioxidants deployed to ameliorate saline stress appears to be important. Taken holistically, our results suggest that the two varieties employ different strategies in allocating resources to cope with saline stress. This conclusion establishes purslane as a suitable model system for the study of saline stress and the molecular basis for differential responses.	[Mulry, Kristina R.; Hanson, Bryan A.] Depauw Univ, Dept Chem & Biochem, Greencastle, IN 46135 USA; [Dudle, Dana A.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA	DePauw University; DePauw University	Hanson, BA (corresponding author), Depauw Univ, Dept Chem & Biochem, Greencastle, IN 46135 USA.	hanson@depauw.edu			Andrew W. Mellon Foundation Environmental Education Grant [40900677]	Andrew W. Mellon Foundation Environmental Education Grant	KRM and BAH were supported by an Andrew W. Mellon Foundation Environmental Education Grant (reference number 40900677) to DePauw University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Al Nasir F, 2010, CLEAN-SOIL AIR WATER, V38, P592, DOI 10.1002/clen.200900307; Alam MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/105695; Alam MA, 2014, SCI WORLD J, DOI 10.1155/2014/627916; Alam MA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296063; Alam MA, 2015, FOOD CHEM, V169, P439, DOI 10.1016/j.foodchem.2014.08.019; Allegra M, 2007, FREE RADICAL RES, V41, P335, DOI 10.1080/10715760601038783; Anastacio A, 2013, INT J FOOD SCI NUTR, V64, P235, DOI 10.3109/09637486.2012.713915; [Anonymous], 1991, WORLDS WEEDS DISTRIB, P78; [Anonymous], 2014, CLIMATE CHANGE 2014; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Dkhil MA, 2011, J MED PLANTS RES, V5, P1589; Dong CX, 2010, CHEM PHARM BULL, V58, P507, DOI 10.1248/cpb.58.507; Elbe JH, 2007, CURRENT PROTOCOLS FO, pF311; Erkan N, 2012, FOOD CHEM, V133, P775, DOI 10.1016/j.foodchem.2012.01.091; Esmaillzadeh A, 2015, J RES MED SCI, V20, P47; Fontana E, 2006, J SCI FOOD AGR, V86, P2417, DOI 10.1002/jsfa.2633; Franco JA, 2011, J HORTIC SCI BIOTECH, V86, P1; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Hanson BA, 2015, HANDYSTUFF HANDY R F; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Hunt John, 2010, P46; Imai S, 2007, J BIOSCI BIOENG, V103, P420, DOI 10.1263/jbb.103.420; Jain G, 2015, ENVIRON EXP BOT, V109, P131, DOI 10.1016/j.envexpbot.2014.09.002; Kafi M, 2011, SOIL SCI PLANT NUTR, V57, P341, DOI 10.1080/00380768.2011.567398; Kanner J, 2001, J AGR FOOD CHEM, V49, P5178, DOI 10.1021/jf010456f; Kilic CC, 2008, AGR WATER MANAGE, V95, P854, DOI 10.1016/j.agwat.2008.01.019; Kugler F, 2004, J AGR FOOD CHEM, V52, P2975, DOI 10.1021/jf035491w; Lee AS, 2012, AM J CHINESE MED, V40, P495, DOI 10.1142/S0192415X12500383; Lee AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/741824; Marino DC, 2009, J AGR FOOD CHEM, V57, P11061, DOI 10.1021/jf902197p; D'Andrea RM, 2014, PHYSIOL PLANTARUM, V152, P414, DOI 10.1111/ppl.12194; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mitich LW, 1997, WEED TECHNOL, V11, P394, DOI 10.1017/S0890037X00043128; Moneim AEA, 2013, PESTIC BIOCHEM PHYS, V105, P203, DOI 10.1016/j.pestbp.2013.02.004; Mortley DG, 2012, HORTSCIENCE, V47, P437, DOI 10.21273/HORTSCI.47.3.437; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murray M, 2014, PHYTOCHEM REV, V13, P139, DOI 10.1007/s11101-013-9294-4; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Ocampo G, 2012, MOL PHYLOGENET EVOL, V63, P97, DOI 10.1016/j.ympev.2011.12.017; Ozgur R, 2013, FUNCT PLANT BIOL, V40, P832, DOI 10.1071/FP12389; Palaniswamy UR, 2001, J AM SOC HORTIC SCI, V126, P537, DOI 10.21273/JASHS.126.5.537; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Plett DC, 2010, PLANT CELL ENVIRON, V33, P612, DOI 10.1111/j.1365-3040.2009.02086.x; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; R Core Team, 2013, R LANG ENV STAT COMP; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; Shen H, 2013, CARBOHYD POLYM, V93, P395, DOI 10.1016/j.carbpol.2012.11.107; SIMOPOULOS AP, 1992, J AM COLL NUTR, V11, P374; Stintzing FC, 2007, TRENDS FOOD SCI TECH, V18, P514, DOI 10.1016/j.tifs.2007.04.012; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Teixeira M, 2009, ANN APPL BIOL, V154, P77, DOI 10.1111/j.1744-7348.2008.00272.x; Tiwari KK, 2008, ENVIRON MONIT ASSESS, V147, P15, DOI 10.1007/s10661-007-0093-5; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Uddin MK, 2014, SCI WORLD J, DOI 10.1155/2014/951019; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Wang CQ, 2007, PLANT SCI, V172, P1, DOI 10.1016/j.plantsci.2006.06.015; Wang CQ, 2010, PHYTOMEDICINE, V17, P527, DOI 10.1016/j.phymed.2009.09.006; Waterhouse A. L., 2002, CURRENT PROTOCOLS FO, P1, DOI DOI 10.1002/0471142913.FAA0101S06; Winter K, 2014, J EXP BOT, V65, P3425, DOI 10.1093/jxb/eru063; Wybraniec S, 2011, J AGR FOOD CHEM, V59, P12163, DOI 10.1021/jf2024769; Yazici I, 2007, ENVIRON EXP BOT, V61, P49, DOI 10.1016/j.envexpbot.2007.02.010; Zhao R, 2013, CARBOHYD POLYM, V96, P376, DOI 10.1016/j.carbpol.2013.04.023; Zhou YX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/925631	71	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138723	10.1371/journal.pone.0138723	http://dx.doi.org/10.1371/journal.pone.0138723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398279	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500098
J	Shimoda, Y; Matsuo, K; Kitamura, Y; Ono, K; Ueyama, T; Matoba, S; Yamada, H; Wu, T; Chen, J; Emoto, N; Ikeda, K				Shimoda, Yoshiaki; Matsuo, Kiyonari; Kitamura, Youhei; Ono, Kazunori; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki; Wu, Tongbin; Chen, Ju; Emoto, Noriaki; Ikeda, Koji			Diabetes-Related Ankyrin Repeat Protein (DARP/Ankrd23) Modifies Glucose Homeostasis by Modulating AMPK Activity in Skeletal Muscle	PLOS ONE			English	Article							KINASE; ACTIVATION; EXPRESSION; IDENTIFICATION; APOPTOSIS; TRANSPORT; PATHWAYS; OBESITY; FAMILY; ROLES	Skeletal muscle is the major site for glucose disposal, the impairment of which closely associates with the glucose intolerance in diabetic patients. Diabetes-related ankyrin repeat protein (DARP/Ankrd23) is a member of muscle ankyrin repeat proteins, whose expression is enhanced in the skeletal muscle under diabetic conditions; however, its role in energy metabolism remains poorly understood. Here we report a novel role of DARP in the regulation of glucose homeostasis through modulating AMP-activated protein kinase (AMPK) activity. DARP is highly preferentially expressed in skeletal muscle, and its expression was substantially upregulated during myotube differentiation of C2C12 myoblasts. Interestingly, DARP-/- mice demonstrated better glucose tolerance despite similar body weight, while their insulin sensitivity did not differ from that in wildtype mice. We found that phosphorylation of AMPK, which mediates insulin-independent glucose uptake, in skeletal muscle was significantly enhanced in DARP-/- mice compared to that in wildtype mice. Gene silencing of DARP in C2C12 myotubes enhanced AMPK phosphorylation, whereas overexpression of DARP in C2C12 myoblasts reduced it. Moreover, DARP-silencing increased glucose uptake and oxidation in myotubes, which was abrogated by the treatment with AICAR, an AMPK activator. Of note, improved glucose tolerance in DARP-/- mice was abolished when mice were treated with AICAR. Mechanistically, gene silencing of DARP enhanced protein expression of LKB1 that is a major upstream kinase for AMPK in myotubes in vitro and the skeletal muscle in vivo. Together with the altered expression under diabetic conditions, our data strongly suggest that DARP plays an important role in the regulation of glucose homeostasis under physiological and pathological conditions, and thus DARP is a new therapeutic target for the treatment of diabetes mellitus.	[Shimoda, Yoshiaki; Matsuo, Kiyonari; Kitamura, Youhei; Ono, Kazunori; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiol, Kamigyo Ku, Kyoto 6028566, Japan; [Wu, Tongbin; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Emoto, Noriaki; Ikeda, Koji] Kobe Pharmaceut Univ, Dept Clin Pharm, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kyoto Prefectural University of Medicine; University of California System; University of California San Diego; Kobe Pharmaceutical University	Ikeda, K (corresponding author), Kobe Pharmaceut Univ, Dept Clin Pharm, Higashinada Ku, 4-19-1 Motoyama Kitamachi, Kobe, Hyogo 6588558, Japan.	ikedak-circ@umin.ac.jp	Chen, Ju/E-5579-2011	Wu, Tongbin/0000-0001-6232-3268; ikeda, Koji/0000-0002-9972-7255; Emoto, Noriaki/0000-0001-6673-2616	 [26670406]		The work was supported by Grant-in Aid for Challenging Exploratory Research (26670406).	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Akakabe Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3389; Andres AM, 2011, FEBS LETT, V585, P1223, DOI 10.1016/j.febslet.2011.03.042; Bang ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093638; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Ebeling P, 1998, FEBS LETT, V436, P301, DOI 10.1016/S0014-5793(98)01149-1; Hilder TL, 2005, J APPL PHYSIOL, V99, P2181, DOI 10.1152/japplphysiol.00743.2005; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Ikeda K, 2006, CIRC RES, V99, P424, DOI 10.1161/01.RES.0000237662.23539.0b; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776; Matsuo K, 2015, J BIOL CHEM, V290, P3784, DOI 10.1074/jbc.M114.605287; Nakano M, 2006, METABOLISM, V55, P300, DOI 10.1016/j.metabol.2005.09.003; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Wang LJ, 2011, ANIM BIOTECHNOL, V22, P87, DOI 10.1080/10495398.2011.559562; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Zou YM, 1997, DEVELOPMENT, V124, P793	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138624	10.1371/journal.pone.0138624	http://dx.doi.org/10.1371/journal.pone.0138624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398569	Green Submitted, gold, Green Published			2022-12-26	WOS:000361797500086
J	Lu, M; Boschetti, C; Tunnacliffe, A				Lu, Meng; Boschetti, Chiara; Tunnacliffe, Alan			Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; DOUBLE-STRAND BREAKS; DISEASE; P53; DYSFUNCTION; AGGREGATION; APOPTOSIS; MOUSE; ATM; ABNORMALITIES	Juxtanuclear aggresomes form in cells when levels of aggregation-prone proteins exceed the capacity of the proteasome to degrade them. It is widely believed that aggresomes have a protective function, sequestering potentially damaging aggregates until these can be removed by autophagy. However, most in-cell studies have been carried out over a few days at most, and there is little information on the long term effects of aggresomes. To examine these long term effects, we created inducible, single-copy cell lines that expressed aggregation-prone polyglutamine proteins over several months. We present evidence that, as perinuclear aggresomes accumulate, they are associated with abnormal nuclear morphology and DNA double-strand breaks, resulting in cell cycle arrest via the phosphorylated p53 (Ser-15)-dependent pathway. Further analysis reveals that aggresomes can have a detrimental effect on mitosis by steric interference with chromosome alignment, centrosome positioning, and spindle formation. The incidence of apoptosis also increased in aggresome-containing cells. These severe defects developed gradually after juxtanuclear aggresome formation and were not associated with small cytoplasmic aggregates alone. Thus, our findings demonstrate that, in dividing cells, aggresomes are detrimental over the long term, rather than protective. This suggests a novel mechanism for polyglutamine-associated developmental and cell biological abnormalities, particularly those with early onset and non-neuronal pathologies.	[Lu, Meng; Boschetti, Chiara; Tunnacliffe, Alan] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England	University of Cambridge	Tunnacliffe, A (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	at10004@cam.ac.uk		Boschetti, Chiara/0000-0003-4552-3975	European Research Council [AdG233232]; Cambridge Overseas Trust; Chinese Scholarship Council	European Research Council(European Research Council (ERC)European Commission); Cambridge Overseas Trust; Chinese Scholarship Council(China Scholarship Council)	This work was supported by an Advanced Investigator Award (AdG233232) from the European Research Council (to A. T.) and by scholarships from the Cambridge Overseas Trust and the Chinese Scholarship Council (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bertoni A, 2011, J BIOL CHEM, V286, P4727, DOI 10.1074/jbc.M110.156521; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bouwman P, 2012, NAT REV CANCER, V12, P587, DOI 10.1038/nrc3342; Bufalino MR, 2014, CELL CYCLE, V13, P1201, DOI 10.4161/cc.28106; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chapple JP, 2008, NEUROSCI LETT, V447, P172, DOI 10.1016/j.neulet.2008.09.075; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Illuzzi J, 2009, J NEUROSCI RES, V87, P733, DOI 10.1002/jnr.21881; Imreh G, 2011, J CELL SCI, V124, P2951, DOI 10.1242/jcs.081612; Jacobsen E, 2004, MOL BRAIN RES, V128, P1, DOI 10.1016/j.molbrainres.2004.05.023; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Lu M, 2015, BIOTECHNOL BIOENG, V112, P1883, DOI 10.1002/bit.25606; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Nanduri P, 2015, J BIOL CHEM, V290, P9455, DOI 10.1074/jbc.M114.627950; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Fernandez-Fernandez MR, 2011, NEUROBIOL DIS, V41, P23, DOI 10.1016/j.nbd.2010.08.014; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009; Shrestha RL, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130108; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614	61	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27986	28000		10.1074/jbc.M115.676437	http://dx.doi.org/10.1074/jbc.M115.676437			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26408200	hybrid, Green Published			2022-12-26	WOS:000365757500045
J	Won, JH; Park, S; Hong, S; Son, S; Yu, JW				Won, Ji-Hee; Park, Sangjun; Hong, Sujeong; Son, Seunghwan; Yu, Je-Wook			Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; APOPTOSIS; DISEASES; DNA; DEUBIQUITINATION; DAMAGE; LEADS	Mitochondrial dysfunction is considered crucial for NLRP3 inflammasome activation partly through its release of mitochondrial toxic products, such as mitochondrial reactive oxygen species (mROS)(2) and mitochondrial DNA (mtDNA). Although previous studies have shown that classical NLRP3-activating stimulations lead to mROS generation and mtDNA release, it remains poorly understood whether and how mitochondrial damage-derived factors may contribute to NLRP3 inflammasome activation. Here, we demonstrate that impairment of the mitochondrial electron transport chain by rotenone primes NLRP3 inflammasome activation only upon costimulation with ATP and not with nigericin or alum. Rotenone-induced priming of NLRP3 in the presence of ATP triggered the formation of specklike NLRP3 or ASC aggregates and the association of NLRP3 with ASC, resulting in NLRP3-dependent caspase-1 activation. Mechanistically, rotenone confers a priming signal for NLRP3 inflammasome activation only in the context of aberrant high-grade, but not low-grade, mROS production and mitochondrial hyperpolarization. By contrast, rotenone/ATP-mediated mtDNA release and mitochondrial depolarization are likely to be merely an indication of mitochondrial damage rather than triggering factors for NLRP3 inflammasome activation. Our results provide a molecular insight into the selective contribution made by mitochondrial dysfunction to the NLRP3 inflammasome pathway.	[Won, Ji-Hee; Park, Sangjun; Hong, Sujeong; Son, Seunghwan; Yu, Je-Wook] Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis,Brain Korea PLUS Proje, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Yu, JW (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis,Brain Korea PLUS Proje, 50-1 Yonsei Ro, Seoul 120752, South Korea.	Jewookyu@yuhs.ac		Yu, Je-Wook/0000-0001-5943-4071; Son, Seunghwan/0000-0003-2408-2613	National Research Foundation of Korea - Korean Government [2012R1A1A2041532, 2013R1A2A2A01067985, 2014R1A4A1008625]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea Grants 2012R1A1A2041532, 2013R1A2A2A01067985, and 2014R1A4A1008625, funded by the Korean Government. The authors declare that they have no conflicts of interest with the contents of this article.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Hwang I, 2015, IMMUNOL CELL BIOL, V93, P591, DOI 10.1038/icb.2014.125; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Iijima T, 2003, BRAIN RES, V993, P140, DOI 10.1016/j.brainres.2003.09.041; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; THOR H, 1982, J BIOL CHEM, V257, P2419; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yu AK, 2015, HUM MOL GENET, V24, P2848, DOI 10.1093/hmg/ddv045; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	34	71	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27425	27437		10.1074/jbc.M115.667063	http://dx.doi.org/10.1074/jbc.M115.667063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26416893	hybrid, Green Published			2022-12-26	WOS:000364794000048
J	Cardoso-Toset, F; Gomez-Laguna, J; Amarilla, SP; Vela, AI; Carrasco, L; Fernandez-Garayzabal, JF; Astorga, RJ; Luque, I				Cardoso-Toset, Fernando; Gomez-Laguna, Jaime; Amarilla, Shyrley P.; Vela, Ana I.; Carrasco, Librado; Fernandez-Garayzabal, Jose F.; Astorga, Rafael J.; Luque, Inmaculada			Multi-Etiological Nature of Tuberculosis-Like Lesions in Condemned Pigs at the Slaughterhouse	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; LYMPH-NODES; GRANULOMATOUS LESIONS; RED DEER; ARCANOBACTERIUM; STREPTOCOCCI; INFECTION; DIAGNOSIS; COMPLEX; AVIUM	Tuberculosis-like lesions (TBL) in pigs have been associated with microorganisms other than mycobacteria. In this work a histopathological and microbiological evaluation of TBL in pigs is shown. A total of 352 samples belonging to 171 pigs totally condemned at slaughterhouse due to generalized TBL were sampled and selected for analysis. Pyogranulomatous (56.2%) and granulomatous lesions (20.2%) were observed in all analysed organs. Most of the granulomas observed in both lymph nodes and lungs belonged to more advanced stages of development (stages III and IV) whereas in the liver and the spleen most of lesions belonged to intermediate stages (stages II and III). Different microorganisms were simultaneously detected from TBL in the 42.7% of the animals. Mycobacterium tuberculosis complex (MTC) (38%), coryneform bacteria (40.3%) and streptococci (28.1%) were the main groups of microorganisms detected after bacteriological analysis, with Trueperella pyogenes and Streptococcus suis as the most frequently isolated species. Mycobacteria belonging to MTC were the most frequently detected pathogens in granulomatous and pyogranulomatous lesions in submandibular lymph nodes (32.7%) and coryneform bacteria were the microorganisms more frequently isolated from lungs (25.9%) and spleen samples (37.2%). These results may provide new insights into the pathogenesis and diagnosis of this pathology. The importance of coryneform bacteria and streptococci in such processes must be evaluated in future studies.	[Cardoso-Toset, Fernando; Astorga, Rafael J.; Luque, Inmaculada] Int Excellence Agrifood Campus, Fac Vet Med, Dept Anim Hlth, CeiA3, Cordoba, Spain; [Cardoso-Toset, Fernando; Gomez-Laguna, Jaime] CICAP Food Res Ctr, Dept R&D, Cordoba, Spain; [Amarilla, Shyrley P.; Carrasco, Librado] Int Excellence Agrifood Campus, Fac Vet Med, Dept Anat & Comparat Pathol, CeiA3, Cordoba, Spain; [Vela, Ana I.; Fernandez-Garayzabal, Jose F.] Univ Complutense, Fac Vet Med, Dept Anim Hlth, E-28040 Madrid, Spain; [Vela, Ana I.; Fernandez-Garayzabal, Jose F.] Univ Complutense, Fac Vet Med, VISAVET Hlth Surveillance Ctr, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Cardoso-Toset, F (corresponding author), Int Excellence Agrifood Campus, Fac Vet Med, Dept Anim Hlth, CeiA3, Cordoba, Spain.	v52catof@uco.es	Luque, Inmaculada/R-9952-2019; studies, IT VISAVET Account for bibliometric/C-3115-2014; Gomez-Laguna, Jaime/AAP-6053-2020; Luque, Inmaculada/K-9464-2014; Vela, Ana I/K-8015-2014; Otero, Librado Carrasco/AAN-8170-2021; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Gomez-Laguna, Jaime/M-1411-2014	Luque, Inmaculada/0000-0003-1838-2636; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Luque, Inmaculada/0000-0003-1838-2636; Vela, Ana I/0000-0001-5004-3103; Otero, Librado Carrasco/0000-0002-4823-758X; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Gomez-Laguna, Jaime/0000-0002-1787-5642; Amarilla, Shyrley Paola/0000-0001-5943-4901	Council of Economy, Science, Innovation and Employment of the Andalusian Government [AGR-2685-2012]; Centre for the Development of Industrial Technology (CDTI) of Spain [IDI-20111632/IDI-20111633]; Agrifood Campus of International Excellence Programme (ceiA3) from the Ministry of Education, Culture and Sport; Santander Universities Global Division	Council of Economy, Science, Innovation and Employment of the Andalusian Government; Centre for the Development of Industrial Technology (CDTI) of Spain; Agrifood Campus of International Excellence Programme (ceiA3) from the Ministry of Education, Culture and Sport; Santander Universities Global Division	This study was financially supported by the Council of Economy, Science, Innovation and Employment of the Andalusian Government (AGR-2685-2012) and by the Centre for the Development of Industrial Technology (CDTI) of Spain (project reference IDI-20111632/IDI-20111633). Cardoso-Toset F was funded by a grant of the Agrifood Campus of International Excellence Programme (ceiA3) from the Ministry of Education, Culture and Sport and by the Santander Universities Global Division.	Adderson EE, 2008, J CLIN MICROBIOL, V46, P921, DOI 10.1128/JCM.01849-07; Bailey SS, 2013, VET J, V198, P391, DOI 10.1016/j.tvjl.2013.08.035; Lara GHB, 2011, RES VET SCI, V90, P185, DOI 10.1016/j.rvsc.2010.06.009; Cardoso-Toset F, 2015, VET J; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081337; Di Marco V, 2012, J CLIN MICROBIOL, V50, P1209, DOI 10.1128/JCM.06544-11; Domingo M, 2014, RES VET SCI, V97, pS20, DOI 10.1016/j.rvsc.2014.03.017; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Garcia-Jimenez WL, 2013, VET IMMUNOL IMMUNOP, V156, P54, DOI 10.1016/j.vetimm.2013.09.008; Gomez-Laguna J, 2010, J VET DIAGN INVEST, V22, P123, DOI 10.5533/2177-8264-201022303; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; Katsumi M, 1998, J VET MED SCI, V60, P129, DOI 10.1292/jvms.60.129; Komijn RE, 2007, VET MICROBIOL, V120, P352, DOI 10.1016/j.vetmic.2006.10.031; Makrai L, 2008, VET MICROBIOL, V131, P318, DOI 10.1016/j.vetmic.2008.04.009; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Martinez J, 2007, VET J, V174, P160, DOI 10.1016/j.tvjl.2006.05.005; Miranda C, 2012, J COMP PATHOL, V147, P401, DOI 10.1016/j.jcpa.2012.05.005; Oliveira M, 2014, BMC VET RES, V218, P1; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; de Val BP, 2014, VET REC, V174, P96, DOI 10.1136/vr.101886; Radostits OM., 2007, VET MED TXB DIS CATT, V10. ed, P2156; Ribeiro MG, 2015, VET QUART, V35, P82, DOI 10.1080/01652176.2015.1022667; Rzewuska M, 2012, VET MICROBIOL, V160, P69, DOI 10.1016/j.vetmic.2012.05.004; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Smibert RM, 1994, METHODS GEN MOL BACT; Ulbegi-Mohyla H, 2009, RES VET SCI, V87, P186, DOI 10.1016/j.rvsc.2009.01.008; Vela AI, 2003, INT J SYST EVOL MICR, V53, P2027, DOI 10.1099/ijs.0.02645-0; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43	34	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139130	10.1371/journal.pone.0139130	http://dx.doi.org/10.1371/journal.pone.0139130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418681	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000362171400048
J	Chao, DHM; Kallemeijn, WW; Marques, ARA; Orre, M; Ottenhoff, R; van Roomen, C; Foppen, E; Renner, MC; Moeton, M; van Eijk, M; Boot, RG; Kamphuis, W; Hol, EM; Aten, J; Overkleeft, HS; Kalsbeek, A; Aerts, JMFG				Chao, Daniela Herrera Moro; Kallemeijn, Wouter W.; Marques, Andre R. A.; Orre, Marie; Ottenhoff, Roelof; van Roomen, Cindy; Foppen, Ewout; Renner, Maria C.; Moeton, Martina; van Eijk, Marco; Boot, Rolf G.; Kamphuis, Willem; Hol, Elly M.; Aten, Jan; Overkleeft, Hermen S.; Kalsbeek, Andries; Aerts, Johannes M. F. G.			Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes	PLOS ONE			English	Article							GAUCHER-DISEASE; ALPHA-SYNUCLEIN; BETA-GLUCOCEREBROSIDASE; PARKINSONS-DISEASE; MOUSE MODEL; INHIBITORS; IDENTIFICATION; EXPRESSION; MUTATIONS; BETA-GLUCOSIDASE-2	Gaucher disease is characterized by lysosomal accumulation of glucosylceramide due to deficient activity of lysosomal glucocerebrosidase (GBA). In cells, glucosylceramide is also degraded outside lysosomes by the enzyme glucosylceramidase 2 (GBA2) of which inherited deficiency is associated with ataxias. The interest in GBA and glucosylceramide metabolism in the brain has grown following the notion that mutations in the GBA gene impose a risk factor for motor disorders such as alpha-synucleinopathies. We earlier developed a beta-glucopyranosylconfigured cyclophellitol-epoxide type activity based probe (ABP) allowing in vivo and in vitro visualization of activemolecules of GBA with high spatial resolution. Labeling occurs through covalent linkage of the ABP to the catalytic nucleophile residue in the enzyme pocket. Here, we describe a method to visualize active GBA molecules in rat brain slices using in vivo labeling. Brain areas related to motor control, like the basal ganglia and motor related structures in the brainstem, show a high content of active GBA. We also developed a beta-glucopyranosyl cyclophellitol-aziridine ABP allowing in situ labeling of GBA2. Labeled GBA2 in brain areas can be identified and quantified upon gel electrophoresis. The distribution of active GBA2 markedly differs from that of GBA, being highest in the cerebellar cortex. The histological findings with ABP labeling were confirmed by biochemical analysis of isolated brain areas. In conclusion, ABPs offer sensitive tools to visualize active GBA and to study the distribution of GBA2 in the brain and thus may find application to establish the role of these enzymes in neurodegenerative disease conditions such as alpha-synucleinopathies and cerebellar ataxia.	[Chao, Daniela Herrera Moro; Kallemeijn, Wouter W.; Marques, Andre R. A.; Ottenhoff, Roelof; van Roomen, Cindy] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Chao, Daniela Herrera Moro; Foppen, Ewout; Kalsbeek, Andries] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Orre, Marie; Renner, Maria C.; Moeton, Martina; Kamphuis, Willem; Hol, Elly M.; Kalsbeek, Andries] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Hol, Elly M.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hol, Elly M.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Overkleeft, Hermen S.] Leiden Univ, Leiden Inst Chem, Dept Bioorgan Synth, NL-2300 RA Leiden, Netherlands; [Kallemeijn, Wouter W.; van Eijk, Marco; Boot, Rolf G.; Aerts, Johannes M. F. G.] Leiden Insitute Chem, Dept Biochem, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC	Aerts, JMFG (corresponding author), Leiden Insitute Chem, Dept Biochem, Leiden, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Marques, André R. A./Q-3892-2018; Kalsbeek, Andries/H-3076-2019; Hol, Elly M/F-1891-2013; Hol, Elly/J-2025-2019; Kallemeijn, Wouter W./F-6801-2014; Aerts, Johannes/A-1028-2009; Kallemeijn, W. W./P-2768-2019	Marques, André R. A./0000-0001-9674-3017; Kalsbeek, Andries/0000-0001-9606-8453; Hol, Elly M/0000-0001-5604-2603; Hol, Elly/0000-0001-5604-2603; Kallemeijn, Wouter W./0000-0002-3660-2930; Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, W. W./0000-0002-3660-2930; Overkleeft, Herman/0000-0001-6976-7005; Boot, Rolf/0000-0002-7031-3390; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112; Herrera Moro Chao, Daniela/0000-0001-8406-1377				AERTS JMFG, 1985, EUR J BIOCHEM, V150, P565, DOI 10.1111/j.1432-1033.1985.tb09058.x; Aerts JMFG, 2011, J INHERIT METAB DIS, V34, P605, DOI 10.1007/s10545-011-9308-6; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Farfel-Becker T, 2014, HUM MOL GENET, V23, P843, DOI 10.1093/hmg/ddt468; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Ghisaidoobe AT, 2014, J MED CHEM, V57, P9096, DOI 10.1021/jm501181z; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Jiang JB, 2015, CHEM SCI, V6, P2782, DOI 10.1039/c4sc03739a; Kallemeijn WW, 2014, J BIOL CHEM, V289, P35351, DOI 10.1074/jbc.M114.593376; Kallemeijn WW, 2014, ADV CARBOHYD CHEM BI, V71, P297, DOI 10.1016/B978-0-12-800128-8.00004-2; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Karssen AM, 2004, ANN NY ACAD SCI, V1032, P308, DOI 10.1196/annals.1314.048; Li KY, 2014, ORG BIOMOL CHEM, V12, P7786, DOI 10.1039/c4ob01611d; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Nordstrom V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001506; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Poole RM, 2014, DRUGS, V74, P1829, DOI 10.1007/s40265-014-0296-3; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Ron I, 2010, HUM MOL GENET, V19, P3771, DOI 10.1093/hmg/ddq292; Rothaug M, 2014, P NATL ACAD SCI USA, V111, P15573, DOI 10.1073/pnas.1405700111; Sardi SP, 2015, PROG NEUROBIOL, V125, P47, DOI 10.1016/j.pneurobio.2014.12.001; Sardi SP, 2012, NEURODEGENER DIS, V10, P195, DOI 10.1159/000335038; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schapira AH, 2015, MOL CELL NEUROSCI; Sekiyama K, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/271732; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Willems LI, 2014, CHEM-EUR J, V20, P10864, DOI 10.1002/chem.201404014; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	47	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138107	10.1371/journal.pone.0138107	http://dx.doi.org/10.1371/journal.pone.0138107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418157	Green Submitted, gold, Green Published			2022-12-26	WOS:000362171400010
J	Dyer, L; Lockyer, P; Wu, YX; Saha, A; Cyr, C; Moser, M; Pi, XC; Patterson, C				Dyer, Laura; Lockyer, Pamela; Wu, Yaxu; Saha, Arnab; Cyr, Chelsea; Moser, Martin; Pi, Xinchun; Patterson, Cam			BMPER Promotes Epithelial-Mesenchymal Transition in the Developing Cardiac Cushions	PLOS ONE			English	Article							NEURAL CREST; HEART; PROTEIN; FIELD; CELLS; SOX9; ALK3	Formation of the cardiac valves is an essential component of cardiovascular development. Consistent with the role of the bone morphogenetic protein (BMP) signaling pathway in cardiac valve formation, embryos that are deficient for the BMP regulator BMPER (BMP-binding endothelial regulator) display the cardiac valve anomaly mitral valve prolapse. However, how BMPER deficiency leads to this defect is unknown. Based on its expression pattern in the developing cardiac cushions, we hypothesized that BMPER regulates BMP2-mediated signaling, leading to fine-tuned epithelial-mesenchymal transition (EMT) and extracellular matrix deposition. In the BMPER-/- embryo, EMT is dysregulated in the atrioventricular and outflow tract cushions compared with their wild-type counterparts, as indicated by a significant increase of Sox9-positive cells during cushion formation. However, proliferation is not impaired in the developing BMPER-/- valves. In vitro data show that BMPER directly binds BMP2. In cultured endothelial cells, BMPER blocks BMP2-induced Smad activation in a dose-dependent manner. In addition, BMP2 increases the Sox9 protein level, and this increase is inhibited by co-treatment with BMPER. Consistently, in the BMPER-/- embryos, semi-quantitative analysis of Smad activation shows that the canonical BMP pathway is significantly more active in the atrioventricular cushions during EMT. These results indicate that BMPER negatively regulates BMP-induced Smad and Sox9 activity during valve development. Together, these results identify BMPER as a regulator of BMP2-induced cardiac valve development and will contribute to our understanding of valvular defects.	[Dyer, Laura; Wu, Yaxu; Saha, Arnab; Cyr, Chelsea; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Lockyer, Pamela] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Moser, Martin] Univ Freiburg, Ctr Heart, Cardiol & Angiol 1, D-79106 Freiburg, Germany; [Pi, Xinchun] Baylor Coll Med, Dept Med Athero & Lipo, Cardiovasc Res Inst, Houston, TX 77030 USA; [Patterson, Cam] New York Presbyterian Hosp, New York, NY 10065 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Baylor College of Medicine; NewYork-Presbyterian Hospital	Pi, XC (corresponding author), Baylor Coll Med, Dept Med Athero & Lipo, Cardiovasc Res Inst, Houston, TX 77030 USA.	xpi@bcm.edu		Dyer, Laura/0000-0002-3052-4601	National Institutes of Health [R01HL061656, R01HL112890]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112890, R01HL061656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (http://report.nih.gov; grants #R01HL061656 and #R01HL112890 for XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Chakraborty S, 2010, PEDIATR CARDIOL, V31, P414, DOI 10.1007/s00246-009-9616-x; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Choi M, 2007, CIRC RES, V100, P220, DOI 10.1161/01.RES.0000257780.60484.6a; Dyer L, 2014, DEV BIOL, V386, P385, DOI 10.1016/j.ydbio.2013.12.019; Dyer LA, 2010, DEV BIOL, V348, P167, DOI 10.1016/j.ydbio.2010.09.021; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lockhart MM, 2014, DEV BIOL, V396, P8, DOI 10.1016/j.ydbio.2014.09.031; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Moreno-Miralles I, 2011, ARTERIOSCL THROM VAS, V31, P2216, DOI 10.1161/ATVBAHA.111.230235; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Van den Berg G, 2007, ANAT REC, V290, P783, DOI 10.1002/ar.20559; Waldo KL, 1996, DEV DYNAM, V205, P281, DOI 10.1002/(SICI)1097-0177(199603)205:3<281::AID-AJA8>3.0.CO;2-E; Willis MS, 2013, CARDIOVASC PATHOL, V22, P228, DOI 10.1016/j.carpath.2012.10.005; Zakin L, 2008, DEV BIOL, V323, P6, DOI 10.1016/j.ydbio.2008.08.019; Zhang J, 2010, CIRC RES, V107, P1209, DOI 10.1161/CIRCRESAHA.110.225318	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139209	10.1371/journal.pone.0139209	http://dx.doi.org/10.1371/journal.pone.0139209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418455	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400064
J	Kawazoe, Y; Miyauchi, M; Nagasaki, A; Furusho, H; Yanagisawa, S; Chanbora, C; Inubushi, T; Hyogo, H; Nakamoto, T; Suzuki, K; Moriwaki, S; Tazuma, S; Niida, S; Takata, T				Kawazoe, Yusuke; Miyauchi, Mutsumi; Nagasaki, Atsuhiro; Furusho, Hisako; Yanagisawa, Syunryo; Chanbora, Chea; Inubushi, Toshihiro; Hyogo, Hideyuki; Nakamoto, Takashi; Suzuki, Keiko; Moriwaki, Sawako; Tazuma, Susumu; Niida, Shumpei; Takata, Takashi			Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-gamma-Glutamyl Transpeptidase Antibody	PLOS ONE			English	Article							BILE-DUCT OBSTRUCTION; HEPATIC OSTEODYSTROPHY; EXPRESSION; OSTEOPOROSIS; ALPHA; RATS; HYPERBILIRUBINEMIA; OSTEOCLASTOGENESIS; TRANSFERASE; SERUM	Background Cholestatic liver diseases exhibit higher levels of serum gamma-glutamyl transpeptidase (GGT) and incidence of secondary osteoporosis. GGT has been identified as a novel bone-resorbing factor that stimulates osteoclast formation. The aim of this study was to elucidate the interaction of elevated GGT levels and cholestatic liver disease-induced bone loss. Methods Wistar rats were divided into three groups: sham-operated control (SO) rats, bile duct ligation (BDL) rats, and anti-GGT antibody-treated BDL rats (AGT). Serum GGT level was measured. Bone mineral density (BMD) was analyzed by dual-energy X-ray absorptiometry. Bone morphometric parameters and microarchitectural properties were determined by micro-computed tomography and histomorphometry of the distal metaphysis of femurs. Alterations of bone metabolism-related factors were evaluated by cytokine array. Effects of GGT on osteoblasts or stromal cells were evaluated by RT-PCR, enzyme activity, and mineralization ability. Results Serum levels of GGT were significantly elevated in the BDL-group. In the BDL group, BMD, bone mass percentage, and osteoblast number were significantly decreased, whereas osteoclast number was significantly increased. These alterations were markedly attenuated in the AGT group. The mRNA levels of vascular endothelial growth factor-A, LPS-induced CXC chemokine, monocyte chemoattractant protein-1, tumor necrosis factor-alpha interleukin-1 beta and receptor activator of nuclear factor-kappa B ligand were upregulated, and those of interferon-gamma and osteoprotegerin were downregulated in the GGT-treated stromal cells. Furthermore, GGT inhibited mineral nodule formation and expression of alkaline phosphatase and bone sialo-protein in osteoblastic cells. Conclusion Our results indicate that elevated GGT level is involved in hepatic osteodystrophy through secretion of bone resorbing factor from GGT-stimulated osteoblasts/bone marrow stromal cells. In addition, GGT also possesses suppressive effects on bone formation. Managing elevated GGT levels by anti-GGT antibody may become a novel therapeutic agent for hepatic osteodystrophy in chronic liver diseases.	[Kawazoe, Yusuke; Miyauchi, Mutsumi; Nagasaki, Atsuhiro; Furusho, Hisako; Yanagisawa, Syunryo; Chanbora, Chea; Inubushi, Toshihiro; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Hyogo, Hideyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Nakamoto, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Radiol, Hiroshima, Japan; [Suzuki, Keiko] Showa Univ, Sch Dent, Dept Pharmacol, Tokyo 142, Japan; [Moriwaki, Sawako; Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Biobank Om Unit, Obu, Aichi, Japan; [Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Showa University; National Center for Geriatrics & Gerontology; Hiroshima University	Niida, S (corresponding author), Natl Ctr Geriatr & Gerontol, Biobank Om Unit, Obu, Aichi, Japan.	sniida@ncgg.go.jp; ttakata@hiroshima-u.ac.jp	Miyauchi, Mutsumi/G-5268-2019; Furusho, Hisako/H-2351-2019		Ministry of Education, Science and Culture [21592328, 20390469]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for scientific research (C) from the Ministry of Education, Science and Culture (#21592328; https://kaken.nii.ac.jp/d/p/21592328.ja.html [MM] and #20390469 [SN]; https://kaken.nii.ac.jp/d/p/20390469.ja.html).	Ackerman Z, 2002, LIVER, V22, P166, DOI 10.1046/j.0106-9543.2002.01566.x; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; ATKINSON M, 1956, Q J MED, V25, P299; BESSEY OA, 1946, J BIOL CHEM, V164, P321; BULLE F, 1990, HEPATOLOGY, V11, P545, DOI 10.1002/hep.1840110404; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Collier J, 2007, HEPATOLOGY, V46, P1271, DOI 10.1002/hep.21852; Fernandez-Martinez E, 2006, EXP TOXICOL PATHOL, V58, P49, DOI 10.1016/j.etp.2006.03.002; Gasser RW, 2008, WIEN MED WOCHENSCHR, V158, P553, DOI 10.1007/s10354-008-0594-z; Gatta A, 2014, CLIN CASES MINER BON, V11, P185, DOI 10.11138/ccmbm/2014.11.3.185; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; Hiramatsu K, 2007, ENDOCRINOLOGY, V148, P2708, DOI 10.1210/en.2007-0215; IKEDA Y, 1995, P NATL ACAD SCI USA, V92, P126, DOI 10.1073/pnas.92.1.126; Ishizuka Y, 2007, J BONE MINER RES, V22, P1933, DOI 10.1359/JBMR.070726; JANES CH, 1995, J CLIN INVEST, V95, P2581, DOI 10.1172/JCI117959; Kitaura H, 2004, J IMMUNOL, V173, P4838, DOI 10.4049/jimmunol.173.8.4838; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; LIEBERMAN MW, 1995, AM J PATHOL, V147, P1175; Lopez-Larramona G, 2011, WORLD J HEPATOL, V3, P300, DOI 10.4254/wjh.v3.i12.300; Mansueto P, 2013, INTERN EMERG MED, V8, P377, DOI 10.1007/s11739-012-0753-5; MINKIN C, 1991, BONE MINER, V13, P191, DOI 10.1016/0169-6009(91)90068-B; Moon SS, 2012, ENDOCRINE, V42, P423, DOI 10.1007/s12020-012-9639-6; Nakchbandi IA, 2009, NAT REV GASTRO HEPAT, V6, P660, DOI 10.1038/nrgastro.2009.166; Niida S, 2004, J BIOL CHEM, V279, P5752, DOI 10.1074/jbc.M311905200; Nilsson M, 2008, J PERIODONTOL, V79, P1689, DOI 10.1902/jop.2008.070599 ; Pereira FA, 2009, CALCIFIED TISSUE INT, V85, P75, DOI 10.1007/s00223-009-9249-3; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Lacativa PGS, 2010, ARQ BRAS ENDOCRINOL, V54, P123, DOI 10.1590/S0004-27302010000200007; Smith DLH, 2006, J CLIN DENSITOM, V9, P105, DOI 10.1016/j.jocd.2005.10.001; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Weinreb M, 2004, J HEPATOL, V40, P385, DOI 10.1016/j.jhep.2003.11.032	32	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139620	10.1371/journal.pone.0139620	http://dx.doi.org/10.1371/journal.pone.0139620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418133	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400096
J	Sothmann, P; Krumkamp, R; Kreuels, B; Sarpong, N; Frank, C; Ehlkes, L; Fobil, J; Gyau, K; Jaeger, A; Bosu, B; Marks, F; Owusu-Dabo, E; Salzberger, B; May, J				Sothmann, Peter; Krumkamp, Ralf; Kreuels, Benno; Sarpong, Nimako; Frank, Clemens; Ehlkes, Lutz; Fobil, Julius; Gyau, Kennedy; Jaeger, Anna; Bosu, Benedicta; Marks, Florian; Owusu-Dabo, Ellis; Salzberger, Bernd; May, Juergen			Urbanicity and Paediatric Bacteraemia in Ghana-A Case-Control Study within a Rural-Urban Transition Zone	PLOS ONE			English	Article							CHILDREN; MALARIA; HEALTH; URBANIZATION; AFRICA; FEVER; POOR; AREA	Background Systemic bacterial infections are a major cause of paediatric febrile illness in sub-Saharan Africa. Aim of this study was to assess the effects of social and geographical determinants on the risk of bacteraemia in a rural-urban transition zone in Ghana. Methods Children below 15 years of age with fever were recruited at an outpatient department in the suburban belt of Kumasi, Ghana's second largest city. Blood was taken for bacterial culture and malaria diagnostics. The socio-economic status of participants was calculated using Principle Component Analysis. A scale, based on key urban characteristics, was established to quantify urbanicity for all communities in the hospital catchment area. A case-control analysis was conducted, where children with and without bacteraemia were cases and controls, respectively. Results Bacteraemia was detected in 72 (3.1%) of 2,306 hospital visits. Non-typhoidal Salmonella (NTS; n = 24; 33.3%) and Salmonella typhi (n = 18; 25.0%) were the most common isolates. Logistic regression analysis showed that bacteraemia was negatively associated with urbanicity (odds ratio [OR] = 0.8; 95% confidence interval [CI]: 0.7-1.0) and socio-economic status (OR = 0.8; 95% CI: 0.6-0.9). Both associations were stronger if only NTS infections were used as cases (OR = 0.5; 95% CI: 0.3-0.8 and OR = 0.6; 95% CI: 0.4-1.0, respectively). Conclusions The results of this study highlight the importance of individual as well as community factors as independent risk factors for invasive bacterial infection (IBI) and especially NTS. Epidemiological data support physicians, public health experts and policy makers to identify disease prevention and treatment needs in order to secure public health in the transitional societies of developing countries.	[Sothmann, Peter; Krumkamp, Ralf; Kreuels, Benno; Frank, Clemens; Ehlkes, Lutz; Jaeger, Anna; May, Juergen] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, D-20359 Hamburg, Germany; [Sothmann, Peter; Kreuels, Benno] Univ Med Ctr Hamburg Eppendorf UKE, Dept Med 1, Div Trop Med, Hamburg, Germany; [Krumkamp, Ralf; Kreuels, Benno; May, Juergen] Partner Site Hamburg Borstel Lubeck, German Ctr Infect Res DZIF, Hamburg, Germany; [Sarpong, Nimako; Gyau, Kennedy; Bosu, Benedicta; Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Frank, Clemens] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Fobil, Julius] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Marks, Florian] Int Vaccine Inst, Seoul, South Korea; [Salzberger, Bernd] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; Kumasi Center for Collaborative Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Ghana; International Vaccine Institute; University of Regensburg	Krumkamp, R (corresponding author), Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	krumkamp@bnitm.de		Marks, Florian/0000-0002-6043-7170; May, Jurgen/0000-0001-7831-8420; Ehlkes, Lutz/0000-0002-0143-7154	Bill & Melinda Gates Foundation [OPPGH5231]; German Centre for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF) [80 00 201-3, TI 03.001, TI 07.001]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); German Centre for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF)	This work was supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/de, grant number: OPPGH5231), as well as by grants from the German Centre for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF, www.dzif.de) to Ralf Krumkamp (grant number: 80 00 201-3, TI 03.001) and Benno Kreuels (grant number: TI 07.001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs HM, 2014, CLIN INFECT DIS, P1; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Cyril S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-513; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; DeVellis RF., 2003, APPL SOCIAL RES METH, V2nd; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Ghana Statistical Service, 2013, 2010 POP HOUS CENS; Ghana Statistical Service, 2010, 2010 POP HOUS CENS; Hay SI, 2005, URBANIZATION MALARIA, V3, P1; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117; Netemeyer R.G., 2003, SCALING PROCEDURES I; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Razak F, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001684; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Takem EN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-400; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; UN Inter-agency Group for Child Mortality Estimation, 2021, LEVELS TRENDS CHILD; UN-HABITAT, 2014, STAT AFR CIT 2014 RE, DOI [10.2174/97816080506351100101, DOI 10.2174/97816080506351100101]; UNICEF, STAT GLANC GHAN; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; WHO, 2013, WORLD MALARIA REPORT 2013, P1	34	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139433	10.1371/journal.pone.0139433	http://dx.doi.org/10.1371/journal.pone.0139433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418004	gold, Green Published			2022-12-26	WOS:000362171400091
J	Toren-Haritan, G; Efrat, S				Toren-Haritan, Ginat; Efrat, Shimon			TGF beta Pathway Inhibition Redifferentiates Human Pancreatic Islet beta Cells Expanded In Vitro	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; INSULIN GENE-TRANSCRIPTION; PROTEIN-KINASE B; SIGNALING PATHWAY; MAFA; MECHANISMS; CANCER; PHOSPHORYLATION; DIFFERENTIATION	In-vitro expansion of insulin-producing cells from adult human pancreatic islets could provide an abundant cell source for diabetes therapy. However, proliferation of beta-cell-derived (BCD) cells is associated with loss of phenotype and epithelial-mesenchymal transition (EMT). Nevertheless, BCD cells maintain open chromatin structure at beta-cell genes, suggesting that they could be readily redifferentiated. The transforming growth factor beta (TGF beta) pathway has been implicated in EMT in a range of cell types. Here we show that human islet cell expansion in vitro involves upregulation of the TGF beta pathway. Blocking TGF beta pathway activation using short hairpin RNA (shRNA) against TGF Chi Receptor 1 (TGFBR1, ALK5) transcripts inhibits BCD cell proliferation and dedifferentiation. Treatment of expanded BCD cells with ALK5 shRNA results in their redifferentiation, as judged by expression of beta-cell genes and decreased cell proliferation. These effects, which are reproducible in cells from multiple human donors, are mediated, at least in part, by AKT-FOXO1 signaling. ALK5 inhibition synergizes with a soluble factor cocktail to promote BCD cell redifferentiation. The combined treatment may offer a therapeutically applicable way for generating an abundant source of functional insulin-producing cells following ex-vivo expansion.	[Toren-Haritan, Ginat; Efrat, Shimon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Efrat, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X	Israel Science Foundation [916/11]	Israel Science Foundation(Israel Science Foundation)	Support was provided by the Israel Science Foundation 916/11 [http://www.isf.org.il/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kelly RJ, 2010, J IMMUNOTOXICOL, V7, P15, DOI 10.3109/15476910903389920; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lenz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112914; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsumura H, 2007, BIOCHEM BIOPH RES CO, V364, P151, DOI 10.1016/j.bbrc.2007.09.110; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nathan G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122108; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sintov E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13024; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu YF, 2009, J NEPHROL, V22, P403; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	48	23	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139168	10.1371/journal.pone.0139168	http://dx.doi.org/10.1371/journal.pone.0139168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418361	gold, Green Submitted, Green Published			2022-12-26	WOS:000362171400056
J	Wong, DY; Ranganath, T; Kasko, AM				Wong, Darice Y.; Ranganath, Thanmayi; Kasko, Andrea M.			Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; CULTURED HUMAN KERATINOCYTES; SINGLET OXYGEN; PHOTODEGRADABLE HYDROGELS; FAMILY-MEMBERS; DRUG-DELIVERY; KAPPA-B; ACTIVATION; P53; PHOTOPOLYMERIZATION	Light is a non-invasive tool that is widely used in a range of biomedical applications. Techniques such as photopolymerization, photodegradation, and photouncaging can be used to alter the chemical and physical properties of biomaterials in the presence of live cells. Long-wave UV light (315 nm-400 nm) is an easily accessible and commonly used energy source for triggering biomaterial changes. Although exposure to low doses of long-wave UV light is generally accepted as biocompatible, most studies employing this wavelength only establish cell viability, ignoring other possible (non-toxic) effects. Since light exposure of wavelengths longer than 315 nm may potentially induce changes in cell behavior, we examined changes in gene expression of human mesenchymal stem cells exposed to light under both 2D and 3D culture conditions, including two different hydrogel fabrication techniques, decoupling UV exposure and radical generation. While exposure to long-wave UV light did not induce significant changes in gene expression regardless of culture conditions, significant changes were observed due to scaffold fabrication chemistry and between cells plated in 2D versus encapsulated in 3D scaffolds. In order to facilitate others in searching for more specific changes between the many conditions, the full data set is available on Gene Expression Omnibus for querying.	[Wong, Darice Y.; Ranganath, Thanmayi; Kasko, Andrea M.] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA 90042 USA	University of California System; University of California Los Angeles	Kasko, AM (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA 90042 USA.	akasko@ucla.edu	Ranganath, Thanmayi/N-8616-2019	Ranganath, Thanmayi/0000-0001-9865-2119	National Institutes of Health through the NIH Director's New Innovator Award Program [1-DP2-OD008533]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008533] Funding Source: NIH RePORTER	National Institutes of Health through the NIH Director's New Innovator Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD008533 awarded to AK. The website for this funding program is http://commonfund.nih.gov/newinnovator/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASUMODAK S, 1993, CANCER RES, V53, P4505; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang TY, ANN REV CELL DEV BIO, V222006, P129; Chaudhuri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7365; Chaudhuri O, 2012, NAT MATER, V11, P568, DOI 10.1038/nmat3366; Djavaheri-Mergny M, 2001, EXP DERMATOL, V10, P204, DOI 10.1034/j.1600-0625.2001.010003204.x; Djavaheri-Mergny M, 1999, BIOCHEM J, V338, P607, DOI 10.1042/0264-6021:3380607; DjavaheriMergny M, 1996, FEBS LETT, V384, P92, DOI 10.1016/0014-5793(96)00294-3; Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W; Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037; GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586; Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s; Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w; Griffin DR, 2010, BIOTECHNOL BIOENG, V107, P1012, DOI 10.1002/bit.22882; Groves JT, 2007, ANNU REV PHYS CHEM, V58, P697, DOI 10.1146/annurev.physchem.56.092503.141216; Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HARRIS MG, 1993, OPTOMETRY VISION SCI, V70, P839, DOI 10.1097/00006324-199310000-00011; Hensman C, 1998, SURG ENDOSC-ULTRAS, V12, P335, DOI 10.1007/s004649900665; HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Iwaguchi S, 2000, COLLOID SURFACE B, V18, P113, DOI 10.1016/S0927-7765(99)00144-7; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kawabata K, 2013, J TOXICOL SCI, V38, P215, DOI 10.2131/jts.38.215; Kersters I, 1998, INDIAN J ENG MATER S, V5, P211; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lajoie P, INT REV CELL MOL BIO, V282, P135; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Lippincott-Schwartz J, ANN REV BIOPHYSICS, V39, P559; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236; Maziere C, 2000, FREE RADICAL BIO MED, V28, P1430, DOI 10.1016/S0891-5849(00)00264-1; Menicanin D, 2009, STEM CELL REV REP, V5, P36, DOI 10.1007/s12015-009-9056-2; Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034; Occhetta P, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035002; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Shamay Y, 2011, BIOMATERIALS, V32, P1377, DOI 10.1016/j.biomaterials.2010.10.029; Silvers AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P302, DOI 10.1562/0031-8655(2002)075<0302:UIIAOA>2.0.CO;2; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; VILE GF, 1995, PHOTOCHEM PHOTOBIOL, V62, P463, DOI 10.1111/j.1751-1097.1995.tb02369.x; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024; WLASCHEK M, 1995, J INVEST DERMATOL, V104, P194, DOI 10.1111/1523-1747.ep12612751; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200	65	46	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139307	10.1371/journal.pone.0139307	http://dx.doi.org/10.1371/journal.pone.0139307			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418040	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400073
J	Delhomme, N; Sundstrom, G; Zamani, N; Lantz, H; Lin, YC; Hvidsten, TR; Hoppner, MP; Jern, P; Van de Peer, Y; Lundeberg, J; Grabherr, MG; Street, NR				Delhomme, Nicolas; Sundstrom, Gorel; Zamani, Neda; Lantz, Henrik; Lin, Yao-Cheng; Hvidsten, Torgeir R.; Hoppner, Marc P.; Jern, Patric; Van de Peer, Yves; Lundeberg, Joakim; Grabherr, Manfred G.; Street, Nathaniel R.			Serendipitous Meta-Transcriptomics: The Fungal Community of Norway Spruce (Picea abies)	PLOS ONE			English	Article							RNA-SEQ DATA; SEQUENCE	After performing de novo transcript assembly of >1 billion RNA-Sequencing reads obtained from 22 samples of different Norway spruce (Picea abies) tissues that were not surface sterilized, we found that assembled sequences captured a mix of plant, lichen, and fungal transcripts. The latter were likely expressed by endophytic and epiphytic symbionts, indicating that these organisms were present, alive, and metabolically active. Here, we show that these serendipitously sequenced transcripts need not be considered merely as contamination, as is common, but that they provide insight into the plant's phyllosphere. Notably, we could classify these transcripts as originating predominantly from Dothideomycetes and Leotiomycetes species, with functional annotation of gene families indicating active growth and metabolism, with particular regards to glucose intake and processing, as well as gene regulation.	[Delhomme, Nicolas; Sundstrom, Gorel; Zamani, Neda; Hvidsten, Torgeir R.; Street, Nathaniel R.] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, Umea, Sweden; [Sundstrom, Gorel; Zamani, Neda; Lantz, Henrik; Hoppner, Marc P.; Jern, Patric; Grabherr, Manfred G.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Lantz, Henrik; Hoppner, Marc P.; Grabherr, Manfred G.] BILS, Uppsala, Sweden; [Lin, Yao-Cheng; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9000 Ghent, Belgium; [Lin, Yao-Cheng; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Van de Peer, Yves] Univ Pretoria, Genom Res Inst, ZA-0002 Pretoria, South Africa; [Lundeberg, Joakim] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Solna, Sweden	Umea University; Uppsala University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Norwegian University of Life Sciences; University of Pretoria; Royal Institute of Technology	Street, NR (corresponding author), Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, Umea, Sweden.	nathaniel.street@umu.se	LIN, Yao-Cheng/B-4394-2008; Van de Peer, Yves/D-4388-2009; Jern, Patric/AAR-2133-2021; Delhomme, Nicolas/B-9187-2015; Hvidsten, Torgeir R./A-3409-2009; Street, Nathaniel Robert/B-3920-2008; Van de Peer, Yves/AAE-7666-2019	LIN, Yao-Cheng/0000-0002-9390-795X; Van de Peer, Yves/0000-0003-4327-3730; Jern, Patric/0000-0003-3393-5825; Delhomme, Nicolas/0000-0002-3053-0796; Hvidsten, Torgeir R./0000-0001-6097-2539; Street, Nathaniel Robert/0000-0001-6031-005X; Van de Peer, Yves/0000-0003-4327-3730; Grabherr, Manfred/0000-0001-8792-6508; Lantz, Henrik/0000-0003-2419-0075	Knut and Alice Wallenberg Foundation; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish foundation for Strategic Research (SSF); Trees and Crops for the Future project; Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks")	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Trees and Crops for the Future project; Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks")(Ghent University)	The authors would like to acknowledge support from the Knut and Alice Wallenberg Foundation. Additional funding was provided by the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (Vinnova), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), the Swedish foundation for Strategic Research (SSF), the Trees and Crops for the Future project, and Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks").	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grabherr MG, 2010, BIOINFORMATICS, V26, P1145, DOI 10.1093/bioinformatics/btq102; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Muller MM, 2000, MYCOL RES, V104, P1139, DOI 10.1017/S0953756200003105; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Rajala T, 2013, FUNGAL BIOL-UK, V117, P182, DOI 10.1016/j.funbio.2013.01.006; Street NR, 2006, PLANT J, V48, P321, DOI 10.1111/j.1365-313X.2006.02864.x; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	12	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139080	10.1371/journal.pone.0139080	http://dx.doi.org/10.1371/journal.pone.0139080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413905	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700039
J	Hotaling, JM; Cohen, AL; Shiffrin, RM; Busemeyer, JR				Hotaling, Jared M.; Cohen, Andrew L.; Shiffrin, Richard M.; Busemeyer, Jerome R.			The Dilution Effect and Information Integration in Perceptual Decision Making	PLOS ONE			English	Article							VISUAL-PERCEPTION; RULES; CATEGORIZATION; HEURISTICS; SIMILARITY; EXEMPLARS; JUDGMENT; SYSTEMS; MODEL	In cognitive science there is a seeming paradox: On the one hand, studies of human judgment and decision making have repeatedly shown that people systematically violate optimal behavior when integrating information from multiple sources. On the other hand, optimal models, often Bayesian, have been successful at accounting for information integration in fields such as categorization, memory, and perception. This apparent conflict could be due, in part, to different materials and designs that lead to differences in the nature of processing. Stimuli that require controlled integration of information, such as the quantitative or linguistic information (commonly found in judgment studies), may lead to suboptimal performance. In contrast, perceptual stimuli may lend themselves to automatic processing, resulting in integration that is closer to optimal. We tested this hypothesis with an experiment in which participants categorized faces based on resemblance to a family patriarch. The amount of evidence contained in the top and bottom halves of each test face was independently manipulated. These data allow us to investigate a canonical example of sub-optimal information integration from the judgment and decision making literature, the dilution effect. Splitting the top and bottom halves of a face, a manipulation meant to encourage controlled integration of information, produced farther from optimal behavior and larger dilution effects. The Multi-component Information Accumulation model, a hybrid optimal/averaging model of information integration, successfully accounts for key accuracy, response time, and dilution effects.	[Hotaling, Jared M.] Univ Basel, Dept Psychol, Basel, Switzerland; [Cohen, Andrew L.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Shiffrin, Richard M.; Busemeyer, Jerome R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Basel; University of Massachusetts System; University of Massachusetts Amherst; Indiana University System; Indiana University Bloomington	Hotaling, JM (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	jaredhotaling@gmail.com	Hotaling, Jared/AAA-1025-2019; Busemeyer, Jerome R./H-9707-2017	Hotaling, Jared/0000-0001-7265-1310; Busemeyer, Jerome R./0000-0002-7594-1871	NSF GRF; NIMH [1 R01 MH12717, 1 R01 MH63993]; NIMH Cognition and Perception [MH068346]; NSF [0817965]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068346, R01MH063993, R01MH012717] Funding Source: NIH RePORTER	NSF GRF(National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH Cognition and Perception; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	J. M. H. was supported by an NSF GRF. A. L. C. and R. M. S. were supported by NIMH Grants 1 R01 MH12717 and 1 R01 MH63993. J. R. B. was supported by NIMH Cognition and Perception MH068346 and NSF Grant 0817965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SW, 1991, J EXP PSYCHOL GEN, V120, P3, DOI 10.1037/0096-3445.120.1.3; ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; ASHBY FG, 1992, J EXP PSYCHOL HUMAN, V18, P50, DOI 10.1037/0096-1523.18.1.50; ASHBY FG, 1990, J EXP PSYCHOL HUMAN, V16, P598, DOI 10.1037/0096-1523.16.3.598; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Auguie B, 2017, GRIDEXTRA MISCELLANE; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; Cohen AL, 2006, J EXP PSYCHOL HUMAN, V32, P574, DOI 10.1037/0096-1523.32.3.574; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Donovan S, 1997, J EXP SOC PSYCHOL, V33, P1, DOI 10.1006/jesp.1996.1309; Eaton JW, 2015, GNU OCTAVE 3 6 4; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Feller, 2008, INTRO PROBABILITY TH; Geisler WS, 2003, COGNITIVE SCI, V27, P379, DOI 10.1016/S0364-0213(03)00009-0; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Hammond K. R., 2000, JUDGMENTS STRESS; HAMMOND KR, 1987, IEEE T SYST MAN CYB, V17, P753, DOI 10.1109/TSMC.1987.6499282; Hastie R, 2001, ANNU REV PSYCHOL, V52, P653, DOI 10.1146/annurev.psych.52.1.653; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; LaBella C, 2004, MEM COGNITION, V32, P1076, DOI 10.3758/BF03196883; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Macmillan N. A., 2004, DETECTION THEORY USE; MARTIN LL, 1990, J PERS SOC PSYCHOL, V59, P27, DOI 10.1037/0022-3514.59.1.27; Massaro D.W., 1998, PERCEIVING TALKING F; McKenzie CRM, 2002, J BEHAV DECIS MAKING, V15, P1, DOI 10.1002/bdm.400; Moran R, 2015, PSYCHON B REV, V22, P38, DOI 10.3758/s13423-014-0669-3; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NISBETT RE, 1981, COGNITIVE PSYCHOL, V13, P248, DOI 10.1016/0010-0285(81)90010-4; Nosofsky RM, 1997, PSYCHOL REV, V104, P266, DOI 10.1037/0033-295X.104.2.266; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; ODEN GC, 1978, PSYCHOL REV, V85, P172, DOI 10.1037/0033-295X.85.3.172; Payne J. W., 1993, ADAPTIVE DECISION MA; Peters E, 2000, PERS SOC PSYCHOL B, V26, P177, DOI 10.1177/0146167200264005; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Runeson S, 2000, PSYCHOL REV, V107, P525, DOI 10.1037/0033-295X.107.3.525; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHANTEAU J, 1975, ACTA PSYCHOL, V39, P83, DOI 10.1016/0001-6918(75)90023-2; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sides A, 2002, MEM COGNITION, V30, P191, DOI 10.3758/BF03195280; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Tenenbaum JB, 2000, ADV NEUR IN, V12, P59; Tenenbaum JB, 1999, ADV NEUR IN, V11, P59; Trueblood JS, 2014, PSYCHOL REV, V121, P179, DOI 10.1037/a0036137; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1994, PSYCHOL REV, V101, P547, DOI 10.1037/0033-295X.101.4.547; TVERSKY A, 1972, PSYCHOL REV, V79, P281, DOI 10.1037/h0032955; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	56	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138481	10.1371/journal.pone.0138481	http://dx.doi.org/10.1371/journal.pone.0138481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406323	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700049
J	Hrynets, Y; Ndagijimana, M; Betti, M				Hrynets, Yuliya; Ndagijimana, Maurice; Betti, Mirko			Rapid Myoglobin Aggregation through Glucosamine-Induced alpha-Dicarbonyl Formation	PLOS ONE			English	Article							MAILLARD REACTION-PRODUCTS; GLYCATION END-PRODUCTS; ANTIOXIDANT CAPACITY; PROTEIN MODIFICATION; CIRCULAR-DICHROISM; DIABETES-MELLITUS; MASS-SPECTROMETRY; IN-VITRO; METHYLGLYOXAL; GLYOXAL	The extent of glycation and conformational changes of horse myoglobin (Mb) upon glycation with N-acetyl-glucosamine (GlcNAc), glucose (Glc) and glucosamine (GlcN) were investigated. Among tested sugars, the rate of glycation with GlcN was the most rapid as shown by MALDI and ESI mass spectrometries. Protein oxidation, as evaluated by the amount of carbonyl groups present on Mb, was found to increase exponentially in Mb-Glc conjugates over time, whereas in Mb-GlcN mixtures the carbonyl groups decreased significantly after maximum at 3 days of the reaction. The reaction between GlcN and Mb resulted in a significantly higher amount of alpha-dicarbonyl compounds, mostly glucosone and 3-deoxyglucosone, ranging from and 27 to 332 mg/L and from 14 to 304 mg/L, respectively. Already at 0.5 days, tertiary structural changes of Mb-GlcN conjugate were observed by altered tryptophan fluorescence. A reduction of metmyoglobin to deoxy-and oxymyoglobin forms was observed on the first day of reaction, coinciding with the greatest amount of glucosone produced. In contrast to native alpha-helical myoglobin, 41% of the glycated protein sequence was transformed into a beta-sheet conformation, as determined by circular dichroism spectropolarimetry. Transmission electron microscopy demonstrated that Mb glycation with GlcN causes the formation of amorphous or fibrous aggregates, started already at 3 reaction days. These aggregates bind to an amyloid-specific dye thioflavin T. With the aid of alpha-dicarbonyl compounds and advanced products of reaction, this study suggests that the Mb glycation with GlcN induces the unfolding of an initially globular protein structure into amyloid fibrils comprised of a beta-sheet structure.	[Hrynets, Yuliya; Ndagijimana, Maurice; Betti, Mirko] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta	Betti, M (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	Mirko.Betti@ales.ualberta.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) [http://www.nserc-crsng.gc.ca/].	Amoresano A, 2000, GLYCOBIOLOGY, V10, P451, DOI 10.1093/glycob/10.5.451; Bhattacherjee A, 2011, INT J BIOL MACROMOL, V48, P202, DOI 10.1016/j.ijbiomac.2010.11.003; Block JA, 2010, OSTEOARTHR CARTILAGE, V18, P5, DOI 10.1016/j.joca.2009.07.005; Bokiej M, 2011, BIOCHEM BIOPH RES CO, V407, P191, DOI 10.1016/j.bbrc.2011.02.138; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; Capuano E, 2011, LWT-FOOD SCI TECHNOL, V44, P793, DOI 10.1016/j.lwt.2010.11.002; Chan JTY, 2011, FOOD CHEM, V127, P109, DOI 10.1016/j.foodchem.2010.12.095; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009052; Chen L, 2009, CELL MOL LIFE SCI, V66, P2559, DOI 10.1007/s00018-009-0058-7; Fogliano V, 2011, FOOD FUNCT, V2, P117, DOI 10.1039/c0fo00156b; Gensberger S, 2012, ANAL BIOANAL CHEM, V403, P2923, DOI 10.1007/s00216-012-5817-x; Gersten RA, 2010, CARBOHYD RES, V345, P2499, DOI 10.1016/j.carres.2010.09.013; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Hail Mark E., 2004, American Biotechnology Laboratory, V22, P12; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Hauser C, 2014, FOOD CHEM, V145, P608, DOI 10.1016/j.foodchem.2013.08.083; Hofmann T, 1999, J AGR FOOD CHEM, V47, P379, DOI 10.1021/jf980626x; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Hrynets Y, 2015, J AGR FOOD CHEM, V63, P6249, DOI 10.1021/acs.jafc.5b02664; Hrynets Y, 2013, FOOD CHEM, V139, P1062, DOI 10.1016/j.foodchem.2013.02.026; HUNT JV, 1988, BIOCHEM J, V250, P87, DOI 10.1042/bj2500087; HUNT JV, 1991, FREE RADICAL RES COM, V12-3, P115, DOI 10.3109/10715769109145775; HUNT JV, 1993, BIOCHEM J, V291, P529, DOI 10.1042/bj2910529; Iannuzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080768; Jin RX, 2013, CARBOHYD RES, V370, P72, DOI 10.1016/j.carres.2012.07.001; Kanzler C, 2014, J AGR FOOD CHEM, V62, P2837, DOI 10.1021/jf404322r; Kapurniotu A, 1998, EUR J BIOCHEM, V251, P208, DOI 10.1046/j.1432-1327.1998.2510208.x; Liggins J, 1997, BBA-MOL BASIS DIS, V1361, P123, DOI 10.1016/S0925-4439(97)00023-9; Liu JH, 2012, FOOD RES INT, V49, P170, DOI 10.1016/j.foodres.2012.07.034; Liu Q, 2014, FOOD SCI BIOTECHNOL, V23, P33, DOI 10.1007/s10068-014-0005-8; Ma G, 2014, J SPECTROSC, V2014, DOI 10.1155/2014/285806; Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Monacelli F, 2013, INT J MOL SCI, V14, P10694, DOI 10.3390/ijms140610694; Mossine VV, 1999, CHEM RES TOXICOL, V12, P230, DOI 10.1021/tx980209e; Nagy A, 2009, CZECH J FOOD SCI, V27, P320, DOI 10.17221/48/2008-CJFS; Niwa T, 2001, KIDNEY INT, V59, pS37, DOI 10.1046/j.1523-1755.2001.59780037.x; Niwa T, 2006, MASS SPECTROM REV, V25, P713, DOI 10.1002/mas.20089; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Papetti A, 2014, FOOD CHEM, V164, P259, DOI 10.1016/j.foodchem.2014.05.022; Picotti P, 2004, PROTEIN SCI, V13, P1572, DOI 10.1110/ps.04635304; Qu CJ, 2006, BBA-MOL BASIS DIS, V1762, P453, DOI 10.1016/j.bbadis.2006.01.005; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Roberts NB, 2001, CLIN CHEM, V47, P316; Roncone R, 2004, EUR J INORG CHEM, P2203, DOI 10.1002/ejic.200400126; Rondeau P, 2011, PROTEIN AGGREGATION, P139; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Sajithlal GB, 1998, FREE RADICAL BIO MED, V25, P265, DOI 10.1016/S0891-5849(98)00035-5; Schwarzenbolz U, 1997, Z LEBENSM UNTERS F A, V205, P121, DOI 10.1007/s002170050137; Shimamura T, 2003, BIOSCI BIOTECH BIOCH, V67, P295, DOI 10.1271/bbb.67.295; Sirangelo I, 2002, J BIOL CHEM, V277, P45887, DOI 10.1074/jbc.M207659200; Stepuro II, 1997, BIOCHEMISTRY-MOSCOW+, V62, P967; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Summa C, 2008, MOL NUTR FOOD RES, V52, P342, DOI 10.1002/mnfr.200700403; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; SWAMY MJ, 1989, BIOSCIENCE REP, V9, P189, DOI 10.1007/BF01115995; Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z; Tang CH, 2011, J AGR FOOD CHEM, V59, P10114, DOI 10.1021/jf202517f; Tang J, 2004, J FOOD SCI, V69, pC717, DOI 10.1111/j.1365-2621.2004.tb09922.x; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Upmacis RK, 1997, J AM CHEM SOC, V119, P10424, DOI 10.1021/ja964249l; Uzzan M, 2007, J FOOD SCI, V72, pE109, DOI 10.1111/j.1750-3841.2007.00284.x; Villamena FA, 2013, MOLECULAR BASIS OF OXIDATIVE STRESS: CHEMISTRY, MECHANISMS, AND DISEASE PATHOGENESIS, P1, DOI 10.1002/9781118355886; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848; Zehl M, 2004, RAPID COMMUN MASS SP, V18, P1932, DOI 10.1002/rcm.1563; Zhang XF, 2004, ANAL BIOCHEM, V325, P255, DOI 10.1016/j.ab.2003.11.001	72	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139022	10.1371/journal.pone.0139022	http://dx.doi.org/10.1371/journal.pone.0139022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406447	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700150
J	Meakin, PJ; Morrison, VL; Sneddon, CC; Savinko, T; Uotila, L; Jalicy, SM; Gabriel, JL; Kang, L; Ashford, MLJ; Fagerholm, SC				Meakin, Paul J.; Morrison, Vicky L.; Sneddon, Claire C.; Savinko, Terhi; Uotila, Liisa; Jalicy, Susan M.; Gabriel, Jennie L.; Kang, Li; Ashford, Michael L. J.; Fagerholm, Susanna C.			Mice Lacking beta2-Integrin Function Remain Glucose Tolerant in Spite of Insulin Resistance, Neutrophil Infiltration and Inflammation	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ADHESION RECEPTORS; ADIPOSE-TISSUE; IN-VIVO; CD18; SKIN; METABOLISM; EXPRESSION; ELASTASE; MUSCLE	Beta2-integrins are important in leukocyte trafficking and function, and are regulated through the binding of cytoplasmic proteins, such as kindlin-3, to their intracellular domain. Here, we investigate the involvement of beta2-integrins in the regulation of metabolic disease using mice where the kindlin-3 binding site in the beta2-integrin cytoplasmic tail has been mutated (TTT/AAA-beta2-integrin knock-in (KI) mice), leading to expressed but dysfunctional beta2-integrins and significant neutrophilia in vivo. Beta2-integrin KI mice fed on a high fat diet showed normal weight gain, and normal accumulation of macrophages and lymphocytes in white adipose tissue (WAT) and liver, but increased neutrophil numbers especially in WAT. In addition, beta2-integrin KI mice fed on a high fat diet showed significantly increased peripheral insulin resistance in response to high-fat feeding. However, this was associated with improved glucose disposal following glucose load. Interestingly, beta2-integrin KI neutrophils produced more elastase in vitro, in response to stimulation. Beta2-integrin KI mice displayed variability of tissue inflammatory status, with liver and WAT exhibiting little or no difference in inflammation compared to high fat fed controls, whereas skeletal muscle demonstrated a raised inflammatory profile in association with higher elastase levels and diminished signalling through the IRS1-PKB pathway. In conclusion, although expression of dysfunctional beta2-integrins increased neutrophil production and infiltration into tissue, skeletal muscle was the most affected tissue exhibiting evidence of higher neutrophil activity and insulin resistance. Thus, beta2-integrins modulate glucose homeostasis during high fat feeding predominantly through actions on skeletal muscle to affect metabolic phenotype in vivo.	[Meakin, Paul J.; Sneddon, Claire C.; Jalicy, Susan M.; Gabriel, Jennie L.; Kang, Li; Ashford, Michael L. J.] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland; [Morrison, Vicky L.; Fagerholm, Susanna C.] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Canc Res, Dundee DD1 9SY, Scotland; [Morrison, Vicky L.; Savinko, Terhi; Uotila, Liisa; Fagerholm, Susanna C.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Dundee; University of Dundee; University of Helsinki	Ashford, MLJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.	m.l.j.ashford@dundee.ac.uk; susanna.fagerholm@helsinki.fi	Meakin, Paul/L-3003-2019	Meakin, Paul/0000-0002-8553-3863; Savinko, Terhi/0000-0003-4483-7235; Uotila, Liisa/0000-0003-4743-9013; Ashford, Michael/0000-0002-0861-7676; Morrison, Vicky/0000-0002-4351-8737; Kang, Li/0000-0002-6990-1996; Fagerholm, Susanna Carola/0000-0002-0354-8763	Biotechnology and Biological Sciences Research Council; Arthritis Research UK; Tenovus Scotland; Academy of Finland; Biocentrum Helsinki; Sigrid Juselius foundation; Diabetes UK; Biotechnology and Biological Sciences Research Council - CASE; AstraZeneca; MRC [MR/K003291/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1133987] Funding Source: researchfish; Diabetes UK [12/0004458] Funding Source: researchfish; Medical Research Council [MR/K003291/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Tenovus Scotland; Academy of Finland(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius foundation(Sigrid Juselius Foundation); Diabetes UK(Diabetes UK); Biotechnology and Biological Sciences Research Council - CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was supported by Biotechnology and Biological Sciences Research Council, Arthritis Research UK, Tenovus Scotland, The Anonymous Trust, the Academy of Finland, Biocentrum Helsinki and the Sigrid Juselius foundation (all to S.C.F) and Diabetes UK and Biotechnology and Biological Sciences Research Council - CASE awards to MLJA. This work was supported in part by a grant from AstraZeneca. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic AM, 2004, MOL MED, V10, P72, DOI 10.2119/2004-00038.Wagner; Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Dong ZM, 1997, P NATL ACAD SCI USA, V94, P7526, DOI 10.1073/pnas.94.14.7526; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Feral CC, 2008, DIABETES, V57, P1842, DOI 10.2337/db07-1751; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gomez JC, 2010, LAB INVEST, V90, P599, DOI 10.1038/labinvest.2010.4; Goulet B, 2008, MOL CANCER RES, V6, P644, DOI 10.1158/1541-7786.MCR-07-0268; Herishanu Y, 2006, EUR J HAEMATOL, V76, P516, DOI 10.1111/j.1600-0609.2006.00658.x; Horwitz BH, 2001, BLOOD, V97, P1578, DOI 10.1182/blood.V97.6.1578; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Morrison VL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6359; Morrison VL, 2013, BLOOD, V122, P1428, DOI 10.1182/blood-2013-02-484998; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Robker RL, 2004, OBES RES, V12, P936, DOI 10.1038/oby.2004.114; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Savinko TS, 2015, J INVEST DERMATOL, V135, P2249, DOI 10.1038/jid.2015.164; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmidt S, 2013, MOL IMMUNOL, V55, P49, DOI 10.1016/j.molimm.2012.11.006; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044	28	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138872	10.1371/journal.pone.0138872	http://dx.doi.org/10.1371/journal.pone.0138872			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405763	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000361800700107
J	Morrison, MC; Mulder, P; Stavro, PM; Saurez, M; Arola-Arnal, A; van Duyvenvoorde, W; Kooistra, T; Wielinga, PY; Kleemann, R				Morrison, Martine C.; Mulder, Petra; Stavro, P. Mark; Saurez, Manuel; Arola-Arnal, Anna; van Duyvenvoorde, Wim; Kooistra, Teake; Wielinga, Peter Y.; Kleemann, Robert			Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; KAPPA-B; CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; VASCULAR-LESIONS; BILBERRY EXTRACT; INFLAMMATION; POLYPHENOLS; CHOLESTEROL; MICE	Background and Aims As dietary saturated fatty acids are associated with metabolic and cardiovascular disease, a potentially interesting strategy to reduce disease risk is modification of the quality of fat consumed. Vegetable oils represent an attractive target for intervention, as they largely determine the intake of dietary fats. Furthermore, besides potential health effects conferred by the type of fatty acids in a vegetable oil, other minor components (e.g. phytochemicals) may also have health benefits. Here, we investigated the potential long-term health effects of isocaloric substitution of dietary fat (i.e. partial replacement of saturated by unsaturated fats), as well as putative additional effects of phytochemicals present in unrefined (virgin) oil on development of non-alcoholic fatty liver disease (NAFLD) and associated atherosclerosis. For this, we used pumpkin seed oil, because it is high in unsaturated fatty acids and a rich source of phytochemicals. Methods ApoE*3Leiden mice were fed a Western-type diet (CON) containing cocoa butter (15% w/w) and cholesterol (1% w/w) for 20 weeks to induce risk factors and disease endpoints. In separate groups, cocoa butter was replaced by refined (REF) or virgin (VIR) pumpkin seed oil (comparable in fatty acid composition, but different in phytochemical content). Results Both oils improved dyslipidaemia, with decreased (V) LDL-cholesterol and triglyceride levels in comparison with CON, and additional cholesterol-lowering effects of VIR over REF. While REF did not affect plasma inflammatory markers, VIR reduced circulating serum amyloid A and soluble vascular adhesion molecule-1. NAFLD and atherosclerosis development was modestly reduced in REF, and VIR strongly decreased liver steatosis and inflammation as well as atherosclerotic lesion area and severity. Conclusions Overall, we show that an isocaloric switch from a diet rich in saturated fat to a diet rich in unsaturated fat can attenuate NAFLD and atherosclerosis development. Phytochemical-rich virgin pumpkin seed oil exerts additional anti-inflammatory effects resulting in more pronounced health effects.	[Morrison, Martine C.; Mulder, Petra; van Duyvenvoorde, Wim; Kooistra, Teake; Wielinga, Peter Y.; Kleemann, Robert] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Morrison, Martine C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Stavro, P. Mark] Bunge Ltd, White Plains, NY USA; [Saurez, Manuel; Arola-Arnal, Anna] Rovira iVirgili Univ, Dept Biochem & Biotechnol, Tarragona, Spain; [Saurez, Manuel; Arola-Arnal, Anna] CEICS, TECNIO, CTNS, Reus, Spain; [Kleemann, Robert] Wageningen Univ, Dept Human & Anim Physiol, NL-6700 AP Wageningen, Netherlands	University of Groningen; Wageningen University & Research	Morrison, MC (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands.	martine.morrison@tno.nl	Arola-Arnal, Anna/C-2087-2015; Morrison, Martine C./C-3168-2014; Recio, Manuel Suarez/F-5039-2016	Arola-Arnal, Anna/0000-0001-6529-1345; Morrison, Martine C./0000-0003-4996-943X; Recio, Manuel Suarez/0000-0003-0122-8253; Mulder, Petra/0000-0002-0982-4466	Netherlands Organisation for Applied Scientific Research (TNO) research program Healthy Nutrition; Bunge Ltd.; TNO; Top Institute Food and Nutrition (TIFN); Bunge Ltd	Netherlands Organisation for Applied Scientific Research (TNO) research program Healthy Nutrition; Bunge Ltd.; TNO; Top Institute Food and Nutrition (TIFN); Bunge Ltd	The study was funded partly by the Netherlands Organisation for Applied Scientific Research (TNO) research program Healthy Nutrition and partly by Bunge Ltd. MCM received funding from TNO and Top Institute Food and Nutrition (TIFN), a public-private partnership on pre-competitive research in food and nutrition. Co-author P. Mark Stavro is employed by Bunge Ltd. Bunge Ltd provided support in the form of salary for author PMS and had a role in data collection (analyses of fatty acid composition of the oils). Bunge Ltd had no role in the data analysis, decision to publish, or preparation of the manuscript. The specific roles of PMS are articulated in the 'author contributions' section.	Aguirre L, 2014, WORLD J GASTROENTERO, V20, P7366, DOI 10.3748/wjg.v20.i23.7366; Allison GL, 2006, J NUTR, V136, p782S, DOI 10.1093/jn/136.3.782S; AlZuhair H, 1997, PHARMACOL RES, V35, P403, DOI 10.1006/phrs.1997.0148; Andjelkovic M, 2010, EUR J LIPID SCI TECH, V112, P208, DOI 10.1002/ejlt.200900021; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Biesalski HK, 2007, CURR OPIN CLIN NUTR, V10, P724, DOI 10.1097/MCO.0b013e3282f0cef2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Farrell N, 2015, FOOD FUNCT, V6, P1278, DOI [10.1039/C4FO01036A, 10.1039/c4fo01036a]; Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Gossell-Williams M, 2008, PHYTOTHER RES, V22, P873, DOI 10.1002/ptr.2381; Gossell-Williams M, 2011, CLIMACTERIC, V14, P558, DOI 10.3109/13697137.2011.563882; Gylling H, 2014, ATHEROSCLEROSIS, V232, P346, DOI 10.1016/j.atherosclerosis.2013.11.043; Janega P, 2014, FOOD FUNCT, V5, P2202, DOI [10.1039/c4fo00097h, 10.1039/C4FO00097H]; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779; Kim DY, 2013, NUTR RES PRACT, V7, P481, DOI 10.4162/nrp.2013.7.6.481; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Monteiro J, 2014, FOOD FUNCT, V5, P426, DOI 10.1039/c3fo60551e; Morrison M, 2014, ATHEROSCLEROSIS, V233, P149, DOI 10.1016/j.atherosclerosis.2013.12.027; Morrison MC, 2015, J HEPATOL, V62, P1180, DOI 10.1016/j.jhep.2014.12.011; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rezig L, 2012, IND CROP PROD, V37, P82, DOI 10.1016/j.indcrop.2011.12.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Shimoda H, 2009, J AGR FOOD CHEM, V57, P1786, DOI 10.1021/jf803441c; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Tang CC, 2014, FOOD FUNCT, V5, P678, DOI 10.1039/c3fo60478k; van de Steeg E, 2013, J PHARMACOL EXP THER, V347, P635, DOI 10.1124/jpet.113.208595; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Verschuren L, 2011, J NUTR, V141, P863, DOI 10.3945/jn.110.133751; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Xu ZR, 2015, NUTRIENTS, V7, P7085, DOI 10.3390/nu7085324; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	55	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139196	10.1371/journal.pone.0139196	http://dx.doi.org/10.1371/journal.pone.0139196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405765	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700187
J	von Stumm, S; Plomin, R				von Stumm, Sophie; Plomin, Robert			Breastfeeding and IQ Growth from Toddlerhood through Adolescence	PLOS ONE			English	Article							COGNITIVE-ABILITIES; INTELLIGENCE; VALIDITY; SAMPLE	Objectives The benefits of breastfeeding for cognitive development continue to be hotly debated but are yet to be supported by conclusive empirical evidence. Methods We used here a latent growth curve modeling approach to test the association of breastfeeding with IQ growth trajectories, which allows differentiating the variance in the IQ starting point in early life from variance in IQ gains that occur later in childhood through adolescence. Breastfeeding (yes/no) was modeled as a direct predictor of three IQ latent growth factors (i.e. intercept, slope and quadratic term) and adjusted for the covariates socioeconomic status, mother's age at birth and gestational stage. Data came from the Twins Early Development Study (TEDS), a prospective cohort study of twins born between 1996 and 1994 in the United Kingdom, who were assessed 9 times on IQ between age 2 and 16 years (N = 11,582). Results Having been breastfed was associated with a small yet significant advantage in IQ at age 2 in girls (beta = .07, CI 95% from 0.64 to 3.01; N = 3,035) but not in boys (beta = .04, CI 95% from -0.14 to 2.41). Having been breastfeeding was neither associated with the other IQ growth factors in girls (slope: beta = .02, CI 95% from -0.25 to 0.43; quadratic: beta = .01, CI 95% from -0.02 to 0.02) nor in boys (slope: beta = .02, CI 95% from -0.30 to 0.47; quadratic: beta = -.01, CI 95% from -0.01 to 0.01). Conclusions Breastfeeding has little benefit for early life intelligence and cognitive growth from toddlerhood through adolescence.	[von Stumm, Sophie] Goldsmiths Univ London, Dept Psychol, London, England; [Plomin, Robert] Univ London, Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London SW3 6LX, England	University of London; Goldsmiths University London; University of London; King's College London	von Stumm, S (corresponding author), Goldsmiths Univ London, Dept Psychol, London, England.	s.vonstumm@gold.ac.uk		von Stumm, Sophie/0000-0002-0447-5471; Plomin, Robert/0000-0002-0756-3629	UK Medical Research Council [G0901245, G0500079]; US National Institutes of Health [HD044454, HD059215]; Medical Research Council [G19/2]; European Research Council [295366]; MRC [G19/2, G0901245, G0500079] Funding Source: UKRI; Medical Research Council [G0500079, G0901245] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059215, R01HD044454] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors gratefully acknowledge the ongoing contribution of the participants in the Twins Early Development Study (TEDS) and their families. TEDS is supported by the UK Medical Research Council [G0901245; and previously G0500079], with additional support from the US National Institutes of Health [HD044454; HD059215]. RP is supported by a Medical Research Council Research Professorship award [G19/2] and a European Research Council Advanced Investigator award [295366].	Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Bartels M, 2002, BEHAV GENET, V32, P237, DOI 10.1023/A:1019772628912; Calvin C, 2009, INTELLIGENCE, V37, P243, DOI 10.1016/j.intell.2008.12.005; Davis OSP, 2008, INTELLIGENCE, V36, P68, DOI 10.1016/j.intell.2007.01.006; Deary IJ, 2010, INT J EPIDEMIOL, V39, P1362, DOI 10.1093/ije/dyq072; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; Ganjavi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019698; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Hanscombe KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030320; Haworth CMA, 2007, TWIN RES HUM GENET, V10, P554, DOI 10.1375/twin.10.4.554; Huang J, 2014, DEVELOPMENTAL SCI, V17, P452, DOI 10.1111/desc.12136; Johnson W, 2004, INTELLIGENCE, V32, P95, DOI 10.1016/S0160-2896(03)00062-X; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Kaplan E, 1998, WISC 3 PROCESS INSTR; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Lo A, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/591531; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; McCarthy D, 1972, MCCARTHY SCALES CHIL; Oliver B, 2002, EARLY CHILD DEV CARE, V172, P337, DOI DOI 10.1080/03004430212713; Petrill SA, 2002, INTELLIGENCE, V30, P353, DOI 10.1016/S0160-2896(02)00087-9; Raven J.C., 1984, LONDON H K LEWIS ITA; Raven JC, 1998, MANUAL RAVENS ADV PR; Saudino KJ, 1998, BRIT J DEV PSYCHOL, V16, P349, DOI 10.1111/j.2044-835X.1998.tb00757.x; Smith P., 2001, COGNITIVE ABILITIES; Walfisch A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003259; Wechsler D., 1992, WECHSLER INTELLIGENC	28	8	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138676	10.1371/journal.pone.0138676	http://dx.doi.org/10.1371/journal.pone.0138676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406251	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700068
J	Lanchava, L; Carlson, K; Sebankova, B; Flegr, J; Nave, G				Lanchava, Lasha; Carlson, Kyle; Sebankova, Blanka; Flegr, Jaroslav; Nave, Gideon			No Evidence of Association between Toxoplasma gondii Infection and Financial Risk Taking in Females	PLOS ONE			English	Article							LATENT TOXOPLASMOSIS; HOST BEHAVIOR; LOSS AVERSION; PARASITE MANIPULATION; TRAFFIC ACCIDENTS; TESTOSTERONE CHANGE; RHD MOLECULE; PREDICTS; DECISION; EXPERIENCE	Background Past research linked Toxoplasma gondii (TG) infection in humans with neurological and mental disorders (e.g., schizophrenia, Alzheimer's disease and attention disorders), irregularities of the dopaminergic and testosterone system, and increased likelihood of being involved in traffic accidents. Methodology/Principal Findings We test for an association between TG infection and financial decision-making (DM) using a case-control design in a sample of female Czech students (n = 79). We estimate each subject's risk attitude and loss aversion using an experimental economic task involving real monetary incentives. We find no significant evidence that either measure of decision-making is associated with TG infection. Conclusion We were unable to find evidence of an association between TG infection and financial decision- making in females.	[Lanchava, Lasha] Ctr Econ Res & Grad Educ & Econ Inst, Prague, Czech Republic; [Carlson, Kyle] CALTECH, Dept Humanities & Social Sci, Pasadena, CA 91125 USA; [Sebankova, Blanka; Flegr, Jaroslav] Charles Univ Prague, Dept Biol, Fac Sci, Prague, Czech Republic; [Nave, Gideon] CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology; Charles University Prague; California Institute of Technology	Nave, G (corresponding author), CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA.	gnave@caltech.edu	Flegr, Jaroslav/A-1564-2008; Šebánková, Blanka/GQH-0803-2022; Flegr, Jaroslav/AAG-7568-2021; Lanchava, Lasha/H-2895-2014	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Lanchava, Lasha/0000-0002-6523-2596	Czech Science Foundation [P402/12/G097]	Czech Science Foundation(Grant Agency of the Czech Republic)	The financial support of the Czech Science Foundation project No. P402/12/G097 DYME Dynamic Models in Economics is acknowledged. URL: http://www.gacr.cz/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Apicella CL, 2014, PSYCHONEUROENDOCRINO, V39, P58, DOI 10.1016/j.psyneuen.2013.09.025; Bauer M, 2014, PSYCHOL SCI, V25, P47, DOI 10.1177/0956797613493444; Benartzi S, 1993, MYOPIC LOSS AVERSION; Benjamin DJ, 2012, ANNU REV ECON, V4, P627, DOI 10.1146/annurev-economics-080511-110939; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; Bisin A., 2005, NEW PALGRAVE DICT EC; Callen M, 2014, AM ECON REV, V104, P123, DOI 10.1257/aer.104.1.123; Camerer C, 1997, Q J ECON, V112, P407, DOI 10.1162/003355397555244; Campbell-Meiklejohn D, 2011, NEUROPSYCHOPHARMACOL, V36, P402, DOI 10.1038/npp.2010.170; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Curcuru S, 2004, HDB FINANCIAL ECONOM, V1; Dohmen T, 2012, REV ECON STUD, V79, P645, DOI 10.1093/restud/rdr027; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; EPSTEIN LG, 1991, J POLIT ECON, V99, P263, DOI 10.1086/261750; Erev I, 2008, J BEHAV DECIS MAKING, V21, P575, DOI 10.1002/bdm.602; Feldman MW, 1996, TRENDS ECOL EVOL, V11, P453, DOI 10.1016/0169-5347(96)10052-5; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fjerdingstad EJ, 2002, EVOLUTION, V56, P553, DOI 10.1111/j.0014-3820.2002.tb01366.x; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061272; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Frydman C, 2011, P ROY SOC B-BIOL SCI, V278, P2053, DOI 10.1098/rspb.2010.2304; Gachter S, 2010, CEDEX DISCUSSION PAP; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Genesove D, 2001, LOSS AVERSION SELLER; Glimcher PW, 2013, NEUROECONOMICS DECIS; Gneezy U, 2003, J FINANC, V58, P821, DOI 10.1111/1540-6261.00547; Guiso L., 2002, HOUSEHOLD PORTFOLIOS; HAMM SL, 1987, J EXP PSYCHOL-ANIM B, V13, P376, DOI 10.1037/0097-7403.13.4.376; HARDIE BGS, 1993, MARKET SCI, V12, P378, DOI 10.1287/mksc.12.4.378; HARRIS JR, 1995, PSYCHOL REV, V102, P458, DOI 10.1037/0033-295X.102.3.458; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Henrich J., 2005, FDN HUMAN SOCIALITY; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Hertwig R, 2009, TRENDS COGN SCI, V13, P517, DOI 10.1016/j.tics.2009.09.004; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; Holub D., 2011, PSYCHIATRIE, V15, P37, DOI DOI 10.6084/M9.FIGSHARE.5593999; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; KAGEL JH, 1986, J COMP PSYCHOL, V100, P95, DOI 10.1037/0735-7036.100.2.95; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kandasamy N, 2014, P NATL ACAD SCI USA, V111, P3608, DOI 10.1073/pnas.1317908111; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Klein SL, 2003, PHYSIOL BEHAV, V79, P441, DOI 10.1016/S0031-9384(03)00163-X; Kocazeybek B, 2009, FORENSIC SCI INT, V187, P103, DOI 10.1016/j.forsciint.2009.03.007; Kramer P, 2015, PERSPECT PSYCHOL SCI, V10, P464, DOI 10.1177/1745691615583131; Libersat F, 2013, J EXP BIOL, V216, P47, DOI 10.1242/jeb.073999; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Moore J., 1990, P193; Norbury A, 2013, J NEUROSCI, V33, P12982, DOI 10.1523/JNEUROSCI.5587-12.2013; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; POKORNY J, 1989, Ceskoslovenska Epidemiologie Mikrobiologie Imunologie, V38, P355; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; POULIN R, 1994, PARASITOLOGY, V109, pS109, DOI 10.1017/S0031182000085127; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; Sapienza P., 2006, DOES CULTURE AFFECT; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Shirbazou S, 2011, JUNDISHAPUR J MICROB, V4, P167; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; St Onge JR, 2010, PSYCHOPHARMACOLOGY, V211, P209, DOI 10.1007/s00213-010-1883-y; Thaler RH, 1997, Q J ECON, V112, P647, DOI 10.1162/003355397555226; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Warren J, 1942, P SOC EXP BIOL MED, V51, P11, DOI 10.3181/00379727-51-13807; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; Yereli K, 2006, FORENSIC SCI INT, V163, P34, DOI 10.1016/j.forsciint.2005.11.002	90	6	6	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0136716	10.1371/journal.pone.0136716	http://dx.doi.org/10.1371/journal.pone.0136716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BS	26401912	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361798100008
J	Caetano-Anolles, K; Seo, M; Rodriguez-Zas, S; Oh, JD; Han, JY; Lee, K; Park, TS; Shin, S; Jiao, ZJ; Ghosh, M; Jeong, DK; Cho, S; Kim, H; Song, KD; Lee, HK				Caetano-Anolles, Kelsey; Seo, Minseok; Rodriguez-Zas, Sandra; Oh, Jae-Don; Han, Jae Yong; Lee, Kichoon; Park, Tae Sub; Shin, Sangsu; Jiao, Zhang Jiao; Ghosh, Mrinmoy; Jeong, Dong Kee; Cho, Seoae; Kim, Heebal; Song, Ki-Duk; Lee, Hak-Kyo			Comprehensive Identification of Sexual Dimorphism-Associated Differentially Expressed Genes in Two-Way Factorial Designed RNA-Seq Data on Japanese Quail (Coturnix coturnix japonica)	PLOS ONE			English	Article							Z-CHROMOSOME; GENERATION; ALIGNMENT; BRAIN; BIRDS; LPA	Japanese quail (Coturnix coturnix japonica) reach sexual maturity earlier, breed rapidly and successfully, and cost less and require less space than other birds raised commercially. Given the value of this species for food production and experimental use, more studies are necessary to determine chromosomal regions and genes associated with gender and breed-differentiation. This study employed Trinity and edgeR for transcriptome analysis of next-generation RNA-seq data, which included 4 tissues obtained from 3 different breeding lines of Japanese quail (random bred control, heavy weight, low weight). Differentially expressed genes shared between female and male tissue contrast groups were analyzed to identify genes related to sexual dimorphism as well as potential novel candidate genes for molecular sexing. Several of the genes identified in the present study as significant sex-related genes have been previously found in avian gene expression analyses (NIPBL, UBAP2), and other genes found differentially expressed in this study and not previously associated with sex-related differences may be considered potential candidates for molecular sexing (TERA, MYP0, PPR17, CASQ2). Additionally, other genes likely associated with neuronal and brain development (CHKA, NYAP), as well as body development and size differentiation (ANKRD26, GRP87) in quail were identified. Expression of homeobox protein regulating genes (HXC4, ISL1) shared between our two sex-related contrast groups (Female Brain vs. Male Brain and Ovary vs. Testis) indicates that these genes may regulate sex-specific anatomical development. Results reveal genetic features of the quail breed and could allow for more effective molecular sexing as well as selective breeding for traits important in commercial production.	[Caetano-Anolles, Kelsey; Rodriguez-Zas, Sandra] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Seo, Minseok; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151741, South Korea; [Oh, Jae-Don; Song, Ki-Duk; Lee, Hak-Kyo] Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju 561756, South Korea; [Han, Jae Yong; Park, Tae Sub; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Han, Jae Yong; Park, Tae Sub; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Shin, Sangsu] Kyungpook Natl Univ, Fac Anim Sci & Biotechnol, Sangju 37224, South Korea; [Jiao, Zhang Jiao; Ghosh, Mrinmoy; Jeong, Dong Kee] Jeju Natl Univ, Fac Biotechnol, Dept Anim Biotechnol, Jeju 690756, South Korea; [Cho, Seoae; Kim, Heebal] Seoul Natl Univ, CHO & KIM Genom, Seoul 151919, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Seoul National University (SNU); Jeonbuk National University; Seoul National University (SNU); Seoul National University (SNU); University System of Ohio; Ohio State University; Kyungpook National University; Jeju National University; Seoul National University (SNU)	Song, KD (corresponding author), Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju 561756, South Korea.	kiduk.song@gmail.com; breedlee@empas.com	Ghosh, Mrinmoy/ABB-4479-2021; Lee, Kichoon/G-2234-2012; Zhang, Jiao Jiao/V-8705-2018; Kim, Heebal/A-8889-2016	Zhang, Jiao Jiao/0000-0002-2699-6729; Kim, Heebal/0000-0003-3064-1303; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Caetano-Anolles, Kelsey/0000-0001-6310-6679; Ghosh, Mrinmoy/0000-0001-6817-622X	Next-Generation BioGreen 21 Program [PJ01104401]; Rural Development Administration, Republic of Korea; Achievement Rewards for College Scientists (ARCS) Foundation; National Science Foundation (NSF) [IIA-1415113]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Achievement Rewards for College Scientists (ARCS) Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ01104401), Rural Development Administration, Republic of Korea, the Achievement Rewards for College Scientists (ARCS) Foundation to KC, and the National Science Foundation (NSF) under Grant No IIA-1415113 to KC.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Blackburn J, 2012, BONE, V50, P756, DOI 10.1016/j.bone.2011.12.002; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen Y., 2014, DIFFERENTIAL EXPRESS; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Cui HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-213; Dawson DA, 2001, MOL ECOL NOTES, V1, P201, DOI 10.1046/j.1471-8278.2001.00060.x; Delfino KR, 2010, NEUROPEPTIDES, V44, P31, DOI 10.1016/j.npep.2009.11.002; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Ellegren H, 2001, EMBO REP, V2, P192, DOI 10.1093/embo-reports/kve050; Gat-Viks I, 2003, BIOINFORMATICS, V19, P2381, DOI 10.1093/bioinformatics/btg330; GOZES I, 1989, J MOL NEUROSCI, V1, P55, DOI 10.1007/BF02896857; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hinshaw W, 1969, COTURNIX COTURNIX CO; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kawahara-Miki R, 2013, GENOMICS, V101, P345, DOI 10.1016/j.ygeno.2013.03.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LAM KSL, 1990, BRAIN RES, V526, P135, DOI 10.1016/0006-8993(90)90259-E; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SI, 2009, POULTRY SCI, V88, P1003, DOI 10.3382/ps.2008-00197; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Maechler M, 2012, CLUSTER CLUSTER ANAL, V1; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mills A, 1994, P 9 EUR POULTR C GLA; Nadeau N, 2008, GENETICS, V178, P777, DOI 10.1534/genetics.107.077073; Nam K, 2008, GENETICS, V180, P1131, DOI 10.1534/genetics.108.090324; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Rawat A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S13; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Suh A, 2011, MOL BIOL EVOL, V28, P2993, DOI 10.1093/molbev/msr147; TOUART L, 2003, REVISED DRAFT DETAIL; Wahlberg P, 2007, CYTOGENET GENOME RES, V117, P22, DOI 10.1159/000103161; WILSON WO, 1961, POULTRY SCI, V40, P651, DOI 10.3382/ps.0400651; WILSON WO, 1971, CALIF AGR, V25, P5; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yokoyama K, 2011, EMBO J, V30, P4739, DOI 10.1038/emboj.2011.348	43	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139324	10.1371/journal.pone.0139324	http://dx.doi.org/10.1371/journal.pone.0139324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418419	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400077
J	Han, QJ; Witschey, WRT; Fang-Yen, CM; Arkles, JS; Barker, AJ; Forfia, PR; Han, YC				Han, Q. Joyce; Witschey, Walter R. T.; Fang-Yen, Christopher M.; Arkles, Jeffrey S.; Barker, Alex J.; Forfia, Paul R.; Han, Yuchi			Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI	PLOS ONE			English	Article							WALL SHEAR-STRESS; BLOOD-FLOW; VALVE MOTION; QUANTIFICATION; REPRODUCIBILITY; MASS; PHYSIOLOGY; VORTICES; PATTERNS; VOLUMES	Introduction Right ventricular (RV) function has increasingly being recognized as an important predictor for morbidity and mortality in patients with pulmonary arterial hypertension (PAH). The increased RV after-load increase RV work in PAH. We used time-resolved 3D phase contrast MRI (4D flow MRI) to derive RV kinetic energy (KE) work density and energy loss in the pulmonary artery (PA) to better characterize RV work in PAH patients. Methods 4D flow and standard cardiac cine images were obtained in ten functional class I/II patients with PAH and nine healthy subjects. For each individual, we calculated the RV KE work density and the amount of viscous dissipation in the PA. Results PAH patients had alterations in flow patterns in both the RV and the PA compared to healthy subjects. PAH subjects had significantly higher RV KE work density than healthy subjects (94.7 +/- 33.7 mJ/mL vs. 61.7 +/- 14.8 mJ/mL, p = 0.007) as well as a much greater percent PA energy loss (21.1 +/- 6.4% vs. 2.2 +/- 1.3%, p = 0.0001) throughout the cardiac cycle. RV KE work density and percent PA energy loss had mild and moderate correlations with RV ejection fraction. Conclusion This study has quantified two kinetic energy metrics to assess RV function using 4D flow. RV KE work density and PA viscous energy loss not only distinguished healthy subjects from patients, but also provided distinction amongst PAH patients. These metrics hold promise as imaging markers for RV function.	[Han, Q. Joyce; Han, Yuchi] Univ Penn, Cardiovasc Div, Philadelphia, PA 19104 USA; [Witschey, Walter R. T.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Fang-Yen, Christopher M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Barker, Alex J.] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Arkles, Jeffrey S.; Forfia, Paul R.] Temple Univ, Cardiovasc Div, Philadelphia, PA 19122 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Han, YC (corresponding author), Univ Penn, Cardiovasc Div, Philadelphia, PA 19104 USA.	yuchi.han@uphs.upenn.edu	Han, Q. Joyce/GLR-1652-2022; Barker, Alex J/G-5884-2012; Fang-Yen, Christopher/AAY-9017-2020	Barker, Alex J/0000-0002-6283-9157; Han, Q. Joyce/0000-0001-7089-1767	FOCUS Junior Faculty Award for Research in Women's Cardiovascular Health by Edna G. Kynett Memorial Foundation; Cardiovascular Medical Research and Education Fund	FOCUS Junior Faculty Award for Research in Women's Cardiovascular Health by Edna G. Kynett Memorial Foundation; Cardiovascular Medical Research and Education Fund	The study is funded by FOCUS Junior Faculty Award for Research in Women's Cardiovascular Health funded by the Edna G. Kynett Memorial Foundation (to YH) and the Cardiovascular Medical Research and Education Fund (http://www.ipahresearch.org/)(to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkles JS, 2011, AM J RESP CRIT CARE, V183, P268, DOI 10.1164/rccm.201004-0601OC; Barker AJ, 2015, MAGN RESON MED, V73, P1904, DOI 10.1002/mrm.25326; Barker AJ, 2014, MAGN RESON MED, V72, P620, DOI 10.1002/mrm.24962; Barker AJ, 2012, CIRC-CARDIOVASC IMAG, V5, P457, DOI 10.1161/CIRCIMAGING.112.973370; Bird R., 2006, WILEY INT EDITION; Bock J., 2007, P 15 ANN M ISMRM; Bolger AF, 2007, J CARDIOVASC MAGN R, V9, P741, DOI 10.1080/10976640701544530; Catalano O, 2007, J CARDIOVASC MED, V8, P807, DOI 10.2459/JCM.0b013e32801105ef; Charonko JJ, 2013, ANN BIOMED ENG, V41, P1049, DOI 10.1007/s10439-013-0755-0; Eriksson J, 2011, AM J PHYSIOL-HEART C, V300, pH2135, DOI 10.1152/ajpheart.00993.2010; Eriksson J, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-9; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Fredriksson AG, 2011, AM J PHYSIOL-HEART C, V301, pH2344, DOI 10.1152/ajpheart.00622.2011; Frydrychowicz A, 2011, INVEST RADIOL, V46, P317, DOI 10.1097/RLI.0b013e3182034fc2; Geiger J, 2011, EUR RADIOL, V21, P1651, DOI 10.1007/s00330-011-2108-4; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Haddad F, 2009, ANESTH ANALG, V108, P407, DOI 10.1213/ane.0b013e31818f8623; Hope MD, 2011, JACC-CARDIOVASC IMAG, V4, P781, DOI 10.1016/j.jcmg.2011.05.004; Kheradvar A, 2012, J AM SOC ECHOCARDIOG, V25, P220, DOI 10.1016/j.echo.2011.10.003; Lee N, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-93; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Markl M, 2011, J MAGN RESON IMAGING, V33, P988, DOI 10.1002/jmri.22519; Nordmeyer S, 2010, J MAGN RESON IMAGING, V32, P677, DOI 10.1002/jmri.22280; Peacock AJ, 2014, CIRC-CARDIOVASC IMAG, V7, P107, DOI 10.1161/CIRCIMAGING.113.000629; Peacock AJ, 2013, EUR RESPIR REV, V22, P526, DOI 10.1183/09059180.00006313; Reiter G, 2015, RADIOLOGY, V275, P71, DOI 10.1148/radiol.14140849; Reiter G, 2008, CIRC-CARDIOVASC IMAG, V1, P23, DOI 10.1161/CIRCIMAGING.108.780247; Reiter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082212; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stewart J., 2008, CALCULUS EARLY TRANS, V6th ed.; TAHARA M, 1981, CIRCULATION, V64, P1249, DOI 10.1161/01.CIR.64.6.1249; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Venkatachari AK, 2007, MAGN RESON IMAGING, V25, P101, DOI 10.1016/j.mri.2006.09.027; Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027; WEYMAN AE, 1974, CIRCULATION, V50, P905, DOI 10.1161/01.CIR.50.5.905	36	28	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138365	10.1371/journal.pone.0138365	http://dx.doi.org/10.1371/journal.pone.0138365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418553	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400014
J	Nishikawa, S; Toshima, T; Kobayashi, M				Nishikawa, Saori; Toshima, Tamotsu; Kobayashi, Masao			Perceived Parenting Mediates Serotonin Transporter Gene (5-HTTLPR) and Neural System Function during Facial Recognition: A Pilot Study	PLOS ONE			English	Article							DIFFERENTIAL SUSCEPTIBILITY; PREFRONTAL CORTEX; LIFE EVENTS; POLYMORPHISM; AMYGDALA; ASSOCIATION; EMOTION; ACTIVATION; GENOTYPE; DISORDER	This study examined changes in prefrontal oxy-Hb levels measured by NIRS (Near-Infrared Spectroscopy) during a facial-emotion recognition task in healthy adults, testing a mediational/moderational model of these variables. Fifty-three healthy adults (male = 35, female = 18) aged between 22 to 37 years old (mean age = 24.05 years old) provided saliva samples, completed a EMBU questionnaire (Swedish acronym for Egna Minnen Betraffande Uppfostran [ My memories of upbringing]), and participated in a facial-emotion recognition task during NIRS recording. There was a main effect of maternal rejection on RoxH (right frontal activation during an ambiguous task), and a gene x environment (GxE) interaction on RoxH, suggesting that individuals who carry the SL or LL genotype and who endorse greater perceived maternal rejection show less right frontal activation than SL/LL carriers with lower perceived maternal rejection. Finally, perceived parenting style played a mediating role in right frontal activation via the 5-HTTLPR genotype. Early-perceived parenting might influence neural activity in an uncertain situation i.e. rating ambiguous faces among individuals with certain genotypes. This preliminary study makes a small contribution to the mapping of an influence of gene and behaviour on the neural system. More such attempts should be made in order to clarify the links.	[Nishikawa, Saori; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Hiroshima, Japan; [Toshima, Tamotsu] Hiroshima Univ, Grad Sch Educ, Dept Psychol, Higashihiroshima, Hiroshima 724, Japan; [Kobayashi, Masao] Hiroshima Univ, Phoenix Leader Educ Program, Hiroshima, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Nishikawa, S (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Hiroshima, Japan.	saolingon@gmail.com; masak@hiroshima-u.ac.jp			Japanese Society for the Promotion of Science [40599213]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by Grant-in-Aid for Young Scientific Research from Japanese Society for the Promotion of Science (40599213); link: http://kaken.nii.ac.jp/d/r/40599213.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DSM 5; Antypa N, 2011, NEUROSCIENCE, V172, P303, DOI 10.1016/j.neuroscience.2010.10.042; Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Briley DA, 2014, PSYCHOL BULL, V140, P1303, DOI 10.1037/a0037091; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Firk C, 2012, SOCIAL COGNITIVE AFF; Gyurak A, 2013, EMOTION, V13, P25, DOI 10.1037/a0029616; Haase CM, 2013, EMOTION, V13, P1068, DOI 10.1037/a0033761; Halliday DWR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094013; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Holmes-Smith P, 2000, INTRO STRUCTURAL EQU; Hosokawa M, 2014, PSYCHIAT CLIN NEUROS; IBM Corp, 2013, IBM SPSS STAT WINDOW; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036513; Loggia ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027764; Long HX, 2013, NEUROSCI BULL, V29, P4, DOI 10.1007/s12264-013-1299-x; Ma Y, 2013, CEREB CORTEX; Maki Y, 2013, INT PSYCHOGERIATR, V25, P105, DOI 10.1017/S1041610212001482; Meyer A, 2015, J ABNORM CHILD PSYCH, V43, P821, DOI 10.1007/s10802-014-9918-1; Miu AC, 2012, GENES BRAIN BEHAV, V11, P398, DOI 10.1111/j.1601-183X.2012.00774.x; Moutsiana C, 2014, J CHILD PSYCHOL PSYC, V55, P999, DOI 10.1111/jcpp.12198; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Nakadoi Y, 2012, PSYCHIAT CLIN NEUROS, V66, P26, DOI 10.1111/j.1440-1819.2011.02290.x; Nardi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082192; Nishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047608; Nishikawa S, 2010, J CHILD FAM STUD, V19, P57, DOI 10.1007/s10826-009-9281-y; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Olsson A, 2014, SOC COGN AFFECT NEUR; Owens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048482; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; Pluess M, 2010, PROG NEURO-PSYCHOPH, V34, P1070, DOI 10.1016/j.pnpbp.2010.05.028; Schardt DM, 2010, NEUROIMAGE, V53, P943, DOI 10.1016/j.neuroimage.2009.11.078; Shibazaki M, 2014, WORLD C FAC EXPR EM; Someya T, 1997, SEISHIN IGAKU, V38, P1065; Szily E, 2008, J NEURAL TRANSM, V115, P819, DOI 10.1007/s00702-008-0029-4; van der Knaap NJF, 2014, J NEUROSCI, V34, P9516, DOI 10.1523/JNEUROSCI.0505-14.2014; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; Wendt J, INT J PSYCH IN PRESS; Williams JR, 2008, WORLD MED J, V54, P120, DOI DOI 10.2471/BLT.08.050955; Yoshida H, 2012, FUK U 68 C PSYCH CHU; Zhang KR, 2009, J AFFECT DISORDERS, V114, P224, DOI 10.1016/j.jad.2008.07.012; Zheng LL, 2011, PSYCHIAT CLIN NEUROS, V65, P648, DOI 10.1111/j.1440-1819.2011.02285.x	49	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0134685	10.1371/journal.pone.0134685	http://dx.doi.org/10.1371/journal.pone.0134685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418317	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400002
J	Hernandez, LMR; Fan, JF; Johnson, MH; de Mejia, EG				Hernandez, Luis M. Real; Fan, Junfeng; Johnson, Michelle H.; de Mejia, Elvira Gonzalez			Berry Phenolic Compounds Increase Expression of Hepatocyte Nuclear Factor-1 alpha (HNF-1 alpha) in Caco-2 and Normal Colon Cells Due to High Affinities with Transcription and Dimerization Domains of HNF-1 alpha	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE IV; GENE-EXPRESSION; IN-VITRO; INHIBIT; INFLAMMATION; MUTATIONS; ENZYMES; BINDING; MODY3	Hepatocyte nuclear factor-1 alpha (HNF-1 alpha) is found in the kidneys, spleen, thymus, testis, skin, and throughout the digestive organs. It has been found to promote the transcription of various proteins involved in the management of type II diabetes, including dipeptidyl peptidase-IV (DPP-IV). Phenolic compounds from berries and citrus fruits are known to inhibit DPP-IV, but have not been tested for their interactions with wild-type HNF-1 alpha. By studying the interactions of compounds from berries and citrus fruits have with HNF-1 alpha, pre-transcriptional mechanisms that inhibit the expression of proteins such as DPP-IV may be elucidated. In this study, the interactions of berry phenolic compounds and citrus flavonoids with the dimerization and transcriptional domains of HNF-1 alpha were characterized using the molecular docking program AutoDock Vina. The anthocyanin delphinidin-3-O-arabinoside had the highest binding affinity for the dimerization domain as a homodimer (-7.2 kcal/mol) and transcription domain (-8.3 kcal/mol) of HNF-1 alpha. Anthocyanins and anthocyanidins had relatively higher affinities than resveratrol and citrus flavonoids for both, the transcription domain and the dimerization domain as a homodimer. The flavonoid flavone had the highest affinity for a single unit of the dimerization domain (-6.5 kcal/mol). Nuclear expression of HNF-1 alpha was measured in Caco-2 and human normal colon cells treated with blueberry and blackberry anthocyanin extracts. All extracts tested increased significantly (P < 0.05) the nuclear expression of HNF-1 alpha in Caco-2 cells by 85.2 to 260% compared to a control. The extracts tested increased significantly (P < 0.02) the nuclear expression of HNF-1 alpha in normal colon cells by 48.6 to 243%. It was confirmed that delphinidin-3-O-glucoside increased by 3-fold nuclear HNF-1 alpha expression in Caco-2 cells (P < 0.05). Anthocyanins significantly increased nuclear HNF-1 alpha expression, suggesting that these compounds might regulate the genes HNF-1 alpha promotes.	[Hernandez, Luis M. Real; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Hernandez, Luis M. Real] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Fan, Junfeng] Beijing Forestry Univ, Coll Biosci & Biotechnol, Beijing 100083, Peoples R China; [Johnson, Michelle H.; de Mejia, Elvira Gonzalez] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Beijing Forestry University; University of Illinois System; University of Illinois Urbana-Champaign	de Mejia, EG (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.	edemejia@illinois.edu		Real Hernandez, Luis/0000-0003-1613-6458				Alzaid F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078932; [Anonymous], 2014, R LANG ENV STAT COMP; Armendariz AD, 2009, CURR OPIN LIPIDOL, V20, P106, DOI 10.1097/MOL.0b013e3283295ee9; Bower AM, 2014, J AGR FOOD CHEM, V62, P6147, DOI 10.1021/jf500639f; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Fan JF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/479505; Galan M, 2011, MOL MED, V17, P256, DOI 10.2119/molmed.2010.00097; Gu N, 2008, CLIN EXP PHARMACOL P, V35, P1433, DOI 10.1111/j.1440-1681.2008.05015.x; Gu N, 2006, BIOCHEM BIOPH RES CO, V346, P1016, DOI 10.1016/j.bbrc.2006.06.010; HANSEN LP, 1993, CURR OPIN GENET DEV, V3, P246, DOI 10.1016/0959-437X(93)90030-S; Jadav P, 2012, BIOORG MED CHEM LETT, V22, P3516, DOI 10.1016/j.bmcl.2012.03.078; Johnson JL, 2011, J MED FOOD, V14, P325, DOI 10.1089/jmf.2010.0310; Johnson MH, 2013, MOL NUTR FOOD RES, V57, P1182, DOI 10.1002/mnfr.201200678; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Luni C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053130; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Brien VP, 2013, J PHARMACOL EXP THER, V347, P181, DOI 10.1124/jpet.113.206359; Parmar HS, 2012, DIABETES RES CLIN PR, V97, P105, DOI 10.1016/j.diabres.2012.02.011; Pedersen KB, 2013, BBA-GENE REGUL MECH, V1829, P1225, DOI 10.1016/j.bbagrm.2013.09.007; Pelletier L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-427; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rose RB, 2000, BIOCHEMISTRY-US, V39, P15062, DOI 10.1021/bi001996t; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sridhar Gumpeny Ramachandra, 2012, Advances in Bioinformatics, V2012, P705435, DOI 10.1155/2012/705435; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yang YM, 2010, MOLECULES, V15, P6332, DOI 10.3390/molecules15096332	29	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138768	10.1371/journal.pone.0138768	http://dx.doi.org/10.1371/journal.pone.0138768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413797	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700022
J	Anderson, J; Wysong, M; Estep, D; Besana, G; Kibwana, S; Varallo, J; Sun, K; Lu, E				Anderson, Jean; Wysong, Megan; Estep, Deb; Besana, Giulia; Kibwana, Sharon; Varallo, John; Sun, Kai; Lu, Enriquito			Evaluation of Cervical Cancer Screening Programs in Cote d'Ivoire, Guyana, and Tanzania: Effect of HIV Status	PLOS ONE			English	Article							VISUAL INSPECTION; ACETIC-ACID; HUMAN-PAPILLOMAVIRUS; INFECTED WOMEN; WESTERN KENYA; PREVENTION; LESIONS; ACCEPTABILITY; FEASIBILITY; PREVALENCE	Background HIV infection increases a woman's risk for cervical cancer, and cervical cancer incidence and mortality rates are higher in countries with high HIV prevalence and limited resources for screening. Visual inspection with acetic acid (VIA) allows screening and treatment of cervical lesions in a single-visit approach (SVA), but data on its performance in HIV-infected women are limited. This study's objective was to examine cervical cancer screening using VIA/SVA in programs serving HIV-infected women. Methods A VIA/SVA program with cryotherapy for VIA-positive lesions was implemented in Cote d'Ivoire, Guyana, and Tanzania from 2009 to 2012. The effect of HIV status on VIA positivity and on presence of cryotherapy-eligible lesions was examined using a cross-sectional study design, with Chi-square tests for comparisons and constructed multivariate logistic regression models. A P-value of <0.05 was significant. Findings VIA was performed on 34,921 women, 10% (3,580) were VIA positive; 2,508 (85%) eligible women received cryotherapy during the same visit; only 234 (52%) of those who postponed returned for treatment; 622 (17%) VIA-positive women had lesions too large to be treated with cryotherapy and were referred for excisional treatment. In multivariate analysis-controlling for HIV status, location of the screening clinic, facility location, facility type, and country-compared to HIV-uninfected/unknown women, HIV-infected women had higher odds of being VIA positive (OR 1.95, 95% CI 1.76, 2.16, P<0.0001) and of having large lesions requiring referral (OR 1.93, 95% CI 1.49, 2.51, P<0.0001). Minor treatment complications occurred in 19 of 3,032 (0.63%) women; none required further intervention. Conclusions This study found that compared to HIV-uninfected/unknown women, HIV-infected women had nearly twice the odds of being VIA-positive and to require referral for large lesions. SVA was safe and resulted in significant reductions in loss to follow-up. There is increased need for excisional treatment in countries with high HIV prevalence.	[Anderson, Jean] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Wysong, Megan; Estep, Deb; Kibwana, Sharon; Varallo, John; Lu, Enriquito] Jhpiego, Baltimore, MD USA; [Besana, Giulia] Jhpiego Tanzania, Dar Es Salaam, Tanzania	Johns Hopkins University; Johns Hopkins Medicine; Jhpiego; Jhpiego	Anderson, J (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21205 USA.	janders@jhmi.edu		Kibwana, Sharon/0000-0002-6344-2303	Cote D'Ivoire: the Centers for Disease Control and Prevention (CDC) [5U2GPS001463 (FOA PS09-904)]	Cote D'Ivoire: the Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding provided by Cote D'Ivoire: the Centers for Disease Control and Prevention (CDC) under the grant number 5U2GPS001463 (FOA PS09-904), "Technical Assistance in the Support of HIV Prevention, Care and Treatment Program in Cote d'Ivoire." Guyana: the generous support of the American people through the United States Agency for International Development (USAID) under the Associate Cooperative Agreement #621-A-00-08-00023-00 (Reference Leader Cooperative Agreement #GHS-A-00-04-00002-00). Tanzania: the generous support of the American people through the United States Agency for International Development (USAID) under Associate Cooperative Agreement #621-A-00-08-00023-00 (Reference Leader Cooperative Agreement #GHS-A-00-04-00002-00). The contents of this paper are the responsibility of Jhpiego and do not necessarily reflect the views of USAID, CDC, or the United States Government.	Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Ashraf H, 2003, LANCET, V361, P2209, DOI 10.1016/S0140-6736(03)13788-9; Atashili J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018527; Cervical Cancer Action (CCA), 2012, PROGR CERV CANC PREV; Cronje HS, 2004, INT J GYNECOL OBSTET, V84, P101, DOI 10.1016/j.ijgo.2003.09.009; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Denny L, 2010, JNCI-J NATL CANCER I, V102, P1557, DOI 10.1093/jnci/djq342; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ferlay J, 2012, IARC CANCERBASE; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; International Agency for Research on Cancer (IARC) World Health Organization, CERV CANC EST INC MO; Joshi S, 2013, AIDS, V27, P607, DOI 10.1097/QAD.0b013e32835b1041; Kahesa C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-262; Khozaim K, 2014, INT J GYNECOL OBSTET, V124, P12, DOI 10.1016/j.ijgo.2013.06.035; Kupets R, 2011, GYNECOL ONCOL, V120, P63, DOI 10.1016/j.ygyno.2010.09.011; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Parkin DM, 2002, CA CANC J CLIN, V55; Phongsavan K, 2011, INT J GYNECOL OBSTET, V114, P268, DOI 10.1016/j.ijgo.2011.03.009; Plotkin M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-120; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Sanghvi H, 2008, REPROD HEALTH MATTER, V16, P67, DOI 10.1016/S0968-8080(08)32401-X; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Sherigar B, 2010, ASIAN PAC J CANCER P, V11, P619; UNAIDS, REG COUNTR; UNAIDS, UNAIDS REP GLOB AIDS; WHO, 2012, DEM PROJ 6 AFR COUNT; World Health Organization, 2011, GLOB HLTH SECT STRAT; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369	36	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139242	10.1371/journal.pone.0139242	http://dx.doi.org/10.1371/journal.pone.0139242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405784	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700197
J	Jonas, R; Klusch, A; Schmelz, M; Petersen, M; Carr, RW				Jonas, Robin; Klusch, Andreas; Schmelz, Martin; Petersen, Marlen; Carr, Richard W.			Assessment of TTX-s and TTX-r Action Potential Conduction along Neurites of NGF and GDNF Cultured Porcine DRG Somata	PLOS ONE			English	Article							ROOT GANGLION NEURONS; RESISTANT SODIUM-CHANNELS; INDUCED CALCIUM-RELEASE; RAT SENSORY NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; MEMBRANE-PROPERTIES; NERVE-TERMINALS; CA2+ RELEASE; NA+ CURRENT; C-FIBERS	Nine isoforms of voltage-gated sodium channels (NaV) have been characterized and in excitable tissues they are responsible for the initiation and conduction of action potentials. For primary afferent neurons residing in dorsal root ganglia (DRG), individual neurons may express multiple NaV isoforms extending the neuron's functional capabilities. Since expression of NaV isoforms can be differentially regulated by neurotrophic factors we have examined the functional consequences of exposure to either nerve growth factor (NGF) or glial cell line-derived neurotrophic factor (GDNF) on action potential conduction in outgrowing cultured porcine neurites of DRG neurons. Calcium signals were recorded using the exogenous intensity based calcium indicator Fluo-8 (R), AM. In 94 neurons, calcium signals were conducted along neurites in response to electrical stimulation of the soma. At an image acquisition rate of 25 Hz it was possible to discern calcium transients in response to individual electrical stimuli. The peak amplitude of electrically-evoked calcium signals was limited by the ability of the neuron to follow the stimulus frequency. The stimulus frequency required to evoke a half-maximal calcium response was approximately 3 Hz at room temperature. In 13 of 14 (93%) NGF-responsive neurites, TTX-r NaV isoforms alone were sufficient to support propagated signals. In contrast, calcium signals mediated by TTX-r NaVs were evident in only 4 of 11 (36%) neurites from somata cultured in GDNF. This establishes a basis for assessing action potential signaling using calcium imaging techniques in individual cultured neurites and suggests that, in the pig, afferent nociceptor classes relying on the functional properties of TTX-r NaV isoforms, such as cold-nociceptors, most probably derive from NGF-responsive DRG neurons.	[Jonas, Robin; Klusch, Andreas; Schmelz, Martin; Petersen, Marlen; Carr, Richard W.] Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Carr, RW (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol, Mannheim, Germany.	richard.carr@medma.uni-heidelberg.de	Carr, Richard/GSD-4859-2022; Schmelz, Martin/A-9327-2013; Carr, Richard/AAE-9188-2020	Schmelz, Martin/0000-0002-9736-7241; Carr, Richard/0000-0001-8617-9133; Jonas, Robin/0000-0002-7708-2898	Deutsche Forschungsgemeinschaft [IRTG 1874/1, FR 937/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from Deutsche Forschungsgemeinschaft (IRTG 1874/1, DIAMICOM) to MS and from the Deutsche Forschungsgemeinschaft to RC (FR 937/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-32; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Blair NT, 2002, J NEUROSCI, V22, P10277; Blair NT, 2003, J NEUROSCI, V23, P10338; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Campenot RB, 2009, NAT PROTOC, V4, P1869, DOI 10.1038/nprot.2009.210; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; Dib-Hajj SD, 1998, J NEUROPHYSIOL, V79, P2668, DOI 10.1152/jn.1998.79.5.2668; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Fang X, 2002, J NEUROSCI, V22, P7425; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Farrag KJ, 2002, BRIT J PHARMACOL, V135, P1449, DOI 10.1038/sj.bjp.0704607; Fjell J, 1999, MOL BRAIN RES, V67, P267, DOI 10.1016/S0169-328X(99)00070-4; Gold MS, 1998, J NEUROSCI, V18, P10345; Gover TD, 2003, J NEUROSCI, V23, P4793; Gover TD, 2007, J PHYSIOL-LONDON, V578, P481, DOI 10.1113/jphysiol.2006.119008; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JEFTINIJA S, 1994, BRAIN RES, V639, P125, DOI 10.1016/0006-8993(94)91772-8; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Klusch A, 2013, J INVEST DERMATOL, V133, P1387, DOI 10.1038/jid.2012.471; Liu M, 2003, J BIOL CHEM, V278, P5462, DOI 10.1074/jbc.M209111200; Lu SG, 2006, J PHYSIOL-LONDON, V577, P169, DOI 10.1113/jphysiol.2006.116418; Molliver DC, 2005, PAIN, V113, P277, DOI 10.1016/j.pain.2004.10.025; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Muroi Y, 2011, J PHYSIOL-LONDON, V589, P5663, DOI 10.1113/jphysiol.2011.215384; Obreja O, 2008, EUR J PAIN, V12, P775, DOI 10.1016/j.ejpain.2007.11.010; Obreja O, 2012, ANESTH ANALG, V115, P560, DOI 10.1213/ANE.0b013e3182542843; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Petersen M, 1996, NEUROSCIENCE, V75, P495, DOI 10.1016/0306-4522(96)00259-X; Pinto V, 2008, J NEUROPHYSIOL, V99, P617, DOI 10.1152/jn.00944.2007; Pristera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040079; QUASTHOFF S, 1995, NEUROSCIENCE, V69, P955, DOI 10.1016/0306-4522(95)00307-5; Ramirez JD, 2014, NEUROLOGY, V83, P1577, DOI 10.1212/WNL.0000000000000913; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Shmigol A, 1995, J PHYSIOL-LONDON, V489, P627, DOI 10.1113/jphysiol.1995.sp021078; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Steffens H, 2001, NEUROSCI RES, V39, P413, DOI 10.1016/S0168-0102(01)00198-5; Stucky CL, 1999, J NEUROSCI, V19, P6497; USACHEV Y, 1993, NEUROSCIENCE, V57, P845, DOI 10.1016/0306-4522(93)90029-F; Usachev YM, 1997, J NEUROSCI, V17, P7404; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Usoskin D, 2010, P NATL ACAD SCI USA, V107, P16336, DOI 10.1073/pnas.0914705107; Vasylyev DV, 2012, J NEUROPHYSIOL, V108, P729, DOI 10.1152/jn.00091.2012; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Wu ZZ, 2004, BRAIN RES, V1029, P251, DOI 10.1016/j.brainres.2004.09.051; YOSHIDA S, 1979, J NEUROPHYSIOL, V42, P1134, DOI 10.1152/jn.1979.42.4.1134; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	62	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139107	10.1371/journal.pone.0139107	http://dx.doi.org/10.1371/journal.pone.0139107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407014	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700173
J	Lagergren, K; Ek, WE; Levine, D; Chow, WH; Bernstein, L; Casson, AG; Risch, HA; Shaheen, NJ; Bird, NC; Reid, BJ; Corley, DA; Hardie, LJ; Wu, AH; Fitzgerald, RC; Pharoah, P; Caldas, C; Romero, Y; Vaughan, TL; MacGregor, S; Whiteman, D; Westberg, L; Nyren, O; Lagergren, J				Lagergren, Katarina; Ek, Weronica E.; Levine, David; Chow, Wong-Ho; Bernstein, Leslie; Casson, Alan G.; Risch, Harvey A.; Shaheen, Nicholas J.; Bird, Nigel C.; Reid, Brian J.; Corley, Douglas A.; Hardie, Laura J.; Wu, Anna H.; Fitzgerald, Rebecca C.; Pharoah, Paul; Caldas, Carlos; Romero, Yvonne; Vaughan, Thomas L.; MacGregor, Stuart; Whiteman, David; Westberg, Lars; Nyren, Olof; Lagergren, Jesper			Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium	PLOS ONE			English	Article							RECEPTOR GENE; GASTROESOPHAGEAL-REFLUX; ESR1 GENE; ASSOCIATION; CANCER; CARCINOMA; PROLIFERATION; VARIABILITY; VARIANTS; BEHAVIOR	Background The strong male predominance in oesophageal adenocarcinoma (OAC) and Barrett's oesophagus (BO) continues to puzzle. Hormonal influence, e.g. oestrogen or oxytocin, might contribute. Methods This genetic-epidemiological study pooled 14 studies from three continents, Australia, Europe, and North America. Polymorphisms in 3 key genes coding for the oestrogen pathway (receptor alpha (ESR1), receptor beta (ESR2), and aromatase (CYP19A1)), and 3 key genes of the oxytocin pathway (the oxytocin receptor (OXTR), oxytocin protein (OXT), and cyclic ADP ribose hydrolase glycoprotein (CD38)), were analysed using a gene-based approach, versatile gene-based test association study (VEGAS). Results Among 1508 OAC patients, 2383 BO patients, and 2170 controls, genetic variants within ESR1 were associated with BO in males (p = 0.0058) and an increased risk of OAC and BO combined in males (p = 0.0023). Genetic variants within OXTR were associated with an increased risk of BO in both sexes combined (p = 0.0035) and in males (p = 0.0012). We followed up these suggestive findings in a further smaller data set, but found no replication. There were no significant associations between the other 4 genes studied and risk of OAC, BO, separately on in combination, in males and females combined or in males only. Conclusion Genetic variants in the oestrogen receptor alpha and the oxytocin receptor may be associated with an increased risk of BO or OAC, but replication in other large samples are needed.	[Lagergren, Katarina; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Ek, Weronica E.; MacGregor, Stuart] QIMR Berghofer Med Res Inst, Stat Genet, Herston, Qld, Australia; [Ek, Weronica E.] Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Levine, David] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Bernstein, Leslie] Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Shaheen, Nicholas J.] Univ N Carolina, UNC Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bird, Nigel C.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Wu, Anna H.] Univ So Calif, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Fitzgerald, Rebecca C.] Univ Cambridge, Hutchison MRC Res Ctr, Canc Unit, Med Res Council MRC, Cambridge, England; [Pharoah, Paul] Univ Cambridge, Dept Publ Hlth, Cambridge, England; [Caldas, Carlos] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Whiteman, David] Queensland Inst Med Res, Canc Control Grp, Herston, Qld 4006, Australia; [Westberg, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; QIMR Berghofer Medical Research Institute; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Saskatchewan; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sheffield; Fred Hutchinson Cancer Center; Kaiser Permanente; University of Leeds; University of Southern California; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Mayo Clinic; Fred Hutchinson Cancer Center; QIMR Berghofer Medical Research Institute; University of Gothenburg; Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden.	jesper.lagergren@ki.se	Hardie, Laura/AAY-6724-2020; Pharoah, Paul/V-6658-2019; Macgregor, Stuart/C-6442-2009; Caldas, Carlos/U-7250-2019; Whiteman, David C/P-2728-2014	Hardie, Laura/0000-0001-5039-2100; Pharoah, Paul/0000-0001-8494-732X; Macgregor, Stuart/0000-0001-6731-8142; Caldas, Carlos/0000-0003-3547-1489; Whiteman, David C/0000-0003-2563-9559; Fitzgerald, Rebecca/0000-0002-3434-3568	NIH [R01CA136725, K05CA124911, NIDDK 02956]; Australian Research Council [FT0990987]; Australian NHMRC; Australian Research Council; Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program; California Tobacco Related Research Program [3RT-0122, 10RT-0251]; Cancer Research UK [C490/A10119, C490/A10124]; Swedish Cancer Society [4559-B01-01XAA, 4758-B02-01XAB]; U.S. National Institutes of Health [P01CA091955, R01CA072866, R01CA57947, R01CA59636, R01CA100264, P30CA016672, R01CA133996, P50CA093459, U01CA57949, U01CA57983, U01CA57923, R01DK63616]; Medical Research Council; Cambridge NIHR Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Wellcome Trust [076113, 090355]; American Digestive Health Foundation; American College of Gastroenterology; Glaxo Wellcome Inc. Institute for Digestive Health; Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Rochester, Minnesota; MRC [MC_U105365007] Funding Source: UKRI; Cancer Research UK [16942, 16561] Funding Source: researchfish; Medical Research Council [MC_U105365007] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672, K05CA124911, R01CA100264, R01CA059636, U01CA057949, R01CA057947, P50CA093459, U01CA057923, R01CA072866, P01CA091955, U01CA057983, R01CA133996, R01CA136725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK100548, R01DK063616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program(Robert Wood Johnson Foundation (RWJF)); California Tobacco Related Research Program; Cancer Research UK(Cancer Research UK); Swedish Cancer Society(Swedish Cancer Society); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Wellcome Trust(Wellcome Trust); American Digestive Health Foundation; American College of Gastroenterology(General Electric); Glaxo Wellcome Inc. Institute for Digestive Health; Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Rochester, Minnesota; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary funding: This work was primarily funded by NIH grant R01CA136725. Personal support: TLV is supported by NIH Career Development Award K05CA124911. DCW is supported by a Future Fellowship (FT0990987) from the Australian Research Council. SM is supported by an Australian NHMRC Career Development Award and an Australian Research Council Fellowship. YR was supported in part by a grant from the NIH (NIDDK 02956) and the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program. Funding of constituent studies: California Tobacco Related Research Program: 3RT-0122, 10RT-0251. Cancer Research UK: C490/A10119, C490/A10124. Swedish Cancer Society: 4559-B01-01XAA, 4758-B02-01XAB. U.S. National Institutes of Health: P01CA091955, R01CA072866, R01CA57947, R01CA59636, R01CA100264, P30CA016672, R01CA133996, P50CA093459, U01CA57949, U01CA57983, U01CA57923, and R01DK63616. Additional funding came from the Medical Research Council, the Cambridge NIHR Biomedical Research Centre and the Cambridge Experimental Cancer Medicine Centre. This study made use of data generated by the Wellcome Trust Case Control Consortium; Funding for the project was provided by the Wellcome Trust under award 076113 and 090355; a full list of the investigators who contributed to the generation of the data is available from the website (http://www.wtccc.org.uk). The Romero Registry Consortium is supported in part by the American Digestive Health Foundation "Endoscopic Research Award," the American College of Gastroenterology "Junior Faculty Development Award," the Glaxo Wellcome Inc. Institute for Digestive Health "Clinical Research Award," and the Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Rochester, Minnesota. The Romero Registry also has charitable gifts from five industry partners (Affymetrix, AstraZeneca, Santarus, Takeda and Wyeth.) None of the funding sources had any involvement in the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun H, 2002, ANTICANCER RES, V22, P1459; Alexandropoulou K, 2013, EUR J GASTROEN HEPAT, V25, P15, DOI 10.1097/MEG.0b013e3283595086; Bodelon C, 2011, CANCER PREV RES, V4, P840, DOI 10.1158/1940-6207.CAPR-10-0389; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CASSONI P, 1994, VIRCHOWS ARCH, V425, P467; Cassoni P, 1998, INT J CANCER, V77, P695, DOI 10.1002/(SICI)1097-0215(19980831)77:5<695::AID-IJC6>3.0.CO;2-Q; Cassoni P, 2000, J PATHOL, V190, P470, DOI 10.1002/(SICI)1096-9896(200003)190:4<470::AID-PATH550>3.0.CO;2-G; Chandanos E, 2009, EUR J CANCER, V45, P3149, DOI 10.1016/j.ejca.2009.09.001; Cronin-Fenton DP, 2010, EUR J CANCER, V46, P2067, DOI 10.1016/j.ejca.2010.03.032; Dahlgren A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001807; Derakhshan MH, 2009, GUT, V58, P16, DOI 10.1136/gut.2008.161331; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Ek WE, 2013, JNCI-J NATL CANCER I, V105, P1711, DOI 10.1093/jnci/djt303; Gouin JP, 2010, PSYCHONEUROENDOCRINO, V35, P1082, DOI 10.1016/j.psyneuen.2010.01.009; Grover S, 2010, AM J MED GENET B, V153B, P1391, DOI 10.1002/ajmg.b.31119; Jansson C, 2005, CANCER EPIDEM BIOMAR, V14, P1754, DOI 10.1158/1055-9965.EPI-05-0140; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Johansson A, 2012, GENES BRAIN BEHAV, V11, P214, DOI 10.1111/j.1601-183X.2011.00744.x; Keene KL, 2008, HUM GENET, V123, P333, DOI 10.1007/s00439-008-0482-z; Kim J, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-77; Konda VJA, 2012, AM J GASTROENTEROL, V107, P827, DOI 10.1038/ajg.2012.70; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; Levran O, 2014, ANN HUM GENET, V78, P290, DOI 10.1111/ahg.12064; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Monstein HJ, 2004, REGUL PEPTIDES, V119, P39, DOI 10.1016/j.regpep.2003.12.017; Morita T, 2004, INT J CANCER, V109, P525, DOI 10.1002/ijc.20017; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Novak JF, 2000, CANCER RES, V60, P3470; Rubenstein JH, 2010, ALIMENT PHARM THER, V32, P1222, DOI 10.1111/j.1365-2036.2010.04471.x; Rutegard M, 2010, EUR J CANCER, V46, P1093, DOI 10.1016/j.ejca.2010.01.029; Schuit SCE, 2005, EUR J ENDOCRINOL, V153, P327, DOI 10.1530/eje.1.01973; Stankova T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-17; Sukocheva OA, 2013, DIS ESOPHAGUS, V26, P628, DOI 10.1111/dote.12000; Taylor JB, 2010, AM J GASTROENTEROL, V105, P1730, DOI 10.1038/ajg.2010.194; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tobias JH, 2007, J CLIN ENDOCR METAB, V92, P2286, DOI 10.1210/jc.2006-2447; Velasco J, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-16; Viero C, 2010, CNS NEUROSCI THER, V16, pe138, DOI 10.1111/j.1755-5949.2010.00185.x; Walum H, 2012, BIOL PSYCHIAT, V71, P419, DOI 10.1016/j.biopsych.2011.09.002; Whittington K, 2007, PROSTATE, V67, P1132, DOI 10.1002/pros.20612	43	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138738	10.1371/journal.pone.0138738	http://dx.doi.org/10.1371/journal.pone.0138738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406593	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700081
J	Mallikarjuna, MG; Thirunavukkarasu, N; Hossain, F; Bhat, JS; Jha, SK; Rathore, A; Agrawal, PK; Pattanayak, A; Reddy, SS; Gularia, SK; Singh, AM; Manjaiah, KM; Gupta, HS				Mallikarjuna, Mallana Gowdra; Thirunavukkarasu, Nepolean; Hossain, Firoz; Bhat, Jayant S.; Jha, Shailendra K.; Rathore, Abhishek; Agrawal, Pawan Kumar; Pattanayak, Arunava; Reddy, Sokka S.; Gularia, Satish Kumar; Singh, Anju Mahendru; Manjaiah, Kanchikeri Math; Gupta, Hari Shanker			Stability Performance of Inductively Coupled Plasma Mass Spectrometry-Phenotyped Kernel Minerals Concentration and Grain Yield in Maize in Different Agro-Climatic Zones	PLOS ONE			English	Article							X ENVIRONMENT INTERACTION; STATISTICAL-ANALYSIS; AMMI ANALYSIS; IRON; ZINC; SELECTION; TRIALS; BIOAVAILABILITY; IMPROVEMENT; SOUTHERN	Deficiency of iron and zinc causes micronutrient malnutrition or hidden hunger, which severely affects similar to 25% of global population. Genetic biofortification of maize has emerged as cost effective and sustainable approach in addressing malnourishment of iron and zinc deficiency. Therefore, understanding the genetic variation and stability of kernel micronutrients and grain yield of the maize inbreds is a prerequisite in breeding micronutrient-rich high yielding hybrids to alleviate micronutrient malnutrition. We report here, the genetic variability and stability of the kernel micronutrients concentration and grain yield in a set of 50 maize inbred panel selected from the national and the international centres that were raised at six different maize growing regions of India. Phenotyping of kernels using inductively coupled plasma mass spectrometry (ICP-MS) revealed considerable variability for kernel minerals concentration (iron: 18.88 to 47.65 mg kg(-1); zinc: 5.41 to 30.85 mg kg(-1); manganese: 3.30 to 17.73 mg kg(-1); copper: 0.53 to 5.48 mg kg(-1)) and grain yield (826.6 to 5413 kg ha(-1)). Significant positive correlation was observed between kernel iron and zinc within (r = 0.37 to r = 0.52, p < 0.05) and across locations (r = 0.44, p < 0.01). Variance components of the additive main effects and multiplicative interactions (AMMI) model showed significant genotype and genotype x environment interaction for kernel minerals concentration and grain yield. Most of the variation was contributed by genotype main effect for kernel iron (39.6%), manganese (41.34%) and copper (41.12%), and environment main effects for both kernel zinc (40.5%) and grain yield (37.0%). Genotype main effect plus genotype-by-environment interaction (GGE) biplot identified several mega environments for kernel minerals and grain yield. Comparison of stability parameters revealed AMMI stability value (ASV) as the better representative of the AMMI stability parameters. Dynamic stability parameter GGE distance (GGED) showed strong and positive correlation with both mean kernel concentrations and grain yield. Inbreds (CM-501, SKV-775, HUZM-185) identified from the present investigation will be useful in developing micronutrient-rich as well as stable maize hybrids without compromising grain yield.	[Mallikarjuna, Mallana Gowdra; Thirunavukkarasu, Nepolean; Hossain, Firoz; Jha, Shailendra K.; Gupta, Hari Shanker] ICAR Indian Agr Res Inst, Div Genet, Maize Res Lab, New Delhi, India; [Bhat, Jayant S.] ICAR Indian Agr Res Inst, Reg Res Ctr, Dharwad, Karnataka, India; [Rathore, Abhishek] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Agrawal, Pawan Kumar] ICAR Vivekanand Parvatiya Krishi Anusandhan Sanst, Almora, India; [Pattanayak, Arunava] ICAR Res Complex North Eastern Hill Reg, Umiam, Meghalaya, India; [Reddy, Sokka S.] Prof Jayshankar Telangana State Agr Univ, Hyderabad, Andhra Pradesh, India; [Gularia, Satish Kumar] CSK Himachal Pradesh Krishi Viswavidyalaya, Bajaura, India; [Singh, Anju Mahendru] ICAR Indian Agr Res Inst, Div Genet, Grain Qual Lab, New Delhi, India; [Manjaiah, Kanchikeri Math] ICAR Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Gupta, HS (corresponding author), Borlaug Inst South Asia, New Delhi, India.	h.s.gupta@cgiar.org	Gowdra, Mallikarjuna Mallana/AAF-3654-2019	/0000-0003-4565-9792	ICAR-NPTC on Functional Genomics [Maize component: 21-22]; DBT, GoI Project on Development of micronutrient enriched maize through molecular breeding -Phase II [102/IFD/SAN/4455/2011-12]; Department of Science & Technology, Government of India [DST/INSPIRE/2011/IF110504]	ICAR-NPTC on Functional Genomics; DBT, GoI Project on Development of micronutrient enriched maize through molecular breeding -Phase II; Department of Science & Technology, Government of India(Department of Science & Technology (India))	This work was supported by the ICAR-NPTC on Functional Genomics (Maize component: 21-22) and the DBT, GoI Project on Development of micronutrient enriched maize through molecular breeding -Phase II (102/IFD/SAN/4455/2011-12). MGM is thankful to the Department of Science & Technology, Government of India, for the INSPIRE Fellowship (DST/INSPIRE/2011/IF110504) to carry out the doctoral degree programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwala S, 2010, FIELD CROP RES, V119, P225, DOI 10.1016/j.fcr.2010.07.010; Annicchiarico P, 1997, THEOR APPL GENET, V94, P1072, DOI 10.1007/s001220050517; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; ARGILLIER O, 1994, AGRONOMIE, V14, P661, DOI 10.1051/agro:19941003; Badu-Apraku B, 2012, FIELD CROP RES, V129, P99, DOI 10.1016/j.fcr.2012.01.018; Banziger Marianne, 2000, Food and Nutrition Bulletin, V21, P397; Bashir EMA, 2014, FIELD CROP RES, V166, P82, DOI 10.1016/j.fcr.2014.06.007; Bashir EMA, 2014, PLANT GENET RESOUR-C, V12, P35, DOI 10.1017/S1479262113000233; BECKER HC, 1988, PLANT BREEDING, V101, P1, DOI 10.1111/j.1439-0523.1988.tb00261.x; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; CASTLEBERRY RM, 1984, CROP SCI, V24, P33, DOI 10.2135/cropsci1984.0011183X002400010008x; Chakraborti M, 2011, J PLANT BIOCHEM BIOT, V20, P224, DOI 10.1007/s13562-011-0050-9; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Fan LJ, 2001, PLANT BREEDING, V120, P139, DOI 10.1046/j.1439-0523.2001.00564.x; FINLAY KW, 1963, AUST J AGR RES, V14, P742, DOI 10.1071/AR9630742; FRANCIS TR, 1978, CAN J PLANT SCI, V58, P1029, DOI 10.4141/cjps78-157; Gauch H.G., 1992, STAT ANAL REGIONAL Y; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Gauch HG, 1997, CROP SCI, V37, P311, DOI 10.2135/cropsci1997.0011183X003700020002x; Gauch HG, 1996, CROP SCI, V36, P838, DOI 10.2135/cropsci1996.0011183X003600040002x; Genstat, 2013, GENST WIND REL 16 1; Ghandilyan A, 2006, PHYSIOL PLANTARUM, V126, P407, DOI 10.1111/j.1399-3054.2006.00646.x; Goyal A, 2011, CAN J PLANT SCI, V91, P125, DOI 10.4141/CJPS10063; Gupta H.S., 2015, NUTR USE EFFICIENCY, P255, DOI [10.1007/978-81-322-2169-2_17, DOI 10.1007/978-81-322-2169-2-17]; Horton S, 2008, CHALLENGE HUNGER MAL, P3; House WA, 1999, FIELD CROP RES, V60, P115, DOI 10.1016/S0378-4290(98)00136-1; Khalid N, 2014, CRIT REV FOOD SCI, V54, P1222, DOI 10.1080/10408398.2011.630541; LIN CS, 1986, CROP SCI, V26, P894, DOI 10.2135/cropsci1986.0011183X002600050012x; LIN CS, 1988, CAN J PLANT SCI, V68, P193, DOI 10.4141/cjps88-018; Long JK, 2004, CROP SCI, V44, P2019, DOI 10.2135/cropsci2004.2019; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mason S. C., 2002, Journal of Crop Production, V5, P75, DOI 10.1300/J144v05n01_04; Menkir A, 2008, FOOD CHEM, V110, P454, DOI 10.1016/j.foodchem.2008.02.025; Milligan SB, 2003, CROP SCI, V43, P1729, DOI 10.2135/cropsci2003.1729; Mohammadi R, 2013, EUPHYTICA, V192, P227, DOI 10.1007/s10681-012-0839-1; Oikeh SO, 2003, J AGR FOOD CHEM, V51, P3688, DOI 10.1021/jf0261708; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Pixley KV, 2011, FIELD CROP RES, V123, P153, DOI 10.1016/j.fcr.2011.05.011; Prasanna BM, 2011, INDIAN J AGR SCI, V81, P704; Purchase J. L., 2000, South African Journal of Plant and Soil, V17, P101; Roostaei M, 2014, CROP J, V2, P154, DOI 10.1016/j.cj.2014.02.002; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; SHUKLA GK, 1972, HEREDITY, V29, P237, DOI 10.1038/hdy.1972.87; Simic D, 2009, J CEREAL SCI, V50, P392, DOI 10.1016/j.jcs.2009.06.014; Velu G, 2011, EUPHYTICA, V180, P251, DOI 10.1007/s10681-011-0387-0; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; WRICKE G, 1962, Z PFLANZENZUCHT, V47, P92; Yan W., 2003, GGE BIPLOT ANAL GRAP; Yan WK, 2007, CROP SCI, V47, P643, DOI 10.2135/cropsci2006.06.0374; Yan WK, 2000, CROP SCI, V40, P597, DOI 10.2135/cropsci2000.403597x; Yan WK, 2001, AGRON J, V93, P1111, DOI 10.2134/agronj2001.9351111x; Yates F, 1938, J AGR SCI, V28, P556, DOI 10.1017/S0021859600050978; Zhang Ze, 1998, Acta Agronomica Sinica, V24, P304; Zobel R.W, 1994, INTSORMIL PUBLICATIO, P80; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x	58	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139067	10.1371/journal.pone.0139067	http://dx.doi.org/10.1371/journal.pone.0139067			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406470	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000361800700160
J	Shpigel, NY; Pasternak, Z; Factor, G; Gottlieb, Y				Shpigel, Nahum Y.; Pasternak, Zohar; Factor, Gilad; Gottlieb, Yuval			Diversity of Bacterial Biofilm Communities on Sprinklers from Dairy Farm Cooling Systems in Israel	PLOS ONE			English	Article							CORYNEBACTERIUM-PSEUDOTUBERCULOSIS INFECTION; MULTIPLE SEQUENCE ALIGNMENT; PYROSEQUENCING ANALYSIS; DRINKING-WATER; HEAT-STRESS; COWS; CATTLE; RESERVOIR; SURFACE; MUSCLE	On dairy farms in hot climates worldwide, cows suffer from heat stress, which is alleviated by the use of water cooling systems. Sprinklers and showerheads are known to support the development of microbial biofilms, which can be a source of infection by pathogenic microorganisms. The aim of this study was to investigate the presence of microbial biofilms in dairy cooling systems, and to analyze their population compositions using culture-independent technique, 16S rRNA gene sequencing. Biofilm samples were collected on eight dairy farms from 40 sprinklers and the microbial constituents were identified by deep sequencing of the 16S rRNA gene. A total of 9,374 operational taxonomic units (OTUs) was obtained from all samples. The mean richness of the samples was 465 +/- 268 OTUs which were classified into 26 different phyla; 76% of the reads belonged to only three phyla: Proteobacteria, Actinobacteria and Firmicutes. Although the most prevalent OTUs (Paracoccus, Methyloversatilis, Brevundimonas, Porphyrobacter, Gp4, Mycobacterium, Hyphomicrobium, Corynebacterium and Clostridium) were shared by all farms, each farm formed a unique microbial pattern. Some known potential human and livestock pathogens were found to be closely related to the OTUs found in this study. This work demonstrates the presence of biofilm in dairy cooling systems which may potentially serve as a live source for microbial pathogens.	[Shpigel, Nahum Y.; Gottlieb, Yuval] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Pasternak, Zohar] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Factor, Gilad] Hachaklait, Mutual Soc Vet Serv, Caesarea, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shpigel, NY (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	nahum.shpigel@mail.huji.ac.il	Gottlieb, Yuval/H-6461-2013		Israeli Dairy Board [705-0048-11]	Israeli Dairy Board	This work was supported by the Israeli Dairy Board (project 705-0048-11). http://www.israeldairy.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor A, 2011, J CLIN MICROBIOL, V49, P449, DOI 10.1128/JCM.01117-10; Berman A, 2008, J DAIRY SCI, V91, P4571, DOI 10.3168/jds.2008-1175; Berman A, 2010, J DAIRY SCI, V93, P242, DOI 10.3168/jds.2009-2601; Berman A, 2009, J ANIM SCI, V87, P3413, DOI 10.2527/jas.2008-1104; Borderas TF, 2004, J DAIRY SCI, V87, P2085, DOI 10.3168/jds.S0022-0302(04)70026-0; Chen CL, 2004, APPL MICROBIOL BIOT, V63, P466, DOI 10.1007/s00253-003-1286-7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esposito A, 2014, FEMS MICROBIOL LETT, V351, P145, DOI 10.1111/1574-6968.12375; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flamenbaum I, 2010, J REPROD DEVELOP, V56, pS36, DOI 10.1262/jrd.1056S36; Gauly M, 2013, ANIMAL, V7, P843, DOI 10.1017/S1751731112002352; Golan L, 2009, J INFECT DIS, V199, P350, DOI 10.1086/596033; Henne K, 2013, WATER RES, V47, P5614, DOI 10.1016/j.watres.2013.06.034; HER E, 1988, J DAIRY SCI, V71, P1085, DOI 10.3168/jds.S0022-0302(88)79656-3; Hogan J, 2012, VET CLIN N AM-FOOD A, V28, P217, DOI 10.1016/j.cvfa.2012.03.009; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Honig H, 2012, J DAIRY SCI, V95, P3736, DOI 10.3168/jds.2011-5054; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kelly JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098542; Koerner RJ, 2009, FEMS IMMUNOL MED MIC, V55, P296, DOI 10.1111/j.1574-695X.2008.00513.x; Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022; Luo JH, 2013, BIORESOURCE TECHNOL, V148, P189, DOI 10.1016/j.biortech.2013.08.109; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Mather P. M., 1976, COMPUTATIONAL METHOD; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Navarro-Noya YE, 2013, MICROB ECOL, V66, P19, DOI 10.1007/s00248-013-0222-3; Percival SL, 2012, INT WOUND J, V9, P14, DOI 10.1111/j.1742-481X.2011.00836.x; Rathnaiah G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00144; Rosenblueth M, 2011, DNA CELL BIOL, V30, P633, DOI 10.1089/dna.2011.1231; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHPIGEL NY, 1993, VET REC, V133, P89, DOI 10.1136/vr.133.4.89; Sun HF, 2014, SCI TOTAL ENVIRON, V472, P99, DOI 10.1016/j.scitotenv.2013.11.017; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Williams MM, 2013, BIOFOULING, V29, P147, DOI 10.1080/08927014.2012.757308; Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009; Yeruham I, 1997, VET REC, V140, P423, DOI 10.1136/vr.140.16.423; Yeruham I, 2000, VET REC, V146, P695, DOI 10.1136/vr.146.24.695; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	49	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139111	10.1371/journal.pone.0139111	http://dx.doi.org/10.1371/journal.pone.0139111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407190	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700175
J	Bauskar, A; Mack, WJ; Mauris, J; Argueso, P; Heur, M; Nagel, BA; Kolar, GR; Gleave, ME; Nakamura, T; Kinoshita, S; Moradian-Oldak, J; Panjwani, N; Pflugfelder, SC; Wilson, MR; Fini, ME; Jeong, SW				Bauskar, Aditi; Mack, Wendy J.; Mauris, Jerome; Argueeso, Pablo; Heur, Martin; Nagel, Barbara A.; Kolar, Grant R.; Gleave, Martin E.; Nakamura, Takahiro; Kinoshita, Shigeru; Moradian-Oldak, Janet; Panjwani, Noorjahan; Pflugfelder, Stephen C.; Wilson, Mark R.; Fini, M. Elizabeth; Jeong, Shinwu			Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye	PLOS ONE			English	Article							APOLIPOPROTEIN-J CLUSTERIN; EPITHELIAL-CELLS; CORNEAL EPITHELIUM; GENE-EXPRESSION; TEAR PROTEOME; IN-VITRO; MATRIX-METALLOPROTEINASE-9; GALECTIN-3; MECHANISMS; RECEPTOR	Dry eye is a common disorder caused by inadequate hydration of the ocular surface that results in disruption of barrier function. The homeostatic protein clusterin (CLU) is prominent at fluid-tissue interfaces throughout the body. CLU levels are reduced at the ocular surface in human inflammatory disorders that manifest as severe dry eye, as well as in a preclinical mouse model for desiccating stress that mimics dry eye. Using this mouse model, we show here that CLU prevents and ameliorates ocular surface barrier disruption by a remarkable sealing mechanism dependent on attainment of a critical all-or-none concentration. When the CLU level drops below the critical all-or-none threshold, the barrier becomes vulnerable to desiccating stress. CLU binds selectively to the ocular surface subjected to desiccating stress in vivo, and in vitro to the galectin LGALS3, a key barrier component. Positioned in this way, CLU not only physically seals the ocular surface barrier, but it also protects the barrier cells and prevents further damage to barrier structure. These findings define a fundamentally new mechanism for ocular surface protection and suggest CLU as a biotherapeutic for dry eye.	[Bauskar, Aditi; Fini, M. Elizabeth; Jeong, Shinwu] Univ So Calif, Keck Sch Med, USC Inst Genet Med, Los Angeles, CA 90033 USA; [Bauskar, Aditi] Univ So Calif, Keck Sch Med, Grad Program Med Biol, Los Angeles, CA 90033 USA; [Mack, Wendy J.] Univ So Calif, Keck Sch Med, Southern Calif Clin & Translat Sci Inst, Los Angeles, CA 90033 USA; [Mack, Wendy J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Mauris, Jerome; Argueeso, Pablo] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA USA; [Mauris, Jerome; Argueeso, Pablo] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Heur, Martin] Univ So Calif, Keck Sch Med, USC Eye Inst, Los Angeles, CA 90033 USA; [Nagel, Barbara A.] St Louis Univ, Sch Med, Dept Pathol, Res Microscopy & Histol Core, St Louis, MO 63104 USA; [Kolar, Grant R.] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Kolar, Grant R.] St Louis Univ, Sch Med, Dept Ophthalmol, St Louis, MO USA; [Gleave, Martin E.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Gleave, Martin E.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan; [Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, Div Biomed Sci, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Ophthalmol, New England Eye Ctr, Boston, MA 02111 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Pflugfelder, Stephen C.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Fini, M. Elizabeth; Jeong, Shinwu] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Southern California; Saint Louis University; Saint Louis University; Saint Louis University; University of British Columbia; University of British Columbia; Kyoto Prefectural University of Medicine; University of Southern California; Tufts University; Tufts University; Baylor College of Medicine; University of Wollongong; University of Southern California; University of Southern California	Jeong, SW (corresponding author), Univ So Calif, Keck Sch Med, USC Inst Genet Med, Los Angeles, CA 90033 USA.	shinwuje@usc.edu	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Jeong, Shinwu/0000-0002-4847-813X; Gleave, Martin/0000-0003-4235-0167; Argueso, Pablo/0000-0001-7321-9503	James H. Zumberge Faculty Research & Innovation Fund; National Institutes of Health [R01-EY009828, R01-EY024031, R01-DE013414, UL1-TR000130]; Research to Prevent Blindness, New York, NY; Keck School of Medicine of USC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024031, R01EY009828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414] Funding Source: NIH RePORTER	James H. Zumberge Faculty Research & Innovation Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Keck School of Medicine of USC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by an award from the James H. Zumberge Faculty Research & Innovation Fund (to SJ) (http://research.usc.edu/zumberge); National Institutes of Health grants R01-EY009828 (to MEF)(https://nei.nih.gov), R01-EY024031 (to PA) (https://nei.nih.gov), R01-DE013414 (to JM-O) (http://www.nidcr.nih.gov) and UL1-TR000130 (formerly UL1-RR031986; sub-award to WJM) (http://www.nih.gov/about/almanac/organization/NCRR.htm); an unrestricted grant from Research to Prevent Blindness, New York, NY (https://www.rpbusa.org/rpb/grants/grants) to the University of Southern California; and start-up funding from the Keck School of Medicine of USC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson MB, 2005, THE DYE NAMICS OF DR; Adisetiyo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069484; Argueso P, 2011, EXP EYE RES, V92, P2, DOI 10.1016/j.exer.2010.11.009; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Bandamwar KL, 2014, CONTACT LENS ANTERIO, V37, P213, DOI 10.1016/j.clae.2013.11.003; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bron AJ, 2015, PROG RETIN EYE RES, V44, P36, DOI 10.1016/j.preteyeres.2014.10.001; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Chieze L, 2011, J MOL BIOL, V410, P60, DOI 10.1016/j.jmb.2011.04.006; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; Clouzeau C, 2012, MOL VIS, V18, P851; COLLARD MW, 1987, BIOCHEMISTRY-US, V26, P3297, DOI 10.1021/bi00386a008; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dabbs RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086989; De Paiva CS, 2006, INVEST OPHTH VIS SCI, V47, P2847, DOI 10.1167/iovs.05-1281; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; DESILVA HV, 1990, J BIOL CHEM, V265, P14292; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Fini ME, 1998, BIOL EXTRAC, P299; Foulks GN, 2007, OCUL SURF, V5, P65, DOI 10.1016/S1542-0124(12)70076-9; Foulks GN, 2014, AM J OPHTHALMOL, V157, P1122, DOI 10.1016/j.ajo.2014.03.002; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2007, INVEST OPHTH VIS SCI, V48, P4391, DOI 10.1167/iovs.07-0770; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; Hochgrebe T, 2000, BIOCHEMISTRY-US, V39, P1411, DOI 10.1021/bi991581b; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Jeong S, 2012, AM J PATHOL, V180, P2028, DOI 10.1016/j.ajpath.2012.01.025; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Karnati R, 2013, EXP EYE RES, V117, P39, DOI 10.1016/j.exer.2013.05.020; Kierzek AM, 2010, MOL BIOSYST, V6, P531, DOI 10.1039/b906951h; Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P13070, DOI 10.1074/jbc.270.22.13070; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Li DQ, 2005, OCUL SURF, V3, pS198; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Li ZR, 2013, INVEST OPHTH VIS SCI, V54, P155, DOI 10.1167/iovs.12-10648; Liang JF, 2014, INT J MOL SCI, V15, P11220, DOI 10.3390/ijms150711220; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Mantelli F, 2013, J CELL PHYSIOL, V228, P2253, DOI 10.1002/jcp.24398; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Matani P, 2007, FRONT BIOSCI-LANDMRK, V12, P3852, DOI 10.2741/2356; Matsumoto H, 2013, CANCER RES, V73, P5206, DOI 10.1158/0008-5472.CAN-13-0359; Matveev V, 2000, J NEUROSCI, V20, P1575; Mauris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072304; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; Nakamura T, 2002, INVEST OPHTH VIS SCI, V43, P1702; Navab M, 2007, J CLIN LIPIDOL, V1, P142, DOI 10.1016/j.jacl.2007.03.002; Nishida I, 1999, BRIT J OPHTHALMOL, V83, P1178, DOI 10.1136/bjo.83.10.1178; Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800; Novack GD, 2014, OCUL SURF, V12, P227, DOI 10.1016/j.jtos.2014.05.001; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Radziwon-Balicka A, 2014, CARCINOGENESIS, V35, P324, DOI 10.1093/carcin/bgt332; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Savkovic V, 2007, BIOCHEM BIOPH RES CO, V356, P431, DOI 10.1016/j.bbrc.2007.02.148; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Shim YJ, 2011, J LEUKOCYTE BIOL, V90, P761, DOI 10.1189/jlb.0311110; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; Sullivan DA, 2012, OCUL SURF, V10, P108, DOI 10.1016/j.jtos.2012.02.001; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Toren PJ, 2013, ASIAN J ANDROL, V15, P342, DOI 10.1038/aja.2013.38; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Tsianou M, 2014, LANGMUIR THE ACS JOU, DOI [10.1021/la5013999, DOI 10.1021/LA5013999]; Uchino Y, 2015, AM J OPHTHALMOL, V159, P1027, DOI 10.1016/j.ajo.2015.02.008; Ulmer TA, 2010, BBA-GEN SUBJECTS, V1800, P336, DOI 10.1016/j.bbagen.2009.07.030; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Villareal Arturo L, 2006, Eye Contact Lens, V32, P272, DOI 10.1097/01.icl.0000224360.10319.b1; Wiechmann AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113810; Williamson JF, 2014, EYE CONTACT LENS, V40, P111, DOI 10.1097/ICL.0000000000000020; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Xiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115333; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053	88	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138958	10.1371/journal.pone.0138958	http://dx.doi.org/10.1371/journal.pone.0138958			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402857	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100045
J	Sun, P; Du, JB; Zhu, X; Ren, CL; Xie, L; Dai, NB; Gu, YY; Yan, CW; Dai, JC; Ma, HX; Jiang, Y; Chen, JP; Hu, ZB; Shen, HB; Wu, HR; Jin, GF				Sun, Ping; Du, Jiangbo; Zhu, Xun; Ren, Chuanli; Xie, Lan; Dai, Ningbin; Gu, Yayun; Yan, Caiwang; Dai, Juncheng; Ma, Hongxia; Jiang, Yue; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing; Wu, Haorong; Jin, Guangfu			Genetic Variation in the 3 '-Untranslated Region of NBN Gene Is Associated with Gastric Cancer Risk in a Chinese Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; BASAL-CELL CARCINOMA; DNA-REPAIR GENES; NBS1 POLYMORPHISM; BREAST-CANCER; LUNG-CANCER; SUSCEPTIBILITY; COMPLEX; DAMAGE; REPLICATION	NBN plays a crucial role in carcinogenesis as a core component for both homologous recombination (HR) and non-homologous end-joining (NHEJ) DNA double-strand breaks (DSBs) repair pathways. Genetic variants in the NBN gene have been associated with multiple cancers risk, suggesting pleiotropic effect on cancer. We hypothesized that genetic variants in the NBN gene may modify the risk of gastric cancer. To test this hypothesis, we evaluated the association between four potentially functional single nucleotide polymorphisms in NBN and gastric cancer risk in a case-control study of 1,140 gastric cancer cases and 1,547 controls in a Chinese population. We found that the A allele of rs10464867 (G>A) was significantly associated with a decreased risk of gastric cancer (odds ratio [OR] = 0.81, 95% confidence interval [95% CI] = 0.71-0.94; P = 4.71x10(-3)). Furthermore, the association between A allele of rs10464867 and decreased risk of gastric cancer was more significantly in elder individuals (per-allele OR = 0.72[0.59-0.88], P = 1.07x10(-3)), and male individuals (per-allele OR = 0.73[0.62-0.87], P = 3.68x10(-4)). We further conducted a haplotype analysis and identified that the NBN A(rs10464867)G(rs14448)G(rs1063053) haplotype conferred stronger protective effect on gastric cancer (OR = 0.76[0.65-0.89], P = 6.39x10(-4)). In summary, these findings indicate that genetic variants at NBN gene may contribute to gastric cancer susceptibility and may further advance our understanding of NBN gene in cancer development.	[Sun, Ping; Wu, Haorong] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou 215004, Peoples R China; [Sun, Ping] Nanjing Med Univ, Affiliated Wuxi Hosp 2, Dept Pathol, Wuxi 214006, Peoples R China; [Du, Jiangbo; Zhu, Xun; Dai, Ningbin; Gu, Yayun; Yan, Caiwang; Dai, Juncheng; Ma, Hongxia; Jiang, Yue; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing; Jin, Guangfu] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China; [Du, Jiangbo; Dai, Ningbin; Gu, Yayun; Dai, Juncheng; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing; Jin, Guangfu] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China; [Ren, Chuanli] Northern Jiangsu Peoples Hosp, Med Lab, Yangzhou 225001, Peoples R China; [Xie, Lan] Tsinghua Univ, Sch Med, Med Syst Biol Res Ctr, Beijing 100084, Peoples R China	Soochow University - China; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Tsinghua University	Jin, GF (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China.	wuhaorong666@126.com; guangfujin@njmu.edu.cn	Dai, Ningbin/AFS-0341-2022	Shen, Hongbing/0000-0002-2581-5906	National Natural Science Foundation of China [81230067, 81422042, 81373090]; Science and Technology Agency of Jiangsu Province, China [BK20130042]; Science and Technology committee of Nanjing, China [BL2012008]; Government of Jiangsu Province, China; Science Foundation for Distinguished Young Scholars in Jiangsu [BK20130042]; Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center) [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Agency of Jiangsu Province, China; Science and Technology committee of Nanjing, China; Government of Jiangsu Province, China; Science Foundation for Distinguished Young Scholars in Jiangsu(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center); Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	81230067, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, HS; 81422042 and 81373090, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, GJ; BK20130042, http://www.jstd.gov.cn/, Science and Technology Agency of Jiangsu Province, China, GJ; BL2012008, http://www.njkj.gov.cn/, Science and Technology committee of Nanjing, China, HS; http://www.jiangsu.gov.cn/, Government of Jiangsu Province, China, HS; Science Foundation for Distinguished Young Scholars in Jiangsu (BK20130042); Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center, BL2012008); and Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Berardinelli F, 2013, CURR GENOMICS, V14, P425, DOI 10.2174/13892029113146660012; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; di Masi A, 2008, CURR GENOMICS, V9, P275, DOI 10.2174/138920208784533610; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Dzikiewicz-Krawczyk A, 2008, MUTAT RES-REV MUTAT, V659, P262, DOI 10.1016/j.mrrev.2008.05.005; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gong YT, 2013, GENE, V519, P335, DOI 10.1016/j.gene.2013.01.059; Gu Daquan, 2011, INSTRUMENTATION TECH, V01, P1, DOI DOI 10.1371/J0URNAL.P0NE; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2014, INFECT IMMUN, V82, P4182, DOI 10.1128/IAI.02368-14; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang MD, 2012, DNA CELL BIOL, V31, P678, DOI 10.1089/dna.2011.1421; Koppensteiner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100041; Lafrance-Vanasse J, 2015, PROG BIOPHYS MOL BIO, V117, P182, DOI 10.1016/j.pbiomolbio.2014.12.004; Li N, 2013, MOL BIOL REP, V40, P3749, DOI 10.1007/s11033-012-2451-9; Liu JW, 2013, ASIAN PAC J CANCER P, V14, P6103, DOI 10.7314/APJCP.2013.14.10.6103; Lu JC, 2006, CARCINOGENESIS, V27, P2209, DOI 10.1093/carcin/bgl077; Margulis V, 2008, CANCER EPIDEM BIOMAR, V17, P2366, DOI 10.1158/1055-9965.EPI-08-0259; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Park SL, 2010, CARCINOGENESIS, V31, P1264, DOI 10.1093/carcin/bgq096; Ryk C, 2006, LUNG CANCER, V54, P285, DOI 10.1016/j.lungcan.2006.08.004; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Shen HB, 2013, J BIOMED RES, V27, P167, DOI 10.7555/JBR.27.20130040; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Silva J, 2012, DNA CELL BIOL, V31, P1182, DOI 10.1089/dna.2011.1562; Slyskova J, 2011, ENVIRON MOL MUTAGEN, V52, P511, DOI 10.1002/em.20650; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Thirumaran RK, 2006, CARCINOGENESIS, V27, P1676, DOI 10.1093/carcin/bgi381; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Wang LX, 2013, MOL BIOL REP, V40, P2711, DOI 10.1007/s11033-012-2358-5; WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang MD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-174; Yuan T, 2011, CANCER EPIDEMIOL, V35, P170, DOI 10.1016/j.canep.2010.08.008; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803	46	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139059	10.1371/journal.pone.0139059	http://dx.doi.org/10.1371/journal.pone.0139059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402912	gold, Green Published, Green Submitted			2022-12-26	WOS:000361798100056
J	Dutt, M; Barthe, G; Irey, M; Grosser, J				Dutt, Manjul; Barthe, Gary; Irey, Michael; Grosser, Jude			Transgenic Citrus Expressing an Arabidopsis NPR1 Gene Exhibit Enhanced Resistance against Huanglongbing (HLB; Citrus Greening)	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; WRKY70 TRANSCRIPTION FACTOR; SALICYLIC-ACID INDUCTION; REAL-TIME PCR; DIAPHORINA-CITRI; DEFENSE RESPONSE; SWEET ORANGE; DISEASE; PROTEIN; OVEREXPRESSION	Commercial sweet orange cultivars lack resistance to Huanglongbing (HLB), a serious phloem limited bacterial disease that is usually fatal. In order to develop sustained disease resistance to HLB, transgenic sweet orange cultivars 'Hamlin' and 'Valencia' expressing an Arabidopsis thaliana NPR1 gene under the control of a constitutive CaMV 35S promoter or a phloem specific Arabidopsis SUC2 (AtSUC2) promoter were produced. Overexpression of AtNPR1 resulted in trees with normal phenotypes that exhibited enhanced resistance to HLB. Phloem specific expression of NPR1 was equally effective for enhancing disease resistance. Transgenic trees exhibited reduced diseased severity and a few lines remained disease-free even after 36 months of planting in a high-disease pressure field site. Expression of the NPR1 gene induced expression of several native genes involved in the plant defense signaling pathways. The AtNPR1 gene being plant derived can serve as a component for the development of an all plant T-DNA derived consumer friendly GM tree.	[Dutt, Manjul; Barthe, Gary; Grosser, Jude] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA; [Irey, Michael] Southern Gardens Citrus, Clewiston, FL USA	State University System of Florida; University of Florida	Dutt, M (corresponding author), Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.	manjul@ufl.edu			Citrus Research & Development Foundation	Citrus Research & Development Foundation	Citrus Research & Development Foundation (www.citrusrdf.org/). Funding Statement: The Citrus Research & Development Foundation provided support in the form of salaries for author MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Southern Gardens Citrus did not provide any financial assistance but assisted in evaluating the authors' transgenic lines in a no-choice greenhouse evaluation study containing free flying potentially CLas containing psyllids. In addition, they provided assistance in qPCR analyses of transgenic leaf samples.	Alves GR, 2014, J ECON ENTOMOL, V107, P691, DOI 10.1603/EC13339; Belasque Junior J., 2010, Citrus Research and Technology, V31, P53, DOI 10.5935/2236-3122.20100005; Bove JM, 2014, PHYTOPARASITICA, V42, P579, DOI 10.1007/s12600-014-0415-4; Burow MD., 1990, PLANT MOL BIOL REP, V8, P124, DOI [10.1007/BF02669766, DOI 10.1007/BF02669766]; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chen Jen-Chih, 2013, Bot Stud, V54, P31, DOI 10.1186/1999-3110-54-31; Chen XH, 2013, PHYSIOL MOL PLANT P, V84, P115, DOI 10.1016/j.pmpp.2013.07.002; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Dutt M, 2008, PLANT SCI, V175, P423, DOI 10.1016/j.plantsci.2008.06.014; Dutt M, 2012, TREE PHYSIOL, V32, P83, DOI 10.1093/treephys/tpr130; Dutt M, 2011, PLANT CELL TISS ORG, V107, P79, DOI 10.1007/s11240-011-9959-x; Dutt M, 2010, PLANT CELL REP, V29, P1251, DOI 10.1007/s00299-010-0910-0; Dutt M, 2009, PLANT CELL TISS ORG, V98, P331, DOI 10.1007/s11240-009-9567-1; Fang DQ, 1997, THEOR APPL GENET, V95, P408, DOI 10.1007/s001220050577; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; FURR JR, 1947, AM J BOT, V34, P1, DOI 10.2307/2437189; Gmitter FG, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P9, DOI 10.1079/9780851990194.0009; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; KUC J, 1982, BIOSCIENCE, V32, P854, DOI 10.2307/1309008; Kumar V, 2013, TRANSGENIC RES, V22, P359, DOI 10.1007/s11248-012-9652-9; Kuykendall L. D., 2007, Journal of Sugar Beet Research, V44, P35; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li ZJ, 2001, PLANT SCI, V160, P877, DOI 10.1016/S0168-9452(01)00336-3; Lin WC, 2004, TRANSGENIC RES, V13, P567, DOI 10.1007/s11248-004-2375-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorens E, 2015, CROP PROT, V74, P77, DOI 10.1016/j.cropro.2015.04.008; Makandar R, 2006, MOL PLANT MICROBE IN, V19, P123, DOI 10.1094/MPMI-19-0123; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Massenti R, 2016, J SCI FOOD AGR, V96, P73, DOI 10.1002/jsfa.7061; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Meyer P, 1996, ANNU REV PLANT PHYS, V47, P23, DOI 10.1146/annurev.arplant.47.1.23; Morris A., 2011, CITRUS IND, P12; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Silva K., 2015, TRANSGENIC RES, V24, P1; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Wally O, 2009, PLANTA, V231, P131, DOI 10.1007/s00425-009-1031-2; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Westbrook CJ, 2011, HORTSCIENCE, V46, P997, DOI 10.21273/HORTSCI.46.7.997; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhang XD, 2010, EUR J PLANT PATHOL, V128, P91, DOI 10.1007/s10658-010-9633-x; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhong XH, 2015, PLANT CELL REP, V34, P1063, DOI 10.1007/s00299-015-1765-1; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	59	104	109	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137134	10.1371/journal.pone.0137134	http://dx.doi.org/10.1371/journal.pone.0137134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398891	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500019
J	Rosenberg, M; Pettifor, A; Nguyen, N; Westreich, D; Bor, J; Barnighausen, T; Mee, P; Twine, R; Tollman, S; Kahn, K				Rosenberg, Molly; Pettifor, Audrey; Nadia Nguyen; Westreich, Daniel; Bor, Jacob; Baernighausen, Till; Mee, Paul; Twine, Rhian; Tollman, Stephen; Kahn, Kathleen			Relationship between Receipt of a Social Protection Grant for a Child and Second Pregnancy Rates among South African Women: A Cohort Study	PLOS ONE			English	Article							SUPPORT GRANT; TEENAGE PREGNANCY; AGINCOURT HEALTH; FERTILITY; CHILDBEARING; POPULATION; SURVIVAL; PROFILE	Background Social protection programs issuing cash grants to caregivers of young children may influence fertility. Grant-related income could foster economic independence and/or increase access to job prospects, education, and health services, resulting in lower pregnancy rates. In the other direction, these programs may motivate family expansion in order to receive larger grants. Here, we estimate the net effect of these countervailing mechanisms among rural South African women. Methods We constructed a retrospective cohort of 4845 women who first became eligible for the Child Support Grant with the birth of their first child between 1998 and 2008, with data originally collected by the Agincourt Health and Socio- Demographic Surveillance System in Mpumalanga province, South Africa. We fit Cox regression models to estimate the hazard of second pregnancy in women who reported grant receipt after birth of first child, relative to non- recipients. As a secondary analysis to explore the potential for grant loss to incentivize second pregnancy, we exploited a natural experiment created by a 2003 expansion of the program's age eligibility criterion from age seven to nine. We compared second pregnancy rates between (i) women with children age seven or eight in 2002 (recently aged out of grant eligibility) to (ii) women with children age seven or eight in 2003 (remained grant-eligible). Results The adjusted hazard ratio for the association between grant exposure and second pregnancy was 0.66 (95% CI: 0.58, 0.75). Women with first children who aged out of grant eligibility in 2002 had similar second pregnancy rates to women with first children who remained grant-eligible in 2003 [IRR (95% CI): 0.9 (0.5, 1.4)]. Conclusions Across both primary and secondary analyses, we found no evidence that the Child Support Grant incentivizes pregnancy. In harmony with South African population policy, receipt of the Child Support Grant may result in longer spacing between pregnancies.	[Rosenberg, Molly; Baernighausen, Till] Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Pettifor, Audrey; Nadia Nguyen; Westreich, Daniel] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Pettifor, Audrey; Mee, Paul; Twine, Rhian; Tollman, Stephen; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Pettifor, Audrey] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Bor, Jacob] Boston Univ, Dept Global Hlth, Boston, MA 02215 USA; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Baernighausen, Till] Wellcome Trust Africa Ctr Hlth & Populat Studies, Mtubatuba, Kwazulu Natal, South Africa; [Mee, Paul] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London WC1, England; [Mee, Paul; Tollman, Stephen; Kahn, Kathleen] Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Global Hlth, Umea Ctr Global Hlth Res, Umea, Sweden; [Tollman, Stephen; Kahn, Kathleen] INDEPTH Network, Accra, Ghana	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Umea University; INDEPTH Network	Rosenberg, M (corresponding author), Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	mrosenb@hsph.harvard.edu	Bärnighausen, Till/Y-2388-2019; Pettifor, Audrey/H-6793-2019	Pettifor, Audrey/0000-0002-3387-0817; Twine, Rhian/0000-0002-0766-6556; Kahn, Kathleen/0000-0003-3339-3931; Tollman, Stephen/0000-0003-0744-7588; Rosenberg, Molly/0000-0001-6679-6791; Westreich, Daniel/0000-0003-3069-1650	National Institutes of Health [T32 HD007168, R24 HD050924, 1R01-HD058482-01]; Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z, 082384/Z/07/Z]; University of the Witwatersrand; Medical Research Council, South Africa; National Institute on Aging (NIA) of the NIH, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, R01HD084233, R01HD058482, R24HD050924, P2CHD050924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust, UK(Wellcome Trust); University of the Witwatersrand; Medical Research Council, South Africa; National Institute on Aging (NIA) of the NIH, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health through Grant Numbers T32 HD007168 and R24 HD050924 to the Carolina Population Center and through Grant Number 1R01-HD058482-01. The Agincourt HDSS is funded by the Wellcome Trust, UK (grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z), with important contributions from the University of the Witwatersrand and the Medical Research Council, South Africa; and the National Institute on Aging (NIA) of the NIH, USA. The Wellcome Trust, UK, provides core funding to the Africa Centre, including for the surveillance on which this work is based (grant 082384/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato M, 2009, AIDS CARE, V21, P60, DOI 10.1080/09540120903112351; Aguero J, 2007, IMPACT UNCONDITIONAL; [Anonymous], 1998, POPULATION POLICY S; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Bor J, 2013, NE U DEV CONS NEUDC; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Collinson MA, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5080; Feldman BS, 2009, STUD FAMILY PLANN, V40, P51, DOI 10.1111/j.1728-4465.2009.00186.x; Garenne M, 2000, STUD FAMILY PLANN, V31, P47, DOI 10.1111/j.1728-4465.2000.00047.x; Goldblatt B, 2003, AGENDA, P78; Grogger J, 1997, EFFECT WELFARE PAYME; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hochfeld T., 2011, INT CONFERENCESOCIAL; Hosegood V, 2005, S AFR J DEMOGR, V10, P43, DOI DOI 10.2307/20853278; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kanku T, 2010, S AFR FAM PRACT, V52, P563, DOI 10.1080/20786204.2010.10874048; Lehohla P., 2010, ESTIMATION FERTILITY; Makiwane M., 2015, IS CHILD SUPPORT GRA; Makiwane M, 2010, DEV SO AFR, V27, P193, DOI 10.1080/03768351003740498; Massyn N., 2014, DURBAN HLTH SYSTEMS; Matsie L, 2009, CHILD SUPPORT GRANTS; McEwen H, 2009, SOCIAL ASSISTANCE GR; Moultrie TA, 2007, SAMJ S AFR MED J, V97, P442; Moultrie TA, 2012, POP STUD-J DEMOG, V66, P241, DOI 10.1080/00324728.2012.701660; Ozawa M N, 1990, Adv Adolesc Mental Health, V4, P281; Richter M, 2009, SAMJ S AFR MED J, V99, P94; Samson M, 2002, SOCIAL SECURITY REFO; SAS, 2012, SAS VERS 9 2, P27513; Stecklov G, 2007, POP STUD-J DEMOG, V61, P125, DOI 10.1080/00324720701300396; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Timaeus IM, 2008, POPUL DEV REV, V34, P483, DOI 10.1111/j.1728-4457.2008.00233.x; Todd JE, 2012, J POPUL ECON, V25, P267, DOI 10.1007/s00148-010-0337-5; Twine R, 2007, SCAND J PUBLIC HEALT, V35, P118, DOI 10.1080/14034950701430008; Udjo EO, 2013, POLITICS POLICY, V41, P833, DOI 10.1111/polp.12049; Udjo EO, 2009, DEV SO AFR, V26, P289, DOI 10.1080/03768350902899603; UNICEF DSD and SASSA, 2012, S AFR CHILD SUPP GRA; Westreich D, 2010, AM J EPIDEMIOL, V171, P691, DOI 10.1093/aje/kwp418; Wilcox BL, 1996, J SOC ISSUES, V52, P71, DOI 10.1111/j.1540-4560.1996.tb01580.x; Williams J, 2013, GLOBAL HEALTH ACTION, V6, P20, DOI 10.3402/gha.v6i0.19236	40	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137352	10.1371/journal.pone.0137352	http://dx.doi.org/10.1371/journal.pone.0137352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26398678	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361797500031
J	Xu, JY; Wu, ZC; Yu, Y; Lv, N; Wang, SZ; Karmonik, C; Liu, JM; Huang, QH				Xu, Jinyu; Wu, Zhichen; Yu, Ying; Lv, Nan; Wang, Shengzhang; Karmonik, Christof; Liu, Jian-Min; Huang, Qinghai			Combined Effects of Flow Diverting Strategies and Parent Artery Curvature on Aneurysmal Hemodynamics: A CFD Study	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSMS; STENT POROSITY; SACCULAR ANEURYSMS; SIMULATION; GEOMETRY; RUPTURE; MODELS; RECONSTRUCTION	Purpose Flow diverters (FD) are increasingly being considered for treating large or giant wide-neck aneurysms. Clinical outcome is highly variable and depends on the type of aneurysm, the flow diverting device and treatment strategies. The objective of this study was to analyze the effect of different flow diverting strategies together with parent artery curvature variations on altering intra-aneurysmal hemodynamics. Methods Four ideal intracranial aneurysm models with different parent artery curvature were constructed. Computational fluid dynamics (CFD) simulations of the hemodynamics before and after applying five types of flow diverting strategies (single FD, single FD with 5% and 10% packing density of coils, two FDs with 25% and 50% overlapping rate) were performed. Changes in pressure, wall shear stress (WSS), relative residence time (RRT), inflow velocity and inflow volume rate were calculated and compared. Results Each flow diverting strategy resulted in enhancement of RRT and reduction of normalized mean WSS, inflow volume rate and inflow velocity in various levels. Among them, 50% overlapped FD induced most effective hemodynamic changes in RRT and inflow volume rate. The mean pressure only slightly decreased after treatment. Regardless of the kind of implantation of FD, the mean pressure, inflow volume rate and inflow velocity increased and the RRT decreased as the curvature of the parent artery increased. Conclusions Of all flow diverting strategies, overlapping FDs induced most favorable hemodynamic changes. Hemodynamics alterations post treatment were substantially influenced by parent artery curvature. Our results indicate the need of an individualized flow diverting strategy that is tailored for a specific aneurysm.	[Xu, Jinyu; Yu, Ying; Lv, Nan; Liu, Jian-Min; Huang, Qinghai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Wu, Zhichen] Fudan Univ, Sch Int Relat & Publ Affairs, Shanghai 200433, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Engn Sci & Mech, Shanghai 200433, Peoples R China; [Karmonik, Christof] Houston Methodist Hosp, Dept Neurosurg, Cerebrovasc Ctr, Houston, TX USA	Naval Medical University; Fudan University; Fudan University; The Methodist Hospital System; The Methodist Hospital - Houston	Liu, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	chstroke@163.com; ocinhqh@163.com			National Natural Science Foundation of China [81171092, 81171093]; Rising-Star Program of Shanghai Science and Technology Committee [11QA1408400]; National Key Technology R&D Program of the Ministry of Science and Technology of China [2011BAI08B06, 2011BAI08B14]; State Scholarship Fund of China Scholarship Council [201406580004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Rising-Star Program of Shanghai Science and Technology Committee; National Key Technology R&D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This research was supported by National Natural Science Foundation of China (Grant No. 81171092 and Grant No. 81171093), Rising-Star Program of Shanghai Science and Technology Committee (Grant no. 11QA1408400), National Key Technology R&D Program of the Ministry of Science and Technology of China (No. 2011BAI08B06 and No. 2011BAI08B14), and State Scholarship Fund of China Scholarship Council (No. 201406580004).	ACHENBACH E, 1971, J FLUID MECH, V46, P321, DOI 10.1017/S0022112071000569; Appanaboyina S, 2008, INT J NUMER METH FL, V57, P475, DOI 10.1002/fld.1590; Augsburger L, 2011, ANN BIOMED ENG, V39, P850, DOI 10.1007/s10439-010-0200-6; Balossino R, 2008, J BIOMECH, V41, P1053, DOI 10.1016/j.jbiomech.2007.12.005; Bowker TJ, 2010, AM J NEURORADIOL, V31, P317, DOI 10.3174/ajnr.A1797; Byrne JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012492; Cebral JR, 2011, AM J NEURORADIOL, V32, P27, DOI 10.3174/ajnr.A2398; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Huang QH, 2013, STROKE, V44, P1936, DOI 10.1161/STROKEAHA.113.001202; Kallmes DF, 2007, STROKE, V38, P2346, DOI 10.1161/STROKEAHA.106.479576; Karmonik C, 2014, AM J NEURORADIOL, V35, P1549, DOI 10.3174/ajnr.A3984; Kim YH, 2010, ANN BIOMED ENG, V38, P2274, DOI 10.1007/s10439-010-9994-5; Kulcsar Z, 2011, AM J NEURORADIOL, V32, P20, DOI 10.3174/ajnr.A2370; Kulcsar Z, 2012, ACTA NEUROCHIR, V154, P1827, DOI 10.1007/s00701-012-1482-2; Larrabide I, 2012, MED IMAGE ANAL, V16, P721, DOI 10.1016/j.media.2010.04.009; Lee SW, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127252; Lieber BB, 2010, STROKE, V41, pS21, DOI 10.1161/STROKEAHA.110.595066; Lieber BB, 1997, ANN BIOMED ENG, V25, P460, DOI 10.1007/BF02684187; Liou TM, 2008, J BIOMECH, V41, P1174, DOI 10.1016/j.jbiomech.2008.01.025; Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461; Lylyk P, 2009, NEUROSURGERY, V64, P632, DOI 10.1227/01.NEU.0000339109.98070.65; Ma D, 2012, J BIOMECH, V45, P2256, DOI 10.1016/j.jbiomech.2012.06.013; Mitsos AP, 2008, NEURORADIOLOGY, V50, P341, DOI 10.1007/s00234-007-0334-x; Moon Ji Young, 2014, Neurointervention, V9, P1, DOI 10.5469/neuroint.2014.9.1.1; Naito T, 2012, ACTA NEUROCHIR, V154, P993, DOI 10.1007/s00701-012-1305-5; Nelson PK, 2011, AM J NEURORADIOL, V32, P34, DOI 10.3174/ajnr.A2421; Qian Y, 2011, AM J NEURORADIOL, V32, P1948, DOI 10.3174/ajnr.A2655; Rayz VL, 2008, ANN BIOMED ENG, V36, P1793, DOI 10.1007/s10439-008-9561-5; Rayz VL, 2010, ANN BIOMED ENG, V38, P3058, DOI 10.1007/s10439-010-0065-8; Sadasivan C, 2009, STROKE, V40, P952, DOI 10.1161/STROKEAHA.108.533760; Seshadhri S, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004410; Szikora I, 2008, INTERV NEURORADIOL, V14, P77, DOI 10.1177/15910199080140S114; Szikora I, 2008, NEURORADIOLOGY, V50, P411, DOI 10.1007/s00234-007-0350-x; Turowski B, 2011, NEURORADIOLOGY, V53, P37, DOI 10.1007/s00234-010-0676-7; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; van Rooij W J, 2010, AJNR Am J Neuroradiol, V31, pE43, DOI 10.3174/ajnr.A2034; Wang KZ, 2012, NEURORADIOLOGY, V54, P607, DOI 10.1007/s00234-011-0922-7; Wang SZ, 2011, COMPUT METHOD BIOMEC, V14, P927, DOI 10.1080/10255842.2010.502531; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066072; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055413, 10.1371/journal.pone.0059050]; Zhang Y, 2013, MED ENG PHYS, V35, P608, DOI 10.1016/j.medengphy.2012.07.005; Zhao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057253; Zhou Y, 2014, AM J NEURORADIOL, V35, P2326, DOI 10.3174/ajnr.A3925	47	14	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138648	10.1371/journal.pone.0138648	http://dx.doi.org/10.1371/journal.pone.0138648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398847	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500088
J	Lewis, KM; Ronish, LA; Rios, E; Kang, C				Lewis, Kevin M.; Ronish, Leslie A.; Rios, Eduardo; Kang, ChulHee			Characterization of Two Human Skeletal Calsequestrin Mutants Implicated in Malignant Hyperthermia and Vacuolar Aggregate Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium-binding protein; malignant hyperthermia; sarcoplasmic reticulum (SR); skeletal muscle; calsequestrin; vacuolar aggregate myopathy	CALCIUM BUFFERING PROPERTIES; SARCOPLASMIC-RETICULUM; CA2+ REGULATION; CASQ1 GENE; MUSCLE; RELEASE; PROTEIN; POLYMERIZATION; BINDING; STORE	Calsequestrin 1 is the principal Ca2+ storage protein of the sarcoplasmic reticulum of skeletal muscle. Its inheritable D244G mutation causes a myopathy with vacuolar aggregates, whereas its M87T variant is weakly associated with malignant hyperthermia. We characterized the consequences of these mutations with studies of the human proteins in vitro. Equilibrium dialysis and turbidity measurements showed that D244G and, to a lesser extent, M87T partially lose Ca2+ binding exhibited by wild type calsequestrin 1 at high Ca2+ concentrations. D244G aggregates abruptly and abnormally, a property that fully explains the protein inclusions that characterize its phenotype. D244G crystallized in low Ca2+ concentrations lacks two Ca2+ ions normally present in wild type that weakens the hydrophobic core of Domain II. D244G crystallized in high Ca2+ concentrations regains its missing ions and Domain II order but shows a novel dimeric interaction. The M87T mutation causes a major shift of the -helix bearing the mutated residue, significantly weakening the back-to-back interface essential for tetramerization. D244G exhibited the more severe structural and biophysical property changes, which matches the different pathophysiological impacts of these mutations.	[Lewis, Kevin M.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Ronish, Leslie A.; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Rios, Eduardo] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Washington State University; Washington State University; Rush University	Kang, C (corresponding author), Washington State Univ, Fulmer 265, Pullman, WA 99164 USA.	chkang@wsu.edu	Regan, Clinton/E-6250-2012	Kang, ChulHee/0000-0002-0693-7860; Lewis, Kevin/0000-0003-3403-9520	National Institutes of Health [1R01GM11125401]; M. J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM11125401 (to E. R and C. K.) and the M. J. Murdock Charitable Trust (to C. K.). The authors declare that they have no conflicts of interest with the content of this article.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Boncompagni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039962; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faggioni M, 2012, PEDIATR CARDIOL, V33, P959, DOI 10.1007/s00246-012-0256-1; Fenelon K, 2012, J GEN PHYSIOL, V140, P403, DOI 10.1085/jgp.201110730; Frisch G. W., 2013, GAUSSIAN 09; Frisch M, 2004, GAUSSVIEW VERSION 3; Kang ChulHee, 2002, Methods Mol Biol, V172, P281; Koput J, 2002, J PHYS CHEM A, V106, P9595, DOI 10.1021/jp026283u; Kraeva N, 2013, ANESTHESIOLOGY, V118, P344, DOI [10.1097/01.anes.0000530185.78660.da, 10.1097/ALN.0b013e318279f925]; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Manno C, 2013, J PHYSIOL-LONDON, V591, P423, DOI 10.1113/jphysiol.2012.243444; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Perni S, 2013, J BIOL CHEM, V288, P31358, DOI 10.1074/jbc.M113.507749; Peterson KA, 2002, J CHEM PHYS, V117, P10548, DOI 10.1063/1.1520138; Qin J, 2009, BIOPHYS J, V97, P1961, DOI 10.1016/j.bpj.2009.07.030; Rios E, 2015, J GEN PHYSIOL, V145, P459, DOI 10.1085/jgp.201411321; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Schrodinger LLC, 2015, SCHROD SUIT 2015 2 P; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Sztretye M, 2011, J GEN PHYSIOL, V138, P211, DOI 10.1085/jgp.201010591; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011	28	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28665	28674		10.1074/jbc.M115.686261	http://dx.doi.org/10.1074/jbc.M115.686261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26416891	Green Published, hybrid			2022-12-26	WOS:000365762300008
J	Ikonomov, OC; Sbrissa, D; Connpton, LM; Kumar, R; Tisdale, EJ; Chen, XQ; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Connpton, Lauren M.; Kumar, Rita; Tisdale, Ellen J.; Chen, Xuequn; Shisheva, Assia			The Protein Complex of Neurodegeneration-related Phosphoinositide Phosphatase Sac3 and ArPIKfyve Binds the Lewy Body-associated Synphilin-1, Preventing Its Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; AGGRESOME FORMATION; MAMMALIAN ORTHOLOG; FIG4 CAUSES; PIKFYVE; INCLUSIONS; MUTATION; DEGRADATION; TRANSPORT	The 5-phosphoinositide phosphatase Sac3, in which loss-of-function mutations are linked to neurodegenerative disorders, forms a stable cytosolic complex with the scaffolding protein ArPIKfyve. The ArPIKfyve-Sac3 heterodimer interacts with the phosphoinositide 5-kinase PIKfyve in a ubiquitous ternary complex that couples PtdIns(3,5) P2 synthesis with turnover at endosomal membranes, thereby regulating the housekeeping endocytic transport in eukaryotes. Neuron-specific associations of the ArPIKfyve-Sac3 heterodimer, which may shed light on the neuropathological mechanisms triggered by Sac3 dysfunction, are unknown. Here we conducted mass spectrometry analysis for brain-derived interactors of ArPIKfyve-Sac3 and unraveled the alpha-synuclein-interacting protein Synphilin-1 (Sph1) as a new component of the ArPIKfyve-Sac3 complex. Sph1, a predominantly neuronal protein that facilitates aggregation of alpha-synuclein, is a major component of Lewy body inclusions in neurodegenerative alpha-synucleinopathies. Modulations in ArPIKfyve/Sac3 protein levels by RNA silencing or overexpression in several mammalian cell lines, including human neuronal SH-SY5Y or primary mouse cortical neurons, revealed that the ArPIKfyve-Sac3 complex specifically altered the aggregation properties of Sph1-GFP. This effect required an active Sac3 phosphatase and proceeded through mechanisms that involved increased Sph1-GFP partitioning into the cytosol and removal of Sph1-GFP aggregates by basal autophagy but not by the proteasomal system. If uncoupled from ArPIKfyve elevation, over-expressed Sac3 readily aggregated, markedly enhancing the aggregation potential of Sph1-GFP. These data identify a novel role of the ArPIKfyve-Sac3 complex in the mechanisms controlling aggregate formation of Sph1 and suggest that Sac3 protein deficiency or overproduction may facilitate aggregation of aggregation-prone proteins, thereby precipitating the onset of multiple neuronal disorders.	[Ikonomov, Ognian C.; Sbrissa, Diego; Connpton, Lauren M.; Kumar, Rita; Chen, Xuequn; Shisheva, Assia] Wayne State Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Kumar, Rita] Wayne State Sch Med, Dept Emergency Med, Detroit, MI 48201 USA; [Tisdale, Ellen J.] Wayne State Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield Ave, Detroit, MI 48201 USA.	ashishev@med.wayne.edu	Regan, Clinton/E-6250-2012	Kumar, Rita/0000-0002-9573-7667	National Institutes of Health [DK58058, GM068813]; Wayne State University; Wayne State University School of Medicine Research Offices; American Diabetes Association [7-13-BS-161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; Wayne State University School of Medicine Research Offices; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK58058 (to A. S.) and GM068813 (to E. J. T) This work was also supported by Wayne State University, the Wayne State University School of Medicine Research Offices, and the American Diabetes Association 7-13-BS-161 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bandopadhyay R, 2005, NEUROBIOL DIS, V20, P401, DOI 10.1016/j.nbd.2005.03.021; Baulac S, 2014, NEUROLOGY, V82, P1068, DOI 10.1212/WNL.0000000000000241; Beyer K, 2009, INT J MOL SCI, V10, P724, DOI 10.3390/ijms10030724; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Campeau PM, 2013, AM J HUM GENET, V92, P781, DOI 10.1016/j.ajhg.2013.03.020; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Drouet V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/289728; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feng HZ, 2012, J BIOL CHEM, V287, P29753, DOI 10.1074/jbc.M112.373191; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Gwinn K, 2011, MOVEMENT DISORD, V26, P2134, DOI 10.1002/mds.23776; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2015, BBA-MOL CELL RES, V1853, P1240, DOI 10.1016/j.bbamcr.2015.01.008; Ikonomov OC, 2013, BIOCHEM BIOPH RES CO, V440, P342, DOI 10.1016/j.bbrc.2013.09.080; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Ikonomov OC, 2010, J BIOL CHEM, V285, P26760, DOI 10.1074/jbc.C110.154658; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, J BIOL CHEM, V284, P23961, DOI 10.1074/jbc.M109.025361; Jin HG, 2008, NEUROSCI LETT, V445, P12, DOI 10.1016/j.neulet.2008.08.073; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kara E, 2014, JAMA NEUROL, V71, P1162, DOI 10.1001/jamaneurol.2014.994; Katsuse O, 2003, J NEUROL SCI, V211, P29, DOI 10.1016/S0022-510X(03)00037-6; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kon T, 2014, NEUROPATHOLOGY, V34, P19, DOI 10.1111/neup.12056; Krenz A, 2009, J NEUROCHEM, V108, P139, DOI 10.1111/j.1471-4159.2008.05755.x; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Lenk GM, 2014, METHOD ENZYMOL, V534, P245, DOI 10.1016/B978-0-12-397926-1.00014-7; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; Li J., 2013, GENEREVIEWS; Muenter MD, 1998, ANN NEUROL, V43, P768, DOI 10.1002/ana.410430612; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nakajima J, 2013, J HUM GENET, V58, P822, DOI 10.1038/jhg.2013.104; Nuber S, 2010, NEUROGENETICS, V11, P107, DOI 10.1007/s10048-009-0212-2; O'Farrell C, 2002, NEUROSCI LETT, V322, P9, DOI 10.1016/S0304-3940(02)00068-X; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Reifler A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-21; Sanderson TH, 2015, NEUROSCIENCE, V301, P71, DOI 10.1016/j.neuroscience.2015.05.078; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; SHISHEVA A, 1995, EUR J CELL BIOL, V68, P143; Shisheva A, 2015, BIOESSAYS, V37, P267, DOI 10.1002/bies.201400129; Shisheva A, 2012, CURR TOP MICROBIOL, V362, P127, DOI 10.1007/978-94-007-5025-8_7; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Swinnen E, 2011, BIOCHEM SOC T, V39, P1476, DOI 10.1042/BST0391476; Szargel R, 2008, CELL MOL LIFE SCI, V65, P80, DOI 10.1007/s00018-007-7343-0; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; Vaccari I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002319; Verdiani S, 2013, AMYOTROPH LAT SCL FR, V14, P228, DOI 10.3109/21678421.2012.760605; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Wong E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2244; Xu W, 2015, NEUROBIOL AGING, V36, P1505, DOI 10.1016/j.neurobiolaging.2014.10.042; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang XB, 2008, BRAIN, V131, P1990, DOI 10.1093/brain/awn114; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	70	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28515	28529		10.1074/jbc.M115.669929	http://dx.doi.org/10.1074/jbc.M115.669929			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405034	hybrid, Green Published			2022-12-26	WOS:000365761900044
J	Barritt, JD; Viles, JH				Barritt, Joseph D.; Viles, John H.			Truncated Amyloid-beta((11-40/42)) from Alzheimer Disease Binds Cu2+ with a Femtomolar Affinity and Influences Fiber Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; VISIBLE CIRCULAR-DICHROISM; HUMAN SERUM-ALBUMIN; PEPTIDES IN-VITRO; PRION PROTEIN; COORDINATION GEOMETRY; MASS-SPECTROMETRY; SENILE PLAQUES; COPPER-BINDING; METAL-BINDING	Alzheimer disease coincides with the formation of extracellular amyloid plaques composed of the amyloid-beta (A beta) peptide. A beta is typically 40 residues long (A beta((1-40))) but can have variable C and N termini. Naturally occurring N-terminally truncated A beta((11-40/42)) is found in the cerebrospinal fluid and has a similar abundance to A beta((1-42)), constituting one-fifth of the plaque load. Based on its specific N-terminal sequence we hypothesized that truncated A beta((11-40/42)) would have an elevated affinity for Cu2+. Various spectroscopic techniques, complemented with transmission electron microscopy, were used to determine the properties of the Cu2+ -A beta((11-40/42)) interaction and how Cu2+ influences amyloid fiber formation. We show that Cu2+ -A beta((11-40)) forms a tetragonal complex with a 34 +/- 5 fM dissociation constant at pH 7.4. This affinity is 3 orders of magnitude tighter than Cu2+ binding to A beta((1-40/42)) and more than an order of magnitude tighter than that of serum albumin, the extracellular Cu2+ transport protein. Furthermore, A beta((11-40/42)) forms fibers twice as fast as A beta((1-40)) with a very different morphology, forming bundles of very short amyloid rods. Substoichiometric Cu2+ drastically perturbs A beta((11-40/42)) assembly, stabilizing much longer fibers. The very tight fM affinity of Cu2+ for A beta((11-40/42)) explains the high levels of Cu2+ observed in Alzheimer disease plaques.	[Barritt, Joseph D.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	j.viles@qmul.ac.uk		Barritt, Joseph/0000-0002-4311-5305	Queen Mary University of London college studentship; BBSRC [BB/M023877/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M023877/1] Funding Source: researchfish	Queen Mary University of London college studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Queen Mary University of London college studentship. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Alies B, 2013, ANAL CHEM, V85, P1501, DOI 10.1021/ac302629u; Alies B, 2012, INORG CHEM, V51, P12988, DOI 10.1021/ic302097d; Bal W, 1998, J INORG BIOCHEM, V70, P33, DOI 10.1016/S0162-0134(98)00010-5; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Dawson R. M. C., 1986, DATA BIOCH RES, P409; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Gala L, 2014, MOLECULES, V19, P980, DOI 10.3390/molecules19010980; Gunderson WA, 2012, J AM CHEM SOC, V134, P18330, DOI 10.1021/ja306946q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Jiang DL, 2013, BIOCHEMISTRY-US, V52, P547, DOI 10.1021/bi301053h; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Klewpatinond M, 2007, FEBS LETT, V581, P1430, DOI 10.1016/j.febslet.2007.02.068; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LAU SJ, 1971, J BIOL CHEM, V246, P5938; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MASUOKA J, 1993, J BIOL CHEM, V268, P21533; Matheou CJ, 2015, BIOCHEM J, V466, P233, DOI 10.1042/BJ20141168; Matlack KES, 2014, P NATL ACAD SCI USA, V111, P4013, DOI 10.1073/pnas.1402228111; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Mital M, 2015, ANGEW CHEM INT EDIT, V54, P10460, DOI 10.1002/anie.201502644; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; PATEL SU, 1993, J AM CHEM SOC, V115, P9285, DOI 10.1021/ja00073a053; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Prince M, 2009, ALZHEIMERS DIS INT W, P1; Rozga M, 2007, J BIOL INORG CHEM, V12, P913, DOI 10.1007/s00775-007-0244-8; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Sharma AK, 2013, METALLOMICS, V5, P1529, DOI 10.1039/c3mt00161j; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Singh Sandeep Kumar, 2013, Int J Alzheimers Dis, V2013, P567128, DOI 10.1155/2013/567128; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Stanyon HF, 2014, FEBS J, V281, P3945, DOI 10.1111/febs.12934; Stanyon HF, 2014, BIOCHEMISTRY-US, V53, P3934, DOI 10.1021/bi500643b; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Sullivan CP, 2011, NEUROSCI LETT, V505, P109, DOI 10.1016/j.neulet.2011.09.071; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; TSANGARIS JM, 1970, J AM CHEM SOC, V92, P4255, DOI 10.1021/ja00717a020; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	78	46	47	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27791	27802		10.1074/jbc.M115.684084	http://dx.doi.org/10.1074/jbc.M115.684084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26408196	Green Published, hybrid			2022-12-26	WOS:000365757500030
J	Birk, A; Rinne, A; Bunemann, M				Birk, Alexandra; Rinne, Andreas; Buenemann, Moritz			Membrane Potential Controls the Efficacy of Catecholamine-induced beta(1)-Adrenoceptor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DOPAMINE D-2S RECEPTOR; DIRECT VOLTAGE CONTROL; NERVOUS-SYSTEM; ACTIVATION; PHOSPHORYLATION; SENSITIVITY; DEPENDENCE; KINETICS; BINDING	Background: The activity of several G(q)- and G(1)-coupled receptors is modulated by the membrane potential. Results: Voltage modulates catecholamine-mediated activation of G(s)-coupled beta(1)- and beta(2)-adrenoceptors. Conclusion: Voltage-dependence of beta(1)-AR is due to alterations in the efficacy of catecholamines. Significance: By modulating catecholamine efficacy on beta(1)-ARs, voltage can modify receptor activity on a very fast time scale. G protein-coupled receptors (GPCRs) are membrane-located proteins and, therefore, are exposed to changes in membrane potential (V-M) in excitable tissues. These changes have been shown to alter receptor activation of certain G(i)-and G(q)-coupled GPCRs. By means of a combination of whole-cell patch-clamp and Forster resonance energy transfer (FRET) in single cells, we demonstrate that the activation of the G(s)-coupled (1)-adrenoreceptor (beta(1)-AR) by the catecholamines isoprenaline (Iso) and adrenaline (Adr) is regulated by V-M. This voltage-dependence is also transmitted to G protein and arrestin 3 signaling. Voltage-dependence of beta(2)-AR activation, however, was weak compared with beta(1)-AR voltage-dependence. Drug efficacy is a major target of beta(1)-AR voltage-dependence as depolarization attenuated receptor activation, even under saturating concentrations of agonists, with significantly faster kinetics than the deactivation upon agonist withdrawal. Also the efficacy of the endogenous full agonist adrenaline was reduced by depolarization. This is a unique finding since reports of natural full agonists at other voltage-dependent GPCRs only show alterations in affinity during depolarization. Based on a Boltzmann function fit to the relationship of V-M and receptor-arrestin 3 interaction we determined the voltage-dependence with highest sensitivity in the physiological range of membrane potential. Our data suggest that under physiological conditions voltage regulates the activity of agonist-occupied beta(1)-adrenoceptors on a very fast time scale.	[Birk, Alexandra; Buenemann, Moritz] Univ Marburg, Inst Pharmacol & Clin Pharm, Biochem Pharmacol Ctr Marburg, D-35043 Marburg, Germany; [Rinne, Andreas] Ruhr Univ Bochum, Inst Physiol, D-44801 Bochum, Germany	Philipps University Marburg; Ruhr University Bochum	Bunemann, M (corresponding author), Univ Marburg, Inst Pharmacol & Clin Pharm, Biochem Pharmacol Ctr Marburg, Karl von Frisch Str 1, D-35043 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de	Rinne, Andreas/G-7986-2017; Rinne, Andreas/AAO-1685-2020	Rinne, Andreas/0000-0003-3535-2498; Rinne, Andreas/0000-0003-3535-2498; Buenemann, Moritz/0000-0002-2259-4378	Deutsche Forschungsgemeinschaft [SFB593]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft as part of the SFB593 "Mechanisms of Cellular Compartmentalization and the Relevance for disease." The authors declare that they have no conflicts of interest with the contents of this article.	Ahles A, 2015, J BIOL CHEM, V290, P1760, DOI 10.1074/jbc.M114.607333; Ben Chaim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074354; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bond R. A., 2015, IUPHAR BPS GUIDE PHA; Gurung IS, 2008, BRIT J PHARMACOL, V154, P882, DOI 10.1038/bjp.2008.97; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; Lohse MJ, 2003, LIFE SCI, V74, P397, DOI 10.1016/j.lfs.2003.09.026; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Martinez-Pinna J, 2010, J PHYSIOL-LONDON, V588, P1683, DOI 10.1113/jphysiol.2009.183418; Moreno-Galindo E. G., 2011, J PHYSL, V7, P1755; Navarro-Polanco RA, 2011, J PHYSIOL-LONDON, V589, P1741, DOI 10.1113/jphysiol.2010.204107; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Parnas I, 2010, PFLUG ARCH EUR J PHY, V460, P975, DOI 10.1007/s00424-010-0872-7; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rinne A, 2013, P NATL ACAD SCI USA, V110, P1536, DOI 10.1073/pnas.1212656110; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Sahlholm K, 2008, SYNAPSE, V62, P476, DOI 10.1002/syn.20509; Sahlholm K, 2012, BBA-BIOMEMBRANES, V1818, P3081, DOI 10.1016/j.bbamem.2012.07.027; Sahlholm K, 2011, NEUROPHARMACOLOGY, V61, P937, DOI 10.1016/j.neuropharm.2011.06.022; Sahlholm K, 2008, BIOCHEM BIOPH RES CO, V377, P1216, DOI 10.1016/j.bbrc.2008.10.117; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Tateyama M, 2013, NEUROPHARMACOLOGY, V65, P173, DOI 10.1016/j.neuropharm.2012.10.006; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838	30	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27311	27320		10.1074/jbc.M115.665000	http://dx.doi.org/10.1074/jbc.M115.665000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26408198	Green Published, hybrid			2022-12-26	WOS:000364794000038
J	Ishtikhar, M; Chandel, TI; Ahmad, A; Ali, MS; Al-lohadan, HA; Atta, AM; Khan, RH				Ishtikhar, Mohd; Chandel, Tajjali Ilm; Ahmad, Aamir; Ali, Mohd Sajid; Al-lohadan, Hamad A.; Atta, Ayman M.; Khan, Rizwan Hasan			Rosin Surfactant QRMAE Can Be Utilized as an Amorphous Aggregate Inducer: A Case Study of Mammalian Serum Albumin	PLOS ONE			English	Article							CIRCULAR-DICHROISM; CATIONIC SURFACTANTS; CORROSION-INHIBITOR; PROTEIN AGGREGATION; AMYLOID FIBRILS; BINDING-SITES; B ISOFORMS; NANOPARTICLES; THYMOQUINONE; FIBRILLATION	Quaternary amine of diethylaminoethyl rosin ester (QRMAE), chemically synthesized bio-compatible rosin based cationic surfactant, has various biological applications including its use as a food product additive. In this study, we examined the amorphous aggregation behavior of mammalian serum albumins at pH 7.5, i.e., two units above their isoelectric points (pI similar to 5.5), and the roles played by positive charge and hydrophobicity of exogenously added rosin surfactant QRMAE. The study was carried out on five mammalian serum albumins, using various spectroscopic methods, dye binding assay, circular dichroism and electron microscopy. The thermodynamics of the binding of mammalian serum albumins to cationic rosin modified surfactant were established using isothermal titration calorimetry (ITC). It was observed that a suitable molar ratio of protein to QRMAE surfactant enthusiastically induces amorphous aggregate formation at a pH above two units of pI. Rosin surfactant QRMAE-albumins interactions revealed a unique interplay between the initial electrostatic and the subsequent hydrophobic interactions that play an important role towards the formation of hydrophobic interactions-driven amorphous aggregate. Amorphous aggregation of proteins is associated with varying diseases, from the formation of protein wine haze to the expansion of the eye lenses in cataract, during the expression and purification of recombinant proteins. This study can be used for the design of novel biomolecules or drugs with the ability to neutralize factor(s) responsible for the aggregate formation, in addition to various other industrial applications.	[Ishtikhar, Mohd; Chandel, Tajjali Ilm; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Prot Biophys Lab, Aligarh 202002, Uttar Pradesh, India; [Ahmad, Aamir] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Ali, Mohd Sajid; Al-lohadan, Hamad A.; Atta, Ayman M.] King Saud Univ, Coll Sci, Dept Chem, Surfactant Res Chair, Riyadh 11541, Saudi Arabia	Aligarh Muslim University; Barbara Ann Karmanos Cancer Institute; Wayne State University; King Saud University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Prot Biophys Lab, Aligarh 202002, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Ali, Mohd Sajid/C-5334-2011; Khan, Rizwan Hasan/F-8276-2014; atta, ayman/ABK-3417-2022; Khan, Rizwan/GXZ-5789-2022; CHANDEL, TAJALLI ILM/AAU-5662-2020; Ishtikhar, Mohd/AAK-8918-2020; atta, ayman/E-9273-2017	Ali, Mohd Sajid/0000-0003-0191-9708; Khan, Rizwan Hasan/0000-0002-9965-8982; CHANDEL, TAJALLI ILM/0000-0002-6082-5544; atta, ayman/0000-0002-9613-3099; Ishtikhar, Mohd/0000-0001-5116-2470	Indian Council of Medical Research (ICMR), New Delhi, India [BIC/11(12)/2013]; Deanship of Scientific Research at King Saud University [RGP-148]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Deanship of Scientific Research at King Saud University(King Saud University)	The financial assistance for the authors was provided by Indian Council of Medical Research (ICMR), New Delhi, India, [BIC/11(12)/2013] in the form of senior research fellowship (http://icmr.nic.in). The authors would also like to thank Deanship of Scientific Research at King Saud University for funding to the research group Project no. RGP-148. The funding agency has no role/no objection for study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Ahmad E, 2013, J BIOMOL STRUCT DYN, V31, P630, DOI 10.1080/07391102.2012.706081; Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; Atta AM, 2014, INT J MOL SCI, V15, P6974, DOI 10.3390/ijms15046974; Atta AM, 2013, INT J ELECTROCHEM SC, V8, P9629; Atta AM, 2011, J APPL POLYM SCI, V122, P183, DOI 10.1002/app.34052; Bai GY, 2001, LANGMUIR, V17, P3522, DOI 10.1021/la000768x; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; El-Mahdy GA, 2013, INT J ELECTROCHEM SC, V8, P5052; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Gull N, 2015, J COLLOID INTERF SCI, V439, P170, DOI 10.1016/j.jcis.2014.10.012; Hebia C, 2014, J PHOTOCH PHOTOBIO B, V130, P254, DOI 10.1016/j.jphotobiol.2013.11.025; Huang H, 2011, ANALYST, V136, P1747, DOI 10.1039/c0an00890g; Ishtikhar M., 2015, J BIOMOL STRUCT DYN, P1, DOI DOI 10.1080/07391102.2015.1054433; Ishtikhar M, 2015, J LUMIN, V167, P399, DOI 10.1016/j.jlumin.2015.06.012; Ishtikhar M, 2015, INT J BIOL MACROMOL, V78, P379, DOI 10.1016/j.ijbiomac.2015.03.069; Ishtikhar M, 2015, RSC ADV, V5, P18218, DOI 10.1039/c4ra09892g; Ishtikhar M, 2014, COLLOID SURFACE B, V123, P469, DOI 10.1016/j.colsurfb.2014.09.044; Ishtikhar M, 2014, MOL BIOSYST, V10, P2954, DOI 10.1039/c4mb00306c; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Kang J, 2004, BBA-GEN SUBJECTS, V1674, P205, DOI 10.1016/j.bbagen.2004.06.021; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Khan JM, 2014, SOFT MATTER, V10, P2591, DOI 10.1039/c3sm52435c; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Khan MV, 2015, INT J BIOL MACROMOL, V78, P417, DOI 10.1016/j.ijbiomac.2015.04.021; Kumar S, 2008, J FLUORESC, V18, P1199, DOI 10.1007/s10895-008-0378-2; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Liu XQ, 2009, GREEN CHEM, V11, P1018, DOI 10.1039/b903955d; Liu Y, 2005, SPECTROCHIM ACTA A, V61, P2245, DOI 10.1016/j.saa.2004.09.004; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; Liu Z, 2014, LANGMUIR, V30, P7968, DOI 10.1021/la501656s; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; MAITI S, 1989, PROG POLYM SCI, V14, P297, DOI 10.1016/0079-6700(89)90005-1; Nada T, 2003, BIOPHYS J, V85, P1876, DOI 10.1016/S0006-3495(03)74615-3; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Norvaisas P, 2012, J PHYS CHEM B, V116, P2138, DOI 10.1021/jp2095888; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Pandey NK, 2014, J BIOMOL STRUCT DYN, V32, P1366, DOI 10.1080/07391102.2013.819300; Qadeer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050633; Sedaghat R, 2014, IRAN J PHARM RES, V13, P227; Selkoe D.J., 2011, COLD SPRING HARB PER, V3; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stranks SD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051907; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Varshney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017230; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vonhoff S, 2010, J PHARMACEUT BIOMED, V51, P39, DOI 10.1016/j.jpba.2009.07.031; Wang SSS, 2011, BBA-MOL CELL BIOL L, V1811, P301, DOI 10.1016/j.bbalip.2011.02.003; Waters EJ, 2005, AUST J GRAPE WINE R, V11, P215, DOI 10.1111/j.1755-0238.2005.tb00289.x; Zheng Y, 2010, MACROMOLECULES, V43; Zsila F, 2013, J PHYS CHEM B, V117, P10798, DOI 10.1021/jp4067108	64	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139027	10.1371/journal.pone.0139027	http://dx.doi.org/10.1371/journal.pone.0139027			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418451	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400035
J	Martinelle, L; Poskin, A; Dal Pozzo, F; De Regge, N; Cay, B; Saegerman, C				Martinelle, Ludovic; Poskin, Antoine; Dal Pozzo, Fabiana; De Regge, Nick; Cay, Brigitte; Saegerman, Claude			Experimental Infection of Sheep at 45 and 60 Days of Gestation with Schmallenberg Virus Readily Led to Placental Colonization without Causing Congenital Malformations	PLOS ONE			English	Article							AKABANE VIRUS; CULICOIDES SPP.; NEWBORN LAMBS; CATTLE; ARTHROGRYPOSIS; ABNORMALITIES; CALVES; FETUSES; IMPACT	Background Main impact of Schmallenberg virus (SBV) on livestock consists in reproductive disorders, with teratogenic effects, abortions and stillbirths. SBV pathogenesis and viral placental crossing remain currently poorly understood. Therefore, we implemented an experimental infection of ewes, inoculated with SBV at 45 or 60 days of gestation (dg). Methodology "Mourerous" breed ewes were randomly separated in three groups: eight and nine ewes were subcutaneously inoculated with 1 ml of SBV infectious serum at 45 and 60 dg, respectively (G45 and G60). Six other ewes were inoculated subcutaneously with sterile phosphate buffer saline as control group. All SBV inoculated ewes showed RNAemia consistent with previously published studies, they seroconverted and no clinical sign was reported. Lambs were born at term via caesarian-section, and right after birth they were blood sampled and clinically examined. Then both lambs and ewes were euthanatized and necropsied. Principal Findings/Significance No lambs showed any malformation suggestive of SBV infection and none of them had RNAemia or anti-SBV antibodies prior to colostrum uptake. Positive SBV RNA detection in organs was rare in both G45 and G60 lambs (2/11 and 1/10, respectively). Nevertheless most of the lambs in G45 (9/11) and G60 (9/10) had at least one extraembryonic structure SBV positive by RTqPCR. The number of positive extraembryonic structures was significantly higher in G60 lambs. Time of inoculation (45 or 60 dg) had no impact on the placental colonization success rate but affected the frequency of detecting the virus in the offspring extraembryonic structures by the time of lambing. SBV readily colonized the placenta when ewes were infected at 45 or 60 dg but infection of the fetuses was limited and did not lead to congenital malformations.	[Martinelle, Ludovic; Poskin, Antoine; Dal Pozzo, Fabiana; Saegerman, Claude] Univ Liege, Fac Vet Med, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, FARAH, Liege, Belgium; [Poskin, Antoine; De Regge, Nick; Cay, Brigitte] Vet & Agrochem Res Ctr CODA CERVA, Operat Directorate Viral Dis, Brussels, Belgium	University of Liege	Martinelle, L (corresponding author), Univ Liege, Fac Vet Med, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, FARAH, Liege, Belgium.	lmartinelle@ulg.ac.be		Saegerman, Claude/0000-0001-9087-7436; Martinelle, Ludovic/0000-0002-7875-8722	Federal Public Service Public Health and Safety of the Food Chain and Environment [RF12/6270]; European Union as outlined in Council by the Union for studies on Schmallenberg virus [2012/349/EU]	Federal Public Service Public Health and Safety of the Food Chain and Environment; European Union as outlined in Council by the Union for studies on Schmallenberg virus	This study was financially supported by Federal Public Service Public Health and Safety of the Food Chain and Environment (RF12/6270), and the European Union as outlined in Council Decision 2012/349/EU concerning a financial contribution by the Union for studies on Schmallenberg virus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2011, VET CLIN N AM-FOOD A, V27, P67, DOI 10.1016/j.cvfa.2010.10.001; Afonso A, 2014, PREV VET MED, V116, P391, DOI 10.1016/j.prevetmed.2014.02.012; Balseiro A, 2013, 1 CONFIRMATION SCHMA; Barbato O, 2009, THERIOGENOLOGY, V72, P993, DOI 10.1016/j.theriogenology.2009.06.020; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; CLARKE GL, 1978, VET PATHOL, V15, P68, DOI 10.1177/030098587801500109; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; De Regge N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087005; De Regge N, 2013, VET MICROBIOL, V162, P595, DOI 10.1016/j.vetmic.2012.11.029; Dominguez M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0248-x; EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106; Elliott RM, 2009, CLIN MICROBIOL INFEC, V15, P510, DOI 10.1111/j.1469-0691.2009.02849.x; EU consortium, 2014, SCHMALL VIR TECHN SC; EVANS CAN, 1974, J PHYSIOL-LONDON, V238, P371, DOI 10.1113/jphysiol.1974.sp010530; Gubbins S, 2014, PREV VET MED, V116, P404, DOI 10.1016/j.prevetmed.2014.02.004; HASHIGUCHI Y, 1979, NATL I ANIM HEALTH Q, V19, P1; Herder V, 2012, VET PATHOL, V49, P588, DOI 10.1177/0300985812447831; Herder V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062939; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Jackson P., 2002, CLIN EXAMINATION FAR, V1rd; KUROGI H, 1975, ARCH VIROL, V47, P71, DOI 10.1007/BF01315594; KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835; KUROGI H, 1977, INFECT IMMUN, V17, P338, DOI 10.1128/IAI.17.2.338-343.1977; LAWN AM, 1969, J ANAT, V105, P557; Luttikholt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100135; Martinelle L, 2017, TRANSBOUND EMERG DIS, V64, P305, DOI 10.1111/tbed.12356; PARSONSON IM, 1988, J COMP PATHOL, V99, P215, DOI 10.1016/0021-9975(88)90073-4; PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977; Peperkamp NH, 2014, VET PATHOLOGY; Poskin A, 2014, VET J, V201, P419, DOI 10.1016/j.tvjl.2014.05.031; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Scharpenberg LG, 1938, J ANAT, V72, P344; Sedda L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03361; Seehusen F, 2014, J COMP PATHOL, V151, P148, DOI 10.1016/j.jcpa.2014.04.006; SILVERSTEIN AM, 1963, J EXP MED, V117, P799, DOI 10.1084/jem.117.5.799; Stockhofe N, 2013, EP 7 ANN M 2013 1 4; Takken W, 2008, PREV VET MED, V87, P41, DOI 10.1016/j.prevetmed.2008.06.015; van Maanen C, 2012, VET REC, V171, P299, DOI 10.1136/vr.101061; Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133; Veldhuis AMB, 2014, VET MICROBIOL, V168, P281, DOI 10.1016/j.vetmic.2013.11.021; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wemike K, 2013, DEV BIOLOGICALS, V135, P175, DOI 10.1159/000312546; Wernike K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098223; Wernike K, 2013, VET MICROBIOL, V166, P461, DOI 10.1016/j.vetmic.2013.06.030; Wernike K, 2013, VET MICROBIOL, V165, P155, DOI 10.1016/j.vetmic.2013.01.040; Wernike K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-84; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	47	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139375	10.1371/journal.pone.0139375	http://dx.doi.org/10.1371/journal.pone.0139375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418420	Green Submitted, Green Published, gold			2022-12-26	WOS:000362171400085
J	Namjou, B; Marsolo, K; Lingren, T; Ritchie, MD; Verma, SS; Cobb, BL; Perry, C; Kitchner, TE; Brilliant, MH; Peissig, PL; Borthwick, KM; Williams, MS; Grafton, J; Jarvik, GP; Holm, IA; Harley, JB				Namjou, Bahram; Marsolo, Keith; Lingren, Todd; Ritchie, Marylyn D.; Verma, Shefali S.; Cobb, Beth L.; Perry, Cassandra; Kitchner, Terrie E.; Brilliant, Murray H.; Peissig, Peggy L.; Borthwick, Kenneth M.; Williams, Marc S.; Grafton, Jane; Jarvik, Gail P.; Holm, Ingrid A.; Harley, John B.			A GWAS Study on Liver Function Test Using eMERGE Network Participants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SERUM BILIRUBIN LEVELS; ALKALINE-PHOSPHATASE; ACTIVE METABOLITE; UGT1A1 GENE; POLYMORPHISMS; VARIANTS; LOCI; ABO; UGT1A1-ASTERISK-28	Introduction Liver enzyme levels and total serum bilirubin are under genetic control and in recent years genome-wide population-based association studies have identified different susceptibility loci for these traits. We conducted a genome-wide association study in European ancestry participants from the Electronic Medical Records and Genomics (eMERGE) Network dataset of patient medical records with available genotyping data in order to identify genetic contributors to variability in serum bilirubin levels and other liver function tests and to compare the effects between adult and pediatric populations. Methods The process of whole genome imputation of eMERGE samples with standard quality control measures have been described previously. After removing missing data and outliers based on principal components (PC) analyses, 3294 samples from European ancestry were used for the GWAS study. The association between each single nucleotide polymorphism (SNP) and total serum bilirubin and other liver function tests was tested using linear regression, adjusting for age, gender, site, platform and ancestry principal components (PC). Results Consistent with previous results, a strong association signal has been detected for UGT1A gene cluster (best SNP rs887829, beta = 0.15, p = 1.30x10(-118)) for total serum bilirubin level. Indeed, in this region more than 176 SNPs (or indels) had p<10(-8) spanning 150Kb on the long arm of chromosome 2q37.1. In addition, we found a similar level of magnitude in a pediatric group (p = 8.26x10(-47), beta = 0.17). Further imputation using sequencing data as a reference panel revealed association of other markers including known TA7 repeat indels (rs8175347) (p = 9.78x10(-117)) and rs111741722 (p = 5.41x10(-119)) which were in proxy (r2 = 0.99) with rs887829. Among rare variants, two Asian subjects homozygous for coding SNP rs4148323 (G71R) were identified. Additional known effects for total serum bilirubin were also confirmed including organic anion transporters SLCO1B1-SLCO1B3, TDRP and ZMYND8 at FDR<0.05 with no gene-gene interaction effects. Phenome-wide association studies (PheWAS) suggest a protective effect of TA7 repeat against cerebrovascular disease in an adult cohort (OR = 0.75, p = 0.0008). Among other liver function tests, we also confirmed the previous effect of the ABO blood group locus for variation in serum alkaline phosphatase (rs579459, p = 9.44x10(-15)). Conclusions Taken together, our data present interesting findings with strong confirmation of previous effects by simply using the eMERGE electronic health record phenotyping. In addition, our findings indicate that similar to the adult population, the UGT1A1 is the main locus responsible for normal variation of serum bilirubin in pediatric populations.	[Namjou, Bahram; Cobb, Beth L.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr CCHMC, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Namjou, Bahram; Marsolo, Keith; Lingren, Todd; Harley, John B.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Marsolo, Keith; Lingren, Todd] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Ritchie, Marylyn D.; Verma, Shefali S.] Penn State Univ, Ctr Syst Genom, University Pk, PA 16802 USA; [Perry, Cassandra] Boston Childrens Hosp BCH, Div Genet & Genom, Boston, MA USA; [Kitchner, Terrie E.; Brilliant, Murray H.; Peissig, Peggy L.] Marshfield Clin Fdn Med Res & Educ, Ctr Human Genet, Marshfield, WI USA; [Borthwick, Kenneth M.; Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA; [Grafton, Jane] Grp Hlth Res Inst, Seattle, WA USA; [Jarvik, Gail P.] Univ Washington, Dept Med, Seattle, WA USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Holm, Ingrid A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Holm, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Holm, Ingrid A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Boston Children's Hospital; Marshfield Clinic; Geisinger Health System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Namjou, B (corresponding author), Cincinnati Childrens Hosp Med Ctr CCHMC, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA.	Bahram.namjou@cchmc.org		Holm, Ingrid/0000-0003-4712-8821	National Institutes of Health [U01HG006828, U01HG006389, U01HG006382, U01HG006375, U01HG006385, U01HG004438]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006389, U01HG006828, U01HG004438, U01HG006382, U01HG006385, U01HG006375, U01HG008657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI024717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (http://www.nih.gov/) grants: U01HG006828-NHGRI-Cincinnati Children's Hospital Medical Center/Boston Children's Hospital (to JBH, IAH, BN, BLC, KM, TL, CP); U01HG006389-NHGRI-Essentia Institute of Rural Health, Marshfield Clinic Research Foundation and Pennsylvania State University (to PLP, MHB, TEK, MDR, SSV); U01HG006382-NHGRI-Geisinger Clinic (to MSW, KMB); U01HG006375-NHGRI-Group Health Cooperative/University of Washington (to GPJ, JG); U01HG006385-NHGRI-Vanderbilt University Medical Center serving as the Coordinating Center and the PGRNSeq dataset (eMERGE PGx); U01HG004438-NHGRI- The Center for Inherited Disease Research (CIDR) serving as a Sequencing Center for eMERGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO S, 1993, BIOCHEM BIOPH RES CO, V197, P1239, DOI 10.1006/bbrc.1993.2610; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Bathum L, 2001, CLIN CHEM, V47, P81; BAYER PM, 1980, CLIN CHIM ACTA, V108, P81, DOI 10.1016/0009-8981(80)90295-8; Berk PD, 2011, CECIL MED; Bielinski SJ, 2011, MAYO CLIN PROC, V86, P606, DOI 10.4065/mcp.2011.0178; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen GJ, 2012, EUR J HUM GENET, V20, P463, DOI 10.1038/ejhg.2011.206; Dai XY, 2013, GENET EPIDEMIOL, V37, P293, DOI 10.1002/gepi.21711; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; HIRANO K, 1987, CLIN CHIM ACTA, V166, P265, DOI 10.1016/0009-8981(87)90429-3; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Innocenti F, 2006, J CLIN ONCOL, V24, P2221, DOI 10.1200/JCO.2005.05.2464; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kim JY, 2014, YONSEI MED J, V55, P232, DOI 10.3349/ymj.2014.55.1.232; Lampe JW, 1999, PHARMACOGENETICS, V9, P341, DOI 10.1097/00008571-199906000-00009; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Namjou B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00401; Nelson D, 2014, ANTIVIR THER, V19, P679, DOI 10.3851/IMP2747; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Pratt DS, 2010, SLEISENGER FORDTRANS; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Rahim F, 2013, GENET RES INT, V2013, DOI 10.1155/2013/546909; Rasmussen-Torvik LJ, 2014, CLIN PHARMACOL THER, V96, P482, DOI 10.1038/clpt.2014.137; Sampietro M, 1999, HAEMATOLOGICA, V84, P150; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sneitz N, 2010, HUM MUTAT, V31, P52, DOI 10.1002/humu.21133; Sugatani J, 2002, BIOCHEM BIOPH RES CO, V292, P492, DOI 10.1006/bbrc.2002.6683; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Vitek L, 2001, AM J CARDIOL, V88, P1218, DOI 10.1016/S0002-9149(01)01962-2; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zucker SD, 2001, P NATL ACAD SCI USA, V98, P12671, DOI 10.1073/pnas.231140698	43	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138677	10.1371/journal.pone.0138677	http://dx.doi.org/10.1371/journal.pone.0138677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413716	gold, Green Published, Green Submitted			2022-12-26	WOS:000362170700020
J	Deckx, S; Carai, P; Bateman, J; Heymans, S; Papageorgiou, AP				Deckx, Sophie; Carai, Paolo; Bateman, John; Heymans, Stephane; Papageorgiou, Anna-Pia			Breeding Strategy Determines Rupture Incidence in Post-Infarct Healing WARPing Cardiovascular Research	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MATRIX PROTEIN WARP; MYOCARDIAL-INFARCTION; THERAPEUTIC ANGIOGENESIS; INCREASED EXPRESSION; CARDIAC-FUNCTION; MOUSE; PROLIFERATION; PERLECAN; SCAR	Background Von Willebrand A domain Related Protein (WARP), is a recently identified extracellular matrix protein. Based upon its involvement in matrix biology and its expression in the heart, we hypothesized that WARP regulates cardiac remodeling processes in the post-infarct healing process. Methods and results In the mouse model of myocardial infarction (MI), WARP expression increased in the infarcted area 3-days post-MI. In the healthy myocardium WARP localized with perlecan in the basement membrane, which was disrupted upon injury. In vitro studies showed high expression of WARP by cardiac fibroblasts, which further increases upon TGF beta stimulation. Furthermore, WARP expression correlated with aSMA and COL1 expression, markers of fibroblast to myofibroblast transition, in vivo and in vitro. Finally, WARP knockdown in vitro affected extra-and intracellular basic fibroblast growth factor production in myofibroblasts. To investigate the function for WARP in infarction healing, we performed an MI study in WARP knockout (KO) mice backcrossed more than 10 times on an Australian C57Bl/6-J background and bred in-house, and compared to wild type (WT) mice of the same C57Bl/6J strain but of commercial European origin. WARP KO mice showed no mortality after MI, whereas 40% of the WT mice died due to cardiac rupture. However, when WARP KO mice were backcrossed on the European C57Bl/6-J background and bred heterozygous inhouse, the previously seen protective effect in the WARP KO mice after MI was lost. Importantly, comparison of the cardiac response post-MI in WT mice bred heterozygous in-house versus commercially purchased WT mice revealed differences in cardiac rupture. Conclusion These data demonstrate a redundant role for WARP in the wound healing process after MI but demonstrate that the continental/breeding/housing origin of mice of the same C57Bl6-J strain is critical in determining the susceptibility to cardiac rupture and stress the importance of using the correct littermate controls.	[Deckx, Sophie; Carai, Paolo; Heymans, Stephane; Papageorgiou, Anna-Pia] Maastricht Univ, Dept Cardiol, Maastricht, Netherlands; [Deckx, Sophie; Carai, Paolo; Heymans, Stephane; Papageorgiou, Anna-Pia] KULeuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Bateman, John] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bateman, John] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia	Maastricht University; KU Leuven; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Deckx, S (corresponding author), Maastricht Univ, Dept Cardiol, Maastricht, Netherlands.	s.deckx@maastrichtuniversity.nl	Papageorgiou, Anna/J-9413-2015	Heymans, Stephane/0000-0001-9477-7803; Bateman, John/0000-0001-8542-0730; Carai, Paolo/0000-0003-0718-4773	ZonMW MKMD; Publiceren van negatieve of neutrale dierexperimentele data-Module Amendement 21; CARIM; European Commission [602904, 261409]; CVON	ZonMW MKMD; Publiceren van negatieve of neutrale dierexperimentele data-Module Amendement 21; CARIM; European Commission(European CommissionEuropean Commission Joint Research Centre); CVON	This research was funded by ZonMW MKMD, Publiceren van negatieve of neutrale dierexperimentele data-Module Amendement 21, http://www.zonmw.nl/nl/programmas/programma-detail/meer-kennis-met-minder-dieren/algemeen/, a CARIM-funded PhD grant, and by the European Commission's grants No 602904 (FIBROTARGETS), No 261409 (MEDIA), and the CVON 2011 (ARENA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Allen JM, 2008, MATRIX BIOL, V27, P295, DOI 10.1016/j.matbio.2008.01.005; Allen JM, 2009, J BIOL CHEM, V284, P12020, DOI 10.1074/jbc.M806968200; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; DeWindt LJ, 1997, J MOL CELL CARDIOL, V29, P2095, DOI 10.1006/jmcc.1997.0444; Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889; Fitzgerald J, 2002, FEBS LETT, V517, P61, DOI 10.1016/S0014-5793(02)02579-6; Fomovsky GM, 2010, AM J PHYSIOL-HEART C, V298, pH221, DOI 10.1152/ajpheart.00495.2009; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldsmith EC, 2014, J MOL CELL CARDIOL, V70, P92, DOI 10.1016/j.yjmcc.2014.01.008; Gorog DA, 2003, J MOL CELL CARDIOL, V35, P705, DOI 10.1016/S0022-2828(03)00082-8; Hansen U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052793; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Liao S, 2009, DEV DYNAM, V238, P249, DOI 10.1002/dvdy.21677; Lindsey ML, 2003, ANN MED, V35, P316, DOI 10.1080/07853890310001285; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Shah AP, 2010, CARDIOVASC RES, V87, P683, DOI 10.1093/cvr/cvq111; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpath.2007.070003; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Zachary I, 2011, HEART, V97, P181, DOI 10.1136/hrt.2009.180414; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139199	10.1371/journal.pone.0139199	http://dx.doi.org/10.1371/journal.pone.0139199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406320	Green Published, gold			2022-12-26	WOS:000361800700189
J	Leguillier, T; Lecso-Bornet, M; Lemus, C; Rousseau-Ralliard, D; Lebouvier, N; Hnawia, E; Nour, M; Aalbersberg, W; Ghazi, K; Raharivelomanana, P; Rat, P				Leguillier, Teddy; Lecso-Bornet, Marylin; Lemus, Christelle; Rousseau-Ralliard, Delphine; Lebouvier, Nicolas; Hnawia, Edouard; Nour, Mohammed; Aalbersberg, William; Ghazi, Kamelia; Raharivelomanana, Phila; Rat, Patrice			The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected Wounds	PLOS ONE			English	Article							MEDICINAL-PLANTS; OXIDATIVE STRESS; EXTRACTS; BACTERIA; AGENTS	Background Calophyllum inophyllum L. (Calophyllaceae) is an evergreen tree ethno-medically used along the seashores and islands of the Indian and Pacific Oceans, especially in Polynesia. Oil extracted from the seeds is traditionally used topically to treat a wide range of skin injuries from burn, scar and infected wounds to skin diseases such as dermatosis, urticaria and eczema. However, very few scientific studies reported and quantified the therapeutic properties of Calophyllum inophyllum oil (CIO). In this work, five CIO from Indonesia (CIO1), Tahiti (CIO2, 3), Fiji islands (CIO4) and New Caledonia (CIO5) were studied and their cytotoxic, wound healing, and antibacterial properties were presented in order to provide a scientific support to their traditional use and verify their safety. Methods The safety of the five CIO was ascertained using the Alamar blue assay on human keratinocyte cells. CIO wound healing properties were determined using the scratch test assay on human keratinocyte cells. CIO-stimulated antibacterial innate immune response was evaluated using ELISA by measuring beta defensin-2 release in human derivative macrophage cells. CIO antibacterial activity was tested using oilogramme against twenty aerobic Gram-bacteria species, twenty aerobic Gram+ bacteria species, including a multi-drug resistant Staphylococcus aureus strain and two anaerobic Gram+ bacteria species e.g. Propionibacterium acnes and Propionibacterium granulosum. To detect polarity profile of the components responsible of the antibacterial activity, we performed bioautography against a Staphylococcus aureus strain. Results Based on Alamar Blue assay, we showed that CIO can be safely used on keratinocyte cells between 2.7% and 11.2% depending on CIO origin. Concerning the healing activity, all the CIO tested accelerated in vitro wound closure, the healing factor being 1.3 to 2.1 higher compared to control when keratinocytes were incubated after scratch with CIO at 0.1%. Furthermore, our results showed that CIO exhibit two distinct antibacterial effects: one against Gram + bacteria by direct inhibition of mitotic growth and another potent effect against Gram-bacteria due to increased release of beta-defensin 2 peptide by macrophages. Interestingly, the needed concentrations of CIO to inhibit bacteria growth and to promote wound healing are lower than concentrations exhibiting cytotoxic effects on keratinocyte cells. Finally, we performed bioautography assay against Staphylococcus aureus to determine polarity profile of the components responsible for CIO antibacterial activity. Our results showed for the five tested CIO that components responsible of the bacterial growth inhibition are the more polar one on the TLC chromatographic profile and are contained in the resinous fraction of the oil. Conclusions This study was conducted to evaluate cytotoxicity, wound healing and antibacterial properties of five CIO traditionally used to treat infected wounds. Using cell and bacteria cultures, we confirmed the pharmacological effects of CIO as wound healing and antimicrobial agent. Moreover, we showed that concentration of CIO needed to exhibit therapeutic effects are lower than concentrations exhibiting cytotoxic effects in vitro. For the first time, this study provides support for traditional uses of CIO. These wound healing and antibiotic properties make CIO a valuable candidate to treat infected wounds especially in tropical areas.	[Leguillier, Teddy; Rat, Patrice] Univ Paris 05, UMR CNRS COMETE 8638, Lab Chim Toxicol Analyt & Cellulaire, Sorbonne Paris Cite,Fac Pharm, Paris, France; Univ Paris 05, Sorbonne Paris Cite, Fac Pharm, Lab Ecosyst Intestinal Probiot Antibio EA 4065, Paris, France; [Lemus, Christelle] Univ Paris 05, UMR CNRS COMETE 8638, Lab Pharmacognosie, Sorbonne Paris Cite,Fac Pharm, Paris, France; [Rousseau-Ralliard, Delphine] INRA, Biol Dev & Reprod, UMR 1198, Jouy En Josas, France; [Lebouvier, Nicolas; Hnawia, Edouard; Nour, Mohammed] Univ Nouvelle Caledonie, Lab Insuiaire Vivant & Environm, EA 4243, Noumea, New Caledonia; [Aalbersberg, William] Univ S Pacific, Inst Appl Sci, Suva, Fiji; [Ghazi, Kamelia] Univ Technol Compiegne, CNRS UMR 7338, Ctr Rech BioMecan & Bioingenierie, Compiegne, France; [Raharivelomanana, Phila] Univ Polynesie Francaise, UMR EIO 241, Equipe Etude Integree Metabolites Secondaires, FAAA, Tahiti, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Nouvelle Caledonie; University of the South Pacific; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Picardie Universites; Universite de Technologie de Compiegne; Ifremer	Rat, P (corresponding author), Univ Paris 05, UMR CNRS COMETE 8638, Lab Chim Toxicol Analyt & Cellulaire, Sorbonne Paris Cite,Fac Pharm, Paris, France.	patrice.rat@parisdescartes.fr	Lebouvier, Nicolas/AAV-3456-2020; ROUSSEAU-RALLIARD, Delphine/AAA-4035-2020	Rousseau (Rousseau-Ralliard), Delphine/0000-0003-2684-1791	Laboratoire Chimie-Toxicologie Analytique et Cellulaire; Fonds Pacifique (project CALOPS)	Laboratoire Chimie-Toxicologie Analytique et Cellulaire; Fonds Pacifique (project CALOPS)	This work was supported by the Laboratoire Chimie-Toxicologie Analytique et Cellulaire and by the Fonds Pacifique (project CALOPS).	Bhatia A, 2014, INT J COSMETIC SCI, V36, P361; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruneton J., 1993, PHARMACOGNOSY PHYTOC; Buonomo R, 2012, J CELL PHYSIOL, V227, P2106, DOI 10.1002/jcp.22944; Butaud J-F, 2008, GUIDE ARBRES POLYNES, P320; Cambie R, 1994, FIJIAN MED PLANTS, P365; Chah KF, 2006, J ETHNOPHARMACOL, V104, P164, DOI 10.1016/j.jep.2005.08.070; Chevalier J, 1951, STUDY NEW CICATRIZIN; Cho-Ngwa F, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-62; Cockerill F, 2012, CLIN LAB STANDARDS I, V32; Dawid-Pac R, 2013, POSTEP DERM ALERGOL, V30, P170, DOI 10.5114/pdia.2013.35620; Dreno B, 2001, EUR J DERMATOL, V11, P549; Dutot M, 2008, EUR J PHARM SCI, V33, P138, DOI 10.1016/j.ejps.2007.10.006; Dutot M, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-48; Dweck A C, 2002, Int J Cosmet Sci, V24, P341, DOI 10.1046/j.1467-2494.2002.00160.x; Dzoyem JP, 2014, J ETHNOPHARMACOL; Eldin HME, 2014, PARASITOL RES, V113, P1949, DOI 10.1007/s00436-014-3845-5; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Girardi C, 2014, J ETHNOPHARMACOL PRE; Grepin F, 1984, TAHITIAN TRADITIONAL; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Kagan IA, 2014, JOVE-J VIS EXP, DOI 10.3791/51411; Kovac-Besovic Elvira E, 2003, Bosn J Basic Med Sci, V3, P19; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Lahlou M, 2004, PHYTOTHER RES, V18, P435, DOI 10.1002/ptr.1465; Laure F, 2008, ANAL CHIM ACTA, V624, P147, DOI 10.1016/j.aca.2008.06.046; Leu T, 2009, MAGN RESON CHEM, V47, P989, DOI 10.1002/mrc.2482; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Mahboubi A, 2014, IRAN J PHARM RES, V13, P559; McLaws FB, 2011, ANTIMICROB AGENTS CH, V55, P1173, DOI 10.1128/AAC.00817-10; Morin C, 2012, J PHARMACOL EXP THER, V343, P115, DOI 10.1124/jpet.111.188599; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; PATIL AD, 1993, J MED CHEM, V36, P4131, DOI 10.1021/jm00078a001; Petard P., 1972, RAAU TAHITI USE POLY; Petard P, 1986, QUELQUES PLANTES UTI; Pidoux M., 2012, Phytotherapie (Paris), V10, P143, DOI 10.1007/s10298-012-0700-7; POCIDALO JJ, 1955, CR SOC BIOL, V149, P357; Prabakaran K, 2012, INT J NAT PROD  0526, P24; RALPH P, 1982, CELL IMMUNOL, V71, P215, DOI 10.1016/0008-8749(82)90257-X; Said T, 2007, EUR J PHARM SCI, V30, P203, DOI 10.1016/j.ejps.2006.11.001; Skrivanova E, 2005, LETT APPL MICROBIOL, V41, P77, DOI 10.1111/j.1472-765X.2005.01709.x; Sofowora A, 2013, AFR J TRADIT COMPLEM, V10, P210, DOI 10.4314/ajtcam.v10i5.2; STEVENS PF, 1980, J ARNOLD ARBORETUM, V61, P117, DOI 10.5962/bhl.part.8541; Suleiman MM, 2010, AFR J TRADIT COMPLEM, V7, P64; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tarrade A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083458; VLIETINCK AJ, 1995, J ETHNOPHARMACOL, V46, P31, DOI 10.1016/0378-8741(95)01226-4; Whistler WA, 1992, FLOWERS PACIFIC ISLA; Yimdjo MC, 2004, PHYTOCHEMISTRY, V65, P2789, DOI 10.1016/j.phytochem.2004.08.024	50	34	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138602	10.1371/journal.pone.0138602	http://dx.doi.org/10.1371/journal.pone.0138602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406588	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700061
J	Nielsen, MJ; Kazankov, K; Leeming, DJ; Karsdal, MA; Krag, A; Barrera, F; McLeod, D; George, J; Gronbaek, H				Nielsen, Mette J.; Kazankov, Konstantin; Leeming, Diana J.; Karsdal, Morten A.; Krag, Aleksander; Barrera, Francisco; McLeod, Duncan; George, Jacob; Gronbaek, Henning			Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; BLOOD-TESTS; FIBROGENESIS; DEGRADATION; PREDICT; MATRIX-METALLOPROTEINASE-9; PROGRESSION; DIAGNOSIS; DISEASE	Background and Aim Detection of advanced fibrosis (Metavir F >= 3) is important to identify patients with a high urgency of antiviral treatments vs. those whose treatment could be deferred (F <= 2). The aim was to assess the diagnostic value of novel serological extracellular matrix protein fragments as potential biomarkers for clinically significant and advanced fibrosis. Methods Specific protein fragments of matrix metalloprotease degraded type I, III, IV and VI collagen (C1M, C3M, C4M, C6M) and type III and IV collagen formation (Pro-C3 and P4NP7S) were assessed in plasma from 403 chronic hepatitis C patients by specific ELISAs. Patients were stratified according to Metavir Fibrosis stage; F0 (n = 46), F1 (n = 161), F2 (n = 95), F3 (n = 44) and F4 (n = 33) based on liver biopsy. Results Pro-C3 was significantly elevated in patients with significant fibrosis (>= F2) compared to F0-F1 (p< 0.05), while the markers C3M, C4M, C6M and P4NP7S were significantly elevated in patients with advanced fibrosis (>= F3) compared to F0-F2 (p< 0.05). C1M showed no difference between fibrosis stages. Using Receiver Operating Characteristics analysis, the best marker for detecting >= F2 and >= F3 was Pro-C3 with AUC = 0.75 and AUC = 0.86. Combination of Pro-C3 and C4M with age, BMI and gender in a multiple ordered logistic regression model improved the diagnostic value for detecting >= F2 and >= F3 with AUC = 0.80 and AUC = 0.88. Conclusion The Pro-C3 protein fragment provided clinically relevant diagnostic accuracy as a single marker of liver fibrosis. A model combining Pro-C3 and C4M along with patient's age, body mass index and gender increased the diagnostic power for identifying clinically significant fibrosis.	[Nielsen, Mette J.; Leeming, Diana J.; Karsdal, Morten A.] Fibrosis Biol & Biomarkers, Nord Biosci A S, Herlev, Denmark; [Nielsen, Mette J.; Krag, Aleksander] Univ Southern Denmark, Odense Univ Hosp, Fac Hlth Sci, Dept Gastroenterol & Hepatol, Odense, Denmark; [Kazankov, Konstantin; Gronbaek, Henning] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, DK-8000 Aarhus, Denmark; [Barrera, Francisco; George, Jacob] Westmead Hosp, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia; [Barrera, Francisco; George, Jacob] Univ Sydney, Sydney, NSW 2006, Australia; [McLeod, Duncan] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Anat Pathol, Sydney, NSW, Australia	Nordic Bioscience; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Nielsen, MJ (corresponding author), Fibrosis Biol & Biomarkers, Nord Biosci A S, Herlev, Denmark.	mju@nordicbioscience.com	Nielsen, Mette Juul/AAP-1647-2020; Gronbaek, Henning/AAJ-3202-2020; Krag, Aleksander/ABH-9649-2020	Gronbaek, Henning/0000-0001-8998-7910; Krag, Aleksander/0000-0002-9598-4932; Karsdal, Morten/0000-0001-5026-8740; Barrera, Francisco/0000-0001-5334-1528	Danish Science Foundation; Danish Ministry of Science and Technology; NOVO Nordisk Foundation; National and Medical Research Council of Australia [1053206, 632630, 1049857, 1047417]; Robert W. Storr Bequest; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish	Danish Science Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science and Technology; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by the Danish Science Foundation, the Danish Ministry of Science and Technology, and the NOVO Nordisk Foundation. Grants were received from the National and Medical Research Council of Australia (Program Grant no. 1053206, project grants 632630, 1049857, and 1047417) and Robert W. Storr Bequest to the Sydney Medical Foundation of the University of Sydney. The funders provided support in the form of salaries for authors MJN, DJL, and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Afdhal NH, 1997, J HEPATOL, V27, P993, DOI 10.1016/S0168-8278(97)80142-0; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fontana RJ, 2010, GUT, V59, P1401, DOI 10.1136/gut.2010.207423; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Guechot J, 1996, CLIN CHEM, V42, P558; Guha IN, 2011, HEPATOLOGY, V54, P1454, DOI 10.1002/hep.24515; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Karsdal MA, 2011, CLIN BIOCHEM, V44, P1278, DOI 10.1016/j.clinbiochem.2011.08.1135; Kazankov K, 2014, HEPATOLOGY; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Leeming DJ, 2013, ALIMENT PHARM THER, V38, P1086, DOI 10.1111/apt.12484; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; Leeming DJ, 2012, HEPATOL RES, V42, P482, DOI 10.1111/j.1872-034X.2011.00946.x; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Li SM, 2014, WORLD J GASTROENTERO, V20, P9528, DOI 10.3748/wjg.v20.i28.9528; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Nielsen MJ, 2015, LIVER INT, V35, P429, DOI 10.1111/liv.12700; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Pares A, 1996, HEPATOLOGY, V24, P1399, DOI 10.1053/jhep.1996.v24.pm0008938169; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Pinzani M, 2010, GUT, V59, P1165, DOI 10.1136/gut.2010.214932; Poordad FF, 2004, EXPERT REV MOL DIAGN, V4, P593, DOI 10.1586/14737159.4.5.593; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; RILEY DJ, 1988, EXP LUNG RES, V14, P549, DOI 10.3109/01902148809087827; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Sharma S, 2014, WORLD J GASTROENTERO, V20, P16820, DOI 10.3748/wjg.v20.i45.16820; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Vassiliadis E, 2011, BIOMARK INSIGHTS, V6, P49, DOI 10.4137/BMI.S6347; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Veidal SS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-5; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024	40	52	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137302	10.1371/journal.pone.0137302	http://dx.doi.org/10.1371/journal.pone.0137302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406331	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700019
J	Zhu, XM; Wang, YF; Zhao, XL; Jiang, CP; Zhang, QY; Jiang, WJ; Wang, Y; Chen, HX; Shou, XF; Zhao, Y; Li, YM; Li, SQ; Ye, HY				Zhu, Xiaoming; Wang, Yongfei; Zhao, Xuelan; Jiang, Cuiping; Zhang, Qiongyue; Jiang, Wenjuan; Wang, Yan; Chen, Haixia; Shou, Xuefei; Zhao, Yao; Li, Yiming; Li, Shiqi; Ye, Hongying			Incidence of Pituitary Apoplexy and Its Risk Factors in Chinese People: A Database Study of Patients with Pituitary Adenoma	PLOS ONE			English	Article							TRANSSPHENOIDAL SURGERY; PRECIPITATING FACTORS; CLINICAL-FEATURES; TUMOR APOPLEXY; MANAGEMENT; CLASSIFICATION; ENDOCRINE; INVASION; GROWTH; SERIES	Background There are few studies of the incidence and clinical characteristics of pituitary apoplexy (PA) in pituitary adenoma patients, and the findings have been inconsistent. Objective The aim of the study was to retrospectively assess the incidence, clinical presentation, surgical management and postoperative complications of PA in pituitary adenoma patients. Methods A database was specifically designed to collect clinical, therapeutic, prognostic and histological information about pituitary adenoma patients. Using multivariate logistic regression, odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to identify associated factors. Results A total of 2021 pituitary adenoma patients were recruited. 97 (4.8%) patients had PA. The incidence of PA was 10.11% in patients with pituitary macroadenoma, and 0.36% in patients with microadenoma. Variables for the logistic regression model independently associated with PA were sex (male vs. female, OR = 2.54, 95% CI: 1.59 similar to 4.07), tumor type (negative staining vs. positive staining, OR = 2.04, 95% CI: 1.29 similar to 3.23), and tumor size (macroadenoma vs. microadenoma, OR = 26.46, 95% CI = 9.66 similar to 72.46). Headache, visual deterioration, and vomiting were the most common symptoms in patients with pituitary adenoma. Patients with and without PA had similar frequency of visual deterioration, head trauma, acromegalic appearance, galactorrhoea, cold intolerance and Cushingoid appearance, but headache, vomiting, ptosis, diplopia, fever and blindness were significantly more common in patients with PA. Pearson Chi-Square tests revealed a significant difference in surgical approach between patients with and without PA (95.88% vs. 85.57%, P = 0.01). Conclusion Our findings suggest that PA is not a rare event. Male sex, non-functioning tumor, and macroadenoma are associated with an increased risk of PA. Compared with pituitary adenoma patients without PA, patients with PA have more severe symptoms.	[Zhu, Xiaoming; Zhao, Xuelan; Jiang, Cuiping; Zhang, Qiongyue; Jiang, Wenjuan; Li, Yiming; Ye, Hongying] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Jiang, Cuiping] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Jiang, Wenjuan] Fudan Univ, Shanghai Med Coll, Jinshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Wang, Yan; Chen, Haixia] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Yongfei; Shou, Xuefei; Zhao, Yao; Li, Shiqi] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Xiaoming; Wang, Yongfei; Wang, Yan; Shou, Xuefei; Zhao, Yao; Li, Yiming; Li, Shiqi; Ye, Hongying] Shanghai Pituitary Tumor Ctr, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Li, SQ (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai Med Coll, Shanghai 200433, Peoples R China.	liu888mm@sina.com; dryehongying@hotmail.com			985 Project (Fudan University) [985 III-YFX0302]; Key Clinical Discipline Programs of the Ministry of Health; Shanghai Committee of Science and Technology of China [11411951900, 11411951901]; National Natural Science Foundation of China [81270955]	985 Project (Fudan University); Key Clinical Discipline Programs of the Ministry of Health; Shanghai Committee of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work were supported by the 985 Project (985 III-YFX0302, Fudan University), the Key Clinical Discipline Programs of the Ministry of Health and by the Shanghai Committee of Science and Technology of China (No. 11411951900, 11411951901) and by National Natural Science Foundation of China(81270955).	Agrawal D, 2005, SURG NEUROL, V63, P42, DOI 10.1016/j.surneu.2004.03.014; Ahmed SK, 2008, ACTA NEUROCHIR, V150, P1193, DOI 10.1007/s00701-008-0130-3; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BILLS DC, 1993, NEUROSURGERY, V33, P602, DOI 10.1227/00006123-199310000-00007; Biousse V, 2001, J NEUROL NEUROSUR PS, V71, P542, DOI 10.1136/jnnp.71.4.542; BONICKI W, 1993, ACTA NEUROCHIR, V120, P118, DOI 10.1007/BF02112028; Capatina C, 2015, EUR J ENDOCRINOL, V172, pR179, DOI 10.1530/EJE-14-0794; Cinar N, 2013, PITUITARY, V16, P483, DOI 10.1007/s11102-012-0444-2; Dubuisson AS, 2007, CLIN NEUROL NEUROSUR, V109, P63, DOI 10.1016/j.clineuro.2006.01.006; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Imboden PNE, 2005, MEDICINE, V84, P188, DOI [10.1097/01.md.0000164205.77287.9c, 10.1097/01.md.0000164205.77287.9e]; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; Liu ZH, 2010, J CLIN NEUROSCI, V17, P694, DOI 10.1016/j.jocn.2009.11.012; McCabe CJ, 2002, J CLIN ENDOCR METAB, V87, P4238, DOI 10.1210/jc.2002-020309; Miyajima K, 2010, ACTA HISTOCHEM CYTOC, V43, P33, DOI 10.1267/ahc.09034; Moller-Goede DL, 2011, EUR J ENDOCRINOL, V164, P37, DOI 10.1530/EJE-10-0651; Mou CZ, 2009, J CLIN NEUROSCI, V16, P64, DOI 10.1016/j.jocn.2008.02.012; Nielsen EH, 2006, CLIN ENDOCRINOL, V64, P319, DOI 10.1111/j.1365-2265.2006.02463.x; Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Ranabir S, 2011, IND J ENDOCRINOL MET, V15, pS188, DOI [DOI 10.4103/2230-8210.84862S188-S196, DOI 10.4103/2230-8210.84862, 10.4103/2230-8210.84862]; Randall BR, 2010, ACTA NEUROCHIR, V152, P1737, DOI 10.1007/s00701-010-0706-6; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Semple PL, 2007, NEUROSURGERY, V61, P956, DOI 10.1227/01.neu.0000303191.57178.2a; Seuk JW, 2011, J KOREAN NEUROSURG S, V49, P339, DOI 10.3340/jkns.2011.49.6.339; Shou XF, 2005, NEUROSURGERY, V56, P249, DOI 10.1227/01.neu.0000147976.06937.1D; Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3; WAKAI S, 1981, J NEUROSURG, V55, P187, DOI 10.3171/jns.1981.55.2.0187; Wang C, 2008, NEUROSURGERY, V62, P947, DOI 10.1227/01.neu.0000318181.80040.99	29	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139088	10.1371/journal.pone.0139088	http://dx.doi.org/10.1371/journal.pone.0139088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407083	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700164
J	Zhao, YL; Liu, F; Liu, Y; Zhou, D; Dai, Q; Liu, SQ				Zhao, Yinglan; Liu, Fang; Liu, Yao; Zhou, Dan; Dai, Qing; Liu, Songqing			Anti-Arthritic Effect of Chebulanin on Collagen-Induced Arthritis in Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TERMINALIA-CHEBULA; TNF-ALPHA; ANIMAL-MODELS; THERAPY; EXTRACT; EPIDEMIOLOGY; PATHOGENESIS; INFLAMMATION; ETANERCEPT	Rheumatoid arthritis is a chronic degenerative autoimmune disease characterized by persistent inflammation of synovial membranes, which leads to cartilage destruction and bone erosion. To date, there are no effective therapies to slow the progress of this degenerative condition. Here, we evaluate the anti-arthritic effect of chebulanin, an abundant anti-inflammatory agent isolated from Terminalia chebula, in collagen induced arthritis in DBA/1 mice by intragastric administration. Arthritic severity was scored by performing histopathological evaluation of the joints and measuring the expression of inflammatory cytokines and relative enzymes by immunohistochemical staining. In parallel, bone destruction and erosion were confirmed by micro-CT. Our data revealed that chebulanin significantly improved the severity of arthritis. Specifically, the histopathological characteristics of the tissues were improved and expression of TNF-alpha, IL-6, MMP-3 and COX-2 in the paws and joints of the treated mice decreased in a dose-dependent manner compared with control mice. Furthermore, micro-CT analysis revealed that chebulanin induced a dose-dependent reduction in cartilage destruction and bone erosion. Taken together, our findings suggest that chebulanin suppresses the expression of inflammatory mediators and prevents cartilage destruction and bone erosion in mice. Therefore, chebulanin is a strong therapeutic alternative for the treatment of RA.	[Zhao, Yinglan; Liu, Fang; Liu, Yao; Dai, Qing; Liu, Songqing] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China; [Zhou, Dan] Tradit Chinese Med Hosp Dianjiang Cty, Chongqing, Peoples R China	Army Medical University	Liu, SQ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China.	songqingliu@hotmail.com	Liu, Songqing/AAM-7520-2020; Liu, Y/AAK-4063-2021		Application and Development Project from Chongqing Science and Technology Commission, China [cstc2014yykfA110023]	Application and Development Project from Chongqing Science and Technology Commission, China	This study was supported by Application and Development Project from Chongqing Science and Technology Commission, China, ( Grant Number: No.cstc2014yykfA110023), Website: http://www.clin.ac.cn/, Grant Recipient: SL.	Atzeni F, 2012, AUTOIMMUN REV, V12, P225, DOI 10.1016/j.autrev.2012.06.008; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Botsios C, 2007, REUMATISMO, V59, P32, DOI 10.4081/reumatismo.2007.32; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Das ND, 2011, PHYTOTHER RES, V25, P927, DOI 10.1002/ptr.3398; Machado MAD, 2013, REV BRAS REUMATOL, V53, P419, DOI 10.1590/S0482-50042013000500009; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008920; Edrees AF, 2005, CLIN EXP RHEUMATOL, V23, P469; Farkouh ME, 2007, ANN RHEUM DIS, V66, P764, DOI 10.1136/ard.2006.066001; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Ferraccioli G, 2010, MOL MED, V16, P552, DOI 10.2119/molmed.2010.00067; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Hashizume M, 2011, ARTHRITIS, DOI 10.1155/2011/765624; Hu YP, 2013, CLIN RHEUMATOL, V32, P161, DOI 10.1007/s10067-012-2041-1; Ito M, 1998, BONE, V23, P163, DOI 10.1016/S8756-3282(98)00083-0; Kannan P, 2009, AFR J MICROBIOL RES, V3, P180; Kozaci LD, 1997, ARTHRITIS RHEUM-US, V40, P164, DOI 10.1002/art.1780400121; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Lee HS, 2005, BIOL PHARM BULL, V28, P1639, DOI 10.1248/bpb.28.1639; Lee WJ, 2014, J MICROBIOL BIOTECHN, V24, P1377, DOI 10.4014/jmb.1405.05030; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Liu M, 2009, FITOTERAPIA, V80, P369, DOI 10.1016/j.fitote.2009.05.006; Luo W, 2012, FOOD CHEM, V132, P1527, DOI 10.1016/j.foodchem.2011.11.146; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Myers LK, 1997, LIFE SCI, V61, P1861, DOI 10.1016/S0024-3205(97)00480-3; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018; Pisetsky DS, 2001, JAMA-J AM MED ASSOC, V286, P2787, DOI 10.1001/jama.286.22.2787; Ribbens C, 2002, ANN RHEUM DIS, V61, P161, DOI 10.1136/ard.61.2.161; Rossini M, 2013, ANN RHEUM DIS, V72, P409; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Seetharaman R, 1999, J IMMUNOL, V163, P1577; Seo JB, 2012, BIOMOL THER, V20, P104, DOI 10.4062/biomolther.2012.20.1.104; Sireeratawong S, 2012, PLANTA MED, V78, P1169; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Tikiz H, 2010, ANATOL J CARDIOL, V10, P98, DOI 10.5152/akd.2010.031; Wang HZ, 2014, J PHARMACOL EXP THER, V350, P435, DOI 10.1124/jpet.114.215145; Widdifield J, 2013, ANN RHEUM DIS, V72, P549; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P716, DOI 10.1196/annals.1361.116	40	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139052	10.1371/journal.pone.0139052	http://dx.doi.org/10.1371/journal.pone.0139052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402786	Green Submitted, Green Published, gold			2022-12-26	WOS:000361798100054
J	Wright, CE; Kushner, EJ; Du, QS; Bautch, VL				Wright, Catherine E.; Kushner, Erich J.; Du, Quansheng; Bautch, Victoria L.			LGN Directs Interphase Endothelial Cell Behavior via the Microtubule Network	PLOS ONE			English	Article							SPINDLE ORIENTATION; VE-CADHERIN; DROSOPHILA NEUROBLASTS; NEUTROPHIL MIGRATION; POLARITY; DIVISION; DYNAMICS; MORPHOGENESIS; ANGIOGENESIS; PINS	Angiogenic sprouts require coordination of endothelial cell (EC) behaviors as they extend and branch. Microtubules influence behaviors such as cell migration and cell-cell interactions via regulated growth and shrinkage. Here we investigated the role of the mitotic polarity protein LGN in EC behaviors and sprouting angiogenesis. Surprisingly, reduced levels of LGN did not affect oriented division of EC within a sprout, but knockdown perturbed overall sprouting. At the cell level, LGN knockdown compromised cell-cell adhesion and migration. EC with reduced LGN levels also showed enhanced growth and stabilization of microtubules that correlated with perturbed migration. These results fit a model whereby LGN influences interphase microtubule dynamics in endothelial cells to regulate migration, cell adhesion, and sprout extension, and reveal a novel non-mitotic role for LGN in sprouting angiogenesis.	[Wright, Catherine E.; Bautch, Victoria L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Kushner, Erich J.; Bautch, Victoria L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Du, Quansheng] Georgia Regents Univ, Inst Mol Med & Genet, Dept Neurol, Augusta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University	Bautch, VL (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	bautch@med.unc.edu		Du, Quansheng/0000-0003-4079-8662	National Institutes of Health [R01 HL43174, R01 HL116719]; NATIONAL CANCER INSTITUTE [T32CA009156, F31CA165891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116719, R01HL043174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institutes of Health: R01 HL43174 (VLB) and R01 HL116719 (VLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Bravi L, 2014, CELL TISSUE RES, V355, P515, DOI 10.1007/s00441-014-1843-7; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chappell JC, 2012, CELLS TISSUES ORGANS, V195, P94, DOI 10.1159/000331398; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ezan J, 2013, NAT CELL BIOL, V15, P1107, DOI 10.1038/ncb2819; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hertwig O., 1884, JENAISCHE Z, pXVIII; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kamath K, 2014, CYTOSKELETON, V71, P46, DOI 10.1002/cm.21153; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Komarova YA, 2012, MOL CELL, V48, P914, DOI 10.1016/j.molcel.2012.10.011; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kulukian A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0016; Kumar S, 2012, BLOOD, V120, P3563, DOI 10.1182/blood-2012-04-426981; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; MALECH HL, 1977, J CELL BIOL, V75, P666, DOI 10.1083/jcb.75.3.666; Mauser JF, 2012, PLOS ONE, V7, P118, DOI 10.1371/journal.pone.0029611; Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Revenu C, 2014, DEVELOPMENT, V141, P1282, DOI 10.1242/dev.101675; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stehbens SJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3159, DOI 10.2741/3442; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wilson EB., 1896, CELL DEV INHERITANCE; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu CY, 2013, J CELL BIOL, V203, P907, DOI 10.1083/jcb.201306032; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138763	10.1371/journal.pone.0138763	http://dx.doi.org/10.1371/journal.pone.0138763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398908	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500103
J	Zhou, XL; Wang, Y; Zhang, CJ; Wang, M; Zhang, M; Yu, LN; Yan, M				Zhou, Xuelong; Wang, Yin; Zhang, Chenjing; Wang, Min; Zhang, Mei; Yu, Lina; Yan, Min			The Role of Dopaminergic VTA Neurons in General Anesthesia	PLOS ONE			English	Article							ISOFLURANE ANESTHESIA; HISTAMINERGIC NEURONS; VOLATILE ANESTHETICS; PROPOFOL ANESTHESIA; SLEEP; INVOLVEMENT; MICE; DEXMEDETOMIDINE; MODULATION; ACTIVATION	Recent studies have demonstrated that the central dopaminergic system is implicated in the mechanism underlying general anesthesia. Here, we investigated whether dopaminergic ventral tegmental area (VTA) neurons participate in general anesthesia. Dopaminergic VTA neurons were selectively ablated from male Sprague Dawley rats via the bilateral infusion of 6-hydroxydopamine (6-OHDA) into the VTA. Two weeks after infusion, the number of dopaminergic neurons in the bilateral VTA was markedly reduced in the 6-OHDA-treated rats compared with the vehicle-treated rats. These bilateral VTA lesions significantly prolonged the recovery time for propofol but did not significantly alter its onset time or 50% effective dose (ED50) value. In addition, the anesthetic responses to isoflurane and ketamine were unaffected by the VTA lesions. Our findings suggested that dopaminergic VTA neurons might be involved in the emergence from propofol anesthesia.	[Zhou, Xuelong; Yu, Lina; Yan, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310000, Zhejiang, Peoples R China; [Wang, Yin] Tai Zhou Peoples Hosp, Dept Anesthesiol, Taizhou 225300, Peoples R China; [Zhang, Chenjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310000, Zhejiang, Peoples R China; [Wang, Min; Zhang, Mei] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou 221000, Peoples R China	Zhejiang University; Zhejiang University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310000, Zhejiang, Peoples R China.	zryanmin@zju.edu.cn						Barrot M, 2012, J NEUROSCI, V32, P14094, DOI 10.1523/JNEUROSCI.3370-12.2012; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Hu FY, 2012, ANESTHESIOLOGY, V117, P1006, DOI 10.1097/ALN.0b013e3182700ab9; Irifune M, 1999, BRIT J ANAESTH, V83, P665, DOI 10.1093/bja/83.4.665; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kohrs R, 1998, ANESTH ANALG, V87, P1186, DOI 10.1097/00000539-199811000-00039; Laalou FZ, 2008, ANESTHESIOLOGY, V108, P888, DOI 10.1097/ALN.0b013e31816d919b; Leung LS, 2011, EXP NEUROL, V228, P259, DOI 10.1016/j.expneurol.2011.01.019; Luo T, 2011, ANESTHESIOLOGY, V115, P36, DOI 10.1097/ALN.0b013e3182207655; Mashour George A, 2012, Anesthesiol Clin, V30, P385, DOI 10.1016/j.anclin.2012.05.003; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; Moore JT, 2012, CURR BIOL, V22, P2008, DOI 10.1016/j.cub.2012.08.042; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Perogamvros L, 2012, NEUROSCI BIOBEHAV R, V36, P1934, DOI 10.1016/j.neubiorev.2012.05.010; Scharf M. T., 2013, CURR ANESTHESIOL REP, V3, P1; Solt K, 2014, ANESTHESIOLOGY, V121, P311, DOI 10.1097/ALN.0000000000000117; Tai SK, 2014, ANESTHESIOLOGY, V120, P392, DOI 10.1097/ALN.0b013e3182a7cab6; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577; Zecharia AY, 2012, J NEUROSCI, V32, P13062, DOI 10.1523/JNEUROSCI.2931-12.2012; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009; Zhou XL, 2015, NEUROSCIENCE, V284, P546, DOI 10.1016/j.neuroscience.2014.10.025	24	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138187	10.1371/journal.pone.0138187	http://dx.doi.org/10.1371/journal.pone.0138187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398236	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500056
J	de la Cruz-Herrera, CF; Baz-Martinez, M; Lang, V; El Motiam, A; Barbazan, J; Couceiro, R; Abal, M; Vidal, A; Esteban, M; Munoz-Fontela, C; Nieto, A; Rodriguez, MS; Collado, M; Rivas, C				de la Cruz-Herrera, C. F.; Baz-Martinez, M.; Lang, V.; El Motiam, A.; Barbazan, J.; Couceiro, R.; Abal, M.; Vidal, A.; Esteban, M.; Munoz-Fontela, C.; Nieto, A.; Rodriguez, M. S.; Collado, M.; Rivas, C.			Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation	ONCOGENE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; CATALYTIC SUBUNIT; TARGET PROTEINS; PTEN; SUMOYLATION; ACTIVATION; P85-BETA; PROLIFERATION; TUMORIGENESIS	Class IA phosphatidylinositol 3-kinases (PI3Ks) are composed of p110 catalytic and p85 regulatory subunits. How regulatory subunits modulate PI3K activity remains only partially understood. Here we identified SUMO (small ubiquitin-related modifier) as a new player modulating this regulation. We demonstrate that both p85 beta and p85 alpha are conjugated to SUMO1 and SUMO2. We identified two lysine residues located at the inter-SH2 domain on p85 beta, a critical region required for inhibition of p110, as being required for SUMO conjugation. A SUMOylation-defective mutant p85 beta shows higher activation of the PI3K pathway, and increased cell migration and transformation. Moreover, the cancer-related KS459del mutant in p85 alpha was less efficiently SUMOylated compared with the wild-type protein. Finally, our results show that SUMO modulates p85 tyrosine phosphorylation, a modification correlating with PI3K pathway activation. Thus, SUMO reduces the levels of tyrosine-phosphorylated-p85 while loss of SUMOylation results in increased tyrosine phosphorylation of p85. In summary, we identify SUMO as a new important player in the regulation of the PI3K pathway through modulation of p85.	[de la Cruz-Herrera, C. F.; Esteban, M.; Nieto, A.; Rivas, C.] CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Darwin 3, Madrid, Spain; [Baz-Martinez, M.; El Motiam, A.; Vidal, A.; Rivas, C.] Univ Santiago de Compostela, Inst Invest Sanitarias IDIS, Ctr Invest Med Mol & Enfermedades Cron CIMUS, Santiago De Compostela, Spain; [Lang, V.; Rodriguez, M. S.] Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian, Gipuzkoa, Spain; [Barbazan, J.; Couceiro, R.; Abal, M.; Collado, M.] Complexo Hosp Univ Santiago de Compostela CHUS, Inst Invest Sanitaria Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Munoz-Fontela, C.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Nieto, A.] CIBER Enfermedades Resp CIBERES, Mallorca, Illes Balears, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Heinrich Pette Institute; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Rivas, C (corresponding author), Campus Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Mol & Cellular Biol, Darwin 3, Madrid 28049, Spain.	crivas@cnb.csic.es	elmotiam, ahmed/AAB-6287-2019; Baz-Martínez, Maite/L-4626-2017; Rivas, Carmen/L-3162-2017; Vidal, Anxo/B-5010-2015; Barbazán, Jorge/AAM-3263-2020; RODRIGUEZ, Manuel S./D-5439-2018; Collado, Manuel/K-8140-2014; Rivas, Carmen/AAB-6278-2019	elmotiam, ahmed/0000-0003-2855-1368; Baz-Martínez, Maite/0000-0001-9160-7833; Rivas, Carmen/0000-0002-0518-7199; Vidal, Anxo/0000-0002-0866-4202; Barbazán, Jorge/0000-0002-7165-8497; Collado, Manuel/0000-0002-0330-0880; Rivas, Carmen/0000-0002-0518-7199; de la Cruz-Herrera, Carlos/0000-0002-7493-5154; Abal Posada, Miguel/0000-0003-3533-7781; Munoz-Fontela, Cesar/0000-0002-7725-2586; ESTEBAN, MARIANO/0000-0003-0846-2827	La Caixa fellowship; CONACYT; ISCIII [PI14/00554];  [BFU2014-58530]	La Caixa fellowship(La Caixa Foundation); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ISCIII(Instituto de Salud Carlos III); 	We thank Drs Lewis Cantley and Lynda Chin who deposited p85 plasmids at Addgene. Funding at the laboratory of CR is provided by BFU2014-58530. CFC-H is supported by La Caixa fellowship and CONACYT. Work in the laboratory of MC is funded by ISCIII (PI14/00554). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cariaga-Martinez AE, 2014, BIOL OPEN, V3, P924, DOI 10.1242/bio.20148185; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cortes I, 2012, P NATL ACAD SCI USA, V109, P11318, DOI 10.1073/pnas.1118138109; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; de la Cruz-Herrera CF, 2015, ONCOGENE, V34, P1442, DOI 10.1038/onc.2014.48; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Ito Y, 2014, P NATL ACAD SCI USA, V111, P16826, DOI 10.1073/pnas.1420281111; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Martinez-Lorenzo MJ, 2000, INT J BIOCHEM CELL B, V32, P435, DOI 10.1016/S1357-2725(99)00142-9; Philp AJ, 2001, CANCER RES, V61, P7426; Quayle SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049466; Risso G, 2013, CELL CYCLE, V12, P3165, DOI 10.4161/cc.26183; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	29	14	14	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2873	2880		10.1038/onc.2015.356	http://dx.doi.org/10.1038/onc.2015.356			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26411363				2022-12-26	WOS:000377473700007
J	Mehler, M; Eckert, CE; Busche, A; Kulhei, J; Michaelis, J; Becker-Baldus, J; Wachtveitl, J; Dotsch, V; Glaubitz, C				Mehler, Michaela; Eckert, Carl Elias; Busche, Alena; Kulhei, Jennifer; Michaelis, Jonas; Becker-Baldus, Johanna; Wachtveitl, Josef; Doetsch, Volker; Glaubitz, Clemens			Assembling a Correctly Folded and Functional Heptahelical Membrane Protein by Protein Trans-splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; EXPRESSED POLYPEPTIDE FRAGMENTS; PHOTOCHEMICAL-REACTION CYCLE; DNAE INTEIN; GREEN PROTEORHODOPSIN; NOSTOC-PUNCTIFORME; PROTON PUMP; BACTERIORHODOPSIN; SPECTROSCOPY; RHODOPSIN	Protein trans-splicing using split inteins is well established as a useful tool for protein engineering. Here we show, for the first time, that this method can be applied to a membrane protein under native conditions. We provide compelling evidence that the heptahelical proteorhodopsin can be assembled from two separate fragments consisting of helical bundles A and B and C, D, E, F, and G via a splicing site located in the BC loop. The procedure presented here is on the basis of dual expression and ligation in vivo. Global fold, stability, and photodynamics were analyzed in detergent by CD, stationary, as well as time-resolved optical spectroscopy. The fold within lipid bilayers has been probed by high field and dynamic nuclear polarization-enhanced solid-state NMR utilizing a C-13-labeled retinal cofactor and extensively C-13-N-15-labeled protein. Our data show unambiguously that the ligation product is identical to its non-ligated counterpart. Furthermore, our data highlight the effects of BC loop modifications onto the photocycle kinetics of proteorhodopsin. Our data demonstrate that a correctly folded and functionally intact protein can be produced in this artificial way. Our findings are of high relevance for a general understanding of the assembly of membrane proteins for elucidating intramolecular interactions, and they offer the possibility of developing novel labeling schemes for spectroscopic applications.	[Mehler, Michaela; Busche, Alena; Kulhei, Jennifer; Michaelis, Jonas; Becker-Baldus, Johanna; Doetsch, Volker; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Mehler, Michaela; Busche, Alena; Kulhei, Jennifer; Michaelis, Jonas; Becker-Baldus, Johanna; Doetsch, Volker; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Eckert, Carl Elias; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Glaubitz, C (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Wachtveitl, Josef/A-7590-2017; Glaubitz, Clemens/D-5714-2011	Wachtveitl, Josef/0000-0002-8496-8240; Glaubitz, Clemens/0000-0002-3554-6586; Becker-Baldus, Johanna/0000-0003-1995-7323; Dotsch, Volker/0000-0001-5720-212X; Michaelis, Jonas Benjamin/0000-0001-9548-2337	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 807, GL 307/4-1]; State of Hesse	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); State of Hesse	This work was supported by Deutsche Forschungsgemeinschaft (DFG)/Sonderforschungsbereich Grant 807 "Transport and Communication across Membranes." The DNP experiments were supported by an equipment grant provided by DFG Grant GL 307/4-1 and Cluster of Excellence Macromolecular Complexes Frankfurt. The Centre for Biomolecular Magnetic Resonance is funded through the State of Hesse. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Ali H, 2007, BIOCONJUGATE CHEM, V18, P1294, DOI 10.1021/bc070055r; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; Brenzel S, 2009, CHEMBIOCHEM, V10, P983, DOI 10.1002/cbic.200900039; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Cheriyan M, 2013, J BIOL CHEM, V288, P6202, DOI 10.1074/jbc.M112.433094; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Hohwy M, 1998, J CHEM PHYS, V108, P2686, DOI 10.1063/1.475661; HUANG KS, 1981, J BIOL CHEM, V256, P3802; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Lee WK, 2009, BIOCHEM BIOPH RES CO, V390, P815, DOI 10.1016/j.bbrc.2009.10.055; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mao JF, 2014, J AM CHEM SOC, V136, P17578, DOI 10.1021/ja5097946; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Mehler M, 2013, BIOPHYS J, V105, P385, DOI 10.1016/j.bpj.2013.06.014; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Neumann J, 2014, ARCH BIOCHEM BIOPHYS, V564, P281, DOI 10.1016/j.abb.2014.07.017; Nielsen SM, 1998, EUR J BIOCHEM, V251, P217, DOI 10.1046/j.1432-1327.1998.2510217.x; Ozawa T, 2001, CURR OPIN CHEM BIOL, V5, P578, DOI 10.1016/S1367-5931(00)00244-1; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Pfleger N, 2008, J BIOMOL NMR, V40, P15, DOI 10.1007/s10858-007-9203-5; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Schubeis T, 2015, CHEMBIOCHEM, V16, P51, DOI 10.1002/cbic.201402446; Shi LC, 2009, J MOL BIOL, V386, P1078, DOI 10.1016/j.jmb.2009.01.011; Song CS, 2006, J AM CHEM SOC, V128, P11385, DOI 10.1021/ja061284b; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Verhoefen MK, 2011, BBA-BIOENERGETICS, V1807, P1583, DOI 10.1016/j.bbabio.2011.09.001; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; WRUBEL W, 1994, FEBS LETT, V349, P433, DOI 10.1016/0014-5793(94)00719-5; Yang JY, 2009, J AM CHEM SOC, V131, P11644, DOI 10.1021/ja9030215; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	45	9	9	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27712	27722		10.1074/jbc.M115.681205	http://dx.doi.org/10.1074/jbc.M115.681205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405032	Green Published, hybrid			2022-12-26	WOS:000365757500024
J	Ichida, Y; Utsunomiya, Y; Yasuda, T; Nakabayashi, K; Sato, T; Onodera, M				Ichida, Yu; Utsunomiya, Yuko; Yasuda, Toru; Nakabayashi, Kazuhiko; Sato, Toshinori; Onodera, Masafumi			Functional Domains of ZFP809 Essential for Nuclear Localization and Gene Silencing	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; EMBRYONIC STEM-CELLS; KRAB DOMAIN; RESTRICTION; SYSTEM; VIRUS; KAP1	Zinc finger protein 809 (ZFP809) is a member of the Kruppel-associated box-containing zinc finger protein (KRAB-ZFP) family, and is highly expressed in mouse immature cells. ZFP809 is known to inhibit the expression of transduced genes driven by Moloney murine leukemia virus (MoMLV)-typed retroviral vectors by binding to the primer binding site (PBS) located downstream of the MLV-long terminal repeat (LTR) of the vectors and recruiting protein complexes that introduce epigenetic silencing marks such as histone modifications and DNA methylation at the MLV-LTR. However, it remains undetermined what domains of ZFP809 among the KRAB domain at N-terminus and the seven zinc fingers are critical for gene silencing. In this study, we assessed subcellular localization, gene silencing ability, and binding ability to the PBS of a series of truncated and mutated ZFP809 proteins. We revealed the essential role of the KRAB A box for all functions assessed, together with the accessory roles of a subset of zinc fingers. Our data also suggest that interaction between KAP1 and the KRAB A box of ZFP809 is critical in KAP1-dependent control of gene silencing for ZFP809 targets.	[Ichida, Yu; Utsunomiya, Yuko; Yasuda, Toru; Onodera, Masafumi] Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, Tokyo 1578535, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo 1578535, Japan; [Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 2238522, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Keio University	Ichida, Y (corresponding author), Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ichida-y@ncchd.go.jp		Sato, Toshinori/0000-0002-4429-6101	Grants-in-Aid for Scientific Research [23241075] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Corsinotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056721; de Sio FRS, 2014, NUCLEUS-PHILA, V5, P138, DOI 10.4161/nucl.28738; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; FRANZ T, 1986, P NATL ACAD SCI USA, V83, P3292, DOI 10.1073/pnas.83.10.3292; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hirasawa R, 2008, DEV CELL, V15, P487, DOI 10.1016/j.devcel.2008.09.006; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Onodera M, 1998, J VIROL, V72, P1769, DOI 10.1128/JVI.72.3.1769-1774.1998; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Suzuki A, 2002, J NEUROCHEM, V82, P953, DOI 10.1046/j.1471-4159.2002.01048.x; Tan XY, 2013, STEM CELL RES, V11, P1045, DOI 10.1016/j.scr.2013.07.006; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang GZ, 2014, J VIROL, V88, P1825, DOI 10.1128/JVI.02578-13; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092155; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139274	10.1371/journal.pone.0139274	http://dx.doi.org/10.1371/journal.pone.0139274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417948	Green Submitted, Green Published, gold			2022-12-26	WOS:000362171400069
J	Nguyen, HT; Jia, W; Beedle, AM; Kennedy, EJ; Murph, MM				Nguyen, Ha T.; Jia, Wei; Beedle, Aaron M.; Kennedy, Eileen J.; Murph, Mandi M.			Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOP; OVARIAN-CANCER CELLS; TUMOR-GROWTH; AUTOTAXIN; LYSOPHOSPHOLIPIDS; IDENTIFICATION; METASTASIS; CARCINOMA; INVASION	Although microRNAs (miRNAs) are small, non-protein-coding entities, they have important roles in post-transcriptional regulation of most of the human genome. These small entities generate fine-tuning adjustments in the expression of mRNA, which can mildly or massively affect the abundance of proteins. Previously, we found that the expression of miR-30c-2-3p is induced by lysophosphatidic acid and has an important role in the regulation of cell proliferation in ovarian cancer cells. The goal here is to confirm that ATF3 mRNA is a target of miR-30c-2-3p silencing, thereby further establishing the functional role of miR-30c-2-3p. Using a combination of bioinformatics, qRT-PCR, immunoblotting and luciferase assays, we uncovered a regulatory pathway between miR-30c-2-3p and the expression of the transcription factor, ATF3. Lysophosphatidic acids triggers the expression of both miR-30c-23p and ATF3, which peak at 1 h and are absent 8 h post stimulation in SKOV-3 and OVCAR-3 serous ovarian cancer cells. The 3'-untranslated region (3'-UTR) of ATF3 was a predicted, putative target for miR-30c-2-3p, which we confirmed as a bona-fide interaction using a luciferase reporter assay. Specific mutations introduced into the predicted site of interaction between miR-30c-2-3p and the 3'-UTR of ATF3 alleviated the suppression of the luciferase signal. Furthermore, the presence of anti-miR-30c-2-3p enhanced ATF3 mRNA and protein after lysophosphatidic acid stimulation. Thus, the data suggest that after the expression of ATF3 and miR-30c-2-3p are elicited by lysophosphatidic acid, subsequently miR-30c-2-3p negatively regulates the expression of ATF3 through post-transcriptional silencing, which prevents further ATF3-related outcomes as a consequence of lysophosphatidic acid signaling.	[Nguyen, Ha T.; Jia, Wei; Beedle, Aaron M.; Kennedy, Eileen J.; Murph, Mandi M.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Murph, MM (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, 240 W Green St, Athens, GA 30602 USA.	mmurph@uga.edu	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Kennedy, Eileen/0000-0001-5610-1677	National Institutes of Health [1R15CA176653-01A1]; American Cancer Society [120634-RSG-11-269-01-CDD]; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [R15CA176653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the National Institutes of Health (1R15CA176653-01A1), a Research Scholar Grant 120634-RSG-11-269-01-CDD from the American Cancer Society and the Georgia Research Alliance.	[Anonymous], 2011, ATF3; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Byrd AE, 2012, J CELL BIOL, V196, P689, DOI 10.1083/jcb.201201077; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jia W, 2011, MOL CANCER RES, V9, P1732, DOI 10.1158/1541-7786.MCR-11-0245; Lan YF, 2012, J AM SOC NEPHROL, V23, P2012, DOI 10.1681/ASN.2012050438; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; Mathew LK, 2014, CANCER DISCOV, V4, P53, DOI 10.1158/2159-8290.CD-13-0291; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Murph MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005583; Nguyen HT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00071; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Shukla K, 2015, MOL ONCOL, V9, P1106, DOI 10.1016/j.molonc.2015.01.008; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang J, 2015, HEPATOLOGY, V61, P561, DOI 10.1002/hep.27491	35	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139489	10.1371/journal.pone.0139489	http://dx.doi.org/10.1371/journal.pone.0139489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418018	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400093
J	Kesimer, M; Cullen, J; Cao, R; Radicioni, G; Mathews, KG; Seiler, G; Gookin, JL				Kesimer, Mehmet; Cullen, John; Cao, Rui; Radicioni, Giorgia; Mathews, Kyle G.; Seiler, Gabriela; Gookin, Jody L.			Excess Secretion of Gel-Forming Mucins and Associated Innate Defense Proteins with Defective Mucin Un-Packaging Underpin Gallbladder Mucocele Formation in Dogs	PLOS ONE			English	Article							GALL-BLADDER MUCOCELES; RESPIRATORY MUCIN; OLIGOMERIC MUCINS; EPITHELIAL-CELLS; GENE-EXPRESSION; CYSTIC-FIBROSIS; TREFOIL FACTORS; MUCUS; DISEASE; GLYCOPROTEIN	Mucosal protection of the gallbladder is vital yet we know very little about the mechanisms involved. In domestic dogs, an emergent syndrome referred to as gallbladder mucocele formation is characterized by excessive secretion of abnormal mucus that results in obstruction and rupture of the gallbladder. The cause of gallbladder mucocele formation is unknown. In these first mechanistic studies of this disease, we investigated normal and mucocele-forming dog gallbladders to determine the source, identity, biophysical properties, and protein associates of the culprit mucins with aim to identify causes for abnormal mucus behavior. We established that mucocele formation involves an adoptive excess secretion of gel forming mucins with abnormal properties by the gallbladder epithelium. The mucus is characterized by a disproportionally significant increase in Muc5ac relative to Muc5b, defective mucin un-packaging, and mucin-interacting innate defense proteins that are capable of dramatically altering the physical and functional properties of mucus. These findings provide an explanation for abnormal mucus behavior and based on similarity to mucus observed in the airways of people with cystic fibrosis, suggest that abnormal mechanisms for maintenance of gallbladder epithelial hydration may be an instigating factor for mucocele formation in dogs.	[Kesimer, Mehmet; Cao, Rui; Radicioni, Giorgia] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Kesimer, Mehmet; Cao, Rui; Radicioni, Giorgia] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Cullen, John] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Mathews, Kyle G.; Gookin, Jody L.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Coll Vet, Dept Clin Sci, Raleigh, NC 27695 USA; [Seiler, Gabriela] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Gookin, JL (corresponding author), N Carolina State Univ, Ctr Comparat Med & Translat Res, Coll Vet, Dept Clin Sci, Raleigh, NC 27695 USA.	Jody_Gookin@ncsu.edu	, Mehmet Kesimer/AHB-9223-2022; Cullen, John M/I-2051-2019	Gookin, Jody/0000-0002-2911-0874	Morris Animal Foundation [D12CA-044]; National Institutes of Health National Heart Lung and Blood Institute [HL103940]; Cystic Fibrosis Foundation [KESIME14XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103940] Funding Source: NIH RePORTER	Morris Animal Foundation; National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were funded by grant D12CA-044 from the Morris Animal Foundation (JLG), and partially supported by grant HL103940 (MK) from the National Institutes of Health National Heart Lung and Blood Institute and grant KESIME14XX0 (MK) from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AL, 2007, JAVMA-J AM VET MED A, V231, P79, DOI 10.2460/javma.231.1.79; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Barbhuiya MA, 2011, PROTEOMICS, V11, P4443, DOI 10.1002/pmic.201100197; BERNHOFT RA, 1983, GASTROENTEROLOGY, V85, P1166; Buisine MP, 2000, J HISTOCHEM CYTOCHEM, V48, P1667, DOI 10.1177/002215540004801210; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Cooper JL, 2013, AM J PHYSIOL-LUNG C, V304, pL184, DOI 10.1152/ajplung.00143.2012; Crews LJ, 2009, JAVMA-J AM VET MED A, V234, P359, DOI 10.2460/javma.234.3.359; CROWTHER RS, 1984, BIORHEOLOGY, V21, P253; Cullen JM, 2014, J VET DIAGN INVEST, V26, P434, DOI 10.1177/1040638714532099; Farid SG, 2011, PROTEOMICS, V11, P2134, DOI 10.1002/pmic.201000653; Farina A, 2011, J PROTEOME RES, V10, P2047, DOI 10.1021/pr200011b; Finzi L, 2006, AM J PATHOL, V169, P2031, DOI 10.2353/ajpath.2006.060146; GEIL RG, 1977, J TOXICOL ENV HEALTH, V3, P179, DOI 10.1080/15287397709529557; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Ho SB, 2000, DIGEST DIS SCI, V45, P1061, DOI 10.1023/A:1005573213100; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Jackowiak H., 2006, Folia Morphologica, V65, P105; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kjellev S, 2006, BRIT J PHARMACOL, V149, P92, DOI 10.1038/sj.bjp.0706840; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; KOVATCH RM, 1965, PATHOL VET, V2, P574, DOI 10.1177/030098586500200605; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; Kuver R, 2006, AM J PHYSIOL-GASTR L, V291, pG1148, DOI 10.1152/ajpgi.00547.2005; Malek S, 2013, VET SURG, V42, P418, DOI 10.1111/j.1532-950X.2012.01072.x; MAUDESLE.LE, 1967, VET REC, V80, P658, DOI 10.1136/vr.80.22.658; Mesich MLL, 2009, J SMALL ANIM PRACT, V50, P630, DOI 10.1111/j.1748-5827.2009.00811.x; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Mollenhauer J, 2000, CANCER RES, V60, P1704; NUNES DP, 1995, BIOCHEM J, V310, P41, DOI 10.1042/bj3100041; Palaniyar N, 2003, ANN NY ACAD SCI, V1010, P471, DOI 10.1196/annals.1299.085; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pike FS, 2004, JAVMA-J AM VET MED A, V224, P1615, DOI 10.2460/javma.2004.224.1615; Ridley C, 2014, J BIOL CHEM, V289, P16409, DOI 10.1074/jbc.M114.566679; RUNDEGREN J, 1987, INFECT IMMUN, V55, P288, DOI 10.1128/IAI.55.2.288-292.1987; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; SCOTT AJ, 1978, GUT, V19, P558, DOI 10.1136/gut.19.6.558; SELMAN PJ, 1995, VET QUART, V17, P128, DOI 10.1080/01652176.1995.9694551; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Sun XS, 2014, AM J PATHOL, V184, P1309, DOI 10.1016/j.ajpath.2014.01.035; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Thornton DJ, 2001, GLYCOBIOLOGY, V11, P969, DOI 10.1093/glycob/11.11.969; Tsukagoshi T, 2012, VET RADIOL ULTRASOUN, V53, P84, DOI 10.1111/j.1740-8261.2011.01868.x; Vandenhaute B, 1997, J HEPATOL, V27, P1057, DOI 10.1016/S0168-8278(97)80150-X; Wiede A, 1999, AM J RESP CRIT CARE, V159, P1330, DOI 10.1164/ajrccm.159.4.9804149; Worley DR, 2004, JAVMA-J AM VET MED A, V225, P1418, DOI 10.2460/javma.2004.225.1418; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020334; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	52	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138988	10.1371/journal.pone.0138988	http://dx.doi.org/10.1371/journal.pone.0138988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414376	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700031
J	Pourzanjani, A; Herzog, ED; Petzold, LR				Pourzanjani, Arya; Herzog, Erik D.; Petzold, Linda R.			On the Inference of Functional Circadian Networks Using Granger Causality	PLOS ONE			English	Article							BRAIN NETWORKS; SYNCHRONIZATION; OSCILLATIONS; SIGNAL; MODEL	Being able to infer one way direct connections in an oscillatory network such as the supra-chiastmatic nucleus (SCN) of the mammalian brain using time series data is difficult but crucial to understanding network dynamics. Although techniques have been developed for inferring networks from time series data, there have been no attempts to adapt these techniques to infer directional connections in oscillatory time series, while accurately distinguishing between direct and indirect connections. In this paper an adaptation of Granger Causality is proposed that allows for inference of circadian networks and oscillatory networks in general called Adaptive Frequency Granger Causality (AFGC). Additionally, an extension of this method is proposed to infer networks with large numbers of cells called LASSO AFGC. The method was validated using simulated data from several different networks. For the smaller networks the method was able to identify all one way direct connections without identifying connections that were not present. For larger networks of up to twenty cells the method shows excellent performance in identifying true and false connections; this is quantified by an area-under-the-curve (AUC) 96.88%. We note that this method like other Granger Causality-based methods, is based on the detection of high frequency signals propagating between cell traces. Thus it requires a relatively high sampling rate and a network that can propagate high frequency signals.	[Pourzanjani, Arya; Petzold, Linda R.] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Herzog, Erik D.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Santa Barbara; Washington University (WUSTL)	Pourzanjani, A (corresponding author), Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA.	arya@umail.ucsb.edu			Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]; National Institute of Health [1R01GM096873-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096873] Funding Source: NIH RePORTER	Institute for Collaborative Biotechnologies from the U.S. Army Research Office; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office: AAP, LRP and National Institute of Health Award number 1R01GM096873-01: AAP, LRP, EDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brockwell P. J., 2002, INTRO TIME SERIES FO, V1; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Freeman GM, 2013, NEURON, V78, P799, DOI 10.1016/j.neuron.2013.04.003; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Hartemink A J, 2001, Pac Symp Biocomput, P422; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Levnajic Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.034101; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Meeker K, 2011, J BIOL RHYTHM, V26, P353, DOI 10.1177/0748730411409863; Nedungadi AG, 2009, J COMPUT NEUROSCI, V27, P55, DOI 10.1007/s10827-008-0126-2; Prignano L, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036112; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Vasalou C, 2009, J BIOL RHYTHM, V24, P243, DOI 10.1177/0748730409333220; Weaver D C, 1999, Pac Symp Biocomput, P112; Wilmer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044633; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yu DC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188701	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137540	10.1371/journal.pone.0137540	http://dx.doi.org/10.1371/journal.pone.0137540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413748	Green Published, gold			2022-12-26	WOS:000362170700009
J	Caillet, P; Payet, C; Polazzi, S; Carty, MJ; Lifante, JC; Duclos, A				Caillet, Pascal; Payet, Cecile; Polazzi, Stephanie; Carty, Matthew J.; Lifante, Jean-Christophe; Duclos, Antoine			Increased Mortality for Elective Surgery during Summer Vacation: A Longitudinal Analysis of Nationwide Data	PLOS ONE			English	Article							SURGICAL MORTALITY; PERFORMANCE; VOLUME	Surgical safety during vacation periods may be influenced by the interplay of several factors, including workers' leave, hospital activity, climate, and the variety of patient cases. This study aimed to highlight an annually recurring peak of surgical mortality during summer in France and explore its main predictors. We selected all elective of open surgical procedures performed in French hospitals between 2007 and 2012. Surgical mortality variation was analyzed over time in relation to workers leaving on vacation, the volume of procedures performed by hospitals, and temperature changes. We ran a multilevel logistic regression for exploring the determinants of surgical mortality, taking into account the clustering of patients within hospitals and adjusting for patient and hospital characteristics. A total of 609 French hospitals had 8,926,120 discharges related to open elective surgery. During 6 years, we found a recurring mortality peak of 1.15%(95% CI 1.09-1.20) in August compared with 0.81% (0.79-0.82, p<.001) in other months. The incidence of worker vacation was 43.0% (38.9-47.2) in August compared with 7.3% (4.6-10.1, p<.001) in other months. Hospital activity decreased substantially in August (78,126 inpatient stays, 75,298-80,954) in relation to other months (128,142, 125,697-130,586, p<.001). After adjusting for all covariates, we found an "August effect" reflecting a higher risk to patients undergoing operations at this time (OR 1.16, 95% CI 1.12-1.19, p<.001). The main study limitation was the absence of data linkage between surgical staffing and mortality at the hospital level. The observed, recurring mortality peak in August raises questions about how to maintain hospital activity and optimal staffing through better regulation of human activities.	[Caillet, Pascal; Payet, Cecile; Polazzi, Stephanie; Duclos, Antoine] Hosp Civils Lyon, Pole Informat Med Evaluat Rech, F-69003 Lyon, France; [Caillet, Pascal] INSERM, Res Unit 1033, F-69003 Lyon, France; [Caillet, Pascal; Payet, Cecile; Polazzi, Stephanie; Lifante, Jean-Christophe; Duclos, Antoine] Univ Lyon 1, Hlth Serv & Performance Res Lab, F-69003 Lyon, France; [Lifante, Jean-Christophe] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Chirurg Gen & Endocrinienne, F-69300 Pierre Benite, France; [Carty, Matthew J.; Duclos, Antoine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Caillet, P (corresponding author), Hosp Civils Lyon, Pole Informat Med Evaluat Rech, F-69003 Lyon, France.	p.caillet@yahoo.fr	Caillet, Pascal/K-5299-2019; Duclos, Antoine/N-3756-2016; Lifante, Jean-Christophe/AAX-2606-2020	Caillet, Pascal/0000-0001-5667-7887; Duclos, Antoine/0000-0002-8915-4203; Polazzi, Stephanie/0000-0003-4622-7983	Hospices Civils de Lyon teaching hospital	Hospices Civils de Lyon teaching hospital	PC, CP, JCL, SP and AD received financial support from Hospices Civils de Lyon teaching hospital for independently conducting the submitted work. MJC received no specific funding for this work.	Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Biausque V, 2012, 2010 EMPLOYEES TOOK; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Couris CM, 2009, J CLIN EPIDEMIOL, V62, P660, DOI 10.1016/j.jclinepi.2008.07.013; Duclos A, 2009, BRIT J SURG, V96, P171, DOI 10.1002/bjs.6418; Duclos A, 2013, MED CARE, V51, P1085, DOI 10.1097/MLR.0b013e3182a97c54; Duclos A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8041; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; French Ministry of Health, 2006, WHIT PLAN CRIS MAN G; Haller G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3974; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; National Institute of Statistics and Economic Studies (INSEE), NAT CENS RES POP FRA; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ray R, 2013, NOVACATION NATION RE; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Technical Agency for Hospital Information (ATIH), FRENCH HOSP EP STAT; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Xu R, 2013, ANN SURG, V258, P953, DOI 10.1097/SLA.0b013e3182864ffe; Zare MM, 2007, ANN SURG, V246, P866, DOI 10.1097/SLA.0b013e3180cc2e60	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137754	10.1371/journal.pone.0137754	http://dx.doi.org/10.1371/journal.pone.0137754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407191	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700025
J	Flamar, AL; Contreras, V; Zurawski, S; Montes, M; Dereuddre-Bosquet, N; Martinon, F; Banchereau, J; Le Grand, R; Zurawski, G; Levy, Y				Flamar, Anne-Laure; Contreras, Vanessa; Zurawski, Sandra; Montes, Monica; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Banchereau, Jacques; Le Grand, Roger; Zurawski, Gerard; Levy, Yves			Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; ANTIGEN PRESENTATION; LANGERHANS CELLS; DEC-205 RECEPTOR; EX-VIVO; CD8(+); PROTEIN; CD4(+); PROGRESSION	Targeting dendritic cell-specific endocytic receptors using monoclonal antibodies fused to desired antigens is an approach widely used in vaccine development to enhance the poor immunogenicity of protein-based vaccines and to induce immune responses. Here, we engineered an anti-human DCIR recombinant antibody, which cross-reacts with the homologous cynomoigous macaque receptor and was fused via the heavy chain C-terminus to HIV Gagp24 protein (alpha DCIR.Gagp24). In vitro, alpha DCIR.Gagp24 expanded multifunctional antigen-specific memory CD4(+) T cells recognizing multiple Gagp24 peptides from HIV-infected patient peripheral blood mononuclear cells. In non human primates, priming with alpha DCIR.Gagp24 without adjuvant elicited a strong anti-Gagp24 antibody response after the second immunization, while in the non-targeted HIV Gagp24 protein control groups the titers were weak. The presence of the double-stranded RNA poly(I:C) adjuvant significantly enhanced the anti-Gagp24 antibody response in all the groups and reduced the discrimination between the different vaccine groups. The avidity of the anti-Gagp24 antibody responses was similar with either alpha DCIR.Gagp24 or Gagp24 immunization, but increased from medium to high avidity in both groups when poly(I: C) was co-administered. This data provides a comparative analysis of DC-targeted and non-targeted proteins for their capacity to induce antigen-specific antibody responses in vivo. This study supports the further development of DCIR-based DC-targeting vaccines for protective durable antibody induction, especially in the absence of adjuvant.	[Flamar, Anne-Laure; Zurawski, Sandra; Montes, Monica; Zurawski, Gerard] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Flamar, Anne-Laure; Contreras, Vanessa; Zurawski, Sandra; Montes, Monica; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Banchereau, Jacques; Le Grand, Roger; Zurawski, Gerard; Levy, Yves] Vaccine Res Inst, Creteil, France; [Flamar, Anne-Laure; Zurawski, Sandra; Montes, Monica; Banchereau, Jacques; Zurawski, Gerard; Levy, Yves] INSERM, UMR 955, Creteil, France; [Contreras, Vanessa; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Le Grand, Roger] Inst Emerging Dis & Innovat Therapies, CEA, Div Immuno Virol, IDMIT Ctr, Fontenay Aux Roses, France; [Contreras, Vanessa; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Le Grand, Roger] INSERM, UMR 1184, Fontenay Aux Roses, France; [Contreras, Vanessa; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Le Grand, Roger] Univ Paris Sud 11, Orsay, France; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Banchereau, Jacques; Levy, Yves] Serv dimmunol Clin, Assistance Publ Hop Paris, Groupe Henri Mondor Albert Chenevier, Creteil, France; [Banchereau, Jacques; Levy, Yves] Univ Paris Est, Fac Med, Creteil, France	Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Jackson Laboratory; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Zurawski, G (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	gerardz@baylorhealth.edu; yves.levy@hmn.aphp.fr	Martinon, Frédéric/Y-3684-2018	Martinon, Frédéric/0000-0001-9634-442X; Contreras, Vanessa/0000-0003-4072-9819	Agence Nationale de Recherche pour le Sida et hepatites virales through Vaccine Research Institute programme [CRA 2007-291]; National Institutes of Health [U-19 AI-57234]; Baylor Healthcare System through Baylor Research Institute; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Agence Nationale de Recherche pour le Sida et hepatites virales through Vaccine Research Institute programme(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Healthcare System through Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by the Agence Nationale de Recherche pour le Sida et hepatites virales through the Vaccine Research Institute programme via a Collaborative Research Agreement (CRA 2007-291)-ALF, VC, SZ, NDB, FM, RL, JB, YL, GZ (www.anrs.fr). The parental anti-DCIR mAb was developed with support from grants from the National Institutes of Health (U-19 AI-57234) and the generosity of the Baylor Healthcare System through the auspices of the Baylor Research Institute -ALF, SZ, JB, GZ (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2013, J IMMUNOL METHODS, V387, P36, DOI 10.1016/j.jim.2012.09.008; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Flamar AL, 2013, AIDS, V27, P2041, DOI 10.1097/QAD.0b013e3283624305; Flamar AL, 2012, J IMMUNOL, V189, P2645, DOI 10.4049/jimmunol.1102390; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Franz B, 2011, BLOOD, V118, P348, DOI 10.1182/blood-2011-03-341917; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; HOGERVORST E, 1995, J INFECT DIS, V171, P811, DOI 10.1093/infdis/171.4.811; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Kneitz RH, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-33; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Park HY, 2013, J IMMUNOL, V191, P4919, DOI 10.4049/jimmunol.1301947; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Romain G, 2012, EUR J IMMUNOL, V42, P2019, DOI 10.1002/eji.201242478; STRATHDEE SA, 1995, J INFECT DIS, V172, P1375, DOI 10.1093/infdis/172.5.1375; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135513	10.1371/journal.pone.0135513	http://dx.doi.org/10.1371/journal.pone.0135513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407317	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700006
J	Friend, K; Brooks, HA; Propson, NE; Thomson, JA; Kimble, J				Friend, Kyle; Brooks, Hunter A.; Propson, Nicholas E.; Thomson, James A.; Kimble, Judith			Embryonic Stem Cell Growth Factors Regulate eIF2 alpha Phosphorylation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DOUBLE-STRANDED-RNA; SELF-RENEWAL; MESSENGER-RNA; TRANSCRIPTION FACTOR; INITIATION FACTOR-2-ALPHA; DEPENDENT STIMULATION; TRANSLATIONAL CONTROL; MOUSE; GCN4	Growth factors and transcription factors are well known to regulate pluripotent stem cells, but less is known about translational control in stem cells. Here, we use embryonic stem cells (ESCs) to investigate a connection between ESC growth factors and eIF2 alpha-mediated translational control (eIF2 alpha phosphorylation promotes protein expression from mRNAs with upstream open-reading frames, or uORFs). We find abundant phosphorylated P-eIF2 alpha (P-eIF2 alpha) in both pluripotent mouse and human ESCs, but little P-eIF2 alpha in ESCs triggered to differentiate. We show that the growth factors LIF (leukemia inhibitory factor) and BMP4 (bone morphogenic protein 4) both maintain P-eIF2 alpha in mESCs, but use distinct mechanisms: LIF inhibits an eIF2 alpha phosphatase whereas BMP4 activates an eIF2 alpha kinase. The mRNAs encoding the pluripotency factors Nanog and c-Myc possess uORFs while Oct4 mRNA does not. We find that salubrinal, a chemical that increases eIF2 alpha phosphorylation, promotes Nanog and c-Myc expression, but not Oct4 expression. These experiments connect ESC growth factors to eIF2 alpha phosphorylation and suggest a chemical substitute for LIF to enhance Nanog and c-Myc expression.	[Friend, Kyle; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Friend, Kyle; Brooks, Hunter A.] Washington & Lee Univ, Dept Chem & Biochem, Lexington, VA 24450 USA; [Propson, Nicholas E.; Thomson, James A.] Morgridge Inst Res, 309 North Orchard St, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Washington & Lee University; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Friend, K (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	friendk@wlu.edu; jekimble@wisc.edu			American Cancer Society [PF-10-127-01-DDC]; National Institutes of Health [1U01 HL099773-01, GM069454]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.F. was supported by PF-10-127-01-DDC from the American Cancer Society. J.T. was supported by National Institutes of Health grant 1U01 HL099773-01. J.K. was supported by National Institutes of Health grant GM069454. J.K. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dumoulin JCM, 1999, HUM REPROD, V14, P465, DOI 10.1093/humrep/14.2.465; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Goplen N, 2008, J IMMUNOL, V180, P4256, DOI 10.4049/jimmunol.180.6.4256; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HOWARD GA, 1970, BIOCHIM BIOPHYS ACTA, V213, P237, DOI 10.1016/0005-2787(70)90028-6; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; LEBLEU B, 1976, P NATL ACAD SCI USA, V73, P3107, DOI 10.1073/pnas.73.9.3107; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Malabanan KP, 2008, CIRC RES, V103, P378, DOI 10.1161/CIRCRESAHA.107.168682; MANZELLA JM, 1991, J BIOL CHEM, V266, P2383; MASTROIANNI L, 1965, J REPROD FERTIL, V9, P99; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Savatier P, 1996, ONCOGENE, V12, P309; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; So JS, 2015, MOL CELL BIOL, V35, P2761, DOI 10.1128/MCB.00215-15; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Steinert S, 2009, CELL COMMUN SIGNA S1, V7, pA37, DOI [10.1186/1478-811X-7-S1-A37, DOI 10.1186/1478-811X-7-S1-A37]; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Warmflash A, 2012, WIRES SYST BIOL MED, V4, P443, DOI 10.1002/wsbm.1182; Watanabe A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0292; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	60	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139076	10.1371/journal.pone.0139076	http://dx.doi.org/10.1371/journal.pone.0139076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406898	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700162
J	Jung, WM; Lim, J; Lee, IS; Park, HJ; Wallraven, C; Chae, Y				Jung, Won-Mo; Lim, Jinwoong; Lee, In-Seon; Park, Hi-Joon; Wallraven, Christian; Chae, Younbyoung			Sensorimotor Learning of Acupuncture Needle Manipulation Using Visual Feedback	PLOS ONE			English	Article							ERROR	Objective Humans can acquire a wide variety of motor skills using sensory feedback pertaining to discrepancies between intended and actual movements. Acupuncture needle manipulation involves sophisticated hand movements and represents a fundamental skill for acupuncturists. We investigated whether untrained students could improve their motor performance during acupuncture needle manipulation using visual feedback (VF). Methods Twenty-one untrained medical students were included, randomly divided into concurrent (n = 10) and post-trial (n = 11) VF groups. Both groups were trained in simple lift/thrusting techniques during session 1, and in complicated lift/thrusting techniques in session 2 (eight training trials per session). We compared the motion patterns and error magnitudes of pre- and post-training tests. Results During motion pattern analysis, both the concurrent and post-trial VF groups exhibited greater improvements in motion patterns during the complicated lifting/thrusting session. In the magnitude error analysis, both groups also exhibited reduced error magnitudes during the simple lifting/thrusting session. For the training period, the concurrent VF group exhibited reduced error magnitudes across all training trials, whereas the post-trial VF group was characterized by greater error magnitudes during initial trials, which gradually reduced during later trials. Conclusions Our findings suggest that novices can improve the sophisticated hand movements required for acupuncture needle manipulation using sensorimotor learning with VF. Use of two types of VF can be beneficial for untrained students in terms of learning how to manipulate acupuncture needles, using either automatic or cognitive processes.	[Jung, Won-Mo; Lim, Jinwoong; Lee, In-Seon; Park, Hi-Joon; Chae, Younbyoung] Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea; [Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Kyung Hee University; Korea University	Chae, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea.	ybchae@khu.ac.kr	Chae, Younbyoung/AAM-1243-2020; Park, Hi-Joon/AAG-1196-2021; Lee, In-Seon/AAM-1252-2020; Park, Hyun Jin/I-4942-2015	Lee, In-Seon/0000-0001-9275-3111; Chae, Younbyoung/0000-0001-6787-2215; Park, Hi-Joon/0000-0002-0538-2664; Wallraven, Christian/0000-0002-2604-9115; Lim, Jinwoong/0000-0003-2080-9432	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0009913]; Korea Institute of Oriental Medicine [K15070]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Institute of Oriental Medicine	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2011-0009913), and the Korea Institute of Oriental Medicine (no. K15070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Davis RT, 2012, ACUPUNCT MED, V30, P113, DOI 10.1136/acupmed-2011-010111; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051417; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; 임진웅, 2014, Journal of Acupuncture Research, V31, P11; Lee IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117992; Lee IS, 2014, J ALTERN COMPLEM MED, V20, P654, DOI 10.1089/acm.2013.0475; Li Jing, 2013, Zhen Ci Yan Jiu, V38, P415; Li J, 2013, ACUPUNCT MED, V31, P172, DOI 10.1136/acupmed-2012-010265; Liu Tang-yi, 2010, Zhen Ci Yan Jiu, V35, P61; Liu Tang-yi, 2009, Zhongguo Zhen Jiu, V29, P927; Liu Tang-Yi, 2008, Zhen Ci Yan Jiu, V33, P330; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Seo Y, 2014, ACUPUNCT MED, V32, P394, DOI 10.1136/acupmed-2014-010585; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112	17	5	6	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139340	10.1371/journal.pone.0139340	http://dx.doi.org/10.1371/journal.pone.0139340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406248	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700208
J	Kulp, AJ; Sun, B; Ai, T; Manning, AJ; Orench-Rivera, N; Schmid, AK; Kuehn, MJ				Kulp, Adam J.; Sun, Bo; Ai, Teresa; Manning, Andrew J.; Orench-Rivera, Nichole; Schmid, Amy K.; Kuehn, Meta J.			Genome-Wide Assessment of Outer Membrane Vesicle Production in Escherichia coli	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; PSEUDOMONAS-AERUGINOSA PAO1; ENVELOPE STRESS; VIRULENCE GENES; LIPOPOLYSACCHARIDE; RELEASE; BIOGENESIS; PROTEINS; TOXIN; DNA	The production of outer membrane vesicles by Gram-negative bacteria has been well documented; however, the mechanism behind the biogenesis of these vesicles remains unclear. Here a high-throughput experimental method and systems-scale analysis was conducted to determine vesiculation values for the whole genome knockout library of Escherichia coli mutant strains (Keio collection). The resultant dataset quantitatively recapitulates previously observed phenotypes and implicates nearly 150 new genes in the process of vesiculation. Gene functional and biochemical pathway analyses suggest that mutations that truncate outer membrane structures such as lipopolysaccharide and enterobacterial common antigen lead to hypervesiculation, whereas mutants in oxidative stress response pathways result in lower levels. This study expands and refines the current knowledge regarding the cellular pathways required for outer membrane vesiculation in E. coli.	[Kulp, Adam J.; Kuehn, Meta J.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Sun, Bo; Ai, Teresa; Schmid, Amy K.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Manning, Andrew J.; Orench-Rivera, Nichole; Kuehn, Meta J.] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA; [Schmid, Amy K.] Duke Univ, Duke Ctr Syst Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Schmid, AK (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	amy.schmid@duke.edu	Kuehn, Meta/AAL-2950-2021	Kuehn, Meta/0000-0003-0519-3019; Sun, Bo/0000-0003-2473-6066	Duke Center for Systems Biology; Duke University Undergraduate Research Support; Duke University Trinity Research Forum; Duke School of Medicine; National Institutes of Health [R01AI079068, R01GM099471]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099471] Funding Source: NIH RePORTER	Duke Center for Systems Biology; Duke University Undergraduate Research Support; Duke University Trinity Research Forum; Duke School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a seed grant from the Duke Center for Systems Biology (http://www.genome.duke.edu/centers/systems-biology/) to AKS and MJK, Duke University Undergraduate Research Support (TA and BS), Duke University Trinity Research Forum (BS), Duke School of Medicine (MJK), and National Institutes of Health grants R01AI079068 (MJK) and R01GM099471 (MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barr K, 1999, J BACTERIOL, V181, P6564, DOI 10.1128/JB.181.20.6564-6568.1999; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Button JE, 2007, J BACTERIOL, V189, P1523, DOI 10.1128/JB.01534-06; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chutkan H, 2011, INFECT IMMUN, V79, P3760, DOI 10.1128/IAI.05336-11; Danese PN, 1998, J BACTERIOL, V180, P5875, DOI 10.1128/JB.180.22.5875-5884.1998; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gorby Y, 2008, GEOBIOLOGY, V6, P232, DOI 10.1111/j.1472-4669.2008.00158.x; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Hu JC, 2014, NUCLEIC ACIDS RES, V42, pD677, DOI 10.1093/nar/gkt1203; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karavolos MH, 2011, EMBO REP, V12, P252, DOI 10.1038/embor.2011.4; Karp Peter D, 2014, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0009-2013; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Klein G, 2014, J BIOL CHEM, V289, P14829, DOI 10.1074/jbc.M113.539494; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Maredia R, 2012, SCI WORLD J, P1, DOI 10.1100/2012/402919; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; McMahon KJ, 2012, J BACTERIOL, V194, P3241, DOI 10.1128/JB.00016-12; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Meno Y, 2000, MICROBIOL IMMUNOL, V44, P271, DOI 10.1111/j.1348-0421.2000.tb02494.x; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Murphy K, 2014, J BACTERIOL, V196, P1306, DOI 10.1128/JB.01463-13; Nishida Kozo, 2014, F1000Res, V3, P144, DOI 10.12688/f1000research.4524.1; Rahman A, 2001, J BACTERIOL, V183, P6509, DOI 10.1128/JB.183.22.6509-6516.2001; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Sabra W, 2003, MICROBIOL-SGM, V149, P2789, DOI 10.1099/mic.0.26443-0; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Schilling B, 2014, INNATE IMMUN-LONDON, V20, P269, DOI 10.1177/1753425913490534; Schooling SR, 2009, J BACTERIOL, V191, P4097, DOI 10.1128/JB.00717-08; Schwechheimer C, 2015, NATURE REV IN PRESS; Schwechheimer C, 2015, MICROBIOLOGYOPEN, V4, P375, DOI 10.1002/mbo3.244; Schwechheimer C, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0324-1; Schwechheimer C, 2013, J BACTERIOL, V195, P4161, DOI 10.1128/JB.02192-12; Schwechheimer C, 2013, BIOCHEMISTRY-US, V52, P3031, DOI 10.1021/bi400164t; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; SONNTAG I, 1978, J BACTERIOL, V136, P280, DOI 10.1128/JB.136.1.280-285.1978; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tashiro Y, 2009, J BACTERIOL, V191, P7509, DOI 10.1128/JB.00722-09; THOMPSON SS, 1985, APPL ENVIRON MICROB, V50, P1038, DOI 10.1128/AEM.50.4.1038-1042.1985; van de Waterbeemd B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054314; Vasilyeva NV, 2008, FEBS J, V275, P3827, DOI 10.1111/j.1742-4658.2008.06530.x; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	67	56	57	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139200	10.1371/journal.pone.0139200	http://dx.doi.org/10.1371/journal.pone.0139200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406465	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700190
J	Marston, S; Montgiraud, C; Munster, AB; Copeland, O; Choi, O; dos Remedios, C; Messer, AE; Ehler, E; Knoll, R				Marston, Steven; Montgiraud, Cecile; Munster, Alex B.; Copeland, O'Neal; Choi, Onjee; dos Remedios, Cristobal; Messer, Andrew E.; Ehler, Elisabeth; Knoll, Ralph			OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency	PLOS ONE			English	Article							OBSCURIN GENE; PHOSPHORYLATION; MUSCLE; TITIN	Background Studies of the functional consequences of DCM-causing mutations have been limited to a few cases where patients with known mutations had heart transplants. To increase the number of potential tissue samples for direct investigation we performed whole exon sequencing of explanted heart muscle samples from 30 patients that had a diagnosis of familial dilated cardiomyopathy and screened for potentially disease-causing mutations in 58 HCM or DCM-related genes. Results We identified 5 potentially disease-causing OBSCN mutations in 4 samples; one sample had two OBSCN mutations and one mutation was judged to be not disease-related. Also identified were 6 truncating mutations in TTN, 3 mutations in MYH7, 2 in DSP and one each in TNNC1, TNNI3, MYOM1, VCL, GLA, PLB, TCAP, PKP2 and LAMA4. The mean level of obscurin mRNA was significantly greater and more variable in healthy donor samples than the DCM samples but did not correlate with OBSCN mutations. A single obscurin protein band was observed in human heart myofibrils with apparent mass 960 +/- 60 kDa. The three samples with OBSCN mutations had significantly lower levels of obscurin immunoreactive material than DCM samples without OBSCN mutations (45 +/- 7, 48 +/- 3, and 72 +/- 6% of control level). Obscurin levels in DCM controls, donor heart and myectomy samples were the same. Conclusions OBSCN mutations may result in the development of a DCM phenotype via haploinsufficiency. Mutations in the obscurin gene should be considered as a significant causal factor of DCM, alone or in concert with other mutations.	[Marston, Steven; Montgiraud, Cecile; Munster, Alex B.; Copeland, O'Neal; Choi, Onjee; Messer, Andrew E.; Knoll, Ralph] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England; [dos Remedios, Cristobal] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Ehler, Elisabeth] Kings Coll London, Randall Div, London WC2R 2LS, England	Imperial College London; University of Sydney; University of London; King's College London	Marston, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, London, England.	s.marston@imperial.ac.uk	Knöll, Ralph/GOH-3587-2022; Ralph, Knoell/AAE-5990-2020	Ralph, Knoell/0000-0001-8871-112X; Munster, Alex/0000-0003-4266-0499; Marston, Steven/0000-0001-6054-6070; Ehler, Elisabeth/0000-0001-5646-5964	British Heart Foundation [RG/11/20/29266]; Medical Research Council [G0400153] Funding Source: researchfish; MRC [G0400153] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by British Heart Foundation programme grant RG/11/20/29266 [https://www.bhf.org.uk/research]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088162; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Borisov AB, 2003, BIOCHEM BIOPH RES CO, V310, P910, DOI 10.1016/j.bbrc.2003.09.035; den Haan AD, 2009, CIRC-CARDIOVASC GENE, V2, P428, DOI 10.1161/CIRCGENETICS.109.858217; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Marangoni S, 2011, CARDIOVASC RES, V91, P606, DOI 10.1093/cvr/cvr142; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Memo M, 2013, CARDIOVASC RES, V99, P65, DOI 10.1093/cvr/cvt071; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Perry NA, 2013, IUBMB LIFE, V65, P479, DOI 10.1002/iub.1157; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0235-3	25	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138568	10.1371/journal.pone.0138568	http://dx.doi.org/10.1371/journal.pone.0138568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406308	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700059
J	Osiowy, C; Giles, E; Trubnikov, M; Choudhri, Y; Andonov, A				Osiowy, Carla; Giles, Elizabeth; Trubnikov, Max; Choudhri, Yogesh; Andonov, Anton			Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; CHRONIC INFECTION; UNITED-STATES; RISK-FACTORS; PREVALENCE; MUTATIONS; DIVERSITY; MUTANTS; ENGLAND; IMPACT	Objective The prevalence and distribution of hepatitis B virus (HBV) genotypes in Canada is not known. Genotypic analysis may contribute to a better understanding of HBV strain distribution and transmission risk. Methods HBV surface antigen (HBsAg) positive samples of acute (n = 152) and chronic (n = 1533) HBV submitted for strain analysis or reference genotype testing between 2006 and 2012 were analyzed. The HBsAg coding region was amplified to determine the HBV genotype by INNO-LiPA assay or sequence analysis. Single and multivariate analyses were used to describe genotypes' associations with known demographic and behavioral risk factors for 126 linked cases of acute HBV. Results Nine genotypes were detected (A to I), including mixed infections. Genotype C (HBV/C) dominated within chronic infections while HBV/D and A prevailed among acute HBV cases. History of incarceration and residing with a chronic HBV carrier or injection drug user were the most frequently reported risks for acute HBV infection. Over time, HBV/A increased among both acute and chronic infections, and HBV/C and HBV/D decreased among chronic infections. Conclusion Chronic and acute HBV genotypes in Canada differ in the relative distribution and their associations with known risk factors, suggesting different routes of transmission and clinical progression of infection.	[Osiowy, Carla; Giles, Elizabeth; Andonov, Anton] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Trubnikov, Max; Choudhri, Yogesh] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Osiowy, C (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	carla.osiowy@phac-aspc.gc.ca	Andonov, Anton/AAJ-6955-2021	Osiowy, Carla/0000-0002-5429-7220	Public Health Agency of Canada	Public Health Agency of Canada	The authors received no specific funding for this work. All funding for this work was through the Public Health Agency of Canada.	Alestig E, 2013, J MED VIROL, V85, P1148, DOI 10.1002/jmv.23580; Allain JP, 2009, BIOLOGICALS, V37, P71, DOI 10.1016/j.biologicals.2009.01.002; Andersson MI, 2012, J CLIN VIROL, V53, P125, DOI 10.1016/j.jcv.2011.10.012; Carballo M, 2014, VIRAL HEPATITIS, 4TH EDITION, P506; Deeks SL, 1998, CAN J PUBLIC HEALTH, V89, P98, DOI 10.1007/BF03404397; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; DOBSON S, 1995, JAMA-J AM MED ASSOC, V274, P1209, DOI 10.1001/jama.274.15.1209; Fisker N, 2004, J CLIN VIROL, V31, P46, DOI 10.1016/j.jcv.2004.05.004; Gilca V, 2006, PEDIATR INFECT DIS J, V25, P372, DOI 10.1097/01.inf.0000207468.04665.ad; Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ishigami M, 2014, LIVER TRANSPLANT, V20, P1211, DOI 10.1002/lt.23935; Ito K, 2014, HEPATOLOGY, V59, P89, DOI 10.1002/hep.26635; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Li D, 2012, CAN J GASTROENTEROL, V26, P597, DOI 10.1155/2012/705094; Liaw YF, 2014, VIRAL HEPATITIS, 4TH EDITION, P143; Lloyd C., 2010, SINNING SINNED STIGM; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Merrill RM, 2011, INT J INFECT DIS, V15, pE78, DOI 10.1016/j.ijid.2010.09.005; Osiowy C, 2003, J CLIN MICROBIOL, V41, P5473, DOI 10.1128/JCM.41.12.5473-5477.2003; Osiowy C, 2002, J CLIN MICROBIOL, V40, P2566, DOI 10.1128/JCM.40.7.2566-2571.2002; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Payne E, 2014, Can Commun Dis Rep, V40, P266; Public Health Agency of Canada, 2009, CAS DEF COMM DIS NAT, p35S2; Public Health Agency of Canada, 2011, BRIEF REP HEP B INF; Public Health Agency of Canada, NOT DIS ON LIN; Public Health Agency of Canada. The Chief Public Health Officer's Report on the State of Public Health, 2008, CHIEF PUBL HLTH OFF; Ramachandran S, 2014, J VIROL, V88, P13971, DOI 10.1128/JVI.01594-14; Rossi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078548; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Rotermann M, 2013, STAT CANADA HLTH REP; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sagnelli C, 2014, J MED VIROL, V86, P1683, DOI 10.1002/jmv.24005; Sherman M., 2013, LIVER DIS CANADA CRI; Sherman Morris, 2007, Can J Gastroenterol, V21 Suppl C, p5C; Sloan RD, 2009, J CLIN VIROL, V44, P157, DOI 10.1016/j.jcv.2008.11.010; Spradling PR, 2014, VIRAL HEPATITIS, 4TH EDITION, P81; Statistics Canada, 2011, IMMIGRATION ETHNOCUL; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Wong VWS, 2012, CURR OPIN INFECT DIS, V25, P570, DOI 10.1097/QCO.0b013e328357f2f8; Wong WWL, 2013, CAN J GASTROENTEROL, V27, P137, DOI 10.1155/2013/924640; Wu H X, 2005, Int J Med Sci, V2, P143; Yano K, 2010, INTERVIROLOGY, V53, P70, DOI 10.1159/000252788; Yotsuyanagi H, 2013, CLIN INFECT DIS, V57, P935, DOI 10.1093/cid/cit348; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149	55	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136074	10.1371/journal.pone.0136074	http://dx.doi.org/10.1371/journal.pone.0136074			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406309	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700009
J	Schmole, AC; Lundt, R; Gennequin, B; Schrage, H; Beins, E; Kramer, A; Zimmer, T; Limmer, A; Zimmer, A; Otte, DM				Schmoele, Anne-Caroline; Lundt, Ramona; Gennequin, Benjamin; Schrage, Hanna; Beins, Eva; Kraemer, Alexandra; Zimmer, Till; Limmer, Andreas; Zimmer, Andreas; Otte, David-Marian			Expression Analysis of CB2-GFP BAC Transgenic Mice	PLOS ONE			English	Article							CANNABINOID CB2 RECEPTORS; B-CELL; MARGINAL ZONE; LYMPHOCYTES; ACTIVATION; RETENTION; SYSTEM	The endocannabinoid system (ECS) is a retrograde messenger system, consisting of lipid signaling molecules that bind to at least two G-protein-coupled receptors, Cannabinoid receptor 1 and 2 (CB1 and 2). As CB2 is primarily expressed on immune cells such as B cells, T cells, macrophages, dendritic cells, and microglia, it is of great interest how CB2 contributes to immune cell development and function in health and disease. Here, understanding the mechanisms of CB2 involvement in immune-cell function as well as the trafficking and regulation of CB2 expressing cells are crucial issues. Up to now, CB2 antibodies produce unclear results, especially those targeting the murine protein. Therefore, we have generated BAC transgenic GFP reporter mice (CB2-GFPTg) to trace CB2 expression in vitro and in situ. Those mice express GFP under the CB2 promoter and display GFP expression paralleling CB2 expression on the transcript level in spleen, thymus and brain tissue. Furthermore, by using fluorescence techniques we show that the major sources for GFP-CB2 expression are B cells in spleen and blood and microglia in the brain. This novel CB2-GFP transgenic reporter mouse line represents a powerful resource to study CB2 expression in different cell types. Furthermore, it could be used for analyzing CB2-mediated mobilization and trafficking of immune cells as well as studying the fate of recruited immune cells in models of acute and chronic inflammation.	[Schmoele, Anne-Caroline; Lundt, Ramona; Gennequin, Benjamin; Schrage, Hanna; Beins, Eva; Kraemer, Alexandra; Zimmer, Till; Zimmer, Andreas; Otte, David-Marian] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Limmer, Andreas] Univ Bonn, Clin Orthopaed & Trauma Surg, Bonn, Germany	University of Bonn; University of Bonn	Schmole, AC (corresponding author), Univ Bonn, Inst Mol Psychiat, Bonn, Germany.	anne.schmoele@uni-bonn.de; d.otte@uni-bonn.de	Zimmer, Andreas/B-8357-2009; Schmöle, Anne/AAH-5325-2019	Beins, Eva/0000-0002-7779-0210; Zimmer, Till/0000-0002-6869-3697	Medical Faculty of the University of Bonn "Bonfor"; Deutsche Forschungsgemeinschaft [FOR 926]	Medical Faculty of the University of Bonn "Bonfor"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partly supported by a start-up grant from the Medical Faculty of the University of Bonn "Bonfor" (to ACS and HS) and the Deutsche Forschungsgemeinschaft, FOR 926 (to ACS, RL, BG and AZ). ACS, RL, EB, DMO and AZ are members of the DFG Cluster of Excellence "Immunosensation." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baek JH, 2013, J NEUROSCI METH, V216, P87, DOI 10.1016/j.jneumeth.2013.03.021; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Benito C, 2003, J NEUROSCI, V23, P11136; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Carayon P, 1998, BLOOD, V92, P3605, DOI 10.1182/blood.V92.10.3605.422k05_3605_3615; DEROCQ JM, 1995, FEBS LETT, V369, P177, DOI 10.1016/0014-5793(95)00746-V; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Lee SF, 2001, EUR J PHARMACOL, V423, P235, DOI 10.1016/S0014-2999(01)01122-0; Lundberg Pontus, 2011, Curr Protoc Mouse Biol, V1, P323, DOI 10.1002/9780470942390.mo110088; Malfitano AM, 2014, SEMIN IMMUNOL, V26, P369, DOI 10.1016/j.smim.2014.04.002; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Otte DM, 2009, EUR NEUROPSYCHOPHARM, V19, P339, DOI 10.1016/j.euroneuro.2008.12.009; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rayman N, 2004, J IMMUNOL, V172, P2111, DOI 10.4049/jimmunol.172.4.2111; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Tanikawa T, 2007, MICROBIOL IMMUNOL, V51, P1013, DOI 10.1111/j.1348-0421.2007.tb03985.x; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Xu H, 2008, IMMUNOLOGY, V125, P218, DOI 10.1111/j.1365-2567.2008.02832.x; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Ziring D, 2006, IMMUNOGENETICS, V58, P714, DOI 10.1007/s00251-006-0138-x	40	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138986	10.1371/journal.pone.0138986	http://dx.doi.org/10.1371/journal.pone.0138986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406232	Green Published, gold			2022-12-26	WOS:000361800700138
J	Seeger, T; Hart, M; Patarroyo, M; Rolauffs, B; Aicher, WK; Klein, G				Seeger, Tanja; Hart, Melanie; Patarroyo, Manuel; Rolauffs, Bernd; Aicher, Wilhelm K.; Klein, Gerd			Mesenchymal Stromal Cells for Sphincter Regeneration: Role of Laminin Isoforms upon Myogenic Differentiation	PLOS ONE			English	Article							STEM-CELLS; SMOOTH-MUSCLE; GROWTH-FACTOR; SELF-RENEWAL; MATRIX; EXPRESSION; THERAPY; NICHE	Multipotent mesenchymal stromal cells (MSCs) are well known for their tri-lineage potential and ability to differentiate in vitro into osteogenic, chondrogenic or adipogenic lineages. By selecting appropriate conditions MSCs can also be differentiated in vitro into the myogenic lineage and are therefore a promising option for cell-based regeneration of muscle tissue such as an aged or damaged sphincter muscle. For the differentiation into the myogenic lineage there is still a need to evaluate the effects of extracellular matrix proteins such as laminins (LM) which are crucial for different stem cell types and for normal muscle function. The laminin family consists of 16 functionally different isoforms with LM-211 being the most abundant isoform of adult muscle tissues. In the sphincter tissue a strong expression of the isoforms LM-211/221, LM-411/421 and LM-511/521 can be detected in the different cell layers. Bone marrow-derived MSCs in culture, however, mainly express the isoforms LM-411 and LM-511, but not LM-211. Even after myogenic differentiation, LM-211 can hardly be detected. All laminin isoforms tested (LM-211, LM-411, LM-511 and LM-521) showed a significant inhibition of the proliferation of undifferentiated MSCs but, with the exception of LM-521, they had no influence on the proliferation of MSCs cultivated in myogenic medium. The strongest cellular adhesion of MSCs was to LM-511 and LM-521, whereas LM-211 was only a weakly-adhesive substrate for MSCs. Myogenic differentiation of MSCs even reduced the interaction with LM-211, but it did not affect the interaction with LM-511 and LM-521. Since during normal myogenesis the latter two isoforms are the major laminins surrounding developing myogenic progenitors, alpha 5 chain-containing laminins are recommended for further improvements of myogenic differentiation protocols of MSCs into smooth muscle cells.	[Seeger, Tanja; Klein, Gerd] Univ Tubingen, Med Res Ctr, Univ Med Clin Dept 2, Tubingen, Germany; [Hart, Melanie; Aicher, Wilhelm K.] Univ Tubingen, Dept Urol, Tubingen, Germany; [Patarroyo, Manuel] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Rolauffs, Bernd] Univ Tubingen, BG Trauma Clin, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Karolinska Institutet; Eberhard Karls University of Tubingen	Klein, G (corresponding author), Univ Tubingen, Med Res Ctr, Univ Med Clin Dept 2, Tubingen, Germany.	gerd.klein@uni-tuebingen.de	Klein, Gerd/C-8499-2013	Aicher, Wilhelm K/0000-0003-2210-6773; Rolauffs, Bernd/0000-0002-3275-8196	German Research Council [KFO273: RO 2511/3-1, AI 16/23-1, KL 709/13-1]	German Research Council(German Research Foundation (DFG))	This work was funded in part by the German Research Council (KFO273: RO 2511/3-1 to B.R.; AI 16/23-1 to W.K.A.; KL 709/13-1 to G.K.) and in part by institutional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimperti S, 2014, J CELL SCI, V127, P2627, DOI 10.1242/jcs.134833; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Furuta Akira, 2007, Rev Urol, V9, P106; Galli D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/762695; Garcia-Castro J, 2008, J CELL MOL MED, V12, P2552, DOI 10.1111/j.1582-4934.2008.00516.x; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Ghosh D, 2014, STEM CELLS DEV, V23, P245, DOI 10.1089/scd.2013.0240; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hart ML, 2013, CURR UROL REP, V14, P476, DOI 10.1007/s11934-013-0352-7; Hergeth SP, 2008, EXP HEMATOL, V36, P1022, DOI 10.1016/j.exphem.2008.03.013; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Klein G, 2015, ADV DRUG DELIVER REV, V82-83, P123, DOI 10.1016/j.addr.2014.10.026; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116183; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Nguyen NM, 2006, DEV BIOL, V294, P271, DOI 10.1016/j.ydbio.2006.03.032; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Ragni E, 2013, EXP CELL RES, V319, P1562, DOI 10.1016/j.yexcr.2013.04.002; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; Ulrich C, 2013, STEM CELLS DEV, V22, P2859, DOI 10.1089/scd.2012.0693; Vaegler M, 2014, CURR STEM CELL RES T, V9, P444, DOI 10.2174/1574888X09666140521144559; Wallner C, 2009, EUR UROL, V55, P932, DOI 10.1016/j.eururo.2008.08.032; Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.tea.2011.0172, 10.1089/ten.TEA.2011.0172]; Wondimu Z, 2004, BLOOD, V104, P1859, DOI 10.1182/blood-2004-01-0396; Wondimu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053648; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Yu HY, 2013, STEM CELLS DEV, V22, P136, DOI 10.1089/scd.2012.0160	45	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137419	10.1371/journal.pone.0137419	http://dx.doi.org/10.1371/journal.pone.0137419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406476	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700020
J	Zougman, A; Banks, RE				Zougman, Alexandre; Banks, Rosamonde E.			C-STrap Sample Preparation Method-In-Situ Cysteinyl Peptide Capture for Bottom-Up Proteomics Analysis in the STrap Format	PLOS ONE			English	Article							PROTEIN MIXTURES; ENRICHMENT; IDENTIFICATION; CHROMATOGRAPHY; RANGE	Recently we introduced the concept of Suspension Trapping (STrap) for bottom-up proteomics sample processing that is based upon SDS-mediated protein extraction, swift detergent removal and rapid reactor-type protein digestion in a quartz depth filter trap. As the depth filter surface is made of silica, it is readily modifiable with various functional groups using the silane coupling chemistries. Thus, during the digest, peptides possessing specific features could be targeted for enrichment by the functionalized depth filter material while non-targeted peptides could be collected as an unbound distinct fraction after the digest. In the example presented here the quartz depth filter surface is functionalized with the pyridyl-dithiol group therefore enabling reversible in-situ capture of the cysteine-containing peptides generated during the STrap-based digest. The described C-STrap method retains all advantages of the original STrap methodology and provides robust foundation for the conception of the targeted in-situ peptide fractionation in the STrap format for bottom-up proteomics. The presented data support the method's use in qualitative and semi-quantitative proteomics experiments.	[Zougman, Alexandre; Banks, Rosamonde E.] St James Univ Hosp, Leeds Inst Canc & Pathol, Canc Res UK Ctr, Clin & Biomed Prote Grp, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital	Zougman, A (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Canc Res UK Ctr, Clin & Biomed Prote Grp, Leeds LS9 7TF, W Yorkshire, England.	a.zougman@leeds.ac.uk			Medical Research Council [MR/L01629X/1] Funding Source: Medline; MRC [MR/L01629X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fujioka H, 2014, J SEP SCI, V37, P1601, DOI 10.1002/jssc.201400135; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hansen KC, 2003, MOL CELL PROTEOMICS, V2, P299, DOI 10.1074/mcp.M300021-MCP200; HARADA K, 1995, EMBO J, V14, P5798, DOI 10.1002/j.1460-2075.1995.tb00268.x; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Liu T, 2005, PROTEOMICS, V5, P1263, DOI 10.1002/pmic.200401055; NAKANO K, 1980, J BIOCHEM-TOKYO, V87, P919, DOI 10.1093/oxfordjournals.jbchem.a132822; Palani A, 2008, J PROTEOME RES, V7, P3591, DOI 10.1021/pr800067x; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; WEITH HL, 1970, BIOCHEMISTRY-US, V9, P4396, DOI 10.1021/bi00824a021; Wisniewski JR, 2013, JOVE-J VIS EXP, DOI 10.3791/50589; Xie XY, 2011, CELL METAB, V14, P378, DOI 10.1016/j.cmet.2011.06.015; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553; Zubarev RA, 2013, PROTEOMICS, V13, P723, DOI 10.1002/pmic.201200451	16	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138775	10.1371/journal.pone.0138775	http://dx.doi.org/10.1371/journal.pone.0138775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407052	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700094
J	Hayat, T; Ali, S; Farooq, MA; Alsaedi, A				Hayat, Tasawar; Ali, Shafqat; Farooq, Muhammad Asif; Alsaedi, Ahmad			On Comparison of Series and Numerical Solutions for Flow of Eyring-Powell Fluid with Newtonian Heating And Internal Heat Generation/Absorption	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HOMOTOPY ANALYSIS METHOD; STAGNATION-POINT FLOW; STRETCHING SURFACE; VERTICAL SURFACE; MASS-TRANSFER; POROUS-MEDIUM; CONVECTION; SHEET; EQUATIONS	In this paper, we have investigated the combined effects of Newtonian heating and internal heat generation/absorption in the two-dimensional flow of Eyring-Powell fluid over a stretching surface. The governing non-linear analysis of partial differential equations is reduced into the ordinary differential equations using similarity transformations. The resulting problems are computed for both series and numerical solutions. Series solution is constructed using homotopy analysis method (HAM) whereas numerical solution is presented by two different techniques namely shooting method and bvp4c. A comparison of homotopy solution with numerical solution is also tabulated. Both solutions are found in an excellent agreement. Dimensionless velocity and temperature profiles are plotted and discussed for various emerging physical parameters.	[Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Ali, Shafqat] Ghulam Ishaq Khan Inst Engn Sci & Technol, Fac Engn Sci, Topi 44000, Pakistan; [Farooq, Muhammad Asif] Natl Univ Sci & Technol, Ctr Adv Math & Phys, Islamabad 44000, Pakistan; [Alsaedi, Ahmad] King Abdulaziz Univ, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; GIK Institute Engineering Science & Technology; National University of Sciences & Technology - Pakistan; King Abdulaziz University	Ali, S (corresponding author), Ghulam Ishaq Khan Inst Engn Sci & Technol, Fac Engn Sci, Topi 44000, Pakistan.	ali.qau1987@gmail.com	Hayat, Tasawar/A-3853-2013; Farooq, Muhammad Asif/W-6601-2019; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Farooq, Muhammad Asif/0000-0001-6262-145X; Alsaedi, Ahmed/0000-0003-3452-8922; ALI, SHAFQAT/0000-0001-9887-3317				Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P3140, DOI 10.1016/j.cnsns.2010.11.018; Abbasbandy S, 2009, COMMUN NONLINEAR SCI, V14, P3591, DOI 10.1016/j.cnsns.2009.01.030; Ahmad A, 2011, APPL MATH LETT, V24, P1905, DOI 10.1016/j.aml.2011.05.016; Bhattacharyya K, 2010, CHEM ENG COMMUN, V197, P1527, DOI 10.1080/00986445.2010.485012; Bhattacharyya K, 2011, J PETROL SCI ENG, V78, P304, DOI 10.1016/j.petrol.2011.06.009; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P302, DOI 10.1016/j.ijheatmasstransfer.2010.09.043; Chaudhary RC, 2007, J ENG PHYS THERMOPH+, V80, P954, DOI 10.1007/s10891-007-0127-4; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Hayat T, 2013, PROG COMPUT FLUID DY, V13, P48, DOI 10.1504/PCFD.2013.050650; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P1817, DOI 10.1016/j.ijheatmasstransfer.2011.10.046; Hayat T, 2012, APPL MATH MECH ENG E, V33, P1299; Hayat T, 2010, SIMULATENEOUS EFFECT, V67, P1341; Jalil M, 2013, INT J NONLIN MECH, V48, P65, DOI 10.1016/j.ijnonlinmec.2012.07.004; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Layek GC, 2007, INT COMMUN HEAT MASS, V34, P347, DOI 10.1016/j.icheatmasstransfer.2006.11.011; Lesnic D, 2004, HEAT MASS TRANSFER, V40, P665, DOI 10.1007/s00231-003-0435-y; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Mukhopadhyay S, 2011, INT J HEAT MASS TRAN, V54, P2751, DOI 10.1016/j.ijheatmasstransfer.2011.03.017; Nadeem S, 2010, COMMUN NONLINEAR SCI, V15, P475, DOI 10.1016/j.cnsns.2009.04.037; Niu J, 2010, PHYS LETT A, V374, P4607, DOI 10.1016/j.physleta.2010.09.028; Patel M, 2009, APPL NUMER MATH, V59, P2584, DOI 10.1016/j.apnum.2009.04.010; Rashidi MM, 2009, COMMUN NONLINEAR SCI, V14, P708, DOI 10.1016/j.cnsns.2007.09.015; Salleh MZ, 2010, J TAIWAN INST CHEM E, V41, P651, DOI 10.1016/j.jtice.2010.01.013; Salleh MZ, 2009, CHEM ENG COMMUN, V196, P987, DOI 10.1080/00986440902797840; Shampine L.F., 2000, TUTORIAL NOTES; Vajravelu K, 2012, APPL MATH MECH-ENGL, V33, P899, DOI 10.1007/s10483-012-1593-8; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Yacob NA, 2011, COMPUT FLUIDS, V47, P16, DOI 10.1016/j.compfluid.2011.01.040; Yao BH, 2009, EUR J MECH B-FLUID, V28, P689, DOI 10.1016/j.euromechflu.2009.06.002; Zhong KG, 2013, EPL-EUROPHYS LETT, V130, P500; Zhong KG, 2011, CHEM ENG SCI, V66, P2660	33	62	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0129613	10.1371/journal.pone.0129613	http://dx.doi.org/10.1371/journal.pone.0129613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402366	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100001
J	Cho, Y; Tokuhara, D; Morikawa, H; Kuwae, Y; Hayashi, E; Hirose, M; Hamazaki, T; Tanaka, A; Kawamura, T; Kawada, N; Shintaku, H				Cho, Yuki; Tokuhara, Daisuke; Morikawa, Hiroyasu; Kuwae, Yuko; Hayashi, Eri; Hirose, Masakazu; Hamazaki, Takashi; Tanaka, Akemi; Kawamura, Tomoyuki; Kawada, Norifumi; Shintaku, Haruo			Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CONTROLLED ATTENUATION PARAMETER; FATTY LIVER; STIFFNESS MEASUREMENT; NONINVASIVE METHOD; METABOLIC SYNDROME; OBESE CHILDREN; FIBROSIS; DISEASE; STEATOSIS	Background & Aims The utility of transient elastography (FibroScan) is well studied in adults but not in children. We sought to assess the feasibility of performing FibroScans and the characteristics of FibroScan-based liver profiles in Japanese obese and non-obese children. Methods FibroScan examinations were performed in pediatric patients (age, 1-18 yr) who visited Osaka City University Hospital. Liver steatosis measured by controlled attenuation parameter (CAP), and hepatic fibrosis evaluated as the liver stiffness measurement (LSM), were compared among obese subjects (BMI percentile >= 90%), non-obese healthy controls, and non-obese patients with liver disease. Results Among 214 children examined, FibroScans were performed successfully in 201 children (93.9%; median, 11.5 yr; range, 1.3-17.6 yr; 115 male). CAP values (mean +/- SD) were higher in the obese group (n = 52, 285 +/- 60 dB/m) compared with the liver disease (n = 40, 202 +/- 62, P<0.001) and the control (n = 107, 179 +/- 41, P<0.001) group. LSM values were significantly higher in the obese group (5.5 +/- 2.3 kPa) than in the control (3.9 +/- 0.9, P<0.001), but there were no significant differences in LSM between the liver disease group (5.4 +/- 4.2) and either the obese or control group. LSM was highly correlated with CAP in the obese group (rho = 0.511) but not in the control (rho = 0.129) or liver disease (rho = 0.170) groups. Conclusions Childhood obesity carries a high risk of hepatic steatosis associated with increased liver stiffness. FibroScan methodology provides simultaneous determination of CAP and LSM, is feasible in children of any age, and is a non-invasive and effective screening method for hepatic steatosis and liver fibrosis in Japanese obese children.	[Cho, Yuki; Tokuhara, Daisuke; Hirose, Masakazu; Hamazaki, Takashi; Tanaka, Akemi; Kawamura, Tomoyuki; Shintaku, Haruo] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan; [Morikawa, Hiroyasu; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Kuwae, Yuko] Osaka City Univ, Grad Sch Med, Dept Pathol, Osaka 558, Japan; [Hayashi, Eri] Izumi Municipal Hosp, Dept Pediat, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Tokuhara, D (corresponding author), Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan.	m1155519@med.osaka-cu.ac.jp	Shintaku, Haruo/AAP-1196-2020; Tokuhara, Daisuke/AAY-2554-2021; Kawamura, Tomoyuki/AAK-1049-2021; kawada, norifumi/AAS-1367-2020	Kawamura, Tomoyuki/0000-0002-3593-9910; Tokuhara, Daisuke/0000-0002-2441-5062	Japan Science and Technology Agency; TANITA Healthy Weight Community Trust	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); TANITA Healthy Weight Community Trust	This work was supported by grants from the Japan Science and Technology Agency (to H.M.) and the TANITA Healthy Weight Community Trust (to D.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2013, LIVER INT, V33, P79, DOI 10.1111/liv.12024; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; de Ledinghen V, 2007, J PEDIATR GASTR NUTR, V45, P443, DOI 10.1097/MPG.0b013e31812e56ff; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Engelmann G, 2012, EUR J PEDIATR, V171, P353, DOI 10.1007/s00431-011-1558-7; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedrich-Rust M, 2010, EUR RADIOL, V20, P2390, DOI 10.1007/s00330-010-1820-9; Goldschmidt I, 2013, J PEDIATR GASTR NUTR, V57, P109, DOI 10.1097/MPG.0b013e31829206a0; Goyal R, 2013, J GASTROEN HEPATOL, V28, P1738, DOI 10.1111/jgh.12318; Kawamoto M, 2006, WORLD J GASTROENTERO, V12, P4325, DOI 10.3748/wjg.v12.i27.4325; Kim SU, 2011, J GASTROEN HEPATOL, V26, P171, DOI 10.1111/j.1440-1746.2010.06385.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kunde SS, 2005, HEPATOLOGY, V42, P650, DOI 10.1002/hep.20818; Lebensztejn DM, 2005, HEPATOLOGY, V41, P1434, DOI 10.1002/hep.20736; Lee CK, 2013, J PEDIATR-US, V163, P1058, DOI 10.1016/j.jpeds.2013.04.044; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Loomba R, 2009, HEPATOLOGY, V50, P1282, DOI 10.1002/hep.23119; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Molleston JP, 2002, AM J GASTROENTEROL, V97, P2460; Mueller S, 2010, WORLD J GASTROENTERO, V16, P966, DOI 10.3748/wjg.v16.i8.966; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; NEEDLEMAN L, 1986, AM J ROENTGENOL, V146, P1011, DOI 10.2214/ajr.146.5.1011; OHTOMO K, 1993, RADIOLOGY, V188, P31, DOI 10.1148/radiology.188.1.8511316; Pacifico L, 2007, ACTA PAEDIATR, V96, P542, DOI 10.1111/j.1651-2227.2007.00186.x; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Antolin GS, 2009, TRANSPL P, V41, P1044, DOI 10.1016/j.transproceed.2009.02.027; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Strauss RS, 2000, J PEDIATR-US, V136, P727, DOI 10.1016/S0022-3476(00)24645-3; Takeda T, 2006, WORLD J GASTROENTERO, V12, P7768, DOI 10.3748/wjg.v12.i48.7768; TOMINAGA K, 1995, DIGEST DIS SCI, V40, P2002, DOI 10.1007/BF02208670; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x	44	45	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137239	10.1371/journal.pone.0137239	http://dx.doi.org/10.1371/journal.pone.0137239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398109	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500025
J	Geng, HL; Sui, ZH; Zhang, S; Du, QW; Ren, YY; Liu, Y; Kong, FN; Zhong, J; Ma, QX				Geng, Huili; Sui, Zhenghong; Zhang, Shu; Du, Qingwei; Ren, Yuanyuan; Liu, Yuan; Kong, Fanna; Zhong, Jie; Ma, Qingxia			Identification of microRNAs in the Toxigenic Dinoflagellate Alexandrium catenella by High-Throughput Illumina Sequencing and Bioinformatic Analysis	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELL-CYCLE REGULATION; SMALL RNAS; ARABIDOPSIS-THALIANA; EXPRESSION PROFILES; PLANT MICRORNAS; GENE-EXPRESSION; ORYZA-SATIVA; CALMODULIN; CALCIUM	Micro-ribonucleic acids (miRNAs) are a large group of endogenous, tiny, non-coding RNAs consisting of 19-25 nucleotides that regulate gene expression at either the transcriptional or post-transcriptional level by mediating gene silencing in eukaryotes. They are considered to be important regulators that affect growth, development, and response to various stresses in plants. Alexandrium catenella is an important marine toxic phytoplankton species that can cause harmful algal blooms (HABs). To date, identification and function analysis of miRNAs in A. catenella remain largely unexamined. In this study, high-throughput sequencing was performed on A. catenella to identify and quantitatively profile the repertoire of small RNAs from two different growth phases. A total of 38,092,056 and 32,969,156 raw reads were obtained from the two small RNA libraries, respectively. In total, 88 mature miRNAs belonging to 32 miRNA families were identified. Significant differences were found in the member number, expression level of various families, and expression abundance of each member within a family. A total of 15 potentially novel miRNAs were identified. Comparative profiling showed that 12 known miRNAs exhibited differential expression between the lag phase and the logarithmic phase. Real-time quantitative RT-PCR (qPCR) was performed to confirm the expression of two differentially expressed miRNAs that were one up-regulated novel miRNA (aca-miR-3p-456915), and one down-regulated conserved miRNA (tae-miR159a). The expression trend of the qPCR assay was generally consistent with the deep sequencing result. Target predictions of the 12 differentially expressed miRNAs resulted in 1813target genes. Gene ontology (GO) analysis and the Kyoto Encyclopedia of Genes and Genomes pathway database (KEGG) annotations revealed that some miRNAs were associated with growth and developmental processes of the alga. These results provide insights into the roles that miRNAs play in the growth of A. catenella, and they provide the basis for further studies of the molecular mechanisms that underlie bloom growth in red tides species.	[Geng, Huili; Sui, Zhenghong; Zhang, Shu; Du, Qingwei; Ren, Yuanyuan; Liu, Yuan; Kong, Fanna; Zhong, Jie; Ma, Qingxia] Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao 266003, Peoples R China	Ocean University of China	Sui, ZH (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao 266003, Peoples R China.	suizhengh@ouc.edu.cn		Du, Qingwei/0000-0001-5714-8987	National Natural Science Foundation of China [41176098]; Shandong Provincial Natural Science Foundation, China [ZR2011DZ002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by The National Natural Science Foundation of China (41176098), and Shandong Provincial Natural Science Foundation, China (ZR2011DZ002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alberts B., 1994, MOL BIOL CELL, P139; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgarten S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-704; Billoud B, 2014, NUCLEIC ACIDS RES, V42, P417, DOI 10.1093/nar/gkt856; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; Burkholder JM, 1998, ECOL APPL, V8, pS37; Burkholder JM, 2008, HARMFUL ALGAE, V8, P77, DOI 10.1016/j.hal.2008.08.010; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; GALLERON C, 1976, J PHYCOL, V12, P69, DOI 10.1111/j.0022-3646.1976.00069.x; Gao DH, 2013, EVOL BIOINFORM, V9, P479, DOI 10.4137/EBO.S12899; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; Hallegraeff G. M., 2003, MANUAL HARMFUL MARIN, P25; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Huang AY, 2011, CHINESE SCI BULL, V56, P2916, DOI 10.1007/s11434-011-4678-6; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Huang JA, 2010, ACTA OCEANOL SIN, V29, P90, DOI 10.1007/s13131-010-0040-0; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu ZH, 1998, PLANT MOL BIOL, V38, P889, DOI 10.1023/A:1006019001200; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Matsuda A, 1999, NIPPON SUISAN GAKK, V65, P847; Matsuyama Y, 1999, JARQ-JPN AGR RES Q, V33, P283; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; Pilcher RLR, 2007, PLANTA, V226, P709, DOI 10.1007/s00425-007-0518-y; Qin YR, 2011, PLANT CELL REP, V30, P1893, DOI 10.1007/s00299-011-1096-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; SCHNEPF E, 1990, ARCH PROTISTENKD, V138, P89, DOI 10.1016/S0003-9365(11)80213-7; SCHNEPF E, 1992, EUR J PROTISTOL, V28, P3, DOI 10.1016/S0932-4739(11)80315-9; Sha ZX, 2014, DEV COMP IMMUNOL, V44, P59, DOI 10.1016/j.dci.2013.11.014; Sournia A, 1995, RED TIDE TOXIC MARIN, P103; Stoecker DK, 1999, J EUKARYOT MICROBIOL, V46, P397, DOI 10.1111/j.1550-7408.1999.tb04619.x; Su C, 2014, GENOMICS, V103, P298, DOI 10.1016/j.ygeno.2014.03.002; Su JQR, 2007, J MICROBIOL METH, V69, P425, DOI 10.1016/j.mimet.2006.07.005; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Toulza E, 2010, APPL ENVIRON MICROB, V76, P4521, DOI 10.1128/AEM.02345-09; Uribe P, 2008, MAR BIOTECHNOL, V10, P692, DOI 10.1007/s10126-008-9107-8; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang C.-Y., 2009, PERIOD OCEAN U CHIN, V39, P127; Wang DZ, 2012, CHINESE SCI BULL, V57, P3328, DOI 10.1007/s11434-012-5160-9; Wang L, 2001, PLANTA, V213, P556, DOI 10.1007/s004250100540; WATILLON B, 1993, PLANT PHYSIOL, V101, P1381, DOI 10.1104/pp.101.4.1381; WEINERT TA, 1993, GENETICS, V134, P63; Wen RB, 2014, J OCEAN U CHINA, V13, P290, DOI 10.1007/s11802-014-2075-x; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang L, 2002, BIOCHEM J, V368, P145, DOI 10.1042/BJ20020780; Zhang S, 2014, GENE, V537, P285, DOI 10.1016/j.gene.2013.12.041; Zhao L, 2007, CHINESE J CELL BIOL, V29, P331; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; [仲洁 Zhong Jie], 2012, [生态学报, Acta Ecologica Sinica], V32, P431; Zhu JF, 2013, PLANT CELL REP, V32, P1339, DOI 10.1007/s00299-013-1446-x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuo JH, 2011, SCI CHINA LIFE SCI, V54, P599, DOI 10.1007/s11427-011-4188-4	78	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138709	10.1371/journal.pone.0138709	http://dx.doi.org/10.1371/journal.pone.0138709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398216	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500097
J	N'Djin, WA; Chapelon, JY; Melodelima, D				N'Djin, W. Apoutou; Chapelon, Jean-Yves; Melodelima, David			An Ultrasound Image-Based Dynamic Fusion Modeling Method for Predicting the Quantitative Impact of In Vivo Liver Motion on Intraoperative HIFU Therapies: Investigations in a Porcine Model	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; ACTIVE BREATHING CONTROL; RESPIRATORY MOTION; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; THERMAL ABLATION; PROSTATE-CANCER; MR-THERMOMETRY; HEAT-TRANSFER; TUMOR MOTION	Organ motion is a key component in the treatment of abdominal tumors by High Intensity Focused Ultrasound (HIFU), since it may influence the safety, efficacy and treatment time. Here we report the development in a porcine model of an Ultrasound (US) image-based dynamic fusion modeling method for predicting the effect of in vivo motion on intraoperative HIFU treatments performed in the liver in conjunction with surgery. A speckle tracking-method was used on US images to quantify in vivo liver motions occurring intraoperatively during breathing and apnea. A fusion modeling of HIFU treatments was implemented by merging dynamic in vivo motion data in a numerical modeling of HIFU treatments. Two HIFU strategies were studied: a spherical focusing delivering 49 juxtapositions of 5-second HIFU exposures and a toroidal focusing using 1 single 40-second HIFU exposure. Liver motions during breathing were spatially homogenous and could be approximated to a rigid motion mainly encountered in the cranial-caudal direction (f = 0.20Hz, magnitude > 13mm). Elastic liver motions due to cardiovascular activity, although negligible, were detectable near millimeter-wide sus-hepatic veins (f = 0.96Hz, magnitude < 1mm). The fusion modeling quantified the deleterious effects of respiratory motions on the size and homogeneity of a standard "cigarshaped" millimetric lesion usually predicted after a 5-second single spherical HIFU exposure in stationary tissues (Dice Similarity Coefficient: DSC<45%). This method assessed the ability to enlarge HIFU ablations during respiration, either by juxtaposing "cigar-shaped" lesions with spherical HIFU exposures, or by generating one large single lesion with toroidal HIFU exposures (DSC>75%). Fusion modeling predictions were preliminarily validated in vivo and showed the potential of using a long-duration toroidal HIFU exposure to accelerate the ablation process during breathing (from 0.5 to 6 cm(3).min(-1)). To improve HIFU treatment control, dynamic fusion modeling may be interesting for assessing numerically focusing strategies and motion compensation techniques in more realistic conditions.	[N'Djin, W. Apoutou; Chapelon, Jean-Yves; Melodelima, David] INSERM, U1032, LabTAU, F-69008 Lyon, France; [N'Djin, W. Apoutou; Chapelon, Jean-Yves; Melodelima, David] Univ Lyon 1, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	N'Djin, WA (corresponding author), INSERM, U1032, LabTAU, F-69008 Lyon, France.	apoutou.ndjin@inserm.fr	N'DJIN, William Apoutou/F-4907-2013; Melodelima, David/N-4670-2017; Melodelima, David/AAR-7183-2020	N'DJIN, William Apoutou/0000-0003-0606-1464; Melodelima, David/0000-0003-3913-1270	Canceropole Lyon Auvergne Rhone Alpes [PDC 2006.4.8]; DGOS (Direction Generale de l'Offre de Soin); INCA (French National Cancer Institute) within the LYRIC project (LYon Recherche Integree en Cancerologie)	Canceropole Lyon Auvergne Rhone Alpes; DGOS (Direction Generale de l'Offre de Soin); INCA (French National Cancer Institute) within the LYRIC project (LYon Recherche Integree en Cancerologie)	This work was supported by the Canceropole Lyon Auvergne Rhone Alpes (PDC 2006.4.8), the DGOS (Direction Generale de l'Offre de Soin) and the INCA (French National Cancer Institute) within the LYRIC project (LYon Recherche Integree en Cancerologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKIN H, 1994, IEEE T BIO-MED ENG, V41, P97, DOI 10.1109/10.284920; Auboiroux V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/421726; Bailey MR, 2003, ACOUST PHYS+, V49, P369, DOI 10.1134/1.1591291; Beddar AS, 2007, INT J RADIAT ONCOL, V67, P630, DOI 10.1016/j.ijrobp.2006.10.007; Cady B, 1998, ANN SURG, V227, P566, DOI 10.1097/00000658-199804000-00019; Chavrier F, 2000, J ACOUST SOC AM, V108, P432, DOI 10.1121/1.429476; Chen L, 1998, J APPL PHYSIOL, V84, P1289, DOI 10.1152/jappl.1998.84.4.1289; Chenot J, 2010, PHYS MED BIOL, V55, P3131, DOI 10.1088/0031-9155/55/11/010; Constanciel E, 2013, IEEE T ULTRASON FERR, V60, P1868, DOI 10.1109/TUFFC.2013.2772; COOPER TE, 1972, J HEAT TRANSF, V94, P133, DOI 10.1115/1.3449883; Crouzet S, 2010, EUR UROL, V58, P559, DOI 10.1016/j.eururo.2010.06.037; Curiel L, 2004, MED BIOL ENG COMPUT, V42, P44, DOI 10.1007/BF02351010; DAMIANOU C, 1994, J ACOUST SOC AM, V95, P1641, DOI 10.1121/1.408550; Daum DR, 1999, ULTRASOUND MED BIOL, V25, P1087, DOI 10.1016/S0301-5629(99)00053-8; de Senneville BD, 2007, MAGN RESON MED, V57, P319, DOI 10.1002/mrm.21124; de Senneville BD, 2010, MAGN RESON MED, V64, P1373, DOI 10.1002/mrm.22514; de Zwart JA, 2001, MAGNET RESON MED, V45, P128, DOI 10.1002/1522-2594(200101)45:1<128::AID-MRM1017>3.0.CO;2-M; Dodd GD, 2000, RADIOGRAPHICS, V20, P9, DOI 10.1148/radiographics.20.1.g00ja019; Duck F.A., 1990, MED PHYS, V18; Dupre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118212; Fehrenbach J, 2010, ULTRASONICS, V50, P44, DOI 10.1016/j.ultras.2009.07.009; Feng M, 2008, INT J RADIAT ONCOL, V72, pS255, DOI 10.1016/j.ijrobp.2008.06.655; Gelet A, 1996, EUR UROL, V29, P174; Gignoux BMH, 2003, ANN CHIR, V128, P18, DOI 10.1016/S0003-3944(02)00004-4; GOSS S A, 1979, Ultrasound in Medicine and Biology, V5, P181, DOI 10.1016/0301-5629(79)90086-3; HARAUZ G, 1979, J NUCL MED, V20, P733; Harris EJ, 2010, PHYS MED BIOL, V55, P3363, DOI 10.1088/0031-9155/55/12/007; Hsu A, 2005, MED PHYS, V32, P1500, DOI 10.1118/1.1915934; Iiyori N, 2005, PHYSIOL GENOMICS, V24, P65, DOI 10.1152/physiolgenomics.00203.2005; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Kirilova A, 2008, INT J RADIAT ONCOL, V71, P1189, DOI 10.1016/j.ijrobp.2007.11.026; Kopelman D, 2006, EUR J RADIOL, V59, P157, DOI 10.1016/j.ejrad.2006.04.008; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; Marquet F, 2011, PHYS MED BIOL, V56, P7061, DOI 10.1088/0031-9155/56/22/005; McDannold N, 2008, J MAGN RESON IMAGING, V28, P1026, DOI 10.1002/jmri.21506; McDannold NJ, 2000, RADIOLOGY, V216, P517, DOI 10.1148/radiology.216.2.r00au42517; McLoughlin James M, 2006, Cancer Control, V13, P32; Melodelima D, 2009, PHYS MED BIOL, V54, P6353, DOI 10.1088/0031-9155/54/20/021; Melodelima D, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-28; Melodelima D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805113; N'Djin WA, 2011, MED PHYS, V38, P1769, DOI 10.1118/1.3551985; N'Djin WA, 2010, PHYS MED BIOL, V55, P2137, DOI 10.1088/0031-9155/55/8/002; NYBORG WL, 1988, PHYS MED BIOL, V33, P785, DOI 10.1088/0031-9155/33/7/002; Olbrich B, 2005, INT CONGR SER, V1281, P248, DOI 10.1016/j.ics.2005.03.285; Parmentier H, 2009, ANN SURG, V249, P129, DOI 10.1097/SLA.0b013e31818c70b6; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Pawlik TM, 2003, ANN SURG ONCOL, V10, P1059, DOI 10.1245/ASO.2003.03.026; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Pepin EW, 2010, PHYS MED BIOL, V55, P3325, DOI 10.1088/0031-9155/55/12/005; Pernot M, 2004, ULTRASOUND MED BIOL, V30, P1239, DOI 10.1016/j.ultrasmedbio.2004.07.021; Poon RTP, 2000, ANN SURG, V231, P544, DOI 10.1097/00000658-200004000-00014; Qin J, 2012, INT J GYNECOL OBSTET, V117, P273, DOI 10.1016/j.ijgo.2012.01.011; Remouchamps VM, 2003, INT J RADIAT ONCOL, V57, P968, DOI 10.1016/S0360-3016(03)00710-7; Rieke V, 2004, MAGNET RESON MED, V51, P1223, DOI 10.1002/mrm.20090; Rijkhorst EJ, 2011, LECT NOTES COMPUT SC, V6891, P605, DOI 10.1007/978-3-642-23623-5_76; Rivoire M, 2002, CANCER, V95, P2283, DOI 10.1002/cncr.10973; Roujol S, 2010, MAGN RESON MED, V63, P1080, DOI 10.1002/mrm.22309; Sanghvi N T, 1999, Eur J Ultrasound, V9, P19; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Seket B, 2007, J SURG RES, V142, P81, DOI 10.1016/j.jss.2006.10.025; SURAMO I, 1984, ACTA RADIOL DIAGN, V25, P129, DOI 10.1177/028418518402500208; Tanter M, 2007, INT J HYPERTHER, V23, P141, DOI 10.1080/02656730701209996; Uchida T, 2009, INT J UROL, V16, P881, DOI 10.1111/j.1442-2042.2009.02389.x; Valvano J. W., 1987, Lasers in the Life Sciences, V1, P219; Vincenot J, 2013, ULTRASOUND MED BIOL, V39, P1241, DOI 10.1016/j.ultrasmedbio.2013.01.019; Weidensteiner C, 2004, J MAGN RESON IMAGING, V19, P438, DOI 10.1002/jmri.20019; WEISS PH, 1972, J NUCL MED, V13, P758; Wong JW, 1999, INT J RADIAT ONCOL, V44, P911, DOI 10.1016/S0360-3016(99)00056-5; Wu F, 2004, ULTRASOUND MED BIOL, V30, P245, DOI 10.1016/j.ultrasmedbio.2003.10.010; Yu WC, 2006, MED IMAGE ANAL, V10, P495, DOI 10.1016/j.media.2005.12.003; Zderic V, 2007, ULTRASOUND MED BIOL, V33, P1251, DOI 10.1016/j.ultrasmedbio.2007.02.010; Zhu H, 2009, EUR J RADIOL, V72, P160, DOI 10.1016/j.ejrad.2008.07.003	72	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137317	10.1371/journal.pone.0137317	http://dx.doi.org/10.1371/journal.pone.0137317			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398366	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500029
J	Perucci, LO; Carneiro, FS; Ferreira, CN; Sugimoto, MA; Soriani, FM; Martins, GG; Lima, KM; Guimaraes, FL; Teixeira, AL; Dusse, LM; Gomes, KB; Sousa, LP				Perucci, Luiza O.; Carneiro, Fernanda S.; Ferreira, Claudia N.; Sugimoto, Michelle A.; Soriani, Frederico M.; Martins, Gustavo G.; Lima, Katia M.; Guimaraes, Flavia L.; Teixeira, Antonio L.; Dusse, Luci M.; Gomes, Karina B.; Sousa, Lirlandia P.			Annexin A1 Is Increased in the Plasma of Preeclamptic Women	PLOS ONE			English	Article							EARLY-ONSET; INFLAMMATION; PREGNANCY; EXPRESSION; RESOLUTION; PROTEIN; PATHOPHYSIOLOGY; GLUCOCORTICOIDS; ECLAMPSIA; DISEASE	Background Preeclampsia (PE) is a pregnancy disease associated with exacerbated inflammatory response. Annexin A1 (AnxA1) is a glucocorticoid-regulated protein endowed with anti-inflammatory and proresolving properties that has been much studied in various animal models of inflammation but poorly studied in the context of human inflammatory diseases. The main objective of this study was to measure AnxA1 levels in PE women and to compare those levels in normotensive pregnant and non-pregnant women. We evaluated the association among AnxA1, ultrasensitive C reactive protein (us-CRP) and soluble tumor necrosis factor alpha receptor type 1 (sTNF-R1) plasma levels of the study participants. Methods This study included 40 non-pregnant, 38 normotensive pregnant and 51 PE women. PE women were stratified in early (N = 23) and late (N = 28) subgroups, according to gestational age (GA) at onset of clinical symptoms. Protein AnxA1 and us-CRP plasma levels were determined by ELISA and immunoturbidimetric assays, respectively. Transcript levels of AnxA1 in peripheral blood mononuclear cells (PBMC) were measured by real time RT-PCR. Results Increased levels of AnxA1 coincided with higher us-CRP levels in the plasma of PE women. Pregnant women with early PE had higher levels of AnxA1 and us-CRP than normotensive pregnant women with GA <34 weeks. No significant difference was found for AnxA1 and us-CRP, comparing late PE and normotensive pregnant women with GA >= 34 weeks. AnxA1 mRNA levels in PBMC were similar among the studied groups. AnxA1 was positively correlated with sTNF-R1, but not with us-CRP. Conclusions Our data show that increased AnxA1 levels were associated with a systemic inflammatory phenotype in PE, suggesting AnxA1 deregulation in PE pathogenesis. However, more studies are needed to clarify the role of AnxA1 and other proresolving molecules in the context of the systemic inflammatory response in this intriguing disease.	[Perucci, Luiza O.; Carneiro, Fernanda S.; Sugimoto, Michelle A.; Lima, Katia M.; Guimaraes, Flavia L.; Dusse, Luci M.; Gomes, Karina B.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Perucci, Luiza O.; Dusse, Luci M.; Gomes, Karina B.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Programa Posgrad Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Ferreira, Claudia N.] Univ Fed Minas Gerais, Cologio Tecn, Belo Horizonte, MG, Brazil; [Sugimoto, Michelle A.; Dusse, Luci M.; Sousa, Lirlandia P.] Univ Fed Minas Gerais, Programa Posgrad Ciencias Farmaceut, Belo Horizonte, MG, Brazil; [Soriani, Frederico M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Martins, Gustavo G.] Hosp Municipal Odilon Behrens, Belo Horizonte, MG, Brazil; [Lima, Katia M.] Univ Fed Minas Gerais, Programa Posgrad Biol Celular, Belo Horizonte, MG, Brazil; [Teixeira, Antonio L.] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Sousa, LP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.	lipsousa72@gmail.com	Sugimoto, Michelle Amantea/ABB-2024-2020; Teixeira, Antonio L/N-3315-2014; Soriani, Frederico M/A-8896-2013	Sugimoto, Michelle Amantea/0000-0002-4527-6065; Teixeira, Antonio L/0000-0002-9621-5422; Soriani, Frederico M/0000-0003-4720-6746; Sousa, Lirlandia/0000-0002-1042-9762; Carneiro, Fernanda/0000-0002-5776-1519; Dusse, Luci/0000-0002-7484-1684	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-00588-11]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (APQ-00588-11; http://www.fapemig.br/) (LPS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) (LPS), Pro-Reitoria de Pesquisa da UFMG (https://www.ufmg.br/prpq/) (LPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECH REP SER, V894, P1; Borges VT, 2015, PREGNANCY HYPERTENSI, V5, P53; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1, DOI 10.1111/j.1600-0609.1995.tb01618.x; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Farzadnia M, 2013, INTERV MED APPL SCI, V5, P26, DOI 10.1556/IMAS.5.2013.1.5; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; Hall DR, 2000, BRIT J OBSTET GYNAEC, V107, P1258, DOI 10.1111/j.1471-0528.2000.tb11617.x; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Perucci LO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097632; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saito S, 2010, IMMUNOL CELL BIOL, V88, P615, DOI 10.1038/icb.2010.68; Sarndahl E, 2010, METABOLISM, V59, P433, DOI 10.1016/j.metabol.2009.07.044; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Solito E, 1998, CYTOKINE, V10, P514, DOI 10.1006/cyto.1997.0325; Sousa LP, 2013, CURR OPIN PHARMACOL, V13, P625, DOI 10.1016/j.coph.2013.03.007; Sun M, 1996, PLACENTA, V17, P181, DOI 10.1016/S0143-4004(96)80012-9; Tsai WH, 2014, CHINESE J PHYSIOL, V57, P1, DOI 10.4077/CJP.2014.BAB193; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; Vong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039244; Wang XZ, 2015, ALZHEIMERS DEMENT, V11, P40, DOI 10.1016/j.jalz.2013.12.024; Zhang Z, 2013, HYPERTENS PREGNANCY, V32, P270, DOI 10.3109/10641955.2013.798332	36	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138475	10.1371/journal.pone.0138475	http://dx.doi.org/10.1371/journal.pone.0138475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398190	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500068
J	Yang, NN; Jiao, P; Zhang, JL; Zhang, XJ; Yao, ST; Zhan, EX; Li, B; Zong, CL; Tian, H; Si, YH; Du, YS; Qin, SC; Wang, H				Yang Nana; Jiao Peng; Zhang Jianlin; Zhang Xiangjian; Yao Shutong; Zhan Enxin; Li Bin; Zong Chuanlong; Tian Hua; Si Yanhong; Du Yunsai; Qin Shucun; Wang Hui			Reverse-D-4F Increases the Number of Endothelial Progenitor Cells and Improves Endothelial Progenitor Cell Dysfunctions in High Fat Diet Mice	PLOS ONE			English	Article							I MIMETIC PEPTIDE; CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; INHIBITS ATHEROSCLEROSIS; BIOLOGICAL FUNCTIONS; PERIPHERAL-BLOOD; VASCULAR REPAIR; BONE-MARROW; EXPRESSION	Although high density lipoprotein (HDL) improves the functions of endothelial progenitor cells (EPCs), the effect of HDL ApoAI mimetic peptide reverse-D-4F (Rev-D4F) on EPC mobilization and repair of EPC dysfunctions remains to be studied. In this study, we investigated the effects of Rev-D4F on peripheral blood cell subpopulations in C57 mice treated with a high fat diet and the mechanism of Rev-D4F in improving the function of EPCs impaired by tumor necrosis factor-alpha (TNF-alpha). The high fat diet significantly decreased the number of EPCs, EPC migratory functions, and the percentage of lymphocytes in the white blood cells. However, it significantly increased the number of white blood cells, the percentage of monocytes in the white blood cells, and the level of vascular endothelial growth factor (VEGF) and TNF-alpha in the plasma. Rev-D4F clearly inhibited the effect of the high fat diet on the quantification of peripheral blood cell subpopulations and cytokine levels, and increased stromal cell derived factor 1 alpha (SDF-1 alpha) in the plasma. We provided in vitro evidence that TNF-alpha impaired EPC proliferation, migration, and tube formation through inactive AKT and eNOS, which was restored by Rev-D4F treatment. In contrast, both the PI3-kinase (PI3K) inhibitor (LY294002) and AKT inhibitor (perifosine) obviously inhibited the restoration of Rev-4F on EPCs impaired by TNF-alpha. Our results suggested that Rev-D4F increases the quantity of endothelial progenitor cells through increasing the SDF-1 alpha levels and decreasing the TNF-alpha level of peripheral blood in high fat diet-induced C57BL/6J mice, and restores TNF-alpha induced dysfunctions of EPCs partly through stimulating the PI3K/AKT signal pathway.	[Yang Nana; Wang Hui] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An, Shandong, Peoples R China; [Yang Nana; Jiao Peng; Yao Shutong; Zhan Enxin; Li Bin; Zong Chuanlong; Tian Hua; Si Yanhong; Du Yunsai; Qin Shucun] Taishan Med Univ, Key Lab Atherosclerosis Univ Shandong, Inst Atherosclerosis, Tai An, Shandong, Peoples R China; [Zhang Xiangjian; Qin Shucun] Hebei Collaborat Innovat Ctr Cardiocerebrovasc Di, Shijiazhuang, Peoples R China; [Zhang Xiangjian; Qin Shucun] Hebei Key Lab Vasc Homeostasis, Shijiazhuang, Peoples R China; [Zhang Jianlin] Cent Hosp Taian, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong First Medical University & Shandong Academy of Medical Sciences	Qin, SC (corresponding author), Taishan Med Univ, Key Lab Atherosclerosis Univ Shandong, Inst Atherosclerosis, Tai An, Shandong, Peoples R China.	shucunqin@hotmail.com; wanghui2328@sdau.edu.cn			National Natural Science Foundation of China [30971098]; Province Natural Science Foundation of Shandong [Z2008C03, ZR2012HL18]; Province Higher University Science and Technology Development Project of Shandong [J14LK03]; Medical Science and Technology Program of Shandong Province [2013WS0319]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Province Higher University Science and Technology Development Project of Shandong; Medical Science and Technology Program of Shandong Province	This study was supported by the National Natural Science Foundation of China (No.30971098), the Province Natural Science Foundation of Shandong (No.Z2008C03), the Province Natural Science Foundation of Shandong (No.ZR2012HL18), Province Higher University Science and Technology Development Project of Shandong (No. J14LK03) and Medical Science and Technology Program of Shandong Province (2013WS0319).	Aguilar EC, 2012, BRAZ J MED BIOL RES, V45, P601, DOI 10.1590/S0100-879X2012007500074; Alexandru N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052058; Bogoslovsky T, 2011, STROKE, V42, P618, DOI 10.1161/STROKEAHA.110.596007; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Chen TG, 2011, CELL PROLIFERAT, V44, P352, DOI 10.1111/j.1365-2184.2011.00764.x; Dinh W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-58; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hulthe J, 2002, CLIN SCI, V103, P123, DOI 10.1042/CS20010366; Kehmeier ES, 2012, CLIN RES CARDIOL, V101, P815, DOI 10.1007/s00392-012-0465-x; Kesh SB, 2013, LIFE SCI, V92, P938, DOI 10.1016/j.lfs.2013.03.015; La Favor JD, 2013, AM J PHYSIOL-REG I, V305, pR423, DOI 10.1152/ajpregu.00049.2013; Lesnik P, 2006, ARTERIOSCL THROM VAS, V26, P965, DOI 10.1161/01.ATV.0000219613.90372.c1; Mackesy DZ, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-34; Mannarino E, 2008, ANGIOLOGY, V59, p69S, DOI 10.1177/0003319708320761; Ou ZJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE683, DOI 10.1152/ajpendo.00136.2012; Peterson SJ, 2007, J PHARMACOL EXP THER, V322, P514, DOI 10.1124/jpet.107.119479; Profumo E, 2007, ATHEROSCLEROSIS, V191, P340, DOI 10.1016/j.atherosclerosis.2006.03.030; Qin SC, 2012, J CARDIOVASC PHARM T, V17, P334, DOI 10.1177/1074248411434598; Rossi F, 2013, OBESITY, V21, P2356, DOI 10.1002/oby.20367; Safranow K, 2009, TISSUE ANTIGENS, V74, P386, DOI 10.1111/j.1399-0039.2009.01332.x; Santos Maria Gisele dos, 2008, Arq Bras Cardiol, V90, P276; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Sun Y, 2012, INT J MOL MED, V30, P622, DOI 10.3892/ijmm.2012.1032; Tsai TH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-137; Tso C, 2006, ARTERIOSCL THROM VAS, V26, P1144, DOI 10.1161/01.ATV.0000216600.37436.cf; Tyrovolas S, 2010, MATURITAS, V65, P122, DOI 10.1016/j.maturitas.2009.07.003; Ueda S, 2012, CARDIOVASC THER, V30, P249, DOI 10.1111/j.1755-5922.2011.00264.x; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vecoli C, 2011, J CELL BIOCHEM, V112, P2616, DOI 10.1002/jcb.23188; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Yang NN, 2013, CYTOTECHNOLOGY, V65, P541, DOI 10.1007/s10616-012-9502-x; Yang NN, 2013, MOL CELL BIOCHEM, V377, P229, DOI 10.1007/s11010-013-1592-z; Ying R, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-180; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	37	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138832	10.1371/journal.pone.0138832	http://dx.doi.org/10.1371/journal.pone.0138832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398523	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500114
J	Prade, E; Bittner, HJ; Sarkar, R; del Amo, JML; Althoff-Ospelt, G; Multhaup, G; Hildebrand, PW; Reif, B				Prade, Elke; Bittner, Heiko J.; Sarkar, Riddhiman; Lopez del Amo, Juan Miguel; Althoff-Ospelt, Gerhard; Multhaup, Gerd; Hildebrand, Peter W.; Reif, Bernd			Structural Mechanism of the Interaction of Alzheimer Disease A beta Fibrils with the Non-steroidal Anti-inflammatory Drug (NSAID) Sulindac Sulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; drug design; protein structure; solid-state NMR; magic angle spinning; ligand interactions	AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE MODULATORS; MOLECULAR-STRUCTURE; EXPERIMENTAL CONSTRAINTS; TRANSMEMBRANE DOMAIN; COMMON MECHANISM; PEPTIDE; RESONANCE; MODEL; OLIGOMERIZATION	Alzheimer disease is the most severe neurodegenerative disease worldwide. In the past years, a plethora of small molecules interfering with amyloid- (A) aggregation has been reported. However, their mode of interaction with amyloid fibers is not understood. Non-steroidal anti-inflammatory drugs (NSAIDs) are known -secretase modulators; they influence A populations. It has been suggested that NSAIDs are pleiotrophic and can interact with more than one pathomechanism. Here we present a magic angle spinning solid-state NMR study demonstrating that the NSAID sulindac sulfide interacts specifically with Alzheimer disease A fibrils. We find that sulindac sulfide does not induce drastic architectural changes in the fibrillar structure but intercalates between the two -strands of the amyloid fibril and binds to hydrophobic cavities, which are found consistently in all analyzed structures. The characteristic Asp(23)-Lys(28) salt bridge is not affected upon interacting with sulindac sulfide. The primary binding site is located in the vicinity of residue Gly(33), a residue involved in Met(35) oxidation. The results presented here will assist the search for pharmacologically active molecules that can potentially be employed as lead structures to guide the design of small molecules for the treatment of Alzheimer disease.	[Prade, Elke; Sarkar, Riddhiman; Reif, Bernd] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Bittner, Heiko J.; Hildebrand, Peter W.] Univ Med Berlin, Inst Med Phys & Biophys, Mol Modeling, D-10117 Berlin, Germany; [Lopez del Amo, Juan Miguel] CIC Energigune, Minano 01510, Alava, Spain; [Althoff-Ospelt, Gerhard] Bruker BioSpin, D-76287 Rheinstetten, Germany; [Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Reif, Bernd] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany	Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; CIC Energigune; Bruker Corporation; Bruker BioSpin GmbH; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Reif, B (corresponding author), Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85747 Garching, Germany.	reif@tum.de	del Amo, Juan Miguel Lopez/I-9392-2012	del Amo, Juan Miguel Lopez/0000-0002-2315-5414; Reif, Bernd/0000-0001-7368-7198; Sarkar, Riddhiman/0000-0001-9055-7897	German Research Foundation [SFB-1035, SFB740]; Norddeutscher Verbund fur Hoch- und Hochstleistungsrechner [bec00085]	German Research Foundation(German Research Foundation (DFG)); Norddeutscher Verbund fur Hoch- und Hochstleistungsrechner	This work was performed in the framework of SFB-1035/Project-B07 and SFB740/Project-B6 (German Research Foundation). The computer time necessary for calculation of docking experiments was provided by Norddeutscher Verbund fur Hoch- und Hochstleistungsrechner Project bec00085.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; [Anonymous], 2014, SCHROD REL 2014 1 MA; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Barrett PJ, 2011, BIOCHEMISTRY-US, V50, P10328, DOI 10.1021/bi201371j; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Ben Khalifa N, 2010, CELL ADHES MIGR, V4, P268, DOI 10.4161/cam.4.2.11476; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BLOEMBERGEN N, 1949, PHYSICA, V15, P386, DOI 10.1016/0031-8914(49)90114-7; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Brunelle P, 2002, J ALZHEIMERS DIS, V4, P283, DOI 10.3233/JAD-2002-4403; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Castellani F, 2003, BIOCHEMISTRY-US, V42, P11476, DOI 10.1021/bi034903r; Chen W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4037; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21990, DOI 10.1073/pnas.1006091107; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Dasari M, 2011, CHEMBIOCHEM, V12, P407, DOI 10.1002/cbic.201000602; Delaunay B, 1934, B ACAD SCI URSS, V6, P793; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Goede A, 1997, J COMPUT CHEM, V18, P1113, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1113::AID-JCC1>3.0.CO;2-U; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; HING AW, 1993, J MAGN RESON SER A, V103, P151, DOI 10.1006/jmra.1993.1146; HING AW, 1992, J MAGN RESON, V96, P205, DOI 10.1016/0022-2364(92)90305-Q; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Husch J, 2011, EUR J PHARM SCI, V44, P103, DOI 10.1016/j.ejps.2011.06.010; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kanski J, 2002, BBA-MOL BASIS DIS, V1586, P190, DOI 10.1016/S0925-4439(01)00097-7; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lopez del Amo JM, 2012, ANGEW CHEM INT EDIT, V51, P6136, DOI 10.1002/anie.201200965; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mithu VS, 2014, J BIOL CHEM, V289, P11122, DOI 10.1074/jbc.M113.519447; Moreno MM, 2009, BBA-BIOMEMBRANES, V1788, P1296, DOI 10.1016/j.bbamem.2009.01.016; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Niu Z, 2014, ANGEW CHEM INT EDIT, V53, P9294, DOI 10.1002/anie.201311106; Olsson F, 2014, J BIOL CHEM, V289, P1540, DOI 10.1074/jbc.M113.498246; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Prade E, 2014, NEW DEV NMR, V3, P533; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Ramamoorthy A, 2013, BIOPHYS J, V105, P287, DOI 10.1016/j.bpj.2013.05.004; Rauk A, 2000, J AM CHEM SOC, V122, P9761, DOI 10.1021/ja994436u; Rauk A., 2000, J AM CHEM SOC, V122, P4185, DOI DOI 10.1021/JA9939688; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Rother K, 2009, NUCLEIC ACIDS RES, V37, pD393, DOI 10.1093/nar/gkn769; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tsai J, 2002, BIOINFORMATICS, V18, P985, DOI 10.1093/bioinformatics/18.7.985; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wanngren J, 2012, J BIOL CHEM, V287, P32640, DOI 10.1074/jbc.M112.376541; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Yesuvadian R, 2014, BIOCHEM BIOPH RES CO, V447, P590, DOI 10.1016/j.bbrc.2014.04.041; Yoo SI, 2011, ANGEW CHEM INT EDIT, V50, P5110, DOI 10.1002/anie.201007824; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	83	21	22	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28737	28745		10.1074/jbc.M115.675215	http://dx.doi.org/10.1074/jbc.M115.675215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26416887	Green Published, hybrid			2022-12-26	WOS:000365762300017
J	Desmond, PF; Muriel, J; Markwardt, ML; Rizzo, MA; Bloch, RJ				Desmond, Patrick F.; Muriel, Joaquin; Markwardt, Michele L.; Rizzo, Mark A.; Bloch, Robert J.			Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE POLARIZATION MICROSCOPY; CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-ATPASE; FUNCTIONAL ASSOCIATION; TRANSMEMBRANE HELICES; SARCOLIPIN DECREASES; CA2+ HOMEOSTASIS; NMR-SPECTROSCOPY; MESSENGER-RNA; PHOSPHOLAMBAN	Small ankyrin 1 (sAnk1) is a 17-kDa transmembrane (TM) protein that binds to the cytoskeletal protein, obscurin, and stabilizes the network sarcoplasmic reticulum in skeletal muscle. We report that sAnk1 shares homology in its TM amino acid sequence with sarcolipin, a small protein inhibitor of the sarco-(endo) plasmic reticulum Ca2+-ATPase (SERCA). Here we investigate whether sAnk1 and SERCA1 interact. Our results indicate that sAnk1 interacts specifically with SERCA1 in sarcoplasmic reticulum vesicles isolated from rabbit skeletal muscle, and in COS7 cells transfected to express these proteins. This interaction was demonstrated by co-immunoprecipitation and an anisotropy-based FRET method. Binding was reduced similar to 2-fold by the replacement of all of the TM amino acids of sAnk1 with leucines by mutagenesis. This suggests that, like sarcolipin, sAnk1 interacts with SERCA1 at least in part via its TM domain. Binding of the cytoplasmic domain of sAnk1 to SERCA1 was also detected in vitro. ATPase activity assays show that co-expression of sAnk1 with SERCA1 leads to a reduction of the apparent Ca2+ affinity of SERCA1 but that the effect of sAnk1 is less than that of sarcolipin. The sAnk1 TM mutant has no effect on SERCA1 activity. Our results suggest that sAnk1 interacts with SERCA1 through its TM and cytoplasmic domains to regulate SERCA1 activity and modulate sequestration of Ca2+ in the sarcoplasmic reticulum lumen. The identification of sAnk1 as a novel regulator of SERCA1 has significant implications for muscle physiology and the development of therapeutic approaches to treat heart failure and muscular dystrophies linked to Ca2+ misregulation.	[Desmond, Patrick F.; Muriel, Joaquin; Markwardt, Michele L.; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Dept Physiol, Baltimore, MD 21230 USA; [Desmond, Patrick F.; Bloch, Robert J.] Univ Maryland, Program Biochem & Mol Biol, Baltimore, MD 21230 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bloch, RJ (corresponding author), HSF1 Rm 580C,685 W Baltimore St, Baltimore, MD 21201 USA.	rbloch@umaryland.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 DK077140, RO1 AR056330]; Training Program in Integrative Membrane Biology [T32 GM08181]; Interdisciplinary Training Program in Muscle Biology [T32 AR 007592]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Integrative Membrane Biology; Interdisciplinary Training Program in Muscle Biology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1 DK077140 (to M. A. R.) and RO1 AR056330 (to R. J. B.).; Supported with funds from the Training Program in Integrative Membrane Biology (T32 GM08181, Dr. M. Trudeau, Principal Investigator) and the Interdisciplinary Training Program in Muscle Biology (T32 AR 007592, Dr. M. Schneider, Principle Investigator). The authors declare that they have no conflicts of interest with the contents of this article.	Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; Ackermann MA, 2011, J CELL SCI, V124, P3619, DOI 10.1242/jcs.085159; Adachi T, 2010, ADV PHARMACOL, V59, P165, DOI 10.1016/S1054-3589(10)59006-9; Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Borzok MA, 2007, J BIOL CHEM, V282, P32384, DOI 10.1074/jbc.M704089200; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Diaz ME, 2005, CELL CALCIUM, V38, P391, DOI 10.1016/j.ceca.2005.06.017; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gayan-Ramirez G, 2000, J PHYSIOL-LONDON, V524, P387, DOI 10.1111/j.1469-7793.2000.t01-2-00387.x; Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; HARRER JM, 1994, MOL CELL BIOCHEM, V140, P185, DOI 10.1007/BF00926757; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Honarnejad K, 2012, INT J BIOCHEM CELL B, V44, P1983, DOI 10.1016/j.biocel.2012.07.019; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hutter MC, 2002, CHEMBIOCHEM, V3, P1200, DOI 10.1002/1439-7633(20021202)3:12<1200::AID-CBIC1200>3.0.CO;2-H; Kabbara AA, 1999, CELL CALCIUM, V25, P227, DOI 10.1054/ceca.1999.0023; Kerr JP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00089; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Kosk-Kosicka Danuta, 2013, Methods Mol Biol, V937, P343; KOSS KL, 1995, CIRC RES, V77, P342, DOI 10.1161/01.RES.77.2.342; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Launikonis BS, 2005, J PHYSIOL-LONDON, V567, P523, DOI 10.1113/jphysiol.2005.087973; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Porter NC, 2005, MOL MEMBR BIOL, V22, P421, DOI 10.1080/09687860500244262; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Schmidt AG, 2002, CARDIOVASC RES, V56, P248, DOI 10.1016/S0008-6363(02)00541-2; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; SOMLYO AV, 1981, J CELL BIOL, V90, P577, DOI 10.1083/jcb.90.3.577; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Tada M, 1998, TRENDS CARDIOVAS MED, V8, P330, DOI 10.1016/S1050-1738(98)00032-2; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1993, J BIOL CHEM, V268, P2809; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Vangheluwe P, 2006, J MOL CELL CARDIOL, V41, P308, DOI 10.1016/j.yjmcc.2006.05.014; WATANABE Y, 1991, J BIOCHEM, V110, P40, DOI 10.1093/oxfordjournals.jbchem.a123540; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621; Ziman AP, 2010, BIOPHYS J, V99, P2705, DOI 10.1016/j.bpj.2010.08.032	90	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27854	27867		10.1074/jbc.M115.676585	http://dx.doi.org/10.1074/jbc.M115.676585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405035	hybrid, Green Published			2022-12-26	WOS:000365757500035
J	Wang, K; Kelley, MH; Wu, WW; Adelman, JP; Maylie, J				Wang, Kang; Kelley, Melissa H.; Wu, Wendy W.; Adelman, John P.; Maylie, James			Apamin Boosting of Synaptic Potentials in Ca(V)2.3 R-Type Ca2+ Channel Null Mice	PLOS ONE			English	Article							ACTIVITY-DEPENDENT TRAFFICKING; DENDRITIC SPINES; CALCIUM-CHANNELS; HIPPOCAMPAL-NEURONS; NICKEL BLOCK; CA1 NEURONS; SUBUNIT; EXPRESSION; CONTRIBUTES; RECEPTORS	SK2- and K(V)4.2-containing K+ channels modulate evoked synaptic potentials in CA1 pyramidal neurons. Each is coupled to a distinct Ca2+ source that provides Ca2+-dependent feedback regulation to limit AMPA receptor (AMPAR)-and NMDA receptor (NMDAR)-mediated postsynaptic depolarization. SK2-containing channels are activated by Ca2+ entry through NMDARs, whereas K(V)4.2-containing channel availability is increased by Ca2+ entry through SNX-482 (SNX) sensitive Ca(V)2.3 R-type Ca2+ channels. Recent studies have challenged the functional coupling between NMDARs and SK2-containing channels, suggesting that synaptic SK2-containing channels are instead activated by Ca2+ entry through R-type Ca2+ channels. Furthermore, SNX has been implicated to have off target affects, which would challenge the proposed coupling between R-type Ca2+ channels and K(V)4.2-containing K+ channels. To reconcile these conflicting results, we evaluated the effect of SK channel blocker apamin and R-type Ca2+ channel blocker SNX on evoked excitatory postsynaptic potentials (EPSPs) in CA1 pyramidal neurons from Ca(V)2.3 null mice. The results show that in the absence of Ca(V)2.3 channels, apamin application still boosted EPSPs. The boosting effect of Ca(V)2.3 channel blockers on EPSPs observed in neurons from wild type mice was not observed in neurons from Ca(V)2.3 null mice. These data are consistent with a model in which SK2-containing channels are functionally coupled to NMDARs and K(V)4.2-containing channels to Ca(V)2.3 channels to provide negative feedback regulation of EPSPs in the spines of CA1 pyramidal neurons.	[Wang, Kang; Kelley, Melissa H.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Wu, Wendy W.; Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA.	mayliej@ohsu.edu	Wang, Kang/AAE-1168-2019	Wang, Kang/0000-0002-4563-7385	National Institute of Health [5R01NS038880-15, 5R01MH093599-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institute of Health, 5R01NS038880-15, JPA; National Institute of Health, 5R01MH093599-03, JPA.	Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Ballesteros-Merino C, 2012, HIPPOCAMPUS, V22, P1467, DOI 10.1002/hipo.20986; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Giessel AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020939; Heath NC, 2014, J NEUROSCI, V34, P8800, DOI 10.1523/JNEUROSCI.0981-14.2014; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kimm T, 2014, J NEUROSCI, V34, P9182, DOI 10.1523/JNEUROSCI.0339-14.2014; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Sochivko D, 2002, J PHYSIOL-LONDON, V542, P699, DOI 10.1113/jphysiol.2002.020677; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Wang K, 2014, NEURON, V81, P379, DOI 10.1016/j.neuron.2013.11.004; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139332	10.1371/journal.pone.0139332	http://dx.doi.org/10.1371/journal.pone.0139332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418566	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400078
J	Banat, GA; Tretyn, A; Pullamsetti, SS; Wilhelm, J; Weigert, A; Olesch, C; Ebel, K; Stiewe, T; Grimminger, F; Seeger, W; Fink, L; Savai, R				Banat, G-Andre; Tretyn, Aleksandra; Pullamsetti, Soni Savai; Wilhelm, Jochen; Weigert, Andreas; Olesch, Catherine; Ebel, Katharina; Stiewe, Thorsten; Grimminger, Friedrich; Seeger, Werner; Fink, Ludger; Savai, Rajkumar			Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; MYELOID CELLS; PLASMA-CELLS; MACROPHAGES; SURVIVAL; PROMOTION; PD-1	Recent studies indicate that the abnormal microenvironment of tumors may play a critical role in carcinogenesis, including lung cancer. We comprehensively assessed the number of stromal cells, especially immune/inflammatory cells, in lung cancer and evaluated their infiltration in cancers of different stages, types and metastatic characteristics potential. Immunohistochemical analysis of lung cancer tissue arrays containing normal and lung cancer sections was performed. This analysis was combined with cyto-/histomorphological assessment and quantification of cells to classify/subclassify tumors accurately and to perform a high throughput analysis of stromal cell composition in different types of lung cancer. In human lung cancer sections we observed a significant elevation/infiltration of total-T lymphocytes (CD3(+)), cytotoxic-T cells (CD8(+)), T-helper cells (CD4(+)), B cells (CD20(+)), macrophages (CD68(+)), mast cells (CD117(+)), mononuclear cells (CD11c(+)), plasma cells, activated-T cells (MUM1(+)), B cells, myeloid cells (PD1(+)) and neutrophilic granulocytes (myeloperoxidase(+)) compared with healthy donor specimens. We observed all of these immune cell markers in different types of lung cancers including squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, small cell carcinoma, papillary adenocarcinoma, metastatic adenocarcinoma, and bronchioloalveolar carcinoma. The numbers of all tumor-associated immune cells (except MUM1(+) cells) in stage III cancer specimens was significantly greater than those in stage I samples. We observed substantial stage-dependent immune cell infiltration in human lung tumors suggesting that the tumormicroenvironment plays a critical role during lung carcinogenesis. Strategies for therapeutic interference with lung cancer microenvironment should consider the complexity of its immune cell composition.	[Banat, G-Andre; Pullamsetti, Soni Savai; Wilhelm, Jochen; Grimminger, Friedrich; Seeger, Werner; Savai, Rajkumar] Univ Giessen & Marburg, Lung Ctr, Internal Med, Giessen, Germany; [Tretyn, Aleksandra; Pullamsetti, Soni Savai; Ebel, Katharina; Seeger, Werner; Savai, Rajkumar] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Weigert, Andreas; Olesch, Catherine] Goethe Univ Frankfurt, Inst Biochem 1, D-60054 Frankfurt, Germany; [Stiewe, Thorsten] Univ Marburg, Mol Oncol, Marburg, Germany; [Fink, Ludger] UEGP, Inst Pathol & Cytol, Wetzlar, Germany	Max Planck Society; Goethe University Frankfurt; Philipps University Marburg	Savai, R (corresponding author), Univ Giessen & Marburg, Lung Ctr, Internal Med, Giessen, Germany.	rajkumar.savai@mpi-bn.mpg.de	Wilhelm, Jochen/AAX-4302-2021; Weigert, Andreas/E-6540-2010	Wilhelm, Jochen/0000-0001-5544-9647; Pullamsetti, Soni Savai/0000-0003-0440-8831; Seeger, Werner/0000-0003-1946-0894; Stiewe, Thorsten/0000-0003-0134-7826; Grimminger, Friedrich/0000-0001-8725-6276; Weigert, Andreas/0000-0002-7529-1952	Verein zur Forderung der Krebsforschung in Giessen e.V; LOEWE Universities of Giessen and Marburg Lung Center (UGMLC)	Verein zur Forderung der Krebsforschung in Giessen e.V; LOEWE Universities of Giessen and Marburg Lung Center (UGMLC)	This work was supported by Verein zur Forderung der Krebsforschung in Giessen e.V, and the LOEWE Universities of Giessen and Marburg Lung Center (UGMLC).	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Bellocq A, 1998, AM J PATHOL, V152, P83; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; El-Nikhely N, 2012, EXPERT OPIN INV DRUG, V21, P1107, DOI 10.1517/13543784.2012.693478; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Fujimoto M, 2013, HUM PATHOL, V44, P1569, DOI 10.1016/j.humpath.2013.01.002; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kataki A, 2002, J LAB CLIN MED, V140, P320, DOI 10.1067/mlc.2002.128317; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Kilic A, 2011, J SURG RES, V167, P207, DOI 10.1016/j.jss.2009.08.029; Lohr M, 2013, CANCER LETT, V333, P222, DOI 10.1016/j.canlet.2013.01.036; LORENZ J, 1994, CLIN INVESTIGATOR, V72, P156; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nana-Sinkam SP, 2013, CHEST, V143, pE30, DOI 10.1378/chest.12-2346; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ohnuki H, 2014, CANCER RES, V74, P2038, DOI 10.1158/0008-5472.CAN-13-3118; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Prado-Garcia H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/741741; Remark R, 2015, AM J RESP CRIT CARE, V191, P377, DOI 10.1164/rccm.201409-1671PP; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Schmall A, 2015, AM J RESP CRIT CARE, V191, P437, DOI 10.1164/rccm.201406-1137OC; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tartour E, 2013, LANCET RESP MED, V1, P551, DOI 10.1016/S2213-2600(13)70159-0; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TURNER H, 2011, R J, V3, P3; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Zaynagetdinov R, 2011, J IMMUNOL, V187, P5703, DOI 10.4049/jimmunol.1100558	42	79	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139073	10.1371/journal.pone.0139073	http://dx.doi.org/10.1371/journal.pone.0139073			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413839	gold, Green Submitted, Green Published			2022-12-26	WOS:000362170700037
J	Poole, CB; Ettwiller, L; Tanner, NA; Evans, TC; Wanji, S; Carlow, CKS				Poole, Catherine B.; Ettwiller, Laurence; Tanner, Nathan A.; Evans, Thomas C., Jr.; Wanji, Samuel; Carlow, Clotilde K. S.			Genome Filtering for New DNA Biomarkers of Loa loa Infection Suitable for Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; WUCHERERIA-BANCROFTI INFECTION; RAPID ASSESSMENT PROCEDURE; REPETITIVE DNA; BRUGIA-MALAYI; HUMAN BLOOD; DIAGNOSTIC SENSITIVITY; FILARIAL PARASITE; LOIASIS RAPLOA; OCCULT LOIASIS	Loa loa infections have emerged as a serious public health problem in patients co-infected with Onchocerca volvulus or Wuchereria bancrofti because of severe adverse neurological reactions after treatment with ivermectin. Accurate diagnostic tests are needed for careful mapping in regions where mass drug administration is underway. Loop-mediated isothermal amplification (LAMP) has become a widely adopted screening method because of its operational simplicity, rapidity and versatility of visual detection readout options. Here, we present a multi-step bioinformatic pipeline to generate diagnostic candidates suitable for LAMP and experimentally validate this approach using one of the identified candidates to develop a species-specific LAMP assay for L. loa. The pipeline identified similar to 140 new L. loa specific DNA repeat families as putative biomarkers of infection. The consensus sequence of one family, repeat family 4 (RF4), was compiled from similar to 350 sequences dispersed throughout the L. loa genome and maps to a L. loa-specific region of the long terminal repeats found at the boundaries of Bel/Pao retrotransposons. PCR and LAMP primer sets targeting RF4 specifically amplified L. loa but not W. bancrofti, O. volvulus, Brugia malayi, human or mosquito DNA. RF4 LAMP detects the DNA equivalent of one microfilaria (100 pg) in 25-30 minutes and as little as 0.060 pg of L. loa DNA (similar to 1/1600th of a microfilaria) purified from spiked blood samples in approximately 50 minutes. In summary, we have successfully employed a bioinformatic approach to mine the L. loa genome for species-specific repeat families that can serve as new DNA biomarkers for LAMP. The RF4 LAMP assay shows promise as a field tool for the implementation and management of mass drug administration programs and warrants further testing on clinical samples as the next stage in development towards this goal.	[Poole, Catherine B.; Ettwiller, Laurence; Tanner, Nathan A.; Evans, Thomas C., Jr.; Carlow, Clotilde K. S.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	carlow@neb.com		Ettwiller, Laurence/0000-0002-3957-6539	New England Biolabs	New England Biolabs	The funder, New England Biolabs, provided support in the form of salaries for authors CKSC, CBP, NAT, LE and TCE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbasi I, 1999, PARASITOL RES, V85, P844, DOI 10.1007/s004360050643; AEBY P, 1986, EMBO J, V5, P3353, DOI 10.1002/j.1460-2075.1986.tb04650.x; Alhassan A, 2015, TRENDS PARASITOL, V31, P391, DOI 10.1016/j.pt.2015.04.006; Azzibrouck GB, 2010, PARASITOLOGY, V137, P1119, DOI 10.1017/S0031182009991740; Bennuru S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003180; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boussinesq M, 2006, ANN TROP MED PARASIT, V100, P715, DOI 10.1179/136485906X112194; Boussinesq M, 2001, J TOXICOL ENV HEAL A, V63, P495; Bowen NJ, 1999, GENOME RES, V9, P924, DOI 10.1101/gr.9.10.924; Burbelo PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08; Chakrabarti R, 2001, NUCLEIC ACIDS RES, V29, P2377, DOI 10.1093/nar/29.11.2377; Chippaux JP, 1996, PARASITOL TODAY, V12, P448, DOI 10.1016/0169-4758(96)40006-0; CHULARERK P, 1970, J PARASITOL, V56, P623, DOI 10.2307/3277640; Copeland CS, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-20; D'Ambrosio MV, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3480; Davis PS, 1995, DROSOPH INF SERV, V76, P134; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; Drame PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Fink DL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001299; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Fischer P, 2000, AM J TROP MED HYG, V62, P291, DOI 10.4269/ajtmh.2000.62.291; Gardon J, 1997, T ROY SOC TROP MED H, V91, P593, DOI 10.1016/S0035-9203(97)90041-9; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; GONZALEZ A, 1984, P NATL ACAD SCI-BIOL, V81, P3356, DOI 10.1073/pnas.81.11.3356; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hoerauf A, 2011, CLIN MICROBIOL INFEC, V17, P977, DOI 10.1111/j.1469-0691.2011.03586.x; Jimenez M, 2011, EXP PARASITOL, V127, P282, DOI 10.1016/j.exppara.2010.06.019; Kelly-Hope LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001605; Klion AD, 2003, J INFECT DIS, V187, P128, DOI 10.1086/345873; KLION AD, 1994, J INFECT DIS, V169, P604, DOI 10.1093/infdis/169.3.604; KLION AD, 1993, J INFECT DIS, V168, P202, DOI 10.1093/infdis/168.1.202; KLION AD, 1991, MOL BIOCHEM PARASIT, V45, P297, DOI 10.1016/0166-6851(91)90098-Q; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; MCREYNOLDS LA, 1986, P NATL ACAD SCI USA, V83, P797, DOI 10.1073/pnas.83.3.797; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okorie PN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002416; Pion SDS, 2004, PARASITOLOGY, V129, P613, DOI 10.1017/S0031182004005694; Pion SDS, 2005, ANN TROP MED PARASIT, V99, P491, DOI 10.1179/136485905X51300; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SIRIDEWA K, 1994, AM J TROP MED HYG, V51, P495, DOI 10.4269/ajtmh.1994.51.495; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Tallon LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-788; Tanner N, 2013, COMPOSITIONS METHODS; Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253; Toure FS, 1998, AM J TROP MED HYG, V59, P144, DOI 10.4269/ajtmh.1998.59.144; Toure FS, 1999, B SOC PATHOL EXOT, V92, P167; Toure FS, 1997, AM J TROP MED HYG, V56, P57, DOI 10.4269/ajtmh.1997.56.57; Uttah E, 2011, J VECTOR DIS, V48, P197; Vasuki V, 2003, ACTA TROP, V86, P109, DOI 10.1016/S0001-706X(02)00267-X; Wanji S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-25; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; XIONG Y, 1993, NUCLEIC ACIDS RES, V21, P2117, DOI 10.1093/nar/21.9.2117; Zhong M, 1996, AM J TROP MED HYG, V54, P357, DOI 10.4269/ajtmh.1996.54.357; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	62	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139286	10.1371/journal.pone.0139286	http://dx.doi.org/10.1371/journal.pone.0139286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414073	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700053
J	Anderson, JC; Willey, CD; Mehta, A; Welaya, K; Chen, DQ; Duarte, CW; Ghatalia, P; Arafat, W; Madan, A; Sudarshan, S; Naik, G; Grizzle, WE; Choueiri, TK; Sonpavde, G				Anderson, Joshua C.; Willey, Christopher D.; Mehta, Amitkumar; Welaya, Karim; Chen, Dongquan; Duarte, Christine W.; Ghatalia, Pooja; Arafat, Waleed; Madan, Ankit; Sudarshan, Sunil; Naik, Gurudatta; Grizzle, William E.; Choueiri, Toni K.; Sonpavde, Guru			High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes	PLOS ONE			English	Article							BIOMARKERS; EVOLUTION; TUMORS; EXOME	Despite the widespread use of kinase-targeted agents in clear cell renal cell carcinoma (CC-RCC), comprehensive kinase activity evaluation (kinomic profiling) of these tumors is lacking. Thus, kinomic profiling of CC-RCC may assist in devising a classification system associated with clinical outcomes, and help identify potential therapeutic targets. Fresh frozen CC-RCC tumor lysates from 41 clinically annotated patients who had localized disease at diagnosis were kinomically profiled using the PamStation (R) 12 high-content phospho-peptide substrate microarray system (PamGene International). Twelve of these patients also had matched normal kidneys available that were also profiled. Unsupervised hierarchical clustering and supervised comparisons based on tumor vs. normal kidney and clinical outcome (tumor recurrence) were performed and coupled with advanced network modeling and upstream kinase prediction methods. Unsupervised clustering analysis of localized CC-RCC tumors identified 3 major kinomic groups associated with inflammation (A), translation initiation (B), and immune response and cell adhesions (C) processes. Potential driver kinases implicated include PFTAIRE (PFTK1), PKG1, and SRC, which were identified in groups A, B, and C, respectively. Of the 9 patients who had tumor recurrence, only one was found in Group B. Supervised analysis showed decreased kinase activity of CDK1 and RSK1-4 substrates in those which progressed compared to others. Twelve tumors with matching normal renal tissue implicated increased PIM's and MAPKAPK's in tumors compared to adjacent normal renal tissue. As such, comprehensive kinase profiling of CC-RCC tumors could provide a functional classification strategy for patients with localized disease and identify potential therapeutic targets.	[Anderson, Joshua C.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Mehta, Amitkumar; Ghatalia, Pooja; Madan, Ankit; Naik, Gurudatta; Sonpavde, Guru] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Chen, Dongquan] Univ Alabama Birmingham, Div Preventat Med, Birmingham, AL USA; [Sudarshan, Sunil] Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA; [Grizzle, William E.] Univ Alabama Birmingham, Div Anat Pathol, Birmingham, AL USA; [Welaya, Karim; Arafat, Waleed] Univ Alexandria, Dept Clin Oncol, Alexandria, Egypt; [Duarte, Christine W.] MMCRI, CORE, Portland, ME USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Kidney Canc Ctr, Dept Med Oncol, Boston, MA 02115 USA; [Choueiri, Toni K.] Harvard Univ, Sch Med, Boston, MA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Egyptian Knowledge Bank (EKB); Alexandria University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sonpavde, G (corresponding author), Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL 35294 USA.	gsonpavde@uabmc.edu	Sonpavde/L-7107-2019; naik, Gurudatta/O-7284-2015; Madan, Ankit/ADN-3478-2022; Choueiri, Toni/K-5238-2019	Sonpavde/0000-0002-1010-9611; naik, Gurudatta/0000-0001-7265-6605; Choueiri, Toni/0000-0002-9201-3217; arafat, waleed/0000-0002-6617-5992; Mehta, Amitkumar/0000-0003-0537-4207; Anderson, Joshua/0000-0002-6977-9054	Egyptian Partnership & Ownership Initiative Fellowship Grant; Comprehensive Cancer Center Pilot Grant Program [P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	Egyptian Partnership & Ownership Initiative Fellowship Grant; Comprehensive Cancer Center Pilot Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Egyptian Partnership & Ownership Initiative Fellowship Grant provided the stipend support for UAB Kinome Core Fellow (KW). The UAB Comprehensive Cancer Center Pilot Grant Program (P30CA013148) provided funding for the experimental work (to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Audenet F, 2012, BJU INT, V109, P1864, DOI 10.1111/j.1464-410X.2011.10661.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Choueiri TK, 2014, ANN ONCOL, V25, P1603, DOI 10.1093/annonc/mdu184; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Duverger A, 2014, J VIROL, V88, P364, DOI 10.1128/JVI.02682-13; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grizzle W.E., 2005, MOL DIAGNOSTICS, V33, P421; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Jarboe JS, 2012, RADIOTHER ONCOL, V103, P380, DOI 10.1016/j.radonc.2012.03.014; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Maroto P, 2014, CLIN CANCER RES, V20, P2060, DOI 10.1158/1078-0432.CCR-13-1351; McGuire JL, 2014, BRAIN RES, V1568, P42, DOI 10.1016/j.brainres.2014.04.029; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Motzer R, 2015, J CLIN ONCOL SUPPL, V33; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Ruijtenbeek R HL, 2009, AACR ANNUAL CONFEREN; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Sonpavde G, 2012, BRIT J CANCER, V107, P1009, DOI 10.1038/bjc.2012.399; Sonpavde G, 2014, EXPERT OPIN INV DRUG, V23, P305, DOI 10.1517/13543784.2014.871259; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versele M, 2009, MOL CANCER THER, V8, P1846, DOI 10.1158/1535-7163.MCT-08-1029	33	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139267	10.1371/journal.pone.0139267	http://dx.doi.org/10.1371/journal.pone.0139267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406598	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700201
J	Pan, R; Chen, HP; Zhang, ML; Wang, QH; Jiang, Y; Liu, X				Pan, Rong; Chen, Hong-Ping; Zhang, Ming-Lu; Wang, Qing-Hua; Jiang, Ying; Liu, Xin			Dissipation Pattern, Processing Factors, and Safety Evaluation for Dimethoate and Its Metabolite (Omethoate) in Tea (Camellia Sinensis)	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE-RESIDUES; BEHAVIOR; DEGRADATION; METHAMIDOPHOS; INSECTICIDES; BIFENTHRIN; KINETICS; ACEPHATE; OOLONG; LEAVES	Residue levels of dimethoate and its oxon metabolite (omethoate) during tea planting, manufacturing, and brewing were investigated using a modified QuEChERS sample preparation and gas chromatography. Dissipation of dimethoate and its metabolite in tea plantation followed the first-order kinetic with a half-life of 1.08-1.27 d. Tea manufacturing has positive effects on dimethoate dissipation. Processing factors of dimethoate are in the range of 2.11-2.41 and 1.41-1.70 during green tea and black tea manufacturing, respectively. Omethoate underwent generation as well as dissipation during tea manufacturing. Sum of dimethoate and omethoate led to a large portion of 80.5-84.9% transferring into tea infusion. Results of safety evaluation indicated that omethoate could bring higher human health risk than dimethoate due to its higher hazard quotient by drinking tea. These results would provide information for the establishment of maximum residue limit and instruction for the application of dimethoate formulation on tea crop.	[Pan, Rong; Chen, Hong-Ping; Zhang, Ming-Lu; Wang, Qing-Hua; Jiang, Ying; Liu, Xin] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Pan, Rong; Zhang, Ming-Lu] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Chen, Hong-Ping; Wang, Qing-Hua; Jiang, Ying; Liu, Xin] Minist Agr, Key Lab Tea Qual & Safety & Risk Assessment, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Ministry of Agriculture & Rural Affairs	Chen, HP (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China.	Thean27@mail.tricaas.com; Liuxin@mail.tricaas.com	Wang, Qinghua/GVT-3252-2022		Modern Agro-Industry Technology Research System [NYCYTX-26]; Innovative Research Team in Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2014-TRICAAS]	Modern Agro-Industry Technology Research System; Innovative Research Team in Chinese Academy of Agricultural Sciences	Funding provided by (1) Modern Agro-Industry Technology Research System (NYCYTX-26); http://119.253.58.231/; (2) Innovative Research Team in Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2014-TRICAAS); http://111.203.20.126/CaasTech/caas/index.jsp.	[Anonymous], 124952011 SANCO; Baruah A. A. L. H., 2010, Pesticide Research Journal, V22, P195; Bisen J. S., 2000, Journal of Plantation Crops, V28, P123; Chen HP, 2013, FOOD CHEM, V138, P976, DOI 10.1016/j.foodchem.2012.10.110; Chen L, 2012, FOOD CONTROL, V25, P433, DOI 10.1016/j.foodcont.2011.11.027; CHEN ZM, 1988, PESTIC SCI, V23, P109, DOI 10.1002/ps.2780230204; Chen ZM, 1997, ENVIRON MONIT ASSESS, V44, P303, DOI 10.1023/A:1005791514357; Diaz-Gomez R, 2014, LWT-FOOD SCI TECHNOL, V59, P896, DOI 10.1016/j.lwt.2014.06.049; Fernandez-Gonzalez R, 2015, CRIT REV FOOD SCI, V55, P1590, DOI 10.1080/10408398.2012.710279; Gupta M, 2009, FOOD ADDIT CONTAM A, V26, P157, DOI 10.1080/02652030802363782; Hou RY, 2013, FOOD ADDIT CONTAM A, V30, P1761, DOI 10.1080/19440049.2013.820356; Jaggi S, 2001, J AGR FOOD CHEM, V49, P5479, DOI 10.1021/jf010436d; Karthika Chinnachamy, 2010, Toxicological and Environmental Chemistry, V92, P1249, DOI 10.1080/02772240903362469; Kaushik G, 2009, FOOD RES INT, V42, P26, DOI 10.1016/j.foodres.2008.09.009; Kong ZQ, 2012, FOOD CONTROL, V23, P149, DOI 10.1016/j.foodcont.2011.07.001; Kumar V, 2006, FOOD CHEM TOXICOL, V44, P595, DOI 10.1016/j.fct.2005.10.009; Lu XS, 2013, FOOD CHEM, V141, P3415, DOI 10.1016/j.foodchem.2013.06.058; Lv YQ, 2007, BIOCHEM ENG J, V36, P221, DOI 10.1016/j.bej.2007.02.023; Mendoza A, 2014, ENVIRON INT, V70, P76, DOI 10.1016/j.envint.2014.05.009; Muthusami S, 2013, MOL BIOL REP, V40, P5587, DOI 10.1007/s11033-013-2660-x; Nagayama T, 1996, J AGR FOOD CHEM, V44, P2388, DOI 10.1021/jf950549v; Ozbey A, 2007, FOOD CHEM, V104, P237, DOI 10.1016/j.foodchem.2006.11.034; Ozbey A, 2007, INT J FOOD SCI TECH, V42, P380, DOI 10.1111/j.1365-2621.2006.01237.x; Pan R, 2015, J AGR FOOD CHEM, V63, P1300, DOI 10.1021/jf504916b; Pappas CJ, 2003, FOOD CHEM, V80, P23, DOI 10.1016/S0308-8146(02)00230-3; Paramasivam M, 2014, CHEMOSPHERE, V111, P291, DOI 10.1016/j.chemosphere.2014.03.111; Perez-Parada A, 2010, J ENVIRON SCI HEAL B, V45, P796, DOI 10.1080/03601234.2010.515180; Regueiro J, 2015, CRIT REV FOOD SCI, V55, P839, DOI 10.1080/10408398.2012.677872; Roast SD, 1999, WATER RES, V33, P319, DOI 10.1016/S0043-1354(98)00248-6; Satheshkumar A, 2014, FOOD CHEM, V145, P1092, DOI 10.1016/j.foodchem.2013.09.042; Seenivasan S, 2009, FOOD CHEM TOXICOL, V47, P502, DOI 10.1016/j.fct.2008.12.010; Sharma D, 2010, TALANTA, V82, P1077, DOI 10.1016/j.talanta.2010.06.043; Shivani Jaggi, 2011, Journal of Environmental Protection, V2, P482, DOI 10.4236/jep.2011.24056; Sood C, 2004, J SCI FOOD AGR, V84, P2123, DOI 10.1002/jsfa.1774; Srinivas PS, 2012, J ENVIRON SCI HEAL B, V47, P700, DOI 10.1080/03601234.2012.669262; Tewary DK, 2005, FOOD CONTROL, V16, P231, DOI 10.1016/j.foodcont.2004.02.004; Utture SC, 2012, FOOD CHEM, V131, P787, DOI 10.1016/j.foodchem.2011.09.044; WAN H, 1991, FOOD ADDIT CONTAM, V8, P497, DOI 10.1080/02652039109374000; Wang J, 2014, J AGR FOOD CHEM, V62, P966, DOI 10.1021/jf404123h; Xia H, 2008, FOOD ADDIT CONTAM A, V25, P70, DOI 10.1080/02652030701523007	40	29	31	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138309	10.1371/journal.pone.0138309	http://dx.doi.org/10.1371/journal.pone.0138309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406463	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700040
J	R-Tavakoli, H; Atyabi, A; Rantanen, A; Laukka, SJ; Nefti-Meziani, S; Heikkila, J				R-Tavakoli, Hamed; Atyabi, Adham; Rantanen, Antti; Laukka, Seppo J.; Nefti-Meziani, Samia; Heikkila, Janne			Predicting the Valence of a Scene from Observers' Eye Movements	PLOS ONE			English	Article								Multimedia analysis benefits from understanding the emotional content of a scene in a variety of tasks such as video genre classification and content-based image retrieval. Recently, there has been an increasing interest in applying human bio-signals, particularly eye movements, to recognize the emotional gist of a scene such as its valence. In order to determine the emotional category of images using eye movements, the existing methods often learn a classifier using several features that are extracted from eye movements. Although it has been shown that eye movement is potentially useful for recognition of scene valence, the contribution of each feature is not well-studied. To address the issue, we study the contribution of features extracted from eye movements in the classification of images into pleasant, neutral, and unpleasant categories. We assess ten features and their fusion. The features are histogram of saccade orientation, histogram of saccade slope, histogram of saccade length, histogram of saccade duration, histogram of saccade velocity, histogram of fixation duration, fixation histogram, top-ten salient coordinates, and saliency map. We utilize machine learning approach to analyze the performance of features by learning a support vector machine and exploiting various feature fusion schemes. The experiments reveal that 'saliency map', 'fixation histogram', 'histogram of fixation duration', and 'histogram of saccade slope' are the most contributing features. The selected features signify the influence of fixation information and angular behavior of eye movements in the recognition of the valence of images.	[R-Tavakoli, Hamed; Heikkila, Janne] Univ Oulu, Dept Comp Sci & Engn, Ctr Machine Vis Res, Oulu, Finland; [Atyabi, Adham; Nefti-Meziani, Samia] Univ Salford Manchester, Autonomous Syst & Adv Robot Res Ctr, Salford, Lancs, England; [Atyabi, Adham] Flinders Univ South Australia, Sch Comp Sci Engn & Math, Adelaide, SA, Australia; [Rantanen, Antti; Laukka, Seppo J.] Univ Oulu, Learning Res Lab LearnLab, Oulu 90014, Finland	University of Oulu; Flinders University South Australia; University of Oulu	R-Tavakoli, H (corresponding author), Aalto Univ, Dept Comp Sci, Espoo, Finland.	Hamed.R-Tavakoli@aalto.fi	Tavakoli, Hamed R./O-9942-2016; Atyabi, Adham/I-9278-2017	Tavakoli, Hamed R./0000-0002-9466-9148; Atyabi, Adham/0000-0003-0232-7157; Nefti-Meziani, Samia/0000-0001-6500-2929	Nokia Scholarships	Nokia Scholarships(Nokia Corporation)	This work was partially supported by Nokia Scholarships. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ab Wahab MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122827; Anderson, 1951, PSYCHOMETRIKA, V16, P31, DOI [10.1007/BF02313425, DOI 10.1007/BF02313425]; [Anonymous], 2005, STUDIES FUZZINESS SO, DOI [DOI 10.1007/B95439, 10.1007/b95439]; Armstrong T, 2009, WHAT THEY SEE IS WHA; Borji A, 2014, J VISION, V14; Borji A, 2013, IEEE I CONF COMP VIS, P921, DOI 10.1109/ICCV.2013.118; Bulling A, 2011, IEEE T PATTERN ANAL, V33, P741, DOI 10.1109/TPAMI.2010.86; Chen NTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086474; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Esfahani MS, 2014, BIOINFORMATICS, V30, P242, DOI 10.1093/bioinformatics/btt662; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; Greene MR, 2012, VISION RES, V62, P1, DOI 10.1016/j.visres.2012.03.019; Henderson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064937; Humphrey K, 2012, J VISION, V12, DOI 10.1167/12.1.22; Irwin D. E., 2004, INTERFACE LANGUAGE V, P105; Isola P, 2011, PROC CVPR IEEE, P145, DOI 10.1109/CVPR.2011.5995721; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kanan C., 2014, ETRA 14 P S EYE TRAC, P287, DOI [10.1145/2578153.2578208, DOI 10.1145/2578153.2578208]; Kootstra G., 2008, P 19 BRIT MACH VIS C, P1115; Lang PJ, 2008, INT AFFECTIVE PICTUR, pA; Lang PJ., 2001, EMOTION, V1, DOI 10.1037/1528-3542.1.3.276; Le Meur Olivier, 2011, P 19 ACM INT C MULT, P373, DOI DOI 10.1145/2072298.2072347; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Ma KT, 2013, LECT NOTES COMPUT SC, V8212, P209, DOI 10.1007/978-3-319-02714-2_18; Mancas M, 2013, IEEE IMAGE PROC, P196, DOI 10.1109/ICIP.2013.6738041; Marcano-Cedeno A., 2010, IECON 2010 - 36th Annual Conference of IEEE Industrial Electronics, P2845, DOI 10.1109/IECON.2010.5675075; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Niu YQ, 2012, ACM T APPL PERCEPT, V9, DOI 10.1145/2325722.2325726; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Olson DL, 2002, ADV DATA MINING TECH; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Powers DMW, 2011, J MACHINE LEARNING T, V2; R-Tavakoli H, 2014, INT C PATT RECOG, P4666, DOI 10.1109/ICPR.2014.798; Ramanathan S, 2010, LECT NOTES COMPUT SC, V6314, P30, DOI 10.1007/978-3-642-15561-1_3; Sanei S, 2007, EEG SIGNAL PROCESSIN; Simola J, 2015, NEUROIMAGE, V106, P21, DOI 10.1016/j.neuroimage.2014.11.030; Subramanian R., 2011, INT C MULTIMEDIA ACM, P33; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tichon JG, 2014, AVIATION PSYCHOL APP, V4, DOI [10.1027/2192-0923/a000052, DOI 10.1027/2192-0923/A000052]; van Steenbergen H, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00281; Vitu F, 2001, VISION RES, V41, P3513, DOI 10.1016/S0042-6989(01)00166-3; Wadlinger HA, 2006, MOTIV EMOTION, V30, P89, DOI 10.1007/s11031-006-9021-1; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138198	10.1371/journal.pone.0138198	http://dx.doi.org/10.1371/journal.pone.0138198			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407322	Green Published, gold, Green Accepted			2022-12-26	WOS:000361800700036
J	Draborg, AH; Lydolph, MC; Westergaard, M; Larsen, SO; Nielsen, CT; Duus, K; Jacobsen, S; Houen, G				Draborg, Anette H.; Lydolph, Magnus C.; Westergaard, Marie; Larsen, Severin Olesen; Nielsen, Christoffer T.; Duus, Karen; Jacobsen, Soren; Houen, Gunnar			Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies	PLOS ONE			English	Article							PRIMARY SJOGRENS-SYNDROME; BLOOD MONONUCLEAR-CELLS; INFECTIOUS-MONONUCLEOSIS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; ADULT PATIENTS; IN-VIVO; PREVALENCE; ANTIGEN; SLE	Objective In this study, we examined the concentration of serum immunoglobulin free light chains (FLCs) in systemic lupus erythematosus (SLE) patients and investigated its association with various disease parameters in order to evaluate the role of FLCs as a potential biomarker in SLE. Furthermore, FLCs' association with Epstein-Barr virus (EBV) antibodies was examined. Methods Using a nephelometric assay, kappa FLC and lambda FLC concentrations were quantified in sera from 45 SLE patients and 40 healthy controls. SLE patients with renal insufficiency were excluded in order to preclude high concentrations of serum FLCs due to decreased clearance. Results Serum FLC concentrations were significantly elevated in SLE patients compared to healthy controls (p<0.0001) also after adjusting for Ig levels (p<0.0001). The concentration of serum FLCs correlated with a global disease activity (SLE disease activity index (SLEDAI)) score of the SLE patients (r = 0.399, p = 0.007). Furthermore, concentrations of FLCs correlated with titers of dsDNA antibodies (r = 0.383, p = 0.009), and FLC levels and SLEDAI scores correlated in the anti-dsDNA-positive SLE patients, but not in anti-dsDNA-negative SLE patients. Total immunoglobulin (IgG and IgA) concentrations correlated with FLC concentrations and elevated FLC levels were additionally shown to associate with the inflammatory marker C-reactive protein and also with complement consumption determined by low C4 in SLE patients. Collectively, results indicated that elevated serum FLCs reflects increased B cell activity in relation to inflammation. SLE patients had an increased seropositivity of EBV-directed antibodies that did not associate with elevated FLC concentrations. An explanation for this could be that serum FLC concentrations reflect the current EBV activity (reactivation) whereas EBV-directed antibodies reflect the extent of previous infection/reactivations. Conclusion SLE patients have elevated concentrations of serum FLCs that correlate with global disease activity scores and especially serologic markers for active disease. These findings are suggestive of circulating FLCs having potential as a new supplementary serologic biomarker in SLE.	[Draborg, Anette H.; Lydolph, Magnus C.; Westergaard, Marie; Larsen, Severin Olesen; Nielsen, Christoffer T.; Duus, Karen; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark; [Nielsen, Christoffer T.; Jacobsen, Soren] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen	Houen, G (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark.	gh@ssi.dk	Jacobsen, Søren/T-2491-2019; Westergaard, Marie Christine Wulff/AGZ-9828-2022	Jacobsen, Søren/0000-0002-5654-4993; Westergaard, Marie/0000-0003-3446-4287				Aggarwal R, 2011, ARTHRIT CARE RES, V63, P891, DOI 10.1002/acr.20446; Auwaerter PG, 1999, JAMA-J AM MED ASSOC, V281, P454, DOI 10.1001/jama.281.5.454; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Berkun Y, 2009, LUPUS, V18, P1129, DOI 10.1177/0961203309345729; Berner BR, 2005, CELL IMMUNOL, V235, P29, DOI 10.1016/j.cellimm.2005.06.010; Chakravarty EF, 2007, ARTHRITIS RHEUM, V56, P2092, DOI 10.1002/art.22641; Chen CJ, 2005, J RHEUMATOL, V32, P44; Chen DY, 2010, J CLIN VIROL, V49, P290, DOI 10.1016/j.jcv.2010.08.015; Chiche L, 2011, CLIN RHEUMATOL, V30, P685, DOI 10.1007/s10067-010-1674-1; Csuka D, 2013, CLIN EXP IMMUNOL, V171, P255, DOI 10.1111/cei.12022; Dall'Era M, 2011, CURR RHEUMATOL REP, V13, P308, DOI 10.1007/s11926-011-0186-6; Draborg AH, 2012, SCAND J RHEUMATOL, V41, P280, DOI 10.3109/03009742.2012.665944; Draborg AH, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000015; Esen BA, 2012, RHEUMATOL INT, V32, P79, DOI 10.1007/s00296-010-1573-4; FAUCI AS, 1981, ARTHRITIS RHEUM, V24, P577, DOI 10.1002/art.1780240402; Gottenberg JE, 2007, ANN RHEUM DIS, V66, P23, DOI 10.1136/ard.2006.052159; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOPPER JE, 1989, J CLIN IMMUNOL, V9, P338, DOI 10.1007/BF00918666; HOPPER JE, 1986, CELL IMMUNOL, V101, P122, DOI 10.1016/0008-8749(86)90191-7; Hopper JE, 2000, J CLIN IMMUNOL, V20, P123, DOI 10.1023/A:1006686514743; Huggins ML, 2005, RHEUMATOL INT, V25, P183, DOI 10.1007/s00296-003-0420-2; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Jolly M, 2014, LUPUS, V23, P881, DOI 10.1177/0961203314530793; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; Kaplan B, 2010, J NEUROIMMUNOL, V229, P263, DOI 10.1016/j.jneuroim.2010.09.002; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Lu JJY, 2007, LUPUS, V16, P168, DOI 10.1177/0961203306075800; Mastroianni-Kirsztajn G, 2008, NEPHRON CLIN PRACT, V110, pC258, DOI 10.1159/000167874; McClain MT, 2006, ARTHRITIS RHEUM-US, V54, P360, DOI 10.1002/art.21682; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Nakano T, 2011, CLIN CHIM ACTA, V412, P843, DOI 10.1016/j.cca.2011.03.007; Namjou B, 2007, AUTOIMMUNITY, V40, P602, DOI 10.1080/08916930701510962; Parks CG, 2005, ARTHRITIS RHEUM-US, V52, P1148, DOI 10.1002/art.20997; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SAKANE T, 1988, ARTHRITIS RHEUM, V31, P80, DOI 10.1002/art.1780310112; Schepers A, 1996, VIROLOGY, V220, P367, DOI 10.1006/viro.1996.0325; Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Stratta P, 1999, NEPHRON, V82, P145, DOI 10.1159/000045391; Tattevin P, 2006, J CLIN MICROBIOL, V44, P1873, DOI 10.1128/JCM.44.5.1873-1874.2006; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; TSOKOS GC, 1983, J IMMUNOL, V131, P1797; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yu SF, 2005, MED MICROBIOL IMMUN, V194, P115, DOI 10.1007/s00430-004-0230-5; Zandman-Goddard G, 2009, ANN NY ACAD SCI, V1173, P658, DOI 10.1111/j.1749-6632.2009.04754.x	51	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138753	10.1371/journal.pone.0138753	http://dx.doi.org/10.1371/journal.pone.0138753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402865	Green Submitted, gold, Green Published			2022-12-26	WOS:000361798100035
J	Katoh, H; Inoue, H; Iwanami, T				Katoh, Hiroshi; Inoue, Hiromitsu; Iwanami, Toru			Changes in Variable Number of Tandem Repeats in 'Candidatus Liberibacter asiaticus' through Insect Transmission	PLOS ONE			English	Article							GREENING DISEASE; DIAPHORINA-CITRI; 1ST REPORT; BACTERIUM	Citrus greening (huanglongbing) is the most destructive citrus disease worldwide. The disease is associated with three species of 'Candidatus Liberibacter' among which 'Ca. Liberibacter asiaticus' has the widest distribution. 'Ca. L. asiaticus' is commonly transmitted by a phloem-feeding insect vector, the Asian citrus psyllid Diaphorina citri. A previous study showed that isolates of 'Ca. L. asiaticus' were clearly differentiated by variable number of tandem repeat (VNTR) profiles at four loci in the genome. In this study, the VNTR analysis was further validated by assessing the stability of these repeats after multiplication of the pathogen upon host-to-host transmission using a 'Ca. L. asiaticus' strain from Japan. The results showed that some tandem repeats showed detectable changes after insect transmission. To our knowledge, this is the first report to demonstrate that the repeat numbers VNTR 002 and 077 of 'Ca. L. asiaticus' change through psyllid transmission. VNTRs in the recipient plant were apparently unrelated to the growing phase of the vector. In contrast, changes in the number of tandem repeats increased with longer acquisition and inoculation access periods, whereas changes were not observed through psyllid transmission after relatively short acquisition and inoculation access periods, up to 20 and 19 days, respectively.	[Katoh, Hiroshi; Iwanami, Toru] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan; [Inoue, Hiromitsu] NARO Inst Fruit Tree Sci, Kuchinotsu Citrus Res Stn, Nagasaki 8592501, Japan		Katoh, H (corresponding author), Utsunomiya Univ, Ctr Biosci Res & Educ, Mine Machi 350, Utsunomiya, Tochigi 3218505, Japan.	katohh@cc.utsunomiya-u.ac.jp			National Agriculture and Food Research Organization; Center for Bioscience Research and Education, Utsunomiya University	National Agriculture and Food Research Organization; Center for Bioscience Research and Education, Utsunomiya University	Funding was provided by National Agriculture and Food Research Organization (http://www.naro.affrc.go.jp/fruit/) and Center for Bioscience Research and Education, Utsunomiya University, http://c-bio.mine.utsunomiya-u.ac.jp/.	AUBERT B, 1987, FRUITS, V42, P149; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brown SE, 2011, NEW DIS REP, V24, P25, DOI DOI 10.5197/J.2044-0588.2011.024.025; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; De Jensen CE, 2010, PHYTOPATHOLOGY, V100, pS34; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Islam MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-39; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Katoh H, 2012, ANN APPL BIOL, V160, P291, DOI 10.1111/j.1744-7348.2012.00541.x; Katoh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106109; Katoh H, 2011, APPL ENVIRON MICROB, V77, P1910, DOI 10.1128/AEM.01571-10; Manjunath KL, 2010, PLANT DIS, V94, P781, DOI 10.1094/PDIS-94-6-0781A; Martinez Y, 2009, PLANT PATHOL, V58, P389, DOI 10.1111/j.1365-3059.2008.01997.x; Matos L, 2009, PLANT DIS, V93, P668, DOI 10.1094/PDIS-93-6-0668B; Matos LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078994; MIYAKAWA T, 1989, Annals of the Phytopathological Society of Japan, V55, P667, DOI 10.3186/jjphytopath.55.667; Oberholzer P. C. J., 1965, P 3 C IOCV, P213; ORISA (Organismo Internacional Regional de Sanidad Agropecuaria), 2011, TALL SENS CENTR PROD; Otake A., 1990, BIBLIO CITRUS GREENI; S. P. CAPOOR, 1963, Decline of Citrus trees in India., P48; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIRTAWIDJAJA S, 1965, P AM SOC HORTIC SCI, V86, P235; Trujillo-Arriaga J, 2010, 2 TALL INT HUANGL PS; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Zhao XY, 1981, P INT SOC CITRICULTU, V1, P466	30	8	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138699	10.1371/journal.pone.0138699	http://dx.doi.org/10.1371/journal.pone.0138699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402645	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100033
J	Manstretta, V; Rossi, V				Manstretta, Valentina; Rossi, Vittorio			Effects of Weather Variables on Ascospore Discharge from Fusarium graminearum Perithecia	PLOS ONE			English	Article							LONG-DISTANCE TRANSPORT; GIBBERELLA-ZEAE; HEAD BLIGHT; VAPOR-PRESSURE; RELATIVE-HUMIDITY; BOTRYTIS-CINEREA; WHEAT; INOCULUM; GERMINATION; RELEASE	Fusarium graminearum is a predominant component of the Fusarium head blight (FHB) complex of small grain cereals. Ascosporic infection plays a relevant role in the spread of the disease. A 3-year study was conducted on ascospore discharge. To separate the effect of weather on discharge from the effect of weather on the production and maturation of ascospores in perithecia, discharge was quantified with a volumetric spore sampler placed near maize stalk residues bearing perithecia with mature ascospores; the residues therefore served as a continuous source of ascospores. Ascospores were discharged from perithecia on 70% of 154 days. Rain (R) and vapor pressure deficit (VPD) were the variables that most affected ascospore discharge, with 84% of total discharges occurring on days with R >= 0.2 mm or VPD <= 11 hPa, and with 70% of total ascospore discharge peaks (>= 30 ascospores/m(3) air per day) occurring on days with R >= 0.2 mm and VPD <= 6.35 hPa. An ROC analysis using these criteria for R and VPD provided True Positive Proportion (TPP) = 0.84 and True Negative Proportion (TNP) = 0.63 for occurrence of ascospore discharge, and TPP = 0.70 and TNP = 0.89 for occurrence of peaks. Globally, 68 ascospores (2.5% of the total ascospores sampled) were trapped on the 17 days when no ascospores were erroneously predicted. When a discharge occurred, the numbers of F. graminearum ascospores sampled were predicted by a multiple regression model with R-2 = 0.68. This model, which includes average and maximum temperature and VPD as predicting variables, slightly underestimated the real data and especially ascospore peaks. Numbers of ascospores in peaks were best predicted by wetness duration of the previous day, minimum temperature, and VPD, with R-2 = 0.71. These results will help refine the epidemiological models used as decision aids in FHB management programs.	[Manstretta, Valentina; Rossi, Vittorio] Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, Italy	Catholic University of the Sacred Heart	Rossi, V (corresponding author), Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, Italy.	vittorio.rossi@unicatt.it	Rossi, Vittorio/I-7869-2012	Rossi, Vittorio/0000-0003-4090-6117; Manstretta, Valentina/0000-0003-2731-8038				Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468; AYERS JE, 1975, PHYTOPATHOLOGY, V65, P835; BAI GH, 1994, PLANT DIS, V78, P760, DOI 10.1094/PD-78-0760; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; Caron D, 2006, P AFPP 8 C INT MAL P, P215; Carroll JE, 2003, PHYTOPATHOLOGY, V93, P1137, DOI 10.1094/PHYTO.2003.93.9.1137; Cavinder B, 2012, JOVE-J VIS EXP, DOI 10.3791/3895; CHANG KF, 1989, CAN J BOT, V67, P104, DOI 10.1139/b89-015; CHELLEMI DO, 1992, CAN J BOT, V70, P1093, DOI 10.1139/b92-134; de Luna L, 2002, CAN J PLANT PATHOL, V24, P457; DEALL MW, 1986, PLANT PATHOL, V35, P74, DOI 10.1111/j.1365-3059.1986.tb01983.x; EVERTS KL, 1990, PHYTOPATHOLOGY, V80, P1387, DOI 10.1094/Phyto-80-1387; Fernando WGD, 2000, CAN J BOT, V78, P497, DOI 10.1139/cjb-78-4-497; Fernando WGD, 1997, PHYTOPATHOLOGY, V87, P414, DOI 10.1094/PHYTO.1997.87.4.414; Francl L, 1999, PLANT DIS, V83, P662, DOI 10.1094/PDIS.1999.83.7.662; Francl L. J., 1998, P 1998 NAT FUS HEAD, P1; FRIEDRICH S, 1995, Z PFLANZENK PFLANZEN, V102, P337; GADOURY DM, 1990, PHYTOPATHOLOGY, V80, P1198, DOI 10.1094/Phyto-80-1198; Gilbert J, 2008, PHYTOPATHOLOGY, V98, P504, DOI 10.1094/PHYTO-98-5-0504; Gourdain E, 2011, P 7 CAN WORKSH FUS H, P44; GROVE GG, 1991, PHYTOPATHOLOGY, V81, P1513, DOI 10.1094/Phyto-81-1513; Hanley JA, 2005, ENCY BIOSTATISTICS, DOI [10.1002/0470011815.b2a04043, DOI 10.1002/0470011815.B2A04043]; Inch S, 2005, CAN J PLANT PATHOL, V27, P357; Inch S, 2000, P 6 EUR FUS SEM 3 CO, P29; INGOLD C. T., 1959, NEW PHYTOL, V58, P46, DOI 10.1111/j.1469-8137.1959.tb05333.x; Keller MD, 2014, AEROBIOLOGIA, V30, P123, DOI 10.1007/s10453-013-9321-3; Keller MD, 2010, PLANT DIS, V94, P1151, DOI 10.1094/PDIS-94-9-1151; KERSSIES A, 1994, EUR J PLANT PATHOL, V100, P123, DOI 10.1007/BF01876246; Leggieri MC, 2013, WORLD MYCOTOXIN J, V6, P389, DOI 10.3920/WMJ2013.1546; Maldonado-Ramirez SL, 2005, AGR FOREST METEOROL, V132, P20, DOI 10.1016/j.agrformet.2005.06.007; MALDONADORAMIRE.SL, 2000, P 2000 NAT FUS HEAD, P159; Manstretta V, 2015, AGR FOREST METEOROL, V207, P83, DOI 10.1016/j.agrformet.2015.04.001; Manstretta V., 2015, THESIS; Markell SG, 2003, PLANT DIS, V87, P814, DOI 10.1094/PDIS.2003.87.7.814; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Osborne LE, 2005, P 2005 NAT FUS HEAD, P129; Panisson E., 2002, Fitopatologia Brasileira, V27, P489, DOI 10.1590/S0100-41582002000500010; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Paul PA, 2007, PHYTOPATHOLOGY, V97, P1608, DOI 10.1094/PHYTO-97-12-1608; Paul PA, 2004, PHYTOPATHOLOGY, V94, P1342, DOI 10.1094/PHYTO.2004.94.12.1342; Paulitz T., 1994, Phytopathology, V84, P1070; Paulitz TC, 1996, PLANT DIS, V80, P674, DOI 10.1094/PD-80-0674; Paulitz TC, 1999, PHYTOPROTECTION, V80, P127, DOI 10.7202/706188ar; Ponte E. M. del, 2003, Plant Health Progress, P1, DOI 10.1094/PHP-2003-0418-01-RS; Ponte E. M. del, 2005, Fitopatologia Brasileira, V30, P55, DOI 10.1590/S0100-41582005000100009; Prados-Ligero AM, 2003, EUR J PLANT PATHOL, V109, P301, DOI 10.1023/A:1023519029605; Prandini A, 2009, FOOD CHEM TOXICOL, V47, P927, DOI 10.1016/j.fct.2008.06.010; Prussin AJ, 2014, PLANT DIS, V98, P504, DOI 10.1094/PDIS-06-13-0664-RE; Prussin AJ, 2014, PLANT DIS, V98, P497, DOI 10.1094/PDIS-04-13-0404-RE; REIS E M, 1988, Fitopatologia Brasileira, V13, P324; REIS E M, 1990, Fitopatologia Brasileira, V15, P339; Rossi V, 2008, PLANT PATHOL, V57, P216, DOI 10.1111/j.1365-3059.2007.01738.x; Rossi V., 2003, Bulletin OEPP, V33, P421, DOI 10.1111/j.1365-2338.2003.00667.x; Rossi V, 2002, J PLANT PATHOL, V84, P53; Rossi V., 2003, Bulletin OEPP, V33, P389, DOI 10.1111/j.1365-2338.2003.00662.x; Ryley MJ, 2008, PLANT PATHOL, V57, P473, DOI 10.1111/j.1365-3059.2007.01819.x; Schmale DG, 2012, AEROBIOLOGIA, V28, P1, DOI 10.1007/s10453-011-9206-2; Schmale DG, 2006, CAN J PLANT PATHOL, V28, P100, DOI 10.1080/07060660609507276; Schmale DG, 2005, CAN J PLANT PATHOL, V27, P376; Schmale DG, 2007, P 2007 NAT FUS HEAD, P70; SCHMALE DG, 2004, PHYTOPATHOLOGY, V94, pS93; Shtienberg D, 1998, EUR J PLANT PATHOL, V104, P753, DOI 10.1023/A:1008690925443; STACK RW, 1989, CAN J PLANT PATHOL, V11, P137, DOI 10.1080/07060668909501128; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Trail F, 2005, FUNGAL GENET BIOL, V42, P528, DOI 10.1016/j.fgb.2005.03.008; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; TRAIL F, 1998, P 1998 NAT FUS HEAD, P11; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; TSCHANZ AT, 1975, PHYTOPATHOLOGY, V65, P597, DOI 10.1094/Phyto-65-597; Van Der Fels-Klerx HJ, 2010, FOOD ADDIT CONTAM A, V27, P636, DOI 10.1080/19440040903571762; Xu XM, 2014, ACTA HORTIC, V1049, P613, DOI 10.17660/ActaHortic.2014.1049.95; Xu XM, 2009, ANNU REV PHYTOPATHOL, V47, P83, DOI 10.1146/annurev-phyto-080508-081737; Xu XM, 1995, PLANT PATHOL, V44, P944, DOI 10.1111/j.1365-3059.1995.tb02652.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	76	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138860	10.1371/journal.pone.0138860	http://dx.doi.org/10.1371/journal.pone.0138860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402063	gold, Green Published, Green Submitted			2022-12-26	WOS:000361798100040
J	Amos, GCA; Borsetto, C; Laskaris, P; Krsek, M; Berry, AE; Newsham, KK; Calvo-Bado, L; Pearce, DA; Vallin, C; Wellington, EMH				Amos, Gregory C. A.; Borsetto, Chiara; Laskaris, Paris; Krsek, Martin; Berry, Andrew E.; Newsham, Kevin K.; Calvo-Bado, Leo; Pearce, David A.; Vallin, Carlos; Wellington, Elizabeth M. H.			Designing and Implementing an Assay for the Detection of Rare and Divergent NRPS and PKS Clones in European, Antarctic and Cuban Soils	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; METAGENOMIC ANALYSIS; GENE CLUSTERS; POLYKETIDE SYNTHASES; BACTERIAL; DNA; IDENTIFICATION; DIVERSITY; LIBRARIES; VIEW	The ever increasing microbial resistome means there is an urgent need for new antibiotics. Metagenomics is an underexploited tool in the field of drug discovery. In this study we aimed to produce a new updated assay for the discovery of biosynthetic gene clusters encoding bioactive secondary metabolites. PCR assays targeting the polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS) were developed. A range of European soils were tested for their biosynthetic potential using clone libraries developed from metagenomic DNA. Results revealed a surprising number of NRPS and PKS clones with similarity to rare Actinomycetes. Many of the clones tested were phylogenetically divergent suggesting they were fragments from novel NRPS and PKS gene clusters. Soils did not appear to cluster by location but did represent NRPS and PKS clones of diverse taxonomic origin. Fosmid libraries were constructed from Cuban and Antarctic soil samples; 17 fosmids were positive for NRPS domains suggesting a hit rate of less than 1 in 10 genomes. NRPS hits had low similarities to both rare Actinobacteria and Proteobacteria; they also clustered with known antibiotic producers suggesting they may encode for pathways producing novel bioactive compounds. In conclusion we designed an assay capable of detecting divergent NRPS and PKS gene clusters from the rare biosphere; when tested on soil samples results suggest the majority of NRPS and PKS pathways and hence bioactive metabolites are yet to be discovered.	[Amos, Gregory C. A.; Borsetto, Chiara; Laskaris, Paris; Krsek, Martin; Berry, Andrew E.; Calvo-Bado, Leo; Wellington, Elizabeth M. H.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Newsham, Kevin K.; Pearce, David A.] NERC, British Antarctic Survey, Ecosyst Programme, Cambridge CB3 OET, England; [Vallin, Carlos] Ctr Pharmaceut Chem, Dept Biomed Res, Havana, Cuba	University of Warwick; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Wellington, EMH (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	E.M.H.Wellington@warwick.ac.uk	Borsetto, Chiara/AAA-7315-2022; Amos, Gregory/C-8790-2014	Borsetto, Chiara/0000-0003-4848-9522; Amos, Gregory/0000-0001-9748-1813; Wellington, ELizabeth/0000-0002-4329-0699; Berry, Andrew/0000-0001-5096-7701; Pearce, David/0000-0001-5292-4596	Biotechnology and Biological Sciences Research Council SysMO grant [P-UK-01-11-3i]; Natural Environment Research Council [NE/E004482/1]; European Union [01783, 289285]; Natural Environment Research Council grant British Antarctic Survey's Long Term Monitoring and Survey Programme; NERC [bas0100036] Funding Source: UKRI; Natural Environment Research Council [bas0100036] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council SysMO grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Union(European Commission); Natural Environment Research Council grant British Antarctic Survey's Long Term Monitoring and Survey Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Biotechnology and Biological Sciences Research Council SysMO grant P-UK-01-11-3i (www.bbsrc.ac.uk), the Natural Environment Research Council grant NE/E004482/1 (www.nerc.ac.uk), the European Union Fifth Framework ACTAPHARM, project number 01783 (http://cordis.europa.eu/home_en.html), the European Union Seventh Framework Programme grant agreement No289285 (www.train-asap.eu), the Natural Environment Research Council grant British Antarctic Survey's Long Term Monitoring and Survey Programme (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; Amos GCA, 2014, VET MICROBIOL, V171, P441, DOI 10.1016/j.vetmic.2014.02.017; Amos GCA, 2015, ISME J, V9, P1467, DOI 10.1038/ismej.2014.237; Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Charlop-Powers Z, 2015, ELIFE, V4, DOI 10.7554/eLife.05048; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Feng ZY, 2012, J AM CHEM SOC, V134, P2981, DOI 10.1021/ja207662w; Gao W, 2014, ORG LETT, V16, P6044, DOI 10.1021/ol5026603; Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hogberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Iorio M, 2012, J NAT PROD, V75, P1991, DOI 10.1021/np300470f; Johnson-Rollings AS, 2014, ISME J, V8, P2148, DOI 10.1038/ismej.2014.130; Kallifidas D, 2012, J AM CHEM SOC, V134, P19552, DOI 10.1021/ja3093828; MCCORMICK M H, 1955, Antibiot Annu, V3, P606; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Newsham KK, 2010, MICROBIOL RES, V165, P523, DOI 10.1016/j.micres.2009.11.005; Owen JG, 2013, P NATL ACAD SCI USA, V110, P11797, DOI 10.1073/pnas.1222159110; Pearce DA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00403; REICHENBACH H, 1993, BIOTECHNOL ADV, V11, P219, DOI 10.1016/0734-9750(93)90042-L; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; SENSI P, 1959, Farmaco Sci, V14, P146; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; Wang H, 2014, P NATL ACAD SCI USA, V111, P9259, DOI 10.1073/pnas.1401734111; Woodhouse JN, 2013, ISME J, V7, P1842, DOI 10.1038/ismej.2013.65; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Zettler J, 2014, CHEMBIOCHEM, V15, P612, DOI 10.1002/cbic.201300712	41	14	14	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138327	10.1371/journal.pone.0138327	http://dx.doi.org/10.1371/journal.pone.0138327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398766	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361797500060
J	Macchiaverni, P; Ynoue, LH; Arslanian, C; Verhasselt, V; Condino-Neto, A				Macchiaverni, Patricia; Ynoue, Leandro H.; Arslanian, Christina; Verhasselt, Valerie; Condino-Neto, Antonio			Early Exposure to Respiratory Allergens by Placental Transfer and Breastfeeding	PLOS ONE			English	Article							HOUSE-DUST-MITE; CORD BLOOD-IGE; ENDOTOXIN EXPOSURE; RISK-FACTOR; ANTIBODIES; SENSITIZATION; MILK; ATOPY; MATTRESS; DISEASE	The relationship between allergen exposure and the onset of or protection from allergic diseases remains unclear. Many factors could be related to immunological responses, such as the age when the exposure occurs, type of allergen, timing, dose, and allergen route. In this study, we investigated whether exposure to respiratory allergens could occur in pregnancy or early life. In particular, we assessed whether Der p 1 and Blo t 5, as well as specific antibodies against these allergens, could be detected in 90 paired cord blood and colostrum samples. Der p 1 was detected in 58.6% of colostrum and 29% of cord blood samples, whereas Blot 5 was positive in 41.3% and 9.6% of the samples, respectively. Similar to specific IgA, which could be detected in all samples for both mites, specific IgG was found in a high number of colostrum samples, 93.5% and 94.8% for Dp and Bt, respectively. Although allergens were not detected in all cord blood samples, a high percentage of them (>= 95%) were positive for specific IgM to both mites in cord blood samples, suggesting that neonates can be exposed and sensitized to airborne allergens during pregnancy. Many studies have attempted to correlate allergen exposure or its prevention in early infancy with the onset of or protection from allergic diseases. However, conflicting and inconsistent data do not show a clear correlation with or suggest a way to prevent allergen sensitization. Nevertheless, these unconvincing results could be better understood if the relationship with many aspects of allergen exposure after pregnancy could be clarified. Thus, it is necessary to address basic issues related to allergen exposure, including the development of reproducible, standardized and reliable methods, and to determine how and where the exposure occurs.	[Macchiaverni, Patricia; Ynoue, Leandro H.; Arslanian, Christina; Condino-Neto, Antonio] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Verhasselt, Valerie] Univ Nice Sophia Antipolis, U924, INSERM, Valbonne, France	Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Condino-Neto, A (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.	condino@icb.usp.br	Macchiaverni, Patricia/K-8507-2018; Condino-Neto, Antonio/D-4762-2012; Verhasselt, Valerie/AAO-2373-2020	Macchiaverni, Patricia/0000-0002-1897-9013; Condino-Neto, Antonio/0000-0002-1069-3117; verhasselt, valerie/0000-0002-5732-9048	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/51290-6, 2010/05221-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), grant numbers: 2012/51290-6 and 2010/05221-7.	Averbeck Marco, 2007, J Dtsch Dermatol Ges, V5, P1015, DOI 10.1111/j.1610-0387.2007.06538.x; Bergmann RL, 1997, CLIN EXP ALLERGY, V27, P752, DOI 10.1046/j.1365-2222.1997.310899.x; Bertino E, 2006, PEDIATR ALLERGY IMMU, V17, P484, DOI 10.1111/j.1399-3038.2006.00449.x; BIRCHER AJ, 1994, CLIN EXP ALLERGY, V24, P367, DOI 10.1111/j.1365-2222.1994.tb00248.x; Casas R, 2001, PEDIATR ALLERGY IMMU, V12, P59, DOI 10.1034/j.1399-3038.2001.012002059.x; Casas R, 2000, J ALLERGY CLIN IMMUN, V105, P1236, DOI 10.1067/mai.2000.105805; Coscia A, 2012, J Biol Regul Homeost Agents, V26, P39; Custovic A, 2015, CLIN EXP ALLERGY, V45, P54, DOI 10.1111/cea.12450; da Silva DR, 2005, PEDIAT ALLERG IMM-UK, V16, P132, DOI 10.1111/j.1399-3038.2005.00210.x; Baldacara RPD, 2013, SAO PAULO MED J, V131, P301, DOI 10.1590/1516-3180.2013.1315502; de Oliveira CH, 2003, ANN ALLERG ASTHMA IM, V91, P559, DOI 10.1016/S1081-1206(10)61534-7; Denis M, 2012, ARCH PEDIATRIE, V19, P305, DOI 10.1016/j.arcped.2011.12.002; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Fernandez-Caldas E, 2014, CHEM IMMUNOL ALLERGY, V100, P234, DOI 10.1159/000358860; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gruzieva O, 2014, PAEDIATR RESPIR REV, V15, P348, DOI 10.1016/j.prrv.2014.07.003; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Holloway JA, 2000, LANCET, V356, P1900, DOI 10.1016/S0140-6736(00)03265-7; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Hurley WL., 2003, ADV DAIRY CHEM PROTE, P421; Janzi M, 2009, CLIN IMMUNOL, V133, P78, DOI 10.1016/j.clim.2009.05.014; Jenmalm MC, 2000, CLIN EXP ALLERGY, V30, P34, DOI 10.1046/j.1365-2222.2000.00771.x; Johansson SGO, 1988, CLIN WORKSH IGE ANT; Jones DD, 2012, J IMMUNOL, V189, P1440, DOI 10.4049/jimmunol.1200878; Kamemura N, 2012, J ALLERGY CLIN IMMUN, V130, P113, DOI 10.1016/j.jaci.2012.02.023; Kane SV, 2009, AM J GASTROENTEROL, V104, P228, DOI 10.1038/ajg.2008.71; Kaufmann P, 1996, ANN ANAT, V178, P485, DOI 10.1016/S0940-9602(96)80102-6; KELLER MA, 1983, J IMMUNOL, V130, P1654; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Lowe LA, 2004, ARCH PEDIAT ADOL MED, V158, P996, DOI 10.1001/archpedi.158.10.996; Macchiaverni P, 2011, SCAND J IMMUNOL, V74, P619, DOI 10.1111/j.1365-3083.2011.02615.x; Macchiaverni P, 2014, CLIN TRANSL ALLER S1, V4, pP1, DOI [10.1186/2045-7022-4-S1-P1, DOI 10.1186/2045-7022-4-S1-P1]; Nabavi M, 2013, ASIAN PAC J ALLERGY, V31, P157, DOI 10.12932/AP0234.31.2.2013; Orru S, 2013, INT J IMMUNOPATH PH, V26, P435, DOI 10.1177/039463201302600216; Palmeira P, 2009, PEDIAT ALLERG IMM-UK, V20, P528, DOI 10.1111/j.1399-3038.2008.00828.x; Patah LEM, 2011, REV SAUDE PUBL, V45, P85; Peters JL, 2009, J ALLERGY CLIN IMMUN, V123, P1041, DOI 10.1016/j.jaci.2009.02.027; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; PICCINNI MP, 1993, INT ARCH ALLERGY IMM, V102, P301, DOI 10.1159/000236541; Savilahti E, 2005, PEDIATR RES, V58, P1300, DOI 10.1203/01.pdr.0000183784.87452.c6; Sigal LH, 2012, JCR-J CLIN RHEUMATOL, V18, P316, DOI 10.1097/RHU.0b013e318269446b; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Simpson A, 2009, CURR ALLERGY ASTHM R, V9, P363, DOI 10.1007/s11882-009-0053-y; Sletten GBG, 2007, PEDIAT ALLERG IMM-UK, V18, P71, DOI 10.1111/j.1399-3038.2006.00489.x; Spieksma FTM, 2004, J ALLERGY CLIN IMMUN, V113, P573, DOI 10.1016/j.jaci.2003.10.064; Szepfalusi Z, 2000, J ALLERGY CLIN IMMUN, V106, P530; Szepfalusi Z, 2006, CLIN EXP ALLERGY, V36, P1130, DOI 10.1111/j.1365-2222.2006.02559.x; Takahashi T, 2002, BIOL NEONATE, V82, P238, DOI 10.1159/000065893; Tobias KRC, 2004, INT ARCH ALLERGY IMM, V133, P365, DOI 10.1159/000077356; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Vance GHS, 2005, CLIN EXP ALLERGY, V35, P1318, DOI 10.1111/j.1365-2222.2005.02346.x; von Mutius E, 2007, IMMUNOBIOLOGY, V212, P433, DOI 10.1016/j.imbio.2007.03.002; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Warner JO, 2000, PEDIAT ALLERG IMM-UK, V11, P12, DOI 10.1034/j.1399-3038.2000.00503.x; WILLOUGHBY JB, 1977, J IMMUNOL, V119, P2137; Zambelli-Weiner A, 2005, J ALLERGY CLIN IMMUN, V115, P1203, DOI 10.1016/j.jaci.2005.03.001	57	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139064	10.1371/journal.pone.0139064	http://dx.doi.org/10.1371/journal.pone.0139064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398234	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500139
J	Stocco, A; Prat, CS; Losey, DM; Cronin, JA; Wu, J; Abernethy, JA; Rao, RPN				Stocco, Andrea; Prat, Chantel S.; Losey, Darby M.; Cronin, Jeneva A.; Wu, Joseph; Abernethy, Justin A.; Rao, Rajesh P. N.			Playing 20 Questions with the Mind: Collaborative Problem Solving by Humans Using a Brain-to-Brain Interface	PLOS ONE			English	Article							MAGNETIC STIMULATION; ATTENTION; CORTEX	We present, to our knowledge, the first demonstration that a non-invasive brain-to-brain interface (BBI) can be used to allow one human to guess what is on the mind of another human through an interactive question-and-answering paradigm similar to the "20 Questions" game. As in previous non-invasive BBI studies in humans, our interface uses electroencephalography (EEG) to detect specific patterns of brain activity from one participant (the "respondent"), and transcranial magnetic stimulation (TMS) to deliver functionally-relevant information to the brain of a second participant (the "inquirer"). Our results extend previous BBI research by (1) using stimulation of the visual cortex to convey visual stimuli that are privately experienced and consciously perceived by the inquirer; (2) exploiting real-time rather than off-line communication of information from one brain to another; and (3) employing an interactive task, in which the inquirer and respondent must exchange information bi-directionally to collaboratively solve the task. The results demonstrate that using the BBI, ten participants (five inquirer-respondent pairs) can successfully identify a "mystery item" using a true/false question-answering protocol similar to the "20 Questions" game, with high levels of accuracy that are significantly greater than a control condition in which participants were connected through a sham BBI.	[Stocco, Andrea; Prat, Chantel S.; Abernethy, Justin A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Stocco, Andrea; Prat, Chantel S.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Losey, Darby M.; Wu, Joseph; Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Cronin, Jeneva A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stocco, A (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	stocco@uw.edu; rao@cs.washington.edu	Stocco, Andrea/A-2159-2013	Stocco, Andrea/0000-0001-8919-3934; Rao, Rajesh P. N./0000-0003-0682-8952	W. M. Keck Foundation	W. M. Keck Foundation(W.M. Keck Foundation)	This research was funded by an award of the W. M. Keck Foundation (http://www.wmkeck.org/) to AS, CSP, and RPNR.	Bestmann S, 2007, CURR BIOL, V17, P134, DOI 10.1016/j.cub.2006.11.063; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Grau C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105225; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; Martinez Pablo, 2007, Comput Intell Neurosci, P94561, DOI 10.1155/2007/94561; Mason RA, 2014, CEREB CORTEX, V24, P1474, DOI 10.1093/cercor/bhs423; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; Meyer P. E., 2009, INFOTHEO INFORM THEO; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; O'Shea J, 2007, CURR BIOL, V17, pR196, DOI 10.1016/j.cub.2007.01.030; Pais-Vieira M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11869; Pais-Vieira M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01319; Rao R., 2013, BRAIN COMPUTER INTER; Rao R. P. N., 2013, DIRECT BRAIN TO BRAI; Rao RPN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111332; Rao RPN, 2014, SCI AM MIND SCI AM I, V25, P36, DOI [10.1038/scientificamericanmind1114-36, DOI 10.1038/SCIENTIFICAMERICANMIND1114-36]; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Veniero D, 2011, PSYCHOPHYSIOLOGY, V48, P1381, DOI 10.1111/j.1469-8986.2011.01218.x; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Yin EW, 2015, IEEE T BIO-MED ENG, V62, P1447, DOI 10.1109/TBME.2014.2320948; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410	25	23	23	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137303	10.1371/journal.pone.0137303	http://dx.doi.org/10.1371/journal.pone.0137303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398267	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500028
J	Xu, MH; Su, LY; Cao, LF; Zhong, HQ; Dong, NN; Dong, ZQ; Xu, J				Xu, Menghua; Su, Liyun; Cao, Lingfeng; Zhong, Huaqing; Dong, Niuniu; Dong, Zuoquan; Xu, Jin			Genotypes of the Enterovirus Causing Hand Foot and Mouth Disease in Shanghai, China, 2012-2013	PLOS ONE			English	Article							OUTBREAK; TAIWAN; SURVEILLANCE; CIRCULATION; INFECTION; SEROTYPES; EPIDEMIC; CHILDREN; A6	Sporadic HFMD (hand foot and mouth disease, HFMD) cases and outbreaks caused by etiologic agents other than EV71 and CA16 have increased globally. We conducted this study to investigate the prevalence and genetic characteristics of enteroviruses, especially the non-EV71 and non-CA16 enteroviruses, causing HFMD in Shanghai. Clinical specimens were collected from patients with a diagnosis of HFMD. A partial length of VP1 was amplified with RT-PCR and subjected to direct sequencing. Phylogenetic analyses were performed using MEGA 5.0. The ages of the HFMD cases ranged from 3 to 96 months, and the male/female ratio was 1.41. The median hospital stay was 2.96 days. Up to 18.0% of patients had neurologic system complications such as encephalitis, meningoencephalitis or meningitis. Of the 480 samples, 417 were positive for enterovirus (86.9%) with RT-PCR. A total of 13 enterovirus genotypes were identified. The most frequent genotypes were CA6 (31.9%), EV71 (30.6%), CA16 (8.8%) and CA10 (7.5%). Infections with CA6, EV71, CA16 and CA10 were prevalent throughout the years of study, while the proportion of CA6 notably increased from Sep. 2012 to Dec. 2013. Phylogenetic analyses showed that EV71 strains belonged to the C4a subgenogroup and CA16 was identified as B1b subgenogroup. The CA6 strains were assigned to genogroup F, whereas the CA10 strains were assigned to genogroup D. Patients infected with CA6 were typically younger, had a shorter hospital stay and had a lower incidence of neurologic system complications when compared to patients infected with EV71. Our study demonstrates that the enterovirus genotypes causing HFMD were diversified, and there was an increasing prevalence of the non-EV71 and non-CA16 enteroviruses from 2012 to 2013. CA6 was the most predominant pathogen causing HFMD from Sep. 2012 to Dec. 2013, and it often caused relatively mild HFMD symptoms. Most severe HFMD cases were associated with EV71 infection.	[Xu, Menghua; Su, Liyun; Cao, Lingfeng; Zhong, Huaqing; Dong, Niuniu; Dong, Zuoquan; Xu, Jin] Fudan Univ, Childrens Hosp, Dept Clin Lab, Shanghai 201102, Peoples R China	Fudan University	Xu, J (corresponding author), Fudan Univ, Childrens Hosp, Dept Clin Lab, Shanghai 201102, Peoples R China.	jin030101@aliyun.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Program of the National Natural Science Foundation of China [NSFC81273204]	Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program of the National Natural Science Foundation of China (NSFC81273204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; King AMQ, VIRUS TAXONOMY CLASS, P855; Leitch ECM, 2009, J CLIN VIROL, V44, P119, DOI 10.1016/j.jcv.2008.11.015; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Davia JL, 2011, PEDIATR DERMATOL, V28, P1, DOI 10.1111/j.1525-1470.2010.01161.x; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mathes EF, 2013, PEDIATRICS, V132, pE149, DOI 10.1542/peds.2012-3175; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Perera D, 2007, ARCH VIROL, V152, P1201, DOI 10.1007/s00705-006-0934-5; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Puenpa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098888; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yang GL, 2014, J XIAN JIAOTONG U ME, V4, P486; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang C, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.12; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	38	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138514	10.1371/journal.pone.0138514	http://dx.doi.org/10.1371/journal.pone.0138514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398767	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500074
J	Zhou, ZC; Liu, SK; Dong, Y; Gao, S; Chen, Z; Jiang, JW; Yang, AF; Sun, HJ; Guan, XY; Jiang, B; Wang, B				Zhou, Zunchun; Liu, Shikai; Dong, Ying; Gao, Shan; Chen, Zhong; Jiang, Jingwei; Yang, Aifu; Sun, Hongjuan; Guan, Xiaoyan; Jiang, Bei; Wang, Bai			High-Density Genetic Mapping with Interspecific Hybrids of Two Sea Urchins, Strongylocentrotus nudus and S-intermedius, by RAD Sequencing	PLOS ONE			English	Article							GENOME EVOLUTION; RECOMBINATION RATES; LINKAGE MAPS; MARKERS; DUPLICATION; INTEGRATION; DISCOVERY; SOFTWARE; INSIGHTS	Sea urchins have long been used as research model organisms for developmental biology and evolutionary studies. Some of them are also important aquaculture species in East Asia. In this work, we report the construction of RAD-tag based high-density genetic maps by genotyping F-1 interspecific hybrids derived from a crossing between a female sea urchin Strongylocentrotus nudus and a male Strongylocentrotus intermedius. With polymorphisms present in these two wild individuals, we constructed a female meiotic map containing 3,080 markers for S. nudus, and a male meiotic map for S. intermedius which contains 1,577 markers. Using the linkage maps, we were able to anchor a total of 1,591 scaffolds (495.9 Mb) accounting for 60.8% of the genome assembly of Strongylocentrotus purpuratus. A genome-wide scan resulted in the identification of one putative QTL for body size which spanned from 25.3 cM to 30.3 cM. This study showed the efficiency of RAD-Seq based high-density genetic map construction using F-1 progenies for species with no prior genomic information. The genetic maps are essential for QTL mapping and are useful as framework to order and orientate contiguous scaffolds from sea urchin genome assembly. The integration of the genetic map with genome assembly would provide an unprecedented opportunity to conduct QTL analysis, comparative genomics, and population genetics studies.	[Zhou, Zunchun; Dong, Ying; Gao, Shan; Chen, Zhong; Jiang, Jingwei; Yang, Aifu; Sun, Hongjuan; Guan, Xiaoyan; Jiang, Bei; Wang, Bai] Liaoning Ocean & Fisheries Sci Res Inst, Liaoning Key Lab Marine Fishery Mol Biol, Dalian 116023, Liaoning, Peoples R China; [Liu, Shikai] Auburn Univ, Fish Mol Genet & Biotechnol Lab, Aquat Genom Unit, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Liu, Shikai] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Zhou, ZC (corresponding author), Liaoning Ocean & Fisheries Sci Res Inst, Liaoning Key Lab Marine Fishery Mol Biol, Dalian 116023, Liaoning, Peoples R China.	zunchunz@hotmail.com	Liu, Shikai/AAO-2247-2021; Pei, Chiang/HGE-6021-2022	Liu, Shikai/0000-0001-5777-489X; 	State High-Technology R & D Project of China [2012AA10A412]; Science & Technology Project of Liaoning Province [2014203006]	State High-Technology R & D Project of China; Science & Technology Project of Liaoning Province	This work was supported by grants from State 863 High-Technology R & D Project of China (2012AA10A412), Science & Technology Project of Liaoning Province (2014203006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 2014, GENETICS, V197, P625, DOI 10.1534/genetics.114.164293; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Jiao WQ, 2014, DNA RES, V21, P85, DOI 10.1093/dnares/dst043; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kondo M, 2012, CURR GENOMICS, V13, P134, DOI 10.2174/138920212799860643; Lenormand T, 2005, PLOS BIOL, V3, P396, DOI 10.1371/journal.pbio.0030063; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Rahman MA, 2005, AQUACULTURE, V245, P121, DOI 10.1016/j.aquaculture.2004.11.049; Sakamoto T, 2000, GENETICS, V155, P1331; SAOTOME K, 1987, ZOOL SCI, V4, P483; SAOTOME K, 1989, CHROM INFOR SERV, V46, P11; Singer A, 2002, GENETICS, V160, P649; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang L, 2003, FISHERIES SCI, V22, P9; [王龙伟 Wang Longwei], 2004, [预测, Forecasting], V23, P1; Zhou ZC, 2006, AQUACULTURE, V259, P56, DOI 10.1016/j.aquaculture.2006.05.010	29	7	9	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138585	10.1371/journal.pone.0138585	http://dx.doi.org/10.1371/journal.pone.0138585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398139	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500081
J	Hornigold, N; Mooney, A				Hornigold, Nick; Mooney, Andrew			Extracellular matrix-induced Hic-5 expression in glomerular mesangial cells leads to a prosclerotic phenotype independent of TGF-beta	FASEB JOURNAL			English	Article						collagen; glomerulosclerosis; scarring	GROWTH-FACTOR-BETA; FOCAL ADHESION PROTEIN; KIDNEY-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; EXPERIMENTAL GLOMERULONEPHRITIS; POSSIBLE INVOLVEMENT; COLLAGEN EXPRESSION; RENAL FIBROSIS; WESTERN BLOTS; LIM PROTEIN	Chronic fibroproliferative diseases account for approximately 45% of all deaths in the developed world. In the kidney, glomerulosclerosis is the underlying pathology in approximately half of patients with renal failure receiving dialysis. Mesangial cell expression of the LIM protein hydrogen peroxide-induced clone-5 (Hic-5) is important in its pathogenesis. Hic-5 expression increases following mesangial cell attachment to collagen I, associated with increased collagen I expression and increased susceptibility to apoptosis both in vitro and in experimental glomerulosclerosis. TGF-beta has an established role in many fibrotic diseases, including glomerulosclerosis, where it increases collagen I deposition in vivo and promotesmesangial cell apoptosis in vitro. Inothercell types, TGF-beta induces Hic-5 expression. We investigated whether Hic-5-induced changes in mesangial cell phenotype were TGF-beta-dependent. Adding exogenous TGF-beta to mesangial cell cultures failed to increase Hic-5 expression; blocking TGF-beta signaling did not reduce Hic-5 expression. However, inducing Hic-5 expression in mesangial cells by adhesion to collagen I led to TGF-beta expression, which was abolished by small interfering RNA (siRNA) Hic-5 knockdown. Mesangial cells expressing Hic-5 showed altered latent TGF-beta-binding protein expression and Smad signaling, with enhanced susceptibility to TGF-beta-induced apoptosis. Mesangial cell attachment to collagen I led to increased Hic-5 expression within 2-4 h and increased procollagen I transcription within 12 h, whereas adding TGF-beta to siRNA Hic-5 knockdown mesangial cells increased procollagen I transcription to a lesser degree after 48 h. Mesangial cell Hic-5 expression was associated with increased alpha-smooth muscle actin and plasminogen activator inhibitor-1 expression. Taken together, these data indicate that there is a prosclerotic feedback loop in mesangial cells dependent on matrix-derived signals in which Hic-5 is a pivotal signaling protein. This feedback loop is TGF-beta-independent. The role of TGF-beta-dependent and -independent sclerotic pathways merit further investigation.	[Hornigold, Nick] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Mooney, Andrew] St James Univ Hosp, Renal Unit, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Mooney, A (corresponding author), St James Univ Hosp, Renal Unit, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	andrew.mooney2@nhs.net			UK National Kidney Research Fund [R/51/01]; Kidney Research UK [18/2/2005]; Special Trustees of Leeds Teaching Hospitals NHS Trust; Yorkshire Kidney Research Fund	UK National Kidney Research Fund(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK)); Special Trustees of Leeds Teaching Hospitals NHS Trust; Yorkshire Kidney Research Fund	The gift of the RMCs from Dr. Masanori Kitamura (University College London, London, United Kingdom) is gratefully acknowledged. This work was generously supported by the UK National Kidney Research Fund (Grant R/51/01), Kidney Research UK (Grant 18/2/2005), The Special Trustees of Leeds Teaching Hospitals NHS Trust, and the Yorkshire Kidney Research Fund. The authors declare no conflicts of interest.	Akagi Y, 1996, KIDNEY INT, V50, P148, DOI 10.1038/ki.1996.297; BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; BORDER WA, 1995, KIDNEY INT, V47, pS59; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Constam DB, 2014, SEMIN CELL DEV BIOL, V32, P85, DOI 10.1016/j.semcdb.2014.01.008; COUCHMAN JR, 1994, KIDNEY INT, V45, P328, DOI 10.1038/ki.1994.42; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukuda N, 2009, J NEPHROL, V22, P708; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gao ZL, 2005, FEBS LETT, V579, P5651, DOI 10.1016/j.febslet.2005.08.086; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Greenhalgh Stephen N, 2013, F1000Prime Rep, V5, P37, DOI 10.12703/P5-37; Guerrero-Santoro J, 2004, J CELL BIOCHEM, V92, P810, DOI 10.1002/jcb.20109; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Hornigold N, 2013, LAB INVEST, V93, P553, DOI 10.1038/labinvest.2013.42; Hornigold N, 2010, KIDNEY INT, V77, P329, DOI 10.1038/ki.2009.417; Hu YH, 1999, P NATL ACAD SCI USA, V96, P10218, DOI 10.1073/pnas.96.18.10218; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Ishino K, 2000, J CELL BIOCHEM, V76, P411, DOI 10.1002/(SICI)1097-4644(20000301)76:3<411::AID-JCB9>3.0.CO;2-J; Jia YF, 2001, J BIOL CHEM, V276, P39911, DOI 10.1074/jbc.M103510200; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khera T, 2006, LAB INVEST, V86, P566, DOI 10.1038/labinvest.3700418; Kim-Kaneyama J, 2002, BIOCHEM BIOPH RES CO, V299, P360, DOI 10.1016/S0006-291X(02)02644-X; Kitamura M, 1997, J CLIN INVEST, V100, P1394, DOI 10.1172/JCI119659; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; LOVETT DH, 1986, KIDNEY INT, V30, P246, DOI 10.1038/ki.1986.176; Ma LJ, 2007, SEMIN IMMUNOPATHOL, V29, P385, DOI 10.1007/s00281-007-0087-y; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Mooney A, 1999, AM J PATHOL, V155, P599, DOI 10.1016/S0002-9440(10)65155-3; Mooney A, 1997, J IMMUNOL, V159, P3949; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Panetti TS, 2004, J THROMB HAEMOST, V2, P1645, DOI 10.1111/j.1538-7836.2004.00902.x; Patel P, 2000, J INVEST MED, V48, P403; Poncelet AC, 1998, AM J PHYSIOL-RENAL, V275, pF458; Savill J, 1996, KIDNEY INT, V49, pS14; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Shibanuma M, 2002, CELL STRUCT FUNCT, V27, P21, DOI 10.1247/csf.27.21; Suga K, 2012, NEPHRON EXP NEPHROL, V120, pE59, DOI 10.1159/000335780; Sugiyama H, 1996, KIDNEY INT, V49, P103, DOI 10.1038/ki.1996.14; Thomas SM, 1999, J CELL SCI, V112, P181; THROCKMORTON DC, 1995, KIDNEY INT, V48, P111, DOI 10.1038/ki.1995.274; Todorovic V, 2012, J CELL BIOCHEM, V113, P410, DOI 10.1002/jcb.23385; Uchida Keiko, 2000, Molecular Cell Biology Research Communications, V4, P98, DOI 10.1006/mcbr.2000.0258; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAMOTO T, 1994, KIDNEY INT, V45, P916, DOI 10.1038/ki.1994.122; Yokoo T, 1997, J IMMUNOL, V159, P2886; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413	69	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4956	4967		10.1096/fj.14-269894	http://dx.doi.org/10.1096/fj.14-269894			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26405299				2022-12-26	WOS:000365523600021
J	Aldrich-Wolfe, L; Travers, S; Nelson, BD				Aldrich-Wolfe, Laura; Travers, Steven; Nelson, Berlin D., Jr.			Genetic Variation of Sclerotinia sclerotiorum from Multiple Crops in the North Central United States	PLOS ONE			English	Article							FUNGAL PLANT PATHOGEN; MICROSATELLITE MARKERS; COMPATIBILITY GROUPS; POPULATION-STRUCTURE; CLONAL LINEAGES; DIVERSITY; CANOLA; DIFFERENTIATION; AGGRESSIVENESS; PROGRAMS	Sclerotinia sclerotiorum is an important pathogen of numerous crops in the North Central region of the United States. The objective of this study was to examine the genetic diversity of 145 isolates of the pathogen from multiple hosts in the region. Mycelial compatibility groups (MCG) and microsatellite haplotypes were determined and analyzed for standard estimates of population genetic diversity and the importance of host and distance for genetic variation was examined. MCG tests indicated there were 49 different MCGs in the population and 52 unique microsatellite haplotypes were identified. There was an association between MCG and haplotype such that isolates belonging to the same MCG either shared identical haplotypes or differed at no more than 2 of the 12 polymorphic loci. For the majority of isolates, there was a one-to-one correspondence between MCG and haplotype. Eleven MCGs shared haplotypes. A single haplotype was found to be prevalent throughout the region. The majority of genetic variation in the isolate collection was found within rather than among host crops, suggesting little genetic divergence of S. sclerotiorum among hosts. There was only weak evidence of isolation by distance. Pairwise population comparisons among isolates from canola, dry bean, soybean and sunflower suggested that gene flow between host-populations is more common for some crops than others. Analysis of linkage disequilibrium in the isolates from the four major crops indicated primarily clonal reproduction, but also evidence of genetic recombination for isolates from canola and sunflower. Accordingly, genetic diversity was highest for populations from canola and sunflower. Distribution of microsatellite haplotypes across the study region strongly suggest that specific haplotypes of S. sclerotiorum are often found on multiple crops, movement of individual haplotypes among crops is common and host identity is not a barrier to gene flow for S. sclerotiorum in the north central United States.	[Aldrich-Wolfe, Laura] Concordia Coll, Dept Biol, Moorhead, MN USA; [Travers, Steven] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Nelson, Berlin D., Jr.] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo	Nelson, BD (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	berlin.nelson@ndsu.edu			USDA National Sclerotinia Initiative; Dept. Plant Pathology, North Dakota State University, Fargo, ND; USDA-ARS award [58-5442-8-233]	USDA National Sclerotinia Initiative; Dept. Plant Pathology, North Dakota State University, Fargo, ND; USDA-ARS award	The funding for this research was from the USDA National Sclerotinia Initiative. The grant was awarded to Berlin D. Nelson Jr., Professor, Dept. Plant Pathology, North Dakota State University, Fargo, ND. The title of the grant was Genetic diversity and virulence of S. sclerotiorum on six crops in the north central Region. USDA-ARS award 58-5442-8-233. The website of the Sclerotinia Initiative is: http://www.ars.usda.gov/Research/docs.htm?docid=20317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ameen G, 2012, PHYTOPATHOLOGY, V102, P4; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Attanayake RN, 2014, HEREDITY, V113, P353, DOI 10.1038/hdy.2014.37; Attanayake RN, 2012, SOIL BIOL BIOCHEM, V55, P28, DOI 10.1016/j.soilbio.2012.06.002; Attanayake RN, 2013, PHYTOPATHOLOGY, V103, P750, DOI 10.1094/PHYTO-07-12-0159-R; Barari H, 2012, ROM AGRIC RES, V29, P323; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; BROWN AHD, 1980, GENETICS, V96, P523; Brueggeman RS, 2013, PHYTOPATHOLOGY, V103, P21; Carbone I, 1999, EVOLUTION, V53, P11, DOI [10.1111/j.1558-5646.1999.tb05329.x, 10.2307/2640916]; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Carpenter MA, 1999, NEW ZEAL J CROP HORT, V27, P13, DOI 10.1080/01140671.1999.9514075; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P1000, DOI 10.1094/PHYTO.1997.87.10.1000; Ekins MG, 2011, AUSTRALAS PLANT PATH, V40, P99, DOI 10.1007/s13313-010-0018-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gomes EV, 2011, J PHYTOPATHOL, V159, P94, DOI 10.1111/j.1439-0434.2010.01724.x; Hambleton S, 2002, CAN J PLANT PATHOL, V24, P309; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Hemmati R, 2009, EUR J PLANT PATHOL, V125, P617, DOI 10.1007/s10658-009-9510-7; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KOHLI Y, 1992, PHYTOPATHOLOGY, V82, P875, DOI 10.1094/Phyto-82-875; Kohli Y, 1996, MOL ECOL, V5, P773, DOI 10.1111/j.1365-294X.1996.tb00373.x; Kull LS, 2004, PLANT DIS, V88, P325, DOI 10.1094/PDIS.2004.88.4.325; Li ZQ, 2009, PHYTOPARASITICA, V37, P77, DOI 10.1007/s12600-008-0003-6; Litholdo CG, 2011, GENET MOL RES, V10, P868, DOI 10.4238/vol10-2gmr937; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Mandal AK, 2012, WORLD J MICROB BIOT, V28, P1849, DOI 10.1007/s11274-011-0981-2; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mert-Turk F, 2007, J PHYTOPATHOL, V155, P182, DOI 10.1111/j.1439-0434.2007.01223.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Otto-Hanson L, 2011, PLANT DIS, V95, P1370, DOI 10.1094/PDIS-11-10-0865; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Sexton AC, 2004, CURR GENET, V46, P357, DOI 10.1007/s00294-004-0543-3; Sexton AC, 2006, GENOME, V49, P1408, DOI 10.1139/G06-101; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; Winton LM, 2006, CAN J PLANT PATHOL, V28, P426, DOI 10.1080/07060660609507316; Wu BM, 2006, PHYTOPATHOLOGY, V96, P1322, DOI 10.1094/PHYTO-96-1322	42	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139188	10.1371/journal.pone.0139188	http://dx.doi.org/10.1371/journal.pone.0139188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417989	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400059
J	Le Sant, G; Ates, F; Brasseur, JL; Nordez, A				Le Sant, Guillaume; Ates, Filiz; Brasseur, Jean-Louis; Nordez, Antoine			Elastography Study of Hamstring Behaviors during Passive Stretching	PLOS ONE			English	Article							SHEAR ELASTIC-MODULUS; MUSCLE-TENDON UNITS; SKELETAL-MUSCLE; GASTROCNEMIUS-MUSCLE; CLINICAL-SIGNIFICANCE; WAVE ELASTOGRAPHY; PELVIC POSITION; STRAIN INJURIES; RISK-FACTORS; LENGTH	Introduction The mechanical properties of hamstring muscles are usually inferred from global passive torque/angle relationships, in combination with adjoining tissues crossing the joint investigated. Shear modulus measurement provides an estimate of changes in muscle-tendon stiffness and passive tension. This study aimed to assess the passive individual behavior of each hamstring muscle in different stretching positions using shear wave elastography. Methods/Results The muscle shear modulus of each hamstring muscle was measured during a standardized slow passive knee extension (PKE, 80% of maximal range of motion) on eighteen healthy male volunteers. Firstly, we assessed the reliability of the measurements. Results were good for semitendinosus (ST, CV: 8.9%-13.4%), semimembranosus (SM, CV: 10.3%-11.2%) and biceps femoris long-head (BF-lh, CV: 8.6%-13.3%), but not for biceps femoris short-head (BF-sh, CV: 20.3%-44.9%). Secondly, we investigated each reliable muscle in three stretch positions: 70 degrees, 90 degrees and 110 degrees of hip flexion. The results showed different values of shear modulus for the same amount of perceived stretch, with the highest measurements in the high-flexed hip situation. Moreover, individual muscles displayed different values, with values increasing or BF-lh, SM and ST, respectively. The inter-subject variability was 35.3% for ST, 27.4% for SM and 30.2% for BF-lh. Conclusion This study showed that the hip needs to be high-flexed to efficiently tension the hamstrings, and reports a higher muscle-tendon stress tolerance at 110 degrees of hip angle. In addition muscles have different passive behaviors, and future works will clarify if it can be linked with rate of injury.	[Le Sant, Guillaume; Ates, Filiz; Nordez, Antoine] Univ Nantes, Fac Sports Sci, Lab Movement Interact Performance EA 4334, Nantes, France; [Le Sant, Guillaume] Sch Physiotherapy IFM3R, Nantes, France; [Brasseur, Jean-Louis] Hop La Pitie Salpetriere, AP HP, Serv Radiol, Paris, France	Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Nordez, A (corresponding author), Univ Nantes, Fac Sports Sci, Lab Movement Interact Performance EA 4334, Nantes, France.	antoine.nordez@univ-nantes.fr	ates, filiz/AAB-2652-2022	Le Sant, Guillaume/0000-0001-7614-6389; Ates, Filiz/0000-0002-5634-3913	European Regional Development Fund [37400]; University of Nantes	European Regional Development Fund(European Commission); University of Nantes	The study was sponsored by grants from the European Regional Development Fund (no. 37400) and the University of Nantes (interdisciplinary program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade RJ, 2015, EFFECTS HIP HEAD POS; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Brasseur J-L, 2011, ACTUALITES ECHOGRAPH, V8, P263; Catheline S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.064301; Chaitow L, 2013, MUSCLE ENERGY TECHNI, V4th; Decoster LC, 2005, J ORTHOP SPORT PHYS, V35, P377, DOI 10.2519/jospt.2005.35.6.377; Decoster LC, 2004, J ATHL TRAINING, V39, P330; Diong J, 2012, CLIN BIOMECH, V27, P893, DOI 10.1016/j.clinbiomech.2012.07.003; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Freitas SR, 2015, EUR J APPL PHYSIOL, V115, P1263, DOI 10.1007/s00421-015-3104-1; Gajdosik RL, 2005, EUR J APPL PHYSIOL, V95, P131, DOI 10.1007/s00421-005-1394-4; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Goldman EF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006782.pub2; Hallen A, 2014, J SPORT SCI, V32, P1229, DOI 10.1080/02640414.2014.905695; Herbert RD, 2015, J PHYSIOL-LONDON, V593, P441, DOI 10.1113/jphysiol.2014.279166; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Herbert RD, 2011, J PHYSIOL-LONDON, V589, P5257, DOI 10.1113/jphysiol.2011.212175; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Herrington L, 2013, J SPORT REHABIL, V22, P254, DOI 10.1123/jsr.22.4.254; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hug F, 2013, J BIOMECH, V46, P2534, DOI 10.1016/j.jbiomech.2013.07.015; Kallerud H, 2013, SPORTS MED, V43, P733, DOI 10.1007/s40279-013-0053-x; Kellis E, 2012, J ELECTROMYOGR KINES, V22, P520, DOI 10.1016/j.jelekin.2012.03.012; Kellis E, 2010, J ELECTROMYOGR KINES, V20, P1237, DOI 10.1016/j.jelekin.2010.07.012; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Koo TK, 2015, J BIOMECH IN PRESS; Kwah LK, 2013, J APPL PHYSIOL, V114, P761, DOI 10.1152/japplphysiol.01430.2011; Lacourpaille L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053159; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Lieber RL, 2001, CLIN ORTHOP RELAT R, P140; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; McHugh MP, 1999, AM J SPORT MED, V27, P594, DOI 10.1177/03635465990270050801; Mendiguchia J, 2012, BRIT J SPORT MED, V46, P81, DOI 10.1136/bjsm.2010.081695; Mitchell B, 2008, PHYS THER SPORT, V9, P202, DOI 10.1016/j.ptsp.2008.08.002; Morris CE, 2006, SPINE, V31, P1060, DOI 10.1097/01.brs.0000214879.93102.4e; Nordez A, 2006, CLIN BIOMECH, V21, P755, DOI 10.1016/j.clinbiomech.2006.03.005; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Riemann BL, 2001, J ATHL TRAINING, V36, P369; Schuermans J, 2014, BRIT J SPORT MED, V48, P1599, DOI 10.1136/bjsports-2014-094017; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SULLIVAN MK, 1992, MED SCI SPORT EXER, V24, P1383; Umegaki H, 2015, MANUAL THER, V20, P610, DOI 10.1016/j.math.2015.02.006; Umegaki H, 2015, MANUAL THER, V20, P134, DOI 10.1016/j.math.2014.07.016; Wang M, 2013, IEEE T MED IMAGING, V32, P1671, DOI 10.1109/TMI.2013.2262948; Webright WG, 1997, J ORTHOP SPORT PHYS, V26, P7, DOI 10.2519/jospt.1997.26.1.7; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Weppler CH, 2010, PHYS THER, V90, P438, DOI 10.2522/ptj.20090012; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801; Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701; Woodley SJ, 2005, CELLS TISSUES ORGANS, V179, P125, DOI 10.1159/000085004	56	43	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139272	10.1371/journal.pone.0139272	http://dx.doi.org/10.1371/journal.pone.0139272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418862	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400068
J	Sirimahachaiyakul, P; Sood, RF; Muffley, LA; Seaton, M; Lin, CT; Qiao, L; Armaly, JS; Hocking, AM; Gibran, NS				Sirimahachaiyakul, Pornthep; Sood, Ravi F.; Muffley, Lara A.; Seaton, Max; Lin, Cheng-Ta; Qiao, Liang; Armaly, Jeffrey S.; Hocking, Anne M.; Gibran, Nicole S.			Race Does Not Predict Melanocyte Heterogeneous Responses to Dermal Fibroblast-Derived Mediators	PLOS ONE			English	Article							CULTURED HUMAN MELANOCYTES; HYPERTROPHIC SCAR; GENE-EXPRESSION; CUTANEOUS SCARS; PIGMENTATION; GROWTH; SKIN; ASSOCIATION; DIFFERENTIATION; PROLIFERATION	Introduction Abnormal pigmentation following cutaneous injury causes significant patient distress and represents a barrier to recovery. Wound depth and patient characteristics influence scar pigmentation. However, we know little about the pathophysiology leading to hyperpigmentation in healed shallow wounds and hypopigmentation in deep dermal wound scars. We sought to determine whether dermal fibroblast signaling influences melanocyte responses. Methods and Materials Epidermal melanocytes from three Caucasians and three African-Americans were genotyped for single nucleotide polymorphisms (SNPs) across the entire genome. Melanocyte genetic profiles were determined using principal component analysis. We assessed melanocyte phenotype and gene expression in response to dermal fibroblast-conditioned medium and determined potential mesenchymal mediators by proteome profiling the fibroblast-conditioned medium. Results Six melanocyte samples demonstrated significant variability in phenotype and gene expression at baseline and in response to fibroblast-conditioned medium. Genetic profiling for SNPs in receptors for 13 identified soluble fibroblast-secreted mediators demonstrated considerable heterogeneity, potentially explaining the variable melanocyte responses to fibroblast-conditioned medium. Discussion Our data suggest that melanocytes respond to dermal fibroblast-derived mediators independent of keratinocytes and raise the possibility that mesenchymal-epidermal interactions influence skin pigmentation during cutaneous scarring.	[Sirimahachaiyakul, Pornthep; Sood, Ravi F.; Muffley, Lara A.; Seaton, Max; Lin, Cheng-Ta; Qiao, Liang; Armaly, Jeffrey S.; Hocking, Anne M.; Gibran, Nicole S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gibran, NS (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	nicoleg@uw.edu		Qiao, Liang/0000-0002-9731-4166; Sirimahachaiyakul, Pornthep/0000-0002-8313-9168	National Institutes of Health [R01GM089704, T32 GM007037]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089704, T32GM007037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by National Institutes of Health grants (R01GM089704; T32 GM007037).	ABDELMALEK Z, 1992, J CELL PHYSIOL, V150, P416, DOI 10.1002/jcp.1041500226; Adini I, 2014, FASEB J OFFICIAL PUB; Adini I, 2014, J CLIN INVEST, V124, P425, DOI 10.1172/JCI69404; Andersen GN, 2005, SCAND J IMMUNOL, V61, P279, DOI 10.1111/j.1365-3083.2005.01565.x; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Cario-Andre M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x; Catania A, 2007, J LEUKOCYTE BIOL, V81, P383, DOI 10.1189/jlb.0706426; Chadwick S, 2012, INDIAN J PLAST SURG, V45, P403, DOI 10.4103/0970-0358.101328; Chadwick SL, 2013, J ANAT, V223, P74, DOI 10.1111/joa.12052; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Chou WC, 2013, NAT MED, V19, P924, DOI 10.1038/nm.3194; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; EHRLICH HP, 1992, PLAST RECONSTR SURG, V90, P993, DOI 10.1097/00006534-199212000-00009; Engrav LH, 2007, J BURN CARE RES, V28, P593, DOI 10.1097/BCR.0B013E318093E482; GORDON PR, 1989, J INVEST DERMATOL, V92, P565, DOI 10.1111/1523-1747.ep12709595; Hedley S, 1996, BRIT J DERMATOL, V135, P888, DOI 10.1046/j.1365-2133.1996.d01-1091.x; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; HIROBE T, 1988, J CELL PHYSIOL, V135, P262, DOI 10.1002/jcp.1041350213; Hirobe T, 2013, J DERMATOL SCI, V71, P45, DOI 10.1016/j.jdermsci.2013.03.012; Holavanahalli RK, 2010, J BURN CARE RES, V31, P631, DOI 10.1097/BCR.0b013e3181e4ca62; Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235; Jagirdar K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12253; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee DY, 2003, ARCH DERMATOL RES, V294, P444, DOI 10.1007/s00403-002-0359-2; Levesque M, 2013, DIS MODEL MECH, V6, P508, DOI 10.1242/dmm.010371; Matsumura H, 2001, WOUND REPAIR REGEN, V9, P269, DOI 10.1046/j.1524-475X.2001.00269.x; Muffley LA, 2012, EXP CELL RES, V318, P2085, DOI 10.1016/j.yexcr.2012.06.002; Muffley LA, 2011, J HISTOCHEM CYTOCHEM, V59, P278, DOI 10.1369/0022155410397999; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Peng HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095186; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Travis TE, 2014, J BURN CARE RES 0826; Tyack Z. F., 1997, Journal of Burn Care and Rehabilitation, V18, P435, DOI 10.1097/00004630-199709000-00012; van der Wal MBA, 2012, WOUND REPAIR REGEN, V20, P676, DOI 10.1111/j.1524-475X.2012.00820.x; Wakamatsu K, 2006, PIGM CELL RES, V19, P154, DOI 10.1111/j.1600-0749.2006.00293.x; Yaar M, 2001, CLIN EXP DERMATOL, V26, P583, DOI 10.1046/j.1365-2230.2001.00895.x; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2007, J INVEST DERMATOL, V127, P1217, DOI 10.1038/sj.jid.5700629; Zhang F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003392; Zhang Zheng, 2012, Mol Biol (Mosk), V46, P628	44	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139135	10.1371/journal.pone.0139135	http://dx.doi.org/10.1371/journal.pone.0139135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418010	Green Submitted, Green Published, gold			2022-12-26	WOS:000362171400051
J	Zhou, S; Jin, X; Chen, XJ; Zhu, JF; Xu, ZP; Wang, XF; Liu, F; Hu, W; Zhou, L; Su, CA				Zhou, Sha; Jin, Xin; Chen, Xiaojun; Zhu, Jifeng; Xu, Zhipeng; Wang, Xuefeng; Liu, Feng; Hu, Wei; Zhou, Liang; Su, Chuan			Heat Shock Protein 60 in Eggs Specifically Induces Tregs and Reduces Liver Immunopathology in Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE MODEL; MANSONI; MODULATE; INFLAMMATION; INFECTIONS; INDUCTION; HEPATITIS; PROTEINS; PATHOGEN	Background Parasitic helminths need to suppress the host immune system to establish chronic infections. Paradoxically, immunosuppression induced by the worm also benefits the host by limiting excessive inflammation and tissue damage, which remains the major cause leading to serious morbidity and mortality. Regulatory T cells (Tregs) are key immune regulators of this mutualism. The successive rise in Tregs during schistosome infection plays a critical role in immunoregulation. We and others previously showed that Schistosoma japonicum (S. japonicum) egg antigens (SEA) induce Tregs both in vitro and in vivo. In addition, we identified that SjHSP60 derived from SEA significantly induces Tregs in vivo and in vitro. However, the contribution of SjHSP60 in SEA to Treg induction and the related mechanisms of the Treg induction have not yet been identified. Methodology/Principal Findings In this study, we showed that S. japonicum stress protein HSP60 (SjHSP60) was constitutively and extensively expressed in eggs of S. japonicum. SjHSP60 specially induced Tregs in vivo and in vitro without inducing other CD4(+) T sub-populations including Th1, Th2 and Th17 cells. Furthermore, we showed that the SjHSP60-depleted SEA almost lost the ability in vitro and displayed a significant impaired ability to induce Tregs in vivo. Finally, our study illustrated that the mechanisms of SjHSP60-mediated induction of Tregs are through both conversion of CD4(+) CD25(-) T cells into CD4(+) CD25(+) Foxp3(+) Tregs and expansion of preexisting CD4(+) CD25(+) Foxp3(+) Tregs in a TLR4-dependent manner. Conclusions/Significance Collectively, our findings identify SjHSP60 as a major parasitic contributor of Treg induction in S. japonicum egg antigens, which not only contributes to the better understanding of the mechanism of immunoregulation during helminth infection, but also suggests its potential as a therapeutic target for control of immunopathology, allergic and autoimmune diseases.	[Zhou, Sha; Jin, Xin; Chen, Xiaojun; Zhu, Jifeng; Xu, Zhipeng; Wang, Xuefeng; Liu, Feng; Su, Chuan] Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Hu, Wei] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Zhou, Liang] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Nanjing Medical University; Fudan University; Northwestern University; Feinberg School of Medicine	Su, CA (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China.	chuansu@njmu.edu.cn	Chen, Xiaojun/P-8288-2017; xu, zhipeng/M-7708-2019; Chen, Xiaojun/AAD-9401-2022	Chen, Xiaojun/0000-0002-3698-2814; xu, zhipeng/0000-0002-8853-5303; Chen, Xiaojun/0000-0002-3698-2814	National Natural Science Foundation of China [81271861]; Research Foundation of Jiangsu Province, China [12KJA310001]; National Institutes of Health, US [AI089954, AI091962]; Jiangsu Provincial Natural Science Foundation of China [BK20130896]; Priority Academic Program for Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Jiangsu Province, China; National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program for Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Natural Science Foundation of China (No. 81271861) and the Research Foundation of Jiangsu Province, China (12KJA310001) to Chuan Su, the National Institutes of Health, US (AI089954 and AI091962) to Liang Zhou, the Jiangsu Provincial Natural Science Foundation of China (BK20130896) to Sha Zhou, and the Priority Academic Program for Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Ausiello CM, 2006, MICROBES INFECT, V8, P714, DOI 10.1016/j.micinf.2005.09.007; Boamah Daniel, 2012, Tropical Medicine and Health, V40, P89, DOI 10.2149/tmh.2012-16; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Compte M, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28810; El-Ahwany E, 2012, KOREAN J PARASITOL, V50, P29, DOI 10.3347/kjp.2012.50.1.29; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Korenjak M, 2014, NUCLEIC ACIDS RES, V42, P8939, DOI 10.1093/nar/gku609; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Lee KA, 2012, EUR J IMMUNOL, V42, P1685, DOI 10.1002/eji.201142322; Lewis CJ, 2011, EUR J IMMUNOL, V41, P2562, DOI 10.1002/eji.201141396; Linsuke S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003387; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; MALKUSCH W, 1995, EXP LUNG RES, V21, P67, DOI 10.3109/01902149509031745; Marquis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086681; Milanez-Almeida P, 2015, EUR J IMMUNOL, V45, P153, DOI 10.1002/eji.201444480; Mo HM, 2007, EXP PARASITOL, V116, P385, DOI 10.1016/j.exppara.2007.02.009; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Pacifico LGG, 2009, INFECT IMMUN, V77, P98, DOI 10.1128/IAI.00783-07; Raghavan S, 2005, FEMS IMMUNOL MED MIC, V44, P121, DOI 10.1016/j.femsim.2004.10.017; Rodrigues V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002567; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Wang XF, 2009, EUR J IMMUNOL, V39, P3052, DOI 10.1002/eji.200939335; Weissler KA, 2015, J IMMUNOL; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; Yang JH, 2007, IMMUNOLOGY, V120, P8, DOI 10.1111/j.1365-2567.2006.02472.x; Zaccone P, 2009, EUR J IMMUNOL, V39, P1098, DOI 10.1002/eji.200838871	38	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139133	10.1371/journal.pone.0139133	http://dx.doi.org/10.1371/journal.pone.0139133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418003	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400050
J	Awan, FM; Naz, A; Obaid, A; Ali, A; Ahmad, J; Anjum, S; Janjua, HA				Awan, Faryal Mehwish; Naz, Anam; Obaid, Ayesha; Ali, Amjad; Ahmad, Jamil; Anjum, Sadia; Janjua, Hussnain Ahmed			Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach	PLOS ONE			English	Article							PLASMA PROTEOME DATABASE; HUMAN HEPATOMA-CELL; ALPHA-FETOPROTEIN; SERUM BIOMARKER; CLINICAL-IMPLICATIONS; CANCER BIOMARKERS; LIVER-CANCER; EXPRESSION; PREDICTION; DIAGNOSIS	Hepatocellular carcinoma (HCC) is the world's third most widespread cancer. Currently available circulating biomarkers for this silently progressing malignancy are not sufficiently specific and sensitive to meet all clinical needs. There is an imminent and pressing need for the identification of novel circulating biomarkers to increase disease-free survival rate. In order to facilitate the selection of the most promising circulating protein biomarkers, we attempted to define an objective method likely to have a significant impact on the analysis of vast data generated from cutting-edge technologies. Current study exploits data available in seven publicly accessible gene and protein databases, unveiling 731 liver-specific proteins through initial enrichment analysis. Verification of expression profiles followed by integration of proteomic datasets, enriched for the cancer secretome, filtered out 20 proteins including 6 previously characterized circulating HCC biomarkers. Finally, interactome analysis of these proteins with midkine (MDK), dickkopf-1 (DKK-1), current standard HCC biomarker alpha-fetoprotein (AFP), its interacting partners in conjunction with HCC-specific circulating and liver deregulated miRNAs target filtration highlighted seven novel statistically significant putative biomarkers including complement component 8, alpha (C8A), mannose binding lectin (MBL2), antithrombin III (SERPINC1), 11 beta-hydroxysteroid dehydrogenase type 1 (HSD11B1), alcohol dehydrogenase 6 (ADH6), beta-ureidopropionase (UPB1) and cytochrome P450, family 2, subfamily A, polypeptide 6 (CYP2A6). Our proposed methodology provides a swift assortment process for biomarker prioritization that eventually reduces the economic burden of experimental evaluation. Further dedicated validation studies of potential putative biomarkers on HCC patient blood samples are warranted. We hope that the use of such integrative secretome, interactome and miRNAs target filtration approach will accelerate the selection of high-priority biomarkers for other diseases as well, that are more amenable to downstream clinical validation experiments.	[Awan, Faryal Mehwish; Naz, Anam; Obaid, Ayesha; Ali, Amjad; Anjum, Sadia; Janjua, Hussnain Ahmed] Natl Univ Sci & Technol, ASAB, Islamabad, Pakistan; [Ahmad, Jamil] Natl Univ Sci & Technol, RCMS, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan	Anjum, S (corresponding author), Univ Hail, Dept Biol, Hayil, Saudi Arabia.	sadiaezza@gmail.com; janjua.hussnain@gmail.com	Anjum, Sadia/AAR-7732-2021; Ali, Amjad/AAG-4441-2021; Naz, Anam/AAU-2282-2020; Ahmad, Jamil/AAF-5499-2021	Anjum, Sadia/0000-0001-9678-7861; Ali, Amjad/0000-0002-0486-4661; Naz, Anam/0000-0002-6514-5417; Ahmad, Jamil/0000-0001-6618-6811; Awan, Faryal Mehwish/0000-0002-8146-8929				Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Ang IL, 2006, J PROTEOME RES, V5, P2691, DOI 10.1021/pr060109r; Behne T, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/859076; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Boutet Emmanuel, 2007, V406, P89; Chai S, 2013, CHIN J CANCER, V32, P419, DOI 10.5732/cjc.013.10038; Chrostek L, 2000, CLIN CHEM LAB MED, V38, P409, DOI 10.1515/CCLM.2000.059; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elfilali A, 2006, NUCLEIC ACIDS RES, V34, pD613, DOI 10.1093/nar/gkj022; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gellert P, 2010, BIOINFORMATICS, V26, P2328, DOI 10.1093/bioinformatics/btq417; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; He X, 2014, NEOPLASMA, V61, P17, DOI 10.4149/neo_2014_001; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077161; Imperlini E, 2013, J CELL BIOCHEM, V114, P2577, DOI 10.1002/jcb.24600; Jelski W, 2008, J CLIN LAB ANAL, V22, P204, DOI 10.1002/jcla.20241; Jezequel P, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas060; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063468; Kimhofer T, 2015, BRIT J CANCER, V112, P1141, DOI 10.1038/bjc.2015.38; Kimura Asako, 2012, Int J Proteomics, V2012, P623190, DOI 10.1155/2012/623190; Klee EW, 2006, CLIN CHEM, V52, P2162, DOI 10.1373/clinchem.2006.072868; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Kotlyar M, 2015, NAT METHODS, V12, P79, DOI [10.1038/NMETH.3178, 10.1038/nmeth.3178]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kulasingam V, 2008, INT J CANCER, V123, P2007, DOI 10.1002/ijc.23844; Lee HJ, 2014, J PROTEOME RES, V13, P2328, DOI 10.1021/pr4011519; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li MS, 2011, INT J CANCER, V128, P524, DOI 10.1002/ijc.25373; Li MS, 2009, INT J CANCER, V124, P2845, DOI 10.1002/ijc.24272; Li P, 2011, WORLD J GASTROENTERO, V17, P4563, DOI 10.3748/wjg.v17.i41.4563; Lin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069747; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Noh CK, 2014, CLIN BIOCHEM, V47, P1257, DOI 10.1016/j.clinbiochem.2014.05.002; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qi J, 2013, NEOPLASMA, V60, P135, DOI 10.4149/neo_2013_018; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rong YF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-68; Scaggiante B, 2014, WORLD J GASTROENTERO, V20, P1268, DOI 10.3748/wjg.v20.i5.1268; Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Song P, 2014, TRANSLATIONAL GASTRO, V3, P103; Srisomsap C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/437143; Stastna M, 2012, PROTEOMICS, V12, P722, DOI 10.1002/pmic.201100346; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Wang HJ, 2014, CLIN SCI, V126, P857, DOI 10.1042/CS20130301; Wang J, 2009, PROTEOM CLIN APPL, V3, P541, DOI 10.1002/prca.200800145; Wang L, 2014, TUMOR BIOL, V35, P9, DOI 10.1007/s13277-013-1141-0; Wang XP, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-25; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wu CC, 2008, PROTEOMICS, V8, P316, DOI 10.1002/pmic.200700819; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yamashita R, 2007, MOL CELL BIOCHEM, V298, P83, DOI 10.1007/s11010-006-9354-9; Yang XQ, 2011, PHYSIOL GENOMICS, V43, P457, DOI 10.1152/physiolgenomics.00178.2010; Zhao X, 2012, SCI CHINA LIFE SCI, V55, P906, DOI 10.1007/s11427-012-4384-x; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu WW, 2013, CLIN CANCER RES, V19, P3944, DOI 10.1158/1078-0432.CCR-12-3363	89	34	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138913	10.1371/journal.pone.0138913	http://dx.doi.org/10.1371/journal.pone.0138913			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414287	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700027
J	Chen, HW; An, J; Wei, SH; Gu, J				Chen, Hongwei; An, Jing; Wei, Shuhe; Gu, Jian			Spatial Patterns and Risk Assessment of Heavy Metals in Soils in a Resource-Exhausted City, Northeast China	PLOS ONE			English	Article							GIS-BASED APPROACH; HEALTH-RISK; AGRICULTURAL SOILS; PADDY FIELD; CONTAMINATION; POLLUTION; ELEMENTS; BASIN	Northeast China is an intensive area of resource-exhausted city, which is facing the challenges of industry conversion and sustainable development. In order to evaluate the soil environmental quality influenced by mining activities over decades, the concentration and spatial distribution of arsenic (As), cadmium (Cd), chromium (Cr), copper (Cu), nickel (Ni), lead (Pb), and Zinc (Zn) in surface soils (0-20cm) of a typical resource-exhausted city were investigated by analyzing 306 soil samples. The results showed that the average concentrations in the samples were 6.17 mg/kg for As, 0.19 mg/kg for Cd, 51.08 mg/kg for Cr, 23.27 mg/kg for Cu, 31.15 mg/kg for Ni, 22.17 mg/kg for Pb, and 54.21 mg/kg for Zn. Metals distribution maps produced by using the inverse distance weighted interpolation method and results revealed that all investigated metals showed distinct geographical patterns, and the concentrations were higher in urban and industrial areas than in farmland. Pearson correlation and principal component analysis showed that there were significant positive correlations (p<0.05) between all of the metals, and As, Cd, Cr, Mn, Ni, Pb, and Zn were closely associated with the first principal component (PC1), which explained 39.81% of the total variance. Cu and As were mainly associated with the second component (PC2). Based on the calculated Nemerow pollution index, percentage for slightly polluted (1<P <= 2) surface soils were reached 57.33%, while 42.65% topsoil samples are moderate polluted (2<P <= 3). According to the results above-mentioned, different soil environmental function areas were classified and proper soil environmental management policy was proposed to decrease the environmental risks in the process of industrial city transformation.	[An, Jing; Wei, Shuhe] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Chen, Hongwei; An, Jing; Wei, Shuhe; Gu, Jian] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Chen, Hongwei] Shenyang Univ, Shenyang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang University	An, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China.	anjing@iae.ac.cn			National Natural Science Foundation of China [21277150, 31370523, 41001340, 41201185]; Ministry of Environmental Protection of the PRC [201209030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Environmental Protection of the PRC	The research was financially supported by the research fund for the National Natural Science Foundation of China (No. 21277150, 31370523, 41001340, 41201185). The authors JA and JG receive the the research fund for public welfare, granted by the Ministry of Environmental Protection of the PRC (No. 201209030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 156182008 GB MIN ENV; Chen X, 2010, J HAZARD MATER, V181, P640, DOI 10.1016/j.jhazmat.2010.05.060; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Gu YG, 2012, ENVIRON POLLUT, V163, P248, DOI 10.1016/j.envpol.2011.12.041; Kelepertzis E, 2014, GEODERMA, V221, P82, DOI 10.1016/j.geoderma.2014.01.007; Krami LK, 2013, ENVIRON MONIT ASSESS, V185, P9871, DOI 10.1007/s10661-013-3298-9; Li QS, 2012, J HAZARD MATER, V227, P148, DOI 10.1016/j.jhazmat.2012.05.023; Li XY, 2013, GEODERMA, V192, P50, DOI 10.1016/j.geoderma.2012.08.011; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Liu XM, 2006, ENVIRON POLLUT, V141, P257, DOI 10.1016/j.envpol.2005.08.048; Modis K, 2014, SOIL SEDIMENT CONTAM, V23, P63, DOI 10.1080/15320383.2013.777393; Navas A, 2002, APPL GEOCHEM, V17, P961, DOI 10.1016/S0883-2927(02)00006-9; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Rosen G. D., 1996, COMPREHENSIVE SURVEY; Schloeder CA, 2001, SOIL SCI SOC AM J, V65, P470, DOI 10.2136/sssaj2001.652470x; Smith TB, 2014, SCI TOTAL ENVIRON, V496, P435, DOI 10.1016/j.scitotenv.2014.07.014; Song S., 2013, INT BUSINESS TIMES; Sow AY, 2013, ENVIRON SCI POLLUT R, V20, P8964, DOI 10.1007/s11356-013-1857-9; Spijker J, 2005, GEODERMA, V127, P24, DOI 10.1016/j.geoderma.2004.11.002; Sun YB, 2011, J HAZARD MATER, V186, P2075, DOI 10.1016/j.jhazmat.2010.12.116; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Tembo BD, 2006, CHEMOSPHERE, V63, P497, DOI 10.1016/j.chemosphere.2005.08.002; Wang J, 2014, J SOLID STATE CHEM, V216, P1, DOI 10.1016/j.jssc.2014.04.008; Wu LH, 2013, ENVIRON SCI POLLUT R, V20, P8342, DOI 10.1007/s11356-013-1532-1; Yang CL, 2013, ENVIRON EARTH SCI, V70, P1903, DOI 10.1007/s12665-013-2282-6; Yang LQ, 2014, CHEMOSPHERE, V103, P121, DOI 10.1016/j.chemosphere.2013.11.047; Yu BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092459; Zhao HR, 2012, SCI TOTAL ENVIRON, V417, P45, DOI 10.1016/j.scitotenv.2011.12.047	29	20	22	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137694	10.1371/journal.pone.0137694	http://dx.doi.org/10.1371/journal.pone.0137694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413806	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700011
J	Barbosa, GM; Colombo, AV; Rodrigues, PH; Simionato, MRL				Barbosa, Graziela Murta; Colombo, Andrea Vieira; Rodrigues, Paulo Henrique; Lorenzetti Simionato, Maria Regina			Intraspecies Variability Affects Heterotypic Biofilms of Porphyromonas gingivalis and Prevotella intermedia: Evidences of Strain-Dependence Biofilm Modulation by Physical Contact and by Released Soluble Factors	PLOS ONE			English	Article							EPITHELIAL-CELLS; PERIODONTITIS; VIRULENCE; ADHERENCE; DYSBIOSIS; BACTERIA; SYNERGY	It is well known that strain and virulence diversity exist within the population structure of Porphyromonas gingivalis. In the present study we investigate intra-and inter-species variability in biofilm formation of Porphyromonas gingivalis and partners Prevotella intermedia and Prevotella nigrescens. All strains tested showed similar hydrophobicity, except for P. gingivalis W83 which has roughly half of the hydrophobicity of P. gingivalis ATCC33277. An intraspecies variability in coaggregation of P. gingivalis with P. intermedia was also found. The association P. gingivalis W83/P. intermedia 17 produced the thickest biofilm and strain 17 was prevalent. In a two-compartment system P. gingivalisW83 stimulates an increase in biomass of strain 17 and the latter did not stimulate the growth of P. gingivalis W83. In addition, P. gingivalis W83 also stimulates the growth of P. intermedia ATCC25611 although strainW83 was prevalent in the association with P. intermedia ATCC25611. P. gingivalis ATCC33277 was prevalent in both associations with P. intermedia and both strains of P. intermedia stimulate the growth of P. gingivalis ATCC33277. FISH images also showed variability in biofilm structure. Thus, the outcome of the association P. gingivalis/P. intermedia seems to be strain-dependent, and both soluble factors and physical contact are relevant. The association P. gingivalis-P. nigrescens ATCC33563 produced larger biomass than each monotypic biofilm, and P. gingivalis was favored in consortia, while no differences were found in the two-compartment system. Therefore, in consortia P. gingivalis-P. nigrescens physical contact seems to favor P. gingivalis growth. The intraspecies variability found in our study suggests strain-dependence in ability of microorganisms to recognize molecules in other bacteria which may further elucidate the dysbiosis event during periodontitis development giving additional explanation for periodontal bacteria, such as P. gingivalis and P. intermedia, among others, to persist and establish chronic infections in the host.	[Barbosa, Graziela Murta; Colombo, Andrea Vieira; Rodrigues, Paulo Henrique; Lorenzetti Simionato, Maria Regina] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Rodrigues, PH (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.	phrodrigues@usp.br; mrsimion@usp.br	Rodrigues, Paulo H/J-6927-2012; Simionato, Maria Regina L./I-2400-2013; Colombo, Andrea V/A-5018-2018; Rodrigues, Paulo/O-2689-2017	Simionato, Maria Regina L./0000-0002-0187-4661; Colombo, Andrea V/0000-0001-8317-4302; Rodrigues, Paulo/0000-0002-4646-6805	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/11199-4, 2013/15977-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by GMB Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/; PHR Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant number 2008/11199-4, http://www.fapesp.br/; MRLS Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant number 2013/15977-7, http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombo AV, 2013, J MED MICROBIOL, V62, P1592, DOI 10.1099/jmm.0.055830-0; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; Durso SC, 2014, CARIES RES, V48, P214, DOI 10.1159/000354410; Frandsen EVG, 2001, INFECT IMMUN, V69, P4479, DOI 10.1128/IAI.69.7.4479-4485.2001; GIBBONS RJ, 1983, INFECT IMMUN, V41, P1190, DOI 10.1128/IAI.41.3.1190-1196.1983; Guentsch A, 2013, J PERIODONTAL RES, V48, P458, DOI 10.1111/jre.12027; Haffajee AD, 2004, J CLIN PERIODONTOL, V31, P996, DOI 10.1111/j.1600-051X.2004.00597.x; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Jiao Y, 2014, J DENT RES, V93, P539, DOI 10.1177/0022034514528212; Kamaguchi A, 2001, MICROBIOL IMMUNOL, V45, P649, DOI 10.1111/j.1348-0421.2001.tb01298.x; Kuboniwa M, 2012, EXPERT REV PROTEOMIC, V9, P311, DOI [10.1586/EPR.12.16, 10.1586/epr.12.16]; Leys EJ, 1999, J CLIN MICROBIOL, V37, P3906, DOI 10.1128/JCM.37.12.3906-3911.1999; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; NAITO Y, 1993, ORAL MICROBIOL IMMUN, V8, P195, DOI 10.1111/j.1399-302X.1993.tb00559.x; Okamoto M, 1999, FEMS MICROBIOL LETT, V178, P299, DOI 10.1016/S0378-1097(99)00372-9; Okuda T, 2012, ANAEROBE, V18, P110, DOI 10.1016/j.anaerobe.2011.09.003; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Rodrigues PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052606; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schillinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037583; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Teles FR, 2012, J PERIODONTOL, V83, P1139, DOI 10.1902/jop.2012.110506; Yamanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-228; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138687	10.1371/journal.pone.0138687	http://dx.doi.org/10.1371/journal.pone.0138687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406499	gold, Green Published			2022-12-26	WOS:000361800700070
J	Beckwith, MS; Beckwith, KS; Sikorski, P; Skogaker, NT; Flo, TH; Halaas, O				Beckwith, Marianne Sandvold; Beckwith, Kai Sandvold; Sikorski, Pawel; Skogaker, Nan Tostrup; Flo, Trude Helen; Halaas, Oyvind			Seeing a Mycobacterium-Infected Cell in Nanoscale 3D: Correlative Imaging by Light Microscopy and FIB/SEM Tomography	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; PHAGOSOME MATURATION; MAMMALIAN-CELLS; FLUORESCENCE; TUBERCULOSIS; AUTOPHAGY; TRANSMISSION; TISSUE; PHAGOLYSOSOME; DEHYDRATION	Mycobacteria pose a threat to the world health today, with pathogenic and opportunistic bacteria causing tuberculosis and non-tuberculous disease in large parts of the population. Much is still unknown about the interplay between bacteria and host during infection and disease, and more research is needed to meet the challenge of drug resistance and inefficient vaccines. This work establishes a reliable and reproducible method for performing correlative imaging of human macrophages infected with mycobacteria at an ultra-high resolution and in 3D. Focused Ion Beam/Scanning Electron Microscopy (FIB/SEM) tomography is applied, together with confocal fluorescence microscopy for localization of appropriately infected cells. The method is based on an Aclar poly(chloro-tri-fluoro) ethylene substrate, micropatterned into an advantageous geometry by a simple thermomoulding process. The platform increases the throughput and quality of FIB/SEM tomography analyses, and was successfully applied to detail the intracellular environment of a whole mycobacterium-infected macrophage in 3D.	[Beckwith, Marianne Sandvold; Flo, Trude Helen] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Beckwith, Marianne Sandvold; Flo, Trude Helen; Halaas, Oyvind] NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Beckwith, Kai Sandvold; Sikorski, Pawel] NTNU, Dept Phys, Trondheim, Norway; [Skogaker, Nan Tostrup] NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Beckwith, MS (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway.	marianne.beckwith@ntnu.no	Halaas, Øyvind/O-2197-2015; Flo, Trude Helen/E-1311-2013; Sikorski, Pawel/A-2304-2009	Halaas, Øyvind/0000-0002-7968-2483; Flo, Trude Helen/0000-0002-2569-0381; Sikorski, Pawel/0000-0001-9413-1623; Beckwith, Marianne Sandvold/0000-0001-8235-3755; Beckwith, Kai Sandvold/0000-0001-5598-5482	Research Council of Norway through its Centres of Excellence [223255/F50];  [197411/V30]	Research Council of Norway through its Centres of Excellence(Research Council of Norway); 	This work was supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223255/F50, and through support to the Norwegian Micro- and Nano-Fabrication Facility, NorFab, project number 197411/V30; http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronskaia AV, 2008, J STRUCT BIOL, V164, P183, DOI 10.1016/j.jsb.2008.07.003; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; BUNGE RP, 1973, BRAIN RES, V57, P261, DOI 10.1016/0006-8993(73)90135-2; Bushby AJ, 2011, NAT PROTOC, V6, P845, DOI 10.1038/nprot.2011.332; COLLINS JS, 1981, J HISTOCHEM CYTOCHEM, V29, P411, DOI 10.1177/29.3.6787116; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; De Winter DAM, 2009, J MICROSC-OXFORD, V233, P372, DOI 10.1111/j.1365-2818.2009.03139.x; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Glauert AM, 1998, BIOL SPECIMEN PREPAR, Vxxi; Griffith DE, 2010, CURR OPIN INFECT DIS, V23, P185, DOI 10.1097/QCO.0b013e328336ead6; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halaas O, 2010, J INFECT DIS, V201, P783, DOI 10.1086/650493; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hosseini R, 2014, AUTOPHAGY, V10, P1844, DOI 10.4161/auto.29992; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Jimenez N, 2006, J MICROSC-OXFORD, V221, P216, DOI 10.1111/j.1365-2818.2006.01558.x; Jimenez N, 2010, J MICROSC-OXFORD, V237, P208, DOI 10.1111/j.1365-2818.2009.03329.x; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; KINGSLEY RE, 1988, J ELECTRON MICR TECH, V10, P77, DOI 10.1002/jemt.1060100110; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; MOLLENHAUER HH, 1993, MICROSC RES TECHNIQ, V26, P496, DOI 10.1002/jemt.1070260604; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Narayan K, 2014, J STRUCT BIOL, V185, P278, DOI 10.1016/j.jsb.2013.11.008; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Ingen J, 2012, AM J RESP CRIT CARE, V186, P559, DOI 10.1164/rccm.201204-0682OC; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Wagner D, 2004, INFECTION, V32, P257, DOI 10.1007/s15010-004-4001-4; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wei DG, 2012, BIOTECHNIQUES, V53, P41, DOI 10.2144/000113850; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	53	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0134644	10.1371/journal.pone.0134644	http://dx.doi.org/10.1371/journal.pone.0134644			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406896	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700002
J	Bu, S; Ruan, DJ; Yang, ZJ; Xing, XY; Zhao, WH; Wang, N; Xie, LD; Yang, WY				Bu, Shi; Ruan, Danjie; Yang, Zhaojun; Xing, Xiaoyan; Zhao, Wenhui; Wang, Na; Xie, Lingding; Yang, Wenying			Sex-Specific Prevalence of Diabetes and Cardiovascular Risk Factors in the Middle-Aged Population of China: A Subgroup Analysis of the 2007-2008 China National Diabetes and Metabolic Disorders Study	PLOS ONE			English	Article							MEN; WOMEN	The sex difference in the prevalence rates of diabetes and cardiovascular diseases (CVDs) among the middle-aged population in China remain largely unknown. Therefore, we analyzed differences in the prevalence of diabetes, self-reported CVDs, and some CVD risk factors among men and women in the middle-aged population (30-49 years) and in individuals aged 50 years and older using data from the China National Diabetes and Metabolic Disorders Study of 2007-2008. Middle-aged men appeared to have significantly a higher prevalence of diabetes and self-reported CVDs than middle-aged women (8.07% vs 5.06% for diabetes, P < 0.001; 0.64% vs 0.22% for CVDs, P < 0.001). Men also showed higher rates of central obesity, hypertension, and dyslipidemia than women (all P < 0.01). Compared with women, men were more likely to drink alcohol and smoke cigarettes but less likely to be under diet control. The sex-specific differences in prediabetes, CVD, and CVD risk factors between men and women were diminished or even reversed in the population aged 50 years and older. No sex-specific differences were found in the prevalences of a family history of diabetes, coronary heart disease, and hypertension (P > 0.05) in middle-aged population. Specific strategies to reduce modifiable risk factors for the prevention and control of diabetes and CVD may be warranted in this population.	[Bu, Shi; Yang, Zhaojun; Xing, Xiaoyan; Zhao, Wenhui; Wang, Na; Xie, Lingding; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China; [Ruan, Danjie] Ist Hosp Huairou Dist, Dept Endocrinol, Beijing 101400, Peoples R China	China-Japan Friendship Hospital	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China.	13366901921@163.com		Yang, Wenying/0000-0002-7997-9404				Chang HY, 2010, DIABETES RES CLIN PR, V90, P358, DOI 10.1016/j.diabres.2010.09.032; Chiou CJ, 2002, PREV MED, V35, P264, DOI 10.1006/pmed.2002.1080; Davies J, 2000, J AM COLL HEALTH, V48, P259, DOI 10.1080/07448480009596267; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Minges KE, 2011, DIABETES RES CLIN PR, V93, P139, DOI 10.1016/j.diabres.2011.06.012; Ofori SN, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0006-4; Pan X, 1997, CHINESE J INTERN MED, V36, P6; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Wang K, 1998, CHIN J EPIDEMIOL, V19, P4; Welin L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-403; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	13	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139039	10.1371/journal.pone.0139039	http://dx.doi.org/10.1371/journal.pone.0139039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406982	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700153
J	Kim, BJ; Park, DR; Nam, TS; Lee, SH; Kim, UH				Kim, Byung-Ju; Park, Dae-Ryoung; Nam, Tae-Sik; Lee, Seo Ho; Kim, Uh-Hyun			Seminal CD38 Enhances Human Sperm Capacitation through Its Interaction with CD31	PLOS ONE			English	Article							ADP-RIBOSYL CYCLASE; TYROSINE PHOSPHORYLATION; PECAM-1; RECEPTOR; PLATELET; KINASE; MOUSE; IDENTIFICATION; PROSTASOMES; ACTIVATION	Human sperm have to undergo a maturational process called capacitation in the female reproductive tract. Capacitation confers upon the sperm an ability to gain hypermotility and undergo acrosome reaction. Previous studies have suggested that seminal plasma proteins induce the capacitation of sperm in the female reproductive tract for the successful fertilization of the oocyte. However, the function of seminal plasma proteins in capacitation remains largely unclear. To the end, we found that soluble CD38 (sCD38) in seminal plasma increases the capacitation of sperm via specific interactions between sCD38 and the CD31 on the sperm. Upon the association of sCD38 with CD31, tyrosine kinase Src phosphorylates CD31, a process blocked by Src inhibitors. Shc, SHP-2, Grb2, and SOS, as well as Src kinase were found to associate with the phosphorylated CD31. The sCD38-induced phosphorylation of CD31 initiates a cascade reaction through the phosphorylation of Erk1/2, which results in the acrosome reaction, and sperm hypermotility. These processes were prevented by Src, Ras and MEK inhibitors. Taken together, these data indicate that the sCD38 present in seminal plasma plays a critical role in the capacitation of sperm.	[Kim, Byung-Ju; Park, Dae-Ryoung; Nam, Tae-Sik; Lee, Seo Ho; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561180, South Korea; [Kim, Byung-Ju; Park, Dae-Ryoung; Nam, Tae-Sik; Lee, Seo Ho; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Jeonju 561180, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561180, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A3A2026453]; Ministry of Education [2015R1D1A4A01016904]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Ministry of Education	This study was supported by the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (2012R1A3A2026453) and by the Ministry of Education (2015R1D1A4A01016904).	Aalberts M, 2013, BBA-PROTEINS PROTEOM, V1834, P2326, DOI 10.1016/j.bbapap.2012.08.008; Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; An NH, 2001, BIOCHEM BIOPH RES CO, V282, P781, DOI 10.1006/bbrc.2001.4654; Anderson B M, 1980, Methods Enzymol, V66, P144; Ashizawa K, 1997, BIOCHEM BIOPH RES CO, V240, P116, DOI 10.1006/bbrc.1997.7626; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Cao MY, 1998, J BIOL CHEM, V273, P15765, DOI 10.1074/jbc.273.25.15765; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; Deaglio S, 1998, J IMMUNOL, V160, P395; ESHRE Andrology Special Interest Grp, 1998, HUM REPROD, V13, P142; Funaro A, 1996, INT IMMUNOL, V8, P1643; Groyer E, 2007, J AM COLL CARDIOL, V50, P344, DOI 10.1016/j.jacc.2007.04.040; Horenstein AL, 1998, BIOCHEM J, V330, P1129; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kim BJ, 2015, P NATL ACAD SCI USA, V112, P1559, DOI 10.1073/pnas.1413493112; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; MANN T, 1978, INT J FERTIL, V23, P133; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Nixon B, 2005, J CELL SCI, V118, P4865, DOI 10.1242/jcs.02604; Ooi EH, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140230; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Wang YJ, 2006, J CELL BIOCHEM, V98, P451, DOI 10.1002/jcb.20827; Wilkinson R, 2002, BLOOD, V100, P184, DOI 10.1182/blood-2002-01-0027; Yanagimachi R., 1994, P189; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	30	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139110	10.1371/journal.pone.0139110	http://dx.doi.org/10.1371/journal.pone.0139110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407101	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700174
J	Klein, S; Herath, CB; Schierwagen, R; Grace, J; Haltenhof, T; Uschner, FE; Strassburg, CP; Sauerbruch, T; Walther, T; Angus, PW; Trebicka, J				Klein, Sabine; Herath, Chandana B.; Schierwagen, Robert; Grace, Josephine; Haltenhof, Tom; Uschner, Frank E.; Strassburg, Christian P.; Sauerbruch, Tilman; Walther, Thomas; Angus, Peter W.; Trebicka, Jonel			Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis	PLOS ONE			English	Article							MAS-RECEPTOR AGONIST; BILE-DUCT LIGATION; PORTAL PRESSURE; AVE 0991; AVE-0991; RATS; ACTIVATION; KINASE; INHIBITION; PEPTIDES	Background & Aims Although in cirrhosis with portal hypertension levels of the vasoconstrictor angiotensin II are increased, this is accompanied by increased production of angiotensin (Ang)-(1-7), the endogenous ligand of the Mas receptor (MasR), which blunts hepatic fibrosis and decreases hepatic vascular resistance. Therefore, we investigated the effects of the non-peptidic Ang-(1-7) agonist, AVE0991, in experimental cirrhosis. Methods Cirrhosis was induced by bile duct ligation (BDL) or carbon tetrachloride (CCl4) intoxication. The coloured microsphere technique assessed portal and systemic hemodynamic effects of AVE0991 in vivo. Hepatic expression of eNOS, p-eNOS, iNOS, JAK2, ROCK and p-Moesin were analyzed by western blots. Activities of ACE and ACE2 were investigated fluorometrically. Moreover, fibrosis was assessed in BDL rats receiving AVE0991. Results In vivo, AVE0991 decreased portal pressure (PP) in both rat models of cirrhosis. Importantly, systemic effects were not observed. The hepatic effects of AVE0991 were based on upregulation of vasodilating pathways involving p-eNOS and iNOS, as well as by down-regulation of the vasoconstrictive pathways (ROCK, p-Moesin). Short-term treatment with AVE0991 decreased the activity of ACE2, long-term treatment did not affect hepatic fibrosis in BDL rats. Conclusions The non-peptidic agonist of Ang-(1-7), AVE0991, decreases portal pressure without influencing systemic pressure. Thus, although it does not inhibit fibrosis, AVE0991 may represent a promising new therapeutic strategy for lowering portal pressure.	[Klein, Sabine; Schierwagen, Robert; Uschner, Frank E.; Strassburg, Christian P.; Sauerbruch, Tilman; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Herath, Chandana B.; Grace, Josephine] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Haltenhof, Tom; Walther, Thomas] Univ Leipzig, Div Women & Child Hlth, Ctr Perinatal Med, Dept Obstet, D-04109 Leipzig, Germany; [Walther, Thomas] Univ Coll, Dept Pharmacol & Therapeut, Cork, Ireland; [Angus, Peter W.] Austin Hlth, Dept Gastroenterol & Hepatol, Heidelberg, Vic, Australia	University of Bonn; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Leipzig University; University College Cork; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Herath, Chandana/AAT-3251-2021; Klein, Sabine/U-1098-2018; Schierwagen, Robert/AAE-6305-2019	Herath, Chandana/0000-0001-9151-8531; Klein, Sabine/0000-0001-6691-2895; Schierwagen, Robert/0000-0002-2195-3666; Trebicka, Jonel/0000-0002-7028-3881; Uschner, Frank Erhard/0000-0002-3760-2887	Deutsche Forschungsgemeinschaft [SFB TRR57 P18, WA1441/22-2]; J. & W. Hector- Foundation [M60.2]; National Health and Medical Research Council (NHMRC) of Australia [APP1008252]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); J. & W. Hector- Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57 P18; WA1441/22-2), J. & W. Hector- Foundation (M60.2) and National Health and Medical Research Council (NHMRC) of Australia (APP1008252).	Barroso LC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/808726; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Chen SL, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/958298; Ferreira AJ, 2001, HYPERTENSION, V38, P665, DOI 10.1161/01.HYP.38.3.665; Ferreira AJ, 2007, AM J PHYSIOL-HEART C, V292, pH1113, DOI 10.1152/ajpheart.00828.2006; Gao RN, 2012, DRUG METAB DISPOS, V40, P556, DOI 10.1124/dmd.111.042689; Grace JA, 2013, GASTROENTEROLOGY, V145, P874, DOI 10.1053/j.gastro.2013.06.036; Grace JA, 2012, CLIN SCI, V123, P225, DOI 10.1042/CS20120030; Granzow M, 2014, HEPATOLOGY, V60, P334, DOI 10.1002/hep.27117; Heller J, 2005, LIVER INT, V25, P657, DOI 10.1111/j.1478-3231.2005.01053.x; Heller J, 2003, EUR J CLIN INVEST, V33, P1006, DOI 10.1046/j.1365-2362.2003.01251.x; Hennenberg M, 2008, GUT, V57, P1300, DOI 10.1136/gut.2007.144584; Herath CB, 2007, J HEPATOL, V47, P387, DOI 10.1016/j.jhep.2007.03.008; Herath CB, 2013, AM J PHYSIOL-GASTR L, V304, pG99, DOI 10.1152/ajpgi.00163.2012; Herath CB, 2009, AM J PHYSIOL-GASTR L, V297, pG98, DOI 10.1152/ajpgi.00045.2009; JAMES J, 1990, LIVER, V10, P1; Klein S, 2012, J HEPATOL, V57, P1220, DOI 10.1016/j.jhep.2012.07.033; Lemos VS, 2005, J CARDIOVASC PHARM, V46, P274, DOI 10.1097/01.fjc.0000175237.41573.63; Lubel JS, 2009, CLIN SCI, V117, P375, DOI 10.1042/CS20080647; Maul J, 2001, FASEB J, V15, P1640, DOI 10.1096/fj.00-097fje; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Moreno M, 2009, AM J PHYSIOL-GASTR L, V296, pG147, DOI 10.1152/ajpgi.00462.2007; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Rodrigues-Machado MG, 2013, BRIT J PHARMACOL, V170, P835, DOI 10.1111/bph.12318; Santos RAS, 2006, CARDIOVASC DRUG REV, V24, P239, DOI 10.1111/j.1527-3466.2006.00239.x; Silva DMR, 2007, PEPTIDES, V28, P702, DOI 10.1016/j.peptides.2006.10.007; Singh K, 2012, J RENIN-ANGIO-ALDO S, V13, P334, DOI 10.1177/1470320311435534; Suski M, 2013, BBA-PROTEINS PROTEOM, V1834, P2463, DOI 10.1016/j.bbapap.2013.08.008; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025; Trebicka J, 2009, HEPATOLOGY, V50, P1924, DOI 10.1002/hep.23222; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wiemer G, 2002, HYPERTENSION, V40, P847, DOI 10.1161/01.HYP.0000037979.53963.8F	35	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138732	10.1371/journal.pone.0138732	http://dx.doi.org/10.1371/journal.pone.0138732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406236	Green Published, gold			2022-12-26	WOS:000361800700078
J	Oelmann, E; Stein, H; Berdel, WE; Herbst, H				Oelmann, Elisabeth; Stein, Harald; Berdel, Wolfgang E.; Herbst, Hermann			Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma	PLOS ONE			English	Article							REED-STERNBERG CELLS; B-CELL; T-CELLS; ACCESSORY PROTEIN; PERIPHERAL-BLOOD; GENE TRANSCRIPTS; NATURAL-KILLER; TUMOR-CELLS; IFN-GAMMA; IL-1	Signaling through the IL-1-receptor type 1 (IL-1R1), IL-1 is required for initiation and maintenance of diverse activities of the immune system. A second receptor, IL-1R2, blocks IL-1 signal transduction. We studied expression of IL-1beta, IL-1R1, and IL-1R2 in 17 Hodgkin lymphomas (HL) by in situ hybridization (ISH). IL-1beta expressing cells, morphologically consistent with endothelial cells and fibroblasts, occurred in all HL tissues with elevated transcript levels in areas of active fibrosis. Hodgkin and Reed-Sternberg (HRS) cells of all cases expressed low IL-1R1 transcript levels in some tumor cells, and high levels of IL-1R2 in large proportions of HRS cells. Only few bystander cells showed low levels of IL-1R1 and IL-1R2 RNA. Supernatants of 4 out of 7 HL-derived cell lines contained soluble IL-1R2 protein at high levels. HL patient sera carried variably amounts of IL-1R2 protein with significantly increased titers in patients with active disease compared to patients in complete remission and control individuals without HL. Western blots and co-immunoprecipitations showed binding of the IL-1R2 to the intracellular IL-1R-accessory protein (IL-1IRAcP). These data suggest functions of the IL-1R2 as a, decoy-receptor" sequestrating paracrine IL-1 extracellularly and intracellularly by engaging IL-1IRAcP, thus depriving IL1-R1 molecules of their extracellular and intracellular ligands. Expression of IL1-R2 by HRS cells seems to contribute to local and systemic modulation of immune function in HL.	[Oelmann, Elisabeth; Berdel, Wolfgang E.] Univ Hosp Muenster, Dept Med A Hematol Oncol, Munster, Germany; [Stein, Harald] Pathodiagnostik Berlin, Berlin, Germany; [Herbst, Hermann] Vivantes Hosp, Inst Pathol, Berlin, Germany	University of Munster	Herbst, H (corresponding author), Vivantes Hosp, Inst Pathol, Berlin, Germany.	hermann.herbst@vivantes.de			Deutsche Forschungsgemeinschaft (DFG) [EXC 1003]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant: Excellence Cluster "Cells in Motion" (EXC 1003) to WEB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Ales-Martinez J E, 1992, Semin Immunol, V4, P195; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; BERTOGLIO JH, 1987, LYMPHOKINE RES, V6, P83; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; Briscoe DM, 1997, J IMMUNOL, V159, P3247; CAROSELLA ED, 1989, CELL IMMUNOL, V121, P269, DOI 10.1016/0008-8749(89)90025-7; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; CONTI P, 1992, SCAND J IMMUNOL, V36, P27, DOI 10.1111/j.1365-3083.1992.tb02937.x; CRUMP WL, 1989, CANCER RES, V49, P149; DAMLE RN, 1990, BRIT J CANCER, V61, P404, DOI 10.1038/bjc.1990.88; DANFORTH DN, 1993, CANCER RES, V53, P1538; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; DREXLER HG, 1993, LEUKEMIA LYMPHOMA, V9, P1, DOI 10.3109/10428199309148499; EBINA N, 1990, BRIT J CANCER, V62, P619, DOI 10.1038/bjc.1990.341; FOSS HD, 1995, AM J PATHOL, V146, P33; FOSS HD, 1993, BRIT J HAEMATOL, V84, P627, DOI 10.1111/j.1365-2141.1993.tb03138.x; FUJIWARA T, 1992, J IMMUNOL, V148, P2941; Gabrilovich D, 2003, CURR DRUG TARGETS, V4, P525, DOI 10.2174/1389450033490849; GIRI JG, 1990, J BIOL CHEM, V265, P17416; GORDON J, 1991, ADV CANCER RES, V56, P313; GORSCHLUTER M, 1995, ANN ONCOL, V6, P477, DOI 10.1093/oxfordjournals.annonc.a059218; HAMBURGER AW, 1987, CANCER RES, V47, P5612; Heath VL, 2002, CURR TOP MICROBIOL, V266, P23; ITO R, 1993, CANCER RES, V53, P4102; IWASAKI T, 1993, CYTOKINE, V5, P416, DOI 10.1016/1043-4666(93)90031-Y; Jona A, 2013, EXP HEMATOL, V41, P995, DOI 10.1016/j.exphem.2013.09.014; Jundt F, 1999, BLOOD, V94, P2065, DOI 10.1182/blood.V94.6.2065.418k15_2065_2071; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; KILIAN PL, 1991, CANCER RES, V51, P1823; Kovalovsky D, 2000, J NEUROIMMUNOL, V109, P23, DOI 10.1016/S0165-5728(00)00298-8; LACHMAN LB, 1986, J IMMUNOL, V136, P3098; LAHM H, 1992, EUR J CANCER, V28A, P1894, DOI 10.1016/0959-8049(92)90031-V; Lang D, 1998, J IMMUNOL, V161, P6871; LARRICK JW, 1989, IMMUNOL TODAY, V10, P61, DOI 10.1016/0167-5699(89)90308-3; Liu YX, 2014, SEMIN CANCER BIOL, V24, P15, DOI 10.1016/j.semcancer.2013.07.002; Malinowsky D, 1998, FEBS LETT, V429, P299, DOI 10.1016/S0014-5793(98)00467-0; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883; MUKHOPADHYAYA R, 1987, BRIT J CANCER, V56, P800, DOI 10.1038/bjc.1987.293; Nakae S, 2001, J IMMUNOL, V167, P90, DOI 10.4049/jimmunol.167.1.90; NAUME B, 1994, SCAND J IMMUNOL, V40, P128, DOI 10.1111/j.1365-3083.1994.tb03441.x; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; NUMEROF RP, 1990, CELL IMMUNOL, V130, P118, DOI 10.1016/0008-8749(90)90166-O; Oelmann E, 1997, INT J CANCER, V71, P1066, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1066::AID-IJC25>3.0.CO;2-A; ONOZAKI K, 1985, J IMMUNOL, V135, P3962; Poppema S, 1998, ANN ONCOL, V9, P21, DOI 10.1023/A:1008458023093; POSTLETHWAITE AE, 1988, J CELL BIOL, V106, P311, DOI 10.1083/jcb.106.2.311; REE HJ, 1987, CANCER, V59, P1717, DOI 10.1002/1097-0142(19870515)59:10<1717::AID-CNCR2820591007>3.0.CO;2-U; ROTHENBERG EV, 1994, EUR J IMMUNOL, V24, P24, DOI 10.1002/eji.1830240105; Saijo Y, 1999, CLIN CANCER RES, V5, P1203; SHIN SS, 1995, ARCH PATHOL LAB MED, V119, P247; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SKEEN MJ, 1995, J IMMUNOL, V154, P5832; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; SOULILLOU JP, 1985, EUR J CANCER CLIN ON, V21, P935, DOI 10.1016/0277-5379(85)90111-7; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steigerwald-Mullen P, 2000, J VIROL, V74, P6748, DOI 10.1128/JVI.74.15.6748-6759.2000; STRICKER K, 1993, EUR J IMMUNOL, V23, P1475, DOI 10.1002/eji.1830230712; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; SYMONS JA, 1995, P NATL ACAD SCI USA, V92, P1714, DOI 10.1073/pnas.92.5.1714; SYMONS JA, 1990, FEBS LETT, V272, P133, DOI 10.1016/0014-5793(90)80466-V; TOSATO G, 1990, BLOOD, V75, P922; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; WILLIAMS JM, 1984, J IMMUNOL, V133, P2986; XERRI L, 1992, INT J CANCER, V50, P689, DOI 10.1002/ijc.2910500504; ZAMKOFF KW, 1985, CLIN IMMUNOL IMMUNOP, V35, P111, DOI 10.1016/0090-1229(85)90084-4; ZEKI K, 1993, J CLIN ENDOCR METAB, V76, P127, DOI 10.1210/jc.76.1.127	76	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138747	10.1371/journal.pone.0138747	http://dx.doi.org/10.1371/journal.pone.0138747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406983	Green Published, gold			2022-12-26	WOS:000361800700083
J	Tan, SP; Zhao, YL; Fan, FM; Zou, YZ; Jin, Z; Zen, YW; Zhu, XL; Yang, FD; Tan, YL; Zhou, DF				Tan, Shuping; Zhao, Yanli; Fan, Fengmei; Zou, Yizhuang; Jin, Zhen; Zen, Yawei; Zhu, Xiaolin; Yang, Fude; Tan, Yunlong; Zhou, Dongfeng			Brain Correlates of Self-Evaluation Deficits in Schizophrenia: A Combined Functional and Structural MRI Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FMRI; REFLECTION; AWARENESS; METAANALYSIS; ACTIVATION; INSIGHT	Self-evaluation plays an important role in adaptive functioning and is a process that is typically impaired in patients with schizophrenia. Underlying neural mechanisms for this dysfunction may be associated with manifested psychosis. However, the brain substrates underlying this deficit are not well known. The present study used brain blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) and gray matter voxel-based morphometry to explore the functional and structural brain correlates of self-evaluation deficits in schizophrenia. Eighteen patients with schizophrenia and 17 healthy controls were recruited and asked to judge whether a set of personality-trait adjectives were appropriate for describing themselves, a familiar other, or whether the adjectives were of positive or negative valence. Patients had slower response times for negative trait attributions than controls did; responses to positive trait attributions were faster than those for negative traits among the patient group, while no differences were observed in the control group. Control subjects showed greater activation within the dorsal medial prefrontal cortex (dMPFC) and the anterior cingulate cortex (ACC) than the patient group during the self-evaluation > semantic positivity-evaluation contrast. Patients showed greater activation mainly within the posterior cingulate gyrus (PCC) as compared to controls for the other-evaluation > semantic positivity-evaluation contrast. Furthermore, gray matter volume was reduced in the MPFC, temporal lobe, cuneus, and the dorsal lateral prefrontal cortex (DLPFC) among the patient group when compared to controls. The present study adds to previous findings regarding self-and other-referential processing in schizophrenia, providing support for neurobiological models of self-reflection impairment.	[Tan, Shuping; Zhou, Dongfeng] Peking Univ, Inst Mental Hlth, Beijing 100191, Peoples R China; [Tan, Shuping; Zhao, Yanli; Fan, Fengmei; Zou, Yizhuang; Zhu, Xiaolin; Yang, Fude; Tan, Yunlong] Beijing Huilongguan Hosp, Ctr Psychiat Res, Beijing 100096, Peoples R China; [Jin, Zhen; Zen, Yawei] 306th Hosp PLA, Magnet Res Imaging Unit, Beijing 100101, Peoples R China	Peking University	Zou, YZ (corresponding author), Beijing Huilongguan Hosp, Ctr Psychiat Res, Beijing 100096, Peoples R China.	yzouy@263.net; zhoudf@bjmu.edu.cn	zhao, yan/GWC-9174-2022		Fund of Capital Medical Development and Research grant [2011-2013-02]; Beijing Municipal Science & Technology Commission [Z141107002514016, D121100005012005]; International Cooperation and Exchange of the National Natural Science Foundation of China [81461130016]; Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding [zy201409]; National Natural Science Foundation of China [81401133]	Fund of Capital Medical Development and Research grant; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Fund of Capital Medical Development and Research grant (2011-2013-02)(SPT), Beijing Municipal Science & Technology Commission (Z141107002514016)(SPT), Beijing Municipal Science & Technology Commission (D121100005012005)(FDY), International Cooperation and Exchange of the National Natural Science Foundation of China (81461130016) (YLT), Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding (zy201409) (FDY) and the National Natural Science Foundation of China (81401133) (YLZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bedford NJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-106; BELL MD, 1994, PSYCHIAT RES, V52, P295, DOI 10.1016/0165-1781(94)90075-2; Blackwood NJ, 2004, PSYCHOL MED, V34, P591, DOI 10.1017/S0033291703008997; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Gilleen J, 2011, SCHIZOPHRENIA BULL, V37, P61, DOI 10.1093/schbul/sbq100; Harvey PO, 2011, SCHIZOPHR RES, V127, P171, DOI 10.1016/j.schres.2010.11.011; Holt DJ, 2011, BIOL PSYCHIAT, V69, P415, DOI 10.1016/j.biopsych.2010.10.003; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Liu JC, 2014, PSYCHIAT RES-NEUROIM, V222, P165, DOI 10.1016/j.pscychresns.2014.04.003; Lysaker PH, 2011, COMPR PSYCHIAT, V52, P253, DOI 10.1016/j.comppsych.2010.07.007; Lysaker PH, 2010, SCHIZOPHR RES, V122, P124, DOI 10.1016/j.schres.2009.04.024; Modinos G, 2011, NEUROPSYCHOLOGY, V25, P295, DOI 10.1037/a0021747; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Murphy ER, 2010, SCHIZOPHR RES, V116, P252, DOI 10.1016/j.schres.2009.11.009; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Pauly KD, 2014, SOC COGN AFFECT NEUR, V9, P1779, DOI 10.1093/scan/nst174; Shad MU, 2011, ASIAN J PSYCHIATR, V4, P248, DOI 10.1016/j.ajp.2011.09.002; Shad MU, 2012, SCHIZOPHR RES, V138, P113, DOI 10.1016/j.schres.2012.03.016; Silva JR, 2008, BIOL RES, V41, P143, DOI [/S0716-97602008000200003, 10.4067/S0716-97602008000200003]; van der Meer L, 2013, SCHIZOPHRENIA BULL, V39, P1352, DOI 10.1093/schbul/sbs122; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; 张智勇, 1998, [心理学报, Acta Psychologica Sinica], V30, P85	28	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138737	10.1371/journal.pone.0138737	http://dx.doi.org/10.1371/journal.pone.0138737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406464	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700080
J	Jung, HY; Lee, S; Heo, YS; Yun, ID				Jung, Ho Yub; Lee, Soochahn; Heo, Yong Seok; Yun, Il Dong			Forest Walk Methods for Localizing Body Joints from Single Depth Image	PLOS ONE			English	Article								We present multiple random forest methods for human pose estimation from single depth images that can operate in very high frame rate. We introduce four algorithms: random forest walk, greedy forest walk, random forest jumps, and greedy forest jumps. The proposed approaches can accurately infer the 3D positions of body joints without additional information such as temporal prior. A regression forest is trained to estimate the probability distribution to the direction or offset toward the particular joint, relative to the adjacent position. During pose estimation, the new position is chosen from a set of representative directions or offsets. The distribution for next position is found from traversing the regression tree from new position. The continual position sampling through 3D space will eventually produce an expectation of sample positions, which we estimate as the joint position. The experiments show that the accuracy is higher than current state-of-the-art pose estimation methods with additional advantage in computation time.	[Jung, Ho Yub; Yun, Il Dong] Hankuk Univ Foreign Studies, Div Comp & Elect Syst Engn, Yongin, South Korea; [Lee, Soochahn] Soonchunhyang Univ, Dept Elect Engn, Asan, South Korea; [Heo, Yong Seok] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea	Hankuk University Foreign Studies; Soonchunhyang University; Ajou University	Heo, YS (corresponding author), Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea.	ysheo@ajou.ac.kr	Heo, Yong Seok/AAD-8816-2021; Lee, Soochahn/AAE-8471-2020	Lee, Soochahn/0000-0002-2975-2519	Hankuk University of Foreign Studies Research Fund; Ajou University; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP) [2015R1A5A7036384]; Basic Science Research Program - Ministry of Education, Science and Technology; Soonchunhyang University	Hankuk University of Foreign Studies Research Fund; Ajou University; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP)(National Research Foundation of Korea); Basic Science Research Program - Ministry of Education, Science and Technology; Soonchunhyang University	This work was supported by Hankuk University of Foreign Studies Research Fund of 2015, and also partially supported by the new faculty research fund of Ajou University. This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (2015R1A5A7036384), and by the Basic Science Research Program funded by the Ministry of Education, Science and Technology. Additional funding for Soochahn Lee was provided by a research fund from Soonchunhyang University.	Agarwal A, 2006, IEEE T PATTERN ANAL, V28, P44, DOI 10.1109/TPAMI.2006.21; Baak A, 2011, P INT C COCMP VIS IC; Bourdev L, 2009, IEEE I CONF COMP VIS, P1365, DOI 10.1109/ICCV.2009.5459303; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cootes TF, 2012, LECT NOTES COMPUT SC, V7578, P278, DOI 10.1007/978-3-642-33786-4_21; D'Ausilio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035757; Elhayek A, 2012, P IEEE C COMP VIS PA; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Ferrari V, 2008, PROC CVPR IEEE, DOI 10.1109/CVPR.2008.4587468; Gall J, 2009, PROC CVPR IEEE, P1746, DOI 10.1109/CVPRW.2009.5206755; Gall J, 2009, PROC CVPR IEEE, P1022, DOI 10.1109/CVPRW.2009.5206740; Ganapathi V, 2012, P EUR C COMP VIS ECC; Ganapathi V, 2010, P IEEE C COMP VIS PA; Gavrila DM, 1996, PROC CVPR IEEE, P73, DOI 10.1109/CVPR.1996.517056; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Girshick R, 2011, P INT C COMP VIS ICC; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Grest D, 2007, SINGLE VIEW MOTION T; Han D, 2014, LECT NOTES COMPUT SC, V8673, P186, DOI 10.1007/978-3-319-10404-1_24; Helten T, 2013, PERSONALIZATION EVAL; Jung HY, 2015, P IEEE C COMP VIS PA; Kwon J., 2010, P IEEE C COMP VIS PA; Microsoft, 2014, KINECTSDK; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Oberg J., 2012, INT C FIELD PROGR LO; Plankers R, 2003, IEEE T PATTERN ANAL, V25, P1182, DOI 10.1109/TPAMI.2003.1227995; Poppe R, 2007, COMPUT VIS IMAGE UND, V108, P4, DOI 10.1016/j.cviu.2006.10.016; Qiao MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085811; Shakhnarovich G., 2003, P INT C COMP VIS ICC; Sharp T, 2008, LECT NOTES COMPUT SC, V5305, P595, DOI 10.1007/978-3-540-88693-8_44; Shotton J, 2013, IEEE T PATTERN ANAL, V35, P2821, DOI 10.1109/TPAMI.2012.241; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Sigal L, 2004, PROC CVPR IEEE, P421; Sun M, 2012, P IEEE C COMP VIS PA; Tang DH, 2014, PROC CVPR IEEE, P3786, DOI 10.1109/CVPR.2014.490; Taylor J, 2012, P IEEE C COMP VIS PA; Toshev A, 2014, PROC CVPR IEEE, P1653, DOI 10.1109/CVPR.2014.214; Wei XL, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2366145.2366207; Xiong XH, 2013, PROC CVPR IEEE, P532, DOI 10.1109/CVPR.2013.75; Yang HD, 2007, PATTERN RECOGN, DOI [10.1016/j.patcog.2007.01.033, DOI 10.1016/J.PATC0G.2007.01.033]; Yang Y, 2011, PROC CVPR IEEE, P1385, DOI 10.1109/CVPR.2011.5995741; Ye M, 2011, P INT C COMP VIS ICC; Ye M, 2014, P IEEE C COMP VIS PA; Zhu Y, 2008, P IEEE CVPR WORKSH T	44	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138328	10.1371/journal.pone.0138328	http://dx.doi.org/10.1371/journal.pone.0138328			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402029	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100020
J	Kim, JW; Kim, SH; Kim, YJ; Lee, KW; Kim, KI; Lee, JS; Kim, CH; Kim, JH				Kim, Jin Won; Kim, Se-Hyun; Kim, Yu Jung; Lee, Keun-Wook; Kim, Kwang-Il; Lee, Jong Seok; Kim, Cheol-Ho; Kim, Jee Hyun		Korean Canc Study Grp Geriatric On	A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7	PLOS ONE			English	Article							CHEMOTHERAPY TOXICITY; INTERNATIONAL-SOCIETY; RISK; PEOPLE	Geriatric assessment (GA) is resource-consuming, necessitating screening tools to select appropriate patients who need full GA. The objective of this study is to design a novel geriatric screening tool with easy-to-answer questions and high performance objectively selected from a large dataset to represent each domain of GA. A development cohort was constructed from 1284 patients who received GA from May 2004 to April 2007. Items representing each domain of functional status, cognitive function, nutritional status, and psychological status in GA were selected according to sensitivity (SE) and specificity (SP). Of the selected items, the final questions were chosen by a panel of oncologists and geriatricians to encompass most domains evenly and also by feasibility and use with cancer patients. The selected screening questions were validated in a separate cohort of 98 cancer patients. The novel screening tool, the Korean Cancer Study Group Geriatric Score (KG)-7, consisted of 7 items representing each domain of GA. KG-7 had a maximal area under the curve (AUC) of 0.93 (95% confidence interval (CI) 0.92-0.95) in the prediction of abnormal GA, which was higher than that of G-8 (0.87, 95% CI 0.85-0.89) within the development cohort. The cut-off value was decided at <= 5 points, with a SE of 95.0%, SP of 59.2%, positive predictive value (PPV) of 85.3%, and negative predictive value (NPV) of 82.6%. In the validation cohort, the AUC was 0.82 (95% CI 0.73-0.90), and the SE, SP, PPV, and NPV were 89.5%, 48.6%, 77.3%, and 75.0%, respectively. Furthermore, patients with higher KG-7 scores showed significantly longer overall survival (OS) in the development and validation cohorts. In conclusions, the KG-7 showed high SE and NPV to predict abnormal GA. The KG-7 also predicted OS. Given the results of our studies, the KG-7 could be used effectively in countries with high patient burden and low resources to select patients in need of full GA and intervention.	[Kim, Jin Won; Kim, Se-Hyun; Kim, Yu Jung; Lee, Keun-Wook; Lee, Jong Seok; Kim, Jee Hyun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Bundang Hosp, Div Hematol & Med Oncol,Dept Internal Med, Songnam, South Korea; [Kim, Kwang-Il; Kim, Cheol-Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Bundang Hosp, Div Geriatr,Dept Internal Med, Songnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Bundang Hosp, Div Hematol & Med Oncol,Dept Internal Med, Songnam, South Korea.	jhkimmd@snu.ac.kr	Kim, Kwang-il/D-8024-2012; Kim, Kwang-il/AAP-7315-2021	Kim, Kwang-il/0000-0002-6658-047X; Kim, Kwang-il/0000-0002-6658-047X; Kwon, Jung Hye/0000-0002-5965-3204; Hong, Soojung/0000-0002-4350-2794	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320370]	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (study no: 1320370).	Audisio RA, 2008, CRIT REV ONCOL HEMAT, V65, P156, DOI 10.1016/j.critrevonc.2007.11.001; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Baitar A, 2013, J GERIATR ONCOL, V4, P32, DOI 10.1016/j.jgo.2012.08.001; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Decoster L, 2015, ANN ONCOL, V26, P288, DOI 10.1093/annonc/mdu210; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Extermann M, 2007, J CLIN ONCOL, V25, P1824, DOI 10.1200/JCO.2007.10.6559; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; Kanesvaran R, 2011, J CLIN ONCOL, V29, P3620, DOI 10.1200/JCO.2010.32.0796; Kellen E, 2010, CRIT REV ONCOL HEMAT, V75, P243, DOI 10.1016/j.critrevonc.2009.12.002; Kenis C, 2014, J CLIN ONCOL, V32, P19, DOI 10.1200/JCO.2013.51.1345; Kim JW, 2014, SUPPORT CARE CANCER, V22, P773, DOI 10.1007/s00520-013-2033-y; Kim YJ, 2011, J CANCER RES CLIN, V137, P839, DOI 10.1007/s00432-010-0945-1; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee DY, 2002, J AM GERIATR SOC, V50, P1233, DOI 10.1046/j.1532-5415.2002.50310.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1111/j.1553-2712.2003.tb01996.x; Overcash JA, 2005, CRIT REV ONCOL HEMAT, V54, P129, DOI 10.1016/j.critrevonc.2004.12.002; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Sattar S, 2014, ONCOLOGIST, V19, P1056, DOI 10.1634/theoncologist.2014-0180; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Wildiers H, 2014, J CLIN ONCOL, V32, P2595, DOI 10.1200/JCO.2013.54.8347	27	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138304	10.1371/journal.pone.0138304	http://dx.doi.org/10.1371/journal.pone.0138304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BS	26401951	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100019
J	Meher, BR; Dixit, A; Bousfield, GR; Lushington, GH				Meher, Biswa Ranjan; Dixit, Anshuman; Bousfield, George R.; Lushington, Gerald H.			Glycosylation Effects on FSH-FSHR Interaction Dynamics: A Case Study of Different FSH Glycoforms by Molecular Dynamics Simulations	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; IN-VITRO; RECEPTOR; ROLES; WATER; RESIDUES; COMPLEX; BINDING; MODELS; SYSTEM	The gonadotropin known as follicle-stimulating hormone (FSH) plays a key role in regulating reproductive processes. Physiologically active FSH is a glycoprotein that can accommodate glycans on up to four asparagine residues, including two sites in the FSH alpha subunit that are critical for biochemical function, plus two sites in the beta subunit, whose differential glycosylation states appear to correspond to physiologically distinct functions. Some degree of FSH beta hypo-glycosylation seems to confer advantages toward reproductive fertility of childbearing females. In order to identify possible mechanistic underpinnings for this physiological difference we have pursued computationally intensive molecular dynamics simulations on complexes between the high affinity site of the gonadal FSH receptor (FSHR) and several FSH glycoforms including fully-glycosylated (FSH24), hypo-glycosylated (e.g., FSH15), and completely deglycosylated FSH (dgFSH). These simulations suggest that deviations in FSH/FSHR binding profile as a function of glycosylation state are modest when FSH is adorned with only small glycans, such as single N-acetylglucosamine residues. However, substantial qualitative differences emerge between FSH15 and FSH24 when FSH is decorated with a much larger, tetra-antennary glycan. Specifically, the FSHR complex with hypo-glycosylated FSH15 is observed to undergo a significant conformational shift after 5-10 ns of simulation, indicating that FSH15 has greater conformational flexibility than FSH24 which may explain the more favorable FSH15 kinetic profile. FSH15 also exhibits a stronger binding free energy, due in large part to formation of closer and more persistent salt-bridges with FSHR.	[Meher, Biswa Ranjan] Univ Kansas, Bioinformat Core Facil, Lawrence, KS 66045 USA; [Dixit, Anshuman] Inst Life Sci, Bhubaneswar 751023, Orissa, India; [Bousfield, George R.] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA; [Lushington, Gerald H.] LiS Consulting, Lawrence, KS USA	University of Kansas; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Wichita State University	Meher, BR (corresponding author), Univ Kansas, Bioinformat Core Facil, Lawrence, KS 66045 USA.	brmeher@gmail.com; lushington_insilico@yahoo.com	BOUSFIELD, George/R-5726-2019; Lushington, Gerald/P-8421-2019; Meher, Biswa/GPX-7920-2022; Lushington, Gerald/AAH-3205-2020	Lushington, Gerald/0000-0001-5821-4253; Meher, Biswa Ranajn/0000-0003-0519-9074	National Institute of Health [P01 AG-029531]; LiS Consulting	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LiS Consulting	This research was supported by National Institute of Health Grant P01 AG-029531 to GRB. LiS Consulting provided support in the form of a salary for GHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2008, SYBYL 8 1; BISHOP LA, 1994, MOL ENDOCRINOL, V8, P722, DOI 10.1210/me.8.6.722; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bousfield GR, 2007, MOL CELL ENDOCRINOL, V260, P40, DOI 10.1016/j.mce.2006.02.017; Bousfield GR, 2014, MOL CELL ENDOCRINOL, V382, P989, DOI 10.1016/j.mce.2013.11.008; CALVO FO, 1986, BIOCHEMISTRY-US, V25, P3938, DOI 10.1021/bi00361a030; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHENG KW, 1975, BIOCHEM J, V149, P123, DOI 10.1042/bj1490123; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Davis John S, 2014, J Glycomics Lipidomics, V4, pe117; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; FLACK MR, 1994, J BIOL CHEM, V269, P14015; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Harvey DJ, 2011, PROTEOMICS, V11, P4291, DOI 10.1002/pmic.201100300; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jankovic M, 2011, J MED BIOCHEM, V30, P213, DOI 10.2478/v10011-011-0023-5; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mizunuma H, 2011, SAISHIN IGAKU, V66, P862; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Ulloa-Aguirre A, 2003, BIOL REPROD, V69, P379, DOI 10.1095/biolreprod.103.016915; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Walton WJ, 2001, J CLIN ENDOCR METAB, V86, P3675, DOI 10.1210/jcem.86.8.7712	32	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137897	10.1371/journal.pone.0137897	http://dx.doi.org/10.1371/journal.pone.0137897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402790	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100014
J	van Zonneveld, M; Ramirez, M; Williams, DE; Petz, M; Meckelmann, S; Avila, T; Bejarano, C; Rios, L; Pena, K; Jager, M; Libreros, D; Amaya, K; Scheldeman, X				van Zonneveld, Maarten; Ramirez, Marleni; Williams, David E.; Petz, Michael; Meckelmann, Sven; Avila, Teresa; Bejarano, Carlos; Rios, Llerme; Pena, Karla; Jaeger, Matthias; Libreros, Dimary; Amaya, Karen; Scheldeman, Xavier			Screening Genetic Resources of Capsicum Peppers in Their Primary Center of Diversity in Bolivia and Peru	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; STABILITY ANALYSIS; CAPSAICINOIDS; SOLANACEAE; BACCATUM; BIODIVERSITY; ACCESSIONS; CULTIVARS; EVOLUTION; SOLANUM	For most crops, like Capsicum, their diversity remains under-researched for traits of interest for food, nutrition and other purposes. A small investment in screening this diversity for a wide range of traits is likely to reveal many traditional varieties with distinguished values. One objective of this study was to demonstrate, with Capsicum as model crop, the application of indicators of phenotypic and geographic diversity as effective criteria for selecting promising genebank accessions for multiple uses from crop centers of diversity. A second objective was to evaluate the expression of biochemical and agromorphological properties of the selected Capsicum accessions in different conditions. Four steps were involved: 1) Develop the necessary diversity by expanding genebank collections in Bolivia and Peru; 2) Establish representative subsets of similar to 100 accessions for biochemical screening of Capsicum fruits; 3) Select promising accessions for different uses after screening; and 4) Examine how these promising accessions express biochemical and agromorphological properties when grown in different environmental conditions. The Peruvian Capsicum collection now contains 712 accessions encompassing all five domesticated species (C. annuum, C. chinense, C. frutescens, C. baccatum, and C. pubescens). The collection in Bolivia now contains 487 accessions, representing all five domesticates plus four wild taxa (C. baccatum var. baccatum, C. caballeroi, C. cardenasii, and C. eximium). Following the biochemical screening, 44 Bolivian and 39 Peruvian accessions were selected as promising, representing wide variation in levels of antioxidant capacity, capsaicinoids, fat, flavonoids, polyphenols, quercetins, tocopherols, and color. In Peru, 23 promising accessions performed well in different environments, while each of the promising Bolivian accessions only performed well in a certain environment. Differences in Capsicum diversity and local contexts led to distinct outcomes in each country. In Peru, mild landraces with high values in health-related attributes were of interest to entrepreneurs. In Bolivia, wild Capsicum have high commercial demand.	[van Zonneveld, Maarten] Biovers Int, Costa Rica Off, Turrialba, Costa Rica; [Ramirez, Marleni; Jaeger, Matthias; Libreros, Dimary; Amaya, Karen; Scheldeman, Xavier] Biovers Int, Reg Off Amer, Cali, Colombia; [Williams, David E.] Interamer Inst Cooperat Agr, San Jose, Costa Rica; [Petz, Michael; Meckelmann, Sven] Univ Wuppertal, Fac Math & Nat Sci, Dept Food Chem, Wuppertal, Germany; [Avila, Teresa] Ctr Invest Fitoecogenet Pairumani, Cochabamba, Bolivia; [Bejarano, Carlos] Fdn Promoc & Invest Prod Andinos PROINPA, Oficina Reg Valle Sur, Sucre, Bolivia; [Rios, Llerme; Pena, Karla] Inst Nacl Innovac Agr, Lima, Peru	Alliance; Bioversity International; Alliance; Bioversity International; University of Wuppertal	van Zonneveld, M (corresponding author), Biovers Int, Costa Rica Off, Turrialba, Costa Rica.	m.vanzonneveld@cgiar.org	Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361; PENA PINEDA, KARLA MONICA/0000-0003-4877-645X	German Society for International Collaboration; Gesellschaft fur Internationale Zusammenarbeit (GIZ); Climate Change, Agriculture and Food Security (CCAFS)	German Society for International Collaboration; Gesellschaft fur Internationale Zusammenarbeit (GIZ); Climate Change, Agriculture and Food Security (CCAFS)	This study is part of the international and interdisciplinary project 'Unravelling the potential of underutilized crop diversity for high-value product differentiation: the case of chilli peppers in Bolivia and Peru' funded by the German Society for International Collaboration, Gesellschaft fur Internationale Zusammenarbeit (GIZ), and contributes to the CGIAR Research Programs on Policies, Institutions and Markets (PIM) and Climate Change, Agriculture and Food Security (CCAFS).	Agricolae Mendiburu F., 2014, STAT PROCEDURES AGR; Albrecht E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-68; Annicchiarico, 2002, GENOTYPE X ENV INTER; [Anonymous], 2010, R LANG ENV STAT COMP; Antonious GF, 2006, J ENVIRON SCI HEAL B, V41, P717, DOI 10.1080/03601230600701908; APEGA UNALM INIA USMP, 2009, AJ PER SAZ MUND; Azurdia C, 2011, ATLAS GUATERMALTECO; Barboza Gloria E., 2010, PhytoKeys, V2, P23, DOI [10.3897/phytokeys.2.730, 10.3897/PhytoKeys.2.730]; BECKER HC, 1988, PLANT BREEDING, V101, P1, DOI 10.1111/j.1439-0523.1988.tb00261.x; Bosland P. W., 1996, Progress in new crops: Proceedings of the Third National Symposium, Indianapolis, Indiana, USA, 22-25 October, 1996., P479; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Devaux A, 2009, FOOD POLICY, V34, P31, DOI 10.1016/j.foodpol.2008.10.007; Eggink PM, 2014, THEOR APPL GENET, V127, P373, DOI 10.1007/s00122-013-2225-3; Eshbaugh WH, 2012, PEPPERS: BOTANY, PRODUCTION AND USES, P14, DOI 10.1079/9781845937676.0014; Grum M., 2007, HDB GENEBANKS, V9; Gurung T, 2012, EUPHYTICA, V187, P11, DOI 10.1007/s10681-012-0672-6; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; IPGRI AVRDC CATIE, 1995, DESCR CAPS; Jager M, 2013, TALLERES ANALISIS MU; Jager M, 2013, RESCATE PROMOCION AJ; Jano P, 2007, CACAO MARKETING CHAI; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kollmannsberger H, 2011, J SCI FOOD AGR, V91, P1598, DOI 10.1002/jsfa.4354; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Libreros D, 2014, CATALOGO AJIES CAPSI; Libreros D, 2013, CATALOGO AJIES CAPSI; Materska M, 2005, J AGR FOOD CHEM, V53, P1750, DOI 10.1021/jf035331k; Meckelmann SW, 2015, EUR FOOD RES TECHNOL, V241, P817, DOI 10.1007/s00217-015-2506-y; Meckelmann SW, 2015, EUR FOOD RES TECHNOL, V240, P273, DOI 10.1007/s00217-014-2325-6; Meckelmann SW, 2013, J AGR FOOD CHEM, V61, P2530, DOI [10.1021/jf304986q, 10.1021/jf304986]; Moscone EA, 2007, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2007.745.5; Moses M, 2014, GENET RESOUR CROP EV, V61, P741, DOI 10.1007/s10722-013-0069-y; Nee M, 2006, BRITTONIA, V58, P322, DOI 10.1663/0007-196X(2006)58[322:NSOSAC]2.0.CO;2; OECD, 2006, SER HARM REG OV BIOT; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254; Ortiz R, 2010, SCI HORTIC-AMSTERDAM, V126, P186, DOI 10.1016/j.scienta.2010.07.007; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; Perry L, 2012, PEPPERS: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9781845937676.0001; Phimchan P, 2012, HORTSCIENCE, V47, P1204, DOI 10.21273/HORTSCI.47.9.1204; Pickersgill B., 1991, Chromosome engineering in plants: genetics, breeding, evolution. Part B., P139; Reifschneider FJB, 2009, CHRON HORTICULT, V49, P19; Thampi PSS, 2003, MED AROM PLANTS, V33, P16; Ugas R, 2013, SERIE PUNTO AJI, V1- 2; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; White D., 2012, MAPTREE MAPPING PRUN; Williams DE, 2004, HOME GARDENS AGROBIO, P256	55	44	44	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0134663	10.1371/journal.pone.0134663	http://dx.doi.org/10.1371/journal.pone.0134663			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402618	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100003
J	Watve, SS; Thomas, J; Hammer, BK				Watve, Samit S.; Thomas, Jacob; Hammer, Brian K.			CytR Is a Global Positive Regulator of Competence, Type VI Secretion, and Chitinases in Vibrio cholerae	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; NATURAL TRANSFORMATION; SENSITIVE SELECTION; BIOFILM FORMATION; EXPRESSION; SYSTEM; PROTEIN; INDUCTION	The facultative pathogen Vibrio cholerae transitions between its human host and aquatic reservoirs where it colonizes chitinous surfaces. Growth on chitin induces expression of chitin utilization genes, genes involved in DNA uptake by natural transformation, and a type VI secretion system that allows contact-dependent killing of neighboring bacteria. We have previously shown that the transcription factor CytR, thought to primarily regulate the pyrimidine nucleoside scavenging response, is required for natural competence in V. cholerae. Through high-throughput RNA sequencing (RNA-seq), we show that CytR positively regulates the majority of competence genes, the three type VI secretion operons, and the four known or predicted chitinases. We used transcriptional reporters and phenotypic analysis to determine the individual contributions of quorum sensing, which is controlled by the transcription factors HapR and QstR; chitin utilization that is mediated by TfoX; and pyrimidine starvation that is orchestrated by CytR, toward each of these processes. We find that in V. cholerae, CytR is a global regulator of multiple behaviors affecting fitness and adaptability in the environment.	[Watve, Samit S.; Thomas, Jacob; Hammer, Brian K.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Hammer, BK (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	brian.hammer@biology.gatech.edu	Hammer, Brian/I-7282-2013; Watve, Samit/K-8326-2019	Hammer, Brian/0000-0002-3767-6034; Watve, Samit/0000-0002-7833-7610	National Science Foundation [MCB-1149925]; Direct For Biological Sciences [1149925] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S Watve, J Thomas, and BK Hammer were supported by a grant MCB-1149925 from the National Science Foundation (http://www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonova ES, 2012, MOL MICROBIOL, V86, P1215, DOI 10.1111/mmi.12054; Antonova ES, 2011, FEMS MICROBIOL LETT, V322, P68, DOI 10.1111/j.1574-6968.2011.02328.x; Barbier CS, 1997, J BIOL CHEM, V272, P16962, DOI 10.1074/jbc.272.27.16962; Bhowmick R, 2007, J APPL MICROBIOL, V103, P97, DOI 10.1111/j.1365-2672.2006.03253.x; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; Blokesch M, 2012, ENVIRON MICROBIOL, V14, P1898, DOI 10.1111/j.1462-2920.2011.02689.x; Borgeaud S, 2015, SCIENCE, V347, P63, DOI 10.1126/science.1260064; Brikun I, 1996, J BACTERIOL, V178, P1614, DOI 10.1128/jb.178.6.1614-1622.1996; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Gumpenberger T, 2016, MOL MICROBIOL, V99, P470, DOI 10.1111/mmi.13143; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; HAMMERJESPERSEN K, 1975, MOL GEN GENET, V137, P327, DOI 10.1007/BF00703258; Haugo AJ, 2002, MOL MICROBIOL, V45, P471, DOI 10.1046/j.1365-2958.2002.03023.x; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lo Scrudato M, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0327-y; Lo Scrudato M, 2013, NUCLEIC ACIDS RES, V41, P3644, DOI 10.1093/nar/gkt041; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Metzger LC, 2014, MOB GENET ELEMENTS, V4, P17987; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rasmussen PB, 1996, P NATL ACAD SCI USA, V93, P10151, DOI 10.1073/pnas.93.19.10151; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Sernova NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044194; Shao Y, 2014, MOL MICROBIOL, V92, P921, DOI 10.1111/mmi.12599; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; SORENSEN KI, 1993, J BACTERIOL, V175, P4137; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Sun SY, 2015, ISME J, V9, P1812, DOI 10.1038/ismej.2014.265; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Team RC, 2013, R LANG ENV STAT COMP; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; Watve Samit S, 2014, Curr Protoc Microbiol, V35, DOI 10.1002/9780471729259.mc06a04s35; WILSON HR, 1992, J BACTERIOL, V174, P514, DOI 10.1128/jb.174.2.514-524.1992; Yamamoto S, 2011, J BACTERIOL, V193, P1953, DOI 10.1128/JB.01340-10; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107; Zolotukhina M, 2003, RES MICROBIOL, V154, P510, DOI 10.1016/S0923-2508(03)00125-6	52	38	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138834	10.1371/journal.pone.0138834	http://dx.doi.org/10.1371/journal.pone.0138834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401962	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100039
J	Ioannou, K; Stel, VS; Dounousi, E; Jager, KJ; Papagianni, A; Pappas, K; Siamopoulos, KC; Zoccali, C; Tsakiris, D				Ioannou, Kyriakos; Stel, Vianda S.; Dounousi, Evangelia; Jager, Kitty J.; Papagianni, Aikaterini; Pappas, Konstantinos; Siamopoulos, Kostas C.; Zoccali, Carmine; Tsakiris, Dimitrios			Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CELL-ADHESION MOLECULES; CARDIOVASCULAR-DISEASE; CAROTID ATHEROSCLEROSIS; RENAL-INSUFFICIENCY; PROGNOSTIC VALUE; RISK-FACTORS; HYPERTROPHY; ASSOCIATION; MORTALITY	Introduction Within this longitudinal study we investigated the association of inflammation markers C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF alpha) and endothelial dysfunction markers intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) with left ventricular mass indexed for height(2.71) (LVMI) in hypertensive predialysis CKD patients. Material and Methods From 2004 to 2005, 182 incident consecutive adult patients from the outpatient CKD clinics of two hospitals in Greece with CKD and hypertension or using antihypertensive medication, were included. Of these, 107 patients underwent CRP (mg/l) and LVMI (g/height(2.71)) measurements annually for three years. Results In the longitudinal analyses, using linear mixed modeling, a higher IL-6 (beta = 1.9 (95% ci:0.38; 3.5), inflammation score based on CRP, IL-6 and TNF-alpha (beta = 5.0 (95% ci:0.72; 9.4) and VCAM-1 (beta = 0.01 (95% ci:0.005; 0.02) were associated with higher LVMI. These models were adjusted for age, gender and primary renal disease, and for confounders that on top changed the beta with >= 10%, i.e. diuretic use (for IL-6 and inflammation score). Conclusion The results suggest that in predialysis CKD patients, inflammation as well as endothelial dysfunction may play an important role towards the increase in LVMI.	[Ioannou, Kyriakos] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Stel, Vianda S.; Jager, Kitty J.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, ERA EDTA Registry, NL-1105 AZ Amsterdam, Netherlands; [Dounousi, Evangelia; Siamopoulos, Kostas C.] Univ Ioannina, Sch Med, Dept Nephrol, GR-45110 Ioannina, Greece; [Papagianni, Aikaterini] Aristotle Univ Thessaloniki, Hippokration Gen Hosp, Dept Nephrol, GR-54006 Thessaloniki, Greece; [Pappas, Konstantinos] Univ Hosp Ioannina, Dept Cardiol, Ioannina, Greece; [Zoccali, Carmine] CNR, IBIM Clin Epidemiol & Pathophysiol Renal Dis & Hy, Renal & Transplantat Unit, Reggio Di Calabria, Italy; [Tsakiris, Dimitrios] Papageorgiou Gen Hosp Thessaloniki, Dept Nephrol, Thessaloniki, Greece	University of Amsterdam; Academic Medical Center Amsterdam; University of Ioannina; Aristotle University of Thessaloniki; University Hospital Ioannina; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Papageorgiou Hospital	Stel, VS (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, ERA EDTA Registry, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.s.stel@amc.uva.nl	Dounousi, Evangelia/AAM-6678-2021; Stefanadis, Christodoulos/ABH-2232-2020; Zoccali, Carmine/AAR-4473-2020; Ntounousi or Dounousi, Evangelia/AAE-7807-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Zoccali, Carmine/0000-0002-6616-1996; Stel, Vianda S/0000-0002-0007-1947; Jager, Kitty/0000-0003-0444-8569; Papagianni, Aikaterini/0000-0003-0437-5208	European Community [HEALTH-F2-2009-241544]; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	European Community(European Commission); European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement number HEALTH-F2-2009-241544 (SysKID). Additionally, this article was written by VSS and KJJ on behalf of the ERA-EDTA Registry which is an official body of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association). The ERA-EDTA Registry is funded by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA).	[Anonymous], 2003, AM J KIDNEY DIS, P41; [Anonymous], 2003, AM J KIDNEY DIS, P42; [Anonymous], 2004, AM J KIDNEY DIS, P43; Ates K, 2005, NEPHRON CLIN PRACT, V101, pC190, DOI 10.1159/000087414; Cottone S, 2007, CLIN NEPHROL, V67, P209; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dervisoglu E, 2012, HIPPOKRATIA, V16, P137; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gonzalez MA, 2003, AM J MED, V115, P99, DOI 10.1016/j.amjmed.2003.09.016; HEIMANN JC, 1991, J CARDIOVASC PHARM, V17, pS122, DOI 10.1097/00005344-199117002-00028; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Jager KJ, 2008, KIDNEY INT, V73, P256, DOI 10.1038/sj.ki.5002650; Jager KJ, 2007, KIDNEY INT, V72, P671, DOI 10.1038/sj.ki.5002397; Kaysen GA, 2004, J AM SOC NEPHROL, V15, P538, DOI 10.1097/01.ASN.0000111744.00916.E6; Kuroda YT, 2001, AM J HYPERTENS, V14, P868, DOI 10.1016/S0895-7061(01)02139-2; Leffondre K, 2014, NEPHROL DIAL TRANSPL; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Losito A, 2003, KIDNEY INT, V64, P616, DOI 10.1046/j.1523-1755.2003.00119.x; Malmqvist K, 2002, J HYPERTENS, V20, P1563, DOI 10.1097/00004872-200208000-00019; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; Mervaala EMA, 1997, JPN CIRC J, V61, P421, DOI 10.1253/jcj.61.421; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Ortega O, 2004, NEPHRON CLIN PRACT, V97, pC125, DOI 10.1159/000079170; Ortega O, 2002, NEPHROL DIAL TRANSPL, V17, P1105, DOI 10.1093/ndt/17.6.1105; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Papagianni A, 2008, AM J NEPHROL, V28, P265, DOI 10.1159/000110895; Park M, 2012, J AM SOC NEPHROL, V23, P1725, DOI 10.1681/ASN.2012020145; Perticone F, 2008, AM J KIDNEY DIS, V52, P74, DOI 10.1053/j.ajkd.2008.02.302; Pupim LB, 2004, KIDNEY INT, V65, P2371, DOI 10.1111/j.1523-1755.2004.00656.x; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sengul E, 2013, RENAL FAILURE, V35, P1089, DOI 10.3109/0886022X.2013.817256; Shi BL, 2010, EUR J INTERN MED, V21, P444, DOI 10.1016/j.ejim.2010.07.001; Stel VS, 2013, NEPHROL DIAL TRANSPL, V28, P136, DOI 10.1093/ndt/gft356; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Tousoulis D, 2006, HEART, V92, P441, DOI 10.1136/hrt.2005.066936; Trevisan R, 2006, J AM SOC NEPHROL, V17, pS145, DOI 10.1681/ASN.2005121320; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Tripepi G, 2011, CLIN J AM SOC NEPHRO, V6, P1714, DOI 10.2215/CJN.11291210; Tripepi G, 2008, KIDNEY INT, V74, P1512, DOI 10.1038/ki.2008.416; Verdecchia P, 2007, CURR OPIN CARDIOL, V22, P329, DOI 10.1097/HCO.0b013e3280ebb413; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS61, DOI 10.1681/ASN.2005121344; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	47	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138461	10.1371/journal.pone.0138461	http://dx.doi.org/10.1371/journal.pone.0138461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398099	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500067
J	Park, JH; Park, HK; Jung, H; Lee, SS; Koo, HK				Park, Joo-Hyun; Park, Hye Kyeong; Jung, Hoon; Lee, Sung-Soon; Koo, Hyeon-Kyoung			Parathyroid Hormone as a Novel Biomarker for Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							VITAMIN-D; 25-HYDROXYVITAMIN D; CLINICAL COPD; MORTALITY; QUESTIONNAIRE; EXACERBATIONS; ASSOCIATION	Objective To understand and predict chronic obstructive pulmonary disease (COPD), a biomarker that reflects disease severity is needed. Research Design and Methods Data from 10269 adults aged over 40 years of age were retrieved from the Korea National Health and Nutrition Examination Survey (KNHANES), and 1302 patients met the criteria for COPD. The association between values of vitamin D and parathyroid hormone (PTH), and COPD severity including lung function and quality of life, were analyzed. Results In COPD patients, lung function was inversely related to PTH values (P = 0.02 for FVC [% predicted]; P < 0.001 for FEV1 [% predicted]); however, the association of lung function with vitamin D levels was not statistically significant in a multivariable analysis. Value of PTH was independently associated with EQ5D-index (P = 0.04), but vitamin D level showed no significant relationship with EQ5D-index (P = 0.59) or EQ5D-VAS (P = 0.81). Conclusions Elevation of PTH, unlike vitamin D, is independently associated with COPD severity, and may be a better biomarker for COPD.	[Park, Joo-Hyun; Park, Hye Kyeong; Jung, Hoon; Lee, Sung-Soon; Koo, Hyeon-Kyoung] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea	Inje University	Koo, HK (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea.	gusrud9@yahoo.co.kr						Afzal S, 2014, THORAX, V69, P24, DOI 10.1136/thoraxjnl-2013-203682; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Canavan JL, 2014, RESPIROLOGY, V19, P1006, DOI 10.1111/resp.12350; Casanova C, 2015, CHEST, V148, P159, DOI 10.1378/chest.14-2449; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Jackson AS, 2013, EUR RESPIR J, V41, P309, DOI 10.1183/09031936.00043112; Malinovschi A, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0131-0; Martineau AR, 2014, LANCET RESP MED; Metzger M, 2013, J CLIN ENDOCR METAB, V98, P2922, DOI 10.1210/jc.2013-1294; Molken MPMHRV, 2006, CHEST, V130, P1117, DOI 10.1378/chest.130.4.1117; Pfeffer PE, 2012, THORAX, V67, P1018, DOI 10.1136/thoraxjnl-2012-202139; Puhan MA, 2014, CHEST, V145, P37, DOI 10.1378/chest.13-1296; Roisin RR, 2011, GLOBAL STRATEGY DIAG; Sambrook PN, 2004, J CLIN ENDOCR METAB, V89, P5477, DOI 10.1210/jc.2004-0307; Skaaby T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090654; Wilke S, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-98; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	19	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138482	10.1371/journal.pone.0138482	http://dx.doi.org/10.1371/journal.pone.0138482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398210	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500069
J	Tinto, N; Cola, A; Piscopo, C; Capuano, M; Galatola, M; Greco, L; Sacchetti, L				Tinto, Nadia; Cola, Arturo; Piscopo, Chiara; Capuano, Marina; Galatola, Martina; Greco, Luigi; Sacchetti, Lucia			High Frequency of Haplotype HLA-DQ7 in Celiac Disease Patients from South Italy: Retrospective Evaluation of 5,535 Subjects at Risk of Celiac Disease	PLOS ONE			English	Article							HLA-DQ; PREVALENCE; DIAGNOSIS; GUIDELINES; SOCIETY	Background Celiac disease (CD) has a strong genetic component mainly due to HLA DQ2/DQ8 encoding genes. However, a minority of CD patients are DQ2/DQ8-negative. To address this issue, we retrospectively characterized HLA haplotypes in 5,535 subjects at risk of CD (either relatives of CD patients or subjects with CD-like symptoms) referred to our center during a 10-year period. Methods We identified loci DQA1/DQB1/DRB1 by sequence-specific oligonucleotide-PCR and sequence-specific primer-PCR; anti-transglutaminase IgA/IgG and anti-endomysium IgA by ELISA and indirect immunofluorescence, respectively. Results We diagnosed CD in 666/5,535 individuals, 4.2% of whom were DQ2/DQ8-negative. Interestingly, DQ7 was one of the most abundant haplotypes in all CD patients and significantly more frequent in DQ2/DQ8-negative (38%) than in DQ2/DQ8-positive CD patients (24%) (p<0.05). Conclusion Our data lend support to the concept that DQ7 represents an additive or independent CD risk haplotype with respect to DQ2/DQ8 haplotypes but this finding should be verified in other large CD populations.	[Tinto, Nadia; Cola, Arturo; Piscopo, Chiara; Capuano, Marina; Galatola, Martina] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Tinto, Nadia; Cola, Arturo; Piscopo, Chiara; Capuano, Marina; Sacchetti, Lucia] CEINGE Adv Biotechnol, Scarl, Naples, Italy; [Galatola, Martina; Greco, Luigi] Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Sacchetti, L (corresponding author), CEINGE Adv Biotechnol, Scarl, Naples, Italy.	sacchett@unina.it	capuano, marina/GLT-0659-2022		CEINGE Regione Campania [DGRC 1901/2009]; MIUR PON project [PON01_02589, PON02_00619_3461281]; POR Campania FSE, Project CREME	CEINGE Regione Campania; MIUR PON project(Ministry of Education, Universities and Research (MIUR)); POR Campania FSE, Project CREME	This work was supported by CEINGE Regione Campania (DGRC 1901/2009), MIUR PON 2007-2013 project PON01_02589 and MIUR PON 2007-2013 project PON02_00619_3461281, POR Campania FSE 2007-2013, Project CREME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergseng E, 2015, IMMUNOGENETICS, V67, P73, DOI 10.1007/s00251-014-0819-9; Bodd M, 2012, HUM IMMUNOL, V73, P376, DOI 10.1016/j.humimm.2012.01.016; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; DiGiacomo D, 2013, WORLD J GASTROENTERO, V19, P2507, DOI 10.3748/wjg.v19.i16.2507; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Fallang LE, 2009, NAT IMMUNOL, V10, P1096, DOI 10.1038/ni.1780; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Gujral N, 2012, WORLD J GASTROENTERO, V18, P6036, DOI 10.3748/wjg.v18.i42.6036; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Izzo V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026920; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Lionetti E, 2014, DIGEST LIVER DIS, V46, P1057, DOI 10.1016/j.dld.2014.08.002; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Megiorni F, 2009, HUM IMMUNOL, V70, P55, DOI 10.1016/j.humimm.2008.10.018; Megiorni F, 2008, AM J GASTROENTEROL, V103, P997, DOI 10.1111/j.1572-0241.2007.01716.x; Mooney PD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1561; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Tinto N, 2008, DIGEST LIVER DIS, V40, P248, DOI 10.1016/j.dld.2007.11.028; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998	21	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138324	10.1371/journal.pone.0138324	http://dx.doi.org/10.1371/journal.pone.0138324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398634	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500059
J	Zhang, ZY; Abdel-Razek, O; Hawgood, S; Wang, GR				Zhang, Zhiyong; Abdel-Razek, Osama; Hawgood, Samuel; Wang, Guirong			Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA KERATITIS; GRAM-POSITIVE BACTERIA; EPITHELIAL-CELLS; STAPHOPAIN-B; HOST-DEFENSE; SP-A; PULMONARY COLLECTINS; CORNEAL INFLAMMATION; LIPOTEICHOIC ACID; NEGATIVE BACTERIA	Staphylococcus aureus is one of the most common pathogens causing keratitis. Surfactant protein D (SP-D) plays a critical role in host defense and innate immunity. In order to investigate the role of SP-D in ocular S. aureus infection, the eyes of wild-type (WT) and SP-D knockout (SP-D KO) C57BL/6 mice were infected with S. aureus (10(7) CFU/eye) in the presence and absence of cysteine protease inhibitor(E-64). Bacterial counts in the ocular surface were examined 3, 6, 12, 24 hrs after infection. Bacterial phagocytosis by neutrophils and bacterial invasion in ocular epithelial cells were evaluated quantitatively. S. aureus-induced ocular injury was determined with corneal fluorescein staining. The results demonstrated that SP-D is expressed in ocular surface epithelium and the lacrimal gland; WT mice had increased clearance of S. aureus from the ocular surface (p<0.05) and reduced ocular injury compared with SP-D KO mice. The protective effects of SP-D include increased bacterial phagocytosis by neutrophils (p<0.05) and decreased bacterial invasion into epithelial cells (p<0.05) in WT mice compared to in SP-D KO mice. In the presence of inhibitor (E-64), WT mice showed enhanced bacterial clearance (p<0.05) and reduced ocular injury compared to absent E-64 while SP-D KO mice did not. Collectively, we concluded that SP-D protects the ocular surface from S. aureus infection but cysteine protease impairs SP-D function in this murine model, and that cysteine protease inhibitor may be a potential therapeutic agent in S. aureus keratitis.	[Zhang, Zhiyong; Abdel-Razek, Osama; Wang, Guirong] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Zhang, Zhiyong] Zhejiang Hosp, Zhejiang Med Coll, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China; [Hawgood, Samuel] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Hawgood, Samuel] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, GR (corresponding author), SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA.	wangg@upstate.edu			Zhejiang Natural Science Foundation Grant [LY14H120005]; Foundation of Zhejiang Educational Committee Grant [Y201122457]; Zhejiang Science and Technology Department Program Grant [2012C33016];  [NIH HL096007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096007] Funding Source: NIH RePORTER	Zhejiang Natural Science Foundation Grant; Foundation of Zhejiang Educational Committee Grant; Zhejiang Science and Technology Department Program Grant; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH HL096007; Zhejiang Natural Science Foundation Grant (No. LY14H120005); The Foundation of Zhejiang Educational Committee Grant (No. Y201122457); Zhejiang Science and Technology Department Program Grant (No. 2012C33016).	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Atochina EN, 2004, J INFECT DIS, V189, P1528, DOI 10.1086/383130; Awasthi S, 2001, AM J RESP CRIT CARE, V163, P389, DOI 10.1164/ajrccm.163.2.2004168; Botas C, 1998, P NATL ACAD SCI USA, V95, P11869, DOI 10.1073/pnas.95.20.11869; Bourbon JR, 2001, COMP BIOCHEM PHYS A, V129, P151, DOI 10.1016/S1095-6433(01)00312-9; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Floyd AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050704; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Gipson IK, 2007, INVEST OPHTH VIS SCI, V48, P4391, DOI 10.1167/iovs.07-0770; Girgis DO, 2003, INVEST OPHTH VIS SCI, V44, P1591, DOI 10.1167/iovs.02-0656; Haynes RJ, 1998, LANCET, V352, P451, DOI 10.1016/S0140-6736(05)79185-6; Heimer SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065797; Hogenkamp A, 2007, MOL IMMUNOL, V44, P3517, DOI 10.1016/j.molimm.2007.03.013; Hu F, 2012, CLIN EXP IMMUNOL, V167, P514, DOI 10.1111/j.1365-2249.2011.04521.x; Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x; Hume EBH, 2001, INVEST OPHTH VIS SCI, V42, P2904; Kantyka T, 2013, J INNATE IMMUN, V5, P251, DOI 10.1159/000345417; Kantyka T, 2011, ADV EXP MED BIOL, V712, P1, DOI 10.1007/978-1-4419-8414-2_1; Kingma PS, 2010, J PEDIATR-US, V156, P349, DOI 10.1016/j.jpeds.2009.11.040; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kishore U, 2005, ARCH IMMUNOL THER EX, V53, P399; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948; Lee HS, 2012, INVEST OPHTH VIS SCI, V53, P5632, DOI 10.1167/iovs.12-9547; Lemp Michael A., 1995, CLAO Journal, V21, P221; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Liu FL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-88; Liu J, 2015, SHOCK, V43, P31, DOI 10.1097/SHK.0000000000000270; Lo KYS, 2013, J MICROBIOL METH, V93, P153, DOI 10.1016/j.mimet.2013.03.004; Machida Y, 2011, J VET DIAGN INVEST, V23, P840, DOI 10.1177/1040638711407901; Malloy JL, 2005, AM J PHYSIOL-LUNG C, V288, pL409, DOI 10.1152/ajplung.00322.2004; Masinick SA, 1997, INVEST OPHTH VIS SCI, V38, P910; McCormack FX, 2006, RESPIROLOGY, V11, pS7, DOI 10.1111/j.1440-1843.2006.00798.x; McCormick CC, 2007, OCUL IMMUNOL INFLAMM, V15, P371, DOI 10.1080/09273940701486423; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Movahedan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069113; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; POTEMPA J, 1988, J BIOL CHEM, V263, P2664; Ricciuto J, 2008, INFECT IMMUN, V76, P5215, DOI 10.1128/IAI.00708-08; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Simons AL, 2013, LAB INVEST, V93, P711, DOI 10.1038/labinvest.2013.62; Sloop GD, 1999, INVEST OPHTH VIS SCI, V40, P385; Smagur J, 2009, BIOL CHEM, V390, P361, DOI 10.1515/BC.2009.042; Smagur J, 2009, J INNATE IMMUN, V1, P98, DOI 10.1159/000181014; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; SUTCLIFFE IC, 1991, J BACTERIOL, V173, P7065, DOI 10.1128/jb.173.22.7065-7069.1991; Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/ERI.11.136, 10.1586/eri.11.136]; Thakur A, 2002, INFECT IMMUN, V70, P2187, DOI 10.1128/IAI.70.4.2187-2197.2002; van de Wetering JK, 2001, J INFECT DIS, V184, P1143, DOI 10.1086/323746; Wang GR, 2010, J BIOL CHEM, V285, P11998, DOI 10.1074/jbc.M109.046243; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yi X, 2000, INVEST OPHTH VIS SCI, V41, P4093; Zhu L, 2012, MOL VIS, V18, P1803	61	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138597	10.1371/journal.pone.0138597	http://dx.doi.org/10.1371/journal.pone.0138597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398197	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500082
J	Daou, S; Hammond-Martel, I; Mashtalir, N; Barbour, H; Gagnon, J; Iannantuono, NVG; Nkwe, NS; Motorina, A; Pak, H; Yu, H; Wurtele, H; Milot, E; Mallette, FA; Carbone, M; Affar, E				Daou, Salima; Hammond-Martel, Ian; Mashtalir, Nazar; Barbour, Haithem; Gagnon, Jessica; Iannantuono, Nicholas V. G.; Nkwe, Nadine Sen; Motorina, Alena; Pak, Helen; Yu, Helen; Wurtele, Hugo; Milot, Eric; Mallette, Frederick A.; Carbone, Michele; Affar, El Bachir			The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell proliferation; cellular senescence; deubiquitylation (deubiquitination); epigenetics; ASXL; BAP1; Calypso; histone H2A ubiquitination; Polycomb Group Proteins	GERMLINE BAP1 MUTATIONS; TUMOR-SUPPRESSOR BAP1; ADDITIONAL-SEX-COMBS; STRAND BREAK REPAIR; BRCA1-ASSOCIATED PROTEIN-1; MYELOID TRANSFORMATION; UBIQUITIN HYDROLASE; ASXL1 MUTATIONS; UVEAL MELANOMA; TARGET GENES	The deubiquitinase (DUB) and tumor suppressor BAP1 catalyzes ubiquitin removal from histone H2A Lys-119 and coordinates cell proliferation, but how BAP1 partners modulate its function remains poorly understood. Here, we report that BAP1 forms two mutually exclusive complexes with the transcriptional regulators ASXL1 and ASXL2, which are necessary for maintaining proper protein levels of this DUB. Conversely, BAP1 is essential for maintaining ASXL2, but not ASXL1, protein stability. Notably, cancer-associated loss of BAP1 expression results in ASXL2 destabilization and hence loss of its function. ASXL1 and ASXL2 use their ASXM domains to interact with the C-terminal domain (CTD) of BAP1, and these interactions are required for ubiquitin binding and H2A deubiquitination. The deubiquitination-promoting effect of ASXM requires intramolecular interactions between catalytic and non-catalytic domains of BAP1, which generate a composite ubiquitin-binding interface (CUBI). Notably, the CUBI engages multiple interactions with ubiquitin involving (i) the ubiquitin carboxyl hydrolase catalytic domain of BAP1, which interacts with the hydrophobic patch of ubiquitin, and (ii) the CTD domain, which interacts with a charged patch of ubiquitin. Significantly, we identified cancer-associated mutations of BAP1 that disrupt the CUBI and notably an in-frame deletion in the CTD that inhibits its interaction with ASXL1/2 and DUB activity and deregulates cell proliferation. Moreover, we demonstrated that BAP1 interaction with ASXL2 regulates cell senescence and that ASXL2 cancer-associated mutations disrupt BAP1 DUB activity. Thus, inactivation of the BAP1/ASXL2 axis might contribute to cancer development.	[Daou, Salima; Hammond-Martel, Ian; Mashtalir, Nazar; Barbour, Haithem; Gagnon, Jessica; Iannantuono, Nicholas V. G.; Nkwe, Nadine Sen; Motorina, Alena; Pak, Helen; Yu, Helen; Wurtele, Hugo; Milot, Eric; Mallette, Frederick A.; Affar, El Bachir] Univ Montreal, Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Daou, Salima; Hammond-Martel, Ian; Mashtalir, Nazar; Barbour, Haithem; Gagnon, Jessica; Iannantuono, Nicholas V. G.; Nkwe, Nadine Sen; Motorina, Alena; Pak, Helen; Yu, Helen; Wurtele, Hugo; Milot, Eric; Mallette, Frederick A.; Affar, El Bachir] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Carbone, Michele] Univ Hawaii Canc Ctr, Thorac Oncol Program, Honolulu, HI 96813 USA	Universite de Montreal; Universite de Montreal; Cancer Research Center of Hawaii	Affar, E (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada.	aelbachir.hmr@ssss.gouv.qc.ca	Mallette, Frédérick A./J-6646-2019	Mallette, Frédérick A./0000-0001-7932-0338; BARBOUR, Haithem/0000-0002-4373-3728	Canadian Institutes of Health Research [MOP-115132, MOP-133442]; Natural Sciences and Engineering Research Council of Canada [355814-2010]; Islamic Development Bank; Ministry of Higher Education; Scientific Research of Tunisia; Cole Foundation; Fonds de la Recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Islamic Development Bank(Islamic Development Bank); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Scientific Research of Tunisia; Cole Foundation; Fonds de la Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP-115132, Natural Sciences and Engineering Research Council of Canada Grant 355814-2010 (to E.B.A.), and Canadian Institutes of Health Research Grant MOP-133442 (to F.A.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. scholarship from the Islamic Development Bank.; Recipient of a Ph.D. scholarship from the Ministry of Higher Education and from Scientific Research of Tunisia and the Cole Foundation.; Recipient of an M.Sc. scholarship from the Fonds de la Recherche du Quebec-Sante.; Recipient of a Ph.D. scholarship from the Canadian Institutes of Health Research Grant.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Balasubramani A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8307; Belle JI, 2014, INT J BIOCHEM CELL B, V50, P161, DOI 10.1016/j.biocel.2014.03.004; Bosch A, 2014, ONCOTARGET, V5, P2065, DOI 10.18632/oncotarget.1779; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Eletr ZM, 2013, FEBS LETT, V587, P3906, DOI 10.1016/j.febslet.2013.10.035; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Gildea JJ, 2000, GENETICS, V156, P645; Goldstein AM, 2011, NAT GENET, V43, P925, DOI 10.1038/ng.956; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Hammond-Martel I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014027; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ismail IH, 2014, CANCER RES, V74, P4282, DOI 10.1158/0008-5472.CAN-13-3109; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ji ZL, 2014, NUCLEIC ACIDS RES, V42, P6232, DOI 10.1093/nar/gku274; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6128; Lee JW, 2007, CANCER LETT, V257, P252, DOI 10.1016/j.canlet.2007.08.004; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Morrow ME, 2013, BIOCHEMISTRY-US, V52, P3564, DOI 10.1021/bi4003106; Murali R, 2013, PATHOLOGY, V45, P1, DOI 10.1097/PAT.0b013e32835af69c; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Okino Y, 2015, J BIOL CHEM, V290, P1580, DOI 10.1074/jbc.M114.609834; Pan H, 2015, INT J BIOCHEM CELL B, V60, P176, DOI 10.1016/j.biocel.2015.01.001; Park UH, 2011, J BIOL CHEM, V286, P1354, DOI 10.1074/jbc.M110.177816; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sanchez-Pulido L, 2012, BIOINFORMATICS, V28, P1953, DOI 10.1093/bioinformatics/bts319; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu F, 2011, ANN HEMATOL, V90, P643, DOI 10.1007/s00277-010-1128-5; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yu H, 2014, P NATL ACAD SCI USA, V111, P285, DOI 10.1073/pnas.1309085110; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	65	71	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28643	28663		10.1074/jbc.M115.661553	http://dx.doi.org/10.1074/jbc.M115.661553			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26416890	Green Published, hybrid			2022-12-26	WOS:000365762300007
J	De, S; Bubnys, A; Alonzo, F; Hyun, J; Lary, JW; Cole, JL; Torres, VJ; Olson, R				De, Swastik; Bubnys, Adele; Alonzo, Francis, III; Hyun, Jinsol; Lary, Jeffrey W.; Cole, James L.; Torres, Victor J.; Olson, Rich			The Relationship between Glycan Binding and Direct Membrane Interactions in Vibrio cholerae Cytolysin, a Channel-forming Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMATION-MECHANISM; HEPTAMERIC TRANSMEMBRANE PORE; PANTON-VALENTINE LEUKOCIDIN; HUMAN C5A RECEPTORS; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ALPHA-TOXIN; EL-TOR; CONFORMATIONAL-CHANGES; PERFRINGOLYSIN-O	Bacterial pore-forming toxins (PFTs) are structurally diverse pathogen-secreted proteins that form cell-damaging channels in the membranes of host cells. Most PFTs are released as watersoluble monomers that first oligomerize on the membrane before inserting a transmembrane channel. To modulate specificity and increase potency, many PFTs recognize specific cell surface receptors that increase the local toxin concentration on cell membranes, thereby facilitating channel formation. Vibrio cholerae cytolysin (VCC) is a toxin secreted by the human pathogen responsible for pandemic cholera disease and acts as a defensive agent against the host immune system. Although it has been shown that VCC utilizes specific glycan receptors on the cell surface, additional direct contacts with the membrane must also play a role in toxin binding. To better understand the nature of these interactions, we conducted a systematic investigation of the membrane-binding surface of VCC to identify additional membrane interactions important in cell targeting. Through cell-based assays on several human-derived cell lines, we show that VC( is unlikely to utilize high affinity protein receptors as do structurally similar toxins from Staphylococcus aureus. Next, we identified a number of specific amino acid residues that greatly diminish the VCC potency against cells and investigated the interplay between glycan binding and these direct lipid contacts. Finally, we used model membranes to parse the importance of these key residues in lipid and cholesterol binding. Our study provides a complete functional map of the VCC membrane-binding surface and insights into the integration of sugar, lipid, and cholesterol binding interactions.	[De, Swastik; Bubnys, Adele; Hyun, Jinsol; Olson, Rich] Wesleyan Univ, Dept Mol Biol & Biochem, Mol Biophys Program, Middletown, CT 06459 USA; [Alonzo, Francis, III; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Lary, Jeffrey W.; Cole, James L.] Univ Connecticut, Biotechnol Bioserv Ctr, Storrs, CT 06269 USA; [Cole, James L.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Cole, James L.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	Wesleyan University; New York University; University of Connecticut; University of Connecticut; University of Connecticut	Olson, R (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, 52 Lawn Ave, Middletown, CT 06459 USA.	rolson@wesleyan.edu	De, Swastik/X-4996-2019	Torres, Victor/0000-0002-7126-0489; De, Swastik/0000-0002-9302-724X	NIAID, National Institutes of Health [R15 AI101977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008271] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health Grant R15 AI101977. The authors declare that they have no conflicts of interest with the contents of this article.	Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Braman J, 1996, Methods Mol Biol, V57, P31; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; DuMont AL, 2013, INFECT IMMUN, V81, P1830, DOI 10.1128/IAI.00095-13; Epand RM, 2010, SUBCELL BIOCHEM, V51, P253, DOI 10.1007/978-90-481-8622-8_9; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Howlader MTH, 2010, APPL ENVIRON MICROB, V76, P860, DOI 10.1128/AEM.02175-09; Kaus K, 2014, J MOL BIOL, V426, P2800, DOI 10.1016/j.jmb.2014.05.021; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laventie BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092094; Levan S, 2013, J MOL BIOL, V425, P944, DOI 10.1016/j.jmb.2012.12.016; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; Rai AK, 2015, MOL MICROBIOL, V97, P1051, DOI 10.1111/mmi.13084; Rai AK, 2013, J BIOL CHEM, V288, P1665, DOI 10.1074/jbc.M112.430181; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Schwiering M, 2013, BBA-BIOMEMBRANES, V1828, P1962, DOI 10.1016/j.bbamem.2013.04.005; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaan AN, 2015, J IMMUNOL, V195, P1034, DOI 10.4049/jimmunol.1500604; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Sutton-Smith M, 2007, GLYCOBIOLOGY, V17, P553, DOI 10.1093/glycob/cwm025; Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 2000, BBA-BIOMEMBRANES, V1509, P264, DOI 10.1016/S0005-2736(00)00303-5	51	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28402	28415		10.1074/jbc.M115.675967	http://dx.doi.org/10.1074/jbc.M115.675967			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26416894	Green Published, hybrid			2022-12-26	WOS:000365761900034
J	Torres-Climent, A; Gomis, P; Martin-Mata, J; Bustamante, MA; Marhuenda-Egea, FC; Perez-Murcia, MD; Perez-Espinosa, A; Paredes, C; Moral, R				Torres-Climent, A.; Gomis, P.; Martin-Mata, J.; Bustamante, M. A.; Marhuenda-Egea, F. C.; Perez-Murcia, M. D.; Perez-Espinosa, A.; Paredes, C.; Moral, R.			Chemical, Thermal and Spectroscopic Methods to Assess Biodegradation of Winery-Distillery Wastes during Composting	PLOS ONE			English	Article							STATE C-13 NMR; FT-IR SPECTROSCOPY; ORGANIC-MATTER; BIOLOGICAL STABILITY; BY-PRODUCTS; GRAPE MARC; EVOLUTION; RESIDUES; NITROGEN; CARBON	The objective of this work was to study the co-composting process of wastes from the winery and distillery industry with animal manures, using the classical chemical methods traditionally used in composting studies together with advanced instrumental methods (thermal analysis, FT-IR and CPMAS C-13 NMR techniques), to evaluate the development of the process and the quality of the end-products obtained. For this, three piles were elaborated by the turning composting system, using as raw materials winery-distillery wastes (grape marc and exhausted grape marc) and animal manures (cattle manure and poultry manure). The classical analytical methods showed a suitable development of the process in all the piles, but these techniques were ineffective to study the humification process during the composting of this type of materials. However, their combination with the advanced instrumental techniques clearly provided more information regarding the turnover of the organic matter pools during the composting process of these materials. Thermal analysis allowed to estimate the degradability of the remaining material and to assess qualitatively the rate of OM stabilization and recalcitrant C in the compost samples, based on the energy required to achieve the same mass losses. FT-IR spectra mainly showed variations between piles and time of sampling in the bands associated to complex organic compounds (mainly at 1420 and 1540 cm(-1)) and to nitrate and inorganic components (at 875 and 1384 cm(-1), respectively), indicating composted material stability and maturity; while CPMAS C-13 NMR provided semi-quantitatively partition of C compounds and structures during the process, being especially interesting their variation to evaluate the biotransformation of each C pool, especially in the comparison of recalcitrant C vs labile C pools, such as Alkyl /O-Alkyl ratio.	[Torres-Climent, A.; Gomis, P.; Martin-Mata, J.; Bustamante, M. A.; Perez-Murcia, M. D.; Perez-Espinosa, A.; Paredes, C.; Moral, R.] Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain; [Marhuenda-Egea, F. C.] Univ Alicante, Dept Agrochem & Biochem, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat d'Alacant	Bustamante, MA (corresponding author), Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain.	marian.bustamante@umh.es	Perez Espinosa, Aurelia/ABC-4951-2021; murcia, perez MD/O-9753-2014; Paredes, Concepcion/C-9325-2012; Marhuenda-Egea, Frutos C/B-3412-2018; Bustamante, Maria Angeles/ABF-3793-2020; Bustamante, Maria Angeles/H-9171-2013; Torres-Climent, Angel/K-7875-2017; Moral, Raul/C-7473-2009	Perez Espinosa, Aurelia/0000-0003-2881-3073; murcia, perez MD/0000-0003-0722-9599; Marhuenda-Egea, Frutos C/0000-0002-0402-9770; Bustamante, Maria Angeles/0000-0001-9931-1711; Bustamante, Maria Angeles/0000-0001-9931-1711; Torres-Climent, Angel/0000-0002-4347-9707; Moral, Raul/0000-0002-4881-480X; Marhuenda-Egea, Frutos/0000-0002-7457-1805; Paredes, Concepcion/0000-0002-9735-5099	Spanish Ministry of Economy and Competitiveness (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+i)); EU [PTQ-12-05655]	Spanish Ministry of Economy and Competitiveness (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+i)); EU(European Commission)	This work was supported by a contract to MABM, Spanish Ministry of Economy and Competitiveness (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+i) 2008-2011), co-funded by the EU through the Social Funds (contract reference PTQ-12-05655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2015, TALANTA, V134, P453, DOI 10.1016/j.talanta.2014.11.056; Ali M, 2012, BIODEGRADATION, V23, P231, DOI 10.1007/s10532-011-9502-0; Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; Arvanitoyannis IS, 2006, INT J FOOD SCI TECH, V41, P475, DOI 10.1111/j.1365-2621.2005.01111.x; Baffi C, 2007, SOIL BIOL BIOCHEM, V39, P1284, DOI 10.1016/j.soilbio.2006.12.004; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bernal MP, 1996, BIOL FERT SOILS, V22, P141, DOI 10.1007/BF00384446; Bustamante MA, 2008, CHEMOSPHERE, V72, P551, DOI 10.1016/j.chemosphere.2008.03.030; Bustamante MA, 2008, WASTE MANAGE, V28, P372, DOI 10.1016/j.wasman.2007.01.013; Bustamante MA, 2007, WATER SCI TECHNOL, V56, P187, DOI 10.2166/wst.2007.488; Bustamante MA, 2013, J CLEAN PROD, V47, P61, DOI 10.1016/j.jclepro.2012.07.018; Bustamante MA, 2012, BIOMASS BIOENERG, V43, P26, DOI 10.1016/j.biombioe.2012.04.010; Bustamante MA, 2010, BIORESOURCE TECHNOL, V101, P4068, DOI 10.1016/j.biortech.2010.01.085; Caricasole P, 2011, WASTE MANAGE, V31, P411, DOI 10.1016/j.wasman.2010.09.020; Castaldi P, 2005, WASTE MANAGE, V25, P209, DOI 10.1016/j.wasman.2004.12.011; Chen YN, 2003, COMPOST SCI UTIL, V11, P152; Dell'Abate MT, 2000, J THERM ANAL CALORIM, V61, P389, DOI 10.1023/A:1010157115211; EC. European Commission, BIOL TREATM IN PRESS; El Ouaqoudi FZ, 2015, ECOL ENG, V75, P217, DOI 10.1016/j.ecoleng.2014.12.004; El Ouaqoudi FZ, 2014, COMPOST SCI UTIL, V22, P188, DOI 10.1080/1065657X.2014.910148; Fernandez FJ, 2008, CHEMOSPHERE, V73, P670, DOI 10.1016/j.chemosphere.2008.07.007; Fernandez JM, 2012, WASTE MANAGE, V32, P158, DOI 10.1016/j.wasman.2011.08.011; Fialho LL, 2010, BIORESOURCE TECHNOL, V101, P1927, DOI 10.1016/j.biortech.2009.10.039; Friedman M, 2014, J AGR FOOD CHEM, V62, P6025, DOI 10.1021/jf501266s; Gomez X, 2007, CHEMOSPHERE, V68, P1889, DOI 10.1016/j.chemosphere.2007.02.065; Haberhauer G, 1998, GEODERMA, V83, P331, DOI 10.1016/S0016-7061(98)00008-1; Hogg D, 2002, COMP COMPOST STANDAR; Keeler C, 2006, GEODERMA, V130, P124, DOI 10.1016/j.geoderma.2005.01.015; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Marhuenda-Egea FC, 2007, CHEMOSPHERE, V68, P301, DOI 10.1016/j.chemosphere.2006.12.075; Martinez-Sabater E, 2009, J AGR FOOD CHEM, V57, P9613, DOI 10.1021/jf901027v; Mathers NJ, 2003, FOREST ECOL MANAG, V175, P467, DOI 10.1016/S0378-1127(02)00182-2; Moldes AB, 2007, APPL BIOCHEM BIOTECH, V141, P27, DOI 10.1007/s12010-007-9208-2; Nelson PN, 2005, BIOGEOCHEMISTRY, V72, P1, DOI 10.1007/s10533-004-0076-3; OIV, OIVS ASS WORLD VIT S; Paradelo R, 2013, J ENVIRON MANAGE, V116, P18, DOI 10.1016/j.jenvman.2012.12.001; Paredes C, 2000, BIOL FERT SOILS, V32, P222, DOI 10.1007/s003740000239; Ranalli G, 2001, J ENVIRON SCI HEAL A, V36, P415, DOI 10.1081/ESE-100103473; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Smernik RJ, 2000, GEODERMA, V96, P159, DOI 10.1016/S0016-7061(00)00007-0; Smidt E, 2002, APPL SPECTROSC, V56, P1170, DOI 10.1366/000370202760295412; Smidt E, 2005, BIODEGRADATION, V16, P67, DOI 10.1007/s10531-004-0430-8; Smidt E, 2005, THERMOCHIM ACTA, V438, P22, DOI 10.1016/j.tca.2005.08.013; Stevenson FJ, 1982, HUMUS CHEM; Wilson M. A., 1987, NMR TECHNIQUES APPL; Zbytniewski R, 2005, BIORESOURCE TECHNOL, V96, P471, DOI 10.1016/j.biortech.2004.05.018; ZUCCONI F, 1981, BIOCYCLE, V22, P54	48	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138925	10.1371/journal.pone.0138925	http://dx.doi.org/10.1371/journal.pone.0138925			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418458	Green Published, gold			2022-12-26	WOS:000362171400026
J	Ayoub, I; Oh, MS; Gupta, R; McFarlane, M; Babinska, A; Salifu, MO				Ayoub, Isabelle; Oh, Man S.; Gupta, Raavi; McFarlane, Michael; Babinska, Anna; Salifu, Moro O.			Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats	PLOS ONE			English	Article							INTESTINAL NECROSIS; KAYEXALATE; PERFORATION	Introduction Based on a single rat study by Lillemoe et al, the consensus has been formed to implicate sorbitol rather than sodium polystyrene sulfonate (SPS) as the culprit for colon necrosis in humans treated with SPS and sorbitol. We tested the hypothesis that colon necrosis by sorbitol in the experiment was due to the high osmolality and volume of sorbitol rather than its chemical nature. Methods 26 rats underwent 5/6 nephrectomy. They were divided into 6 groups and given enema solutions under anesthesia (normal saline, 33% sorbitol, 33% mannitol, SPS in 33% sorbitol, SPS in normal saline, and SPS in distilled water). They were sacrificed after 48 hours of enema administration or earlier if they were very sick. The gross appearance of the colon was visually inspected, and then sliced colon tissues were examined under light microscopy. Results 1 rat from the sorbitol and 1 from the mannitol group had foci of ischemic colonic changes. The rats receiving SPS enema, in sorbitol, normal saline, distilled water, had crystal deposition with colonic necrosis and mucosal erosion. All the rats not given SPS survived until sacrificed at 48 h whereas 11 of 13 rats that received SPS in sorbitol, normal saline or distilled water died or were clearly dying and sacrificed sooner. There was no difference between sorbitol and mannitol when given without SPS. Conclusions In a surgical uremic rat model, SPS enema given alone or with sorbitol or mannitol seemed to cause colon necrosis and high mortality rate, whereas 33% sorbitol without SPS did not.	[Ayoub, Isabelle; Oh, Man S.; McFarlane, Michael; Babinska, Anna; Salifu, Moro O.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Ayoub, Isabelle] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Gupta, Raavi] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Salifu, MO (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.	moro.salifu@downstate.edu						Abraham SC, 2001, AM J SURG PATHOL, V25, P637, DOI 10.1097/00000478-200105000-00011; Akagun T, 2011, CLIN KIDNEY J, V4, P402, DOI 10.1093/ndtplus/sfr113; ARVANITAKIS C, 1973, GASTROENTEROLOGY, V64, P533; Cheng ES, 2002, BURNS, V28, P189, DOI 10.1016/S0305-4179(01)00099-7; Dardik A, 2000, SOUTH MED J, V93, P511; Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761; Gardiner GW, 1997, CAN J GASTROENTEROL, V11, P573, DOI 10.1155/1997/370814; GERSTMAN BB, 1992, AM J KIDNEY DIS, V20, P159, DOI 10.1016/S0272-6386(12)80544-0; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; Kao CC, 2013, J FORMOS MED ASS; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; LILLEMOE KD, 1987, SURGERY, V101, P267; McGowan CE, 2009, SOUTH MED J, V102, P493, DOI 10.1097/SMJ.0b013e31819e8978; Shioya Takeshi, 2007, Journal of Nippon Medical School, V74, P359, DOI 10.1272/jnms.74.359; Thomas A, 2009, AM J MED SCI, V337, P305, DOI 10.1097/MAJ.0b013e31818dd715; THOROUGHMAN J C, 1959, Am Surg, V25, P533; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG463, DOI 10.1152/ajpgi.2000.279.2.G463	17	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137636	10.1371/journal.pone.0137636	http://dx.doi.org/10.1371/journal.pone.0137636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413782	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700010
J	Johnston, SC; Lin, KL; Twenhafel, NA; Raymond, JLW; Shamblin, JD; Wollen, SE; Wlazlowski, CB; Wilkinson, ER; Botto, MA; Goff, AJ				Johnston, Sara C.; Lin, Kenny L.; Twenhafel, Nancy A.; Raymond, Jo Lynne W.; Shamblin, Joshua D.; Wollen, Suzanne E.; Wlazlowski, Carly B.; Wilkinson, Eric R.; Botto, Miriam A.; Goff, Arthur J.			Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure	PLOS ONE			English	Article							MARBURG-VIRUS-DISEASE; HEMORRHAGIC-FEVER; ANGOLA INFECTION; PATHOGENESIS; OUTBREAK	Marburg virus infection in humans causes a hemorrhagic disease with a high case fatality rate. Countermeasure development requires the use of well-characterized animal models that mimic human disease. To further characterize the cynomolgus macaque model of MARV/Angola, two independent dose response studies were performed using the intramuscular or aerosol routes of exposure. All animals succumbed at the lowest target dose; therefore, a dose effect could not be determined. For intramuscular-exposed animals, 100 PFU was the first target dose that was not significantly different than higher target doses in terms of time to disposition, clinical pathology, and histopathology. Although a significant difference was not observed between aerosol-exposed animals in the 10 PFU and 100 PFU target dose groups, 100 PFU was determined to be the lowest target dose that could be consistently obtained and accurately titrated in aerosol studies.	[Johnston, Sara C.; Shamblin, Joshua D.; Wollen, Suzanne E.; Wlazlowski, Carly B.; Wilkinson, Eric R.; Botto, Miriam A.; Goff, Arthur J.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Lin, Kenny L.] US Army, Med Res Inst Infect Dis, Nonclin Dev Div, Ft Detrick, MD 21702 USA; [Twenhafel, Nancy A.; Raymond, Jo Lynne W.] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA		Johnston, SC (corresponding author), US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	sara.c.johnston2.ctr@mail.mil	Twenhafel, Nancy/Z-1522-2019	Wollen-Roberts, Suzanne/0000-0002-9409-2756	Translational Medical Technologies; Joint Science and Technology Office for Chemical and Biological Defense	Translational Medical Technologies; Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Translational Medical Technologies and the Joint Science and Technology Office for Chemical and Biological Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves DA, 2010, VET PATHOL, V47, P831, DOI 10.1177/0300985810378597; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; Beer B, 1999, NATURWISSENSCHAFTEN, V86, P8, DOI 10.1007/s001140050562; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Bray M, 2002, ANTIVIR RES, V54, P1, DOI 10.1016/S0166-3542(02)00005-0; Colebunders R, 2007, J INFECT DIS, V196, pS148, DOI 10.1086/520543; Fauci AS, 2005, ACAD MED, V80, P1079, DOI 10.1097/00001888-200512000-00002; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; KILEY MP, 1988, J GEN VIROL, V69, P1957, DOI 10.1099/0022-1317-69-8-1957; Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P219, DOI 10.1053/j.spid.2005.05.001; Lin KL, 2015, J VIROL, V89, P9875, DOI 10.1128/JVI.01147-15; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Martini G A, 1968, Ger Med Mon, V13, P457; Sanchez A, 2007, FIELDS VIROLOGY, V1, P1409; Slenczka WG, 1999, CURR TOP MICROBIOL, V235, P49; SMITH DH, 1982, LANCET, V1, P816	18	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138843	10.1371/journal.pone.0138843	http://dx.doi.org/10.1371/journal.pone.0138843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413900	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700024
J	Brunjes, PC; Osterberg, SK				Brunjes, Peter C.; Osterberg, Stephen K.			Developmental Markers Expressed in Neocortical Layers Are Differentially Exhibited in Olfactory Cortex	PLOS ONE			English	Article							INTERMEDIATE PROGENITOR CELLS; COMMISSURAL FIBER SYSTEMS; POSTMITOTIC NEURONS; PIRIFORM CORTEX; LAMINAR FATE; RAT; EVOLUTION; DOPAMINE; NUCLEUS; GENES	Neurons in the cerebral cortex stratify on the basis of their time of origin, axonal terminations and the molecular identities assigned during early development. Olfactory cortices share many feature with the neocortex, including clear lamination and similar cell types. The present study demonstrates that the markers differentially expressed in the projection neurons of the cerebral cortex are also found in olfactory areas. Three of the four regions examined (pars principalis of the anterior olfactory nucleus: AONpP, anterior and posterior piriform cortices: APC, PPC, and the olfactory tubercle) expressed transcription factors found in deep or superficial neurons in the developing neocortex, though large differences were found between areas. For example, while the AONpP, APC and PPC all broadly expressed the deep cortical marker CTIP2, NOR1 (NR4a3) levels were higher in AONpP and DAARP32 was more prevalent in the APC and PPC. Similar findings were encountered for superficial cortical markers: all three regions broadly expressed CUX1, but CART was only observed in the APC and PPC. Furthermore, regional variations were observed even within single structures (e.g., NOR1 was found primarily in in the dorsal region of AONpP and CART expression was observed in a discrete band in the middle of layer 2 of both the APC and PPC). Experiments using the mitotic marker EDU verified that the olfactory cortices and neocortex share similar patterns of neuronal production: olfactory cells that express markers found in the deep neocortex are produced earlier than those that express superficial makers. Projection neurons were filled by retrograde tracers injected into the olfactory bulb to see if olfactory neurons with deep and superficial markers had different axonal targets. Unlike the cerebral cortex, no specificity was observed: neurons with each of the transcription factors examined were found to be labelled. Together the results indicate that olfactory cortices are complex: they differ from each other and each is formed from a variable mosaic of neurons. The results suggest that the olfactory cortices are not merely a remnant architype of the primordial forebrain but varied and independent regions.	[Brunjes, Peter C.; Osterberg, Stephen K.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	University of Virginia	Brunjes, PC (corresponding author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	brunjes@virginia.edu			National Institute for Deafness and Communicative Disorders of the National Institutes of Health [DC00338]	National Institute for Deafness and Communicative Disorders of the National Institutes of Health	Funded by grant DC00338 from the National Institute for Deafness and Communicative Disorders of the National Institutes of Health, http://www.nidcd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei S, 2011, NEUROSCIENCE, V287, P137; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BAYER SA, 1985, INT J DEV NEUROSCI, V3, P135, DOI 10.1016/0736-5748(85)90004-8; BAYER SA, 1986, INT J DEV NEUROSCI, V4, P225, DOI 10.1016/0736-5748(86)90062-6; BAYER SA, 1986, INT J DEV NEUROSCI, V4, P251, DOI 10.1016/0736-5748(86)90063-8; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bekkers JM, 2013, TRENDS NEUROSCI, V36, P429, DOI 10.1016/j.tins.2013.04.005; Blackstad T, 1976, THE NEURON, P49; Brox A, 2004, J COMP NEUROL, V474, P562, DOI 10.1002/cne.20152; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Brunjes PC, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00044; Brunjes PC, 2013, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00051; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Ceci ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044716; Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060; Dugas-Ford J, 2015, ANNU REV NEUROSCI, V38, P351, DOI 10.1146/annurev-neuro-071714-033911; Ekstrand JJ, 2001, J COMP NEUROL, V434, P289, DOI 10.1002/cne.1178; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Moreno FG, 2008, CEREB CORTEX, V18, P1239, DOI 10.1093/cercor/bhm154; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Heimer L, 1987, LIMBIC MECH, P95; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hoerder-Suabedissen A, 2013, CEREB CORTEX, V23, P1473, DOI 10.1093/cercor/bhs137; Huang ZJ, 2014, NEURON, V83, P1284, DOI 10.1016/j.neuron.2014.08.041; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Karten HJ, 2013, CURR BIOL, V23, pR12, DOI 10.1016/j.cub.2012.11.013; Kay RB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00111; KRIEGSTEIN AR, 1986, J NEUROSCI, V6, P178; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; Lodato S, 2015, TRENDS NEUROSCI, V38, P117, DOI 10.1016/j.tins.2014.11.003; Luzzati F, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00162; MacDonald JL, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: PATTERNING AND CELL TYPE SPECIFICATION IN THE DEVELOPING CNS AND PNS, P475, DOI 10.1016/B978-0-12-397265-1.00098-8; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Medina L, 2009, SEMIN CELL DEV BIOL, V20, P698, DOI 10.1016/j.semcdb.2009.04.008; MILLHOUSE OE, 1984, J COMP NEUROL, V228, P571, DOI 10.1002/cne.902280409; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; Molnar Z, 2002, BIOESSAYS, V24, P530, DOI 10.1002/bies.10100; Molnar Z, 2011, BRAIN BEHAV EVOLUT, V78, P94, DOI 10.1159/000327325; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mori K, 2004, OLFACTORY SYSTEM ODO, P1; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Nieuwenhuys R, 1998, CENTRAL NERVOUS SYST, V3, P1932; OUIMET CC, 1984, J NEUROSCI, V4, P111; Petrof I, 2012, J COMP NEUROL, V520, P1678, DOI 10.1002/cne.23006; Pigache R M, 1970, Ergeb Anat Entwicklungsgesch, V43, P3; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Root DH, 2015, PROG NEUROBIOL, V130, P29, DOI 10.1016/j.pneurobio.2015.03.005; Sarma AA, 2011, CEREB CORTEX, V21, P1231, DOI 10.1093/cercor/bhq199; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shepherd GM, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00030; Smith Y, 1999, J COMP NEUROL, V407, P491, DOI 10.1002/(SICI)1096-9861(19990517)407:4<491::AID-CNE3>3.0.CO;2-0; Striedter GF, 2005, PRINCIPLES BRAIN EVO, P259; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Takahashi T, 1999, J NEUROSCI, V19, P10357; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vasistha NA, 2015, CEREB CORTEX, V25, P3290, DOI 10.1093/cercor/bhu125; Vyas A, 2003, J COMP NEUROL, V466, P545, DOI 10.1002/cne.10900; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027	74	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138541	10.1371/journal.pone.0138541	http://dx.doi.org/10.1371/journal.pone.0138541			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407299	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700056
J	He, SL; Yang, LY; Li, DZ; Li, M				He, Shaolin; Yang, Liyuan; Li, Dazhu; Li, Ming			Kruppel-Like Factor 2-Mediated Suppression of MicroRNA-155 Reduces the Proinflammatory Activation of Macrophages	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ATHEROSCLEROSIS; EXPRESSION; KLF2; INHIBITION; MODELS; CELLS	Objective Recent evidence indicates that significant interactions exist between Kruppel-like factor 2 (KLF2) and microRNAs (miRNAs) in endothelial cells. Because KLF2 is known to exert anti-inflammatory effects and inhibit the pro-inflammatory activation of monocytes, we sought to identify how inflammation-associated miR-155 is regulated by KLF2 in macrophages. Approach and Results Peritoneal macrophages from wild-type (WT) C57Bl6 mice were transfected with either recombinant adenovirus vector expressing KLF2 (Ad-KLF2) or siRNA targeting KLF2 (KLF2-siRNA) for 24 h-48 h, then stimulated with oxidized low-density lipoproteins (ox-LDL, 50 mu g/mL) for 24 h. Quantitative real-time polymerase chain reaction showed that KLF2 markedly reduced the expression of miR-155 in quiescentox-LDL-stimulated macrophages. We also found that the increased expression of miR-155, monocyte chemoattractant protein (MCP-1) and interleukin (IL)-6 and the decreased expression of the suppressor of cytokine signaling (SOCS)-1 and IL-10 in ox-LDL-treated macrophages were significantly suppressed by KLF2. Most importantly, over-expression of miR-155 could partly reverse the suppressive effects of KLF2 on the inflammatory response of macrophages. Conversely, the suppression of miR-155 in KLF2 knockdown macrophages significantly overcame the pro-inflammatory properties associated with KLF2 knockdown. Finally, Ad-KLF2 significantly attenuated the diet-induced formation of atherosclerotic lesions in apolipoprotein E-deficient (apoE(-/-)) mice, which was associated with a significantly reduced expression of miR-155 and its relative inflammatory cytokine genes in the aortic arch and inmacrophages. Conclusion KLF2-mediated suppression of miR-155 reduced the inflammatory response of macrophages.	[He, Shaolin; Li, Dazhu; Li, Ming] Huazhong Univ Sci & Technol, Dept Cardiol, Inst Cardiovasc Dis, Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Liyuan] HuBei Univ Med, XiangYang Peoples Hosp 1, Dept Cardiol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine	Li, M (corresponding author), Huazhong Univ Sci & Technol, Dept Cardiol, Inst Cardiovasc Dis, Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China.	liming518888cn@163.com		li, ming/0000-0002-8934-1084	National Natural Science Foundation of China [81172781, 81500338]; Independent Innovation Foundation of Huazhong University of Science and Technology [0118530232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Huazhong University of Science and Technology	This work was supported by the National Natural Science Foundation of China to Dr. Ming Li (No. 81172781) and Dr. Shaolin He (No. 81500338). The Independent Innovation Foundation of Huazhong University of Science and Technology (No. 0118530232) to Dr. Shaolin He.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lin J, 2010, J LIPID RES, V51, P1208, DOI 10.1194/jlr.D000497; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Manoharan P, 2014, J BIOL CHEM, V289, P31638, DOI 10.1074/jbc.M114.579763; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Montgomery RL, 2010, CURR DRUG TARGETS, V11, P936; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tian FJ, 2014, CARDIOVASC RES, V103, P100, DOI 10.1093/cvr/cvu070; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Yang K, 2011, FEBS LETT, V585, P854, DOI 10.1016/j.febslet.2011.02.009; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Yu JC, 2013, NEUROL SCI, V34, P1283, DOI 10.1007/s10072-012-1228-1; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	36	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139060	10.1371/journal.pone.0139060	http://dx.doi.org/10.1371/journal.pone.0139060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406238	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700158
J	Rylance, J; Chimpini, C; Semple, S; Russell, DG; Jackson, MJ; Heyderman, RS; Gordon, SB				Rylance, Jamie; Chimpini, Chikondi; Semple, Sean; Russell, David G.; Jackson, Malcolm J.; Heyderman, Robert S.; Gordon, Stephen B.			Chronic Household Air Pollution Exposure Is Associated with Impaired Alveolar Macrophage Function in Malawian Non-Smokers	PLOS ONE			English	Article							NF-KAPPA-B; WOOD SMOKE; STREPTOCOCCUS-PNEUMONIAE; INFLAMMATORY RESPONSE; EPITHELIAL-CELLS; CIGARETTE-SMOKE; TNF-ALPHA; PULMONARY; ACTIVATION; PARTICLES	Background Household air pollution in low income countries is an important cause of mortality from respiratory infection. We hypothesised that chronic smoke exposure is detrimental to alveolar macrophage function, causing failure of innate immunity. We report the relationship between macrophage function and prior smoke exposure in healthy Malawians. Methods Healthy subjects exposed daily to cooking smoke at home volunteered for bronchoalveolar lavage. Alveolar macrophage particulate content was measured as a known correlate of smoke exposure. Phagocytosis and intraphagosomal function (oxidative burst and proteolysis) were measured by a flow cytometric assay. Cytokine responses in macrophages were compared following re-exposure in vitro to wood smoke, before and after glutathione depletion. Results Volunteers had a range of alveolar macrophage particulate loading. The macrophage capacity for phagosomal oxidative burst was negatively associated with alveolar macrophage particulate content (n = 29, r(2) = 0.16, p = 0.033), but phagocytosis per se and proteolytic function were unaffected. High particulate content was associated with lower baseline CXCL8 release (ratio 0.51, CI 0.29-0.89) and lower final concentrations on re-exposure to smoke in vitro (ratio 0.58, CI 0.34-0.97). Glutathione depletion augmented CXCL8 responses by 1.49x (CI 1.02-2.17) compared with wood smoke alone. This response was specific to smoke as macrophages response to LPS were not modulated by glutathione. Conclusion Chronic smoke exposure is associated with reduced human macrophage oxidative burst, and dampened inflammatory cytokine responses. These are critical processes in lung defence against infection and likely to underpin the relationship between air pollution and pneumonia.	[Rylance, Jamie; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Rylance, Jamie; Gordon, Stephen B.] Aintree Univ Hosp NHS Fdn Trust, Dept Resp Med, Ctr Clin Sci, Liverpool L9 7AL, Merseyside, England; [Rylance, Jamie; Chimpini, Chikondi; Heyderman, Robert S.; Gordon, Stephen B.] Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [Semple, Sean] Univ Aberdeen, Scottish Ctr Indoor Air, Div Appl Hlth Sci, Aberdeen AB9 1FX, Scotland; [Russell, David G.] Cornell Univ, Coll Vet Med, Microbiol & Immunol, Ithaca, NY 14853 USA; [Jackson, Malcolm J.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Liverpool; University of Aberdeen; Cornell University; University of Liverpool	Rylance, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	jamie.rylance@lstmed.ac.uk	Russell, David G/N-5280-2019; Rylance, Jamie/ABD-9314-2021	Russell, David G/0000-0002-9748-750X; Semple, Sean/0000-0002-0462-7295; Rylance, Jamie/0000-0002-2323-3611; Heyderman, Robert/0000-0003-4573-449X; Jackson, Malcolm/0000-0003-3683-8297; Gordon, Stephen/0000-0001-6576-1116	Wellcome Trust [086756/B/08/Z, 083606/A/07/Z]; Malawi-Liverpool-Wellcome Trust [084679/Z/08/Z]; MRC [MR/L009242/1, G1002120, MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G1002120, MR/L009242/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Malawi-Liverpool-Wellcome Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded and supported by a Wellcome Trust grant 086756/B/08/Z (JR); a Wellcome Trust Project Grant 083606/A/07/Z (RSH); and Malawi-Liverpool-Wellcome Trust Clinical Research Programme 084679/Z/08/Z (RSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Antonicelli F, 2004, AM J PHYSIOL-LUNG C, V286, pL1319, DOI 10.1152/ajplung.00329.2003; Barlow PG, 2008, CELL BIOL TOXICOL, V24, P243, DOI 10.1007/s10565-007-9033-y; Barregard L, 2008, OCCUP ENVIRON MED, V65, P319, DOI 10.1136/oem.2006.032458; Becher R, 2007, INHAL TOXICOL, V19, P645, DOI 10.1080/08958370701353528; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; de Oliveira S, 2015, J IMMUNOL, V194, P1523, DOI 10.4049/jimmunol.1402386; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Fullerton DG, 2009, TROP MED INT HEALTH, V14, P349, DOI 10.1111/j.1365-3156.2009.02230.x; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; Gosset P, 1999, EUR RESPIR J, V14, P98, DOI 10.1034/j.1399-3003.1999.14a17.x; Jimenez LA, 2002, AM J PHYSIOL-LUNG C, V282, pL237, DOI 10.1152/ajplung.00024.2001; Kampfrath T, 2011, CIRC RES, V108, P716, DOI 10.1161/CIRCRESAHA.110.237560; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kocbach A, 2008, TOXICOLOGY, V247, P123, DOI 10.1016/j.tox.2008.02.014; Kubatova A, 2006, CHEM RES TOXICOL, V19, P255, DOI 10.1021/tx050172f; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Leonard SS, 2000, TOXICOLOGY, V150, P147, DOI 10.1016/S0300-483X(00)00256-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marriott HM, 2006, J IMMUNOL, V177, P6480, DOI 10.4049/jimmunol.177.9.6480; Metcalfe HJ, 2014, CLIN EXP IMMUNOL, V176, P461, DOI 10.1111/cei.12289; Nadigel J, 2013, PULM PHARMACOL THER, V26, P596, DOI 10.1016/j.pupt.2013.03.002; Okuma T, 2006, INT J EXP PATHOL, V87, P475, DOI 10.1111/j.1365-2613.2006.00502.x; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Rylance J, 2014, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2014-0188OC, DOI 10.1165/RCMB.2014-01880C]; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwartz J, 2000, EPIDEMIOLOGY, V11, P666, DOI 10.1097/00001648-200011000-00009; Seagrave JC, 2005, INHAL TOXICOL, V17, P657, DOI 10.1080/08958370500189529; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Sigaud S, 2007, TOXICOL APPL PHARM, V223, P1, DOI 10.1016/j.taap.2007.04.014; Stone WL, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-1; Swiston JR, 2008, EUR RESPIR J, V32, P129, DOI 10.1183/09031936.00097707; Tellabati A, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-30; Tesfaigzi Y, 2005, TOXICOL SCI, V88, P505, DOI 10.1093/toxsci/kfi317; Xu F, 2008, AM J RESP CELL MOL, V39, P522, DOI 10.1165/rcmb.2007-0328OC	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138762	10.1371/journal.pone.0138762	http://dx.doi.org/10.1371/journal.pone.0138762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406307	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000361800700089
J	Su, JH; Aryal, A; Nan, ZB; Ji, WH				Su, Junhu; Aryal, Achyut; Nan, Zhibiao; Ji, Weihong			Climate Change-Induced Range Expansion of a Subterranean Rodent: Implications for Rangeland Management in Qinghai-Tibetan Plateau	PLOS ONE			English	Article							ZOKORS MYOSPALAX-FONTANIERII; NICHE CONSERVATISM; COMMUNITY; RESPONSES; ECOLOGY; VARIABILITY; PREDICTION; IMPACTS; FACE	Disturbances, both human-induced and natural, may re-shape ecosystems by influencing their composition, structure, and functional processes. Plateau zokor (Eospalax baileyi) is a typical subterranean rodent endemic to Qinghai-Tibetan Plateau (QTP), which are considered ecosystem engineers influencing the alpine ecosystem function. It is also regarded as a pest aggravating the degradation of overgrazed grassland and subject to regular control in QTP since 1950s. Climate change has been predicted in this region but little research exists exploring its impact on such subterranean rodent populations. Using plateau zokor as a model, through maximum entropy niche-based modeling (Maxent) and sustainable habitat models, we investigate zokor habitat dynamics driven by the future climate scenarios. Our models project that zokor suitable habitat will increase by 6.25% in 2050 in QTP. The predication indicated more threats in terms of grassland degradation as zokor suitable habitat will increase in 2050. Distribution of zokors will shift much more in their southern range with lower elevation compare to northern range with higher elevation. The estimated distance of shift ranges from 1 km to 94 km from current distribution. Grassland management should take into account such predictions in order to design mitigation measures to prevent further grassland degradation in QTP under climate change scenarios.	[Su, Junhu; Ji, Weihong] Gansu Agr Univ, Coll Grassland Sci, Key Lab Grassland Ecosyst, Minist Educ,Pratacultural Engn Lab Gansu Prov,Sin, Lanzhou 730070, Peoples R China; [Su, Junhu; Aryal, Achyut; Ji, Weihong] Gansu Agr Univ, Gansu Agr Univ Massey Univ Res Ctr Grassland Biod, Lanzhou 730070, Peoples R China; [Su, Junhu; Nan, Zhibiao] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Aryal, Achyut; Ji, Weihong] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand	Gansu Agricultural University; Gansu Agricultural University; Lanzhou University; Massey University	Ji, WH (corresponding author), Gansu Agr Univ, Coll Grassland Sci, Key Lab Grassland Ecosyst, Minist Educ,Pratacultural Engn Lab Gansu Prov,Sin, Lanzhou 730070, Peoples R China.	j.j.weihong@massey.ac.nz		Aryal, Achyut/0000-0001-6658-8714; Aryal, Achyut/0000-0002-2695-9901	National Natural Science Foundation of China [31460566]; National Science Foundation for Post-doctoral Scientists of China [2015M572614]; Agricultural Innovation Research Project of Gansu Province [GNCX-2014-27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Agricultural Innovation Research Project of Gansu Province	Funding: Funding for this project was provided by the National Natural Science Foundation of China (Grant No. 31460566), National Science Foundation for Post-doctoral Scientists of China (Grant No. 2015M572614) and Agricultural Innovation Research Project of Gansu Province (Grant No. GNCX-2014-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Arthur A. D., 2007, ACIAR Technical Reports Series; Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Davis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131067; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fan NaiChang, 1999, Ecologically-based management of rodent pests., P285; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; FRANK CL, 1988, J MAMMAL, V69, P358, DOI 10.2307/1381386; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gottfried Michael, 1999, Diversity and Distributions, V5, P241, DOI 10.1046/j.1472-4642.1999.00058.x; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Latham J, 2014, INT S LAND COVER MAP; Lu XM, 2015, ECOL LETT, V18, P48, DOI 10.1111/ele.12391; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Sharmila S, 2015, GLOBAL PLANET CHANGE, V124, P62, DOI 10.1016/j.gloplacha.2014.11.004; Smith AT, 2010, GUIDE ESTIMATES PRB; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sperber K, 2013, CLIM DYNAM, V41, P2711, DOI 10.1007/s00382-012-1607-6; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Su JH, 2014, BIOCHEM SYST ECOL, V57, P128, DOI 10.1016/j.bse.2014.07.017; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; Tang LZ, 2013, TURK J ZOOL, V37, P143, DOI 10.3906/zoo-1204-18; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang Quanye, 1993, Acta Theriologica Sinica, V13, P31; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilkes A., 2008, 67 ICRAF; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Zeng J.X., 1984, ACTA BIOL PLAT SIN, V3, P163; Zhang YM, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P237, DOI 10.1007/978-3-540-69276-8_17; Zhang YM, 2003, MAMMAL REV, V33, P284, DOI 10.1046/j.1365-2907.2003.00020.x; Zhang YM, 2003, J MAMMAL, V84, P644, DOI 10.1644/1545-1542(2003)084&lt;0644:EOPZMF&gt;2.0.CO;2; Zhao Fang, 2015, Zhongguo Zhong Yao Za Zhi, V40, P399; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x	53	37	47	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138969	10.1371/journal.pone.0138969	http://dx.doi.org/10.1371/journal.pone.0138969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406891	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700132
J	Trogden, KP; Rogers, SL				Trogden, Kathryn P.; Rogers, Stephen L.			TOG Proteins Are Spatially Regulated by Rac-GSK3 beta to Control Interphase Microtubule Dynamics	PLOS ONE			English	Article							PLUS END-TRACKING; MINI SPINDLES; XMAP215; EB1; DOMAINS; RAC1; CELL; LOCALIZATION; ASSOCIATION; DOWNSTREAM	Microtubules are regulated by a diverse set of proteins that localize to microtubule plus ends (+TIPs) where they regulate dynamic instability and mediate interactions with the cell cortex, actin filaments, and organelles. Although individual + TIPs have been studied in depth and we understand their basic contributions to microtubule dynamics, there is a growing body of evidence that these proteins exhibit cross-talk and likely function to collectively integrate microtubule behavior and upstream signaling pathways. In this study, we have identified a novel protein-protein interaction between the XMAP215 homologue in Drosophila, Mini spindles (Msps), and the CLASP homologue, Orbit. These proteins have been shown to promote and suppress microtubule dynamics, respectively. We show that microtubule dynamics are regionally controlled in cells by Rac acting to suppress GSK3 beta in the peripheral lamellae/lamellipodium. Phosphorylation of Orbit by GSK3 beta triggers a relocalization of Msps from the microtubule plus end to the lattice. Mutation of the Msps-Orbit binding site revealed that this interaction is required for regulating microtubule dynamic instability in the cell periphery. Based on our findings, we propose that Msps is a novel Rac effector that acts, in partnership with Orbit, to regionally regulate microtubule dynamics.	[Trogden, Kathryn P.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rogers, Stephen L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Rogers, Stephen L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogers, SL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	srogers@bio.unc.edu		Trogden, Kathryn/0000-0003-3288-3859	NIH [R01GM081645, R03HD077523]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD077523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Funded by NIH Grant numbers: R01GM081645 and R03HD077523, http://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Applewhite DA, 2013, MOL BIOL CELL, V24, P2885, DOI 10.1091/mbc.E12-11-0798; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grimaldi AD, 2014, DEV CELL, V30, P343, DOI 10.1016/j.devcel.2014.06.026; Grode KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123912; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lacroix B, 2014, DEV CELL, V29, P203, DOI 10.1016/j.devcel.2014.03.007; Leano JB, 2013, STRUCTURE, V21, P939, DOI 10.1016/j.str.2013.04.018; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Lowery LA, 2010, GENETICS, V185, P1311, DOI 10.1534/genetics.110.115626; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051442; Peters KA, 2013, MOL BIOL CELL, V24, P3460, DOI 10.1091/mbc.E12-11-0813; Roberts DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031284; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; Sousa A, 2007, CELL MOTIL CYTOSKEL, V64, P605, DOI 10.1002/cm.20208; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138966	10.1371/journal.pone.0138966	http://dx.doi.org/10.1371/journal.pone.0138966			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406596	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700131
J	Becknell, B; Mohamed, AZ; Li, BR; Wilhide, ME; Ingraham, SE				Becknell, Brian; Mohamed, Ahmad Z.; Li, Birong; Wilhide, Michael E.; Ingraham, Susan E.			Urine Stasis Predisposes to Urinary Tract Infection by an Opportunistic Uropathogen in the Megabladder (Mgb) Mouse	PLOS ONE			English	Article							MURINE MODEL; PATHOGENESIS; BLADDER	Purpose Urinary stasis is a risk factor for recurrent urinary tract infection (UTI). Homozygous mutant Megabladder (Mgb-/-) mice exhibit incomplete bladder emptying as a consequence of congenital detrusor aplasia. We hypothesize that this predisposes Mgb-/- mice to spontaneous and experimental UTI. Methods Mgb-/-, Mgb+/-, and wild-type female mice underwent serial ultrasound and urine cultures at 4, 6, and 8 weeks to detect spontaneous UTI. Urine bacterial isolates were analyzed by Gram stain and speciated. Bladder stones were analyzed by x-ray diffractometry. Bladders and kidneys were subject to histologic analysis. The pathogenicity of coagulase-negative Staphylococcus (CONS) isolated from Mgb-/- urine was tested by transurethral administration to culture-negative Mgb-/- or wild-type animals. The contribution of urinary stasis to CONS susceptibility was evaluated by cutaneous vesicostomy in Mgb-/- mice. Results Mgb-/- mice develop spontaneous bacteriuria (42%) and struvite bladder stones (31%) by 8 weeks, findings absent in Mgb+/- and wild-type controls. CONS was cultured as a solitary isolate from Mgb-/- bladder stones. Bladders and kidneys from mice with struvite stones exhibit mucosal injury, inflammation, and fibrosis. These pathologic features of cystitis and pyelonephritis are replicated by transurethral inoculation of CONS in culture-negative Mgb-/- females, whereas wild-type animals are less susceptible to CONS colonization and organ injury. Cutaneous vesicostomy prior to CONS inoculation significantly reduces the quantity of CONS recovered from Mgb-/- urine, bladders, and kidneys. Conclusions CONS is an opportunistic uropathogen in the setting of urinary stasis, leading to enhanced UTI incidence and severity in Mgb-/- mice.	[Becknell, Brian; Ingraham, Susan E.] Nationwide Childrens Hosp, Nephrol Sect, Columbus, OH 43205 USA; [Becknell, Brian; Ingraham, Susan E.] Ohio State Univ, Sch Med, Dept Pediat, Columbus, OH 43210 USA; [Becknell, Brian; Li, Birong; Wilhide, Michael E.; Ingraham, Susan E.] Nationwide Childrens, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Mohamed, Ahmad Z.] Univ Louisville, Dept Urol, Louisville, KY 40292 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Louisville	Becknell, B (corresponding author), Nationwide Childrens Hosp, Nephrol Sect, Columbus, OH 43205 USA.	brian.becknell2@nationwidechildrens.org			National Institutes of Health Grant (NIDDK) [K08 DK092340];  [NIDDK K08 DK102594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK092340, K08DK102594] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SEI is supported by the National Institutes of Health Grant (NIDDK) K08 DK092340. BB is supported by NIDDK K08 DK102594.	Balsara ZR, 2013, INFECT IMMUN, V81, P3018, DOI 10.1128/IAI.00255-13; Becknell B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077714; Becknell B, 2013, UROLOGY, V81, P943, DOI 10.1016/j.urology.2013.02.003; Becknell B, 2012, J PEDIATR UROL, V8, P470, DOI 10.1016/j.jpurol.2011.10.021; Carpenter Ashley R, 2012, Methods Mol Biol, V886, P403, DOI 10.1007/978-1-61779-851-1_35; Carpenter Ashley R, 2012, Methods Mol Biol, V886, P393, DOI 10.1007/978-1-61779-851-1_34; Chaudhry R, 2014, J UROLOGY, V191, P1454, DOI 10.1016/j.juro.2013.12.013; Flannigan R, 2014, NAT REV UROL, V11, P333, DOI 10.1038/nrurol.2014.99; GATERMANN S, 1989, INFECT IMMUN, V57, P110, DOI 10.1128/IAI.57.1.110-116.1989; Gatermann S, 1988, FEMS Microbiol Immunol, V1, P179; Ingraham SE, 2011, PEDIATR NEPHROL, V26, P1453, DOI 10.1007/s00467-011-1799-8; Ingraham SE, 2010, PEDIATR RES, V68, P500, DOI 10.1203/PDR.0b013e3181f82f15; JOHNSON DE, 1993, INFECT IMMUN, V61, P3422, DOI 10.1128/IAI.61.8.3422-3428.1993; Klein FA, 1997, CLIN TRANSPLANT, V11, P110; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; McHugh KM, 2014, PEDIATR NEPHROL, V29, P645, DOI 10.1007/s00467-013-2658-6; Noh PH, 1999, J UROLOGY, V162, P1399, DOI 10.1016/S0022-5347(05)68320-6; Pohl M, 2012, PEDIATR NEPHROL, V27, P443, DOI 10.1007/s00467-011-1999-2; REINBERG Y, 1991, J UROLOGY, V145, P1017, DOI 10.1016/S0022-5347(17)38518-X; SELLIN M, 1975, LANCET, V2, P570; Singh S, 2007, J AM SOC NEPHROL, V18, P461, DOI 10.1681/ASN.2006040405; ZDERIC SA, 1988, J UROLOGY, V139, P1047, DOI 10.1016/S0022-5347(17)42766-2; Zeidan S, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.02.020	23	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139077	10.1371/journal.pone.0139077	http://dx.doi.org/10.1371/journal.pone.0139077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401845	Green Submitted, Green Published, gold			2022-12-26	WOS:000361798100058
J	Cox, F; Roos, A; Hafkemeijer, N; Baart, M; Tolboom, J; Dekking, L; Stittelaar, K; Goudsmit, J; Radosevic, K; Saeland, E				Cox, Freek; Roos, Anna; Hafkemeijer, Nicole; Baart, Matthijs; Tolboom, Jeroen; Dekking, Liesbeth; Stittelaar, Koert; Goudsmit, Jaap; Radosevic, Katarina; Saeland, Eirikur			Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; MONOCLONAL-ANTIBODIES; VIRAL NEURAMINIDASE; VIRUS INFECTION; A VIRUSES; HEMAGGLUTININ; PROSPECTS; SEVERITY; IMMUNITY; CELLS	There is a constant threat of zoonotic influenza viruses causing a pandemic outbreak in humans. It is virtually impossible to predict which virus strain will cause the next pandemic and it takes a considerable amount of time before a safe and effective vaccine will be available once a pandemic occurs. In addition, development of pandemic vaccines is hampered by the generally poor immunogenicity of avian influenza viruses in humans. An effective pre-pandemic vaccine is therefore required as a first line of defense. Broadening of the protective efficacy of current seasonal vaccines by adding an adjuvant may be a way to provide such first line of defense. Here we evaluate whether a seasonal trivalent virosomal vaccine (TVV) adjuvated with the saponin-based adjuvant Matrix-M (MM) can confer protection against avian influenza H5 and H7 virus strains in mice and ferrets. We demonstrate that mice were protected from death against challenges with H5N1 and H7N7, but that the protection was not complete as evidenced by severe clinical signs. In ferrets, protection against H7N9 was not observed. In contrast, reduced upper and lower respiratory tract viral loads and reduced lung pathology, was achieved in H5N1 challenged ferrets. Together these results suggest that, at least to some extent, Matrix-M adjuvated seasonal virosomal influenza vaccine can serve as an interim measure to decrease morbidity and mortality associated with a pandemic outbreak.	[Cox, Freek; Roos, Anna; Hafkemeijer, Nicole; Baart, Matthijs; Tolboom, Jeroen; Dekking, Liesbeth; Goudsmit, Jaap; Radosevic, Katarina; Saeland, Eirikur] Ctr Excellence Janssen Res & Dev, Janssen Prevent Ctr, Leiden, Netherlands; [Stittelaar, Koert] Viroclin Biosci, Rotterdam, Netherlands		Saeland, E (corresponding author), Janssen Res & Dev, Infect Dis & Vaccines Therapeut Area, Leiden, Netherlands.	Esaeland@its.jnj.com						Baras B, 2011, VACCINE, V29, P2120, DOI 10.1016/j.vaccine.2010.12.125; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Doyle TM, ANTIVIRAL RES; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Jegaskanda S, 2014, J INFECT DIS; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Kreijtz J. H., 2014, J INFECT DIS; Kreijtz JHCM, 2013, VACCINE, V31, P4995, DOI 10.1016/j.vaccine.2013.06.071; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; Pedersen G, 2011, INFLUENZA OTHER RESP, V5, P426, DOI 10.1111/j.1750-2659.2011.00256.x; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Radosevic K, 2008, VACCINE, V26, P3640, DOI 10.1016/j.vaccine.2008.04.071; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Sambhara S, 1998, J INFECT DIS, V177, P1266, DOI 10.1086/515285; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; SMITH H, 1988, REV INFECT DIS, V10, P56; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; van den Brand JMA, 2011, J VIROL, V85, P2851, DOI 10.1128/JVI.01939-10; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, INFL HUM AN INT SUMM; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; World Health Organization, 9 WHO	47	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0135723	10.1371/journal.pone.0135723	http://dx.doi.org/10.1371/journal.pone.0135723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402787	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100004
J	Fujiwara, N; Mazzola, M; Cai, E; Wang, M; Cave, JW				Fujiwara, Nana; Mazzola, Michael; Cai, Elizabeth; Wang, Meng; Cave, John W.			TMPyP4, a Stabilizer of Nucleic Acid Secondary Structure, Is a Novel Acetylcholinesterase Inhibitor	PLOS ONE			English	Article							QUADRUPLEX-INTERACTIVE AGENTS; HUMAN TUMOR-CELLS; IN-VIVO; CATIONIC PORPHYRINS; TELOMERASE INHIBITION; DNA; GROWTH; EXPRESSION; TARGETS; CANCER	The porphyrin compound, TMPyP4 (5,10,15,20-Tetrakis-(N-methyl-4-pyridyl) porphine), is widely used as a photosensitizer and a modulator of nucleic acid secondary structure stability. Our group recently showed in cultured cells and forebrain slice cultures that this compound can also down regulate expression of Tyrosine hydroxylase (Th), which encodes the rate-limiting enzyme in catecholamine biosynthesis, by stabilizing DNA secondary structures in the Th proximal promoter. The current study sought to establish whether treatment with TMPyP4 could modify mouse Th expression levels in vivo. Intraperitoneal administration of low TMPyP4 doses (10mg/kg), similar to those used for photosensitization, did not significantly reduce Th transcript levels in several catecholaminergic regions. Administration of a high dose (40 mg/kg), similar to those used for tumor xenograph reduction, unexpectedly induced flaccid paralysis in an age and sex-dependent manner. In vitro analyses revealed that TMPyP4, but not putative metabolites, inhibited Acetylcholinesterase activity and pre-treatment of TMPyP4 with Hemeoxygenase-2 (HO-2) rescued Acetylcholinesterase function. Age-dependent differences in HO-2 expression levels may account for some of the variable in vivo effects of high TMPyP4 doses. Together, these studies indicate that only low doses of TMPyP4, such as those typically used for photosensitization, are well tolerated in vivo. Thus, despite its widespread use in vitro, TMPyP4 is not ideal for modifying neuronal gene expression in vivo by manipulating nucleic acid secondary structure stability, which highlights the need to identify more clinically suitable compounds that can modulate nucleic acid secondary structure and gene expression.	[Fujiwara, Nana; Mazzola, Michael; Cai, Elizabeth; Wang, Meng; Cave, John W.] Burke Med Res Inst, White Plains, NY 10605 USA; [Cave, John W.] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA	Cornell University	Cave, JW (corresponding author), Burke Med Res Inst, White Plains, NY 10605 USA.	joc2042@med.cornell.edu		Cave, John/0000-0003-1792-7219	National Institutes of Health [DC008955]; Burke Medical Research Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Medical Research Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health DC008955 to JWC, and Burke Medical Research Institute to JWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.77; Amato J, 2014, CHEMMEDCHEM, V9, P2026, DOI 10.1002/cmdc.201402153; Banerjee K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6769; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Dhayan H, 2014, ARCH BIOCHEM BIOPHYS, V560, P52, DOI 10.1016/j.abb.2014.07.016; Duchler M, 2012, J DRUG TARGET, V20, P389, DOI 10.3109/1061186X.2012.669384; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; Grand CL, 2002, MOL CANCER THER, V1, P565; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Izbicka E, 2000, ANTICANCER RES, V20, P3205; Izbicka E, 1999, CANCER RES, V59, P639; Liu AH, 2013, ASIAN PAC J CANCER P, V14, P5371, DOI 10.7314/APJCP.2013.14.9.5371; Liu W, 2005, NUCLEOS NUCLEOT NUCL, V24, P1801, DOI 10.1080/15257770500267238; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Mitra S, 2011, LASER SURG MED, V43, P324, DOI 10.1002/lsm.21049; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Parrotta L, 2014, EXPERT OPIN DRUG DIS, V9, P1167, DOI 10.1517/17460441.2014.941353; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Rapozzi V, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-75; Rha SY, 2000, CLIN CANCER RES, V6, P987; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Shammas MA, 2003, MOL CANCER THER, V2, P825; Shklover J, 2010, NUCLEIC ACIDS RES, V38, P2369, DOI 10.1093/nar/gkp1208; Stefanovic S, 2015, RNA, V21, P48, DOI 10.1261/rna.046722.114; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; VILLANUEVA A, 1993, CANCER LETT, V73, P59, DOI 10.1016/0304-3835(93)90188-F	33	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139167	10.1371/journal.pone.0139167	http://dx.doi.org/10.1371/journal.pone.0139167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402367	gold, Green Submitted, Green Published			2022-12-26	WOS:000361798100062
J	Liu, FW; Zhou, J; Zhang, SS; Liu, LL; Zhou, LX; Fan, WH				Liu, Fenwu; Zhou, Jun; Zhang, Shasha; Liu, Lanlan; Zhou, Lixiang; Fan, Wenhua			Schwertmannite Synthesis through Ferrous Ion Chemical Oxidation under Different H2O2 Supply Rates and Its Removal Efficiency for Arsenic from Contaminated Groundwater	PLOS ONE			English	Article							ACID-MINE DRAINAGE; ACIDITHIOBACILLUS-FERROOXIDANS; AQUEOUS-SOLUTION; SURFACE-AREA; ADSORPTION; REMEDIATION; CATALYST; AS(III); SULFATE; NITRATE	Schwertmannite-mediated removal of arsenic from contaminated water has attracted increasing attention. However, schwertmannite chemical synthesis behavior under different H2O2 supply rates for ferrous ions oxidation is unclear. This study investigated pH, ferrous ions oxidation efficiency, and total iron precipitation efficiency during schwertmannite synthesis by adding H2O2 into FeSO4 center dot 7H(2)O solution at different supply rates. Specific surface area and arsenic (III) removal capacity of schwertmannite have also been studied. Results showed that pH decreased from similar to 3.48 to similar to 1.96, similar to 2.06, similar to 2.12, similar to 2.14, or similar to 2.17 after 60 h reaction when the ferrous ions solution received the following corresponding amounts of H2O2: 1.80 mL at 2 h (treatment 1); 0.90 mL at 2 h and 14 h (treatment 2); 0.60 mL at 2, 14, and 26 h (treatment 3); 0.45 mL at 2, 14, 26, and 38 h (treatment 4), or 0.36 mL at 2, 14, 26, 38, and 50 h (treatment 5). Slow H2O2 supply significantly inhibited the total iron precipitation efficiency but improved the specific surface area or arsenic (III) removal capacity of schwertmannite. For the initial 50.0 mu g/L arsenic (III)-contaminated water under pH similar to 7.0 and using 0.25 g/L schwertmannite as an adsorbent, the total iron precipitation efficiency, specific surface area of the harvested schwertmannite, and schwertmannite arsenic(III) removal efficiency were 29.3%, 2.06 m(2)/g, and 81.1%, respectively, in treatment 1. However, the above parameters correspondingly changed to 17.3%, 16.30 m(2)/g, and 96.5%, respectively, in treatment 5.	[Liu, Fenwu; Zhang, Shasha; Liu, Lanlan; Fan, Wenhua] Shanxi Agr Univ, Coll Resource & Environm, Environm Engn Lab, Taigu, Peoples R China; [Zhou, Jun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Zhou, Lixiang] Nanjing Agr Univ, Dept Environm Engn, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	Shanxi Agricultural University; Nanjing Tech University; Nanjing Agricultural University	Fan, WH (corresponding author), Shanxi Agr Univ, Coll Resource & Environm, Environm Engn Lab, Taigu, Peoples R China.	wenhuafan2000@163.com	Zhou, Li/GSE-4531-2022		National Natural Science Foundation of China [41371476, 21407102]; Natural Science Foundation of Shanxi Province, China [2015011022]; Program for The Top Young Innovative Talents of Shanxi Agricultural University [TYIT 201405]; Jiangsu Province Science Foundation [BK 20130931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); Program for The Top Young Innovative Talents of Shanxi Agricultural University; Jiangsu Province Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (41371476, 21407102), the Natural Science Foundation of Shanxi Province, China (2015011022), the Program for The Top Young Innovative Talents of Shanxi Agricultural University (TYIT 201405), and the Jiangsu Province Science Foundation for Youths (BK 20130931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelo J, 2012, J COLLOID INTERF SCI, V386, P338, DOI 10.1016/j.jcis.2012.07.008; Arcibar-Orozco JA, 2014, CHEM ENG J, V249, P201, DOI 10.1016/j.cej.2014.03.096; Boddu VM, 2008, WATER RES, V42, P633, DOI 10.1016/j.watres.2007.08.014; Brikowski TH, 2014, J HYDROL, V518, P342, DOI 10.1016/j.jhydrol.2013.09.021; Burton ED, 2006, GEOCHIM COSMOCHIM AC, V70, P5455, DOI 10.1016/j.gca.2006.08.016; Burton ED, 2013, ENVIRON SCI TECHNOL, V47, P2221, DOI 10.1021/es303867t; Burton ED, 2009, ENVIRON SCI TECHNOL, V43, P9202, DOI 10.1021/es902461x; Dou XM, 2013, WATER RES, V47, P2938, DOI 10.1016/j.watres.2013.01.035; Fytianos K, 2004, ENVIRON MONIT ASSESS, V93, P55, DOI 10.1023/B:EMAS.0000016791.73493.aa; Guo HM, 2014, APPL GEOCHEM, V41, P196, DOI 10.1016/j.apgeochem.2013.12.016; HoungAloune S, 2014, HYDROMETALLURGY, V147, P30, DOI 10.1016/j.hydromet.2014.04.001; Jain CK, 2000, WATER RES, V34, P4304, DOI 10.1016/S0043-1354(00)00182-2; JCPDS (Joint Committee on Powder Diffraction Standards), 2002, MIN POWD DIFFR FIL; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; Li BH, 2015, ECOL ENG, V77, P196, DOI 10.1016/j.ecoleng.2015.01.027; [李浙英 Li Zheying], 2011, [环境科学学报, Acta Scientiae Circumstantiae], V31, P460; Liao YH, 2011, CHEMOSPHERE, V83, P295, DOI 10.1016/j.chemosphere.2010.12.060; Liao YH, 2009, MAT SCI ENG C-BIO S, V29, P211, DOI 10.1016/j.msec.2008.06.011; [刘奋武 Liu Fenwu], 2015, [环境科学学报, Acta Scientiae Circumstantiae], V35, P476; Liu FenWu, 2014, China Environmental Science, V34, P713; [刘奋武 Liu Fenwu], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2445; Liu FW, 2013, ACTA SCI CIRCUMSTANT, V35, P3025; Mahler J, 2013, APPL GEOCHEM, V37, P179, DOI 10.1016/j.apgeochem.2013.07.025; Maillot F, 2013, GEOCHIM COSMOCHIM AC, V104, P310, DOI 10.1016/j.gca.2012.11.016; Malik PK, 2003, SEP PURIF TECHNOL, V31, P241, DOI 10.1016/S1383-5866(02)00200-9; Manna B, 2007, J HAZARD MATER, V144, P522, DOI 10.1016/j.jhazmat.2006.10.066; Nakaya S, 2011, J HYDROL, V409, P724, DOI 10.1016/j.jhydrol.2011.09.006; Paikaray S, 2011, CHEM GEOL, V283, P134, DOI 10.1016/j.chemgeo.2010.08.011; Rahaman MS, 2008, BIORESOURCE TECHNOL, V99, P2815, DOI 10.1016/j.biortech.2007.06.038; RAO SR, 1995, MINER ENG, V8, P905, DOI 10.1016/0892-6875(95)00052-R; Regenspurg S, 2004, GEOCHIM COSMOCHIM AC, V68, P1185, DOI 10.1016/j.gca.2003.07.015; Sankar MS, 2014, SCI TOTAL ENVIRON, V488, P574, DOI 10.1016/j.scitotenv.2014.02.077; Shan HM, 2013, PROCED EARTH PLAN SC, V7, P373, DOI 10.1016/j.proeps.2013.03.053; Song J, 2015, INT J ENVIRON SCI TE, V12, P1559, DOI 10.1007/s13762-014-0528-9; Ungureanu G, 2015, J ENVIRON MANAGE, V151, P326, DOI 10.1016/j.jenvman.2014.12.051; Vithana CL, 2014, CHEM GEOL, V372, P1, DOI 10.1016/j.chemgeo.2014.02.012; Wang JM, 2008, CHEMOSPHERE, V72, P381, DOI 10.1016/j.chemosphere.2008.02.045; Wang M, 2012, HYDROMETALLURGY, V125, P152, DOI 10.1016/j.hydromet.2012.06.003; Wang WM, 2013, J HAZARD MATER, V262, P412, DOI 10.1016/j.jhazmat.2013.08.076; Whittington BI, 2008, MINER ENG, V21, P396, DOI 10.1016/j.mineng.2007.10.021; Xu YQ, 2014, J ENVIRON SCI-CHINA, V26, P1463, DOI 10.1016/j.jes.2014.05.012; Yin H, 2015, CHEMOSPHERE, V124, P116, DOI 10.1016/j.chemosphere.2014.11.076; Zhu JY, 2013, MAT SCI ENG C-MATER, V33, P2679, DOI 10.1016/j.msec.2013.02.026	43	26	28	8	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138891	10.1371/journal.pone.0138891	http://dx.doi.org/10.1371/journal.pone.0138891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398214	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500125
J	Ostensson, E; Froberg, M; Leval, A; Hellstrom, AC; Backlund, M; Zethraeus, N; Andersson, S				Ostensson, Ellinor; Froberg, Maria; Leval, Amy; Hellstrom, Ann-Cathrin; Backlund, Magnus; Zethraeus, Niklas; Andersson, Sonia			Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination	PLOS ONE			English	Article							CERVICAL-CANCER; GENITAL WARTS; BURDEN; MANAGEMENT; CARE; DYSPLASIA; SAMPLES; WOMEN	Objective Costs associated with HPV-related diseases such as cervical dysplasia, cervical cancer, and genital warts have not been evaluated in Sweden. These costs must be estimated in order to determine the potential savings if these diseases were eradicated and to assess the combined cost-effectiveness of HPV vaccination and cervical cancer screening. The present study aimed to estimate prevention, management, and treatment costs associated with cervical dysplasia, cervical cancer, and genital warts from a societal perspective in Sweden in 2009, 1 year before the quadrivalent HPV vaccination program was implemented. Methods and Materials Data from the Swedish cervical cancer screening program was used to calculate the costs associated with prevention (cytological cervical cancer screening), management (colposcopy and biopsy following inadequate/abnormal cytological results), and treatment of CIN. Swedish official statistics were used to estimate treatment costs associated with cervical cancer. Published epidemiological data were used to estimate the number of incident, recurrent, and persistent cases of genital warts; a clinical expert panel assessed management and treatment procedures. Estimated visits, procedures, and use of medications were used to calculate the annual cost associated with genital warts. Results From a societal perspective, total estimated costs associated with cervical cancer and genital warts in 2009 were (sic)106.6 million, of which (sic)81.4 million (76%) were direct medical costs. Costs associated with prevention, management, and treatment of CIN were (sic)74 million; screening and management costs for women with normal and inadequate cytology alone accounted for 76% of this sum. The treatment costs associated with incident and prevalent cervical cancer and palliative care were (sic)23 million. Estimated costs for incident, recurrent and persistent cases of genital warts were (sic)9.8 million. Conclusion Prevention, management, and treatment costs associated with cervical dysplasia, cervical cancer, and genital warts are substantial. Defining these costs is important for future cost-effectiveness analyses of the quadrivalent HPV vaccination program in Sweden.	[Ostensson, Ellinor; Andersson, Sonia] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Froberg, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family Med & Community Med, Stockholm, Sweden; [Leval, Amy] Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Leval, Amy] Dept Communicable Dis Control & Prevent Stockholm, Stockholm, Sweden; [Hellstrom, Ann-Cathrin] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Backlund, Magnus] Karolinska Inst, Solna MedS, Dept Med, Stockholm, Sweden; [Zethraeus, Niklas] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Ostensson, E (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden.	ellinor.ostensson@ki.se	Bäcklund, Magnus/I-3192-2019	Bäcklund, Magnus/0000-0003-0397-6538; Ostensson, Ellinor/0000-0003-0668-088X	Swedish Cancer Foundation [070623, CAN 2007/1044, 11 0544, CAN 2011/471]; KI Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097]	Swedish Cancer Foundation; KI Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council)	This study received funding from the Swedish Cancer Foundation (www.cancerfonden.se; 070623, CAN 2007/1044, 11 0544, CAN 2011/471), KI Cancer Strategic Grants (www.ki.se; 5888/05-722), the Swedish Research Council (www.vr.se; 521-2008-2899), and the Stockholm County Council (www.skl.s; 20130097). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; Annemans Lieven, 2008, J Med Econ, V11, P135, DOI 10.3111/13696990801961611; [Anonymous], 2007, UK NATL GUIDELINE MA; Anttila A, 2009, EUR J CANCER, V45, P2685, DOI 10.1016/j.ejca.2009.07.017; Arbyn M, 2007, ANN ONCOL, V18, P1423, DOI 10.1093/annonc/mdm377; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arveux P, 2007, B CANCER, V94, P219; Bergeron C, 2006, Gynecol Obstet Fertil, V34, P1036, DOI 10.1016/j.gyobfe.2006.09.005; Bergeron C, 2008, INT J TECHNOL ASSESS, V24, P10, DOI 10.1017/S0266462307080026; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Beutner KR, 1997, PAPILLOMAVIRUS REPOR, V8, P69; Bosch XF, 2003, J NATL CANC I MONOGR, V31, P3, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003479; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Desai S, 2011, SEX TRANSM INFECT, V87, P464, DOI 10.1136/sti.2010.048421; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Engholm GFJ, 2015, NORDCAN CANC INCIDEN; Fauci J, 2012, GYNECOL ONCOL, V127, P175, DOI 10.1016/j.ygyno.2012.06.025; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GROSS G, 1985, J INVEST DERMATOL, V85, P147, DOI 10.1111/1523-1747.ep12276576; Gyllensten U, 2011, BRIT J CANCER, V105, P694, DOI 10.1038/bjc.2011.277; Health Protection Agency, 2009, SUPPL TABL SEX TRANS; Hemsjukvard I, 1997, ADV HOME CARE SWEDEN; *HLTH PROT AG, 2007, TEST TIM HIV OTH SEX; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kulasingam S, 2007, SEX HEALTH, V4, P165, DOI 10.1071/SH07043; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Lacey CJ, 2012, J EUR ACAD DERMATOL, V3, P263, DOI [DOI 10.1111/J.1468-3083.2012.04493.X, 10.1111/j.1468-3083.2012.04493.x]; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Lopez-Acevedo M, 2013, GYNECOL ONCOL, V131, P215, DOI 10.1016/j.ygyno.2013.06.012; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Ostensson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128270; Ostensson E, 2013, ACTA OBSTET GYN SCAN, V92, P830, DOI 10.1111/aogs.12143; Ostensson E, 2010, ACTA OBSTET GYN SCAN, V89, P1316, DOI 10.3109/00016349.2010.512066; Raymakers AJN, 2012, PHARMACOECONOMICS, V30, P1, DOI 10.2165/11591170-000000000-00000; Socialstyrelsen, 2008, HPV VACC SWED VACC P; Sparen P, 2010, SWEDISH NATL QUALITY; Swedish National Oncologic Center, CANC INC SWED 2010; von Krogh G, 2000, SEX TRANSM INFECT, V76, P162, DOI 10.1136/sti.76.3.162; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9	46	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139062	10.1371/journal.pone.0139062	http://dx.doi.org/10.1371/journal.pone.0139062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398189	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500138
J	Yu, HQ; Chen, Z; Zhang, HY; Wong, KKL; Chen, YM; Liu, HF				Yu, Haiqing; Chen, Zhi; Zhang, Heye; Wong, Kelvin Kian Loong; Chen, Yunmei; Liu, Huafeng			Reconstruction for 3D PET Based on Total Variation Constrained Direct Fourier Method	PLOS ONE			English	Article							TOTAL VARIATION REGULARIZATION; POSITRON-EMISSION-TOMOGRAPHY; WHOLE-BODY PET; IMAGE-RECONSTRUCTION; 3-D PET; ALGORITHMS; PERFORMANCE; SCANNER; ACCELERATION; SYSTEM	This paper presents a total variation (TV) regularized reconstruction algorithm for 3D positron emission tomography (PET). The proposed method first employs the Fourier rebinning algorithm (FORE), rebinning the 3D data into a stack of ordinary 2D data sets as sinogram data. Then, the resulted 2D sinogram are ready to be reconstructed by conventional 2D reconstruction algorithms. Given the locally piece-wise constant nature of PET images, we introduce the total variation (TV) based reconstruction schemes. More specifically, we formulate the 2D PET reconstruction problem as an optimization problem, whose objective function consists of TV norm of the reconstructed image and the data fidelity term measuring the consistency between the reconstructed image and sinogram. To solve the resulting minimization problem, we apply an efficient methods called the Bregman operator splitting algorithm with variable step size (BOSVS). Experiments based on Monte Carlo simulated data and real data are conducted as validations. The experiment results show that the proposed method produces higher accuracy than conventional direct Fourier (DF) (bias in BOSVS is 70% of ones in DF, variance of BOSVS is 80% of ones in DF).	[Yu, Haiqing; Chen, Zhi; Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Heye] Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Wong, Kelvin Kian Loong] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, Australia; [Chen, Yunmei] Univ Florida, Dept Math, Gainesville, FL 32611 USA	Zhejiang University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Western Australia; State University System of Florida; University of Florida	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, Hangzhou 310003, Zhejiang, Peoples R China.	liuhf@zju.edu.cn	Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Wong, Kelvin Kian Loong/0000-0002-8600-1105; 	National Natural Science Foundation of China [61427807, 61271083]; Shenzhen Innovation Funding [SGLH20131010110119871, GJHZ20140415152115754]; Natural Science Foundation of Zhejiang [LR12F03001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Innovation Funding; Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province)	This work is supported in part by the National Natural Science Foundation of China (No: 61427807, 61271083), by the Shenzhen Innovation Funding (SGLH20131010110119871 and GJHZ20140415152115754), by Natural Science Foundation of Zhejiang (No: LR12F03001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn ST, 2011, IEEE T MED IMAGING, V30, P1808, DOI 10.1109/TMI.2011.2149537; Asma E, 2012, QUANTITATIVELY ACCUR; Bai B, 2014, PHYS MED BIOL, V59, P925, DOI 10.1088/0031-9155/59/4/925; Bai B, 2006, IEEE NUCL SCI CONF R, P2787, DOI 10.1109/NSSMIC.2006.356457; Bailey D L, 1992, Ann Nucl Med, V6, P123; Burger M, 2014, ARXIV14031272; Chatziioannou A, 2000, IEEE T MED IMAGING, V19, P507, DOI 10.1109/42.870260; Chen YM, 2013, COMPUT OPTIM APPL, V54, P317, DOI 10.1007/s10589-012-9519-2; Daube-Witherspoon ME, 2012, IEEE T MED IMAGING, V31, P1461, DOI 10.1109/TMI.2012.2190088; De Francesco S, 2004, P SOC PHOTO-OPT INS, V5370, P666, DOI 10.1117/12.534189; DEFRISE M, 1994, PHYS MED BIOL, V39, P305, DOI 10.1088/0031-9155/39/3/001; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Defrise M, 1999, INVERSE PROBL, V15, P1047, DOI 10.1088/0266-5611/15/4/314; Defrise M, 2011, US Patent, Patent No. [8,000,513, 8000513]; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Dutta J, 2012, PHYS MED BIOL, V57, P1459, DOI 10.1088/0031-9155/57/6/1459; Fessler JA, 1999, IEEE T IMAGE PROCESS, V8, P688, DOI 10.1109/83.760336; Frese T, 2003, IEEE T MED IMAGING, V22, P258, DOI 10.1109/TMI.2002.808353; Hawe D, 2012, WIRES COMPUT STAT, V4, P316, DOI 10.1002/wics.1196; Ibaraki M, 2011, PHYS MED BIOL, V56, P3061, DOI 10.1088/0031-9155/56/10/011; Jonsson E, 1998, TOTAL VARIATION REGU, P98; Kaufman L, 1996, IEEE T MED IMAGING, V15, P385, DOI 10.1109/42.500147; Kim KS, 2011, PHYS MED BIOL, V56, P4991, DOI 10.1088/0031-9155/56/15/021; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Kinouchi S, 2012, IEEE NUCL SCI CONF R, P3412; Kisilev P, 2001, IEEE IMAGE PROC, P702, DOI 10.1109/ICIP.2001.959142; Knesaurek K, 2012, NUCL INSTRUM METH A, V689, P29, DOI 10.1016/j.nima.2012.06.032; Lu L, 2014, SOC NUCL MED ANN M, V55, P374; Magdics M, 2011, IEEE NUCL SCI CONF R, P4086, DOI 10.1109/NSSMIC.2011.6153777; Matej S, 2001, IEEE T NUCL SCI, V48, P1378, DOI 10.1109/23.958359; Mishra A, 2010, COMP ROB VIS CRV 201, P301; Pauleit D, 2004, J NUCL MED, V45, P374; Rapisarda E, 2014, COMPUT MED IMAG GRAP, V38, P445, DOI 10.1016/j.compmedimag.2014.05.004; Razifar Pasha, 2005, BMC Med Imaging, V5, P5, DOI 10.1186/1471-2342-5-5; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Scheins J, 2014, EJNMMI PHYS, V1, P1; Schleyer PJ, 2011, PHYS MED BIOL, V56, P3953, DOI 10.1088/0031-9155/56/13/013; Seemann MD, 2006, EUR J MED RES, V11, P58; Somayajula S, 2011, IEEE T MED IMAGING, V30, P537, DOI 10.1109/TMI.2010.2076827; Surti S, 2007, J NUCL MED, V48, P471; Tong Shan, 2010, Imaging Med, V2, P529, DOI 10.2217/iim.10.49; Ueda S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-514; Valk P.E., 2003, POSITRON EMISSION TO; Watson CC, 2000, IEEE T NUCL SCI, V47, P1587, DOI 10.1109/23.873020; Xu JJ, 2013, LECT NOTES COMPUT SC, V8149, P501, DOI 10.1007/978-3-642-40811-3_63; Ye XJ, 2011, IEEE T MED IMAGING, V30, P1055, DOI 10.1109/TMI.2010.2073717; Zaidi H, 2011, PHYS MED BIOL, V56, P3091, DOI 10.1088/0031-9155/56/10/013; Zhang J, 2013, IEEE INT SYMP CIRC S, P2836; Zhang XQ, 2011, J SCI COMPUT, V46, P20, DOI 10.1007/s10915-010-9408-8; Zhou J, 2011, PHYS MED BIOL, V56, P6739, DOI 10.1088/0031-9155/56/20/015; ZUBAL IG, 1994, MED PHYS, V21, P299, DOI 10.1118/1.597290	51	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138483	10.1371/journal.pone.0138483	http://dx.doi.org/10.1371/journal.pone.0138483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398232	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500070
J	Couoh-Cardel, S; Milgrom, E; Wilkens, S				Couoh-Cardel, Sergio; Milgrom, Elena; Wilkens, Stephan			Affinity Purification and Structural Features of the Yeast Vacuolar ATPase V-o Membrane Sector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; N-TERMINAL DOMAIN; H+-ATPASE; SUBUNIT-C; CRYSTAL-STRUCTURE; PROTON CHANNEL; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; PROTEIN; PUMP	The membrane sector (V-o) of the proton pumping vacuolar ATPase (V-ATPase, V1Vo-ATPase) from Saccharomyces cerevisiae was purified to homogeneity, and its structure was characterized byEMof single molecules and two-dimensional crystals. Projection images of negatively stained V-o two-dimensional crystals showed a ring-like structure with a large asymmetric mass at the periphery of the ring. A cryo-EM reconstruction of V-o from single-particle images showed subunits a and d in close contact on the cytoplasmic side of the proton channel. A comparison of three-dimensional reconstructions of free V-o and V-o as part of holo V1Vo revealed that the cytoplasmic N-terminal domain of subunit a (a(NT)) must undergo a large conformational change upon enzyme disassembly or (re) assembly from V-o, V-1, and subunit C. Isothermal titration calorimetry using recombinant subunit d and a(NT) revealed that the two proteins bind each other with a Kd of similar to 5 mu M. Treatment of the purified V-o sector with 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] resulted in selective release of subunit d, allowing purification of a V-o Delta d complex. Passive proton translocation assays revealed that both V-o and V-o Delta d are impermeable to protons. We speculate that the structural change in subunit a upon release of V-1 from V-o during reversible enzyme dissociation plays a role in blocking passive proton translocation across free V-o and that the interaction between a(NT) and d seen in free V-o functions to stabilize the V-o sector for efficient reassembly of V1Vo.	[Couoh-Cardel, Sergio; Milgrom, Elena; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu		Couoh-Cardel, Sergio/0000-0002-5186-4648	National Science Foundation; NIGMS/National Institutes of Health under National Science Foundation [DMR-1332208]; NIGMS/National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM058600] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS/National Institutes of Health under National Science Foundation; NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Patricia Kane for reagents and help with yeast molecular biology and Nicholas J. Stam, Stuti Sharma, and Dr. Rebecca A. Oot for discussions. We thank Dr. Karlett Parra for the plasmid encoding yeast V-ATPase subunit d and Dr. Lee Parsons for generating the subunit d expression construct. We also thank Robert Carroll for generating the a<INF>NT(1</INF> <INF>372)</INF> expression construct and Dr. Richard Gillilan for help with BioSAXS data collection. Part of this work is on the basis of research conducted at the Cornell High-Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the NIGMS/National Institutes of Health under National Science Foundation Award DMR-1332208, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by Award GM-103485 from the NIGMS/National Institutes of Health.	Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Blake-Palmer KG, 2009, CURR OPIN NEPHROL HY, V18, P433, DOI 10.1097/MNH.0b013e32832e9c58; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brown D, 1997, J EXP BIOL, V200, P257; Compton MA, 2006, J BIOL CHEM, V281, P15312, DOI 10.1074/jbc.M600890200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kartner N, 2014, EXPERT OPIN DRUG DIS, V9, P505, DOI 10.1517/17460441.2014.902155; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MOSHER ME, 1983, J BACTERIOL, V156, P1078, DOI 10.1128/JB.156.3.1078-1092.1983; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Stewart Alastair G, 2013, Bioarchitecture, V3, P2, DOI 10.4161/bioa.23301; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang Y, 2007, J BIOL CHEM, V282, P34058, DOI 10.1074/jbc.M704331200; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	63	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27959	27971		10.1074/jbc.M115.662494	http://dx.doi.org/10.1074/jbc.M115.662494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26416888	Green Published, hybrid			2022-12-26	WOS:000365757500043
J	Carmona-Antonanzas, G; Carmichael, SN; Heumann, J; Taggart, JB; Gharbi, K; Bron, JE; Bekaert, M; Sturm, A				Carmona-Antonanzas, Greta; Carmichael, Stephen N.; Heumann, Jan; Taggart, John B.; Gharbi, Karim; Bron, James E.; Bekaert, Michael; Sturm, Armin			A Survey of the ATP-Binding Cassette (ABC) Gene Superfamily in the Salmon Louse (Lepeophtheirus salmonis)	PLOS ONE			English	Article							FARMED ATLANTIC SALMON; MULTIDRUG-RESISTANCE; SEA LICE; P-GLYCOPROTEIN; MULTIXENOBIOTIC RESISTANCE; IVERMECTIN RESISTANCE; PESTICIDE RESISTANCE; EFFLUX TRANSPORTERS; DROSOPHILA; FAMILY	Salmon lice, Lepeophtheirus salmonis (Kroyer, 1837), are fish ectoparasites causing significant economic damage in the mariculture of Atlantic salmon, Salmo salar Linnaeus, 1758. The control of L. salmonis at fish farms relies to a large extent on treatment with anti-parasitic drugs. A problem related to chemical control is the potential for development of resistance, which in L. salmonis is documented for a number of drug classes including organophosphates, pyrethroids and avermectins. The ATP-binding cassette (ABC) gene superfamily is found in all biota and includes a range of drug efflux transporters that can confer drug resistance to cancers and pathogens. Furthermore, some ABC transporters are recognised to be involved in conferral of insecticide resistance. While a number of studies have investigated ABC transporters in L. salmonis, no systematic analysis of the ABC gene family exists for this species. This study presents a genome-wide survey of ABC genes in L. salmonis for which, ABC superfamily members were identified through homology searching of the L. salmonis genome. In addition, ABC proteins were identified in a reference transcriptome of the parasite generated by high-throughput RNA sequencing (RNA-seq) of a multi-stage RNA library. Searches of both genome and transcriptome allowed the identification of a total of 33 genes / transcripts coding for ABC proteins, of which 3 were represented only in the genome and 4 only in the transcriptome. Eighteen sequences were assigned to ABC subfamilies known to contain drug transporters, i.e. subfamilies B (4 sequences), C (11) and G (2). The results suggest that the ABC gene family of L. salmonis possesses fewer members than recorded for other arthropods. The present survey of the L. salmonis ABC gene superfamily will provide the basis for further research into potential roles of ABC transporters in the toxicity of salmon delousing agents and as potential mechanisms of drug resistance.	[Carmona-Antonanzas, Greta; Carmichael, Stephen N.; Heumann, Jan; Taggart, John B.; Bron, James E.; Bekaert, Michael; Sturm, Armin] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Gharbi, Karim] Univ Edinburgh, Edinburgh Genom, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Stirling; University of Edinburgh	Sturm, A (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	armin.sturm@stir.ac.uk	Bron, James E/B-6231-2018; Gharbi, Karim/C-5771-2012	Bron, James E/0000-0003-3544-0519; Gharbi, Karim/0000-0003-1092-4488; Taggart, John/0000-0002-3843-9663; Bekaert, Michael/0000-0002-1206-7654; Sturm, Armin/0000-0003-2632-1999	United Kingdom Biotechnology and Biological Sciences Research Council [BB/L022923/1]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Scottish Salmon Producer's Organisation; Moredun Foundation; Merck Animal Health; Natural Environment Research Council [R8/H10/56]; Medical Research Council [MR/K001744/1]; Biotechnological and Biological Research Council [BB/J004243/1]; BBSRC [BB/L024004/1, BB/L022923/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L024004/1, BB/L022923/1] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Scottish Salmon Producer's Organisation; Moredun Foundation; Merck Animal Health(Merck & Company); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnological and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by United Kingdom Biotechnology and Biological Sciences Research Council grant BB/L022923/1 awarded to Armin Sturm. The authors further gratefully acknowledge funding received from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland). MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The authors are further thankful to the Scottish Salmon Producer's Organisation and the Moredun Foundation for financial support to Stephen N. Carmichael, and to Merck Animal Health for financial support to Jan Heumann. Illumina RNA-seq was carried out by Edinburgh Genomics, the University of Edinburgh. Edinburgh Genomics is partly supported through core grants from Natural Environment Research Council (R8/H10/56), Medical Research Council (MR/K001744/1) and Biotechnological and Biological Research Council (BB/J004243/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergen AAB, 2007, PFLUG ARCH EUR J PHY, V453, P685, DOI 10.1007/s00424-005-0039-0; Besnier F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-937; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Campos B, 2014, AQUAT TOXICOL, V148, P139, DOI 10.1016/j.aquatox.2014.01.001; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Dicker AJ, 2011, INT J PARASITOL, V41, P935, DOI 10.1016/j.ijpara.2011.03.015; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epel D, 2008, ENVIRON SCI TECHNOL, V42, P3914, DOI 10.1021/es087187v; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052; Gokirmak T, 2012, J BIOL CHEM, V287, P43876, DOI 10.1074/jbc.M112.424879; Gonzalez-Cabo P, 2011, J BIOL CHEM, V286, P21304, DOI 10.1074/jbc.M110.211201; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Heumann J, 2014, AQUACULTURE, V424, P207, DOI 10.1016/j.aquaculture.2013.12.015; Heumann J, 2012, COMP BIOCHEM PHYS C, V155, P198, DOI 10.1016/j.cbpc.2011.08.004; Huang H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004844; Igboeli OO, 2012, AQUACULTURE, V344, P40, DOI 10.1016/j.aquaculture.2012.03.026; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320; Lanning CL, 1996, BBA-GEN SUBJECTS, V1291, P155, DOI 10.1016/0304-4165(96)00060-8; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Miller DS, 2002, AM J PHYSIOL-REG I, V282, pR191, DOI 10.1152/ajpregu.00305.2001; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Sevatdal S, 2005, PEST MANAG SCI, V61, P772, DOI 10.1002/ps.1057; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Skern-Mauritzen R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-32; SlimIt Bekaert M., 2013, SLIMLT; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Treasurer JW, 2000, AQUAC RES, V31, P855, DOI 10.1046/j.1365-2109.2000.00517.x; Tribble ND, 2007, MOL BIOCHEM PARASIT, V153, P59, DOI 10.1016/j.molbiopara.2007.02.002; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; Wenzel JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3177, DOI 10.2741/2305; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Xu JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-874; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zaja R, 2008, AQUAT TOXICOL, V90, P322, DOI 10.1016/j.aquatox.2008.09.012	77	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137394	10.1371/journal.pone.0137394	http://dx.doi.org/10.1371/journal.pone.0137394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418738	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400006
J	Ghosh, N; Sircar, G; Saha, B; Pandey, N; Bhattacharya, SG				Ghosh, Nandini; Sircar, Gaurab; Saha, Bodhisattwa; Pandey, Naren; Bhattacharya, Swati Gupta			Search for Allergens from the Pollen Proteome of Sunflower (Helianthus annuus L.): A Major Sensitizer for Respiratory Allergy Patients	PLOS ONE			English	Article							IMMUNOPROTEOMIC APPROACH; IMMUNOGLOBULIN-E; MUGWORT POLLEN; FOOD ALLERGY; IDENTIFICATION; RAGWEED; RESPONSES; PROTEINS; WHEAT	Background Respiratory allergy triggered by pollen allergens is increasing at an alarming rate worldwide. Sunflower pollen is thought to be an important source of inhalant allergens. Present study aims to identify the prevalence of sunflower pollinosis among the Indian allergic population and characterizes the pollen allergens using immuno-proteomic tools. Methodology Clinico-immunological tests were performed to understand the prevalence of sensitivity towards sunflower pollen among the atopic population. Sera from selected sunflower positive patients were used as probe to detect the IgE-reactive proteins from the one and two dimensional electrophoretic separated proteome of sunflower pollen. The antigenic nature of the sugar moiety of the glycoallergens was studied by meta-periodate modification of IgE-immunoblot. Finally, these allergens were identified by mass-spectrometry. Results Prevalence of sunflower pollen sensitization was observed among 21% of the pollen allergic population and associated with elevated level of specific IgE and histamine in the sera of these patients. Immunoscreening of sunflower pollen proteome with patient sera detected seven IgE-reactive proteins with varying molecular weight and pI. Hierarchical clustering of 2D-immunoblot data highlighted three allergens characterized by a more frequent immunoreactivity and increased levels of IgE antibodies in the sera of susceptible patients. These allergens were considered as the major allergens of sunflower pollen and were found to have their glycan moiety critical for inducing IgE response. Homology driven search of MS/MS data of these IgE-reactive proteins identified seven previously unreported allergens from sunflower pollen. Three major allergenic proteins were identified as two pectate lyases and a cysteine protease. Conclusion Novelty of the present report is the identification of a panel of seven sunflower pollen allergens for the first time at immuno-biochemical and proteomic level, which substantiated the clinical evidence of sunflower allergy. Further purification and recombinant expression of these allergens will improve component-resolved diagnosis and therapy of pollen allergy.	[Ghosh, Nandini; Sircar, Gaurab; Saha, Bodhisattwa; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Pandey, Naren] Belle Vue Clin, Dept Allergy & Asthma, Kolkata, India	Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Kolkata, W Bengal, India.	swati@jcbose.ac.in	Ghosh, Nandini/AAX-9639-2021	Ghosh, Nandini/0000-0003-0422-6923; Sircar, Gaurab/0000-0002-9067-4564	Indian Council of Medical Research [3/1/3/WL/JRF-2011/HRD-102 (41416)]; Council of Scientific and Industrial Research [03/015(0414)/2011-EMR-I]; University Grant Commission [F.2-8/2002(SA-I)]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India)	NG, GS and BS received funding from Indian Council of Medical Research (Grant No. 3/1/3/WL/JRF-2011/HRD-102 (41416) Dated 19.3.2012), Council of Scientific and Industrial Research (Grant No.03/015(0414)/2011-EMR-I) and University Grant Commission (Grant No. F.2-8/2002(SA-I)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Asero R, 2014, ANN ALLERG ASTHMA IM, V113, P307, DOI 10.1016/j.anai.2014.06.009; Asturias JA, 1998, MOL IMMUNOL, V35, P469, DOI 10.1016/S0161-5890(98)00036-4; Atis S, 2002, ALLERGY, V57, P35, DOI 10.1034/j.1398-9995.2002.01012.x; Benndorf D, 2008, ALLERGY, V63, P454, DOI 10.1111/j.1398-9995.2007.01603.x; Bodinier M, 2008, INT ARCH ALLERGY IMM, V146, P307, DOI 10.1159/000121465; Bouley J, 2015, J ALLERGY CLIN IMMUN; Calcedo R, 2012, REV IBEROAM MICOL, V29, P172, DOI 10.1016/j.riam.2011.07.004; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Chevalier F, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-23; Crameri R, 1998, INT ARCH ALLERGY IMM, V115, P99, DOI 10.1159/000023889; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; DELAHOZ F, 1994, ALLERGY, V49, P848, DOI 10.1111/j.1398-9995.1994.tb00786.x; Dey D, 2014, INT ARCH ALLERGY IMM, V164, P218, DOI 10.1159/000365629; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Hosoki K, 2015, CURR OPIN ALLERGY CL, V15, P79, DOI 10.1097/ACI.0000000000000136; Jeong KY, 2005, CLIN DIAGN LAB IMMUN, V12, P1451, DOI 10.1128/CDLI.12.12.1451-1454.2005; JIMENEZ A, 1994, INT ARCH ALLERGY IMM, V105, P297, DOI 10.1159/000236772; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard R, 2010, J BIOL CHEM, V285, P27192, DOI 10.1074/jbc.M110.127118; Luoto Susanne, 2008, Clin Mol Allergy, V6, P7, DOI 10.1186/1476-7961-6-7; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Monaci L, 2009, TRAC-TREND ANAL CHEM, V28, P581, DOI 10.1016/j.trac.2009.02.013; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Pazmandi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052085; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; PLATTSMILLS TAE, 1981, J ALLERGY CLIN IMMUN, V67, P129, DOI 10.1016/0091-6749(81)90008-7; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; RAO M, 1985, CLIN ALLERGY, V15, P449, DOI 10.1111/j.1365-2222.1985.tb02294.x; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh AB, 2012, ASIA PAC ALLERGY, V2, P210, DOI 10.5415/apallergy.2012.2.3.210; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Sousa R, 2014, J INVEST ALLERG CLIN, V24, P177; SRIRAMARAO P, 1991, CLIN EXP ALLERGY, V21, P55, DOI 10.1111/j.1365-2222.1991.tb00804.x; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4; Yoshida K, 2007, TREE PHYSIOL, V27, P1	42	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138992	10.1371/journal.pone.0138992	http://dx.doi.org/10.1371/journal.pone.0138992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418046	Green Submitted, Green Published, gold			2022-12-26	WOS:000362171400031
J	Inoue, O; Hokamura, K; Shirai, T; Osada, M; Tsukiji, N; Hatakeyama, K; Umemura, K; Asada, Y; Suzuki-Inoue, K; Ozaki, Y				Inoue, Osamu; Hokamura, Kazuya; Shirai, Toshiaki; Osada, Makoto; Tsukiji, Nagaharu; Hatakeyama, Kinta; Umemura, Kazuo; Asada, Yujiro; Suzuki-Inoue, Katsue; Ozaki, Yukio			Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis	PLOS ONE			English	Article							LECTIN RECEPTOR CLEC-2; ATHEROSCLEROTIC LESIONS; IN-VIVO; GLYCOPROTEIN-VI; TISSUE FACTOR; ACTIVATION; S100A13; AGGREGATION; INVOLVEMENT; PODOPLANIN	The platelet receptor CLEC-2 is involved in thrombosis/hemostasis, but its ligand, podoplanin, is expressed only in advanced atherosclerotic lesions. We investigated CLEC-2 ligands in vessel walls. Recombinant CLEC-2 bound to early atherosclerotic lesions and normal arterial walls, co-localizing with vascular smooth muscle cells (VSMCs). Flow cytometry and immunocytochemistry showed that recombinant CLEC-2, but not an anti-podoplanin antibody, bound to VSMCs, suggesting that CLEC-2 ligands other than podoplanin are present in VSMCs. VSMCs stimulated platelet granule release and supported thrombus formation under flow, dependent on CLEC-2. The time to occlusion in a FeCl3-induced animal thrombosis model was significantly prolonged in the absence of CLEC-2. Because the internal elastic lamina was lacerated in our FeCl3-induced model, we assume that the interaction between CLEC-2 and its ligands in VSMCs induces thrombus formation. Protein arrays and Biacore analysis were used to identify S100A13 as a CLEC-2 ligand in VSMCs. However, S100A13 is not responsible for the above-described VSMC-induced platelet activation, because S100A13 is not expressed on the surface of normal VSMCs. S100A13 was released upon oxidative stress and expressed in the luminal area of atherosclerotic lesions. Suspended S100A13 did not activate platelets, but immobilized S100A13 significantly increased thrombus formation on collagen-coated surfaces. Taken together, we proposed that VSMCs stimulate platelets through CLEC-2, possibly leading to thrombus formation after plaque erosion and stent implantation, where VSMCs are exposed to blood flow. Furthermore, we identified S100A13 as one of the ligands on VSMCs.	[Inoue, Osamu; Shirai, Toshiaki; Osada, Makoto; Tsukiji, Nagaharu; Suzuki-Inoue, Katsue; Ozaki, Yukio] Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, Yamanashi 4093898, Japan; [Hokamura, Kazuya] Hamamatsu Univ, Dept Pharmacol, Sch Med, Shizuoka, Japan; [Hatakeyama, Kinta; Umemura, Kazuo; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan	University of Yamanashi; Hamamatsu University School of Medicine; University of Miyazaki	Suzuki-Inoue, K (corresponding author), Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	katsuei@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [20390268]; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP) [LS052]; Grants-in-Aid for Scientific Research [26461399] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (YO, No. 20390268, https://www.jsps.go.jp/english/e-grants/index.html), the Takeda Science Foundation (OI, http://www.takeda-sci.or.jp/), and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP) (KS-I, LS052, http://www.jsps.go.jp/english/e-jisedai/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender M, 2013, ARTERIOSCL THROM VAS, V33, P926, DOI 10.1161/ATVBAHA.112.300672; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Blanc A, 2003, INT J MOL MED, V11, P229; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Cosemans JMEM, 2013, CARDIOVASC RES, V99, P342, DOI 10.1093/cvr/cvt110; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Hatakeyama K, 1997, ATHEROSCLEROSIS, V133, P213, DOI 10.1016/S0021-9150(97)00132-9; Hatakeyama K, 2012, THROMB RES, V129, pE70, DOI 10.1016/j.thromres.2012.01.003; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; HIRATA Y, 1994, ATHEROSCLEROSIS, V107, P117, DOI 10.1016/0021-9150(94)90147-3; Hughes CE, 2010, J THROMB HAEMOST, V8, P2328, DOI 10.1111/j.1538-7836.2010.04006.x; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Ishikawa T, 2004, HEART, V90, P1206, DOI 10.1136/hrt.2003.017921; Kathir KM, 2010, BBA-BIOMEMBRANES, V1798, P297, DOI 10.1016/j.bbamem.2009.09.024; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kikuchi S, 1998, ARTERIOSCL THROM VAS, V18, P1069, DOI 10.1161/01.ATV.18.7.1069; Lambros MP, 2011, BIOCHEM BIOPH RES CO, V405, P102, DOI 10.1016/j.bbrc.2010.12.135; Landriscina M, 2006, J NEURO-ONCOL, V80, P251, DOI 10.1007/s11060-006-9189-y; Li CY, 2010, MOL VIS, V16, P2225; Mandinov L, 2003, P NATL ACAD SCI USA, V100, P6700, DOI 10.1073/pnas.1231994100; Mandinova A, 2003, J CELL SCI, V116, P2687, DOI 10.1242/jcs.00471; Massi D, 2010, MODERN PATHOL, V23, P804, DOI 10.1038/modpathol.2010.54; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Mohan SK, 2011, J BIOL CHEM, V286, P14608, DOI 10.1074/jbc.M110.201954; Morowski M, 2013, BLOOD, V121, P4938, DOI 10.1182/blood-2012-10-461459; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Pierce A, 2008, EUR J CANCER, V44, P151, DOI 10.1016/j.ejca.2007.10.017; Ridinger K, 2000, J BIOL CHEM, V275, P8686, DOI 10.1074/jbc.275.12.8686; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Shin Y, 1998, BIOCHEM BIOPH RES CO, V245, P741, DOI 10.1006/bbrc.1998.8516; Siddiqi OK, 2012, CURR OPIN CARDIOL, V27, P634, DOI 10.1097/HCO.0b013e3283587c7e; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tsuruo T, 2008, P JPN ACAD A-MATH, V84, P189, DOI 10.2183/pjab/84.189	42	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139357	10.1371/journal.pone.0139357	http://dx.doi.org/10.1371/journal.pone.0139357			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418160	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400083
J	Singh, AK; Berbis, MA; Ballmann, MZ; Kilcoyne, M; Menendez, M; Nguyen, TH; Joshi, L; Canada, FJ; Jimenez-Barbero, J; Benko, M; Harrach, B; van Raaij, MJ				Singh, Abhimanyu K.; Berbis, M. Alvaro; Ballmann, Monika Z.; Kilcoyne, Michelle; Menendez, Margarita; Nguyen, Thanh H.; Joshi, Lokesh; Javier Canada, F.; Jimenez-Barbero, Jesus; Benko, Maria; Harrach, Balazs; van Raaij, Mark J.			Structure and Sialyllactose Binding of the Carboxy-Terminal Head Domain of the Fibre from a Siadenovirus, Turkey Adenovirus 3	PLOS ONE			English	Article							HEMORRHAGIC ENTERITIS VIRUS; MARBLE SPLEEN DISEASE; CELLULAR RECEPTOR; CRYSTAL-STRUCTURE; GENE-THERAPY; SIALIC-ACID; GENOME ORGANIZATION; ATTACHMENT PROTEIN; NMR-SPECTROSCOPY; AVIAN ADENOVIRUS	The virulent form of turkey adenovirus 3 (TAdV-3), also known as turkey hemorrhagic enteritis virus (THEV), is an economically important poultry pathogen, while the avirulent form is used as a vaccine. TAdV-3 belongs to the genus Siadenovirus. The carboxy-terminal region of its fibre does not have significant sequence similarity to any other adenovirus fibre heads of known structure. Two amino acid sequence differences between virulent and avirulent TAdV-3 map on the fibre head: where virulent TAdV-3 contains Ile354 and Thr376, avirulent TAdV-3 contains Met354 and Met376. We determined the crystal structures of the trimeric virulent and avirulent TAdV-3 fibre head domains at 2.2 angstrom resolution. Each monomer contains a beta-sandwich, which, surprisingly, resembles reovirus fibre head more than other adenovirus fibres, although the ABCJ-GHID topology is conserved in all. A beta-hairpin insertion in the C-strand of each trimer subunit embraces its neighbouring monomer. The avirulent and virulent TAdV-3 fibre heads are identical apart from the exact orientation of the beta-hairpin insertion. In vitro, sialyllactose was identified as a ligand by glycan microarray analysis, nuclear magnetic resonance spectroscopy, and crystallography. Its dissociation constant was measured to be in the mM range by isothermal titration calorimetry. The ligand binds to the side of the fibre head, involving amino acids Glu392, Thr419, Val420, Lys421, Asn422, and Gly423 binding to the sialic acid group. It binds slightly more strongly to the avirulent form. We propose that, in vivo, the TAdV-3 fibre may bind a sialic acid-containing cell surface component.	[Singh, Abhimanyu K.; Nguyen, Thanh H.; van Raaij, Mark J.] CSIC, CNB, Dept Estruct Macromol, Madrid, Spain; [Berbis, M. Alvaro; Javier Canada, F.; Jimenez-Barbero, Jesus] CSIC, CIB, Dept Biol Fis Quim, Madrid, Spain; [Ballmann, Monika Z.; Benko, Maria; Harrach, Balazs] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Hungary; [Kilcoyne, Michelle; Joshi, Lokesh] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Glycosci Grp, Galway, Ireland; [Kilcoyne, Michelle] Natl Univ Ireland Galway, Sch Nat Sci, Microbiol, Galway, Ireland; [Menendez, Margarita] CSIC, IQFR, Dept Quim Fis Biol, E-28006 Madrid, Spain; [Menendez, Margarita] CIBER Enfermedades Resp CIBERES, E-28006 Madrid, Spain; [Jimenez-Barbero, Jesus] Ctr Invest Cooperat Biociencias CIC BioGUNE, Derio, Spain; [Jimenez-Barbero, Jesus] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Basque Foundation for Science	van Raaij, MJ (corresponding author), CSIC, CNB, Dept Estruct Macromol, Madrid, Spain.	mjvanraaij@cnb.csic.es	Harrach, Balázs/A-3680-2008; Cañada, Francisco J./D-5837-2014; JIMENEZ-BARBERO, JESUS/D-4431-2014; Singh, Abhimanyu K./U-5881-2019; BENKO, Maria/A-4135-2008; Harrach, Balazs/AAC-2154-2020; Menendez, Margarita/M-1795-2014; van Raaij, Mark J/B-3678-2009; Singh, Abhimanyu K./C-2243-2019	Harrach, Balázs/0000-0002-1410-6469; Cañada, Francisco J./0000-0003-4462-1469; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Singh, Abhimanyu K./0000-0002-9998-020X; Menendez, Margarita/0000-0002-3267-4443; van Raaij, Mark J/0000-0002-4781-1375; Singh, Abhimanyu K./0000-0002-9998-020X; NGUYEN, THANH-HONG/0000-0002-7079-4200; Kilcoyne, Michelle/0000-0002-8870-1308; Joshi, Lokesh/0000-0002-3612-0747	Spanish Ministry of Economy and Competitiveness [BFU2011-24843, CTQ2012-32025, BFU2012-36825]; MHit; Comunidad de Madrid [BIPEDD2-CM]; CIBER of Respiratory Diseases (CIBERES) from the Institute of Health Carlos III; European Union [BM1003, CM1102 COST actions]; GLYCOPHARM ITN project; GlycoHIT project [260600]; TIDA award from Science Foundation Ireland [13/TIDA/B2687]; Enterprise Ireland; Hungarian Scientific Research Fund [OTKA K100163]; La Caixa; Spanish Ministry of Economy and Competitiveness (FPI); CSIC-VAST	Spanish Ministry of Economy and Competitiveness(Spanish Government); MHit; Comunidad de Madrid(Comunidad de Madrid); CIBER of Respiratory Diseases (CIBERES) from the Institute of Health Carlos III; European Union(European Commission); GLYCOPHARM ITN project; GlycoHIT project; TIDA award from Science Foundation Ireland(Science Foundation Ireland); Enterprise Ireland; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); La Caixa(La Caixa Foundation); Spanish Ministry of Economy and Competitiveness (FPI)(Spanish Government); CSIC-VAST	This research was sponsored by grants BFU2011-24843 (to MJvR), CTQ2012-32025 (to JJB) and BFU2012-36825 (to MM) from the Spanish Ministry of Economy and Competitiveness, the MHit (to JJB) and BIPEDD2-CM (to MM) projects from the Comunidad de Madrid, the CIBER of Respiratory Diseases (CIBERES) from the Institute of Health Carlos III (to MM), the European Union-funded BM1003 and CM1102 COST actions (to JJB), the GLYCOPHARM ITN project (to JJB), the GlycoHIT project (grant no. 260600; to MK and LJ), a TIDA (13/TIDA/B2687) award from Science Foundation Ireland and Enterprise Ireland (to MK) and by grant OTKA K100163 from the Hungarian Scientific Research Fund (to MB and BH). AKS, MAB and THN were recipients of pre-doctoral fellowships from La Caixa, the Spanish Ministry of Economy and Competitiveness (FPI) and CSIC-VAST, respectively.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2002, VIROLOGY, V302, P33, DOI 10.1006/viro.2002.1503; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Ballmann MZ, 2013, MAGY ALLATORVOSOK, V135, P78; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beach NM, 2009, AVIAN DIS, V53, P370, DOI 10.1637/8575-010509-Reg.1; Beach NM, 2009, J GEN VIROL, V90, P1978, DOI 10.1099/vir.0.010090-0; Benko M, 1998, ARCH VIROL, V143, P829, DOI 10.1007/s007050050335; Benko M., 2008, ENCY VIROLOGY, V3rd, P24; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2000, J GEN VIROL, V81, P2431, DOI 10.1099/0022-1317-81-10-2431; DOMERMUTH CH, 1979, AVIAN DIS, V23, P30, DOI 10.2307/1589668; DOMERMUTH CH, 1977, AVIAN DIS, V21, P557, DOI 10.2307/1589414; DOMERMUTH CH, 1979, AVIAN DIS, V23, P479, DOI 10.2307/1589578; Dupeux F, 2011, ACTA CRYSTALLOGR D, V67, P915, DOI 10.1107/S0907444911036225; El Bakkouri M, 2008, VIROLOGY, V378, P169, DOI 10.1016/j.virol.2008.05.011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Gerlach JQ, 2011, ADV EXP MED BIOL, V705, P257, DOI 10.1007/978-1-4419-7877-6_12; Guardado-Calvo P, 2007, J GEN VIROL, V88, P2407, DOI 10.1099/vir.0.82845-0; Guardado-Calvo P, 2010, J VIROL, V84, P10558, DOI 10.1128/JVI.00997-10; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; HESS M, 1995, J MOL BIOL, V252, P379, DOI 10.1006/jmbi.1995.0504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joseph HM, 2014, VET MICROBIOL, V172, P35, DOI 10.1016/j.vetmic.2014.04.006; Kilcoyne M, 2012, ANAL METHODS-UK, V4, P2721, DOI 10.1039/c2ay25532d; Kilcoyne M, 2012, ANAL CHEM, V84, P3330, DOI 10.1021/ac203404n; Kirchner E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000235; Kovacs ER, 2011, INFECT GENET EVOL, V11, P1058, DOI 10.1016/j.meegid.2011.03.021; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lenman A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004657; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mitraki A, 2006, ADV PROTEIN CHEM, V73, P97, DOI 10.1016/S0065-3233(06)73004-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Noureddini SC, 2005, MOL PHARMACEUT, V2, P341, DOI 10.1021/mp050045c; Palya V, 2007, ACTA VET HUNG, V55, P135, DOI 10.1556/AVet.55.2007.1.13; Park YM, 2012, VIROLOGY, V422, P144, DOI 10.1016/j.virol.2011.10.008; Penzes JJ, 2014, J VIROL, V88, P11304, DOI 10.1128/JVI.00306-14; Pitcovski J, 1998, VIROLOGY, V249, P307, DOI 10.1006/viro.1998.9336; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Martin CS, 2012, VIRUSES-BASEL, V4, P847, DOI 10.3390/v4050847; Schelling P, 2007, J BIOL CHEM, V282, P11582, DOI 10.1074/jbc.M610805200; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; SILIM A, 1978, AVIAN DIS, V22, P106, DOI 10.2307/1589513; Singh AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114373; Singh AK, 2013, ACTA CRYSTALLOGR F, V69, P1135, DOI 10.1107/S174430911302397X; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; Thomson D, 2002, VIRUS RES, V83, P189, DOI 10.1016/S0168-1702(01)00437-3; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; Wellehan JFX, 2009, AVIAN PATHOL, V38, P413, DOI 10.1080/03079450903183660; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X	81	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139339	10.1371/journal.pone.0139339	http://dx.doi.org/10.1371/journal.pone.0139339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418008	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400080
J	Fan, LY; Sun, Y; Lee, HJ; Yang, SC; Chen, TF; Lin, KN; Lin, CC; Wang, PN; Tang, LY; Chiu, MJ				Fan, Ling-Yun; Sun, Yu; Lee, Huey-Jane; Yang, Shu-Chien; Chen, Ta-Fu; Lin, Ker-Neng; Lin, Chung-Chi; Wang, Pei-Ning; Tang, Li-Yu; Chiu, Ming-Jang			Marital Status, Lifestyle and Dementia: A Nationwide Survey in Taiwan	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; COGNITIVE DECLINE; ALZHEIMERS-DISEASE; INDIVIDUALS; POPULATION; IMPAIRMENT; PREVALENCE; AGE; DURATION; SUBTYPES	Background Evidence of an association between lifestyle and marital status and risk of dementia is limited in Asia. Methods In this nationwide population-based cross-sectional survey, participants were selected by computerized random sampling from all 19 counties in Taiwan. A total of 10432 residents were assessed by a door-to-door in-person survey, among whom 7035 were normal and 929 were diagnosed with dementia using the criteria recommended by National Institute on Aging-Alzheimer's Association. Premorbid lifestyle habits and demographic data including marital status were compared between normal subjects and participants with dementia. Results After adjustment for age, gender, education, body mass index, smoking, drinking, marital status, sleep habits, exercise, social engagement and co-morbidities including hypertension, diabetes and cerebrovascular diseases, an increased risk for dementia was found in people with widow or widower status (OR 1.42, 95% CI 1.15-1.77) and people who used to take a nap in the afternoon (OR 1.33, 95% CI 1.02-1.72). Decreased risk was found in people with the habit of regular exercise (OR 0.12, 95% CI 0.09-0.16), adequate night sleep (OR 0.55, 95% CI 0.39-0.76) and regular social engagement (OR 0.53, 95% CI 0.36-0.77). Conclusions Our results provide preliminary evidence of possible risk-reduction effects for dementia, including regular exercise even in modest amounts, social engagement and adequate night sleep, whereas people with the widow/widower status or who used to take an afternoon nap might have increased risk of dementia.	[Fan, Ling-Yun; Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei, Taiwan; [Fan, Ling-Yun; Chen, Ta-Fu; Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Huey-Jane; Yang, Shu-Chien; Tang, Li-Yu] Taiwan Alzheimers Dis Assoc, Taipei, Taiwan; [Lin, Ker-Neng; Wang, Pei-Ning] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Chung-Chi] Chung Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Psychol, Coll Sci, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Chiu, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	mjchiu@ntu.edu.tw	Chiu, Ming-Jang/AAR-3940-2020	Chiu, Ming-Jang/0000-0002-4158-4423; Chen, Ta-Fu/0000-0003-1988-6924	Ministry of Health and Welfare [DOH100-TD-M113-100001]; Taiwan Alzheimer's Disease Association	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Taiwan Alzheimer's Disease Association	The project was supported in part by Ministry of Health and Welfare (DOH100-TD-M113-100001) and in part by Taiwan Alzheimer's Disease Association. The Ministry of Health and Welfare has contributed in part to the study design by setting the aims for this project.	Aartsen MJ, 2005, PSYCHOL MED, V35, P217, DOI 10.1017/S0033291704002831; Asada T, 2000, SLEEP, V23, P629; Auyeung TW, 2013, AGE, V35, P479, DOI 10.1007/s11357-011-9366-6; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Brooks A, 2006, SLEEP, V29, P831, DOI 10.1093/sleep/29.6.831; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Elcombe EL, 2014, JAD; Ficca G, 2010, SLEEP MED REV, V14, P249, DOI 10.1016/j.smrv.2009.09.005; Glei DA, 2005, INT J EPIDEMIOL, V34, P864, DOI 10.1093/ije/dyi049; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Lin KP, 2015, ARCH GERONTOL GERIAT, V60, P501, DOI 10.1016/j.archger.2015.01.009; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu CK TC, 2007, RES APPL PSYCHOL, V7, P157; LIU HC, 1994, PSYCHOL MED, V24, P763, DOI 10.1017/S0033291700027914; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Merlino G, 2010, SLEEP MED, V11, P372, DOI 10.1016/j.sleep.2009.07.018; Mousavi-Nasab SMH, 2012, SCAND J PSYCHOL, V53, P1, DOI 10.1111/j.1467-9450.2011.00926.x; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Shyu YIL, 2001, J FORMOS MED ASSOC, V100, P676; Solomon A, 2014, J INTERN MED, V275, P229, DOI 10.1111/joim.12178; Sorman DE, 2014, J GERONTOL B-PSYCHOL, V69, P493, DOI 10.1093/geronb/gbt056; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; Xavier FMF, 2002, J CLIN EXP NEUROPSYC, V24, P294, DOI 10.1076/jcen.24.3.294.983; Yang SY, 2014, J FORMOSAN MED ASS	33	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139154	10.1371/journal.pone.0139154	http://dx.doi.org/10.1371/journal.pone.0139154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26413719	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700046
J	Arias, CI; Siri, SO; Conde, C				Arias, Cristina Isabel; Siri, Sebastian Omar; Conde, Cecilia			Involvement of SARA in Axon and Dendrite Growth	PLOS ONE			English	Article							RECEPTOR ACTIVATION SARA; FYVE DOMAIN PROTEIN; SMAD ANCHOR; RECYCLING COMPARTMENT; SECRETORY TRAFFICKING; MEMBRANE DYNAMICS; EARLY ENDOSOMES; RAB PROTEINS; CELL-SURFACE; TRANSPORT	SARA (Smad Anchor for Receptor Activation) plays a crucial role in Rab5-mediated endocytosis in cell lines localizing to early endosomes where it regulates morphology and function. Here, we analyzed the role of SARA during neuronal development and tested whether it functions as a regulator of endocytic trafficking of selected axonal and membrane proteins. Suppression of SARA perturbs the appearance of juxtanuclear endocytic recycling compartments and the neurons show long axons with large growth cones. Furthermore, surface distribution of the cell adhesion molecule L1 in axons and the fusion of vesicles containing transferring receptor (TfR) in dendrites were increased in neurons where SARA was silenced. Conversely, SARA overexpression generated large early endosomes and reduced neurite outgrowth. Taken together, our findings suggest a significant contribution of SARA to key aspects of neuronal development, including neurite formation.	[Arias, Cristina Isabel; Siri, Sebastian Omar; Conde, Cecilia] INIMEC CONICET, Lab Neurobiol, Cordoba, Argentina; [Siri, Sebastian Omar; Conde, Cecilia] Natl Univ Cordoba, Cordoba, Argentina; [Siri, Sebastian Omar; Conde, Cecilia] Inst Univ Ciencias Biomed Cordoba, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Conde, C (corresponding author), INIMEC CONICET, Lab Neurobiol, Cordoba, Argentina.	cconde@immf.uncor.edu		Conde, Cecilia/0000-0002-5103-6391	FONCyT (Argentina) [PICT 2008-0671, PICT V 2010-1277]; Agencia Cordoba Ciencia (Argentina); CONICET (Argentina)	FONCyT (Argentina)(FONCyT); Agencia Cordoba Ciencia (Argentina); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding: This work was supported by grants from FONCyT (Argentina): PICT 2008-0671 to CC and PICT V 2010-1277 and Agencia Cordoba Ciencia (Argentina) to A. Caceres and CC. CIA and SOS hold a doctoral fellowship from CONICET (Argentina).	Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Bisbal M, 2009, J BIOL CHEM, V284, P9489, DOI 10.1074/jbc.M808586200; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chang HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105299; Chavrier P, 1997, CYTOMETRY, V29, P41, DOI 10.1002/(SICI)1097-0320(19970901)29:1<41::AID-CYTO4>3.0.CO;2-G; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Corbeel L, 2008, EUR J PEDIATR, V167, P723, DOI 10.1007/s00431-008-0740-z; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Falk J, 2014, J NEUROSCI, V34, P373, DOI 10.1523/JNEUROSCI.0876-13.2014; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kostaras E, 2013, ONCOGENE, V32, P5220, DOI 10.1038/onc.2012.554; Krauss M, 2011, REV PHYSIOL BIOCH P, V161, P45, DOI 10.1007/112_2008_2; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2012, J BIOL CHEM, V287, P35815, DOI 10.1074/jbc.M112.380493; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Shieh JC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017802, 10.1371/journal.pone.0019481]; Shilo BZ, 2011, EMBO J, V30, P3516, DOI 10.1038/emboj.2011.269; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Villarroel-Campos D, 2014, J NEUROCHEM, V129, P240, DOI 10.1111/jnc.12676; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Winckler B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001826; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Yap CC, 2008, J CELL SCI, V121, P1514, DOI 10.1242/jcs.022442; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	80	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138792	10.1371/journal.pone.0138792	http://dx.doi.org/10.1371/journal.pone.0138792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405814	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700097
J	Koh, SH; Liang, AC; Takahashi, Y; Maki, T; Shindo, A; Osumi, N; Zhao, J; Lin, H; Holder, JC; Chuang, TT; McNeish, JD; Arai, K; Lo, EH				Koh, Seong-Ho; Liang, Anna C.; Takahashi, Yoko; Maki, Takakuni; Shindo, Akihiro; Osumi, Noriko; Zhao, Jing; Lin, Hong; Holder, Julie C.; Chuang, Tsu Tshen; McNeish, John D.; Arai, Ken; Lo, Eng H.			Differential Effects of Isoxazole-9 on Neural Stem/Progenitor Cells, Oligodendrocyte Precursor Cells, and Endothelial Progenitor Cells	PLOS ONE			English	Article							STROKE RECOVERY; SMALL-MOLECULE; STEM-CELLS; BRAIN; ANGIOGENESIS; NEUROGENESIS; PROLIFERATION; TRANSLATION; THERAPY; FATE	Adult mammalian brain can be plastic after injury and disease. Therefore, boosting endogenous repair mechanisms would be a useful therapeutic approach for neurological disorders. Isoxazole-9 (Isx-9) has been reported to enhance neurogenesis from neural stem/progenitor cells (NSPCs). However, the effects of Isx-9 on other types of progenitor/precursor cells remain mostly unknown. In this study, we investigated the effects of Isx-9 on the three major populations of progenitor/precursor cells in brain: NSPCs, oligodendrocyte precursor cells (OPCs), and endothelial progenitor cells (EPCs). Cultured primary NSPCs, OPCs, or EPCs were treated with various concentrations of Isx-9 (6.25, 12.5, 25, 50 mu M), and their cell numbers were counted in a blinded manner. Isx-9 slightly increased the number of NSPCs and effectively induced neuronal differentiation of NSPCs. However, Isx-9 significantly decreased OPC number in a concentration-dependent manner, suggesting cytotoxicity. Isx-9 did not affect EPC cell number. But in a matrigel assay of angiogenesis, Isx-9 significantly inhibited tube formation in outgrowth endothelial cells derived from EPCs. This potential anti-tube-formation effect of Isx-9 was confirmed in a brain endothelial cell line. Taken together, our data suggest that mechanisms and targets for promoting stem/progenitor cells in the central nervous system may significantly differ between cell types.	[Koh, Seong-Ho; Liang, Anna C.; Takahashi, Yoko; Maki, Takakuni; Shindo, Akihiro; Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol & Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Koh, Seong-Ho; Liang, Anna C.; Takahashi, Yoko; Maki, Takakuni; Shindo, Akihiro; Arai, Ken; Lo, Eng H.] Harvard Univ, Sch Med, Charlestown, MA USA; [Koh, Seong-Ho] Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea; [Takahashi, Yoko; Osumi, Noriko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Dev Neurosci, Sendai, Miyagi 980, Japan; [Zhao, Jing; Lin, Hong; Holder, Julie C.; Chuang, Tsu Tshen; McNeish, John D.] GlaxoSmithKline, Regenerat Med Discovery Performance Unit, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Hanyang University; Tohoku University; GlaxoSmithKline	Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Radiol & Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.	Lo@helix.mgh.harvard.edu	眞木, 崇州/AAO-1160-2020; Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452	National Institutes of Health [P01-NS55104]; Uehara Memorial Foundation; Glaxo-Smith-Kline-Harvard-Stem-Cell-Institute consortium; Glaxo-Smith-Kline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065089, P01NS055104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Glaxo-Smith-Kline-Harvard-Stem-Cell-Institute consortium; Glaxo-Smith-Kline(GlaxoSmithKline); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported in part by grants from the National Institutes of Health (P01-NS55104), the Uehara Memorial Foundation, and the Glaxo-Smith-Kline-Harvard-Stem-Cell-Institute consortium. Salaries for authors with primary appointments with Glaxo-Smith-Kline (JZ, HL, JCH, TTC, and JDM) were paid by Glaxo-Smith-Kline. JZ, HL, JCH, TTC, and JDM participated in study design and data analysis.	Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Diamandis T, 2015, STROKE, V46, P588, DOI 10.1161/STROKEAHA.114.007105; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Hayakawa K, 2012, P NATL ACAD SCI USA, V109, P7505, DOI 10.1073/pnas.1121146109; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Jang W, 2015, MOL NEUROBIOL, V51, P558, DOI 10.1007/s12035-014-8835-1; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Miyamoto N, 2013, STROKE, V44, P3516, DOI 10.1161/STROKEAHA.113.002813; Park HH, 2014, NEUROBIOL AGING, V35, P1255, DOI 10.1016/j.neurobiolaging.2013.12.015; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Rosell A, 2009, J CEREBR BLOOD F MET, V29, P933, DOI 10.1038/jcbfm.2009.17; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Xing CH, 2012, J CEREBR BLOOD F MET, V32, P983, DOI 10.1038/jcbfm.2012.48; Zhang J, 2009, J CEREBR BLOOD F MET, V29, P1166, DOI 10.1038/jcbfm.2009.41; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	25	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138724	10.1371/journal.pone.0138724	http://dx.doi.org/10.1371/journal.pone.0138724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407349	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700076
J	Mali, I; Wang, HH; Grant, WE; Feldman, M; Forstner, MRJ				Mali, Ivana; Wang, Hsiao-Hsuan; Grant, William E.; Feldman, Mark; Forstner, Michael R. J.			Modeling Commercial Freshwater Turtle Production on US Farms for Pet and Meat Markets	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; HARVEST; TRADE; EXTINCTION; CHINA; ASIA	Freshwater turtles are being exploited for meat, eggs, traditional medicine, and pet trade. As a response, turtle farming became a booming aquaculture industry in the past two decades, specifically in the southeastern states of the United States of America (US) and across Southeast Asia. However, US turtle farms are currently producing turtles only for the pet trade while commercial trappers remain focused on catching the largest individuals from the wild. In our analyses we have created a biological and economic model that describes farming operations on a representative turtle farm in Louisiana. We first modeled current production of hatchling and yearling red-eared slider turtles (Trachemys scripta elegans) (i.e., traditional farming) for foreign and domestic pet markets, respectively. We tested the possibility of harvesting adult turtles from the breeding stock for sale to meat markets to enable alternative markets for the farmers, while decreasing the continued pressures on wild populations (i.e., non-traditional farming). Our economic model required current profit requirements of similar to$13/turtle or similar to$20.31/kg of meat from non-traditional farming in order to acquire the same profit as traditional farming, a value which currently exceeds market values of red-eared sliders. However, increasing competition with Asian turtle farms and decreasing hatchling prices may force the shift in the US toward producing turtles for meat markets. In addition, our model can be modified and applied to more desirable species on the meat market once more knowledge is acquired about species life histories and space requirements under farmed conditions.	[Mali, Ivana; Forstner, Michael R. J.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Wang, Hsiao-Hsuan; Grant, William E.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas State University System; Texas State University San Marcos; Texas A&M University System; Texas A&M University College Station	Mali, I (corresponding author), Eastern New Mexico Univ, Dept Biol, Portales, NM 88130 USA.	im1040@txstate.edu	Wang, Hsiao-Hsuan/AAE-7933-2020	Wang, Hsiao-Hsuan/0000-0002-7850-0406				Alves RRN, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-3; Brown DJ, 2011, J WILDLIFE MANAGE, V75, P486, DOI 10.1002/jwmg.73; Ceballos CP, 2004, WILDLIFE SOC B, V32, P881, DOI 10.2193/0091-7648(2004)032[0881:TTINAE]2.0.CO;2; Chen TH, 2009, CHELONIAN CONSERV BI, V8, P11, DOI 10.2744/CCB-0747.1; Cheung SM, 2006, AQUAT CONSERV, V16, P751, DOI 10.1002/aqc.803; Close Lisa M., 1997, Chelonian Conservation and Biology, V2, P563; Eagle J, 2004, MAR POLICY, V28, P259, DOI 10.1016/j.marpol.2003.08.001; Eisemberg CC, 2011, BIOL CONSERV, V144, P2282, DOI 10.1016/j.biocon.2011.06.005; Ernst CH, 2009, TURTLES US CANADA; EWERT MA, 1994, J EXP ZOOL, V270, P3, DOI 10.1002/jez.1402700103; Fordham DA, 2008, J APPL ECOL, V45, P52, DOI 10.1111/j.1365-2664.2007.01414.x; Gong SP, 2009, ORYX, V43, P213, DOI 10.1017/S0030605308000902; HALLIDAY TR, 1980, BIOL CONSERV, V17, P157, DOI 10.1016/0006-3207(80)90046-4; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Heinsohn R, 2004, ANIM CONSERV, V7, P417, DOI 10.1017/S1367943004001593; Heykoop J., 2001, Marine Resource Economics, V16, P127; Hughes DW, 1999, AQUACULT ECON MANAG, V3, P250; Jonzen N, 2001, MAR ECOL PROG SER, V210, P291, DOI 10.3354/meps210291; Klemens MW, 2000, TURTLE CONSERVATION; Louisiana State University AgCenter, 2013, AGR IS BACKB LOUIS E; Mali I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086478; Meng Xianlin, 2002, Turtle and Tortoise Newsletter, V5, P15; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Pongtanapanich T., 2007, WITTHAYASAN KASETSAR, V22, P42; Porter M.E, 1980, COMPETITIVE STRATEGY; Shi HT, 2008, ORYX, V42, P147, DOI 10.1017/S0030605308000562; Shi HT, 2007, CONSERV BIOL, V21, P5, DOI 10.1111/j.1523-1739.2006.00622_2.x; Wibbels T, 1998, J EXP ZOOL, V281, P409, DOI 10.1002/(SICI)1097-010X(19980801)281:5<409::AID-JEZ6>3.0.CO;2-S; Zimmer-Shaffer SA, 2014, CHELONIAN CONSERV BI, V13, P227, DOI 10.2744/CCB-1109.1	29	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139053	10.1371/journal.pone.0139053	http://dx.doi.org/10.1371/journal.pone.0139053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407157	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700155
J	Petric, RC; Braicu, C; Bassi, C; Pop, L; Taranu, I; Dragos, N; Dumitrascu, D; Negrini, M; Berindan-Neagoe, I				Petric, Roxana Cojocneanu; Braicu, Cornelia; Bassi, Cristian; Pop, Laura; Taranu, Ionelia; Dragos, Nicolae; Dumitrascu, Dan; Negrini, Massimo; Berindan-Neagoe, Ioana			Interspecies Gene Name Extrapolation-A New Approach	PLOS ONE			English	Article							MICROBIOTA	The use of animal models has facilitated numerous scientific developments, especially when employing "omics" technologies to study the effects of various environmental factors on humans. Our study presents a new bioinformatics pipeline suitable when the generated microarray data from animal models does not contain the necessary human gene name annotation. We conducted single color gene expression microarray on duodenum and spleen tissue obtained from pigs which have been exposed to zearalenone and Escherichia coli contamination, either alone or combined. By performing a combination of file format modifications and data alignments using various online tools as well as a command line environment, we performed the pig to human gene name extrapolation with an average yield of 58.34%, compared to 3.64% when applying more simple methods. In conclusion, while online data analysis portals on their own are of great importance in data management and assessment, our new pipeline provided a more effective approach for a situation which can be frequently encountered by researchers in the "omics" era.	[Petric, Roxana Cojocneanu] Univ Babes Bolyai, Dept Biol, R-3400 Cluj Napoca, Romania; [Petric, Roxana Cojocneanu; Braicu, Cornelia; Pop, Laura; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania; [Bassi, Cristian] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Taranu, Ionelia] Natl Inst Res & Dev Biol & Anim Nutr, Balotesti, Romania; [Dragos, Nicolae] Inst Biol Res, Taxon & Ecol Dept, Cluj Napoca, Romania; [Dumitrascu, Dan] Iuliu Hatieganu Univ Med & Pharm, Dept Internal Med 2, Cluj Napoca, Romania; [Negrini, Massimo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Negrini, Massimo] Univ Ferrara, LTTA, I-44100 Ferrara, Italy; [Berindan-Neagoe, Ioana] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Braicu, Cornelia; Berindan-Neagoe, Ioana] Oncol Inst Prof Dr Ion Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Dept Immunol, Cluj Napoca, Romania	Babes Bolyai University from Cluj; Iuliu Hatieganu University of Medicine & Pharmacy; University of Ferrara; National Research Institute for Biological Sciences; Iuliu Hatieganu University of Medicine & Pharmacy; University of Ferrara; University of Ferrara; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy	Petric, RC (corresponding author), Univ Babes Bolyai, Dept Biol, R-3400 Cluj Napoca, Romania.	cojocneanur@gmail.com	Pop, Laura/AAY-8349-2020; Negrini, Massimo/J-2377-2016; Berindan-Neagoe, Ioana/AAH-9854-2019; Bassi, Cristian/K-2356-2018	Pop, Laura/0000-0002-5806-0220; Negrini, Massimo/0000-0002-0007-1920; Bassi, Cristian/0000-0002-5823-709X; Taranu, Ionelia/0000-0003-0727-5827; Cojocneanu, Roxana-Maria/0000-0002-7450-9454	Romanian Ministry of Research and Technology [PNII-PCCA-102/2011-2016]	Romanian Ministry of Research and Technology	This work was supported by funds from the Romanian Ministry of Research and Technology: PNII-PCCA-102/2011-2016 with title "Impact of feed co-contamination and mitigating solutions to increase feed safety, animal health and food quality" (CB IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cekanova M, 2014, DRUG DES DEV THER, V8, P1911, DOI 10.2147/DDDT.S49584; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Huffnagle Gary, 2008, Adv Exp Med Biol, V635, pv; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kollarczik Birgit, 1994, Natural Toxins, V2, P105, DOI 10.1002/nt.2620020303; Piotrowska M, 2014, TOXINS, V6, P2064, DOI 10.3390/toxins6072064; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Zammataro L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S8	11	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138751	10.1371/journal.pone.0138751	http://dx.doi.org/10.1371/journal.pone.0138751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407293	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700086
J	Wang, HM; Zhao, X; Guo, CH; Ren, DQ; Zhao, YD; Xiao, W; Jiao, WJ				Wang, Hongmei; Zhao, Xin; Guo, Caihong; Ren, Dunqiang; Zhao, Yandong; Xiao, Wei; Jiao, Wenjie			Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GENE-DELIVERY; DRUG; P53; APOPTOSIS; DEATH; BCL-2	Metastasis and drug resistance are major barriers for the treatment of non-small cell lung cancer (NSCLC). To explore new therapeutic options, we successfully encapsulated MicroRNA-34a (miR-34a), a potent endogenous tumor suppressor in NSCLC into S6 aptamer-conjugated dendrimer to form lung cancer-targeted gene delivery nanoparticles (PAM-Ap/pMiR-34a NPs). PAM-Ap/pMiR-34a NPs had a diameter of 100-200 nm and Zeta potential of similar to 30 mV at applied N/P ratio. The aptamer conjugation significantly improved cellular uptake as well as gene transfection efficiency of PAM-Ap/pMiR-34a NPs in cultured NSCLC cells. We showed that PAM-Ap/pMiR-34a NPs enhanced the regulation of targeted genes, BCL-2 and p53 in vitro. In addition, we revealed PAM-Ap/pMiR-34a NPs significantly inhibited cell growth, migration, invasion and induced apoptosis of lung cancer cells compared with non-targeted NPs. The method provided a novel therapeutic strategy for the experimental treatment of NSCLC.	[Wang, Hongmei; Guo, Caihong; Ren, Dunqiang] Qingdao Univ, Affiliated Hosp, Dept Resp, Qingdao 266071, Peoples R China; [Zhao, Yandong; Jiao, Wenjie] Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Peoples R China; [Wang, Hongmei; Xiao, Wei] Shandong Univ, Sch Med, Qilu Hosp, Dept Resp, Jinan 250100, Peoples R China; [Zhao, Xin] Clin North Sea Fleet PLA Navy, Qingdao, Peoples R China	Qingdao University; Qingdao University; Shandong University	Jiao, WJ (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Peoples R China.	jiaowenjie@163.com		Dunqiang, Ren/0000-0002-9601-7899	Science and Technology Development Plan Project of Shandong Province [2013WS0273]	Science and Technology Development Plan Project of Shandong Province	This research was supported by Science and Technology Development Plan Project of Shandong Province (2013WS0273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi E, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-247; Basarkar A, 2007, INT J NANOMED, V2, P353; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Clarke DTW, 2014, NAT NANOTECHNOL, V9, P568, DOI 10.1038/nnano.2014.155; Du YZ, 2011, INT J NANOMED, V6, P1559, DOI 10.2147/IJN.S23828; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kesharwani P, 2014, PROG POLYM SCI, V39, P268, DOI 10.1016/j.progpolymsci.2013.07.005; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Liang X, 2014, INT J NANOMED, V9, P419, DOI 10.2147/IJN.S51919; Liu HM, 2012, J AM CHEM SOC, V134, P17680, DOI 10.1021/ja307290j; Ma D, 2014, BIOMATERIALS, V35, P4357, DOI 10.1016/j.biomaterials.2014.01.070; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Pryor JB, 2014, INT J NANOMED, V9, P1947, DOI 10.2147/IJN.S60220; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Tan WH, 2011, TRENDS BIOTECHNOL, V29, P634, DOI 10.1016/j.tibtech.2011.06.009; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Walsh CM, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00003; Wang MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4053; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4	40	50	51	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139136	10.1371/journal.pone.0139136	http://dx.doi.org/10.1371/journal.pone.0139136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406332	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700179
J	Wang, XY; Xu, XD; Lu, XY; Zhang, YB; Pan, WQ				Wang, Xinye; Xu, Xindong; Lu, Xingyu; Zhang, Yuanbin; Pan, Weiqing			Transcriptome Bioinformatical Analysis of Vertebrate Stages of Schistosoma japonicum Reveals Alternative Splicing Events	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PRE-MESSENGER-RNA; GENE; REGULATORS; RECEPTORS; PROTEINS; FAMILY; DATABASE; INTRONS; TOPHAT	Alternative splicing is a molecular process that contributes greatly to the diversification of proteome and to gene functions. Understanding the mechanisms of stage-specific alternative splicing can provide a better understanding of the development of eukaryotes and the functions of different genes. Schistosoma japonicum is an infectious blood-dwelling trematode with a complex lifecycle that causes the tropical disease schistosomiasis. In this study, we analyzed the transcriptome of Schistosoma japonicum to discover alternative splicing events in this parasite, by applying RNA-seq to cDNA library of adults and schistosomula. Results were validated by RT-PCR and sequencing. We found 11,623 alternative splicing events among 7,099 protein encoding genes and average proportion of alternative splicing events per gene was 42.14%. We showed that exon skip is the most common type of alternative splicing events as found in high eukaryotes, whereas intron retention is the least common alternative splicing type. According to intron boundary analysis, the parasite possesses same intron boundaries as other organisms, namely the classic "GT-AG" rule. And in alternative spliced introns or exons, this rule is less strict. And we have attempted to detect alternative splicing events in genes encoding proteins with signal peptides and transmembrane helices, suggesting that alternative splicing could change subcellular locations of specific gene products. Our results indicate that alternative splicing is prevalent in this parasitic worm, and that the worm is close to its hosts. The revealed secretome involved in alternative splicing implies new perspective into understanding interaction between the parasite and its host.	[Wang, Xinye; Xu, Xindong; Zhang, Yuanbin; Pan, Weiqing] Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China; [Lu, Xingyu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Naval Medical University	Pan, WQ (corresponding author), Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China.	wqpan0912@aliyun.com			National Natural Science Foundation of China [81430051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81430051). The URL of funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrotis A, 2000, FEBS LETT, V467, P128, DOI 10.1016/S0014-5793(00)01132-7; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BORSI L, 1990, FEBS LETT, V261, P175, DOI 10.1016/0014-5793(90)80664-5; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Chacko E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S11; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; DeMarco R, 2006, MOL BIOCHEM PARASIT, V150, P123, DOI 10.1016/j.molbiopara.2006.07.002; DeMarco R, 2010, GENOME RES, V20, P1112, DOI 10.1101/gr.100099.109; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Garg G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S8; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Harr B, 2010, MOL ECOL, V19, P228, DOI 10.1111/j.1365-294X.2009.04490.x; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Korner M, 2009, AM J PATHOL, V175, P461, DOI 10.2353/ajpath.2009.081135; Konrad L, 2008, ANDROLOGIA, V40, P358, DOI 10.1111/j.1439-0272.2008.00869.x; Konrad L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-318; Labadorf A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-114; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Piao XY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-715; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Ram D, 2004, PARASITOLOGY, V129, P587, DOI 10.1017/S003118200400602X; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Roger E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000330; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; SHOEMAKER CB, 1992, MOL BIOCHEM PARASIT, V53, P17, DOI 10.1016/0166-6851(92)90003-3; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; YASURAOKA K, 1979, Southeast Asian Journal of Tropical Medicine and Public Health, V10, P630; Ye Xiao-Ping, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P575; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	55	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138470	10.1371/journal.pone.0138470	http://dx.doi.org/10.1371/journal.pone.0138470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407301	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700046
J	Werner, M; Driftmann, S; Kleinehr, K; Kaiser, GM; Mathe, Z; Treckmann, JW; Paul, A; Skibbe, K; Timm, J; Canbay, A; Gerken, G; Schlaak, JF; Broering, R				Werner, Melanie; Driftmann, Sabrina; Kleinehr, Kathrin; Kaiser, Gernot M.; Mathe, Zotlan; Treckmann, Juergen-Walter; Paul, Andreas; Skibbe, Kathrin; Timm, Joerg; Canbay, Ali; Gerken, Guido; Schlaak, Joerg F.; Broering, Ruth			All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; CARBOHYDRATE-RECOGNITION SYSTEMS; RAT-LIVER; HUMAN HEPATOCYTES; KUPFFER CELLS; FIBROTIC HUMAN; CULTURE; EXPRESSION; INFORMATION	Background & Aims Liver cells are key players in innate immunity. Thus, studying primary isolated liver cells is necessary for determining their role in liver physiology and pathophysiology. In particular, the quantity and quality of isolated cells are crucial to their function. Our aim was to isolate a large quantity of high-quality human parenchymal and non-parenchymal cells from a single liver specimen. Methods Hepatocytes, Kupffer cells, liver sinusoidal endothelial cells, and stellate cells were isolated from liver tissues by collagenase perfusion in combination with low-speed centrifugation, density gradient centrifugation, and magnetic-activated cell sorting. The purity and functionality of cultured cell populations were controlled by determining their morphology, discriminative cell marker expression, and functional activity. Results Cell preparation yielded the following cell counts per gram of liver tissue: 2.0 +/- 0.4x10(7) hepatocytes, 1.8 +/- 0.5x10(6) Kupffer cells, 4.3 +/- 1.9x10(5) liver sinusoidal endothelial cells, and 3.2 +/- 0.5x10(5) stellate cells. Hepatocytes were identified by albumin (95.5 +/- 1.7%) and exhibited time-dependent activity of cytochrome P450 enzymes. Kupffer cells expressed CD68 (94.5 +/- 1.2%) and exhibited phagocytic activity, as determined with 1 mu m latex beads. Endothelial cells were CD146+ (97.8 +/- 1.1%) and exhibited efficient uptake of acetylated low-density lipoprotein. Hepatic stellate cells were identified by the expression of a-smooth muscle actin (97.1 +/- 1.5%). These cells further exhibited retinol (vitamin A)-mediated autofluorescence. Conclusions Our isolation procedure for primary parenchymal and non-parenchymal liver cells resulted in cell populations of high purity and quality, with retained physiological functionality in vitro. Thus, this system may provide a valuable tool for determining liver function and disease.	[Werner, Melanie; Driftmann, Sabrina; Kleinehr, Kathrin; Canbay, Ali; Gerken, Guido; Schlaak, Joerg F.; Broering, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45147 Essen, Germany; [Kaiser, Gernot M.; Mathe, Zotlan; Treckmann, Juergen-Walter; Paul, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, D-45147 Essen, Germany; [Mathe, Zotlan] Semmelweis Univ, Dept Transplantat Surg, H-1085 Budapest, Hungary; [Skibbe, Kathrin; Timm, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45147 Essen, Germany; [Timm, Joerg] Univ Hosp Dusseldorf, Inst Virol, Dusseldorf, Germany	University of Duisburg Essen; University of Duisburg Essen; Semmelweis University; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Broering, R (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Hufelandstr 55, D-45147 Essen, Germany.	ruth.broering@uni-duisburg-essen.de	Timm, Jörg/P-7652-2019; Broering, Ruth/W-9401-2019; Canbay, Ali/AAL-9620-2020	Timm, Jörg/0000-0001-7799-3045; Broering, Ruth/0000-0002-7125-3246; Canbay, Ali/0000-0001-6069-7899	Deutsche Forschungsgemeinschaft [SCHL377/2-4, SCHL377/6-2, TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SCHL377/2-4 & 6-2 to JFS, TRR60 to JFS and RB, http://dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabraba EB, 2007, J IMMUNOL METHODS, V326, P139, DOI 10.1016/j.jim.2007.06.014; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346; Beilfuss A, 2014, GUT; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; BRAET F, 1994, LAB INVEST, V70, P944; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Broering R, 2014, J VIRAL HEPATITIS, V21, P480, DOI 10.1111/jvh.12174; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Chang WJ, 2014, ACTA BIOCH BIOPH SIN, V46, P291, DOI 10.1093/abbs/gmt143; Clavien PA, 1996, GASTROENTEROLOGY, V110, P1891, DOI 10.1053/gast.1996.v110.pm8964415; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Dini L, 2002, MICROSC RES TECHNIQ, V57, P530, DOI 10.1002/jemt.10107; DIXON JL, 1993, J LIPID RES, V34, P167; Elvevold K H, 2004, COMP HEPATOL, V3, P1; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gerlach JC, 2001, J SURG RES, V100, P39, DOI 10.1006/jsre.2001.6224; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; HUBBARD AL, 1979, J CELL BIOL, V83, P65, DOI 10.1083/jcb.83.1.65; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; Ikejima K, 1999, AM J PHYSIOL-GASTR L, V276, pG591, DOI 10.1152/ajpgi.1999.276.3.G591; IRVING MG, 1984, GASTROENTEROLOGY, V87, P1233; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Kawai S, 2003, VIRCHOWS ARCH, V443, P78, DOI 10.1007/s00428-003-0804-4; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; KNOOK DL, 1982, EXP CELL RES, V139, P468, DOI 10.1016/0014-4827(82)90283-X; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Laba A, 2005, ARCH IMMUNOL THER EX, V53, P442; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Liu ZX, 2006, EXPERT OPIN DRUG MET, V2, P493, DOI 10.1517/17425255.2.4.493; Mason TM, 1998, CRIT REV CL LAB SCI, V35, P461, DOI 10.1080/10408369891234246; McCune JS, 2000, CLIN PHARMACOL THER, V68, P356, DOI 10.1067/mcp.2000.110215; McCuskey R, 2012, ZAKIM BOYERS HEPATOL, V6th, P3; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mezaki Y, 2013, MED HYPOTHESES, V81, P222, DOI 10.1016/j.mehy.2013.04.045; Milosevic N, 1999, EUR J PHARMACOL, V368, P75, DOI 10.1016/S0014-2999(98)00988-1; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135; Nakamura A, 2010, MED MOL MORPHOL, V43, P107, DOI 10.1007/s00795-009-0484-5; Pfeiffer E, 2015, EXP BIOL MED, V240, P645, DOI 10.1177/1535370214558025; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Valatas V, 2003, CELL BIOL INT, V27, P67, DOI 10.1016/S1065-6995(02)00249-4; von Kupffer K. W., 1876, ARCH MIKROSK ANAT, V12, P353, DOI DOI 10.1007/BF02933897; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; WISSE E, 1976, CELL TISSUE RES, V173, P423, DOI 10.1007/BF00224305; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zeng WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070832	63	54	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138655	10.1371/journal.pone.0138655	http://dx.doi.org/10.1371/journal.pone.0138655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407160	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700065
J	Blecha, KA; Alldredge, MW				Blecha, Kevin A.; Alldredge, Mat W.			Improvements on GPS Location Cluster Analysis for the Prediction of Large Carnivore Feeding Activities: Ground-Truth Detection Probability and Inclusion of Activity Sensor Measures	PLOS ONE			English	Article							KILL RATES; PANTHERA-PARDUS; PREY; SELECTION; TELEMETRY; PUMAS; MOVEMENT; BEHAVIOR; HABITAT; COUGARS	Animal space use studies using GPS collar technology are increasingly incorporating behavior based analysis of spatio-temporal data in order to expand inferences of resource use. GPS location cluster analysis is one such technique applied to large carnivores to identify the timing and location of feeding events. For logistical and financial reasons, researchers often implement predictive models for identifying these events. We present two separate improvements for predictive models that future practitioners can implement. Thus far, feeding prediction models have incorporated a small range of covariates, usually limited to spatio-temporal characteristics of the GPS data. Using GPS collared cougar (Puma concolor) we include activity sensor data as an additional covariate to increase prediction performance of feeding presence/absence. Integral to the predictive modeling of feeding events is a ground-truthing component, in which GPS location clusters are visited by human observers to confirm the presence or absence of feeding remains. Failing to account for sources of ground-truthing false-absences can bias the number of predicted feeding events to be low. Thus we account for some ground-truthing error sources directly in the model with covariates and when applying model predictions. Accounting for these errors resulted in a 10% increase in the number of clusters predicted to be feeding events. Using a double-observer design, we show that the ground-truthing false-absence rate is relatively low (4%) using a search delay of 2-60 days. Overall, we provide two separate improvements to the GPS cluster analysis techniques that can be expanded upon and implemented in future studies interested in identifying feeding behaviors of large carnivores.	[Blecha, Kevin A.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Alldredge, Mat W.] Colorado Pk & Wildlife, Mammals Res Div, Ft Collins, CO USA	Colorado State University	Blecha, KA (corresponding author), Colorado Pk & Wildlife, Terr Sect, Gunnison, CO USA.	kevin.blecha@state.co.us		Blecha, Kevin/0000-0002-9284-0685	Colorado Parks and Wildlife Game Cash Funds; USFWS Federal Aid Grant [W-204-R1]	Colorado Parks and Wildlife Game Cash Funds; USFWS Federal Aid Grant	Funding was provided from Colorado Parks and Wildlife Game Cash Funds and USFWS (www.FWS.gov) Federal Aid Grant #W-204-R1.	Alldredge MW, 2008, 3001 WP COL PARKS WI; Anderson AE, 1974, WILDLIFE MONOGR, V39, P9; Anderson C R, 2006, J WILDLIFE MANAGE, V67, P307; Armstrong DM, 2011, MAMMALS OF COLORADO, 2ND EDITION, P1; Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; Bacon MM, 2010, CAN FIELD NAT, V124, P242, DOI 10.22621/cfn.v124i3.1080; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Banfield JE, 2012, COUGAR RESPONSE ROAD; Bauer JW, 2005, SOUTHWEST NAT, V50, P466, DOI 10.1894/0038-4909(2005)050[0466:SBIP]2.0.CO;2; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; BURKHOLDER BOB L., 1959, JOUR WILDLIFE MANAGEMENT, V23, P1, DOI 10.2307/3797740; Burnham K. P., 2002, MODEL SELECTION MODE; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Frohlich M, 2012, S AFR J WILDL RES, V42, P104, DOI 10.3957/056.042.0208; Gervasi V, 2006, WILDLIFE SOC B, V34, P1314, DOI 10.2193/0091-7648(2006)34[1314:AIMTMA]2.0.CO;2; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hebblewhite M, 2003, WILDLIFE SOC B, V31, P933; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; HOSMER DW, 2000, WILEY PS TX, P1; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P644, DOI 10.2193/2009-252; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; McClintock BT, 2013, ECOLOGY, V94, P838, DOI 10.1890/12-0954.1; Miller CS, 2013, J MAMMAL, V94, P845, DOI 10.1644/12-MAMM-A-209.1; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Rauset GR, 2012, J WILDLIFE MANAGE, V76, P1597, DOI 10.1002/jwmg.452; Rieth WR, 2010, COUGAR RESOURCE SELE; Ross PI, 1996, ALCES N AM, V32, P1; Ruth TK, 2010, J WILDLIFE MANAGE, V74, P1122, DOI 10.2193/2009-058; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; Svoboda NJ, 2013, WILDLIFE BIOL, V19, P78, DOI 10.2981/12-031; Tambling CJ, 2010, J WILDLIFE MANAGE, V74, P549, DOI 10.2193/2009-010; Wang YW, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0030-0; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Zeller KA, 2014, LANDSCAPE ECOL, V29, P541, DOI 10.1007/s10980-014-9991-4	41	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138915	10.1371/journal.pone.0138915	http://dx.doi.org/10.1371/journal.pone.0138915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398546	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500128
J	Gao, L; Ma, YQ; Zhao, WY; Wei, ZY; Gleason, ML; Chen, HC; Hao, L; Sun, GY; Zhang, R				Gao, Liu; Ma, Yongqiang; Zhao, Wanyu; Wei, Zhuoya; Gleason, Mark L.; Chen, Hongcai; Hao, Lu; Sun, Guangyu; Zhang, Rong			Three New Species of Cyphellophora (Chaetothyriales) Associated with Sooty Blotch and Flyspeck	PLOS ONE			English	Article							PHIALOPHORA-VERRUCOSA COMPLEX; SECONDARY STRUCTURE; PHYLOGENETIC INFERENCE; RIBOSOMAL DNA; NUCLEAR RDNA; APPLE; ITS2; FUNGI; IDENTIFICATION; INFECTIONS	The genus Cyphellophora includes human- and plant-related species from mammal skin and nails, plant materials, and food. On the basis of analysis of ITS, LSU, TUB2 and RPB1 data and morphological characters, three new species, Cyphellophora phyllostachysdis, C. artocarpi and C. musae, associated with sooty blotch and flyspeck disease, were added to this genus. The 2D structure of ITS1 and ITS2 confirmed this taxonomic status. Pathogenicity tests on apple fruit indicated that C. artocarpi could be a sooty blotch and flyspeck pathogen of apple.	[Gao, Liu; Zhao, Wanyu; Wei, Zhuoya; Chen, Hongcai; Hao, Lu; Sun, Guangyu; Zhang, Rong] Northwest A&F Univ, Dept State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Liu; Zhao, Wanyu; Wei, Zhuoya; Chen, Hongcai; Hao, Lu; Sun, Guangyu; Zhang, Rong] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi Provinc, Peoples R China; [Ma, Yongqiang] Qinghai Acad Agr & Forestry Sci, Inst Plant Protect, Xining, Qinghai Provinc, Peoples R China; [Gleason, Mark L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Northwest A&F University - China; Northwest A&F University - China; Qinghai University; Iowa State University	Sun, GY (corresponding author), Northwest A&F Univ, Dept State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi Provinc, Peoples R China.	sgy@nwsuaf.edu.cn; rongzh@nwsuaf.edu.cn	gao, Liu/AAH-5970-2019		National Natural Science Foundation of China [31170015, 31171797]; 111 Project from Education Ministry of China [B07049];  [CARS-28]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project); 	This work was supported by the National Natural Science Foundation of China (31170015, 31171797), the 111 Project from Education Ministry of China (B07049) and the earmarked fund for China Agriculture Research System (CARS-28) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MMD, 2010, PHYTOPATHOLOGY, V100, P345, DOI 10.1094/PHYTO-100-4-0345; Batzer JC, 2008, MYCOLOGIA, V100, P246, DOI 10.3852/mycologia.100.2.246; Batzer JC, 2005, MYCOLOGIA, V97, P1268, DOI 10.3852/mycologia.97.6.1268; Belding RD, 2000, PLANT DIS, V84, P767, DOI 10.1094/PDIS.2000.84.7.767; COLBY AS, 1920, T ILLINOIS STATE ACA, V13, P139; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 1998, PROTIST, V149, P135, DOI 10.1016/S1434-4610(98)70018-5; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; Crous PW, 2007, STUD MYCOL, P185, DOI 10.3114/sim.2007.58.07; Crous PW, 2009, PERSOONIA, V22, P139, DOI 10.3767/003158509X461701; Crous PW, 2004, STUD MYCOL, P19; CUBETA MA, 1991, PHYTOPATHOLOGY, V81, P1395, DOI 10.1094/Phyto-81-1395; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; de Hoog GS, 2011, PERSOONIA, V27, P46, DOI 10.3767/003158511X614258; de Hoog GS, 2000, MYCOSES, V43, P409, DOI 10.1111/j.1439-0507.2000.00601.x; de Hoog GS, 1999, STUD MYCOL, P107; DE VRIES G. A., 1962, MYCOPATHOL ET MYCOL APPL, V16, P47, DOI 10.1007/BF02136180; Decock C, 2003, ANTON LEEUW INT J G, V84, P209, DOI 10.1023/A:1026015031851; DEVRIES GA, 1986, A VAN LEEUW J MICROB, V52, P141, DOI 10.1007/BF00429317; Eckhard M, 2007, MYCOSES, V50, P14, DOI 10.1111/j.1439-0507.2007.01425.x; Feng PY, 2014, FUNGAL DIVERS, V65, P17, DOI 10.1007/s13225-012-0194-5; Gams W., 1976, STUDIES MYCOLOGY BAA, V13, P1; Gao L, 2014, EUR J PLANT PATHOL, V139, P117, DOI 10.1007/s10658-013-0370-9; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gleason ML, 2011, PLANT DIS, V95, P368, DOI 10.1094/PDIS-08-10-0590; Grabowski M., 2007, Folia Horticulturae, V19, P89; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Li HY, 2011, FUNGAL DIVERS, V46, P53, DOI 10.1007/s13225-010-0074-9; Li HY, 2010, MYCOL PROG, V9, P245, DOI 10.1007/s11557-009-0633-1; Lopez MJ, 2007, JAVMA-J AM VET MED A, V230, P84, DOI 10.2460/javma.230.1.84; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Matsushima T., 1987, MATSUSHIMA MYCOLOGIC, V5, P1; Mayfield DA, 2013, EUR J PLANT PATHOL, V135, P805, DOI 10.1007/s10658-012-0123-1; Medlar EM., 1915, MYCOLOGIA, V7, P200, DOI [10.1080/00275514.1915.12021711, DOI 10.1080/00275514.1915.12021711]; Mirzwa-Mroz E, 2011, ACTA SCI POL-HORTORU, V10, P191; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reblova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063547; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schulenburg JHGV, 1999, J MOL EVOL, V48, P2, DOI 10.1007/PL00006441; SUN G, 2008, PHYTOPATHOLOGY S, V98, pS153; Sun GuangYu, 2003, Acta Phytopathologica Sinica, V33, P479; SUTTON BC, 1991, MYCOPATHOLOGIA, V114, P159, DOI 10.1007/BF00437207; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Untereiner WA, 2008, BOTANY, V86, P742, DOI 10.1139/B08-057; Van Wormhoudt A, 2011, GENETICA, V139, P1217, DOI 10.1007/s10709-011-9623-8; VANNUES RW, 1995, J MOL BIOL, V250, P24, DOI 10.1006/jmbi.1995.0355; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; WALZ A, 1987, A VAN LEEUW J MICROB, V53, P143, DOI 10.1007/BF00393842; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Williamson SM, 2000, PLANT DIS, V84, P714, DOI 10.1094/PDIS.2000.84.7.714; Yang HL, 2010, PERSOONIA, V24, P29, DOI 10.3767/003158510X492101; Yue CY, 2007, HORTSCIENCE, V42, P1366, DOI 10.21273/HORTSCI.42.6.1366; Zhuang JL, 2010, MYCOTAXON, V113, P405, DOI 10.5248/113.405; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	25	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0136857	10.1371/journal.pone.0136857	http://dx.doi.org/10.1371/journal.pone.0136857			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398347	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500015
J	Crump, SM; Hu, ZY; Kant, R; Levy, DI; Goldstein, SAN; Abbott, GW				Crump, Shawn M.; Hu, Zhaoyang; Kant, Ritu; Levy, Daniel I.; Goldstein, Steve A. N.; Abbott, Geoffrey W.			Kcne4 deletion sex- and age-specifically impairs cardiac repolarization in mice	FASEB JOURNAL			English	Article							MINK-RELATED PEPTIDES; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; INHIBITORY SUBUNIT; K+ CURRENTS; HUMAN HEART; MOUSE; HORMONES; KCNQ1; TRAFFICKING	Myocardial repolarization capacity varies with sex, age, and pathology; the molecular basis for this variation is incompletely understood. Here, we show that the transcript for KCNE4, a voltage-gated potassium (K-v) channel beta subunit associated with human atrial fibrillation, was 8-fold more highly expressed in the male left ventricle compared with females in young adult C57BL/6 mice (P < 0.05). Similarly, K-v current density was 25% greater in ventricular myocytes from young adult males (P < 0.05). Germ-line Kcne4 deletion eliminated the sex-specific K-v current disparity by diminishing ventricular fast transient outward current (I-to,I-f) and slowly activating K+ current (I-K,I- slow1). Kcne4 deletion also reduced K-v currents in male mouse atrial myocytes, by >45% (P < 0.001). As we previously found for K(v)4.2 (which generates mouse I-to,I-f), heterologously expressed KCNE4 functionally regulated K(v)1.5 (the K-v alpha subunit that generates I-Kslow1 in mice). Ofnote, inpostmenopausal female mice, ventricular repolarization was impaired by Kcne4 deletion, and ventricular Kcne4 expression increased to match that of males. Moreover, castration diminished male ventricular Kcne4 expression 2.8-fold, whereas 5 alpha-dihydrotestosterone (DHT) implants in castrated mice increased Kcne4 expression >3-fold (P = 0.01) to match noncastrated levels. KCNE4 is thereby shown to be a DHT-regulated determinant of cardiac excitability and a molecular substrate for sex- and age-dependent cardiac arrhythmogenesis.	[Crump, Shawn M.; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92697 USA; [Crump, Shawn M.; Kant, Ritu; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Hu, Zhaoyang] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610064, Peoples R China; [Hu, Zhaoyang] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu 610064, Peoples R China; [Levy, Daniel I.] Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA; [Goldstein, Steve A. N.] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Sichuan University; Sichuan University; University of Chicago; Brandeis University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, A-360 Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061; Levy, Daniel/0000-0003-0603-0297	U.S. National Institutes of Health National Heart, Lung and Blood Institute (NHLBI) [HL079275, HL105949]; NHLBI [HL079275-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105949, R01HL079275] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung and Blood Institute (NHLBI); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Daniel Neverisky and Soo Min Lee (University of California, Irvine) for expert technical assistance. This work was funded by U.S. National Institutes of Health National Heart, Lung and Blood Institute (NHLBI) Grants HL079275 (to G.W.A.) and HL105949 (to S.A.N.G.). S.M.C. was supported by NHLBI Postdoctoral Diversity Supplement HL079275-S1 (to G.W.A.).	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bou-Abboud E, 2000, J PHYSIOL-LONDON, V529, P345, DOI 10.1111/j.1469-7793.2000.00345.x; Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012; Crump SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00003; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Fulop L, 2006, ACTA PHYSIOL, V188, P163, DOI 10.1111/j.1748-1716.2006.01618.x; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Grunnet M, 2003, BIOPHYS J, V85, P1525, DOI 10.1016/S0006-3495(03)74585-8; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Kanda VA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00231; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kundu P, 2008, MOL CELL ENDOCRINOL, V292, P50, DOI 10.1016/j.mce.2008.06.003; Kurokawa Junko, 2012, Handb Exp Pharmacol, P237, DOI 10.1007/978-3-642-30726-3_12; Levy DI, 2008, AM J PHYSIOL-RENAL, V295, pF380, DOI 10.1152/ajprenal.00598.2007; Levy DI, 2010, J PHYSIOL-LONDON, V588, P2657, DOI 10.1113/jphysiol.2010.191395; Ma KJ, 2007, CHINESE MED J-PEKING, V120, P150, DOI 10.1097/00029330-200701020-00017; Magnani JW, 2014, CIRC-ARRHYTHMIA ELEC, V7, P307, DOI 10.1161/CIRCEP.113.001322; Mao Ting, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P916; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Nerbonne JM, 2001, CIRC RES, V89, P944, DOI 10.1161/hh2301.100349; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang PC, 2010, J CARDIOVASC PHARM, V56, P123, DOI 10.1097/FJC.0b013e3181d6f7dd; Zeng Zhi-yu, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P987; Zeng ZY, 2007, CARDIOLOGY, V108, P97, DOI 10.1159/000095943	38	19	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					360	369		10.1096/fj.15-278754	http://dx.doi.org/10.1096/fj.15-278754			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26399785	Green Submitted, Green Published			2022-12-26	WOS:000367621000034
J	Chan, R; Wong, VWS; Chu, WCW; Wong, GLH; Li, LS; Leung, J; Chim, AML; Yeung, DKW; Sea, MMM; Woo, J; Chan, FKL; Chan, HLY				Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Leung, Jason; Chim, Angel Mei-Ling; Yeung, David Ka-Wai; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen			Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							MEDITERRANEAN DIET; INSULIN-RESISTANCE; CHINESE POPULATION; RISK-FACTORS; PATTERN; CONSUMPTION; OVERWEIGHT; STEATOSIS; ADHERENCE; SEVERITY	Dietary pattern analysis is an alternative approach to examine the association between diet and nonalcoholic fatty liver disease (NAFLD). This study examined the association of two diet-quality scores, namely Diet Quality Index-International (DQI-I) and Mediterranean Diet Score (MDS) with NAFLD prevalence. Apparently healthy Chinese adults (332 male, 465 female) aged 18 years or above were recruited through a population screening between 2008 and 2010 in a cross-sectional population-based study in Hong Kong. DQI-I and MDS, as well as major food group and nutrient intakes were calculated based on dietary data from a food frequency questionnaire. NAFLD was defined as intrahepatic triglyceride content at >= 5% by proton-magnetic resonance spectroscopy. Multivariate logistic regression models were used to examine the association between each diet-quality score or dietary component and prevalent NAFLD with adjustment for potential lifestyle, metabolic and genetic factors. A total of 220 subjects (27.6%) were diagnosed with NAFLD. DQI-I but not MDS was associated with the prevalence of NAFLD. A 10-unit decrease in DQI-I was associated with 24% increase in the likelihood of having NAFLD in the age and sex adjusted model (95% CI: 1.06-1.45, p = 0.009), and the association remained significant when the model was further adjusted for other lifestyle factors, metabolic and genetic factors [OR: 1.26 (95% CI: 1.03-1.54), p = 0.027]. Multivariate regression analyses showed an inverse association of the intake of vegetables and legumes, fruits and dried fruits, as well as vitamin C with the NAFLD prevalence (p<0.05). In conclusion, a better diet quality as characterized by a higher DQI-I and a higher consumption of vegetables, legumes and fruits was associated with a reduced likelihood of having NAFLD in Hong Kong Chinese.	[Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Chim, Angel Mei-Ling; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Ruth; Sea, Mandy Man-Mei; Woo, Jean] Chinese Univ Hong Kong, Ctr Nutr Studies, Hong Kong, Hong Kong, Peoples R China; [Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Chu, Winnie Chiu-Wing] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Yeung, David Ka-Wai] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Woo, Jean/K-2625-2014; Wong, Vincent WS/K-3864-2014; Chan, Henry Lik-Yuen/B-9636-2008; Chu, Winnie CW/F-8449-2014; Wong, Grace LH/L-8586-2014; Chan, Ruth/K-4995-2014; Chan, Francis K. L./F-4851-2010	Woo, Jean/0000-0001-7593-3081; Wong, Vincent WS/0000-0003-2215-9410; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Chu, Winnie CW/0000-0003-4962-4132; Wong, Grace LH/0000-0002-2863-9389; Chan, Francis K. L./0000-0001-7388-2436; Chan, Ruth/0000-0002-5725-4066	Health and Health Services Research Fund - Government of Hong Kong SAR [07080081]; Centre for Nutritional Studies, under Chinese University of Hong Kong	Health and Health Services Research Fund - Government of Hong Kong SAR; Centre for Nutritional Studies, under Chinese University of Hong Kong	The study was supported by funding from the Health and Health Services Research Fund sponsored by the Government of Hong Kong SAR (Reference number 07080081) and the Centre for Nutritional Studies, under the auspices of The Chinese University of Hong Kong. The Centre for Nutritional Studies did have a role in the data collection and analysis.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abenavoli L, 2014, WORLD J GASTROENTERO, V20, P16831, DOI 10.3748/wjg.v20.i45.16831; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkerwi A, 2014, BR J NUTR, V5, P1; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Centre for Food Safety, 2006, NUTR INF INQ; Chan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122406; Chang JiHo, 2014, Journal of Nutrition and Health, V47, P330, DOI 10.4163/jnh.2014.47.5.330; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Cortez-Pinto H, 2006, CLIN NUTR, V25, P816, DOI 10.1016/j.clnu.2006.01.027; Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Ferolla SM, 2013, CLINICS, V68, P11, DOI 10.6061/clinics/2013(01)OA03; George SM, 2014, AM J EPIDEMIOL, V180, P616, DOI 10.1093/aje/kwu173; Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Kani AH, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10943; Kim CH, 2010, OBES SURG, V20, P154, DOI 10.1007/s11695-008-9549-0; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Koch M, 2014, AM J CLIN NUTR, V99, P369, DOI 10.3945/ajcn.113.070219; Kontogianni MD, 2014, CLIN NUTR, V33, P678, DOI 10.1016/j.clnu.2013.08.014; Krupp D, 2012, J NUTR, V142, P313, DOI 10.3945/jn.111.150540; Leung S, 1998, AUST J NUTR DIET, V55, pS11; Masarone M, 2014, REV RECENT CLIN TRIA, V9, P126, DOI 10.2174/1574887109666141216111143; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Oddy WH, 2013, AM J GASTROENTEROL, V108, P778, DOI 10.1038/ajg.2013.95; Oya J, 2010, EUR J CLIN NUTR, V64, P1179, DOI 10.1038/ejcn.2010.139; Ricci G, 2011, NUTRITION, V27, P672, DOI 10.1016/j.nut.2010.07.014; Santoro N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037827; Sathiaraj E, 2011, EUR J CLIN NUTR, V65, P533, DOI 10.1038/ejcn.2011.3; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Slattery ML, 2008, AM J CLIN NUTR, V88, P14, DOI 10.1093/ajcn/88.1.14; Sofi F, 2014, WORLD J GASTROENTERO, V20, P7339, DOI 10.3748/wjg.v20.i23.7339; Solga S, 2004, DIGEST DIS SCI, V49, P1578, DOI 10.1023/B:DDAS.0000043367.69470.b7; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trovato GM, 2013, AM J GASTROENTEROL, V108, P1932, DOI 10.1038/ajg.2013.356; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; WHO, 2003, DIET NUTR PREVENTION, V916; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wong VWS, 2013, J HEPATOL, V59, P536, DOI 10.1016/j.jhep.2013.04.013; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Woo J, 2008, EUR J CLIN NUTR, V62, P480, DOI 10.1038/sj.ejcn.1602702; Woo J, 2001, EUR J CLIN NUTR, V55, P215, DOI 10.1038/sj.ejcn.1601150; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yang YX, 2004, CHINA FOOD COMPOSITI; Yu R, 2011, PUBLIC HEALTH NUTR, V14, P1133, DOI 10.1017/S136898001100053X; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	56	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139310	10.1371/journal.pone.0139310	http://dx.doi.org/10.1371/journal.pone.0139310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418083	Green Submitted, gold, Green Published			2022-12-26	WOS:000362171400074
J	Chang, HP; Cheng, TC; Wu, YQ; Hu, WB; Long, RW; Liu, C; Zhao, P; Xia, QY				Chang, Huaipu; Cheng, Tingcai; Wu, Yuqian; Hu, Wenbo; Long, Renwen; Liu, Chun; Zhao, Ping; Xia, Qingyou			Transcriptomic Analysis of the Anterior Silk Gland in the Domestic Silkworm (Bombyx mori) - Insight into the Mechanism of Silk Formation and Spinning	PLOS ONE			English	Article							CUTICULAR PROTEINS; FIBROIN; GENES; CUTICLE; GENOME; IONS; PH; IDENTIFICATION; PROFILES; SEQUENCE	Silk proteins are synthesized in the middle and posterior silk glands of silkworms, then transit into the anterior of the silk gland, where the silk fibers are produced, stored and processed. The mechanism of formation and spinning of the silk fibers has not been fully elucidated, and transcriptome analyses specific to the anterior silk gland have not been reported. In the present study, we explored gene expression profiles in five regions of silk gland samples using the RNA-Seq method. As a result, there were 959,979,570 raw reads obtained, of which 583,068,172 reads were mapped to the silkworm genome. A total of 7419 genes were found to be expressed in terms of reads per kilobase of exon model per million mapped reads >= 5 in at least one sample. The gene numbers and expression levels of the expressed genes differed between these regions. The differentially expressed genes were analyzed, and 282 genes were detected as up-regulated in the anterior silk gland, compared with the other parts. Functions of these genes were addressed using the gene ontology and Kyoto Encyclopedia of Genes and Genomes databases, and seven key pathways were enriched. It suggested that the ion transportation, energy metabolism, protease inhibitors and cuticle proteins played essential roles in the process of silk formation and spinning in the anterior silk gland. In addition, 210 genes were found differently expressed between males and females, which should help to elucidate the mechanism of the quality difference in silk fibers from male and female silkworms.	[Chang, Huaipu; Cheng, Tingcai; Wu, Yuqian; Hu, Wenbo; Long, Renwen; Liu, Chun; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Chang, Huaipu] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		Xia, Qingyou/0000-0002-9263-2886; cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; Fundamental Research Funds for the Central Universities [XDJK2013A019, XDJK2013C128]; Chongqing Fundamental and Frontier Research Program [cstc2013jcyjA0500]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chongqing Fundamental and Frontier Research Program	QX was supported by the National Basic Research Program of China (2012CB114600), and the Fundamental Research Funds for the Central Universities (XDJK2013A019). HC was supported by Chongqing Fundamental and Frontier Research Program (cstc2013jcyjA0500), and the Fundamental Research Funds for the Central Universities (XDJK2013C128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1972, ACTA CHEM SCAND, V26, P3097, DOI 10.3891/acta.chem.scand.26-3097; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; Andersen SO, 1998, INSECT BIOCHEM MOLEC, V28, P421, DOI 10.1016/S0965-1748(98)00028-9; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Boggavarapu R, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0167-8; Dang QQ, 2010, BIOMACROMOLECULES, V11, P1796, DOI 10.1021/bm1002398; Davies GJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073225; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fang SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1287-9; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; He YX, 2012, J MOL BIOL, V418, P197, DOI 10.1016/j.jmb.2012.02.040; Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Lee SM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-52; Li XG, 2008, BIOPOLYMERS, V89, P497, DOI 10.1002/bip.20905; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Ma L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-182; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qin LG, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu088; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Royer C, 2011, INSECT BIOCHEM MOLEC, V41, P118, DOI 10.1016/j.ibmb.2010.11.003; Ruan QX, 2008, FEBS J, V275, P219, DOI 10.1111/j.1742-4658.2007.06191.x; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Utturkar SM, 2014, BIOINFORMATICS, V30, P2709, DOI 10.1093/bioinformatics/btu391; Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P227, DOI 10.1016/S0141-8130(99)00005-7; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang SH, 2014, J PROTEOME RES, V13, P735, DOI 10.1021/pr4008333; Wang Xin, 2014, Scientia Agricultura Sinica, V47, P1611; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xie F, 2006, INT J BIOL MACROMOL, V38, P284, DOI 10.1016/j.ijbiomac.2006.03.021; Yi QY, 2013, PROTEOMICS, V13, P2657, DOI 10.1002/pmic.201200443; Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005; Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m; Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	46	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139424	10.1371/journal.pone.0139424	http://dx.doi.org/10.1371/journal.pone.0139424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418001	Green Submitted, gold, Green Published			2022-12-26	WOS:000362171400090
J	Kang, JH; Kwak, HJ; Choi, HE; Kim, J; Hong, S; Kim, OH; Oh, BC; Cheon, HG				Kang, Ju-Hee; Kwak, Hyun Jeong; Choi, Hye-Eun; Kim, Juyoung; Hong, Sangmee; Kim, Ok-Hee; Oh, Byung Chul; Cheon, Hyae Gyeong			Involvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast Differentiation	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PPAR-GAMMA; HIF-ALPHA; IN-VITRO; THIAZOLIDINEDIONES; EXPRESSION; ADIPOCYTE; UBIQUITINATION; OSTEOGENESIS; DESTRUCTION	Rosiglitazone is a well-known anti-diabetic drug that increases insulin sensitivity via peroxisome proliferator-activated receptor. (PPAR.) activation, but unfortunately it causes bone loss in animals and humans. A previous study showed that prolyl hydroxylase domain protein (PHD) plays a role in rosiglitazone-induced adipocyte differentiation. Based on the inverse relationship between adipocyte and osteoblast differentiation, we investigated whether PHD is involved in the effects of rosiglitazone on osteoblast differentiation. Rosiglitazone inhibited osteoblast differentiation in a concentration-dependent manner, and in parallel induced three PHD isoforms (PHD1, 2, and 3). PHD inhibitors and knockdown of each isoform prevented the inhibitory effects of rosiglitazone on osteoblast differentiation and increased the expression of Runx2, a transcription factor essential for osteoblastogenesis. MG-132, a proteasomal inhibitor also prevented the rosiglitazone-induced degradation of Runx2. Furthermore, both increased PHD isoform expressions and reduced osteoblast differentiation by rosiglitazone were prevented by PPAR. antagonists, indicating these effects were mediated via PPAR. activation. In vivo oral administration of rosiglitazone to female ICR mice for 8 weeks reduced bone mineral densities and plasma alkaline phosphatase (ALP) activity, and increased PHD expression in femoral primary bone marrow cells and the ubiquitination of Runx2. Together, this suggests that the rosiglitazone-induced suppression of osteoblast differentiation is at least partly induced via PPAR.-mediated PHD induction and subsequent promotion of the ubiquitination and degradation of Runx2.	[Kang, Ju-Hee; Kwak, Hyun Jeong; Choi, Hye-Eun; Kim, Juyoung; Cheon, Hyae Gyeong] Gachon Univ, Sch Med, Dept Pharmacol, Inchon, South Korea; [Hong, Sangmee; Kim, Ok-Hee; Oh, Byung Chul] Gachon Univ, Dept Mol Med, Inchon, South Korea; [Cheon, Hyae Gyeong] Gil Med Ctr, Gachon Med Res Inst, Inchon, South Korea	Gachon University; Gachon University; Gachon University	Cheon, HG (corresponding author), Gachon Univ, Sch Med, Dept Pharmacol, Inchon, South Korea.	hgcheon@gachon.ac.kr		Kim, Ok-Hee/0000-0003-3801-9463; Oh, Byung-Chul/0000-0002-4277-7083	Korean National Research Foundation (NRF) - Korean government (MEST) [2011-0013253]	Korean National Research Foundation (NRF) - Korean government (MEST)	This work was supported by the Korean National Research Foundation (NRF) funded by the Korean government (MEST) (Grant no. 2011-0013253).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Beck GR, 2013, TRANSL RES, V161, P145, DOI 10.1016/j.trsl.2012.08.006; BERESFORD JN, 1992, J CELL SCI, V102, P341; Broulik PD, 2013, FOLIA BIOL PRAHA, V57, P133; Bruedigam C, 2010, STEM CELLS, V28, P916, DOI 10.1002/stem.405; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Irwin R, 2007, J CELL BIOCHEM, V100, P762, DOI 10.1002/jcb.21083; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kim J, 2014, J BIOL CHEM, V289, P2755, DOI 10.1074/jbc.M113.493650; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Liu XD, 2014, CELL BIOCHEM BIOPHYS, V69, P141, DOI 10.1007/s12013-013-9780-8; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; McDonough AK, 2008, NAT CLIN PRACT ENDOC, V4, P507, DOI 10.1038/ncpendmet0920; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schwartz AV, 2006, PPAR RES, V2006, P1; Solomon DH, 2009, J CLIN ENDOCR METAB, V94, P2792, DOI 10.1210/jc.2008-2157; Soroceanu MA, 2004, J ENDOCRINOL, V183, P203, DOI 10.1677/joe.1.05723; Sottile V, 2014, CALCIFIED TISSUE INT, V75, P329; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zipori Dov, 2006, Curr Stem Cell Res Ther, V1, P95, DOI 10.2174/157488806775269133; Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024; Zou D, 2011, CELL PROLIFERAT, V44, P234, DOI 10.1111/j.1365-2184.2011.00747.x	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139093	10.1371/journal.pone.0139093	http://dx.doi.org/10.1371/journal.pone.0139093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418009	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400040
J	Leve, F; Peres-Moreira, RJ; Binato, R; Abdelhay, E; Morgado-Diaz, JA				Leve, Fernanda; Peres-Moreira, Rubem J.; Binato, Renata; Abdelhay, Eliana; Morgado-Diaz, Jose A.			LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; COLORECTAL-CANCER; CYCLIN D1; STIMULATE PROLIFERATION; PROTEIN EXPRESSION; TUMOR-CELLS; CROSS-TALK; ACTIVATION; INVASION; MOTILITY	Lysophosphatidic acid (LPA) plays a critical role in the proliferation and migration of colon cancer cells; however, the downstream signaling events underlying these processes remain poorly characterized. The aim of this study was to investigate the signaling pathways triggered by LPA to regulate the mechanisms involved in the progression of colorectal cancer (CRC). We have used three cell line models of CRC, and initially analyzed the expression profile of LPA receptors (LPAR). Then, we treated the cells with LPA and events related to their tumorigenic potential, such as migration, invasion, anchorage-independent growth, proliferation as well as apoptosis and cell cycle were evaluated. We used the Chip array technique to analyze the global gene expression profiling that occurs after LPA treatment, and we identified cell signaling pathways related to the cell cycle. The inhibition of these pathways verified the conclusions of the transcriptomic analysis. We found that the cell lines expressed LPAR1, -2 and -3 in a differential manner and that 10 mu M LPA did not affect cell migration, invasion and anchorage-independent growth, but it did induce proliferation and cell cycle progression in HCT-116 cells. Although LPA in this concentration did not induce transcriptional activity of beta-catenin, it promoted the activation of Rho and STAT3. Moreover, ROCK and STAT-3 inhibitors prevented LPA-induced proliferation, but ROCK inhibition did not prevent STAT-3 activation. Finally, we observed that LPA regulates the expression of genes related to the cell cycle and that the combined inhibition of ROCK and STAT-3 prevented cell cycle progression and increased the LPA-induced expression of cyclins E1, A2 and B1 to a greater degree than either inhibitor alone. Overall, these results demonstrate that LPA increases the proliferative potential of colon adenocarcinoma HCT-116 cells through a mechanism involving cooperation between the Rho-ROCK and STAT3 pathways involved in cell cycle control.	[Leve, Fernanda] Inst Nacl Metrol Qualidade & Tecnol INMETRO, Diretoria Metrol Aplicada Ciencias Vida Dimav, Duque De Caxias, RJ, Brazil; [Peres-Moreira, Rubem J.; Morgado-Diaz, Jose A.] Inst Nacl Canc INCA, Ctr Pesquisas, Grp Biol Estrutural, Div Biol Celular, Rio De Janeiro, RJ, Brazil; [Binato, Renata; Abdelhay, Eliana] Inst Nacl Canc INCA, Ctr Transplante Medula Ossea CEMO, Rio De Janeiro, RJ, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); National Cancer Institute (Inca)	Morgado-Diaz, JA (corresponding author), Inst Nacl Canc INCA, Ctr Pesquisas, Grp Biol Estrutural, Div Biol Celular, Rio De Janeiro, RJ, Brazil.	jmorgado@inca.gov.br	Morgado-Diaz, Jose A./A-9649-2010	Leve, Fernanda/0000-0001-5466-0950	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Cancer-INCT [573806/2008-0, 170.026/2008]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) [26/11703/2013]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Cancer-INCT; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Cancer-INCT (573806/2008-0 and 170.026/2008) to JAMD; and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) (26/11703/2013) to JAMD.	Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Erickson A, 2001, PROSTAGLANDINS, V64, P63; Fukui R, 2012, TUMOR BIOL, V33, P1899, DOI 10.1007/s13277-012-0450-z; Grabsch H, 2004, AM J CLIN PATHOL, V122, P511, DOI 10.1309/54H4Q88A1UBBWPTE; Guo L, 2015, CELL SIGNAL; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lassmann S, 2007, J CLIN PATHOL, V60, P173, DOI 10.1136/jcp.2005.035113; Lee SJ, 2013, J BIOL CHEM, V288, P25244, DOI 10.1074/jbc.M113.489708; Lee SJ, 2010, INT J BIOCHEM CELL B, V42, P1907, DOI 10.1016/j.biocel.2010.09.021; Leve F, 2012, J CELL BIOCHEM, V113, P2549, DOI 10.1002/jcb.24153; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Mishra R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0300-x; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Muller R, 2010, TUMOR BIOL, V31, P341, DOI 10.1007/s13277-010-0043-7; PartekInc, 2008, PART DISC SUIT TM; Pramanik KC, 2015, ONCOTARGET; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Samsonov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068391; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Shida D, 2003, CANCER RES, V63, P1706; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shin KJ, 2009, J CANCER RES CLIN, V135, P45, DOI 10.1007/s00432-008-0441-z; Slattery ML, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.21841; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sun H, 2009, WORLD J GASTROENTERO, V15, P4547, DOI 10.3748/wjg.15.4547; Lopez PJT, 2014, CLIN MED INSIGHTS-GA, V7, P33, DOI 10.4137/CGast.S14039; Tsujino M, 2010, VIRCHOWS ARCH, V457, P669, DOI 10.1007/s00428-010-0960-2; Wang A, 1996, J CANCER RES CLIN, V122, P122, DOI 10.1007/BF01226270; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhao M, 2011, CURR MED CHEM, V18, P4012, DOI 10.2174/092986711796957284; Zhao Y, 2013, BIOCHEM BIOPH RES CO, V432, P488, DOI 10.1016/j.bbrc.2013.02.009; Zhao ZW, 2007, J CLIN ONCOL, V25, P2696, DOI 10.1200/JCO.2006.08.5571	51	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139094	10.1371/journal.pone.0139094	http://dx.doi.org/10.1371/journal.pone.0139094			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418031	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400041
J	Lee, S; Xu, S; Bivila, CP; Lee, H; Park, MS; Lim, YW; Yamamoto, N				Lee, Seungeun; Xu, Siyu; Bivila, Chemmeri Padasseri; Lee, Hyeyoung; Park, Myung Soo; Lim, Young Woon; Yamamoto, Naomichi			Triazole Susceptibilities in Thermotolerant Fungal Isolates from Outdoor Air in the Seoul Capital Area in South Korea	PLOS ONE			English	Article							RESISTANT ASPERGILLUS-FUMIGATUS; AZOLE RESISTANCE; ANTIFUNGAL AGENTS; AIRBORNE FUNGI; CYP51A; ITRACONAZOLE; VORICONAZOLE; ENVIRONMENT; MECHANISMS; MUTATIONS	Emerging fungi resistant to triazoles are a concern because of the increased use of medical triazoles and exposure to agricultural triazoles. However, little is known about the levels of triazole susceptibility in outdoor airborne fungi making it difficult to assess the risks of inhalation exposure to airborne, antifungal-resistant fungi. This study examined triazole susceptibilities of the airborne thermotolerant fungi isolated from the ambient air of the Seoul Capital Area of South Korea. We used impactor air sampling with triazole-containing nutrient agar plates as the collection substrates to screen for airborne fungal isolates based on their triazole susceptibilities. This study estimated that 0.17% of all the culturable fungi belong to the pathogenic thermotolerant taxa, among which each isolate of Aspergillus niger and Aspergillus tubingensis showed a minimum inhibitory concentration (MIC) of 2 mu g/mL or greater for itraconazole. Their concentration in air was 0.4 CFU/m(3). Seven human pathogenic Paecilomyces variotii isolates had MICs of 32 mu g/mL or greater and lower than 2 mu g/mL for the agricultural fungicide tebuconazole and the medical triazole itraconazole, respectively. Though the concentration was low, our results confirm the presence of airborne fungi with high MICs for itraconazole in ambient air. Inhalation is an important exposure route because people inhale more than 10 m(3) of air each day. Vigilance is preferred over monitoring for the emergence of triazole-resistant fungal pathogens in ambient outdoor air.	[Lee, Seungeun; Xu, Siyu; Bivila, Chemmeri Padasseri; Lee, Hyeyoung; Yamamoto, Naomichi] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul 151742, South Korea; [Park, Myung Soo; Lim, Young Woon] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yamamoto, N (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul 151742, South Korea.	nyamamoto@snu.ac.kr	Yamamoto, Naomichi/D-4099-2014	Yamamoto, Naomichi/0000-0002-5969-5500	National Research Foundation of Korea - Ministry of Education, Science and Technology [2013R1A1A1004497]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology (2013R1A1A1004497) (N.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 1998, ANTIMICROB AGENTS CH, V42, P1601, DOI 10.1128/AAC.42.7.1601; Ahmad S, 2014, ENVIRON RES, V133, P20, DOI 10.1016/j.envres.2014.05.009; Alcazar-Fuoli L, 2009, ANTIMICROB AGENTS CH, V53, P4514, DOI 10.1128/AAC.00585-09; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Audenaert K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-112; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Bartlett KH, 2004, ANN OCCUP HYG, V48, P547, DOI 10.1093/annhyg/meh051; Brochu P, 2006, HUM ECOL RISK ASSESS, V12, P675, DOI 10.1080/10807030600801550; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chowdhary A, 2014, J ANTIMICROB CHEMOTH, V69, P2979, DOI 10.1093/jac/dku259; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; CLSI, 2008, APPROVED STANDARD M3; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Domson, 1984, MOULD ALLERGY, P66; Espinel-Ingroff A, 2010, J CLIN MICROBIOL, V48, P3251, DOI 10.1128/JCM.00536-10; Espinel-Ingroff A, 2001, MYCOPATHOLOGIA, V150, P101, DOI 10.1023/A:1010954803886; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gheith S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-19; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gutierrez F, 2005, EUR J CLIN MICROBIOL, V24, P607, DOI 10.1007/s10096-005-0013-y; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Kahle M, 2008, ENVIRON SCI TECHNOL, V42, P7193, DOI 10.1021/es8009309; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; KWOK IMY, 1993, PESTIC SCI, V39, P1, DOI 10.1002/ps.2780390102; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1080/15298668991375164; MADELIN TM, 1992, J APPL BACTERIOL, V72, P400, DOI 10.1111/j.1365-2672.1992.tb01853.x; McGrath JJ, 1999, CURR MICROBIOL, V38, P33, DOI 10.1007/PL00006768; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; MORRING KL, 1983, AM IND HYG ASSOC J, V44, P662, DOI 10.1080/15298668391405526; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pitman SK, 2011, EXPERT OPIN EMERG DR, V16, P559, DOI 10.1517/14728214.2011.607811; Reponen T, 1996, ATMOS ENVIRON, V30, P3967, DOI 10.1016/1352-2310(96)00128-8; Rial-Otero R, 2005, J AGR FOOD CHEM, V53, P4471, DOI 10.1021/jf047848h; Seo Young-Ho, 2013, Prev Nutr Food Sci, V18, P145, DOI 10.3746/pnf.2013.18.2.145; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Spiess B, 2012, ANTIMICROB AGENTS CH, V56, P3905, DOI 10.1128/AAC.05902-11; Spolti P, 2014, PLANT DIS, V98, P607, DOI 10.1094/PDIS-10-13-1051-RE; Steiner B, 2013, CASE REP INFECT DIS, V2013, DOI 10.1155/2013/273848; STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375, DOI 10.1128/AEM.46.2.375-378.1983; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; VANDENBOSSCHE H, 1993, ANTIMICROB AGENTS CH, V37, P2101, DOI 10.1128/AAC.37.10.2101; Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Wei XL, 2015, J MICROBIOL, V53, P91, DOI 10.1007/s12275-015-5014-7; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yamamoto N, 2011, INDOOR AIR, V21, P521, DOI 10.1111/j.1600-0668.2011.00732.x; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Yoshida T, 1997, ANTIMICROB AGENTS CH, V41, P1349, DOI 10.1128/AAC.41.6.1349	62	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138725	10.1371/journal.pone.0138725	http://dx.doi.org/10.1371/journal.pone.0138725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405807	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700077
J	Sherman, LS; Schrankel, CS; Brown, KJ; Smith, LC				Sherman, Lauren S.; Schrankel, Catherine S.; Brown, Kristy J.; Smith, L. Courtney			Extraordinary Diversity of Immune Response Proteins among Sea Urchins: Nickel-Isolated Sp185/333 Proteins Show Broad Variations in Size and Charge	PLOS ONE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; SHOTGUN PROTEOMICS; GENE FAMILY; PEPTIDE IDENTIFICATION; COMPLEMENT HOMOLOG; CELOMIC FLUID; EXPRESSION; CELOMOCYTES; CELLS; LOCALIZATION	Effective protection against pathogens requires the host to produce a wide range of immune effector proteins. The Sp185/333 gene family, which is expressed by the California purple sea urchin Strongylocentrotus purpuratus in response to bacterial infection, encodes a highly diverse repertoire of anti-pathogen proteins. A subset of these proteins can be isolated by affinity to metal ions based on multiple histidines, resulting in one to four bands of unique molecular weight on standard Western blots, which vary depending on the individual sea urchin. Two dimensional gel electrophoresis (2DE) of nickel-isolated protein samples followed by Western blot was employed to detect nickel-isolated Sp185/333 (Ni-Sp185/333) proteins and to evaluate protein diversity in animals before and after immune challenge with marine bacteria. Ni-Sp185/333 proteins of the same molecular weight on standard Western blots appear as a broad complex of variants that differ in pI on 2DE Western blots. The Ni-Sp185/333 protein repertoire is variable among animals, and shows a variety of changes among individual sea urchins in response to immune challenges with both the same and different species of bacteria. The extraordinary diversity of the Ni-Sp185/333 proteins may provide significant anti-pathogen capabilities for sea urchins that survive solely on innate immunity.	[Sherman, Lauren S.; Schrankel, Catherine S.; Smith, L. Courtney] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Brown, Kristy J.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	George Washington University; Children's National Health System	Smith, LC (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	csmith@gwu.edu		Sherman, Lauren/0000-0001-5534-5725	National Science Foundation [MCB-0744999, IOS-1146124]; National Institutes of Health [5R24HD050846-10, 2P30HD040677-14, UL1TR000075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding: This work was supported by the National Science Foundation, www.nsf.gov (MCB-0744999, IOS-1146124 to LCS), and the National Institutes of Health, www.nih.gov (5R24HD050846-10, 2P30HD040677-14, UL1TR000075 to KJB).	Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Asahida T, 1996, FISHERIES SCI, V62, P727, DOI 10.2331/fishsci.62.727; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2008, J MOL BIOL, V379, P912, DOI 10.1016/j.jmb.2008.04.037; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Courtney Smith L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00070; D'Andrea-Winslow L, 2012, INTEGR ZOOL, V7, P61, DOI [10.1111/j.1749-4877.2012.00276.x, 10.1111/j.1749-4877.2011.00279.x]; Dheilly NM, 2013, DEV COMP IMMUNOL, V40, P35, DOI 10.1016/j.dci.2013.01.007; Dheilly NM, 2011, IMMUNOL CELL BIOL, V89, P861, DOI 10.1038/icb.2011.3; Dheilly NM, 2009, J IMMUNOL, V182, P2203, DOI 10.4049/jimmunol.07012766; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Ghosh J, 2010, DEV COMP IMMUNOL, V34, P235, DOI 10.1016/j.dci.2009.10.008; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; GUERINOT ML, 1982, INT J SYST BACTERIOL, V32, P350, DOI 10.1099/00207713-32-3-350; Hathout Y, 2002, J PROTEOME RES, V1, P435, DOI 10.1021/pr020006i; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hillier BJ, 2007, GENOMICS, V89, P721, DOI 10.1016/j.ygeno.2007.02.009; HUTCHINSON F, 1975, BRIT J DERMATOL, V93, P557, DOI 10.1111/j.1365-2133.1975.tb02249.x; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Lambert LA, 2012, BBA-GEN SUBJECTS, V1820, P244, DOI 10.1016/j.bbagen.2011.06.002; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Majeske AJ, 2014, J IMMUNOL, V193, P5678, DOI 10.4049/jimmunol.1401681; Majeske AJ, 2013, INNATE IMMUN-LONDON, V19, P569, DOI 10.1177/1753425912473850; Multerer KA, 2004, IMMUNOGENETICS, V56, P89, DOI 10.1007/s00251-004-0665-2; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Oren M, EVOLUTION I IN PRESS; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rast JP, 2000, CURR TOP MICROBIOL, V248, P3; Reeves EKM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-26; SERVICE M, 1984, COMP BIOCHEM PHYS B, V79, P161, DOI 10.1016/0305-0491(84)90008-7; Smith LC, 2010, DIS MODEL MECH, V3, P274, DOI 10.1242/dmm.004697; SMITH LC, 1992, MOL BIOL CELL, V3, P403, DOI 10.1091/mbc.3.4.403; SMITH LC, 1995, DEV COMP IMMUNOL, V19, P217, DOI 10.1016/0145-305X(95)00009-I; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006	41	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138892	10.1371/journal.pone.0138892	http://dx.doi.org/10.1371/journal.pone.0138892			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406912	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700112
J	Siddique, J; Ruhnke, GW; Flores, A; Prochaska, MT; Paesch, E; Meltzer, DO; Whelan, CT				Siddique, Juned; Ruhnke, Gregory W.; Flores, Andrea; Prochaska, Micah T.; Paesch, Elizabeth; Meltzer, David O.; Whelan, Chad T.			Applying Classification Trees to Hospital Administrative Data to Identify Patients with Lower Gastrointestinal Bleeding	PLOS ONE			English	Article							EPIDEMIOLOGY; OUTCOMES	Background Lower gastrointestinal bleeding (LGIB) is a common cause of acute hospitalization. Currently, there is no accepted standard for identifying patients with LGIB in hospital administrative data. The objective of this study was to develop and validate a set of classification algorithms that use hospital administrative data to identify LGIB. Methods Our sample consists of patients admitted between July 1, 2001 and June 30, 2003 (derivation cohort) and July 1, 2003 and June 30, 2005 (validation cohort) to the general medicine inpatient service of the University of Chicago Hospital, a large urban academic medical center. Confirmed cases of LGIB in both cohorts were determined by reviewing the charts of those patients who had at least 1 of 36 principal or secondary International Classification of Diseases, Ninth revision, Clinical Modification (ICD-9-CM) diagnosis codes associated with LGIB. Classification trees were used on the data of the derivation cohort to develop a set of decision rules for identifying patients with LGIB. These rules were then applied to the validation cohort to assess their performance. Results Three classification algorithms were identified and validated: a high specificity rule with 80.1% sensitivity and 95.8% specificity, a rule that balances sensitivity and specificity (87.8% sensitivity, 90.9% specificity), and a high sensitivity rule with 100% sensitivity and 91.0% specificity. Conclusion These classification algorithms can be used in future studies to evaluate resource utilization and assess outcomes associated with LGIB without the use of chart review.	[Siddique, Juned] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Ruhnke, Gregory W.; Flores, Andrea; Prochaska, Micah T.; Paesch, Elizabeth; Meltzer, David O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Whelan, Chad T.] Loyola Univ, Stritch Sch Med, Dept Med, Maywood, IL 60153 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; Loyola University Chicago	Siddique, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	siddique@northwestern.edu			NIH [K07 CA154862, KM1 CA156717]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023007] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA154862, KM1CA156717] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Siddique was supported by NIH grant K07 CA154862 (www.nih.gov). Ruhnke was supported by NIH grant KM1 CA156717 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 1984, CLASSIFICATION REGRE; Fisher DA, 2010, DIGEST DIS SCI, V55, P1721, DOI 10.1007/s10620-010-1200-y; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Hastie T., 2015, STAT LEARNING SPARSI; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; R Core Team, 2012, R LANG ENV STAT COMP; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2005, GASTROENTEROL CLIN N, V34, P643, DOI 10.1016/j.gtc.2005.08.007; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Therneau T.M., 2012, R PACKAGE SURVIVAL V, P1; Whelan CT, 2010, J HOSP MED, V5, P141, DOI 10.1002/jhm.606; Yu O, 2011, EPIDEMIOL INFECT, V139, P1296, DOI 10.1017/S0950268810002529	17	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138987	10.1371/journal.pone.0138987	http://dx.doi.org/10.1371/journal.pone.0138987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406318	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700139
J	Xiao, ZC; Guo, WT; Yuen, SMWK; Wang, RW; Zhang, L; Van Petegem, F; Chen, SRW				Xiao, Zhichao; Guo, Wenting; Yuen, Siobhan M. Wong King; Wang, Ruiwu; Zhang, Lin; Van Petegem, Filip; Chen, S. R. Wayne			The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor	PLOS ONE			English	Article							VENTRICULAR-TACHYCARDIA; CRYSTAL-STRUCTURES; RELEASE; REGION; SENSITIVITY; THRESHOLD; PROTEINS; DOMAINS; ROLES; FORMS	The N-terminal domain of the cardiac ryanodine receptor (RyR2) harbors a large number of naturally occurring mutations that are associated with stress-induced ventricular tachyarrhythmia and sudden death. Nearly all these disease-associated N-terminal mutations are located at domain interfaces or buried within domains. Mutations at these locations would alter domain-domain interactions or the stability/folding of domains. Recently, a novel RyR2 mutation H29D associated with ventricular arrhythmia at rest was found to enhance the activation of single RyR2 channels by diastolic levels of cytosolic Ca2+. Unlike other N-terminal disease-associated mutations, the H29D mutation is located on the surface of the N-terminal domain. It is unclear how this surface-exposed H29D mutation that does not appear to interact with other parts of the RyR2 structure could alter the intrinsic properties of the channel. Here we carried out detailed functional characterization of the RyR2-H29D mutant at the molecular and cellular levels. We found that the H29D mutation has no effect on the basal level or the Ca2+ dependent activation of [H-3]ryanodine binding to RyR2, the cytosolic Ca2+ activation of single RyR2 channels, or the cytosolic Ca2+- or caffeine-induced Ca2+ release in HEK293 cells. In addition, the H29D mutation does not alter the propensity for spontaneous Ca2+ release or the thresholds for Ca2+ release activation or termination. Furthermore, the H29D mutation does not have significant impact on the thermal stability of the N-terminal region (residues 1-547) of RyR2. Collectively, our data show that the H29D mutation exerts little or no effect on the function of RyR2 or on the folding stability of the N-terminal region. Thus, our results provide no evidence that the H29D mutation enhances the cytosolic Ca2+ activation of RyR2.	[Xiao, Zhichao; Guo, Wenting; Wang, Ruiwu; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Xiao, Zhichao; Guo, Wenting; Wang, Ruiwu; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Biochem Mol Biol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Yuen, Siobhan M. Wong King; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of British Columbia	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; CIHR [125893]; Alberta Innovates [201500221] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Alberta, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research to S.R.W.C., who is an Alberta Innovates-Health Solutions (AIHS) Scientist. FVP is supported by the CIHR (125893).	Amador FJ, 2013, J MOL BIOL, V425, P4034, DOI 10.1016/j.jmb.2013.08.015; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Cheung JW, 2015, INT J CARDIOL, V180, P228, DOI 10.1016/j.ijcard.2014.11.119; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Liu YJ, 2013, BIOCHEM J, V454, P123, DOI 10.1042/BJ20130594; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Meli AC, 2011, CIRC RES, V109, P281, DOI 10.1161/CIRCRESAHA.111.244970; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	37	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139058	10.1371/journal.pone.0139058	http://dx.doi.org/10.1371/journal.pone.0139058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405799	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700157
J	Villanueva, S; Burgos, J; Lopez-Cayuqueo, KI; Lai, KMV; Valenzuela, DM; Cid, LP; Sepulveda, FV				Villanueva, Sandra; Burgos, Johanna; Lopez-Cayuqueo, Karen I.; Lai, Ka-Man Venus; Valenzuela, David M.; Pablo Cid, L.; Sepulveda, Francisco V.			Cleft Palate, Moderate Lung Developmental Retardation and Early Postnatal Lethality in Mice Deficient in the Kir7.1 Inwardly Rectifying K+ Channel	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; LEBER CONGENITAL AMAUROSIS; PERMEATION PROPERTIES; POTASSIUM CHANNELS; KCNJ13; CELLS; PALATOGENESIS; LOCALIZATION; EXPRESSION; DISRUPTION	Kir7.1 is an inwardly rectifying K+ channel of the Kir superfamily encoded by the kcnj13 gene. Kir7.1 is present in epithelial tissues where it colocalizes with the Na+/K+-pump probably serving to recycle K+ taken up by the pump. Human mutations affecting Kir7.1 are associated with retinal degeneration diseases. We generated a mouse lacking Kir7.1 by ablation of the Kcnj13 gene. Homozygous mutant null mice die hours after birth and show cleft palate and moderate retardation in lung development. Kir7.1 is expressed in the epithelium covering the palatal processes at the time at which palate sealing takes place and our results suggest it might play an essential role in late palatogenesis. Our work also reveals a second unexpected role in the development and the physiology of the respiratory system, where Kir7.1 is expressed in epithelial cells all along the respiratory tree.	[Villanueva, Sandra; Burgos, Johanna; Lopez-Cayuqueo, Karen I.; Pablo Cid, L.; Sepulveda, Francisco V.] Ctr Estudios Cientif CECs, Valdivia, Chile; [Burgos, Johanna] Univ Austral Chile, Ciencias Vet, Valdivia, Chile; [Lai, Ka-Man Venus; Valenzuela, David M.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	Universidad Austral de Chile; Regeneron	Sepulveda, FV (corresponding author), Ctr Estudios Cientif CECs, Valdivia, Chile.	fsepulveda@cecs.cl	Lopez-Cayuqueo, Karen/ABA-1967-2020	Lopez-Cayuqueo, Karen/0000-0001-8409-7345; Cid, Pablo/0000-0003-0394-0498; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598; Villanueva, Sandra/0000-0002-2515-145X	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile (FONDECYT) [1120743]; Centres of Excellence Base Financing Programme of the Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (Conicyt)	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centres of Excellence Base Financing Programme of the Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (Conicyt)	This work was funded funded by the Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile (FONDECYT) grant 1120743. The Centro de Estudios Cientificos (CECs) is funded by the Centres of Excellence Base Financing Programme of the Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (Conicyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN D, 1977, J ANAT, V123, P649; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Dahal GR, 2012, DEVELOPMENT, V139, P3653, DOI 10.1242/dev.078592; Derst C, 2001, KIDNEY INT, V59, P2197; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Doring F, 1998, J NEUROSCI, V18, P8625; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Girault A, 2014, AM J PHYSIOL-CELL PH, V306, pC307, DOI 10.1152/ajpcell.00226.2013; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Huang X, 2014, J CELL BIOL, V206, P151, DOI 10.1083/jcb.201404136; Iseki S, 2011, DEV GROWTH DIFFER, V53, P259, DOI 10.1111/j.1440-169X.2010.01245.x; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nakamura N, 1999, BIOCHEM J, V342, P329, DOI 10.1042/0264-6021:3420329; Navis A, 2015, CURR OPIN GENET DEV, V32, P24, DOI 10.1016/j.gde.2015.01.010; Ookata K, 2000, J AM SOC NEPHROL, V11, P1987, DOI 10.1681/ASN.V11111987; Ozturk F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-113; Partiseti M, 1998, FEBS LETT, V434, P171, DOI 10.1016/S0014-5793(98)00972-7; Pattnaik BR, 2015, HUM MUTAT, V36, P720, DOI 10.1002/humu.22807; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Sepulveda FV, 2015, PHYSIOL REV, V95, P179, DOI 10.1152/physrev.00016.2014; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139284	10.1371/journal.pone.0139284	http://dx.doi.org/10.1371/journal.pone.0139284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402555	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100064
J	Longchamp, A; Allagnat, F; Alonso, F; Kuppler, C; Dubuis, C; Ozaki, CK; Mitchell, JR; Berceli, S; Corpataux, JM; Deglise, S; Haefliger, JA				Longchamp, Alban; Allagnat, Florent; Alonso, Florian; Kuppler, Christopher; Dubuis, Celine; Ozaki, Charles-Keith; Mitchell, James R.; Berceli, Scott; Corpataux, Jean-Marc; Deglise, Sebastien; Haefliger, Jacques-Antoine			Connexin43 Inhibition Prevents Human Vein Grafts Intimal Hyperplasia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; SHEAR-STRESS; GAP-JUNCTIONS; UP-REGULATION; PROTEIN CX37; NITRIC-OXIDE; C-JUN; EXPRESSION; MIGRATION	Venous bypass grafts often fail following arterial implantation due to excessive smooth muscle cells (VSMC) proliferation and consequent intimal hyperplasia (IH). Intercellular communication mediated by Connexins (Cx) regulates differentiation, growth and proliferation in various cell types. Microarray analysis of vein grafts in a model of bilateral rabbit jugular vein graft revealed Cx43 as an early upregulated gene. Additional experiments conducted using an ex-vivo human saphenous veins perfusion system (EVPS) confirmed that Cx43 was rapidly increased in human veins subjected ex-vivo to arterial hemodynamics. Cx43 knock-down by RNA interference, or adenoviral-mediated overexpression, respectively inhibited or stimulated the proliferation of primary human VSMC in vitro. Furthermore, Cx blockade with carbenoxolone or the specific Cx43 inhibitory peptide (43)gap26 prevented the burst in myointimal proliferation and IH formation in human saphenous veins. Our data demonstrated that Cx43 controls proliferation and the formation of IH after arterial engraftment.	[Longchamp, Alban; Allagnat, Florent; Alonso, Florian; Dubuis, Celine; Corpataux, Jean-Marc; Deglise, Sebastien; Haefliger, Jacques-Antoine] CHU Vaudois, Dept Vasc Surg, Expt Med Lab, CH-1011 Lausanne, Switzerland; [Longchamp, Alban; Ozaki, Charles-Keith] Harvard Univ, Sch Med, Dept Surg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kuppler, Christopher; Berceli, Scott] Univ Florida, Coll Med, Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA; [Kuppler, Christopher; Berceli, Scott] Univ Florida, Coll Med, Div Vasc & Endovasc Surg, Gainesville, FL USA; [Longchamp, Alban; Mitchell, James R.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Harvard T.H. Chan School of Public Health	Haefliger, JA (corresponding author), CHU Vaudois, Dept Vasc Surg, Expt Med Lab, CH-1011 Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Allagnat, Florent/X-3772-2019; Allagnat, Florent/A-4471-2017; Alonso, Florian/AAA-2776-2020; Allagnat, Florent/AAY-7188-2021	Allagnat, Florent/0000-0001-6528-679X; Alonso, Florian/0000-0002-6794-1513; Allagnat, Florent/0000-0001-6528-679X; Longchamp, Alban/0000-0002-1743-4935; Berceli, Scott/0000-0003-2257-0111; Deglise, Sebastien/0000-0001-8244-952X; Haefliger, Jacques-Antoine/0000-0003-2732-1667	Swiss National Science Foundation (SNSF) [31003A-155897, P1LAP3_158895]; Octav and the Marcella Botnar Foundation; Muschamp Foundation; American Heart Association [12GRNT9510001, 12GRNT1207025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL119178] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Octav and the Marcella Botnar Foundation; Muschamp Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Swiss National Science Foundation (SNSF, www.snf.ch) 31003A-155897 to JAH; the Octav and the Marcella Botnar Foundation to JAH; the Muschamp Foundation (http://www.s-a-v.org/-Fondations-associees-.html) to SD; The American Heart Association (http://www.heart.org) 12GRNT9510001 and 12GRNT1207025 to CKO; and the Swiss National Science Foundation (SNSF, www.snf.ch) P1LAP3_158895 to AL.	Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Ataya B, 2011, TRENDS CARDIOVAS MED, V21, P157, DOI 10.1016/j.tcm.2012.05.002; Behrens J, 2010, EUR J CELL BIOL, V89, P828, DOI 10.1016/j.ejcb.2010.06.003; Berard X, 2013, J VASC SURG, V57, P1371, DOI 10.1016/j.jvs.2012.09.041; Brisset AC, 2009, ANTIOXID REDOX SIGN, V11, P267, DOI 10.1089/ars.2008.2115; Chadjichristos CE, 2006, CIRCULATION, V113, P2835, DOI 10.1161/CIRCULATIONAHA.106.627703; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Chen CH, 2015, AM J PHYSIOL-CELL PH, V309, pC600, DOI 10.1152/ajpcell.00155.2015; Corpataux JM, 2005, J SURG RES, V129, P52, DOI 10.1016/j.jss.2005.05.016; Corpataux JM, 2005, EUR J VASC ENDOVASC, V29, P177, DOI 10.1016/j.ejvs.2004.11.003; Darzynkiewicz Zbigniew, 2004, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0507s60; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Deglise S, 2005, J VASC SURG, V41, P1043, DOI 10.1016/j.jvs.2005.02.036; DeSart KM, 2015, J VASC SURG, V62, P1296, DOI 10.1016/j.jvs.2014.05.015; Dubuis C, 2013, J PHARMACOL EXP THER, V347, P574, DOI 10.1124/jpet.113.208769; Fernandez CM, 2004, ANN BIOMED ENG, V32, P1484, DOI 10.1114/B:ABME.0000049033.65547.cf; Geimonen E, 1998, J CLIN ENDOCR METAB, V83, P1177, DOI 10.1210/jc.83.4.1177; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Halidi N, 2012, CELL COMMUN ADHES, V19, P25, DOI 10.3109/15419061.2012.690792; Holt J, 1992, Cancer Treat Res, V63, P301; Jia GH, 2008, J MOL CELL CARDIOL, V44, P882, DOI 10.1016/j.yjmcc.2008.03.002; Jia GH, 2007, J SURG RES, V142, P137, DOI 10.1016/j.jss.2006.11.007; Jiang ZH, 2004, AM J PHYSIOL-HEART C, V286, pH240, DOI 10.1152/ajpheart.00760.2003; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Le Gal L, 2014, HYPERTENSION, V63, P1198, DOI 10.1161/HYPERTENSIONAHA.113.02976; Liao YB, 2007, ARTERIOSCL THROM VAS, V27, P1037, DOI 10.1161/ATVBAHA.106.137182; Longchamp A, 2014, JOVE-J VIS EXP, DOI 10.3791/52079; Longchamp A, 2014, BIOMATERIALS, V35, P2588, DOI 10.1016/j.biomaterials.2013.12.041; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Martin D, 2008, DIABETOLOGIA, V51, P1429, DOI 10.1007/s00125-008-0984-1; Martin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045844; Meens MJ, 2013, CARDIOVASC RES, V99, P304, DOI 10.1093/cvr/cvt095; Mendoza-Naranjo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037374; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Pfenniger A, 2012, J MOL CELL CARDIOL, V53, P299, DOI 10.1016/j.yjmcc.2012.05.011; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Pitha J, 2011, INT ANGIOL, V30, P221; Plenz G, 2004, EUR J CELL BIOL, V83, P521, DOI 10.1078/0171-9335-00417; Polacek D, 1997, J VASC RES, V34, P19, DOI 10.1159/000159198; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Wang LH, 2005, INT J CARDIOL, V100, P467, DOI 10.1016/j.ijcard.2004.12.005; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yeh HI, 1997, ARTERIOSCL THROM VAS, V17, P3174, DOI 10.1161/01.ATV.17.11.3174	47	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138847	10.1371/journal.pone.0138847	http://dx.doi.org/10.1371/journal.pone.0138847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398895	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500117
J	Saksena, S; Fox, J; Epprecht, M; Tran, CC; Nong, DH; Spencer, JH; Nguyen, L; Finucane, ML; Tran, VD; Wilcox, BA				Saksena, Sumeet; Fox, Jefferson; Epprecht, Michael; Tran, Chinh C.; Nong, Duong H.; Spencer, James H.; Lam Nguyen; Finucane, Melissa L.; Tran, Vien D.; Wilcox, Bruce A.			Evidence for the Convergence Model: The Emergence of Highly Pathogenic Avian Influenza (H5N1) in Viet Nam	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; RED-RIVER DELTA; RISK-FACTORS; HABITAT FRAGMENTATION; SOUTHEAST-ASIA; MAINLAND CHINA; SUBTYPE H5N1; A H7N9; HEALTH; PREDICTION	Building on a series of ground breaking reviews that first defined and drew attention to emerging infectious diseases (EID), the 'convergence model' was proposed to explain the multifactorial causality of disease emergence. The model broadly hypothesizes disease emergence is driven by the co-incidence of genetic, physical environmental, ecological, and social factors. We developed and tested a model of the emergence of highly pathogenic avian influenza (HPAI) H5N1 based on suspected convergence factors that are mainly associated with land-use change. Building on previous geospatial statistical studies that identified natural and human risk factors associated with urbanization, we added new factors to test whether causal mechanisms and pathogenic landscapes could be more specifically identified. Our findings suggest that urbanization spatially combines risk factors to produce particular types of peri-urban landscapes with significantly higher HPAI H5N1 emergence risk. The work highlights that peri-urban areas of Viet Nam have higher levels of chicken densities, duck and geese flock size diversities, and fraction of land under rice or aquaculture than rural and urban areas. We also found that land-use diversity, a surrogate measure for potential mixing of host populations and other factors that likely influence viral transmission, significantly improves the model's predictability. Similarly, landscapes where intensive and extensive forms of poultry production overlap were found at greater risk. These results support the convergence hypothesis in general and demonstrate the potential to improve EID prevention and control by combing geospatial monitoring of these factors along with pathogen surveillance programs.	[Saksena, Sumeet; Fox, Jefferson; Tran, Chinh C.; Nong, Duong H.] East West Ctr, Honolulu, HI 96848 USA; [Epprecht, Michael] Univ Bern, Bern, Switzerland; [Spencer, James H.] Clemson Univ, Clemson, SC USA; [Lam Nguyen; Tran, Vien D.] Vietnam Natl Univ Agr, Hanoi, Vietnam; [Finucane, Melissa L.] RAND Corp, Pittsburgh, PA USA; [Wilcox, Bruce A.] Mahihdol Univ, Bangkok, Thailand	East West Center; University of Bern; Clemson University; Vietnam National University of Agriculture (VNUA); RAND Corporation	Saksena, S (corresponding author), East West Ctr, Honolulu, HI 96848 USA.	saksenas@eastwestcenter.org	Nong, Duong/O-8753-2017	Nong, Duong/0000-0001-9867-5249; Fox, Jefferson/0000-0002-0508-654X	U.S. National Science Foundation [DEB-0909410]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was funded by the U.S. National Science Foundation Grant # DEB-0909410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, CURR SCI INDIA, V97, P73; Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Aoyama Y, 2010, J REGIONAL SCI, V50, P1001, DOI 10.1111/j.1467-9787.2010.00709_1.x; Arcaya M, 2012, HEALTH PLACE, V18, P824, DOI 10.1016/j.healthplace.2012.03.010; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Birley MH, 1998, ENVIRON URBAN, V10, P89, DOI 10.1177/095624789801000120; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Burgos S., 2007, International Journal of Poultry Science, V6, P709; Cao CX, 2010, CHINESE SCI BULL, V55, P4168, DOI 10.1007/s11434-010-4225-x; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Despommier D, 2006, ECOHEALTH, V3, P281, DOI 10.1007/s10393-006-0063-3; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; Dhingra MS, 2014, SPAT SPATIO-TEMPORAL, V11, P45, DOI 10.1016/j.sste.2014.06.003; Ducheyne E, 2009, PREV VET MED, V91, P11, DOI 10.1016/j.prevetmed.2009.05.009; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fang LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02722; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Forman RTT, 1995, LAND MOSAICS ECOLOGY, Vxx; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Guerrini L, 2008, J MED ENTOMOL, V45, P1180, DOI 10.1603/0022-2585(2008)45[1180:FAFPOS]2.0.CO;2; Gunderson L.H., 2003, NAVIGATING SOCIAL EC, P33; Hartemink N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020817; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Horby PW, 2013, EMERG INFECT DIS, V19, P853, DOI 10.3201/eid1906.121783; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Lederberg J, 1992, EMERGING INFECT MICR, Vxii; Leo L, 2011, PREV VET MED, V102, P50, DOI 10.1016/j.prevetmed.2011.06.006; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Mathur MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106171; McDade TW, 2001, SOC SCI MED, V53, P55, DOI 10.1016/S0277-9536(00)00313-0; McGarigal Kevin, 1994, FRAGSTATS SPATIAL PA; McGee T.G., 1991, EXTENDED METROPOLIS, P15; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Morens DM, 2012, MBIO, V3, DOI 10.1128/mBio.00494-12; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Paul M, 2011, ACTA TROP, V118, P209, DOI 10.1016/j.actatropica.2011.03.009; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Paul MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101958; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Saksena S, 2014, APPL GEOGR, V50, P80, DOI 10.1016/j.apgeog.2014.02.010; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Smolinski MS, 2005, MICROBIAL THREATS HL, Vix; Smolinski MS, 2003, MICROBIAL THREATS HL, Vxxviii; Spencer JH, 2013, J URBAN HEALTH, V90, P343, DOI 10.1007/s11524-012-9719-1; Stevens KB, 2013, SPAT SPATIO-TEMPORAL, V4, P1, DOI 10.1016/j.sste.2012.11.002; Suzan G, 2008, ANN NY ACAD SCI, V1149, P80, DOI 10.1196/annals.1428.063; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thanapongtharm W, 2013, GEOSPATIAL HEALTH, V8, P193, DOI 10.4081/gh.2013.66; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; Tran CC, 2013, ISPRS INT J GEO-INF, V2, P1106, DOI 10.3390/ijgi2041106; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Wartenber CM, 1966, VONTHUNENS ISOLATED; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701; Wilcox Bruce A., 2005, EcoHealth, V2, P244, DOI 10.1007/s10393-005-8961-3; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; Williams RAJ, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-47; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014	80	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138138	10.1371/journal.pone.0138138	http://dx.doi.org/10.1371/journal.pone.0138138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398118	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500053
J	Tsoumani, KT; Drosopoulou, E; Bourtzis, K; Gariou-Papalexiou, A; Mavragani-Tsipidou, P; Zacharopoulou, A; Mathiopoulos, KD				Tsoumani, Konstantina T.; Drosopoulou, Elena; Bourtzis, Kostas; Gariou-Papalexiou, Aggeliki; Mavragani-Tsipidou, Penelope; Zacharopoulou, Antigone; Mathiopoulos, Kostas D.			Achilles, a New Family of Transcriptionally Active Retrotransposons from the Olive Fruit Fly, with Y Chromosome Preferential Distribution	PLOS ONE			English	Article							SEX-DETERMINING REGION; LONG TERMINAL REPEATS; TRANSPOSABLE ELEMENTS; DROSOPHILA-MELANOGASTER; CERATITIS-CAPITATA; BACTROCERA-OLEAE; CHIRONOMUS-THUMMI; DNA-SEQUENCES; GENOME SIZE; BOMBYX-MORI	Sex chromosomes have many unusual features relative to autosomes. The in depth exploration of their structure will improve our understanding of their origin and divergence (degeneration) as well as the evolution of genetic sex determination pathways which, most often are attributed to them. In Tephritids, the structure of Y chromosome, where the male-determining factor M is localized, is largely unexplored and limited data concerning its sequence content and evolution are available. In order to get insight into the structure and organization of the Y chromosome of the major olive insect pest, the olive fly Bactrocera oleae, we characterized sequences from a Pulse Field Gel Electrophoresis (PFGE)-isolated Y chromosome. Here, we report the discovery of the first olive fly LTR retrotransposon with increased presence on the Y chromosome. The element belongs to the BEL-Pao superfamily, however, its sequence comparison with the other members of the superfamily suggests that it constitutes a new family that we termed Achilles. Its similar to 7.5 kb sequence consists of the 5'LTR, the 5'non-coding sequence and the open reading frame (ORF), which encodes the polyprotein Gag-Pol. In situ hybridization to the B. oleae polytene chromosomes showed that Achilles is distributed in discrete bands dispersed on all five autosomes, in all centromeric regions and in the granular heterochromatic network corresponding to the mitotic sex chromosomes. The between sexes comparison revealed a variation in Achilles copy number, with male flies possessing 5-10 copies more than female (CI range: 18-38 and 12-33 copies respectively per genome). The examination of its transcriptional activity demonstrated the presence of at least one intact active copy in the genome, showing a differential level of expression between sexes as well as during embryonic development. The higher expression was detected in male germline tissues (testes). Moreover, the presence of Achilles-like elements in different species of the Tephritidae family suggests an ancient origin of this element.	[Tsoumani, Konstantina T.; Mathiopoulos, Kostas D.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Drosopoulou, Elena; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki AUTH, Dept Genet Dev & Mol Biol, Thessaloniki, Greece; [Bourtzis, Kostas] IMBB, Insect Mol Genet Grp, Iraklion 71110, Greece; [Bourtzis, Kostas] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Bourtzis, Kostas] Joint FAO IAEA, Insect Pest Control Lab, Div Nucl Tech Food & Agr, Vienna, Austria; [Gariou-Papalexiou, Aggeliki; Zacharopoulou, Antigone] Univ Patras, Dept Biol, Div Genet Cell & Dev Biol, Patras, Greece	University of Thessaly; Aristotle University of Thessaloniki; University of Patras; International Atomic Energy Agency; University of Patras	Mathiopoulos, KD (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	kmathiop@bio.uth.gr	Mathiopoulos, Kostas/K-9548-2019; DROSOPOULOU, ELENA/N-2176-2015; Drosopoulou, Elena/AAX-6493-2020	Mathiopoulos, Kostas/0000-0002-2875-5697; Drosopoulou, Elena/0000-0001-9805-0572	Hellenic General Secretariat of Research and Technology [99 ED529]; Pythagoras II grant from the Greek Ministry of National Education and Religious Affairs; Biochemistry and Biotechnology Department of the University of Thessaly	Hellenic General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); Pythagoras II grant from the Greek Ministry of National Education and Religious Affairs; Biochemistry and Biotechnology Department of the University of Thessaly	This work was partially supported by a grant from the Hellenic General Secretariat of Research and Technology (99 ED529), the Pythagoras II grant from the Greek Ministry of National Education and Religious Affairs and the two Graduate Programs of the Biochemistry and Biotechnology Department of the University of Thessaly ('Biotechnology - Nutrition and Environment' and 'Molecular Biology and Genetics applications'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2001, MOL GENET GENOMICS, V265, P375, DOI 10.1007/s004380000428; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANLEITNER JE, 1992, CHROMOSOMA, V101, P271, DOI 10.1007/BF00346005; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; BEDO DG, 1985, CHROMOSOMA, V92, P344, DOI 10.1007/BF00327465; BEDO DG, 1987, GENOME, V29, P598, DOI 10.1139/g87-101; Benachenhou F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005179; Biemont C, 2005, CYTOGENET GENOME RES, V110, P25, DOI 10.1159/000084935; Carvalho AB, 2009, TRENDS GENET, V25, P270, DOI 10.1016/j.tig.2009.04.002; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; COVEY SN, 1986, NUCLEIC ACIDS RES, V14, P623, DOI 10.1093/nar/14.2.623; de la Chaux N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-154; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Drosopoulou E, 1995, J MOL EVOL; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Eickbush TH, 2002, CURR OPIN GENET DEV, V12, P669, DOI 10.1016/S0959-437X(02)00359-3; FELDER H, 1994, GENE, V149, P219, DOI 10.1016/0378-1119(94)90153-8; Frame IG, 2001, GENE, V263, P219, DOI 10.1016/S0378-1119(00)00567-9; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gabrieli P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017747; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; HAGELE K, 1985, CHROMOSOMA, V91, P167, DOI 10.1007/BF00328214; HE M, 1995, J MOL EVOL, V41, P141, DOI 10.1007/BF00170665; Hoskins R, 2007, SCIENCE; Kaiser VB, 2010, ANNU REV GENET, V44, P91, DOI 10.1146/annurev-genet-102209-163600; Kakani EG, 2013, B ENTOMOL RES, V103, P36, DOI 10.1017/S0007485312000478; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kogan GL, 2003, MOL GENET GENOMICS, V269, P234, DOI 10.1007/s00438-003-0827-1; KRAEMER C, 1993, CHROMOSOMA, V102, P553, DOI 10.1007/BF00368348; Krzywinski J, 2005, GENETICS, V169, P185, DOI 10.1534/genetics.104.034264; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lifschitz E, 1989, CERATITIS CAPITATA C; LOCKE J, 1993, CHROMOSOMA, V102, P718, DOI 10.1007/BF00650898; Marsano R, 2004, MOL GENET; Mavragani-Tsipidou P., 2014, PROTOCOLS CYTOGENETI; MAVRAGANITSIPIDOU P, 1992, GENOME, V35, P373, DOI 10.1139/g92-056; Pearce S, 1999, PLANT; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rohr CJB, 2002, MOL BIOL EVOL, V19, P149, DOI 10.1093/oxfordjournals.molbev.a004067; Sagri E, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S8; Sagri E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-714; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J, 1989, MOL CLONING; SEMESHIN VF, 1995, GENOME, V38, P652, DOI 10.1139/g95-083; Shearman DCA, 2002, GENETICA, V116, P25, DOI 10.1023/A:1020955507978; Shigenobu S, 2006, PROC; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith C, 2007, SCIENCE; Soleimani VD, 2006, GENOME, V49, P389, DOI 10.1139/G05-119; STEINEMANN M, 1991, CHROMOSOMA, V101, P169, DOI 10.1007/BF00355366; Steinemann M, 1997, GENETICS, V145, P261; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; Steinemann S, 2005, BIOESSAYS; Torti C, 2000, CHROMOSOMA, V108, P523, DOI 10.1007/s004120050404; Tsoumani KT, 2012, J APPL ENTOMOL, V136, P626, DOI 10.1111/j.1439-0418.2011.01684.x; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Tsoumani KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079393; Vicoso B, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002078; Vicoso B, 2013, NATURE, V499, P332, DOI 10.1038/nature12235; Wei KHC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002077; White I.M., 1992, FRUIT FLIES EC SIGNI; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Willhoeft U, 1996, GENETICS, V144, P737; Wong LH, 2004, TRENDS GENET, V20, P611, DOI 10.1016/j.tig.2004.09.011; XIONG Y, 1993, NUCLEIC ACIDS RES, V21, P2117, DOI 10.1093/nar/21.9.2117; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Zambetaki A, 1999, GENOME, V42, P744, DOI 10.1139/gen-42-4-744; Zhou Q, 2000, GENOME, V43, P434, DOI 10.1139/gen-43-3-434; [No title captured]	76	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137050	10.1371/journal.pone.0137050	http://dx.doi.org/10.1371/journal.pone.0137050			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398504	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500016
J	Wu, HB; Wang, Z; Wang, QS; Han, YJ; Wang, M; Zhou, WL; Li, HS				Wu, Hu-bing; Wang, Zhen; Wang, Quan-shi; Han, Yan-jian; Wang, Meng; Zhou, Wen-lan; Li, Hong-sheng			Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BRAIN-TUMORS; NEUROPILIN-1 EXPRESSION; 5-AMINOLEVULINIC ACID; CELL MIGRATION; HOMING PEPTIDE; GRADE GLIOMA; FDG PET/CT; RESECTION; EXTENT	Background Neuropilin (NRP) receptors are overexpressed in glioma tumor tissue, and therefore may be a potential target for imaging markers. We investigated whether labelled tLyP-1, an NRP targeting peptide, could be used as the targeting ligand for developing reagents for imaging glioma tumors. Methods The tLyP-1 peptide (CGNKRTR) was labeled with 5-carboxyfluorescein (FAM) or F-18-fluoride. A control peptide (MAQKTSH) was also labeled with FAM. The in vitro binding between FAM-tLyP-1 and U87MG cells and in vivo biodistribution of FAM-tLyP-1 in a U87MG glioblastoma xenograft model (nude mouse) were determined. The in vivo biodistribution of F-18-tLyP-1 was also determined by microPET/CT. Results In vitro, FAM-tLyP-1 was strongly taken up by U87MG cells at very low concentrations (1 mu M). In vivo, FAM-tLyP-1 accumulated in glioma (U87MG) tumors, but uptake was minimal in the normal brain tissue 1 h after administration. The distribution of FAM-tLyP-1 in the tumor tissue was consistent with expression of NRP1. The tumor/brain fluorescence intensity ratio in mice treated with FAM-tLyP-1 was significantly higher than the control FAM-labeled peptide 1 h after administration (3.44 +/- 0.83 vs. 1.32 +/- 0.15; t = 5.547, P = 0.001). Uptake of FAM-tLyP-1 in glioma tumors could be blocked by administering an excess of non-conjugated tLyP-1 peptide. [Lys4]tLyP-1 was labeled with F-18 to synthesis a PET (F-18-tLyP-1). MicroPET/CT imaging showed the tumor was visualized clearly with a high tumor/brain radiolabel ratio at 60 min (2.69 +/- 0.52) and 120 min (3.11 +/- 0.25). Conclusion Taken together, our results suggest that tLyP-1 could be developed as a novel fluorescent or radio labelled tracer for imaging glioma.	[Wu, Hu-bing; Wang, Zhen; Wang, Quan-shi; Han, Yan-jian; Wang, Meng; Zhou, Wen-lan; Li, Hong-sheng] Southern Med Univ, Nanfang Hosp, NanFang PET Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Wu, HB (corresponding author), Southern Med Univ, Nanfang Hosp, NanFang PET Ctr, Guangzhou, Guangdong, Peoples R China.	wuhbym@163.com			National Natural Science Foundation Project of China [81071175, 81371591]	National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Natural Science Foundation Project of China (81071175), and National Natural Science Foundation Project of China (81371591).	Agarwal A, 2014, AM J ROENTGENOL, V203, P1109, DOI 10.2214/AJR.13.12256; Akcan M, 2011, J MED CHEM, V54, P782, DOI 10.1021/jm101018r; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Broholm H, 2004, APMIS, V112, P257, DOI 10.1111/j.1600-0463.2004.apm11204-0505.x; Butte PV, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13497; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Chung HW, 2014, J CANCER RES CLIN, V140, P89, DOI 10.1007/s00432-013-1545-7; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Gallamini A, 2014, CANCERS, V6, P1821, DOI 10.3390/cancers6041821; Galldiks N, 2013, J NUCL MED, V54, P2046, DOI 10.2967/jnumed.113.123836; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Guo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037506; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Karayan-Tapon L, 2008, BRIT J CANCER, V99, P1153, DOI 10.1038/sj.bjc.6604641; Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008; Kostakoglu Lale, 2014, Clin Adv Hematol Oncol, V12, P20; Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laverman P, 2014, J LABELLED COMPD RAD, V57, P219, DOI 10.1002/jlcr.3161; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Nasarre C, 2009, CELL ADHES MIGR, V3, P383, DOI 10.4161/cam.3.4.9934; Nihashi T, 2013, AM J ROENTGENOL, V200, pW654, DOI 10.2214/AJR.12.9168; Ojeda PG, 2014, FUTURE MED CHEM, V6, P1617, DOI [10.4155/FMC.14.93, 10.4155/fmc.14.93]; Park JH, 2010, P NATL ACAD SCI USA, V107, P981, DOI 10.1073/pnas.0909565107; Parker MW, 2012, BIOCHEMISTRY-US, V51, P9437, DOI 10.1021/bi3012143; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Roder C, 2014, EJSO-EUR J SURG ONC, V40, P297, DOI 10.1016/j.ejso.2013.11.022; Roth L, 2012, ONCOGENE, V31, P3754, DOI 10.1038/onc.2011.537; Ruffini F, 2013, INT J ONCOL, V43, P297, DOI 10.3892/ijo.2013.1948; Singhal T, 2012, J NUCL MED, V53, P1709, DOI 10.2967/jnumed.111.102533; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2011, J NEUROSURG, V114, P613, DOI 10.3171/2010.3.JNS097; Susheela SP, 2013, J CANCER RES THER, V9, P715, DOI 10.4103/0973-1482.126464; Tate MC, 2015, CANCER TREAT RES, V163, P31, DOI 10.1007/978-3-319-12048-5_3; Utsuki S, 2007, NEUROL MED-CHIR, V47, P210, DOI 10.2176/nmc.47.210; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948; Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zachary I, 2014, CHEM IMMUNOL ALLERGY, V99, P37, DOI 10.1159/000354169; Zhang L, 2013, CANCER RES, V73, P3316, DOI 10.1158/0008-5472.CAN-12-3015; Zhang XZ, 2006, J NUCL MED, V47, P113; Zinn PO, 2013, INT J ONCOL, V42, P929, DOI 10.3892/ijo.2013.1770	47	5	7	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137676	10.1371/journal.pone.0137676	http://dx.doi.org/10.1371/journal.pone.0137676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398657	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500045
J	Zhu, LF; Xu, XL; Wang, LM; Dong, H; Yu, B				Zhu, Lingfeng; Xu, Xiaoling; Wang, Limin; Dong, Hui; Yu, Bo			The D-Lactate Dehydrogenase from Sporolactobacillus inulinus Also Possessing Reversible Deamination Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; GLUTAMATE-DEHYDROGENASE; CRYSTAL-STRUCTURE; 2-HYDROXYACID DEHYDROGENASE; VANCOMYCIN RESISTANCE; SUBSTRATE-SPECIFICITY; EFFICIENT PRODUCTION; ACID DEHYDROGENASES; ANGSTROM RESOLUTION; TERNARY COMPLEX	Hydroxyacid dehydrogenases are responsible for the conversion of 2-keto acids to 2-hydroxyacids and have a wide range of biotechnological applications. In this study, a D-lactate dehydrogenase (D-LDH) from a Sporolactobacillus inulinus strain was experimentally verified to have both the D-LDH and glutamate dehydrogenase (GDH) activities (reversible deamination). The catalytic mechanism was demonstrated by identification of key residues from the crystal structure analysis and site-directed mutagenesis. The Arg(234) and Gly(79) residues of this enzyme play a significant role in both D-LDH and GDH activities. His(295) and Phe(298) in DLDH744 were identified to be key residues for lactate dehydrogenase (LDH) activity only whereas Tyr(101) is a unique residue that is critical for GDH activity. Characterization of the biochemical properties contributes to understanding of the catalytic mechanism of this novel D-lactate dehydrogenase enzyme.	[Zhu, Lingfeng; Wang, Limin; Yu, Bo] Chinese Acad Sci, CAS Key Lab Microbial Physiol & Metab Engn, Inst Microbiol, Beijing 100101, Peoples R China; [Dong, Hui] Chinese Acad Med Sci, Inst Radiat Med, Key Lab Tianjin Radiat & Mol Nucl Med, Tianjin, Peoples R China; [Dong, Hui] Peking Union Med Coll, Tianjin 300192, Peoples R China; [Xu, Xiaoling] Hangzhou Normal Univ, Sch Med, Inst Ageing Res, Hangzhou 311121, Zhejiang, Peoples R China; [Zhu, Lingfeng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hangzhou Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, H (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Key Lab Tianjin Radiat & Mol Nucl Med, Tianjin, Peoples R China.	donghui@irm-cams.ac.cn; yub@im.ac.cn	Xu, Xiaoling/ABC-2449-2021	Xu, Xiaoling/0000-0001-8995-1213; Zhu, Lingfeng/0000-0002-9145-5419	National Natural Science Foundation of China [31170116, 31300601]; PUMC Youth Fund [33320140186]; Youth Innovation Promotion Association, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PUMC Youth Fund; Youth Innovation Promotion Association, Chinese Academy of Sciences	This work was partially supported by grants from the National Natural Science Foundation of China (31170116 & 31300601) and the PUMC Youth Fund (33320140186). BY is supported by the Youth Innovation Promotion Association, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonyuk SV, 2009, ACTA CRYSTALLOGR F, V65, P1209, DOI 10.1107/S1744309109044935; ARTHUR M, 1991, GENE, V103, P133, DOI 10.1016/0378-1119(91)90405-Z; Auerbach G, 1998, STRUCTURE, V6, P769, DOI 10.1016/S0969-2126(98)00078-1; Baker PJ, 1998, NAT STRUCT BIOL, V5, P561, DOI 10.1038/817; Booth MPS, 2006, J MOL BIOL, V360, P178, DOI 10.1016/j.jmb.2006.05.018; BRITTON KL, 1993, J MOL BIOL, V234, P938, DOI 10.1006/jmbi.1993.1647; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dengler U, 1997, J MOL BIOL, V267, P640, DOI 10.1006/jmbi.1996.0864; Fujii T, 2011, BBA-PROTEINS PROTEOM, V1814, P1669, DOI 10.1016/j.bbapap.2011.05.024; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; GOLDBERG JD, 1994, J MOL BIOL, V236, P1123, DOI 10.1016/0022-2836(94)90016-7; Gunka K, 2010, J MOL BIOL, V400, P815, DOI 10.1016/j.jmb.2010.05.055; Ha JY, 2007, J MOL BIOL, V366, P1294, DOI 10.1016/j.jmb.2006.12.038; HOLBROOK JJ, 1973, BIOCHEM J, V131, P729, DOI 10.1042/bj1310729; Holton SJ, 2013, J STRUCT BIOL, V181, P179, DOI 10.1016/j.jsb.2012.10.009; Hummel W, 1999, TRENDS BIOTECHNOL, V17, P487, DOI 10.1016/S0167-7799(98)01207-4; Jiang X, 2013, BIORESOURCE TECHNOL, V143, P665, DOI 10.1016/j.biortech.2013.06.049; Kochhar S, 2000, EUR J BIOCHEM, V267, P1633, DOI 10.1046/j.1432-1327.2000.01155.x; Li Y, 2013, BIORESOURCE TECHNOL, V142, P186, DOI 10.1016/j.biortech.2013.04.124; OLSON JA, 1952, J BIOL CHEM, V197, P67; Peng LL, 2013, BIORESOURCE TECHNOL, V149, P169, DOI 10.1016/j.biortech.2013.09.047; POPOV VO, 1994, BIOCHEM J, V301, P625, DOI 10.1042/bj3010625; Razeto A, 2002, J MOL BIOL, V318, P109, DOI 10.1016/S0022-2836(02)00086-4; Richter N, 2011, ENG LIFE SCI, V11, P26, DOI 10.1002/elsc.201000151; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sharkey MA, 2013, FEBS J, V280, P4681, DOI 10.1111/febs.12439; Singh RK, 2014, FEBS J, V281, P5498, DOI 10.1111/febs.13091; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Stoll VS, 1996, STRUCTURE, V4, P437, DOI 10.1016/S0969-2126(96)00049-4; Tamura Y, 2002, APPL ENVIRON MICROB, V68, P947, DOI 10.1128/AEM.68.2.947-951.2002; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wada Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1087, DOI 10.1271/bbb.70827; Wang LM, 2014, APPL ENVIRON MICROB, V80, P7134, DOI 10.1128/AEM.01864-14; WIGLEY DB, 1992, J MOL BIOL, V223, P317, DOI 10.1016/0022-2836(92)90733-Z; Woodyer R, 2005, BIOCHEMISTRY-US, V44, P4765, DOI 10.1021/bi047868c; Yu B, 2011, J BACTERIOL, V193, P5864, DOI 10.1128/JB.05934-11; Zhu LF, 2015, APPL ENVIRON MICROB, V81, P6294, DOI 10.1128/AEM.01871-15	39	9	10	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139066	10.1371/journal.pone.0139066	http://dx.doi.org/10.1371/journal.pone.0139066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398356	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500140
J	Saha, S; Chakraborty, PK; Xiong, XH; Dwivedi, SKD; Mustafi, SB; Leigh, NR; Ramchandran, R; Mukherjee, P; Bhattacharya, R				Saha, Sounik; Chakraborty, Prabir K.; Xiong, Xunhao; Dwivedi, Shailendra Kumar Dhar; Mustafi, Soumyajit Banerjee; Leigh, Noah R.; Ramchandran, Ramani; Mukherjee, Priyabrata; Bhattacharya, Resham			Cystathionine beta-synthase regulates endothelial function via protein S-sulfhydration	FASEB JOURNAL			English	Article						angiogenesis; VEGFRs; signal transduction; metabolism	ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; HYDROGEN-SULFIDE; GROWTH-FACTOR; HOMOCYSTEINE METABOLISM; VASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; REDOX REGULATION; TRANSCRIPTION	Deficiencies of the human cystathionine beta-synthase (CBS) enzyme are characterized by a plethora of vascular disorders and hyperhomocysteinemia. However, several clinical trials demonstrated that despite reduction in homocysteine levels, disease outcome remained unaffected, thus the mechanism of endothelial dysfunction is poorly defined. Here, we show that the loss of CBS function in endothelial cells (ECs) leads to a significant down-regulation of cellular hydrogen sulfide (H2S) by 50% and of glutathione (GSH) by 40%. Silencing CBS in ECs compromised phenotypic and signaling responses to the VEGF that were potentiated by decreased transcription of VEGF receptor (VEGFR)-2 and neuropilin (NRP)-1, the primary receptors regulating endothelial function. Transcriptional down-regulation of VEGFR-2 and NRP-1 was mediated by a lack in stability of the transcription factor specificity protein 1 (Sp1), which is a sulfhydration target of H2S at residues Cys68 and Cys755. Reinstating H2S but not GSH in CBS-silenced ECs restored Sp1 levels and its binding to the VEGFR-2 promoter and VEGFR-2, NRP-1 expression, VEGF-dependent proliferation, and migration phenotypes. Thus, our study emphasizes the importance of CBS-mediated protein S-sulfhydration in maintaining vascular health and function.	[Saha, Sounik; Chakraborty, Prabir K.; Xiong, Xunhao; Mukherjee, Priyabrata; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA; [Dwivedi, Shailendra Kumar Dhar; Mustafi, Soumyajit Banerjee; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Leigh, Noah R.; Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Dev Vasc Biol Program & Zebrafish Drug Screening, Milwaukee, WI 53226 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Medical College of Wisconsin	Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA.	priyabrata-mukherjee@ouhsc.edu; resham-bhattacharya@ouhsc.edu	Dwivedi, Shailendra Kumar Dhar/Q-2204-2019		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [RO1HL120585]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant RO1HL120585. The authors thank Dr. Virginie Sjoelund (Mass Spectrometry Facility, University of Oklahoma Health Sciences Center Core Laboratories) for Sp1 sulfhydration analysis.	Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Beltowski Jerzy, 2005, Postepy Hig Med Dosw (Online), V59, P392; Bhattacharya R, 2009, J CELL SCI, V122, P1025, DOI 10.1242/jcs.041913; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brattstrom L, 2000, AM J CLIN NUTR, V72, P315; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Castro R, 2005, J MOL MED, V83, P831, DOI 10.1007/s00109-005-0679-8; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Chompoosor A, 2010, SMALL, V6, P2246, DOI 10.1002/smll.201000463; Durand P, 2001, LAB INVEST, V81, P645, DOI 10.1038/labinvest.3780275; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ganapathy PS, 2009, INVEST OPHTH VIS SCI, V50, P4460, DOI 10.1167/iovs.09-3402; Hoefer IE, 2007, CARDIOVASC RES, V76, P1, DOI 10.1016/j.cardiores.2007.07.010; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kondo S, 2006, MOL CANCER THER, V5, P129, DOI 10.1158/1535-7163.MCT-05-0097; Kraus JP, 1999, HUM MUTAT, V13, P362; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Paul BD, 2015, METHOD ENZYMOL, V555, P79, DOI 10.1016/bs.mie.2014.11.021; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Qipshidze N, 2012, INT J BIOL SCI, V8, P430, DOI 10.7150/ijbs.3632; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Szabo C, 2011, BRIT J PHARMACOL, V164, P853, DOI 10.1111/j.1476-5381.2010.01191.x; Van Campenhout A, 2009, ATHEROSCLEROSIS, V202, P557, DOI 10.1016/j.atherosclerosis.2008.05.031; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Wallace JL, 2015, NAT REV DRUG DISCOV, V14, P329, DOI 10.1038/nrd4433; Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Warren CM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004235; Weiss N, 2002, ARTERIOSCL THROM VAS, V22, P34, DOI 10.1161/hq1201.100456; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Wu XS, 1996, MOL CELL BIOL, V16, P1035; Yap S, 2000, SEMIN THROMB HEMOST, V26, P335, DOI 10.1055/s-2000-8100; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	61	81	85	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					441	456		10.1096/fj.15-278648	http://dx.doi.org/10.1096/fj.15-278648			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26405298	Green Published			2022-12-26	WOS:000367621000041
J	Tsukamoto, H; Kubo, Y; Farrens, DL; Koyanagi, M; Terakita, A; Furutani, Y				Tsukamoto, Hisao; Kubo, Yoshihiro; Farrens, David L.; Koyanagi, Mitsumasa; Terakita, Akihisa; Furutani, Yuji			Retinal Attachment Instability Is Diversified among Mammalian Melanopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GANGLION-CELLS; CONFORMATIONAL-CHANGE; COUPLED RHODOPSIN; CRYSTAL-STRUCTURE; VISUAL PIGMENT; CONE OPSINS; LIGAND-FREE; LIGHT; EXPRESSION; PHOTOTRANSDUCTION	Melanopsins play a key role in non-visual photoreception in mammals. Their close phylogenetic relationship to the photopigments in invertebrate visual cells suggests they have evolved to acquire molecular characteristics that are more suited for their non-visual functions. Here we set out to identify such characteristics by comparing the molecular properties of mammalian melanopsin to those of invertebrate melanopsin and visual pigment. Our data show that the Schiff base linking the chromophore retinal to the protein is more susceptive to spontaneous cleavage in mammalian melanopsins. We also find this stability is highly diversified between mammalian species, being particularly unstable for human melanopsin. Through mutagenesis analyses, we find that this diversified stability is mainly due to parallel amino acid substitutions in extracellular regions. We propose that the different stability of the retinal attachment in melanopsins may contribute to functional tuning of non-visual photoreception in mammals.	[Tsukamoto, Hisao; Furutani, Yuji] Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Tsukamoto, Hisao; Furutani, Yuji] SOKENDAI, Dept Struct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Kubo, Yoshihiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan; [Kubo, Yoshihiro] SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400193, Japan; [Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Oregon Health & Science University; Osaka Metropolitan University	Tsukamoto, H (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	tsukamoh@ims.ac.jp	Furutani, Yuji/J-8337-2019; Regan, Clinton/E-6250-2012	Furutani, Yuji/0000-0001-5284-8773; Koyanagi, Mitsumasa/0000-0002-7741-918X; Kubo, Yoshihiro/0000-0001-6707-0837; Terakita, Akihisa/0000-0002-8379-8913	JSPS KAKENHI Grant [25840122]; National Institutes of Health [NEI R01EY015436]; Novartis Foundation (Japan) for the Promotion of Science; Uehara Memorial Foundation; Cooperative Study Program of National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research [26640047, 26291070, 15H05777] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Foundation (Japan) for the Promotion of Science(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation); Cooperative Study Program of National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by JSPS KAKENHI Grant 25840122 (to H. T.), National Institutes of Health Grant NEI R01EY015436 (to D. L. F.), the Novartis Foundation (Japan) for the Promotion of Science, Uehara Memorial Foundation, and the Cooperative Study Program of National Institute for Physiological Sciences. The authors declare that they have no conflict of interest regarding this study.	Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cameron EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113138; Chew KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098356; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Fahrenkrug J, 2014, J BIOL CHEM, V289, P35482, DOI 10.1074/jbc.M114.586529; Farrens DL, 2012, RESONANCE, V17, P1165, DOI 10.1007/s12045-012-0133-5; Ferrer C, 2012, J NEUROSCI, V32, P17977, DOI 10.1523/JNEUROSCI.3069-12.2012; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fujiwara Y, 2002, J GEN PHYSIOL, V120, P677, DOI 10.1085/jgp.20028663; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hughes S, 2015, CELL MOL LIFE SCI, V72, P165, DOI 10.1007/s00018-014-1664-6; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jacobs GH, 2013, VISUAL NEUROSCI, V30, P39, DOI 10.1017/S0952523812000429; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; Jones KA, 2013, NAT CHEM BIOL, V9, P630, DOI [10.1038/NCHEMBIO.1333, 10.1038/nchembio.1333]; Kawamura S, 2004, J MOL EVOL, V58, P314, DOI 10.1007/s00239-003-2553-z; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kono M, 2006, FEBS LETT, V580, P229, DOI 10.1016/j.febslet.2005.12.002; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Lucas RJ, 2006, P NATL ACAD SCI USA, V103, P10153, DOI 10.1073/pnas.0603955103; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nagata T, 2012, SCIENCE, V335, P469, DOI 10.1126/science.1211667; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Provencio I., 2012, WILEY INTERDISCIPLIN, P228, DOI [DOI 10.1002/WMTS.29, 10.1002/wmts.29]; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Ramon E, 2003, J BIOL CHEM, V278, P6427, DOI 10.1074/jbc.M210929200; Ramon E, 2009, PHOTOCHEM PHOTOBIOL, V85, P509, DOI 10.1111/j.1751-1097.2008.00504.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Travis GH, 2005, NEURON, V46, P840, DOI 10.1016/j.neuron.2005.06.003; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Tu DC, 2006, P NATL ACAD SCI USA, V103, P10426, DOI 10.1073/pnas.0600917103; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105	71	13	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27176	27187		10.1074/jbc.M115.666305	http://dx.doi.org/10.1074/jbc.M115.666305			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26416885	hybrid, Green Published			2022-12-26	WOS:000364794000027
J	Srivastava, V; Verma, PK				Srivastava, Vikas; Verma, Praveen Kumar			Genome Wide Identification of LIM Genes in Cicer arietinum and Response of Ca-2LIMs in Development, Hormone and Pathogenic Stress	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; ORGAN SIZE; TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; FAMILY; DOMAIN; CHICKPEA; SEQUENCE; DA1; SEED	The eukaryotic lineage-specific LIM protein (LIN11, ISL1, and MEC3) family play pivotal role in modulation of actin dynamics and transcriptional regulation. The systematic investigation of this family has not been carried in detail and rare in legumes. Current study involves the mining of Cicer arietinum genome for the genes coding for LIM domain proteins and displayed significant homology with LIM genes of other species. The analysis led to the identification of 15 members, which were positioned on chickpea chromosomes. The phylogenetic and motif analysis suggested their categorization into two sub-families i.e., Ca-2LIMs and Ca-DA1/DAR, which comprised of nine and six candidates, respectively. Further sub-categories of Ca-2LIMs were recognised as alpha LIM, beta LIM, dLIM and delta LIM. The LIM genes within their sub-families displayed conserved genomic and motif organization. The expression pattern of Ca-2LIMs across developmental and reproductive tissues demonstrated strong correlation with established consensus. The Ca-2LIM belongs to PLIM and GLIM (XLIM) was found highly expressed in floral tissue. Others showed ubiquitous expression pattern with their dominance in stem. Under hormonal and pathogenic conditions these LIMs were found to up-regulate during salicylic acid, abscisic acid and Ascochyta rabiei treatment or infection; and down-regulated in response to jasmonic acid treatment. The findings of this work, particularly in terms of modulation of LIM genes under biotic stress will open up the way to further explore and establish the role of chickpea LIMs in plant defense response.	[Srivastava, Vikas; Verma, Praveen Kumar] Natl Inst Plant Genome Res, Plant Immun Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Verma, PK (corresponding author), Natl Inst Plant Genome Res, Plant Immun Lab, Aruna Asaf Ali Marg, New Delhi, India.	pkv@nipgr.ac.in	Srivastava, Vikas/R-4437-2016	Srivastava, Vikas/0000-0003-4168-3197	Department of Biotechnology, Government of India [BT/PR12919/AGR/02/676/2009]; National Institute of Plant Genome Research (NIPGR), New Delhi; NIPGR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Plant Genome Research (NIPGR), New Delhi; NIPGR	This work is supported by a research grant provided by Department of Biotechnology, Government of India, for Next Generation Challenge Program on Chickpea Genomics project (Sanction No. BT/PR12919/AGR/02/676/2009), and National Institute of Plant Genome Research (NIPGR), New Delhi. VS acknowledges NIPGR for short term research fellowship. Authors also acknowledge Central Instrument Facility, NIPGR, for Real-Time PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud D, 2007, DNA RES, V14, P103, DOI 10.1093/dnares/dsm013; Arnaud Dominique, 2012, BMC Res Notes, V5, P102, DOI 10.1186/1756-0500-5-102; BALTZ R, 1992, PLANT CELL, V4, P1465, DOI 10.1105/tpc.4.12.1465; Bi DL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00071; Broun P, 2004, CURR OPIN PLANT BIOL, V7, P202, DOI 10.1016/j.pbi.2004.01.013; Du L, 2014, PLANT CELL, V26, P665, DOI 10.1105/tpc.114.122663; Eliasson A, 2000, MOL GEN GENET, V264, P257, DOI 10.1007/s004380000312; Ganguly M, 2014, THEOR APPL GENET, V127, P2555, DOI 10.1007/s00122-014-2397-5; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; HA CV, 2014, PLOS ONE, V0009; Han LB, 2013, PLANT CELL, V25, P4421, DOI 10.1105/tpc.113.116970; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kawaoka A, 2006, SILVAE GENET, V55, P269, DOI 10.1515/sg-2006-0035; Kawaoka A, 2001, PHYTOCHEMISTRY, V57, P1149, DOI 10.1016/S0031-9422(01)00054-1; Kawaoka A, 2000, PLANT J, V22, P289, DOI 10.1046/j.1365-313x.2000.00737.x; Li L, 2015, PLANT BIOLOGY, V17, P528, DOI 10.1111/plb.12243; Li Y, 2013, PLANT PHYSIOL BIOCH, V66, P34, DOI 10.1016/j.plaphy.2013.01.018; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Moes D, 2013, MOL PLANT, V6, P483, DOI 10.1093/mp/sss075; Nizam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095989; Nizam S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04013; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Park JI, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-641; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Peng YC, 2015, PLANT CELL, V27, P649, DOI 10.1105/tpc.114.132274; Peng YC, 2013, PLANT PHYSIOL, V161, P1542, DOI 10.1104/pp.112.210237; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033128; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703691200; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wang HJ, 2008, PLANT PHYSIOL, V147, P1619, DOI 10.1104/pp.108.118604; Xia T, 2013, PLANT CELL, V25, P3347, DOI 10.1105/tpc.113.115063; Yang HB, 2010, PLANT J, V63, P283, DOI 10.1111/j.1365-313X.2010.04241.x; Zhao M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0519-0; Zhao M, 2014, GENOME BIOL EVOL, V6, P1000, DOI 10.1093/gbe/evu076; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	47	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138719	10.1371/journal.pone.0138719	http://dx.doi.org/10.1371/journal.pone.0138719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418014	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400021
J	Wang, KJ; Liu, DW; Hernandez-Sanchez, J; Chen, J; Liu, CK; Wu, ZF; Fang, MY; Li, N				Wang, Kejun; Liu, Dewu; Hernandez-Sanchez, Jules; Chen, Jie; Liu, Chengkun; Wu, Zhenfang; Fang, Meiying; Li, Ning			Genome Wide Association Analysis Reveals New Production Trait Genes in a Male Duroc Population	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PROMOTER REGION; MEAT QUALITY; LOCI; GROWTH; PIGS; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; RELEVANCE	In this study, 796 male Duroc pigs were used to identify genomic regions controlling growth traits. Three production traits were studied: food conversion ratio, days to 100 KG, and average daily gain, using a panel of 39,436 single nucleotide polymorphisms. In total, we detected 11 genome-wide and 162 chromosome-wide single nucleotide polymorphism trait associations. The Gene ontology analysis identified 14 candidate genes close to significant single nucleotide polymorphisms, with growth-related functions: six for days to 100 KG (WT1, FBXO3, DOCK7, PPP3CA, AGPAT9, and NKX6-1), seven for food conversion ratio (MAP2, TBX15, IVL, ARL15, CPS1, VWC2L, and VAV3), and one for average daily gain (COL27A1). Gene ontology analysis indicated that most of the candidate genes are involved in muscle, fat, bone or nervous system development, nutrient absorption, and metabolism, which are all either directly or indirectly related to growth traits in pigs. Additionally, we found four haplotype blocks composed of suggestive single nucleotide polymorphisms located in the growth trait-related quantitative trait loci and further narrowed down the ranges, the largest of which decreased by similar to 60 Mb. Hence, our results could be used to improve pig production traits by increasing the frequency of favorable alleles via artificial selection.	[Wang, Kejun; Chen, Jie; Liu, Chengkun; Fang, Meiying] China Agr Univ, Coll Anim Sci & Technol, MOA Lab Anim Genet & Breeding, Dept Anim Genet & Breeding,Natl Engn Lab Anim Bre, Beijing 100193, Peoples R China; [Liu, Dewu; Wu, Zhenfang] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou 510642, Guangdong, Peoples R China; [Hernandez-Sanchez, Jules] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Res Methods Grp, Kelvin Grove, Qld 4059, Australia; [Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; South China Agricultural University; Queensland University of Technology (QUT); China Agricultural University	Fang, MY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, MOA Lab Anim Genet & Breeding, Dept Anim Genet & Breeding,Natl Engn Lab Anim Bre, Beijing 100193, Peoples R China.	meiying@cau.edu.cn		Chengkun, Liu/0000-0002-1730-0136; Wu, Zhenfang/0000-0002-5586-6771	National High Technology and Science Development Plan of China [2011AA100302]; Natural Science Foundation of China (NSFC) [31072002, 31372275]; State Major Basic Research Development Program of China [2014CB138504]; Program for New Century Excellent Talents in University [NCET-11-0480]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National High Technology and Science Development Plan of China(National High Technology Research and Development Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Major Basic Research Development Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by the National High Technology and Science Development Plan of China (2011AA100302), Natural Science Foundation of China (NSFC, Grant 31072002, 31372275), State Major Basic Research Development Program of China 973 Project (2014CB138504), Program for New Century Excellent Talents in University (NCET-11-0480), and Program for Changjiang Scholar and Innovation Research Team in University (IRT1191).	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bai Y, 2015, ANIM GENET, V46, P16, DOI 10.1111/age.12257; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055951; Dai XJ, 2008, J DERMATOL SCI, V50, P53, DOI 10.1016/j.jdermsci.2007.10.011; Doerge RW, 1996, GENETICS, V142, P285; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Fehm HL, 2004, MED KLIN, V99, P674, DOI 10.1007/s00063-004-1099-1; Finckh U, 1998, HUM MUTAT, V12, P206, DOI 10.1002/(SICI)1098-1004(1998)12:3<206::AID-HUMU8>3.3.CO;2-K; Fontanesi L, 2014, J ANIM SCI, V92, P1385, DOI 10.2527/jas.2013-7059; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; GEORGES M, 1995, GENETICS, V139, P907; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Grosse-Brinkhaus Christine, 2014, BMC Proc, V8, pS2, DOI 10.1186/1753-6561-8-S5-S2; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Jung EJ, 2014, ANIM GENET, V45, P442, DOI 10.1111/age.12117; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nissen PM, 2004, J ANIM SCI, V82, P414; Ohyama Y, 2012, BIOCHEM BIOPH RES CO, V418, P12, DOI 10.1016/j.bbrc.2011.12.075; Onteru SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061756; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Sahana G, 2013, J ANIM SCI, V91, P1041, DOI 10.2527/jas.2012-5643; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Stringer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027964; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tu PA, 2012, ANIM BIOTECHNOL, V23, P291, DOI 10.1080/10495398.2012.709205; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	49	42	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139207	10.1371/journal.pone.0139207	http://dx.doi.org/10.1371/journal.pone.0139207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418247	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400062
J	Yao, LL; Shi, JY; Miao, XL				Yao, Lili; Shi, Jianye; Miao, Xiaoling			Mixed Wastewater Coupled with CO2 for Microalgae Culturing and Nutrient Removal	PLOS ONE			English	Article							LIPID PRODUCTION; MORPHOLOGICAL-CHANGES; AMMONIA INHIBITION; OIL ACCUMULATION; STRAIN; BIOMASS; ARTHROSPIRA; CULTIVATION; EFFICIENCY; OCULATA	Biomass, nutrient removal capacity, lipid productivity and morphological changes of Chlorella sorokiniana and Desmodesmus communis were investigated in mixed wastewaters with different CO2 concentrations. Under optimal condition, which was 1: 3 ratio of swine wastewater to second treated municipal wastewater with 5% CO2, the maximum biomass concentrations were 1.22 g L-1 and 0.84 g L-1 for C. sorokiniana and D. communis, respectively. Almost all of the ammonia and phosphorus were removed, the removal rates of total nitrogen were 88.05% for C. sorokiniana and 83.18% for D. communis. Lipid content reached 17.04% for C. sorokiniana and 20.37% for D. communis after 10 days culture. CO2 aeration increased intracellular particle numbers of both microalgae and made D. communis tend to be solitary. The research suggested the aeration of CO2 improve the tolerance of microalgae to high concentration of NH4-N, and nutrient excess stress could induce lipid accumulation of microalgae.	[Yao, Lili; Shi, Jianye; Miao, Xiaoling] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Yao, Lili; Shi, Jianye; Miao, Xiaoling] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Yao, Lili; Shi, Jianye; Miao, Xiaoling] Shanghai Jiao Tong Univ, Biomass Energy Res Ctr, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Miao, XL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	miaoxiaoling@sjtu.edu.cn			National High Technology Research and Development Program (863 Program) of China [2013AA065805]; NSFC [41476122, J1210047]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National High Technology Research and Development Program (863 Program) of China (No. 2013AA065805). It was also supported by NSFC (No. 41476122 and No. J1210047).	APHA, 2012, 3120 APHA, V22nd; AZOV Y, 1982, APPL ENVIRON MICROB, V43, P735, DOI 10.1128/AEM.43.4.735-739.1982; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai T, 2013, RENEW SUST ENERG REV, V19, P360, DOI 10.1016/j.rser.2012.11.030; Chiu SY, 2009, BIORESOURCE TECHNOL, V100, P833, DOI 10.1016/j.biortech.2008.06.061; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Dai GZ, 2014, PLANT CELL ENVIRON, V37, P840, DOI 10.1111/pce.12202; Devi MP, 2012, RENEW ENERG, V43, P276, DOI 10.1016/j.renene.2011.11.021; Drath M, 2008, PLANT PHYSIOL, V147, P206, DOI 10.1104/pp.108.117218; Gentili FG, 2014, BIORESOURCE TECHNOL, V169, P27, DOI 10.1016/j.biortech.2014.06.061; Gonzalez LE, 1997, BIORESOURCE TECHNOL, V60, P259, DOI 10.1016/S0960-8524(97)00029-1; HESSEN DO, 1993, ARCH HYDROBIOL, V127, P129; Hu B, 2012, BIORESOURCE TECHNOL, V126, P71, DOI 10.1016/j.biortech.2012.09.031; Ji F, 2014, BIORESOURCE TECHNOL, V161, P200, DOI 10.1016/j.biortech.2014.03.034; Kerr RA, 2011, SCIENCE, V331, P1510, DOI 10.1126/science.331.6024.1510; Kumar K, 2011, BIORESOURCE TECHNOL, V102, P4945, DOI 10.1016/j.biortech.2011.01.054; Markou G, 2014, BIORESOURCE TECHNOL, V166, P259, DOI 10.1016/j.biortech.2014.05.040; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Molinuevo-Salces B, 2010, BIORESOURCE TECHNOL, V101, P5144, DOI 10.1016/j.biortech.2010.02.006; Olguin EJ, 2003, J APPL PHYCOL, V15, P249, DOI 10.1023/A:1023856702544; Pan YY, 2011, BIORESOURCE TECHNOL, V102, P10510, DOI 10.1016/j.biortech.2011.08.091; Pancha I, 2014, BIORESOURCE TECHNOL, V156, P146, DOI 10.1016/j.biortech.2014.01.025; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Peccia J, 2013, TRENDS BIOTECHNOL, V31, P134, DOI 10.1016/j.tibtech.2013.01.010; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Ruangsomboon S, 2012, BIORESOURCE TECHNOL, V109, P261, DOI 10.1016/j.biortech.2011.07.025; Sahu AK, 2013, J ENVIRON MANAGE, V122, P113, DOI 10.1016/j.jenvman.2013.02.038; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Singh NK, 2011, AGRON SUSTAIN DEV, V31, P605, DOI 10.1007/s13593-011-0018-0; Sydney EB, 2010, BIORESOURCE TECHNOL, V101, P5892, DOI 10.1016/j.biortech.2010.02.088; Tang DH, 2011, BIORESOURCE TECHNOL, V102, P3071, DOI 10.1016/j.biortech.2010.10.047; TILLBERG JE, 1989, PHYSIOL PLANTARUM, V75, P315, DOI 10.1111/j.1399-3054.1989.tb04633.x; Wang LA, 2010, APPL BIOCHEM BIOTECH, V162, P1174, DOI 10.1007/s12010-009-8866-7; Wu PF, 2013, BIORESOURCE TECHNOL, V133, P102, DOI 10.1016/j.biortech.2013.01.109	35	46	48	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139117	10.1371/journal.pone.0139117	http://dx.doi.org/10.1371/journal.pone.0139117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418261	gold, Green Submitted, Green Published			2022-12-26	WOS:000362171400044
J	Yi, GQ; Yuan, JW; Bi, HJ; Yan, W; Yang, N; Qu, LJ				Yi, Guoqiang; Yuan, Jingwei; Bi, Huijuan; Yan, Wei; Yang, Ning; Qu, Lujiang			In-Depth Duodenal Transcriptome Survey in Chickens with Divergent Feed Efficiency Using RNA-Seq	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; RENIN-ANGIOTENSIN SYSTEM; GASTROINTESTINAL-TRACT; PRODUCTION TRAITS; OXIDATIVE STRESS; WEIGHT-GAIN; PROTEIN; REVEALS; MUSCLE; FAT	Since the feed cost is a major determinant of profitability in poultry industry, how to improve feed efficiency through genetic selection is an intriguing subject for breeders and producers. As a more suitable indicator assessing feed efficiency, residual feed intake (RFI) is defined as the difference between observed and expected feed intake based on maintenance and growth. However, the genetic mechanisms responsible for RFI in chickens are still less well appreciated. In this study, we investigated the duodenal transcriptome architecture of extreme RFI phenotypes in the six brown-egg dwarf hens (three per group) using RNA sequencing technology. Among all mapped reads, an average of 75.62% fell into annotated exons, 5.50% were located in introns, and the remaining 18.88% were assigned to inter-genic regions. In total, we identified 41 promising candidate genes by differential expression analysis between the low and high RFI groups. Furthermore, qRT-PCR assays were designed for 10 randomly chosen genes, and nine (90.00%) were successfully validated. Functional annotation analyses revealed that these significant genes belong to several specific biological functions related to digestibility, metabolism and biosynthesis processes as well as energy homeostasis. We also predicted 253 intergenic coding transcripts, and these transcripts were mainly involved in fundamental biological regulation and metabolism processes. Our findings provided a pioneering exploration of biological basis underlying divergent RFI using RNA-Seq, which pinpoints promising candidate genes of functional relevance, is helpful to guide future breeding strategies to optimize feed efficiency and assists in improving the current gene annotation in chickens.	[Qu, Lujiang] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Qu, LJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	quluj@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National High Technology Research and Development Program of China [2013AA102501]; National Natural Science Foundation of China [31320103905]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]; China Agriculture Research Systems [CARS-41]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Agriculture Research Systems	This work was funded in part by grants of the National High Technology Research and Development Program of China (2013AA102501), National Natural Science Foundation of China (31320103905), Program for Changjiang Scholars and Innovative Research Team in University (IRT1191), and China Agriculture Research Systems (CARS-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggrey SE, 2013, POULTRY SCI, V92, P2600, DOI 10.3382/ps.2013-03302; Aggrey SE, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-25; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Burden CJ, 2014, PEERJ, V2, DOI 10.7717/peerj.576; Cassis LA, 1998, AM J PHYSIOL-ENDOC M, V274, pE867, DOI 10.1152/ajpendo.1998.274.5.E867; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Coble DJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1084; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; De Koning DJ, 2004, GENET RES, V83, P211, DOI 10.1017/S0016672304006846; de Koning DJ, 2003, J ANIM SCI, V81, P1158; de Verdal H, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-71; de Verdal H, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-59; Dogan A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-386; Do DN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-27; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Grzincic EM, 2015, NANOSCALE, V7, P1349, DOI 10.1039/c4nr05166a; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hamill RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-453; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoque MA, 2009, J ANIM SCI, V87, P3069, DOI 10.2527/jas.2008-1268; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Hussong M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.157; Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071763; Karisa B, 2014, ANIM SCI J, V85, P374, DOI 10.1111/asj.12159; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUITING P, 1991, BRIT POULTRY SCI, V32, P763, DOI 10.1080/00071669108417402; LUITING P, 1991, LIVEST PROD SCI, V27, P321, DOI 10.1016/0301-6226(91)90127-C; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nafikov RA, 2007, J NUTR, V137, P702, DOI 10.1093/jn/137.3.702; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Odawara J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-516; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Parsanejad R, 2004, POULTRY SCI, V83, P1518, DOI 10.1093/ps/83.9.1518; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Rekaya R, 2013, POULTRY SCI, V92, P923, DOI 10.3382/ps.2012-02649; Saintilan R, 2013, J ANIM SCI, V91, P2542, DOI 10.2527/jas.2012-5687; Savary K, 2005, BLOOD, V105, P103, DOI 10.1182/blood-2004-04-1570; Schurch NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094270; Seyednasrollah F, 2013, BRIEF BIOINFORM; Sultan M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-675; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Eerden E, 2004, POULTRY SCI, V83, P1602, DOI 10.1093/ps/83.9.1602; Wang XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112896; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weisinger RS, 1997, PEPTIDES, V18, P977, DOI 10.1016/S0196-9781(97)00077-6; Willems OW, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-26; Wolc A, 2013, POULTRY SCI, V92, P2270, DOI 10.3382/ps.2013-03085; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yi GQ, 2014, POULTRY SCI, V93, P2963, DOI 10.3382/ps.2014-04178; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang W, 2003, WORLD POULTRY SCI J, V59, P328, DOI 10.1079/WPS20030020	71	27	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0136765	10.1371/journal.pone.0136765	http://dx.doi.org/10.1371/journal.pone.0136765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418546	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400004
J	Maesako, M; Uemura, M; Tashiro, Y; Sasaki, K; Watanabe, K; Noda, Y; Ueda, K; Asada-Utsugi, M; Kubota, M; Okawa, K; Ihara, M; Shimohama, S; Uemura, K; Kinoshita, A				Maesako, Masato; Uemura, Maiko; Tashiro, Yoshitaka; Sasaki, Kazuki; Watanabe, Kiwamu; Noda, Yasuha; Ueda, Karin; Asada-Utsugi, Megumi; Kubota, Masakazu; Okawa, Katsuya; Ihara, Masafumi; Shimohama, Shun; Uemura, Kengo; Kinoshita, Ayae			High Fat Diet Enhances beta-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting beta-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SECRETASE PROTEIN; MEMORY DEFICITS; TRANSGENIC MICE; CELL-SURFACE; DEMENTIA; RISK; ENDOCYTOSIS; GENERATION; MUTATION	Obesity and type 2 diabetes are risk factors of Alzheimer's disease (AD). We reported that a high fat diet (HFD) promotes amyloid precursor protein (APP) cleavage by beta-site APP cleaving enzyme 1 (BACE1) without increasing BACE1 levels in APP transgenic mice. However, the detailed mechanism had remained unclear. Here we demonstrate that HFD promotes BACE1/Adaptor protein-2 (AP-2)/clathrin complex formation by increasing AP-2 levels in APP transgenic mice. In Swedish APP overexpressing Chinese hamster ovary (CHO) cells as well as in SH-SY5Y cells, overexpression of AP-2 promoted the formation of BACE1/AP2/ clathrin complex, increasing the level of the soluble form of APP beta (sAPP beta). On the other hand, mutant D495R BACE1, which inhibits formation of this trimeric complex, was shown to decrease the level of sAPP beta. Overexpression of AP-2 promoted the internalization of BACE1 from the cell surface, thus reducing the cell surface BACE1 level. As such, we concluded that HFD may induce the formation of the BACE1/AP-2/clathrin complex, which is followed by its transport of BACE1 from the cell surface to the intracellular compartments. These events might be associated with the enhancement of beta-site cleavage of APP in APP transgenic mice. Here we present evidence that HFD, by regulation of subcellular trafficking of BACE1, promotes APP cleavage.	[Maesako, Masato; Sasaki, Kazuki; Noda, Yasuha; Ueda, Karin; Asada-Utsugi, Megumi; Kubota, Masakazu; Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Uemura, Maiko; Watanabe, Kiwamu; Uemura, Kengo] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Tashiro, Yoshitaka] Kyoto Univ, Grad Sch Med, SK Project Med Innovat Ctr, Kyoto, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Shizuoka, Japan; [Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Osaka, Japan; [Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido, Japan; [Uemura, Kengo] Ishiki Hosp, Kagoshima, Japan	Kyoto University; Kyoto University; Kyoto University; Kyowa Kirin Ltd; National Cerebral & Cardiovascular Center - Japan; Sapporo Medical University	Kinoshita, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Alzheimers Dis Re, Charlestown, MA 02129 USA.	kinoshita.ayae.6v@kyoto-u.ac.jp	Ihara, Masafumi/O-5020-2019; Uemura, Maiko/L-7293-2016	Ihara, Masafumi/0000-0002-7102-4048; Uemura, Maiko/0000-0001-8356-1409	Ministry of Education, Culture, Sports, Science and Technology, Japan [24111524, 23591243, 13J00221]; Japan Society for the Promotion of Science [820130600001]; Kyowa Hakko Kirin Co., Ltd	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyowa Hakko Kirin Co., Ltd(Kyowa Kirin Ltd)	AK, K. Uemura and MM are funded with Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (AK: 24111524, K. Uemura: 23591243, MM: 13J00221, URL: http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). MM is funded with Japan Society for the Promotion of Science research fellowship (820130600001, URL: http://www.jsps.go.jp/). Kyowa Hakko Kirin Co., Ltd provided support in the form of salary for author KO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charlwood J, 2001, J BIOL CHEM, V276, P16739, DOI 10.1074/jbc.M009361200; Chia PZC, 2013, TRAFFIC, V14, P997, DOI 10.1111/tra.12088; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; KOO EH, 1994, J BIOL CHEM, V269, P17386; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maesako M, 2011, NEUROSCIENCE, V177, P298, DOI 10.1016/j.neuroscience.2010.12.017; Maesako M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072796; Maesako M, 2012, J BIOL CHEM, V287, P23024, DOI 10.1074/jbc.M112.367011; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun XL, 2006, FASEB J, V20, P1361, DOI 10.1096/fj.05-5628com; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Zhang T, 2009, NEUROSCIENCE, V161, P1045, DOI 10.1016/j.neuroscience.2009.04.032; Zhu L., 2012, ADV DIFFERENTIAL EQU, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0045033	47	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0131199	10.1371/journal.pone.0131199	http://dx.doi.org/10.1371/journal.pone.0131199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414661	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700001
J	Mancini, G; Zazza, C				Mancini, Giordano; Zazza, Costantino			F429 Regulation of Tunnels in Cytochrome P450 2B4: A Top Down Study of Multiple Molecular Dynamics Simulations	PLOS ONE			English	Article							COMPOUND-I; MECHANISTIC IMPLICATIONS; CATALYTIC CYCLE; OXIDATION; QM/MM; SPIN; HYDROXYLATION; EQUILIBRIUM; METABOLISM; REACTIVITY	The root causes of the outcomes of the single-site mutation in enzymes remain by and large not well understood. This is the case of the F429H mutant of the cytochrome P450 (CYP) 2B4 enzyme where the substitution, on the proximal surface of the active site, of a conserved phenylalanine 429 residue with histidine seems to hamper the formation of the active species, Compound I (porphyrin cation radical-Fe-(IV) = O, Cpd I) from the ferric hydroperoxo (Fe-(III) OOH-, Cpd 0) precursor. Here we report a study based on extensive molecular dynamic (MD) simulations of 4 CYP-2B4 point mutations compared to the WT enzyme, having the goal of better clarifying the importance of the proximal Phe429 residue on CYP 2B4 catalytic properties. To consolidate the huge amount of data coming from five simulations and extract the most distinct structural features of the five species studied we made an extensive use of cluster analysis. The results show that all studied single polymorphisms of F429, with different side chain properties: i) drastically alter the reservoir of conformations accessible by the protein, perturbing global dynamics ii) expose the thiolate group of residue Cys436 to the solvent, altering the electronic properties of Cpd0 and iii) affect the various ingress and egress channels connecting the distal sites with the bulk environment, altering the reversibility of these channels. In particular, it was observed that the wild type enzyme exhibits unique structural features as compared to all mutant species in terms of weak interactions (hydrogen bonds) that generate a completely different dynamical behavior of the complete system. Albeit not conclusive, the current computational investigation sheds some light on the subtle and critical effects that proximal single-site mutations can exert on the functional mechanisms of human microsomal CYPs which should go rather far beyond local structure characterization.	[Mancini, Giordano] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Mancini, Giordano] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Zazza, Costantino] Univ Roma La Sapienza, I-00185 Rome, Italy	Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome	Mancini, G (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	giordano.mancini@sns.it		ZAZZA, Costantino/0000-0002-9050-1874	Futuro in Ricerca (FIRB) [RBFR12ETL5]	Futuro in Ricerca (FIRB)	This work was funded by Futuro in Ricerca (FIRB) project no RBFR12ETL5 (http://firb.miur.it/). Computational resources were granted by access to the Avogadro Computational Cluster at Scuola Normale Superiore.	Altarsha M, 2010, J BIOL INORG CHEM, V15, P361, DOI 10.1007/s00775-009-0608-3; Altarsha M, 2009, J AM CHEM SOC, V131, P4755, DOI 10.1021/ja808744k; Bathelt CM, 2005, J AM CHEM SOC, V127, P12900, DOI 10.1021/ja0520924; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bertz RJ, 1997, CLIN PHARMACOKINET, V32, P210, DOI 10.2165/00003088-199732030-00004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cohen S, 2006, J AM CHEM SOC, V128, P11028, DOI 10.1021/ja063269c; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Daidone I, 2012, WIRES COMPUT MOL SCI, V2, P762, DOI 10.1002/wcms.1099; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2008, BIOCHEMISTRY-US, V47, P9661, DOI 10.1021/bi800926x; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Fishelovitch D, 2010, J PHYS CHEM B, V114, P5964, DOI 10.1021/jp101894k; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; GUNSALUS IC, 1975, ANNU REV BIOCHEM, V44, P377, DOI 10.1146/annurev.bi.44.070175.002113; HARRIS D, 1993, J AM CHEM SOC, V115, P8775, DOI 10.1021/ja00072a034; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isobe H, 2011, J PHYS CHEM B, V115, P10730, DOI 10.1021/jp206004y; Kumar D, 2005, J PHYS CHEM B, V109, P19946, DOI 10.1021/JP054754h; Kumar D, 2012, J PHYS CHEM B, V116, P718, DOI 10.1021/jp2113522; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lian P, 2013, J PHYS CHEM B, V117, P7849, DOI 10.1021/jp312107r; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; Lonsdale R, 2011, J AM CHEM SOC, V133, P15464, DOI 10.1021/ja203157u; Lonsdale R, 2010, J PHYS CHEM B, V114, P1156, DOI 10.1021/jp910127j; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Oprea TI, 1997, P NATL ACAD SCI USA, V94, P2133, DOI 10.1073/pnas.94.6.2133; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Shahrokh K, 2012, BBA-GEN SUBJECTS, V1820, P1605, DOI 10.1016/j.bbagen.2012.05.011; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Shaik S, 2011, J CHEM THEORY COMPUT, V7, P327, DOI 10.1021/ct100554g; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Sheng X, 2009, J AM CHEM SOC, V131, P2971, DOI 10.1021/ja808982g; Shimada T, 2013, CHEM RES TOXICOL, V26, P517, DOI 10.1021/tx300492j; SLIGAR SG, 1979, BIOCHEMISTRY-US, V18, P2290, DOI 10.1021/bi00578a024; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Tatoli S, 2009, BIOPHYS CHEM, V141, P87, DOI 10.1016/j.bpc.2008.12.015; Usharani D, 2012, J AM CHEM SOC, V134, P4053, DOI 10.1021/ja211905e; van Eldik R, 2012, INORGANIC BIOINORGAN; Wrighton SA, 2000, DRUG METAB REV, V32, P339, DOI 10.1081/DMR-100102338; Yang YT, 2014, BIOCHEMISTRY-US, V53, P5080, DOI 10.1021/bi5003794; Zheng JJ, 2006, J AM CHEM SOC, V128, P13204, DOI 10.1021/ja063439l	64	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137075	10.1371/journal.pone.0137075	http://dx.doi.org/10.1371/journal.pone.0137075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26415031	Green Submitted, gold, Green Published			2022-12-26	WOS:000362170700006
J	Villalobos, JA; Yi, BR; Wallace, IS				Villalobos, Jose A.; Yi, Bo R.; Wallace, Ian S.			2-Fluoro-L-Fucose Is a Metabolically Incorporated Inhibitor of Plant Cell Wall Polysaccharide Fucosylation	PLOS ONE			English	Article							3-DEOXY-D-MANNO-2-OCTULOSONIC ACID KDO; DE-NOVO SYNTHESIS; GDP-L-FUCOSE; RHAMNOGALACTURONAN-II; ARABIDOPSIS-THALIANA; PECTIC POLYSACCHARIDE; MUR1 GENE; XYLOGLUCAN; GLYCANS; BIOSYNTHESIS	The monosaccharide L-fucose (L-Fuc) is a common component of plant cell wall polysaccharides and other plant glycans, including the hemicellulose xyloglucan, pectic rhamnogalacturonan-I (RG-I) and rhamnogalacturonan-II (RG-II), arabinogalactan proteins, and N-linked glycans. Mutations compromising the biosynthesis of many plant cell wall polysaccharides are lethal, and as a result, small molecule inhibitors of plant cell wall polysaccharide biosynthesis have been developed because these molecules can be applied at defined concentrations and developmental stages. In this study, we characterize novel small molecule inhibitors of plant fucosylation. 2-fluoro-L-fucose (2F-Fuc) analogs caused severe growth phenotypes when applied to Arabidopsis seedlings, including reduced root growth and altered root morphology. These phenotypic defects were dependent upon the L-Fuc salvage pathway enzyme L-Fucose Kinase/GDP-L-Fucose Pyrophosphorylase (FKGP), suggesting that 2F-Fuc is metabolically converted to the sugar nucleotide GDP-2F-Fuc, which serves as the active inhibitory molecule. The L-Fuc content of cell wall matrix polysaccharides was reduced in plants treated with 2F-Fuc, suggesting that this molecule inhibits the incorporation of L-Fuc into these polysaccharides. Additionally, phenotypic defects induced by 2F-Fuc treatment could be partially relieved by the exogenous application of boric acid, suggesting that 2F-Fuc inhibits RG-II biosynthesis. Overall, the results presented here suggest that 2F-Fuc is a metabolically incorporated inhibitor of plant cellular fucosylation events, and potentially suggest that other 2-fluorinated monosaccharides could serve as useful chemical probes for the inhibition of cell wall polysaccharide biosynthesis.	[Villalobos, Jose A.; Yi, Bo R.; Wallace, Ian S.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Wallace, IS (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	iwallace@unr.edu			National Science Foundation Integrative Organismal Systems grant [1449068]; Direct For Biological Sciences [1449068] Funding Source: National Science Foundation	National Science Foundation Integrative Organismal Systems grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by National Science Foundation Integrative Organismal Systems grant number 1449068 (www.nsf.gov/ios). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson CT, 2012, P NATL ACAD SCI USA, V109, P1329, DOI 10.1073/pnas.1120429109; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Baskin JM, 2010, P NATL ACAD SCI USA, V107, P10360, DOI 10.1073/pnas.0912081107; BAUER WD, 1973, PLANT PHYSIOL, V51, P174, DOI 10.1104/pp.51.1.174; Bonin CP, 2000, PLANT J, V21, P445, DOI 10.1046/j.1365-313x.2000.00698.x; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chormova D, 2015, PHYTOCHEMISTRY, V117, P220, DOI 10.1016/j.phytochem.2015.06.016; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; Dehnert KW, 2011, ACS CHEM BIOL, V6, P547, DOI 10.1021/cb100284d; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Glushka JN, 2003, CARBOHYD RES, V338, P341, DOI 10.1016/S0008-6215(02)00461-5; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; HEIM DR, 1990, PLANT PHYSIOL, V93, P695, DOI 10.1104/pp.93.2.695; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; KEEGSTRA K, 1973, PLANT PHYSIOL, V51, P188, DOI 10.1104/pp.51.1.188; Kobayashi M, 2011, PLANT CELL PHYSIOL, V52, P1832, DOI 10.1093/pcp/pcr120; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Liang Y, 2013, J EXP BOT, V64, P5537, DOI 10.1093/jxb/ert321; Lodowska J, 2013, CAN J MICROBIOL, V59, P645, DOI 10.1139/cjm-2013-0490; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pellerin P, 1996, CARBOHYD RES, V290, P183, DOI 10.1016/0008-6215(96)00139-5; Perrin RM, 2003, PLANT PHYSIOL, V132, P768, DOI 10.1104/pp.102.016642; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rodriguez-Carvajal MA, 2003, CARBOHYD RES, V338, P651, DOI 10.1016/S0008-6215(03)00003-X; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; Seveno M, 2010, GLYCOBIOLOGY, V20, P617, DOI 10.1093/glycob/cwq011; Seveno M, 2009, PLANTA, V230, P947, DOI 10.1007/s00425-009-0996-1; Smyth KM, 2013, CARBOHYD RES, V380, P70, DOI 10.1016/j.carres.2013.07.006; Smyth KM, 2013, MOL PLANT, V6, P981, DOI 10.1093/mp/sst011; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Voxeur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051129; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095245	55	15	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139091	10.1371/journal.pone.0139091	http://dx.doi.org/10.1371/journal.pone.0139091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414071	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700042
J	Aseervatham, J; Tran, L; Machaca, K; Boudker, O				Aseervatham, Jaya; Tran, Lucky; Machaca, Khaled; Boudker, Olga			The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; INTRINSIC DISORDER; HENT1 EXPRESSION; CELLULAR UPTAKE; IDENTIFICATION; CLONING; FAMILY; ENT1; GEMCITABINE; ADENOSINE	Equilibrative nucleoside transporters (ENTs) are integral membrane proteins, which reside in plasma membranes of all eukaryotic cells and mediate thermodynamically downhill transport of nucleosides. This process is essential for nucleoside recycling, and also plays a key role in terminating adenosine-mediated cellular signaling. Furthermore, ENTs mediate the uptake of many drugs, including anticancer and antiviral nucleoside analogues. The structure and mechanism, by which ENTs catalyze trans-membrane transport of their substrates, remain unknown. To identify the core of the transporter needed for stability, activity, and for its correct trafficking to the plasma membrane, we have expressed human ENT deletion mutants in Xenopus laevis oocytes and determined their localization, transport properties and susceptibility to inhibition. We found that the carboxyl terminal trans-membrane segments are essential for correct protein folding and trafficking. In contrast, the soluble extracellular and intracellular loops appear to be dispensable, and must be involved in the fine-tuning of transport regulation.	[Tran, Lucky; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Aseervatham, Jaya; Machaca, Khaled] Qatar Fdn, Weill Cornell Med Coll, Dept Physiol & Biophys, Doha, Qatar	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Boudker, O (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	olb2003@med.cornell.edu	Aseervatham, Jaya/AFV-7295-2022; Machaca, Khaled/AAF-3579-2019	Aseervatham, Jaya/0000-0002-0160-0951; 	Qatar National Research Fund; National Priorities Research Program [08-233-1-045]	Qatar National Research Fund(Qatar National Research Fund (QNRF)); National Priorities Research Program	Support was provided by Qatar National Research Fund, National Priorities Research Program Grant #08-233-1-045 [http://www.qnrf.org/en-us/] to JA, LT, OB, and KM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic Y, 2002, MOL BIOL EVOL, V19, P2199, DOI 10.1093/oxfordjournals.molbev.a004044; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Bone DBJ, 2007, MOL MEMBR BIOL, V24, P294, DOI 10.1080/09687860701210617; Borbath I, 2012, EUR J CANCER, V48, P990, DOI 10.1016/j.ejca.2011.11.006; Chen LM, 2011, J PHYSIOL-LONDON, V589, P877, DOI 10.1113/jphysiol.2010.198713; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Crawford CR, 1998, J BIOL CHEM, V273, P5288, DOI 10.1074/jbc.273.9.5288; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GRIFFITH DA, 1991, ADV EXP MED BIOL, V309, P431; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Handa M, 2001, GENE, V262, P301, DOI 10.1016/S0378-1119(00)00555-2; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Nivillac NMI, 2009, BBA-BIOMEMBRANES, V1788, P2326, DOI 10.1016/j.bbamem.2009.08.003; Nordh S, 2014, WORLD J GASTROENTERO, V20, P8482, DOI 10.3748/wjg.v20.i26.8482; Norholm AB, 2011, BIOCHEMISTRY-US, V50, P3469, DOI 10.1021/bi1019989; Reyes G, 2011, MOL MEMBR BIOL, V28, P412, DOI 10.3109/09687688.2011.604861; Reyes G, 2011, BIOCHEM CELL BIOL, V89, P246, DOI [10.1139/o10-155, 10.1139/O10-155]; Riegelhaupt PM, 2010, J BIOL CHEM, V285, P17001, DOI 10.1074/jbc.M110.115758; Robillard KR, 2008, MOL PHARMACOL, V74, P264, DOI 10.1124/mol.107.041871; Stolk M, 2005, BIOCHEM J, V386, P281, DOI 10.1042/BJ20041571; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vickers MF, 1999, BIOCHEM J, V339, P21, DOI 10.1042/0264-6021:3390021; Wall MJ, 2014, J NEUROPHYSIOL; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ward JL, 2003, ARCH BIOCHEM BIOPHYS, V411, P19, DOI 10.1016/S0003-9861(02)00718-X; Wu SK, 2005, J DRUG TARGET, V13, P521, DOI 10.1080/10611860500403099; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Yao SYM, 2011, J BIOL CHEM, V286, P32552, DOI 10.1074/jbc.M111.236117; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022	41	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136779	10.1371/journal.pone.0136779	http://dx.doi.org/10.1371/journal.pone.0136779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406980	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700013
J	Bennani-Baiti, B; Toegel, S; Viernstein, H; Urban, E; Noe, CR; Bennani-Baiti, IM				Bennani-Baiti, Barbara; Toegel, Stefan; Viernstein, Helmut; Urban, Ernst; Noe, Christian R.; Bennani-Baiti, Idriss M.			Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells	PLOS ONE			English	Article							ENDOGENOUS REFERENCE GENES; COLONIC EPITHELIAL-CELLS; LOW-GRADE INFLAMMATION; NECROSIS-FACTOR-ALPHA; REAL-TIME PCR; NF-KAPPA-B; ADHESION MOLECULES; OXIDATIVE STRESS; DRUG-RESISTANCE; EXPRESSION	Endothelial cells are often present at inflammation sites. This is the case of endothelial cells of the blood-brain barrier (BBB) of patients afflicted with neurodegenerative disorders such as Alzheimer's, Parkinson's, or multiple sclerosis, as well as in cases of bacterial meningitis, trauma, or tumor-associated ischemia. Inflammation is a known modulator of gene expression through the activation of transcription factors, mostly NF-kappa B. RLIP76 (a.k.a. RALBP1), an ATP-dependent transporter of electrophile-glutathione conjugates, modulates BBB permeability through the regulation of tight junction function, cell adhesion, and exocytosis. Genes and pathways regulated by RLIP76 are transcriptional targets of tumor necrosis factor alpha (TNF-alpha) pro-inflammatory molecule, suggesting that RLIP76 may also be an inflammation target. To assess the effects of TNF-alpha on RLIP76, we faced the problem of choosing reference genes impervious to TNF-alpha. Since such genes were not known in human BBB endothelial cells, we subjected these to TNF-alpha, and measured by quantitative RT-PCR the expression of housekeeping genes commonly used as reference genes. We find most to be modulated, and analysis of several inflammation datasets as well as a meta-analysis of more than 5000 human tissue samples encompassing more than 300 cell types and diseases show that no single housekeeping gene may be used as a reference gene. Using three different algorithms, however, we uncovered a reference geneset impervious to TNF-alpha, and show for the first time that RLIP76 expression is induced by TNF-alpha and follows the induction kinetics of inflammation markers, suggesting that inflammation can influence RLIP76 expression at the BBB. We also show that MRP1 (a.k.a. ABCC1), another electrophile-glutathione transporter, is not modulated in the same cells and conditions, indicating that RLIP76 regulation by TNF-alpha is not a general property of glutathione transporters. The reference geneset uncovered herein should aid in future gene expression studies in inflammatory conditions of the BBB.	[Bennani-Baiti, Barbara; Urban, Ernst; Noe, Christian R.] Univ Vienna, Inst Pharmaceut Chem, Dept Med Chem, A-1090 Vienna, Austria; [Bennani-Baiti, Barbara] Med Univ Vienna, Vienna Gen Hosp AKH, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria; [Toegel, Stefan] Med Univ Vienna, Dept Orthopaed, Karl Chiari Lab Orthopaed Biol, A-1090 Vienna, Austria; [Viernstein, Helmut] Univ Vienna, Dept Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria; [Bennani-Baiti, Idriss M.] B2 Sci Grp, A-1010 Vienna, Austria	University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna	Bennani-Baiti, IM (corresponding author), B2 Sci Grp, Werdertorgasse 12-3-6, A-1010 Vienna, Austria.	ibennani@refgd.com	Toegel, Stefan/J-6548-2019	Toegel, Stefan/0000-0003-4317-1769				Ammar Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003710; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antoniades C, 2007, CLIN CARDIOL, V30, P295, DOI 10.1002/clc.20101; Arnaud C, 2005, ARCH MAL COEUR VAISS, V98, P661; Awasthi S, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-61; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Bae YS, 2013, BIOCHEM BIOPH RES CO, V433, P175, DOI 10.1016/j.bbrc.2013.02.056; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Barar J, 2010, MED SCI MONITOR, V16, pBR52; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Beekhuizen H, 1998, TRANSPL P, V30, P4251, DOI 10.1016/S0041-1345(98)01405-5; Bennani-Baiti B, 2012, GENE, V491, P103, DOI 10.1016/j.gene.2011.09.035; Bennani-Baiti IM, 2011, J PATHOL, V225, P353, DOI 10.1002/path.2966; Bennani-Baiti IM, 2010, CLIN CANCER RES, V16, P3769, DOI 10.1158/1078-0432.CCR-10-0558; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Chapouly C, 2015, BRAIN, V138, P1548, DOI 10.1093/brain/awv077; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cummings M, 2014, INFLAMMATION, V37, P1889, DOI 10.1007/s10753-014-9920-3; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Bernardino TCD, 2015, NEUROSCI LETT, V597, P154, DOI 10.1016/j.neulet.2015.04.046; Deban L, 2008, AM J PATHOL, V172, P1457, DOI 10.2353/ajpath.2008.070593; Dupuis N, 2015, CNS NEUROSCI THER, V21, P141, DOI 10.1111/cns.12371; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; GIMBRONE MA, 1990, ANN NY ACAD SCI, V598, P77, DOI 10.1111/j.1749-6632.1990.tb42279.x; Golias C, 2007, IN VIVO, V21, P757; Gonzalez-Burgos E, 2013, PLANTA MED, V79, P1545, DOI 10.1055/s-0033-1350797; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P115; Gorter JA, 2015, EPILEPSY BEHAV, V49, P13, DOI 10.1016/j.yebeh.2015.04.047; Gu J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-47; Higashi Y, 2008, HYPERTENSION, V51, P446, DOI 10.1161/HYPERTENSIONAHA.107.101535; Horowitz S, 2007, AM J PHYSIOL-GASTR L, V292, pG1323, DOI 10.1152/ajpgi.00499.2006; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Kalinowska A, 2006, EUR J NEUROL, V13, P1284, DOI 10.1111/j.1468-1331.2006.01640.x; Kaminski R, 1998, PHARMACOL RES, V37, P375, DOI 10.1006/phrs.1998.0309; Kerekes G, 2008, J RHEUMATOL, V35, P398; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Kupatt C, 2000, Z KARDIOL, V89, P96; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381; Lee S, 2014, BIOCHEM BIOPH RES CO, V454, P560, DOI 10.1016/j.bbrc.2014.10.114; Lee S, 2014, FASEB J, V28, P4158, DOI 10.1096/fj.14-255711; Lee S, 2012, CANCER RES, V72, P5165, DOI 10.1158/0008-5472.CAN-12-0468; Lee YW, 2004, MOL MED, V10, P19, DOI 10.2119/2004-00024.Lee; Leinonen ES, 2004, J INTERN MED, V256, P119, DOI 10.1111/j.1365-2796.2004.01350.x; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liverani E, 2013, INT J BIOCHEM CELL B, V45, P2715, DOI 10.1016/j.biocel.2013.09.009; Lok CAR, 2006, J LAB CLIN MED, V147, P310, DOI 10.1016/j.lab.2006.02.004; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marboeuf P, 2008, J THROMB HAEMOST, V6, P195; Minagar A, 2006, NEUROL RES, V28, P230, DOI 10.1179/016164106X98080; Minten C, 2014, BRAIN, V137, P1454, DOI 10.1093/brain/awu045; Montero-Melendez T, 2014, INFLAMMATION, V37, P1059, DOI 10.1007/s10753-014-9829-x; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007; Neuhaus W, 2012, PHARMAZIE, V67, P432, DOI 10.1691/ph.2012.1742; Neuhaus W, 2011, BRAIN RES, V1394, P49, DOI 10.1016/j.brainres.2011.04.003; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinhu L, 2008, RESPIROLOGY, V13, P990, DOI 10.1111/j.1440-1843.2008.01396.x; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Plattner VE, 2010, INT J PHARMACEUT, V387, P34, DOI 10.1016/j.ijpharm.2009.11.030; Poetsch V, 2010, PHARMAZIE, V65, P267, DOI 10.1691/ph.2010.9319; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Rodriguez-Gaztelumendi A, 2011, TOXICOL LETT, V207, P1, DOI 10.1016/j.toxlet.2011.08.014; Ruminy P, 2001, INFLAMM RES, V50, P383, DOI 10.1007/PL00000260; Schinzari F, 2008, CLIN PHARMACOL THER, V83, P70, DOI 10.1038/sj.clpt.6100229; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; SHARIEF MK, 1992, J INFECT DIS, V166, P350, DOI 10.1093/infdis/166.2.350; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Singhal SS, 2010, INT J CANCER, V126, P1327, DOI 10.1002/ijc.24767; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P761, DOI 10.1016/j.bcp.2008.10.006; Singhal SS, 2005, BIOCHEM PHARMACOL, V70, P481, DOI 10.1016/j.bcp.2005.05.005; Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tian H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh119; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tudur Smith C, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001911, DOI 10.1002/14651858.CD001911]; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vatsyayan R, 2010, BIOCHEM PHARMACOL, V79, P1699, DOI 10.1016/j.bcp.2010.01.016; Vatsyayan R, 2009, INT J ONCOL, V34, P1505, DOI 10.3892/ijo_00000279; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang GY, 2015, CELL MOL NEUROBIOL, V35, P1105, DOI 10.1007/s10571-015-0204-8; Wang LF, 2015, MOL NEUROBIOL, V52, P478, DOI 10.1007/s12035-014-8848-9; Wang Q, 2011, TOXICOL IN VITRO, V25, P991, DOI 10.1016/j.tiv.2009.11.006; Wei Ruoxin, 2013, BMC Res Notes, V6, P46, DOI 10.1186/1756-0500-6-46; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2002, BIOCHEM J, V368, P665, DOI 10.1042/BJ20020950; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	107	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139101	10.1371/journal.pone.0139101	http://dx.doi.org/10.1371/journal.pone.0139101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406496	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700170
J	Chiang, JK; Kao, YH; Lai, NS				Chiang, Jui-Kun; Kao, Yee-Hsin; Lai, Ning-Sheng			The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE-CARE; CARDIOPULMONARY-RESUSCITATION; COMORBIDITY INDEX; CONTROLLED-TRIAL; END; QUALITY; HOME; INDICATORS; AGGRESSIVENESS	Background The healthcare costs of cancer care are highest in the last month of life. The effect of hospice care on end-of-life (EOL) healthcare costs is not clearly understood. Purpose The purpose of this study was to evaluate the effect of hospice care on survival and healthcare costs for lung cancer patients in their final month of life. Methods We adopted Taiwan's National Health Insurance Research Claims Database to analyze data for 3399 adult lung cancer patients who died in 1997-2011. A logistic regression analysis was performed to determine the predictors of high healthcare cost, defined as costs falling above the 90th percentile. Patients who received hospice cares were assigned to a hospice (H) group and those who did not were assigned to a non-hospice (non-H) group. Results The patients in the H group had a longer mean (median) survival time than those in the non-H group did (1.40 +/- 1.61 y (0.86) vs. 1.10 +/- 1.47 (0.61), p<0.001). The non-H group had a lower mean healthcare cost than the H group (US $1,821 +/- 2,441 vs. US $1,839 +/- 1,638, p<0.001). And, there were a total of 340 patients (10%) with the healthcare costs exceeding the 90th percentile (US $4,721) as the cutoff value of high cost. The non-H group had a higher risk of high cost than the H group because many more cases in the non-H group had lower costs. Moreover, the risk of high health care costs were predicted for patients who did not receive hospice care (odds ratio [OR]: 3.68, 95% confidence interval [CI]: 2.44-5.79), received chemotherapy (OR: 1.51, 95% CI: 1.18-1.96) and intubation (OR: 2.63, 95% CI: 1.64-4.16), and those who had more emergency department visits (OR: 1.78, 95% CI: 1.24-2.52), longer hospital admission in days (OR: 1.08, 95% CI: 1.07-1.09), and received radiotherapy (OR: 1.33, 95% CI: 1.00-1.78). Lower risks of high health care costs were observed in patients with low socioeconomic status (OR: 0.58, 95% CI: 0.40-0.83), or previous employment (OR: 0.66, 95% CI: 0.47-0.92). After propensity-score matching, the patients of the non-H group had a higher mean cost and a higher risk of high cost. Similar results were obtained from logistic regression analysis in propensity score-matched patients. Conclusions The survival of the hospice group was longer than non-H group, and patients in the non-H group were 3.74 times more likely to have high healthcare costs at EOL. The positive predictors for high health care costs were patients who did not receive hospice care, who received chemotherapy and intubation, who had more emergency department visits and longer hospital admission, and who received radiotherapy. Negative predictors were patients who had a low socioeconomic status or previous employment. The issue of how to reduce the high health care costs for patients with lung cancer in the last month of life is a challenge for policy makers and health care providers.	[Chiang, Jui-Kun] Buddhist Dalin Tzu Chi Hosp, Dept Family Med, Chiayi, Taiwan; [Kao, Yee-Hsin] Tainan Municipal Hosp, Dept Family Med, Tainan, Taiwan; [Lai, Ning-Sheng] Buddhist Dalin Tzu Chi Hosp, Dept Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Chiang, JK (corresponding author), Tainan Municipal Hosp, Dept Family Med, Tainan, Taiwan.	m2200767@gmail.com; tzuchilai@gmail.com			Buddhist Dalin Tzu Chi Hospital [DTCRD 102(2)-E-01, DTCRD 103(2)-E-03]	Buddhist Dalin Tzu Chi Hospital	JK Chiang received research grants from Buddhist Dalin Tzu Chi Hospital (DTCRD 102(2)-E-01, DTCRD 103(2)-E-03).	Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Campbell DE, 2004, ANN INTERN MED, V140, P269, DOI 10.7326/0003-4819-140-4-200402170-00009; Carlson MDA, 2010, J CLIN ONCOL, V28, P4371, DOI 10.1200/JCO.2009.26.1818; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chastek B, 2012, J ONCOL PRACT, V8, p75S, DOI 10.1200/JOP.2011.000469; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DiMartino LD, 2014, J PALLIAT MED, V17, P1384, DOI 10.1089/jpm.2014.0092; Dudgeon DJ, 2008, J PAIN SYMPTOM MANAG, V35, P573, DOI 10.1016/j.jpainsymman.2007.07.013; Dy SM, 2010, CANCER-AM CANCER SOC, V116, P3267, DOI 10.1002/cncr.25109; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fassbender K, 2005, PALLIATIVE MED, V19, P513, DOI 10.1191/0269216305pm1071oa; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finlay IG, 2002, ANN ONCOL, V13, P257, DOI 10.1093/annonc/mdf668; Forrest LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001376; Gomes B, 2013, PROG PALLIAT CARE, V21, P204, DOI 10.1179/1743291X13Y.0000000065; Gomes B, 2014, JAMA-J AM MED ASSOC, V311, P1060, DOI 10.1001/jama.2014.553; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Gomez-Batiste X, 2012, J PAIN SYMPTOM MANAG, V43, P783, DOI 10.1016/j.jpainsymman.2011.05.006; Gonsalves WI, 2011, J PALLIAT MED, V14, P1231, DOI 10.1089/jpm.2011.0131; Grande GE, 2000, PALLIATIVE MED, V14, P375, DOI 10.1191/026921600701536200; Grunfeld E, 2008, CANCER, V112, P2301, DOI 10.1002/cncr.23428; Grunfeld E, 2006, PALLIATIVE MED, V20, P769, DOI 10.1177/0269216306072553; Hatziandreu E, 2008, THE POTENTIAL COST S; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; Hurria A, 2008, J CLIN ONCOL, V26, P5386, DOI 10.1200/JCO.2008.17.6891; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; KANE RL, 1984, LANCET, V1, P890; Kim YA, 2014, ANN SURG, V259, P569, DOI 10.1097/SLA.0b013e318291db9d; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klinger CA, 2014, PALLIATIVE MED, V28, P111, DOI 10.1177/0269216313493342; Kreng VB, 2011, HEALTH POLICY, V100, P203, DOI 10.1016/j.healthpol.2010.08.003; Langton JM, 2014, PALLIATIVE MED, V28, P1167, DOI 10.1177/0269216314533813; Lee CC, 2011, STROKE, V42, P48, DOI 10.1161/STROKEAHA.110.597070; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lo JC, 2002, SOC SCI MED, V54, P981, DOI 10.1016/S0277-9536(01)00071-5; Lorenz KA, 2006, J CLIN ONCOL, V24, P4933, DOI 10.1200/JCO.2006.06.8650; Marcus MW, 2015, ONCOL LETT, V9, P1902, DOI 10.3892/ol.2015.2916; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Morss S, 2011, J PALLIAT MED, V14, P451, DOI 10.1089/jpm.2010.0434; Obermeyer Z, 2014, JAMA-J AM MED ASSOC, V312, P1888, DOI 10.1001/jama.2014.14950; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Rodrigues G, 2011, PRACT RADIAT ONCOL, V1, P60, DOI 10.1016/j.prro.2011.01.005; Saito AM, 2011, J PALLIAT MED, V14, P929, DOI 10.1089/jpm.2010.0522; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Seow H, 2009, CANCER-AM CANCER SOC, V115, P3820, DOI 10.1002/cncr.24439; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Tang ST, 2009, ANN ONCOL, V20, P343, DOI 10.1093/annonc/mdn602; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2014, JAMA-J AM MED ASSOC, V312, P1868, DOI 10.1001/jama.2014.14949; Wang HM, 2011, J PAIN SYMPTOM MANAG, V42, P400, DOI 10.1016/j.jpainsymman.2010.12.011; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yu KH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3806; Zhang Z, 2015, AM J HOSP PALLIAT ME, V32, P210, DOI 10.1177/1049909113520215	63	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138773	10.1371/journal.pone.0138773	http://dx.doi.org/10.1371/journal.pone.0138773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406871	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700092
J	Formenti, N; Trogu, T; Pedrotti, L; Gaffuri, A; Lanfranchi, P; Ferrari, N				Formenti, Nicoletta; Trogu, Tiziana; Pedrotti, Luca; Gaffuri, Alessandra; Lanfranchi, Paolo; Ferrari, Nicola			Toxoplasma gondii Infection in Alpine Red Deer (Cervuselaphus): Its Spread and Effects on Fertility	PLOS ONE			English	Article							CERVUS-ELAPHUS; ROE DEER; NEOSPORA-CANINUM; RISK-FACTORS; ANTIBODIES; PREVALENCE; SHEEP; SEROPREVALENCE; GOATS; REINDEER	In contrast to the depth of knowledge on the pathological effects of parasitism in domestic animals, the impact of the vast majority of parasites on wildlife hosts is poorly understood and, besides, information from domestics is rarely usable to disclose the parasites' impact on free-ranging populations' dynamics. Here we use Toxoplasmosis as a study model since, until now, the infection process and the protozoan's effects in natural conditions has received little attention. We analysed 81 sera from red deer (Cervuselaphus) sampled in Italian Alps and through generalized linear models we evaluated (1) the epidemiological factors influencing T. gondii infection dynamics; (2) its impact on female fertility. High seroprevalence of T. gondii infection was recorded in yearling (1 year-old; prevalence = 52.4%) and adult (> 2 year-old; prevalence = 51.3%) red deer, while calves (< 1 year-old) did not contract the infection suggesting horizontal transmission as the main route of infection. The stable prevalence between yearlings and adults and the higher serological titres of younger individuals lead to two alternative infection processes suggesting a difference between age classes or in acquiring the infection or in responding to the pathogen. No associations between T. gondii serological titres and pregnancy status was observed indicating no direct effect on the probability of being pregnant; nevertheless a relation between females' higher serological titres and lower foetal development emerged, suggesting potential effects of the parasite infection on deer reproduction. The results demonstrate high seroprevalence of T. gondii infection in free-ranging red deer and, furthermore, the effect on foetal development suggests the potential impact of the parasite on red deer fertility and thus on its population dynamics.	[Formenti, Nicoletta; Trogu, Tiziana; Lanfranchi, Paolo; Ferrari, Nicola] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Pedrotti, Luca] Consorzio Parco Nazl Stelvio, Bormio, Sondrio, Italy; [Gaffuri, Alessandra] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Bergamo, Italy	University of Milan; IZS Lombardia e Emilia	Formenti, N (corresponding author), Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy.	nicoletta_formenti@yahoo.it	gaffuri, alessandra/AFF-0288-2022; Ferrari, Nicola/E-6331-2013; Formenti, Nicoletta/AAC-5752-2022; Lanfranchi, Paolo/K-5976-2017	Ferrari, Nicola/0000-0001-8959-3495; Lanfranchi, Paolo/0000-0002-8266-5481; Formenti, Nicoletta/0000-0003-1516-1256	Progetto Giovani "Valorizzazione dei prodotti tipici dell'agroalimentare e sicurezza alimentare attraverso nuovi sistemi di caratterizzazione e garanzia di qualita"; Italian Ministry of University and Research (PRIN project) [2010P7LFW4]	Progetto Giovani "Valorizzazione dei prodotti tipici dell'agroalimentare e sicurezza alimentare attraverso nuovi sistemi di caratterizzazione e garanzia di qualita"; Italian Ministry of University and Research (PRIN project)(Ministry of Education, Universities and Research (MIUR))	This research was supported by a grant from Progetto Giovani 2009 "Valorizzazione dei prodotti tipici dell'agroalimentare e sicurezza alimentare attraverso nuovi sistemi di caratterizzazione e garanzia di qualita" (PL) and partially by the Italian Ministry of University and Research (PRIN project n. 2010P7LFW4) (PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM CL, 1988, ANIM PROD, V46, P131, DOI 10.1017/S0003356100003196; Alberti EG, 2014, SMALL RUMINANT RES, V120, P155, DOI 10.1016/j.smallrumres.2014.04.017; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; ALBON SD, 1986, J ZOOL, V209, P447, DOI 10.1111/j.1469-7998.1986.tb03603.x; ANDERSON ML, 1994, VET CLIN N AM-FOOD A, V10, P439, DOI 10.1016/S0749-0720(15)30531-4; Aubert D, 2010, VET PARASITOL, V171, P346, DOI 10.1016/j.vetpar.2010.03.033; Beral M, 2012, ECOHEALTH, V9, P303, DOI 10.1007/s10393-012-0786-2; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; Chikweto A, 2011, J PARASITOL, V97, P950, DOI 10.1645/GE-2811.1; Chong CK, 2011, KOREAN J PARASITOL, V49, P207, DOI 10.3347/kjp.2011.49.3.207; Citterio CV, 2006, J PARASITOL, V92, P918, DOI 10.1645/GE-3551.1; Clementino MM, 2007, VET PARASITOL, V146, P199, DOI 10.1016/j.vetpar.2007.02.036; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Darabus G, 2014, J ZOO WILDLIFE MED, V45, P239, DOI 10.1638/2012-0170.1; Dubey JP, 2008, INT J PARASITOL, V38, P1057, DOI 10.1016/j.ijpara.2007.11.010; DUBEY JP, 1992, J PARASITOL, V78, P151, DOI 10.2307/3283705; Duncanson P, 2001, INT J PARASITOL, V31, P1699, DOI 10.1016/S0020-7519(01)00282-X; Elmore SA, 2012, VECTOR-BORNE ZOONOT, V12, P1, DOI 10.1089/vbz.2011.0705; European Food Safety Authority, 2007, EFSA J, V583, P28; Figliuolo LPC, 2004, SMALL RUMINANT RES, V55, P29, DOI 10.1016/j.smallrumres.2003.12.013; Fox MT, 1997, VET PARASITOL, V72, P285, DOI 10.1016/S0304-4017(97)00102-7; Gaffuri A, 2006, J WILDLIFE DIS, V42, P685, DOI 10.7589/0090-3558-42.3.685; Gamarra JA, 2008, VET PARASITOL, V153, P152, DOI 10.1016/j.vetpar.2008.01.028; Gauss CBL, 2006, VET PARASITOL, V136, P193, DOI 10.1016/j.vetpar.2005.11.013; Gebremedhin EZ, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0222-7; Gebremedhin EZ, 2013, RES VET SCI, V95, P894, DOI 10.1016/j.rvsc.2013.08.007; Gibson AK., 2011, PLOS NEGLECT TROP D, V5, P5; GUINNESS FE, 1978, J REPROD FERTIL, V54, P325, DOI 10.1530/jrf.0.0540325; Hejlicek K, 1997, J WILDLIFE DIS, V33, P480, DOI 10.7589/0090-3558-33.3.480; Hernandez M, 2014, TRANSBOUND EMERG DIS, V61, P477, DOI 10.1111/tbed.12049; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Hudson PJ, 1995, ECOLOGY INFECT DIS N, P146; Huong LTT, 1998, VET PARASITOL, V75, P53, DOI 10.1016/S0304-4017(97)00178-7; Jittapalapong S, 2005, VET PARASITOL, V127, P17, DOI 10.1016/j.vetpar.2004.08.019; Jokelainen P, 2011, J WILDLIFE DIS, V47, P154, DOI 10.7589/0090-3558-47.1.154; Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008; Kapperud G, 1996, AM J EPIDEMIOL, V144, P405, DOI 10.1093/oxfordjournals.aje.a008942; Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002; KOJOLA I, 1989, EVOLUTION, V43, P1331, DOI [10.2307/2409370, 10.1111/j.1558-5646.1989.tb02582.x]; Lello J, 2005, INT J PARASITOL, V35, P1509, DOI 10.1016/j.ijpara.2005.06.002; Magnino S, 2011, GAME MEAT HYGIENE IN FOCUS: MICROBIOLOGY, EPIDEMIOLOGY, RISK ANALYSIS AND QUALITY ASSURANCE, P223; Masala G, 2003, VET PARASITOL, V117, P15, DOI 10.1016/j.vetpar.2003.07.012; Misurova L, 2009, ACTA VET BRNO, V78, P259, DOI 10.2754/avb200978020259; Morley EK, 2008, PARASITOLOGY, V135, P169, DOI 10.1017/S0031182007003721; Onyiche ThankGod Emmanuel, 2015, J Parasit Dis, V39, P309, DOI 10.1007/s12639-013-0350-1; Opsteegh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016240; Pedersen AB, 2015, TRENDS PARASITOL, V31, P200, DOI 10.1016/j.pt.2015.02.004; Pereira-Bueno J, 2004, VET PARASITOL, V121, P33, DOI 10.1016/j.vetpar.2004.02.004; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rossi GF, 2011, VET PARASITOL, V175, P252, DOI 10.1016/j.vetpar.2010.10.017; Shadfar S., 2012, Global Veterinaria, V9, P117; Sobrino R, 2007, VET PARASITOL, V148, P187, DOI 10.1016/j.vetpar.2007.06.038; Turchetto S, 2014, HYSTRIX, V25, P25, DOI 10.4404/hystrix-25.1-9460; van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X; Vikoren T, 2004, VET PARASITOL, V120, P159, DOI 10.1016/j.vetpar.2003.12.015	55	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138472	10.1371/journal.pone.0138472	http://dx.doi.org/10.1371/journal.pone.0138472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405785	Green Published, gold			2022-12-26	WOS:000361800700047
J	Marcolino-Gomes, J; Rodrigues, FA; Fuganti-Pagliarini, R; Nakayama, TJ; Reis, RR; Farias, JRB; Harmon, FG; Molinari, HBC; Molinari, MDC; Nepomuceno, A				Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Nakayama, Thiago Jonas; Reis, Rafaela Ribeiro; Farias, Jose Renato Boucas; Harmon, Frank G.; Correa Molinari, Hugo Bruno; Correa Molinari, Mayla Daiane; Nepomuceno, Alexandre			Transcriptome-Wide Identification of Reference Genes for Expression Analysis of Soybean Responses to Drought Stress along the Day	PLOS ONE			English	Article							ARABIDOPSIS CIRCADIAN CLOCK; OSMOTIC ADJUSTMENT; QPCR DATA; TIME; NORMALIZATION; TOLERANCE; THALIANA; PCR; OVEREXPRESSION; VALIDATION	The soybean transcriptome displays strong variation along the day in optimal growth conditions and also in response to adverse circumstances, like drought stress. However, no study conducted to date has presented suitable reference genes, with stable expression along the day, for relative gene expression quantification in combined studies on drought stress and diurnal oscillations. Recently, water deficit responses have been associated with circadian clock oscillations at the transcription level, revealing the existence of hitherto unknown processes and increasing the demand for studies on plant responses to drought stress and its oscillation during the day. We performed data mining from a transcriptome-wide background using microarrays and RNA-seq databases to select an unpublished set of candidate reference genes, specifically chosen for the normalization of gene expression in studies on soybean under both drought stress and diurnal oscillations. Experimental validation and stability analysis in soybean plants submitted to drought stress and sampled during a 24 h timecourse showed that four of these newer reference genes (FYVE, NUDIX, Golgin-84 and CYST) indeed exhibited greater expression stability than the conventionally used housekeeping genes (ELF1-beta and beta-actin) under these conditions. We also demonstrated the effect of using reference candidate genes with different stability values to normalize the relative expression data from a drought-inducible soybean gene (DREB5) evaluated in different periods of the day.	[Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Nakayama, Thiago Jonas; Reis, Rafaela Ribeiro; Farias, Jose Renato Boucas; Correa Molinari, Mayla Daiane; Nepomuceno, Alexandre] Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil; [Marcolino-Gomes, Juliana; Reis, Rafaela Ribeiro; Correa Molinari, Mayla Daiane] Univ Estadual Londrina, Dept Biol, Londrina, Parana, Brazil; [Nakayama, Thiago Jonas] Univ Fed Vicosa, Dept Crop Sci, Vicosa, MG, Brazil; [Harmon, Frank G.] USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; [Harmon, Frank G.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Correa Molinari, Hugo Bruno] Brazilian Agr Res Corp, Embrapa Agroenergy, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Londrina; Universidade Federal de Vicosa; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Nepomuceno, A (corresponding author), Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil.	alexandre.nepomuceno@embrapa.br	Fuganti-Pagliarini, Renata/S-6089-2019; molinari, mayla/AAX-7450-2020	molinari, mayla/0000-0002-9135-0422; Fuganti-Pagliarini, Renata/0000-0001-9282-2826	National Council for Scientific and Technological Development (CNPq); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the National Council for Scientific and Technological Development (CNPq) and the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Babita M, 2010, ENVIRON EXP BOT, V69, P243, DOI 10.1016/j.envexpbot.2010.05.006; Bekh-Ochir D, 2013, PLANTA, V237, P1509, DOI 10.1007/s00425-013-1859-3; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Galeou A, 2012, PLANT SCI, V184, P141, DOI 10.1016/j.plantsci.2011.12.014; Goyer A, 2013, BIOCHEM J, V454, P533, DOI 10.1042/BJ20130516; Graf A, 2011, TRENDS PLANT SCI, V16, P169, DOI 10.1016/j.tplants.2010.12.003; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang H, 2012, PLANT MOL BIOL REP, V30, P973, DOI 10.1007/s11105-011-0401-7; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Jensen RB, 2001, IDENTIFICATION PTDIN, V173, P165; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Marcolino-Gomes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086402; Marcolino-Gomes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062294; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Osterrieder A, 2012, J MICROSC-OXFORD, V247, P68, DOI 10.1111/j.1365-2818.2012.03620.x; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Pavlopoulou A, 2009, GENOMICS, V93, P350, DOI 10.1016/j.ygeno.2008.12.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Rodrigues FA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1731-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez A, 2011, PLANT SIGNAL BEHAV, V6, P223, DOI 10.4161/psb.6.2.14893; So HA, 2013, GENES GENOM, V35, P247, DOI 10.1007/s13258-013-0078-4; Song YH, 2012, PLANT J, V69, P332, DOI 10.1111/j.1365-313X.2011.04793.x; Squires JE, 2011, EPIGENETICS: A REFERENCE MANUAL, P227; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GD, 2014, PLANT PHYSIOL BIOCH, V82, P95, DOI 10.1016/j.plaphy.2014.05.011; Wilkins O, 2010, PLANT J, V63, P715, DOI 10.1111/j.1365-313X.2010.04274.x; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x	58	26	27	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139051	10.1371/journal.pone.0139051	http://dx.doi.org/10.1371/journal.pone.0139051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407065	Green Published, gold			2022-12-26	WOS:000361800700154
J	Nehra, S; Bhardwaj, V; Ganju, L; Saraswat, D				Nehra, Sarita; Bhardwaj, Varun; Ganju, Lilly; Saraswat, Deepika			Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; INDUCED APOPTOSIS; GENE-EXPRESSION; HEART-FAILURE; P53; CURCUMIN; MECHANISMS; ACETYLTRANSFERASE	Hypoxia induced oxidative stress incurs pathophysiological changes in hypertrophied cardiomyocytes by promoting translocation of p53 to mitochondria. Here, we investigate the cardio-protective efficacy of nanocurcumin in protecting primary human ventricular cardiomyocytes (HVCM) from hypoxia induced damages. Hypoxia induced hypertrophy was confirmed by FITC-phenylalanine uptake assay, atrial natriuretic factor (ANF) levels and cell size measurements. Hypoxia induced translocation of p53 was investigated by using mitochondrial membrane permeability transition pore blocker cyclosporin A (blocks entry of p53 to mitochondria) and confirmed by western blot and immunofluorescence. Mitochondrial damage in hypertrophied HVCM cells was evaluated by analysing bio-energetic, anti-oxidant and metabolic function and substrate switching form lipids to glucose. Nanocurcumin prevented translocation of p53 to mitochondria by stabilizing mitochondrial membrane potential and de-stressed hypertrophied HVCM cells by significant restoration in lactate, acetyl-coenzyme A, pyruvate and glucose content along with lactate dehydrogenase (LDH) and 5' adenosine monophosphate-activated protein kinase (AMPK alpha) activity. Significant restoration in glucose and modulation of GLUT-1 and GLUT-4 levels confirmed that nanocurcumin mediated prevention of substrate switching. Nanocurcumin prevented of mitochondrial stress as confirmed by c-fos/c-jun/p53 signalling. The data indicates decrease in p-300 histone acetyl transferase (HAT) mediated histone acetylation and GATA-4 activation as pharmacological targets of nanocurcumin in preventing hypoxia induced hypertrophy. The study provides an insight into propitious therapeutic effects of nanocurcumin in cardio-protection and usability in clinical applications.	[Nehra, Sarita; Bhardwaj, Varun; Ganju, Lilly; Saraswat, Deepika] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Dept Expt Biol, Expt Biol Div, New Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Saraswat, D (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Dept Expt Biol, Expt Biol Div, New Delhi, India.	deepika_saras@yahoo.com			University Grants Commission fellowship; Council for Scientific and Industrial Research fellowship	University Grants Commission fellowship(University Grants Commission, India); Council for Scientific and Industrial Research fellowship	The present work was funded by research fellowship only. Sarita Nehra is a recipient of University Grants Commission fellowship. Varun Bhardwaj is a recipient of Council for Scientific and Industrial Research fellowship.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Akhtar F, 2012, BIOTECHNOL ADV, V30, P310, DOI 10.1016/j.biotechadv.2011.05.009; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Cardaci S, 2008, MOL PHARMACOL, V74, P1234, DOI 10.1124/mol.108.048975; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Chem JB, 2005, J BIOL CHEM, DOI [10.1074/jbc.M410670200, DOI 10.1074/JBC.M410670200]; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Feridooni T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022801; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Gowda PS, 2012, J BIOL CHEM, V287, P17554, DOI 10.1074/jbc.M111.319277; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; HEBERT GA, 1981, J CLIN MICROBIOL, V13, P498; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Iosefson O, 2010, FEBS LETT, V584, P1080, DOI 10.1016/j.febslet.2010.02.019; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kang YJ, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434844; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Moe KT, 2014, J PHYSIOL BIOCHEM, V70, P769, DOI 10.1007/s13105-014-0345-0; Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005; Moribe K, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/138929; Nehra S, 2014, J CARDIOVASC PHARM, V64, P375, DOI 10.1097/FJC.0000000000000130; Nehra S, 2015, J PHYSIOL BIOCHEM, V71, P239, DOI 10.1007/s13105-015-0405-0; Ohno T, 1998, ALTERN ANIM TEST EXP, V145, P131; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pires IM, 2010, CELL CYCLE, V9, P2502, DOI 10.4161/cc.9.13.12059; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rosenblatt-Velin N, 2001, CARDIOVASC RES, V52, P407, DOI 10.1016/S0008-6363(01)00393-5; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sermeus A, 2011, Cell Death Dis, V2, pe164, DOI 10.1038/cddis.2011.48; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shehzad A, 2014, J NANOSCI NANOTECHNO, V14, P803, DOI 10.1166/jnn.2014.9103; Song ZM, 2011, J COLLOID INTERF SCI, V354, P116, DOI 10.1016/j.jcis.2010.10.024; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tardy-Cantalupi I, 1999, J MOL CELL CARDIOL, V31, P1143, DOI 10.1006/jmcc.1999.0952; Tiwari MN, 2013, FREE RADICAL BIO MED, V65, P704, DOI 10.1016/j.freeradbiomed.2013.07.042; UTLEY HG, 1967, ARCH BIOCHEM BIOPHYS, V118, P29, DOI 10.1016/0003-9861(67)90273-1; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; VENTURACLAPIER RF, 2003, J PHYSL, V555, P1, DOI DOI 10.1113/JPHYSIOL.2003.055095; Waterborg J. H., 1984, METHOD MOL BIOL, V1, P3; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	65	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139121	10.1371/journal.pone.0139121	http://dx.doi.org/10.1371/journal.pone.0139121			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406246	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700178
J	Raj, A; Shim, H; Gilad, Y; Pritchard, JK; Stephens, M				Raj, Anil; Shim, Heejung; Gilad, Yoav; Pritchard, Jonathan K.; Stephens, Matthew			msCentipede: Modeling Heterogeneity across Genomic Sites and Replicates Improves Accuracy in the Inference of Transcription Factor Binding	PLOS ONE			English	Article							OPEN CHROMATIN	Understanding global gene regulation depends critically on accurate annotation of regulatory elements that are functional in a given cell type. CENTIPEDE, a powerful, probabilistic framework for identifying transcription factor binding sites from tissue-specific DNase I cleavage patterns and genomic sequence content, leverages the hypersensitivity of factor-bound chromatin and the information in the DNase I spatial cleavage profile characteristic of each DNA binding protein to accurately infer functional factor binding sites. However, the model for the spatial profile in this framework fails to account for the substantial variation in the DNase I cleavage profiles across different binding sites. Neither does it account for variation in the profiles at the same binding site across multiple replicate DNase I experiments, which are increasingly available. In this work, we introduce new methods, based on multi-scale models for inhomogeneous Poisson processes, to account for such variation in DNase I cleavage patterns both within and across binding sites. These models account for the spatial structure in the heterogeneity in DNase I cleavage patterns for each factor. Using DNase-seq measurements assayed in a lymphoblastoid cell line, we demonstrate the improved performance of this model for several transcription factors by comparing against the Chip-seq peaks for those factors. Finally, we explore the effects of DNase I sequence bias on inference of factor binding using a simple extension to our framework that allows for a more flexible background model. The proposed model can also be easily applied to paired-end ATAC-seq and DNase-seq data. msCentipede, a Python implementation of our algorithm, is available at http://rajanil.github.io/msCentipede.	[Raj, Anil; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Shim, Heejung; Gilad, Yoav; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	Stanford University; University of Chicago; Stanford University; Howard Hughes Medical Institute; University of Chicago	Raj, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	rajanil@stanford.edu; hjshim@gmail.com; gilad@uchicago.edu; pritch@stanford.edu; mstephens@uchicago.edu		Raj, Anil/0000-0003-4412-0883; Shim, Heejung/0000-0002-1375-9310	NIH [HG02585, HG007036, MH084703]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007036, R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from the NIH (HG02585 to M.S., HG007036 to J.K.P., and MH084703 to Y.G. and J.K.P.), and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal Matthew James, 2003, VARIATIONAL ALGORITH; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He HH, 2014, NAT METHODS, V11, P73, DOI [10.1038/NEMTH.2762, 10.1038/nmeth.2762]; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kolaczyk ED, 1999, J AM STAT ASSOC, V94, P920, DOI 10.2307/2670007; Koohy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069853; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Luo Kaixuan, 2013, Pac Symp Biocomput, P80; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shim H, 2015, BAYESIAN MULTI UNPUB; Shim H, 2015, ANN APPL STAT, V9, P665, DOI 10.1214/14-AOAS776; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Varadhan R, 2008, SCAND J STAT, V35, P335, DOI 10.1111/j.1467-9469.2007.00585.x; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	25	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138030	10.1371/journal.pone.0138030	http://dx.doi.org/10.1371/journal.pone.0138030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406244	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700028
J	Zhao, H; Shao, JC; Han, GQ; Yang, DZ; Lv, JH				Zhao, Hui; Shao, Jinchao; Han, Guoqi; Yang, Dezhou; Lv, Jianhai			Influence of Typhoon Matsa on Phytoplankton Chlorophyll-a off East China	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; SUBSURFACE CHLOROPHYLL; TROPICAL CYCLONE; WATER; SATELLITE; PACIFIC; MAXIMUM; BLOOMS; STRAIT; OCEAN	Typhoons can cause strong disturbance, mixing, and upwelling in the upper layer of the oceans. Rich nutrients from the subsurface layer can be brought to the euphotic layer, which will induce the phytoplankton to breed and grow rapidly. In this paper, we investigate the impact of an intense and fast moving tropical storm, Typhoon Matsa, on phytoplankton chlorophyll-a (Chl-a) concentration off East China. By using satellite remote sensing data, we analyze the changes of Chl-a concentration, Sea Surface Temperature (SST) and wind speed in the pre- and post-typhoon periods. We also give a preliminary discussion on the different responses of the Chl-a concentration between nearshore and offshore waters. In nearshore/coastal regions where nutrients are generally rich, the Chl-a maximum occurs usually at the surface or at the layer close to the surface. And, in offshore tropical oligotrophic oceans, the subsurface maxima of Chl-a exist usually in the stratified water column. In an offshore area east of Taiwan, the Chl-a concentration rose gradually in about two weeks after the typhoon. However, in a coastal area north of Taiwan high Chl-a concentration decreased sharply before landfall, rebounded quickly to some degree after landfall, and restored gradually to the pre-typhoon level in about two weeks. The Chl-a concentration presented a negative correlation with the wind speed in the nearshore area during the typhoon, which is opposite to the response in the offshore waters. The phenomena may be attributable to onshore advection of low Chl-a water, coastal downwelling and intensified mixing, which together bring pre-typhoon surface Chl-a downward in the coastal area. In the offshore area, the typhoon may trigger increase of Chl-a concentration through uptake of nutrients by typhoon-induced upwelling and entrainment mixing.	[Zhao, Hui; Shao, Jinchao] Guangdong Ocean Univ, Guangdong Key Lab Climate Resource & Environm Con, Coll Ocean & Meteorol, Zhanjiang, Peoples R China; [Han, Guoqi] Fisheries & Oceans Canada, Northwest Atlantic Fisheries Ctr, St John, NF, Canada; [Yang, Dezhou] Chinese Acad Sci, Key Lab Ocean Circulat & Waves, Qingdao, Peoples R China; [Yang, Dezhou] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Lv, Jianhai] Marine & Fishery Environm Monitoring Ctr Guangzho, Guangzhou, Guangdong, Peoples R China	Guangdong Ocean University; Fisheries & Oceans Canada; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhao, H (corresponding author), Guangdong Ocean Univ, Guangdong Key Lab Climate Resource & Environm Con, Coll Ocean & Meteorol, Zhanjiang, Peoples R China.	huizhao1978@163.com	Han, Guoqi/T-7365-2019		Foundation for Distinguished Young Teacher in Higher Education of Guangdong [YQ2013092]; National Natural Science Foundation of China [41376125, 41006070]; Strategic Priority Research Program of the Chinese Academy of Sciences, China [XDA11020305, CDA11010301, XDA11010302]; Canadian Space Agency Government Related Initiative Program (GRIP)	Foundation for Distinguished Young Teacher in Higher Education of Guangdong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences, China; Canadian Space Agency Government Related Initiative Program (GRIP)	The present research is supported by the Foundation for Distinguished Young Teacher in Higher Education of Guangdong (YQ2013092), the National Natural Science Foundation of China (41376125 and 41006070), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11020305, CDA11010301, and XDA11010302), China and the Canadian Space Agency Government Related Initiative Program (GRIP).	ANTHES RA, 1978, J ATMOS SCI, V35, P1240, DOI 10.1175/1520-0469(1978)035<1240:ROTHBL>2.0.CO;2; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Chen CTA, 2003, J MARINE SYST, V42, P65, DOI 10.1016/S0924-7963(03)00065-4; [陈光华 CHEN Guanghua], 2006, [地球科学进展, Advance in Earth Sciences], V21, P610; Chen XQ, 2000, OCEANOGRAPHY CHINA N, P151; Chen YQ, 2012, INT J REMOTE SENS, V33, P7444, DOI 10.1080/01431161.2012.685976; Elsner JB, 2003, CLIMATE RES, V25, P43, DOI 10.3354/cr025043; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; FURUYA K, 1990, MAR BIOL, V107, P529, DOI 10.1007/BF01313438; [高姗 Gao Shan], 2010, [海洋学报, Acta Oceanologica Sinica], V32, P168; Gong X, 2015, BIOGEOSCIENCES, V12, P905, DOI 10.5194/bg-12-905-2015; [宫响 Gong Xiang], 2012, [地球科学进展, Advance in Earth Sciences], V27, P539; Han GQ, 2012, J MARINE SYST, V100, P19, DOI 10.1016/j.jmarsys.2012.03.012; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Ke Zhi-xin, 2013, Journal of Tropical Oceanography, V32, P51, DOI 10.3969/j.issn.1009-5470.2013.04.008; Lin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017141; MARRA J, 1990, DEEP-SEA RES, V37, P127, DOI 10.1016/0198-0149(90)90032-Q; McClanahan T, 2015, FISH FISH, V16, P78, DOI 10.1111/faf.12045; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; PRICE JF, 1981, J PHYS OCEANOGR, V11, P153, DOI 10.1175/1520-0485(1981)011<0153:UORTAH>2.0.CO;2; Ren FM, 2002, ADV ATMOS SCI, V19, P943; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Stewart RH, 2002, INTRO PHYS OCEANOGRA, P148; Sun L, 2010, MAR ECOL PROG SER, V404, P39, DOI 10.3354/meps08477; Tang DL, 2002, REMOTE SENS ENVIRON, V83, P457, DOI 10.1016/S0034-4257(02)00062-7; Watson R, 2014, FISH FISH, V15, P231, DOI 10.1111/faf.12013; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Wu LG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022937; Yang Xiao-xia, 2010, Journal of Tropical Oceanography, V29, P26; YENTSCH CHARLES S., 1965, DEEP SEA RES, V12, P653, DOI 10.1016/0011-7471(65)91864-4; Zhang F, 2001, MAR SCI, V25, P1; Zhao H, 2008, MAR ECOL PROG SER, V365, P57, DOI 10.3354/meps07488; [赵辉 Zhao Hui], 2005, [海洋学报, Acta Oceanologica Sinica], V27, P45; Zhao H, 2013, J GEOPHYS RES-BIOGEO, V118, P412, DOI 10.1002/jgrg.20041; Zhao H, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005384; Zheng GM, 2007, MAR ECOL PROG SER, V333, P61, DOI 10.3354/meps333061; Zhou WH, 2012, ESTUAR COAST SHELF S, V111, P35, DOI 10.1016/j.ecss.2012.06.004	37	30	34	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137863	10.1371/journal.pone.0137863	http://dx.doi.org/10.1371/journal.pone.0137863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407324	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700026
J	Jiaox, X; Khan, SY; Irum, B; Khan, AO; Wang, QW; Kabir, F; Khan, AA; Husnain, T; Akram, J; Riazuddin, S; Hejtmancik, JF; Riazuddin, SA				Jiaox, Xiaodong; Khan, Shahid Y.; Irum, Bushra; Khan, Arif O.; Wang, Qiwei; Kabir, Firoz; Khan, Asma A.; Husnain, Tayyab; Akram, Javed; Riazuddin, Sheikh; Hejtmancik, J. Fielding; Riazuddin, S. Amer			Missense Mutations in CRYAB Are Liable for Recessive Congenital Cataracts	PLOS ONE			English	Article							B-CRYSTALLIN MUTATION; CONSANGUINEOUS PAKISTANI FAMILIES; POSTERIOR POLAR CATARACT; NONSENSE MUTATION; NUCLEAR CATARACT; CHINESE FAMILY; GENE CAUSES; LOCUS; CARDIOMYOPATHY; BLINDNESS	Purpose This study was initiated to identify causal mutations responsible for autosomal recessive congenital cataracts in consanguineous familial cases. Methods Affected individuals underwent a detailed ophthalmological and clinical examination, and slit-lamp photographs were ascertained for affected individuals who have not yet been operated for the removal of the cataractous lens. Blood samples were obtained, and genomic DNA was extracted from white blood cells. A genome-wide scan was completed with short tandem repeat (STR) markers, and the logarithm of odds (LOD) scores were calculated. Protein coding exons of CRYAB were sequenced, bi-directionally. Evolutionary conservation was investigated by aligning CRYAB orthologues, and the expression of Cryab in embryonic and postnatal mice lens was investigated with TaqMan probe. Results The clinical and ophthalmological examinations suggested that all affected individuals had nuclear cataracts. Genome-wide linkage analysis suggested a potential region on chromosome 11q23 harboring CRYAB. DNA sequencing identified a missense variation: c.34C> T (p.R12C) in CRYAB that segregated with the disease phenotype in the family. Subsequent interrogation of our entire cohort of familial cases identified a second familial case localized to chromosome 11q23 harboring a c.31C> T (p.R11C) mutation. In silico analyses suggested that the mutations identified in familial cases, p.R11C and p.R12C will not be tolerated by the three-dimensional structure of CRYAB. Real-time PCR analysis identified the expression of Cryab in mouse lens as early as embryonic day 15 (E15) that increased significantly until postnatal day 6 (P6) with steady level of expression thereafter. Conclusion Here, we report two novel missense mutations, p.R11C and p.R12C, in CRYAB associated with autosomal recessive congenital nuclear cataracts.	[Jiaox, Xiaodong; Wang, Qiwei; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Khan, Shahid Y.; Irum, Bushra; Kabir, Firoz; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Irum, Bushra; Khan, Asma A.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Khan, Arif O.] King Khalid Eye Specialist Hosp, Riyadh 12329, Saudi Arabia; [Akram, Javed; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.	riazuddin@jhmi.edu	Khan, Asma Al/AAH-5277-2021; Husnain, Tayyab/AAE-9033-2019		National Eye Institute [1R01EY022714]; Knight Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [ZIAEY000281, R01EY022714] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knight Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute, Grant 1R01EY022714 (SAR), Knight Templar Eye Foundation Grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA and the Higher Education Commission, Islamabad Pakistan.	Abu Safieh L, 2009, MOL VIS, V15, P980; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Butt T, 2007, MOL VIS, V13, P1635; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Chen Q, 2009, MOL VIS, V15, P1359; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; Del Bigio MR, 2011, ANN NEUROL, V69, P866, DOI 10.1002/ana.22331; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Devi RR, 2008, MOL VIS, V14, P1157; DUBIN RA, 1990, GENOMICS, V7, P594, DOI 10.1016/0888-7543(90)90204-8; FOSTER A, 1990, INT OPHTHALMOL, V14, P135, DOI 10.1007/BF00158310; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Hejtmancik JF, 2003, DEV OPHTHALMOL, V37, P67; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan AO, 2010, OPHTHALMIC GENET, V31, P30, DOI 10.3109/13816810903452047; Khan SY, 2015, MOL VIS, V21, P871; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/archpedi.1987.04460120087041; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; Sun WM, 2011, MOL VIS, V17, P2197; van der Smagt JJ, 2014, CLIN GENET, V85, P381, DOI 10.1111/cge.12169; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	41	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137973	10.1371/journal.pone.0137973	http://dx.doi.org/10.1371/journal.pone.0137973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402864	Green Submitted, gold, Green Published			2022-12-26	WOS:000361798100015
J	Mansourvar, M; Shamshirband, S; Raj, RG; Gunalan, R; Mazinani, I				Mansourvar, Marjan; Shamshirband, Shahaboddin; Raj, Ram Gopal; Gunalan, Roshan; Mazinani, Iman			An Automated System for Skeletal Maturity Assessment by Extreme Learning Machines	PLOS ONE			English	Article							BONE-AGE ASSESSMENT; SEGMENTATION; CARPAL; PREDICTION; NETWORKS; GREULICH; PYLE	Assessing skeletal age is a subjective and tedious examination process. Hence, automated assessment methods have been developed to replace manual evaluation in medical applications. In this study, a new fully automated method based on content-based image retrieval and using extreme learning machines (ELM) is designed and adapted to assess skeletal maturity. The main novelty of this approach is it overcomes the segmentation problem as suffered by existing systems. The estimation results of ELM models are compared with those of genetic programming (GP) and artificial neural networks (ANNs) models. The experimental results signify improvement in assessment accuracy over GP and ANN, while generalization capability is possible with the ELM approach. Moreover, the results are indicated that the ELM model developed can be used confidently in further work on formulating novel models of skeletal age assessment strategies. According to the experimental results, the new presented method has the capacity to learn many hundreds of times faster than traditional learning methods and it has sufficient overall performance in many aspects. It has conclusively been found that applying ELM is particularly promising as an alternative method for evaluating skeletal age.	[Mansourvar, Marjan; Shamshirband, Shahaboddin; Raj, Ram Gopal] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia; [Gunalan, Roshan] Univ Malaya, Fac Med, Kuala Lumpur 50603, Malaysia; [Mazinani, Iman] Univ Malaya, Fac Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Mansourvar, M (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia.	mansourvar@um.edu.my	S.Band, Shahab/AAD-3311-2021; mansourvar, marjan/AAM-7846-2020; Gunalan, Roshan/AFK-0450-2022; Mansourvar, Marjan/AAE-2310-2019; S.Band, Shahab/ABI-7388-2020; Gunalan, Roshan/ABA-2001-2020; Raj, Ram Gopal/B-3399-2010	Gunalan, Roshan/0000-0002-5430-5542; Mansourvar, Marjan/0000-0001-6492-7858; S.Band, Shahab/0000-0002-8963-731X; Raj, Ram Gopal/0000-0002-8627-1113; Shamshirband, Shahaboddin/0000-0002-6605-498X	University of Malaya Research Grant (UMRG) [RP026-14AET]	University of Malaya Research Grant (UMRG)	University of Malaya Research Grant (UMRG), grant number. RP026-14AET.	Aja-Fernandez S, 2004, J BIOMED INFORM, V37, P99, DOI 10.1016/j.jbi.2004.01.002; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Annema A, 1994, PRECISION REQUIREMEN; Babovic V., 2005, ENCY HYDROLOGICAL SC; Bull RK, 1999, ARCH DIS CHILD, V81, P172, DOI 10.1136/adc.81.2.172; Chai HY, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-87; Chai HY., 2011, INT J MATH MODELS ME, V5, P628; Choras R S., 2007, INT J BIOL BIOMEDICA, V1, P6; Deng Z, 2014, MINIMAX PROBABILITY; Drew PJ, 2000, SURGERY, V127, P3, DOI 10.1067/msy.2000.102173; Fischer B, 2011, BONE AGE ASSESSMENT; Fischer B, 2012, INT J COMPUT ASS RAD, V7, P389, DOI 10.1007/s11548-011-0627-8; Gertych A, 2007, PATTERN ANAL APPL, V10, P115, DOI 10.1007/s10044-006-0056-4; Ghouti L, 2013, PROCEDIA COMPUT SCI, V19, P305, DOI 10.1016/j.procs.2013.06.043; Giordano D, 2010, IEEE T INSTRUM MEAS, V59, P2539, DOI 10.1109/TIM.2010.2058210; Han CC, 2007, PATTERN RECOGN, V40, P2994, DOI 10.1016/j.patcog.2007.01.010; HOPFIELD JJ, 1988, IEEE CIRCUIT DEVIC, V4, P3, DOI 10.1109/101.8118; Huang G, 2015, NEURAL NETWORKS, V61, P32, DOI 10.1016/j.neunet.2014.10.001; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P863, DOI 10.1109/TNN.2006.875974; Jonsson K., 2002, ACTA RADIOL, V43, P236, DOI [10.1034/j.1600-0455.2002.430228_5.x, DOI 10.1034/J.1600-0455.2002.430228_5.X]; Khu ST, 2001, J AM WATER RESOUR AS, V37, P439, DOI 10.1111/j.1752-1688.2001.tb00980.x; Koza JR, 1992, GENETIC PROGRAMMING; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu J, 2008, COMPUT MED IMAG GRAP, V32, P678, DOI 10.1016/j.compmedimag.2008.08.005; Mahmoodi S, 2000, IEEE T INF TECHNOL B, V4, P292, DOI 10.1109/4233.897061; MANOS G, 1993, IMAGE VISION COMPUT, V11, P100, DOI 10.1016/0262-8856(93)90076-S; Mansourvar M, 2014, INT J INFORM TECHNOL, V20; Mansourvar M, 2014, QUANTITATIVE STUDY D, P659; Mansourvar M, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/391626; Mansourvar M, 2014, J FORENSIC LEG MED, V22, P26, DOI 10.1016/j.jflm.2013.11.011; Mansourvar M, 2012, MALAYS J COMPUT SCI, V25, P107; MICHAEL DJ, 1989, IEEE T MED IMAGING, V8, P64, DOI 10.1109/42.20363; Nian R, 2014, NEUROCOMPUTING, V128, P273, DOI 10.1016/j.neucom.2013.03.054; Patil ST, 2012, FORENSIC SCI INT, V216, DOI 10.1016/j.forsciint.2011.09.022; PIETKA E, 1993, IEEE T MED IMAGING, V12, P44, DOI 10.1109/42.222665; Sebastian TB, 2003, MED IMAGE ANAL, V7, P21, DOI 10.1016/S1361-8415(02)00065-8; Singh R., 2007, INT J INTELLIGENT TE, V2, P256; Takekawa T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00005; Tristan-Vega A, 2008, IEEE T BIO-MED ENG, V55, P1463, DOI 10.1109/TBME.2008.918554; Wang DA, 2014, NEUROCOMPUTING, V128, P258, DOI 10.1016/j.neucom.2012.12.062; Wang XY, 2014, NEUROCOMPUTING, V145, P90, DOI 10.1016/j.neucom.2014.05.068; Wong PK, 2015, RENEW ENERG, V74, P640, DOI 10.1016/j.renene.2014.08.075; Yazdani S, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0207-7; Yu Q, 2014, NEUROCOMPUTING, V128, P296, DOI 10.1016/j.neucom.2013.01.063; Zhan YB, 2011, NEUROCOMPUTING, V74, P1985, DOI 10.1016/j.neucom.2010.06.029; Zhang AF, 2007, COMPUT MED IMAG GRAP, V31, P299, DOI 10.1016/j.compmedimag.2007.02.008; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012	50	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138493	10.1371/journal.pone.0138493	http://dx.doi.org/10.1371/journal.pone.0138493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402795	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100026
J	Thomas, HB; Moots, RJ; Edwards, SW; Wright, HL				Thomas, Huw B.; Moots, Robert J.; Edwards, Steven W.; Wright, Helen L.			Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies	PLOS ONE			English	Article							EXPRESSION ANALYSIS; GRANULOCYTES; EOSINOPHILS; TOPHAT	Protocols for the isolation of neutrophils from whole blood often result in neutrophil preparations containing low numbers (similar to 5%) of contaminating leukocytes, and it is possible that these contaminating cells contribute to highly sensitive assays that measure neutrophil gene expression (e.g. qPCR). We investigated the contribution of contaminating leukocytes on the transcriptome profile of human neutrophils following stimulation with inflammatory cytokines (GM-CSF, TNF alpha), using RNA-Seq. Neutrophils were isolated using Polymorphprep or the StemCell untouched neutrophil isolation kit (negative selection of "highly pure" neutrophils). The level of contamination was assessed by morphology and flow cytometry. The major source of contamination in Polymorphprep neutrophil preparations was from eosinophils and was highly donor dependent. Contaminating cells were largely, but not completely, absent in neutrophil suspensions prepared using negative selection, but the overall yield of neutrophils was decreased by around 50%. RNA-seq analysis identified only 25 genes that were significantly differentially-expressed between Polymorphprep and negatively-selected neutrophils across all three treatment groups (untreated, GM-CSF, TNFa). The expression levels of 34 cytokines/chemokines both before and after GM-CSF or TNFa treatment were not significantly different between neutrophil isolation methods and therefore not affected by contributions from non-neutrophil cell types. This work demonstrates that low numbers (<5%) of contaminating leukocytes in neutrophil preparations contribute very little to the overall gene expression profile of cytokine-stimulated neutrophils, and that protocols for the isolation of highly pure neutrophils result in significantly lower yields of cells which may hinder investigations where large numbers of cells are required or where volumes of blood are limited.	[Thomas, Huw B.; Edwards, Steven W.; Wright, Helen L.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Moots, Robert J.] Univ Liverpool, Univ Hosp Aintree, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Wright, HL (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	hlwright@liv.ac.uk	Wright, Helen/O-2555-2019; Moots, Robert/AAM-8091-2020	Wright, Helen/0000-0003-0442-3134; Thomas, Huw/0000-0001-9626-9706; Edwards, Steven/0000-0002-7074-0552	Biotechnology and Biological Sciences Research Council [BB/H016163/1]; UCB-Pharma under a CASE award; Arthritis Research UK [19437]; Versus Arthritis [19437] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UCB-Pharma under a CASE award; Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	HBT was funded by the Biotechnology and Biological Sciences Research Council under grant no. BB/H016163/1 and UCB-Pharma under a CASE award http://www.bbsrc.ac.uk. HLW was funded by Arthritis Research UK under grant number 19437 http://www.arthritisresearchuk.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson-Boutelliez C, 2001, J CLIN PERIODONTOL, V28, P650, DOI 10.1034/j.1600-051x.2001.028007650.x; Cowburn AS, 2011, AM J RESP CELL MOL, V44, P879, DOI 10.1165/rcmb.2010-0101OC; Degel Jonathan, 2010, Clin Lab Sci, V23, P94; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gopinath R, 1997, CYTOMETRY, V30, P313; Hasenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017314; Kabanova S, 2009, INT J MED SCI, V6, P156; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Stejskal S, 2010, FOLIA BIOL-PRAGUE, V56, P252; Tamarozzi F, 2014, IMMUNOL LETT, V162, P194, DOI 10.1016/j.imlet.2014.10.025; Tamassia N, 2013, J IMMUNOL, V190, P1921, DOI 10.4049/jimmunol.1203022; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; WEIL GJ, 1981, BLOOD, V57, P1099; Wright HL, 2015, RHEUMATOLOGY, V54, P188, DOI 10.1093/rheumatology/keu299; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11; Zimmermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7061	28	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138982	10.1371/journal.pone.0138982	http://dx.doi.org/10.1371/journal.pone.0138982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401909	Green Submitted, Green Published, gold			2022-12-26	WOS:000361798100048
J	Zakiewicz, IM; Majka, P; Wojcik, DK; Bjaalie, JG; Leergaard, TB				Zakiewicz, Izabela M.; Majka, Piotr; Wojcik, Daniel K.; Bjaalie, Jan G.; Leergaard, Trygve B.			Three-Dimensional Histology Volume Reconstruction of Axonal Tract Tracing Data: Exploring Topographical Organization in Subcortical Projections from Rat Barrel Cortex	PLOS ONE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PRIMARY SOMATOSENSORY CORTEX; WAXHOLM SPACE ATLAS; MOUSE-BRAIN; CORTICOTHALAMIC PROJECTIONS; CORTICOPONTINE PROJECTIONS; COMPUTER RECONSTRUCTION; NEURONAL POPULATIONS; SPATIAL-DISTRIBUTION; IMAGE REGISTRATION	Topographical organization is a hallmark of the mammalian brain, and the spatial organization of axonal connections in different brain regions provides a structural framework accommodating specific patterns of neural activity. The presence, amount, and spatial distribution of axonal connections are typically studied in tract tracing experiments in which axons or neurons are labeled and examined in histological sections. Three-dimensional (3-D) reconstruction techniques are used to achieve more complete visualization and improved understanding of complex topographical relationships. 3-D reconstruction approaches based on manually or semi-automatically recorded spatial points representing axonal labeling have been successfully applied for investigation of smaller brain regions, but are not practically feasible for whole-brain analysis of multiple regions. We here reconstruct serial histological images from four whole brains (originally acquired for conventional microscopic analysis) into volumetric images that are spatially registered to a 3-D atlas template. The aims were firstly to evaluate the quality of the 3-D reconstructions and the usefulness of the approach, and secondly to investigate axonal projection patterns and topographical organization in rat corticostriatal and corticothalamic pathways. We demonstrate that even with the limitations of the original routine histological material, the 3-D reconstructed volumetric images allow efficient visualization of tracer injection sites and axonal labeling, facilitating detection of spatial distributions and across-case comparisons. Our results further show that clusters of S1 corticostriatal and corticothalamic projections are distributed within narrow, elongated or spherical subspaces extending across the entire striatum / thalamus. We conclude that histology volume reconstructions facilitate mapping of spatial distribution patterns and topographical organization. The reconstructed image volumes are shared via the Rodent Brain Workbench (www.rbwb.org).	[Zakiewicz, Izabela M.; Bjaalie, Jan G.; Leergaard, Trygve B.] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Zakiewicz, Izabela M.; Majka, Piotr; Wojcik, Daniel K.] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland	University of Oslo; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Leergaard, TB (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway.	t.b.leergaard@medisin.uio.no	Wojcik, Daniel/C-6334-2008; Majka, Piotr/P-9741-2016; Bjaalie, Jan G. G./AAW-6445-2021	Wojcik, Daniel/0000-0003-0812-9872; Majka, Piotr/0000-0002-9055-8686; Bjaalie, Jan G. G./0000-0001-7899-906X; Leergaard, Trygve B./0000-0001-5965-8470	EMBIO/MLS@UIO [PS-V08]; Research Council of Norway (Norwegian Node of the International Neuroinformatics Coordinating Facility) [214842]; European Commission (FP7-ICT-FET-F, The Human Brain Project) [604102]; European Regional Development Fund under the Operational Programme Innovative Economy [POIG .02.03. 00-00-003 / 09]	EMBIO/MLS@UIO; Research Council of Norway (Norwegian Node of the International Neuroinformatics Coordinating Facility); European Commission (FP7-ICT-FET-F, The Human Brain Project); European Regional Development Fund under the Operational Programme Innovative Economy	This work was supported by EMBIO/MLS@UIO (PS-V08, http://www.uio.no/forskning/tverrfak/mls/om/) to TBL; The Research Council of Norway (Norwegian Node of the International Neuroinformatics Coordinating Facility, project ID 214842, (http://www.forskningsradet.no) and the European Commission (FP7-ICT-2013-FET-F, The Human Brain Project, project ID 604102, https://www.humanbrainproject.eu/) to JGB; and the European Regional Development Fund under the Operational Programme Innovative Economy (POIG .02.03. 00-00-003 / 09, http://www.poig.gov.pl/english/Strony/Introduction.aspx) to DKW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2014, NEUROIMAGE, V84, P505, DOI 10.1016/j.neuroimage.2013.08.067; Alloway KD, 2003, BRAIN RES, V968, P54, DOI 10.1016/S0006-8993(02)04265-8; Alloway KD, 1999, J NEUROSCI, V19, P10908, DOI 10.1523/JNEUROSCI.19-24-10908.1999; Alloway KD, 2006, J COMP NEUROL, V499, P33, DOI 10.1002/cne.21039; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bjaalie JG, 2005, NEUROSCIENCE, V136, P681, DOI 10.1016/j.neuroscience.2005.06.036; Bjaalie JG, 1997, NEUROREPORT, V8, P1651, DOI 10.1097/00001756-199705060-00019; BLACKSTAD TW, 1984, NEUROSCIENCE, V13, P827, DOI 10.1016/0306-4522(84)90099-X; Boy J, 2006, NEUROIMAGE, V33, P449, DOI 10.1016/j.neuroimage.2006.05.055; Brevik A, 2001, ANAT EMBRYOL, V204, P319, DOI 10.1007/s004290100202; Brodal A, 1981, NEUROLOGICAL ANATOMY; BRODAL P, 1992, NEUROSCI RES, V13, P83, DOI 10.1016/0168-0102(92)90092-Q; Brown LL, 1998, J COMP NEUROL, V392, P468; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Choe AS, 2011, MAGN RESON IMAGING, V29, P683, DOI 10.1016/j.mri.2011.02.022; Dauguet J, 2007, J NEUROSCI METH, V164, P191, DOI 10.1016/j.jneumeth.2007.04.017; DESCHENES M, 1994, BRAIN RES, V664, P215, DOI 10.1016/0006-8993(94)91974-7; Deschenes M, 2005, PROG BRAIN RES, V149, P31, DOI 10.1016/S0079-6123(05)49003-2; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5; Frackowiak R, 2015, PHILOS T R SOC B, V370, P1668; Gaffling S, 2015, IEEE T MED IMAGING, V34, P514, DOI 10.1109/TMI.2014.2361784; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Ju T, 2006, J NEUROSCI METH, V156, P84, DOI 10.1016/j.jneumeth.2006.02.020; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kjonigsen LJ, 2015, NEUROIMAGE, V108, P441, DOI 10.1016/j.neuroimage.2014.12.080; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Leergaard TB, 2000, J COMP NEUROL, V422, P246, DOI 10.1002/(SICI)1096-9861(20000626)422:2<246::AID-CNE7>3.0.CO;2-R; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Leergaard TB, 2003, ANAT EMBRYOL, V206, P149, DOI 10.1007/s00429-002-0272-7; LEERGAARD TB, 1995, NEUROSCI RES, V22, P231, DOI 10.1016/0168-0102(95)00899-6; Leergaard TB, 2000, J NEUROSCI, V20, P8474, DOI 10.1523/JNEUROSCI.20-22-08474.2000; Leergaard TB, 2006, EUR J NEUROSCI, V24, P2801, DOI 10.1111/j.1460-9568.2006.05150.x; Leergaard TB, 2007, FRONT NEUROSCI-SWITZ, V1, P211, DOI 10.3389/neuro.01.1.1.016.2007; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Majka P, 2012, NEUROINFORMATICS, V10, P181, DOI 10.1007/s12021-011-9138-6; Malmierca MS, 1998, J NEUROSCI, V18, P10603; Markram H, 2013, FUNCT NEUROL, V28, P145, DOI [10.11138/FNeur/2013.28.3.145, 10.11138/FNeur/2013.28.3.144]; NIKUNDIWE AM, 1994, EUR J NEUROSCI, V6, P173, DOI 10.1111/j.1460-9568.1994.tb00259.x; Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005; Odeh F, 2011, NEUROIMAGE, V54, P2603, DOI 10.1016/j.neuroimage.2010.11.032; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Swanson LW, 2007, BRAIN RES REV, V55, P356, DOI 10.1016/j.brainresrev.2006.12.006; Tiesinga P, 2015, CURR OPIN NEUROBIOL, V32, P107, DOI 10.1016/j.conb.2015.02.003; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wright AK, 1999, NEUROSCIENCE, V88, P119, DOI 10.1016/S0306-4522(98)00186-9; Yang ZY, 2012, J NEUROSCI METH, V211, P210, DOI 10.1016/j.jneumeth.2012.08.021; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x; Zakiewicz IM, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00005; Zakiewicz IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022669	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137571	10.1371/journal.pone.0137571	http://dx.doi.org/10.1371/journal.pone.0137571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398192	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500040
J	Chen, LJ; Hambright, WS; Na, R; Ran, QT				Chen, Liuji; Hambright, William Sealy; Na, Ren; Ran, Qitao			Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NONAPOPTOTIC CELL-DEATH; TRANSGENIC MICE; OXIDATIVE DAMAGE; APOPTOSIS; GPX4; GENERATION; PROTECTS; PHGPX	Glutathione peroxidase 4 (GPX4), an antioxidant defense enzyme active in repairing oxidative damage to lipids, is a key inhibitor of ferroptosis, a non-apoptotic form of cell death involving lipid reactive oxygen species. Here we show that GPX4 is essential for motor neuron health and survival in vivo. Conditional ablation of Gpx4 in neurons of adult mice resulted in rapid onset and progression of paralysis and death. Pathological inspection revealed that the paralyzed mice had a dramatic degeneration of motor neurons in the spinal cord but had no overt neuron degeneration in the cerebral cortex. Consistent with the role of GPX4 as a ferroptosis inhibitor, spinal motor neuron degeneration induced by Gpx4 ablation exhibited features of ferroptosis, including no caspase-3 activation, no TUNEL staining, activation of ERKs, and elevated spinal inflammation. Supplementation with vitamin E, another inhibitor of ferroptosis, delayed the onset of paralysis and death induced by Gpx4 ablation. Also, lipid peroxidation and mitochondrial dysfunction appeared to be involved in ferroptosis of motor neurons induced by Gpx4 ablation. Taken together, the dramatic motor neuron degeneration and paralysis induced by Gpx4 ablation suggest that ferroptosis inhibition by GPX4 is essential for motor neuron health and survival in vivo.	[Chen, Liuji; Hambright, William Sealy; Na, Ren; Ran, Qitao] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Ran, Qitao] South Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Ran, QT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ran@uthscsa.edu			Department of Veterans Affairs; Alzheimer's Association; William and Ella Owens Medical Research Foundation; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Alzheimer's Association(Alzheimer's Association); William and Ella Owens Medical Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a merit review grant from the Department of Veterans Affairs, a grant from the Alzheimer's Association, and an award from The William and Ella Owens Medical Research Foundation. To whom correspondence should be addressed: Dept. of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229. Tel.: 210-567-3842; Fax: 210-567-6781; E-mail: ran@uthscsa.edu.	Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Chen LJ, 2014, NEUROBIOL AGING, V35, P2552, DOI 10.1016/j.neurobiolaging.2014.05.007; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Girotti AW, 1998, J LIPID RES, V39, P1529; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Heimer-McGinn V, 2011, GENESIS, V49, P942, DOI 10.1002/dvg.20777; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Liang HY, 2007, BIOCHEM BIOPH RES CO, V356, P893, DOI 10.1016/j.bbrc.2007.03.045; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Ran QT, 2003, FREE RADICAL BIO MED, V35, P1101, DOI 10.1016/S0891-5849(03)00466-0; Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3; Tomik B, 2005, FOLIA NEUROPATHOL, V43, P75; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yamazaki M, 2005, NEUROPATHOLOGY, V25, P381, DOI 10.1111/j.1440-1789.2005.00648.x; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118	23	237	248	8	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28097	28106		10.1074/jbc.M115.680090	http://dx.doi.org/10.1074/jbc.M115.680090			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26400084	Green Published, hybrid			2022-12-26	WOS:000365761900006
J	Li, DC; Nichols, CG; Sala-Rabanal, M				Li, Dan C.; Nichols, Colin G.; Sala-Rabanal, Monica			Role of a Hydrophobic Pocket in Polyamine Interactions with the Polyspecific Organic Cation Transporter OCT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; SENSORINEURAL DEAFNESS; INWARD RECTIFICATION; PHYSIOLOGICAL ROLES; POTASSIUM CHANNELS; LACTOSE PERMEASE; ESCHERICHIA-COLI; MOLECULAR-BASIS; AMINO-ACIDS; MUTATIONS	Organic cation transporter 3 (OCT3, SLC22A3) is a polyspecific, facilitative transporter expressed in astrocytes and in placental, intestinal, and blood-brain barrier epithelia, and thus elucidating the molecular mechanisms underlying OCT3 substrate recognition is critical for the rational design of drugs targeting these tissues. The pharmacology of OCT3 is distinct from that of other OCTs, and here we investigated the role of a hydrophobic cavity tucked within the translocation pathway in OCT3 transport properties. Replacement of an absolutely conserved Asp by charge reversal (D478E), neutralization (D478N), or even exchange (D478E) abolished MPP+ uptake, demonstrating this residue to be obligatory for OCT3-mediated transport. Mutations at non-conserved residues lining the putative binding pocket of OCT3 to the corresponding residue in OCT1 (L166F, F450L, and E451Q) reduced the rate of MPP+ transport, but recapitulated the higher sensitivity pharmacological profile of OCT1. Thus, interactions of natural polyamines (putrescine, spermidine, spermine) and polyamine-like potent OCT1 blockers (1,10-diaminodecane, decamethonium, bistriethylaminodecane, and 1,10-bisquinuclidinedecane) with wild-type OCT3 were weak, but were significantly potentiated in the mutant OCT3s. Conversely, a reciprocal mutation in OCT1 (F161L) shifted the polyamine-sensitivity phenotype toward that of OCT3. Further analysis indicated that OCT1 and OCT3 can recognize essentially the same substrates, but the strength of substrate-transporter interactions is weaker in OCT3, as informed by the distinct makeup of the hydrophobic cleft. The residues identified here are key contributors to both the observed differences between OCT3 and OCT1 and to the mechanisms of substrate recognition by OCTs in general.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, CIMED, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sala-Rabanal, M (corresponding author), 660 South Euclid, St Louis, MO 63110 USA.	msala@wustl.edu	Regan, Clinton/E-6250-2012; Sala-Rabanal, Monica/AAU-2383-2021	Li, Dan/0000-0003-3000-5681	National Institutes of Health [HL54171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL54171 (to C. G. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Bednarczyk D, 2003, MOL PHARMACOL, V63, P489, DOI 10.1124/mol.63.3.489; Benedikt J, 2012, NEUROREPORT, V23, P1021, DOI 10.1097/WNR.0b013e32835aa04b; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Choi MK, 2008, DRUG METAB PHARMACOK, V23, P243, DOI 10.2133/dmpk.23.243; Ciarimboli G, 2011, EXPERT OPIN DRUG MET, V7, P159, DOI 10.1517/17425255.2011.547474; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170; Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Higashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102234; Hosoya K, 2011, CLIN EXP NEPHROL, V15, P478, DOI 10.1007/s10157-011-0460-y; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inazu M, 2003, J NEUROCHEM, V84, P43, DOI 10.1046/j.1471-4159.2003.01566.x; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lips KS, 2005, AM J RESP CELL MOL, V33, P79, DOI 10.1165/rcmb.2004-0363OC; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Muller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011; Muth A, 2014, J MED CHEM, V57, P348, DOI 10.1021/jm401174a; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pelis RM, 2006, J BIOL CHEM, V281, P35272, DOI 10.1074/jbc.M606561200; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Sala-Rabanal M, 2013, MOL PHARMACEUT, V10, P1450, DOI 10.1021/mp400024d; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Sata R, 2005, J PHARMACOL EXP THER, V315, P888, DOI 10.1124/jpet.105.086827; Schmitt BM, 2005, J BIOL CHEM, V280, P24481, DOI 10.1074/jbc.M414550200; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Suhre WM, 2005, MOL PHARMACOL, V67, P1067, DOI 10.1124/mol.104.004713; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Wright SH, 2005, TOXICOL APPL PHARM, V204, P309, DOI 10.1016/j.taap.2004.10.021; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Zhang XH, 2005, J BIOL CHEM, V280, P34813, DOI 10.1074/jbc.M506342200; Zolk O, 2012, ANN MED, V44, P119, DOI 10.3109/07853890.2010.549144; Zolk O, 2009, N-S ARCH PHARMACOL, V379, P337, DOI 10.1007/s00210-008-0369-5	46	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27633	27643		10.1074/jbc.M115.668913	http://dx.doi.org/10.1074/jbc.M115.668913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405039	Green Published, hybrid			2022-12-26	WOS:000365757500018
J	Rhayem, Y; Le Stunff, C; Khalek, WA; Auzan, C; Bertherat, J; Linglart, A; Couvineau, A; Silve, C; Clauser, E				Rhayem, Yara; Le Stunff, Catherine; Khalek, Waed Abdel; Auzan, Colette; Bertherat, Jerome; Linglart, Agnes; Couvineau, Alain; Silve, Caroline; Clauser, Eric			Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; IDENTIFIES PDE4D MUTATIONS; HORMONE RESISTANCE; REGULATORY SUBUNIT; COUPLED RECEPTORS; GENE; DELETION; MUTANT; BRET	The main target of cAMP is PKA, the main regulatory subunit of which (PRKAR1A) presents mutations in two genetic disorders: acrodysostosis and Carney complex. In addition to the initial recurrent mutation (R368X) of the PRKAR1A gene, several missense and nonsense mutations have been observed recently in acrodysostosis with hormonal resistance. These mutations are located in one of the two cAMP-binding domains of the protein, and their functional characterization is presented here. Expression of each of the PRKAR1A mutants results in a reduction of forskolin-induced PKA activation (measured by a reporter assay) and an impaired ability of cAMP to dissociate PRKAR1A from the catalytic PKA subunits by BRET assay. Modeling studies and sensitivity to cAMP analogs specific for domain A (8-piperidinoadenosine 3',5'-cyclic monophosphate) or domain B (8-(6-aminohexyl)aminoadenosine-3',5'-cyclic monophosphate) indicate that the mutations impair cAMP binding locally in the domain containing the mutation. Interestingly, two of these mutations affect amino acids for which alternative amino acid substitutions have been reported to cause the Carney complex phenotype. To decipher the molecular mechanism through which homologous substitutions can produce such strikingly different clinical phenotypes, we studied these mutations using the same approaches. Interestingly, the Carney mutants also demonstrated resistance to cAMP, but they expressed additional functional defects, including accelerated PRKAR1A protein degradation. These data demonstrate that a cAMP binding defect is the common molecular mechanism for resistance of PKA activation in acrodysosotosis and that several distinct mechanisms lead to constitutive PKA activation in Carney complex.	[Rhayem, Yara; Khalek, Waed Abdel; Auzan, Colette; Clauser, Eric] Univ Paris 05, INSERM U970, Paris Ctr Rech Cardiovasc, F-75015 Paris, France; [Rhayem, Yara; Silve, Caroline; Clauser, Eric] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75014 Paris, France; [Bertherat, Jerome] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France; [Le Stunff, Catherine; Silve, Caroline] Univ Paris 11, Hop Bicetre, INSERM U1169, F-94270 Le Kremlin Bicetre, France; [Bertherat, Jerome] Univ Paris 05, INSERM U1060, Inst Cochin, F-75014 Paris, France; [Linglart, Agnes] Hop Bicetre, AP HP, Serv Endocrinol Pediat, F-94270 Le Kremlin Bicetre, France; [Couvineau, Alain] Univ Paris Diderot, Fac Med, ERL CNRS 8252, UMR INSERM 1149, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Clauser, E (corresponding author), INSERM U970, PARCC, 56 Rue Leblanc, F-75015 Paris, France.	eric.clauser@inserm.fr	LE STUNFF, CATHERINE/Y-3270-2018; couvineau, alain/G-3641-2013; couvineau, alain/T-3466-2019; Linglart, Agnès/A-8047-2016	LE STUNFF, CATHERINE/0000-0001-8419-0451; couvineau, alain/0000-0003-2912-5168; couvineau, alain/0000-0003-2912-5168; Linglart, Agnès/0000-0003-3455-002X; BERTHERAT, Jerome/0000-0003-2551-3008	INSERM; Assistance Publique, Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Assistance Publique, Hopitaux de Paris	This work was supported by recurrent funding from INSERM and Assistance Publique, Hopitaux de Paris.	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Bae E, 2005, J BIOL CHEM, V280, P30943, DOI 10.1074/jbc.M504216200; Bataille MG, 2014, EUR J ENDOCRINOL, V170, P151, DOI 10.1530/EJE-13-0740; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Greene EL, 2008, HUM MUTAT, V29, P633, DOI 10.1002/humu.20688; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Linglart A, 2012, J CLIN ENDOCR METAB, V97, pE2328, DOI 10.1210/jc.2012-2326; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Muhn F, 2013, CLIN GENET, V84, P531, DOI 10.1111/cge.12106; Nagasaki K, 2012, J CLIN ENDOCR METAB, V97, pE1808, DOI 10.1210/jc.2012-1369; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; Schwede F, 2000, BIOCHEMISTRY-US, V39, P8803, DOI 10.1021/bi000304y; Silve C, 2012, Bonekey Rep, V1, P225, DOI 10.1038/bonekey.2012.225; SKALHEGG BS, 1992, J BIOL CHEM, V267, P15707; Solberg R, 1997, ENDOCRINOLOGY, V138, P169, DOI 10.1210/en.138.1.169; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WETTERS TV, 1983, MOL CELL BIOL, V3, P250, DOI 10.1128/MCB.3.2.250	29	23	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27816	27828		10.1074/jbc.M115.656553	http://dx.doi.org/10.1074/jbc.M115.656553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405036	Green Published, hybrid			2022-12-26	WOS:000365757500032
J	Zhou, JL; Ueda, K; Zhao, J; Sparrow, JR				Zhou, Jilin; Ueda, Keiko; Zhao, Jin; Sparrow, Janet R.			Correlations between Photodegradation of Bisretinoid Constituents of Retina and Dicarbonyl Adduct Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; PIGMENT EPITHELIAL-CELLS; HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; CROSS-LINKING; MOUSE MODEL; FUNDUS AUTOFLUORESCENCE; LIPOFUSCIN PIGMENTS	Non-enzymatic collagen cross-linking and carbonyl adduct deposition are features of Bruch's membrane aging in the eye, and disturbances in extracellular matrix turnover are considered to contribute to Bruch's membrane thickening. Because bisretinoid constituents of the lipofuscin of retinal pigment epithelial (RPE) cells are known to photodegrade to mixtures of aldehyde-bearing fragments and small dicarbonyls (glyoxal (GO) and methylglyoxal (MG)), we investigated RPE lipofuscin as a source of the reactive species that covalently modify protein side chains. Abca4(-/-) and Rdh8(-/-)/Abca4(-/-) mice that are models of accelerated bisretinoid formation were studied and pre-exposure of mice to 430 nm light enriched for dicarbonyl release by bisretinoid photodegradation. MG protein adducts were elevated in posterior eyecups of mutant mice, whereas carbonylation of an RPE-specific protein was observed in Abca4(-/-) but not in wild-type mice under the same conditions. Immunolabeling of cryostat-sectioned eyes harvested from Abca4(-/-) mice revealed that carbonyl adduct deposition in Bruch's membrane was accentuated. Cell-based assays corroborated these findings in mice. Moreover, the receptor for advanced glycation end products that recognizes MG and GO adducts and glyoxylase 1 that metabolizes MG and GO were up-regulated in Abca4(-/-) mice. Additionally, in acellular assays, peptides were cross-linked in the presence of A2E (adduct of two vitamin A aldehyde and ethanolamine) photodegradation products, and in a zymography assay, reaction of collagen IV with products of A2E photodegradation resulted in reduced cleavage by the matrix metalloproteinases MMP2 and MMP9. In conclusion, these mechanistic studies demonstrate a link between the photodegradation of RPE bisretinoid fluorophores and aging changes in underlying Bruch's membrane that can confer risk of age-related macular degeneration.	[Zhou, Jilin; Ueda, Keiko; Zhao, Jin; Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA; [Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.	jrs88@columbia.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [EY12951, P30EY019007]; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012951, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY12951 and P30EY019007, Foundation Fighting Blindness, and a grant from Research to Prevent Blindness (to the Dept. of Ophthalmology, Columbia University). The authors declare that they have no conflicts of interest with the contents of this article.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; ALEXANDER JP, 1990, INVEST OPHTH VIS SCI, V31, P2520; Alge-Priglinger CS, 2009, INVEST OPHTH VIS SCI, V50, P5495, DOI 10.1167/iovs.08-3193; Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015062; Bondeva T, 2011, AM J PHYSIOL-RENAL, V301, pF852, DOI 10.1152/ajprenal.00575.2010; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; CANELLAS PF, 1981, J IMMUNOL METHODS, V47, P375, DOI 10.1016/0022-1759(81)90294-5; Cano M, 2011, AM J PATHOL, V179, P850, DOI 10.1016/j.ajpath.2011.04.010; Chellan P, 2001, J BIOL CHEM, V276, P3895, DOI 10.1074/jbc.M008626200; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cousins SW, 2003, INVEST OPHTH VIS SCI, V44, P1221, DOI 10.1167/iovs.02-0285; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Gliem M, 2015, INVEST OPHTH VIS SCI, V56, P2664, DOI 10.1167/iovs.14-15733; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Guo L, 1999, INVEST OPHTH VIS SCI, V40, P2676; Hageman GS, 1999, MOL VIS, V5; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Howes KA, 2004, INVEST OPHTH VIS SCI, V45, P3713, DOI 10.1167/iovs.04-0404; HUNT RC, 1993, INVEST OPHTH VIS SCI, V34, P3179; Hussain AA, 2010, EXP EYE RES, V90, P703, DOI 10.1016/j.exer.2010.02.013; Hussain AA, 2011, INVEST OPHTH VIS SCI, V52, P4459, DOI 10.1167/iovs.10-6678; Ishibashi T, 1998, ARCH OPHTHALMOL-CHIC, V116, P1629, DOI 10.1001/archopht.116.12.1629; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kumar A, 2010, INVEST OPHTH VIS SCI, V51, P2664, DOI 10.1167/iovs.09-4195; Kurz A, 2011, CELL MOL LIFE SCI, V68, P721, DOI 10.1007/s00018-010-0483-7; Linares M, 2011, J PROTEOME RES, V10, P1719, DOI 10.1021/pr101014e; Litwinoff EMS, 2015, CLIN PHARMACOL THER, V98, P135, DOI 10.1002/cpt.148; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Manigrasso MB, 2014, TRENDS ENDOCRIN MET, V25, P15, DOI 10.1016/j.tem.2013.08.002; Martens S, 2015, NAT CELL BIOL, V17, P841, DOI 10.1038/ncb3198; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Meade SJ, 2003, BIOORGAN MED CHEM, V11, P853, DOI 10.1016/S0968-0896(02)00564-3; Miller AG, 2003, BIOORGAN MED CHEM, V11, P843, DOI 10.1016/S0968-0896(02)00565-5; Mott JD, 1997, KIDNEY INT, V52, P1302, DOI 10.1038/ki.1997.455; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; Odani H, 1998, FEBS LETT, V427, P381, DOI 10.1016/S0014-5793(98)00416-5; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pageon H, 2015, BIORESEARCH OPEN ACC, V4, P54, DOI 10.1089/biores.2014.0053; Pang JJ, 2005, MOL VIS, V11, P152; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P38, DOI 10.1016/S0002-9394(14)75576-X; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Simons BL, 2002, PROTEIN SCI, V11, P1558, DOI 10.1110/ps.4390102; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Talent JM, 1998, ANAL BIOCHEM, V263, P31, DOI 10.1006/abio.1998.2752; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Voziyan P, 2014, CLIN CHEM LAB MED, V52, P39, DOI 10.1515/cclm-2012-0818; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wilker SC, 2001, ANAL BIOCHEM, V290, P353, DOI 10.1006/abio.2001.4992; Wu L, 2014, INVEST OPHTH VIS SCI, V55, P1910, DOI 10.1167/iovs.14-13867; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xue MZ, 2012, BIOCHEM J, V443, P213, DOI 10.1042/BJ20111648; Yamada Y, 2006, EXP EYE RES, V82, P840, DOI 10.1016/j.exer.2005.10.005; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Yoon KD, 2011, MOL VIS, V17, P1839; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zhou JL, 2006, REJUV RES, V9, P256, DOI 10.1089/rej.2006.9.256; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	90	18	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27215	27227		10.1074/jbc.M115.680363	http://dx.doi.org/10.1074/jbc.M115.680363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26400086	Green Published, hybrid			2022-12-26	WOS:000364794000030
J	Feige, MJ; Behnke, J; Mittag, T; Hendershot, LM				Feige, Matthias J.; Behnke, Julia; Mittag, Tanja; Hendershot, Linda M.			Dimerization-dependent Folding Underlies Assembly Control of the Clonotypic alpha beta T Cell Receptor Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN LIGHT-CHAIN; ENDOPLASMIC-RETICULUM; ANTIGEN RECEPTOR; QUALITY-CONTROL; DISULFIDE BOND; IN-VIVO; SURFACE EXPRESSION; HEAVY-CHAINS; TCR CHAINS; PROTEIN	In eukaryotic cells, secretory pathway proteins must pass stringent quality control checkpoints before exiting the endoplasmic reticulum (ER). Acquisition of native structure is generally considered to be the most important prerequisite for ER exit. However, structurally detailed protein folding studies in the ER are few. Furthermore, aberrant ER quality control decisions are associated with a large and increasing number of human diseases, highlighting the need for more detailed studies on the molecular determinants that result in proteins being either secreted or retained. Here we used the clonotypic alpha beta chains of the T cell receptor (TCR) as a model to analyze lumenal determinants of ER quality control with a particular emphasis on how proper assembly of oligomeric proteins can be monitored in the ER. A combination of in vitro and in vivo approaches allowed us to provide a detailed model for alpha beta TCR assembly control in the cell. We found that folding of the TCR alpha chain constant domain C alpha is dependent on alpha beta heterodimerization. Furthermore, our data show that some variable regions associated with either chain can remain incompletely folded until chain pairing occurs. Together, these data argue for template-assisted folding at more than one point in the TCR alpha/beta assembly process, which allows specific recognition of unassembled clonotypic chains by the ER chaperone machinery and, therefore, reliable quality control of this important immune receptor. Additionally, it highlights an unreported possible limitation in the alpha and beta chain combinations that comprise the T cell repertoire.	[Feige, Matthias J.; Behnke, Julia; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Mittag, Tanja] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Feige, Matthias/0000-0001-5435-4312; Mittag, Tanja/0000-0002-1827-3811	Hartwell Center; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	Hartwell Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Johannes Buchner, Technische Universitat Munchen, for support of several in vitro experiments. We also thank the protein production facility, the Hartwell Center, and the mass spectrometry core of St. Jude Children's Research Hospital for support.	Arnaud J, 1997, INT IMMUNOL, V9, P615, DOI 10.1093/intimm/9.4.615; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Behnke J, 2014, J BIOL CHEM, V289, P2899, DOI 10.1074/jbc.M113.507491; BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; DAVID V, 1993, J BIOL CHEM, V268, P9585; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Dietrich J, 1999, EUR J IMMUNOL, V29, P1719, DOI 10.1002/(SICI)1521-4141(199905)29:05<1719::AID-IMMU1719>3.3.CO;2-D; Fayadat L, 2003, MOL BIOL CELL, V14, P1268, DOI 10.1091/mbc.E02-06-0363; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gardner TG, 2000, ARCH BIOCHEM BIOPHYS, V378, P182, DOI 10.1006/abbi.2000.1804; GASCOIGNE NRJ, 1990, J BIOL CHEM, V265, P9296; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; KEARSE KP, 1995, IMMUNITY, V2, P391; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MALLABIABARRENA A, 1992, NATURE, V357, P593, DOI 10.1038/357593a0; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; Shimizu Y, 2009, P NATL ACAD SCI USA, V106, P17013, DOI 10.1073/pnas.0811591106; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; van Leeuwen J. E, 1996, J BIOL CHEM, V271, P9660; VanLeeuwen JEM, 1996, J BIOL CHEM, V271, P25345, DOI 10.1074/jbc.271.41.25345; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	56	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26821	26831		10.1074/jbc.M115.689471	http://dx.doi.org/10.1074/jbc.M115.689471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26400083	Green Published, hybrid			2022-12-26	WOS:000364793600044
J	Mori, K; Fujisawa, T; Kusagaya, H; Yamanaka, K; Hashimoto, D; Enomoto, N; Inui, N; Nakamura, Y; Maekawa, M; Suda, T				Mori, Kazutaka; Fujisawa, Tomoyuki; Kusagaya, Hideki; Yamanaka, Katsumasa; Hashimoto, Dai; Enomoto, Noriyuki; Inui, Naoki; Nakamura, Yutaro; Maekawa, Masato; Suda, Takafumi			Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells	PLOS ONE			English	Article							MESSENGER-RNA; IMMUNE-RESPONSES; SEVERE ASTHMA; P38 MAPK; EXPRESSION; ACTIVATION; INNATE; INFLAMMATION; PATHWAY; ALPHA	Viral respiratory infections activate the innate immune response in the airway epithelium through Toll-like receptors (TLRs) and induce airway inflammation, which causes acute exacerbation of asthma. Although increases in IL-17A expression were observed in the airway of severe asthma patients, the interaction between IL-17A and TLR activation in airway epithelium remains poorly understood. In this study, we demonstrated that IL-17A and polyI: C, the ligand of TLR3, synergistically induced the expression of proinflammatory cytokines and chemokines (G-CSF, IL-8, CXCL1, CXCL5, IL-1F9), but not type I interferon (IFN-alpha 1, -beta) in primary culture of normal human bronchial epithelial cells. Synergistic induction after co-stimulation with IL-17A and polyI: C was observed from 2 to 24 hours after stimulation. Treatment with cycloheximide or actinomycin D had no effect, suggesting that the synergistic induction occurred without de novo protein synthesis or mRNA stabilization. Inhibition of the TLR3, TLR/TIR-domain-containing adaptor-inducing interferon beta (TRIF), NF-kappa B, and IRF3 pathways decreased the polyI: C-and IL-17A/polyI: C-induced G-CSF and IL-8 mRNA expression. Comparing the levels of mRNA induction between co-treatment with IL-17A/polyI: C and treatment with polyI: C alone, blocking the of NF-kappa B pathway significantly attenuated the observed synergism. In western blotting analysis, activation of both NF-kappa B and IRF3 was observed in treatment with polyI: C and co-treatment with IL-17A/polyI: C; moreover, co-treatment with IL-17A/polyI: C augmented I kappa B-alpha phosphorylation as compared to polyI: C treatment alone. Collectively, these findings indicate that IL-17A and TLR3 activation cooperate to induce proinflammatory responses in the airway epithelium via TLR3/TRIF-mediated NF-kappa B/IRF3 activation, and that enhanced activation of the NF-kappa B pathway plays an essential role in synergistic induction after co-treatment with IL-17A and polyI: C in vitro.	[Mori, Kazutaka; Fujisawa, Tomoyuki; Kusagaya, Hideki; Hashimoto, Dai; Enomoto, Noriyuki; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamanaka, Katsumasa; Maekawa, Masato] Hamamatsu Univ Sch Med, Dept Lab Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Fujisawa, T (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	fujisawa@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264; Maekawa, Masato/0000-0001-9710-5324	Japan Society for the Promotion of Science (JSPS KAKENHI) [26,461,186]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (C) 26,461,186 from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/ (JSPS KAKENHI Grant Number 26,461,186) (TF).	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; [Anonymous], 2014, THORAX, V69, P1; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Hot A, 2012, ANN RHEUM DIS, V71, P768, DOI 10.1136/annrheumdis-2011-200468; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Hung LY, 2008, CRIT REV IMMUNOL, V28, P269, DOI 10.1615/CritRevImmunol.v28.i4.10; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kusagaya H, 2014, AM J RESP CELL MOL, V50, P30, DOI 10.1165/rcmb.2013-0130OC; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mizunoe S, 2012, J PHARMACOL SCI, V118, P512, DOI 10.1254/jphs.11240FP; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; van den Berg A, 2005, AM J RESP CELL MOL, V33, P97, DOI 10.1165/rcmb.2005-0022OC; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001	38	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139491	10.1371/journal.pone.0139491	http://dx.doi.org/10.1371/journal.pone.0139491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418032	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400094
J	Patterson, D; Hicks, T; Dufilie, A; Grinstein, G; Plante, E				Patterson, Dianne; Hicks, Thomas; Dufilie, Andrew; Grinstein, Georges; Plante, Elena			Dynamic Data Visualization with Weave and Brain Choropleths	PLOS ONE			English	Article							SCHIZOPHRENIA; INFORMATION; COGNITION; CORTEX; ATLAS	This article introduces the neuroimaging community to the dynamic visualization workbench, Weave (https://www.oicweave.org/), and a set of enhancements to allow the visualization of brain maps. The enhancements comprise a set of brain choropleths and the ability to display these as stacked slices, accessible with a slider. For the first time, this allows the neuroimaging community to take advantage of the advanced tools already available for exploring geographic data. Our brain choropleths are modeled after widely used geographic maps but this mashup of brain choropleths with extant visualization software fills an important neuroinformatic niche. To date, most neuroinformatic tools have provided online databases and atlases of the brain, but not good ways to display the related data (e.g., behavioral, genetic, medical, etc). The extension of the choropleth to brain maps allows us to leverage general-purpose visualization tools for concurrent exploration of brain images and related data. Related data can be represented as a variety of tables, charts and graphs that are dynamically linked to each other and to the brain choropleths. We demonstrate that the simplified region-based analyses that underlay choropleths can provide insights into neuroimaging data comparable to those achieved by using more conventional methods. In addition, the interactive interface facilitates additional insights by allowing the user to filter, compare, and drill down into the visual representations of the data. This enhanced data visualization capability is useful during the initial phases of data analysis and the resulting visualizations provide a compelling way to publish data as an online supplement to journal articles.	[Patterson, Dianne; Plante, Elena] Univ Arizona, Speech Language & Hearing Sci Dept, Tucson, AZ 85721 USA; [Hicks, Thomas] Univ Arizona, Sch Informat Sci Technol & Arts, Tucson, AZ USA; [Dufilie, Andrew; Grinstein, Georges] Univ Massachusetts Lowell, Dept Comp Sci, Lowell, MA USA	University of Arizona; University of Arizona; University of Massachusetts System; University of Massachusetts Lowell	Patterson, D (corresponding author), Univ Arizona, Speech Language & Hearing Sci Dept, Tucson, AZ 85721 USA.	dkp@email.arizona.edu		Patterson, Dianne/0000-0001-7518-3110	National Institute of Deafness and Other Communication Disorders [1R01 DC011276]; Association of State & Territorial Health Office: Weave PHCP Integration; University of Massachusetts - Boston/National Institutes of Health: Visualizing Highway Pollution and its Effects; Pacific Northwest National Laboratories: VAST Challenge support; Association of State and Territorial Health Office/Centers for Disease Control: BRFSS on the Cloud - Demonstration of Internet Panel Recruitment, Management; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011276] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Association of State & Territorial Health Office: Weave PHCP Integration; University of Massachusetts - Boston/National Institutes of Health: Visualizing Highway Pollution and its Effects; Pacific Northwest National Laboratories: VAST Challenge support; Association of State and Territorial Health Office/Centers for Disease Control: BRFSS on the Cloud - Demonstration of Internet Panel Recruitment, Management; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was funded in part by a grant from the National Institute of Deafness and Other Communication Disorders 1R01 DC011276, http://www.nidcd.nih.gov/Pages/default.aspx (EP); the Association of State & Territorial Health Office: Weave PHCP Integration (2014-2015), http://www.astho.org/, (GG); University of Massachusetts - Boston/National Institutes of Health: Visualizing Highway Pollution and its Effects-(2014-2016), http://www.nih.gov/ (GG); Pacific Northwest National Laboratories: VAST Challenge 2014 support (2014), http://www.pnnl.gov/; (GG), and Association of State and Territorial Health Office/Centers for Disease Control: BRFSS on the Cloud - Demonstration of Internet Panel Recruitment, Management (2015), http://www.astho.org/, (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bakker R, 2013, CORD C P; Baumann A, 2011, EXPLORATORY PRESENTA, P200, DOI [10.1109/IV.2011.82, DOI 10.1109/IV.2011.82]; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Bostock M, 2013, CARTOGR J, V50, P129, DOI 10.1179/0008704113Z.00000000078; Butler H., 2008, GEOJSON FORMAT SPECI; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Friendly M, 2008, MICHAEL FRIENDLY; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Griffiths JD, 2013, CEREB CORTEX, V23, P139, DOI 10.1093/cercor/bhr386; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Kim C, 2015, NEUROSCI LETT, V595, P25, DOI 10.1016/j.neulet.2015.03.044; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Majka P, 2012, NEUROINFORMATICS, V10, P181, DOI 10.1007/s12021-011-9138-6; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mattschey J, 2015, BNA NEUROSCIENCE FES, P309; Maye A, 2006, INT J NEUROSCI, V116, P431, DOI 10.1080/00207450500505860; Norman K, 2003, DYNAMIC QUERY CHOROP; Nurseitov Nurzhan, 2009, Proceedings on the ISCA 22nd International Conferenceon Computers and Their Applications in Industry and Engineering. CAINE-2009, P157; Patterson RE, 2014, COMPUT GRAPH-UK, V42, P42, DOI 10.1016/j.cag.2014.03.002; Pickle, 2003, CARTOGR GEOGR INF SC, V30, P237, DOI [DOI 10.1559/152304003100011171, 10.1559/152304003100011171]; Plante E, 2014, NEUROPSYCHOLOGIA, V62, P77, DOI 10.1016/j.neuropsychologia.2014.07.007; Sherif T, 2014, FRONT NEUROINFORM, V8, DOI [10.3389/fninf.2014.00054, 10.3389/fninf.2014.00089]; Shirer W, 2011, CEREB CORTEX; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139453	10.1371/journal.pone.0139453	http://dx.doi.org/10.1371/journal.pone.0139453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418012	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400092
J	Parker, ML; Peng, FN; Boulanger, MJ				Parker, Michelle L.; Peng, Fangni; Boulanger, Martin J.			The Structure of Plasmodium falciparum Blood-Stage 6-Cys Protein Pf41 Reveals an Unexpected Intra-Domain Insertion Required for Pf12 Coordination	PLOS ONE			English	Article							TOXOPLASMA-GONDII; GENETIC DIVERSITY; SURFACE-ANTIGENS; MALARIA; IMMUNITY; IDENTIFICATION; PREDICTION; APOPTOSIS; DISTINCT; REGIONS	Plasmodium falciparum is an apicomplexan parasite and the etiological agent of severe human malaria. The complex P. falciparum life cycle is supported by a diverse repertoire of surface proteins including the family of 6-Cys s48/45 antigens. Of these, Pf41 is localized to the surface of the blood-stage merozoite through its interaction with the glycophosphatidylinositol-anchored Pf12. Our recent structural characterization of Pf12 revealed two juxtaposed 6-Cys domains (D1 and D2). Pf41, however, contains an additional segment of 120 residues predicted to form a large spacer separating its two 6-Cys domains. To gain insight into the assembly mechanism and overall architecture of the Pf12-Pf41 complex, we first determined the 2.45 angstrom resolution crystal structure of Pf41 using zinc single-wavelength anomalous dispersion. Structural analysis revealed an unexpected domain organization where the Pf41 6-Cys domains are, in fact, intimately associated and the additional residues instead map predominately to an inserted domain-like region (ID) located between two beta-strands in D1. Notably, the ID is largely proteolyzed in the final structure suggesting inherent flexibility. To assess the contribution of the ID to complex formation, we engineered a form of Pf41 where the ID was replaced by a short glycine-serine linker and showed by isothermal titration calorimetry that binding to Pf12 was abrogated. Finally, protease protection assays showed that the proteolytic susceptibility of the ID was significantly reduced in the complex, consistent with the Pf41 ID directly engaging Pf12. Collectively, these data establish the architectural organization of Pf41 and define an essential role for the Pf41 ID in promoting assembly of the Pf12-Pf41 heterodimeric complex.	[Parker, Michelle L.; Peng, Fangni; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	mboulang@uvic.ca			Canadian Institutes of Health Research (CIHR) [MOP82915]; Canada Research Chair program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant MOP82915 to MJB. MJB also acknowledges the Canada Research Chair program for salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forero-Rodriguez J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-388; Fukuchi S, 2006, J MOL BIOL, V355, P845, DOI 10.1016/j.jmb.2005.10.037; Garcia J, 2009, VACCINE, V27, P3953, DOI 10.1016/j.vaccine.2009.04.039; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Ramphul UN, 2015, P NATL ACAD SCI USA, V112, P1273, DOI 10.1073/pnas.1423586112; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Taechalertpaisarn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041937; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang Y, 2014, INFECT GENET EVOL, V28, P167, DOI 10.1016/j.meegid.2014.09.026; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139407	10.1371/journal.pone.0139407	http://dx.doi.org/10.1371/journal.pone.0139407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414347	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700057
J	Yumnam, B; Negi, T; Maldonado, JE; Fleischer, RC; Jhala, YV				Yumnam, Bibek; Negi, Tripti; Maldonado, Jesus E.; Fleischer, Robert C.; Jhala, Yadvendradev V.			Phylogeography of the Golden Jackal (Canis aureus) in India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; RED FOX; SEQUENCES; REGION; AMPLIFICATION; VARIABILITY; EXPANSION	The golden jackal (Canis aureus) is one of the most common and widely distributed carnivores in India but phylogeographic studies on the species have been limited across its range. Recent studies have observed absence of mitochondrial (mt) DNA diversity in European populations while some North African populations of golden jackal were found to carry gray wolf (Canis lupus lupaster) mtDNA lineages. In the present study, we sequenced 440 basepairs (bp) of control region (CR) and 412 bp of cytochrome b (cyt b) gene of mtDNA from 62 golden jackals sampled from India (n = 55), Israel (n = 2) and Bulgaria (n = 5), to obtain a total of eighteen haplotypes, comprising sixteen from India and one each from Israel and Bulgaria. Except for three previously described haplotypes represented by one cyt b and one CR haplotype both from India, and one CR haplotype from Bulgaria, all haplotypes identified in this study are new. Genetic diversity was high in golden jackals compared to that reported for other canids in India. Unlike the paraphyletic status of African conspecifics with the gray wolf, the Indian (and other Eurasian) golden jackal clustered in a distinct but shallow monophyletic clade, displaying no evidence of admixture with sympatric and related gray wolf and domestic dog clades in the region. Phylogeographic analyses indicated no clear pattern of genetic structuring of the golden jackal haplotypes and the median joining network revealed a star-shaped polytomy indicative of recent expansion of the species from India. Indian haplotypes were observed to be interior and thus ancestral compared to haplotypes from Europe and Israel, which were peripheral and hence more derived. Molecular tests for demographic expansion confirmed a recent event of expansion of golden jackals in the Indian subcontinent, which can be traced back similar to 37,000 years ago during the late Pleistocene. Our results suggest that golden jackals have had a potentially longer evolutionary history in India than in other parts of the world, although further sampling from Africa, the Middle East and south-east Asia is needed to test this hypothesis.	[Yumnam, Bibek; Negi, Tripti; Jhala, Yadvendradev V.] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Maldonado, Jesus E.; Fleischer, Robert C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20013 USA	Wildlife Institute of India; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History	Jhala, YV (corresponding author), Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India.	jhalay@wii.gov.in	Maldonado, Jesus/AIE-8664-2022; Jhala, Yadvendradev/AAL-9711-2020	Maldonado, Jesus/0000-0002-4282-1072; 	Wildlife Institute of India; Fulbright Fellowship; Smithsonian Conservation Biology Institute	Wildlife Institute of India; Fulbright Fellowship; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute)	The field and laboratory study was supported by funding from the Wildlife Institute of India to YVJ; BY received a Fulbright Fellowship to work at the Smithsonian Institution; TN received a short term visitor grant from Smithsonian Conservation Biology Institute for data analysis at SCBI.	Adams J.M., 1997, REV ATLAS PALAEOVEGE; Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Aiyaduraj Ambika, 2006, Journal of the Bombay Natural History Society, V103, P5; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bozarth CA, 2011, J MAMMAL, V92, P283, DOI 10.1644/10-MAMM-A-141.1; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Cohen TM, 2013, CONSERV GENET, V14, P55, DOI 10.1007/s10592-012-0423-1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabbri E, 2014, CONSERV GENET, V15, P187, DOI 10.1007/s10592-013-0530-7; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frenzel B, 1992, ATLAS PALEOCLIMATES; Fu YX, 1997, GENETICS, V147, P915; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jhala YV, 2008, IUCN 2013 IUCN RED L; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koepfli KP, 2015, CURR BIOL, V25, P2158, DOI 10.1016/j.cub.2015.06.060; KRYSTUFEK B, 1990, FOLIA ZOOL, V39, P291; Krystufek B, 1997, MAMMAL REV, V27, P109, DOI 10.1111/j.1365-2907.1997.tb00375.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Markina N, 2002, DOG JACKAL HYBRIDS A; Moehlman P.D., 1989, P143; MOEHLMAN PD, 1987, AM SCI, V75, P366; Moura AE, 2014, CONSERV GENET, V15, P405, DOI 10.1007/s10592-013-0547-y; Nei M., 1987, MOL EVOLUTIONARY GEN; Paxinos E, 1997, MOL ECOL, V6, P483, DOI 10.1046/j.1365-294X.1997.00206.x; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Simon C., 1991, NATO ASI Series Series H Cell Biology, V57, P33; Sterndale R.A., 1884, NATURAL HIST MAMMALI; Taberlet Pierre, 1996, P125; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Zachos FE, 2009, BIOCHEM GENET, V47, P241, DOI 10.1007/s10528-009-9221-y	48	10	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138497	10.1371/journal.pone.0138497	http://dx.doi.org/10.1371/journal.pone.0138497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414163	gold, Green Published, Green Submitted			2022-12-26	WOS:000362170700017
J	Chang, CJ; Chen, NC; Lao, CK; Huang, YC				Chang, Chun-Jui; Chen, Ning-Chun; Lao, Chong-Kei; Huang, Yhu-Chering			Nasal Staphylococcus aureus and Methicillin-Resistant S. aureus Carriage among Janitors Working in Hospitals in Northern Taiwan	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; MOLECULAR EPIDEMIOLOGY; CLINICAL-FEATURES; RISK-FACTORS; COLONIZATION; CHILDREN; INFECTIONS; PREVALENCE	Background Staphylococcus aureus is an important cause of infection, and brings additional concern with methicillin resistance. In addition, nasal methicillin-resistant Staphylococcus aureus (MRSA) colonization rates among health care workers are higher than that for general population. To determine the prevalence rate and risk factors for the colonization of S. aureus, including MRSA, among janitors working in hospitals in northern Taiwan, we conducted this study. Methods Between June and August, 2014, a total of 186 janitors, 111 working in hospitals and 75 working in non-medical institutions, were recruited. Specimens were obtained from the nares of the subjects for the detection of S. aureus, with a questionnaire completed for each subject. All the S. aureus isolates, including MRSA and methicillin-susceptible S. aureus (MSSA), were further molecularly characterized. Results The nasal carriage rate of S. aureus was 15.3% for hospital janitors and 13.3% for non-medical janitors. The carriage rate of MRSA was 3.6% for hospital janitors and 1.3% for non-medical janitors. No statistically significant difference was found in the nasal carriage rate of S. aureus (p = 0.707) and MRSA (p = 0.65) between hospital janitors and non-medical janitors. Hospital janitors working in hospital more than 6 years and cleaning microbiologic laboratories were significantly associated with nasal S. aureus colonization. All 5 MRSA isolates carried either staphylococcal cassette chromosome type IV or V and three of them belonged to sequence type (ST) 59, the community clone prevailing in Taiwan. Of the 22 MSSA isolates, six pulsotypes were identified, with one major type for 14 isolates (shared by five STs) and another type for 4 isolates (all belonged to ST 188). Conclusion Exposure to the hospital environment may not increase the nasal carriage rate of S. aureus, including MRSA, among janitors in hospitals in Taiwan. However, for janitors in the hospital setting, working for more than six years in hospital and cleaning laboratories may be risks factors for carrying S. aureus.	[Chang, Chun-Jui; Chen, Ning-Chun; Lao, Chong-Kei; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp Linko, Dept Pediat, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.	ychuang@adm.cgmh.org.tw			Ministry of Science and Technology, Executive Yuan of Taiwan [NSC 102-2628-B-182A-010-MY3]; Medical Foundation in Memory of Dr. Deh-Lin Cheng	Ministry of Science and Technology, Executive Yuan of Taiwan; Medical Foundation in Memory of Dr. Deh-Lin Cheng	Funding: This work was supported by a grant from Ministry of Science and Technology, Executive Yuan of Taiwan (NSC 102-2628-B-182A-010-MY3) and partly by a grant from Medical Foundation in Memory of Dr. Deh-Lin Cheng.	da Silva ECBF, 2008, BRAZ J INFECT DIS, V12, P504, DOI 10.1590/S1413-86702008000600012; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2005, PEDIATR INFECT DIS J, V24, P276, DOI 10.1097/01.inf.0000154333.46032.0f; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082472; Huang YC, 2012, J PERINAT MED, V40, P307, DOI [10.1515/JPM.2011.114, 10.1515/jpm.2011.114]; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Institute CaLS, 2012, PERF STAND ANT DISK; Kuo CY, 2014, NEONATOLOGY, V105, P142, DOI 10.1159/000356733; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otter JA, 2012, J HOSP INFECT, V81, P143, DOI 10.1016/j.jhin.2012.04.009; Schmidlin M, 2010, J APPL MICROBIOL, V109, P1284, DOI 10.1111/j.1365-2672.2010.04749.x; Shiomori T, 2000, J ALLERGY CLIN IMMUN, V105, P449, DOI 10.1067/mai.2000.104256; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138971	10.1371/journal.pone.0138971	http://dx.doi.org/10.1371/journal.pone.0138971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407070	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700134
J	Zhang, ZJ; Pan, XY; Zhang, ZY; He, KS; Li, B				Zhang, Zhijie; Pan, Xiaoyun; Zhang, Ziyan; He, Kate S.; Li, Bo			Specialist Insect Herbivore and Light Availability Do Not Interact in the Evolution of an Invasive Plant	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; INTRODUCED POPULATIONS; PHENOTYPIC PLASTICITY; RESOURCE AVAILABILITY; SIMULATED HERBIVORY; COMPETITIVE ABILITY; BIOMASS ALLOCATION; GROWTH; TOLERANCE; RESPONSES	Release from specialist insect herbivores may allow invasive plants to evolve traits associated with decreased resistance and increased competitive ability. Given that there may be genetic trade-off between resistance and tolerance, invasive plants could also become more tolerant to herbivores. Although it is widely acknowledged that light availability affects tolerance to herbivores, little information is available for whether the effect of light availability on tolerance differ between the introduced and native populations. We conducted a common garden experiment in the introduced range of Alternanthera philoxeroides using ten invasive US and ten native Argentinean populations at two levels of light availability and in the presence or absence of a specialist stem-boring insect Agasicles hygrophila. Plant biomass (total and storage root biomass), two allocation traits (root/shoot ratio and branch intensity, branches biomass/main stem biomass) and two functional traits (specific stem length and specific leaf area), which are potentially associated with herbivore resistance and light capture, were measured. Overall, we found that A. philoxeroides from introduced ranges had comparable biomass and tolerance to specialist herbivores, lower branch intensity, lower specific stem length and specific leaf area. Moreover, introduced populations displayed higher shade tolerance of storage root biomass and lower plastic response to shading in specific stem length. Finally, light availability had no significant effect on evolution of tolerance to specialist herbivores of A. philoxeroides. Our results suggest that post-introduction evolution might have occurred in A. philoxeroides. While light availability did not influence the evolution of tolerance to specialist herbivores, increased shade tolerance and release from specialist insects might have contributed to the successful invasion of A. philoxeroides.	[Zhang, Zhijie; Pan, Xiaoyun; Zhang, Ziyan; Li, Bo] Fudan Univ, Inst Biodivers Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [He, Kate S.] Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA	Fudan University; Murray State University	Pan, XY (corresponding author), Fudan Univ, Inst Biodivers Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	xypan@fudan.edu.cn	Li, Bo/AAA-8968-2020; Li, Bo/B-8016-2010; Zhang, Zhijie/S-9662-2019	Li, Bo/0000-0002-7294-6888; Li, Bo/0000-0002-0439-5666; Zhang, Zhijie/0000-0003-0463-2665	National Natural Science Foundation of China [31070369, 31370433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (Grant Nos. 31070369, 31370433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWARD RD, 1993, OECOLOGIA, V95, P358, DOI 10.1007/BF00320989; Aphalo PJ, 1999, J EXP BOT, V50, P1629, DOI 10.1093/jexbot/50.340.1629; Atwood J. P., 2011, NeoBiota, P7, DOI 10.3897/neobiota.10.954; Bergman M, 2002, OIKOS, V96, P164, DOI 10.1034/j.1600-0706.2002.960118.x; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blumenthal D, 2005, SCIENCE, V310, P243, DOI 10.1126/science.1114851; Bossdorf O, 2004, ECOL LETT, V7, P346, DOI 10.1111/j.1461-0248.2004.00583.x; Bossdorf O, 2004, AM J BOT, V91, P856, DOI 10.3732/ajb.91.6.856; Buckingham Gary R., 1996, Castanea, V61, P232; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWalt SJ, 2004, OECOLOGIA, V138, P521, DOI 10.1007/s00442-003-1462-6; Flory SL, 2011, ECOLOGY, V92, P2248, DOI 10.1890/11-0363.1; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Geng XuYan, 2013, American Journal of Plant Sciences, V4, P1839, DOI 10.4236/ajps.2013.49226; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Huang W, 2012, ECOLOGY, V93, P2343, DOI 10.1890/11-1964.1; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Jia X, 2009, BIOL INVASIONS, V11, P743, DOI 10.1007/s10530-008-9288-0; LONGSTRETH DJ, 1984, BOT GAZ, V145, P105, DOI 10.1086/337432; Ma RY, 2001, ECOLOGIEAL ADATATION; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MADDOX DM, 1971, BIOSCIENCE, V21, P985, DOI 10.2307/1296135; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; Matlaga DP, 2012, INVAS PLANT SCI MANA, V5, P363, DOI 10.1614/IPSM-D-11-00056.1; Meyer GA, 2008, BIOL INVASIONS, V10, P303, DOI 10.1007/s10530-007-9131-z; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; Pan XY, 2013, J SYST EVOL, V51, P308, DOI 10.1111/j.1759-6831.2012.00239.x; Pan XY, 2013, J SYST EVOL, V51, P318, DOI 10.1111/jse.12001; Pan XY, 2012, BIOL INVASIONS, V14, P1, DOI 10.1007/s10530-011-9941-x; Pearcy RW, 2005, NEW PHYTOL, V166, P791, DOI 10.1111/j.1469-8137.2005.01328.x; Pigliucci M., 2001, SYN ECO EVO; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Reed C. F., 1970, USDA HDB, V366; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rogers WE, 2002, BASIC APPL ECOL, V3, P297, DOI 10.1078/1439-1791-00120; Salgado-Luarte C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011460; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; Sosa A, 2004, P 11 INT S BIOL CONT; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Stewart CA, 1999, NEW ZEAL J ZOOL, V26, P191, DOI 10.1080/03014223.1999.9518189; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Vogt G. B., 1979, PROBABLE EVOLUTION M; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zhang DY, 2006, J THEOR BIOL, V242, P935, DOI 10.1016/j.jtbi.2006.05.016; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x; Zou JW, 2009, BASIC APPL ECOL, V10, P79, DOI 10.1016/j.baae.2007.11.010	55	5	6	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139234	10.1371/journal.pone.0139234	http://dx.doi.org/10.1371/journal.pone.0139234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407176	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700195
J	Demain, B; Davoust, C; Plas, B; Bolan, F; Boulanouar, K; Renaud, L; Darmana, R; Vaysse, L; Vieu, C; Loubinoux, I				Demain, Boris; Davoust, Carole; Plas, Benjamin; Bolan, Faye; Boulanouar, Kader; Renaud, Luc; Darmana, Robert; Vaysse, Laurence; Vieu, Christophe; Loubinoux, Isabelle			Corticospinal Tract Tracing in the Marmoset with a Clinical Whole-Body 3T Scanner Using Manganese-Enhanced MRI	PLOS ONE			English	Article							CIRCUITS IN-VIVO; BRAIN PLASTICITY; COMMON MARMOSET; VISUAL PATHWAY; CONNECTIVITY; TRANSPORT; STROKE; PROJECTIONS; RECOVERY; CORTEX	Manganese-enhanced MRI (MEMRI) has been described as a powerful tool to depict the architecture of neuronal circuits. In this study we investigated the potential use of in vivo MRI detection of manganese for tracing neuronal projections from the primary motor cortex (M1) in healthy marmosets (Callithrix Jacchus). We determined the optimal dose of manganese chloride (MnCl2) among 800, 400, 40 and 8nmol that led to manganese-induced hyperintensity furthest from the injection site, as specific to the corticospinal tract as possible, and that would not induce motor deficit. A commonly available 3T human clinical MRI scanner and human knee coil were used to follow hyperintensity in the corticospinal tract 24h after injection. A statistical parametric map of seven marmosets injected with the chosen dose, 8 nmol, showed the corticospinal tract and M1 connectivity with the basal ganglia, substantia nigra and thalamus. Safety was determined for the lowest dose that did not induce dexterity and grip strength deficit, and no behavioral effects could be seen in marmosets who received multiple injections of manganese one month apart. In conclusion, our study shows for the first time in marmosets, a reliable and reproducible way to perform longitudinal ME-MRI experiments to observe the integrity of the marmoset corticospinal tract on a clinical 3T MRI scanner.	[Demain, Boris; Davoust, Carole; Plas, Benjamin; Bolan, Faye; Boulanouar, Kader; Darmana, Robert; Vaysse, Laurence; Loubinoux, Isabelle] INSERM, UMR 825, Imagerie Cerebrale & Handicaps Neurol, F-31024 Toulouse, France; [Demain, Boris; Davoust, Carole; Plas, Benjamin; Bolan, Faye; Boulanouar, Kader; Darmana, Robert; Vaysse, Laurence; Loubinoux, Isabelle] Univ Toulouse, UPS, CHU Purpan, UMR 825,Imagerie Cerebrale & Handicaps Neurol, F-31059 Toulouse 9, France; [Demain, Boris; Vieu, Christophe] CNRS LAAS, F-31077 Toulouse, France; [Plas, Benjamin] Ctr Hosp Univ Toulouse, Pole Neurosci, Toulouse, France; [Renaud, Luc] CNRS, Ctr Rech Cerveau & Cognit, UMR 5549, F-31024 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Loubinoux, I (corresponding author), INSERM, UMR 825, Imagerie Cerebrale & Handicaps Neurol, F-31024 Toulouse, France.	isabelle.loubinoux@inserm.fr	Loubinoux, Isabelle/E-5537-2016	Loubinoux, Isabelle/0000-0003-4461-0890; Vaysse, Laurence/0000-0001-6371-9360; Bolan, Faye/0000-0003-4182-544X; Helene, Gros-Dagnac/0000-0002-3758-6231	Fondation Avenir [ET3-713]; Institut de France [R13098BB]; Institut des Sciences du Cerveau de Toulouse; Midi-Pyrenees Region; COMUE [RA12P0110]	Fondation Avenir; Institut de France; Institut des Sciences du Cerveau de Toulouse; Midi-Pyrenees Region(Region Occitanie); COMUE	The investigations were supported by grants from Fondation Avenir noET3-713, Institut de France noR13098BB and Institut des Sciences du Cerveau de Toulouse. BD was supported by a doctoral fellowship Midi-Pyrenees Region and COMUE no RA12P0110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrini PR, 2003, NMR BIOMED, V16, P252, DOI 10.1002/nbm.834; Bilgen M, 2006, J NEUROSCI METH, V156, P17, DOI 10.1016/j.jneumeth.2006.02.001; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Bock NA, 2008, BRAIN RES, V1198, P160, DOI 10.1016/j.brainres.2007.12.065; Bock NA, 2009, NMR BIOMED, V22, P730, DOI 10.1002/nbm.1384; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; Cross DJ, 2004, NEUROIMAGE, V23, P1326, DOI 10.1016/j.neuroimage.2004.07.038; Daoust A, 2014, NEUROIMAGE, V96, P133, DOI 10.1016/j.neuroimage.2014.03.071; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Gobbo OL, 2012, MAGN RESON MED, V68, P234, DOI 10.1002/mrm.23210; Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061; Lee JW, 2007, MAGN RESON IMAGING, V25, P652, DOI 10.1016/j.mri.2006.10.003; Lee JS, 2005, NEUROIMAGE, V26, P771, DOI 10.1016/j.neuroimage.2005.02.036; Leergaard T, 2003, NEUROIMAGE; Lemon RN, 1999, EXP BRAIN RES, V128, P6, DOI 10.1007/s002210050811; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Matsuda K, 2010, NEUROIMAGE, V50, P366, DOI 10.1016/j.neuroimage.2010.01.008; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Murayama Y, 2006, MAGN RESON IMAGING, V24, P349, DOI 10.1016/j.mri.2005.12.031; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Pautler RG, 2004, NMR BIOMED, V17, P595, DOI 10.1002/nbm.942; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pautler Robia G, 2006, Methods Mol Med, V124, P365; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Simmons JM, 2008, J NEUROSCI, V28, P7637, DOI 10.1523/JNEUROSCI.1488-08.2008; SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8; Soria G, 2008, NEUROIMAGE, V41, P668, DOI 10.1016/j.neuroimage.2008.03.018; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Thuen M, 2005, J MAGN RESON IMAGING, V22, P492, DOI 10.1002/jmri.20400; Tucciarone J, 2009, NEUROIMAGE, V44, P923, DOI 10.1016/j.neuroimage.2008.07.036; Van der Linden A, 2002, NEUROSCIENCE, V112, P467, DOI 10.1016/S0306-4522(02)00070-2; Van der Linden A, 2004, NMR BIOMED, V17, P602, DOI 10.1002/nbm.936; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van der Zijden JP, 2008, J CEREBR BLOOD F MET, V28, P832, DOI 10.1038/sj.jcbfm.9600576; van der Zijden JP, 2007, NEUROIMAGE, V34, P1650, DOI 10.1016/j.neuroimage.2006.11.001; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; Watanabe T, 2001, MAGNET RESON MED, V46, P424, DOI 10.1002/mrm.1209; Watanabe T, 2002, MAGN RESON MED, V48, P852, DOI 10.1002/mrm.10276; Yamada M, 2008, RADIOLOGY, V249, P855, DOI 10.1148/radiol.2493072141; Yuasa S., 2010, STEREOTAXIC ATLAS MA	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138308	10.1371/journal.pone.0138308	http://dx.doi.org/10.1371/journal.pone.0138308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398500	gold, Green Published			2022-12-26	WOS:000361797500058
J	Martinez, R; Blasina, A; Hallin, JF; Hu, WY; Rymer, I; Fan, J; Hoffman, RL; Murphy, S; Marx, M; Yanochko, G; Trajkovic, D; Dinh, D; Timofeevski, S; Zhu, Z; Sun, PQ; Lappin, PB; Murray, BW				Martinez, Ricardo; Blasina, Alessandra; Hallin, Jill F.; Hu, Wenyue; Rymer, Isha; Fan, Jeffery; Hoffman, Robert L.; Murphy, Sean; Marx, Matthew; Yanochko, Gina; Trajkovic, Dusko; Dinh, Dac; Timofeevski, Sergei; Zhu, Zhou; Sun, Peiquing; Lappin, Patrick B.; Murray, Brion W.			Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; BREAST-CANCER; CHROMOSOMAL INSTABILITY; CDK4/6 INHIBITION; MICROTUBULES; KINETOCHORES; MECHANISMS; ANEUPLOIDY; EVOLUTION; DISCOVERY	Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is well-tolerated. A critical cell cycle process that could be targeted is the mitotic checkpoint (spindle assembly checkpoint) which governs the metaphase-to-anaphase transition and insures proper chromosomal segregation. The mitotic checkpoint kinase Mps1 was selected to explore whether enhancement in genomic instability is a viable therapeutic strategy. The basal-a subset of triple-negative breast cancer was chosen as a model system because it has a higher incidence of chromosomal instability and Mps1 expression is up-regulated. Depletion of Mps1 reduces tumor cell viability relative to normal cells. Highly selective, extremely potent Mps1 kinase inhibitors were created to investigate the roles of Mps1 catalytic activity in tumor cells and normal physiology (PF-7006, PF-3837; K-i<0.5 nM; cellular IC50 2-6 nM). Treatment of tumor cells in vitro with PF-7006 modulates expected Mps1-dependent biology as demonstrated by molecular and phenotypic measures (reduced pHH3-Ser(10) levels, shorter duration of mitosis, micro-nucleation, and apoptosis). Tumor-bearing mice treated with PF-7006 exhibit tumor growth inhibition concomitant with pharmacodynamic modulation of a downstream biomarker (pHH3-Ser(10)). Unfortunately, efficacy only occurs at drug exposures that cause dose-limiting body weight loss, gastrointestinal toxicities, and neutropenia. Mps1 inhibitor toxicities may be mitigated by inducing G(1) cell cycle arrest in Rb1-competent cells with the cyclin-dependent kinase-4/6 inhibitor palbociclib. Using an isogenic cellular model system, PF-7006 is shown to be selectively cytotoxic to Rb1-deficient cells relative to Rb1-competent cells (also a measure of kinase selectivity). Human bone marrow cells pretreated with palbociclib have decreased PF-7006-dependent apoptosis relative to cells without palbociclib pretreatment. Collectively, this study raises a concern that single agent therapies inhibiting Mps1 will not be well-tolerated clinically but may be when combined with a selective CDK4/6 drug.	[Martinez, Ricardo; Blasina, Alessandra; Hallin, Jill F.; Rymer, Isha; Fan, Jeffery; Murphy, Sean; Dinh, Dac; Timofeevski, Sergei; Zhu, Zhou; Murray, Brion W.] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA; [Hoffman, Robert L.; Marx, Matthew] Pfizer Worldwide Res & Dev, Worldwide Med Chem, San Diego, CA 92121 USA; [Hu, Wenyue; Yanochko, Gina; Trajkovic, Dusko; Lappin, Patrick B.] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, San Diego, CA 92121 USA; [Sun, Peiquing] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Pfizer; Pfizer; Pfizer; Scripps Research Institute	Murray, BW (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res Unit, 10724 Sci Ctr Dr, San Diego, CA 92121 USA.	brion.murray@pfizer.com		Marx, Matthew/0000-0003-2351-4787; Yanochko-Hoffman, Gina/0000-0001-5769-9797	Pfizer Inc.; National Institutes of Health [CA131231, CA172115, CA106768]; NATIONAL CANCER INSTITUTE [R01CA106768, R01CA131231, R01CA172115] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funder (Pfizer Inc.) provided support in the form of salaries for authors [RM, AB, JFH, WH, IR, JF, RLH, SM, MM, GY, DT, DD, ST, ZZ, PL, BWM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Peiquing Sun is on faculty of The Scripps Research Institute and is supported by the National Institutes of Health (CA131231, CA172115 and CA106768).	Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.14; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jemaa M, 2012, EMBO MOL MED, V4, P500, DOI 10.1002/emmm.201200228; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kondoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080349; Kumar DV, 2012, BIOORG MED CHEM LETT, V22, P4377, DOI 10.1016/j.bmcl.2012.04.131; Kung PP, 2014, MOL CANCER THER, V13, P2104, DOI 10.1158/1535-7163.MCT-14-0083-T; Kusakabe K, 2015, J MED CHEM, V58, P1760, DOI 10.1021/jm501599u; Kusakabe K, 2013, J MED CHEM, V56, P4343, DOI 10.1021/jm4000215; Kusakabe K, 2012, ACS MED CHEM LETT, V3, P560, DOI 10.1021/ml3000879; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Laufer R, 2014, BIOORGAN MED CHEM, V22, P4968, DOI 10.1016/j.bmc.2014.06.027; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; McClendon AK, 2012, CELL CYCLE, V11, P2747, DOI 10.4161/cc.21127; Migliaccio I, 2014, CURR OPIN ONCOL, V26, P568, DOI 10.1097/CCO.0000000000000129; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Murphy CG, 2015, ONCOLOGIST, V20, P483, DOI 10.1634/theoncologist.2014-0443; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Rocca A, 2014, EXPERT OPIN PHARMACO, V15, P407, DOI 10.1517/14656566.2014.870555; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Slee RB, 2014, MOL CANCER THER, V13, P307, DOI 10.1158/1535-7163.MCT-13-0324; Tannous BA, 2013, JNCI-J NATL CANCER I, V105, P1322, DOI 10.1093/jnci/djt168; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; von Schubert C, 2015, CELL REP, V12, P66, DOI 10.1016/j.celrep.2015.06.007; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104723; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Zhou T, 2002, P NATL ACAD SCI USA, V99, P2049, DOI 10.1073/pnas.261714399	48	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138616	10.1371/journal.pone.0138616	http://dx.doi.org/10.1371/journal.pone.0138616			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398286	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500084
J	Garrone, A; Archipowa, N; Zipfel, PF; Hermann, G; Dietzek, B				Garrone, Alessio; Archipowa, Nataliya; Zipfel, Peter F.; Hermann, Gudrun; Dietzek, Benjamin			Plant Protochlorophyllide Oxidoreductases A and B CATALYTIC EFFICIENCY AND INITIAL REACTION STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITED-STATE DYNAMICS; CHLOROPHYLL BIOSYNTHESIS; LIGHT; NADPH; COMPLEX; PROTEIN; BARLEY; IDENTIFICATION; PURIFICATION; PORA	The enzyme protochlorophyllide oxidoreductase (POR, EC 1.3.1.33) has a key role in plant development. It catalyzes one of the later steps in chlorophyll synthesis, the light-induced reduction of protochlorophyllide (PChlide) into chlorophyllide (Chlide) in the presence of NADPH. Two isozymes of plant POR, POR A and POR B from barley, which differ in their function during plant life, are compared with respect to their substrate binding affinity, catalytic efficiency, and catalytic mechanism. POR B as compared with POR A shows an 5-fold higher binding affinity for PChlide and an about 6-fold higher catalytic efficiency measured as k(cat)/K-m. Based on the reaction intermediates, which can be trapped at low temperatures the same reaction mechanism operates in both POR A and POR B. In contrast to results reported for POR enzymes from cyanobacteria, the initial light-driven step, which occurs at temperatures below 180 K already involves the full chemistry of the photoreduction and yields the reaction product, Chlide, in an enzyme-bound form. The subsequent dark reactions, which include cofactor (NADP(+)) release and cofactor(NADPH) rebinding, show different temperature dependences for PORA and PORB and suggest a higher conformational flexibility of POR B in the surrounding active center. Both the higher substrate binding affinity and well adapted enzyme dynamics are held responsible for the increased catalytic activity of POR B as compared with POR A.	[Garrone, Alessio; Archipowa, Nataliya; Hermann, Gudrun; Dietzek, Benjamin] Leibniz Inst Nat Prod Res & Infect Biol, Dept Biochem & Biophys, D-07743 Jena, Germany; [Garrone, Alessio; Archipowa, Nataliya; Hermann, Gudrun; Dietzek, Benjamin] Leibniz Inst Nat Prod Res & Infect Biol, Dept Phys Chem, D-07743 Jena, Germany; [Garrone, Alessio; Dietzek, Benjamin] Leibniz Inst Nat Prod Res & Infect Biol, Leibniz Inst Photon Technol, D-07743 Jena, Germany; [Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07743 Jena, Germany; [Zipfel, Peter F.; Hermann, Gudrun] Univ Jena, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Leibniz Institut fur Photonische Technologien; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Hermann, G (corresponding author), Univ Jena, Inst Biochem & Biophys, Philosophenweg 12, D-07743 Jena, Germany.	Gudrun.Hermann@uni-jena.de			Deutsche Forschungsgemeinschaft, Jena School for Microbial Communication (JSMC)	Deutsche Forschungsgemeinschaft, Jena School for Microbial Communication (JSMC)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft, Jena School for Microbial Communication (JSMC) (to A. G., G. H., and B. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; BAKER ME, 1994, BIOCHEM J, V300, P605; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Buhr F, 2008, P NATL ACAD SCI USA, V105, P12629, DOI 10.1073/pnas.0803950105; Colindres-Rojas M, 2011, BIOPHYS J, V100, P260, DOI 10.1016/j.bpj.2010.11.054; Dietzek B, 2009, CHEMPHYSCHEM, V10, P144, DOI 10.1002/cphc.200800536; Gabruk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116990; Hanf R, 2012, CHEMPHYSCHEM, V13, P2013, DOI 10.1002/cphc.201200194; Hanf R, 2011, J PHYS CHEM A, V115, P7873, DOI 10.1021/jp2035899; Heyes DJ, 2008, BIOCHEMISTRY-US, V47, P10991, DOI 10.1021/bi801521c; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2000, FEBS LETT, V483, P47, DOI 10.1016/S0014-5793(00)02081-0; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Holtorf H, 1996, PLANT MOL BIOL, V31, P387, DOI 10.1007/BF00021799; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Martin GEM, 1997, BIOCHEM J, V325, P139, DOI 10.1042/bj3250139; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Pattanayak GK, 2002, BIOCHEM BIOPH RES CO, V291, P921, DOI 10.1006/bbrc.2002.6543; Reinbothe C, 2003, J BIOL CHEM, V278, P807, DOI 10.1074/jbc.M209738200; Reinbothe C, 1997, P NATL ACAD SCI USA, V94, P8890, DOI 10.1073/pnas.94.16.8890; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; REINBOTHE S, 1995, PLANT CELL, V7, P161, DOI 10.1105/tpc.7.2.161; REINBOTHE S, 1995, PLANT CELL, V7, P1933, DOI 10.1105/tpc.7.11.1933; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; REINBOTHE S, 1995, J CELL BIOL, V129, P299, DOI 10.1083/jcb.129.2.299; Scrutton NS, 2012, PHYS CHEM CHEM PHYS, V14, P8818, DOI 10.1039/c2cp23789j; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; Sytina OA, 2010, J PHYS CHEM B, V114, P4335, DOI 10.1021/jp9089326; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang J, 2004, PLANT BIOLOGY, V6, P537, DOI 10.1055/s-2004-821270; Yin L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0262; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Yuan M, 2012, J PLANT PHYSIOL, V169, P1311, DOI 10.1016/j.jplph.2012.05.010	45	20	20	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28530	28539		10.1074/jbc.M115.663161	http://dx.doi.org/10.1074/jbc.M115.663161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26408201	hybrid, Green Published			2022-12-26	WOS:000365761900045
J	Anashkin, VA; Salminen, A; Tuominen, HK; Orlov, VN; Lahti, R; Baykov, AA				Anashkin, Viktor A.; Salminen, Anu; Tuominen, Heidi K.; Orlov, Victor N.; Lahti, Reijo; Baykov, Alexander A.			Cystathionine beta-Synthase (CBS) Domain-containing Pyrophosphatase as a Target for Diadenosine Polyphosphates in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-SYNTHESIS; ESCHERICHIA-COLI; HEAT-SHOCK; BINDING; 5',5'''-P-1,P-4-TETRAPHOSPHATE; PROTEINS; APPPPA; TRIPHOSPHATE; KINETICS; STRESS	Among numerous proteins containing pairs of regulatory cystathionine beta-synthase (CBS) domains, family II pyrophosphatases (CBS-PPases) are unique in that they generally contain an additional DRTGG domain between the CBS domains. Adenine nucleotides bind to the CBS domains in CBS-PPases in a positively cooperative manner, resulting in enzyme inhibition (AMP or ADP) or activation (ATP). Here we show that linear P-1,P-n-diadenosine 5'-polyphosphates (Ap(n)As, where n is the number of phosphate residues) bind with nanomolar affinity to DRTGG domain-containing CBS-PPases of Desulfitobacterium hafniense, Clostridium novyi, and Clostridium perfringens and increase their activity up to 30-, 5-, and 7-fold, respectively. Ap(4)A, Ap(5)A, and Ap(6)A bound noncooperatively and with similarly high affinities to CBS-PPases, whereas Ap(3)A bound in a positively cooperative manner and with lower affinity, like mononucleotides. All Ap(n)As abolished kinetic cooperativity (non-Michaelian behavior) of CBS-PPases. The enthalpy change and binding stoichiometry, as determined by isothermal calorimetry, were similar to 10 kcal/mol nucleotide and 1 mol/mol enzyme dimer for Ap(4)A and Ap(5)A but 5.5 kcal/mol and 2 mol/mol for Ap(3)A, AMP, ADP, and ATP, suggesting different binding modes for the two nucleotide groups. In contrast, Eggerthella lenta and Moorella thermoacetica CBS-PPases, which contain noDRTGG domain, were not affected by Ap(n)As and showed no enthalpy change, indicating the importance of the DTRGG domain for Ap(n)A binding. These findings suggest that Ap(n)As can control CBS-PPase activity and hence affect pyrophosphate level and biosynthetic activity in bacteria.	[Anashkin, Viktor A.; Salminen, Anu; Tuominen, Heidi K.; Lahti, Reijo] Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; [Anashkin, Viktor A.; Orlov, Victor N.; Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys Chem Biol, Moscow 119899, Russia; [Anashkin, Viktor A.; Orlov, Victor N.; Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University; Lomonosov Moscow State University	Lahti, R (corresponding author), Univ Turku, Dept Biochem, Vatselankatu 2, FIN-20014 Turku, Finland.	reijo.lahti@utu.fi; baykov@genebee.msu.su	Tuominen, Heidi/A-7075-2010; Anashkin, Viktor/C-1893-2014; Орлов, Виктор/AAH-3795-2019; Baykov, Alexander/AAH-5301-2021; Baykov, Alexander A/C-7981-2012	Tuominen, Heidi/0000-0003-2412-7658; Орлов, Виктор/0000-0001-5641-864X; Anashkin, Victor/0000-0002-9890-6796; Baykov, Alexander/0000-0002-2495-8200	Academy of Finland [139031]; Russian Foundation for Basic Research [12-04-01002, 15-04-04828]	Academy of Finland(Academy of Finland); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Academy of Finland Grant 139031 and Russian Foundation for Basic Research Grants 12-04-01002 and 15-04-04828. The authors declare that they have no conflicts of interest with the contents of this article.	Aguado-Llera D, 2010, FEBS LETT, V584, P4485, DOI 10.1016/j.febslet.2010.10.006; Azhar MA, 2014, BIOORG MED CHEM LETT, V24, P2928, DOI 10.1016/j.bmcl.2014.04.076; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bisswanger H., 2008, ENZYME KINETICS PRIN, P14; BOCHNER BR, 1986, J BACTERIOL, V168, P931, DOI 10.1128/jb.168.2.931-935.1986; Conant AR, 2008, VASC PHARMACOL, V48, P157, DOI 10.1016/j.vph.2008.01.005; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fraga H, 2011, BBA-GEN SUBJECTS, V1810, P1195, DOI 10.1016/j.bbagen.2011.09.010; Garrison PN, 1992, AP4A OTHER DINUCLEOS, P29; Giraldez L, 2001, J NEUROSCI RES, V64, P174, DOI 10.1002/jnr.1063; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; Gomez-Villafuertes R, 2004, J PHARMACOL EXP THER, V308, P1148, DOI 10.1124/jpet.103.061564; Guo W, 2011, BIOORG MED CHEM LETT, V21, P7175, DOI 10.1016/j.bmcl.2011.09.070; Guranowski A, 2000, PHARMACOL THERAPEUT, V87, P117, DOI 10.1016/S0163-7258(00)00046-2; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Heinonen J.K., 2001, BIOL ROLE INORGANIC, P123, DOI [10.1007/978-1-4615-1433-6_5, DOI 10.1007/978-1-4615-1433-6_5]; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jamsen J, 2012, BIOCHEMISTRY-MOSCOW+, V77, P165, DOI 10.1134/S0006297912020071; Jamsen J, 2007, BIOCHEM J, V408, P327, DOI 10.1042/BJ20071017; Jiang YL, 2011, J BIOL CHEM, V286, P35906, DOI 10.1074/jbc.M111.228585; JOHNSTONE DB, 1991, EMBO J, V10, P3897, DOI 10.1002/j.1460-2075.1991.tb04959.x; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; Marques AFP, 1998, J NEUROCHEM, V71, P1241; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Nishimura A, 1997, GENES CELLS, V2, P401, DOI 10.1046/j.1365-2443.1997.1300328.x; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; PLATEAU P, 1994, ADV MICROB PHYSIOL, V36, P81, DOI 10.1016/S0065-2911(08)60177-0; REISS JR, 1965, J ORG CHEM, V30, P3381, DOI 10.1021/jo01021a029; Salminen A, 2014, J BIOL CHEM, V289, P22865, DOI 10.1074/jbc.M114.589473; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sillero MAG, 2002, EUR J BIOCHEM, V269, P5323, DOI 10.1046/j.1432-1033.2002.03253.x; Tanner JA, 2006, BIOCHEMISTRY-US, V45, P3095, DOI 10.1021/bi052529k; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Tshori S., 2013, TOP CURR CHEM, V344, P10; Tuominen H, 2010, J MOL BIOL, V398, P400, DOI 10.1016/j.jmb.2010.03.019; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; Vartanian AA, 2003, BIOCHEM PHARMACOL, V65, P227, DOI 10.1016/S0006-2952(02)01481-8; Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3	44	15	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27594	27603		10.1074/jbc.M115.680272	http://dx.doi.org/10.1074/jbc.M115.680272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26400082	Green Published, hybrid			2022-12-26	WOS:000365757500015
J	Morou-Bermudez, E; Rodriguez, S; Bello, AS; Dominguez-Bello, MG				Morou-Bermudez, Evangelia; Rodriguez, Selena; Bello, Angel S.; Dominguez-Bello, Maria G.			Urease and Dental Plaque Microbial Profiles in Children	PLOS ONE			English	Article							STREPTOCOCCUS-SALIVARIUS UREASE; ORAL BACTERIA; CARIES; 3-YEAR; PERIOD; QIIME	Objective Urease enzymes produced by oral bacteria generate ammonia, which can have a significant impact on the oral ecology and, consequently, on oral health. To evaluate the relationship of urease with dental plaque microbial profiles in children as it relates to dental caries, and to identify the main contributors to this activity. Methods 82 supragingival plaque samples were collected from 44 children at baseline and one year later, as part of a longitudinal study on urease and caries in children. DNA was extracted; the V3-V5 region of the 16S rRNA gene was amplified and sequenced using 454 pyrosequencing. Urease activity was measured using a spectrophotometric assay. Data were analyzed with Qiime. Results Plaque urease activity was significantly associated with the composition of the microbial communities of the dental plaque (Baseline P = 0.027, One Year P = 0.012). The bacterial taxa whose proportion in dental plaque exhibited significant variation by plaque urease levels in both visits were the family Pasteurellaceae (Baseline P<0.001; One Year P = 0.0148), especially Haemophilus parainfluenzae. No association was observed between these bacteria and dental caries. Bacteria in the genus Leptotrichia were negatively associated with urease and positively associated with dental caries (Bonferroni P<0.001). Conclusions Alkali production by urease enzymes primarily from species in the family Pasteurellaceae can be an important ecological determinant in children's dental plaque. Further studies are needed to establish the role of urease-associated bacteria in the acid/base homeostasis of the dental plaque, and in the development and prediction of dental caries in children.	[Morou-Bermudez, Evangelia; Bello, Angel S.] Univ Puerto Rico, Sch Dent Med, San Juan, PR 00936 USA; [Rodriguez, Selena] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Dominguez-Bello, Maria G.] NYU, Sch Med, New York, NY USA; [Dominguez-Bello, Maria G.] Univ Puerto Rico, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; New York University; University of Puerto Rico	Morou-Bermudez, E (corresponding author), Univ Puerto Rico, Sch Dent Med, Med Sci Campus, San Juan, PR 00936 USA.	evangelia.morou@upr.edu			National Institute for Dental and Craniofacial Research [K23 DE015285]; National Institute On Minority Health And Health Disparities of the National Institutes of Health [2U54MD007587]; RCMI grant [G12 MD007600]; NSF [MRI-R2-0959864]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103475]; Molecular Science Research Center of the UPR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE015285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600, U54MD007587] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Minority Health And Health Disparities of the National Institutes of Health; RCMI grant; NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Molecular Science Research Center of the UPR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by K23 DE015285 (PI: Morou-Bermudez, Evangelia) from the National Institute for Dental and Craniofacial Research, by 2U54MD007587 from the National Institute On Minority Health And Health Disparities of the National Institutes of Health (PI: Cruz, M and Luciano C), and by RCMI grant #G12 MD007600 (PI: Emma Fernandez-Repollet). Data generation for this publication was performed at the Sequencing and Genomics Facility (SGF) of the University of Puerto Rico. Data was generated from equipment financially supported by an NSF MRI-R2-0959864. SGF is supported in part by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health, P20 GM103475, and the Molecular Science Research Center of the UPR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YYM, 1996, FEMS MICROBIOL LETT, V135, P223, DOI 10.1016/0378-1097(95)00454-8; Chen YYM, 1998, J BACTERIOL, V180, P5769, DOI 10.1128/JB.180.21.5769-5775.1998; Chen YYM, 2000, J BACTERIOL, V182, P4667, DOI 10.1128/JB.182.16.4667-4669.2000; Cortes DF, 2003, CARIES RES, V37, P8, DOI 10.1159/000068230; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Faith DP, 2006, EVOL BIOINFORM, V2, P277; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Kianoush N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092940; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; KOPSTEIN J, 1977, CLIN SCI MOL MED, V52, P9, DOI 10.1042/cs0520009; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Morou-Bermudez E, 2011, ARCH ORAL BIOL, V56, P1560, DOI 10.1016/j.archoralbio.2011.06.017; Morou-Bermudez E, 2011, ARCH ORAL BIOL, V56, P1282, DOI 10.1016/j.archoralbio.2011.04.015; Morou-Bermudez E, 1999, INFECT IMMUN, V67, P504, DOI 10.1128/IAI.67.2.504-512.1999; Nascimento MM, 2009, ORAL MICROBIOL IMMUN, V24, P89, DOI 10.1111/j.1399-302X.2008.00477.x; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; SALAKO NO, 1989, ARCH ORAL BIOL, V34, P787, DOI 10.1016/0003-9969(89)90029-0; Shu M, 2007, ORAL MICROBIOL IMMUN, V22, P61, DOI 10.1111/j.1399-302X.2007.00325.x; Shu M, 2003, INFECT IMMUN, V71, P7188, DOI 10.1128/IAI.71.12.7188-7192.2003; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; SISSONS CH, 1988, ARCH ORAL BIOL, V33, P727, DOI 10.1016/0003-9969(88)90006-4; Thompson J, 2012, MOL ORAL MICROBIOL, V27, P34, DOI 10.1111/j.2041-1014.2011.00627.x	28	16	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139315	10.1371/journal.pone.0139315	http://dx.doi.org/10.1371/journal.pone.0139315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418220	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400075
J	Ziperstein, MJ; Guzman, A; Kaufman, LJ				Ziperstein, Michelle J.; Guzman, Asja; Kaufman, Laura J.			Breast Cancer Cell Line Aggregate Morphology Does Not Predict Invasive Capacity	PLOS ONE			English	Article							GENE-EXPRESSION; EXTRACELLULAR-MATRIX; 3-DIMENSIONAL CULTURE; EPITHELIAL-CELLS; MIGRATION; COLLAGEN; TUMORS; MODELS; 3D; REORGANIZATION	To invade and metastasize to distant loci, breast cancer cells must breach the layer of basement membrane surrounding the tumor and then invade through the dense collagen I-rich extracellular environment of breast tissue. Previous studies have shown that breast cancer cell aggregate morphology in basement membrane extract correlated with cell invasive capacity in some contexts. Moreover, cell lines from the same aggregate morphological class exhibited similarities in gene expression patterns. To further assess the capacity of cell and aggregate morphology to predict invasive capacity in physiologically relevant environments, six cell lines with varied cell aggregate morphologies were assessed in a variety of assays including a 3D multicellular invasion assay that recapitulates cell-cell and cell-environment contacts as they exist in vivo in the context of the primary breast tumor. Migratory and invasive capacities as measured through a 2D gap assay and a 3D spheroid invasion assay reveal that breast cancer cell aggregate morphology alone is insufficient to predict migratory speed in 2D or invasive capacity in 3D. Correlations between the 3D spheroid invasion assay and gene expression profiles suggest this assay as an inexpensive functional method to predict breast cancer invasive capacity.	[Ziperstein, Michelle J.; Guzman, Asja; Kaufman, Laura J.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Kaufman, LJ (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	kaufman@chem.columbia.edu	Kaufman, Laura/ABC-7682-2021	Kaufman, Laura/0000-0002-3754-0831	National Science Foundation; National Institutes of Health [PESO 1227297]; Columbia University	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University	This work was supported by the National Science Foundation and the National Institutes of Health (http://www.nsf.gov/pubs/2012/nsf12514/nsf12514.htm) via PESO 1227297 to LJK. Additional funding provided by Columbia University through support of graduate student teaching assistants (MJZ) and through discretionary funds for LJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Boyd NF, 2011, BREAST CANCER RES, V13, P12; Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707; Calvo V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3359; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gehler S, 2013, CRIT REV EUKAR GENE, V23, P139, DOI 10.1615/CritRevEukarGeneExpr.2013006647; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kraning-Rush CM, 2013, INTEGR BIOL-UK, V5, P606, DOI 10.1039/c3ib20196a; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Liu Y, 2014, BRIT J CANCER, V110, P2063, DOI 10.1038/bjc.2014.105; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Shi QM, 2014, P NATL ACAD SCI USA, V111, P658, DOI 10.1073/pnas.1311312110; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6	51	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139523	10.1371/journal.pone.0139523	http://dx.doi.org/10.1371/journal.pone.0139523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418047	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400095
J	Ainembabazi, JH; Tripathi, L; Rusike, J; Abdoulaye, T; Manyong, V				Ainembabazi, John Herbert; Tripathi, Leena; Rusike, Joseph; Abdoulaye, Tahirou; Manyong, Victor			Ex-Ante Economic Impact Assessment of Genetically Modified Banana Resistant to Xanthomonas Wilt in the Great Lakes Region of Africa	PLOS ONE			English	Article							FARM-LEVEL; MODIFIED COTTON; BACTERIAL WILT; GM RICE; ADOPTION; WELFARE; PRODUCTIVITY; EXPRESSION; BENEFITS; DISEASE	Background Credible empirical evidence is scanty on the social implications of genetically modified (GM) crops in Africa, especially on vegetatively propagated crops. Little is known about the future success of introducing GM technologies into staple crops such as bananas, which are widely produced and consumed in the Great Lakes Region of Africa (GLA). GM banana has a potential to control the destructive banana Xanthomonas wilt disease. Objective To gain a better understanding of future adoption and consumption of GM banana in the GLA countries which are yet to permit the production of GMcrops; specifically, to evaluate the potential economic impacts of GM cultivars resistant to banana Xanthomonas wilt disease. Data Sources The paper uses data collected from farmers, traders, agricultural extension agents and key informants in the GLA. Analysis We analyze the perceptions of the respondents about the adoption and consumption of GM crop. Economic surplus model is used to determine future economic benefits and costs of producing GM banana. Results On the release of GM banana for commercialization, the expected initial adoption rate ranges from 21 to 70%, while the ceiling adoption rate is up to 100%. Investment in the development of GM banana is economically viable. However, aggregate benefits vary substantially across the target countries ranging from US$20 million to 953 million, highest in countries where disease incidence and production losses are high, ranging from 51 to 83% of production. Conclusion The findings support investment in the development of GM banana resistant to Xanthomonas wilt disease. The main beneficiaries of this technology development are farmers and consumers, although the latter benefit more than the former from reduced prices. Designing a participatory breeding program involving farmers and consumers signifies the successful adoption and consumption of GM banana in the target countries.	[Ainembabazi, John Herbert] Int Inst Trop Agr, Kampala, Uganda; [Tripathi, Leena] Int Inst Trop Agr, Nairobi, Kenya; [Rusike, Joseph; Manyong, Victor] Int Inst Trop Agr, Dar Es Salaam, Tanzania; [Abdoulaye, Tahirou] Int Inst Trop Agr, Ibadan, Nigeria; [Rusike, Joseph] AGRA, Nairobi, Kenya	CGIAR; International Institute of Tropical Agriculture (IITA)	Ainembabazi, JH (corresponding author), Int Inst Trop Agr, Kampala, Uganda.	J.Ainembabazi@cgiar.org			United States Agency for International Development [MTO 069018]	United States Agency for International Development(United States Agency for International Development (USAID))	The study was funded by the United States Agency for International Development. Grant number: MTO 069018. Funding received was by LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele S, 2007, J CROP IMPROV, V19, P173, DOI 10.1300/J411v19n01_09; Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Alston JM, 1998, SCI SCARCITY PRINCIP; Bennett R, 2006, REV AGR ECON, V28, P59, DOI 10.1111/j.1467-9353.2006.00273.x; Blomme G, 2013, BANANA SYSTEMS HUMID; Cabanilla LS, 2004, INT J BIOTECHNOL, V10, P1; Demont M, 2013, NEW BIOTECHNOL, V30, P426, DOI 10.1016/j.nbt.2013.04.004; Finger R, 2011, SUSTAINABILITY-BASEL, V3, P743, DOI 10.3390/su3050743; Fulton M, 2004, AM J AGR ECON, V86, P42, DOI 10.1111/j.0092-5853.2004.00561.x; Gouse M., 2006, AgBioForum, V9, P15; Hareau GG, 2006, FOOD POLICY, V31, P162, DOI 10.1016/j.foodpol.2005.10.005; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Hudson D., 2014, AgBioForum, V17, P1; Kalyebara M. R., 2006, African Crop Science Journal, V14, P93; Karamura E, 2010, ACTA HORTIC, V879, P749, DOI 10.17660/ActaHortic.2010.879.81; Kayobyo G, 2005, ASS IMP BAN BACT WIL; Kikulwe EM, 2011, AGR ECON-BLACKWELL, V42, P547, DOI 10.1111/j.1574-0862.2010.00529.x; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Namukwaya B, 2012, TRANSGENIC RES, V21, P855, DOI 10.1007/s11248-011-9574-y; Napasintuwong O., 2009, AgBioForum, V12, P209; Qaim M, 2006, REV AGR ECON, V28, P48, DOI 10.1111/j.1467-9353.2006.00272.x; Qaim M, 2005, AGR ECON, V32, P73, DOI 10.1111/j.0169-5150.2005.00006.x; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; Qaim M, 2005, AM J AGR ECON, V87, P1317, DOI 10.1111/j.1467-8276.2005.00825.x; Smale M., 2007, Research Report - International Food Policy Research Institute; Tripathi JN, 2014, PLANT BIOTECHNOL J, V12, P663, DOI 10.1111/pbi.12170; Tripathi L, 2013, ACTA HORTIC, V974, P81; Tripathi L, 2014, NAT BIOTECHNOL, V32, P868, DOI 10.1038/nbt.3007; Tripathi L, 2010, MOL PLANT PATHOL, V11, P721, DOI 10.1111/j.1364-3703.2010.00639.x; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; Yorobe Jr JM, 2009, PROJECTED IMPACTS AG, P23	31	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138998	10.1371/journal.pone.0138998	http://dx.doi.org/10.1371/journal.pone.0138998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26414379	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700032
J	Darrouzet, E; Gevar, J; Guignard, Q; Aron, S				Darrouzet, Eric; Gevar, Jeremy; Guignard, Quentin; Aron, Serge			Production of Early Diploid Males by European Colonies of the Invasive Hornet Vespa velutina nigrithorax	PLOS ONE			English	Article							CHINENSIS-ANTENNALIS HYMENOPTERA; JAPANESE PAPER WASP; COMPLEMENTARY SEX DETERMINATION; ANT SOLENOPSIS-INVICTA; YELLOW-LEGGED HORNET; POLISTES-CHINENSIS; SNELLENI HYMENOPTERA; GENETIC-VARIATION; WORKER; POPULATION	The invasive yellow-legged hornet Vespa velutina nigrithorax was accidentally introduced in Europe in the early 2000s. As is the case in colonies of other wasp and hornet species, V. velutina colonies are known to produce sexuals (males and new queens) at the end of the summer. We show that early-stage colonies in French populations frequently produce males well before the usual reproductive period. The vast majority of the males produced are diploid, which is consistent with the loss of genetic diversity previously reported in introduced populations in France. Since males do not participate in colony activities, the production of early diploid males at the expense of workers is expected to hamper colony growth and, ultimately, decrease the expansion of the species in its invasive range in Europe.	[Darrouzet, Eric; Gevar, Jeremy; Guignard, Quentin] Univ Tours, CNRS, UMR 7261, IRBI,Fac Sci, F-37200 Tours, France; [Aron, Serge] Univ Libre Bruxelles, Evolut Biol & Ecol, B-1050 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Universite Libre de Bruxelles	Darrouzet, E (corresponding author), Univ Tours, CNRS, UMR 7261, IRBI,Fac Sci, Parc Grandmt, F-37200 Tours, France.	eric.darrouzet@univ-tours.fr	Guignard, Quentin/ABB-6250-2021	Guignard, Quentin/0000-0002-9566-4365	local government (Region Centre, France); Belgium's National Fund for Scientific Research	local government (Region Centre, France)(Region Centre-Val de Loire); Belgium's National Fund for Scientific Research	This work was funded by the local government (Region Centre, France) (ED) and several grants from Belgium's National Fund for Scientific Research (SA).	ADAMS J, 1977, GENETICS, V86, P583; Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Aron S, 2005, CURR BIOL, V15, P824, DOI 10.1016/j.cub.2005.03.017; Ayabe T, 2004, CHROMOSOME RES, V12, P215, DOI 10.1023/B:CHRO.0000021880.83639.4b; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cournault L, 2008, INSECT SOC, V55, P283, DOI 10.1007/s00040-008-1003-8; Cournault L, 2009, NATURWISSENSCHAFTEN, V96, P1393, DOI 10.1007/s00114-009-0590-1; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Darrouzet E., 2014, SANTE ABEILLE, V259, P49; Darrouzet E., 2012, ESPECES, V6, P30; Darrouzet E, 2015, APIDOLOGIE, V46, P130, DOI 10.1007/s13592-014-0297-y; Darvill B, 2012, MOL ECOL, V21, P3988, DOI 10.1111/j.1365-294X.2012.05679.x; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; de Haro L, 2010, TOXICON, V55, P650, DOI 10.1016/j.toxicon.2009.08.005; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duchateau MJ, 1994, INSECT SOC, V42, P255; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Goldarazena A., 2015, Bulletin OEPP, V45, P133, DOI 10.1111/epp.12185; Hagiwara Y, 2002, INSECT SOC, V49, P191, DOI 10.1007/s00040-002-8300-4; Harpur BA, 2013, ENTOMOL EXP APPL, V146, P156, DOI 10.1111/j.1570-7458.2012.01306.x; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; KASUYA E, 1983, RES POPUL ECOL, V25, P143, DOI 10.1007/BF02528789; KASUYA E, 1981, INSECT SOC, V28, P341, DOI 10.1007/BF02224190; KERR WE, 1987, INSECT SOC, V34, P274, DOI 10.1007/BF02224359; Liebert AE, 2004, INSECT SOC, V51, P205, DOI 10.1007/s00040-004-0754-0; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; NAITO T, 1991, J HERED, V82, P101, DOI 10.1093/oxfordjournals.jhered.a111042; Packer L, 2001, CONSERV ECOL, V5; PAGE RE, 1982, AM NAT, V119, P263, DOI 10.1086/283907; PAGE RE, 1989, AM NAT, V134, P731, DOI 10.1086/285008; PAMILO P, 1994, ETHOL ECOL EVOL, V6, P221, DOI 10.1080/08927014.1994.9522996; PLOWRIGHT RC, 1979, CAN ENTOMOL, V111, P289, DOI 10.4039/Ent111289-3; ROSS KG, 1986, BEHAV ECOL SOCIOBIOL, V19, P283, DOI 10.1007/BF00300643; ROSS KG, 1993, AM NAT, V141, P554, DOI 10.1086/285491; ROSS KG, 1993, GENETICS, V135, P843; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Suzuki T, 1997, NATURWISSENSCHAFTEN, V84, P304, DOI 10.1007/s001140050399; Suzuki T, 1998, ETHOL ECOL EVOL, V10, P347, DOI 10.1080/08927014.1998.9522848; SUZUKI T, 1985, ANN ENTOMOL SOC AM, V78, P736, DOI 10.1093/aesa/78.6.736; Tsuchida K, 2004, J ETHOL, V22, P119, DOI 10.1007/s10164-003-0109-8; Tsuchida K, 2002, INSECT SOC, V49, P120, DOI 10.1007/s00040-002-8289-8; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Villemant C, 2011, BIOL CONSERV, V144, P2142, DOI 10.1016/j.biocon.2011.04.009; Whitehorn PR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-152; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; Yamasaki K, 2011, ENTOMOL SCI, V14, P383, DOI 10.1111/j.1479-8298.2011.00460.x; Zayed A, 2001, HEREDITY, V87, P631, DOI 10.1046/j.1365-2540.2001.00952.x; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	58	32	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0136680	10.1371/journal.pone.0136680	http://dx.doi.org/10.1371/journal.pone.0136680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414951	gold, Green Published, Green Submitted			2022-12-26	WOS:000362170700004
J	Golz, G; Karadas, G; Alutis, ME; Fischer, A; Kuhl, AA; Breithaupt, A; Gobel, UB; Alter, T; Bereswill, S; Heimesaat, MM				Goelz, Greta; Karadas, Guel; Alutis, Marie E.; Fischer, Andre; Kuehl, Anja A.; Breithaupt, Angele; Goebel, Ulf B.; Alter, Thomas; Bereswill, Stefan; Heimesaat, Markus M.			Arcobacter butzleri Induce Colonic, Extra-Intestinal and Systemic Inflammatory Responses in Gnotobiotic IL-10 Deficient Mice in a Strain-Dependent Manner	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI INFECTION; SPP.; ENTEROCOLITIS; ADHERENCE; INVASION; HUMANS; VIBRIO; CELLS	Background The immunopathological impact of human Arcobacter (A.) infections is under current debate. Episodes of gastroenteritis with abdominal pain and acute or prolonged watery diarrhea were reported for A. butzleri infected patients. Whereas adhesive, invasive and cytotoxic capacities have been described for A. butzleri in vitro, only limited information is available about the immunopathogenic potential and mechanisms of infection in vivo. Methodology/Principal Findings Gnotobiotic IL-10(-/-) mice were generated by broad-spectrum antibiotic treatment and perorally infected with the A. butzleri strains CCUG 30485 and C1 shown to be invasive in cell culture assays. Bacterial colonization capacities, clinical conditions, intestinal, extra-intestinal and systemic immune responses were monitored at day six and 16 postinfection (p.i.). Despite stable intestinal A. butzleri colonization at high loads, gnotobiotic IL-10(-/-) mice were virtually unaffected and did not display any overt symptoms at either time point. Notably, A. butzleri infection induced apoptosis of colonic epithelial cells which was paralleled by increased abundance of proliferating cells. Furthermore A. butzleri infection caused a significant increase of distinct immune cell populations such as T and B cells, regulatory T cells, macrophages and monocytes in the colon which was accompanied by elevated colonic TNF, IFN-gamma, nitric oxide (NO), IL-6, IL-12p70 and MCP-1 concentrations. Strikingly, A. butzleri induced extra-intestinal and systemic immune responses as indicated by higher NO concentrations in kidney and increased TNF, IFN-gamma, IL-12p70 and IL-6 levels in serum samples of infected as compared to naive mice. Overall, inflammatory responses could be observed earlier in the course of infection by the CCUG 30485 as compared to the C1 strain. Conclusion/Significance Peroral A. butzleri infection induced not only intestinal but also extra-intestinal and systemic immune responses in gnotobiotic IL-10(-/-) mice in a strain-dependent manner. These findings point towards an immunopathogenic potential of A. butzleri in vertebrate hosts.	[Goelz, Greta; Karadas, Guel; Alter, Thomas] Free Univ Berlin, Inst Food Hyg, Berlin, Germany; [Alutis, Marie E.; Fischer, Andre; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.] Charite, Dept Med Gastroenterol Infect Dis & Rheumatol, Res Ctr ImmunoSci RCIS, D-13353 Berlin, Germany; [Breithaupt, Angele] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Golz, G (corresponding author), Free Univ Berlin, Inst Food Hyg, Berlin, Germany.	greta.goelz@fu-berlin.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013; Alter, Thomas/J-4810-2014	Breithaupt, Angele/0000-0002-6373-5923; Alter, Thomas/0000-0002-6048-5666; Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387	German Research Foundation (DFG) [SFB633, TP A7, TP Z1, TP B6]; German Federal Ministery of Education and Research (BMBF) [TP1.1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to AF, SB and UBG (SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6), and from the German Federal Ministery of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adesiji Y O, 2012, West Afr J Med, V31, P186; Adesiji YO, 2010, CENT EUR J MED, V5, P470, DOI 10.2478/s11536-009-0109-3; Adesiji YO, 2009, SIERRA LEONE J BIOME, V1, P4; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bucker R, 2009, J INFECT DIS, V200, P756, DOI 10.1086/600868; Carbone M, 2003, FOOD MICROBIOL, V20, P611, DOI 10.1016/S0740-0020(02)00172-7; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Ferreira S, 2015, CRIT REV MICROBIOL; Golla SC, 2002, J FOOD PROTECT, V65, P1849, DOI 10.4315/0362-028X-65.12.1849; Gugliandolo C, 2008, MAR POLLUT BULL, V56, P600, DOI 10.1016/j.marpolbul.2007.12.001; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00077; Heimesaat MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090148; Ho HTK, 2007, FEMS IMMUNOL MED MIC, V50, P51, DOI 10.1111/j.1574-695X.2007.00230.x; Ho HTK, 2006, VET MICROBIOL, V115, P1, DOI 10.1016/j.vetmic.2006.03.004; Karadas G, 2013, J APPL MICROBIOL, V115, P583, DOI 10.1111/jam.12245; KIEHLBAUCH JA, 1991, J CLIN MICROBIOL, V29, P376, DOI 10.1128/JCM.29.2.376-385.1991; Lappi V, 2013, FOODBORNE PATHOG DIS, V10, P250, DOI 10.1089/fpd.2012.1307; Levican A, 2013, APPL ENVIRON MICROB, V79, P4951, DOI 10.1128/AEM.01073-13; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Musmanno RA, 1997, MICROBIOLOGICA, V20, P63; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Tompkin RB, 2002, MICROBIOLOGICAL TEST, P171; Van den Abeele AM, 2014, EMERG INFECT DIS, V20, P1731, DOI 10.3201/eid2010.140433; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Villarruel-Lopez A, 2003, J FOOD PROTECT, V66, P1374, DOI 10.4315/0362-028X-66.8.1374; Wesley IV, 1996, INFECT IMMUN, V64, P2295, DOI 10.1128/IAI.64.6.2295-2299.1996; Wesley IV, 1999, POULTRY SCI, V78, P536, DOI 10.1093/ps/78.4.536; zur Bruegge J, 2014, INT J MED MICROBIOL, V304, P1209, DOI 10.1016/j.ijmm.2014.08.017	32	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139402	10.1371/journal.pone.0139402	http://dx.doi.org/10.1371/journal.pone.0139402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406497	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700210
J	Harvey, TJ; Murphy, RM; Morrison, JL; Posterino, GS				Harvey, Thomas J.; Murphy, Robyn M.; Morrison, Janna L.; Posterino, Giuseppe S.			Maternal Nutrient Restriction Alters Ca2+ Handling Properties and Contractile Function of Isolated Left Ventricle Bundles in Male But Not Female Juvenile Rats	PLOS ONE			English	Article							TROPONIN-I PHOSPHORYLATION; HIGH-ALTITUDE HYPOXIA; CARDIAC-MUSCLE; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; GROWTH RESTRICTION; GESTATIONAL-AGE; BIRTH-WEIGHT; FETAL SHEEP; CAFFEINE	Intrauterine growth restriction (IUGR), defined as a birth weight below the 10th centile, may be caused by maternal undernutrition, with evidence that IUGR offspring have an increased risk of cardiovascular disease (CVD) in adulthood. Calcium ions (Ca2+) are an integral messenger for several steps associated with excitation-contraction coupling (ECC); the cascade of events from the initiation of an action potential at the surface membrane, to contraction of the cardiomyocyte. Any changes in Ca2+ storage and release from the sarcoplasmic reticulum (SR), or sensitivity of the contractile apparatus to Ca2+ may underlie the mechanism linking IUGR to an increased risk of CVD. This study aimed to explore the effects of maternal nutrient restriction on cardiac function, including Ca2+ handling by the SR and force development by the contractile apparatus. Juvenile Long Evans hooded rats born to Control (C) and nutrient restricted (NR) dams were anaesthetized for collection of the heart at 1012 weeks of age. Left ventricular bundles from male NR offspring displayed increased maximum Ca2+-activated force, and decreased protein content of troponin I (cTnI) compared to C males. Furthermore, male NR offspring showed a reduction in rate of rise of the caffeine-induced Ca2+ force response and a decrease in the protein content of ryanodine receptor (RYR2). These physiological and biochemical findings observed in males were not evident in female offspring. These findings illustrate a sex-specific effect of maternal NR on cardiac development, and also highlight a possible mechanism for the development of hypertension and hypertrophy in male NR offspring.	[Harvey, Thomas J.; Posterino, Giuseppe S.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Murphy, Robyn M.] La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic, Australia; [Morrison, Janna L.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	La Trobe University; La Trobe University; University of South Australia	Harvey, TJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia.	tj3harvey@students.latrobe.edu.au	Morrison, Janna/B-8308-2009; Moro, Valentina/K-6464-2016; Moro, Valentina/AAM-2224-2021; Scandola, Michele/D-8107-2013; Aglioti, Salvatore M/E-9829-2012	Morrison, Janna/0000-0002-8602-8519; Moro, Valentina/0000-0002-7119-7264; Moro, Valentina/0000-0002-7119-7264; Scandola, Michele/0000-0003-0853-8975; Murphy, Robyn/0000-0003-3697-589X; Posterino, Giuseppe/0000-0003-2539-1469	School of Life Sciences, La Trobe University; National Health and Medical Research Council of Australia [1051460]; South Australian Cardiovascular Research Network Fellowship [CR10A4988]; National Health and Medical Research Council of Australia Career Development Fellowship [APP1066916]	School of Life Sciences, La Trobe University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); South Australian Cardiovascular Research Network Fellowship; National Health and Medical Research Council of Australia Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by internal funds from the School of Life Sciences, La Trobe University, GP, TH. RMM was funded by the National Health and Medical Research Council of Australia (grant number 1051460, https://www.nhmrc.gov.au). JLM was funded by a South Australian Cardiovascular Research Network Fellowship (CR10A4988, http://www.heartfoundation.org.au/research/funding/Pages/south-australian-cardiovascular-research-development-program.aspx), and the National Health and Medical Research Council of Australia Career Development Fellowship (APP1066916 (https://www.nhmrc.gov.au/grants-funding/apply-funding/career-development-fellowships).	Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; ARNER A, 1995, J MOL CELL CARDIOL, V27, P615, DOI 10.1016/S0022-2828(08)80055-7; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bertram C, 2008, J PHYSIOL-LONDON, V586, P2217, DOI 10.1113/jphysiol.2007.147967; BRILLANTES AM, 1992, CIRC RES, V71, P18, DOI 10.1161/01.RES.71.1.18; Browne VA, 1997, AM J PHYSIOL-HEART C, V272, pH1196, DOI 10.1152/ajpheart.1997.272.3.H1196; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Haugaard CT, 2001, SCAND J LAB ANIM SCI, V28, P10; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; HERLAND JS, 1990, J PHYSIOL-LONDON, V426, P1; Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908; Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060; Kabbara AA, 1997, AM J PHYSIOL-HEART C, V273, pH1347, DOI 10.1152/ajpheart.1997.273.3.H1347; KABBARA AA, 1994, PFLUG ARCH EUR J PHY, V428, P331, DOI 10.1007/BF00724515; Kabbara AA, 1997, AM J PHYSIOL-HEART C, V272, pH1001, DOI 10.1152/ajpheart.1997.272.2.H1001; Kentish JC, 1997, CARDIOVASC RES, V33, P314, DOI 10.1016/S0008-6363(96)00217-9; Kruger M, 2006, AM J PHYSIOL-HEART C, V291, pH496, DOI 10.1152/ajpheart.00114.2006; Li ZC, 2012, PROCEEDINGS OF THE ASME 6TH INTERNATIONAL CONFERENCE ON ENERGY SUSTAINABILITY - 2012, PTS A AND B, P1; Mach Mojmir, 2009, Interdiscip Toxicol, V2, P28, DOI 10.2478/v10102-009-0005-3; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Murphy RM, 2011, AM J PHYSIOL-HEART C, V300, pH595, DOI 10.1152/ajpheart.00902.2010; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; Onishi J, 2004, J SOC GYNECOL INVEST, V11, P1, DOI 10.1016/j.jsgi.2003.07.003; Onishi J, 2003, J SOC GYNECOL INVEST, V10, P189, DOI 10.1016/S1071-5576(03)00042-X; Palmer S, 1997, CIRC RES, V80, P682, DOI 10.1161/01.RES.80.5.682; Posterino GS, 2011, J APPL PHYSIOL, V111, P236, DOI 10.1152/japplphysiol.00067.2011; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Schillinger W, 1996, MOL CELL BIOCHEM, V161, P297, DOI 10.1007/BF00240062; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; Stephenson DG, 2008, J PHYSIOL-LONDON, V586, P695, DOI 10.1113/jphysiol.2007.148270; Tare M, 2014, CLIN SCI LOND; Unterscheider J, 2014, EUR J OBSTET GYN R B, V174, P41, DOI 10.1016/j.ejogrb.2013.11.022; VIJAYAKUMAR M, 1995, BRIT HEART J, V73, P363; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wagner R, 2004, BRIT J PHARMACOL, V141, P624, DOI 10.1038/sj.bjp.0705655; Weiwad WKK, 2000, J MOL CELL CARDIOL, V32, P247, DOI 10.1006/jmcc.1999.1069; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Yaras N, 2005, DIABETES, V54, P3082, DOI 10.2337/diabetes.54.11.3082	49	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138388	10.1371/journal.pone.0138388	http://dx.doi.org/10.1371/journal.pone.0138388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406887	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361800700042
J	Luo, YW; Wang, XY; Wang, HR; Xu, Y; Wen, QY; Fan, SQ; Zhao, R; Jiang, SH; Yang, J; Liu, YK; Li, XY; Xiong, W; Ma, J; Peng, SP; Zeng, ZY; Li, XL; Phillips, JB; Li, GY; Tan, M; Zhou, M				Luo, Yanwei; Wang, Xinye; Wang, Heran; Xu, Yang; Wen, Qiuyuan; Fan, Songqing; Zhao, Ran; Jiang, Shihe; Yang, Jing; Liu, Yukun; Li, Xiayu; Xiong, Wei; Ma, Jian; Peng, Shuping; Zeng, Zhaoyang; Li, Xiaoling; Phillips, Joshua B.; Li, Guiyuan; Tan, Ming; Zhou, Ming			High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel	PLOS ONE			English	Article							PRO-APOPTOTIC BAK; BCL-2 EXPRESSION; MITOCHONDRIAL; RESISTANCE; DEATH; MCL-1; GENE; TRASTUZUMAB; SUPPRESSION; CARCINOMA	Breast cancer has become the leading cause of cancer-related death among women. A large number of patients become resistant to drug chemotherapy. Paclitaxel (Taxol) is an effective chemotherapeutic agent used to treat cancer patients. Taxol has been widely used in human malignancies including breast cancer because it can stabilize microtubules resulting in cell death by causing an arrest during the G2/M phase of the cell cycle. Pro-apoptotic Bcl-2 antagonist killer 1 (Bak) plays an important role in Taxol-induced apoptosis in breast cancer. In our present study, we investigated the expression of the Bak protein and clinicopathological correlations in a large sample of breast cancer tissues by immunohistochemistry. We found that the percentage of high scores of Bak expression in breast cancer was significantly lower than that of the non-cancerous breast control tissue. In addition, lower Bak expression was positively associated with the clinical TNM stage of breast cancer with a significant decrease in overall survival compared with those with higher Bak expression especially in the Luminal and HER2 subtypes. Importantly, higher Bak expression predicted a favorable clinical outcome in the cases treated with Taxol indicated by a higher overall survival than that of patients with lower Bak expression especially in Luminal and HER2 subtypes. Furthermore, these results were confirmed in vitro since overexpression of Bak sensitized breast cancer cells to Taxol by inhibiting proliferation and promoting apoptosis; in contrast, downregulation of Bak through siRNA transfection inhibited Taxol induced-apoptosis. Therefore, our results demonstrate that Bak acts as a sensitive biomarker and favorable prognostic factor for Taxol treatment in breast cancer. The restoration of Bak expression would be therapeutically beneficial for Taxol resistant breast cancer patients.	[Luo, Yanwei; Wang, Xinye; Wang, Heran; Xu, Yang; Zhao, Ran; Jiang, Shihe; Yang, Jing; Liu, Yukun; Xiong, Wei; Ma, Jian; Peng, Shuping; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Zhou, Ming] Cent South Univ, Canc Res Inst, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Phillips, Joshua B.; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Wen, Qiuyuan; Fan, Songqing] Cent South Univ, Xiang Ya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Li, Xiayu] Cent South Univ, Xiang Ya Hosp 3, Changsha 410013, Hunan, Peoples R China	Central South University; University of South Alabama; Central South University; Central South University	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.	mtan@health.southalabama.edu; zhouming2001@163.com	li, xia/HHZ-7468-2022; Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898	National Natural Science Foundation of China [81328019, 81171934, 81572748]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants obtained from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Nos. 81328019, 81171934, 81572748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Hern RP, 2013, NAT REV CLIN ONCOL, V10, P357, DOI 10.1038/nrclinonc.2013.67; Austreid E, 2014, EXPERT OPIN PHARMACO, V15, P681, DOI 10.1517/14656566.2014.885952; Barille-Nion S, 2012, ANTICANCER RES, V32, P4225; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Bonnefoi H, 2015, ANN ONCOL, V26, P325, DOI 10.1093/annonc/mdu551; Chang J, 2003, CANCER-AM CANCER SOC, V97, P545, DOI 10.1002/cncr.11083; Chen LY, 2015, BREAST CANCER RES TR, V149, P631, DOI 10.1007/s10549-015-3288-4; Courneya KS, 2014, BRIT J CANCER, V111, P1718, DOI 10.1038/bjc.2014.466; Duckworth CA, 2015, AM J PHYSIOL-GASTR L, V309, pG420, DOI 10.1152/ajpgi.00404.2014; Eguchi H, 2000, CELL DEATH DIFFER, V7, P439, DOI 10.1038/sj.cdd.4400675; Fan SQ, 2006, HUM PATHOL, V37, P593, DOI 10.1016/j.humpath.2006.01.010; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Grabow S, 2014, BLOOD, V124, P3939, DOI 10.1182/blood-2014-09-601567; Gratas C, 2014, ONCOTARGET, V5, P2428, DOI 10.18632/oncotarget.1642; Janssen K, 2009, J CELL SCI, V122, P4481, DOI 10.1242/jcs.055772; Kanczuga-Koda L, 2010, ONCOL LETT, V1, P1067, DOI 10.3892/ol.2010.178; Kenicer J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-762; Kondo S, 2000, CANCER RES, V60, P4328; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Lian JQ, 2012, MOL CANCER THER, V11, P416, DOI 10.1158/1535-7163.MCT-11-0559; Matissek KJ, 2014, PHARM RES-DORDR, V31, P2503, DOI 10.1007/s11095-014-1346-y; Miller AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060685; Miura D, 2014, J NIPPON MED SCH, V81, P211, DOI 10.1272/jnms.81.211; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Shinde AM, 2015, BREAST, V24, P18, DOI 10.1016/j.breast.2014.10.008; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Thomas S, 2011, BREAST CANCER RES TR, V130, P437, DOI 10.1007/s10549-011-1364-y; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Tong QS, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-33; Wang H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-37; Yao Q, 2011, TUMOR BIOL, V32, P1163, DOI 10.1007/s13277-011-0219-9; Ye CG, 2013, BBA-MOL CELL RES, V1833, P2970, DOI 10.1016/j.bbamcr.2013.08.001; Yoshino T, 2006, CLIN CANCER RES, V12, P6116, DOI 10.1158/1078-0432.CCR-06-0147; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	37	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138955	10.1371/journal.pone.0138955	http://dx.doi.org/10.1371/journal.pone.0138955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406239	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700128
J	Rajalakshmi, R; Arulmalar, S; Usha, M; Prathiba, V; Kareemuddin, KS; Anjana, RM; Mohan, V				Rajalakshmi, Ramachandran; Arulmalar, Subramanian; Usha, Manoharan; Prathiba, Vijayaraghavan; Kareemuddin, Khaji Syed; Anjana, Ranjit Mohan; Mohan, Viswanathan			Validation of Smartphone Based Retinal Photography for Diabetic Retinopathy Screening	PLOS ONE			English	Article							PREVALENCE; EYE; OPHTHALMOSCOPY; SPECIFICITY; SENSITIVITY	Aim To evaluate the sensitivity and specificity of "fundus on phone' (FOP) camera, a smartphone based retinal imaging system, as a screening tool for diabetic retinopathy (DR) detection and DR severity in comparison with 7-standard field digital retinal photography. Design Single-site, prospective, comparative, instrument validation study. Methods 301 patients (602 eyes) with type 2 diabetes underwent standard seven-field digital fundus photography with both Carl Zeiss fundus camera and indigenous FOP at a tertiary care diabetes centre in South India. Grading of DR was performed by two independent retina specialists using modified Early Treatment of Diabetic Retinopathy Study grading system. Sight threatening DR (STDR) was defined by the presence of proliferative DR(PDR) or diabetic macular edema. The sensitivity, specificity and image quality were assessed. Results The mean age of the participants was 53.5 +/- 9.6 years and mean duration of diabetes 12.5 +/- 7.3 years. The Zeiss camera showed that 43.9% had non-proliferative DR(NPDR) and 15.3% had PDR while the FOP camera showed that 40.2% had NPDR and 15.3% had PDR. The sensitivity and specificity for detecting any DR by FOP was 92.7%(95% CI 87.8-96.1) and 98.4%(95% CI 94.3-99.8) respectively and the kappa (kappa) agreement was 0.90 (95% CI-0.85-0.95 p<0.001) while for STDR, the sensitivity was 87.9% (95% CI 83.2-92.9), specificity 94.9% (95% CI 89.7-98.2) and. agreement was 0.80 (95% CI 0.71-0.89 p<0.001), compared to conventional photography. Conclusion Retinal photography using FOP camera is effective for screening and diagnosis of DR and STDR with high sensitivity and specificity and has substantial agreement with conventional retinal photography.	[Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; Dr Mohans Diabet Special Ctr, Collaborating Ctr Noncommunicable Dis Prevent & C, IDF Ctr Educ, WHO, Madras, Tamil Nadu, India	Madras Diabetes Research Foundation; World Health Organization	Mohan, V (corresponding author), Madras Diabet Res Fdn, Madras, Tamil Nadu, India.	drmohans@diabetes.ind.in						Ahmed J, 2006, DIABETES CARE, V29, P2205, DOI 10.2337/dc06-0295; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; [Anonymous], 1991, Ophthalmology, V98, P786; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gupta V, 2014, INDIAN J OPHTHALMOL, V62, P851, DOI 10.4103/0301-4738.141039; Hutchinson A, 2000, DIABETIC MED, V17, P495, DOI 10.1046/j.1464-5491.2000.00250.x; *INT DIAB FED, 2014, DIABETES ATLAS; Javitt J C, 1995, Pharmacoeconomics, V8 Suppl 1, P33; Kumar S, 2012, TELEMED E-HEALTH, V18, P158, DOI 10.1089/tmj.2011.0089; Lord RK, 2010, OPHTHALMOLOGY, V117, P1274, DOI 10.1016/j.ophtha.2010.01.001; Mohan Viswanathan, 2014, J Diabetes Sci Technol, V8, P256; MOSS SE, 1985, OPHTHALMOLOGY, V92, P62; Murgatroyd H, 2004, BRIT J OPHTHALMOL, V88, P920, DOI 10.1136/bjo.2003.026385; Namperumalsamy P, 2003, DIABETES CARE, V26, P1831, DOI 10.2337/diacare.26.6.1831; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Rajalakshmi R, 2014, J DIABETES COMPLICAT, V28, P291, DOI 10.1016/j.jdiacomp.2013.12.008; Raman R., 2007, DIABETES CARE, V30, P1, DOI [10.2337/dc07-0052, DOI 10.2337/DC07-0052]; Rema M, 2007, INDIAN J MED RES, V125, P297; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Russo A, 2015, AM J OPHTHALMOL, V159, P360, DOI 10.1016/j.ajo.2014.11.008; Scanlon PH, 2005, DIABETES CARE, V28, P2448, DOI 10.2337/diacare.28.10.2448; Scanlon PH, 2003, BRIT J OPHTHALMOL, V87, P1258, DOI 10.1136/bjo.87.10.1258; Scanlon PH, 2003, DIABETIC MED, V20, P467, DOI 10.1046/j.1464-5491.2003.00954.x; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Vashist Praveen, 2011, Indian J Community Med, V36, P247, DOI 10.4103/0970-0218.91324; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2	27	90	93	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138285	10.1371/journal.pone.0138285	http://dx.doi.org/10.1371/journal.pone.0138285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401839	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100018
J	Crovo, JA; Mendonca, MT; Holt, DE; Johnston, CE				Crovo, Jenna A.; Mendonca, Mary T.; Holt, Daniel E.; Johnston, Carol E.			Stress and Auditory Responses of the Otophysan Fish, Cyprinella venusta, to Road Traffic Noise	PLOS ONE			English	Article							HEARING-LOSS; SHIP NOISE; SIGNALS; COMMUNICATION; SENSITIVITY; RECOVERY; SOUNDS	Noise pollution from anthropogenic sources is an increasingly problematic challenge faced by many taxa, including fishes. Recent studies demonstrate that road traffic noise propagates effectively from bridge crossings into surrounding freshwater ecosystems; yet, its effect on the stress response and auditory function of freshwater stream fishes is unexamined. The blacktail shiner (Cyprinella venusta) was used as a model to investigate the degree to which traffic noise impacts stress and hearing in exposed fishes. Fish were exposed to an underwater recording of traffic noise played at approximately 140 dB re 1 mu Pa. Waterborne cortisol samples were collected and quantified using enzyme immunoassay (EIA). Auditory thresholds were assessed in control and traffic exposed groups by measuring auditory evoked potentials (AEPs). After acute exposure to traffic noise, fish exhibited a significant elevation in cortisol levels. Individuals exposed to 2 hours of traffic noise playback had elevated hearing thresholds at 300 and 400 Hz, corresponding to the most sensitive bandwidth for this species.	[Crovo, Jenna A.; Johnston, Carol E.] Auburn Univ, Coll Agr, Sch Fisheries Aquaculture & Aquat Sci, Fish Biodivers Lab, Auburn, AL 36849 USA; [Mendonca, Mary T.] Auburn Univ, Coll Sci & Math, Dept Biol Sci, Auburn, AL 36849 USA; [Holt, Daniel E.] Columbus State Univ, Coll Letters & Sci, Dept Earth & Space Sci, Columbus, GA USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University System of Georgia; Columbus State University	Crovo, JA (corresponding author), Auburn Univ, Coll Agr, Sch Fisheries Aquaculture & Aquat Sci, Fish Biodivers Lab, Auburn, AL 36849 USA.	jac0058@tigermail.auburn.edu			Auburn University Graduate School; Fish Biodiversity lab	Auburn University Graduate School; Fish Biodiversity lab	This research was funded in part by the Auburn University Graduate School. Additional expenditures for this project were funded by the Fish Biodiversity lab. The graduate school had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2013, FUNCT ECOL, V27, P289, DOI 10.1111/1365-2435.12032; Amorim MCP, 2000, J FISH BIOL, V57, P895, DOI 10.1006/jfbi.2000.1356; Amoser S, 2003, J ACOUST SOC AM, V113, P2170, DOI 10.1121/1.1557212; Blickley JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050462; Caiger PE, 2012, MAR ECOL PROG SER, V466, P225, DOI 10.3354/meps09933; Caro T, 2014, CURR BIOL, V24, pR722, DOI 10.1016/j.cub.2014.07.007; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Crino OL, 2013, J EXP BIOL, V216, P2055, DOI 10.1242/jeb.081109; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Hastings MC, 2010, J ACOUST SOC AM; Hawkins AD, 2000, ENVIRON BIOL FISH, V59, P29, DOI 10.1023/A:1007615517287; Higgs D. M., 2001, JARO-J ASSOC RES OTO, V3, P174, DOI [10.1007/s101620020035, DOI 10.1007/S101620020035]; Holt DE, 2014, ENVIRON BIOL FISH, V97, P1207, DOI 10.1007/s10641-013-0208-5; Holt DE, 2015, BIOL CONSERV, V187, P27, DOI 10.1016/j.biocon.2015.04.004; Holt DE, 2011, ENVIRON BIOL FISH, V91, P121, DOI 10.1007/s10641-010-9756-0; Holt DE, 2014, BEHAV ECOL, DOI [10.1093/beheco/aru028, DOI 10.1093/BEHEC0/ARU028]; Jacobsen L, 2014, J FISH BIOL, V84, P1768, DOI 10.1111/jfb.12395; Johnston CE, 2000, ECOL FRESHW FISH, V9, P170, DOI 10.1111/j.1600-0633.2000.eff090306.x; Kaiser K, 2015, CONSERV PHYSL, DOI [10.1093/conphys/cou061, DOI 10.1093/CONPHYS/C0U061]; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; McIntyre E, 2014, ANIM BEHAV, V87, P85, DOI 10.1016/j.anbehav.2013.10.013; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Neo YY, 2014, BIOL CONSERV, V178, P65, DOI 10.1016/j.biocon.2014.07.012; Phillips CT, 2008, ENVIRON BIOL FISH, V82, P265, DOI 10.1007/s10641-007-9279-5; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; Scholik AR, 2002, COMP BIOCHEM PHYS A, V133, P43, DOI 10.1016/S1095-6433(02)00108-3; Scholik AR, 2002, ENVIRON BIOL FISH, V63, P203, DOI 10.1023/A:1014266531390; Schrode KM, 2014, J COMP PHYSIOL A, V200, P221, DOI 10.1007/s00359-014-0880-8; Schroeder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039200; Shannon G, 2014, ANIM BEHAV, V94, P135, DOI 10.1016/j.anbehav.2014.06.004; Simpson SD, 2015, GLOBAL CHANGE BIOL, V21, P586, DOI 10.1111/gcb.12685; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Watts RD, 2007, SCIENCE, V316, P736, DOI 10.1126/science.1138141; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020	38	15	17	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137290	10.1371/journal.pone.0137290	http://dx.doi.org/10.1371/journal.pone.0137290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398211	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500027
J	Reis, M; Valer, FB; Vieira, CP; Vieira, J				Reis, Micael; Valer, Felipe B.; Vieira, Cristina P.; Vieira, Jorge			Drosophila americana Diapausing Females Show Features Typical of Young Flies	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; REPRODUCTIVE DIAPAUSE; PHOTOPERIODIC REGULATION; GEOGRAPHIC-VARIATION; CLIMATIC ADAPTATION; NATURAL-SELECTION; MOLECULAR-BASIS; COLD TOLERANCE; ACTIN GENES; EXPRESSION	Diapause is a period of arrested development which is controlled physiologically, preprogrammed environmentally and characterized by metabolic depression that can occur during any stage of insect development. Nevertheless, in the genus Drosophila, diapause is almost always associated with the cessation of ovarian development and reproductive activity in adult females. In this work, we show that, in D. americana (a temperate species of the virilis group), diapause is a genetically determined delay in ovarian development that is triggered by temperature and/or photoperiod. Moreover, we show that in this species diapause incidence increases with latitude, ranging from 13% in the southernmost to 91% in the northernmost range of the distribution. When exposed to diapause inducing conditions, both diapausing and non-diapausing females show a 10% increase in lifespan, that is further increased by 18.6% in diapausing females, although senescence is far from being negligible. ActinD1 expression levels suggest that diapausing females are biologically much younger than their chronological age, and that the fly as a whole, rather than the ovarian development alone, which is phenotypically more evident, is delayed by diapause. Therefore, diapause candidate genes that show expression levels that are compatible with flies younger than their chronological age may not necessarily play a role in reproductive diapause and in adaptation to seasonally varying environmental conditions.	[Reis, Micael; Vieira, Cristina P.; Vieira, Jorge] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Reis, Micael; Valer, Felipe B.; Vieira, Cristina P.; Vieira, Jorge] Univ Porto, Inst Biol Mol & Celular, P-4100 Porto, Portugal; [Valer, Felipe B.] Univ Fed Pelotas UFPel, Inst Biol, Pelotas, RS, Brazil	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade Federal de Pelotas	Vieira, J (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Jorge/J-7477-2013; Vieira, Cristina P./K-1775-2013	Vieira, Jorge/0000-0001-7032-5220; Vieira, Cristina P./0000-0002-7139-2107; Reis, Micael/0000-0002-2601-0886; Berti Valer, Felipe/0000-0001-6286-3811	national funds through FCT - Fundacao para a Ciencia e a Tecnologia/MEC - Ministerio da Educacao e Ciencia; FEDER funds within the partnership agreement PT2020;  [SFRH/BD/61142/2009]	national funds through FCT - Fundacao para a Ciencia e a Tecnologia/MEC - Ministerio da Educacao e Ciencia; FEDER funds within the partnership agreement PT2020; 	This work was financially supported by national funds through FCT - Fundacao para a Ciencia e a Tecnologia/MEC - Ministerio da Educacao e Ciencia, and when applicable, co-funded by FEDER funds within the partnership agreement PT2020 related with the research unit number 4293. Micael Reis was funded by a PhD grant attributed by FCT with the reference SFRH/BD/61142/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, FLY, V1, P307, DOI 10.4161/fly.5532; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Cogni R, 2013, EVOLUTION; COURCHESNESMITH CL, 1989, DEV BIOL, V133, P313, DOI 10.1016/0012-1606(89)90036-5; Danks H.V., 1987, INSECT DORMANCY ECOL, V1, P439; Danks HV, 2002, EUR J ENTOMOL, V99, P127, DOI 10.14411/eje.2002.021; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Fonseca NA, 2013, GENOME BIOL EVOL, V5, P661, DOI 10.1093/gbe/evt037; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Henneguy LF, 1904, INSECTES MORPHOLOGIE; ICHIJO N, 1986, EVOLUTION, V40, P418, DOI 10.1111/j.1558-5646.1986.tb00482.x; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Kauranen H, 2013, J INSECT PHYSIOL, V59, P662, DOI 10.1016/j.jinsphys.2013.04.007; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; KIMURA MT, 1984, PHYSIOL ENTOMOL, V9, P425, DOI 10.1111/j.1365-3032.1984.tb00784.x; King R. C., 1970, Int. Rev. Cytol., V28, P125, DOI 10.1016/S0074-7696(08)62542-5; Kubrak OI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113051; LANKINEN P, 1986, Journal of Biological Rhythms, V1, P101, DOI 10.1177/074873048600100202; Lankinen P, 2013, J INSECT PHYSIOL, V59, P745, DOI 10.1016/j.jinsphys.2013.05.006; Lee SF, 2011, MOL ECOL, V20, P2973, DOI 10.1111/j.1365-294X.2011.05155.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeb J, 1917, J BIOL CHEM, V32, P103; Lovato TL, 2001, INSECT MOL BIOL, V10, P333, DOI 10.1046/j.0962-1075.2001.00270.x; Lumme J., 1978, P145; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; Salminen TS, 2012, J INSECT PHYSIOL, V58, P1541, DOI 10.1016/j.jinsphys.2012.09.007; Salminen TS, 2013, J INSECT PHYSIOL, V59, P450, DOI 10.1016/j.jinsphys.2013.02.005; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; Schmidt PS, 2006, EVOLUTION, V60, P1602, DOI 10.1111/j.0014-3820.2006.tb00505.x; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; Tyukmaeva VI, 2011, ECOL EVOL, V1, P160, DOI 10.1002/ece3.14; Vesala L, 2012, J INSECT PHYSIOL, V58, P704, DOI 10.1016/j.jinsphys.2012.02.004; Vesala L, 2011, J INSECT PHYSIOL, V57, P46, DOI 10.1016/j.jinsphys.2010.09.007; WATABE H-A, 1983, Kontyu, V51, P628; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WILLIAMS KD, 1993, HEREDITY, V71, P312, DOI 10.1038/hdy.1993.141; Yamada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027493	52	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138758	10.1371/journal.pone.0138758	http://dx.doi.org/10.1371/journal.pone.0138758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398836	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500102
J	Shi, K; Carpenter, MA; Kurahashi, K; Harris, RS; Aihara, H				Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki			Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE; RETROVIRAL RESTRICTION; CYTOSINE DEAMINATION; AID/APOBEC FAMILY; FOREIGN DNA; HIV-1; BINDING; ENZYME; VIF; HYPERMUTATION	Functional and deep sequencing studies have combined to demonstrate the involvement of APOBEC3B in cancer mutagenesis. APOBEC3B is a single-stranded DNA cytosine deaminase that functions normally as a nuclear-localized restriction factor of DNA-based pathogens. However, it is overexpressed in cancer cells and elicits an intrinsic preference for 5'-Tc motifs in single-stranded DNA, which is the most frequently mutated dinucleotide in breast, head/neck, lung, bladder, cervical, and several other tumor types. In many cases, APOBEC3B mutagenesis accounts for the majority of both dispersed and clustered (kataegis) cytosine mutations. Here, we report the first structures of the APOBEC3B catalytic domain in multiple crystal forms. These structures reveal a tightly closed active site conformation and suggest that substrate accessibility is regulated by adjacent flexible loops. Residues important for catalysis are identified by mutation analyses, and the results provide insights into the mechanism of target site selection. We also report a nucleotide (dCMP)-bound crystal structure that informs a multistep model for binding single-stranded DNA. Overall, these high resolution crystal structures provide a framework for further mechanistic studies and the development of novel anti-cancer drugs to inhibit this enzyme, dampen tumor evolution, and minimize adverse outcomes such as drug resistance and metastasis.	[Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Harris, Reuben S.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), Univ Minnesota, Howard Hughes Med Inst, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu; aihar001@umn.edu		, Ke/0000-0003-4175-3714; Carpenter, Michael/0000-0001-9524-5323	National Institutes of Health from the NIGMS [GM095558, GM109770]; NIAID [AI064046]; NIGMS [GM091743, GM110734, P41 GM103403]; U.S. Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064046, R01AI064046, R56AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095558, R01GM109770, R01GM110734, P41GM103403, P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM095558 and GM109770 from the NIGMS (to the Aihara lab), AI064046 from the NIAID and GM091743 from the NIGMS (to the Harris lab), GM110734 from the NIGMS (to M. A. C.), and P41 GM103403 from the NIGMS (to Advanced Photon Source NE CAT beamlines). Advanced Photon Source is a U.S. Department of Energy Office of Science User Facility operated by Argonne National Laboratory under contract DE-AC02-06CH11357. R. S. H. is a co-founder of ApoGen Biotechnologies Inc. The other authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fossat N, 2014, RNA BIOL, V11, P1233, DOI 10.1080/15476286.2014.996054; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDougle RM, 2013, VIROLOGY, V441, P31, DOI 10.1016/j.virol.2013.03.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shindo Keisuke, 2012, Biology (Basel), V1, P260, DOI 10.3390/biology1020260; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Xu L., 2015, UROL ONCOL, V33, pe1, DOI DOI 10.1016/J.UR0L0NC.2015.05.009	65	73	76	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28120	28130		10.1074/jbc.M115.679951	http://dx.doi.org/10.1074/jbc.M115.679951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26416889	hybrid, Green Published			2022-12-26	WOS:000365761900008
J	Barroso, M; Tucker, H; Drake, L; Nichol, K; Drake, JR				Barroso, Margarida; Tucker, Heidi; Drake, Lisa; Nichol, Kathleen; Drake, James R.			Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FRET MICROSCOPY; IG-ALPHA/BETA; HLA-DM; RESOLUTION; MEMBRANES; BINDING; BETA	Antigen processing and MHC class II-restricted antigen presentation by antigen-presenting cells such as dendritic cells and B cells allows the activation of naive CD4+ T cells and cognate interactions between B cells and effector CD4+ T cells, respectively. B cells are unique among class II-restricted antigen-presenting cells in that they have a clonally restricted antigen-specific receptor, the B cell receptor (BCR), which allows the cell to recognize and respond to trace amounts of foreign antigen present in a sea of self-antigens. Moreover, engagement of peptide-class II complexes formed via BCR-mediated processing of cognate antigen has been shown to result in a unique pattern of B cell activation. Using a combined biochemical and imaging/FRET approach, we establish that internalized antigen-BCR complexes associate with intracellular class II molecules. We demonstrate that the M1-paired MHC class II conformer, shown previously to be critical for CD4 T cell activation, is incorporated selectively into these complexes and loaded selectively with peptide derived from BCR-internalized cognate antigen. These results demonstrate that, in B cells, internalized antigen-BCR complexes associate with intracellular MHC class II molecules, potentially defining a site of class II peptide acquisition, and reveal a selective role for the M1-paired class II conformer in the presentation of cognate antigen. These findings provide key insights into the molecular mechanisms used by B cells to control the source of peptides charged onto class II molecules, allowing the immune system to mount an antibody response focused on BCR-reactive cognate antigen.	[Barroso, Margarida] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Tucker, Heidi; Drake, Lisa; Nichol, Kathleen; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC-151, Albany, NY 12208 USA.	drakej@mail.amc.edu	Regan, Clinton/E-6250-2012	Barroso, Margarida/0000-0002-0407-3181	National Institutes of Health [AI-097673, CA-161782]; NATIONAL CANCER INSTITUTE [R21CA161782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI-097673 (to J. R. D.) and CA-161782 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Busman-Sahay K, 2011, J IMMUNOL, V186, P6710, DOI 10.4049/jimmunol.1100336; Cassard S, 1998, J IMMUNOL, V160, P1767; CHESNUT RW, 1986, ADV IMMUNOL, V39, P51; CHESNUT RW, 1985, CRC CR REV IMMUNOL, V5, P263; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Dixon AM, 2014, J BIOL CHEM, V289, P11695, DOI 10.1074/jbc.M113.516997; Drake JR, 1997, J EXP MED, V186, P1299, DOI 10.1084/jem.186.8.1299; Eastman S, 1996, EUR J IMMUNOL, V26, P385, DOI 10.1002/eji.1830260218; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Hulpke S, 2013, TRENDS BIOCHEM SCI, V38, P412, DOI 10.1016/j.tibs.2013.06.003; Jin L, 2008, IMMUNOL LETT, V116, P184, DOI 10.1016/j.imlet.2007.11.023; Katkere B, 2012, J BIOL CHEM, V287, P16636, DOI 10.1074/jbc.M112.357640; Katkere B, 2010, J IMMUNOL, V185, P5032, DOI 10.4049/jimmunol.1001653; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; Macmillan H, 2014, J IMMUNOL, V193, P2641, DOI 10.4049/jimmunol.1400075; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; Nashar TO, 2006, J IMMUNOL, V176, P827, DOI 10.4049/jimmunol.176.2.827; Nashar TO, 2005, J IMMUNOL, V174, P1306, DOI 10.4049/jimmunol.174.3.1306; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; Talati R, 2014, METHODS, V66, P139, DOI 10.1016/j.ymeth.2013.08.017; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Wallrabe H, 2007, MOL BIOL CELL, V18, P2226, DOI 10.1091/mbc.E06-08-0700; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435	30	23	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27101	27112		10.1074/jbc.M115.649582	http://dx.doi.org/10.1074/jbc.M115.649582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26400081	Green Published, hybrid			2022-12-26	WOS:000364794000020
J	Barrera, SP; Castrejon-Tellez, V; Trinidad, M; Robles-Escajeda, E; Vargas-Medrano, J; Varela-Ramirez, A; Miranda, M				Barrera, Susana P.; Castrejon-Tellez, Vicente; Trinidad, Margarita; Robles-Escajeda, Elisa; Vargas-Medrano, Javier; Varela-Ramirez, Armando; Miranda, Manuel			PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination	PLOS ONE			English	Article							PROTEIN-KINASE-C; NEURONAL GLYCINE TRANSPORTER-2; NMDA RECEPTOR ACTIVATION; DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; PHORBOL-ESTER; REGULATED ENDOCYTOSIS; SURFACE EXPRESSION; TERMINAL DOMAIN; SYNTAXIN 1A	Neurotransmitter transporter ubiquitination is emerging as the main mechanism for endocytosis and sorting of cargo into lysosomes. In this study, we demonstrate PKC-dependent ubiquitination of three different isoforms of the glycine transporter 1 (GlyT1). Incubation of cells expressing transporter with the PKC activator phorbol ester induced a dramatic, time-dependent increase in GlyT1 ubiquitination, followed by accumulation of GlyT1 in EEA1 positive early endosomes. This occurred via a mechanism that was abolished by inhibition of PKC. GlyT1 endocytosis was confirmed in both retinal sections and primary cultures of mouse amacrine neurons. Replacement of only all lysines in the N- and C-termini to arginines prevented ubiquitination and endocytosis, displaying redundancy in the mechanism of ubiquitination. Interestingly, a 40-50% reduction in glycine uptake was detected in phorbol-ester stimulated cells expressing the WT-GlyT1, whereas no significant change was for the mutant protein, demonstrating that endocytosis participates in the reduction of uptake. Consistent with previous findings for the dopamine transporter DAT, ubiquitination of GlyT1 tails functions as sorting signal to deliver transporter into the lysosome and removal of ubiquitination sites dramatically attenuated the rate of GlyT1 degradation. Finally, we showed for the first time that PKC-dependent GlyT1 phosphorylation was not affected by removal of ubiquitination sites, suggesting separate PKC-dependent signaling events for these post-translational modifications.	[Miranda, Manuel] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Miranda, M (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	mmiranda3@utep.edu	Varela-Ramirez, Armando/ABI-4315-2020; Vargas Medrano, Javier/AAW-4666-2021	Varela-Ramirez, Armando/0000-0002-2071-4874; Vargas Medrano, Javier/0000-0002-5424-4225; Castrejon Tellez, Vicente/0000-0002-8518-6961	National Institutes of Mental Health (NIMH) [NIMH 5SC1MH 086070-04]; National Institute on Minority Health and Health Disparities (NIMHD-NIH) [2G12MD007592]; Vulnerability Issues in Drug Abuse (VIDA) [DA029989]; HHMI grant [52005908]; National Institute of General Medical Sciences, Research Initiative for Scientific Enhancement (NIGMS RISE) [R25 GM069621-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [SC1MH086070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA029989] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities (NIMHD-NIH); Vulnerability Issues in Drug Abuse (VIDA); HHMI grant(Howard Hughes Medical Institute); National Institute of General Medical Sciences, Research Initiative for Scientific Enhancement (NIGMS RISE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grant NIMH 5SC1MH 086070-04 to MM from the National Institutes of Mental Health (NIMH) and also in part by the grant 2G12MD007592 to the Border Biomedical Research Center at University of Texas at El Paso (UTEP) from the National Institute on Minority Health and Health Disparities (NIMHD-NIH) and by the Vulnerability Issues in Drug Abuse (VIDA) grant DA029989. SB was supported by a fellowship from the HHMI grant #52005908 and ERE by National Institute of General Medical Sciences, Research Initiative for Scientific Enhancement (NIGMS RISE) training grant R25 GM069621-10.	Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; de Juan-Sanz J, 2011, TRAFFIC; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; Gant VU, 2014, J VIROL, V88, P5912, DOI 10.1128/JVI.03032-13; Garcia-Tardon N, 2012, J BIOL CHEM, V287, P19177, DOI 10.1074/jbc.M112.355909; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hanley JG, 2000, J BIOL CHEM, V275, P840, DOI 10.1074/jbc.275.2.840; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Horiuchi M, 2005, J NEUROCHEM, V94, P307, DOI 10.1111/j.1471-4159.2005.03198.x; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Imamura Y, 2008, J NEUROCHEM, V105, P2454, DOI 10.1111/j.1471-4159.2008.05324.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Jursky F, 1996, J NEUROCHEM, V67, P336; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mohler H, 2011, BIOCHEM PHARMACOL, V81, P1065, DOI 10.1016/j.bcp.2011.02.003; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Mortensen OV, 2008, MOL BIOL CELL, V19, P2818, DOI 10.1091/mbc.E07-09-0980; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; SATO K, 1995, J NEUROCHEM, V65, P1967; Sheldon AL, 2008, NEUROCHEM INT, V53, P296, DOI 10.1016/j.neuint.2008.07.010; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sung U, 2003, J NEUROSCI, V23, P1697; Supplisson S, 1997, J NEUROSCI, V17, P4580; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Vargas-Medrano J, 2011, NEUROCHEM INT, V59, P1123, DOI 10.1016/j.neuint.2011.08.006; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Yamada H, 2012, BIOMED RES-TOKYO, V33, P1; Yang XF, 2013, J CELL SCI, V126, P4230, DOI 10.1242/jcs.128603; ZAFRA F, 1995, J NEUROSCI, V15, P3952	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138897	10.1371/journal.pone.0138897	http://dx.doi.org/10.1371/journal.pone.0138897			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418248	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400024
J	Fang, XM; Chen, FS; Wan, SZ; Yang, QP; Shi, JM				Fang, Xiang-Min; Chen, Fu-Sheng; Wan, Song-Ze; Yang, Qing-Pei; Shi, Jian-Min			Topsoil and Deep Soil Organic Carbon Concentration and Stability Vary with Aggregate Size and Vegetation Type in Subtropical China	PLOS ONE			English	Article							MICROBIAL BIOMASS; FOREST SOIL; LAND-USE; STOICHIOMETRIC CONTROLS; RAPID ACCUMULATION; MATTER; SEQUESTRATION; NITROGEN; STABILIZATION; DYNAMICS	The impact of reforestation on soil organic carbon (OC), especially in deep layer, is poorly understood and deep soil OC stabilization in relation with aggregation and vegetation type in afforested area is unknown. Here, we collected topsoil (0-15 cm) and deep soil (30-45 cm) from six paired coniferous forests (CF) and broad-leaved forests (BF) reforested in the early 1990s in subtropical China. Soil aggregates were separated by size by dry sieving and OC stability was measured by closed-jar alkali-absorption in 71 incubation days. Soil OC concentration and mean weight diameter were higher in BF than CF. The cumulative carbon mineralization (C-min, mgCO(2)-C kg(-1) soil) varied with aggregate size in BF and CF topsoils, and in deep soil, it was higher in larger aggregates than in smaller aggregates in BF, but not CF. The percentage of soil OC mineralized (SOCmin,% SOC) was in general higher in larger aggregates than in smaller aggregates. Meanwhile, SOCmin was greater in CF than in BF at topsoil and deep soil aggregates. In comparison to topsoil, deep soil aggregates generally exhibited a lower C-min, and higher SOCmin. Total nitrogen (N) and the ratio of carbon to phosphorus (C/P) were generally higher in BF than in CF in topsoil and deep soil aggregates, while the same trend of N/P was only found in deep soil aggregates. Moreover, the SOCmin negatively correlated with OC, total N, C/P and N/P. This work suggests that reforested vegetation type might play an important role in soil OC storage through internal nutrient cycling. Soil depth and aggregate size influenced OC stability, and deep soil OC stability could be altered by vegetation reforested about 20 years.	[Fang, Xiang-Min; Chen, Fu-Sheng; Wan, Song-Ze; Yang, Qing-Pei; Shi, Jian-Min] Jiangxi Agr Univ, Coll Forestry, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang 330045, Peoples R China	Jiangxi Agricultural University	Chen, FS (corresponding author), Jiangxi Agr Univ, Coll Forestry, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang 330045, Peoples R China.	chenfush@yahoo.com			National Basic Research Program of China (973 Program) [2012CB416903]; National Natural Science Foundation of China [31160107, 31360179]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Basic Research Program of China (973 Program, 2012CB416903) and the National Natural Science Foundation of China (31160107 & 31360179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2004, SOIL BIOL BIOCHEM, V36, P859, DOI 10.1016/j.soilbio.2004.02.004; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Blume E, 2002, APPL SOIL ECOL, V20, P171, DOI 10.1016/S0929-1393(02)00025-2; Buchkowski RW, 2015, ECOLOGY, V96, P1139, DOI 10.1890/14-1327.1; Casals P, 2014, PLANT SOIL, V374, P643, DOI 10.1007/s11104-013-1884-9; Chen FS, 2014, APPL SOIL ECOL, V75, P181, DOI 10.1016/j.apsoil.2013.11.011; Chen FS, 2014, GEODERMA, V214, P19, DOI 10.1016/j.geoderma.2013.10.009; Creamer CA, 2014, SOIL BIOL BIOCHEM, V79, P50, DOI 10.1016/j.soilbio.2014.08.019; Drury CF, 2004, SOIL TILL RES, V79, P87, DOI 10.1016/j.still.2004.03.020; Fang XM, 2014, CHINESE GEOGR SCI, V24, P297, DOI 10.1007/s11769-014-0670-9; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Gong X, 2013, FOREST ECOL MANAG, V300, P77, DOI 10.1016/j.foreco.2012.12.002; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Harper RJ, 2013, PLANT SOIL, V368, P641, DOI 10.1007/s11104-013-1600-9; Hirsch AI, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000921; Huang WJ, 2013, PLANT SOIL, V364, P181, DOI 10.1007/s11104-012-1355-8; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaiser C, 2014, ECOL LETT, V17, P680, DOI 10.1111/ele.12269; Kemper WD, 1986, METHODS SOIL ANAL 1; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Lewandrowski J, 2014, FOREST POLICY ECON, V38, P90, DOI 10.1016/j.forpol.2013.06.014; Li CH, 2013, PLANT SOIL, V369, P645, DOI 10.1007/s11104-013-1605-4; Li SZ, 2009, THESIS CENTRAL S U F; Liu Yuanqiu, 2005, Yingyong Shengtai Xuebao, V16, P1735; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Martens DA, 2000, SOIL BIOL BIOCHEM, V32, P361, DOI 10.1016/S0038-0717(99)00162-5; Nottingham AT, 2015, SOIL BIOL BIOCHEM, V80, P26, DOI 10.1016/j.soilbio.2014.09.012; Ota M, 2013, J GEOPHYS RES-BIOGEO, V118, P1646, DOI 10.1002/2013JG002379; Paul EA, 1997, SOIL SCI SOC AM J, V61, P1058, DOI 10.2136/sssaj1997.03615995006100040011x; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Puget P, 2000, EUR J SOIL SCI, V51, P595, DOI 10.1046/j.1365-2389.2000.00353.x; Qayyum MF, 2012, J ENVIRON QUAL, V41, P1210, DOI 10.2134/jeq2011.0058; Rabbi SMF, 2014, GEODERMA, V216, P10, DOI 10.1016/j.geoderma.2013.10.023; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Rumpel C, 2008, GEODERMA, V145, P347, DOI 10.1016/j.geoderma.2008.04.001; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sainju UM, 2006, SOIL SCI, V171, P937, DOI 10.1097/01.ss0000228062.30958.5a; Sanderman J, 2009, BIOGEOCHEMISTRY, V92, P41, DOI 10.1007/s10533-008-9249-9; SCHARPENSEEL HW, 1989, SCI TOTAL ENVIRON, V81-2, P99, DOI 10.1016/0048-9697(89)90115-0; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J., 2002, ENCY SOIL SCI, P936, DOI DOI 10.1081/E-ESS-120001812; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; Sommer R, 2000, PLANT SOIL, V219, P231, DOI 10.1023/A:1004772301158; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wei XH, 2013, FOREST ECOL MANAG, V300, P60, DOI 10.1016/j.foreco.2012.06.018; Wei XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032054; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wigley BJ, 2013, ACTA OECOL, V51, P17, DOI 10.1016/j.actao.2013.05.007; Xie JS, 2013, FOREST ECOL MANAG, V300, P53, DOI 10.1016/j.foreco.2012.06.038; Zou LQ, 2015, CAN J FOREST RES, V45, P26, DOI 10.1139/cjfr-2014-0275	64	32	37	9	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139380	10.1371/journal.pone.0139380	http://dx.doi.org/10.1371/journal.pone.0139380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418563	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400086
J	Frey, S; Reschka, EJ; Poggeler, S				Frey, Stefan; Reschka, Eva J.; Poeggeler, Stefanie			Germinal Center Kinases SmKIN3 and SmKIN24 Are Associated with the Sordaria macrospora Striatin-Interacting Phosphatase and Kinase (STRIPAK) Complex	PLOS ONE			English	Article							SEPTATION INITIATION NETWORK; PROTEIN-PROTEIN INTERACTIONS; FRUITING BODY DEVELOPMENT; MATING-TYPE GENES; SEXUAL DEVELOPMENT; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; ASCOSPORE GERMINATION; ENDOPLASMIC-RETICULUM	The striatin-interacting phosphatase and kinase (STRIPAK) complex is composed of striatin, protein phosphatase PP2A and protein kinases that regulate development in animals and fungi. In the filamentous ascomycete Sordaria macrospora, it is required for fruitingbody development and cell fusion. Here, we report on the presence and function of STRI-PAK-associated kinases in ascomycetes. Using the mammalian germinal center kinases (GCKs) MST4, STK24, STK25 and MINK1 as query, we identified the two putative homologs SmKIN3 and SmKIN24 in S. macrospora. A BLASTP search revealed that both kinases are conserved among filamentous ascomycetes. The physical interaction of the striatin homolog PRO11 with SmKIN3 and SmKIN24 were verified by yeast two-hybrid (Y2H) interaction studies and for SmKIN3 by co-Immunoprecipitation (co-IP). In vivo localization found that both kinases were present at the septa and deletion of both Smkin3 and Smkin24 led to abnormal septum distribution. While deletion of Smkin3 caused larger distances between adjacent septa and increased aerial hyphae, deletion of Smkin24 led to closer spacing of septa and to sterility. Although phenotypically distinct, both kinases appear to function independently because the double-knockout strain Delta Smkin3/Delta Smkin24 displayed the combined phenotypes of each single-deletion strain.	[Frey, Stefan; Reschka, Eva J.; Poeggeler, Stefanie] Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany; [Poeggeler, Stefanie] Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Poggeler, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany.	spoegge@gwdg.de			Deutsche Forschungsgemeinschaft (DFG) [PO523/4-1, PO523/4-2]; Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft) [GSC 226/1, GSC 226/2]; Hans-Bockler Stiftung [Forder-Nr 377645]; Gottingen University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft); Hans-Bockler Stiftung; Gottingen University	Deutsche Forschungsgemeinschaft (DFG) (Grants PO523/4-1, PO523/4-2) SP. SF and EJR were supported by the Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft Grants GSC 226/1, GSC 226/2), EJR was supported by the Hans-Bockler Stiftung (Forder-Nr 377645). The authors acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker D M, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1307s27; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Bernhards Y, 2011, CURR GENET, V57, P133, DOI 10.1007/s00294-010-0333-z; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Boyce KJ, 2011, TRENDS MICROBIOL, V19, P400, DOI 10.1016/j.tim.2011.04.006; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chen CC, 2014, J BIOL CHEM, V289, P9651, DOI 10.1074/jbc.M113.529297; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Dettmann A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004762; Dettmann A, 2013, MOL MICROBIOL, V90, P796, DOI 10.1111/mmi.12399; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Dirschnabel DE, 2014, GENETICS, V196, P729, DOI 10.1534/genetics.113.159368; Dvash E, 2010, EUKARYOT CELL, V9, P502, DOI 10.1128/EC.00230-09; Elleuche S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005177; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; ESSER K, 1982, CRYPTOGAMS CYANAOBAC; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Frey S, 2015, MOL MICROBIOL, V97, P676, DOI 10.1111/mmi.13054; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heilig Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004306; Heilig Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079464; Hergovich A, 2012, SEMIN CELL DEV BIOL, V23, P794, DOI 10.1016/j.semcdb.2012.04.001; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Hyodo T, 2012, J BIOL CHEM, V287, P25019, DOI 10.1074/jbc.M112.372342; Jacobsen S, 2002, CURR GENET, V41, P150, DOI 10.1007/s00294-002-0276-0; James P, 1996, GENETICS, V144, P1425; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Kawabata T, 2007, FUNGAL GENET NEWSL, V54, P5, DOI [10.4148/1941-4765.1096, DOI 10.4148/1941-4765.1096]; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Kuck U, 2009, MYCOTA, V15, P17; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai FJ, 2011, FEMS YEAST RES, V11, P72, DOI 10.1111/j.1567-1364.2010.00691.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WS, 2004, FEBS LETT, V572, P41, DOI 10.1016/j.febslet.2004.07.007; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; Delgado-Alvarez DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096744; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Maerz S, 2010, CURR OPIN MICROBIOL, V13, P663, DOI 10.1016/j.mib.2010.08.010; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Masloff S, 1999, GENETICS, V152, P191; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Morrell JL, 2004, CURR BIOL, V14, P579, DOI 10.1016/j.cub.2004.03.036; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Nordzieke S, 2015, EUKARYOT CELL, V14, P345, DOI 10.1128/EC.00241-14; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2007, MOL MICROBIOL, V64, P923, DOI 10.1111/j.1365-2958.2007.05694.x; Nowrousian M, 2012, G3-GENES GENOM GENET, V2, P261, DOI 10.1534/g3.111.001479; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Poggeler S, 2004, EUKARYOT CELL, V3, P232, DOI 10.1128/EC.3.1.232-240.2004; Poggeler S, 1997, J MICROBIOL METH, V29, P49, DOI 10.1016/S0167-7012(97)00018-3; Poggeler S, 1997, GENETICS, V147, P567; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Poggeler S, 2006, MYCOTA, P325; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Pracheil T, 2013, J BIOL CHEM, V288, P16986, DOI 10.1074/jbc.M113.451674; Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305; Ray S, 2010, J CELL BIOL, V190, P793, DOI 10.1083/jcb.201002055; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sambrook J., 2001, MOL CLONING LAB MANU; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Teichert I., 2014, ADV GENET, V87, P201; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wang CL, 2010, FUNGAL GENET BIOL, V47, P789, DOI 10.1016/j.fgb.2010.06.007; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Wu HY, 2011, INT J BIOCHEM CELL B, V43, P742, DOI 10.1016/j.biocel.2011.01.015; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	90	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139163	10.1371/journal.pone.0139163	http://dx.doi.org/10.1371/journal.pone.0139163			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418262	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400055
J	Portero, R; Quaine, F; Cahouet, V; Leouffre, M; Serviere, C; Portero, P				Portero, Raphael; Quaine, Franck; Cahouet, Violaine; Leouffre, Marc; Serviere, Christine; Portero, Pierre			Influence of Cervical Muscle Fatigue on Musculo-Tendinous Stiffness of the Head-Neck Segment during Cervical Flexion	PLOS ONE			English	Article							MYOFIBRILLAR FATIGUE; EXTENSOR MUSCLES; SPINAL STABILITY; ACTIVATION; FAILURE; FIBERS	Aim The aim of this study is to determine if the fatigue of cervical muscles has a significant influence on the head-neck segment musculo-tendinous stiffness. Methods Ten men (aged 21.2 +/- 1.9 years) performed four quick-release trials of flexion at 30 and 50% MVC before and after the induction of muscular fatigue on cervical flexors. Electromyographic activity was recorded on the sternocleidomastoids (SCM) and spinal erectors (SE), bilaterally. Musculo-tendinous stiffness was calculated through the quick-release method adapted to the head-neck segment. Results We noticed a significant linear increase of the head-neck segment musculo-tendinous stiffness with the increase of exertion level both before (P < 0.0001) and after the fatigue procedure (P < 0.0001). However, this linear relationship was not different before and after the fatigue procedure. EMG analysis revealed a significant increase of the root mean square for the right SCM (P = 0.0002), the left SCM (P < 0.0001), the right SE (P < 0.0001), and the left SE (P < 0.0001) and a significant decrease of the median power frequency only for the right (P = 0.0006) and the left (P = 0.0003) SCM with muscular fatigue. Discussion We did not find significant changes in the head-neck segment musculo-tendinous stiffness with fatigue of cervical muscles. We found a significant increase in EMG activity in the SCM and the SE after the induction of fatigue of the SCM. Our findings suggest that with fatigue of cervical flexors, neck muscle activity is modulated in order to maintain the musculo-tendinous stiffness at a steady state.	[Portero, Raphael; Quaine, Franck; Cahouet, Violaine; Leouffre, Marc; Serviere, Christine] Univ Grenoble 1, UMR CNRS 5216, GIPSA Lab, Dept Automat, Grenoble, France; [Portero, Pierre] Univ Paris Est, UPEC, Bioingn Tissus & Neuroplasticite, EA 7377, Creteil, France; [Portero, Raphael; Portero, Pierre] Hop Rothschild, AP HP, Serv Reeduc Neuroorthoped, F-75571 Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite	Portero, P (corresponding author), Univ Paris Est, UPEC, Bioingn Tissus & Neuroplasticite, EA 7377, Creteil, France.	pierre.portero@u-pec.fr		Portero, Raphael/0000-0003-3406-1736				Basmajian J., 1985, MUSCLES ALIVE THEIR; Cholewicki J, 1997, SPINE, V22, P2207, DOI 10.1097/00007632-199710010-00003; Cornu C, 2001, J PHYSIOL-LONDON, V533, P605, DOI 10.1111/j.1469-7793.2001.0605a.x; Dupeyron A, 2010, J ELECTROMYOGR KINES, V20, P426, DOI 10.1016/j.jelekin.2009.05.004; EDMAN KAP, 1990, J PHYSIOL-LONDON, V424, P133, DOI 10.1113/jphysiol.1990.sp018059; EDMAN KAP, 1992, J PHYSIOL-LONDON, V457, P655, DOI 10.1113/jphysiol.1992.sp019400; Edman KAP, 1995, ADV EXP MED BIOL, V384, P29; Edwards R H, 1981, Ciba Found Symp, V82, P1; Enoka M, 2008, J PHYSL, V586, P11; Ettema GJC, 1997, EXP PHYSIOL, V82, P107, DOI 10.1113/expphysiol.1997.sp004001; GOUBEL F, 1973, ARCH INT PHYSIOL BIO, V81, P697; Granata KP, 2001, J BIOMECH, V34, P1117, DOI 10.1016/S0021-9290(01)00081-1; Granata KR, 2004, HUM FACTORS, V46, P81, DOI 10.1518/hfes.46.1.81.30391; Grondin Diane E, 2009, J Electromyogr Kinesiol, V19, pe237, DOI 10.1016/j.jelekin.2008.05.006; Herrmann CM, 2006, J ELECTROMYOGR KINES, V16, P637, DOI 10.1016/j.jelekin.2005.11.004; Lambertz D, 2008, J BIOMECH, V41, P3270, DOI 10.1016/j.jbiomech.2008.08.022; Oksa J, 1999, AVIAT SPACE ENVIR MD, V70, P556; Oksa J, 1996, AVIAT SPACE ENVIR MD, V67, P1138; Piscione J., 2004, Archives of Physiology and Biochemistry, V112, P74; Portero R, 2013, J BIOMECH, V46, P925, DOI 10.1016/j.jbiomech.2012.12.009; Rezasoltani A, 2005, BRIT J SPORT MED, V39, P440, DOI 10.1136/bjsm.2004.013961; Richmond F.J., 1988, CONTROL HEAD MOVEMEN, P1; Sacher N, 2012, TRAFFIC INJ PREV, V13, P529, DOI 10.1080/15389588.2012.672783; Sanchez-Zuriaga D, 2010, SPINE, V35, P517; Sanchez-Zuriaga D, 2010, SPINE, V35, P517, DOI 10.1097/BRS.0b013e3181b967ea; Schieppati M, 2003, NEUROSCIENCE, V121, P277, DOI 10.1016/S0306-4522(03)00439-1; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Sparto PJ, 1998, SPINE, V23, P2563, DOI 10.1097/00007632-199812010-00011; Sparto PJ, 1997, J SPINAL DISORD, V10, P145; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x; VIGREUX B, 1980, EUR J APPL PHYSIOL O, V45, P11, DOI 10.1007/BF00421196; Zajac FE, 1989, CRC CRITICAL REV BIO, V17, P359; Zhang LQ, 2001, J NEUROPHYSIOL, V86, P1086, DOI 10.1152/jn.2001.86.3.1086	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139333	10.1371/journal.pone.0139333	http://dx.doi.org/10.1371/journal.pone.0139333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418000	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400079
J	Chowers, M; Carmeli, Y; Shitrit, P; Elhayany, A; Geffen, K				Chowers, Michal; Carmeli, Yehuda; Shitrit, Pnina; Elhayany, Asher; Geffen, Keren			Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; HOSPITAL ADMISSION; COLONIZATION; SURVEILLANCE; BACTEREMIA; DESTROY; SEARCH; RISK	Introduction Our objective was to assess the cost implications of a vertical MRSA prevention program that led to a reduction in MRSA bacteremia. Methods We performed a matched historical cohort study and cost analysis in a single hospital in Israel for the years 2005-2011. The cost of MRSA bacteremia was calculated as total hospital cost for patients admitted with bacteremia and for patients with hospital-acquired bacteremia, the difference in cost compared to matched controls. The cost of prevention was calculated as the sum of the cost of microbiology tests, single-use equipment used for patients in isolation, and infection control personnel. Results An average of 20,000 patients were screened yearly. The cost of prevention was $208,100 per year, with the major contributor being laboratory cost. We calculated that our intervention averted 34 cases of bacteremia yearly: 17 presenting on admission and 17 acquired in the hospital. The average cost of a case admitted with bacteremia was $14,500, and the net cost attributable to nosocomial bacteremia was $9,400. Antibiotics contributed only 0.4% of the total disease management cost. When the annual cost of averted cases of bacteremia and that of prevention were compared, the intervention resulted in annual cost savings of $199,600. Conclusions A vertical MRSA prevention program targeted at high-risk patients, which was highly effective in preventing bacteremia, is cost saving. These results suggest that allocating resources to targeted prevention efforts might be beneficial even in a single institution in a high incidence country.	[Chowers, Michal; Shitrit, Pnina] Meir Med Ctr, Infect Dis Unit, Kefar Sava, Israel; [Chowers, Michal; Carmeli, Yehuda; Shitrit, Pnina] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Med Ctr & Sch Med, Natl Ctr Infect & Antibiot Resistance Control, Tel Aviv, Israel; [Elhayany, Asher] Bar Ilan Univ, Dept Management, Ramat Gan, Israel; [Geffen, Keren] Meir Med Ctr, Dept Econ, Kefar Sava, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine	Chowers, M (corresponding author), Meir Med Ctr, Infect Dis Unit, Kefar Sava, Israel.	chowersm@post.tau.ac.il		Chowers, Michal/0000-0001-6148-254X	Israel National Institute for Health Policy Research [2011/164]	Israel National Institute for Health Policy Research	This work was supported by the Israel National Institute for Health Policy Research (2011/164).	Chowers MY, 2009, INFECT CONT HOSP EP, V30, P778, DOI 10.1086/599019; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; European Antimicrobial Resistance Surveillance System (EARSS), 2009, EARSS ANN REP 2008 O; Farbman L, 2013, CLIN MICROBIOL INFEC, V19, pE582, DOI 10.1111/1469-0691.12280; Fatkenheuer G, 2014, LANCET; Gavalda L, 2006, INFECT CONT HOSP EP, V27, P1264, DOI 10.1086/507968; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jones M, 2014, CLIN INFECT DIS, V58, P32, DOI 10.1093/cid/cit668; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Rubio-Terres C, 2010, CLIN MICROBIOL INFEC, V16, P722, DOI 10.1111/j.1469-0691.2009.02902.x; Schulgen G, 2000, J CLIN EPIDEMIOL, V53, P409, DOI 10.1016/S0895-4356(99)00182-1; Septimus E, 2014, INFECT CONT HOSP EP, V35, P797, DOI [10.1086/676535, 10.1017/S0899823X00193808]; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Tubbicke A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-438; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vos MC, 2005, J CLIN MICROBIOL, V43, P2034, DOI 10.1128/JCM.43.4.2034-2035.2005; Wassenberg MWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011562; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; West TE, 2006, INFECT CONT HOSP EP, V27, P233, DOI 10.1086/500372	22	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138999	10.1371/journal.pone.0138999	http://dx.doi.org/10.1371/journal.pone.0138999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406889	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700142
J	Ding, GH; Li, CY; Han, X; Chi, CY; Zhang, DW; Liu, BD				Ding, Guohua; Li, Chunye; Han, Xu; Chi, Chunyu; Zhang, Dawei; Liu, Baodong			Effects of Lead on Ultrastructure of Isoetes sinensis Palmer (Isoetaceae), a Critically Endangered Species in China	PLOS ONE			English	Article							ACCUMULATION	Isoetes sinensis Palmer (Isoetaceae) is a critically endangered fern that is a marsh plant (that is an aquatic or amphibious plant) in China. To evaluate damage or influence of lead (Pb) on cell ultrastructure in I. sinensis, we used 2000 mg.L-1 Pb(NO3)(2) solution to treat I. sinensis for 35d, and used transmission electron microscope (TEM) to observe the cell ultrastructure of leaf blades and roots of the plant. Our results indicated that Pb induced distinct changes of the organelles including chloroplast, mitochondria, nucleolus and vacuole. The level of damage organ was lower leaf > upper leaf > root The typical performance of the damages caused by lead shown that part of the nucleolus cracked; the cristae dilated, matrix vacuolized and membrane structure blurred in mitochondria; the vacuole cracked; grana lamella decreased, stroma lamella loosed, starch grains decreased, and membrane structure was disrupted in chloroplasts; Pb deposits were present on cell wall. The damages to chloroplasts and mitochondria were relatively severe, while damage to the nucleus was relatively lighter. The damage to the cell ultrastructure of leaf blades with direct contact with Pb was more severe than that without direct contact with Pb.	[Ding, Guohua; Chi, Chunyu; Liu, Baodong] Key Lab Plant Biol Coll Heilongjiang Prov, Harbin 150025, Peoples R China; [Ding, Guohua; Li, Chunye; Han, Xu; Chi, Chunyu; Liu, Baodong] Harbin Normal Univ, Coll Life Sci & Technol, Harbin 150025, Peoples R China; [Zhang, Dawei] Harbin Normal Univ, Modern Expt Ctr, Harbin 150025, Peoples R China	Harbin Normal University; Harbin Normal University	Liu, BD (corresponding author), Key Lab Plant Biol Coll Heilongjiang Prov, Harbin 150025, Peoples R China.	99bd@163.com	Ding, Guohua/L-3429-2013	Ding, Guohua/0000-0002-1714-5324	National Science Foundation of China [31170294]; Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Heilongjiang Province; Harbin Normal University [KJTD2011-2]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Heilongjiang Province; Harbin Normal University	The paper was supported by the National Science Foundation of China (31170294) and by the Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Heilongjiang Province and Harbin Normal University (KJTD2011-2).	Alkhatib R, 2012, BIOL PLANTARUM, V56, P711, DOI 10.1007/s10535-012-0241-9; Chen YY, 2012, AQUAT BOT, V96, P52, DOI 10.1016/j.aquabot.2011.09.001; DOLLARD GJ, 1986, ENVIRON POLLUT A, V40, P109, DOI 10.1016/0143-1471(86)90078-4; IRMER U, 1986, ENVIRON EXP BOT, V26, P97, DOI 10.1016/0098-8472(86)90002-X; Jiang XingYu, 2001, Chinese Journal of Applied and Environmental Biology, V7, P92; Kang M, 2005, ANN BOT-LONDON, V96, P1265, DOI 10.1093/aob/mci277; Kaur G, 2013, PROTOPLASMA, V250, P53, DOI 10.1007/s00709-011-0372-4; Krzeslowska M, 1996, BIOL PLANTARUM, V38, P253, DOI 10.1007/BF02873855; Li ZZ, 2012, AM J BOT, V99, pE184, DOI 10.3732/ajb.1100319; Liu Yansheng, 2007, Chinese Journal of Applied and Environmental Biology, V13, P647; Poonanm G, 1994, APOSSIBLE BIOINDICAT, V44, P201; Rebechin H, 1972, J CELL BIOL, V55, P213; Wang JY, 2005, J NATURAL HIST INT J, V60, P358; Wiwanitkit Viroj, 2008, Indian J Occup Environ Med, V12, P116, DOI 10.4103/0019-5278.44692; Zhang H, 2014, J PHOTOCH PHOTOBIO B, V136, P46, DOI 10.1016/j.jphotobiol.2014.04.020; Zhang ZW, 2014, ENVIRON SCI POLLUT R, V21, P11938, DOI 10.1007/s11356-014-3100-8	16	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139231	10.1371/journal.pone.0139231	http://dx.doi.org/10.1371/journal.pone.0139231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407078	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700194
J	Ruff, M; Leyme, A; Le Cann, F; Bonnier, D; Le Seyec, J; Chesnel, F; Fattet, L; Rimokh, R; Baffet, G; Theret, N				Ruff, Michael; Leyme, Anthony; Le Cann, Fabienne; Bonnier, Dominique; Le Seyec, Jacques; Chesnel, Franck; Fattet, Laurent; Rimokh, Ruth; Baffet, Georges; Theret, Nathalie			The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-beta-Induced Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							CELL LUNG CARCINOMAS; HUMAN BREAST-CANCER; MELTRIN-ALPHA; TUMOR PROGRESSION; EXPRESSION; GENE; PROLIFERATION; SMAD3; INDUCTION; SIGNATURE	The increased expression of the Disintegrin and Metalloprotease ADAM12 has been associated with human cancers, however its role remain unclear. We have previously reported that ADAM12 expression is induced by the transforming growth factor, TGF-beta and promotes TGF-beta-dependent signaling through interaction with the type II receptor of TGF-beta. Here we explore the implication of ADAM12 in TGF-beta-mediated epithelial to mesenchymal transition (EMT), a key process in cancer progression. We show that ADAM12 expression is correlated with EMT markers in human breast cancer cell lines and biopsies. Using a non-malignant breast epithelial cell line (MCF10A), we demonstrate that TGF-beta-induced EMT increases expression of the membrane-anchored ADAM12L long form. Importantly, ADAM12L overexpression in MCF10A is sufficient to induce loss of cell-cell contact, reorganization of actin cytoskeleton, up-regulation of EMT markers and chemoresistance. These effects are independent of the proteolytic activity but require the cytoplasmic tail and are specific of ADAM12L since overexpression of ADAM12S failed to induce similar changes. We further demonstrate that ADAM12L-dependent EMT is associated with increased phosphorylation of Smad3, Akt and ERK proteins. Conversely, inhibition of TGF-beta receptors or ERK activities reverses ADAM12L-induced mesenchymal phenotype. Together our data demonstrate that ADAM12L is associated with EMT and contributes to TGF-beta-dependent EMT by favoring both Smad-dependent and Smad-independent pathways.	[Ruff, Michael; Leyme, Anthony; Le Cann, Fabienne; Bonnier, Dominique; Le Seyec, Jacques; Baffet, Georges; Theret, Nathalie] Univ Rennes 1, IRSET, INSERM U1085, Rennes, France; [Chesnel, Franck] Univ Rennes 1, CNRS IGDR UMR6290, Rennes, France; [Fattet, Laurent; Rimokh, Ruth] Ctr Rech Cancerol Lyon, INSERM U1052, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Theret, N (corresponding author), Univ Rennes 1, IRSET, INSERM U1085, Rennes, France.	nathalie.theret@univ-rennes1.fr	theret, nathalie/ABG-6780-2020; Fattet, Laurent/ABH-5434-2020; LI, HUI/G-1227-2011; Baffet, Georges/I-2574-2015; FATTET, Laurent/W-8392-2019; Theret, Nathalie/I-2871-2015; Le Seyec, Jacques/J-5680-2015; Baffet, Georges/M-1583-2016; Rimokh, Ruth/G-7506-2014; Le Seyec, Jacques/GLU-3933-2022	theret, nathalie/0000-0002-5857-7828; Fattet, Laurent/0000-0001-5152-4937; LI, HUI/0000-0002-4114-8349; Theret, Nathalie/0000-0002-5857-7828; Le Seyec, Jacques/0000-0002-1118-3311	Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale Contre le Cancer	Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale Contre le Cancer	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bourd-Boittin K, 2008, J BIOL CHEM, V283, P26000, DOI 10.1074/jbc.M709829200; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; DeMaio L, 2012, J PATHOL, V226, P633, DOI 10.1002/path.3016; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Frohlich C, 2011, MOL CANCER RES, V9, P1449, DOI 10.1158/1541-7786.MCR-11-0100; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gruel Jeremy, 2009, BMC Res Notes, V2, P193, DOI 10.1186/1756-0500-2-193; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim JJ, 2014, STEM CELLS, V32, P1468, DOI 10.1002/stem.1675; Kim YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040820; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Kornberg LJ, 2005, LARYNGOSCOPE, V115, P690, DOI 10.1097/01.mlg.0000161333.67977.93; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Leyme A, 2012, MOL BIOL CELL, V23, P3461, DOI 10.1091/mbc.E11-11-0918; Li H, 2013, BREAST CANCER RES TR, V139, P691, DOI 10.1007/s10549-013-2602-2; Li H, 2012, BREAST CANCER RES TR, V135, P759, DOI 10.1007/s10549-012-2220-4; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masaki M, 2005, ENDOCRINOLOGY, V146, P1752, DOI 10.1210/en.2004-1082; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Narita D, 2010, ROM J MORPHOL EMBRYO, V51, P669; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Okano K, 2006, J BIOL CHEM, V281, P26196, DOI 10.1074/jbc.M606710200; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Qi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092536; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rocks N, 2008, CELL PROLIFERAT, V41, P988, DOI 10.1111/j.1365-2184.2008.00557.x; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Shao SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085936; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thodeti CK, 2005, FEBS LETT, V579, P5589, DOI 10.1016/j.febslet.2005.09.024; Tian BL, 2002, J CLIN PATHOL-MOL PA, V55, P394, DOI 10.1136/mp.55.6.394; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	62	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139179	10.1371/journal.pone.0139179	http://dx.doi.org/10.1371/journal.pone.0139179			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407179	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700185
J	Fabris, S; MacLean, DA				Fabris, Sergio; MacLean, David A.			Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy	PLOS ONE			English	Article							INDUCED CARDIOTOXICITY; ADENOSINE CONCENTRATIONS; CARDIAC-MUSCLE; NITRIC-OXIDE; ADRIAMYCIN; TISSUE; RAT; ANTHRACYCLINES; ACCUMULATION; APOPTOSIS	Doxorubicin remains one of the most widely used chemotherapeutic agents however its effect on healthy tissue, such as skeletal muscle, remains poorly understood. The purpose of the current study was to examine the accumulation of doxorubicin (DOX) and its metabolite doxorubicinol (DOXol) in skeletal muscle of the rat up to 8 days after the administration of a 1.5 or 4.5 mg kg(-1) i.p. dose. Subsequent to either dose, DOX and DOXol were observed in skeletal muscle throughout the length of the experiment. Interestingly an efflux of DOX was examined after 96 hours, followed by an apparent re-uptake of the drug which coincided with a spike and rapid decrease of plasma DOX concentrations. The interstitial space within the muscle did not appear to play a significant rate limiting compartment for the uptake or release of DOX or DOXol from the tissue to the circulation. Furthermore, there was no evidence that DOX preferentially accumulated in a specific muscle group with either dose. It appears that the sequestering of drug in skeletal muscle plays an acute and important role in the systemic availability and metabolism of DOX which may have a greater impact on the clinical outcome than previously considered.	[Fabris, Sergio; MacLean, David A.] Laurentian Univ, Biomol Sci, Sudbury, ON P3E 2C6, Canada; [MacLean, David A.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [MacLean, David A.] Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada	Laurentian University; Northern Ontario School of Medicine; Northern Ontario School of Medicine	Fabris, S (corresponding author), Laurentian Univ, Biomol Sci, Sudbury, ON P3E 2C6, Canada.	fabris.sergio@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp) to DAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AB, 2004, J AM CHEM SOC, V126, P9168, DOI 10.1021/ja0492539; Arnold RD, 2004, J CHROMATOGR B, V808, P141, DOI 10.1016/j.jchromb.2004.04.030; Arola OJ, 2000, CANCER RES, V60, P1789; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Bains OS, 2010, J PHARMACOL EXP THER, V332, P755, DOI 10.1124/jpet.109.160614; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; BOUCEK RJ, 1987, J BIOL CHEM, V262, P15851; CIACCIO M, 1993, ARCH BIOCHEM BIOPHYS, V302, P103, DOI 10.1006/abbi.1993.1186; CUSACK BJ, 1993, CANCER CHEMOTH PHARM, V32, P53, DOI 10.1007/BF00685876; DELGADO JMR, 1972, ARCH INT PHARMACOD T, V198, P9; DOROSHOW JH, 1985, AM J PATHOL, V118, P288; Erzen I, 2011, PHYSIOL RES, V60, P1, DOI 10.33549/physiolres.931988; GEORGES E, 1990, P NATL ACAD SCI USA, V87, P152, DOI 10.1073/pnas.87.1.152; Gibson NM, 2014, XENOBIOTICA, V44, P472, DOI 10.3109/00498254.2013.846489; Gilliam LAA, 2011, ANTIOXID REDOX SIGN, V15, P2543, DOI 10.1089/ars.2011.3965; GOORMAGHTIGH E, 1990, BIOPHYS CHEM, V35, P247, DOI 10.1016/0301-4622(90)80012-V; Guerra J, 2005, HEMATOL J, V5, P584, DOI 10.1038/sj.thj.6200573; Hayward R, 2013, J PHYSIOL BIOCHEM, V69, P177, DOI 10.1007/s13105-012-0200-0; Heibein AD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-381; Hellsten Y, 1998, CIRCULATION, V98, P6, DOI 10.1161/01.CIR.98.1.6; Iqbal M, 2008, PHARMACOL REP, V60, P382; JENSEN RA, 1984, J CARDIOVASC PHARM, V6, P186; Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251; Leuenberger UA, 2008, EUR J APPL PHYSIOL, V102, P457, DOI 10.1007/s00421-007-0601-x; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Lim S, 2013, INT J BIOCHEM CELL B, V45, P1784, DOI 10.1016/j.biocel.2013.05.025; MacLean DA, 1998, CIRCULATION, V98, P1990, DOI 10.1161/01.CIR.98.19.1990; MacLean DA, 2001, AM J PHYSIOL-HEART C, V280, pH546, DOI 10.1152/ajpheart.2001.280.2.H546; MacLean DA, 1999, J APPL PHYSIOL, V87, P1483, DOI 10.1152/jappl.1999.87.4.1483; Mahnik SN, 2006, CHEMOSPHERE, V65, P1419, DOI 10.1016/j.chemosphere.2006.03.069; Minotti G, 1998, FASEB J, V12, P541, DOI 10.1096/fasebj.12.7.541; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Mordente A, 2009, CURR MED CHEM, V16, P1656, DOI 10.2174/092986709788186228; Murakami S, 2010, ACTA MED OKAYAMA, V64, P11; MUSHLIN PS, 1993, BRIT J PHARMACOL, V110, P975, DOI 10.1111/j.1476-5381.1993.tb13909.x; Nagi MN, 2000, PHARMACOL RES, V41, P283, DOI 10.1006/phrs.1999.0585; OLSON RD, 1988, P NATL ACAD SCI USA, V85, P3585, DOI 10.1073/pnas.85.10.3585; PETERS JH, 1981, CANCER CHEMOTH PHARM, V7, P65; Sacco G, 2003, BRIT J PHARMACOL, V139, P641, DOI 10.1038/sj.bjp.0705270; Shin M, 2010, HISTOCHEM CELL BIOL, V133, P677, DOI 10.1007/s00418-010-0700-3; SKOVSGAARD T, 1982, PHARMACOL THERAPEUT, V18, P293, DOI 10.1016/0163-7258(82)90034-1; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Teraoka K, 2000, EUR J HEART FAIL, V2, P373, DOI 10.1016/S1388-9842(00)00111-2; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; van Asperen J, 1999, BRIT J CANCER, V79, P108, DOI 10.1038/sj.bjc.6690019; van Norren K, 2009, BRIT J CANCER, V100, P311, DOI 10.1038/sj.bjc.6604858; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yu AP, 2014, ACTA PHYSIOL, V211, P201, DOI 10.1111/apha.12263	51	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139070	10.1371/journal.pone.0139070	http://dx.doi.org/10.1371/journal.pone.0139070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401619	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100057
J	Nichols, TA; Anderson, TW; Sirovic, A				Nichols, Tye A.; Anderson, Todd W.; Sirovic, Ana			Intermittent Noise Induces Physiological Stress in a Coastal Marine Fish	PLOS ONE			English	Article							PLASMA-CORTISOL LEVELS; ANTHROPOGENIC NOISE; ATLANTIC SALMON; RESPONSES; SOUND; CORTICOSTERONE; HEARING; BEHAVIOR; IMPACTS; NOVELTY	Anthropogenic noise in the ocean has increased substantially in recent decades, and motorized vessels produce what is likely the most common form of underwater noise pollution. Noise has the potential to induce physiological stress in marine fishes, which may have negative ecological consequences. In this study, physiological effects of increased noise (playback of boat noise recorded in the field) on a coastal marine fish (the giant kelpfish, Heterostichus rostratus) were investigated by measuring the stress responses (cortisol concentration) of fish to increased noise of various temporal dynamics and noise levels. Giant kelpfish exhibited acute stress responses when exposed to intermittent noise, but not to continuous noise or control conditions (playback of recorded natural ambient sound). These results suggest that variability in the acoustic environment may be more important than the period of noise exposure for inducing stress in a marine fish, and provide information regarding noise levels at which physiological responses occur.	[Nichols, Tye A.; Anderson, Todd W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Nichols, Tye A.; Anderson, Todd W.] San Diego State Univ, Coastal & Marine Inst, San Diego, CA 92182 USA; [Sirovic, Ana] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Nichols, TA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tyenichs@gmail.com			California State University Council on Ocean Affairs, Science Technology [CSUCOAST-TYENIC-SDSU-AY1213]	California State University Council on Ocean Affairs, Science Technology	TN received funding from The California State University Council on Ocean Affairs, Science & Technology in the form of a COAST Graduate Student Award for Marine Science Research. Award #: CSUCOAST-TYENIC-SDSU-AY1213. Funding institution website: http://www.calstate.edu/coast/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalbers SA, 2008, T AM FISH SOC, V137, P542, DOI 10.1577/T04-058.1; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Anderson PA, 2011, AQUACULTURE, V311, P129, DOI 10.1016/j.aquaculture.2010.11.013; Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; BARTON BA, 1988, PROG FISH CULT, V50, P16, DOI 10.1577/1548-8640(1988)050&lt;0016:FADCAS&gt;2.3.CO;2; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; BASSETT JR, 1973, PHYSIOL BEHAV, V10, P901, DOI 10.1016/0031-9384(73)90060-7; Bruintjes R, 2013, ANIM BEHAV, V85, P1343, DOI 10.1016/j.anbehav.2013.03.025; Buscaino G, 2010, MAR ENVIRON RES, V69, P136, DOI 10.1016/j.marenvres.2009.09.004; Campeau S, 1997, J NEUROENDOCRINOL, V9, P577; DEBOER SF, 1989, PHYSIOL BEHAV, V45, P789, DOI 10.1016/0031-9384(89)90296-5; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; FEIST G, 1990, GEN COMP ENDOCR, V80, P299, DOI 10.1016/0016-6480(90)90174-K; Finfer DC, 2008, APPL ACOUST, V69, P464, DOI 10.1016/j.apacoust.2007.05.008; Graham AL, 2008, AQUAT CONSERV, V18, P1315, DOI 10.1002/aqc.941; GUE M, 1987, DIGEST DIS SCI, V32, P1411, DOI 10.1007/BF01296668; Haviland-Howell G, 2007, J ACOUST SOC AM, V122, P151, DOI 10.1121/1.2717766; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Kasumyan A. O., 2005, J ICHTHYOL, V45, pS223; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Luczkovich Joseph J., 1999, Bioacoustics, V10, P143; McCormick SD, 1998, AQUACULTURE, V168, P221, DOI 10.1016/S0044-8486(98)00351-2; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Melamed S, 1996, J OCCUP ENVIRON MED, V38, P252, DOI 10.1097/00043764-199603000-00009; MESA MG, 1994, T AM FISH SOC, V123, P786, DOI 10.1577/1548-8659(1994)123<0786:EOMASO>2.3.CO;2; Millidine KJ, 2006, FUNCT ECOL, V20, P839, DOI 10.1111/j.1365-2435.2006.01166.x; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MUIR JL, 1986, PHYSIOL BEHAV, V37, P285, DOI 10.1016/0031-9384(86)90234-9; Neo YY, 2014, BIOL CONSERV, V178, P65, DOI 10.1016/j.biocon.2014.07.012; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; Parvulescu A, 1967, ACOUSTICS SMALL TANK; PICKERING AD, 1983, GEN COMP ENDOCR, V49, P232, DOI 10.1016/0016-6480(83)90139-9; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Ross D, 2005, IEEE J OCEANIC ENG, V30, P257, DOI 10.1109/JOE.2005.850879; Ross D., 1976, MECH UNDERWATER NOIS; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Sink TD, 2007, FISH PHYSIOL BIOCHEM, V33, P189, DOI 10.1007/s10695-007-9130-0; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Sogard SM, 1997, B MAR SCI, V60, P1129; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; STEPIEN CA, 1986, FISH B-NOAA, V84, P809; THORPE JE, 1987, GEN COMP ENDOCR, V65, P19, DOI 10.1016/0016-6480(87)90217-6; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Voellmy IK, 2014, ANIM BEHAV, V89, P191, DOI 10.1016/j.anbehav.2013.12.029; Wahlberg M, 2005, MAR ECOL PROG SER, V288, P295, DOI 10.3354/meps288295; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Wiggins Sean M., 2007, International Symposium on Underwater Technology 2007. International Workshop on Scientific Use of Submarine Cables and Related Technologies 2007, P551; Woodley CM, 2003, OECOLOGIA, V136, P155, DOI 10.1007/s00442-003-1236-1; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020; Wysocki LE, 2007, AQUACULTURE, V272, P687, DOI 10.1016/j.aquaculture.2007.07.225	54	62	64	7	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139157	10.1371/journal.pone.0139157	http://dx.doi.org/10.1371/journal.pone.0139157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402068	Green Submitted, gold, Green Published			2022-12-26	WOS:000361798100060
J	Morita, M; Nakane, A; Fujii, Y; Maekawa, S; Kudo, Y				Morita, Mitsuhiro; Nakane, Akira; Fujii, Yuki; Maekawa, Shohei; Kudo, Yoshihisa			High Cell Density Upregulates Calcium Oscillation by Increasing Calcium Store Content via Basal Mitogen-Activated Protein Kinase Activity	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOLIPASE-C; CA2+ SIGNALS; RECEPTOR; EXPRESSION; DYNAMICS; GROWTH; IP3; PHOSPHORYLATION; MODULATION	Calcium releases of non-excitable cells are generally a combination of oscillatory and non-oscillatory patterns, and factors affecting the calcium dynamics are still to be determined. Here we report the influence of cell density on calcium increase patterns of clonal cell lines. The majority of HeLa cells seeded at 1.5 x 10(4)/cm(2) showed calcium oscillations in response to histamine and ATP, whereas cells seeded at 0.5 x 10(4)/cm(2) largely showed transient and sustained calcium increases. Cell density also affected the response of HEK293 cells to ATP in a similar manner. High cell density increased the basal activity of the mitogen-activated protein ( MAP) kinase and calcium store content, and both calcium oscillation and calcium store content were down-regulated by a MAP kinase inhibitor, U0126. Thus, MAP kinase-mediated regulation of calcium store likely underlie the effect of cell density on calcium oscillation. Calcium increase patterns of HeLa cells were conserved at any histamine concentrations tested, whereas the overexpression of histamine H1 receptor, which robustly increased histamine-induced inositol phospholipid hydrolysis, converted calcium oscillations to sustained calcium increases only at high histamine concentrations. Thus, the consequence of modulating inositol phospholipid metabolism was distinct from that of changing cell density, suggesting the effect of cell density is not attributed to inositol phospholipid metabolism. Collectively, our results propose that calcium increase patterns of non-excitable cells reflect calcium store, which is regulated by the basal MAP kinase activity under the influence of cell density.	[Morita, Mitsuhiro; Fujii, Yuki; Maekawa, Shohei] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo, Japan; [Nakane, Akira; Kudo, Yoshihisa] Tokyo Univ Pharm & Life Sci, Lab Cellular Neurobiol, Sch Life Sci, Tokyo, Japan	Kobe University; Tokyo University of Pharmacy & Life Sciences	Morita, M (corresponding author), Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo, Japan.	mmorita@boar.kobe-u.ac.jp		Morita, Mitsuhiro/0000-0002-9891-0242; Kudo, Yoshihisa/0000-0002-5978-8264	Ministry of Education, Science and Culture in Japan (Japan) [10214204, 15082101, 23122513, 23300133]; Smoking Research Foundation (Japan); Takeda Science Foundation (Japan); Centers of Biomedical Research Excellence from National Institute of Health/National Center for Research Resources (USA) [PR15636]; Grants-in-Aid for Scientific Research [26430071] Funding Source: KAKEN	Ministry of Education, Science and Culture in Japan (Japan); Smoking Research Foundation (Japan); Takeda Science Foundation (Japan)(Takeda Science Foundation (TSF)); Centers of Biomedical Research Excellence from National Institute of Health/National Center for Research Resources (USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in Aid for Scientific Research on Priority Areas (B) (10214204), Grant-in Aid for Scientific Research on Priority Areas (15082101), Grant-in-Aid for Scientific Research on the Innovative area (23122513), Grant-in-Aid for Scientific Research (B) (23300133, Japan), all from the Ministry of Education, Science and Culture in Japan, Smoking Research Foundation (Japan), Takeda Science Foundation (Japan), and the Centers of Biomedical Research Excellence (PR15636) from National Institute of Health/National Center for Research Resources (USA).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Chiarugi Paola, 2003, Ital J Biochem, V52, P28; ELLEM KAO, 1988, CARCINOGENESIS, V9, P797, DOI 10.1093/carcin/9.5.797; Falcke M, 2003, BIOPHYS J, V84, P28, DOI 10.1016/S0006-3495(03)74830-9; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; GILON P, 1993, J BIOL CHEM, V268, P22265; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Legrand G, 2001, J BIOL CHEM, V276, P47608, DOI 10.1074/jbc.M107011200; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Montero M, 2003, J BIOL CHEM, V278, P49972, DOI 10.1074/jbc.M308378200; Morita M, 2004, J PHARMACOL SCI, V94, P25, DOI 10.1254/jphs.94.25; Morita M, 2003, J NEUROSCI, V23, P10944; Morita M, 2007, FEBS J, V274, P5147, DOI 10.1111/j.1742-4658.2007.06035.x; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rintoul GL, 2003, CELL CALCIUM, V34, P131, DOI 10.1016/S0143-4160(03)00041-1; Roxas JL, 2012, INFECT IMMUN, V80, P3850, DOI 10.1128/IAI.00335-12; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Sinnecker D, 2004, CELL CALCIUM, V35, P29, DOI 10.1016/S0143-4160(03)00169-6; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137610	10.1371/journal.pone.0137610	http://dx.doi.org/10.1371/journal.pone.0137610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398212	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500041
J	Philippe, N; Maigre, L; Santini, S; Pinet, E; Claverie, JM; Davin-Regli, AV; Pages, JM; Masi, M				Philippe, Nadege; Maigre, Laure; Santini, Sebastien; Pinet, Elizabeth; Claverie, Jean-Michel; Davin-Regli, Anne-Veronique; Pages, Jean-Marie; Masi, Muriel			In Vivo Evolution of Bacterial Resistance in Two Cases of Enterobacter aerogenes Infections during Treatment with Imipenem	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SPECTRUM BETA-LACTAMASES; ENVELOPE STRESS-RESPONSE; CYSTIC-FIBROSIS PATIENTS; GRAM-NEGATIVE BACTERIA; MULTIDRUG EFFLUX PUMP; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; MEMBRANE-PERMEABILITY; MOLECULAR EPIDEMIOLOGY	Infections caused by multidrug resistant (MDR) bacteria are a major concern worldwide. Changes in membrane permeability, including decreased influx and/or increased efflux of antibiotics, are known as key contributors of bacterial MDR. Therefore, it is of critical importance to understand molecular mechanisms that link membrane permeability to MDR in order to design new antimicrobial strategies. In this work, we describe genotype-phenotype correlations in Enterobacter aerogenes, a clinically problematic and antibiotic resistant bacterium. To do this, series of clinical isolates have been periodically collected from two patients during chemotherapy with imipenem. The isolates exhibited different levels of resistance towards multiple classes of antibiotics, consistently with the presence or the absence of porins and efflux pumps. Transport assays were used to characterize membrane permeability defects. Simultaneous genome-wide analysis allowed the identification of putative mutations responsible for MDR. The genome of the imipenem-susceptible isolate G7 was sequenced to closure and used as a reference for comparative genomics. This approach uncovered several loci that were specifically mutated in MDR isolates and whose products are known to control membrane permeability. These were omp35 and omp36, encoding the two major porins; rob, encoding a global AraC-type transcriptional activator; cpxA, phoQ and pmrB, encoding sensor kinases of the CpxRA, PhoPQ and PmrAB two-component regulatory systems, respectively. This report provides a comprehensive analysis of membrane alterations relative to mutational steps in the evolution of MDR of a recognized nosocomial pathogen.	[Philippe, Nadege; Maigre, Laure; Pinet, Elizabeth; Davin-Regli, Anne-Veronique; Pages, Jean-Marie; Masi, Muriel] Aix Marseille Univ, UMR Transporteurs Membranaires Chimioresistance &, F-13385 Marseille 05, France; [Philippe, Nadege; Maigre, Laure; Pinet, Elizabeth; Davin-Regli, Anne-Veronique; Pages, Jean-Marie; Masi, Muriel] Inst Rech Biomed Armees, F-13385 Marseille 05, France; [Santini, Sebastien; Claverie, Jean-Michel] CNRS, Lab Informat Genom & Struct, Inst Microbiol Mediterranee, UMR7256,FR3479, FR-13288 Marseille 09, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Masi, M (corresponding author), Aix Marseille Univ, UMR Transporteurs Membranaires Chimioresistance &, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.	muriel.masi@univ-amu.fr	Claverie, Jean Michel/Z-2183-2019; Masi, Muriel/N-6758-2018; Claverie, Jean-Michel/AAG-4889-2019; PAGES, jean-marie/F-2555-2013	Masi, Muriel/0000-0002-1444-7511; Claverie, Jean-Michel/0000-0003-1424-0315; PAGES, jean-marie/0000-0001-7092-7977; Santini, Sebastien/0000-0001-7087-1950; Philippe, Nadege/0000-0001-9154-0341	Innovative Medicines Initiatives Joint Undertaking [115525]; European Union; Aix-Marseille Universite; Service de Sante des Armees	Innovative Medicines Initiatives Joint Undertaking; European Union(European Commission); Aix-Marseille Universite; Service de Sante des Armees	The research leading to these results was conducted as part of the TRANSLOCATION consortium and has received support from the Innovative Medicines Initiatives Joint Undertaking under Grant Agreement no115525, resources which are composed of financial contribution from the European Union's seventh framework program (FP7/2007-2013) and EFPIA companies in kind contribution. This work was also supported by Aix-Marseille Universite and Service de Sante des Armees. The authorhs assert that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arpin C, 1996, J CLIN MICROBIOL, V34, P2163, DOI 10.1128/JCM.34.9.2163-2169.1996; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrow K, 2009, ANTIMICROB AGENTS CH, V53, P5150, DOI 10.1128/AAC.00893-09; Batchelor E, 2005, J BACTERIOL, V187, P5723, DOI 10.1128/JB.187.16.5723-5731.2005; Blair JMA, 2015, P NATL ACAD SCI USA, V112, P3511, DOI 10.1073/pnas.1419939112; Bohnert JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021196; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Bornet C, 2000, J CLIN MICROBIOL, V38, P1048, DOI 10.1128/JCM.38.3.1048-1052.2000; Bosi C, 1999, J CLIN MICROBIOL, V37, P2165, DOI 10.1128/JCM.37.7.2165-2169.1999; CDC U, 2013, ANTIBIOTIC RESISTANC; CHAPMAN JS, 1989, ANTIMICROB AGENTS CH, V33, P27, DOI 10.1128/AAC.33.1.27; Charrel RN, 1996, ANTIMICROB AGENTS CH, V40, P2854, DOI 10.1128/AAC.40.12.2854; Chen HD, 2013, ANNU REV MICROBIOL, V67, P83, DOI 10.1146/annurev-micro-092412-155751; Chevalier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003203; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; DavinRegli A, 1996, J CLIN MICROBIOL, V34, P1474, DOI 10.1128/JCM.34.6.1474-1480.1996; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; DECHAMPS C, 1993, J CLIN MICROBIOL, V31, P123, DOI 10.1128/JCM.31.1.123-127.1993; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Diene SM, 2013, MOL BIOL EVOL, V30, P369, DOI 10.1093/molbev/mss236; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Jayol A, 2014, ANTIMICROB AGENTS CH, V58, P4762, DOI 10.1128/AAC.00084-14; Koutsolioutsou A, 2005, ANTIMICROB AGENTS CH, V49, P2746, DOI 10.1128/AAC.49.7.2746-2752.2005; Lavigne JP, 2012, CLIN MICROBIOL INFEC, V18, P539, DOI 10.1111/j.1469-0691.2011.03607.x; Lavigne JP, 2013, INT J ANTIMICROB AG, V41, P130, DOI 10.1016/j.ijantimicag.2012.10.010; Lavigne JP, 2004, J CLIN MICROBIOL, V42, P3805, DOI 10.1128/JCM.42.8.3805-3808.2004; Lee EH, 1996, ANTIMICROB AGENTS CH, V40, P2029, DOI 10.1128/AAC.40.9.2029; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Miller AK, 2011, ANTIMICROB AGENTS CH, V55, P5761, DOI 10.1128/AAC.05391-11; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Moskowitz SM, 2012, ANTIMICROB AGENTS CH, V56, P1019, DOI 10.1128/AAC.05829-11; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Perez A, 2012, ANTIMICROB AGENTS CH, V56, P6256, DOI 10.1128/AAC.01085-12; Raivio TL, 2014, BBA-MOL CELL RES, V1843, P1529, DOI 10.1016/j.bbamcr.2013.10.018; Robert J, 2014, J ANTIMICROB CHEMOTH, V69, P2706, DOI 10.1093/jac/dku208; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Shin SH, 2012, J BACTERIOL, V194, P2373, DOI 10.1128/JB.00028-12; Shprung T, 2012, J BIOL CHEM, V287, P4544, DOI 10.1074/jbc.M111.278523; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Sun S, 2009, ANTIMICROB AGENTS CH, V53, P2298, DOI 10.1128/AAC.01016-08; Thiolas A, 2005, ANTIMICROB AGENTS CH, V49, P1354, DOI 10.1128/AAC.49.4.1354-1358.2005; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Tran QT, 2009, ANTIMICROB AGENTS CH, V53, P1652, DOI 10.1128/AAC.00822-08; Tsai YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079640; Villa L, 2013, ANTIMICROB AGENTS CH, V57, P1965, DOI 10.1128/AAC.01297-12; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng J, 2009, J ANTIMICROB CHEMOTH, V63, P95, DOI 10.1093/jac/dkn448; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	58	32	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138828	10.1371/journal.pone.0138828	http://dx.doi.org/10.1371/journal.pone.0138828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398358	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500113
J	Platt, ERM; Ord, TJ				Platt, Edward R. M.; Ord, Terry J.			Population Variation in the Life History of a Land Fish, Alticus arnoldorum, and the Effects of Predation and Density	PLOS ONE			English	Article							SIZE-SELECTIVE MORTALITY; JUVENILE MORTALITY; AGE; EVOLUTION; BLENNY; GROWTH; MATURATION; BLENNIIDAE; MATURITY	Life history variation can often reflect differences in age-specific mortality within populations, with the general expectation that reproduction should be shifted away from ages experiencing increased mortality. Investigators of life history in vertebrates frequently focus on the impact of predation, but there is increasing evidence that predation may have unexpected impacts on population density that in turn prompt unexpected changes in life history. There are also other reasons why density might impact life history independently of predation or mortality more generally. We investigated the consequences of predation and density on life history variation among populations of the Pacific leaping blenny, Alticus arnoldorum. This fish from the island of Guam spends its adult life out of the water on rocks in the splash zone, where it is vulnerable to predation and can be expected to be sensitive to changes in population density that impact resource availability. We found populations invested more in reproduction as predation decreased, while growth rate varied primarily in response to population density. These differences in life history among populations are likely plastic given the extensive gene flow among populations revealed by a previous study. The influence of predation and density on life history was unlikely to have operated independently of each other, with predation rate tending to be associated with reduced population densities. Taken together, our results suggest predation and density can have complex influences on life history, and that plastic life history traits could allow populations to persist in new or rapidly changing environments.	[Ord, Terry J.] Univ New S Wales, Evolut & Ecol Res Ctr, Kensington, NSW 2052, Australia; Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Ord, TJ (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Kensington, NSW 2052, Australia.	t.ord@unsw.edu.au	Ord, Terry J/C-6870-2009	Ord, Terry J/0000-0002-2608-2150	Australian Research Council [DP120100356]; School of BEES	Australian Research Council(Australian Research Council); School of BEES	This work was supported by an Australian Research Council grant to TJO (DP120100356), and a postgraduate research award from the School of BEES to ERMP.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Bates D., 2008, LME4 LINEAR MIXED EF; BELK MC, 1995, J FISH BIOL, V47, P237, DOI 10.1111/j.1095-8649.1995.tb01891.x; Bhikajee M, 2006, AFR ZOOL, V41, P1, DOI 10.3377/1562-7020(2006)41[1:LHCOAM]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron TC, 2013, ECOL LETT, V16, P754, DOI 10.1111/ele.12107; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Carlson BA, 1992, THESIS U HAWAII; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; Fairbairn DJ, 2013, ODD COUPLES: EXTRAORDINARY DIFFERENCES BETWEEN THE SEXES IN THE ANIMAL KINGDOM, P1; FORRESTER GE, 1990, ECOLOGY, V71, P1666, DOI 10.2307/1937576; Furness AI, 2012, EVOLUTION, V66, P1240, DOI 10.1111/j.1558-5646.2011.01520.x; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Ghani NIA, 2013, J EVOLUTION BIOL, V26, P775, DOI 10.1111/jeb.12085; Hernandez-Miranda E, 2009, REV BIOL MAR OCEANOG, V44, P619; Hsieh STT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011197; Hundt PJ, 2014, ICHTHYOL RES, V61, P76, DOI 10.1007/s10228-013-0366-7; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; MARTIN KLM, 1989, COPEIA, P723; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; MICHOD RE, 1979, AM NAT, V113, P531, DOI 10.1086/283411; Morgans CL, 2014, BMC EVOL BIOL, V14, DOI [10.1186/1471-2148-14-97, 10.1186/s12883-014-0203-2]; Morgans CL, 2013, ANIM BEHAV, V86, P1241, DOI 10.1016/j.anbehav.2013.09.027; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Nunez J, 2009, FISH PHYSIOL BIOCHEM, V35, P167, DOI 10.1007/s10695-008-9241-2; Ord TJ, 2011, ETHOLOGY, V117, P918, DOI 10.1111/j.1439-0310.2011.01949.x; OSENBERG CW, 1992, ECOLOGY, V73, P255, DOI 10.2307/1938737; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; Schroder A, 2014, TRENDS ECOL EVOL, V29, P614, DOI 10.1016/j.tree.2014.08.006; Shimizu N, 2006, J ZOOL, V269, P357, DOI 10.1111/j.1469-7998.2006.00113.x; Sogard SM, 1997, B MAR SCI, V60, P1129; Stearns S.C., 1992, pi; SUNOBE T, 1995, ENVIRON BIOL FISH, V43, P195, DOI 10.1007/BF00002491; Torres-Dowdall J, 2012, FUNCT ECOL, V26, P616, DOI 10.1111/j.1365-2435.2012.01980.x; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; VICTOR BC, 1986, ECOL MONOGR, V56, P145, DOI 10.2307/1942506; Walsh MR, 2008, P NATL ACAD SCI USA, V105, P594, DOI 10.1073/pnas.0710051105; Zar JH, 1999, BIOSTATISTICAL ANAL; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	45	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137244	10.1371/journal.pone.0137244	http://dx.doi.org/10.1371/journal.pone.0137244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398191	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500026
J	Sengupta, S; Prajapati, RK; Mukhopadhyay, J				Sengupta, Shreya; Prajapati, Ranjit Kumar; Mukhopadhyay, Jayanta			Promoter Escape with Bacterial Two-component sigma Factor Suggests Retention of sigma Region Two in the Elongation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE HOLOENZYME; TRANSCRIPTION INITIATION; OXALATE DECARBOXYLASE; PROTEINS; SUBUNIT; RELEASE	The transition from the formation of the RNA polymerase (RNAP)-promoter open complex step to the productive elongation complex step involves "promoter escape" of RNAP. From the structure of RNAP, a promoter escape model has been proposed that suggests that the interactions between sigma R4 and RNAP and sigma R4 and DNA are destabilized upon transition to elongation. This accounts for the reduced affinity of sigma to RNAP and stochastic release of sigma. However, as the loss of interaction of sigma R4 with RNAP results in the release of intact sigma, assessing this interaction remains challenging to be experimentally verified. Here we study the promoter escape model using a two-component sigma factor YvrI and YvrHa from Bacillus subtilis that independently contributes to the functions of sigma R4 and sigma R2 in a RNAP-promoter complex. Our results show that YvrI, which mimics sigma R4, is released gradually as transcription elongation proceeds, whereas YvrHa, which mimics sigma R2 is retained throughout the elongation complexes. Thus our result validates the proposed model for promoter escape and also suggests that promoter escape involves little or no change in the interaction of sigma R2 with RNAP.	[Sengupta, Shreya; Prajapati, Ranjit Kumar; Mukhopadhyay, Jayanta] Bose Inst, Dept Chem, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute	Mukhopadhyay, J (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India.	jayanta@jcbose.ac.in		Prajapati, Ranjit/0000-0002-9294-3537; SENGUPTA, SHREYA/0000-0002-7801-984X	Department of Biotechnology, Ministry of Science and Technology, India [BT/PR 5345/MED/29/648/2012]; CSIR India	Department of Biotechnology, Ministry of Science and Technology, India; CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Research Grant BT/PR 5345/MED/29/648/2012 from the Department of Biotechnology, Ministry of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of fellowships from CSIR India.	Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, P NATL ACAD SCI USA, V106, P21323, DOI 10.1073/pnas.0910006106; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; METZGER W, 1993, J MOL BIOL, V232, P35, DOI 10.1006/jmbi.1993.1368; Moerke Nathan J, 2009, Curr Protoc Chem Biol, V1, P1, DOI 10.1002/9780470559277.ch090102; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Mukhopadhyay J, 2003, METHOD ENZYMOL, V371, P144; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Raffaelle M, 2005, MOL CELL, V20, P357, DOI 10.1016/j.molcel.2005.10.011; Rudra P, 2015, NUCLEIC ACIDS RES, V43, P5855, DOI 10.1093/nar/gkv516; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wade JT, 2004, P NATL ACAD SCI USA, V101, P17777, DOI 10.1073/pnas.0404305101; Yang X, 2008, PROTEIN EXPRES PURIF, V59, P86, DOI 10.1016/j.pep.2008.01.006	26	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28575	28583		10.1074/jbc.M115.666008	http://dx.doi.org/10.1074/jbc.M115.666008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26400263	hybrid, Green Published			2022-12-26	WOS:000365761900048
J	Mittal, SK; Cho, KJ; Ishido, S; Roche, PA				Mittal, Sharad K.; Cho, Kyung-Jin; Ishido, Satoshi; Roche, Paul A.			Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; NEGATIVE REGULATION; PEPTIDE COMPLEXES; IMMUNE-RESPONSES; DOWN-REGULATION; T-CELLS; IL-10; UBIQUITINATION; EXPRESSION; MONOCYTES	Efficient immune responses require regulated antigen presentation to CD4 T cells. IL-10 inhibits the ability of dendritic cells (DCs) and macrophages to stimulate antigen-specific CD4 T cells; however, the mechanisms by which IL-10 suppresses antigen presentation remain poorly understood. We now report that IL-10 stimulates expression of the E3 ubiquitin ligase March-I in activated macrophages, thereby down-regulating MHC-II, CD86, and antigen presentation to CD4 T cells. By contrast, IL-10 does not stimulate March-I expression in DCs, does not suppress MHC-II or CD86 expression on either resting or activated DCs, and does not affect antigen presentation by activated DCs. IL-10 does, however, inhibit the process of DC activation itself, thereby reducing the efficiency of antigen presentation in a March-I-independent manner. Thus, IL-10 suppression of antigen presenting cell function in macrophages is March-I-dependent, whereas in DCs, suppression is March- I-independent.	[Mittal, Sharad K.; Cho, Kyung-Jin; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ishido, Satoshi] Showa Pharmaceut Univ, Lab Integrat Infect Immun, Machida, Tokyo 1948543, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Showa Pharmaceutical University	Roche, PA (corresponding author), NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Intramural Research Program of the National Institutes of Health (to P. A. R.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. I.), and the Japan Society for the Promotion of Science (to S. I.). The authors declare that they have no conflicts of interest with the contents of this article.	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Avdic S, 2013, J VIROL, V87, P10273, DOI 10.1128/JVI.00912-13; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Chattopadhyay G, 2013, J IMMUNOL, V191, P5875, DOI 10.4049/jimmunol.1301693; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Haase C, 2002, IMMUNOLOGY, V107, P489, DOI 10.1046/j.1365-2567.2002.01529.x; Hunt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037330; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishido S, 2009, CURR OPIN IMMUNOL, V21, P78, DOI 10.1016/j.coi.2009.01.002; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KOERNER TJ, 1987, J IMMUNOL, V139, P239; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Li JF, 2000, HUM IMMUNOL, V61, P486, DOI 10.1016/S0198-8859(00)00099-9; MALEFYT RD, 1991, J EXP MED, V174, P915; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Pajkrt D, 1997, J IMMUNOL, V158, P3971; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schrum AG, 2005, EUR J IMMUNOL, V35, P449, DOI 10.1002/eji.200425635; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Vremec D, 2011, INNATE IMMUN-LONDON, V17, P338, DOI 10.1177/1753425910371396; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	39	79	82	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27158	27167		10.1074/jbc.M115.682708	http://dx.doi.org/10.1074/jbc.M115.682708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26408197	hybrid, Green Published			2022-12-26	WOS:000364794000025
J	Biggs, SN; Walter, LM; Jackman, AR; Nisbet, LC; Weichard, AJ; Hollis, SL; Davey, MJ; Anderson, V; Nixon, GM; Horne, RSC				Biggs, Sarah N.; Walter, Lisa M.; Jackman, Angela R.; Nisbet, Lauren C.; Weichard, Aidan J.; Hollis, Samantha L.; Davey, Margot J.; Anderson, Vicki; Nixon, Gillian M.; Horne, Rosemary S. C.			Long-Term Cognitive and Behavioral Outcomes following Resolution of Sleep Disordered Breathing in Preschool Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; APNEA SYNDROME; BLOOD-PRESSURE; ADENOTONSILLECTOMY; TONSILLECTOMY; MANAGEMENT; REGRESSION; DIAGNOSIS; DEFICITS; GROWTH	This study aimed to determine the long term effects of resolution of SDB in preschool children, either following treatment or spontaneous recovery, on cognition and behavior. Children diagnosed with SDB at 3-5y (N = 35) and non-snoring controls (N = 25), underwent repeat polysomnography (PSG) and cognitive and behavioral assessment 3 years following a baseline study. At follow-up, children with SDB were grouped into Resolved and Unresolved. Resolution was defined as: obstructive apnea hypopnea index (OAHI) <= 1 event/h; no snoring detected on PSG; and no parental report of habitual snoring. 57% (20/35) of children with SDB received treatment, with SDB resolving in 60% (12/20). 43% (15/35) were untreated, of whom 40% (6/15) had spontaneous resolution of SDB. Cognitive reduced between baseline and follow-up, however this was not related to persistent disease, with no difference in cognitive outcomes between Resolved, Unresolved or Control groups. Behavioral functioning remained significantly worse in children originally diagnosed with SDB compared to control children, regardless of resolution. Change in OAHI did not predict cognitive or behavioral outcomes, however a reduction in nocturnal arousals, irrespective of full resolution, was associated with improvement in attention and aggressive behavior. These results suggest that resolution of SDB in preschool children has little effect on cognitive or behavioral outcomes over the long term. The association between sleep fragmentation and behavior appears independent of SDB, however may be moderated by concomitant SDB. This challenges the assumption that treatment of SDB will ameliorate associated cognitive and behavioural deficits and supports the possibility of a SDB phenotype.	[Biggs, Sarah N.; Walter, Lisa M.; Nisbet, Lauren C.; Weichard, Aidan J.; Hollis, Samantha L.; Davey, Margot J.; Nixon, Gillian M.; Horne, Rosemary S. C.] Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Biggs, Sarah N.; Walter, Lisa M.; Davey, Margot J.; Nixon, Gillian M.; Horne, Rosemary S. C.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Davey, Margot J.; Nixon, Gillian M.] Monash Med Ctr, Monash Childrens, Melbourne Childrens Sleep Ctr, Melbourne, Vic, Australia; [Jackman, Angela R.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci Res, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; Monash University; University of Melbourne; Murdoch Children's Research Institute	Biggs, SN (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia.	sarah.biggs@monash.edu		Walter, Lisa/0000-0003-1158-493X; Biggs, Sarah/0000-0002-1144-2694; Horne, Rosemary/0000-0003-3575-0461	National Health and Medical Research Council of Australia [APP1008919]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This research was funded by the National Health and Medical Research Council of Australia (APP1008919). The Hudson Institute of Medical Research is supported by the Victorian Government's Operational Infrastructure Support Program.	Achenbach T. M., 2001, MANUAL ASEBA PRESCHO; Achenbach TM, 2001, MANUAL ASEBA SCH BAS; Ali NJ, 1996, EUR J PEDIATR, V155, P56, DOI 10.1007/BF02115629; Biggs SN, 2014, SLEEP, V37, P77, DOI 10.5665/sleep.3312; Biggs SN, 2014, SLEEP MED R IN PRESS; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bourke R, 2011, SLEEP MED, V12, P489, DOI 10.1016/j.sleep.2010.11.010; Chervin RD, 2006, PEDIATRICS, V117, pE769, DOI 10.1542/peds.2005-1837; Chervin RD, 2014, J CLIN SLEEP MED, V10, P903, DOI 10.5664/jcsm.3968; Chervin RD, 2012, CHEST, V142, P101, DOI 10.1378/chest.11-2456; Constantin E, 2007, J PEDIATR-US, V150, P540, DOI 10.1016/j.jpeds.2007.01.026; Curtis JL, 2015, OTOLARYNG HEAD NECK, V152, P691, DOI 10.1177/0194599815572123; Dillon JE, 2007, J AM ACAD CHILD PSY, V46, P1425, DOI 10.1097/chi.0b013e31814b8eb2; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Gioia G. A., 2002, BEHAV RATING INVENTO; Gioia GA, 2000, BEHAV RATING EXECUTI; Giordani B, 2008, J INT NEUROPSYCH SOC, V14, P571, DOI 10.1017/S1355617708080776; Giordani B, 2012, J INT NEUROPSYCH SOC, V18, P212, DOI 10.1017/S1355617711001743; Gozal D, 2006, SLEEP MED REV, V10, P83, DOI 10.1016/j.smrv.2005.07.005; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; GUILLEMINAULT C, 1982, EUR J PEDIATR, V139, P165, DOI 10.1007/BF01377349; Guilleminault C, 2007, OTOLARYNG HEAD NECK, V136, P169, DOI 10.1016/j.otohns.2006.09.021; Harvey JMM, 1999, J PAEDIATR CHILD H, V35, P136, DOI 10.1046/j.1440-1754.1999.t01-1-00336.x; Huang YS, 2014, SLEEP, V37, P71, DOI 10.5665/sleep.3310; Iber C., 2007, AASM MANUAL SCORING; Jackman AR, 2013, SLEEP, V36, P1639, DOI 10.5665/sleep.3116; Jackman AR, 2012, SLEEP MED, V13, P621, DOI 10.1016/j.sleep.2012.01.013; JEANS WD, 1981, BRIT J RADIOL, V54, P117, DOI 10.1259/0007-1285-54-638-117; Joosten Simon A, 2014, Ann Am Thorac Soc, V11, P761, DOI 10.1513/AnnalsATS.201309-306OC; Katz Eliot S, 2008, Proc Am Thorac Soc, V5, P253, DOI 10.1513/pats.200707-111MG; Katz ES, 2002, J PEDIATR-US, V140, P589, DOI 10.1067/mpd.2002.123290; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kohler MJ, 2010, NAT SCI SLEEP, V2, P159, DOI 10.2147/NSS.S6934; Kohler MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007343; Korkman M., 2007, NEPSY 2 DEVELOPMENTA; Korkman M., 2007, NEPSY 2, V2nd; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Marcus CL, 2002, PEDIATRICS, V109, P704; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Mindell JA, 2013, SLEEP MED, V14, P1283, DOI 10.1016/j.sleep.2013.09.002; Mitchell RB, 2006, OTOLARYNG HEAD NECK, V134, P374, DOI 10.1016/j.otohns.2005.11.035; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; Nisbet LC, 2013, SLEEP MED, V14, P1310, DOI 10.1016/j.sleep.2013.07.010; Nisbet LC, 2013, SLEEP MED, V14, P1123, DOI 10.1016/j.sleep.2013.06.010; Nisbet LC, 2013, SLEEP, V36, P1219, DOI 10.5665/sleep.2890; Nixon GM, 2014, J CLIN SLEEP MED; O'Brien LM, 2003, PEDIATRICS, V111, P554, DOI 10.1542/peds.111.3.554; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Owens Judith, 2000, Sleep Breath, V4, P67, DOI 10.1055/s-2000-19814; Rapoport JL, 2008, NEUROPSYCHOPHARMACOL, V33, P181, DOI 10.1038/sj.npp.1301553; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Roid GH., 2003, STANFORD BINET INTEL, V5th; Tabachnick B. G., 2001, USING MULTIVARIATE S; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Vlahandonis A, 2013, SLEEP MED, V14, P1295, DOI 10.1016/j.sleep.2013.07.014; Wei JL, 2007, ARCH OTOLARYNGOL, V133, P974, DOI 10.1001/archotol.133.10.974; Wei JL, 2009, ARCH OTOLARYNGOL, V135, P642, DOI 10.1001/archoto.2009.74; WITTIG RM, 1984, AM REV RESPIR DIS, V129, P244; ZACHARY RA, 1985, J CLIN PSYCHOL, V41, P86, DOI 10.1002/1097-4679(198501)41:1<86::AID-JCLP2270410115>3.0.CO;2-W	64	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139142	10.1371/journal.pone.0139142	http://dx.doi.org/10.1371/journal.pone.0139142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418065	Green Published, gold			2022-12-26	WOS:000362171400053
J	Rebe, K; Lewis, D; Myer, L; de Swardt, G; Struthers, H; Kamkuemah, M; McIntyre, J				Rebe, Kevin; Lewis, David; Myer, Landon; de Swardt, Glenn; Struthers, Helen; Kamkuemah, Monika; McIntyre, James			A Cross Sectional Analysis of Gonococcal and Chlamydial Infections among Men-Who-Have-Sex-with-Men in Cape Town, South Africa	PLOS ONE			English	Article							RECTAL GONORRHEA; HIV; RISK; PREVALENCE; TRANSMISSION	Background Men-who-have-sex-with-men (MSM) are at high risk of HIV and sexually transmitted infection (STI) transmission. Asymptomatic STIs are common in MSM and remain undiagnosed and untreated where syndromic management is advocated. Untreated STIs could be contributing to high HIV rates. This study investigated symptomatic (SSTI) and asymptomatic STIs (ASTIs) in MSM in Cape Town. Methods MSM, 18 years and above, were enrolled into this study. Participants underwent clinical and microbiological screening for STIs. Urine, oro-pharyngeal and anal swab specimens were collected for STI analysis, and blood for HIV and syphilis screening. A psychosocial and sexual questionnaire was completed. STI specimens were analysed for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) infection. Results 200 MSM were recruited with a median age of 32 years (IQR 26-39.5). Their median number of sex partners within the last year was 5 (IQR 2-20). 155/200 (78%) reported only male sex partners while 45/200 (23%) reported sex with men and women. 77/200 (39%) reported transactional sex. At enrolment, 88/200 (44%) were HIV positive and 8/112 (7%) initially HIV-negative participants seroconverted during the study. Overall, 47/200 (24%) screened positive for either NG or CT. There were 32 MSM (16%) infected with NG and 7 (3.5%) of these men had NG infections at two anatomical sites (39 NG positive results in total). Like-wise, there were 23 MSM (12%) infected with CT and all these men had infections at only one site. Eight of the 47 men (17%) were infected with both NG and CT. ASTI was more common than SSTI irrespective of anatomical site, 38 /200 (19%) versus 9/200 (5%) respectively (p<0.001). The anus was most commonly affected, followed by the oro-pharynx and then urethra. Asymptomatic infection was associated with transgender identity (OR 4.09 CI 1.60-5.62), >= 5 male sex partners in the last year (OR 2.50 CI 1.16-5.62) and transactional sex (OR 2.33 CI 1.13-4.79) but not with HIV infection. Conclusions Asymptomatic STI was common and would not have been detected using a syndromic management approach. Although molecular screening for NG/CT is costly, in our study only four MSM needed to be screened to detect one case. This supports dual NG/CT molecular screening for MSM, which, in the case of confirmed NG infections, may trigger further culture-based investigations to determine gonococcal antimicrobial susceptibility in the current era of multi-drug resistant gonorrhoea.	[Rebe, Kevin; de Swardt, Glenn; Struthers, Helen; McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa; [Rebe, Kevin; de Swardt, Glenn; Struthers, Helen; McIntyre, James] Anova Hlth Inst, Cape Town, South Africa; [Rebe, Kevin; Struthers, Helen] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Lewis, David] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr HIV & Sexually Transmitted Infect, Johannesburg, South Africa; [Lewis, David] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Lewis, David] Western Sydney Sexual Hlth Ctr, Parramatta, Australia; [Lewis, David] Univ Sydney, Westmead Clin Sch, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia; [Lewis, David] Univ Sydney, Westmead Clin Sch, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Myer, Landon; Kamkuemah, Monika; McIntyre, James] Univ Cape Town, Sch Publ & Family Med, Div Epidemiol & Biostat, ZA-7925 Cape Town, South Africa	University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Cape Town; University of Sydney; University of Sydney; University of Cape Town	Rebe, K (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.	rebe@anovhealth.co.za	McIntyre, James/V-7115-2019; Kamkuemah, Monika/GRY-4837-2022	Lewis, David/0000-0002-5534-8392; Kamkuemah, Monika/0000-0002-7603-2792	Presidents Emergency Fund for AIDS Relief / United States Agency for International Development [AID-674-A-12-00015]	Presidents Emergency Fund for AIDS Relief / United States Agency for International Development(United States Agency for International Development (USAID))	Funded by Presidents Emergency Fund for AIDS Relief / United States Agency for International Development Cooperative Agreement No. AID-674-A-12-00015 (www.pepfar.gov). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Beck EC, 2015, J AQUIR IMMUNE DEFIC; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Burrell E, 2010, SEX HEALTH, V7, P149, DOI 10.1071/SH09090; Carpenter RJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002775; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Council SANA, 2012, NAT STRAT PLAN HIV S; De Swardt G, 2010, MSM IN YOUR POCKET; De Swardt G, 2010, TOP BOTTOM SEX POSIT; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Kelley CF, 2011, J INFECT DIS, V204, P761, DOI 10.1093/infdis/jir400; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lewis DA, 2013, J ANTIMICROB CHEMOTH, V68, P1267, DOI 10.1093/jac/dkt034; Lewis DA, 2010, SEX TRANSM INFECT, V86, P415, DOI 10.1136/sti.2010.042648; Rebe KB, 2013, S AFR J HIV MED, V14, P52, DOI [10.7196/SAJHIVMED.841, 10.7196/sajhivmed.841]; Rebe KB, 2010, INT AIDS SOC C VIENN; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Rispel LC, 2011, JAIDS-J ACQ IMM DEF, V57, P69, DOI 10.1097/QAI.0b013e318211b40a; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Sanders EJ, 2014, SEX TRANSM INFECT, V90, P94, DOI 10.1136/sextrans-2013-051078; Sanders EJ, 2010, SEX TRANSM INFECT, V86, P440, DOI 10.1136/sti.2010.043224; Sheibe A, 2014, EY POPULATIONS KEY S; South African Department of Health, 2003, 1 LIN COMPR MAN CONT; Turner AN, 2013, SEX TRANSM DIS, V40, P433, DOI 10.1097/OLQ.0b013e31828fd163; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Wand Handan, 2015, J Int AIDS Soc, V18, P19866, DOI 10.7448/IAS.18.1.19866; World Health Organisation, 2011, CONS GUID US ANT DRU	30	38	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138315	10.1371/journal.pone.0138315	http://dx.doi.org/10.1371/journal.pone.0138315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418464	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400013
J	Tang, X; Sun, B; Yang, YH; Tong, ZH				Tang, Xiao; Sun, Bing; Yang, Yuanhua; Tong, Zhaohui			A Survey of the Knowledge of Venous Thromboembolism Prophylaxis among the Medical Staff of Intensive Care Units in North China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PATIENTS ANTITHROMBOTIC THERAPY; CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; THROMBOPROPHYLAXIS; PREVENTION; VTE; THROMBOSIS	Background Guideline concordance for venous thromboembolism (VTE) prophylaxis in critically ill patients in intensive care units (ICUs) varies across different countries. Objective To explore how the medical staff of ICUs in China comprehend and practice VTE prophylaxis. Method Questionnaires comprising 39 questions and including 4 dimensions of thromboprophylaxis were administered in ICUs in North China. Results In all, 52 ICUs at 23 tertiary hospitals in 7 Chinese provinces and municipalities were surveyed. A total of 2500 questionnaires were sent, and 1861 were returned, corresponding to a response rate of approximately 74.4%. Of all surveyed medical staff, 36.5% of physicians and 22.2% of nurses were aware of the guidelines in China, and 19.0% of physicians and 9.5% of nurses comprehended the 9th edition of the guidelines of the American College of Chest Physicians (ACCP). Additionally, 37.6% of the medical staff chose a prophylaxis method based on the related guidelines, and 10.3% could demonstrate the exact indication for mechanical pattern application. Worries about skin injury, difficulty with removal and discomfort during mechanical thromboprophylaxis were cited by more than 30% of nurses, which was significantly more frequent than for physicians (graduated compression stockings: 54.3% VS 34.1%, 60.7% VS 49%, and 59.4% VS 54%, p = 0.000; intermittent pneumatic compression: 31% VS 22.2%, 19.2% VS 13.9%, and 37.8% VS 27.2%, p = 0.000). Conclusions and Relevance The knowledge of VTE prophylaxis among the medical staff of ICUs in North China remains limited, which may lead to a lack of standardization of VTE prophylaxis. Strengthened, standardized training may help medical staff to improve their comprehension of the relevant guidelines and may finally reduce the occurrence of VTE in ICUs and improve the prognosis of critically ill patients with VTE.	[Tang, Xiao; Sun, Bing; Yang, Yuanhua; Tong, Zhaohui] Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Tang, Xiao; Sun, Bing; Yang, Yuanhua; Tong, Zhaohui] Beijing Inst Resp Med, Beijing, Peoples R China	Capital Medical University	Sun, B (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China.	ricusunbing@126.com			Beijing Municipal Administration of Hospitals of China;  [ZYLX201312]	Beijing Municipal Administration of Hospitals of China; 	This study was funded by Beijing Municipal Administration of Hospitals of China. ZHT is the recipient of the funding (ZYLX201312). ZHT drafted the manuscript and gave final approval of the version to be published.	Arabi YM, 2013, CHEST, V144, P152, DOI 10.1378/chest.12-2028; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Geerts W, 2002, J CRIT CARE, V17, P95, DOI 10.1053/jcrc.2002.33941; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; group OBFARBIBSPMSSSCTCZaV-Ns, 2014, MAEDICA J CLIN MED, V9, P6; Ho KM, 2011, CHEST, V140, P1436, DOI 10.1378/chest.11-1444; Jose A., 2014, EUROPEAN J INTERNAL, V25, P717, DOI [10.1016/j.ejim.2014.07.005, DOI 10.1016/J.EJIM.2014.07.005]; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kim H, 2015, J CLIN NURS, V24, P308, DOI 10.1111/jocn.12610; Lauzier F, 2014, CRIT CARE, V18, DOI 10.1186/cc13844; Medicine CSoCC, 2009, CHINESE J INTERNAL M, V48, P788; Ribic C, 2009, J CRIT CARE, V24, P197, DOI 10.1016/j.jcrc.2008.11.002; Schaden E, 2012, INTENS CARE MED, V38, P984, DOI 10.1007/s00134-012-2533-0	14	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139162	10.1371/journal.pone.0139162	http://dx.doi.org/10.1371/journal.pone.0139162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418162	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400054
J	Badhwar, R; Bagler, G				Badhwar, Rahul; Bagler, Ganesh			Control of Neuronal Network in Caenorhabditis elegans	PLOS ONE			English	Article							NERVOUS-SYSTEM; PLUGIN	Caenorhabditis elegans, a soil dwelling nematode, is evolutionarily rudimentary and contains only similar to 300 neurons which are connected to each other via chemical synapses and gap junctions. This structural connectivity can be perceived as nodes and edges of a graph. Controlling complex networked systems (such as nervous system) has been an area of excitement for mankind. Various methods have been developed to identify specific brain regions, which when controlled by external input can lead to achievement of control over the state of the system. But in case of neuronal connectivity network the properties of neurons identified as driver nodes is of much importance because nervous system can produce a variety of states (behaviour of the animal). Hence to gain insight on the type of control achieved in nervous system we implemented the notion of structural control from graph theory to C. elegans neuronal network. We identified 'driver neurons' which can provide full control over the network. We studied phenotypic properties of these neurons which are referred to as 'phenoframe' as well as the 'genoframe' which represents their genetic correlates. We find that the driver neurons are primarily motor neurons located in the ventral nerve cord and contribute to biological reproduction of the animal. Identification of driver neurons and its characterization adds a new dimension in controllability of C. elegans neuronal network. This study suggests the importance of driver neurons and their utility to control the behaviour of the organism.	[Badhwar, Rahul; Bagler, Ganesh] Indian Inst Technol Jodhpur, Ctr Biol Inspired Syst Sci, Jodhpur, Rajasthan, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Bagler, G (corresponding author), Indian Inst Technol Jodhpur, Ctr Biol Inspired Syst Sci, Jodhpur, Rajasthan, India.	bagler@iitj.ac.in; ganesh.bagler@gmail.com	; Bagler, Ganesh/A-1102-2009	Badhwar, Rahul/0000-0002-1985-6162; Bagler, Ganesh/0000-0003-1924-6070				Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Dinitz Y, 1970, DOKL AKAD NAUK SSSR, V11, P1277; Duff IS, 2011, ACM T MATH SOFTWARE, V38, DOI 10.1145/2049673.2049677; HALL DH, 1991, J NEUROSCI, V11, P1; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luenberger DG, 2002, IEEE T AUTOMATIC CON, P440; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Micali S., 1980, 21st Annual Symposium on Foundations of Computer Science, P17; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Mucha M, 2004, ANN IEEE SYMP FOUND, P248, DOI 10.1109/FOCS.2004.40; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048013; Von Stetina SE, 2005, INT REV NEUROBIOL, V69, P125, DOI 10.1016/S0074-7742(05)69005-8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Zhang XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112039	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139204	10.1371/journal.pone.0139204	http://dx.doi.org/10.1371/journal.pone.0139204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413834	gold, Green Submitted, Green Published			2022-12-26	WOS:000362170700049
J	Tomioka, K; Kurumatani, N; Hosoi, H				Tomioka, Kimiko; Kurumatani, Norio; Hosoi, Hiroshi			Social Participation and the Prevention of Decline in Effectance among Community-Dwelling Elderly: A Population-Based Cohort Study	PLOS ONE			English	Article							SELF-RATED HEALTH; LEVEL FUNCTIONAL-CAPACITY; OLDER-ADULTS; INCIDENT DISABILITY; GENDER-DIFFERENCES; DEPRESSION; ONSET; ASSOCIATION; INVOLVEMENT; PREDICTORS	Background We examined the association between a decline in effectance and social participation (SP) from the perspective of the number and the type of SP in a prospective cohort study. Methods Included in this analysis were community-dwelling elderly aged >= 65 without dependency on the basic activities of daily living and reporting a perfect baseline effectance score (n = 4,588; mean age 72.8 +/- 5.7). SP was categorized into 5 types: neighborhood associations, hobby groups, local event groups, senior citizen clubs, and volunteer groups. Effectance was evaluated using the Tokyo Metropolitan Institute of Gerontology Index of Competence. Using logistic regression analysis, odds ratio (OR) and a 95% confidence interval (CI) for a decline in effectance were calculated. Age, family, BMI, pensions, medical history, medications, alcohol, smoking, cognitive function, depression, social support, ADL, and IADL were used as covariates. Results During the 3-year follow-up, 17.8% of eligible participants reported a decline in effectance. After adjustment for covariates, participation in various groups was associated with the preservation of effectance for both genders. Regarding the type of SP, among females, participation in neighborhood associations (OR: 0.62, 95% CI: 0.48-0.81), hobby groups (0.58, 0.430.77), local event groups (0.63, 0.47-0.86), and volunteer groups (0.53, 0.35-0.82) was inversely associated with a decline in effectance. Among males, the beneficial effect was more likely limited to hobby groups (0.59, 0.43-0.81) and volunteer groups (0.57, 0.39-0.83). Conclusions Our results suggest that participation in a variety of social groups is effective for maintenance of older people's effectance, while the beneficial effect of each type of SP on effectance is stronger for females than for males. Recommending community-dwelling elderly to participate in social groups appropriate for their gender may be effective for successful aging.	[Tomioka, Kimiko; Kurumatani, Norio; Hosoi, Hiroshi] Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan	Nara Medical University	Tomioka, K (corresponding author), Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan.	tkimiko@naramed-u.ac.jp			Nara Medical University	Nara Medical University	This work was supported by center administrative expense from Nara Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rayya HM, 2005, INTERNET J HLTH, V5, P2; Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; Antonucci T.C., 1994, WOMEN GROWING OLDER, P239; Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Cabinet Office Government of Japan, 2014, ANN REP AG SOC 2014; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; Desrosiers J, 2004, AGING CLIN EXP RES, V16, P406; Desrosiers J, 2009, ARCH GERONTOL GERIAT, V49, P397, DOI 10.1016/j.archger.2008.12.006; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Fujiwara Y., 2002, GERIATR GERONTOL INT, V2, P57; Fujiwara Y, 2016, GERIATR GERONTOL INT, V16, P126, DOI 10.1111/ggi.12441; GRAND A, 1988, SOC SCI MED, V27, P1337, DOI 10.1016/0277-9536(88)90198-0; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Herzog AR, 1998, PSYCHOL AGING, V13, P179, DOI 10.1037/0882-7974.13.2.179; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; Hsu HC, 2007, AGING MENT HEALTH, V11, P699, DOI 10.1080/13607860701366335; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kishimoto Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1189; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Koyano W., 1987, JPN J PUBLIC HLTH, V34, P109; Lachman ME, 1998, PSYCHOL AGING, V13, P553, DOI 10.1037/0882-7974.13.4.553; Lawton MP, 1972, RES PLANNING ACTION, P122; Levasseur M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1824-0; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Lindstrom M, 2006, SOC SCI MED, V62, P280, DOI 10.1016/j.socscimed.2005.06.005; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; MAHONEY F I, 1965, Md State Med J, V14, P61; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Nilsson CJ, 2008, J AGING HEALTH, V20, P235, DOI 10.1177/0898264307310474; Norton MC, 2006, J GERONTOL B-PSYCHOL, V61, pP129, DOI 10.1093/geronb/61.3.P129; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; STRAWBRIDGE WJ, 1993, GERONTOLOGIST, V33, P603, DOI 10.1093/geront/33.5.603; Sun W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-297; Takagi D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-701; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Tsubota-Utsugi M, 2011, J AM GERIATR SOC, V59, P1993, DOI 10.1111/j.1532-5415.2011.03633.x; Unger JB, 1997, ANN BEHAV MED, V19, P152, DOI 10.1007/BF02883332; Wilson RS, 2015, NEUROPSYCHOLOGY, V29, P561, DOI 10.1037/neu0000154; World Health Organization, 2002, ACT AG POL FRAM; World Health Organization (WHO) Scientific Group on the Epidemiology of Aging, 1984, TECHNICAL REPORT SER, V706; Zunzunegui M V, 2005, Eur J Ageing, V2, P40, DOI 10.1007/s10433-005-0021-x	50	38	38	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139065	10.1371/journal.pone.0139065	http://dx.doi.org/10.1371/journal.pone.0139065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406326	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700159
J	Witte, K; Koch, E; Volk, HD; Wolk, K; Sabat, R				Witte, Katrin; Koch, Egon; Volk, Hans-Dieter; Wolk, Kerstin; Sabat, Robert			The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROUP A-STREPTOCOCCI; DOUBLE-BLIND; IN-VITRO; IL-22; CELLS; KERATINOCYTES; EFFICACY; DIFFERENTIATION; EXPRESSION	Pelargonium sidoides is a medical herb and respective extracts are used very frequently for the treatment of respiratory tract infections. However, the effects of Pelargonium sidoides and a special extract prepared from its roots (EPs 7630) on human immune cells are not fully understood. Here we demonstrate that EPs 7630 induced a rapid and dose-dependent production of TNF-alpha, IL-6, and IL-10 by human blood immune cells. This EPs 7630-induced cytokine profile was more pro-inflammatory in comparison with the profile induced by viral or bacterial infection-mimicking agents. The search for EPs 7630 target cells revealed that T-cells did not respond to EPs 7630 stimulation by production of TNF-alpha, IL-6, or IL-10. Furthermore, pretreatment of T-cells with EPs 7630 did not modulate their TNF-alpha, IL-6, and IL-10 secretion during subsequent activation. In contrast to lymphocytes, monocytes showed clear intracellular TNF-alpha staining after EPs 7630 treatment. Accordingly, EPs 7630 predominantly provoked activation of MAP kinases and inhibition of p38 strongly reduced the monocyte TNF-alpha production. The pretreatment of blood immune cells with EPs 7630 lowered their secretion of TNF-alpha and IL-10 and caused an IL-6 dominant response during second stimulation with viral or bacterial infection-mimicking agents. In summary, we demonstrate that EPs 7630 activates human monocytes, induces MAP kinase-dependent pro-inflammatory cytokines in these cells, and specifically modulates their production capacity of mediators known to lead to an increase of acute phase protein production in the liver, neutrophil generation in the bone marrow, and the generation of adaptive Th17 and Th22 cells.	[Witte, Katrin; Wolk, Kerstin; Sabat, Robert] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol Dermatol M, Berlin, Germany; [Witte, Katrin; Volk, Hans-Dieter; Wolk, Kerstin] Univ Hosp Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Koch, Egon] Dr Willmar Schwabe GmbH & Co KG, Preclin Res, Karlsruhe, Germany; [Volk, Hans-Dieter] Univ Hosp Charite, Inst Med Immunol, Berlin, Germany; [Wolk, Kerstin; Sabat, Robert] Univ Hosp Charite, Psoriasis Res & Treatment Ctr, Berlin, Germany; [Sabat, Robert] Univ Hosp Charite, Res Ctr Immunosci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Dr. Willmar Schwabe GmbH & Co. KG; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sabat, R (corresponding author), Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol Dermatol M, Berlin, Germany.	robert.sabat@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Wolk, Kerstin/0000-0002-7689-4130	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany	RS received a research grant from Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. Additionally, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany provided support in the form of research material (EPs 7630) and salaries for author EK. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agbabiaka TB, 2008, PHYTOMEDICINE, V15, P378, DOI 10.1016/j.phymed.2007.11.023; Bachert C, 2009, RHINOLOGY, V47, P51; BEIL W, 2007, PHYTOMEDICINE S1, V14, P5, DOI DOI 10.1016/J.PHYMED.2006.11.024]; Bereznoy VV, 2003, ALTERN THER HEALTH M, V9, P68; Brendler T, 2008, J ETHNOPHARMACOL, V119, P420, DOI 10.1016/j.jep.2008.07.037; Conrad A, 2007, PHYTOMEDICINE, V14, P46, DOI 10.1016/j.phymed.2006.11.016; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Helfer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087487; Janecki A, 2011, J ETHNOPHARMACOL, V133, P147, DOI 10.1016/j.jep.2010.09.018; Janecki A, 2010, MOLECULES, V15, P7139, DOI 10.3390/molecules15107139; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kolodziej H, 2005, BIOORGAN MED CHEM, V13, P6470, DOI 10.1016/j.bmc.2005.07.012; Kolodziej H, 2003, PHYTOMEDICINE, V10, P18, DOI 10.1078/1433-187X-00307; Kolodziej H, 2007, PHYTOMEDICINE, V14, P9, DOI 10.1016/j.phymed.2006.11.021; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lizogub VG, 2007, EXPLORE-NY, V3, P573, DOI 10.1016/j.explore.2007.09.004; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Matthys H, 2013, RESP MED, V107, P691, DOI 10.1016/j.rmed.2013.02.011; Michaelis M, 2011, PHYTOMEDICINE, V18, P384, DOI 10.1016/j.phymed.2010.09.008; Neugebauer P, 2005, PHYTOMEDICINE, V12, P46, DOI 10.1016/j.phymed.2003.11.005; Pugh ND, 2008, INT IMMUNOPHARMACOL, V8, P1023, DOI 10.1016/j.intimp.2008.03.007; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Schnitzler P, 2008, PHYTOMEDICINE, V15, P1108, DOI 10.1016/j.phymed.2008.06.009; Schoetz K, 2008, PLANTA MED, V74, P667, DOI 10.1055/s-2008-1074515; Thale C, 2011, PLANTA MED, V77, P718, DOI 10.1055/s-0030-1250567; Theisen LL, 2012, ANTIVIR RES, V94, P147, DOI 10.1016/j.antiviral.2012.03.006; Trun W, 2006, PHYTOMEDICINE, V13, P570, DOI 10.1016/j.phymed.2005.07.004; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Wittschier N, 2007, PHYTOMEDICINE, V14, P285, DOI 10.1016/j.phymed.2006.12.008; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0	37	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138075	10.1371/journal.pone.0138075	http://dx.doi.org/10.1371/journal.pone.0138075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406906	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700032
J	Kopp, CW; Cleland, EE				Kopp, Christopher W.; Cleland, Elsa E.			A Range-Expanding Shrub Species Alters Plant Phenological Response to Experimental Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; BIOTIC INTERACTIONS; COMMUNITY RESPONSES; LEAF PHENOLOGY; SHIFTS; ABUNDANCE; TREES	Shifts in plant species phenology (the timing of life-history events such as flowering) have been observed worldwide in concert with rising global temperatures. While most species display earlier phenology with warming, there is large variation among, and even within, species in phenological sensitivity to rising temperatures. Other indirect effects of climate change, such as shifting species composition and altered species interactions, may also be contributing to shifting plant phenology. Here, we describe how experimental warming and the presence of a range-expanding species, sagebrush (Artemisia rothrockii), interact to influence the flowering phenology (day of first and peak flowering) and production (number of flowers) of an alpine cushion plant, Trifolium andersonii, in California's White Mountains. Both first flowering and peak flowering were strongly accelerated by warming, but not when sagebrush was present. Warming significantly increased flower production of T. andersonii, but less so in the presence of sagebrush. A shading treatment delayed phenology and lowered flower production, suggesting that shading may be the mechanism by which sagebrush presence delayed flowering of the understory species. This study demonstrates that species interactions can modify phenological responses to climate change, and suggests that indirect effects of rising temperatures arising from shifting species ranges and altered species interactions may even exceed the direct effects of rising temperatures on phenology.	[Kopp, Christopher W.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Cleland, Elsa E.] Univ Calif San Diego, Div Biol Sci, Ecol Behav & Evolut Sect, San Diego, CA 92103 USA	University of British Columbia; University of California System; University of California San Diego	Kopp, CW (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ckopp@biodiversity.ubc.ca		Cleland, Elsa/0000-0003-3920-0029	University of California, San Diego Division of Biological Sciences; Jean Marie Messier Memorial Endowment; White Mountain Research Center; UC Natural Reserve System; California Native Plant Society; Bristlecone Chapter of the California Native Plant Society; American Alpine Club; Nevada Native Plant Society; ARCS (Achievement Rewards for College Scientists) Foundation; National Science Foundation Graduate STEM Fellows in K-12 Education (GK-12) Program [DGE-1007911]	University of California, San Diego Division of Biological Sciences; Jean Marie Messier Memorial Endowment; White Mountain Research Center; UC Natural Reserve System; California Native Plant Society; Bristlecone Chapter of the California Native Plant Society; American Alpine Club; Nevada Native Plant Society; ARCS (Achievement Rewards for College Scientists) Foundation; National Science Foundation Graduate STEM Fellows in K-12 Education (GK-12) Program	Support was provided by the University of California, San Diego Division of Biological Sciences (http://biology.ucsd.edu); Jean Marie Messier Memorial Endowment; White Mountain Research Center (http://www.wmrc.edu); UC Natural Reserve System (http://nrs.ucop.edu); California Native Plant Society (http://www.cnps.org); Bristlecone Chapter of the California Native Plant Society (http://bristleconecnps.org); American Alpine Club (http://www.americanalpineclub.org); Nevada Native Plant Society (https://nvnps.org); ARCS (Achievement Rewards for College Scientists) Foundation (https://www.arcsfoundation.org/san_diego/); and the National Science Foundation Graduate STEM Fellows in K-12 Education (GK-12) Program (DGE-1007911) (http://www.gk12.org).	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Augspurger CK, 2003, TREE PHYSIOL, V23, P517, DOI 10.1093/treephys/23.8.517; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Cramer W, 2014, PART A GLOBAL AND SE, P979; Delzon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080443; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Galloway LF, 2009, NEW PHYTOL, V182, P1003, DOI 10.1111/j.1469-8137.2009.02803.x; Gould AMA, 2000, AM MIDL NAT, V144, P36, DOI 10.1674/0003-0031(2000)144[0036:EOTEIS]2.0.CO;2; Hall C, 1991, NATURAL HISTORY OF T; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Kopp CW, 2014, J VEG SCI, V25, P135, DOI 10.1111/jvs.12072; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kudo G, 2013, ECOLOGY, V94, P2311, DOI 10.1890/12-2003.1; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molau U, 1996, INTERNATIONAL TUNDRA; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Saccone P, 2009, J VEG SCI, V20, P403, DOI 10.1111/j.1654-1103.2009.01012.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wipf S, 2006, GLOBAL CHANGE BIOL, V12, P1496, DOI 10.1111/j.1365-2486.2006.01185.x; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x	38	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139029	10.1371/journal.pone.0139029	http://dx.doi.org/10.1371/journal.pone.0139029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402617	Green Submitted, gold, Green Published			2022-12-26	WOS:000361798100053
J	Song, J; Yoo, J; Kwon, A; Kim, D; Nguyen, HK; Lee, BY; Suh, W; Min, KH				Song, Jiho; Yoo, Jakyung; Kwon, Ara; Kim, Doran; Hong Khanh Nguyen; Lee, Bong-Yong; Suh, Wonhee; Min, Kyung Hoon			Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases	PLOS ONE			English	Article							CELL LUNG-CANCER; METASTATIC BREAST-CANCER; PHASE-II; COLORECTAL-CANCER; PLUS ERLOTINIB; ONCOLOGY-GROUP; PAZOPANIB; THERAPY; AGENTS; BEVACIZUMAB	Antiangiogenic agents have been widely investigated in combination with standard chemotherapy or targeted cancer agents for better management of advanced cancers. Therapeutic agents that concurrently inhibit epidermal growth factor receptor and other angiokinases could be useful alternatives to combination therapies for epidermal growth factor receptor-dependent cancers. Here, we report the synthesis of an indole derivative of pazopanib using a bioisosteric replacement strategy, which was designated MKP101. MKP101 inhibited not only the epidermal growth factor receptor with an IC50 value of 43 nM but also inhibited angiokinases as potently as pazopanib. In addition, MKP101 effectively inhibited vascular endothelial growth factor-induced endothelial proliferation, tube formation, migration of human umbilical vein endothelial cells and proliferation of HCC827, an epidermal growth factor receptor-addicted cancer cell line. A docking model of MKP101 and the kinase domain of the epidermal growth factor receptor was generated to predict its binding mode, and validated by synthesizing and evaluating MKP101 derivatives. Additionally, a study of structure-activity relationships of indolylamino or indolyloxy pyrimidine analogues derived from MKP101 demonstrated that selectivity for epidermal growth factor receptor and other angiokinases, especially vascular endothelial growth factor receptor 2 depends on the position of substituents on pyrimidine and the type of link between pyrimidine and the indole moiety. We believe that this study could provide a basis for developing angiokinase inhibitors having high affinity for the epidermal growth factor receptor, from the pyrimidine scaffold.	[Song, Jiho; Kwon, Ara; Kim, Doran; Hong Khanh Nguyen; Suh, Wonhee; Min, Kyung Hoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Yoo, Jakyung; Lee, Bong-Yong] Daewoong Pharmaceut Co Ltd, Life Sci Res Inst, Gyeonggi Do, South Korea	Chung Ang University	Suh, W (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	wsuh@cau.ac.kr; khmin@cau.ac.kr		Song, Jiho/0000-0002-0528-8096	Korea Drug Development Fund (KDDF) - Ministry of Science, ICT and Future Planning [KDDF-201208-07]; Bio & Medical Technology Development Program of the NRF - Korean government (MSIP) [NRF-2012M3A9C7050137, NRF-2012M3A9C6050368]; Daewoong Pharmaceutical Co., Ltd.; Korea Drug Development Fund (KDDF) - Ministry of Trade, Industry Energy [KDDF-201208-07]; Korea Drug Development Fund (KDDF) - Ministry of Health Welfare [KDDF-201208-07]	Korea Drug Development Fund (KDDF) - Ministry of Science, ICT and Future Planning; Bio & Medical Technology Development Program of the NRF - Korean government (MSIP); Daewoong Pharmaceutical Co., Ltd.; Korea Drug Development Fund (KDDF) - Ministry of Trade, Industry Energy; Korea Drug Development Fund (KDDF) - Ministry of Health Welfare	This research was supported by Korea Drug Development Fund (KDDF) funded by Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health & Welfare (KDDF-201208-07) and by the Bio & Medical Technology Development Program of the NRF funded by the Korean government (MSIP) (NRF-2012M3A9C7050137 and 2012M3A9C6050368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Daewoong Pharmaceutical Co., Ltd. provided support in the form of salaries for authors JY and BYL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Aggarwal C, 2012, CANCER BIOL THER, V13, P247, DOI 10.4161/cbt.19594; Al-Husein B, 2012, PHARMACOTHERAPY, V32, P1095, DOI 10.1002/phar.1147; Altorki N, 2010, J CLIN ONCOL, V28, P3131, DOI 10.1200/JCO.2009.23.9749; [Anonymous], 2013, EP VERS 2 4; [Anonymous], 2013, IMP VERS 5 9; [Anonymous], 2013, PRIM VERS 3 2; [Anonymous], 2013, LIGPREP VERS 2 6; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bukowski RM, 2010, NAT REV DRUG DISCOV, V9, P17, DOI 10.1038/nrd3073; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; FLUDZINSKI P, 1987, J MED CHEM, V30, P1535, DOI 10.1021/jm00392a001; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Harris PA, 2008, J MED CHEM, V51, P4632, DOI 10.1021/jm800566m; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Jia YP, 2014, CHEM BIOL DRUG DES, V83, P306, DOI 10.1111/cbdd.12243; Kumar R, 2009, BRIT J CANCER, V101, P1717, DOI 10.1038/sj.bjc.6605366; Limaverde-Sousa G, 2014, CANCER TREAT REV, V40, P548, DOI 10.1016/j.ctrv.2013.11.009; Majem M, 2013, CLIN TRANSL ONCOL, V15, P343, DOI 10.1007/s12094-012-0964-2; Miles D, 2002, ONCOLOGIST, V7, P13; Mina LA, 2013, INVEST NEW DRUG, V31, P1307, DOI 10.1007/s10637-013-9976-1; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Poindessous V, 2011, CLIN CANCER RES, V17, P6522, DOI 10.1158/1078-0432.CCR-11-1607; Qi HF, 2014, BIOORG MED CHEM LETT, V24, P1108, DOI 10.1016/j.bmcl.2014.01.003; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scagliotti GV, 2013, J THORAC ONCOL, V8, P1529, DOI 10.1097/JTO.0000000000000005; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Schrodinger LLC, 2013, MAESTR VERS 9 4; Schrodinger scientist(s), 2013, SMALL MOL DRUG DISC; SCRI Development Innovations LLC, 2000, RAND DOUBL BLIND TRI; Verweij J, 2013, EXPERT OPIN PHARMACO, V14, P929, DOI 10.1517/14656566.2013.780030; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	35	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138823	10.1371/journal.pone.0138823	http://dx.doi.org/10.1371/journal.pone.0138823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401847	Green Submitted, Green Published, gold			2022-12-26	WOS:000361798100038
J	Wang, W; He, Y; Yu, GD; Li, BL; Sexton, DW; Wileman, T; Roberts, AA; Hamilton, CJ; Liu, RX; Chao, YM; Shan, YJ; Bao, YP				Wang, Wei; He, Yan; Yu, Guodong; Li, Baolong; Sexton, Darren W.; Wileman, Thomas; Roberts, Alexandra A.; Hamilton, Chris J.; Liu, Ruoxi; Chao, Yimin; Shan, Yujuan; Bao, Yongping			Sulforaphane Protects the Liver against CdSe Quantum Dot-Induced Cytotoxicity	PLOS ONE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; PROSTATE-CANCER CELLS; OXIDATIVE STRESS; CACO-2 CELLS; CHEMOPREVENTIVE AGENT; SIGNALING PATHWAYS; GENE-EXPRESSION; HUMAN HEPG2; GLUTATHIONE; AUTOPHAGY	The potential cytotoxicity of cadmium selenide (CdSe) quantum dots (QDs) presents a barrier to their use in biomedical imaging or as diagnostic and therapeutic agents. Sulforaphane (SFN) is a chemoprotective compound derived from cruciferous vegetables which can up-regulate antioxidant enzymes and induce apoptosis and autophagy. This study reports the effects of SFN on CdSe QD-induced cytotoxicity in immortalised human hepatocytes and in the livers of mice. CdSe QDs induced dose-dependent cell death in hepatocytes with an IC50 = 20.4 mu M. Pre-treatment with SFN (5 mu M) increased cell viability in response to CdSe QDs (20 mu M) from 49.5 to 89.3%. SFN induced a pro-oxidant effect characterized by depletion of intracellular reduced glutathione during short term exposure (3-6 h), followed by up-regulation of antioxidant enzymes and glutathione levels at 24 h. SFN also caused Nrf2 translocation into the nucleus, up-regulation of antioxidant enzymes and autophagy. siRNA knockdown of Nrf2 suggests that the Nrf2 pathway plays a role in the protection against CdSe QD-induced cell death. Wortmannin inhibition of SFN-induced autophagy significantly suppressed the protective effect of SFN on CdSe QD-induced cell death. Moreover, the role of autophagy in SFN protection against CdSe QD-induced cell death was confirmed using mouse embryonic fibroblasts lacking ATG5. CdSe QDs caused significant liver damage in mice, and this was decreased by SFN treatment. In conclusion, SFN attenuated the cytotoxicity of CdSe QDs in both human hepatocytes and in the mouse liver, and this protection was associated with the induction of Nrf2 pathway and autophagy.	[Wang, Wei; Yu, Guodong; Sexton, Darren W.; Wileman, Thomas; Bao, Yongping] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [He, Yan] Harbin Inst Technol, Dept Pathol, Harbin 150006, Heilongjiang, Peoples R China; [Li, Baolong] Heilongjiang Univ Chinese Med, Ctr Safety Evaluat Drugs, Harbin, Heilongjiang, Peoples R China; [Roberts, Alexandra A.; Hamilton, Chris J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Liu, Ruoxi; Chao, Yimin] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Shan, Yujuan] Harbin Inst Technol, Sch Food Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China	University of East Anglia; Harbin Institute of Technology; Heilongjiang University of Chinese Medicine; University of East Anglia; University of East Anglia; Harbin Institute of Technology	Shan, YJ (corresponding author), Harbin Inst Technol, Sch Food Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China.	shanyujuan@hit.edu.cn; y.bao@uea.ac.uk	Chao, Yimin/A-4054-2008; Sexton, Darren/AAF-3171-2020; hamilton, chris/C-5651-2009; Bao, Yongping/A-6951-2010	Chao, Yimin/0000-0002-8488-2690; Bao, Yongping/0000-0002-6425-0370; Roberts, Alexandra/0000-0002-0705-1615; Sexton, Darren/0000-0003-3344-3150	Cancer Prevention Research Trust, UK; BBSRC, UK [BB/H013504/1]; National Natural Science Foundation, China [81101735]; Biotechnology and Biological Sciences Research Council [BB/H013504/1] Funding Source: researchfish; BBSRC [BB/H013504/1] Funding Source: UKRI	Cancer Prevention Research Trust, UK; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was, in part, supported by awards from the Cancer Prevention Research Trust, UK, the BBSRC (BB/H013504/1), UK, and the National Natural Science Foundation, China (No 81101735).	Akhtar MJ, 2012, J TOXICOL SCI, V37, P139, DOI 10.2131/jts.37.139; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bacon JR, 2007, J AGR FOOD CHEM, V55, P1170, DOI 10.1021/jf062398+; Bacon JR, 2003, CARCINOGENESIS, V24, P1903, DOI 10.1093/carcin/bgg157; Bao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114764; Barrera LN, 2012, BBA-MOL CELL RES, V1823, P1914, DOI 10.1016/j.bbamcr.2012.07.007; Basten GP, 2002, CARCINOGENESIS, V23, P1399, DOI 10.1093/carcin/23.8.1399; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; Chu MQ, 2012, BIOMATERIALS, V33, P7071, DOI 10.1016/j.biomaterials.2012.06.062; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Emmert SW, 2010, BIOORG MED CHEM LETT, V20, P2675, DOI 10.1016/j.bmcl.2010.01.044; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Harris KE, 2008, J NUTR BIOCHEM, V19, P246, DOI 10.1016/j.jnutbio.2007.02.014; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Huber WW, 2007, CURR OPIN PHARMACOL, V7, P404, DOI 10.1016/j.coph.2007.05.005; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Kim BR, 2003, CANCER RES, V63, P7520; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li D, 2012, FOOD CHEM, V133, P300, DOI 10.1016/j.foodchem.2012.01.026; Li J., 2014, J ENG SCI TECHNOL, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0100685; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Lu YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093013; Mastrangelo L, 2008, CANCER RES, V68, P5487, DOI 10.1158/0008-5472.CAN-07-6171; McConnachie LA, 2013, NANOTOXICOLOGY, V7, P181, DOI 10.3109/17435390.2011.648224; Nagy A, 2012, ACS NANO, V6, P4748, DOI 10.1021/nn204886b; NEWTON GL, 1995, METHOD ENZYMOL, V251, P148, DOI 10.1016/0076-6879(95)51118-0; Ni T, 2002, J AM CHEM SOC, V124, P3980, DOI 10.1021/ja017149a; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; OCHI T, 1988, CHEM-BIOL INTERACT, V65, P1, DOI 10.1016/0009-2797(88)90026-9; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Pelley JL, 2009, TOXICOL SCI, V112, P276, DOI 10.1093/toxsci/kfp188; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Ramirez MC, 2009, J NUTR BIOCHEM, V20, P195, DOI 10.1016/j.jnutbio.2008.02.002; Rikans LE, 2000, J BIOCHEM MOL TOXIC, V14, P110, DOI 10.1002/(SICI)1099-0461(2000)14:2<110::AID-JBT7>3.0.CO;2-J; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Techapiesancharoenkij N, 2015, TOXICOL APPL PHARM, V282, P52, DOI 10.1016/j.taap.2014.11.004; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Wang FQ, 2012, NUTR RES, V32, P374, DOI 10.1016/j.nutres.2012.03.014; Wang Lin, 2008, Journal of Nanobiotechnology, V6, P11, DOI 10.1186/1477-3155-6-11; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhao JJ, 2013, ONCOTARGETS THER, V6, P303, DOI 10.2147/OTT.S38453	67	23	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138771	10.1371/journal.pone.0138771	http://dx.doi.org/10.1371/journal.pone.0138771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402917	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100036
J	Hossain, MB; Oshima, T; Hirose, S; Wang, J; Tokumoto, T				Hossain, Md. Babul; Oshima, Takayuki; Hirose, Shizuka; Wang, Jun; Tokumoto, Toshinobu			Expression and Purification of Human Membrane Progestin Receptor alpha (mPR alpha)	PLOS ONE			English	Article							YEAST PICHIA-PASTORIS; BREAST-CANCER CELLS; OOCYTE MATURATION; PROGESTERONE-MEMBRANE-RECEPTOR-COMPONENT-1 PGMRC1; FUNCTIONAL-CHARACTERIZATION; BINDING CHARACTERISTICS; ANDROGEN RECEPTORS; MEIOTIC MATURATION; RAINBOW-TROUT; IDENTIFICATION	Membrane progestin receptors (mPRs) are responsible for mediating the rapid, nongenomic activity of progestins and belong to the G protein-coupled receptor (GPCR) family. mPRs are also considered as attractive proteins to draw a new medicinal approach. In this study, we optimized a procedure for the expression and purification of recombinant human mPR alpha protein (hmPR alpha) by a methylotropic yeast, Pichia pastoris, expression system. The protein expressed in crude membrane fractions exhibited a binding affinity of Kd = 3.8 nM and Bmax = 288.8 fmol/mg for progesterone. These results indicated that the hmPR alpha expressed in yeast was active. Solubilized hmPR alpha was purified through three column chromatography steps. A nickel-nitrilotriacetic acid (Ni-NTA) column was first used, and the mPR alpha proteins were then bound to cellulose resin with free amino groups (Cellufine Amino) and finally passed through an SP-Sepharose column. The optimization of expression and purification conditions resulted in a high yield of purified hmPR alpha (1.3-1.5 mg from 1 L culture). The purified hmPR alpha protein demonstrated progesterone binding (Kd = 5.2 nM and Bmax = 111.6 fmol/mg). The results indicated that we succeeded in solubilizing and purifying hmPR alpha in an active form. Sufficient amount of active hmPR alpha protein will support the establishment of applications for the screening of ligands for mPR alpha.	[Hossain, Md. Babul; Oshima, Takayuki; Wang, Jun; Tokumoto, Toshinobu] Shizuoka Univ, Natl Univ Corp, Grad Sch Sci & Technol,Integrated Biosci Sect, Suruga Ku, Shizuoka 4228529, Japan; [Hirose, Shizuka; Tokumoto, Toshinobu] Shizuoka Univ, Natl Univ Corp, Fac Sci,Dept Biol Sci, Suruga Ku, Shizuoka 4228529, Japan	Shizuoka University; Shizuoka University	Tokumoto, T (corresponding author), Shizuoka Univ, Natl Univ Corp, Grad Sch Sci & Technol,Integrated Biosci Sect, Suruga Ku, Ohya 836, Shizuoka 4228529, Japan.	sbttoku@ipc.shizuoka.ac.jp	Tokumoto, Toshinobu/R-7653-2019	Tokumoto, Toshinobu/0000-0001-9086-3608	JSPS KAKENHI [25440154]; grant from The Naito Foundation; Japanese environmental agency [ExTEND2005]; SUNBOR grant from Suntory Institute For Bioorganic Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant from The Naito Foundation; Japanese environmental agency; SUNBOR grant from Suntory Institute For Bioorganic Research	This work was supported by JSPS KAKENHI Grant Number 25440154 (to TT) and a grant from The Naito Foundation (to TT), the Japanese environmental agency (ExTEND2005 FS to TT) and a SUNBOR grant from Suntory Institute For Bioorganic Research (to TT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambhaikar M, 1998, MOL HUM REPROD, V4, P413, DOI 10.1093/molehr/4.5.413; Asada H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-24; Ashley RL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-42; Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; Berg AH, 2014, ENDOCRINOLOGY, V155, P4237, DOI 10.1210/en.2014-1198; Boonyaratanakornkit V, 2004, ESSAYS BIOCHEM, V40, P105, DOI 10.1042/bse0400105; Chien CH, 2009, HUM REPROD, V24, P1968, DOI 10.1093/humrep/dep099; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Dressing GE, 2012, HORM CANCER-US, V3, P101, DOI 10.1007/s12672-012-0106-x; Frye CA, 2013, J NEUROENDOCRINOL, V25, P1002, DOI 10.1111/jne.12105; Frye CA, 2014, STEROIDS, V81, P17, DOI 10.1016/j.steroids.2013.11.009; Hanna R, 2006, J ENDOCRINOL, V190, P247, DOI 10.1677/joe.1.06694; Hanna RN, 2009, GEN COMP ENDOCR, V161, P153, DOI 10.1016/j.ygcen.2008.10.006; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Intlekofer KA, 2011, NEUROSCIENCE, V172, P55, DOI 10.1016/j.neuroscience.2010.10.051; JALABERT B, 1986, FISH PHYSIOL BIOCHEM, V2, P65, DOI 10.1007/BF02264074; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; LaCava J, 2015, BIOTECHNIQUES, V58, P103, DOI 10.2144/000114262; Lu J, 2015, J ENDOCRINOL, V224, P183, DOI 10.1530/JOE-14-0470; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mizutani K, 2004, BIOSCI BIOTECH BIOCH, V68, P376, DOI 10.1271/bbb.68.376; Mizutani K, 2010, BIOSCI BIOTECH BIOCH, V74, P309, DOI 10.1271/bbb.90635; Mourot B, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-6; Ndiaye K, 2012, J REPROD IMMUNOL, V95, P15, DOI 10.1016/j.jri.2012.04.004; Oshima T, 2014, BIOMED RES-TOKYO, V35, P47, DOI 10.2220/biomedres.35.47; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; Rae MT, 1998, J ENDOCRINOL, V159, P413, DOI 10.1677/joe.0.1590413; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Stanczyk FZ, 2003, STEROIDS, V68, P879, DOI 10.1016/j.steroids.2003.08.003; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Thomas P, 2014, ENDOCRINOLOGY, V155, P4250, DOI 10.1210/en.2014-1201; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002; Tokumoto T, 2007, ENDOCRINOLOGY, V148, P3459, DOI 10.1210/en.2006-1694; Tokumoto T, 2012, GEN COMP ENDOCR, V177, P168, DOI 10.1016/j.ygcen.2012.03.005; Tubbs C, 2009, ENDOCRINOLOGY, V150, P473, DOI 10.1210/en.2008-0512; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Vares G, 2015, CANCER LETT, V362, P167, DOI 10.1016/j.canlet.2015.03.030; Xie MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035198; Zeder-Lutz G, 2006, PROTEIN EXPRES PURIF, V50, P118, DOI 10.1016/j.pep.2006.05.017; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100; Zuo LA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2588	49	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138739	10.1371/journal.pone.0138739	http://dx.doi.org/10.1371/journal.pone.0138739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398701	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500101
J	Yang, JW; Kim, HS; Im, JH; Kim, JW; Jun, DW; Lim, SC; Lee, K; Choi, JM; Kim, SK; Kang, KW				Yang, Jin Won; Kim, Hyo Seon; Im, Ji Hye; Kim, Ji Won; Jun, Dae Won; Lim, Sung Chul; Lee, Kyeong; Choi, Jong Min; Kim, Sang Kyum; Kang, Keon Wook			GPR119: a promising target for nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						AMPK; SREBP-1; steatosis	ACTIVATED PROTEIN-KINASE; GLUCAGON-LIKE PEPTIDE-1; HEPATIC STEATOSIS; COUPLED RECEPTOR; GLYCEMIC CONTROL; X RECEPTORS; INSULIN; AMPK; GLUCOSE; CELLS	Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver. G-protein-coupled receptor 119 (GPR119) is a promising target for type 2 diabetes. However, the role of GPR119 activation in hepatic steatosis and its precise mechanism has not been investigated. In primary cultured hepatocytes from wild-type and GPR119 knockout (KO) mice, expression of lipogenic enzymes was elevated in GPR119 KO hepatocytes. Treatment of hepatocytes and HepG2 cells with GPR119 agonists in phase 2 clinical trials (MBX-2982 [MBX] and GSK1292263) inhibited protein expression of both nuclear and total sterol regulatory element binding protein (SREBP)-1, a key lipogenesis transcription factor. Oral administration of MBX in mice fed a high-fat diet potently inhibited hepatic lipid accumulation and expression levels of SREBP-1 and lipogenesis-related genes, whereas the hepatic antilipogenesis effects of MBX were abolished in GPR119 KO mice. MBX activated AMPK and increased Ser-372 phosphorylation of SREBP-1c, an inhibitory form of SREBP-1c. Moreover, inhibition of AMPK recovered MBX-induced down-regulation of SREBP-1. These findings demonstrate for the first time that the GPR119 ligand alleviates hepatic steatosis by inhibiting SREBP-1-mediated lipogenesis in hepatocytes.	[Yang, Jin Won; Kim, Hyo Seon; Im, Ji Hye; Kim, Ji Won; Kang, Keon Wook] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Yang, Jin Won; Kim, Hyo Seon; Im, Ji Hye; Kim, Ji Won; Kang, Keon Wook] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Jun, Dae Won] Han Yang Univ, Dept Internal Med, Seoul, South Korea; [Lim, Sung Chul] Chosun Univ, Coll Med, Dept Pathol, Gwangju, South Korea; [Lee, Kyeong] Dongguk Univ, Coll Pharm, Goyang, South Korea; [Choi, Jong Min; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Chosun University; Dongguk University; Chungnam National University	Kang, KW (corresponding author), Seoul Natl Univ, Coll Pharm, Gwanakro 1, Seoul 151742, South Korea.	kwkang@snu.ac.kr	; Kim, Hyo Seon/B-3373-2018	Kim, Sang Kyum/0000-0001-5769-0792; Kim, Hyo Seon/0000-0003-1926-7840	National Research Foundation of Korea - Korean government [2014M3A9A8064408, 2012M3A9C1053532, 2007-005681]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	The authors acknowledge financial support from the National Research Foundation of Korea, funded by the Korean government (2014M3A9A8064408, 2012M3A9C1053532, and 2007-005681).	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bonini J.A., 2002, U.S. Patent, Patent No. [6468756, 6,468,756-B1]; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Chu ZL, 2010, MOL ENDOCRINOL, V24, P161, DOI 10.1210/me.2009-0239; Cornall LM, 2013, MOL CELL ENDOCRINOL, V365, P108, DOI 10.1016/j.mce.2012.10.003; Cornall LM, 2013, EXPERT OPIN INV DRUG, V22, P487, DOI 10.1517/13543784.2013.775245; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hansen HS, 2012, TRENDS PHARMACOL SCI, V33, P374, DOI 10.1016/j.tips.2012.03.014; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; Lan H, 2009, J ENDOCRINOL, V201, P219, DOI 10.1677/JOE-08-0453; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Odori S, 2013, METABOLISM, V62, P70, DOI 10.1016/j.metabol.2012.06.010; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Poor M, 2014, J PHOTOCH PHOTOBIO B, V132, P1, DOI 10.1016/j.jphotobiol.2014.01.016; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Xiao X, 2013, ACTA BIOCH BIOPH SIN, V45, P2, DOI 10.1093/abbs/gms112; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	39	32	35	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					324	335		10.1096/fj.15-273771	http://dx.doi.org/10.1096/fj.15-273771			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26399788				2022-12-26	WOS:000367621000031
J	Kantola, K; Hedman, L; Tanner, L; Simell, V; Makinen, M; Partanen, J; Sadeghi, M; Veijola, R; Knip, M; Ilonen, J; Hyoty, H; Toppari, J; Simell, O; Hedman, K; Soderlund-Venermo, M				Kantola, Kalle; Hedman, Lea; Tanner, Laura; Simell, Ville; Makinen, Marjaana; Partanen, Juulia; Sadeghi, Mohammadreza; Veijola, Riitta; Knip, Mikael; Ilonen, Jorma; Hyoty, Heikki; Toppari, Jorma; Simell, Olli; Hedman, Klaus; Soderlund-Venermo, Maria			B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN; DENGUE VIRUS-INFECTION; INFLUENZA-A VIRUSES; ACUTE GASTROENTERITIS; LINE U937; CHILDREN; DISEASE; RISK; ASSOCIATION	Human bocaviruses (HBoVs) 1-4 are recently discovered, antigenically similar parvoviruses. We examined the hypothesis that the antigenic similarity of these viruses could give rise to clinically and diagnostically important immunological interactions. IgG and IgM EIAs as well as qPCR were used to study similar to 2000 sera collected from infancy to early adolescence at 3-6-month intervals from 109 children whose symptoms were recorded. We found that HBoV1-4-specific seroprevalences at age 6 years were 80%, 48%, 10%, and 0%, respectively. HBoV1 infections resulted in significantly weaker IgG responses among children who had pre-existing HBoV2 IgG, and vice versa. Furthermore, we documented a complete absence of virus type-specific immune responses in six viremic children who had pre-existing IgG for another bocavirus, indicating that not all HBoV infections can be diagnosed serologically. Our results strongly indicate that interactions between consecutive HBoV infections affect HBoV immunity via a phenomenon called "original antigenic sin", cross-protection, or both; however, without evident clinical consequences but with important ramifications for the serodiagnosis of HBoV infections. Serological data is likely to underestimate human exposure to these viruses.	[Kantola, Kalle; Hedman, Lea; Partanen, Juulia; Sadeghi, Mohammadreza; Hedman, Klaus; Soderlund-Venermo, Maria] Univ Helsinki, Dept Virol, Helsinki, Finland; [Hedman, Lea; Hedman, Klaus] Helsinki Univ Hosp, Lab Serv, Helsinki, Finland; [Tanner, Laura; Ilonen, Jorma; Toppari, Jorma] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Simell, Ville; Makinen, Marjaana; Ilonen, Jorma; Toppari, Jorma; Simell, Olli] Univ Turku, Medicity, Turku, Finland; [Veijola, Riitta] Univ Oulu, Dept Paediat, Oulu, Finland; [Knip, Mikael] Univ Helsinki, Helsinki, Finland; [Knip, Mikael] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Knip, Mikael] Res Programs Unit, Diabet & Obes, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Tampere Ctr Child Hlth Res, Tampere, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio, Finland; [Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Hyoty, Heikki] Univ Tampere, Dept Virol, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Tampere University; Tampere University Hospital; University of Eastern Finland; University of Turku; Tampere University	Kantola, K (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.	kalle.kantola@helsinki.fi	Söderlund-Venermo, Maria/AAX-2112-2020; Mäkinen, Marjaana/H-8065-2019; Knip, Mikael/AAL-3773-2020; Hedman, Klaus/D-5379-2009	Mäkinen, Marjaana/0000-0003-1319-0707; sadeghi, mohammad reza/0000-0002-2725-6407; Hyoty, Heikki/0000-0003-0370-4145; Ilonen, Jorma/0000-0002-9973-2062; Hedman, Klaus/0000-0003-1779-7960; Knip, Mikael/0000-0003-0474-0033	Academy of Finland [1257964]; Helsinki Biomedical Graduate School; Helsinki University Hospital Research Education; Research & Development Funds; Medical Society of Finland; University of Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Helsinki Biomedical Graduate School; Helsinki University Hospital Research Education; Research & Development Funds; Medical Society of Finland; University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Financial support was provided by The Academy of Finland (www.aka.fi/en) project 1257964) to KH and MSV, The Helsinki Biomedical Graduate School (www.helsinki.fi/dpbm) to KK, Helsinki University Hospital Research & Education, and Research & Development Funds (www.hus.fi/en) to KH, The Medical Society of Finland (www.fls.fi/sallskapet/) to KK, KH and MSV, The Research Funds of the University of Helsinki (www.helsinki.fi/en) to MSV, and The Sigrid Juselius Foundation (www.sigridjuselius.fi/foundation) to KH, MSV, and OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Blessing K, 2009, PEDIATR INFECT DIS J, V28, P1018, DOI 10.1097/INF.0b013e3181a854ae; Bloom ME, 2001, J VIROL, V75, P11116, DOI 10.1128/JVI.75.22.11116-11127.2001; Chieochansin T, 2009, EMERG INFECT DIS, V15, P1503, DOI 10.3201/eid1509.090394; Christensen A, 2013, EMERG INFECT DIS, V19, P574, DOI 10.3201/eid1904.121775; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; DAVENPORT FM, 1956, J EXP MED, V104, P85, DOI 10.1084/jem.104.1.85; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Guo LN, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-636; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Ilonen J, 2002, AM J MED GENET, V115, P30, DOI 10.1002/ajmg.10341; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; KANNO H, 1993, J VIROL, V67, P7017, DOI 10.1128/JVI.67.12.7017-7024.1993; Kantola K, 2008, CLIN INFECT DIS, V46, P540, DOI 10.1086/526532; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Lehtoranta L, 2012, INT J PEDIATR OTORHI, V76, P206, DOI 10.1016/j.ijporl.2011.10.025; Li XM, 2015, J GEN VIROL, V96, P3099, DOI 10.1099/jgv.0.000253; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martin ET, 2015, J INFECT DIS; Meriluoto M, 2012, EMERG INFECT DIS, V18, P264, DOI 10.3201/eid1802.111293; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Munakata Y, 2006, VIROLOGY, V345, P251, DOI 10.1016/j.virol.2005.09.040; Nawaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041346; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Paloniemi M, 2014, EUR J PEDIATR, V173, P1051, DOI 10.1007/s00431-014-2290-x; Proenca-Modena JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021083; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; TAMURA M, 1991, VIROLOGY, V182, P211, DOI 10.1016/0042-6822(91)90664-W; TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994; van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141; von Kietzell K, 2014, J VIROL, V88, P8102, DOI 10.1128/JVI.00649-14; von Linstow ML, 2008, PEDIATR INFECT DIS J, V27, P897, DOI 10.1097/INF.0b013e3181757b16	41	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139096	10.1371/journal.pone.0139096	http://dx.doi.org/10.1371/journal.pone.0139096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418064	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400042
J	Saito, S; Hirata, Y; Sasahara, K; Suzuki, H				Saito, Shota; Hirata, Yoshito; Sasahara, Kazutoshi; Suzuki, Hideyuki			Tracking Time Evolution of Collective Attention Clusters in Twitter: Time Evolving Nonnegative Matrix Factorisation	PLOS ONE			English	Article								Micro-blogging services, such as Twitter, offer opportunities to analyse user behaviour. Discovering and distinguishing behavioural patterns in micro-blogging services is valuable. However, it is difficult and challenging to distinguish users, and to track the temporal development of collective attention within distinct user groups in Twitter. In this paper, we formulate this problem as tracking matrices decomposed by Nonnegative Matrix Factorisation for time-sequential matrix data, and propose a novel extension of Nonnegative Matrix Factorisation, which we refer to as Time Evolving Nonnegative Matrix Factorisation (TENMF). In our method, we describe users and words posted in some time interval by a matrix, and use several matrices as time-sequential data. Subsequently, we apply Time Evolving Nonnegative Matrix Factorisation to these time-sequential matrices. TENMF can decompose time-sequential matrices, and can track the connection among decomposed matrices, whereas previous NMF decomposes a matrix into two lower dimension matrices arbitrarily, which might lose the time-sequential connection. Our proposed method has an adequately good performance on artificial data. Moreover, we present several results and insights from experiments using real data from Twitter.	[Saito, Shota; Hirata, Yoshito; Suzuki, Hideyuki] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan; [Hirata, Yoshito; Suzuki, Hideyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Sasahara, Kazutoshi] Nagoya Univ, Grad Sch Informat Sci, Dept Complex Syst Sci, Nagoya, Aichi 4648601, Japan	University of Tokyo; University of Tokyo; Nagoya University	Saito, S (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan.	ssaito@sat.t.u-tokyo.ac.jp	Hirata, Yoshito/L-9297-2018; Suzuki, Hideyuki/A-4161-2013	Hirata, Yoshito/0000-0002-9245-2543; Suzuki, Hideyuki/0000-0002-8150-140X; Sasahara, Kazutoshi/0000-0003-2572-0648	Aihara Innovative Mathematical Modelling Project; Japanese Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)	Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research was supported by the Aihara Innovative Mathematical Modelling Project, the Japanese Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139085	10.1371/journal.pone.0139085	http://dx.doi.org/10.1371/journal.pone.0139085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417999	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400039
J	Liu, F; Zhao, YL; Wang, XL; Hu, HB; Peng, HS; Wang, W; Wang, JF; Zhang, XH				Liu, Fei; Zhao, Yi-Lei; Wang, Xiaolei; Hu, Hongbo; Peng, Huasong; Wang, Wei; Wang, Jing-Fang; Zhang, Xuehong			Elucidation of Enzymatic Mechanism of Phenazine Biosynthetic Protein PhzF Using QM/MM and MD Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PSEUDOMONAS-FLUORESCENS 2-79; PARTICLE MESH EWALD; TRANSITION-STATE; PK(A) VALUES; FORCE-FIELD; AERUGINOSA; PYOCYANIN; BACTERIA; DENSITY	The phenazine biosynthetic pathway is of considerable importance for the pharmaceutical industry. The pathway produces two products: phenazine-1,6-dicarboxylic acid and phenazine-1-carboxylic acid. PhzF is an isomerase that catalyzes trans-2,3-dihydro-3-hydroxyanthranilic acid isomerization and plays an essential role in the phenazine biosynthetic pathway. Although the PhzF crystal structure has been determined recently, an understanding of the detailed catalytic mechanism and the roles of key catalytic residues are still lacking. In this study, a computational strategy using a combination of molecular modeling, molecular dynamics simulations, and quantum mechanics/molecular mechanics simulations was used to elucidate these important issues. The Apo enzyme, enzyme-substrate complexes with negatively charged Glu45, enzyme-transition state analog inhibitor complexes with neutral Glu45, and enzyme-product complexes with negatively charged Glu45 structures were optimized and modeled using a 200 ns molecular dynamics simulation. Residues such as Gly73, His74, Asp208, Gly212, Ser213, and water, which play important roles in ligand binding and the isomerization reaction, were comprehensively investigated. Our results suggest that the Glu45 residue at the active site of PhzF acts as a general base/acid catalyst during proton transfer. This study provides new insights into the detailed catalytic mechanism of PhzF and the results have important implications for PhzF modification.	[Liu, Fei; Zhao, Yi-Lei; Wang, Xiaolei; Hu, Hongbo; Peng, Huasong; Wang, Wei; Zhang, Xuehong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xuehzhang@sjtu.edu.cn	Wang, Jingfang/Q-2597-2018; wang, xiao/HGB-7081-2022	Wang, Jingfang/0000-0002-1355-5481; wang, xiao/0000-0002-4088-3341	National Key Basic Research Program of China [2012CB721005]; National Natural Science Foundation of China [31270084]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (No. 2012CB721005), and the National Natural Science Foundation of China (No. 31270084). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; [Anonymous], 2014, INT ENCY STAT SCI; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; Beifuss U, 2005, NATURAL PRODUCTS SYN; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; Blankenfeldt W, 2013, MICROBIAL PHENAZINES; Blankenfeldt W, 2014, CURR OPIN STRUC BIOL, V29, P26, DOI 10.1016/j.sbi.2014.08.013; Campos SRR, 2009, J PHYS CHEM B, V113, P15989, DOI 10.1021/jp902991u; CASEWIT CJ, 1992, J AM CHEM SOC, V114, P10035, DOI 10.1021/ja00051a041; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P969, DOI 10.1094/MPMI.2001.14.8.969; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Frisch G. W., 2013, GAUSSIAN 09; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l; Kondratyuk TP, 2012, MAR DRUGS, V10, P451, DOI 10.3390/md10020451; Kozuch S, 2006, J AM CHEM SOC, V128, P3355, DOI 10.1021/ja0559146; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liger D, 2005, PROTEINS, V60, P778, DOI 10.1002/prot.20548; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2004, ACTA CRYSTALLOGR D, V60, P184, DOI [10.1107/S090744490302571X, 10.1107/S0907444903025]; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McDonald M, 2001, J AM CHEM SOC, V123, P9459, DOI 10.1021/ja011243+; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Mitomo D, 2006, PROTEINS, V64, P883, DOI 10.1002/prot.21069; Ohfuji K, 2004, BIOSENS BIOELECTRON, V19, P1237, DOI 10.1016/j.bios.2003.11.010; Parsons JF, 2004, BIOCHEMISTRY-US, V43, P12427, DOI 10.1021/bi049059z; Parsons JF, 2004, ACTA CRYSTALLOGR D, V60, P2110, DOI 10.1107/S0907444904022474; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santos AS, 2005, ELECTROANAL, V17, P1103, DOI 10.1002/elan.200403222; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schoental R, 1941, BRIT J EXP PATHOL, V22, P137; Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Torres CI, 2010, FEMS MICROBIOL REV, V34, P3, DOI 10.1111/j.1574-6976.2009.00191.x; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; van der Kamp MW, 2013, BIOCHEMISTRY-US, V52, P2708, DOI 10.1021/bi400215w; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai C, 2013, J PHYS CHEM B, V117, P12202, DOI 10.1021/jp405974b; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09	63	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139081	10.1371/journal.pone.0139081	http://dx.doi.org/10.1371/journal.pone.0139081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414009	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700040
J	Luo, YG; Wang, DF; Liu, K; Weng, J; Guan, YF; Chan, KCC; Chu, WCW; Shi, L				Luo, Yun-gang; Wang, Defeng; Liu, Kai; Weng, Jian; Guan, Yuefeng; Chan, Kate C. C.; Chu, Winnie C. W.; Shi, Lin			Brain Structure Network Analysis in Patients with Obstructive Sleep Apnea	PLOS ONE			English	Article							WORKING-MEMORY; ANATOMICAL NETWORKS; CORTICAL THICKNESS; CHINESE CHILDREN; ORGANIZATION; PRESSURE; DYSFUNCTION; ACTIVATION; HEALTH	Childhood obstructive sleep apnea (OSA) is a sleeping disorder commonly affecting school-aged children and is characterized by repeated episodes of blockage of the upper airway during sleep. In this study, we performed a graph theoretical analysis on the brain morphometric correlation network in 25 OSA patients (OSA group; 5 female; mean age, 10.1 +/- 1.8 years) and investigated the topological alterations in global and regional properties compared with 20 healthy control individuals (CON group; 6 females; mean age, 10.4 +/- 1.8 years). A structural correlation network based on regional gray matter volume was constructed respectively for each group. Our results revealed a significantly decreased mean local efficiency in the OSA group over the density range of 0.32-0.44 (p < 0.05). Regionally, the OSAs showed a tendency of decreased betweenness centrality in the left angular gyrus, and a tendency of decreased degree in the right lingual and inferior frontal (orbital part) gyrus (p < 0.005, uncorrected). We also found that the network hubs in OSA and controls were distributed differently. To the best of our knowledge, this is the first study that characterizes the brain structure network in OSA patients and invests the alteration of topological properties of gray matter volume structural network. This study may help to provide new evidence for understanding the neuropathophysiology of OSA from a topological perspective.	[Luo, Yun-gang; Guan, Yuefeng] Jilin Univ, Hosp 2, Dept Stomatol, Changchun 130041, Jilin Province, Peoples R China; [Wang, Defeng; Liu, Kai; Weng, Jian; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Res Ctr Med Image Comp, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Guan, Yuefeng; Chu, Winnie C. W.] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng; Liu, Kai] Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Liu, Kai] Chinese Univ Hong Kong, Inst Adv Engn, Shatin, Hong Kong, Peoples R China; [Chan, Kate C. C.] Chinese Univ Hong Kong, Dept Paediat, Shatin, Hong Kong, Peoples R China; [Shi, Lin] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Jilin University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Luo, YG (corresponding author), Jilin Univ, Hosp 2, Dept Stomatol, Changchun 130041, Jilin Province, Peoples R China.	luoyungang@sohu.com; shilin@cuhk.edu.hk	Chu, Winnie CW/F-8449-2014; Shi, Lin/K-5241-2014; Chan, Kate Ching-ching/P-2947-2018	Chu, Winnie CW/0000-0003-4962-4132; Shi, Lin/0000-0003-2318-4669; Chan, Kate Ching-ching/0000-0001-7272-8285	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 475711, CUHK 416712, CUHK 411811, CUHK 473012, CUHK 14113214]; Shenzhen Science and Technology Innovation Committee [CXZZ20140606164105361]; National Natural Science Foundation of China [81271653, 81201157]; Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong [BME-p2-13/BME-CUHK]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Shenzhen Science and Technology Innovation Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong(Chinese University of Hong Kong)	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK 475711, CUHK 416712, CUHK 411811, CUHK 473012, CUHK 14113214), a grant from Shenzhen Science and Technology Innovation Committee (Project No. CXZZ20140606164105361), grants from the National Natural Science Foundation of China (Project No. 81271653 and 81201157), and a grant from the Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong (Project No. BME-p2-13/BME-CUHK).	Antczak J, 2007, J PHYSIOL PHARMACOL, V58, P25; Avants BB, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.3; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bennett LS, 1999, AM J RESP CRIT CARE, V159, P1884, DOI 10.1164/ajrccm.159.6.9808107; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Carroll JL, 2003, CLIN CHEST MED, V24, P261, DOI 10.1016/S0272-5231(03)00024-8; Castronovo V, 2009, SLEEP, V32, P1161, DOI 10.1093/sleep/32.9.1161; Chan KC, 2014, SLEEP MED, V15, P1055, DOI 10.1016/j.sleep.2014.04.011; Decary A, 2000, SLEEP, V23, P369; Dominguez D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021909; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Huynh NT, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00058; Joo EY, 2007, SLEEP, V30, P1515, DOI 10.1093/sleep/30.11.1515; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li AM, 2008, THORAX, V63, P803, DOI 10.1136/thx.2007.091132; Li AM, 2006, PEDIATR PULM, V41, P1153, DOI 10.1002/ppul.20505; Li AM, 2010, THORAX, V65, P991, DOI 10.1136/thx.2010.134858; Liu K, 2015, NEUROSCI LETT, V589, P169, DOI 10.1016/j.neulet.2015.01.037; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marcus CL, 2008, CHEST, V134, P1114, DOI 10.1378/chest.08-2011; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Pagel JF, 2003, SLEEP MED, V4, P235, DOI 10.1016/S1389-9457(02)00255-1; Peng DC, 2014, NEUROPSYCH DIS TREAT, V10, P1819, DOI 10.2147/NDT.S67805; Prilipko O, 2011, SLEEP, V34, P293, DOI 10.1093/sleep/34.3.293; Psychological Corporation, 1981, HONG KONG WECHSL INT; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; Simmons MS, 2009, J AM DENT ASSOC, V140, P536, DOI 10.14219/jada.archive.2009.0221; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sweet LH, 2010, BRAIN IMAGING BEHAV, V4, P155, DOI 10.1007/s11682-010-9095-y; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tsang CSL, 2006, EYE, V20, P38, DOI 10.1038/sj.eye.6701785; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Zhang Q, 2013, SLEEP, V36, P651, DOI 10.5665/sleep.2620	54	15	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139055	10.1371/journal.pone.0139055	http://dx.doi.org/10.1371/journal.pone.0139055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413809	gold, Green Published, Green Submitted			2022-12-26	WOS:000362170700036
J	Dao, T; Hong, XM; Wang, XB; Tang, WY				Dao, Tyna; Hong, Xiumei; Wang, Xiaobin; Tang, Wan-Yee			Aberrant 5 '-CpG Methylation of Cord Blood TNF alpha Associated with Maternal Exposure to Polybrominated Diphenyl Ethers	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; PERSISTENT ORGANIC POLLUTANTS; DNA METHYLATION; GENE-EXPRESSION; BDE-47; PROMOTER; CELLS; BIRTH; HYPOMETHYLATION	Growing evidence suggests that maternal exposures to endocrine disrupting chemicals during pregnancy may lead to poor pregnancy outcomes and increased fetal susceptibility to adult diseases. Polybrominated diphenyl ethers (PBDEs), which are ubiquitously used flame-retardants, could leach into the environment; and become persistent organic pollutants via bioaccumulation. In the United States, blood PBDE levels in adults range from 30100 ng/g-lipid but the alarming health concern revolves around children who have reported blood PBDE levels 3 to 9-fold higher than adults. PBDEs disrupt endocrine, immune, reproductive and nervous systems. However, the mechanism underlying its adverse health effect is not fully understood. Epigenetics is a possible biological mechanism underlying maternal exposure-child health outcomes by regulating gene expression without changes in the DNA sequence. We sought to examine the relationship between maternal exposure to environmental PBDEs and promoter methylation of a proinflammatory gene, tumor necrosis factor alpha (TNF alpha). We measured the maternal blood PBDE levels and cord blood TNF alpha promoter methylation levels on 46 paired samples of maternal and cord blood from the Boston Birth Cohort (BBC). We showed that decreased cord blood TNF alpha methylation associated with high maternal PBDE47 exposure. CpG site-specific methylation showed significantly hypomethylation in the girl whose mother has a high blood PBDE47 level. Consistently, decreased TNF alpha methylation associated with an increase in TNF alpha protein level in cord blood. In conclusion, our finding provided evidence that in utero exposure to PBDEs may epigenetically reprogram the offspring's immunological response through promoter methylation of a proinflammatory gene.	[Dao, Tyna; Tang, Wan-Yee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Hong, Xiumei; Wang, Xiaobin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Human Populat & Reprod Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tang, WY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	wtang@jhsph.edu		Tang, Wan-Yee/0000-0002-0663-9820	National Institutes of Health [R00ES016817, R21HD066471]; Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016817, T32ES007141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was in part supported by National Institutes of Health grants R00ES016817 (WYT) and R21HD066471 (XBW). Other supports were come Discretionary Fund (WYT) from Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MA, 2014, ENVIRON INT, V63, P130, DOI 10.1016/j.envint.2013.11.009; Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Byun HM, 2015, TOXICOLOGY, V328, P152, DOI 10.1016/j.tox.2014.12.019; Costa LG, 2007, NEUROTOXICOLOGY, V28, P1047, DOI 10.1016/j.neuro.2007.08.007; Costa LG, 2014, TOXICOL LETT, V230, P282, DOI 10.1016/j.toxlet.2013.11.011; Du P, 2015, INT J DEV NEUROSCI; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Emond C, 2013, TOXICOL APPL PHARM, V273, P335, DOI 10.1016/j.taap.2013.09.007; Eskenazi B, 2013, ENVIRON HEALTH PERSP, V121, P257, DOI 10.1289/ehp.1205597; EVANS HL, 1995, CLIN CHEM, V41, P1874; Falvo JV, 2013, ADV IMMUNOL, V118, P37, DOI 10.1016/B978-0-12-407708-9.00002-9; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Geyer H.J., 2004, ORGANOHALOGEN COMP, V66, P3820; GOLDFELD AE, 1994, J EXP MED, V180, P763, DOI 10.1084/jem.180.2.763; Golikova EA, 2013, J ASTHMA, V50, P705, DOI 10.3109/02770903.2013.796972; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Hermsdorff HH, 2013, CYTOKINE, V64, P265, DOI 10.1016/j.cyto.2013.05.028; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Hong XM, 2012, SEMIN IMMUNOPATHOL, V34, P655, DOI 10.1007/s00281-012-0323-y; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huen K, 2014, ENVIRON MOL MUTAGEN, V55, P209, DOI 10.1002/em.21845; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koenig CM, 2012, NEUROTOXICOL TERATOL, V34, P571, DOI 10.1016/j.ntt.2012.09.005; Koh TW, 2010, INT J HYG ENVIR HEAL, V213, P59, DOI 10.1016/j.ijheh.2009.09.004; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liu XB, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/692467; Liu X, 2014, ENVIRON MOL MUTAGEN, V55, P223, DOI 10.1002/em.21827; Liu X, 2012, HUM GENET, V131, P341, DOI 10.1007/s00439-011-1079-5; Martin PA, 2007, ENVIRON TOXICOL CHEM, V26, P988, DOI 10.1897/06-246R.1; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Nasiri R, 2013, J INVEST ALLERG CLIN, V23, P455; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Ranjbar S, 2006, J IMMUNOL, V176, P4182, DOI 10.4049/jimmunol.176.7.4182; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sanders JM, 2006, XENOBIOTICA, V36, P824, DOI 10.1080/00498250600815906; Singh AK, 2015, MOL NEUROBIOL; Sjodin A, 2004, ANAL CHEM, V76, P4508, DOI 10.1021/ac0495384; Staskal DF, 2006, TOXICOL SCI, V94, P28, DOI 10.1093/toxsci/kfl091; Staskal DF, 2005, TOXICOL SCI, V83, P215, DOI 10.1093/toxsci/kfi018; Stock W, 2000, LANCET, V355, P1351, DOI 10.1016/S0140-6736(00)02125-5; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Suvorov A, 2011, J APPL TOXICOL, V31, P179, DOI 10.1002/jat.1580; Suvorov A, 2011, J APPL TOXICOL, V31, P477, DOI 10.1002/jat.1667; Suvorov A, 2009, NEONATOLOGY, V95, P203, DOI 10.1159/000155651; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tang WY, 2008, ENDOCRINOLOGY, V149, P5922, DOI 10.1210/en.2008-0682; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Ta TA, 2011, NEUROTOXICOL TERATOL, V33, P393, DOI 10.1016/j.ntt.2011.02.003; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; US-EPA, 2010, EXP ASS POL DIPH ETH; Viviani B, 2014, NEUROTOXICOLOGY, V43, P10, DOI 10.1016/j.neuro.2014.03.004; Wang DL, 2012, EPIGENETICS-US, V7, P594, DOI 10.4161/epi.20117; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; Woods R, 2012, HUM MOL GENET, V21, P2399, DOI 10.1093/hmg/dds046	65	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138815	10.1371/journal.pone.0138815	http://dx.doi.org/10.1371/journal.pone.0138815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406892	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700102
J	Godfrey, J; Jeanguenin, L; Castro, N; Olney, JJ; Dudley, J; Pipkin, J; Walls, SM; Wang, W; Herr, DR; Harris, GL; Brasser, SM				Godfrey, Jessica; Jeanguenin, Lisa; Castro, Norma; Olney, Jeffrey J.; Dudley, Jason; Pipkin, Joseph; Walls, Stanley M.; Wang, Wei; Herr, Deron R.; Harris, Greg L.; Brasser, Susan M.			Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats	PLOS ONE			English	Article							INDUCED APOPTOTIC NEURODEGENERATION; MODERATE ALCOHOL; INSULIN-RESISTANCE; BRAIN-DAMAGE; CARDIOVASCULAR PROTECTION; RISK-FACTORS; DRINKING; SPHINGOSINE; MODEL; EXPOSURE	Heavy alcohol consumption has detrimental neurologic effects, inducing widespread neuronal loss in both fetuses and adults. One proposed mechanism of ethanol-induced cell loss with sufficient exposure is an elevation in concentrations of bioactive lipids that mediate apoptosis, including the membrane sphingolipid metabolites ceramide and sphingosine. While these naturally-occurring lipids serve as important modulators of normal neuronal development, elevated levels resulting from various extracellular insults have been implicated in pathological apoptosis of neurons and oligodendrocytes in several neuroinflammatory and neurodegenerative disorders. Prior work has shown that acute administration of ethanol to developing mice increases levels of ceramide in multiple brain regions, hypothesized to be a mediator of fetal alcohol-induced neuronal loss. Elevated ceramide levels have also been implicated in ethanol-mediated neurodegeneration in adult animals and humans. Here, we determined the effect of chronic voluntary ethanol consumption on lipid profiles in brain and peripheral tissues from adult alcohol-preferring (P) rats to further examine alterations in lipid composition as a potential contributor to ethanol-induced cellular damage. P rats were exposed for 13 weeks to a 20% ethanol intermittent-access drinking paradigm (45 ethanol sessions total) or were given access only to water (control). Following the final session, tissues were collected for subsequent chromatographic analysis of lipid content and enzymatic gene expression. Contrary to expectations, ethanol-exposed rats displayed substantial reductions in concentrations of ceramides in forebrain and heart relative to non-exposed controls, and modest but significant decreases in liver cholesterol. qRT-PCR analysis showed a reduction in the expression of sphingolipid delta(4)-desaturase (Degs2), an enzyme involved in de novo ceramide synthesis. These findings indicate that ethanol intake levels achieved by alcohol-preferring P rats as a result of chronic voluntary exposure may have favorable vs. detrimental effects on lipid profiles in this genetic line, consistent with data supporting beneficial cardioprotective and neuroprotective effects of moderate ethanol consumption.	[Godfrey, Jessica; Castro, Norma; Olney, Jeffrey J.; Dudley, Jason; Pipkin, Joseph; Brasser, Susan M.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Jeanguenin, Lisa; Walls, Stanley M.; Herr, Deron R.; Harris, Greg L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Wang, Wei; Herr, Deron R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	California State University System; San Diego State University; California State University System; San Diego State University; National University of Singapore	Harris, GL (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	gharris@mail.sdsu.edu; sbrasser@mail.sdsu.edu	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896	National Institutes of Health [AA015741, AA023291, AA015512]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015741, R21AA023291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health grants AA015741 and AA023291(SMB) and AA015512 (Indiana Alcohol Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Agag LH, 2005, FREE RADICAL BIO MED, V39, P540, DOI 10.1016/j.freeradbiomed.2005.04.007; Bae M, 2014, J NEUROCHEM, V131, P645, DOI 10.1111/jnc.12834; BARNES DE, 1981, DEV BRAIN RES, V1, P333, DOI 10.1016/0165-3806(81)90071-7; Beresewicz A, 2002, J PHYSIOL PHARMACOL, V53, P371; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Brasser SM, 2004, ALCOHOL CLIN EXP RES, V28, P1074, DOI 10.1097/01.ALC.0000130802.07692.29; Cargiulo T, 2007, AM J HEALTH-SYST PH, V64, pS5, DOI 10.2146/ajhp060647; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Chakraborty G, 2012, J NEUROCHEM, V121, P806, DOI 10.1111/j.1471-4159.2012.07723.x; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Chen WJA, 1996, PHARM TOXIC, P343; Chen YH, 2003, ALCOHOL ALCOHOLISM, V38, P18, DOI 10.1093/alcalc/agg014; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Cohen AC, 2007, ALCOHOL CLIN EXP RES, V31, P1558, DOI 10.1111/j.1530-0277.2007.00450.x; Collins MA, 2010, MOL NEUROBIOL, V41, P420, DOI 10.1007/s12035-010-8138-0; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; Dasgupta S, 2007, NEUROCHEM RES, V32, P2217, DOI 10.1007/s11064-007-9445-3; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; de la Monte SM, 2008, J GASTROEN HEPATOL, V23, pE477, DOI 10.1111/j.1440-1746.2008.05339.x; de la Monte SM, 2009, INT J ENV RES PUB HE, V6, P2055, DOI 10.3390/ijerph6072055; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Getz GS, 2008, J LIPID RES, V49, P2077, DOI 10.1194/jlr.E800015-JLR200; Goswami R, 2000, J NEUROSCI RES, V60, P141, DOI 10.1002/(SICI)1097-4547(20000415)60:2<141::AID-JNR2>3.0.CO;2-5; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Herr DR, 2004, J BIOL CHEM, V279, P12685, DOI 10.1074/jbc.M310647200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Ichi I, 2006, LIPIDS, V41, P859, DOI 10.1007/s11745-006-5041-6; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Kamada Kazuma, 2004, Pathophysiology, V10, P131, DOI 10.1016/j.pathophys.2003.10.010; KORTHIUS RJ, 2006, MICROVASCULAR RES BI, P777; Krenz M, 2012, J MOL CELL CARDIOL, V52, P93, DOI 10.1016/j.yjmcc.2011.10.011; Lucas DL, 2005, J AM COLL CARDIOL, V45, P1916, DOI 10.1016/j.jacc.2005.02.075; Lumeng L., 1977, ALC ALDEHYDE MET SYS, VIII, P537; Mitchell RM, 2009, J NEUROCHEM, V111, P580, DOI 10.1111/j.1471-4159.2009.06351.x; Miyamae Masami, 2010, Curr Drug Abuse Rev, V3, P39; O'Keefe JH, 2014, MAYO CLIN PROC, V89, P382, DOI 10.1016/j.mayocp.2013.11.005; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Poli A, 2013, NUTR METAB CARDIOVAS, V23, P487, DOI 10.1016/j.numecd.2013.02.007; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Roux A, 2015, ACS CHEM NEUROSCI, V6, P247, DOI 10.1021/cn500174c; Saito M, 2005, ALCOHOL CLIN EXP RES, V29, P1374, DOI 10.1097/01.alc.0000175011.22307.61; Saito M, 2010, J NEUROCHEM, V115, P168, DOI 10.1111/j.1471-4159.2010.06913.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Singh AK, 2007, ALCOHOL ALCOHOLISM, V42, P385, DOI 10.1093/alcalc/agl120; Sivaswamy S, 2010, EUR J NEUROSCI, V32, P1800, DOI 10.1111/j.1460-9568.2010.07451.x; SPIEGEL S, 1993, ADV LIPID RES, V25, P105; Sprow GM, 2012, PHYSIOL BEHAV, V106, P325, DOI 10.1016/j.physbeh.2011.12.026; Standridge JB, 2004, SOUTH MED J, V97, P664, DOI 10.1097/00007611-200407000-00012; Thiele TE, 2014, ALCOHOL, V48, P235, DOI 10.1016/j.alcohol.2013.08.005; Thompson PL, 2013, MED J AUSTRALIA, V198, P419, DOI 10.5694/mja12.10922; Ussher JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037703; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Walls SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003970; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yamaguchi T, 2002, AM J PHYSIOL-HEART C, V283, pH1019, DOI 10.1152/ajpheart.00173.2002; Yamaguchi T, 2007, AM J PHYSIOL-HEART C, V292, pH1435, DOI 10.1152/ajpheart.00282.2006; Zhou HZ, 2002, AM J PHYSIOL-HEART C, V283, pH165, DOI 10.1152/ajpheart.00408.2001	70	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139012	10.1371/journal.pone.0139012	http://dx.doi.org/10.1371/journal.pone.0139012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405804	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700147
J	Gouveia-Figueira, S; Karlsson, J; Deplano, A; Hashemian, S; Svensson, M; Sundbom, MF; Congiu, C; Onnis, V; Fowler, CJ				Gouveia-Figueira, Sandra; Karlsson, Jessica; Deplano, Alessandro; Hashemian, Sanaz; Svensson, Mona; Sundbom, Marcus Fredriksson; Congiu, Cenzo; Onnis, Valentina; Fowler, Christopher J.			Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUGS; LINEAR-MODELS; ANANDAMIDE; IBUPROFEN; FLURBIPROFEN; OXYGENATION; ENZYME; COX-2; ENDOCANNABINOIDS; INDOMETHACIN	Background Increased endocannabinoid tonus by dual-action fatty acid amide hydrolase (FAAH) and substrate selective cyclooxygenase (COX-2) inhibitors is a promising approach for pain-relief. One such compound with this profile is 2-(2-fluorobiphenyl-4-yl)-N-(3-methylpyridin-2-yl)propanamide (Flu-AM1). These activities are shown by Flu-AM1 racemate, but it is not known whether its two single enantiomers behave differently, as is the case towards COX-2 for the parent flurbiprofen enantiomers. Further, the effects of the compound upon COX-2-derived lipids in intact cells are not known. Methodology/Principal Findings COX inhibition was determined using an oxygraphic method with arachidonic acid and 2-arachidonoylglycerol (2-AG) as substrates. FAAH was assayed in mouse brain homogenates using anandamide (AEA) as substrate. Lipidomic analysis was conducted in unstimulated and lipopolysaccharide + interferon gamma-stimulated RAW 264.7 macrophage cells. Both enantiomers inhibited COX-2 in a substrate-selective and time-dependent manner, with IC50 values in the absence of a preincubation phase of: (R)-Flu-AM1, COX-1 (arachidonic acid) 6 mu M; COX-2 (arachidonic acid) 20 mu M; COX-2 (2-AG) 1 mu M; (S)-Flu-AM1, COX-1 (arachidonic acid) 3 mu M; COX-2 (arachidonic acid) 10 mu M; COX-2 (2-AG) 0.7 mu M. The compounds showed no enantiomeric selectivity in their FAAH inhibitory properties. (R)-Flu-AM1 (10 mu M) greatly inhibited the production of prostaglandin D2 and E2 in both unstimulated and lipopolysaccharide + interferon.-stimulated RAW 264.7 macrophage cells. Levels of 2-AG were not affected either by (R)-Flu-AM1 or by 10 mu M flurbiprofen, either alone or in combination with the FAAH inhibitor URB597 (1 mu M). Conclusions/Significance Both enantiomers of Flu-AM1 are more potent inhibitors of 2-AG compared to arachidonic acid oxygenation by COX-2. Inhibition of COX in lipopolysaccharide + interferon.-stimulated RAW 264.7 cells is insufficient to affect 2-AG levels despite the large induction of COX-2 produced by this treatment.	[Gouveia-Figueira, Sandra; Karlsson, Jessica; Hashemian, Sanaz; Svensson, Mona; Sundbom, Marcus Fredriksson; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden; [Gouveia-Figueira, Sandra] Umea Univ, Dept Chem, Umea, Sweden; [Deplano, Alessandro; Congiu, Cenzo; Onnis, Valentina] Univ Cagliari, Dept Life & Environm Sci, Unit Pharmaceut Pharmacol & Nutraceut Sci, Cagliari, Italy	Umea University; Umea University; University of Cagliari	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019; Onnis, Valentina/B-1649-2008; Deplano, Alessandro/T-8589-2018	Fowler, Christopher J./0000-0002-6658-7874; Onnis, Valentina/0000-0002-2438-725X; Deplano, Alessandro/0000-0002-8451-5831; Karlsson, Jessica/0000-0001-8572-5841	Swedish Medical Research Council [12158]; Umea University Medical Faculty; Italian Ministero dell'Istruzione, Universita e della Ricerca [20105YY2HL_002]; Regione Autonoma della Sardegna [L.R. 7/2007, 2012_CRP-59473]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Umea University Medical Faculty; Italian Ministero dell'Istruzione, Universita e della Ricerca; Regione Autonoma della Sardegna(Regione Sardegna)	This work was supported by grants from the Swedish Medical Research Council (Grant no. 12158, medicine, to CJF), the Research Funds of Umea University Medical Faculty (to CJF), the Italian Ministero dell'Istruzione, Universita e della Ricerca (PRIN 2010-2011, Prot. no. 20105YY2HL_002, to VO) and from the Regione Autonoma della Sardegna (Project L.R. 7/2007, Prot. no. 2012_CRP-59473, to VO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087542; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cipriano M, 2013, EUR J PHARMACOL, V720, P383, DOI 10.1016/j.ejphar.2013.09.065; Cocco MT, 2003, EUR J MED CHEM, V38, P513, DOI 10.1016/S0223-5234(03)00074-6; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fowler CJ, 2013, J ENZYM INHIB MED CH, V28, P172, DOI 10.3109/14756366.2011.643304; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P468, DOI 10.1016/j.tips.2012.05.003; Fowler CJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P191, DOI 10.1006/abbi.1998.1025; Geisslinger G, 1996, J CLIN PHARMACOL, V36, P513, DOI 10.1002/j.1552-4604.1996.tb05041.x; Gouveia-Figueira S, 2015, PROSTAGLAND IN PRESS, DOI [10. 1016/ j. prostaglandins. 2015. 06. 003, DOI 10.1016/J.PROSTAGLANDINS.2015.06.003]; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Holt S, 2007, EUR J PHARMACOL, V565, P26, DOI 10.1016/j.ejphar.2007.02.051; Hwang D, 1996, BIOCHEM BIOPH RES CO, V226, P810, DOI 10.1006/bbrc.1996.1433; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043023; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; McKean JW, 2004, STAT SCI, V19, P562, DOI 10.1214/088342304000000549; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Murakami T, 2007, FEBS LETT, V581, P140, DOI 10.1016/j.febslet.2006.12.017; Naidu PS, 2009, J PHARMACOL EXP THER, V329, P48, DOI 10.1124/jpet.108.143487; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Onnis V, 2010, J MED CHEM, V53, P2286, DOI 10.1021/jm901891p; Pestonjamasp VK, 1998, BBA-LIPID LIPID MET, V1394, P249, DOI 10.1016/S0005-2760(98)00110-6; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; R Core TeamR, LANG ENV STAT COMP; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Sasso O, 2015, FASEB J, V29, P2616, DOI 10.1096/fj.15-270637; Tsuboi K, 2007, BBA-MOL CELL BIOL L, V1771, P623, DOI 10.1016/j.bbalip.2007.03.005; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139212	10.1371/journal.pone.0139212	http://dx.doi.org/10.1371/journal.pone.0139212			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406890	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700192
J	Ishizaki, K; Nishihama, R; Ueda, M; Inoue, K; Ishida, S; Nishimura, Y; Shikanai, T; Kohchi, T				Ishizaki, Kimitsune; Nishihama, Ryuichi; Ueda, Minoru; Inoue, Keisuke; Ishida, Sakiko; Nishimura, Yoshiki; Shikanai, Toshiharu; Kohchi, Takayuki			Development of Gateway Binary Vector Series with Four Different Selection Markers for the Liverwort Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENE ORGANIZATION; COMPLETE SEQUENCE; CELL FATE; ARABIDOPSIS; L.; VISUALIZATION; EXPRESSION; EVOLUTION; AGARTRAP	We previously reported Agrobacterium-mediated transformation methods for the liverwort Marchantia polymorpha using the hygromycin phosphotransferase gene as a marker for selection with hygromycin. In this study, we developed three additional markers for M. polymorpha transformation: the gentamicin 3'-acetyltransferase gene for selection with gentamicin; a mutated acetolactate synthase gene for selection with chlorsulfuron; and the neomycin phosphotransferase II gene for selection with G418. Based on these four marker genes, we have constructed a series of Gateway binary vectors designed for transgenic experiments on M. polymorpha. The 35S promoter from cauliflower mosaic virus and endogenous promoters for constitutive and heat-inducible expression were used to create these vectors. The reporters and tags used were Citrine, 3xCitrine, Citrine-NLS, TagRFP, tdTomato, tdTomato-NLS, GR, SRDX, SRDX-GR, GUS, ELuc(PEST), and 3xFLAG. These vectors, designated as the pMpGWB series, will facilitate molecular genetic analyses of the emerging model plant M. polymorpha.	[Ishizaki, Kimitsune; Nishihama, Ryuichi; Inoue, Keisuke; Ishida, Sakiko; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Ishizaki, Kimitsune] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Ueda, Minoru; Nishimura, Yoshiki; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto, Japan	Kyoto University; Kobe University; Kyoto University	Kohchi, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	tkohchi@lif.kyoto-u.ac.jp	Nishihama, Ryuichi/X-8623-2019; Shikanai, Toshiharu/AAK-9112-2020; Ishizaki, Kimitsune/L-4480-2019; Ueda, Minoru/AAF-1885-2019	Nishihama, Ryuichi/0000-0002-7032-732X; Ishizaki, Kimitsune/0000-0003-0504-8196; Ueda, Minoru/0000-0002-7750-6056; Nishimura, Yoshiki/0000-0001-8686-9206; Kohchi, Takayuki/0000-0002-9712-4872	MEXT KAKENHI [23012025, 25113009, 25119711, 15H01233]; JSPS KAKENHI [24580140, 24570048, 26650095]; JSPS [21-764, 24-7049]; Asahi Glass Foundation; SUNTORY Foundation for Life Sciences; Grants-in-Aid for Scientific Research [26650111, 15H04391] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Glass Foundation; SUNTORY Foundation for Life Sciences(Suntory Foundation for Life Sciences); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: MEXT KAKENHI Grants-in-Aid for Scientific Research on Priority Areas (23012025 to T. K.) and for Scientific Research on Innovative Areas (25113009 to T. K., 25119711 and 15H01233 to K.Is.); by JSPS KAKENHI Grants-in-Aid for Scientific Research (C) (24580140 to K. Is., 24570048 to R.N.) and for Challenging Exploratory Research (26650095 to T.K.); by a research fellowship from the JSPS for young scientists (21-764 to M.U., 24-7049 to K.In). URL for Kakenhi: http://www.jsps.go.jp/english/e-grants/index.html. This work was also funded by the Asahi Glass Foundation (http://www.af-info.or.jp/en/index.html) and the SUNTORY Foundation for Life Sciences (http://www.sunbor.or.jp/egs/index.html) to K.Is. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; AOYAMA T, 1995, PLANT CELL, V7, P1773, DOI 10.1105/tpc.7.11.1773; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; CARRER H, 1991, PLANT MOL BIOL, V17, P301, DOI 10.1007/BF00039510; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; Flores-Sandoval E, 2016, PLANT CELL PHYSIOL, V57, P281, DOI 10.1093/pcp/pcv068; Flores-Sandoval E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005207; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Ishizaki K, 2012, J PLANT RES, V125, P643, DOI 10.1007/s10265-012-0477-7; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kanazawa T, 2016, PLANT CELL PHYSIOL, V57, P307, DOI 10.1093/pcp/pcv076; Kanazawa T, 2013, PLANT CELL PHYSIOL, V54, P1736, DOI 10.1093/pcp/pct119; Kato H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005084; Kawai K, 2008, J PESTIC SCI, V33, P128, DOI 10.1584/jpestics.G07-29; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Komatsu A, 2014, PLANT PHYSIOL, V166, P411, DOI 10.1104/pp.114.245100; Kubota A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4668; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mitsuda N, 2011, METHODS MOL BIOL, V754, P87, DOI 10.1007/978-1-61779-154-3_5; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nishihama R, 2016, PLANT CELL PHYSIOL, V57, P271, DOI 10.1093/pcp/pcv102; Nishihama R, 2015, J PLANT RES, V128, P407, DOI 10.1007/s10265-015-0724-9; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Tsuboyama S, 2014, PLANT CELL PHYSIOL, V55, P229, DOI 10.1093/pcp/pct168; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Ueda M, 2013, GENOME BIOL EVOL, V5, P1836, DOI 10.1093/gbe/evt137; Viviani VR, 1999, PHOTOCHEM PHOTOBIOL, V70, P254, DOI 10.1111/j.1751-1097.1999.tb07997.x; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104	50	117	117	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138876	10.1371/journal.pone.0138876	http://dx.doi.org/10.1371/journal.pone.0138876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406247	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700108
J	Kanatani, S; Uhlen, P; Barragan, A				Kanatani, Sachie; Uhlen, Per; Barragan, Antonio			Infection by Toxoplasma gondii Induces Amoeboid-Like Migration of Dendritic Cells in a Three-Dimensional Collagen Matrix	PLOS ONE			English	Article							LEUKOCYTE MIGRATION; LIGANDS; DISSEMINATION; RESISTANCE; INDUCTION; ANTIGEN; EDGE; 3D	Toxoplasma gondii, an obligate intracellular parasite of humans and other warm-blooded vertebrates, invades a variety of cell types in the organism, including immune cells. Notably, dendritic cells (DCs) infected by T. gondii acquire a hypermigratory phenotype that potentiates parasite dissemination by a 'Trojan horse' type of mechanism in mice. Previous studies have demonstrated that, shortly after parasite invasion, infected DCs exhibit hypermotility in 2-dimensional confinements in vitro and enhanced transmigration in transwell systems. However, interstitial migration in vivo involves interactions with the extracellular matrix in a 3-dimensional (3D) space. We have developed a collagen matrix-based assay in a 96-well plate format that allows quantitative locomotion analyses of infected DCs in a 3D confinement over time. We report that active invasion of DCs by T. gondii tachyzoites induces enhanced migration of infected DCs in the collagen matrix. Parasites of genotype II induced superior DC migratory distances than type I parasites. Moreover, Toxoplasma-induced hypermigration of DCs was further potentiated in the presence of the CCR7 chemotactic cue CCL19. Blocking antibodies to integrins (CD11a, CD11b, CD18, CD29, CD49b) insignificantly affected migration of infected DCs in the 3D matrix, contrasting with their inhibitory effects on adhesion in 2D assays. Morphological analyses of infected DCs in the matrix were consistent with the acquisition of an amoeboid-like migratory phenotype. Altogether, the present data show that the Toxoplasma-induced hypermigratory phenotype in a 3D matrix is consistent with integrin-independent amoeboid DC migration with maintained responsiveness to chemotactic and chemokinetic cues. The data support the hypothesis that induction of amoeboid hypermigration and chemotaxis/chemokinesis in infected DCs potentiates the dissemination of T. gondii.	[Kanatani, Sachie; Barragan, Antonio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Kanatani, Sachie; Barragan, Antonio] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska Institutet	Barragan, A (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	antonio.barragan@su.se	Barragan, Antonio/AAL-8618-2020; Barragan, Antonio/P-6278-2015	Barragan, Antonio/0000-0001-7746-9964; Barragan, Antonio/0000-0001-7746-9964; kanatani, sachie/0000-0002-7072-0447; Uhlen, Per/0000-0003-1446-1062	Vetenskapsradet (Swedish Research Council)	Vetenskapsradet (Swedish Research Council)(Swedish Research Council)	Funding was provided by Vetenskapsradet (Swedish Research Council), http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Collantes-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032123; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; de Vries IJM, 2003, CANCER RES, V63, P12; DEBRUYN PPH, 1946, ANAT REC, V95, P177, DOI 10.1002/ar.1090950209; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hitziger N, 2005, CELL MICROBIOL, V7, P837, DOI 10.1111/j.1462-5822.2005.00517.x; John B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002246; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2011, MICROBES INFECT, V13, P96, DOI 10.1016/j.micinf.2010.10.002; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ricart BG, 2011, J IMMUNOL, V186, P53, DOI 10.4049/jimmunol.1002358; Shutt DC, 2000, CELL MOTIL CYTOSKEL, V46, P200, DOI 10.1002/1097-0169(200007)46:3<200::AID-CM5>3.0.CO;2-M; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Ueno N, 2014, CELL MICROBIOL, V16, P580, DOI 10.1111/cmi.12239; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; van Helden SFG, 2010, J IMMUNOL, V184, P1280, DOI 10.4049/jimmunol.0900764; Weidner JM, 2014, INT J PARASITOL, V44, P85, DOI 10.1016/j.ijpara.2013.09.006; Weidner JM, 2013, CELL MICROBIOL, V15, P1735, DOI 10.1111/cmi.12145	36	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139104	10.1371/journal.pone.0139104	http://dx.doi.org/10.1371/journal.pone.0139104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406763	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700171
J	Lagzi, F; Rotter, S				Lagzi, Fereshteh; Rotter, Stefan			Dynamics of Competition between Subnetworks of Spiking Neuronal Networks in the Balanced State	PLOS ONE			English	Article							PERSISTENT ACTIVITY; SYNAPTIC ACTIVITY; DECISION-MAKING; NEURAL BASIS; MODEL; CORTEX; OSCILLATIONS; VARIABILITY; INTEGRATION; PERCEPTION	We explore and analyze the nonlinear switching dynamics of neuronal networks with non-homogeneous connectivity. The general significance of such transient dynamics for brain function is unclear; however, for instance decision-making processes in perception and cognition have been implicated with it. The network under study here is comprised of three subnetworks of either excitatory or inhibitory leaky integrate-and-fire neurons, of which two are of the same type. The synaptic weights are arranged to establish and maintain a balance between excitation and inhibition in case of a constant external drive. Each subnetwork is randomly connected, where all neurons belonging to a particular population have the same in-degree and the same out-degree. Neurons in different subnetworks are also randomly connected with the same probability; however, depending on the type of the pre-synaptic neuron, the synaptic weight is scaled by a factor. We observed that for a certain range of the "within" versus "between" connection weights (bifurcation parameter), the network activation spontaneously switches between the two sub-networks of the same type. This kind of dynamics has been termed "winnerless competition", which also has a random component here. In our model, this phenomenon is well described by a set of coupled stochastic differential equations of Lotka-Volterra type that imply a competition between the subnetworks. The associated mean-field model shows the same dynamical behavior as observed in simulations of large networks comprising thousands of spiking neurons. The deterministic phase portrait is characterized by two attractors and a saddle node, its stochastic component is essentially given by the multiplicative inherent noise of the system. We find that the dwell time distribution of the active states is exponential, indicating that the noise drives the system randomly from one attractor to the other. A similar model for a larger number of populations might suggest a general approach to study the dynamics of interacting populations of spiking networks.	[Lagzi, Fereshteh] Bernstein Ctr Freiburg, Freiburg, Germany; Fac Biol, Freiburg, Germany		Lagzi, F (corresponding author), Bernstein Ctr Freiburg, Freiburg, Germany.	fereshteh.lagzi@bcf.uni-freiburg.de			German Ministry of Education and Research (BMBF) [BFNT 01GQ0830]; German Research Foundation (DFG) [EXC 1086]; INTERREG IV Rhin Superieur program; European Funds for Regional Development (FEDER) [A31]; Ministry of Science, Research and Arts and the Universities of the State of Baden-Wurttemberg, Germany	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); INTERREG IV Rhin Superieur program; European Funds for Regional Development (FEDER)(European Commission); Ministry of Science, Research and Arts and the Universities of the State of Baden-Wurttemberg, Germany	Funding: Funding by the German Ministry of Education and Research (BMBF, grant BFNT 01GQ0830) and the German Research Foundation (DFG, grant EXC 1086) is gratefully acknowledged. The authors also thank the TIGER project funded by INTERREG IV Rhin Superieur program and European Funds for Regional Development (FEDER, #A31). This work was performed on the computational resource bwUniCluster funded by the Ministry of Science, Research and Arts and the Universities of the State of Baden-Wurttemberg, Germany, within the framework program bwHPC. The article processing charge was covered by the open access publication fund of the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Afraimovich V, 2008, CHAOS, V18, DOI 10.1063/1.2991108; Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Amari S, 1977, SYSTEMS NEUROSCIENCE, V119, P165, DOI [DOI 10.1016/B978-0-12-491850-4.50009-X, 10.1007/978-3-642-46466-9]; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Bick C, 2010, DYNAM SYST, V25, P97, DOI 10.1080/14689360903322227; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Braun J, 2010, NEUROIMAGE, V52, P740, DOI 10.1016/j.neuroimage.2009.12.126; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 1998, NETWORK-COMP NEURAL, V9, P123, DOI 10.1088/0954-898X/9/1/007; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; Colliaux D, 2009, COGN NEURODYNAMICS, V3, P141, DOI 10.1007/s11571-009-9078-0; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Dayan P, 1998, NEURAL COMPUT, V10, P1119, DOI 10.1162/089976698300017377; Dayan P, 2001, COMPUTATIONAL NEUROS; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doiron B, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00056; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Flannery B. P., 1992, NUMERICAL RECIPES IN; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Fukai T, 1997, NEURAL COMPUT, V9, P77, DOI 10.1162/neco.1997.9.1.77; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; GERSTNER W, 1995, PHYS REV E, V51, P738, DOI 10.1103/PhysRevE.51.738; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Hahnloser RHR, 2003, NEURAL COMPUT, V15, P621, DOI 10.1162/089976603321192103; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; HernandezBermejo B, 1997, MATH BIOSCI, V140, P1, DOI 10.1016/S0025-5564(96)00131-9; Jones E., 2001, SCIPY OPEN SOURCE SC; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lagzi F, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00142; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Litwin-Kumar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6319; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Lotka AJ, 1919, P N A S, P410; Lotka AJ, 1926, AM MATH MONTHLY, V33, P426, DOI [10.2307/2298330, DOI 10.2307/2298330]; Marti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002534; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; McCormick DA, 2005, CURR BIOL, V15, pR294, DOI 10.1016/j.cub.2005.04.009; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088254; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Neves FS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018701; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Polk A, 2012, P NATL ACAD SCI USA, V109, P6295, DOI 10.1073/pnas.1121274109; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; PRAJNESHU, 1987, J THEOR BIOL, V125, P61, DOI 10.1016/S0022-5193(87)80179-0; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Salinas E, 2003, NEURAL COMPUT, V15, P1439, DOI 10.1162/089976603321891756; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SIEGERT AJF, 1951, PHYS REV, V81, P617, DOI 10.1103/PhysRev.81.617; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Steriade M., 2005, BRAINSTEM CONTROL WA; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; van der Hofstad R., 2014, RANDOM GRAPHS VOMPLE, V1; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Volterra V., 1931, VARIATIONS FLUCTUATI; WALKER P, 1975, PERCEPT PSYCHOPHYS, V18, P467, DOI 10.3758/BF03204122; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	80	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138947	10.1371/journal.pone.0138947	http://dx.doi.org/10.1371/journal.pone.0138947			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407178	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700125
J	Lin, XL; Stur, E; Ekrem, T				Lin, Xiaolong; Stur, Elisabeth; Ekrem, Torbjorn			Exploring Genetic Divergence in a Species-Rich Insect Genus Using 2790 DNA Barcodes	PLOS ONE			English	Article							NON-BITING MIDGES; DIPTERA CHIRONOMIDAE; MITOCHONDRIAL-DNA; IMMATURE STAGES; WULP DIPTERA; IDENTIFICATION; DELIMITATION; TAXONOMY; SEQUENCE; PATTERNS	DNA barcoding using a fragment of the mitochondrial cytochrome c oxidase subunit 1 gene (COI) has proven to be successful for species-level identification in many animal groups. However, most studies have been focused on relatively small datasets or on large datasets of taxonomically high-ranked groups. We explore the quality of DNA barcodes to delimit species in the diverse chironomid genus Tanytarsus (Diptera: Chironomidae) by using different analytical tools. The genus Tanytarsus is the most species-rich taxon of tribe Tanytarsini (Diptera: Chironomidae) with more than 400 species worldwide, some of which can be notoriously difficult to identify to species-level using morphology. Our dataset, based on sequences generated from own material and publicly available data in BOLD, consist of 2790 DNA barcodes with a fragment length of at least 500 base pairs. A neighbor joining tree of this dataset comprises 131 well separated clusters representing 121 morphological species of Tanytarsus: 77 named, 16 unnamed and 28 unidentified theoretical species. For our geographically widespread dataset, DNA barcodes unambiguously discriminate 94.6% of the Tanytarsus species recognized through prior morphological study. Deep intraspecific divergences exist in some species complexes, and need further taxonomic studies using appropriate nuclear markers as well as morphological and ecological data to be resolved. The DNA barcodes cluster into 120-242 molecular operational taxonomic units (OTUs) depending on whether Objective Clustering, Automatic Barcode Gap Discovery (ABGD), Generalized Mixed Yule Coalescent model (GMYC), Poisson Tree Process (PTP), subjective evaluation of the neighbor joining tree or Barcode Index Numbers (BINs) are used. We suggest that a 4-5% threshold is appropriate to delineate species of Tanytarsus non-biting midges.	[Lin, Xiaolong; Stur, Elisabeth; Ekrem, Torbjorn] Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Lin, XL (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, N-7034 Trondheim, Norway.	xiaolong.lin@ntnu.no	Ekrem, Torbjørn/AAC-4087-2021	Ekrem, Torbjørn/0000-0003-3469-9211; Lin, Xiao-Long/0000-0001-6544-6204	Research Council of Norway [226134/F50]; Norwegian Biodiversity Information Centre [14-14, 70184209]	Research Council of Norway(Research Council of Norway); Norwegian Biodiversity Information Centre	Part of the DNA barcode data in this publication was generated in collaboration with the Norwegian Barcode of Life Network (NorBOL) funded by the Research Council of Norway (226134/F50) and the Norwegian Biodiversity Information Centre (14-14, 70184209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1985, J AM MOSQUITO CONTR, V1, P63; [Anonymous], 2014, TRACER V1 6; Armitage PD, 1995, CHIRONOMIDAE BIOL EC, VXII; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brodin Y, 2013, MOL ECOL RESOUR, V13, P996, DOI 10.1111/1755-0998.12053; Carew ME, 2005, ANN ENTOMOL SOC AM, V98, P587, DOI 10.1603/0013-8746(2005)098[0587:TUODMI]2.0.CO;2; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Cranston PS, 2013, RAFFLES B ZOOL, V61, P779; Da Silva FL, 2014, ZOOTAXA, V3769, P1, DOI 10.11646/zootaxa.3769.1.1; Demin AG, 2011, RUSS J GENET+, V47, P1168, DOI 10.1134/S1022795411100061; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Ekrem T, 2004, DEUT ENTOMOL Z, V51, P97; Ekrem T, 2003, ANN ENTOMOL SOC AM, V96, P265, DOI 10.1603/0013-8746(2003)096[0265:NATIDA]2.0.CO;2; Ekrem T, 2001, AUST J ENTOMOL, V40, P312, DOI 10.1046/j.1440-6055.2001.00246.x; Ekrem T, 2002, HYDROBIOLOGIA, V474, P1, DOI 10.1023/A:1016527603086; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Ekrem T, 2010, ORG DIVERS EVOL, V10, P397, DOI 10.1007/s13127-010-0034-y; Ekrem Torbjorn, 2001, Tijdschrift voor Entomologie, V144, P5; Ekrem Torbjorn, 2007, P87; Epler J., 2013, INSECT SYSTEMATICS E, P387; Ezard T, 2009, PACKAGE SPLITS SPECI; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gay L, 2007, MOL ECOL, V16, P3215, DOI 10.1111/j.1365-294X.2007.03363.x; Gilka W, 2008, ENTOMOL FENNICA, V19, P41, DOI 10.33338/ef.84412; Gilka W, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2197.1.3; GLOVER B, 1973, Australian Journal of Zoology Supplementary Series, P403; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hawlitschek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073368; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckman KL, 2007, MOL PHYLOGENET EVOL, V43, P353, DOI 10.1016/j.ympev.2007.03.005; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Huemer P, 2014, ZOOKEYS, P91, DOI 10.3897/zookeys.404.7234; Hunter SJ, 2008, MOL ECOL RESOUR, V8, P56, DOI 10.1111/j.1471-8286.2007.01879.x; Ilmonen J, 2009, ZOOL J LINN SOC-LOND, V156, P847, DOI 10.1111/j.1096-3642.2009.00500.x; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Langton PH, 1998, J KANSAS ENTOMOL SOC, V71, P208; LINDEBERG BERNHARD, 1963, ANN ENTOMOL FENN, V29, P118; LINDEBERG BERNHARD, 1967, ANN ZOOL FENN, V4, P45; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maddison WP., 2008, EVOLUTION, V62, P1103; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McKie BG, 2005, CAN J ZOOL, V83, P553, DOI 10.1139/Z05-051; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; MOUBAYED Z, 1990, HYDROBIOLOGIA, V203, P29, DOI 10.1007/BF00005610; Nzelu CO, 2015, ACTA TROP, V145, P45, DOI 10.1016/j.actatropica.2015.02.003; Oba Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116612; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Ree Han-Il, 2010, Korean Journal of Systematic Zoology, V26, P115; Reiss F, 1971, ARCH HYDROBIOL S, V40, P75; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Resch MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090653; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rosenberg D.M., 1992, NETHERLANDS J AQUATI, V26, P101, DOI DOI 10.1007/BF02255231; Saether OA, 1969, SOME NEARCTIC PONDON; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanseverino AM, 2006, THESIS LMU MUNICH MU; Sari A, 2015, BIOCHEM SYST ECOL, V59, P229, DOI 10.1016/j.bse.2015.01.005; Sasa M, 1987, STUDIES CHIRONOMID M; Sasa Manabu, 2000, Tropical Medicine, V42, P1; Sasa Manabu, 1998, Tropical Medicine, V40, P47; Schmidt S, 2015, MOL ECOL RESOUR; Silva FL, 2014, B ENTOMOL RES, V104, P65, DOI 10.1017/S0007485313000515; Silva FL, 2015, ZOOL SCR, V44, P59, DOI 10.1111/zsc.12089; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sinclair CS, 2008, B ENTOMOL RES, V98, P555, DOI 10.1017/S0007485308005865; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Smith PJ, 2005, J FISH BIOL, V67, P1178, DOI 10.1111/j.0022-1112.2005.00804.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stur E, 2011, ZOOTAXA, P27, DOI 10.11646/zootaxa.2743.1.2; Sublette JE, 1994, SPIXIANA S, P20; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Team RC, 2012, LANG ENV STAT COMP, DOI DOI 10.1093/MOLBEV/MSH110; Turney S, 2015, PEERJ, V3, DOI 10.7717/peerj.1168; Webb JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038063; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Wulp F. M., 1874, TIJDSCHRIFT ENTOMOLO, V17, P109; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1	105	72	76	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138993	10.1371/journal.pone.0138993	http://dx.doi.org/10.1371/journal.pone.0138993			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406595	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700141
J	Majid, L; Zagorodnyaya, T; Plant, EP; Petrovskaya, S; Bidzhieva, B; Ye, ZP; Simonyan, V; Chumakov, K				Majid, Laassri; Zagorodnyaya, Tatiana; Plant, Ewan P.; Petrovskaya, Svetlana; Bidzhieva, Bella; Ye, Zhiping; Simonyan, Vahan; Chumakov, Konstantin			Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; LIVE VIRAL VACCINES; A VIRUS; GEL-ELECTROPHORESIS; SIALIC-ACID; HEMAGGLUTININ; NEURAMINIDASE; RNA; SPECIFICITY; POPULATIONS	Virus growth during influenza vaccine manufacture can lead to mutations that alter antigenic properties of the virus, and thus may affect protective potency of the vaccine. Different reassortants of pandemic "swine" H1N1 influenza A vaccine (121XP, X-179A and X-181) viruses as well as wild type A/California/07/2009(H1N1) and A/PR/8/34 strains were propagated in embryonated eggs and used for DNA/RNA Illumina HiSeq and MiSeq sequencing. The RNA sequences of these viruses published in NCBI were used as references for alignment of the sequencing reads generated in this study. Consensus sequences of these viruses differed from the NCBI-deposited sequences at several nucleotides. 121XP stock derived by reverse genetics was more heterogeneous than X-179A and X-181 stocks prepared by conventional reassortant technology. Passaged 121XP virus contained four non-synonymous mutations in the HA gene. One of these mutations (Lys(226)Glu) was located in the Ca antigenic site of HA (present in 18% of the population). Two non-synonymous mutations were present in HA of viruses derived from X-179A: Pro(314)Gln (18%) and Asn(146)Asp (78%). The latter mutation located in the Sa antigenic site was also detected at a low level (11%) in the wild-type A/California/07/2009(H1N1) virus, and was present as a complete substitution in X-181 viruses derived from X-179A virus. In the passaged X-181 viruses, two mutations emerged in HA: a silent mutation A(1398)G (31%) in one batch and G(756)T (Glu(252)Asp, 47%) in another batch. The latter mutation was located in the conservative region of the antigenic site Ca. The protocol for RNA sequencing was found to be robust, reproducible, and suitable for monitoring genetic consistency of influenza vaccine seed stocks.	[Majid, Laassri; Zagorodnyaya, Tatiana; Plant, Ewan P.; Petrovskaya, Svetlana; Bidzhieva, Bella; Ye, Zhiping; Simonyan, Vahan; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Majid, L (corresponding author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	majid.laassri@fda.hhs.gov	Plant, Ewan/AAB-1911-2020	Plant, Ewan/0000-0003-0166-5939				Amexis G, 2001, P NATL ACAD SCI USA, V98, P12097, DOI 10.1073/pnas.211423298; Bidzhieva B, 2014, J VIROL METHODS, V201, P86, DOI 10.1016/j.jviromet.2014.02.012; Bidzhieva B, 2014, J VIROL METHODS, V199, P68, DOI 10.1016/j.jviromet.2013.12.018; Cherkasova E, 2003, P NATL ACAD SCI USA, V100, P9398, DOI 10.1073/pnas.1633511100; Chumakov K M, 1999, Dev Biol Stand, V100, P67; CHUMAKOV KM, 1991, P NATL ACAD SCI USA, V88, P199, DOI 10.1073/pnas.88.1.199; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Girard MP, 2006, VACCINE, V24, P2732, DOI 10.1016/j.vaccine.2005.10.014; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hughes MT, 2001, J VIROL, V75, P3766, DOI 10.1128/JVI.75.8.3766-3770.2001; Jing XH, 2012, VACCINE, V30, P4144, DOI 10.1016/j.vaccine.2012.04.073; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Laassri M, 2003, J VIROL METHODS, V112, P67, DOI 10.1016/S0166-0934(03)00193-9; Laassri M, 2012, VIRAL GENOMES - MOLECULAR STRUCTURE, DIVERSITY, GENE EXPRESSION MECHANISMS AND HOST-VIRUS INTERACTIONS, P181; Lamb RA, 2007, ORTHOMYXOVIRIDAE VIR; MAASSAB HF, 1985, VACCINE, V3, P355, DOI 10.1016/0264-410X(85)90124-0; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; McCarthy MW, 2004, ANN PHARMACOTHER, V38, P2086, DOI 10.1345/aph.1E191; Monto AS, 2011, VACCINE, V29, P6427, DOI 10.1016/j.vaccine.2011.06.113; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neverov A, 2010, P NATL ACAD SCI USA, V107, P20063, DOI 10.1073/pnas.1012537107; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAYMOND FL, 1986, VIROLOGY, V148, P275, DOI 10.1016/0042-6822(86)90325-9; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; WEBSTER RG, 1975, INFLUENZA VIRUSES IN, P269; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Organization, 2009, CHAR EM INFL A H1N1; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138650	10.1371/journal.pone.0138650	http://dx.doi.org/10.1371/journal.pone.0138650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407068	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700064
J	Mugita, Y; Minematsu, T; Huang, LJ; Nakagami, G; Kishi, C; Ichikawa, Y; Nagase, T; Oe, M; Noguchi, H; Mori, T; Abe, M; Sugama, J; Sanada, H				Mugita, Yuko; Minematsu, Takeo; Huang, Lijuan; Nakagami, Gojiro; Kishi, Chihiro; Ichikawa, Yoshie; Nagase, Takashi; Oe, Makoto; Noguchi, Hiroshi; Mori, Taketoshi; Abe, Masatoshi; Sugama, Junko; Sanada, Hiromi			Histopathology of Incontinence-Associated Skin Lesions: Inner Tissue Damage Due to Invasion of Proteolytic Enzymes and Bacteria in Macerated Rat Skin	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; TRANSDERMAL DELIVERY; PERINEAL DERMATITIS; TRYPSIN	A common complication in patients with incontinence is perineal skin lesions, which are recognized as a form of dermatitis. In these patients, perineal skin is exposed to digestive enzymes and intestinal bacterial flora, as well as excessive water. The relative contributions of digestive enzymes and intestinal bacterial flora to skin lesion formation have not been fully shown. This study was conducted to reveal the process of histopathological changes caused by proteases and bacterial inoculation in skin maceration. For skin maceration, agarose gel containing proteases was applied to the dorsal skin of male Sprague-Dawley rats for 4 h, followed by Pseudomonas aeruginosa inoculation for 30 min. Macroscopic changes, histological changes, bacterial distribution, inflammatory response, and keratinocyte proliferation and differentiation were examined. Proteases induced digestion in the prickle cell layer of the epidermis, and slight bleeding in the papillary dermis and around hair follicles in the macerated skin without macroscopic evidence of erosion. Bacterial inoculation of the skin macerated by proteolytic solution resulted in the formation of bacteria-rich clusters comprising numerous microorganisms and inflammatory cells within the papillary dermis, with remarkable tissue damage around the clusters. Tissue damage expanded by day 2. On day 3, the proliferative keratinocyte layer was elongated from the bulge region of the hair follicles. Application of proteases and P. aeruginosa induced skin lesion formation internally without macroscopic erosion of the overhydrated area, suggesting that the histopathology might be different from regular dermatitis. The healing process of this lesion is similar to transepidermal elimination.	[Mugita, Yuko; Minematsu, Takeo; Huang, Lijuan; Nakagami, Gojiro; Kishi, Chihiro; Nagase, Takashi; Abe, Masatoshi; Sanada, Hiromi] Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Grad Sch Med, Tokyo, Japan; [Mugita, Yuko] Japan Soc Promot Sci, Tokyo, Japan; [Huang, Lijuan] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Ichikawa, Yoshie] Univ Shizuoka, Sch Nursing, Shizuoka 4228526, Japan; [Oe, Makoto] Univ Tokyo, Grad Sch Med, Dept Adv Nursing Technol, Tokyo, Japan; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol Molten, Tokyo, Japan; [Abe, Masatoshi] Sapporo Skin Clin, Sapporo, Hokkaido, Japan; [Sugama, Junko] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Nursing, Kanazawa, Ishikawa 9201192, Japan	University of Tokyo; Japan Society for the Promotion of Science; Tokyo University of Science; University of Shizuoka; University of Tokyo; University of Tokyo; Kanazawa University	Sanada, H (corresponding author), Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Grad Sch Med, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Nakagami, Gojiro/V-9093-2019; Noguchi, Hiroshi/GQI-0676-2022; Mori, Taketoshi/E-3849-2016	Nakagami, Gojiro/0000-0002-9650-2464; Noguchi, Hiroshi/0000-0002-5303-5210; Mugita, Yuko/0000-0003-4964-7107; Mori, Taketoshi/0000-0002-7208-6435; Minematsu, Takeo/0000-0001-5859-7290	Japan Society for the Promotion of Science [24-3913]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by a Grant-in-Aid for Fellows of Japan Society for the Promotion of Science (#24-3913, http://www.jsps.go.jp/english/e-grants/). Japan Society for the Promotion of Science had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM RA, 1995, MOL MICROBIOL, V16, P485, DOI 10.1111/j.1365-2958.1995.tb02413.x; BAYOUMI AHM, 1978, BRIT J DERMATOL, V99, P611, DOI 10.1111/j.1365-2133.1978.tb07054.x; Berardesca E, 1997, Skin Res Technol, V3, P126, DOI 10.1111/j.1600-0846.1997.tb00174.x; BERG RW, 1994, PEDIATR DERMATOL, V11, P18, DOI 10.1111/j.1525-1470.1994.tb00066.x; Bliss DZ, 2006, NURS RES, V55, P243, DOI 10.1097/00006199-200607000-00004; Bouwstra JA, 2008, J INVEST DERMATOL, V128, P378, DOI 10.1038/sj.jid.5700994; Buckingham K W, 1986, Pediatr Dermatol, V3, P107, DOI 10.1111/j.1525-1470.1986.tb00499.x; Driver DS, 2007, CRIT CARE NURSE, V27, P42; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Gray M, 2007, J WOUND OSTOMY CONT, V34, P45, DOI 10.1097/00152192-200701000-00008; KHARAZMI A, 1991, IMMUNOL LETT, V30, P201, DOI 10.1016/0165-2478(91)90026-7; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kudo A., 2003, JUNTENDO MED COLL NU, V14, P202; Langemo D, 2011, ADV SKIN WOUND CARE, V24, P126, DOI 10.1097/01.ASW.0000395037.28398.6c; Li YZ, 2008, BIOL PHARM BULL, V31, P1574, DOI 10.1248/bpb.31.1574; Li Y, 2009, J PHARM PHARMACOL, V61, P1005, DOI 10.1211/jpp/61.08.0003; Meyer-Hoffert U, 2004, EXP DERMATOL, V13, P234, DOI 10.1111/j.0906-6705.2004.00159.x; Minematsu T, 2011, J JPN WOCM, V15, P278; Minematsu T, 2011, J DERMATOL SCI, V62, P160, DOI 10.1016/j.jdermsci.2011.03.005; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Nakagami G, 2006, DERMATOLOGY, V213, P293, DOI 10.1159/000096192; Nakagami G, 2011, WOUND REPAIR REGEN, V19, P214, DOI 10.1111/j.1524-475X.2010.00653.x; Onunkwo CC, 2010, ARCH DERMATOL RES, V302, P375, DOI 10.1007/s00403-010-1030-y; Rogiers V, 2001, SKIN PHARMACOL APPL, V14, P117, DOI 10.1159/000056341; Shigeta Y, 2009, J CLIN NURS, V18, P1607, DOI 10.1111/j.1365-2702.2008.02606.x; SMITH JS, 1971, CAN MED ASSOC J, V104, P691; Tan G, 2010, J PHARM SCI-US, V99, P730, DOI 10.1002/jps.21863; Taylor R M, 1986, Clin Dermatol, V4, P18, DOI 10.1016/0738-081X(86)90059-3; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Warner RR, 1999, J INVEST DERMATOL, V113, P960, DOI 10.1046/j.1523-1747.1999.00774.x; Wilson D, 2005, OSTOMY WOUND MANAG, V51, P52	31	24	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138117	10.1371/journal.pone.0138117	http://dx.doi.org/10.1371/journal.pone.0138117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407180	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700035
J	Murphy, MSQ; Seaborn, GEJ; Redfearn, DP; Smith, GN				Murphy, Malia S. Q.; Seaborn, Geoffrey E. J.; Redfearn, Damian P.; Smith, Graeme N.			Reduced Heart Rate Variability and Altered Cardiac Conduction after Pre-Eclampsia	PLOS ONE			English	Article							P-WAVE DURATION; BLOOD-PRESSURE; DISEASE RISK; PREGNANCY; WOMEN; PARAMETERS; FAILURE; HEALTH	Pre-eclampsia is a hypertensive disorder of pregnancy that is associated with elevated maternal risk for cardiovascular disease. The aims of this study were to determine the effect of normal pregnancy on postpartum parameters of the electrocardiogram, and furthermore to determine how a history of pre-eclampsia may affect these parameters. Ten-minute high-resolution (1000 Hz) orthogonal Holter electrocardiogram (ECG) recordings were used to measure heart rate variability (HRV). Signal-averaged P-wave and QRS complex durations were determined. Participants included non-pregnant controls, normotensive parous controls and women with a recent history of PE. While reductions in HRV induced by uncomplicated pregnancy returned to non-pregnant levels by 6-8 months postpartum HRV remained reduced in women with a history of PE compared to control groups. In addition, P-Wave and QRS complex durations were prolonged in PE subjects at 6-8 months postpartum compared to control groups. Only QRS duration was independent of differences in blood pressure. These results suggest increased sympathetic cardiac activity, and delayed myocardial conduction in women after PE; alterations consistent with cardiac remodeling and increased risk for arrhythmia. In examining the association between PE and cardiovascular disease, identification of ECG abnormalities soon after pregnancy in women with a history of PE highlights a unique opportunity for early identification and screening in this population before other risk factors become apparent.	[Murphy, Malia S. Q.; Seaborn, Geoffrey E. J.; Redfearn, Damian P.; Smith, Graeme N.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Seaborn, Geoffrey E. J.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Redfearn, Damian P.] Kingston Gen Hosp, Dept Cardiol, Kingston, ON K7L 2V7, Canada; [Smith, Graeme N.] Kingston Gen Hosp, Dept Obstet & Gynecol, Kingston, ON K7L 2V7, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Smith, GN (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	gns@queensu.ca	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Murphy, Malia/0000-0002-4566-4957	Canadian Institute of Health Research [299823]; Ontario Graduate Scholarship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding was provided by the Canadian Institute of Health Research (#299823; GNS, DPR), and an Ontario Graduate Scholarship was awarded to MSQM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Chamchad D, 2007, INT J OBSTET ANESTH, V16, P106, DOI 10.1016/j.ijoa.2006.08.008; Dhingra R, 2006, HYPERTENSION, V47, P861, DOI 10.1161/01.HYP.0000217141.20163.23; Drost JT, 2012, MATURITAS, V73, P148, DOI 10.1016/j.maturitas.2012.06.006; Ekholm EMK, 1997, AM J OBSTET GYNECOL, V177, P1208, DOI 10.1016/S0002-9378(97)70041-3; Eneroth E, 1999, HYPERTENS PREGNANCY, V18, P1, DOI 10.3109/10641959909009606; Eneroth E, 1998, GYNECOL OBSTET INVES, V45, P170, DOI 10.1159/000009949; ENEROTHGRIMFORS E, 1994, ACTA OBSTET GYN SCAN, V73, P680, DOI 10.3109/00016349409029402; Faber R, 2004, J HUM HYPERTENS, V18, P707, DOI 10.1038/sj.jhh.1001730; Kirbas O, 2014, EUR J OBSTET GYN R B, V183, P141, DOI 10.1016/j.ejogrb.2014.10.042; Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003; Magnani JW, 2011, HEART RHYTHM, V8, P93, DOI 10.1016/j.hrthm.2010.09.020; Melchiorre K, 2011, HYPERTENSION, V58, P709, DOI 10.1161/HYPERTENSIONAHA.111.176537; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Raffaelli R, 2014, HYPERTENS RES, V37, P984, DOI 10.1038/hr.2014.102; Ray JG, 2012, HEART, V98, P1136, DOI 10.1136/heartjnl-2011-301548; Redfearn DP, 2006, PACE, V29, P1089, DOI 10.1111/j.1540-8159.2006.00469.x; Redfearn DP, 2006, ANN NONINVAS ELECTRO, V11, P12, DOI 10.1111/j.1542-474X.2006.00058.x; Scholten RR, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.025; Scholten RR, 2014, AM J PHYSIOL-HEART C, V307, pH418, DOI 10.1152/ajpheart.00128.2014; Smith GN, 2013, J OBSTET GYNAECOL CA, V35, P831, DOI 10.1016/S1701-2163(15)30841-0; Spaan J, 2012, HYPERTENSION, V60, P1368, DOI 10.1161/HYPERTENSIONAHA.112.198812; Stein PK, 1999, AM J OBSTET GYNECOL, V180, P978, DOI 10.1016/S0002-9378(99)70670-8; Strobl I, 2011, BJOG-INT J OBSTET GY, V118, P76, DOI 10.1111/j.1471-0528.2010.02780.x; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Walther T, 2014, HYPERTENS PREGNANCY, V33, P1, DOI 10.3109/10641955.2013.821481; Whitsel EA, 2001, EUR HEART J, V22, P165, DOI 10.1053/euhj.2000.2262; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269	30	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138664	10.1371/journal.pone.0138664	http://dx.doi.org/10.1371/journal.pone.0138664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407294	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700066
J	Peery, AF; Sandler, RS; Galanko, JA; Bresalier, RS; Figueiredo, JC; Ahnen, DJ; Barry, EL; Baron, JA				Peery, Anne F.; Sandler, Robert S.; Galanko, Joseph A.; Bresalier, Robert S.; Figueiredo, Jane C.; Ahnen, Dennis J.; Barry, Elizabeth L.; Baron, John A.			Risk Factors for Hemorrhoids on Screening Colonoscopy	PLOS ONE			English	Article							CONSTIPATION; PREVALENCE	Background Constipation, a low fiber diet, sedentary lifestyle and gravidity are commonly assumed to increase the risk of hemorrhoids. However, evidence regarding these factors is limited. We examined the association between commonly cited risk factors and the prevalence of hemorrhoids. Methods We performed a cross sectional study of participants who underwent a colonoscopy in a colorectal adenoma prevention trial and who had a detailed assessment of bowel habits, diet and activity. The presence of hemorrhoids was extracted from the subjects' colonoscopy reports. We used logistic regression to estimate odds ratios and 95% confidence intervals while adjusting for age and sex. Results The study included 2,813 participants. Of these, 1,074 had hemorrhoids recorded. Constipation was associated with an increased prevalence of hemorrhoids (OR 1.43, 95% CI 1.11, 1.86). Of the fiber subtypes, high grain fiber intake was associated with a reduced risk (OR for quartile 4 versus quartile 1 = 0.78, 95% CI 0.62, 0.98). We found no association when comparing gravid and nulligravida women (OR 0.93, 95% CI 0.62-1.40). Sedentary behavior was associated with a reduced risk (OR 0.80, 95% CI 0.65-0.98), but not physical activity (OR 0.83, 95% CI 0.66-1.03). Neither being overweight nor obese was associated with the presence of hemorrhoids (OR 0.89, 95% CI 0.72-1.09 and OR 0.86, 95% CI 0.70-1.06). Conclusions Constipation is associated with an increased risk of hemorrhoids. Gravidity and physical activity do not appear to be associated. High grain fiber intake and sedentary behavior are associated with a decreased risk of hemorrhoids.	[Peery, Anne F.; Sandler, Robert S.; Galanko, Joseph A.; Baron, John A.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Figueiredo, Jane C.] Univ Calif Los Angeles, Keck Sch Med, Los Angeles, CA USA; [Ahnen, Dennis J.] Univ Colorado, Denver, CO 80202 USA; [Barry, Elizabeth L.; Baron, John A.] Geisel Sch Med Dartmouth, Hanover, NH USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Denver; Dartmouth College	Peery, AF (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	Anne_Peery@med.unc.edu	Barry, Elizabeth/AAB-7916-2019	Bresalier, Robert/0000-0002-9740-281X	National Institutes of Health [R01 CA098286]; National Center for Advancing Translational Sciences, National Institutes of Health [1KL2TR001109]; NATIONAL CANCER INSTITUTE [R01CA098286, P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by grants from the National Institutes of Health (R01 CA098286) and by the National Center for Advancing Translational Sciences, National Institutes of Health, Grant 1KL2TR001109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2006, AM J GASTROENTEROL, V101, P181, DOI 10.1111/j.1572-0241.2005.00359.x; Avsar AF, 2010, J OBSTET GYNAECOL, V30, P231, DOI 10.3109/01443610903439242; Bharucha AE, 2013, GASTROENTEROLOGY, V144, P218, DOI 10.1053/j.gastro.2012.10.028; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Delco F, 1998, DIS COLON RECTUM, V41, P1534, DOI 10.1007/BF02237302; Drossman DA, 1994, FUNCTIONAL GASTROINT; Everhart JE, 2009, GASTROENTEROLOGY, V136, P741, DOI 10.1053/j.gastro.2009.01.015; Ganz RA, 2013, CLIN GASTROENTEROL H, V11, P593, DOI 10.1016/j.cgh.2012.12.020; Johannsson HO, 2005, AM J GASTROENTEROL, V100, P401, DOI 10.1111/j.1572-0241.2005.40195.x; JOHANSON JF, 1994, AM J GASTROENTEROL, V89, P1981; JOHANSON JF, 1990, GASTROENTEROLOGY, V98, P380, DOI 10.1016/0016-5085(90)90828-O; Riss S, 2011, COLORECTAL DIS, V13, pE227, DOI 10.1111/j.1463-1318.2011.02632.x; Riss S, 2012, INT J COLORECTAL DIS, V27, P215, DOI 10.1007/s00384-011-1316-3; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Waye JD, 1999, AM J GASTROENTEROL, V94, P1429, DOI 10.1111/j.1572-0241.1999.1429_a.x; Whitehead W. E., 1991, GASTROENTEROLOGY INT, V4, P99; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	18	36	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139100	10.1371/journal.pone.0139100	http://dx.doi.org/10.1371/journal.pone.0139100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406337	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700169
J	White, MJV; Gomer, RH				White, Michael J. V.; Gomer, Richard H.			Trypsin, Tryptase, and Thrombin Polarize Macrophages towards a Pro-Fibrotic M2a Phenotype	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; MAST-CELL TRYPTASE; UP-REGULATION; FIBROCYTE DIFFERENTIATION; ACTIVATED MACROPHAGES; EXPRESSION; FIBROSIS; INJURY; ORCHESTRATE; SECRETION	For both wound healing and the formation of a fibrotic lesion, circulating monocytes enter the tissue and differentiate into fibroblast-like cells called fibrocytes and pro-fibrotic M2a macrophages, which together with fibroblasts form scar tissue. Monocytes can also differentiate into classically activated M1 macrophages and alternatively activated M2 macrophages. The proteases thrombin, which is activated during blood clotting, and tryptase, which is released by activated mast cells, potentiate fibroblast proliferation and fibrocyte differentiation, but their effect on macrophages is unknown. Here we report that thrombin, tryptase, and the protease trypsin bias human macrophage differentiation towards a pro-fibrotic M2a phenotype expressing high levels of galectin-3 from unpolarized monocytes, or from M1 and M2 macrophages, and that these effects appear to operate through protease-activated receptors. These results suggest that proteases can initiate scar tissue formation by affecting fibroblasts, fibrocytes, and macrophages.	[White, Michael J. V.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; White, Michael/0000-0002-9615-2249	National Institutes of Health (NIH) [HL118507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant HL118507, "Pentraxin regulation of macrophage differentiation". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-139; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DAWES KE, 1993, EUR J CELL BIOL, V61, P126; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Devouassoux G, 1999, J ALLERGY CLIN IMMUN, V104, P811, DOI 10.1016/S0091-6749(99)70292-7; Drew Philip, 2007, Int Wound J, V4, P149, DOI 10.1111/j.1742-481X.2007.00337.x; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Duitman J, 2014, MOL MED, V20, P410, DOI 10.2119/molmed.2014.00027; EKLUND A, 1993, SARCOIDOSIS, V10, P12; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gilpin SE, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-48; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; Gudbrandsdottir S, 2013, J IMMUNOL, V191, P4059, DOI 10.4049/jimmunol.1201103; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Hermes B, 2000, J INVEST DERMATOL, V114, P51, DOI 10.1046/j.1523-1747.2000.00837.x; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McGaha TL, 2003, ARTHRITIS RHEUM-US, V48, P2275, DOI 10.1002/art.11089; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naldini A, 2005, J LEUKOCYTE BIOL, V78, P736, DOI 10.1189/jlb.0205082; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Pesci A, 1996, CHEST, V110, P383, DOI 10.1378/chest.110.2.383; PILCHER BK, 1994, EXP CELL RES, V211, P368, DOI 10.1006/excr.1994.1100; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Undas A, 2001, BLOOD, V98, P2423, DOI 10.1182/blood.V98.8.2423; Vowden Kathryn R, 2009, J Tissue Viability, V18, P7, DOI 10.1016/j.jtv.2008.11.004; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WALLS AF, 1991, CLIN SCI, V81, P183, DOI 10.1042/cs0810183; Weiclenbusch M, 2012, J INNATE IMMUN, V4, P463, DOI 10.1159/000336717; White MJV, 2015, J IMMUNOL, V195, P1858, DOI 10.4049/jimmunol.1500365; White MJV, 2015, J IMMUNOL, V194, P142, DOI 10.4049/jimmunol.1401777; White MJV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070795; White MJ, 2014, J IMMUNOLOGY; Wygrecka M, 2013, AM J PATHOL, V182, P2094, DOI 10.1016/j.ajpath.2013.02.013; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412	64	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138748	10.1371/journal.pone.0138748	http://dx.doi.org/10.1371/journal.pone.0138748			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407067	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700084
J	Lee, CPL; Choi, H; Soo, KC; Tan, MH; Chay, WY; Chia, KS; Liu, J; Li, JM; Hartman, M				Lee, Charmaine Pei Ling; Choi, Hyungwon; Soo, Khee Chee; Tan, Min-Han; Chay, Wen Yee; Chia, Kee Seng; Liu, Jenny; Li, Jingmei; Hartman, Mikael			Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GAIL MODEL; ETHNIC-DIFFERENCES; ASIAN WOMEN; SUSCEPTIBILITY; POPULATION; SINGAPORE; LOCUS; POLYMORPHISMS; DETERMINANTS	Introduction Known prediction models for breast cancer can potentially by improved by the addition of mammographic density and common genetic variants identified in genome-wide associations studies known to be associated with risk of the disease. We evaluated the benefit of including mammographic density and the cumulative effect of genetic variants in breast cancer risk prediction among women in a Singapore population. Methods We estimated the risk of breast cancer using a prospective cohort of 24,161 women aged 50 to 64 from Singapore with available mammograms and known risk factors for breast cancer who were recruited between 1994 and 1997. We measured mammographic density using the medio-lateral oblique views of both breasts. Each woman's genotype for 75 SNPs was simulated based on the genotype frequency obtained from the Breast Cancer Association Consortium data and the cumulative effect was summarized by a genetic risk score (GRS). Any improvement in the performance of our proposed prediction model versus one containing only variables from the Gail model was assessed by changes in receiver-operating characteristic and predictive values. Results During 17 years of follow-up, 680 breast cancer cases were diagnosed. The multivariate-adjusted hazard ratios (95% confidence intervals) were 1.60 (1.22-2.10), 2.20 (1.65-2.92), 2.33 (1.71-3.20), 2.12 (1.43-3.14), and 3.27 (2.24-4.76) for the corresponding mammographic density categories: 11-20cm(2), 21-30cm(2), 31-40cm(2), 41-50cm(2), 51-60cm(2), and 1.10 (1.03-1.16) for GRS. At the predicted absolute 10-year risk thresholds of 2.5% and 3.0%, a model with mammographic density and GRS could correctly identify 0.9% and 0.5% more women who would develop the disease compared to a model using only the Gail variables, respectively. Conclusion Mammographic density and common genetic variants can improve the discriminatory power of an established breast cancer risk prediction model among females in Singapore.	[Lee, Charmaine Pei Ling] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Lee, Charmaine Pei Ling; Choi, Hyungwon; Chia, Kee Seng; Liu, Jenny; Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Soo, Khee Chee; Tan, Min-Han; Chay, Wen Yee] Natl Canc Ctr, Singapore, Singapore; [Li, Jingmei] Genome Inst Singapore, Human Genet, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore 117548, Singapore; [Hartman, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Karolinska Institutet	Hartman, M (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	mikael_hartman@nuhs.edu.sg	Tan, Min/GQQ-2702-2022; Choi, Hyungwon/S-8824-2019; Li, Jingmei/I-2904-2012; Hartman, Mikael/B-4324-2011	Choi, Hyungwon/0000-0002-6687-3088; Li, Jingmei/0000-0001-8587-7511; Hartman, Mikael/0000-0001-5726-9965	Cancer Research UK [C1287/A10118, C1287/A12014]; European Community [223175, HEALTH-F2-2009-223175]	Cancer Research UK(Cancer Research UK); European Community(European Commission)	BCAC is funded by Cancer Research UK [C1287/A10118, C1287/A12014] and by the European Community's Seventh Framework Programme under grant agreement number 223175 (grant number HEALTH-F2-2009-223175) (COGS).	Anderson BO, 2006, BREAST J, V12, pS54, DOI 10.1111/j.1075-122X.2006.00203.x; Anothaisintawee T, 2012, BREAST CANCER RES TR, V133, P1, DOI 10.1007/s10549-011-1853-z; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Chan M, 2012, BREAST CANCER RES TR, V136, P209, DOI 10.1007/s10549-012-2234-y; Chay WY, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3104; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; Dai JC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3101; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; Do CB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002973; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Gao F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-529; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Haiman CA, 2003, BREAST CANCER RES TR, V77, P27, DOI 10.1023/A:1021112121782; Haiman CA, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr434; Hartman M, 2011, BREAST CANCER RES TR, V127, P805, DOI 10.1007/s10549-010-1279-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KATO I, 1995, CANCER CAUSE CONTROL, V6, P431, DOI 10.1007/BF00052183; Lai JH, 2004, CANCER EPIDEM BIOMAR, V13, P573; Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mulhall C, 2005, CANCER EPIDEM BIOMAR, V14, P2648, DOI 10.1158/1055-9965.EPI-04-0374; Ng EH, 1998, CANCER-AM CANCER SOC, V82, P1521, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1521::AID-CNCR14>3.3.CO;2-B; Novotny J, 2006, BREAST CANCER RES TR, V95, P29, DOI 10.1007/s10549-005-9027-5; NRoDO, 2014, SINGAPORE CANCER REG; Odefrey F, 2010, CANCER RES, V70, P1449, DOI 10.1158/0008-5472.CAN-09-3495; Parsa Parisa, 2006, Asian Pac J Cancer Prev, V7, P509; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Seow A KW, 2004, SINGAPORE CANCER REG; Sim XL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-261; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stone J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2778; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Tamimi RM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1655; Thomas DB, 2002, CANCER EPIDEM BIOMAR, V11, P565; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Tice JA, 2005, CANCER EPIDEM BIOMAR, V14, P324, DOI 10.1158/1055-9965.EPI-04-0289; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Torres-Mejia G, 2005, CANCER EPIDEM BIOMAR, V14, P1052, DOI 10.1158/1055-9965.EPI-04-0717; Vachon CM, 2007, CANCER RES, V67, P8412, DOI 10.1158/0008-5472.CAN-07-1076; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P43, DOI 10.1158/1055-9965.EPI-06-0738; Vachon CM, 2012, CANCER EPIDEM BIOMAR, V21, P1156, DOI 10.1158/1055-9965.EPI-12-0066; Vachon CM, 1999, J NATL CANCER I, V91, P1778, DOI 10.1093/jnci/91.20.1778; van Duijnhoven FJB, 2005, CANCER EPIDEM BIOMAR, V14, P2655, DOI 10.1158/1055-9965.EPI-05-0398; Wong CS, 2011, BRIT J CANCER, V104, P871, DOI 10.1038/sj.bjc.6606085; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zheng W, 2013, HUM MOL GENET, V22, P2539, DOI 10.1093/hmg/ddt089; Zheng W, 2010, JNCI-J NATL CANCER I, V102, P972, DOI 10.1093/jnci/djq170; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	58	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0136650	10.1371/journal.pone.0136650	http://dx.doi.org/10.1371/journal.pone.0136650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401662	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100007
J	Liu, T; Tian, CF; Chen, WX				Liu, Tao; Tian, Chang Fu; Chen, Wen Xin			Site-Specific Ser/Thr/Tyr Phosphoproteome of Sinorhizobium meliloti at Stationary Phase	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; RHIZOBIUM-MELILOTI; ESCHERICHIA-COLI; BRADYRHIZOBIUM-JAPONICUM; PROTEIN-KINASES; SERINE/THREONINE/TYROSINE PHOSPHOPROTEOME; PHOSPHOGLUCOSAMINE MUTASE; SUCCINOGLYCAN PRODUCTION; PHOSPHORYLATED PROTEINS; BIOSYNTHETIC-PATHWAY	Sinorhizobium meliloti, a facultative microsymbiont of alfalfa, should fine-tune its cellular processes to live saprophytically in soils characterized with limited nutrients and diverse stresses. In this study, TiO2 enrichment and LC-MS/MS were used to uncover the site-specific Ser/Thr/Tyr phosphoproteome of S. meliloti in minimum medium at stationary phase. There are a total of 96 unique phosphorylated sites, with a Ser/Thr/Tyr distribution of 63: 28: 5, in 77 proteins. Phosphoproteins identified in S. meliloti showed a wide distribution pattern regarding to functional categories, such as replication, transcription, translation, posttranslational modification, transport and metabolism of amino acids, carbohydrate, inorganic ion, succinoglycan etc. Ser/Thr/Tyr phosphosites identified within the conserved motif in proteins of key cellular function indicate a crucial role of phosphorylation in modulating cellular physiology. Moreover, phosphorylation in proteins involved in processes related to rhizobial adaptation was also discussed, such as those identified in SMa0114 and PhaP2 (polyhydroxybutyrate synthesis), ActR (pH stress and microaerobic adaption), SupA (potassium stress), chaperonin GroEL2 (viability and potentially symbiosis), and ExoP (succinoglycan synthesis and secretion). These Ser/Thr/Tyr phosphosites identified herein would be helpful for our further investigation and understanding of the role of phosphorylation in rhizobial physiology.	[Liu, Tao; Tian, Chang Fu; Chen, Wen Xin] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Liu, Tao; Tian, Chang Fu; Chen, Wen Xin] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Liu, Tao; Tian, Chang Fu; Chen, Wen Xin] China Agr Univ, Minist Agr, Key Lab Soil Microbiol, Beijing 100094, Peoples R China; [Liu, Tao; Tian, Chang Fu; Chen, Wen Xin] China Agr Univ, Rhizobium Res Ctr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Tian, CF (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	cftian@cau.edu.cn	Tian, Chang Fu/O-4482-2019; Tian, Chang Fu/C-2507-2012	Tian, Chang Fu/0000-0002-0479-363X; Tian, Chang Fu/0000-0002-0479-363X	Program for New Century Excellent Talents in University [NCET-13-0561]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by Program for New Century Excellent Talents in University NCET-13-0561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2001, ARCH MICROBIOL, V176, P151, DOI 10.1007/s002030100293; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood PV, 2011, AMINO ACIDS, V40, P1035, DOI 10.1007/s00726-010-0738-5; Bai X, 2012, APPL MICROBIOL BIOT, V95, P201, DOI 10.1007/s00253-012-4156-3; Bardin SD, 1998, GENETICS, V148, P1689; BATTISTI L, 1992, P NATL ACAD SCI USA, V89, P5625, DOI 10.1073/pnas.89.12.5625; Bauer E, 1998, J BACTERIOL, V180, P3853, DOI 10.1128/JB.180.15.3853-3863.1998; Bittner AN, 2007, J BACTERIOL, V189, P1884, DOI 10.1128/JB.01542-06; Bobik C, 2006, J BACTERIOL, V188, P4890, DOI 10.1128/JB.00251-06; BROCKWELL J, 1995, SOIL BIOL BIOCHEM, V27, P683, DOI 10.1016/0038-0717(95)98649-9; Chen Z, 2014, J PROTEOME RES, V13, P2511, DOI 10.1021/pr401290u; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuiv PO, 2008, MOL MICROBIOL, V70, P1261, DOI 10.1111/j.1365-2958.2008.06479.x; Davalos M, 2004, FEMS MICROBIOL LETT, V241, P33, DOI 10.1016/j.femsle.2004.09.041; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; DEPHILIP P, 1990, J BACTERIOL, V172, P4255, DOI 10.1128/jb.172.8.4255-4262.1990; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Fenner BJ, 2004, FEMS MICROBIOL LETT, V236, P21, DOI 10.1111/j.1574-6968.2004.tb09622.x; Garcia PP, 2010, J BACTERIOL, V192, P5725, DOI 10.1128/JB.00629-10; Gonzalez JE, 1998, P NATL ACAD SCI USA, V95, P13477, DOI 10.1073/pnas.95.23.13477; Goodwin RA, 2014, J BACTERIOL, V196, P1901, DOI 10.1128/JB.01489-14; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jia RZ, 2013, SOIL BIOL BIOCHEM, V57, P960, DOI 10.1016/j.soilbio.2012.07.021; Jia RZ, 2008, ANN MICROBIOL, V58, P731, DOI 10.1007/BF03175583; Jofre E, 2009, MOL PLANT MICROBE IN, V22, P1656, DOI 10.1094/MPMI-22-12-1656; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; LAINE B, 1983, EUR J BIOCHEM, V131, P325, DOI 10.1111/j.1432-1033.1983.tb07265.x; Lin DX, 2009, FEMS MICROBIOL LETT, V293, P35, DOI 10.1111/j.1574-6968.2009.01500.x; Lin MH, 2009, MOL CELL PROTEOMICS, V8, P2613, DOI 10.1074/mcp.M900276-MCP200; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Macek B, 2011, PROTEOMICS, V11, P3002, DOI 10.1002/pmic.201100012; Manteca A, 2011, J PROTEOME RES, V10, P5481, DOI 10.1021/pr200762y; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; Mijakovic I, 2012, FEMS MICROBIOL REV, V36, P877, DOI 10.1111/j.1574-6976.2011.00314.x; Misra SK, 2011, PROTEOMICS, V11, P4155, DOI 10.1002/pmic.201100259; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Nogales J, 2009, FEMS MICROBIOL LETT, V293, P177, DOI 10.1111/j.1574-6968.2009.01527.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parker JL, 2010, PROTEOMICS, V10, P2486, DOI 10.1002/pmic.201000090; Peoples MB, 2012, CROP PASTURE SCI, V63, P759, DOI 10.1071/CP12123; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pinedo CA, 2008, J BACTERIOL, V190, P2947, DOI 10.1128/JB.01917-07; Prell J, 2012, MOL MICROBIOL, V84, P117, DOI 10.1111/j.1365-2958.2012.08014.x; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; RUSANGANWA E, 1993, GENE, V126, P67, DOI 10.1016/0378-1119(93)90591-P; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; Summers ML, 1998, MOL PLANT MICROBE IN, V11, P1094, DOI 10.1094/MPMI.1998.11.11.1094; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tiwari RP, 1996, MICROBIOL-UK, V142, P1693, DOI 10.1099/13500872-142-7-1693; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; VITERI SE, 1987, APPL ENVIRON MICROB, V53, P1872, DOI 10.1128/AEM.53.8.1872-1875.1987; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Voisin S, 2007, PROTEOMICS, V7, P4338, DOI 10.1002/pmic.200700483; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; Wang CX, 2007, J BACTERIOL, V189, P9050, DOI 10.1128/JB.01190-07; Yang MK, 2013, J PROTEOME RES, V12, P1909, DOI 10.1021/pr4000043; Yao SY, 2004, J BACTERIOL, V186, P6042, DOI [10.1128/JB.186.18.6042-6049.2004, 10.1128/jb.186.18.6042-6049.2004]; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002	72	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139143	10.1371/journal.pone.0139143	http://dx.doi.org/10.1371/journal.pone.0139143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401955	Green Submitted, Green Published, gold			2022-12-26	WOS:000361798100059
J	Rebolledo, D; Lasa, R; Guevara, R; Murillo, R; Williams, T				Rebolledo, Dulce; Lasa, Rodrigo; Guevara, Roger; Murillo, Rosa; Williams, Trevor			Baculovirus-Induced Climbing Behavior Favors Intraspecific Necrophagy and Efficient Disease Transmission in Spodoptera exigua	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; HELIOTHIS-ZEA LEPIDOPTERA; BEET ARMYWORM; HOST-PLANT; HORIZONTAL TRANSMISSION; CANNIBALISM; NOCTUIDAE; PATHOGEN; LARVAE; NUCLEOPOLYHEDROVIRUS	Shortly prior to death, many species of Lepidoptera infected with nucleopolyhedrovirus climb upwards on the host plant. This results in improved dissemination of viral occlusion bodies over plant foliage and an increased probability of transmission to healthy conspecific larvae. Following applications of Spodoptera exigua multiple nucleopolyhedrovirus for control of Spodoptera exigua on greenhouse-grown sweet pepper crops, necrophagy was observed by healthy S. exigua larvae that fed on virus-killed conspecifics. We examined whether this risky behavior was induced by olfactory or phagostimulant compounds associated with infected cadavers. Laboratory choice tests and olfactometer studies, involving infected and non-infected cadavers placed on spinach leaf discs, revealed no evidence for greater attraction of healthy larvae to virus-killed over non-infected cadavers. Physical contact or feeding on infected cadavers resulted in a very high incidence of transmission (82-93% lethal disease). Observations on the behavior of S. exigua larvae on pepper plants revealed that infected insects died on the uppermost 10% of foliage and closer to the plant stem than healthy conspecifics of the same stage, which we considered clear evidence of baculovirus-induced climbing behavior. Healthy larvae that subsequently foraged on the plant were more frequently observed closer to the infected than the non-infected cadaver. Healthy larvae also encountered and fed on infected cadavers significantly more frequently and more rapidly than larvae that fed on non-infected cadavers. Intraspecific necrophagy on infected cadavers invariably resulted in virus transmission and death of the necrophagous insect. We conclude that, in addition to improving the dissemination of virus particles over plant foliage, baculovirus-induced climbing behavior increases the incidence of intraspecific necrophagy in S. exigua, which is the most efficient mechanism of transmission of this lethal pathogen.	[Rebolledo, Dulce; Lasa, Rodrigo; Guevara, Roger; Williams, Trevor] Inst Ecol AC, Xalapa 91070, Veracruz, Mexico; [Murillo, Rosa] CSIC, Inst Agrobiotecnol, Pamplona 31192, Spain	Instituto de Ecologia - Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB)	Williams, T (corresponding author), Inst Ecol AC, Xalapa 91070, Veracruz, Mexico.	trevor.inecol@gmail.com	Guevara, Roger/F-3287-2010; Williams, Trevor/F-1447-2011; Murillo, Rosa/G-5506-2010; Williams, Trevor/ABG-3961-2020; Williams, Trevor/J-4239-2013; Lasa, Rodrigo/Q-6288-2018	Guevara, Roger/0000-0003-0768-3580; Williams, Trevor/0000-0003-3414-3440; Murillo, Rosa/0000-0001-9535-0000; Williams, Trevor/0000-0003-3414-3440; Lasa, Rodrigo/0000-0003-1175-7538	Consejo Nacional de Ciencia y Tecnologia (Mexico); Fomento de la Produccion Academica grant from the Instituto de Ecologia AC	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fomento de la Produccion Academica grant from the Instituto de Ecologia AC	DR received a Consejo Nacional de Ciencia y Tecnologia (Mexico) scholarship, a student mobility grant and a Fomento de la Produccion Academica grant from the Instituto de Ecologia AC. The authors received no specific funding for this work.	ALZUBAIDI FS, 1983, ENVIRON ENTOMOL, V12, P1687; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Bogner FX, 1996, J CHEM ECOL, V22, P1439, DOI 10.1007/BF02027723; BOMAR CR, 1994, J CHEM ECOL, V20, P2261, DOI 10.1007/BF02033201; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; Brooks Wayne M., 1993, P231; Brown MW, 2004, ANN ENTOMOL SOC AM, V97, P500, DOI 10.1603/0013-8746(2004)097[0500:SAOCNI]2.0.CO;2; CAPINERA JL, 1976, J INVERTEBR PATHOL, V28, P277, DOI 10.1016/0022-2011(76)90138-5; CARTER JB, 1973, J INVERTEBR PATHOL, V21, P136, DOI 10.1016/0022-2011(73)90193-6; Chapman JW, 2000, BEHAV ECOL SOCIOBIOL, V48, P321, DOI 10.1007/s002650000237; Chapman JW, 1999, ECOL ENTOMOL, V24, P268, DOI 10.1046/j.1365-2311.1999.00224.x; Chilcutt CF, 2006, J ECON ENTOMOL, V99, P728, DOI 10.1603/0022-0493-99.3.728; Cory JS, 1997, BACULOVIRUSES, P301, DOI DOI 10.1007/978-1-4899-1834-5_12; DAMICO V, 1995, ENVIRON ENTOMOL, V24, P1144, DOI 10.1093/ee/24.5.1144; DHANDAPANI N, 1993, INSECT SCI APPL, V14, P427, DOI 10.1017/S1742758400014089; DIAL CI, 1990, ANN ENTOMOL SOC AM, V83, P258, DOI 10.1093/aesa/83.2.258; Elgar M., 1992, CANNIBALISM ECOLOGY, V1st; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elvira S, 2010, J ECON ENTOMOL, V103, P577, DOI 10.1603/EC09325; FOWLER HG, 1989, REV MICROBIOL, V20, P115; George J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062632; Gog Linus, 2014, Insects, V5, P668, DOI 10.3390/insects5030668; Goulson D, 1997, OECOLOGIA, V109, P219, DOI 10.1007/s004420050076; Harrison R, 2012, INSECT PATHOLOGY, 2ND EDITION, P73, DOI 10.1016/B978-0-12-384984-7.00004-X; Herniou EA., 2011, VIRUS TAXONOMY, P163; Hoover K, 2011, SCIENCE, V333, P6048; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; Hunter-Fujita FR, 1998, INSECT VIRUSES PEST; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; JONES KA, 1993, BIOCONTROL SCI TECHN, V3, P189, DOI 10.1080/09583159309355275; JOYNER K, 1985, ANN ENTOMOL SOC AM, V78, P24, DOI 10.1093/aesa/78.1.24; Kamita SG, 2005, P NATL ACAD SCI USA, V102, P2584, DOI 10.1073/pnas.0409457102; Katsuma S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002644; Lam K, 2010, J CHEM ECOL, V36, P141, DOI 10.1007/s10886-010-9741-2; Lasa R, 2007, BIOCONTROL SCI TECHN, V17, P221, DOI 10.1080/09583150701211335; Lee KP, 2002, J INSECT PHYSIOL, V48, P655, DOI 10.1016/S0022-1910(02)00088-4; Lee Y, 2000, MICROBIAL ECOL, V39, P301; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mburu DM, 2013, J CHEM ECOL, V39, P101, DOI 10.1007/s10886-012-0207-6; Meyling NV, 2006, ECOL ENTOMOL, V31, P162, DOI 10.1111/j.0307-6946.2006.00781.x; Munoz D, 1997, APPL ENVIRON MICROB, V63, P3025; Muscio OA, 1997, J MED ENTOMOL, V34, P253, DOI 10.1093/jmedent/34.3.253; Parker BJ, 2010, J ANIM ECOL, V79, P863, DOI 10.1111/j.1365-2656.2010.01690.x; Pierce Naomi E., 1995, Journal of the Lepidopterists' Society, V49, P412; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; RAFFA KF, 1987, ENVIRON ENTOMOL, V16, P672, DOI 10.1093/ee/16.3.672; Rasband W.S., 2014, IMAGE PROCESSING ANA; Raymond B, 2005, J INVERTEBR PATHOL, V88, P49, DOI 10.1016/j.jip.2004.09.005; Reed DJ, 1996, OECOLOGIA, V105, P189, DOI 10.1007/BF00328545; Richards A, 1999, OECOLOGIA, V118, P29, DOI 10.1007/s004420050700; Richardson ML, 2010, ANNU REV ENTOMOL, V55, P39, DOI 10.1146/annurev-ento-112408-085314; Ros VID, 2015, MOL ECOL, V24, P249, DOI 10.1111/mec.13019; Rudolf VHW, 2007, P R SOC B, V274, P1205, DOI 10.1098/rspb.2006.0449; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Shapiro M, 2002, J ECON ENTOMOL, V95, P243, DOI 10.1603/0022-0493-95.2.243; SMITS PH, 1987, ENTOMOL EXP APPL, V43, P67, DOI 10.1007/BF00350377; SMITS PH, 1988, J INVERTEBR PATHOL, V51, P107, DOI 10.1016/0022-2011(88)90066-3; van Houte S, 2014, NATURWISSENSCHAFTEN, V101, P347, DOI 10.1007/s00114-014-1160-8; van Houte S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046933; Vasconcelos SD, 1996, BIOL CONTROL, V7, P299, DOI 10.1006/bcon.1996.0098; Vasconcelos SD, 1996, J INVERTEBR PATHOL, V68, P269, DOI 10.1006/jipa.1996.0095; Wang XG, 2014, ENTOMOL EXP APPL, V151, P112, DOI 10.1111/eea.12174; Whitman D. W., 1994, Functional dynamics of phytophagous insects., P161; Williams T, 2006, ECOL ENTOMOL, V31, P106, DOI 10.1111/j.0307-6946.2006.00771.x; Yanagawa A, 2011, J INVERTEBR PATHOL, V108, P1, DOI 10.1016/j.jip.2011.06.001	67	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0136742	10.1371/journal.pone.0136742	http://dx.doi.org/10.1371/journal.pone.0136742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402061	gold, Green Published, Green Submitted			2022-12-26	WOS:000361798100009
J	Rohner, F; Kangambega, MO; Khan, N; Kargougou, R; Garnier, D; Sanou, I; Ouaro, BD; Petry, N; Wirth, JP; Jooste, P				Rohner, Fabian; Kangambega, Marcelline O.; Khan, Noor; Kargougou, Robert; Garnier, Denis; Sanou, Ibrahima; Ouaro, Bertine D.; Petry, Nicolai; Wirth, James P.; Jooste, Pieter			Comparative Validation of Five Quantitative Rapid Test Kits for the Analysis of Salt Iodine Content: Laboratory Performance, User- and Field-Friendliness	PLOS ONE			English	Article								Background Iodine deficiency has important health and development consequences and the introduction of iodized salt as national programs has been a great public health success in the past decades. To render national salt iodization programs sustainable and ensure adequate iodization levels, simple methods to quantitatively assess whether salt is adequately iodized are required. Several methods claim to be simple and reliable, and are available on the market or are in development. Objective This work has validated the currently available quantitative rapid test kits (quantRTK) in a comparative manner for both their laboratory performance and ease of use in field settings. Methods Laboratory performance parameters (linearity, detection and quantification limit, intra- and inter-assay imprecision) were conducted on 5 quantRTK. We assessed inter-operator imprecision using salt of different quality along with the comparison of 59 salt samples from across the globe; measurements were made both in a laboratory and a field setting by technicians and non-technicians. Results from the quantRTK were compared against iodometric titration for validity. An 'ease-of-use' rating system was developed to identify the most suitable quantRTK for a given task. Results Most of the devices showed acceptable laboratory performance, but for some of the devices, use by non-technicians revealed poorer performance when working in a routine manner. Of the quantRTK tested, the iCheck (R) and I-Reader (R) showed most consistent performance and ease of use, and a newly developed paper-based method (saltPAD) holds promise if further developed. Conclusions User- and field-friendly devices are now available and the most appropriate quantRTK can be selected depending on the number of samples and the budget available.	[Rohner, Fabian; Petry, Nicolai; Wirth, James P.] GroundWork LLC, Crans Pres Celigny, Switzerland; [Kangambega, Marcelline O.; Sanou, Ibrahima] Lab Natl Sante Publ, Ouagadougou, Burkina Faso; [Khan, Noor] Micronutrient Initiat, Ottawa, ON, Canada; [Kargougou, Robert; Garnier, Denis] UNICEF, Ouagadougou, Burkina Faso; [Ouaro, Bertine D.] Minist Sante, Direct Nutr, Ouagadougou, Burkina Faso; [Jooste, Pieter] Iodine Global Network South Africa, Cape Town, South Africa; [Jooste, Pieter] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa	North West University - South Africa	Rohner, F (corresponding author), GroundWork LLC, Crans Pres Celigny, Switzerland.	fabian@groundworkhealth.org	Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952; Wirth, James P/0000-0002-4733-0379	GroundWork LLC	GroundWork LLC	This analysis was conducted as part of Agreement 10-1528-GROWOR-01 between The Micronutrient Initiative (www.micronutrient.org) and GroundWork LLC. FR, NP and JPW are employees of GroundWork LLC (www.groundworkhealth.org). GroundWork LLC provided support in the form of salaries for authors FR, NP and JPW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	A.O.A.C, 1984, OFF METH; [Anonymous], 2007, ASS IOD DEF DIS MON; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dearth-Wesley Tracy, 2004, Food and Nutrition Bulletin, V25, P130; Diosady L. L., 1999, Food and Nutrition Bulletin, V20, P208; EuSalt, 2005, 0022005 EUSALTAS; Guamuch M, 2007, MANUAL LAB METHODS F; Horton S, 2008, COPENHAGEN CONSENSUS, P1; ICH guidelines, 2005, VAL AN PROC TEXT MET; Jooste PL, 2010, BEST PRACT RES CL EN, V24, P77, DOI 10.1016/j.beem.2009.08.006; Myers NM, 2015, ANAL CHEM, V87, P3764, DOI 10.1021/ac504269q; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Paik M. C., 2013, STAT METHODS RATES P; Pandav CS, 2000, B WORLD HEALTH ORGAN, V78, P975; Rohner F, 2014, J NUTR, V144, p1322S, DOI 10.3945/jn.113.181974; Rohner F, 2012, FOOD NUTR BULL, V33, pS330, DOI 10.1177/15648265120334S309; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3	17	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138530	10.1371/journal.pone.0138530	http://dx.doi.org/10.1371/journal.pone.0138530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401655	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100027
J	Varasteh, S; Braber, S; Akbari, P; Garssen, J; Fink-Gremmels, J				Varasteh, Soheil; Braber, Saskia; Akbari, Peyman; Garssen, Johan; Fink-Gremmels, Johanna			Differences in Susceptibility to Heat Stress along the Chicken Intestine and the Protective Effects of Galacto-Oligosaccharides	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTORS; BROILER-CHICKENS; GROWTH-PERFORMANCE; MANNAN-OLIGOSACCHARIDES; IMPAIRS PERFORMANCE; LIPID-PEROXIDATION; PROBIOTIC MIXTURE; OXIDATIVE STRESS; EPITHELIAL-CELLS; LIPOIC ACID	High ambient temperatures negatively affect the human well-being as well as animal welfare and production. The gastrointestinal tract is predominantly responsive to heat stress. The currently available information about the multifaceted response to heat stress within different parts of the intestine is limited, especially in avian species. Hence, this study aims to evaluate the heat stress-induced sequence of events in the intestines of chickens. Furthermore, the gut health-promoting effect of dietary galacto-oligosaccharides (GOS) was investigated in these heat stress-exposed chickens. Chickens were fed a control diet or diet supplemented with 1% or 2.5% GOS (6 days) prior to and during a temperature challenge for 5 days (38-39 degrees C, 8h per day). The parameters measured in different parts of the intestines included the genes (qPCR) HSF1, HSF3, HSP70, HSP90, E-cadherin, claudin-1, claudin-5, ZO-1, occludin, TLR-2, TLR-4, IL-6, IL-8, HO-1, HIF-1 alpha) and their associated proteins HSP70, HSP90 and pan-cadherin (western blots). In addition, IL-6 and IL-8 plasma concentrations were measured by ELISA. In the jejunum, HSF3, HSP70, HSP90, E-cadherin, claudin-5, ZO-1, TLR-4, IL-6 and IL-8 mRNA expression and HSP70 protein expression were increased after heat stress exposure and a more pronounced increase in gene expression was observed in ileum after heat stress exposure, and in addition HSF1, claudin-1 and HIF1a mRNA levels were upregulated. Furthermore, the IL-8 plasma levels were decreased in chickens exposed to heat stress. Interestingly, the heat stress-related effects in the jejunum were prevented in chickens fed a GOS diet, while dietary GOS did not alter these effects in ileum. In conclusion, our results demonstrate the differences in susceptibility to heat stress along the intestine, where the most obvious modification in gene expression is observed in ileum, while dietary GOS only prevent the heat stress-related changes in jejunum.	[Varasteh, Soheil; Braber, Saskia; Akbari, Peyman; Fink-Gremmels, Johanna] Univ Utrecht, Div Vet Pharm Pharmacol & Toxicol, Utrecht, Netherlands; [Varasteh, Soheil; Akbari, Peyman; Garssen, Johan] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Garssen, Johan] Nutricia Res, Utrecht, Netherlands	Utrecht University; Utrecht University; Danone Nutricia	Braber, S (corresponding author), Univ Utrecht, Div Vet Pharm Pharmacol & Toxicol, Utrecht, Netherlands.	S.Braber@uu.nl	Fink-Gremmels, Johanna/G-3707-2012; garssen, johan/I-7159-2016; Begaud, Xavier/H-7141-2016	Begaud, Xavier/0000-0002-0731-1384				Akbari P, 2015, J NUTR, V145, P1604, DOI 10.3945/jn.114.209486; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Al-Sheraji SH, 2013, J FUNCT FOODS, V5, P1542, DOI 10.1016/j.jff.2013.08.009; Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; BAILEY JS, 1991, POULTRY SCI, V70, P2433, DOI 10.3382/ps.0702433; Baurhoo B, 2007, POULTRY SCI, V86, P1070, DOI 10.1093/ps/86.6.1070; Bruno-Barcena JM, 2015, J FUNCT FOODS, V12, P92, DOI 10.1016/j.jff.2014.10.029; Chausse AM, 2011, INFECT IMMUN, V79, P3445, DOI 10.1128/IAI.00025-11; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Cray JA, 2013, ENVIRON MICROBIOL, V15, P287, DOI 10.1111/1462-2920.12018; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gu XH, 2012, POULTRY SCI, V91, P790, DOI 10.3382/ps.2011-01628; Habibian M, 2016, BIOL TRACE ELEM RES, V169, P142, DOI 10.1007/s12011-015-0404-6; Hamano Y, 2014, BRIT POULTRY SCI, V55, P343, DOI 10.1080/00071668.2014.903559; Hao Y, 2012, POULTRY SCI, V91, P781, DOI 10.3382/ps.2011-01627; Imik H, 2012, BRIT POULTRY SCI, V53, P800, DOI 10.1080/00071668.2012.740615; Jeurink PV, 2013, AM J CLIN NUTR, V98, p572S, DOI 10.3945/ajcn.112.038596; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Jung SJ, 2008, POULTRY SCI, V87, P1694, DOI 10.3382/ps.2007-00489; Lambert GP, 2002, J APPL PHYSIOL, V92, P1750, DOI 10.1152/japplphysiol.00787.2001; Lang BJ, 2012, CELL STRESS CHAPERON, V17, P765, DOI 10.1007/s12192-012-0349-z; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Luo XJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2399; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Naito Y, 2011, J CLIN BIOCHEM NUTR, V48, P126, DOI 10.3164/jcbn.10-61; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Peterson CY, 2010, SURG INFECT, V11, P137, DOI 10.1089/sur.2009.053; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Santos RR, 2015, AVIAN PATHOL, V44, P19, DOI 10.1080/03079457.2014.988122; Settar P, 1999, POULTRY SCI, V78, P1353, DOI 10.1093/ps/78.10.1353; Sohail MU, 2012, POULTRY SCI, V91, P2235, DOI 10.3382/ps.2012-02182; Song J, 2014, POULTRY SCI, V93, P581, DOI 10.3382/ps.2013-03455; Spring P, 2000, POULTRY SCI, V79, P205, DOI 10.1093/ps/79.2.205; Stacchiotti A, 2004, HISTOL HISTOPATHOL, V19, P1209, DOI 10.14670/HH-19.1209; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stocki P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/617213; Syafwan S, 2011, WORLD POULTRY SCI J, V67, P653, DOI 10.1017/S0043933911000742; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tanabe M, 1997, J BIOL CHEM, V272, P15389, DOI 10.1074/jbc.272.24.15389; Tomasello G, 2011, EUR J HISTOCHEM, V55, P210, DOI 10.4081/ejh.2011.e38; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; van der Hoeven-Hangoor E, 2013, POULTRY SCI, V92, P2713, DOI 10.3382/ps.2013-03017; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; van Eden W, 2015, ENDOCR METAB IMMUNE, V15, P31, DOI 10.2174/1871530314666140922145333; Varasteh S, 2015, J FUNCT FOODS, V16, P265, DOI 10.1016/j.jff.2015.04.045; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wyatt TT, 2015, ENVIRON MICROBIOL, V17, P395, DOI 10.1111/1462-2920.12558; Xie JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102204; Xu DN, 2015, BIOL TRACE ELEM RES, V168, P235, DOI 10.1007/s12011-015-0351-2; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176; Zhang WW, 2014, GENET MOL RES, V13, P9787, DOI 10.4238/2014.November.27.6; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhong Y, 2009, CLIN NUTR, V28, P575, DOI 10.1016/j.clnu.2009.04.026	68	132	137	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138975	10.1371/journal.pone.0138975	http://dx.doi.org/10.1371/journal.pone.0138975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402906	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100046
J	Borri, M; Schmidt, MA; Powell, C; Koh, DM; Riddell, AM; Partridge, M; Bhide, SA; Nutting, CM; Harrington, KJ; Newbold, KL; Leach, MO				Borri, Marco; Schmidt, Maria A.; Powell, Ceri; Koh, Dow-Mu; Riddell, Angela M.; Partridge, Mike; Bhide, Shreerang A.; Nutting, Christopher M.; Harrington, Kevin J.; Newbold, Katie L.; Leach, Martin O.			Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DCE-MRI; CANCER; RADIOTHERAPY; TUMORS; INFORMATION	Purpose To describe a methodology, based on cluster analysis, to partition multi-parametric functional imaging data into groups (or clusters) of similar functional characteristics, with the aim of characterizing functional heterogeneity within head and neck tumour volumes. To evaluate the performance of the proposed approach on a set of longitudinal MRI data, analysing the evolution of the obtained sub-sets with treatment. Material and Methods The cluster analysis workflow was applied to a combination of dynamic contrast-enhanced and diffusion-weighted imaging MRI data from a cohort of squamous cell carcinoma of the head and neck patients. Cumulative distributions of voxels, containing pre and post-treatment data and including both primary tumours and lymph nodes, were partitioned into k clusters (k = 2, 3 or 4). Principal component analysis and cluster validation were employed to investigate data composition and to independently determine the optimal number of clusters. The evolution of the resulting sub-regions with induction chemotherapy treatment was assessed relative to the number of clusters. Results The clustering algorithm was able to separate clusters which significantly reduced in voxel number following induction chemotherapy from clusters with a non-significant reduction. Partitioning with the optimal number of clusters (k = 4), determined with cluster validation, produced the best separation between reducing and non-reducing clusters. Conclusion The proposed methodology was able to identify tumour sub-regions with distinct functional properties, independently separating clusters which were affected differently by treatment. This work demonstrates that unsupervised cluster analysis, with no prior knowledge of the data, can be employed to provide a multi-parametric characterization of functional heterogeneity within tumour volumes.	[Borri, Marco; Schmidt, Maria A.; Koh, Dow-Mu; Leach, Martin O.] Royal Marsden NHS Fdn Trust, CR UK Canc Imaging Ctr, London, England; [Borri, Marco; Schmidt, Maria A.; Koh, Dow-Mu; Leach, Martin O.] Inst Canc Res, London SW3 6JB, England; [Powell, Ceri; Bhide, Shreerang A.; Nutting, Christopher M.; Harrington, Kevin J.; Newbold, Katie L.] Royal Marsden NHS Fdn Trust, Head & Neck Unit, London, England; [Koh, Dow-Mu; Riddell, Angela M.] Royal Marsden NHS Fdn Trust, Dept Radiol, London, England; [Partridge, Mike] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Oxford	Borri, M (corresponding author), Royal Marsden NHS Fdn Trust, CR UK Canc Imaging Ctr, London, England.	marco.borri@icr.ac.uk	Newbold, Kate/AAA-9176-2022; leach, martin o/C-2248-2008	leach, martin o/0000-0002-0756-5368; Harrington, Kevin/0000-0002-6014-348X; Schmidt, Maria/0000-0001-8993-5301; Borri, Marco/0000-0002-3287-9350; Koh, Dow-Mu/0000-0001-7654-8011	Cancer Research UK (CR-UK) and the Engineering and Physical Sciences Research Council (EPSRC) Cancer Imaging Centre [C1060/A10334, C1090/A16464]; National Institute for Health Research (NIHR); MRC award [G0701533]; CR-UK programme grant [C7224/A13407]; MRC [MR/M009068/1, G0701533] Funding Source: UKRI; Cancer Research UK [16464, 16049, 13407, 16466] Funding Source: researchfish; Medical Research Council [MR/M009068/1, G0701533] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish	Cancer Research UK (CR-UK) and the Engineering and Physical Sciences Research Council (EPSRC) Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK programme grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support of the Cancer Research UK (CR-UK) and the Engineering and Physical Sciences Research Council (EPSRC) Cancer Imaging Centre in association with the Medical Research Council (MRC) and Department of Health (England) (grants C1060/A10334, C1090/A16464); the National Institute for Health Research (NIHR) funding to the Clinical Research Facility in Imaging and to the Biomedical Research Centre at the Royal Marsden NHS Foundation Trust and Institute of Cancer Research; the MRC award for the 3T Clinical Research Infrastructure Facility (G0701533); the CR-UK programme grant C7224/A13407. MOL is an NIHR Senior Investigator. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, RADIOTHER ONCOL, V94, P161, DOI 10.1016/j.radonc.2009.12.021; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; Craciunescu OI, 2012, INT J RADIAT ONCOL, V82, pE345, DOI 10.1016/j.ijrobp.2011.05.059; d'Arcy JA, 2006, RADIOGRAPHICS, V26, P621, DOI 10.1148/rg.262045187; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3; McPhail LD, 2010, RADIOLOGY, V254, P110, DOI 10.1148/radiol.2541090395; Newbold K, 2006, BRIT J RADIOL, V79, P554, DOI 10.1259/bjr/48822193; Nuyts S, 2007, Cancer Imaging, V7 Spec No A, pS50, DOI 10.1102/1470-7330.2007.9009; Overgaard J, 1998, RADIOTHER ONCOL, V46, P135, DOI 10.1016/S0167-8140(97)00220-X; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Powell C, 2013, RADIOTHER ONCOL, V106, P112, DOI 10.1016/j.radonc.2012.09.009; Quon H, 2012, SEMIN RADIAT ONCOL, V22, P220, DOI 10.1016/j.semradonc.2012.03.007; Riches SF, 2009, AM J ROENTGENOL, V193, P1583, DOI 10.2214/AJR.09.2540; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Schmithorst V.J., 2010, CCHIPS CINCINNATI CH; Smith L. I., 2002, TUTORIAL PRINCIPAL C; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Vandecaveye V, 2007, INT J RADIAT ONCOL, V67, P960, DOI 10.1016/j.ijrobp.2006.09.020; Walker-Samuel S, 2006, PHYS MED BIOL, V51, P3593, DOI 10.1088/0031-9155/51/14/021; Wang P, 2012, MED PHYS, V39, P5277, DOI 10.1118/1.4737022	25	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138545	10.1371/journal.pone.0138545	http://dx.doi.org/10.1371/journal.pone.0138545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398888	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500075
J	Wallace, HM; Leonhardt, SD				Wallace, Helen Margaret; Leonhardt, Sara Diana			Do Hybrid Trees Inherit Invasive Characteristics? Fruits of Corymbia torelliana X C. citriodora Hybrids and Potential for Seed Dispersal by Bees	PLOS ONE			English	Article							AUSTRALIAN STINGLESS BEES; LONG-DISTANCE DISPERSAL; CUTICULAR PROFILES; HYBRIDIZATION; RESIN; PLANTATIONS; HYMENOPTERA; POPULATIONS; CARBONARIA; EUCALYPTUS	Tree invasions have substantial impacts on biodiversity and ecosystem functioning, and trees that are dispersed by animals are more likely to become invasive. In addition, hybridisation between plants is well documented as a source of new weeds, as hybrids gain new characteristics that allow them to become invasive. Corymbia torelliana is an invasive tree with an unusual animal dispersal mechanism: seed dispersal by stingless bees, that hybridizes readily with other species. We examined hybrids between C. torelliana and C. citriodora subsp. citriodora to determine whether hybrids have inherited the seed dispersal characteristics of C. torelliana that allow bee dispersal. Some hybrid fruits displayed the characteristic hollowness, resin production and resin chemistry associated with seed dispersal by bees. However, we did not observe bees foraging on any hybrid fruits until they had been damaged. We conclude that C. torelliana and C. citriodora subsp. citriodora hybrids can inherit some fruit characters that are associated with dispersal by bees, but we did not find a hybrid with the complete set of characters that would enable bee dispersal. However, around 20,000 hybrids have been planted in Australia, and ongoing monitoring is necessary to identify any hybrids that may become invasive.	[Wallace, Helen Margaret] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, DC 4558, Australia; [Leonhardt, Sara Diana] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany	University of the Sunshine Coast; University of Wurzburg	Wallace, HM (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, DC 4558, Australia.	hwallace@usc.edu.au	Wallace, Helen/AAB-3162-2019; Leonhardt, Sara/AAI-6901-2020	Wallace, Helen/0000-0002-8801-4401; Leonhardt, Sara/0000-0002-8154-9569	Australian Research Council Linkage Grant [LP0218877]; Queensland Government Smart State Program via the Smart Forests Alliance Queensland; Deutsche Forschungs-Gemeinschaft (DFG) [LE 2750/1-1]; German Excellence Initiative	Australian Research Council Linkage Grant(Australian Research Council); Queensland Government Smart State Program via the Smart Forests Alliance Queensland; Deutsche Forschungs-Gemeinschaft (DFG)(German Research Foundation (DFG)); German Excellence Initiative	This work was funded in part by an Australian Research Council Linkage Grant LP0218877 to HMW and the Queensland Government Smart State Program via the Smart Forests Alliance Queensland to HMW. Funding for SDL was provided by the Deutsche Forschungs-Gemeinschaft (DFG project: LE 2750/1-1) and by a grant of the German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacelar-Lima Christinny Giselly, 2006, Acta Amaz., V36, P343, DOI 10.1590/S0044-59672006000300009; Barbour RC, 2008, FOREST ECOL MANAG, V256, P1, DOI 10.1016/j.foreco.2008.03.028; Boland D, 1976, AUST SEED SCI NEWS, V2, P11; Caplat P, 2014, BIOL INVASIONS, V16, P677, DOI 10.1007/s10530-013-0608-7; Carr D, 1987, EUCALYPTUS; Dickinson GR, 2010, SILVAE GENET, V59, P233, DOI 10.1515/sg-2010-0028; Dickinson GR, 2013, ANN FOREST SCI, V70, P1, DOI 10.1007/s13595-012-0231-2; Dickinson GR, 2012, ANN BOT-LONDON, V109, P1215, DOI 10.1093/aob/mcs050; Drescher N, 2014, OECOLOGIA, V176, P943, DOI 10.1007/s00442-014-3070-z; Hayes RA, 2013, AUST J BOT, V61, P52, DOI 10.1071/BT12224; Hill K. D., 1995, Telopea, V6, P185; Klumpp J., 2007, AUSTR STINGLESS BEES; Langenheim J.H., 2003, PLANT RESINS CHEM EV; Lee D. J., 2007, Australian Forestry, V70, P11; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Leonhardt SD, 2015, CHEMOECOLOGY, V25, P159, DOI 10.1007/s00049-015-0185-6; Leonhardt SD, 2014, ANIM BEHAV, V98, P41, DOI 10.1016/j.anbehav.2014.09.024; Leonhardt SD, 2014, APIDOLOGIE, V45, P514, DOI 10.1007/s13592-013-0266-x; Leonhardt SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023445; Leonhardt SD, 2011, AUSTRAL ECOL, V36, P537, DOI 10.1111/j.1442-9993.2010.02184.x; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; Lesser MR, 2013, ECOL LETT, V16, P380, DOI 10.1111/ele.12053; Massaro CF, 2015, PHYTOTHER RES, V29, P48, DOI 10.1002/ptr.5225; Massaro FC, 2011, NATURWISSENSCHAFTEN, V98, P329, DOI 10.1007/s00114-011-0770-7; Nahrung HF, 2009, J CHEM ECOL, V35, P1043, DOI 10.1007/s10886-009-9682-9; Nobakht M, 2014, MOLECULES, V19, P17862, DOI 10.3390/molecules191117862; Nunez CV, 2008, APIDOLOGIE, V39, P618, DOI 10.1051/apido:2008047; Potts BM, 2004, NEW FOREST, V27, P115, DOI 10.1023/A:1025021324564; R Core Team, 2020, R LANG ENV STAT COMP; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Roubik DW, 2006, APIDOLOGIE, V37, P124, DOI 10.1051/apido:2006026; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; Wallace HM, 2008, DIVERS DISTRIB, V14, P87, DOI 10.1111/j.1472-4642.2007.00427.x; Wallace HM, 2010, APIDOLOGIE, V41, P428, DOI 10.1051/apido/2009074; WALLACE HM, 1995, OECOLOGIA, V104, P12, DOI 10.1007/BF00365556; Wu W, 2013, BIOL INVASIONS, V15, P75, DOI 10.1007/s10530-012-0269-y	38	4	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138868	10.1371/journal.pone.0138868	http://dx.doi.org/10.1371/journal.pone.0138868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418155	Green Published, gold			2022-12-26	WOS:000362171400023
J	Pender, A; Garcia-Murillas, I; Rana, S; Cutts, RJ; Kelly, G; Fenwick, K; Kozarewa, I; de Castro, DG; Bhosle, J; O'Brien, M; Turner, NC; Popat, S; Downward, J				Pender, Alexandra; Garcia-Murillas, Isaac; Rana, Sareena; Cutts, Rosalind J.; Kelly, Gavin; Fenwick, Kerry; Kozarewa, Iwanka; de Castro, David Gonzalez; Bhosle, Jaishree; O'Brien, Mary; Turner, Nicholas C.; Popat, Sanjay; Downward, Julian			Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach	PLOS ONE			English	Article							DNA; MUTATIONS; AFATINIB	Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung cancer. The range of KRAS point mutations observed in NSCLC necessitates a multiplex approach to efficient mutation detection in circulating DNA. Here we report the design and optimisation of three discriminatory ddPCR multiplex assays investigating nine different KRAS mutations using PrimePCR (TM) ddPCR (TM) Mutation Assays and the Bio-Rad QX100 system. Together these mutations account for 95% of the nucleotide changes found in KRAS in human cancer. Multiplex reactions were optimised on genomic DNA extracted from KRAS mutant cell lines and tested on DNA extracted from fixed tumour tissue from a cohort of lung cancer patients without prior knowledge of the specific KRAS genotype. The multiplex ddPCR assays had a limit of detection of better than 1 mutant KRAS molecule in 2,000 wild-type KRAS molecules, which compared favourably with a limit of detection of 1 in 50 for next generation sequencing and 1 in 10 for Sanger sequencing. Multiplex ddPCR assays thus provide a highly efficient methodology to identify KRAS mutations in lung adenocarcinoma.	[Pender, Alexandra; Rana, Sareena; Downward, Julian] Inst Canc Res, Div Mol Pathol, Lung Canc Grp, London SW3 6JB, England; [Pender, Alexandra; Bhosle, Jaishree; O'Brien, Mary; Turner, Nicholas C.; Popat, Sanjay] Royal Marsden NHS Fdn Trust, Dept Med, London, England; [Pender, Alexandra; Kelly, Gavin; Downward, Julian] Francis Crick Inst, London, England; [Garcia-Murillas, Isaac; Cutts, Rosalind J.; Fenwick, Kerry; Kozarewa, Iwanka; Turner, Nicholas C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [de Castro, David Gonzalez] Inst Canc Res, Ctr Mol Pathol, Sutton, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London; Royal Marsden NHS Foundation Trust; Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Downward, J (corresponding author), Inst Canc Res, Div Mol Pathol, Lung Canc Grp, London SW3 6JB, England.	julian.downward@crick.ac.uk	Popat, Sanjay/AAO-1634-2021; Kelly, Gavin/ABG-2715-2021	Popat, Sanjay/0000-0003-2087-4963; Kelly, Gavin/0000-0001-7219-560X; garcia-murillas, isaac/0000-0001-8183-7969; Downward, Julian/0000-0002-2331-4729; Pender, Alexandra/0000-0001-5912-2457; Turner, Nicholas/0000-0001-8937-0873	National Health Service (England); Institute of Cancer Research; Cancer Research UK, Stratified Medicine Programme; Revere Charitable Trust; Pierre-Fabre Ltd.; European Research Council; Wellcome Trust [103799/Z/14/Z]; Cancer Research UK [15680] Funding Source: researchfish; National Institute for Health Research [ACF-2011-22-003] Funding Source: researchfish; Wellcome Trust [103799/A/14/Z] Funding Source: researchfish; The Francis Crick Institute [10071, 10074, 10002, 10070] Funding Source: researchfish	National Health Service (England); Institute of Cancer Research; Cancer Research UK, Stratified Medicine Programme; Revere Charitable Trust; Pierre-Fabre Ltd.; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	The authors gratefully acknowledge the support of this work by the National Health Service (England), through funding to the National Institute for Health Research Biomedical Research Centre at The Royal Marsden Hospital. They also gratefully acknowledge funding from the Institute of Cancer Research and Cancer Research UK, Stratified Medicine Programme. This research was also supported in part by the Revere Charitable Trust, an unrestricted educational grant from Pierre-Fabre Ltd., the European Research Council Advanced Grant RASTARGET and the Wellcome Trust Senior Investigator Award, 103799/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Health and Social Care Information Centre, 2013, NAT LUNG CANC AUD RE; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Leary AF, 2012, EUR J CANCER, V48, P61, DOI 10.1016/j.ejca.2011.09.022; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Popat S, 2014, LUNG CANCER, V85, P230, DOI 10.1016/j.lungcan.2014.05.007; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359	16	48	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139074	10.1371/journal.pone.0139074	http://dx.doi.org/10.1371/journal.pone.0139074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413866	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700038
J	Buccellato, E; Melis, M; Biagi, C; Donati, M; Motola, D; Vaccheri, A				Buccellato, Elena; Melis, Mauro; Biagi, Chiara; Donati, Monia; Motola, Domenico; Vaccheri, Alberto			Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; CARDIOVASCULAR RISKS; AZITHROMYCIN; PRESCRIPTIONS; POPULATION; ASSOCIATION; CHILDREN; PROFILE; DEATH	Objectives To evaluate antibiotic consumption in the pediatric wards of Emilia-Romagna Region, from 2004 to 2011, with a focus on the antibiotics reserved to the most serious infections, and to analyse the ADRs reported for antibiotics by the pediatric wards of Emilia-Romagna hospitals. Methods Reference population was represented by all the patients (0-14 years old) admitted to the pediatric wards of all the hospitals of Emilia-Romagna Region. Drug consumption was expressed as number of DDDs per 100 Bed-Days (BD) and data were analysed by active substance, by therapeutic subgroups or by ward type. The time trends of antibiotic consumption were statistically analysed by linear regression. All the suspected ADR reports associated with antibiotics, reported between January 2004 and December 2011 were drawn by the Italian Spontaneous Reporting Database. Results Overall antibiotic consumption showed only a slight increase (p = 0.224). Among the pediatric wards, pediatric surgery showed the highest increase from 2004 to 2011 (p = 0.011). Penicillins and beta-lactamase inhibitors was the first therapeutic group with a statistically significant increase over years (p = 0.038), whereas penicillins with extended spectrum presented a statistically significant reduction (p = 0.008). Moreover, only 5 drugs out of the 8 antibiotics reserved to the most serious infections were used. Pharmacovigilance data showed 27 spontaneous ADR reports associated to ATC J01 drugs. Amoxicillin/clavulanic acid had the highest number of ADR reports (n = 7). Conclusions The steadily increasing consumption in penicillins and a-lactamase inhibitors, in association with a considerable decrease of plain penicillins, raises a serious concern. Pharmacovigilance reports seem to suggest a safe use of antibiotics in the hospital setting of Emilia-Romagna. Further studies to investigate the reason for prescribing antibiotics in children inpatients are needed.	[Buccellato, Elena; Melis, Mauro; Biagi, Chiara; Donati, Monia; Motola, Domenico; Vaccheri, Alberto] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, I-40126 Bologna, Italy	University of Bologna	Vaccheri, A (corresponding author), Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Via Irnerio 48, I-40126 Bologna, Italy.	alberto.vaccheri@unibo.it			Emilia-Romagna Region Health Authority	Emilia-Romagna Region Health Authority	This research was supported by an institutional grant from the Emilia-Romagna Region Health Authority.	AIFA. Italian Medicines Agency, 2012, IT MED AG ANT US SOL; AIFA. Italian Medicines Agency, 2010, IT MED AG ANT DIF TU; AIFA. Italian Medicines Agency, 2008, IT MED AG ANT SI MA; AIFA. Italian Medicines Agency, 2009, IT MED AG ANT US CON; [Anonymous], 2012, USO MED ITALIA RAPPO; Biagi C, 2013, EUR J CLIN PHARMACOL, V69, P237, DOI 10.1007/s00228-012-1321-7; Blix HS, 2007, J ANTIMICROB CHEMOTH, V59, P971, DOI 10.1093/jac/dkm032; Brass EP, 2013, NEW ENGL J MED, V369, P580, DOI 10.1056/NEJMc1306999; Buccellato E, 2014, EXPERT REV ANTI-INFE, V12, P383, DOI 10.1586/14787210.2014.884459; Chiappini E, 2011, CLIN THER, V33, P48, DOI 10.1016/j.clinthera.2011.02.001; Ciofi DAM, 2008, EURO SURVEILLANCE BU, V13, P541; Clavenna A, 2009, EUR J PEDIATR, V168, P173, DOI 10.1007/s00431-008-0725-y; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; Clavenna A, 2009, EUR J CLIN PHARMACOL, V65, P749, DOI 10.1007/s00228-009-0679-7; Control EC, 2011, ECDC SURV REP SURV A; Di Mario S, 2008, QUADERNI ACP, V15, P76; ESAC-Net, 2011, TOT ANT US 2011 EXPR; Gagliotti C, 2005, ACTA PAEDIATR, V94, P1502, DOI 10.1080/08035250510036714; Hoffman-Terry ML, 1999, AM J MED, V106, P44, DOI 10.1016/S0002-9343(98)00362-3; Iannini Paul B, 2002, Expert Opin Drug Saf, V1, P121, DOI 10.1517/14740338.1.2.121; ISTAT TN, 2011, IT CENS STRUTT DEM P; Khosropour CM, 2014, NEW ENGL J MED, V370, P1961, DOI 10.1056/NEJMc1401831; KRAMER MS, 1985, J PEDIATR-US, V106, P305, DOI 10.1016/S0022-3476(85)80314-0; Maria Luisa Moro A. P, 2010, USO ANTIBIOTICI RESI; McMurray JJV, 2013, NEW ENGL J MED, V369, P579, DOI 10.1056/NEJMc1306999; Mori F, 2014, INT J IMMUNOPATH PH, V27, P121, DOI 10.1177/039463201402700116; Mosholder AD, 2013, NEW ENGL J MED, V368, P1665, DOI 10.1056/NEJMp1302726; NICE, 2008, NAT I HLTH CAR EXC P; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Piovani D, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-46; Piovani D, 2012, EUR J CLIN PHARMACOL, V68, P997, DOI 10.1007/s00228-011-1204-3; Region Sa, 2014, RAPP SORV ANT US ANT; Regoli M, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-10; Resi D, 2003, J ANTIMICROB CHEMOTH, V52, P282, DOI 10.1093/jac/dkg302; Rossignoli A, 2007, EUR J CLIN PHARMACOL, V63, P1099, DOI 10.1007/s00228-007-0376-3; Salvo F, 2007, J ANTIMICROB CHEMOTH, V60, P121, DOI 10.1093/jac/dkm111; Shea K., WONDER DRUGS DONT WO; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Thrane N, 1999, PEDIATR INFECT DIS J, V18, P333, DOI 10.1097/00006454-199904000-00004; Vaccheri A, 2002, J ANTIMICROB CHEMOTH, V50, P989, DOI 10.1093/jac/dkf239; van Houten MA, 1998, INT J ANTIMICROB AG, V10, P161, DOI 10.1016/S0924-8579(98)00022-3; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139097	10.1371/journal.pone.0139097	http://dx.doi.org/10.1371/journal.pone.0139097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405817	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700167
J	Guwatudde, D; Mutungi, G; Wesonga, R; Kajjura, R; Kasule, H; Muwonge, J; Ssenono, V; Bahendeka, SK				Guwatudde, David; Mutungi, Gerald; Wesonga, Ronald; Kajjura, Richard; Kasule, Hafisa; Muwonge, James; Ssenono, Vincent; Bahendeka, Silver K.			The Epidemiology of Hypertension in Uganda: Findings from the National Non-Communicable Diseases Risk Factor Survey	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; BLOOD-PRESSURE; PREVALENCE; COMMUNITY; DISTRICT; URBAN	Background Hypertension is an important contributor to global burden of disease and mortality, and is a growing public health problem in sub-Saharan Africa. However, most sub-Saharan African countries lack detailed countrywide data on hypertension and other non-communicable diseases (NCD) risk factors that would provide benchmark information for design of appropriate interventions. We analyzed blood pressure data from Uganda's nationwide NCD risk factor survey conducted in 2014, to describe the prevalence and distribution of hypertension in the Ugandan population, and to identify the associated factors. Methods The NCD risk factor survey drew a countrywide sample stratified by the four regions of the country, and with separate estimates for rural and urban areas. The World Health Organization's STEPs tool was used to collect data on demographic and behavioral characteristics, and physical and biochemical measurements. Prevalence rate ratios (PRR) using modified Poison regression modelling was used to identify factors associated with hypertension. Results Of the 3906 participants, 1033 were classified as hypertensive, giving an overall prevalence of 26.4%. Prevalence was highest in the central region at 28.5%, followed by the eastern region at 26.4%, western region at 26.3%, and northern region at 23.3%. Prevalence in urban areas was 28.9%, and 25.8% in rural areas. The differences between regions, and between rural-urban areas were not statistically significant. Only 7.7% of participants with hypertension were aware of their high blood pressure. The prevalence of pre-hypertension was also high at 36.9%. The only modifiable factor found to be associated with hypertension was higher body mass index (BMI). Compared to participants with BMI less than 25 kg/m(2), prevalence was significantly higher among participants with BMI between 25 to 29.9 kg/m(2) with an adjusted PRR = 1.46 [95% CI = 1.25-1.71], and even higher among obese participants (BMI >= 30 kg/m(2)) with an adjusted PRR = 1.60 [95% CI = 1.29-1.99]. The un-modifiable factor found to be associated with hypertension was older age with an adjusted PRR of 1.02 [95% CI = 1.02-1.03] per yearly increase in age. Conclusions The prevalence of hypertension in Uganda is high, with no significant differences in distribution by geographical location. Only 7.7% of persons with hypertension were aware of their hypertension, indicating a high burden of undiagnosed and un-controlled high blood pressure. Thus a big percentage of persons with hypertension are at high risk of hypertension-related cardiovascular NCDs.	[Guwatudde, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Mutungi, Gerald] Minist Hlth, Control Noncommunicable Dis Desk, Kampala, Uganda; [Wesonga, Ronald] Makerere Univ, Coll Business & Management Sci, Sch Stat & Planning, Kampala, Uganda; [Kajjura, Richard] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Kasule, Hafisa] WHO, Uganda Country Off, Kampala, Uganda; [Muwonge, James; Ssenono, Vincent] Uganda Bur Stat, Div Socioecon Surveys, Kampala, Uganda; [Bahendeka, Silver K.] Nsambya Hosp, Dept Internal Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University; World Health Organization	Guwatudde, D (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.	dguwatudde@musph.ac.ug	PAN, ZEQIANG/X-6341-2018; Wesonga, Ronald/E-9373-2016	Wesonga, Ronald/0000-0003-4887-9088; Silver, Bahendeka/0000-0001-8080-7872	Uganda government; World Health Organization; World Diabetes Foundation; United Nations Development Program	Uganda government; World Health Organization(World Health Organization); World Diabetes Foundation; United Nations Development Program	The conduct of the survey was supported by funding from the Uganda government, the World Health Organization, the World Diabetes Foundation, and the United Nations Development Program.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Bromfield S, 2013, CURR HYPERTENS REP, V15, P134, DOI 10.1007/s11906-013-0340-9; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Mendis Shanthi, 2003, Ethn Dis, V13, pS67; Mondo CK, 2013, CARDIOVASC J AFR, V24, P52, DOI 10.5830/CVJA-2012-081; Musinguzi G, 2015, J CLIN HYPERTENS, V17, P63, DOI 10.1111/jch.12371; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Rehm J, 2004, COMP QUANTIFICATION, V102, P959, DOI [10.1542/peds.102.5.e54, DOI 10.1542/PEDS.102.5.E54]; Sit JWH, 2010, J CARDIOVASC NURS, V25, P461, DOI 10.1097/JCN.0b013e3181dcb551; Suri MFK, 2006, J CARDIOVASC NURS, V21, P478, DOI 10.1097/00005082-200611000-00012; UBOS, 2015, NAT POP HOUS CENS 20; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2009, WHO STEPWISE APPR SU; WHO, 2013, WHO HLTH PEOPL WHAT; World Health Organization, 2004, GLOB STAT REP ALC 20, DOI [10.1016/j.revpalbo.2010.09.001, DOI 10.1016/J.REVPALBO.2010.09.001, 10. 1016/j. revpalbo. 2010. 09. 001]; World Health Organization, 2013, WORLD WHO 2000 2025; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	106	106	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138991	10.1371/journal.pone.0138991	http://dx.doi.org/10.1371/journal.pone.0138991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406462	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700140
J	Hsu, HY; Chen, SH; Cha, YR; Tsukamoto, K; Lin, CY; Han, YS				Hsu, Hsiang-Yi; Chen, Shu-Hwa; Cha, Yuh-Ru; Tsukamoto, Katsumi; Lin, Chung-Yen; Han, Yu-San			De Novo Assembly of the Whole Transcriptome of the Wild Embryo, Preleptocephalus, Leptocephalus, and Glass Eel of Anguilla japonica and Deciphering the Digestive and Absorptive Capacities during Early Development	PLOS ONE			English	Article							RNA-SEQ DATA; JAPANESE EEL; PROVIDES INSIGHTS; FINE-STRUCTURE; PROTEIN; EXPRESSION; GENOME; QUANTIFICATION; GENERATION; ADAPTATION	Natural stocks of Japanese eel (Anguilla japonica) have decreased drastically because of overfishing, habitat destruction, and changes in the ocean environment over the past few decades. However, to date, artificial mass production of glass eels is far from reality because of the lack of appropriate feed for the eel larvae. In this study, wild glass eel, leptocephali, preleptocephali, and embryos were collected to conduct RNA-seq. Approximately 279 million reads were generated and assembled into 224,043 transcripts. The transcript levels of genes coding for digestive enzymes and nutrient transporters were investigated to estimate the capacities for nutrient digestion and absorption during early development. The results showed that the transcript levels of protein digestion enzymes were higher than those of carbohydrate and lipid digestion enzymes in the preleptocephali and leptocephali, and the transcript levels of amino acid transporters were also higher than those of glucose and fructose transporters and the cholesterol transporter. In addition, the transcript levels of glucose and fructose transporters were significantly raising in the leptocephali. Moreover, the transcript levels of protein, carbohydrate, and lipid digestion enzymes were balanced in the glass eel, but the transcript levels of amino acid transporters were higher than those of glucose and cholesterol transporters. These findings implied that preleptocephali and leptocephali prefer high-protein food, and the nutritional requirements of monosaccharides and lipids for the eel larvae vary with growth. An online database (http://molas.iis.sinica.edu.tw/jpeel/) that will provide the sequences and the annotated results of assembled transcripts was established for the eel research community.	[Hsu, Hsiang-Yi; Cha, Yuh-Ru; Han, Yu-San] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan; [Chen, Shu-Hwa; Lin, Chung-Yen] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Dept Marine Sci & Resources, Fujisawa, Kanagawa, Japan	National Taiwan University; Academia Sinica - Taiwan; Nihon University	Lin, CY (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	cylin@iis.sinica.edu.tw; yshan@ntu.edu.tw	Lin, Chung-Yen/AAQ-3833-2021	Lin, Chung-Yen/0000-0002-4733-9488; Hsu, Hsiang-yi/0000-0001-7177-6816	Ministry of Science and Technology, Executive Yuan, Taiwan [NSC 99-2313-B-002-021-MY3, NSC 102-2628-B-002 -023 -MY3]; Council of Agriculture, Executive Yuan, Taiwan [103AS-11.3.4-FA-F1]	Ministry of Science and Technology, Executive Yuan, Taiwan; Council of Agriculture, Executive Yuan, Taiwan	YSH thanks the Ministry of Science and Technology, Executive Yuan, Taiwan (NSC 99-2313-B-002-021-MY3, NSC 102-2628-B-002 -023 -MY3), and the Council of Agriculture, Executive Yuan, Taiwan (103AS-11.3.4-FA-F1) for the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baillon L, 2015, ECOTOXICOLOGY, V24, P71, DOI 10.1007/s10646-014-1356-x; BERNBACK S, 1990, J CLIN INVEST, V85, P1221, DOI 10.1172/JCI114556; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Chen JZ, 2014, ESTUAR COAST SHELF S, V151, P361, DOI 10.1016/j.ecss.2014.06.004; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Churcher AM, 2015, MOL ECOL, V24, P822, DOI 10.1111/mec.13065; Dirks RP, 2014, GEN COMP ENDOCR, V204, P267, DOI 10.1016/j.ygcen.2014.06.023; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Furuita H, 2014, FISHERIES SCI, V80, P581, DOI 10.1007/s12562-014-0713-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Holt J., 2011, LARVAL FISH NUTR; Ijiri S., 2011, AQUACULT EUR, V36, P13; Ishikawa S, 2001, FISHERIES SCI, V67, P1097, DOI 10.1046/j.1444-2906.2001.00366.x; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kleppe L, 2014, MOL REPROD DEV, V81, P619, DOI 10.1002/mrd.22328; Kurokawa T, 2002, FISHERIES SCI, V68, P736, DOI 10.1046/j.1444-2906.2002.00487.x; Kurokawa T, 2003, EEL BIOL, P435; Kuroki M, 2009, J FISH BIOL, V74, P1853, DOI 10.1111/j.1095-8649.2009.02299.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Masuda Yoshitsugu, 2012, Bulletin of Fisheries Research Agency, P111; Michael D, 2014, GASTROINTESTINAL SYS, P159; Miller Michael J., 2012, Coastal Marine Science, V35, P277; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Mochioka N, 1996, MAR BIOL, V125, P447; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murashita K, 2013, FISH PHYSIOL BIOCHEM, V39, P895, DOI 10.1007/s10695-012-9749-3; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Ohta H, 1997, FISH PHYSIOL BIOCHEM, V17, P163, DOI 10.1023/A:1007720600588; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; OTAKE T, 1993, MAR ECOL PROG SER, V92, P27, DOI 10.3354/meps092027; Otake T, 1996, FISHERIES SCI, V62, P28, DOI 10.2331/fishsci.62.28; Ozaki Y, 2006, FISHERIES SCI, V72, P13, DOI 10.1111/j.1444-2906.2006.01110.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PFEILER E, 1991, J FISH BIOL, V38, P533, DOI 10.1111/j.1095-8649.1991.tb03140.x; Pujolar JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-507; RATH J, 1994, APPL ENVIRON MICROB, V60, P807, DOI 10.1128/AEM.60.3.807-813.1994; Satoh H., 1979, IDEN, V33, P23; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sonnhammer ELL, 1998, ISMB 98 P; Sudo R, 2013, COMP BIOCHEM PHYS A, V164, P10, DOI 10.1016/j.cbpa.2012.09.019; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; TANAKA H, 1995, FISHERIES SCI, V61, P171, DOI 10.2331/fishsci.61.171; Tanaka H, 2001, AQUACULTURE, V201, P51, DOI 10.1016/S0044-8486(01)00553-1; Tanaka H., 1998, FARMING JAPAN, V32, P22; Tatsukawa K., 2003, EEL BIOL, P293; Tesch F-W., 2003, EEL, DOI [10.1002/9780470995389, DOI 10.1002/9780470995389]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tse WKF, 2013, J PROTEOMICS, V89, P81, DOI 10.1016/j.jprot.2013.05.026; Tsukamoto K., 2014, 144 ANN M AM FISH SO; Tsukamoto Katsumi, 2009, P21; Wang Y, 1980, J FISH CHINA, V4, P147; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0; Yu TC, 1993, J TAIWAN FISH RES, V1, P27	63	17	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139105	10.1371/journal.pone.0139105	http://dx.doi.org/10.1371/journal.pone.0139105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406914	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700172
J	Huang, J; Yang, XT; Zhang, CM; Yin, X; Liu, SP; Li, XG				Huang, Jian; Yang, Xiaoting; Zhang, Chunmei; Yin, Xiao; Liu, Shipeng; Li, Xingang			Development of Chloroplast Microsatellite Markers and Analysis of Chloroplast Diversity in Chinese Jujube (Ziziphus jujuba Mill.) and Wild Jujube (Ziziphus acidojujuba Mill.)	PLOS ONE			English	Article							SEQUENCE REPEATS; GENE FLOW; DNA; POLYMORPHISM	Ziziphus is an important genus within the family Rhamnaceae. This genus includes several important fruit tree species that are widely planted in China and India, such as the Chinese jujube (Ziziphus jujuba Mill.), the wild jujube (Z. acidojujuba), and the Indian jujube (Z. mauritiana). However, information about their domestication based on the chlorotype diversity of Chinese jujube population is lacking. In this study, chloroplast microsatellite (cpSSR) markers were developed and used to investigate the genetic relationships between and domestication of jujube cultivars and wild jujube populations. Primer sets flanking each of the 46 cpSSR loci in non-coding regions of the chloroplast genome sequence of Z. jujuba Mill. cv. 'Junzao' were designed. In total, 10 markers showed polymorphisms from 15 samples (9 jujube cultivars and 6 wild jujube individuals), of which 8 loci were due to variations in the number of mononucleotide (A/T) repeats and 2 were due to indels. Six cpSSR markers were used in further analyses of 81 additional samples (63 jujube cultivars, 17 wild jujube samples, and 1 Indian jujube). Using these cpSSR markers, the number of alleles per locus ranged from two to four. In general, the Shannon Index (I) for each cpSSR ranged from 0.159 to 0.1747, and the diversity indices (h) and uh were 0.061 to 0.435 and 0.062 to 0.439, respectively. Seven chlorotypes were found; the Indian jujube showed distinct chlorotypes, and both the Chinese and wild jujube had four chlorotypes and shared two chlorotypes. A dominant chlorotype (G) accounted for 53 of 72 jujube cultivars and 13 of 23 wild jujube individuals. All chlorotypes were highly localized along the Yellow River, from the mid-to the lower reaches, suggesting a wide origin of jujube. These cpSSR markers can be applied to population and evolution studies of Chinese jujube and wild jujube.	[Huang, Jian; Li, Xingang] Northwest A&F Univ, Coll Forestry, Res Ctr Jujube Engn & Technol, State Forestry Adm, Yangling, Peoples R China; [Huang, Jian; Liu, Shipeng] Yanan Univ, Coll Life Sci, Key Lab Jujube Shaanxi Prov, Yanan, Peoples R China; [Yang, Xiaoting; Zhang, Chunmei; Yin, Xiao] Northwest A&F Univ, Coll Forestry, Key Comprehens Lab Forest Shaanxi Prov, Yangling, Peoples R China	Northwest A&F University - China; Yanan University; Northwest A&F University - China	Li, XG (corresponding author), Northwest A&F Univ, Coll Forestry, Res Ctr Jujube Engn & Technol, State Forestry Adm, Yangling, Peoples R China.	xingangle@nwsuaf.edu.cn			Ministry of Science and Technology of P.R. China [2013BAD14B03, 2013BAD20B03]; Natural Science Foundation of Shaanxi Province [2013JQ3001]; Key Laboratory Project on jujube of Shaanxi Province [14JS114]	Ministry of Science and Technology of P.R. China(Ministry of Science and Technology, China); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Key Laboratory Project on jujube of Shaanxi Province	This work was supported by the Projects in the National Science & Technology Pillar Program (grant no. 2013BAD14B03 and 2013BAD20B03) from the Ministry of Science and Technology of P.R. China (www.most.gov.cn/) to XL; Natural Science Foundation of Shaanxi Province for young scientist (grant No: 2013JQ3001) to JH (http://www.sninfo.gov.cn); and Key Laboratory Project on jujube of Shaanxi Province (14JS114) (http://www.snedu.gov.cn) to SL & JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; Delplancke M, 2012, EVOL APPL, V5, P317, DOI 10.1111/j.1752-4571.2011.00223.x; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Deng ZN, 2007, SCI HORTIC-AMSTERDAM, V111, P186, DOI 10.1016/j.scienta.2006.10.004; Ebert D, 2009, MOL ECOL RESOUR, V9, P673, DOI 10.1111/j.1755-0998.2008.02319.x; Guichoux E, 2011, MOL ECOL RESOUR, V11; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Islam MB, 2006, SYST BOT, V31, P826, DOI 10.1600/036364406779695997; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Li Li, 2009, Scientia Agricultura Sinica, V42, P1713; Li RuiHuan, 2012, Journal of Fruit Science, V29, P366; Liu MJ, 1995, ACTA HORTIC, P161, DOI 10.17660/ActaHortic.1995.390.23; Liu Ping, 2005, Scientia Silvae Sinicae, V41, P182; Liu W, 2013, TREE GENET GENOMES, V9, P975, DOI 10.1007/s11295-013-0610-3; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peng JianYing, 2000, Acta Horticulturae Sinica, V27, P171; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qu Z, 1993, FRUIT TREE RECORDS C; Wang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099842; Wang YongKang, 2007, Journal of Fruit Science, V24, P146; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zeinalabedini M, 2010, SCI HORTIC-AMSTERDAM, V125, P593, DOI 10.1016/j.scienta.2010.05.007; Zhang CM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0809-y; Zhao Jin, 2003, Scientia Agricultura Sinica, V36, P590	31	32	34	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0134519	10.1371/journal.pone.0134519	http://dx.doi.org/10.1371/journal.pone.0134519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406601	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700001
J	Ker, DFE; Sharma, R; Wang, ETH; Yang, YP				Ker, Dai Fei Elmer; Sharma, Rashmi; Wang, Evelyna Tsi Hsin; Yang, Yunzhi Peter			Development of mRuby2-Transfected C3H10T1/2 Fibroblasts for Musculoskeletal Tissue Engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; POSTCONFLUENCE INHIBITION; SIGNALING PATHWAY; SKELETAL-MUSCLE; ADIPOSE-TISSUE; DIFFERENTIATION; ADULT; MULTIPLE	Mouse C3H10T1/2 fibroblasts are multipotent, mesenchymal stemcell (MSC)-like progenitor cells that are widely used in musculoskeletal research. In this study, we have established a clonal population of C3H10T1/2 cells stably-transfected with mRuby2, an orange-red fluorescence reporter gene. Flow cytometry analysis and fluorescence imaging confirmed successful transfection of these cells. Cell counting studies showed that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells proliferated at similar rates. Adipogenic differentiation experiments demonstrated that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells stained positive for Oil Red O and showed increased expression of adipogenic genes including adiponectin and lipoprotein lipase. Chondrogenic differentiation experiments demonstrated that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells stained positive for Alcian Blue and showed increased expression of chondrogenic genes including aggrecan. Osteogenic differentiation experiments demonstrated that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells stained positive for alkaline phosphatase (ALP) as well as Alizarin Red and showed increased expression of osteogenic genes including alp, ocn and osf-1. When seeded on calcium phosphate-based ceramic scaffolds, mRuby2-transfected C3H10T1/2 cells maintained even fluorescence labeling and osteogenic differentiation. In summary, mRuby2-transfected C3H10T1/2 cells exhibitmRuby2 fluorescence and showed little-to-no difference in terms of cell proliferation and differentiation as untransfected C3H10T1/2 cells. These cells will be available from American Type Culture Collection (ATCC; CRL-3268) and may be a valuable tool for preclinical studies.	[Ker, Dai Fei Elmer; Yang, Yunzhi Peter] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Sharma, Rashmi; Yang, Yunzhi Peter] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Evelyna Tsi Hsin; Yang, Yunzhi Peter] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Yang, YP (corresponding author), Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA.	ypyang@stanford.edu	Ker, Dai Fei Elmer/R-5959-2018	Ker, Dai Fei Elmer/0000-0003-3434-8390; Wang, Evelyna/0000-0002-5697-474X	NIH S10 Shared Instrument Grant [S10RR027431-01]; NIH [R01AR057837, R01DE021468]; Department of Defense [W81XWH-10-1-0966]; Stanford Startup Funding; AO Startup Grant [S-13-134K]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021468] Funding Source: NIH RePORTER	NIH S10 Shared Instrument Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Stanford Startup Funding; AO Startup Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Flow cytometry sorting and analysis was performed on an instrument in the Stanford Shared FACS Facility obtained using NIH S10 Shared Instrument Grant S10RR027431-01. This work was supported by NIH grants R01AR057837 (YPY) and R01DE021468 (YPY), Department of Defense (W81XWH-10-1-0966; YPY), Stanford Startup Funding (YPY) and AO Startup Grant (Project S-13-134K; DFEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir J, 2014, PM&R, V6, P61, DOI 10.1016/j.pmrj.2013.05.007; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Chen WCW, 2014, JOVE-J VIS EXP, DOI 10.3791/51195; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; COLONTEICHER L, 1993, NUCLEIC ACIDS RES, V21, P2223, DOI 10.1093/nar/21.9.2223; Cooper GM, 2011, PLAST RECONSTR SURG, V127, P88, DOI 10.1097/PRS.0b013e3181fad311; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gordeladze JO, 2008, EXP CELL RES, V314, P1495, DOI 10.1016/j.yexcr.2007.12.023; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Kaukua N, 2014, NATURE, V513, P551, DOI 10.1038/nature13536; Ker EDF, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025; Ker EDF, 2011, BIOMATERIALS, V32, P3413, DOI 10.1016/j.biomaterials.2011.01.036; Kinnaird T, 2004, CIRCULATION, V109; Krawiec JT, 2015, TISSUE ENG PT A, V21, P426, DOI [10.1089/ten.tea.2014.0208, 10.1089/ten.TEA.2014.0208]; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Laschke MW, 2014, EUR CELLS MATER, V28, P287, DOI 10.22203/eCM.v028a20; Lin CS, 2013, HISTOL HISTOPATHOL, V28, P1109, DOI 10.14670/HH-28.1109; Liu YX, 2010, J BIOMED MATER RES A, V92A, P997, DOI 10.1002/jbm.a.32443; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; Nakajima R, 2014, J DENT RES, V93, P1133, DOI 10.1177/0022034514549377; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRENTICE AI, 1967, J CLIN PATHOL, V20, P717, DOI 10.1136/jcp.20.5.717; Qin YH, 2014, POSTGRAD MED J, V90, P643, DOI 10.1136/postgradmedj-2013-132387; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Roy R, 2010, DIFFERENTIATION, V79, P211, DOI 10.1016/j.diff.2010.03.003; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tille JC, 2002, EXP CELL RES, V280, P179, DOI 10.1006/excr.2002.5635; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	55	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139054	10.1371/journal.pone.0139054	http://dx.doi.org/10.1371/journal.pone.0139054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407291	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700156
J	Morello, E; Mallet, A; Konto-Ghiorghi, Y; Chaze, T; Mistou, MY; Oliva, G; Oliveira, L; Di Guilmi, AM; Trieu-Cuot, P; Dramsi, S				Morello, Eric; Mallet, Adeline; Konto-Ghiorghi, Yoan; Chaze, Thibault; Mistou, Michel-Yves; Oliva, Giulia; Oliveira, Liliana; Di Guilmi, Anne-Marie; Trieu-Cuot, Patrick; Dramsi, Shaynoor			Evidence for the Sialylation of PilA, the PI-2a Pilus-Associated Adhesin of Streptococcus agalactiae Strain NEM316	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; LINKED PROTEIN GLYCOSYLATION; CELL-SHAPE; DISEASE; BIOSYNTHESIS; PATHOGENS; SRR1	Streptococcus agalactiae (or Group B Streptococcus, GBS) is a commensal bacterium present in the intestinal and urinary tracts of approximately 30% of humans. We and others previously showed that the PI-2a pilus polymers, made of the backbone pilin PilB, the tip adhesin PilA and the cell wall anchor protein PilC, promote adhesion to host epithelia and biofilm formation. Affinity-purified PI-2a pili from GBS strain NEM316 were recognized by N-acetylneuraminic acid (NeuNAc, also known as sialic acid) specific lectins such as Elderberry Bark Lectin (EBL) suggesting that pili are sialylated. Glycan profiling with twenty different lectins combined with monosaccharide composition by HPLC suggested that affinity-purified PI-2a pili are modified by N-glycosylation and decorated with sialic acid attached to terminal galactose. Analysis of various relevant mutants in the PI-2a pilus operon by flow-cytometry and electron microscopy analyses pointed to PilA as the pilus subunit modified by glycosylation. Double labeling using PilB antibody and EBL lectin, which specifically recognizes N-acetylneuraminic acid attached to galactose in alpha-2, 6, revealed a characteristic binding of EBL at the tip of the pilus structures, highly reminiscent of PilA localization. Expression of a secreted form of PilA using an inducible promoter showed that this recombinant PilA binds specifically to EBL lectin when produced in the native GBS context. In silico search for potentially glycosylated asparagine residues in PilA sequence pointed to N427 and N597, which appear conserved and exposed in the close homolog RrgA from S. pneumoniae, as likely candidates. Conversion of these two asparagyl residues to glutamyl resulted in a higher instability of PilA. Our results provide the first evidence that the tip PilA adhesin can be glycosylated, and suggest that this modification is critical for PilA stability and may potentially influence interactions with the host.	[Morello, Eric; Konto-Ghiorghi, Yoan; Oliva, Giulia; Oliveira, Liliana; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Bacteries Pathogenes Gram Positif, Paris, France; [Morello, Eric; Konto-Ghiorghi, Yoan; Oliva, Giulia; Oliveira, Liliana; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, ERL 3526, Paris, France; [Mallet, Adeline] Inst Pasteur, Imagopole, Ultrastruct Microscopy Platform, Paris, France; [Chaze, Thibault] Inst Pasteur, Spectrometrie Masse Struct & Prote, Paris, France; [Chaze, Thibault; Mistou, Michel-Yves] INRA, UMR 1319, MICALIS, Jouy En Josas, France; [Di Guilmi, Anne-Marie] Univ Grenoble Alpes, IBS, Grenoble, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Dramsi, S (corresponding author), INSERM, U1100, Fac Med Francois Rabelais Tours, Ctr Etud Pathol Resp, Tours, France.	shaynoor.dramsi@pasteur.fr	Mistou, Michel-Yves/AAY-2688-2021; Oliveira, Liliana/K-5859-2013; Oliveira, Liliana/AAX-9115-2021; MORELLO, Eric/P-8087-2016	Oliveira, Liliana/0000-0001-5222-7600; Oliveira, Liliana/0000-0001-5222-7600; MORELLO, Eric/0000-0002-2009-4919; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Mistou, Michel-Yves/0000-0001-9732-3970; Di Guilmi, Anne Marie/0000-0001-7335-3470	French National Research Agency [ANR-10-BLANC-1314 Glyco-Path]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	French National Research Agency(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	This study has received funding from the French National Research Agency (ANR-10-BLANC-1314 Glyco-Path) attributed to SD; and from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID) to PTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Chaze T, 2014, MOL CELL PROTEOMICS, V13, P2168, DOI 10.1074/mcp.M114.038075; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Dramsi S, 2012, MICROB DRUG RESIST, V18, P286, DOI 10.1089/mdr.2012.0005; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Landemarre L, 2013, GLYCOCONJUGATE J, V30, P195, DOI 10.1007/s10719-012-9433-y; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Nothaft H, 2010, METHODS MOL BIOL, V600, P227, DOI 10.1007/978-1-60761-454-8_16; Nouaille S, 2006, APPL ENVIRON MICROB, V72, P2272, DOI 10.1128/AEM.72.3.2272-2279.2006; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Reinscheid DJ, 2002, MICROBIOL-SGM, V148, P3245, DOI 10.1099/00221287-148-10-3245; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; VANASSELDONK M, 1990, GENE, V95, P155, DOI 10.1016/0378-1119(90)90428-T; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1	28	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138103	10.1371/journal.pone.0138103	http://dx.doi.org/10.1371/journal.pone.0138103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407005	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700033
J	Petit, NY; Lambert-Niclot, S; Marcelin, AG; Garcia, S; Marodon, G				Petit, Nicolas Y.; Lambert-Niclot, Sidonie; Marcelin, Anne-Genevieve; Garcia, Sylvie; Marodon, Gilles			HIV Replication Is Not Controlled by CD8(+) T Cells during the Acute Phase of the Infection in Humanized Mice	PLOS ONE			English	Article							DEPLETION; PATHOGENESIS; RESPONSES; VIREMIA; MOUSE; MODEL	HIV replication follows a well-defined pattern during the acute phase of the infection in humans. After reaching a peak during the first few weeks after infection, viral replication resolves to a set-point thereafter. There are still uncertainties regarding the contribution of CD8(+) T cells in establishing this set-point. An alternative explanation, supported by in silico modeling, would imply that viral replication is limited by the number of available targets for infection, i.e. CD4(+) CCR5(+) T cells. Here, we used NOD. SCID. gc(-/-) mice bearing human CD4(+) CCR5(+) and CD8(+) T cells derived from CD34(+) progenitors to investigate the relative contribution of both in viral control after the peak. Using low dose of a CCR5-tropic HIV virus, we observed an increase in viral replication followed by "spontaneous" resolution of the peak, similar to humans. To rule out any possible role for CD8(+) T cells in viral control, we infected mice in which CD8(+) T cells had been removed by a depleting antibody. Globally, viral replication was not affected by the absence of CD8(+) T cells. Strikingly, resolution of the viral peak was equally observed in mice with or without CD8(+) T cells, showing that CD8(+) T cells were not involved in viral control in the early phase of the infection. In contrast, a marked and specific loss of CCR5-expressing CD4(+) T cells was observed in the spleen and in the bone marrow, but not in the blood, of infected animals. Our results strongly suggest that viral replication during the acute phase of the infection in humanized mice is mainly constrained by the number of available targets in lymphoid tissues rather than by CD8(+) T cells.	[Petit, Nicolas Y.; Marodon, Gilles] Univ Paris 06, INSERM, Sorbonne Univ, CNRS,CIMI, Paris, France; [Lambert-Niclot, Sidonie; Marcelin, Anne-Genevieve] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Garcia, Sylvie] Inst Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marodon, G (corresponding author), Univ Paris 06, INSERM, Sorbonne Univ, CNRS,CIMI, Paris, France.	gilles.marodon@upmc.fr	marodon, gilles/E-7202-2017; Marcelin, Anne-Genevieve/D-8272-2014	marodon, gilles/0000-0003-4889-6785; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Garcia, Sylvie/0000-0002-7655-8911	Agence Nationale de la Recherche contre le SIDA et les Hepatites (ANRS); SIDAction; ANRS	Agence Nationale de la Recherche contre le SIDA et les Hepatites (ANRS); SIDAction; ANRS(ANRSFrench National Research Agency (ANR))	This work was funded by grants to GM and AGM form the Agence Nationale de la Recherche contre le SIDA et les Hepatites (ANRS). NP was supported by grant from SIDAction and ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bruel T, 2015, J VIROL, V89, P3542, DOI 10.1128/JVI.03723-14; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; Centlivre M, 2007, AIDS, V21, P1, DOI 10.1097/QAD.0b013e3280117f7f; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Gorantla S, 2010, J IMMUNOL, V184, P7082, DOI 10.4049/jimmunol.1000438; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mueller YM, 2009, J IMMUNOL, V183, P5006, DOI 10.4049/jimmunol.0900141; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Perelson AS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-96; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138420	10.1371/journal.pone.0138420	http://dx.doi.org/10.1371/journal.pone.0138420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407077	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700044
J	Sjolund, BM; Wimo, A; Engstrom, M; von Strauss, E				Sjolund, Britt-Marie; Wimo, Anders; Engstrom, Maria; von Strauss, Eva			Incidence of ADL Disability in Older Persons, Physical Activities as a Protective Factor and the Need for Informal and Formal Care - Results from the SNAC-N Project	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEMENTED ELDERLY PERSONS; RESOURCE UTILIZATION; FUNCTIONAL STATUS; RISK-FACTORS; POPULATION; ADULTS; HOME; EXERCISE; HEALTH	Background The aim of the study was to examine 1) the incidence of disability in Activities of Daily Living (ADL), in persons 78 years and older 2) explore whether being physical active earlier is a significant predictor of being disability free at follow-up and 3) describe the amount of informal and formal care in relation to ADL-disability. Methods Data were used from a longitudinal community-based study in Nordanstig (SNAC-N), a part of the Swedish National Study on Aging and Care (SNAC). To study objectives 1) and 2) all ADL-independent participants at baseline (N = 307) were included; for objective 3) all participants 78 years and older were included (N = 316). Data were collected at baseline and at 3- and 6-year follow-ups. ADL-disability was defined as a need for assistance in one or more activities. Informal and formal care were measured using the Resource utilization in Dementia (RUD)-instrument. Results The incidence rates for men were similar in the age groups 78-81and 84 years and older, 42.3 vs. 42.5/1000 person-years. For women the incidence rate for ADL-disability increased significantly from the age group 78-81 to the age group 84 years and older, 20.8 vs. 118.3/ 1000 person-years. In the age group 78-81 years, being physically active earlier (aOR 6.2) and during the past 12 month (aOR 2.9) were both significant preventive factors for ADLdisability. Both informal and formal care increased with ADL-disability and the amount of informal care was greater than formal care. The incidence rate for ADL-disability increases with age for women and being physically active is a protective factor for ADL-disability. Conclusion The incidence rate for ADL-disability increases with age for women, and being physical active is a protective factor for ADL-disability.	[Sjolund, Britt-Marie; Wimo, Anders; von Strauss, Eva] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Sjolund, Britt-Marie; Wimo, Anders; von Strauss, Eva] Stockholm Univ, S-10691 Stockholm, Sweden; [Sjolund, Britt-Marie; Engstrom, Maria] Univ Gavle, Dept Hlth & Caring Sci, Fac Hlth & Occupat Studies, Gavle, Sweden; [Wimo, Anders] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Engstrom, Maria] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [von Strauss, Eva] Swedish Red Cross Univ Coll, Stockholm, Sweden	Karolinska Institutet; Stockholm University; University of Gavle; Karolinska Institutet; Uppsala University	Sjolund, BM (corresponding author), Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.	britt-marie.sjolund@hig.se	Engström, Maria/R-3969-2016; Wimo, Anders/ABA-2678-2021	Engström, Maria/0000-0002-9912-5350; von Strauss, Eva/0000-0001-5800-6454	Swedish Brain Power; Center for Gender Medicine at Karolinska Institutet; Alzheimer Foundation Sweden; Karolinska Institutet Foundations	Swedish Brain Power; Center for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Alzheimer Foundation Sweden; Karolinska Institutet Foundations(Karolinska Institutet)	Funding: This study was supported by grants from the Swedish Brain Power, Center for Gender Medicine at Karolinska Institutet, the Alzheimer Foundation Sweden, and Karolinska Institutet Foundations. The sponsors had no role in the design, methods, participant recruitment, data collection, analysis, or preparation of the manuscript.	Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Andren S, 2008, J CLIN NURS, V17, P790, DOI 10.1111/j.1365-2702.2007.02066.x; Balzi D, 2010, AGE AGEING, V39, P92, DOI 10.1093/ageing/afp209; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Chou CH, 2012, ARCH PHYS MED REHAB, V93, P237, DOI 10.1016/j.apmr.2011.08.042; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Di Bari M, 2008, AGING CLIN EXP RES, V20, P31, DOI 10.1007/BF03324745; Feng QS, 2013, J GERONTOL B-PSYCHOL, V68, P476, DOI 10.1093/geronb/gbt012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries JF, 2002, B WORLD HEALTH ORGAN, V80, P245; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Gschwind YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-105; Guralnik J M, 1997, J Am Med Womens Assoc (1972), V52, P113; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hardy SE, 2008, GERONTOLOGY, V54, P79, DOI 10.1159/000115004; Hellstrom Y, 2004, HEALTH SOC CARE COMM, V12, P504, DOI 10.1111/j.1365-2524.2004.00519.x; JOHANSSON L, 1991, HEALTH POLICY, V18, P231, DOI 10.1016/0168-8510(91)90024-R; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; King J, 2012, J AM GERIATR SOC, V60, P569, DOI 10.1111/j.1532-5415.2011.03844.x; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602; Lindholm C, 2013, INT J GERIATR PSYCH, V28, P454, DOI 10.1002/gps.3844; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; MANTON KG, 1995, J GERONTOL B-PSYCHOL, V50, pS194, DOI 10.1093/geronb/50B.4.S194; Nordberg G, 2005, INT J GERIATR PSYCH, V20, P862, DOI 10.1002/gps.1371; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Paillard-Borg S, 2012, J ALZHEIMERS DIS, V31, P835, DOI 10.3233/JAD-2012-120724; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Perez LG, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130032; Pinkhasov RM, 2010, INT J CLIN PRACT, V64, P465, DOI 10.1111/j.1742-1241.2009.02289.x; Rejeski WJ, 2008, J GERONTOL B-PSYCHOL, V63, pP19, DOI 10.1093/geronb/63.1.P19; Shah RC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-63; Tas U, 2007, PREV MED, V44, P272, DOI 10.1016/j.ypmed.2006.11.007; von Stauss E, 2000, J AM GERIATR SOC, V48, P1462, DOI 10.1111/j.1532-5415.2000.tb02638.x; Wimo A, 2011, INT J GERIATR PSYCH, V26, P56, DOI 10.1002/gps.2488; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2007, ARCH GERONTOL GERIAT, V44, P71, DOI 10.1016/j.archger.2006.03.001	42	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138901	10.1371/journal.pone.0138901	http://dx.doi.org/10.1371/journal.pone.0138901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407207	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700115
J	Anderson, JL; Park, A; Akiyama, R; Tap, WD; Denny, CT; Federman, N				Anderson, Jennifer L.; Park, Ann; Akiyama, Ryan; Tap, William D.; Denny, Christopher T.; Federman, Noah			Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; REFRACTORY EWING SARCOMA; ADVANCED SOLID TUMORS; ANTIBODY CIXUTUMUMAB; MONOCLONAL-ANTIBODY; RECEPTOR ANTIBODY; DOSE-ESCALATION; PHASE-2 TRIAL; FAMILY TUMORS; OPEN-LABEL	Pediatric bone and soft tissue sarcomas often display increased Akt phosphorylation through up regulation of insulin-like growth factor (IGF1) signaling. Additionally, Akt signaling has been linked to resistance to IGF1 receptor (IGF1R) and mTOR (mammalian target of rapamycin) inhibitors in sarcoma, further demonstrating the role of Akt in tumor survival. This suggests targeting components of the PI3K/Akt pathway may be an effective therapeutic strategy. Here, we investigated the in vitro activity of the pan-class I PI3K inhibitor buparlisib (BKM120) in pediatric bone and soft tissue sarcomas. Buparlisib inhibited activation of Akt and signaling molecules downstream of mTORC1 (mTOR complex 1) in Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma cell lines. Anti-proliferative effects were observed in both anchorage dependent and independent conditions and apoptosis was induced within 24 hours of drug treatment. Buparlisib demonstrated cytotoxicity as a single agent, but was found to be more effective when used in combination. Synergy was observed when buparlisib was combined with the IGF1R inhibitor NVP-AEW541 and the mTORC1 inhibitor rapamycin. The addition of NVP-AEW541 also further reduced phospho-Akt levels and more potently induced apoptosis compared to buparlisib treatment alone. Additionally, the combination of buparlisib with the MEK1/2 inhibitor trametinib resulted in synergy in sarcoma cell lines possessing MAPK pathway mutations. Taken together, these data indicate buparlisib could be a novel therapy for the treatment of pediatric bone and soft tissue sarcomas.	[Anderson, Jennifer L.; Park, Ann; Akiyama, Ryan; Denny, Christopher T.; Federman, Noah] Univ Calif Los Angeles, Dept Pediat, Div Hematol Oncol, Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA; [Tap, William D.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumors, Sarcoma Med Oncol Serv, New York, NY 10021 USA; [Tap, William D.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Denny, Christopher T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Denny, Christopher T.; Federman, Noah] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Denny, Christopher T.; Federman, Noah] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Federman, N (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Hematol Oncol, Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA.	nfederman@mednet.ucla.edu			Kurelt Foundation; St. Baldrick's Foundation; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant [UL1TR000124]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Kurelt Foundation; St. Baldrick's Foundation; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research funding was provided by a grant from the Kurelt Foundation (www.kureit.org). Dr. Federman is supported by a St. Baldrick's Foundation (www.stbaldricks.org) career development award. The research described was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2014, MOL CANCER RES, V12, P1740, DOI 10.1158/1541-7786.MCR-14-0159; Anderson JL, 2012, PEDIATR RES, V72, P112, DOI 10.1038/pr.2012.54; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brachmann SM, 2012, MOL CANCER THER, V11, P1747, DOI 10.1158/1535-7163.MCT-11-1021; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Gobin B, 2015, INT J CANCER, V136, P784, DOI 10.1002/ijc.29040; Gobin B, 2014, CANCER LETT, V344, P291, DOI 10.1016/j.canlet.2013.11.017; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Massacesi C, 2013, ANN NY ACAD SCI, V1280, P19, DOI 10.1111/nyas.12060; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pappo AS, 2014, CANCER-AM CANCER SOC, V120, P2448, DOI 10.1002/cncr.28728; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Reynolds CP, 2013, PEDIATR BLOOD CANCER, V60, P791, DOI 10.1002/pbc.24301; Rodon J, 2014, INVEST NEW DRUG, V32, P670, DOI 10.1007/s10637-014-0082-9; Schoffski P, 2013, EUR J CANCER, V49, P3219, DOI 10.1016/j.ejca.2013.06.010; Schwartz GK, 2013, LANCET ONCOL, V14, P371, DOI 10.1016/S1470-2045(13)70049-4; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Subbiah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018424; Tap WD, 2012, J CLIN ONCOL, V30, P1849, DOI 10.1200/JCO.2011.37.2359; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990	35	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0133610	10.1371/journal.pone.0133610	http://dx.doi.org/10.1371/journal.pone.0133610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402468	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100002
J	Bekada, A; Arauna, LR; Deba, T; Calafell, F; Benhamamouch, S; Comas, D				Bekada, Asmahan; Arauna, Lara R.; Deba, Tahria; Calafell, Francesc; Benhamamouch, Soraya; Comas, David			Genetic Heterogeneity in Algerian Human Populations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; IBERIAN PENINSULA; AFRICA; HISTORY; RESOLUTION; FLOW; POLYMORPHISMS; HAPLOGROUPS; DIVERSITY; SEQUENCES	The demographic history of human populations in North Africa has been characterized by complex processes of admixture and isolation that have modeled its current gene pool. Diverse genetic ancestral components with different origins (autochthonous, European, Middle Eastern, and sub-Saharan) and genetic heterogeneity in the region have been described. In this complex genetic landscape, Algeria, the largest country in Africa, has been poorly covered, with most of the studies using a single Algerian sample. In order to evaluate the genetic heterogeneity of Algeria, Y-chromosome, mtDNA and autosomal genome-wide makers have been analyzed in several Berber- and Arab-speaking groups. Our results show that the genetic heterogeneity found in Algeria is not correlated with geography or linguistics, challenging the idea of Berber groups being genetically isolated and Arab groups open to gene flow. In addition, we have found that external sources of gene flow into North Africa have been carried more often by females than males, while the North African autochthonous component is more frequent in paternally transmitted genome regions. Our results highlight the different demographic history revealed by different markers and urge to be cautious when deriving general conclusions from partial genomic information or from single samples as representatives of the total population of a region.	[Bekada, Asmahan; Benhamamouch, Soraya] Univ Oran 1 Ahmad Ben Bella, Fac Sci Nat & Vie, Dept Biotechnol, Oran, Algeria; [Arauna, Lara R.; Calafell, Francesc; Comas, David] Univ Pompeu Fabra, Inst Biol Evolut CSIC UPF, Dept Ciencies Expt & Salut, Barcelona 08003, Spain; [Deba, Tahria] Ctr Hosp Univ Oran, Ctr Transfus Sanguine, Oran, Algeria	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Comas, D (corresponding author), Univ Pompeu Fabra, Inst Biol Evolut CSIC UPF, Dept Ciencies Expt & Salut, Doctor Aiguader 88, Barcelona 08003, Spain.	david.comas@upf.edu	Calafell, Francesc/C-8595-2014; Comas, David/D-5382-2014; Arauna, Lara R/AFR-3858-2022	Calafell, Francesc/0000-0002-1083-9438; Comas, David/0000-0002-5075-0956; 	Ministerio de Economia y Competitividad [CGL2013-44351-P]; Direccio General de Recerca, Generalitat de Catalunya [2014SGR866]	Ministerio de Economia y Competitividad(Spanish Government); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by the Ministerio de Economia y Competitividad grant CGL2013-44351-P and by Direccio General de Recerca, Generalitat de Catalunya grant 2014SGR866. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Benyoucef B, 1986, MZAB PRATIQUES ESPAC, P20; Bisson J., 1986, ANNUAIRE AFRIQUE NOR, VXXV, P329; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 1997, HUM BIOL, V69, P295; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Camps G., 1974, CIVILISATIONS PRE HI, P374; Cann HM, 2002, SCIENCE, V296, P261; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Coudray C, 2006, ANTROPO, V11, P75; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Djebar A, 2001, LOIN MED FILLES ISMA; Ennafaa H, 2011, J HUM GENET, V56, P734, DOI 10.1038/jhg.2011.92; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fadhlaoui-Zid K, 2004, ANN HUM GENET, V68, P222, DOI 10.1046/j.1529-8817.2004.00096.x; Fadhlaoui-zid K, 2009, ANTROPO, V8, P73; Fadhlaoui-Zid K, 2015, J HUM GENET, V60, P41, DOI 10.1038/jhg.2014.99; Fadhlaoui-Zid K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080293; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V145, P107, DOI 10.1002/ajpa.21472; Fentress Elizabeth, 1996, BERBERS; Gonzalez AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-223; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Ibn Khaldun, 1852, HIST BERBERES DYNAST; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Martinez-Cruz B, 2012, MOL BIOL EVOL, V29, P2211, DOI 10.1093/molbev/mss091; Martinez-Cruz Begona, 2011, Investig Genet, V2, P13, DOI 10.1186/2041-2223-2-13; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Robino C, 2008, INT J LEGAL MED, V122, P251, DOI 10.1007/s00414-007-0203-5; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Secher B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-109; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Tillion G, 1966, HAREM COUSSINS EDITI; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	55	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138453	10.1371/journal.pone.0138453	http://dx.doi.org/10.1371/journal.pone.0138453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402429	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100023
J	Zhao, N; Liu, YJ; Chang, ZQ; Li, KN; Zhang, R; Zhou, YS; Qiu, FJ; Han, XL; Xu, Y				Zhao, Ning; Liu, Yongjing; Chang, Zhiqiang; Li, Kening; Zhang, Rui; Zhou, Yuanshuai; Qiu, Fujun; Han, Xiaole; Xu, Yan			Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; LET-7 MICRORNA FAMILY; GENE-EXPRESSION DATA; TRANSCRIPTION FACTOR; CYCLE REGULATION; BINDING SITES; BREAST-CANCER; MICROARRAY; DATABASE; NETWORK	Changes in intermolecular interactions (differential interactions) may influence the progression of cancer. Specific genes and their regulatory networks may be more closely associated with cancer when taking their transcriptional and post-transcriptional levels and dynamic and static interactions into account simultaneously. In this paper, a differential interaction analysis was performed to detect lung adenocarcinoma-related genes. Furthermore, a miRNA-TF (transcription factor) synergistic regulation network was constructed to identify three kinds of co-regulated motifs, namely, triplet, crosstalk and joint. Not only were the known cancer-related miRNAs and TFs (let-7, miR-15a, miR-17, TP53, ETS1, and so on) were detected in the motifs, but also the miR-15, let-7 and miR-17 families showed a tendency to regulate the triplet, crosstalk and joint motifs, respectively. Moreover, several biological functions (i.e., cell cycle, signaling pathways and hemopoiesis) associated with the three motifs were found to be frequently targeted by the drugs for lung adenocarcinoma. Specifically, the two 4-node motifs (crosstalk and joint) based on co-expression and interaction had a closer relationship to lung adenocarcinoma, and so further research was performed on them. A 10-gene biomarker (UBC, SRC, SP1, MYC, STAT3, JUN, NR3C1, RB1, GRB2 and MAPK1) was selected from the joint motif, and a survival analysis indicated its significant association with survival. Among the ten genes, JUN, NR3C1 and GRB2 are our newly detected candidate lung adenocarcinoma-related genes. The genes, regulators and regulatory motifs detected in this work will provide potential drug targets and new strategies for individual therapy.	[Zhao, Ning; Liu, Yongjing; Chang, Zhiqiang; Li, Kening; Zhang, Rui; Zhou, Yuanshuai; Qiu, Fujun; Han, Xiaole; Xu, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China	Harbin Medical University	Xu, Y (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	xuyan@ems.hrbmu.edu.cn		Zhao, Ning/0000-0002-6660-5606	National Natural Science Foundation of China [81372492]; Natural Science Foundation of Heilongjiang Province [D201116]; Scientific Research Fund of Heilongjiang Provincial Education Department [12541278]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Scientific Research Fund of Heilongjiang Provincial Education Department	This work was supported in part by the National Natural Science Foundation of China (Grant No. 81372492) and part by the Natural Science Foundation of Heilongjiang Province (Grant No. D201116) and Scientific Research Fund of Heilongjiang Provincial Education Department (Grant No. 12541278).	Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; DALY RJ, 1994, ONCOGENE, V9, P2723; Di Paola R, 2009, INT J IMMUNOPATH PH, V22, P937, DOI 10.1177/039463200902200409; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; GRIFFIN CA, 1985, CANCER RES, V45, P272; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karjalainen JM, 2000, BRIT J CANCER, V82, P2015; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li KN, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-122; Lin CC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-18; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Lind GE, 2006, CELL ONCOL, V28, P259; Liu XP, 2012, J AM MED INFORM ASSN, V19, P241, DOI 10.1136/amiajnl-2011-000658; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Portales-Casamar E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r207; Qiu CX, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-90; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Schulte JH, 2008, CANCER LETT, V271, P56, DOI 10.1016/j.canlet.2008.05.039; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Toyooka S, 2003, HUM MUTAT, V21, P229, DOI 10.1002/humu.10177; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; VOLM M, 1992, ANTICANCER RES, V12, P11; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yamaguchi E, 2007, TOHOKU J EXP MED, V213, P41, DOI 10.1620/tjem.213.41; Young RP, 2013, CANCER-AM CANCER SOC, V119, P1761, DOI 10.1002/cncr.27953; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Zajac-Kaye M, 2001, LUNG CANCER-J IASLC, V34, pS43, DOI 10.1016/S0169-5002(01)00343-9; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang W, 2014, TUMORI J, V100, P338, DOI 10.1700/1578.17222; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	60	3	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139165	10.1371/journal.pone.0139165	http://dx.doi.org/10.1371/journal.pone.0139165			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402252	gold, Green Published, Green Submitted			2022-12-26	WOS:000361798100061
J	Cisneros, E; Zhou, SL; Borner, J				Cisneros, Elas; Zhou, Sophie Lian; Boerner, Jan			Naming and Shaming for Conservation: Evidence from the Brazilian Amazon	PLOS ONE			English	Article							PROPENSITY SCORE; PROTECTED AREAS; DEFORESTATION; DETERMINANTS; POLICIES; MODEL	Deforestation in the Brazilian Amazon has dropped substantially after a peak of over 27 thousand square kilometers in 2004. Starting in 2008, the Brazilian Ministry of the Environment has regularly published blacklists of critical districts with high annual forest loss. Farms in blacklisted districts face additional administrative hurdles to obtain authorization for clearing forests. In this paper we add to the existing literature on evaluating the Brazilian anti-deforestation policies by specifically quantifying the impact of blacklisting on deforestation. We first use spatial matching techniques using a set of covariates that includes official blacklisting criteria to identify control districts. We then explore the effect of blacklisting on change in deforestation in double difference regressions with panel data covering the period from 2002 to 2012. Multiple robustness checks are conducted including an analysis of potential causal mechanisms behind the success of the blacklist. We find that the blacklist has considerably reduced deforestation in the affected districts even after controlling for the potential mechanism effects of field-based enforcement, environmental registration campaigns, and rural credit.	[Cisneros, Elas] Univ Bonn, Zentrum Entwicklungsforsch, Bonn, Germany; [Zhou, Sophie Lian] Univ Bonn, Inst Food & Resource Econ, Bonn, Germany; [Boerner, Jan] Ctr Int Forestry Res CIFOR, Bonn, Germany	University of Bonn; University of Bonn; CGIAR; Center for International Forestry Research (CIFOR)	Cisneros, E (corresponding author), Univ Bonn, Zentrum Entwicklungsforsch, Bonn, Germany.	e.cisneros@uni-bonn.de	Cisneros, Elías/GNH-3294-2022; Börner, Jan/ABF-8775-2021	Börner, Jan/0000-0003-3034-5360; Cisneros, Elias/0000-0002-9784-9240	Robert Bosch Foundation [32.5.8043.0012.0]; European Commission [DCI-ENV/2011/269520]	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Robert Bosch Foundation (Grant: 32.5.8043.0012.0), www.bosch-stiftung.de and the European Commission (Grant: DCI-ENV/2011/269520), http://ec.europa.eu.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andersen LE, 1996, J ENVIRON DEV, V5, P309, DOI DOI 10.1177/107049659600500304; Angelsen A., 2001, Agricultural technologies and tropical deforestation, DOI 10.1079/9780851994512.0000; Araujo C, 2009, ECOL ECON, V68, P2461, DOI 10.1016/j.ecolecon.2008.12.015; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Assuncao J, 2013, DEFORESTATION BRAZIL; AssuncAo J, 2014, GETTING GREENER GOIN; Assuncao J, 2013, DOES CREDIT AFFECT D; Assuncao J., 2012, DEFORESTATION SLOWDO; Azevedo A, 2014, CADASTRO AMBIENTAL R; Blackman A, 2010, REV ENV ECON POLICY, V4, P234, DOI 10.1093/reep/req005; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Burgess R, 2012, Q J ECON, V127, P1707, DOI 10.1093/qje/qjs034; Canova NP, 2012, ECOL ECON, V83, P19, DOI 10.1016/j.ecolecon.2012.07.019; CEPAL-IPEA-GIZ, 2011, AV PLAN AC PREV CONT; Aguiar APD, 2007, ECOL MODEL, V209, P169, DOI 10.1016/j.ecolmodel.2007.06.019; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Flores CA, 2009, IZA DISCUSSION PAPER, V2009; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gaventa J., 2010, SYNTHESIS REPORT REV; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Hahn JY, 2001, ECONOMETRICA, V69, P201, DOI 10.1111/1468-0262.00183; HALVORSEN R, 1980, AM ECON REV, V70, P474; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Heckman JJ, 1999, ECON J, V109, P313, DOI 10.1111/1468-0297.00451; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Jacobs JB, 1992, CRIMINAL JUSTICE ETH, V11, P64; Jalan J, 1998, J PUBLIC ECON, V67, P65, DOI 10.1016/S0047-2727(97)00052-2; KAIMOWITZ D., 1998, EC MODELS TROPICAL D; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Laporte A, 2005, ECON LETT, V88, P389, DOI 10.1016/j.econlet.2005.04.002; Luttrell C, 2014, ENVIRON SCI POLICY, V35, P67, DOI 10.1016/j.envsci.2012.10.001; Mueller B, 2010, LAW POLICY, V32, P104; Nelson A, TRAVEL TIME MAJOR CI; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; ROSENBAUM PR, 1984, J ROY STAT SOC A STA, V147, P656, DOI 10.2307/2981697; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Tan YL, 2014, GOVERNANCE, V27, P37, DOI 10.1111/gove.12018; Tietenberg T, 1998, ENVIRON RESOUR ECON, V11, P587, DOI 10.1023/A:1008291411492; Viana C, 2012, C INT SOC EC EC 2012	48	54	54	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0136402	10.1371/journal.pone.0136402	http://dx.doi.org/10.1371/journal.pone.0136402			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26398096	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500011
J	Leibowitz, AA; Garcia-Aguilar, AT; Farrell, K				Leibowitz, Arleen A.; Garcia-Aguilar, Agustin T.; Farrell, Kevin			Initial Health Assessments and HIV Screening under the Affordable Care Act	PLOS ONE			English	Article							UNITED-STATES; TRANSMISSION; PREVENTION; UNAWARE; AWARE	Background The Centers for Disease Control and Prevention (CDC) estimates that 156,300 (95% CI 144,100-165,900) Americans living with HIV in 2012 were unaware of their infection. To increase knowledge of HIV status, CDC guidelines seek to make HIV screening a routine part of medical care. This paper examines how routinely California primary care providers test for HIV and how providers' knowledge of California's streamlined testing requirements, use of sexual histories, and having an electronic medical record prompt for HIV testing, relate to test offers. Methods We surveyed all ten California health plans offered under health reform's Insurance Exchange (response rate = 50%) and 322 primary care providers to those plans (response rate = 19%) to assess use of HIV screening and risk assessments. Results Only 31.7% of 60 responding providers reported offering HIV tests to all or most new enrollees and only 8.8% offered an HIV test of blood samples all or most of the time despite the California law requiring that providers offer HIV testing of blood samples in primary care settings. Twenty-eight of the 60 providers (46.6%) were unaware that California had reduced barriers to HIV screening by eliminating the requirement for written informed consent and pre-test counseling. HIV screening of new enrollees all or most of the time was reported by 53.1% of the well-informed providers, but only 7.1% of the less informed providers, a difference of 46 percentage points (95% CI: 21.0%-66.5%). Providers who routinely obtained sexual histories were 29 percentage points (95% CI: 0.2%-54.9%) more likely to screen for HIV all or most of the time than those who did not ask sexual histories. Conclusion Changing HIV screening requirements is important, but not sufficient to make HIV testing a routine part of medical care. Provider education to increase knowledge about the changed HIV testing requirements could positively impact testing rates.	[Leibowitz, Arleen A.; Garcia-Aguilar, Agustin T.; Farrell, Kevin] Univ Calif Los Angeles, Luskin Sch Publ Affairs, Dept Publ Policy, Los Angeles, CA 90095 USA; [Garcia-Aguilar, Agustin T.; Farrell, Kevin] AIDS Project Los Angeles, Los Angeles, CA 90005 USA	University of California System; University of California Los Angeles	Leibowitz, AA (corresponding author), Univ Calif Los Angeles, Luskin Sch Publ Affairs, Dept Publ Policy, Box 951656, Los Angeles, CA 90095 USA.	leibowia@luskin.ucla.edu			California HIV/AIDS Research Program [RP11-LA-020]; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH [MH58107]; UCLA Center for AIDS Research (CFAR) grant [5P30AI028697]; National Center for Advancing Translational Sciences through UCLA CTSI [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH; UCLA Center for AIDS Research (CFAR) grant; National Center for Advancing Translational Sciences through UCLA CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by California HIV/AIDS Research Program, grant RP11-LA-020, www.californiaaidsresearch.org; The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant MH58107, www.nimh.nih.gov; the UCLA Center for AIDS Research (CFAR) grant 5P30AI028697, www.niaid.nih.gov; and The National Center for Advancing Translational Sciences through UCLA CTSI Grant UL1TR000124, www.ncats.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of California HIV/AIDS Research Program or of NIH.	Arya Monisha, 2014, J Int Assoc Provid AIDS Care, V13, P296, DOI 10.1177/2325957413517140; Berkenblit GV, 2012, J GEN INTERN MED, V27, P839, DOI 10.1007/s11606-012-1985-9; Branson BM, 2013, JAIDS-J ACQ IMM DEF, V63, pS117, DOI 10.1097/QAI.0b013e3182986f25; Cahill S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107104; *CDCP, 2006, REV REC HIV TEST AD; Centers for Disease Control and Prevention, 2015, HIV SURVEILLANCE S, V20; Centers for Disease Control and Prevention, 1998, NO HLTH INS AG 65 US; Centers for Disease Control and Prevention, 2012, HIV SURV REP DIAGN H, V24; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Department of Managed Health Care Division of Plan Surveys, 2012, 1115 WAIV CONT CAR C; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Edelstein ZR, 2015, JAIDS-J ACQ IMM DEF, V68, pS45, DOI 10.1097/QAI.0000000000000390; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hallmark CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110010; Hamel L, HIV AIDS LIVES GAY B; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNaghten AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051231; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Sanchez TH, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3378; SANTNER TJ, 1980, J AM STAT ASSOC, V75, P386, DOI 10.2307/2287464; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; U.S. Preventive Services Task Force, 2014, GRAD DEF JUL 2012; Wagner Z, 2014, HEALTH AFFAIR, V33, P378, DOI 10.1377/hlthaff.2013.0996; Zielinski M, 2015, JAIDS-J ACQ IMM DEF, V68, pS21, DOI 10.1097/QAI.0000000000000392	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139361	10.1371/journal.pone.0139361	http://dx.doi.org/10.1371/journal.pone.0139361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418260	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400084
J	Shukla, AM; Bose, C; Karaduta, OK; Apostolov, EO; Kaushal, GP; Fahmi, T; Segal, MS; Shah, SV				Shukla, Ashutosh M.; Bose, Chhanda; Karaduta, Oleg K.; Apostolov, Eugene O.; Kaushal, Gur P.; Fahmi, Tariq; Segal, Mark S.; Shah, Sudhir V.			Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; AUTOPHAGY; MICE; HEMODIALYSIS; LIPOPROTEIN; SURVIVAL; THERAPY; ALPHA; MOUSE	Cardiovascular disease is the largest cause of morbidity and mortality among patients with chronic kidney disease (CKD) and end-stage kidney disease, with nearly half of all deaths attributed to cardiovascular disease. Hydroxychloroquine (HCQ), an anti-inflammatory drug, has been shown to have multiple pleiotropic actions relevant to atherosclerosis. We conducted a proof-of-efficacy study to evaluate the effects of hydroxychloroquine in an animal model of atherosclerosis in ApoE knockout mice with and without chronic kidney disease. Forty male, 6-week-old mice were divided into four groups in a 2 x 2 design: sham placebo group; sham treatment group; CKD placebo group; and CKD treatment group. CKD was induced by a two-step surgical procedure. All mice received a high-fat diet through the study duration and were sacrificed after 16 weeks of therapy. Mice were monitored with ante-mortem ultrasonic echography (AUE) for atherosclerosis and vascular stiffness and with post-mortem histology studies for atherosclerosis. Therapy with HCQ significantly reduced the severity of atherosclerosis in CKD mice and sham treated mice. HCQ reduced the area of aortic atherosclerosis on en face examination by approximately 60% in HCQ treated groups compared to the non-treated groups. Additionally, therapy with HCQ resulted in significant reduction in vascular endothelial dysfunction with improvement in vascular elasticity and flow patterns and better-preserved vascular wall thickness across multiple vascular beds. More importantly, we found that presence of CKD had no mitigating effect on HCQ's anti-atherosclerotic and vasculoprotective effects. These beneficial effects were not due to any significant effect of HCQ on inflammation, renal function, or lipid profile at the end of 16 weeks of therapy. This study, which demonstrates structural and functional protection against atherosclerosis by HCQ, provides a rationale to evaluate its use in CKD patients. Further studies are needed to define the exact mechanisms through which HCQ confers these benefits.	[Shukla, Ashutosh M.; Segal, Mark S.] North Florida South Georgia Vet Healthcare Syst, Gainesville, FL 32608 USA; [Shukla, Ashutosh M.; Segal, Mark S.] Univ Florida, Gainesville, FL USA; [Bose, Chhanda; Karaduta, Oleg K.; Apostolov, Eugene O.; Kaushal, Gur P.; Fahmi, Tariq; Shah, Sudhir V.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Bose, Chhanda; Karaduta, Oleg K.; Apostolov, Eugene O.; Kaushal, Gur P.; Fahmi, Tariq; Shah, Sudhir V.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Shukla, AM (corresponding author), North Florida South Georgia Vet Healthcare Syst, Gainesville, FL 32608 USA.	ashutosh.shukla@medicine.ufl.edu		KARADUTA, OLEG/0000-0003-3873-052X	South Central Veterans Administration Healthcare Network pilot project [VISN-16]; Gatorade research fund, University of Florida, DoM	South Central Veterans Administration Healthcare Network pilot project; Gatorade research fund, University of Florida, DoM	This work was supported by South Central Veterans Administration Healthcare Network pilot project grant (VISN-16); and Gatorade research fund, University of Florida, DoM.	[Anonymous], 2012, US REN DAT SYST 2012; Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Aronoff GR, 2007, DRUG PRESCRIBING REN, V5th; Bengtsson C, 2010, BASIC CLIN PHARMACOL, V107, P919, DOI 10.1111/j.1742-7843.2010.00604.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Borba EF, 2001, J RHEUMATOL, V28, P780; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; GAGNON RF, 1990, NEPHRON, V54, P70, DOI 10.1159/000185812; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Ghigo D, 1998, J CLIN INVEST, V102, P595, DOI 10.1172/JCI1052; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gomez-Guzman M, 2014, HYPERTENSION, V64, P330, DOI 10.1161/HYPERTENSIONAHA.114.03587; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Ivanovski O, 2008, J UROLOGY, V179, P1631, DOI 10.1016/j.juro.2007.11.042; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Lavandero S, 2013, AUTOPHAGY, V9, P1455, DOI 10.4161/auto.25969; Lesiak A, 2010, LUPUS, V19, P683, DOI 10.1177/0961203309356455; Leung N, 2010, AM J TRANSPLANT, V10, P558, DOI 10.1111/j.1600-6143.2009.02959.x; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; LORBER M, 1985, BRIT J RHEUMATOL, V24, P250; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; McCullough PA, 2008, CLIN J AM SOC NEPHRO, V3, P1585, DOI 10.2215/CJN.01930408; Mei Y, 2015, BBA-MOL BASIS DIS, V1852, P243, DOI 10.1016/j.bbadis.2014.05.005; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; PICOT S, 1991, J INFECT DIS, V164, P830, DOI 10.1093/infdis/164.4.830; Razani B, 2010, J LIPID RES, V51, P1738, DOI 10.1194/jlr.M003681; Ruiz-Irastorza G, 2006, LUPUS, V15, P577, DOI 10.1177/0961203306071872; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Siso A, 2008, LUPUS, V17, P281, DOI 10.1177/0961203307086503; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Tawakol A, 2003, J AM COLL CARDIOL, V42, P687, DOI 10.1016/S0735-1097(03)00771-X; Tawakol A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186039; Todorovic Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092673; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wikstrom J, 2005, J AM COLL CARDIOL, V46, P720, DOI 10.1016/j.jacc.2005.04.053; Williams ME, 2010, CLIN J AM SOC NEPHRO, V5, P1595, DOI 10.2215/CJN.09301209	45	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139226	10.1371/journal.pone.0139226	http://dx.doi.org/10.1371/journal.pone.0139226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414017	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700051
J	Fisch, AS; Yerges-Armstrong, LM; Backman, JD; Wang, H; Donnelly, P; Ryan, KA; Parihar, A; Pavlovich, MA; Mitchell, BD; O'Connell, JR; Herzog, W; Harman, CR; Wren, JD; Lewis, JP				Fisch, Adam S.; Yerges-Armstrong, Laura M.; Backman, Joshua D.; Wang, Hong; Donnelly, Patrick; Ryan, Kathleen A.; Parihar, Ankita; Pavlovich, Mary A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Herzog, William; Harman, Christopher R.; Wren, Jonathan D.; Lewis, Joshua P.			Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial Dysfunction	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; PEAR1; IDENTIFICATION; EXPRESSION; PHENOTYPE; ENDOGLIN; REVEALS; VARIANT; PLAYS; CELLS	Platelet Endothelial Aggregation Receptor 1 (PEAR1) is a newly identified membrane protein reported to be involved in multiple vascular and thrombotic processes. While most studies to date have focused on the effects of this receptor in platelets, PEAR1 is located in multiple tissues including the endothelium, where it is most highly expressed. Our first objective was to evaluate the role of PEAR1 in endothelial function by examining flow-mediated dilation of the brachial artery in 641 participants from the Heredity and Phenotype Intervention Heart Study. Our second objective was to further define the impact of PEAR1 on cardiovascular disease computationally through meta-analysis of 75,000 microarrays, yielding insights regarding PEAR1 function, and predictions of phenotypes and diseases affected by PEAR1 dysregulation. Based on the results of this meta-analysis we examined whether genetic variation in PEAR1 influences endothelial function using an ex vivo assay of endothelial cell migration. We observed a significant association between rs12041331 and flow-mediated dilation in participants of the Heredity and Phenotype Intervention Heart Study (P = 0.02). Meta-analysis results revealed that PEAR1 expression is highly correlated with several genes (e.g. ANG2, ACVRL1, ENG) and phenotypes (e.g. endothelial cell migration, angiogenesis) that are integral to endothelial function. Functional validation of these results revealed that PEAR1 rs12041331 is significantly associated with endothelial migration (P = 0.04). Our results suggest for the first time that genetic variation of PEAR1 is a significant determinant of endothelial function through pathways implicated in cardiovascular disease.	[Fisch, Adam S.; Yerges-Armstrong, Laura M.; Backman, Joshua D.; Wang, Hong; Donnelly, Patrick; Ryan, Kathleen A.; Parihar, Ankita; Pavlovich, Mary A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Lewis, Joshua P.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Fisch, Adam S.; Yerges-Armstrong, Laura M.; Backman, Joshua D.; Wang, Hong; Donnelly, Patrick; Ryan, Kathleen A.; Parihar, Ankita; Pavlovich, Mary A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Lewis, Joshua P.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Herzog, William] Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, Baltimore, MD USA; [Harman, Christopher R.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Wren, Jonathan D.] Oklahoma Med Res Fdn, Program Arthrit & Clin Immunol Res, Oklahoma City, OK 73104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Lewis, JP (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	jlewis2@medicine.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Vandenbriele, Christophe/ABF-7540-2020; Wren, Jonathan D/E-5611-2011	Vandenbriele, Christophe/0000-0001-5151-6400; Wren, Jonathan D/0000-0003-2776-3545; Lewis, Joshua/0000-0002-4107-6066; Mitchell, Braxton/0000-0003-4920-4744	National Institute of General Medical Sciences [U01GM074518, P20GM103636, U54GM104938, K23GM102678]; National Heart, Lung, and Blood Institute [U01HL072515, K01HL116770, T32HL072751]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK072488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072751, U01HL072515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, K23GM102678, P20GM103636, U54GM104938] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Support was provided by: U01GM074518 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx]; U01HL072515 National Heart, Lung, and Blood Institute [http://www.nhlbi.nih.gov/] to author BDM; P20GM103636 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx] to author JDW; U54GM104938 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx] to author JDW; K01HL116770 National Heart, Lung, and Blood Institute [http://www.nhlbi.nih.gov/] to author LMYA; K23GM102678 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx] to author JPL; P30DK072488 National Institute of Diabetes and Digestive and Kidney Diseases [http://www.niddk.nih.gov/Pages/default.aspx] to author BDM; T32HL072751 National Heart, Lung, and Blood Institute [http://www.nhlbi.nih.gov/] to author ASF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 1999, AM J MED GENET, V86, P156, DOI 10.1002/(SICI)1096-8628(19990910)86:2<156::AID-AJMG13>3.0.CO;2-5; Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Atkinson G, 2014, INT J CARDIOL, V172, P261, DOI 10.1016/j.ijcard.2013.12.264; Atkinson G, 2013, ATHEROSCLEROSIS, V226, P425, DOI 10.1016/j.atherosclerosis.2012.11.027; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Berg J, 2003, J MED GENET, V40, P585, DOI 10.1136/jmg.40.8.585; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Cheung Ambrose L, 2007, Curr Protoc Microbiol, VAppendix 4, p4B, DOI 10.1002/9780471729259.mca04bs4; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Dozmorov MG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S2; Faraday N, 2011, BLOOD, V118, P3367, DOI 10.1182/blood-2010-11-320788; Gandhapudi SK, 2015, J IMMUNOL, V194, P3820, DOI 10.4049/jimmunol.1301542; Gillis Jesse, 2013, BMC Bioinformatics, V14 Suppl 3, pS15; Gu Y, 2006, BLOOD, V107, P1951, DOI 10.1182/blood-2005-05-1834; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kauskot A, 2013, BLOOD, V121, P5208, DOI 10.1182/blood-2012-10-462887; Kauskot A, 2012, BLOOD, V119, P4056, DOI 10.1182/blood-2011-11-392787; Kim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064179; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; Lewis JP, 2013, CIRC-CARDIOVASC GENE, V6, P184, DOI 10.1161/CIRCGENETICS.111.964627; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Nanda N, 2005, J BIOL CHEM, V280, P24680, DOI 10.1074/jbc.M413411200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Suzuki K, 2008, ATHEROSCLEROSIS, V197, P212, DOI 10.1016/j.atherosclerosis.2007.03.023; Towner RA, 2013, NEURO-ONCOLOGY, V15, P1625, DOI 10.1093/neuonc/not124; Towner RA, 2013, NEUROSURGERY, V72, P77, DOI 10.1227/NEU.0b013e318276b29d; Vandenbriele C, 2015, CARDIOVASC RES, V108, P124, DOI 10.1093/cvr/cvv193; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xiang Q, 2013, PHARMACOGENOMICS, V14, P1179, DOI [10.2217/pgs.13.108, 10.2217/PGS.13.108]; Yan LF, 2014, EXP TOXICOL PATHOL, V66, P61, DOI 10.1016/j.etp.2013.08.004	40	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138795	10.1371/journal.pone.0138795	http://dx.doi.org/10.1371/journal.pone.0138795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406321	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700099
J	Lu, ZD; Du, R; Du, PR; Qin, SS; Liang, ZM; Li, ZM; Wang, YL; Wang, YF				Lu, Zedong; Du, Rui; Du, Pengrui; Qin, Saisai; Liang, Zongmin; Li, Ziming; Wang, Yaling; Wang, Yanfen			Influences of Land Use/Cover Types on Nitrous Oxide Emissions during Freeze-Thaw Periods from Waterlogged Soils in Inner Mongolia	PLOS ONE			English	Article							BEECH FOREST ECOSYSTEM; N-SATURATED SPRUCE; N2O EMISSIONS; INTERANNUAL VARIABILITY; GRASSLAND ECOSYSTEMS; SPATIAL VARIABILITY; METHANE EMISSIONS; CONTINUOUS RECORD; CARBON-DIOXIDE; LIMED SOIL	Nitrous oxide emissions during freeze/thaw periods contribute significantly to annual soil N2O emissions budgets in middle-and high-latitude areas; however, the freeze/thaw-related N2O emissions from waterlogged soils have hardly been studied in the Hulunber Grassland, Inner Mongolia. For this study, the effects of changes in land use/cover types on N2O emissions during freeze-thaw cycles were investigated to more accurately quantify the annual N2O emissions from grasslands. Soil cores from six sites were incubated at varying temperature (ranging from -15 to 10 degrees C) to simulate freeze-thaw cycles. N2O production rates were low in all soil cores during freezing periods, but increased markedly after soil thawed. Mean rates of N2O production differed by vegetation type, and followed the sequence: Leymus chinensis (LC) and Artemisia tanacetifolia (AT) steppes > LC steppes >= Stipa baicalensis (SB) steppes. Land use types (mowing and grazing) had differing effects on freeze/thaw-related N2O production. Grazing significantly reduced N2O production by 36.8%, while mowing enhanced production. The production of N2O was related to the rate at which grassland was mowed, in the order: triennially (M3) > once annually (M1) >= unmown (UM). Compared with the UM control plot, the M3 and M1 mowing regimes enhanced N2O production by 57.9% and 13.0% respectively. The results of in situ year-round measurements showed that large amounts of N2O were emitted during the freeze-thaw period, and that annual mean fluxes of N2O were 9.21 mu g N2O-N m(-2) h(-1) (ungrazed steppe) and 6.54 mu g N2O-N m(-2) h(-1) (grazed steppe). Our results further the understanding of freeze/thaw events as enhancing N2O production, and confirm that different land use/cover types should be differentiated rather than presumed to be equivalent, regarding nitrous oxide emission. Even so, further research involving multi-year and intensive measurements of N2O emission is still needed.	[Lu, Zedong; Du, Rui; Du, Pengrui; Qin, Saisai; Liang, Zongmin; Li, Ziming; Wang, Yaling; Wang, Yanfen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Du, R (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	ruidu@ucas.ac.cn		wang, yan fen/0000-0001-5666-9289	Chinese Academy of Sciences [XDA0520402]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Chinese Academy of Sciences (Program No.: XDA0520402) http://people.ucas.ac.cn/similar to ruidu?language=cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Ball BC, 1997, J ENVIRON QUAL, V26, P1399, DOI 10.2134/jeq1997.00472425002600050029x; BOUWMAN AF, 1995, J GEOPHYS RES-ATMOS, V100, P2785, DOI 10.1029/94JD02946; BREMNER JM, 1980, GEOPHYS RES LETT, V7, P641, DOI 10.1029/GL007i009p00641; BREMNER JM, 1978, SCIENCE, V199, P295, DOI 10.1126/science.199.4326.295; BREMNER JM, 1975, SOIL BIOL BIOCHEM, V7, P383, DOI 10.1016/0038-0717(75)90054-1; Butterbach-Bahl K, 2002, PLANT SOIL, V240, P77, DOI 10.1023/A:1015856617553; CHEN Y, 1995, AGR ECOSYST ENVIRON, V55, P123, DOI 10.1016/0167-8809(95)00611-U; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; CHRISTENSEN S, 1991, J SOIL SCI, V42, P637, DOI 10.1111/j.1365-2389.1991.tb00110.x; CHRISTENSEN S, 1990, J SOIL SCI, V41, P1, DOI 10.1111/j.1365-2389.1990.tb00039.x; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Corre MD, 1996, SOIL SCI SOC AM J, V60, P1806, DOI 10.2136/sssaj1996.03615995006000060028x; Davidson E. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P219; DENMEAD OT, 1979, SOIL SCI SOC AM J, V43, P726, DOI 10.2136/sssaj1979.03615995004300040020x; Du R, 2006, SOIL BIOL BIOCHEM, V38, P3474, DOI 10.1016/j.soilbio.2006.06.012; Du Rui, 2004, Huanjing Kexue, V25, P12; EDWARDS AC, 1986, SOIL USE MANAGE, V2, P86, DOI 10.1111/j.1475-2743.1986.tb00688.x; FLESSA H, 1995, J GEOPHYS RES-ATMOS, V100, P23115, DOI 10.1029/95JD02270; Garcia-Salamanca A, 2013, MICROB BIOTECHNOL, V6, P36, DOI 10.1111/j.1751-7915.2012.00358.x; GOODROAD LL, 1984, CAN J SOIL SCI, V64, P187, DOI 10.4141/cjss84-020; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; GROFFMAN PM, 1989, SOIL BIOL BIOCHEM, V21, P613, DOI 10.1016/0038-0717(89)90053-9; HEANEY DJ, 1988, SOIL SCI SOC AM J, V52, P667, DOI 10.2136/sssaj1988.03615995005200030013x; Hiernaux P, 1998, PLANT ECOL, V138, P191, DOI 10.1023/A:1009752606688; Holst J, 2008, PLANT SOIL, V308, P105, DOI 10.1007/s11104-008-9610-8; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Hyde BP, 2006, NUTR CYCL AGROECOSYS, V75, P187, DOI 10.1007/s10705-006-9026-x; Jin HJ, 1999, CHINESE SCI BULL, V44, P2282, DOI 10.1007/BF02885940; Kaiser EA, 1996, PLANT SOIL, V181, P57, DOI 10.1007/BF00011292; Katayanagi N, 2012, SOIL SCI PLANT NUTR, V58, P261, DOI 10.1080/00380768.2012.670810; Klemedtsson L, 2005, GLOBAL CHANGE BIOL, V11, P1142, DOI 10.1111/j.1365-2486.2005.00973.x; Laverman AM, 2001, SOIL BIOL BIOCHEM, V33, P683, DOI 10.1016/S0038-0717(00)00180-2; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Li X Z, 1999, THESIS CHINESE ACAD; [刘光生 Liu Guangsheng], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P555; Liu XR, 2010, NUTR CYCL AGROECOSYS, V86, P231, DOI 10.1007/s10705-009-9287-2; Lu ZD, 2015, FRONT EARTH SCI-PRC, V9, P473, DOI 10.1007/s11707-014-0486-z; Ludwig B, 2006, SOIL BIOL BIOCHEM, V38, P3516, DOI 10.1016/j.soilbio.2006.06.006; Ludwig B, 2004, J PLANT NUTR SOIL SC, V167, P678, DOI 10.1002/jpln.200421462; Malla G, 2005, CHEMOSPHERE, V58, P141, DOI 10.1016/j.chemosphere.2004.09.003; Marschner H., 1998, Soil chemistry and ecosystem health., P191; MATSON PA, 1991, BIOGEOCHEMISTRY, V14, P1; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Muller C, 2002, SOIL BIOL BIOCHEM, V34, P1325, DOI 10.1016/S0038-0717(02)00076-7; NAETH MA, 1991, CAN J SOIL SCI, V71, P313, DOI 10.4141/cjss91-031; NAGELE W, 1990, BIOL FERT SOILS, V10, P139; Neilson CB, 2001, SOIL SCI SOC AM J, V65, P1723, DOI 10.2136/sssaj2001.1723; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; NORMAN M. J. T., 1960, JOUR BRIT GRASSLAND SOC, V15, P145, DOI 10.1111/j.1365-2494.1960.tb00170.x; Nyborg M, 1997, CAN J SOIL SCI, V77, P153, DOI 10.4141/S96-105; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paniagua A, 1999, AGR ECOSYST ENVIRON, V72, P215, DOI 10.1016/S0167-8809(98)00183-2; Papen H, 1999, J GEOPHYS RES-ATMOS, V104, P18487, DOI 10.1029/1999JD900293; Pei Z Y, 2003, THESIS CHINESE ACAD; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Rosen CJ, 2007, HORTTECHNOLOGY, V17, P422, DOI 10.21273/HORTTECH.17.4.422; Saggar S, 2004, NEW ZEAL J AGR RES, V47, P513, DOI 10.1080/00288233.2004.9513618; SKOGLAND T, 1988, SOIL BIOL BIOCHEM, V20, P851, DOI 10.1016/0038-0717(88)90092-2; Song CC, 2006, ATMOS ENVIRON, V40, P6879, DOI 10.1016/j.atmosenv.2005.08.028; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Teepe R, 2000, SOIL BIOL BIOCHEM, V32, P1807, DOI 10.1016/S0038-0717(00)00078-X; Teepe R, 2001, SOIL BIOL BIOCHEM, V33, P1269, DOI 10.1016/S0038-0717(01)00084-0; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Vestgarden LS, 2009, GLOBAL CHANGE BIOL, V15, P876, DOI 10.1111/j.1365-2486.2008.01722.x; Wagner-Riddle C, 2007, GLOBAL CHANGE BIOL, V13, P1722, DOI 10.1111/j.1365-2486.2007.01388.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang YS, 2005, CHEMOSPHERE, V58, P205, DOI 10.1016/j.chemosphere.2004.04.043; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Weintraub MN, 2005, BIOSCIENCE, V55, P408, DOI 10.1641/0006-3568(2005)055[0408:NCATSO]2.0.CO;2; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Wu X, 2014, BIOL FERT SOILS, V50, P295, DOI 10.1007/s00374-013-0853-z; Xu R, 2004, THESIS CHINESE ACAD; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081466; Yanai J, 2003, J ENVIRON QUAL, V32, P1965, DOI 10.2134/jeq2003.1965; Yanai Y, 2004, SOIL SCI PLANT NUTR, V50, P821, DOI 10.1080/00380768.2004.10408542; Yao Z, 2010, J GEOPHYS RES, V115; Zancarini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047096; Zhang L, 2012, CHINA PLOS ONE, V7, DOI [10.1371/journal.pone.0035952, DOI 10.1371/J0URNAL.P0NE.0035952]; Zhong L, 2014, SOIL BIOL BIOCHEM, V69, P1, DOI 10.1016/j.soilbio.2013.10.028; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110; Zou Y, 2011, ACTA ECOL SIN, V31, P150, DOI [10.1016/j.chnaes.2011.03.004, DOI 10.1016/J.CHNAES.2011.03.004]	84	8	8	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139316	10.1371/journal.pone.0139316	http://dx.doi.org/10.1371/journal.pone.0139316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407303	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700206
J	Masconi, KL; Matsha, TE; Erasmus, RT; Kengne, AP				Masconi, Katya L.; Matsha, Tandi E.; Erasmus, Rajiv T.; Kengne, Andre P.			Effects of Different Missing Data Imputation Techniques on the Performance of Undiagnosed Diabetes Risk Prediction Models in a Mixed-Ancestry Population of South Africa	PLOS ONE			English	Article							MULTIPLE IMPUTATION; SCORE; REGRESSION; VALUES	Background Imputation techniques used to handle missing data are based on the principle of replacement. It is widely advocated that multiple imputation is superior to other imputation methods, however studies have suggested that simple methods for filling missing data can be just as accurate as complex methods. The objective of this study was to implement a number of simple and more complex imputation methods, and assess the effect of these techniques on the performance of undiagnosed diabetes risk prediction models during external validation. Methods Data from the Cape Town Bellville-South cohort served as the basis for this study. Imputation methods and models were identified via recent systematic reviews. Models' discrimination was assessed and compared using C-statistic and non-parametric methods, before and after recalibration through simple intercept adjustment. Results The study sample consisted of 1256 individuals, of whom 173 were excluded due to previously diagnosed diabetes. Of the final 1083 individuals, 329 (30.4%) had missing data. Family history had the highest proportion of missing data (25%). Imputation of the outcome, undiagnosed diabetes, was highest in stochastic regression imputation (163 individuals). Overall, deletion resulted in the lowest model performances while simple imputation yielded the highest C-statistic for the Cambridge Diabetes Risk model, Kuwaiti Risk model, Omani Diabetes Risk model and Rotterdam Predictive model. Multiple imputation only yielded the highest C-statistic for the Rotterdam Predictive model, which were matched by simpler imputation methods. Conclusions Deletion was confirmed as a poor technique for handling missing data. However, despite the emphasized disadvantages of simpler imputation methods, this study showed that implementing these methods results in similar predictive utility for undiagnosed diabetes when compared to multiple imputation.	[Masconi, Katya L.; Erasmus, Rajiv T.] NHLS, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa; [Masconi, Katya L.; Erasmus, Rajiv T.] Univ Stellenbosch, Cape Town, South Africa; [Masconi, Katya L.; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Technol, Cape Town, South Africa; [Kengne, Andre P.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa	Stellenbosch University; South African Medical Research Council; Cape Peninsula University of Technology; University of Cape Town	Kengne, AP (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Kengne, Andre Pascal/ABB-3696-2020	Matsha, Tandi/0000-0001-5251-030X; Kengne, Andre Pascal/0000-0002-5183-131X	South African National Research Foundation; Carl & Emily Fuchs Foundation	South African National Research Foundation(National Research Foundation - South Africa); Carl & Emily Fuchs Foundation	KLM was supported by a scholarship from the South African National Research Foundation and the Carl & Emily Fuchs Foundation. The authors received no other specific funding for this work.	Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Alzola C., 2006, INTRO S HMISC DESIGN, P310; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Baker J, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-47; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Buuren S., 2011, J STAT SOFTWARE, V45; City of Cape Town, 2013, CITY CAPE TOWN 2011; City of Cape Town, 2006, CITY CAPE TOWN CENSU; CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Graham JW, 1996, MULTIVAR BEHAV RES, V31, P197, DOI 10.1207/s15327906mbr3102_3; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Kengne AP, 2014, CRIT REV CL LAB SCI, V51, P1, DOI 10.3109/10408363.2013.853025; Little R.J.A., 2002, STAT ANAL MISSING DA; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Masconi K, 2015, DIABETOLOGY METABOLI; Masconi KL, 2015, EPMA J, V6, DOI 10.1186/s13167-015-0028-0; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Rubin D. B., 2004, MULTIPLE IMPUTATION; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Steyerberg E., 2009, CLIN PREDICTION MODE; The R Foundation, 2015, R PROJECT STAT COMPU; Vach W, 1997, STAT MED, V16, P57; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; World Health Organization, 2003, WHONMHMNC031	37	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139210	10.1371/journal.pone.0139210	http://dx.doi.org/10.1371/journal.pone.0139210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406594	Green Published, gold			2022-12-26	WOS:000361800700191
J	Mustafa, T; Horton, DR; Cooper, WR; Swisher, KD; Zack, RS; Pappu, HR; Munyaneza, JE				Mustafa, Tariq; Horton, David R.; Cooper, W. Rodney; Swisher, Kylie D.; Zack, Richard S.; Pappu, Hanu R.; Munyaneza, Joseph E.			Use of Electrical Penetration Graph Technology to Examine Transmission of 'Candidatus Liberibacter solanacearum' to Potato by Three Haplotypes of Potato Psyllid (Bactericera cockerelli; Hemiptera: Triozidae)	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; STYLET PENETRATION; 1ST REPORT; INOCULATION; ACQUISITION; BEHAVIOR; PLANT; ASSOCIATION; BIOLOGY; APHIDS	The potato psyllid, Bactericera cockerelli (Sulc) (Hemiptera: Triozidae), is a vector of the phloem-limited bacterium 'Candidatus Liberibacter solanacearum' (Lso), the putative causal agent of zebra chip disease of potato. Little is known about how potato psyllid transmits Lso to potato. We used electrical penetration graph (EPG) technology to compare stylet probing behaviors and efficiency of Lso transmission of three haplotypes of potato psyllid (Central, Western, Northwestern). All haplotypes exhibited the full suite of stylet behaviors identified in previous studies with this psyllid, including intercellular penetration and secretion of the stylet pathway, xylem ingestion, and phloem activities, the latter comprising salivation and ingestion. The three haplotypes exhibited similar frequency and duration of probing behaviors, with the exception of salivation into phloem, which was of higher duration by psyllids of the Western haplotype. We manipulated how long psyllids were allowed access to potato ("inoculation access period", or IAP) to examine the relationship between phloem activities and Lso transmission. Between 25 and 30% of psyllids reached and salivated into phloem at an IAP of 1 hr, increasing to almost 80% of psyllids as IAP was increased to 24 h. Probability of Lso-transmission was lower across all IAP levels than probability of phloem salivation, indicating that a percentage of infected psyllids which salivated into the phloem failed to transmit Lso. Logistic regression showed that probability of transmission increased as a function of time spent salivating into the phloem; transmission occurred as quickly as 5 min following onset of salivation. A small percentage of infected psyllids showed extremely long salivation events but nonetheless failed to transmit Lso, for unknown reasons. Information from these studies increases our understanding of Lso transmission by potato psyllid, and demonstrates the value of EPG technology in exploring questions of vector efficiency.	[Mustafa, Tariq; Horton, David R.; Cooper, W. Rodney; Swisher, Kylie D.; Munyaneza, Joseph E.] USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA; [Mustafa, Tariq; Zack, Richard S.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Pappu, Hanu R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; Washington State University	Munyaneza, JE (corresponding author), USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA.	Joseph.Munyaneza@ars.usda.gov	Cooper, William/ABB-1389-2020; Mustafa, Tariq/AAU-4194-2021	Cooper, William/0000-0001-7983-3627; Mustafa, Tariq/0000-0002-6083-5806	Northwest Potato Research Consortium, Washington State Potato Commission; United States Department of Agriculture, Agricultural Research Service State Cooperative Potato Research Program; United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [2009-51181-20176]	Northwest Potato Research Consortium, Washington State Potato Commission; United States Department of Agriculture, Agricultural Research Service State Cooperative Potato Research Program; United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative	Funding: Financial support for this research was partially provided by the Northwest Potato Research Consortium, Washington State Potato Commission; United States Department of Agriculture, Agricultural Research Service State Cooperative Potato Research Program; and United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (Project #2009-51181-20176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2006, LOGISTIC REGRESSION; Arp A, 2014, ENVIRON ENTOMOL, V43, P344, DOI 10.1603/EN13256; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; Butler CD, 2012, ENTOMOL EXP APPL, V142, P247, DOI 10.1111/j.1570-7458.2012.01219.x; Cooper WR, 2015, ANN ENTOMOL SOC AM, V108, P137, DOI 10.1093/aesa/sau048; Cooper WR, 2014, ANN ENTOMOL SOC AM, V107, P204, DOI 10.1603/AN13087; Crosslin JM, 2012, PLANT DIS, V96, P453, DOI 10.1094/PDIS-10-11-0853; Crosslin JM, 2012, PLANT DIS, V96, P452, DOI 10.1094/PDIS-10-11-0894; Fereres A, 2001, VIRUS INSECT PLANT I; Gbur EE, 2012, ACSESS PUBL, P1, DOI 10.2134/2012.generalized-linear-mixed-models; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; Moreno A, 2012, J GEN VIROL, V93, P662, DOI 10.1099/vir.0.037887-0; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza J. E., 2007, PLANT SCI, V59, P30; Munyaneza JE., 2008, SUBPLANT SCI, V60, P27; Munyaneza JE, 2015, AM J POTATO RES, V92, P230, DOI 10.1007/s12230-015-9448-6; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Mustafa T, 2015, ENVIRON ENTOMOL, V44, P593, DOI 10.1093/ee/nvv018; Mustafa T, 2015, ENVIRON ENTOMOL, V44, P300, DOI 10.1093/ee/nvu029; Nischwitz C., 2015, UTAH PESTS NEWS, V9, P1; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Pearson CC, 2014, ANN ENTOMOL SOC AM, V107, P650, DOI 10.1603/AN13178; POWELL G, 1991, ANN APPL BIOL, V119, P313, DOI 10.1111/j.1744-7348.1991.tb04870.x; Prager SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094047; Sandanayaka WRM, 2014, ENTOMOL EXP APPL, V151, P170, DOI 10.1111/eea.12179; Sandanayaka WRM, 2013, ARTHROPOD-PLANT INTE, V7, P137, DOI 10.1007/s11829-012-9238-8; SAS Institute, 2012, SAS REL 9 3 ED; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Stafford CA, 2009, ENTOMOL EXP APPL, V130, P130, DOI 10.1111/j.1570-7458.2008.00813.x; Swisher KD, 2014, AM J POTATO RES, V91, P485, DOI 10.1007/s12230-014-9378-8; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2013, ENVIRON ENTOMOL, V42, P381, DOI 10.1603/EN12261; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Symmes EJ, 2008, ENTOMOL EXP APPL, V129, P258, DOI 10.1111/j.1570-7458.2008.00784.x; Thinakaran J, 2015, ANN ENTOMOL SOC AM, V108, P459, DOI 10.1093/aesa/sav030; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P177, DOI 10.1007/BF00361930; Tjallingii WF, 2001, VIRUS INSECT PLANT I; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	46	34	34	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138946	10.1371/journal.pone.0138946	http://dx.doi.org/10.1371/journal.pone.0138946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407093	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700124
J	Nagel, S; Ehrentraut, S; Meyer, C; Kaufmann, M; Drexler, HG; MacLeod, RAF				Nagel, Stefan; Ehrentraut, Stefan; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.			Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma	PLOS ONE			English	Article							REED-STERNBERG CELLS; ZINC-FINGERS; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; GROWTH; AMPLIFICATION; INHIBITION; INDUCTION; RECURRENT; EVOLUTION	In Hodgkin lymphoma (HL) we recently reported that deregulated homeobox gene MSX1 mediates repression of the B-cell specific transcription factor ZHX2. In this study we investigated regulation of MSX1 in this B-cell malignancy. Accordingly, we analyzed expression and function of OTX homeobox genes which activate MSX1 transcription during embryonal development in the neural plate border region. Our data demonstrate that OTX1 and OTX2 are aberrantly expressed in both HL patients and cell lines. Moreover, both OTX loci are targeted by genomic gains in overexpressing cell lines. Comparative expression profiling and subsequent pathway modulations in HL cell lines indicated that aberrantly enhanced FGF2-signalling activates the expression of OTX2. Downstream analyses of OTX2 demonstrated transcriptional activation of genes encoding transcription factors MSX1, FOXC1 and ZHX1. Interestingly, examination of the physiological expression profile of ZHX1 in normal hematopoietic cells revealed elevated levels in T-cells and reduced expression in B-cells, indicating a discriminatory role in lymphopoiesis. Furthermore, two OTX-negative HL cell lines overexpressed ZHX1 in correlation with genomic amplification of its locus at chromosomal band 8q24, supporting the oncogenic potential of this gene in HL. Taken together, our data demonstrate that deregulated homeobox genes MSX1 and OTX2 respectively impact transcriptional inhibition of (B-cell specific) ZHX2 and activation of (T-cell specific) ZHX1. Thus, we show how reactivation of a specific embryonal gene regulatory network promotes disturbed B-cell differentiation in HL.	[Nagel, Stefan; Ehrentraut, Stefan; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.] German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Lines, Leibniz Inst DSMZ, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Lines, Leibniz Inst DSMZ, Braunschweig, Germany.	sna@dsmz.de						Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Aldinucci D, 2010, J PATHOL, V221, P248, DOI 10.1002/path.2711; Atayar C, 2005, AM J PATHOL, V166, P127, DOI 10.1016/S0002-9440(10)62238-9; Barthelemy I, 1996, BIOCHEM BIOPH RES CO, V224, P870, DOI 10.1006/bbrc.1996.1114; Bayarsaihan D, 2003, P NATL ACAD SCI USA, V100, P10358, DOI 10.1073/pnas.1834010100; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Binato R, 2007, BIOCHEM BIOPH RES CO, V358, P655, DOI 10.1016/j.bbrc.2007.04.190; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Bohle V, 2013, LEUKEMIA, V27, P671, DOI 10.1038/leu.2012.280; Boon K, 2005, CANCER RES, V65, P703; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Butler AB, 2000, ANAT REC, V261, P111, DOI 10.1002/1097-0185(20000615)261:3<111::AID-AR6>3.0.CO;2-F; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Chen JY, 2009, INT J DEV BIOL, V53, P733, DOI 10.1387/ijdb.072513cj; Chen SL, 2013, J CELL BIOCHEM, V114, P2323, DOI 10.1002/jcb.24579; Dimitrova L, 2014, LEUKEMIA, V28, P213, DOI 10.1038/leu.2013.211; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Fazi B, 2009, ONCOGENE, V28, P3814, DOI 10.1038/onc.2009.233; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Gan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039770; Gharbaran R, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-62; Giefing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084928; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hertel CB, 2002, ONCOGENE, V21, P4908, DOI 10.1038/sj.onc.1205629; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Joos S, 2000, CANCER RES, V60, P549; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Khnykin D, 2006, J PATHOL, V208, P431, DOI 10.1002/path.1900; Koshida S, 2002, DEV BIOL, V244, P9, DOI 10.1006/dbio.2002.0581; Krenacs L, 1998, BLOOD, V92, P1308, DOI 10.1182/blood.V92.4.1308.416k32_1308_1316; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Kwiecinska A, 2014, GENE CHROMOSOME CANC, V53, P750, DOI 10.1002/gcc.22184; MacLeod RAF, 2000, LEUKEMIA, V14, P1803, DOI 10.1038/sj.leu.2401894; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14; Nagel S, 2005, LEUKEMIA, V19, P841, DOI 10.1038/sj.leu.2403716; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2014, GENE CHROMOSOME CANC, V53, P917, DOI 10.1002/gcc.22204; Nagel S, 2014, LEUKEMIA LYMPHOMA, V55, P1893, DOI 10.3109/10428194.2013.864762; Nagel S, 2013, GENE CHROMOSOME CANC, V52, P741, DOI 10.1002/gcc.22069; Nagel S, 2012, LEUKEMIA RES, V36, P646, DOI 10.1016/j.leukres.2011.10.019; Nagel S, 2011, GENE CHROMOSOME CANC, V50, P996, DOI 10.1002/gcc.20920; Nelms B.L., 2010, TRANSCRIPTIONAL CONT; Ogata-Kawata H, 2007, FRONT BIOSCI-LANDMRK, V12, P1911, DOI 10.2741/2197; Omodei D, 2009, AM J PATHOL, V175, P2609, DOI 10.2353/ajpath.2009.090542; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Re D, 2001, CANCER RES, V61, P2080; Renne C, 2006, AM J PATHOL, V169, P655, DOI 10.2353/ajpath.2006.060020; Robel L, 1995, J NEUROSCI, V15, P7879; Sakurai Y, 2010, DEV BIOL, V347, P392, DOI 10.1016/j.ydbio.2010.08.028; Samuel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089110; SCHLEGELBERGER B, 1994, LEUKEMIA, V8, P72; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Schmidt A, 2010, GENE CHROMOSOME CANC, V49, P803, DOI 10.1002/gcc.20789; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Shou ZF, 2004, BIOCHEM BIOPH RES CO, V314, P885, DOI 10.1016/j.bbrc.2003.12.162; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Singh N, 2013, DEV BIOL, V377, P333, DOI 10.1016/j.ydbio.2013.03.008; Sohlbach K, 2012, LEUKEMIA LYMPHOMA, V53, P996, DOI 10.3109/10428194.2011.634046; Stanelle J, 2010, BLOOD, V116, P4202, DOI 10.1182/blood-2010-01-265827; Stein H, 2001, BLOOD, V97, P496, DOI 10.1182/blood.V97.2.496; Tomsa JM, 1999, DEV BIOL, V207, P26, DOI 10.1006/dbio.1998.9163; Yamada K, 2002, BIOCHEM BIOPH RES CO, V297, P368, DOI 10.1016/S0006-291X(02)02203-9; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507	80	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138416	10.1371/journal.pone.0138416	http://dx.doi.org/10.1371/journal.pone.0138416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406991	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700043
J	Qu, SJ; Ji, Y; Goh, M				Qu, Shaojian; Ji, Ying; Goh, Mark			The Robust Weighted Multi-Objective Game	PLOS ONE			English	Article							MODELS	This paper studies a class of multi-objective n-person non-zero sum games through a robust weighted approach where each player has more than one competing objective. This robust weighted multi-objective game model assumes that each player attaches a set of weights to its objectives instead of accessing accurate weights. Each player wishes to minimize its maximum weighted sum objective where the maximization is pointing to the set of weights. To address this new model, a new equilibrium concept-robust weighted Nash equilibrium is obtained. The existence of this new concept is proven on suitable assumptions about the multi-objective payoffs.	[Qu, Shaojian] Shanghai Univ Sci & Technol, Sch Business, Shanghai, Peoples R China; [Qu, Shaojian; Ji, Ying; Goh, Mark] Natl Univ Singapore, Logist Inst Asia Pacific, Singapore 117548, Singapore; [Ji, Ying] Harbin Inst Technol, Ctr Nat Sci, Harbin 150006, Peoples R China; [Goh, Mark] Natl Univ Singapore, NUS Business Sch, Singapore 117548, Singapore	University of Shanghai for Science & Technology; National University of Singapore; Harbin Institute of Technology; National University of Singapore	Qu, SJ (corresponding author), Shanghai Univ Sci & Technol, Sch Business, Shanghai, Peoples R China.	qushaojian@163.com	goh, mark/GQO-8860-2022; goh, mark/AAC-4268-2022	goh, mark/0000-0002-3620-7658; goh, mark/0000-0002-3620-7658	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [TP2014043]; Science and Engineering Research Council (SERC), A*STAR [1121790043]; Natural Scientific Foundation of China [71201040, 11201099]	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Engineering Research Council (SERC), A*STAR(Agency for Science Technology & Research (A*STAR)); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: The work is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. TP2014043). The work is also supported by a research Grant from Science and Engineering Research Council (SERC), A*STAR (Title of Supported Project: Master Facilitative Control Tower for Risk Management of Complex Supply Chains and Ref Number: 1121790043) and by Natural Scientific Foundation of China (No. 71201040, No. 11201099).	Blackwell David, 1956, PAC J MATH, V6, P1, DOI [10.2140/pjm.1956.6.1, DOI 10.2140/PJM.1956.6.1]; Hu J, 2012, OPER RES, V60, P936, DOI 10.1287/opre.1120.1071; Kakutani S., 1941, DUKE MATH J, P457, DOI DOI 10.1215/S0012-7094-41-00838-4; Lozovanu D., 2005, B ACAD STIINTE REPUB, V3, P115; Peng JW, 2011, J OPTIMIZ THEORY APP, V150, P416, DOI 10.1007/s10957-011-9839-x; WANG SY, 1993, J OPTIMIZ THEORY APP, V79, P373, DOI 10.1007/BF00940586; WEBER M, 1993, EUR J OPER RES, V67, P1, DOI 10.1016/0377-2217(93)90318-H; Yu J, 1998, COMPUT MATH APPL, V35, P17, DOI 10.1016/S0898-1221(98)00053-4	9	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138970	10.1371/journal.pone.0138970	http://dx.doi.org/10.1371/journal.pone.0138970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406986	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700133
J	Yang, Y; Yao, KH; Ma, X; Shi, W; Yuan, L; Yang, YH				Yang, Ying; Yao, Kaihu; Ma, Xiang; Shi, Wei; Yuan, Lin; Yang, Yonghong			Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014)	PLOS ONE			English	Article							SEQUENCE VARIATION; RESISTANCE; STRAINS; PERIOD; TOXIN; IMMUNIZATION; SURVEILLANCE; POLYMORPHISM; NETHERLANDS; VACCINATION	Objectives To investigate changes in virulence-related genotypes and in the antimicrobial susceptibility of Bordetella pertussis isolates collected from the 1970s to 2014 in the northern part of China. Methods A total of 124 B. pertussis isolates from three periods, the 1970s, 2000-2008, and May 2013-Sept 2014, were typed by multilocus sequence typing (MLST) and tested for antimicrobial susceptibility and virulence-related genes. A fragment of the 23S rRNA gene from each of the 99 isolates from 2013-2014 was amplified and sequenced. Results All isolates from 2000-2008 and 2013-2014 were identified as ST2, whereas isolates from the 1970s were ST1. PtxA2/ptxC1/ptxP1/prn1/fim2-1/fim3-1/tcfA2, which was the same as the vaccine strain, was the only type in the 1970s. During the 2000s and 2013-2014, the virulence type ptxA1/ptxC1/ptxP1/prn1/fim2-1/fim3-1/tcfA2 was dominant, with frequencies of 68.4% and 91.9%, respectively. Nine ptxP3 strains, which were more virulent, were detected after 2000. All 124 isolates were susceptible to levofloxacin, sulphamethoxazole/trimethoprim and tetracycline. The isolates from the 1970s and 2000-2008 were susceptible to all tested macrolides, whereas 91.9% of the 2013-2014 isolates were highly resistant (minimal inhibitory concentration, MIC >256 mu g/ml). No ptxP3 strain was resistant to macrolides. All erythromycin-resistant strains except for one had the A2047G mutation in the 23S rRNA gene. Conclusions Macrolide resistance of the B. pertussis population has been a serious problem in the northern part of China. Because most of the epidemic clone of the pathogen expresses the same antigen profiles as the vaccine strain, except ptxA, improvements in immunization strategies may prevent the spread of infection and drug resistance.	[Yang, Ying; Yao, Kaihu; Shi, Wei; Yuan, Lin; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst,Minist Educ,Key Lab Major, Beijing Key Lab Pediat Resp Infect Dis,Natl Clin, Beijing, Peoples R China; [Yang, Ying; Yao, Kaihu; Shi, Wei; Yuan, Lin; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst,Minist Educ,Natl Key Disc, Beijing Key Lab Pediat Resp Infect Dis,Natl Clin, Beijing, Peoples R China; [Ma, Xiang] Shandong Univ, Qilu Childrens Hosp, Resp Dept, Jinan 250100, Peoples R China	Capital Medical University; Capital Medical University; Shandong University	Yang, YH (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst,Minist Educ,Key Lab Major, Beijing Key Lab Pediat Resp Infect Dis,Natl Clin, Beijing, Peoples R China.	yyh628628@sina.com	ma, xiang/GSE-2438-2022	ma, xiang/0000-0001-6139-4355	Beijing Municipal Science and Technology Commission [2014-bjsekyjs-3]; National Clinical Center Project from the Ministry of Science and Technology of the People's Republic of China [2013BAI09B11]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Clinical Center Project from the Ministry of Science and Technology of the People's Republic of China	Funding: This study was financially supported by the Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission (2014-bjsekyjs-3) and the National Clinical Center Project from the Ministry of Science and Technology of the People's Republic of China (Grant No. 2013BAI09B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; [Anonymous], 2010, IMM PROF CHIN, P12; Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; Bartkus JM, 2003, J CLIN MICROBIOL, V41, P1167, DOI 10.1128/JCM.41.3.1167-1172.2003; BASS JW, 1994, PEDIATR INFECT DIS J, V13, P343, DOI 10.1097/00006454-199405000-00002; deMelker HE, 1997, EMERG INFECT DIS, V3, P175, DOI 10.3201/eid0302.970211; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fry NK, 2010, EUR J CLIN MICROBIOL, V29, P1183, DOI 10.1007/s10096-010-0976-1; Godfroid F, 2005, EXPERT REV VACCINES, V4, P757, DOI 10.1586/14760584.4.5.757; Gordon KA, 2001, ANTIMICROB AGENTS CH, V45, P3599, DOI 10.1128/AAC.45.12.3599-3600.2001; Guillot S, 2012, EMERG INFECT DIS, V18, P966, DOI 10.3201/eid1806.120091; Hill BC, 2000, J CLIN MICROBIOL, V38, P1151, DOI 10.1128/JCM.38.3.1151-1155.2000; Horiba K, 2014, JPN J INFECT DIS, V67, P345, DOI 10.7883/yoken.67.345; Jung Sang-Oun, 2011, Osong Public Health Res Perspect, V2, P115, DOI 10.1016/j.phrp.2011.08.003; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; LEWIS K, 1995, PEDIATR INFECT DIS J, V14, P388, DOI 10.1097/00006454-199505000-00010; Li YR, 2015, APMIS, V123, P361, DOI 10.1111/apm.12357; Liang XF., 2007, NATL IMMUNIZATION PR, V13, P245, DOI DOI 10.3969/J.ISSN.1006-916X.2007.03.015; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Mosiej E, 2015, EUR J CLIN MICROBIOL, V34, P147, DOI 10.1007/s10096-014-2216-6; Packard ER, 2004, J MED MICROBIOL, V53, P355, DOI 10.1099/jmm.0.05515-0; Shahcheraghi F, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.10880; Simmonds K, 2014, INT J INFECT DIS, V29, P223, DOI 10.1016/j.ijid.2014.10.028; Sintchenko V, 2007, J ANTIMICROB CHEMOTH, V60, P1178, DOI 10.1093/jac/dkm343; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Gent M, 2015, EUR J CLIN MICROBIOL, V34, P821, DOI 10.1007/s10096-014-2297-2; Wang JM, 2002, EMERG INFECT DIS, V8, P859, DOI 10.3201/eid0808.010442; Wang Z, 2014, CLIN MICROBIOL INFEC, V20, pO825, DOI 10.1111/1469-0691.12671; World Health Organization, 2004, LAB MAN DIAGN WHOOP; Xu YH, 2015, HUM VACC IMMUNOTHER, V11, P421, DOI 10.4161/21645515.2014.988549; Yao SM, 2008, J MED MICROBIOL, V57, P1577, DOI 10.1099/jmm.0.2008/002857-0; Zhang L, 2010, EMERG INFECT DIS, V16, P1695, DOI 10.3201/eid1611.100401; Zhang Q, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-138; Zhang WS, 2008, EUR J CLIN PHARMACOL, V64, P821, DOI 10.1007/s00228-008-0489-3; Zhang XL, 2000, CHIN J VAC IMMUN, V6, P93	39	36	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138941	10.1371/journal.pone.0138941	http://dx.doi.org/10.1371/journal.pone.0138941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406905	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700122
J	Zeng, SY; Gong, Y; Zhang, YP; Chen, SB; Chen, JY; Lin, CQ; Peng, JH; Hou, ZD; Zhong, JQ; Liang, HJ; Huang, GH; Wang, DM; Lai, HY; Li, LP; Zeng, QY				Zeng, Shao-ying; Gong, Yao; Zhang, Yu-ping; Chen, Su-biao; Chen, Jun-yang; Lin, Chu-qing; Peng, Jian-hua; Hou, Zhi-duo; Zhong, Jian-qiu; Liang, Hong-jin; Huang, Guo-hai; Wang, Dan-min; Lai, Huai-yuan; Li, Li-ping; Zeng, Qing Yu			Changes in the Prevalence of Rheumatic Diseases in Shantou, China, in the Past Three Decades: A COPCORD Study	PLOS ONE			English	Article							RISK-FACTORS; ANKYLOSING-SPONDYLITIS; KNEE OSTEOARTHRITIS; AMERICAN-COLLEGE; CRITERIA; GOUT; CLASSIFICATION; EPIDEMIOLOGY; POPULATION; ARTHRITIS	This study aimed to clarify changes in the prevalence of rheumatic diseases in Shantou, China, in the past 3 decades and validate whether stair-climbing is a risk factor for knee pain and knee osteoarthritis (KOA). The World Health Organization-International League Against Rheumatism Community Oriented Program for Control of Rheumatic Diseases (COPCORD) protocol was implemented. In all, 2337 adults living in buildings without elevators and 1719 adults living in buildings with elevators were surveyed. The prevalence of rheumatic pain at any site and in the knee was 15.7% and 10.2%, respectively; both types of pain had a significantly higher incidence in residents of buildings without elevators than was reported by people who lived in buildings with elevators (14.9% vs. 10.6% and 11.32% vs. 8.82%, respectively) (both P < 0.0001). The prevalence of rheumatic pain in the neck, lumbar spine, shoulder, elbow, and foot was 5.6%, 4.5%, 3.1%, 1.4%, and 1.8%, respectively; these findings were similar to the data from the 1987 rural survey, but were somewhat lower than data reported in the urban and suburban surveys of the 1990s, with the exception of neck and lumbar pain. The prevalence of KOA, gout, and fibromyalgia was 7.10%, 1.08%, and 0.07%, respectively, and their prevalence increased significantly compared with those in previous studies from the 20th century. There were no significant differences in the prevalence of rheumatoid arthritis (RA) (0.35%) or ankylosing spondylitis (AS) (0.31%) compared to that reported in prior surveys. The prevalence of KOA was higher in for residents of buildings without elevators than that in those who had access to elevators (16-64 years, 5.89% vs. 3.95%, P = 0.004; 16-> 85 years, 7.64% vs. 6.26%, P = 0.162). The prevalence of RA and AS remained stable, whereas that of KOA, gout, and fibromyalgia has increased significantly in Shantou, China, during the past 3 decades. Stair-climbing might be an important risk factor for knee pain and KOA.	[Zeng, Shao-ying; Li, Li-ping] Shantou Univ, Coll Med, Ctr Injury Prevent Res, Shantou, Peoples R China; [Gong, Yao; Zhang, Yu-ping; Chen, Su-biao; Peng, Jian-hua; Huang, Guo-hai; Wang, Dan-min; Zeng, Qing Yu] Shantou Univ, Coll Med, Dept Rheumatol, Shantou, Peoples R China; [Chen, Jun-yang] Third Shantou Municipal Hosp, Shantou, Peoples R China; [Lin, Chu-qing; Lai, Huai-yuan] Fourth Shantou Municipal Hosp, Shantou, Peoples R China; [Hou, Zhi-duo; Zhong, Jian-qiu; Liang, Hong-jin] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University	Li, LP (corresponding author), Shantou Univ, Coll Med, Ctr Injury Prevent Res, Shantou, Peoples R China.	lpli@stu.edu.cn; qyzeng@stu.edu.cn	Hou, Zhiduo/AAA-8076-2022	Hou, Zhi-duo/0000-0001-7734-001X	Asia Pacific League of Association for Rheumatology (APLAR) Community Oriented program for Control of Rheumatic Diseases (COPCORD); Shantou University Medical College [LDo30601]	Asia Pacific League of Association for Rheumatology (APLAR) Community Oriented program for Control of Rheumatic Diseases (COPCORD); Shantou University Medical College	This work was supported by Asia Pacific League of Association for Rheumatology (APLAR) Community Oriented program for Control of Rheumatic Diseases (COPCORD), Grant 2012, and partly supported by a grant from Shantou University Medical College (NO.LDo30601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Caughey D, 1988, SEAPAL B, V7, P11; Chen R, 2000, CHIN J RHEUMATOL, V4, P240; Chen R, 1993, J SHANTOU U MED COLL, V2, P54; Chen SL, 1998, CHINESE MED J-PEKING, V111, P228; Chen SL, 1996, 8 AS PAC LEAG ASS RH, ps182; Chen SL, 1991, APLAR RHEUMATOLOGY S, V18, p10S; Chopra A, 2001, J Assoc Physicians India, V49, P240; Chopra A, 2015, J INDIAN J RHEUMATOL, V10, P70, DOI DOI 10.1016/J.INJR.2015.04.002; CHOU CT, 1994, J RHEUMATOL, V21, P302; Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301; Dai SM, 2003, J RHEUMATOL, V30, P2245; Darmawan J, 2007, CLIN RHEUMATOL, V26, P853, DOI 10.1007/s10067-007-0553-x; Du H, 2005, RHEUMATOL INT, V25, P585, DOI 10.1007/s00296-004-0492-7; [方卫纲 FANG Weigang], 2006, [基础医学与临床, Basic Medical Sciences and Clinics], V26, P781; Haq SA, 2005, J RHEUMATOL, V32, P348; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; Lin L., 2007, SHANXI MED J, V8, P678; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; NISHIKAI M, 1992, J RHEUMATOL, V19, P110; Pelaez-Ballestas I, 2011, J RHEUMATOL, V38, P3, DOI 10.3899/jrheum.100951; Shi Fang, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1136; Silman AJ, 1993, OSTEOARTHRITIS, P257; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WIGLEY RD, 1994, J RHEUMATOL, V21, P1484; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yang X Y, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P10; Zang CH., 2007, CHIN REMEDIES CLIN, V8, P597; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zeng QY, 2006, CHINESE MED J-PEKING, V119, P1522, DOI 10.1097/00029330-200609020-00004; Zeng QY, 2005, J RHEUMATOL, V32, P920; Zeng QY, 2004, J RHEUMATOL, V31, P2439; Zeng QY, 2003, CHINESE MED J-PEKING, V116, P66; Zeng QY, 1987, CHINESE J INTERN MED, V26, P387; Zeng QY, 1995, APLAR B, V13, P74; Zeng QY, 1993, J SHANTOU U MED COLL, V6, P46; Zhang NZ, 1985, S 2 NAT C RHEUM CHIN, P99; Zhang NZ, 1988, S 3 NAT C RHEUM CHIN, P1; Zhang NZ, 1994, CHINESE J INTERN MED, V34, P84	42	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138492	10.1371/journal.pone.0138492	http://dx.doi.org/10.1371/journal.pone.0138492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406469	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700050
J	Guitet, S; Herault, B; Molto, Q; Brunaux, O; Couteron, P				Guitet, Stephane; Herault, Bruno; Molto, Quentin; Brunaux, Olivier; Couteron, Pierre			Spatial Structure of Above-Ground Biomass Limits Accuracy of Carbon Mapping in Rainforest but Large Scale Forest Inventories Can Help to Overcome	PLOS ONE			English	Article							TROPICAL FOREST; LIVE BIOMASS; REGIONAL-VARIATION; NATIONAL FOREST; TREE DIVERSITY; UNCERTAINTY; AMAZON; EMISSIONS; BALANCE; DENSITY	Precise mapping of above-ground biomass (AGB) is a major challenge for the success of REDD+ processes in tropical rainforest. The usual mapping methods are based on two hypotheses: a large and long-ranged spatial autocorrelation and a strong environment influence at the regional scale. However, there are no studies of the spatial structure of AGB at the landscapes scale to support these assumptions. We studied spatial variation in AGB at various scales using two large forest inventories conducted in French Guiana. The dataset comprised 2507 plots (0.4 to 0.5 ha) of undisturbed rainforest distributed over the whole region. After checking the uncertainties of estimates obtained from these data, we used half of the dataset to develop explicit predictive models including spatial and environmental effects and tested the accuracy of the resulting maps according to their resolution using the rest of the data. Forest inventories provided accurate AGB estimates at the plot scale, for a mean of 325 Mg. ha(-1). They revealed high local variability combined with a weak autocorrelation up to distances of no more than 10 km. Environmental variables accounted for a minor part of spatial variation. Accuracy of the best model including spatial effects was 90 Mg. ha(-1) at plot scale but coarse graining up to 2-km resolution allowed mapping AGB with accuracy lower than 50 Mg. ha(-1). Whatever the resolution, no agreement was found with available pan-tropical reference maps at all resolutions. We concluded that the combined weak autocorrelation and weak environmental effect limit AGB maps accuracy in rainforest, and that a trade-off has to be found between spatial resolution and effective accuracy until adequate "wall-to-wall" remote sensing signals provide reliable AGB predictions. Waiting for this, using large forest inventories with low sampling rate (< 0.5%) may be an efficient way to increase the global coverage of AGB maps with acceptable accuracy at kilometric resolution.	[Guitet, Stephane; Brunaux, Olivier] ONF, R&D Dept, Cayenne, French Guiana; [Guitet, Stephane] INRA, UMR Amap, F-34060 Montpellier, France; [Herault, Bruno] Ctr Cooperat Int Rech Agronom Dev CIRAD, UMR EcoFoG, Kourou, French Guiana; [Molto, Quentin] CIRAD, UR BSEF, Montpellier, France; [Guitet, Stephane; Couteron, Pierre] IRD, UMR Amap, Montpellier, France	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; CIRAD; CIRAD; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Guitet, S (corresponding author), ONF, R&D Dept, Cayenne, French Guiana.	stephane.guitet@cirad.fr	Hérault, Bruno/B-2765-2011; Guitet, Stéphane/F-5616-2016	Hérault, Bruno/0000-0002-6950-7286; Guitet, Stéphane/0000-0003-2374-4240	Office National des Forets (ONF); Parc Amazonien de Guyane (PAG); French Ministry of the Environment (MEDD); European Union (UE) [FEDER 30453]; project Observatoire du Carbone (Region Guyane)	Office National des Forets (ONF); Parc Amazonien de Guyane (PAG); French Ministry of the Environment (MEDD); European Union (UE)(European Commission); project Observatoire du Carbone (Region Guyane)	Office National des Forets (ONF), Parc Amazonien de Guyane (PAG), the ECOTROP and BGF programs of the French Ministry of the Environment (MEDD), and the PO-FEDER program of the European Union (UE, ref. FEDER 30453-28/10/2009) provided funding for part of the data collection. Funding for publication came from the project Observatoire du Carbone (European structural fundings, Region Guyane). BH benefited from an 'Investissement d'Avenir' grant managed by the Agence Nationale de la recherche (CEBA, ref ANR-10-LABX-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2012, BIOGEOSCIENCES DISCU, V9, P2445, DOI DOI 10.5194/BGD-9-2445-2012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Baccini A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045011; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker DJ, 2010, ENVIRON SCI POLICY, V13, P249, DOI 10.1016/j.envsci.2010.03.004; Baraloto C, 2013, BIOTROPICA, V45, P288, DOI 10.1111/btp.12006; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Bastin JF, 2014, ECOL APPL, V24, P1984, DOI 10.1890/13-1574.1; Basuki TM, 2012, GEOCARTO INT, V27, P329, DOI 10.1080/10106049.2011.634928; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chen Q, 2015, REMOTE SENS ENVIRON, V160, P134, DOI 10.1016/j.rse.2015.01.009; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark ML, 2011, REMOTE SENS ENVIRON, V115, P2931, DOI 10.1016/j.rse.2010.08.029; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; Deblauwe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048766; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Glenday J, 2006, FOREST ECOL MANAG, V235, P72, DOI 10.1016/j.foreco.2006.08.014; Gond V, 2011, INT J APPL EARTH OBS, V13, P357, DOI 10.1016/j.jag.2011.01.004; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Guitet S, 2014, FOREST ECOL MANAG, V328, P270, DOI 10.1016/j.foreco.2014.05.045; Guitet S, 2013, J MAPS, V9, P325, DOI 10.1080/17445647.2013.785371; Hawes JE, 2012, FOREST ECOL MANAG, V281, P163, DOI 10.1016/j.foreco.2012.06.023; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Huffman GJ, 2007, JOURNAL OF HYDROMETE, V8; Ioki K, 2014, FOREST ECOL MANAG, V328, P335, DOI 10.1016/j.foreco.2014.06.003; Kasischke ES, 1997, REMOTE SENS ENVIRON, V59, P141, DOI 10.1016/S0034-4257(96)00148-4; Keller M, 2001, FOREST ECOL MANAG, V154, P371, DOI 10.1016/S0378-1127(01)00509-6; Laumonier Y, 2010, FOREST ECOL MANAG, V259, P505, DOI 10.1016/j.foreco.2009.11.007; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Maniatis D., 2011, International Journal of Forestry Research, V2011, P134526, DOI 10.1155/2011/134526; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; Mascaro Joseph, 2014, Carbon Balance Manag, V9, P7, DOI 10.1186/s13021-014-0007-0; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; McRoberts RE, 2014, FOREST SCI, V60, P34, DOI 10.5849/forsci.12-141; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Molto Q, 2014, BIOGEOSCIENCES, V11, P3121, DOI 10.5194/bg-11-3121-2014; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P1853, DOI 10.1016/j.foreco.2008.07.022; Oldeman RAA, 1972, LARCHITECTURE DE LA; Ollier S, 2003, REMOTE SENS ENVIRON, V85, P453, DOI 10.1016/S0034-4257(03)00038-5; Ploton P, 2012, ECOL APPL, V22, P993, DOI 10.1890/11-1606.1; Proisy C, 2007, REMOTE SENS ENVIRON, V109, P379, DOI 10.1016/j.rse.2007.01.009; Propastin P, 2013, GISCI REMOTE SENS, V50, P633, DOI 10.1080/15481603.2013.850305; Qureshi A, 2012, ENVIRON SCI POLICY, V16, P81, DOI 10.1016/j.envsci.2011.11.001; Rejou-Mechain M, 2014, BIOGEOSCIENCES DISCU, V11, P5711, DOI DOI 10.5194/BGD-11-5711-2014; Rejou-Mechain M, 2008, J TROP ECOL, V24, P663, DOI 10.1017/S0266467408005506; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Ribeiro Jr P. J., 2001, R NEWS, V1, P14; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Rutishauser E, 2010, J VEG SCI, V21, P672, DOI 10.1111/j.1654-1103.2010.01175.x; Saatchi S., 2009, BIOGEO SCI DISCUSS, V6, P5461, DOI [10.5194/bgd-6-5461-2009, DOI 10.5194/BGD-6-5461-2009]; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sales MH, 2007, ECOL MODEL, V205, P221, DOI 10.1016/j.ecolmodel.2007.02.033; Traissac S, 2014, J VEG SCI, V25, P491, DOI 10.1111/jvs.12080; Truffet C., 2003, GEOL FR, P5; Valeix J., 1989, BOIS FOR TROP, V219, P13; Vincent G, 2014, OECOLOGIA, V175, P439, DOI 10.1007/s00442-014-2913-y; Wagner F, 2010, BIOTROPICA, V42, P664, DOI 10.1111/j.1744-7429.2010.00644.x; Zanne A.E., 2009, DRYAD IDENTIFIER HTT, P235	67	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138456	10.1371/journal.pone.0138456	http://dx.doi.org/10.1371/journal.pone.0138456			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402522	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100024
J	Ilie, DE; Cean, A; Cziszter, LT; Gavojdian, D; Ivan, A; Kusza, S				Ilie, Daniela Elena; Cean, Ada; Cziszter, Ludovic Toma; Gavojdian, Dinu; Ivan, Alexandra; Kusza, Szilvia			Microsatellite and Mitochondrial DNA Study of Native Eastern European Cattle Populations: The Case of the Romanian Grey	PLOS ONE			English	Article							GENETIC DIVERSITY; ALLELE FREQUENCY; BOS-TAURUS; BREEDS; SOFTWARE; ORIGINS; MUTATIONS; SEQUENCE; GROWTH; TESTS	The Eastern European Grey cattle are regarded as the direct descendants of the aurochs (Bos taurus primigenius). Nowadays in Romania, less than 100 Grey animals are being reared and included in the national gene reserve. We examined the genetic diversity among Romanian Grey, Brown, Spotted and Black and White cattle breeds, with a particular focus on Romanian Grey through the use of (i) 11 bovine specific microsatellite markers on 83 animals and (ii) 638 bp length of mitochondrial DNA (mtDNA) D-loop region sequence data from a total of 81 animals. Both microsatellite and mtDNA analysis revealed a high level of genetic variation in the studied breeds. In Romanian Grey a total of 100 alleles were found, the mean number of observed alleles per locus was 9.091; the average observed heterozygosity was 0.940; the Wright's fixation index (F-IS) was negative (-0.189) and indicates that there is no inbreeding and no selection pressure. MtDNA analysis revealed 52 haplotypes with 67 variable sites among the Romanian cattle breeds without any insertion or deletion. Haplotype diversity was 0.980 +/- 0.007 and ranged from 0.883 +/- 0.056 (Brown) to 0.990 +/- 0.028 (Spotted and Black and White). The highest genetic variability of the mtDNA was recorded in the Grey breed, where 18 haplotypes were identified. The most frequent mtDNA D-loop region belonged to T3 haplogroup (80.247%), which was found across all studied breeds, while T2 haplotypes (16.049%) was only found in Grey, Spotted and Black and White genotypes. The T1 haplotypes (3.704%) were found in the Grey and Spotted. The current results contribute to the general knowledge on genetic diversity found in Eastern European cattle breeds and could prove a valuable tool for the conservation efforts of animal genetic resources (FAnGR).	[Ilie, Daniela Elena; Cean, Ada] Res & Dev Stn Bovine, Dept Res, Arad, Romania; [Cziszter, Ludovic Toma] Banats Univ Agr Sci & Vet Med King Michael I Roma, Dept Anim Prod Engn, Timisoara, Timis, Romania; [Gavojdian, Dinu] Res & Dev Stn Sheep & Goats, Dept Res, Caras Severin, Romania; [Ivan, Alexandra] Univ Med & Farm Timisoara, Dept Funct Sci, Timisoara, Timis, Romania; [Kusza, Szilvia] Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, Anim Genet Lab, Debrecen, Hungary	Banat University of Agricultural Sciences & Veterinary Medicine; Victor Babes University of Medicine & Pharmacy, Timisoara; University of Debrecen	Kusza, S (corresponding author), Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, Anim Genet Lab, Debrecen, Hungary.	kusza@agr.unideb.hu	Gavojdian, Dinu/AAD-2019-2020; Ilie, Daniela Elena/D-7257-2015	Ilie, Daniela Elena/0000-0002-0464-3199; Cziszter, Ludovic/0000-0003-1896-1515; Gavojdian, Dinu/0000-0001-9603-881X	UEFISCDI, PN II PCCA (CONSENS acronym) [120/2012]	UEFISCDI, PN II PCCA (CONSENS acronym)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	The study was supported by a UEFISCDI, PN II PCCA under grant agreement number 120/2012 (CONSENS acronym), project title: Translating stem cell technologies to the conservation of highly endangered species.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; ANARZ, 2014, ANN REP NAT AG AN IM; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Bacila V, 2011, PODOLIC CATTLE, P118; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Belkhir K, 2004, GENETIX V 4 05 LOGIC; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Brzustowski J, 2002, DOH ASSIGNMENT TEST; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Chelmu SS, 2013, ROM BIOTECH LETT, V18, P8715; Cornuet JM, 1996, GENETICS, V144, P2001; Creanga S., 2011, Lucrari Stiintifice - Universitatea de Stiinte Agricole si Medicina Veterinara, Seria Zootehnie, V56, P3; Creanga S, 2010, GREY STEPPE BREED RO; D'ANDREA M., 2011, ITAL J ANIM SCI, V10, P237; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dudu A., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P64; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Epstein H., 1984, EVOLUTION DOMESTICAT, P6; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2011, FAO STAT YB 2010; FAO, 2003, COUNTR REP SOW AN GR; FAO, 2015, LIST DOM AN DIV; FAO, 2011, MOL GEN CHAR AN GEN; Felius M., 2011, Diversity, V3, P660, DOI 10.3390/d3040660; Fu YX, 1997, GENETICS, V147, P915; Georgescu SE, 2009, ROM BIOTECH LETT, V14, P4194; Georgescu SE, 2012, ANAL GENETIC VARIATI, P27; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Goudet J, 2002, FSTAT 2 9 3 2; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hiemstra SJ, 2012, LOCAL CATTLE BREEDS; Hristov P, 2015, ANIM GENET, V46, P92, DOI 10.1111/age.12253; Ivankovic A, 2014, CZECH J ANIM SCI, V59, P519, DOI 10.17221/7733-CJAS; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kantanen J, 2009, HEREDITY, V103, P404, DOI 10.1038/hdy.2009.68; Keros T, 2015, ACTA VET-BEOGRAD, V65, P89, DOI 10.1515/acve-2015-0007; Keros T, 2013, ACTA VET BRNO, V82, P135, DOI 10.2754/avb201382020135; Khalaf M., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P77; Kusza S, 2014, 3 INT S HUNT MOD ASP, P61; Kusza S, 2008, SMALL RUMINANT RES, V78, P13, DOI 10.1016/j.smallrumres.2008.04.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Li Meng-Hua, 2011, BMC Res Notes, V4, P37, DOI 10.1186/1756-0500-4-37; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magee D. A., 2014, Animal Frontiers, V4, P7, DOI 10.2527/af.2014-0017; Manatrinon S, 2008, ARCH TIERZUCHT, V51, P426, DOI 10.5194/aab-51-426-2008; Manunza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055891; Moioli B, 2004, J HERED, V95, P250, DOI 10.1093/jhered/esh032; Ozsensoy Y., 2014, Journal of Advanced Veterinary and Animal Research, V1, P86; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Pieragostini E, 2000, COMP BIOCHEM PHYS B, V127, P1, DOI 10.1016/S0305-0491(00)00218-2; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Seroussi E, 2010, ANIMAL, V4, P1818, DOI 10.1017/S1751731110001151; Steinborn R, 1998, BBA-GENE STRUCT EXPR, V1397, P295, DOI 10.1016/S0167-4781(98)00019-0; Stevanovic J, 2010, CZECH J ANIM SCI, V55, P221, DOI 10.17221/183/2009-CJAS; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teneva A., 2005, Biotechnology in Animal Husbandry, V21, P35; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Xuan TP, 2010, ROM BIOTECH LETT, V15, P5287; Zsolnai A, 2014, ANIM SCI PAP REP, V32, P121	70	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138736	10.1371/journal.pone.0138736	http://dx.doi.org/10.1371/journal.pone.0138736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398563	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500100
J	Marubodee, R; Ogiso-Tanaka, E; Isemura, T; Chankaew, S; Kaga, A; Naito, K; Ehara, H; Tomooka, N				Marubodee, Rusama; Ogiso-Tanaka, Eri; Isemura, Takehisa; Chankaew, Sompong; Kaga, Akito; Naito, Ken; Ehara, Hiroshi; Tomooka, Norihiko			Construction of an SSR and RAD-Marker Based Molecular Linkage Map of Vigna vexillata (L.) A. Rich	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; ANGULARIS WILLD. OHWI; WILD ACCESSIONS; GENOME SEQUENCE; SALT TOLERANCE; TRAITS; DOMESTICATION; CROP; RESISTANCE; EVOLUTION	Vigna vexillata (L.) A. Rich. (tuber cowpea) is an underutilized crop for consuming its tuber and mature seeds. Wild form of V. vexillata is a pan-tropical perennial herbaceous plant which has been used by local people as a food. Wild V. vexillata has also been considered as useful gene(s) source for V. unguiculata (cowpea), since it was reported to have various resistance gene(s) for insects and diseases of cowpea. To exploit the potential of V. vexillata, an SSR-based linkage map of V. vexillata was developed. A total of 874 SSR markers successfully amplified single DNA fragment in V. vexillata among 1,336 SSR markers developed from Vigna angularis (azuki bean), V. unguiculata and Phaseolus vulgaris (common bean). An F-2 population of 300 plants derived from a cross between salt resistant (V1) and susceptible (V5) accessions was used for mapping. A genetic linkage map was constructed using 82 polymorphic SSR markers loci, which could be assigned to 11 linkage groups spanning 511.5 cM in length with a mean distance of 7.2 cM between adjacent markers. To develop higher density molecular linkage map and to confirm SSR markers position in a linkage map, RAD markers were developed and a combined SSR and RAD markers linkage map of V. vexillata was constructed. A total of 559 (84 SSR and 475 RAD) markers loci could be assigned to 11 linkage groups spanning 973.9 cM in length with a mean distance of 1.8 cM between adjacent markers. Linkage and genetic position of all SSR markers in an SSR linkage map were confirmed. When an SSR genetic linkage map of V. vexillata was compared with those of V. radiata and V. unguiculata, it was suggested that the structure of V. vexillata chromosome was considerably differentiated. This map is the first SSR and RAD marker-based V. vexillata linkage map which can be used for the mapping of useful traits.	[Marubodee, Rusama; Ehara, Hiroshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5140102, Japan; [Chankaew, Sompong] Khon Kaen Univ, Dept Plant Sci & Agr Resources, Fac Agr, Khon Kaen 40002, Thailand; [Ogiso-Tanaka, Eri; Isemura, Takehisa; Kaga, Akito; Naito, Ken; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan	Mie University; Khon Kaen University; National Institute of Agrobiological Sciences - Japan	Tomooka, N (corresponding author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Kannondai 2-1-2, Tsukuba, Ibaraki 3058602, Japan.	tomooka@affrc.go.jp	Ogiso-Tanaka, Eri/P-3518-2019; Ogiso-Tanaka, Eri/GWR-3103-2022	Ogiso-Tanaka, Eri/0000-0002-7655-3408; Marubodee, Rusama/0000-0003-1797-4541; Naito, Ken/0000-0002-0273-7837	Ph.D. scholarship program of Monbukagakusho (MEXT), Japan; Genebank Project of the National Institute of Agrobiological Sciences (NIAS), Japna; Grants-in-Aid for Scientific Research [25292209] Funding Source: KAKEN	Ph.D. scholarship program of Monbukagakusho (MEXT), Japan; Genebank Project of the National Institute of Agrobiological Sciences (NIAS), Japna; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Ph.D. scholarship program of Monbukagakusho (MEXT), Japan to RM, Genebank Project of the National Institute of Agrobiological Sciences (NIAS), Japna to NT, study design, data collection and analysis, publication, preparation of the manuscript.	[Anonymous], 1981, HDB LEGUMES WORLD EC; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Ashraf M, 2013, PLANT BREEDING, V132, P10, DOI 10.1111/pbr.12000; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Baudoin JP, 1987, MUNGB P 2 INT S NOV; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaitieng B, 2006, THEOR APPL GENET, V113, P1261, DOI 10.1007/s00122-006-0380-5; CHANDEL KPS, 1972, CURR SCI INDIA, V41, P537; Chankaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104990; Chankaew S, 2014, THEOR APPL GENET, V127, P691, DOI 10.1007/s00122-013-2251-1; Choi HW, 2013, GENES GENOM, V35, P257, DOI 10.1007/s13258-013-0089-1; Damayanti F, 2010, CROP PASTURE SCI, V61, P798, DOI 10.1071/CP10084; Damayanti F, 2010, CROP PASTURE SCI, V61, P785, DOI 10.1071/CP10060; Damayanti F, 2010, CROP PASTURE SCI, V61, P771, DOI 10.1071/CP10029; Fatokun C. A., 1997, Advances in cowpea research, P50; FATOKUN CA, 1993, THEOR APPL GENET, V86, P97, DOI 10.1007/BF00223813; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Garba M., 1998, Proceedings of 2nd International Symposium on Tuberous Legumes, Celaya, Guanajuato, Mexico, 5-8 August 1996., P61; Goel S, 2002, MOL PHYLOGENET EVOL, V22, P1, DOI 10.1006/mpev.2001.1037; Gomathinayagam P, 1998, EUPHYTICA, V102, P203, DOI 10.1023/A:1018381614098; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Hegarty M, 2013, PLANT BIOTECHNOL J, V11, P572, DOI 10.1111/pbi.12045; Isemura T, 2007, ANN BOT-LONDON, V100, P1053, DOI 10.1093/aob/mcm155; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; Jackai LEN, 1996, CROP PROT, V15, P753, DOI 10.1016/S0261-2194(96)00050-6; JAMES AT, 1991, AUST J BOT, V39, P415, DOI 10.1071/BT9910415; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Kang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08069; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Karuniawan A, 2006, GENET RESOUR CROP EV, V53, P213, DOI 10.1007/s10722-005-1654-5; Kongjaimun A, 2012, GENOME, V55, P81, DOI [10.1139/G11-078, 10.1139/g11-078]; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lattanzio V, 2005, J SCI FOOD AGR, V85, P839, DOI 10.1002/jsfa.2024; LAWN RJ, 1988, BIOLOGIST, V35, P267; Lawn RJ, 2002, AUST J AGR RES, V53, P1305, DOI 10.1071/AR02065; Leguminosae Verdcourt B., 1971, FLORA TROPICAL E AFR, V4, P652; Li CD, 2001, CROP SCI, V41, P189, DOI 10.2135/cropsci2001.411189x; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; MARECHAL R, 1978, Boissiera, V28, P1; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087138; Maxted N, 2004, AFRICAN VIGNA AN ECO; MILLER IL, 1981, TROP GRASSLANDS, V15, P39; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Ogundiwin EA, 2005, PLANT BREEDING, V124, P392, DOI 10.1111/j.1439-0523.2005.01130.x; Ogundiwin EA, 2002, PLANT BREEDING, V121, P517, DOI 10.1046/j.1439-0523.2002.00769.x; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; SASIKUMAR B, 1988, ECON BOT, V42, P292; Spinosa A, 1998, GENET RESOUR CROP EV, V45, P347, DOI 10.1023/A:1008632919530; TATEISHI Y, 1990, SERIES ENTOM, V46, P189; Thottappilly G., 1994, International Journal of Tropical Plant Diseases, V12, P75; Tomooka N, 2012, PLANT GENET RESOUR, V12, pS168; Tomooka N., 2014, BROADENING GENETIC B, P175; United States of America. National Research Council (NRC), 1979, VIGN VEX TROP LEG RE, P34; Van Ooijen JW, 2006, JOINMAP VERSION 4 0; VANDERBORGHT T, 1989, Bulletin du Jardin Botanique National de Belgique, V59, P179, DOI 10.2307/3668164; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Verdcourt B., 1970, KEW B, V24, P440; Wang LX, 2015, J PLANT RES, V128, P653, DOI 10.1007/s10265-015-0720-0; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	66	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138942	10.1371/journal.pone.0138942	http://dx.doi.org/10.1371/journal.pone.0138942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398819	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500130
J	Prescott, HMA; Manning, C; Gardner, A; Ritchie, WA; Pizzi, R; Girling, S; Valentine, I; Wang, CD; Jahoda, CAB				Prescott, Hilary M. A.; Manning, Craig; Gardner, Aaron; Ritchie, William A.; Pizzi, Romain; Girling, Simon; Valentine, Iain; Wang, Chengdong; Jahoda, Colin A. B.			Giant Panda (Ailuropoda melanoleuca) Buccal Mucosa Tissue as a Source of Multipotent Progenitor Cells	PLOS ONE			English	Article							SKIN-DERIVED PRECURSORS; PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; SOMATIC-CELLS; DERMIS; NICHE; SKPS	Since the first mammal was cloned, the idea of using this technique to help endangered species has aroused considerable interest. However, several issues limit this possibility, including the relatively low success rate at every stage of the cloning process, and the dearth of usable tissues from these rare animals. IPS cells have been produced from cells from a number of rare mammalian species and this is the method of choice for strategies to improve cloning efficiency and create new gametes by directed differentiation. Nevertheless information about other stem cell/progenitor capabilities of cells from endangered species could prove important for future conservation approaches and adds to the knowledge base about cellular material that can be extremely limited. Multipotent progenitor cells, termed skin-derived precursor (SKP) cells, can be isolated directly from mammalian skin dermis, and human cheek tissue has also been shown to be a good source of SKP-like cells. Recently we showed that structures identical to SKPs termed m-SKPs could be obtained from monolayer/two dimensional (2D) skin fibroblast cultures. Here we aimed to isolate m-SKPs from cultured cells of three endangered species; giant panda (Ailuropoda melanoleuca); red panda (Ailurus fulgens); and Asiatic lion (Panthera leo persica). m-SKP-like spheres were formed from the giant panda buccal mucosa fibroblasts; whereas dermal fibroblast (DF) cells cultured from abdominal skin of the other two species were unable to generate spheres. Under specific differentiation culture conditions giant panda spheres expressed neural, Schwann, adipogenic and osteogenic cell markers. Furthermore, these buccal mucosa derived spheres were shown to maintain expression of SKP markers: nestin, versican, fibronectin, and P75 and switch on expression of the stem cell marker ABCG2. These results demonstrate that giant panda cheek skin can be a useful source of m-SKP multipotent progenitors. At present lack of sample numbers means that we can only postulate why we were unable to obtain m-SKPs from the lion and red panda cultures. However the giant panda observations point to the value of archiving cells from rare species, and the possibilities for later progenitor cell derivation.	[Prescott, Hilary M. A.; Manning, Craig; Gardner, Aaron; Jahoda, Colin A. B.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Ritchie, William A.] Roslin Embryol Ltd, Macmerry EH33 1QB, East Lothian, Scotland; [Pizzi, Romain; Girling, Simon; Valentine, Iain] Royal Zool Soc Scotland, Edinburgh EH13 6TS, Midlothian, Scotland; [Wang, Chengdong] China Conservat & Res Ctr Giant Panda, Dujiangyan 611844, Sichuan Provinc, Peoples R China	Durham University	Jahoda, CAB (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	colin.jahoda@durham.ac.uk	Gardner, Aaron/H-1511-2012; Pizzi, Romain/AAW-6360-2020	Gardner, Aaron/0000-0001-8729-9823; Pizzi, Romain/0000-0002-9030-9559; Jahoda, Colin/0000-0002-1762-1220; Girling, Simon/0000-0001-9927-9491	Royal Zoological Society of Edinburgh; Durham University	Royal Zoological Society of Edinburgh; Durham University	This work was funded by the Royal Zoological Society of Edinburgh and Durham University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Nun IF, 2011, NAT METHODS, V8, P829, DOI [10.1038/NMETH.1706, 10.1038/nmeth.1706]; BENIRSCHKE K, 1984, ZOO BIOL, V3, P325, DOI 10.1002/zoo.1430030405; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Chi GF, 2011, TISSUE ENG REGEN MED, V8, P238; Clarke A. G., 2009, International Zoo Yearbook, V43, P222, DOI 10.1111/j.1748-1090.2008.00074.x; Davis NG, 2013, WOUND REPAIR REGEN, V21, P571, DOI 10.1111/wrr.12054; Gago N, 2009, STEM CELLS, V27, P1164, DOI 10.1002/stem.27; Hill RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050742; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; Hunt DPJ, 2009, CURR OPIN BIOTECH, V20, P522, DOI 10.1016/j.copbio.2009.10.004; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Kwok CKM, 2013, J PEDIATR SURG, V48, P619, DOI 10.1016/j.jpedsurg.2012.08.026; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Loi P, 2007, TRENDS BIOTECHNOL, V25, P195, DOI 10.1016/j.tibtech.2007.03.007; Ruetze M, 2013, J DERMATOL SCI, V69, P132, DOI 10.1016/j.jdermsci.2012.10.007; Santos RR, 2010, ANIM REPROD SCI, V122, P151, DOI 10.1016/j.anireprosci.2010.08.010; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Verma R, 2012, THERIOGENOLOGY, V77, P220, DOI 10.1016/j.theriogenology.2011.09.022; Wenzel V, 2012, BIOL OPEN, V1, P516, DOI 10.1242/bio.20121149; Yoshikawa K, 2013, BIOCHEM BIOPH RES CO, V431, P104, DOI 10.1016/j.bbrc.2012.12.069; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhou SY, 2010, CELL RES, V20, P850, DOI 10.1038/cr.2010.78	24	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138840	10.1371/journal.pone.0138840	http://dx.doi.org/10.1371/journal.pone.0138840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398672	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000361797500115
J	Reynolds, MH; Courtot, KN; Berkowitz, P; Storlazzi, CD; Moore, J; Flint, E				Reynolds, Michelle H.; Courtot, Karen N.; Berkowitz, Paul; Storlazzi, Curt D.; Moore, Janet; Flint, Elizabeth			Will the Effects of Sea-Level Rise Create Ecological Traps for Pacific Island Seabirds?	PLOS ONE			English	Article							POPULATION-DYNAMICS; HAWAIIAN-ISLANDS; CLIMATE; CONSERVATION; LAYSAN; VULNERABILITY; PROJECTIONS; HABITAT; TSUNAMI; EVENTS	More than 18 million seabirds nest on 58 Pacific islands protected within vast U.S. Marine National Monuments (1.9 million km(2)). However, most of these seabird colonies are on low-elevation islands and sea-level rise (SLR) and accompanying high-water perturbations are predicted to escalate with climate change. To understand how SLR may impact protected islands and insular biodiversity, we modeled inundation and wave-driven flooding of a globally important seabird rookery in the subtropical Pacific. We acquired new high-resolution Digital Elevation Models (DEMs) and used the Delft3D wave model and ArcGIS to model wave heights and inundation for a range of SLR scenarios (+0.5, +1.0, +1.5, and +2.0 m) at Midway Atoll. Next, we classified vegetation to delineate habitat exposure to inundation and identified how breeding phenology, colony synchrony, and life history traits affect species-specific sensitivity. We identified 3 of 13 species as highly vulnerable to SLR in the Hawaiian Islands and quantified their atoll-wide distribution (Laysan albatross, Phoebastria immutabilis; black-footed albatross, P. nigripes; and Bonin petrel, Pterodroma hypoleuca). Our models of wave-driven flooding forecast nest losses up to 10% greater than passive inundation models at +1.0 m SLR. At projections of +2.0 m SLR, approximately 60% of albatross and 44% of Bonin petrel nests were overwashed displacing more than 616,400 breeding albatrosses and petrels. Habitat loss due to passive SLR may decrease the carrying capacity of some islands to support seabird colonies, while sudden high-water events directly reduce survival and reproduction. This is the first study to simulate wave-driven flooding and the combined impacts of SLR, groundwater rise, and storm waves on seabird colonies. Our results highlight the need for early climate change planning and restoration of higher elevation seabird refugia to prevent low-lying protected islands from becoming ecological traps in the face of rising sea levels.	[Reynolds, Michelle H.; Courtot, Karen N.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, POB 44, Hawaii Natl Pk, HI 96718 USA; [Berkowitz, Paul] Univ Hawai Hilo, Hawai Cooperat Studies Unit, Hilo, HI USA; [Storlazzi, Curt D.] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA USA; [Moore, Janet] St Marys Univ, Halifax, NS B3H 3C3, Canada; [Flint, Elizabeth] US Fish & Wildlife Serv, Pacific Isl Refuges & Monuments Off, Honolulu, HI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Saint Marys University - Canada; United States Department of the Interior; US Fish & Wildlife Service	Reynolds, MH (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, POB 44, Hawaii Natl Pk, HI 96718 USA.	mreynolds@usgs.gov		Courtot, Karen/0000-0002-8849-4054	National Climate Change and Wildlife Science Center NCCWSC; USFWS National Wildlife Refuge System Inventory and Monitoring [IAA F11RG00373, IAA F11RG00376]; US Geological Survey Pacific Island Ecosystems Research Center; US Geological Survey Pacific Coastal and Marine Science Center; US Fish and Wildlife Service	National Climate Change and Wildlife Science Center NCCWSC; USFWS National Wildlife Refuge System Inventory and Monitoring; US Geological Survey Pacific Island Ecosystems Research Center; US Geological Survey Pacific Coastal and Marine Science Center; US Fish and Wildlife Service(US Fish & Wildlife Service)	This study was funded primarily by the National Climate Change and Wildlife Science Center NCCWSC's FY09 RFP (https://nccwsc.usgs.gov/projects-list/5050cc14e4b0be20bb30eac8) with supplemental funding from USFWS National Wildlife Refuge System Inventory and Monitoring grants IAA F11RG00373 and IAA F11RG00376 ("Predicting the Impact of Storm Waves and Sea-Level Rise within the Papahanaumokuakea Marine National Monument"). These funders had no role in directing the study design, data collection, analysis, decision to publish this article, or preparation of this manuscript. Partial funding was provided salary support by the US Geological Survey's Pacific Island Ecosystems Research Center and Pacific Coastal and Marine Science Center and US Fish and Wildlife Service. These entities provided scientists' salary support, in kind support, data collection facilitation, author salary support, and supported publication of this work.	[Anonymous], 2009, PRESIDENTIAL PROCLAM; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; [Anonymous], 1909, 1019 HAW ISL RES; [Anonymous], 2014, PRESIDENTIAL PROCLAM; [Anonymous], 1996, 13022 ADM MIDW ISL; [Anonymous], 2006, PRESIDENTIAL PROCLAM; Athens JS, 2007, PAC SCI, V61, P17, DOI 10.1353/psc.2007.0001; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Aucan J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052993; Awkerman J.A., 2009, BIRDS N AM ONLINE; Awkerman JA, 2008, BIRDS N AM ONLINE, V65; Awkerman JA, 2006, BIOL CONSERV, V133, P483, DOI 10.1016/j.biocon.2006.07.010; Baker J.D., 2006, ENDANGER SPECIES RES, V2, P21, DOI DOI 10.3354/ESR002021; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Berkowitz P, 2012, USGS OPEN-FILE REP, P72; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Breid J, 2002, BIOL MARINE BIRDS; Bried J, 2003, ANIM BEHAV, V65, P235, DOI 10.1006/anbe.2002.2045; Burney DA, 2001, ECOL MONOGR, V71, P615, DOI 10.1890/0012-9615(2001)071[0615:FEFADB]2.0.CO;2; CITTA J, 2007, HSCU007 U HAW HIL; Clapp RB, 1975, ATOLL RES B, P186; Clifford LD, 2001, J ANIM ECOL, V70, P539, DOI 10.1046/j.1365-2656.2001.00521.x; Coastal Services Center, 2010, MAPP IN UNC; Coulson J.C., 2001, BIOL MARINE BIRDS, P100; DigitalGlobe Inc, 2011, WORLDVIEW 2 SA UNPUB; Dunbar P, 2011, GEOMAT NAT HAZ RISK, V2, P305, DOI 10.1080/19475705.2011.632443; Dutch Institute for Delta Technology, 2011, DELFT HYDR SOFTW DEF; Environmental Systems Research Institute, 2010, ARCGIS 10 0 SP3; FEARE CJ, 1976, J ZOOL, V179, P317; Finkelstein ME, 2010, ANIM CONSERV, V13, P148, DOI 10.1111/j.1469-1795.2009.00311.x; Fisher Harvey I., 1946, CONDOR, V48, P3, DOI 10.2307/1364149; FISHER HI, 1972, AUK, V89, P381, DOI 10.2307/4084213; Fletcher CH, 2009, SHORE BEACH, V77, P4; Flint E, 2011, ALBATROSS POPU UNPUB; Flint E, 2012, MANAGEMENT BLACK FOO; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Friedlander AK, 2009, 84 NOAA NOS NCCOS BI; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gaston AT, 2009, CONDOR, V111, P111, DOI 10.1525/cond.2009.080077; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Gesch DB, 2009, COASTAL ELEVATIONS C, V4, P25; Gillett NP, 2011, NAT GEOSCI, V4, P83, DOI 10.1038/NGEO1047; Gingerich SB, 2008, 20085236 US GEOL SUR, P95; Grady AE, 2013, GEOPHYS RES LETT, V40, P3096, DOI 10.1002/grl.50577; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Grothe P.R., 2010, DIGITAL ELEVATION MO; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Handel CM, 2000, ANIM BEHAV, V60, P471, DOI 10.1006/anbe.2000.1505; Hatfield JS, 2012, CONSERV BIOL, V26, P667, DOI 10.1111/j.1523-1739.2012.01853.x; Hazin Maria Carolina, 2006, Revista Brasileira de Ornitologia, V14, P261; Hu AX, 2013, NAT CLIM CHANGE, V3, P730, DOI [10.1038/nclimate1869, 10.1038/NCLIMATE1869]; Iwamura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015103; Jevrejeva S, 2012, GLOBAL PLANET CHANGE, V80-81, P14, DOI 10.1016/j.gloplacha.2011.09.006; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Lindsey GD, 1997, TECHNICAL OPTIONS RE; Mayer T, 2005, UNPUB; Merrifield MA, 2011, J CLIMATE, V24, P4126, DOI 10.1175/2011JCLI3932.1; Miller TE, 2010, PLANT ECOL, V206, P97, DOI 10.1007/s11258-009-9626-z; Mimura N, 1999, CLIM RES, V12, P137, DOI 10.3354/cr012137; Moore J. D., 2009, THESIS; Mousavi ME, 2011, CLIMATIC CHANGE, V104, P575, DOI 10.1007/s10584-009-9790-0; National Oceanic and Atmospheric Administration, 2012, MIDW AT PI 1 3 ARC 2; NOAA (National Oceanic and Atmospheric Administration), 2011, TID CURR SILV SPRING; NOAA (National Oceanic and Atmospheric Administration), 2010, MAPP IN UN; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; Orlic M, 2013, NAT CLIM CHANGE, V3, P735, DOI [10.1038/NCLIMATE1877, 10.1038/nclimate1877]; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Page-Albins KN, 2012, PAC SCI, V66, P481, DOI 10.2984/66.4.6; Perrette M, 2013, EARTH SYST DYNAM, V4, P11, DOI 10.5194/esd-4-11-2013; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; PhotoSat Information Ltd, 2011, DIG TERR MOD UNPUB; Pyle R. L., 2017, BIRDS HAWAIIAN ISLAN; Rahmstorf S, 2012, ENVIRON RES LETT, V7, DOI [10.1088/1748-9326/7/4/044035, 10.1088/1748-9326/7/2/021001]; Rauzon M. J., 2001, ISLES REFUGE WILDLIF, V1st; Reynolds M.H., 2012, 20121182 US GEOL SUR; Reynolds MH, 2013, HCSU037 U HAW HIL; RICE DALE W., 1962, AUK, V79, P517; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Ris RC, 1999, J GEOPHYS RES-OCEANS, V104, P7667, DOI 10.1029/1998JC900123; Robbins CS, 1966, 85 US FISH WILDL SER; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Roby DD, 2002, J WILDLIFE MANAGE, V66, P662, DOI 10.2307/3803132; Rotzoll K, 2007, J AM WATER RESOUR AS, V43, P334, DOI 10.1111/j.1752-1688.2007.00026.x; Rotzoll K, 2013, NAT CLIM CHANGE, V3, P477, DOI [10.1038/NCLIMATE1725, 10.1038/nclimate1725]; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schreiber EA, 2002, BIOL MARINE BIRDS, P665; Seavey JR, 2011, BIOL CONSERV, V144, P393, DOI 10.1016/j.biocon.2010.09.017; Seto NW, 1999, BIRDS N AM ONLINE, V385; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Stockdon HF, 2006, COAST ENG, V53, P573, DOI 10.1016/j.coastaleng.2005.12.005; Storlazzi CD, 2011, CORAL REEFS, V30, P83, DOI 10.1007/s00338-011-0723-9; Storlazzi C. D., 2013, 20131069 US GEOL SUR; Storlazzi C.D, 2005, SCI INVESTIGATIONS R; Storlazzi CD, 2010, CONT SHELF RES, V30, P1582, DOI 10.1016/j.csr.2010.06.004; Tillmann P, 2013, CLIMATE CHANGE EFFEC; U. S. Fish and Wildlife Service, 2008, BIRDS CONS; UNESCO (United Nations Educational Scientific and Cultural Organization), 2010, DEC AD WORLD HER COM; US Army Corps of Engineers, WAV INF STUD WAV HIN; US Fish and Wildlife Service, 2013, ANN REP LANDS CONTR; USFWS (U.S. Fish and Wildlife Service), 2014, FIN ENV ASS NIH EC R; van der Meer E, 2015, ANIM CONSERV, V18, P359, DOI 10.1111/acv.12182; Vanderwerf EA, 2003, WILSON BULL, V115, P258, DOI 10.1676/03-028; VanderWerf EA, 2007, PAC SCI, V61, P39, DOI 10.1353/psc.2007.0012; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Viera VM, 2006, POLAR BIOL, V29, P713, DOI 10.1007/s00300-006-0128-3; Villanoy C, 2012, CLIMATIC CHANGE, V112, P493, DOI 10.1007/s10584-012-0399-3; Warham J., 1996, BEHAV POPULATION BIO; Watanabe M, 2014, GEOPHYS RES LETT, V41, P3227, DOI 10.1002/2014GL059692; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Weimerskirch H, 2001, BIOL MARINE BIRDS; Wetzel FT, 2013, GLOBAL CHANGE BIOL, V19, P2058, DOI 10.1111/gcb.12185; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Woodroffe CD, 2008, GLOBAL PLANET CHANGE, V62, P77, DOI 10.1016/j.gloplacha.2007.11.001; Work TM, 2010, J WILDLIFE DIS, V46, P499, DOI 10.7589/0090-3558-46.2.499; Young HS, 2015, BIOL CONSERV, V181, P226, DOI 10.1016/j.biocon.2014.10.027; Young Lindsay C., 2014, Marine Ornithology, V42, P99; Young LC, 2013, BIOL INVASIONS, V15, P2627, DOI 10.1007/s10530-013-0479-y	119	26	26	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0136773	10.1371/journal.pone.0136773	http://dx.doi.org/10.1371/journal.pone.0136773			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398209	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500013
J	Nagaoka, K; Fujii, K; Zhang, H; Usuda, K; Watanabe, G; Ivshina, M; Richter, JD				Nagaoka, K.; Fujii, K.; Zhang, H.; Usuda, K.; Watanabe, G.; Ivshina, M.; Richter, J. D.			CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis	ONCOGENE			English	Article							MESSENGER-RNA TRANSLATION; CYTOPLASMIC POLYADENYLATION; CELLULAR SENESCENCE; SYNAPTIC PLASTICITY; KNOCKOUT MICE; IN-VIVO; GROWTH; DIFFERENTIATION; MORPHOGENESIS; LOCALIZATION	In mouse mammary epithelial cells, cytoplasmic polyadenylation element binding protein 1 (CPEB1) mediates the apical localization of ZO-1 mRNA, which encodes a critical tight junction component. In mice lacking CPEB1 and in cultured cells from which CPEB has been depleted, randomly distributed ZO-1 mRNA leads to the loss of cell polarity. We have investigated whether this diminution of polarity results in an epithelial-to-mesenchyme (EMT) transition and possible increased metastatic potential. Here, we show that CPEB1-depleted mammary epithelial cells alter their gene expression profile in a manner consistent with an EMT and also become motile, which are made particularly robust when cells are treated with transforming growth factor-beta, an enhancer of EMT. CPEB1-depleted mammary cells become metastatic to the lung following injection into mouse fat pads while ectopically expressed CPEB1 prevents metastasis. Surprisingly, CPEB1 depletion causes some EMT/metastasis-related mRNAs to have shorter poly(A) tails while other mRNAs to have longer poly(A) tails. Matrix metalloproteinase 9 (MMP9) mRNA, which encodes a metastasis-promoting factor, undergoes poly(A) lengthening and enhanced translation upon CPEB reduction. Moreover, in human breast cancer cells that become progressively more metastatic, CPEB1 is reduced while MMP9 becomes more abundant. These data suggest that at least in part, CPEB1 regulation of MMP9 mRNA expression mediates metastasis of breast cancer cells.	[Nagaoka, K.; Fujii, K.; Zhang, H.; Usuda, K.; Watanabe, G.] Tokyo Univ Agr & Technol, Dept Vet Med, Lab Vet Physiol, Tokyo, Japan; [Ivshina, M.; Richter, J. D.] Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA	Tokyo University of Agriculture & Technology; University of Massachusetts System; University of Massachusetts Worcester	Nagaoka, K; Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	nagaokak@cc.tuat.ac.jp; joel.richter@umassmed.edu	Watanabe/G-1134-2013; Nagaoka, Kentaro/C-2019-2013	Watanabe/0000-0001-7611-4678; Nagaoka, Kentaro/0000-0003-1038-1380; Ivshina, Maria/0000-0002-0999-3470	NIH [GM46779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM46779 (to JDR).	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Bestman JE, 2008, P NATL ACAD SCI USA, V105, P20494, DOI 10.1073/pnas.0806296105; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; D'Ambrogio A, 2012, CELL REP, V2, P1537, DOI 10.1016/j.celrep.2012.10.023; Du L, 2005, RNA, V11, P1340, DOI 10.1261/rna.2870505; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Groppo R, 2011, MOL CELL BIOL, V31, P2707, DOI 10.1128/MCB.05133-11; Grudzien-Nogalska E, 2014, J CELL SCI, V127, P2326, DOI 10.1242/jcs.144956; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Janusz A, 2013, J NEUROSCI, V33, P18234, DOI 10.1523/JNEUROSCI.2207-13.2013; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Knights Alexander J, 2012, Trends Cancer Res, V8, P61; Kochanek DM, 2013, MOL CANCER RES, V11, P149, DOI 10.1158/1541-7786.MCR-12-0498; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin CL, 2010, RNA, V16, P338, DOI 10.1261/rna.1779810; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Nagaoka K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1678; Nairismagi ML, 2012, ONCOGENE, V31, P4960, DOI 10.1038/onc.2011.650; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shen WH, 2014, CELL REP, V6, P737, DOI 10.1016/j.celrep.2014.01.024; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Udagawa T, 2013, NAT MED, V19, P1473, DOI 10.1038/nm.3353; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304	40	52	53	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2893	2901		10.1038/onc.2015.350	http://dx.doi.org/10.1038/onc.2015.350			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26411364	Green Accepted			2022-12-26	WOS:000377473700009
J	Booth, EA; Vane, EW; Dovala, D; Thorner, J				Booth, Elizabeth A.; Vane, Eleanor W.; Dovala, Dustin; Thorner, Jeremy			A Forster Resonance Energy Transfer (FRET)-based System Provides Insight into the Ordered Assembly of Yeast Septin Hetero-octamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREVISIAE CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; FILAMENT FORMATION; PROTEIN INTERACTIONS; GENE-PRODUCT; MAMMALIAN SEPTINS; DIVISION CYCLE; MYOSIN-II; BUD NECK	Prior studies in both budding yeast (Saccharomyces cerevisiae) and in human cells have established that septin protomers assemble into linear hetero-octameric rods with 2-fold rotational symmetry. In mitotically growing yeast cells, five septin subunits are expressed (Cdc3, Cdc10, Cdcl 1, Cdc12, and Shsl) and assemble into two types of rods that differ only in their terminal subunit: Cdc11-Cdc12-Cdc3-Cdc10-Cdc10-Cdc3-Cdc12-Cdc11 and Shs1-Cdc12-Cdc3-Cdc10-Cdc10-Cdc3-Cdc12-Shs1. EM analysis has shown that, under low salt conditions, the Cdc11-capped rods polymerize end to end to form long paired filaments, whereas Shsl-capped rods form arcs, spirals, and rings. To develop a facile method to study septin polymerization in vitro, we exploited our previous work in which we generated septin complexes in which all endogenous cysteine (Cys) residues were eliminated by site-directed mutagenesis, except an introduced E294C mutation in Cdc11 in these experiments. Mixing samples of a preparation of such single-Cys containing Cdc11-capped rods that have been separately derivatized with organic dyes that serve as donor and acceptor, respectively, for FRET provided a spectroscopic method to monitor filament assembly mediated by Cdc11-Cdc11 interaction and to measure its affinity under specified conditions. Modifications of this same FRET scheme also allow us to assess whether Shsi-capped rods are capable of end to end association either with themselves or with Cdcll-capped rods. This FRET approach also was used to follow the binding to septin filaments of a septin-interacting protein, the type II myosin-binding protein Bni5.	[Booth, Elizabeth A.; Vane, Eleanor W.; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA; [Dovala, Dustin] Univ Calif San Francisco, Sch Med, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Rm 526,Barker Hall, Berkeley, CA 94720 USA.	jthorner@berkeley.edu	Regan, Clinton/E-6250-2012; THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	Amgen Scholars Summer Research Fellowship at University of California Berkeley; National Institutes of Health [GM21841, GM101314]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101314, R01GM021841] Funding Source: NIH RePORTER	Amgen Scholars Summer Research Fellowship at University of California Berkeley; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Amgen Scholars Summer Research Fellowship at University of California Berkeley (to E. W. V.) and by National Institutes of Health R01 Grants GM21841 (to J. T) and GM101314 (to J. T. and Berkeley colleague, Prof. Eva Nogales, jointly). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Soufi W., 2009, REV FLUORESCENCE, P23; Barth P, 2008, J AM CHEM SOC, V130, P12038, DOI 10.1021/ja802447e; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bertin A, 2012, MOL BIOL CELL, V23, P423, DOI 10.1091/mbc.E11-10-0850; Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; BONNE D, 1985, J BIOL CHEM, V260, P2819; Bridges AA, 2015, J BIOL CHEM, V290, P17173, DOI 10.1074/jbc.R114.634444; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Buttery SM, 2012, MOL BIOL CELL, V23, P4041, DOI 10.1091/mbc.E12-05-0395; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Cid VJ, 1998, MICROBIOL-SGM, V144, P3463, DOI 10.1099/00221287-144-12-3463; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; de Val N, 2013, PROTEINS, V81, P1964, DOI 10.1002/prot.24345; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Egelhofer TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002022; Fang XD, 2010, J CELL BIOL, V191, P1333, DOI 10.1083/jcb.201005134; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Finnigan GC, 2015, GENETICS, V200, P821, DOI 10.1534/genetics.115.176503; Finnigan GC, 2015, GENETICS, V200, P841, DOI 10.1534/genetics.115.176495; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; Hansen SD, 2013, METHODS MOL BIOL, V1046, P145, DOI 10.1007/978-1-62703-538-5_9; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Iwase M, 2007, GENETICS, V177, P215, DOI 10.1534/genetics.107.073007; Kaplan C, 2015, NANO LETT, V15, P3859, DOI 10.1021/acs.nanolett.5b00693; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee PR, 2002, MOL CELL BIOL, V22, P6906, DOI 10.1128/MCB.22.19.6906-6920.2002; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Marques ID, 2012, CELL BIOCHEM BIOPHYS, V62, P317, DOI 10.1007/s12013-011-9307-0; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; MCMURRAY MA, 2008, SEPTINS, P49; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Miller DJ, 2004, J PHYSIOL-LONDON, V555, P585, DOI 10.1113/jphysiol.2004.060731; Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pringle JR, 2008, SEPTINS, P7; Renz C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-60; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; SACKETT DL, 1990, J BIOL CHEM, V265, P14899; Schneider C, 2013, J CELL SCI, V126, P3390, DOI 10.1242/jcs.125302; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zent E, 2014, BIOL CHEM, V395, P169, DOI 10.1515/hsz-2013-0268; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082; Zeraik AE, 2014, J BIOL CHEM, V289, P7799, DOI 10.1074/jbc.M113.525352; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	79	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28388	+		10.1074/jbc.M115.683128	http://dx.doi.org/10.1074/jbc.M115.683128			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26416886	Green Published, hybrid			2022-12-26	WOS:000365761900033
J	Han, SS; Wang, G; Jin, Y; Ma, ZL; Jia, WJ; Wu, X; Wang, XY; He, MY; Cheng, X; Li, WJ; Yang, XS; Liu, GS				Han, Sha-sha; Wang, Guang; Jin, Ya; Ma, Zheng-lai; Jia, Wei-jing; Wu, Xia; Wang, Xiao-yu; He, Mei-yao; Cheng, Xin; Li, Wei-jing; Yang, Xuesong; Liu, Guo-sheng			Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; OXIDATIVE STRESS; DIASTOLIC DYSFUNCTION; CARDIOMYOPATHY; EXPRESSION; CHICK; APOPTOSIS; INSIGHTS; NKX2-5; EMBRYO	Hyperglycemia in diabetic mothers enhances the risk of fetal cardiac hypertrophy during gestation. However, the mechanism of high-glucose-induced cardiac hypertrophy is not largely understood. In this study, we first demonstrated that the incidence rate of cardiac hypertrophy dramatically increased in fetuses of diabetic mothers using color ultrasound examination. In addition, human fetal cardiac hypertrophy was successfully mimicked in a streptozotocin (STZ)-induced diabetes mouse model, in which mouse cardiac hypertrophy was diagnosed using type-M ultrasound and a histological assay. PH3 immunofluorescent staining of mouse fetal hearts and in vitro-cultured H9c2 cells indicated that cell proliferation decreased in E18.5, E15.5 and E13.5 mice, and cell apoptosis in H9c2 cells increased in the presence of high glucose in a dose-dependent manner. Next, we found that the individual cardiomyocyte size increased in pre-gestational diabetes mellitus mice and in response to high glucose exposure. Meanwhile, the expression of beta-MHC and BMP-10 was up-regulated. Nkx2.5 immunofluorescent staining showed that the expression of Nkx2.5, a crucial cardiac transcription factor, was suppressed in the ventricular septum, left ventricular wall and right ventricular wall of E18.5, E15.5 and E13.5 mouse hearts. However, cardiac hypertrophy did not morphologically occur in E13.5 mouse hearts. In cultured H9c2 cells exposed to high glucose, Nkx2.5 expression decreased, as detected by both immunostaining and western blotting, and the expression of KCNE1 and Cx43 was also restricted. Taken together, alterations in cell size rather than cell proliferation or apoptosis are responsible for hyperglycemia-induced fetal cardiac hypertrophy. The aberrant expression of Nkx2.5 and its regulatory target genes in the presence of high glucose could be a principal component of pathogenesis in the development of fetal cardiac hypertrophy.	[Han, Sha-sha; Jin, Ya; Jia, Wei-jing; Wu, Xia; He, Mei-yao; Liu, Guo-sheng] Jinan Univ, Affiliated Hosp 1, Inst Fetal Preterm Labor Med, Dept Pediat & Neonatol, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Guang; Ma, Zheng-lai; Wang, Xiao-yu; Cheng, Xin; Yang, Xuesong] Jinan Univ, Coll Med, Div Histol & Embryol, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Guangdong, Peoples R China; [Li, Wei-jing] Jinan Univ, Affiliated Hosp 1, Dept Fetal Med, Guangzhou 510630, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Yang, XS (corresponding author), Jinan Univ, Coll Med, Div Histol & Embryol, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Guangdong, Peoples R China.	yang_xuesong@126.com; tlgs@jnu.edu.cn	Wang, Guang/AAC-4624-2019		NSFC [81571436, 31401230]; Science and Technology Program of Guangzhou [201510010073]; Science and Technology Planning Project of Guangdong Province [2014A020213008]; China Postdoctoral Science Foundation [2015T80940, 2014M560694]; Fundamental Research Funds for the Central Universities [21614319, 21615421]; Funds for Young Creative Talents of Higher Education in Guangdong Province [2014KQNCX026]	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou; Science and Technology Planning Project of Guangdong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Funds for Young Creative Talents of Higher Education in Guangdong Province	This study was supported by NSFC grant (81571436, 31401230); Science and Technology Program of Guangzhou (201510010073); Science and Technology Planning Project of Guangdong Province (2014A020213008); China Postdoctoral Science Foundation (2015T80940, 2014M560694); the Fundamental Research Funds for the Central Universities (21614319, 21615421); and The Funds for Young Creative Talents of Higher Education in Guangdong Province (2014KQNCX026).	Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Aman J, 2011, NEONATOLOGY, V100, P147, DOI 10.1159/000323741; Azakie A, 2006, J THORAC CARDIOV SUR, V132, P1262, DOI 10.1016/j.jtcvs.2006.08.005; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Corrigan N, 2013, REPROD SCI, V20, P781, DOI 10.1177/1933719112466298; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Ding F, 2013, AMINO ACIDS, V45, P339, DOI 10.1007/s00726-013-1504-2; Ejdesjo A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1198, DOI 10.1152/ajpendo.00661.2011; Gheorman L, 2011, ROM J MORPHOL EMBRYO, V52, P1127; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; Huynh K, 2012, DIABETOLOGIA, V55, P1544, DOI 10.1007/s00125-012-2495-3; Jaiswal A, 2010, MOL CELL BIOCHEM, V345, P231, DOI 10.1007/s11010-010-0577-4; Jin YM, 2013, EXP CLIN ENDOCR DIAB, V121, P448, DOI 10.1055/s-0033-1349080; Kobylinska J, 2013, POSTEP HIG MED DOSW, V67, P950, DOI 10.5604/17322693.1066060; Kumar SD, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-34; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li XZ, 2012, DIABETES, V61, P2084, DOI 10.2337/db11-1624; Li Y, 2014, INT J CARDIOL, V176, P62, DOI 10.1016/j.ijcard.2014.06.044; Maron BJ, 2010, CIRCULATION, V121, P445, DOI 10.1161/CIRCULATIONAHA.109.878579; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; MORKIN E, 1972, CIRC RES, V30, P690, DOI 10.1161/01.RES.30.6.690; Munshi NV, 2012, CIRC RES, V110, P1525, DOI 10.1161/CIRCRESAHA.111.260026; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Qin RJ, 1981, ZHONGHUA ER KE ZA ZH, V19, P92; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Simeone RM, 2015, AM J PREV MED, V48, P195, DOI 10.1016/j.amepre.2014.09.002; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Terada R, 2011, CARDIOVASC RES, V91, P289, DOI 10.1093/cvr/cvr037; Xu JJ, 2014, CRIT CARE MED, V42, pE583, DOI 10.1097/CCM.0000000000000415; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zangen Sarah W, 2002, Int J Exp Diabetes Res, V3, P247, DOI 10.1080/15604280214933; Zhang L, 2014, DEV BIOL, V390, P68, DOI 10.1016/j.ydbio.2014.02.023	37	28	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139141	10.1371/journal.pone.0139141	http://dx.doi.org/10.1371/journal.pone.0139141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418041	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400052
J	Brown, AN; Vied, C; Dennis, JH; Bhide, PG				Brown, Amber N.; Vied, Cynthia; Dennis, Jonathan H.; Bhide, Pradeep G.			Nucleosome Repositioning: A Novel Mechanism for Nicotine- and Cocaine-Induced Epigenetic Changes	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; SH-SY5Y CELLS; TRANSCRIPTIONAL REGULATION; ACETYLCHOLINE-RECEPTOR; DNA ELEMENTS; COMPLEX-I; EXPRESSION; DOPAMINE; GENOME; EXPOSURE	Drugs of abuse modify behavior by altering gene expression in the brain. Gene expression can be regulated by changes in DNA methylation as well as by histone modifications, which alter chromatin structure, DNA compaction and DNA accessibility. In order to better understand the molecular mechanisms directing drug-induced changes in chromatin structure, we examined DNA-nucleosome interactions within promoter regions of 858 genes in human neuroblastoma cells (SH-SY5Y) exposed to nicotine or cocaine. Widespread, drug- and time-resolved repositioning of nucleosomes was identified at the transcription start site and promoter region of multiple genes. Nicotine and cocaine produced unique and shared changes in terms of the numbers and types of genes affected, as well as repositioning of nucleosomes at sites which could increase or decrease the probability of gene expression based on DNA accessibility. Half of the drug-induced nucleosome positions approximated a theoretical model of nucleosome occupancy based on physical and chemical characteristics of the DNA sequence, whereas the basal or drug naive positions were generally DNA sequence independent. Thus we suggest that nucleosome repositioning represents an initial dynamic genome-wide alteration of the transcriptional landscape preceding more selective downstream transcriptional reprogramming, which ultimately characterizes the cell-and tissue-specific responses to drugs of abuse.	[Brown, Amber N.; Vied, Cynthia; Bhide, Pradeep G.] Florida State Univ, Coll Med, Dept Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA; [Dennis, Jonathan H.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bhide, PG (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA.	pradeep.bhide@med.fsu.edu	Brown, Amber N/G-4543-2012	Vied, Cynthia/0000-0003-3941-3614; Bhide, Pradeep/0000-0003-4236-9415	Jim and Betty Ann Rodgers Chair Funds at the FSU College of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033775] Funding Source: NIH RePORTER	Jim and Betty Ann Rodgers Chair Funds at the FSU College of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Jim and Betty Ann Rodgers Chair Funds at the FSU College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379; Ballare C, 2013, NUCLEUS-AUSTIN, V4, P189, DOI 10.4161/nucl.25108; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Bellucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027959; Ben-Shachar D, 2004, BIOCHEM PHARMACOL, V67, P1965, DOI 10.1016/j.bcp.2004.02.015; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Bhide PG, 1996, J COMP NEUROL, V374, P506; Biederman J, 2006, BIOL PSYCHIAT, V59, P258, DOI 10.1016/j.biopsych.2005.07.009; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Brenner-Lavie H, 2008, BBA-BIOENERGETICS, V1777, P173, DOI 10.1016/j.bbabio.2007.10.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Dorofeeva NA, 2013, J EVOL BIOCHEM PHYS+, V49, P175, DOI 10.1134/S0022093013020060; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Druliner BR, 2013, CELL CYCLE, V12, P1536, DOI 10.4161/cc.24664; Dunckley T, 2003, J BIOL CHEM, V278, P15633, DOI 10.1074/jbc.M210389200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066629; Feng J, 2013, CURR OPIN NEUROBIOL, V23, P521, DOI 10.1016/j.conb.2013.01.001; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Holloway AC, 2014, AM J PHYSIOL-ENDOC M, V306, pE443, DOI 10.1152/ajpendo.00478.2013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUGHES P, 1995, PHARMACOL REV, V47, P133; JAEGER AW, 1982, EMBO J, V1, P811, DOI 10.1002/j.1460-2075.1982.tb01252.x; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jouvert P, 2004, J NEUROSCI, V24, P10716, DOI 10.1523/JNEUROSCI.1398-04.2004; Koranda JL, 2014, J NEUROPHYSIOL, V111, P103, DOI 10.1152/jn.00269.2013; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Lyn-Cook L, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-15; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; McCarthy DM, 2014, PROG BRAIN RES, V211, P277, DOI 10.1016/B978-0-444-63425-2.00012-X; McCarthy DM, 2012, DEV NEUROSCI-BASEL, V34, P174, DOI 10.1159/000337172; Mychasiuk R, 2013, BEHAV BRAIN RES, V256, P655, DOI 10.1016/j.bbr.2013.09.006; Ohtani N, 2003, J NEUROSCI, V23, P2840; Osborne JK, 2014, MOL BIOL CELL, V25, P1782, DOI 10.1091/mbc.E13-06-0316; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Popolo M, 2004, DEV NEUROSCI-BASEL, V26, P229, DOI 10.1159/000082140; Ridley DL, 2002, BRIT J PHARMACOL, V135, P1051, DOI 10.1038/sj.bjp.0704508; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodrigues AC, 2011, BIOPHARM DRUG DISPOS, V32, P355, DOI 10.1002/bdd.764; Sexton BS, 2014, GENOME RES, V24, P251, DOI 10.1101/gr.160150.113; Skene PJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02042; Tanaka Yoshiaki, 2009, Genome Inform, V23, P169; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Trauth JA, 2000, BRAIN RES, V867, P29, DOI 10.1016/S0006-8993(00)02208-3; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Vera DL, 2014, PLANT CELL, V26, P3883, DOI 10.1105/tpc.114.130609; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	61	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139103	10.1371/journal.pone.0139103	http://dx.doi.org/10.1371/journal.pone.0139103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414157	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700043
J	Neto, PSGD; Cavalcanti, GDC; Madeiro, F; Ferreira, TAE				de Mattos Neto, Paulo S. G.; Cavalcanti, George D. C.; Madeiro, Francisco; Ferreira, Tiago A. E.			An Approach to Improve the Performance of PM Forecasters	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; PARTICULATE MATTER; PREDICTION MODEL; HYBRID ARIMA; REGRESSION; POLLUTION; SYSTEM; PM2.5; MORTALITY; EXPOSURE	The particulate matter (PM) concentration has been one of the most relevant environmental concerns in recent decades due to its prejudicial effects on living beings and the earth's atmosphere. High PM concentration affects the human health in several ways leading to short and long term diseases. Thus, forecasting systems have been developed to support decisions of the organizations and governments to alert the population. Forecasting systems based on Artificial Neural Networks (ANNs) have been highlighted in the literature due to their performances. In general, three ANN-based approaches have been found for this task: ANN trained via learning algorithms, hybrid systems that combine search algorithms with ANNs, and hybrid systems that combine ANN with other forecasters. Independent of the approach, it is common to suppose that the residuals (error series), obtained from the difference between actual series and forecasting, have a white noise behavior. However, it is possible that this assumption is infringed due to: misspecification of the forecasting model, complexity of the time series or temporal patterns of the phenomenon not captured by the forecaster. This paper proposes an approach to improve the performance of PM forecasters from residuals modeling. The approach analyzes the remaining residuals recursively in search of temporal patterns. At each iteration, if there are temporal patterns in the residuals, the approach generates the forecasting of the residuals in order to improve the forecasting of the PM time series. The proposed approach can be used with either only one forecaster or by combining two or more forecasting models. In this study, the approach is used to improve the performance of a hybrid system (HS) composed by genetic algorithm (GA) and ANN from residuals modeling performed by two methods, namely, ANN and own hybrid system. Experiments were performed for PM2.5 and PM10 concentration series in Kallio and Vallila stations in Helsinki and evaluated from six metrics. Experimental results show that the proposed approach improves the accuracy of the forecasting method in terms of fitness function for all cases, when compared with the method without correction. The correction via HS obtained a superior performance, reaching the best results in terms of fitness function and in five out of six metrics. These results also were found when a sensitivity analysis was performed varying the proportions of the sets of training, validation and test. The proposed approach reached consistent results when compared with the forecasting method without correction, showing that it can be an interesting tool for correction of PM forecasters.	[de Mattos Neto, Paulo S. G.; Cavalcanti, George D. C.] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil; [Madeiro, Francisco] Univ Catolica Pernambuco, Recife, PE, Brazil; [Ferreira, Tiago A. E.] Univ Fed Rural Pernambuco, Dept Estat & Informat, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Catolica de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE)	Neto, PSGD (corresponding author), Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil.	psgmn@cin.ufpe.br	Cavalcanti, George DC/C-2364-2017; Ferreira, Tiago A E/A-7448-2016; Madeiro, Francisco/B-4866-2019	Cavalcanti, George DC/0000-0001-7714-2283; Ferreira, Tiago A E/0000-0002-2131-9825; Madeiro, Francisco/0000-0002-6123-0390; de Mattos Neto, Paulo/0000-0002-2396-7973	CNPq; Facepe	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Facepe(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was partially supported by Brazilian agencies: CNPq and Facepe.	Al-Alawi SM, 2008, ENVIRON MODELL SOFTW, V23, P396, DOI 10.1016/j.envsoft.2006.08.007; Antanasijevic DZ, 2013, SCI TOTAL ENVIRON, V443, P511, DOI 10.1016/j.scitotenv.2012.10.110; Bank W., 2008, GLOB MON REP 2008 MD; Sanchez AB, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/238259; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Box G.E.P., 2008, WILEY SER PROBAB ST; Brody H, 2014, NATURE, V513, pS1, DOI 10.1038/513S1a; Caselli M, 2009, WATER AIR SOIL POLL, V201, P365, DOI 10.1007/s11270-008-9950-2; Csavina J, 2014, SCI TOTAL ENVIRON, V487, P82, DOI 10.1016/j.scitotenv.2014.03.138; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; de Gennaro G, 2013, SCI TOTAL ENVIRON, V463, P875, DOI 10.1016/j.scitotenv.2013.06.093; Neto PSGD, 2014, ENG APPL ARTIF INTEL, V32, P185, DOI 10.1016/j.engappai.2014.03.010; de Mattos Neto PSG, 2010, IEEE WORLD C COMP IN, P1; Diaz-Robles LA, 2008, ATMOS ENVIRON, V42, P8331, DOI 10.1016/j.atmosenv.2008.07.020; Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035; Ettouney RS, 2009, MANAG ENVIRON QUAL, V20, P668, DOI 10.1108/14777830910990843; European Environment Agency, 2014, AIR QUAL EUR REP 201; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033385; Ferreira TAE, 2008, NEURAL PROCESS LETT, V28, P113, DOI 10.1007/s11063-008-9085-x; Firmino PRA, 2015, NEUROCOMPUTING, V153, P242, DOI 10.1016/j.neucom.2014.11.030; Firmino PRA, 2014, NEURAL NETWORKS, V50, P1, DOI 10.1016/j.neunet.2013.10.008; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Harrison RM, 2000, SCI TOTAL ENVIRON, V249, P85, DOI 10.1016/S0048-9697(99)00513-6; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Kim JW, 2014, TOX RESEARCH, V30, P65, DOI 10.5487/TR.2014.30.2.065; Kleinman Michael T., 2014, CENTRAL NERVOUS SYST; Kukkonen J, 2003, ATMOS ENVIRON, V37, P4539, DOI 10.1016/S1352-2310(03)00583-1; Kurt A, 2010, EXPERT SYST APPL, V37, P7986, DOI 10.1016/j.eswa.2010.05.093; Lima AR, 2010, GECCO-2010 COMPANION PUBLICATION: PROCEEDINGS OF THE 12TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P2015; Mishra D, 2015, ATMOS ENVIRON, V102, P239, DOI 10.1016/j.atmosenv.2014.11.050; Niska H, 2005, ATMOS ENVIRON, V39, P6524, DOI 10.1016/j.atmosenv.2005.07.035; Ordieres JB, 2005, ENVIRON MODELL SOFTW, V20, P547, DOI 10.1016/j.envsoft.2004.03.010; Pascal M, 2014, ATMOS ENVIRON, V95, P175, DOI 10.1016/j.atmosenv.2014.06.030; Perez P, 2006, ATMOS ENVIRON, V40, P2845, DOI 10.1016/j.atmosenv.2006.01.010; Perez P, 2012, ATMOS ENVIRON, V60, P271, DOI 10.1016/j.atmosenv.2012.06.024; Qin SS, 2014, ATMOS ENVIRON, V98, P665, DOI 10.1016/j.atmosenv.2014.09.046; Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010; Sharma S, 2003, INT J ENVIRON POLLUT, V19, P442, DOI 10.1504/IJEP.2003.004327; Silva DA, 2014, EXPERT SYST APPL, V41, P7147, DOI 10.1016/j.eswa.2014.06.001; Siwek K, 2012, ENG APPL ARTIF INTEL, V25, P1246, DOI 10.1016/j.engappai.2011.10.013; Slini T, 2006, ENVIRON MODELL SOFTW, V21, P559, DOI 10.1016/j.envsoft.2004.06.011; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3951, DOI 10.3748/wjg.v19.i25.3951; Tong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108076; Ul-Saufie AZ, 2013, ATMOS ENVIRON, V77, P621, DOI 10.1016/j.atmosenv.2013.05.017; Vlachogianni A, 2011, SCI TOTAL ENVIRON, V409, P1559, DOI 10.1016/j.scitotenv.2010.12.040; Voukantsis D, 2011, SCI TOTAL ENVIRON, V409, P1266, DOI 10.1016/j.scitotenv.2010.12.039; Wang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075220; Westerlund J, 2014, ATMOS ENVIRON, V89, P22, DOI 10.1016/j.atmosenv.2014.02.015; Wong MS, 2015, ATMOS RES, V158, P89, DOI 10.1016/j.atmosres.2015.02.006; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhou Lei, 2014, Biomed Res Int, V2014, P748068, DOI 10.1155/2014/748068	53	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138507	10.1371/journal.pone.0138507	http://dx.doi.org/10.1371/journal.pone.0138507			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414182	gold, Green Published, Green Submitted			2022-12-26	WOS:000362170700018
J	Corzo-Martinez, M; Luscher, A; de las Rivas, B; Munoz, R; Moreno, J				Corzo-Martinez, Marta; Luscher, Alice; de las Rivas, Blanca; Munoz, Rosario; Moreno, Javier			Valorization of Cheese and Tofu Whey through Enzymatic Synthesis of Lactosucrose	PLOS ONE			English	Article							NONDIGESTIBLE OLIGOSACCHARIDES; LEVANSUCRASE; SUCROSE; TRIMETHYLSILYL; TRISACCHARIDES; MICROFLORA; MODULATION; PROBIOTICS; MICROBIOTA; PERMEATE	This work deals with the development of a new bioprocess for the efficient synthesis of lactosucrose, a potential prebiotic oligosaccharide with a high value-added, from two important and inexpensive agro-industrial by-products such as tofu whey and cheese whey permeate. The bioconversion is driven by the ability of the enzyme levansucrase SacB from Bacillus subtilis CECT 39 to transfructosylate lactose contained in the cheese whey permeate by using not only sucrose but also raffinose and stachyose, which are present in considerable amounts in the tofu whey, as suitable donors of fructosyl moieties. The maximum lactosucrose concentration obtained from both by-products was 80.1 g L-1 after a short reaction time 120 min at 37 degrees C, leading to productivity and specific productivity values of 40.1 g lactosucrose L-1 h(-1) and 80.1 mg lactosucrose U enzyme(-1) h(-1), respectively. Findings contained in this work could provide a new strategy to valorize agro-industrial by-products as cheese whey permeate and, specially, tofu whey by means of their use as renewable resources in the enzymatic synthesis of bioactive oligosaccharides.	[Corzo-Martinez, Marta; Luscher, Alice; Moreno, Javier] CEI UAM CSIC, CIAL CSIC UAM, Inst Invest Ciencias Alimentac, Madrid 28049, Spain; [de las Rivas, Blanca; Munoz, Rosario] ICTAN CSIC, Inst Ciencia & Tecnol Alimentos Nutr, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)	Moreno, J (corresponding author), CEI UAM CSIC, CIAL CSIC UAM, Inst Invest Ciencias Alimentac, C Nicolas Cabrera 9, Madrid 28049, Spain.	javier.moreno@csic.es	Moreno, F. Javier/B-1817-2008; Muñoz, Rosario/H-8597-2012; MARTINEZ, MARTA CORZO/D-2146-2015; de las Rivas, Blanca/K-3899-2014	Moreno, F. Javier/0000-0002-7637-9542; Muñoz, Rosario/0000-0003-4170-9713; MARTINEZ, MARTA CORZO/0000-0002-6284-3236; de las Rivas, Blanca/0000-0002-8357-5226	Ministerio de Economia y Competitividad [AGL2011-27884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been financed by project AGL2011-27884 from Ministerio de Economia y Competitividad.	Aachary AA, 2011, COMPR REV FOOD SCI F, V10, P2, DOI 10.1111/j.1541-4337.2010.00135.x; Andersone I, 2004, ENG LIFE SCI, V4, P56, DOI 10.1002/elsc.200400006; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Arakawa K., 2002, Journal of Applied Glycoscience, V49, P63; Ben Ounis W, 2008, DESALINATION, P229; Brokl M, 2009, J CHROMATOGR A, V1216, P4689, DOI 10.1016/j.chroma.2009.03.069; Choi HJ, 2004, BIOTECHNOL PROGR, V20, P1876, DOI 10.1021/bp049770v; Corzo-Martinez M, 2013, J SCI FOOD AGR, V93, P1591, DOI 10.1002/jsfa.5929; Diez-Municio M, 2015, THESIS AUTONOMOUS U, P127; Diez-Municio M, 2012, J AGR FOOD CHEM, V60, P1945, DOI 10.1021/jf204956v; Foda MI, 2000, PROCESS BIOCHEM, V35, P581, DOI 10.1016/S0032-9592(99)00108-9; Fuzfai Z, 2008, J CHROMATOGR A, V1177, P183, DOI 10.1016/j.chroma.2007.11.023; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Han WC, 2007, J BIOTECHNOL, V131, pS113, DOI 10.1016/j.jbiotec.2007.07.195; Han WC, 2009, J MICROBIOL BIOTECHN, V19, P1153, DOI 10.4014/jmb.0901.045; Kanauchi O, 2003, CURR PHARM DESIGN, V9, P333, DOI 10.2174/1381612033391883; KANEKO T, 1994, BIOSCI BIOTECH BIOCH, V58, P2288, DOI 10.1271/bbb.58.2288; Kimura Y, 2002, J NUTR, V132, P80, DOI 10.1093/jn/132.1.80; Kitahata S, 1993, OLIGOSACCHARIDES PRO, P158; LEIVA MHL, 1995, PROCESS BIOCHEM, V30, P757, DOI 10.1016/0032-9592(95)00006-H; Madsen KL, 2001, CAN J GASTROENTEROL, V15, P817, DOI 10.1155/2001/690741; Montilla A, 2009, J AGR FOOD CHEM, V57, P5007, DOI 10.1021/jf900309x; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Mu WM, 2013, APPL MICROBIOL BIOT, V97, P1821, DOI 10.1007/s00253-013-4687-2; Mussatto SI, 2007, CARBOHYD POLYM, V68, P587, DOI 10.1016/j.carbpol.2006.12.011; OHKUSA T, 1995, DIGESTION, V56, P415, DOI 10.1159/000201269; Park HE, 2003, ENZYME MICROB TECH, V32, P820, DOI 10.1016/S0141-0229(03)00062-0; Park NH, 2005, BIOTECHNOL LETT, V27, P495, DOI 10.1007/s10529-005-2539-6; PETERSSON G, 1974, CARBOHYD RES, V33, P47, DOI 10.1016/S0008-6215(00)82939-0; Playne MJ, 2009, ADV DAIRY CHEM, V3, P121, DOI DOI 10.1007/978-0-387-84865-5; Rastall RA, 2010, ANNU REV FOOD SCI T, V1, P305, DOI 10.1146/annurev.food.080708.100746; Sako T, 1999, INT DAIRY J, V9, P69, DOI 10.1016/S0958-6946(99)00046-1; Sanz ML, 2004, J CHROMATOGR A, V1059, P143, DOI 10.1016/j.chroma.2004.09.095; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Steer T, 2000, NUTR RES REV, V13, P229, DOI 10.1079/095442200108729089; Sudyani Y, 2007, ANN INT C CHEM SCI, P47; Teramoto F, 1996, J GASTROENTEROL, V31, P33, DOI 10.1007/BF01211184; Thi LN, 2003, INT J FOOD MICROBIOL, V89, P67, DOI 10.1016/S0168-1605(03)00109-0; van Hijum SAFT, 2004, MICROBIOL-SGM, V150, P621, DOI 10.1099/mic.0.26671-0; Visnapuu T, 2009, RAPID COMMUN MASS SP, V23, P1337, DOI 10.1002/rcm.4007; Zuluaga J, 2011, BIOL TRACE ELEM RES, V144, P1302, DOI 10.1007/s12011-011-9140-8	41	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139035	10.1371/journal.pone.0139035	http://dx.doi.org/10.1371/journal.pone.0139035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406885	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700152
J	Glenn, JD; Smith, MD; Kirby, LA; Baxi, EG; Whartenby, KA				Glenn, Justin D.; Smith, Matthew D.; Kirby, Leslie A.; Baxi, Emily G.; Whartenby, Katharine A.			Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; IN-VITRO; T-CELLS; ENCEPHALITOGENIC ANTIGENS; IMMUNE DEVIATION; MYELIN ANTIGENS; MODEL; TH17; REMYELINATION	Mesenchymal stem cells (MSCs) are pleiotropic cells with potential therapeutic benefits for a wide range of diseases. Because of their immunomodulatory properties they have been utilized to treat autoimmune diseases such as multiple sclerosis (MS), which is characterized by demyelination. The microenvironment surrounding MSCs is thought to affect their differentiation and phenotype, which could in turn affect the efficacy. We thus sought to dissect the potential for differential impact of MSCs on central nervous system (CNS) disease in T cell mediated and non-T cell mediated settings using the MOG(35-55) experimental autoimmune encephalomyelitis (EAE) and cuprizone-mediated demyelination models, respectively. As the pathogeneses of MS and EAE are thought to be mediated by IFN gamma-producing (T(H)1) and IL-17A-producing (T(H)17) effector CD4+ T cells, we investigated the effect of MSCs on the development of these two key pathogenic cell groups. Although MSCs suppressed the activation and effector function of T(H)17 cells, they did not affect T(H)1 activation, but enhanced T(H)1 effector function and ultimately produced no effect on EAE. In the non-T cell mediated cuprizone model of demyelination, MSC administration had a positive effect, with an overall increase in myelin abundance in the brain of MSC-treated mice compared to controls. These results highlight the potential variability of MSCs as a biologic therapeutic tool in the treatment of autoimmune disease and the need for further investigation into the multifaceted functions of MSCs in diverse microenvironments and the mechanisms behind the diversity.	[Glenn, Justin D.; Smith, Matthew D.; Kirby, Leslie A.; Baxi, Emily G.; Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Whartenby, KA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	whartenby@jhmi.edu		Smith, Matthew/0000-0001-6614-569X; Glenn, Justin/0000-0002-3567-6233; Kirby, Leslie/0000-0003-4467-2661	nmss.org; Silverman foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	nmss.org; Silverman foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by nmss.org and Silverman foundation (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton SM, 2015, BIOMED J, V38, P206, DOI 10.4103/2319-4170.158510; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bruck W, 2005, J NEUROL, V252, pV10, DOI 10.1007/s00415-005-5003-6; Buckland Jenny, 2014, Nat Rev Rheumatol, V10, P699, DOI 10.1038/nrrheum.2014.183; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duffy MM, 2011, EUR J IMMUNOL, V41, P2840, DOI 10.1002/eji.201141499; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Faunce DE, 2004, J IMMUNOL, V172, P1991, DOI 10.4049/jimmunol.172.4.1991; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Glenn JD, 2014, STEM CELLS, V32, P2744, DOI 10.1002/stem.1755; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gran B, 2010, TRENDS MOL MED, V17, P119; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hedayatpour A, 2013, CELL J, V15, P142; Jaramillo-Merchan J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.304; Kang ZZ, 2012, J NEUROSCI, V32, P8284, DOI 10.1523/JNEUROSCI.0841-12.2012; Kasarello K, 2015, MED SCI MONITOR, V21, P1587, DOI 10.12659/MSM.892764; Lanza C, 2009, J NEUROCHEM, V110, P1674, DOI 10.1111/j.1471-4159.2009.06268.x; Leech MD, 2007, EUR J IMMUNOL, V37, P3576, DOI 10.1002/eji.200737148; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069795; Pender MP, 2007, CURR ALLERGY ASTHM R, V7, P285, DOI 10.1007/s11882-007-0043-x; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Rivera FJ, 2012, BIOL RES, V45, P257, DOI 10.4067/S0716-97602012000300007; Robinson AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107649; Sajic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030708; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Skarica M, 2009, J IMMUNOL, V182, P4192, DOI 10.4049/jimmunol.0803631; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Sun B, 2010, J NEUROIMMUNOL, V226, P116, DOI 10.1016/j.jneuroim.2010.05.042; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tatara R, 2011, CYTOTHERAPY, V13, P686, DOI 10.3109/14653249.2010.542456; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962	53	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139008	10.1371/journal.pone.0139008	http://dx.doi.org/10.1371/journal.pone.0139008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407166	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700145
J	Kitterer, D; Latus, J; Pohlmann, C; Alscher, MD; Kimmel, M				Kitterer, Daniel; Latus, Joerg; Poehlmann, Christoph; Alscher, M. Dominik; Kimmel, Martin			Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: Antimicrobial Susceptibility Profiles of a Referral Center in GERMANY over 32 Years	PLOS ONE			English	Article							CAPD PERITONITIS; INFECTIONS; EXPERIENCE; ORGANISMS; CEFAZOLIN; UPDATE; TRENDS	Objectives Peritonitis is one of the most important causes of treatment failure in peritoneal dialysis (PD) patients. This study describes changes in characteristics of causative organisms in PD-related peritonitis and antimicrobial susceptibility. Methods In this single center study we analyzed retrospective 487 susceptibility profiles of the peritoneal fluid cultures of 351 adult patients with peritonitis from 1979 to 2014 (divided into three time periods, P1-P3). Results Staphylococcus aureus decreased from P1 compared to P2 and P3 (P<0.05 and P<0.01, respectively). Methicillin-resistant S. aureus (MRSA) occurred only in P3. Methicillin-resistant Staphylococcus epidermidis (MRSE) increased in P3 over P1 and P2 (P<0.0001, respectively). In P2 and P3, vancomycin resistant enterococci were detected. The percentage of gram-negative organisms remained unchanged. Third generation cephalosporin resistant gram-negative rods (3GCR-GN) were found exclusively in P3. Cefazolin-susceptible gram-positive organisms decreased over the three decades (93% in P1, 75% in P2 and 58% in P3, P<0.01, P<0.05 and P<0.0001, respectively). Vancomycin susceptibility decreased and gentamicin susceptibility in gram-negatives was 94% in P1, 82% in P2 and 90% in P3. Ceftazidim susceptibility was 84% in P2 and 93% in P3. Conclusions Peritonitis caused by MSSA decreased, but peritonitis caused by MRSE increased. MRSA peritonitis is still rare. Peritonitis caused by 3GCR-GN is increasing. An initial antibiotic treatment protocol should be adopted for PD patients to provide continuous surveillance.	[Kitterer, Daniel; Latus, Joerg; Alscher, M. Dominik; Kimmel, Martin] Robert Bosch Krankenhaus, Dept Internal Med, Div Nephrol, Stuttgart, Germany; [Poehlmann, Christoph] Robert Bosch Krankenhaus, Dept Diagnost & Lab Med, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus	Kimmel, M (corresponding author), Robert Bosch Krankenhaus, Dept Internal Med, Div Nephrol, Stuttgart, Germany.	martin.kimmel@rbk.de	Kimmel, Martin/AAM-2514-2021					BAZZATO G, 1984, T AM SOC ART INT ORG, V30, P690; Bending M, 1996, J AM SOC NEPHROL, V7, P2403; Boeschoten EW, 2006, NEPHROL DIAL TRANSPL, V21, pii31; Boudville N, 2012, J AM SOC NEPHROL, V23, P1398, DOI 10.1681/ASN.2011121135; Chao CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110315; Daly C, 2001, COCHRANE DB SYST REV; Friedman O, 2008, PERITON DIALYSIS INT, V28, P195; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; HOLLEY JL, 1990, AM J KIDNEY DIS, V16, P142, DOI 10.1016/S0272-6386(12)80569-5; Institute CaLS, 2014, PERF STAND ANT SUSC; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kavanagh D, 2004, NEPHROL DIAL TRANSPL, V19, P2584, DOI 10.1093/ndt/gfh386; KEANE WF, 1993, PERITON DIALYSIS INT, V13, P14; Kim DK, 2004, PERITON DIALYSIS INT, V24, P424; Leung CB, 2004, PERITON DIALYSIS INT, V24, P440; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Piraino B, 2011, PERITON DIALYSIS INT, V31, P614, DOI 10.3747/pdi.2011.00057; Strippoli GFM, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004679.PUB2; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Troidle Laura, 2006, Ann Clin Microbiol Antimicrob, V5, P6, DOI 10.1186/1476-0711-5-6; van Esch S, 2014, PERITON DIALYSIS INT, V34, P162, DOI 10.3747/pdi.2013.00275; Vlaar PJ, 2013, PERITON DIALYSIS INT, V33, P708, DOI 10.3747/pdi.2012.00155; WEBER J, 1989, PERITON DIALYSIS INT, V9, P191; Yip T, 2006, PERITON DIALYSIS INT, V26, P191	25	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135969	10.1371/journal.pone.0135969	http://dx.doi.org/10.1371/journal.pone.0135969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405797	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700007
J	Liu, L; Zhang, J; Yang, XM; Fang, C; Xu, HL; Xi, XW				Liu, Lei; Zhang, Jing; Yang, Xiaoming; Fang, Chi; Xu, Huali; Xi, Xiaowei			SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer	PLOS ONE			English	Article							CASSETTE TRANSPORTER GENES; EXPRESSION; ONCOGENE; CELLS; APOPTOSIS; NUCLEAR	SALL4 plays important roles in the development and progression of many cancers. However, the role and molecular mechanism of SALL4 in endometrial cancer remain elusive. In the present research, we have demonstrated that the expression of SALL4 was upregulated in endometrial cancer and correlated positively with tumor stage, metastases and poor survival of patients. The overexpression of SALL4 promoted the invasiveness in endometrial cancer cells, as indicated by the upregulation of mesenchymal cell marker N-cadherin and downregulation of the epithelial marker E-cadherin, and invasion assays in vitro. Additionally, there was also an increase in drug resistance in these cell models due to the upregulation of ATP-binding cassette multidrug transporter ABCB1 expression. Moreover, we also found that ABCB1 was critical for SALL4-induced drug resistance. In contrast, SALL4 knockdown restored drug sensitivity, reversed EMT, diminished cell metastasis and suppressed the downregulation of E-cadherin and the upregulation of N-cadherin and ABCB1. Furthermore, we showed that SALL4 upregulated c-Myc expression and c-Myc was a direct target for SALL4 by ChIP assay, depletion of c-Myc with siRNA abolished the SALL4-induced downregulation of E-cadherin, upregulation of N-cadherin and ABCB1, suggesting that c-Myc was a downstream target for SALL4 and required for SALL4-induced EMT, invasion and drugs resistance in endometrial cancer cells. These results indicated that SALL4 could induce EMT and resistance to antineoplastic drugs through the regulation of c-Myc. SALL4 and c-Myc may be novel therapeutic targets for endometrial cancer.	[Zhang, Jing; Yang, Xiaoming; Fang, Chi; Xu, Huali; Xi, Xiaowei] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xi, XW (corresponding author), Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China.	xixiaoweix66@126.com			National Natural Science Foundation of China (NSFC) [81172478]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (NSFC No. 81172478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Bahng AY, 2012, J GYNECOL ONCOL, V23, P257, DOI 10.3802/jgo.2012.23.4.257; BAI MK, 1994, ONCOLOGY, V51, P314; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Forghanifard MM, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-6; Geisler JP, 2004, INT J GYNECOL CANCER, V14, P133, DOI 10.1111/j.1048-891x.2004.14027.x; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hermeking H, 2003, CURR CANCER DRUG TAR, V3, P163, DOI 10.2174/1568009033481949; Hupfeld T, 2013, BRIT J HAEMATOL, V161, P204, DOI 10.1111/bjh.12246; Itou J, 2013, FEBS LETT, V587, P3115, DOI 10.1016/j.febslet.2013.07.049; Jeong HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018372; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Li A, 2015, ONCOGENE, V34, P63, DOI 10.1038/onc.2013.529; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Saito T, 2003, CANCER-AM CANCER SOC, V97, P1002, DOI 10.1002/cncr.11157; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Tanaka Y, 2013, CANCER BIOL THER, V14, P13, DOI 10.4161/cbt.22625; Terek MC, 2003, INT J GYNECOL CANCER, V13, P673, DOI 10.1046/j.1525-1438.2003.13324.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953; Yuan Y, 2014, BIORESOURCE TECHNOL, V174, P1, DOI 10.1016/j.biortech.2014.07.104; Zhang L, 2014, ONCOGENE, V33, P5491, DOI 10.1038/onc.2013.495; Zhang ZB, 2013, INT J ONCOL, V43, P1194, DOI 10.3892/ijo.2013.2054	41	48	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138515	10.1371/journal.pone.0138515	http://dx.doi.org/10.1371/journal.pone.0138515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407074	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700054
J	Nguyen, KP; McGilvray, KC; Puttlitz, CM; Mukhopadhyay, S; Chabasse, C; Sarkar, R				Nguyen, Khanh P.; McGilvray, Kirk C.; Puttlitz, Christian M.; Mukhopadhyay, Subhradip; Chabasse, Christine; Sarkar, Rajabrata			Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus Resolution	PLOS ONE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; VENOUS THROMBOSIS; MATRIX-METALLOPROTEINASE; EXPRESSION; MIGRATION; MODEL; CYTOKINES; DELETION; BEHAVIOR; INJURY	Objective Deep venous thrombosis is a common vascular problem with long-term complications including post-thrombotic syndrome. Post-thrombotic syndrome consists of leg pain, swelling and ulceration that is related to incomplete or maladaptive resolution of the venous thrombus as well as loss of compliance of the vein wall. We examine the role of metalloproteinase-9 (MMP-9), a gene important in extracellular remodeling in other vascular diseases, in mediating thrombus resolution and biomechanical changes of the vein wall. Methods and Results The effects of targeted deletion of MMP-9 were studied in an in vivo murine model of thrombus resolution using the FVB strain of mice. MMP-9 expression and activity significantly increased on day 3 after DVT. The lack of MMP-9 impaired thrombus resolution by 27% and this phenotype was rescued by the transplantation of wildtype bone marrow cells. Using novel biomechanical techniques, we demonstrated that the lack of MMP-9 significantly decreased thrombus-induced loss of vein wall compliance. Biomechanical analysis of the contribution of individual structural components showed that MMP-9 affected the elasticity of the extracellular matrix and collagen-elastin fibers. Biochemical and histological analyses correlated with these biomechanical effects as thrombi of mice lacking MMP-9 had significantly fewer macrophages and collagen as compared to those of wildtype mice. Conclusions MMP-9 mediates thrombus-induced loss of vein wall compliance by increasing stiffness of the extracellular matrix and collagen-elastin fibers during thrombus resolution. MMP-9 also mediates macrophage and collagen content of the resolving thrombus and bone-marrow derived MMP-9 plays a role in resolution of thrombus mass. These disparate effects of MMP-9 on various aspects of thrombus illustrate the complexity of individual protease function on biomechanical and morphometric aspects of thrombus resolution.	[Nguyen, Khanh P.] Oregon Hlth & Sci Univ, Div Vasc Surg, Portland, OR 97201 USA; [McGilvray, Kirk C.; Puttlitz, Christian M.] Colorado State Univ, Dept Mech Engn, Orthopaed Bioengn Res Lab, Ft Collins, CO 80523 USA; [McGilvray, Kirk C.; Puttlitz, Christian M.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA; [Mukhopadhyay, Subhradip; Chabasse, Christine; Sarkar, Rajabrata] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mukhopadhyay, Subhradip; Chabasse, Christine; Sarkar, Rajabrata] Univ Maryland, Div Vasc Surg, Baltimore, MD 21201 USA	Oregon Health & Science University; Colorado State University; Colorado State University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sarkar, R (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	rsarkar@smail.umaryland.edu	mcgilvray, kirk/AAG-8307-2019		NIH [1F32HL091643-01, R01 HL083917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091643, R01HL083917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH F32 Grant: 1F32HL091643-01 (KN) and RO1 Grant: R01 HL083917 (RS).	Ali T, 2006, J VASC SURG, V43, P601, DOI 10.1016/j.jvs.2005.10.073; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Baldwin JF, 2012, J VASC SURG, V56, P1089, DOI 10.1016/j.jvs.2012.02.054; Dahi S, 2005, J VASC SURG, V42, P539, DOI 10.1016/j.jvs.2005.04.051; Deatrick KB, 2005, J VASC SURG, V42, P140, DOI 10.1016/j.jvs.2005.04.014; Deatrick KB, 2013, J VASC SURG, V58, P1375, DOI 10.1016/j.jvs.2012.11.088; Deatrick KB, 2013, THROMB RES, V132, P360, DOI 10.1016/j.thromres.2013.06.027; Deatrick KB, 2011, J VASC SURG, V53, P139, DOI 10.1016/j.jvs.2010.07.043; Dewyer NA, 2007, J SURG RES, V142, P357, DOI 10.1016/j.jss.2007.03.064; FUNG YC, 1993, J BIOMECH ENG-T ASME, V115, P453, DOI 10.1115/1.2895523; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gossage JA, 2006, J VASC SURG, V44, P1085, DOI 10.1016/j.jvs.2006.07.020; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Henke PK, 2007, THROMB HAEMOSTASIS, V98, P1045, DOI 10.1160/TH07-03-0190; Henke PK, 2006, J IMMUNOL, V177, P3388, DOI 10.4049/jimmunol.177.5.3388; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Henke PK, 2006, THROMB HAEMOSTASIS, V95, P272, DOI 10.1160/Th05-02-0099; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Holzapfel GA, 2007, INT J CARDIOL, V116, P78, DOI 10.1016/j.ijcard.2006.03.033; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McGilvray KC, 2010, J BIOMECH, V43, P2941, DOI 10.1016/j.jbiomech.2010.07.012; Modarai B, 2005, CIRCULATION, V111, P2645, DOI 10.1161/CIRCULATIONAHA.104.492678; Myers DD, 2006, J VASC SURG, V44, P625, DOI 10.1016/j.jvs.2006.05.021; NEGLEN P, 1995, J CARDIOVASC SURG, V36, P225; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Sacks MS, 2003, ANNU REV BIOMED ENG, V5, P251, DOI 10.1146/annurev.bioeng.5.011303.120714; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; Sood V, 2010, THROMB HAEMOSTASIS, V104, P1174, DOI 10.1160/TH10-03-0184; Sood V, 2010, ANN VASC SURG, V24, P233, DOI 10.1016/j.avsg.2009.11.002; Vande Geest JP, 2004, J BIOMECH ENG-T ASME, V126, P815, DOI 10.1115/1.1824121; Varma MR, 2003, J VASC SURG, V38, P1090, DOI 10.1016/S0741-5214(03)00431-2; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WAKEFIELD TW, 1993, THROMB HAEMOSTASIS, V69, P164; WAKEFIELD TW, 1995, ARTERIOSCL THROM VAS, V15, P258, DOI 10.1161/01.ATV.15.2.258; Xia MH, 1996, J IMMUNOL, V156, P160; XIE JP, 1991, J BIOMECH ENG-T ASME, V113, P36, DOI 10.1115/1.2894083; Zhang HQ, 2011, J NEUROSCI, V31, P15894, DOI 10.1523/JNEUROSCI.3943-11.2011	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139145	10.1371/journal.pone.0139145	http://dx.doi.org/10.1371/journal.pone.0139145			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406902	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700182
J	Perez-Aso, M; Mediero, A; Low, YC; Levine, J; Cronstein, BN				Perez-Aso, Miguel; Mediero, Aranzazu; Low, Yee Cheng; Levine, Jamie; Cronstein, Bruce N.			Adenosine A2A receptor plays an important role in radiation-induced dermal injury	FASEB JOURNAL			English	Article						ZM241385; skin; radiotherapy lesions; therapeutic	COLLAGEN VASCULAR-DISEASE; INDUCED ATP RELEASE; DELTA T-CELLS; IONIZING-RADIATION; A(2A) RECEPTORS; INDUCED FIBROSIS; PHARMACOLOGICAL BLOCKADE; CARDIAC FIBROBLASTS; LATE COMPLICATIONS; ENDOTHELIAL-CELLS	Ionizing radiation is a common therapeutic modality and following irradiation dermal changes, including fibrosis and atrophy, may lead to permanent changes. We have previously demonstrated that occupancy of A(2A) receptor (A(2A)R) stimulates collagen production, so we determined whether blockade or deletion of A(2A)R could prevent radiation-induced fibrosis. After targeted irradiation (40 Gy) of the skin of wild-type (WT) or A(2A)R knockout (A(2A)RKO) mice, the A(2A)R antagonist ZM241385 was applied daily for 28 d. In irradiated WT mice treated with the A(2A)R antagonist, there was a marked reduction in collagen content and skin thickness, and ZM241385 treatment reduced the number of myofibroblasts and angiogenesis. After irradiation, there is an increase in loosely packed collagen fibrils, which is significantly diminished by ZM241385. Irradiation also induced an increase in epidermal thickness, prevented by ZM241385, by increasing the number of proliferating keratinocytes. Similarly, in A2ARKO mice, the changes in collagen alignment, skin thickness, myofibroblast content, angiogenesis, and epidermal hyperplasia were markedly reduced following irradiation. Radiation-induced changes in the dermis and epidermis were accompanied by an infiltrate of T cells, which was prevented in both ZM241385-treated and A2ARKO mice. Radiation therapy is administered to a significant number of patients with cancer, and radiation reactions may limit this therapeutic modality. Our findings suggest that topical application of an A(2A)R antagonist prevents radiation dermatitis and may be useful in the prevention or amelioration of radiation changes in the skin.	[Perez-Aso, Miguel; Mediero, Aranzazu; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY 10016 USA; [Low, Yee Cheng; Levine, Jamie] NYU, Sch Med, Ctr Canc, New York, NY 10016 USA	New York University; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020	Mediero, Aranzazu/0000-0002-5368-574X; Pintor, Jesus/0000-0002-9191-7679; Perez-Aso, Miguel/0000-0002-4703-4182; Cronstein, Bruce/0000-0002-4295-7383	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR68593]; New York University-Health and Hospitals Corporation Clinical and Translational Science Institute [UL1TR000038]; Laura and Isaac Perlmutter Cancer Center; NIH National Cancer Institute Cancer Center Support grant [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR056672, R01AR056672, R01AR068593] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University-Health and Hospitals Corporation Clinical and Translational Science Institute; Laura and Isaac Perlmutter Cancer Center; NIH National Cancer Institute Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR56672 and AR68593), New York University-Health and Hospitals Corporation Clinical and Translational Science Institute (UL1TR000038), the Laura and Isaac Perlmutter Cancer Center, and NIH National Cancer Institute Cancer Center Support grant (P30CA016087).	ABUSHAKRA M, 1993, J RHEUMATOL, V20, P1601; BENTZEN SM, 1989, RADIOTHER ONCOL, V15, P267, DOI 10.1016/0167-8140(89)90095-9; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Bordignon M, 2008, MOL MED REP, V1, P485; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Chen AM, 2001, CANCER J, V7, P480; Chen YH, 2004, AM J PHYSIOL-HEART C, V287, pH2478, DOI 10.1152/ajpheart.00217.2004; Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3; DECONNO F, 1991, J PAIN SYMPTOM MANAG, V6, P247, DOI 10.1016/0885-3924(91)90015-V; DEUSSEN A, 1993, AM J PHYSIOL, V264, pH692, DOI 10.1152/ajpheart.1993.264.3.H692; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Dubey RK, 1998, HYPERTENSION, V31, P943, DOI 10.1161/01.HYP.31.4.943; Duncan W, 1996, RADIOTHER ONCOL, V41, P203, DOI 10.1016/S0167-8140(96)01838-5; Fernandez P, 2008, AM J PATHOL, V172, P1675, DOI 10.2353/ajpath.2008.070952; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; HEAP BJ, 1973, J ANAT, V115, P315; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Holler V, 2009, J INVEST DERMATOL, V129, P1280, DOI 10.1038/jid.2008.360; HOPEWELL JW, 1990, INT J RADIAT BIOL, V57, P751, DOI 10.1080/09553009014550911; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF282, DOI 10.1152/ajprenal.00113.2005; Islam MR, 2012, AM J PHYSIOL-CELL PH, V303, pC924, DOI 10.1152/ajpcell.00459.2011; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen JM, 2011, STRAHLENTHER ONKOL, V187, P378, DOI 10.1007/s00066-011-2224-8; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Katebi M, 2008, INFLAMMATION, V31, P299, DOI 10.1007/s10753-008-9078-y; Kumar S, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-40; Lataillade JJ, 2007, REGEN MED, V2, P785, DOI 10.2217/17460751.2.5.785; Lazzerini PE, 2012, J MOL MED, V90, P331, DOI 10.1007/s00109-011-0824-5; Lee JW, 2010, ARCH OTOLARYNGOL, V136, P714, DOI 10.1001/archoto.2010.107; MCDONALD S, 1995, INT J RADIAT ONCOL, V31, P1187, DOI 10.1016/0360-3016(94)00429-O; McQuestion Maurene, 2011, Semin Oncol Nurs, V27, pe1, DOI 10.1016/j.soncn.2011.02.009; Mendelsohn Felicia A, 2002, Adv Skin Wound Care, V15, P216, DOI 10.1097/00129334-200209000-00007; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Morris MM, 1997, J CLIN ONCOL, V15, P2728, DOI 10.1200/JCO.1997.15.7.2728; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Muller K, 2011, J DERMATOL SCI, V61, P199, DOI 10.1016/j.jdermsci.2011.01.003; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Perez-Aso M, 2012, FASEB J, V26, P4254, DOI 10.1096/fj.12-209627; Phan C, 2003, CANCER J, V9, P461, DOI 10.1097/00130404-200311000-00005; Robertson C, 1998, INT J RADIAT ONCOL, V40, P319, DOI 10.1016/S0360-3016(97)00716-5; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Ryan JL, 2012, J INVEST DERMATOL, V132, P985, DOI 10.1038/jid.2011.411; Salvo N, 2010, CURR ONCOL, V17, P94; Schmuth M, 2001, ARCH DERMATOL, V137, P1019; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC	61	25	25	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					457	465		10.1096/fj.15-280388	http://dx.doi.org/10.1096/fj.15-280388			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26415936	Green Published			2022-12-26	WOS:000367621000042
J	Fariss, CJ; Linder, FJ; Jones, ZM; Crabtree, CD; Biek, MA; Ross, ASM; Kaur, T; Tsai, M				Fariss, Christopher J.; Linder, Fridolin J.; Jones, Zachary M.; Crabtree, Charles D.; Biek, Megan A.; Ross, Ana-Sophia M.; Kaur, Taranamol; Tsai, Michael			Human Rights Texts: Converting Human Rights Primary Source Documents into Data	PLOS ONE			English	Article							GOVERNMENT RESPECT; POLITICAL-SCIENCE; INFORMATION; REPRESSION; INTEGRITY; SELECTION; TREATIES; AID	We introduce and make publicly available a large corpus of digitized primary source human rights documents which are published annually by monitoring agencies that include Amnesty International, Human Rights Watch, the Lawyers Committee for Human Rights, and the United States Department of State. In addition to the digitized text, we also make available and describe document-term matrices, which are datasets that systematically organize the word counts from each unique document by each unique term within the corpus of human rights documents. To contextualize the importance of this corpus, we describe the development of coding procedures in the human rights community and several existing categorical indicators that have been created by human coding of the human rights documents contained in the corpus. We then discuss how the new human rights corpus and the existing human rights datasets can be used with a variety of statistical analyses and machine learning algorithms to help scholars understand how human rights practices and reporting have evolved over time. We close with a discussion of our plans for dataset maintenance, updating, and availability.	[Fariss, Christopher J.; Linder, Fridolin J.; Jones, Zachary M.; Crabtree, Charles D.; Biek, Megan A.; Ross, Ana-Sophia M.] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA; [Kaur, Taranamol; Tsai, Michael] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California San Diego	Fariss, CJ (corresponding author), Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA.	cjf20@psu.edu	Fariss, Christopher J/AAG-9477-2021; Fariss, Christopher/AAN-9494-2020	Fariss, Christopher J/0000-0001-9837-186X; Linder, Fridolin/0000-0002-0499-0676; Crabtree, Charles/0000-0001-5144-8671	McCourtney Institute for Democracy Innovation Grant at Pennsylvania State University; College of Liberal Arts at Pennsylvania State University; National Science Foundation under IGERT [DGE-1144860]	McCourtney Institute for Democracy Innovation Grant at Pennsylvania State University; College of Liberal Arts at Pennsylvania State University; National Science Foundation under IGERT(National Science Foundation (NSF))	CJF acknowledges research funding from The McCourtney Institute for Democracy Innovation Grant, and the College of Liberal Arts, both at Pennsylvania State University. FJL acknowledges support by the National Science Foundation under IGERT Grant DGE-1144860, Big Data Social Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A., 2011, P WORKSH LANG SOC ME; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; BRYSK A, 1994, HUM RIGHTS QUART, V16, P676, DOI 10.2307/762564; Carey S. C., 2010, POLITICS HUMAN RIGHT; CARLETON D, 1985, HUM RIGHTS QUART, V7, P205, DOI 10.2307/762080; Cingranelli DL, 1999, INT STUD QUART, V43, P407, DOI 10.1111/0020-8833.00126; Cingranelli DL, 2015, CINGRANELLI RICHARDS; Conrad CR, 2013, INT STUD PERSPECT, V14, P199, DOI 10.1111/j.1528-3585.2012.00471.x; CONRAD COURTENAY R., 2011, ILL TREATMENT TORTUR; Conrad CR, 2015, AM POLITICA IN PRESS; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Crabtree CD, 2015, RES POLITICS, V2, DOI 10.1177/2053168015605343; D'Orazio V, 2014, POLITICAL ANAL; Dancy G, 2014, HUMAN RIGHTS FUTURES; Davenport C., 2010, MEDIA BIAS PERSPECTI; Davenport C, 2007, ANNU REV POLIT SCI, V10, P1, DOI 10.1146/annurev.polisci.10.101405.143216; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Fariss CJ, 2014, J CONFLICT RESOLUT, V58, P1003, DOI 10.1177/0022002713487314; Fariss CJ, 2014, AM POLIT SCI REV, V108, P297, DOI 10.1017/S0003055414000070; Fariss CJ., 2015, BRIT J POLI IN PRESS; Gastil Raymond, 1980, FREEDOM WORLD POLITI; Gibney, 1996, POLICY STUDIES DEV N, V4, P73; Gibney M., 2015, POLITICAL TERROR SCA; Gibney Mark, 1988, OPEN BORDERS CLOSED, P151; Goldstein Robert Justin, 1978, POLITICAL REPRESSION; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Hastie T., 2008, ELEMENTS STAT LEARNI; Hathaway OA, 2002, YALE LAW J, V111, P1935, DOI 10.2307/797642; Hill DW, 2014, AM POLIT SCI REV, V108, P661, DOI 10.1017/S0003055414000306; Hill DW, 2013, INT STUD QUART, V57, P219, DOI 10.1111/isqu.12022; Hill DW, 2010, J POLIT, V72, P1161, DOI 10.1017/S0022381610000599; Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x; Innes JE, 1992, HUMAN RIGHTS STAT GE; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055760; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; Keith LC, 2012, PA STUD HUM RIGHTS, P1; King G, 2014, SCIENCE, V345, P891, DOI 10.1126/science.1251722; King G, 2013, AM POLIT SCI REV, V107, P326, DOI 10.1017/S0003055413000014; Landman T, 2005, BRIT J POLIT SCI, V35, P549, DOI 10.1017/S0007123405000293; Landman T, 2004, HUM RIGHTS QUART, V26, P906, DOI 10.1353/hrq.2004.0049; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lucas C, 2015, POLIT ANAL, V23, P254, DOI 10.1093/pan/mpu019; Lupu Y, 2013, AM J POLIT SCI, V57, P912, DOI 10.1111/ajps.12033; Lupu Y, 2013, INT ORGAN, V67, P469, DOI 10.1017/S002081831300012X; Lustick IS, 1996, AM POLIT SCI REV, V90, P605, DOI 10.2307/2082612; Monroe BL, 2011, POLITICAL ANAL; Monroe BL, 2015, PS-POLIT SCI POLIT, V48, P71, DOI 10.1017/S1049096514001760; Monroe BL, 2008, POLIT ANAL, V16, P372, DOI 10.1093/pan/mpn018; Poe S., 2019, UNDERSTANDING HUMAN, P16; POE SC, 1993, INT INTERACT, V18, P309, DOI 10.1080/03050629308434811; POE SC, 1994, AM POLIT SCI REV, V88, P853, DOI 10.2307/2082712; POE SC, 1990, HUM RIGHTS QUART, V12, P499, DOI 10.2307/762497; Poe SC, 2001, HUM RIGHTS QUART, V23, P650, DOI 10.1353/hrq.2001.0041; Poe Steven C., 1991, INT INTERACT, V16, P295, DOI DOI 10.1080/03050629108434763; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Richards DL, 2001, INT STUD QUART, V45, P219, DOI 10.1111/0020-8833.00189; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Schnakenberg KE, 2014, POLIT SCI RES METH, V2, P1, DOI 10.1017/psrm.2013.15; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Settle JE, 2016, POLIT SCI RES METH, V4, P361, DOI 10.1017/psrm.2015.1; Sikkink Kathryn, 2012, JUSTICE CASCADE HUMA; Wood RM, 2010, HUM RIGHTS QUART, V32, P367, DOI 10.1353/hrq.0.0152	65	22	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138935	10.1371/journal.pone.0138935	http://dx.doi.org/10.1371/journal.pone.0138935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418817	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400028
J	Geduhn, A; Jacob, J; Schenke, D; Keller, B; Kleinschmidt, S; Esther, A				Geduhn, Anke; Jacob, Jens; Schenke, Detlef; Keller, Barbara; Kleinschmidt, Sven; Esther, Alexandra			Relation between Intensity of Biocide Practice and Residues of Anticoagulant Rodenticides in Red Foxes (Vulpes vulpes)	PLOS ONE			English	Article							NONTARGET SMALL MAMMALS; RATTUS-NORVEGICUS; EXPOSURE; WILDLIFE; DIET; BROMADIOLONE; BRODIFACOUM; POPULATIONS; RESISTANCE; RISK	Anticoagulant rodenticides (ARs) are commonly used to control rodent infestations for biocidal and plant protection purposes. This can lead to AR exposure of non-target small mammals and their predators, which is known from several regions of the world. However, drivers of exposure variation are usually not known. To identify environmental drivers of AR exposure in non-targets we analyzed 331 liver samples of red foxes (Vulpes vulpes) for residues of eight ARs and used local parameters (percentage of urban area and livestock density) to test for associations to residue occurrence. 59.8% of samples collected across Germany contained at least one rodenticide, in 20.2% of cases at levels at which biological effects are suspected. Second generation anticoagulants (mainly brodifacoum and bromadiolone) occurred more often than first generation anticoagulants. Local livestock density and the percentage of urban area were good indicators for AR residue occurrence. There was a positive association between pooled ARs and brodifacoum occurrence with livestock density as well as of pooled ARs, brodifacoum and difenacoum occurrence with the percentage of urban area on administrative district level. Pig holding drove associations of livestock density to AR residue occurrence in foxes. Therefore, risk mitigation strategies should focus on areas of high pig density and on highly urbanized areas to minimize non-target risk.	[Geduhn, Anke; Jacob, Jens; Esther, Alexandra] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Plant Protect Hort & Forests, Vertebrate Res, Munster, North Rhine Wes, Germany; [Geduhn, Anke] Univ Munster, Inst Landscape Ecol, D-48149 Munster, North Rhine Wes, Germany; [Schenke, Detlef] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Ecol Chem Plant Anal & Stored Product Protec, Berlin, Germany; [Keller, Barbara; Kleinschmidt, Sven] Food & Vet Inst Braunschweig Hannover, Lower Saxony State Off Consumer Protect & Food Sa, Hannover, Lower Saxony, Germany	Julius Kuhn-Institut; University of Munster; Julius Kuhn-Institut	Geduhn, A (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Plant Protect Hort & Forests, Vertebrate Res, Munster, North Rhine Wes, Germany.	Anke.Geduhn@jki.bund.de	Jacob, Jens/C-2189-2013; Jacob, Jens/AAZ-7850-2020	Jacob, Jens/0000-0002-5136-6606	Federal Environment Agency within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [3710 63 401]	Federal Environment Agency within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety	This study was funded by the Federal Environment Agency (http://www.umweltbundesamt.de/en) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (grant number 3710 63 401). The funders had no role in study design, data collection and analysis, or decision to publish. An employee of the Federal Environment Agency provided comments and authorised the manuscript.	Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z; Alterio N, 1997, J ZOOL, V243, P863, DOI 10.1111/j.1469-7998.1997.tb01986.x; [Anonymous], 2013, R LANG ENV STAT COMP; Bates D., 2007, LME4 PACKAGE R PACKA, P74; Battersby S., 2008, COMMENSAL RODENTS PU, P387; BAuA, 2014, LIST BIOZ PROD 14 RO; Berny PJ, 1997, CHEMOSPHERE, V35, P1817, DOI 10.1016/S0045-6535(97)00242-7; Bontzorlos VA, 2005, FOLIA ZOOL, V54, P99; Borner K, 2014, VERSCHIEDENEN ANTHR; Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x; Braun M, 2005, DIE SAUGETIERE; Buckle A, 2013, PEST MANAG SCI, V69, P233, DOI 10.1002/ps.3373; Buckle AP, 1994, RODENT PESTS THEIR C; Coeurdassier M, 2014, CONSERV BIOL; Coeurdassier M, 2012, IBIS, V154, P136, DOI 10.1111/j.1474-919X.2011.01193.x; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Daniels MJ, 2003, EPIDEMIOL INFECT, V130, P561, DOI 10.1017/S0950268803008483; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831; EPA, 1998, EPA738R98007; Erickson W., 2004, POTENTIAL RISKS 9 RO, P1; Fisher P, 2003, PERSISTENCE 4 ANTICO, V139, P5; Geduhn A, 2014, SCI TOTAL ENVIRON, V496, P328, DOI 10.1016/j.scitotenv.2014.07.049; Giraudoux P, 2006, ENVIRON RES, V102, P291, DOI 10.1016/j.envres.2006.02.008; Goldyn B, 2003, Z JAGDWISS, V49, P191, DOI 10.1007/BF02189737; Hosea RC, 2000, PROC VERTEBR PEST C, P236; Hughes J, 2013, ECOTOXICOLOGY, V22, P974, DOI 10.1007/s10646-013-1074-9; Jacquot M, 2013, J APPL ECOL, V50, P1406, DOI 10.1111/1365-2664.12151; Laakso S, 2010, LIT REV RESIDUES ANT; Lambert O, 2007, B ENVIRON CONTAM TOX, V79, P91, DOI 10.1007/s00128-007-9134-6; Lopez-Perea JJ, 2015, SCI TOTAL ENVIRON, V511, P259, DOI 10.1016/j.scitotenv.2014.12.042; LUND M, 1964, NATURE, V203, P778, DOI 10.1038/203778a0; Maroni Marco, 2000, Toxicology, V143, P91; McDonald RA, 1998, ENVIRON POLLUT, V103, P17, DOI 10.1016/S0269-7491(98)00141-9; McMillin SC, 2008, P VERTEBR PEST C, V23, P163; Meerburg BG, 2004, NJAS-WAGEN J LIFE SC, V52, P195, DOI 10.1016/S1573-5214(04)80014-9; Meisner K, 2014, ACTA THERIOL WARSZ, P1; MENDENHALL V M, 1980, Wildlife Society Bulletin, V8, P311; Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1; Pelz HJ, 2007, INT J PEST MANAGE, V53, P299, DOI 10.1080/09670870701245223; Proulx G, 2012, INTEGR ZOOL, V7, P41, DOI [10.1111/j.1749-4877.2012.00274.x, 10.1111/j.1749-4877.2011.00276.x]; Raoul F, 2003, INT J PARASITOL, V33, P945, DOI 10.1016/S0020-7519(03)00127-9; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; Sage M, 2010, ENVIRON RES, V110, P664, DOI 10.1016/j.envres.2010.07.009; Sanchez-Barbudo IS, 2012, SCI TOTAL ENVIRON, V420, P280, DOI 10.1016/j.scitotenv.2012.01.028; Shore RF, 2003, ENVIRON POLLUT, V122, P183, DOI 10.1016/S0269-7491(02)00297-X; Statistische Amter des Bundes und der Lander, 2014, STAT AMT BUND LAND; Stone WB, 1999, J WILDLIFE DIS, V35, P187, DOI 10.7589/0090-3558-35.2.187; Tosh DG, 2011, ENVIRON POLLUT, V159, P3106, DOI 10.1016/j.envpol.2011.03.028; Tosh DG, 2012, ECOTOXICOLOGY, V21, P1325, DOI 10.1007/s10646-012-0886-3; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; Valchev I, 2008, TURK J VET ANIM SCI, V32, P237; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Walker LA, 2008, SCI TOTAL ENVIRON, V392, P93, DOI 10.1016/j.scitotenv.2007.10.061; Zuur Alain F., 2009, P1	56	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139191	10.1371/journal.pone.0139191	http://dx.doi.org/10.1371/journal.pone.0139191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418154	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400061
J	Yang, HK; Kim, MJ; Hwang, JM				Yang, Hee Kyung; Kim, Mi-Jin; Hwang, Jeong-Min			Predictive Factors Affecting Long-Term Outcome of Unilateral Lateral Rectus Recession	PLOS ONE			English	Article							STRABISMUS SURGERY; CONSECUTIVE ESOTROPIA; PRISMATIC CORRECTION; SURGICAL OUTCOMES; EXOTROPIA; ANGLE; CHILDREN; ALIGNMENT	Background There are few long-term outcome reports of unilateral lateral rectus (LR) recession for exotropia including a large number of subjects. Previous reports on unilateral LR recession commonly show extremely low rates of initial overcorrection and large exodrifts after surgery suggesting that the surgical dose may be increased. However, little is known of the long-term outcome of a large unilateral LR recession for exotropia. Objectives To determine long-term outcomes and predictive factors of recurrence after a large unilateral LR recession in patients with exotropia. Data Extraction Retrospective analysis was performed on 92 patients aged 3 to 17 years who underwent 10 mm unilateral LR recession for exotropia of <= 25 prism diopters (Delta) with prism and alternate cover testing and were followed up for more than 2 years after surgery. Final success rates within 10 Delta of exophoria/tropia and 5. of esophoria/tropia at distance in the primary position, improvement in stereopsis and the predictive factors for recurrence were evaluated. Results At 24 months after surgery, 54% of patients had ocular alignment meeting the defined criteria of success, 45% had recurrence and 1% had overcorrection. After a mean follow-up of 39 months, 36% showed success, 63% showed recurrence and 1% resulted in overcorrection. The average time of recurrence was 23.4 +/- 14.7 months (range, 1-60 months) and the rate of recurrence per person-year was 23% after unilateral LR recession. Predictive factors of recurrence were a larger preoperative near angle of deviation (>16 Delta) and larger initial postoperative exodeviation (> 5 Delta) at distance. Conclusions Long-term outcome of unilateral LR recession for exotropia showed low success rates with high recurrence, thus should be reserved for patients with a small preoperative near angle of exodeviation.	[Yang, Hee Kyung; Kim, Mi-Jin; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea.	hjm@snu.ac.kr	Kim, Mi Jin/GXH-9639-2022		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2013R1A1A2010606]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A2010606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Choi J, 2011, J AAPOS, V15, P224, DOI 10.1016/j.jaapos.2010.12.019; Dadeya S, 2003, J PEDIAT OPHTH STRAB, V40, P283, DOI 10.3928/0191-3913-20030901-09; Deacon BS, 2014, J AAPOS, V18, P572, DOI 10.1016/j.jaapos.2014.08.010; DEUTSCH JA, 1992, ANN OPHTHALMOL, V24, P111; Feretis D, 1990, J Pediatr Ophthalmol Strabismus, V27, P315; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Kim C, 2005, EYE, V19, P637, DOI 10.1038/sj.eye.6701604; Kim HJ, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-46; Kim KE, 2014, AM J OPHTHALMOL, V157, P1214, DOI 10.1016/j.ajo.2014.02.038; Kim SH, 2006, EYE, V20, P785, DOI 10.1038/sj.eye.6702002; Lee EK, 2015, BRIT J OPHTHALMOL, V99, P342, DOI 10.1136/bjophthalmol-2014-305861; Lee EK, 2013, OPHTHALMOLOGY, V120, P504, DOI 10.1016/j.ophtha.2012.08.026; Lee Kyoungsook, 2011, Korean J Ophthalmol, V25, P329, DOI 10.3341/kjo.2011.25.5.329; Leow PL, 2010, J PEDIAT OPHTH STRAB, V47, P12, DOI 10.3928/01913913-20100106-04; Livir-Rallatos G, 2002, J AAPOS, V6, P77, DOI 10.1067/mpa.2002.122059; Menon V, 2010, J PEDIAT OPHTH STRAB, V47, P288, DOI 10.3928/01913913-20091118-07; Nelson LB, 1998, J PEDIAT OPHTH STRAB, V35, P132; NELSON LB, 1992, J PEDIATR OPHTHALMOL, V29, P357; Oh JY, 2006, EYE, V20, P1268, DOI 10.1038/sj.eye.6702091; Olitsky SE, 1998, J PEDIAT OPHTH STRAB, V35, P146; SCHWARTZ RL, 1980, J PEDIAT OPHTH STRAB, V17, P359; Spierer A, 2005, OPHTHAL SURG LAS IM, V36, P114, DOI 10.3928/1542-8877-20050301-06; Tibrewal S, 2015, J AAPOS, V19, P293, DOI 10.1016/j.jaapos.2015.03.010; Wang LH, 2010, CURR OPIN OPHTHALMOL, V21, P335, DOI 10.1097/ICU.0b013e32833bd953; Wang LH, 2010, J PEDIAT OPHTH STRAB, V47, P242, DOI 10.3928/01913913-20091019-12; WEAKLEY DR, 1993, OPHTHALMIC SURG LAS, V24, P458; Wright KW., 2007, COLOR ATLAS STRABISM, P13648; Yang HK, 2011, OPHTHALMOLOGY, V118, P1512, DOI 10.1016/j.ophtha.2011.01.004	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137687	10.1371/journal.pone.0137687	http://dx.doi.org/10.1371/journal.pone.0137687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418819	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400007
J	Ali, A; Ali, I				Ali, Akhtar; Ali, Ijaz			The Complete Genome Phylogeny of Geographically Distinct Dengue Virus Serotype 2 Isolates (1944-2013) Supports Further Groupings within the Cosmopolitan Genotype	PLOS ONE			English	Article							MOLECULAR EVOLUTION; NUCLEOTIDE-SEQUENCE; HEMORRHAGIC-FEVER; PUERTO-RICO; AMINO-ACID; TYPE-2; REEMERGENCE; EPIDEMIC; CIRCULATION; EMERGENCE	Dengue virus serotype 2 (DENV-2) isolates have been implicated in deadly outbreaks of dengue fever (DF) and dengue hemorrhagic fever (DHF) in several regions of the world. Phylogenetic analysis of DENV-2 isolates collected from particular countries has been performed using partial or individual genes but only a few studies have examined complete whole-genome sequences collected worldwide. Herein, 50 complete genome sequences of DENV-2 isolates, reported over the past 70 years from 19 different countries, were downloaded from GenBank. Phylogenetic analysis was conducted and evolutionary distances of the 50 DENV-2 isolates were determined using maximum likelihood (ML) trees or Bayesian phylogenetic analysis created from complete genome nucleotide (nt) and amino acid (aa) sequences or individual gene sequences. The results showed that all DENV-2 isolates fell into seven main groups containing five previously defined genotypes. A Cosmopolitan genotype showed further division into three groups (C-I, C-II, and C-III) with the C-I group containing two subgroups (C-IA and C-IB). Comparison of the aa sequences showed specific mutations among the various groups of DENV-2 isolates. A maximum number of aa mutations was observed in the NS5 gene, followed by the NS2A, NS3 and NS1 genes, while the smallest number of aa substitutions was recorded in the capsid gene, followed by the PrM/M, NS4A, and NS4B genes. Maximum evolutionary distances were found in the NS2A gene, followed by the NS4A and NS4B genes. Based on these results, we propose that genotyping of DENV-2 isolates in future studies should be performed on entire genome sequences in order to gain a complete understanding of the evolution of various isolates reported from different geographical locations around the world.	[Ali, Akhtar; Ali, Ijaz] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	University of Tulsa	Ali, A (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	akhtar-ali@utulsa.edu	Ali, Akhtar/AAA-7582-2021; ALI, IJAZ/AAC-2691-2019	Ali, Akhtar/0000-0003-3474-0253; ALI, IJAZ/0000-0003-2163-8874	Department of Biological Science; Office of Research and Sponsored Programs	Department of Biological Science; Office of Research and Sponsored Programs	Department of Biological Science and Office of Research and Sponsored Programs.	Ali A, 2013, BIOHELIKON IMMUN DIS, V1, P1, DOI DOI 10.1186/S12985-016-0603-6; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495; Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013; Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095; Dash PK, 2013, BIOCHEM BIOPH RES CO, V436, P478, DOI 10.1016/j.bbrc.2013.05.130; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Fatima Z, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-200; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; Franco L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001251; Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11; GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Idrees M., 2012, AM J BIOMED SCI, V4, P307, DOI [10.5099/aj120400307, DOI 10.5099/AJ120400307]; Khan MA, 2011, PLOS ONE, V8; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kurosu T, 2014, JPN J INFECT DIS, V67, P132, DOI 10.7883/yoken.67.132; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Ma XZ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-56; McBride W. J. H., 1995, Communicable Diseases Intelligence, V19, P522; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Osman O, 2008, VIRUS RES, V135, P48, DOI 10.1016/j.virusres.2008.02.006; Pickett BE, 2013, VIROLOGY, V447, P45, DOI 10.1016/j.virol.2013.08.021; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; Sotomayor-Bonilla J, 2014, AM J TROP MED HYG, V91, P129, DOI 10.4269/ajtmh.13-0524; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Yamashita A, 2013, FUTURE VIROL, V8, P1061, DOI 10.2217/fvl.13.99; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087630	56	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138900	10.1371/journal.pone.0138900	http://dx.doi.org/10.1371/journal.pone.0138900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414178	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700026
J	Bologna, A; Detrain, C				Bologna, Audrey; Detrain, Claire			Steep Decline and Cessation in Seed Dispersal by Myrmica rubra Ants	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; LEAF-CUTTING ANTS; MULTIVARIATE DATA-ANALYSIS; MYRMECOCHOROUS PLANTS; FORAGING ACTIVITY; DECIDUOUS FOREST; COLONY GROWTH; REMOVAL RATES; HYMENOPTERA; ELAIOSOMES	Myrmecochorous diaspores bear a nutrient-rich appendage, the elaiosome, attractive to ant workers that retrieve them into the nest, detach the elaiosome and reject the seed intact. While this interaction is beneficial for the plant partner by ensuring its seed dispersal, elaiosome consumption has various effects -positive, negative or none - on ants' demography and survival, depending on both the ant/plant species involved. In this context, the contribution of ants to seed dispersal strongly varies according to the ant/plant pairs considered. In this paper, we investigate whether the dynamics of myrmecochory also vary on a temporal scale, for a given pair of partners: Myrmica rubra ants and Viola odorata seeds. During their first encounter with seeds, ants collect all the diaspores and eat the majority of elaiosomes. Both the harvesting effort and the elaiosome consumption decline when seeds are offered on the next week and completely cease for the following weeks. This is related to a decrease in the number of foragers reaching the food source, as well as to a reduced probability for an ant contacting a seed to retrieve it. Seed retrieval is not reactivated after seven weeks without any encounter with V. odorata seeds. By contrast, naive ant colonies only fed with fruit flies do not show a decline of prey harvesting of which the speed of retrieval even increases over the successive weeks. Myrmecochory may thus be labile at the scale of a fruiting season due to the ability of ants to steeply tune and cease for several months the harvesting of these seemingly poorly rewarding items and to maintain cessation of seed exploitation. The present study emphasizes the importance of a long-lasting follow up of the myrmecochory process, to assess the stability of this ant-plant partnership and to identify mechanisms of adaptive harvesting in ants.	[Bologna, Audrey; Detrain, Claire] Univ Libre Bruxelles, Serv Ecol Sociale, Brussels, Belgium	Universite Libre de Bruxelles	Bologna, A (corresponding author), Univ Libre Bruxelles, Serv Ecol Sociale, Brussels, Belgium.	aubologn@ulb.ac.be			FRIA (Fonds pour la formation a la recherche dans l'Industrie et dans l'Agriculture) Ph.D. grant; FRFC from FRS-FNRS [2.4579.12]	FRIA (Fonds pour la formation a la recherche dans l'Industrie et dans l'Agriculture) Ph.D. grant(Fonds de la Recherche Scientifique - FNRS); FRFC from FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This study was funded by a FRIA (Fonds pour la formation a la recherche dans l'Industrie et dans l'Agriculture) Ph.D. grant attributed to Audrey Bologna, as well by an FRFC grant (2.4579.12) from FRS-FNRS.	Barroso A, 2013, INSECT SOC, V60, P75, DOI 10.1007/s00040-012-0268-0; Bas JM, 2009, ACTA OECOL, V35, P380, DOI 10.1016/j.actao.2009.02.003; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Berg RY, 1981, ROLE ANTS SEED DISPE, P383; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Bono JM, 2002, INSECT SOC, V49, P320, DOI 10.1007/PL00012655; Boulay R, 2007, P ROY SOC B-BIOL SCI, V274, P2515, DOI 10.1098/rspb.2007.0594; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; BREW CR, 1989, OECOLOGIA, V80, P490, DOI 10.1007/BF00380071; BULOWOLSEN A, 1984, AM MIDL NAT, V112, P251, DOI 10.2307/2425432; BURROWS FM, 1975, NEW PHYTOL, V75, P405, DOI 10.1111/j.1469-8137.1975.tb01404.x; Caut S, 2013, ECOL ENTOMOL, V38, P390, DOI 10.1111/een.12028; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Champagne D, 1991, PYSIOLOGICAL ENTOMOL, V15, P105; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; COX DR, 1972, J R STAT SOC B, V34, P187; DEBISEAU JC, 1994, J INSECT BEHAV, V7, P767, DOI 10.1007/BF01997125; Detrain C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P331; Detrain C, 2000, INSECT SOC, V47, P56, DOI 10.1007/s000400050009; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Dupuy F, 2006, ANIM BEHAV, V72, P1081, DOI 10.1016/j.anbehav.2006.03.011; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; ELMES GW, 1991, INSECT SOC, V38, P51, DOI 10.1007/BF01242713; ELMES GW, 1973, J ANIM ECOL, V42, P761, DOI 10.2307/3136; Elmes GW, 1975, POPULATION STUDIES G; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; Fischer RC, 2005, INSECT SOC, V52, P55, DOI 10.1007/s00040-004-0773-x; Fokuhl G, 2007, ECOL RES, V22, P845, DOI 10.1007/s11284-006-0331-2; Gammans N, 2005, OECOLOGIA, V146, P43, DOI 10.1007/s00442-005-0154-9; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gorb E, 2000, ECOL RES, V15, P187, DOI 10.1046/j.1440-1703.2000.00338.x; GORB SN, 1995, OIKOS, V73, P367, DOI 10.2307/3545960; Gorb SN, 1999, OIKOS, V84, P110, DOI 10.2307/3546871; Gorb SN, 2000, ACTA OECOL, V21, P293, DOI 10.1016/S1146-609X(00)01081-X; Gove AD, 2007, OECOLOGIA, V153, P687, DOI 10.1007/s00442-007-0756-5; Guitian J, 2006, PLANT SPEC BIOL, V21, P165, DOI 10.1111/j.1442-1984.2006.00162.x; GUNTHER RW, 1989, AM MIDL NAT, V122, P321, DOI 10.2307/2425919; HADLEY M, 1972, Ekologia polska, V20, P173; HANZAWA FM, 1985, AM J BOT, V72, P1707, DOI 10.2307/2443727; Heithaus ER, 2005, J INSECT BEHAV, V18, P827, DOI 10.1007/s10905-005-8743-3; Herz H, 2008, BEHAV ECOL, V19, P575, DOI 10.1093/beheco/arn016; HIGASHI S, 1989, OIKOS, V54, P389, DOI 10.2307/3565300; HORVITZ CC, 1981, OECOLOGIA, V51, P47, DOI 10.1007/BF00344651; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; JENSEN TF, 1978, OIKOS, V31, P207, DOI 10.2307/3543564; Kay A, 2004, BEHAV ECOL, V15, P63, DOI 10.1093/beheco/arg106; KJELLSSON G, 1985, OECOLOGIA, V67, P416, DOI 10.1007/BF00384949; Lambinon J., 2012, NOUVELLE FLORE BELGI, V6; Le Roux AM, 2002, J CHEM ECOL, V28, P2307, DOI 10.1023/A:1021009618298; LEE JC, 1988, PHYSIOL ENTOMOL, V13, P291, DOI 10.1111/j.1365-3032.1988.tb00481.x; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; Marussich WA, 2006, INSECT SOC, V53, P403, DOI 10.1007/s00040-005-0888-3; Morales MA, 1998, ECOLOGY, V79, P734, DOI 10.1890/0012-9658(1998)079[0734:FFSDMS]2.0.CO;2; NAKANISHI H, 1994, ECOL RES, V9, P1, DOI 10.1007/BF02347236; Oberrath R, 2002, ECOLOGY, V83, P1412, DOI 10.1890/0012-9658(2002)083[1412:PAOADP]2.0.CO;2; Ohkawara K, 2005, PLANT SPEC BIOL, V20, P145, DOI 10.1111/j.1442-1984.2005.00133.x; OHKAWARA K, 1994, OECOLOGIA, V100, P135, DOI 10.1007/BF00317140; OOSTERMEIJER JGB, 1989, OECOLOGIA, V78, P302, DOI 10.1007/BF00379102; Orians G.H., 1979, P155; Passera L., 2005, FOURMIS COMPORTEMENT; Pfeiffer M, 2010, FUNCT ECOL, V24, P545, DOI 10.1111/j.1365-2435.2009.01661.x; RAHBE Y, 1988, B ENTOMOL RES, V78, P329, DOI 10.1017/S0007485300013092; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; Saverschek N, 2011, ANIM BEHAV, V82, P453, DOI 10.1016/j.anbehav.2011.05.015; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; Schmidt A., 1938, Zeitschrift fuer Vergleichende Physiologie Berlin, V25, P351; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SEIFERT B, 1996, AMEISEN BEOBACHTEN B; Sernander R., 1906, K SVEN VETENSKAPSAKA, V41, P410; Servigne P, 2008, INSECT SOC, V55, P220, DOI 10.1007/s00040-008-0991-8; Sheridan SL, 1996, J INSECT PHYSIOL, V42, P149, DOI 10.1016/0022-1910(95)00087-9; Sousa-Souto L, 2008, SOCIOBIOLOGY, V52, P645; Souza JM, 2012, AN ACAD BRAS CIENC, V84, P43, DOI 10.1590/S0001-37652012000100006; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; Thiele T, 2014, J CHEM ECOL, V40, P617, DOI 10.1007/s10886-014-0460-y; THOMPSON JN, 1981, AM NAT, V117, P104, DOI 10.1086/283691; Turner KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071871; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004; von Beeren C, 2014, ANIM BEHAV, V89, P71, DOI 10.1016/j.anbehav.2013.12.006; Walin L, 2001, ECOL ENTOMOL, V26, P537, DOI 10.1046/j.1365-2311.2001.00350.x; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; Willson M. F., 2000, Seeds: the ecology of regeneration in plant communities, P85, DOI 10.1079/9780851994321.0085	90	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139365	10.1371/journal.pone.0139365	http://dx.doi.org/10.1371/journal.pone.0139365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414161	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700054
J	Shi, C; Huang, X; Zhang, B; Zhu, D; Luo, HQ; Lu, QQ; Xiong, WC; Mei, L; Luo, SW				Shi, Chao; Huang, Xuan; Zhang, Bin; Zhu, Dan; Luo, Huqiao; Lu, Quqin; Xiong, Wen-Cheng; Mei, Lin; Luo, Shiwen			The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein	PLOS ONE			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; POLYALANINE EXPANSION MUTANT; UBIQUITIN-PROTEASOME SYSTEM; REDUCE AGGREGATE FORMATION; MOLECULAR CHAPERONES; CELL-DEATH; TRANSGENIC MICE; QUALITY-CONTROL; HSP90; CHIP	Background Since the identification of poly-alanine expanded poly(A) binding protein nuclear 1 (PABPN1) as the genetic cause of oculopharyngeal muscular dystrophy (OPMD), considerable progress has beenmade in our understanding of the pathogenesis of the disease. However, the molecular mechanisms that regulate the onset and progression of the disease remain unclear. Results In this study, we show that PABPN1 interacts with and is stabilized by heat shock protein 90 (HSP90). Treatment with the HSP90 inhibitor 17-AAG disrupted the interaction of mutant PABPN1 with HSP90 and reduced the formation of intranuclear inclusions (INIs). Furthermore, mutant PABPN1 was preferentially degraded in the presence of 17-AAG compared with wild-type PABPN1 in vitro and in vivo. The effect of 17-AAG was mediated through an increase in the interaction of PABPN1 with the carboxyl terminus of heat shock protein 70-interacting protein (CHIP). The overexpression of CHIP suppressed the aggregation of mutant PABPN1 in transfected cells. Conclusions Our results demonstrate that the HSP90 molecular chaperone system plays a crucial role in the selective elimination of abnormal PABPN1 proteins and also suggest a potential therapeutic application of the HSP90 inhibitor 17-AAG for the treatment of OPMD.	[Shi, Chao; Huang, Xuan; Luo, Shiwen] Nanchang Univ, Ctr Med Expt, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zhang, Bin] Huazhong Univ Sci & Technol, Sch Basic Med, Tongji Med Coll, Dept Physiol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Bin; Zhu, Dan; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Zhang, Bin; Zhu, Dan; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Luo, Huqiao] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Lu, Quqin] Nanchang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanchang, Jiangxi, Peoples R China	Nanchang University; Huazhong University of Science & Technology; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Shanghai Jiao Tong University; Nanchang University	Mei, L (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA.	lmei@gru.edu; shiwenluo@ncu.edu.cn		Shi, Chao/0000-0003-2347-6127; ZHU, DAN/0000-0003-2735-8996; Zhang, Bin/0000-0003-1323-8678	China National Basic Research Program [2010CB535001]; National Natural Science Foundation of China [81060095]; Science & Technology Support Plan of Jiangxi Province [2010BSA12700]	China National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Support Plan of Jiangxi Province	This work was supported in part by grants from the China National Basic Research Program (2010CB535001 to S.L.), the National Natural Science Foundation of China (81060095 to S.L.) and the Science & Technology Support Plan of Jiangxi Province (2010BSA12700 to S.L.).	Abu-Baker A, 2005, TRAFFIC, V6, P766, DOI 10.1111/j.1600-0854.2005.00315.x; Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Anvar SY, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-15; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bao YP, 2004, J MED GENET, V41, P47, DOI 10.1136/jmg.2003.014548; Bao YP, 2002, J BIOL CHEM, V277, P12263, DOI 10.1074/jbc.M109633200; Bengoechea R, 2012, NEUROBIOL DIS, V46, P118, DOI 10.1016/j.nbd.2011.12.052; Bhattacharjee RB, 2012, CELL BIOL INT, V36, P697, DOI 10.1042/CBI20110348; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brais B, 2003, CYTOGENET GENOME RES, V100, P252, DOI 10.1159/000072861; Brais Bernard, 2011, Handb Clin Neurol, V101, P181, DOI 10.1016/B978-0-08-045031-5.00014-1; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Chen L, 2009, CELL IMMUNOL, V258, P38, DOI 10.1016/j.cellimm.2009.03.009; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088386; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Chiosis G, 2003, MOL CANCER THER, V2, P123; Clare DK, 2013, BIOPOLYMERS, V99, P846, DOI 10.1002/bip.22361; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dion P, 2005, NEUROBIOL DIS, V18, P528, DOI 10.1016/j.nbd.2004.09.021; Fan XP, 2003, CAN J NEUROL SCI, V30, P8, DOI 10.1017/S0317167100002365; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Hino H, 2004, HUM MOL GENET, V13, P181, DOI 10.1093/hmg/ddh017; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Laederich MB, 2011, J BIOL CHEM, V286, P19597, DOI 10.1074/jbc.M110.206151; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Neckers L, 2002, CLIN CANCER RES, V8, P962; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Wang QS, 2005, HUM MOL GENET, V14, P3673, DOI 10.1093/hmg/ddi395; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138936	10.1371/journal.pone.0138936	http://dx.doi.org/10.1371/journal.pone.0138936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414348	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700030
J	Chiu, HY; Huang, HL; Li, CH; Chen, HA; Yeh, CL; Chiu, SH; Lin, WC; Cheng, YP; Tsai, TF; Ho, SY				Chiu, Hsien-Yi; Huang, Hui-Ling; Li, Chien-Hsun; Chen, Hung-An; Yeh, Chia-Lun; Chiu, Shih-Hsiang; Lin, Wei-Chun; Cheng, Yu-Pin; Tsai, Tsen-Fang; Ho, Shinn-Ying			Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study	PLOS ONE			English	Article							SUBCLINICAL RENAL DYSFUNCTION; INSURANCE RESEARCH DATABASE; ISCHEMIC-STROKE; FOLLOW-UP; EVENTS; CYCLOSPORINE; PROGRESSION; PREVALENCE; VALIDATION; PREDICTOR	Background and Objectives There have been few large population-based studies of the association between rheumatoid arthritis (RA) and chronic kidney disease (CKD) and glomerulonephritis. This nationwide cohort study investigated the risks of developing CKD and glomerulonephritis in patients with RA, and the associated risks for cardiovascular complications. Methods From the Taiwan National Health Insurance Research Database, we identified a study cohort of 12,579 patients with RA and randomly selected 37,737 subjects without RA as a control cohort. Each subject was individually followed for up for 5 years, and the risk of CKD was analyzed using Cox proportional hazards regression models. Results During the follow-up period, after adjusting for traditional cardiovascular risk factors RA was independently associated with a significantly increased risk of CKD (adjusted hazard ratio [aHR] 1.31; 95% confidence interval [CI] 1.23-1.40) and glomerulonephritis (aHR 1.55; 95% CI 1.37-1.76). Increased risk of CKD was also associated with the use of non-steroidal anti-inflammatory drugs, cyclosporine, glucocorticoids, mycophenolate mofetil, and cyclophosphamide. Patients with comorbidities had even greater increased risk of CKD. Moreover, RA patients with concurrent CKD had significantly higher likelihood of developing ischemic heart disease and stroke. Conclusions RA patients had higher risk of developing CKD and glomerulonephritis, independent of traditional cardiovascular risk factors. Their increased risk of CKD may be attributed to glomerulonephritis, chronic inflammation, comorbidities, and renal toxicity of antirheumatic drugs. Careful monitoring of renal function in RA patients and tight control of their comorbid diseases and cardiovascular risk factors are warranted.	[Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Li, Chien-Hsun; Chen, Hung-An; Yeh, Chia-Lun; Chiu, Shih-Hsiang; Lin, Wei-Chun; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Hui-Ling; Ho, Shinn-Ying] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Li, Chien-Hsun] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Hsin Chu Branch, Hsinchu, Taiwan; [Cheng, Yu-Pin] Cathay Gen Hosp, Dept Dermatol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.	tftsai@yahoo.com; syho@mail.nctu.edu.tw		Ho, Shinn-Ying/0000-0002-1901-8353; TSAI, TSEN-FANG/0000-0002-1498-1474; LI, CHIEN-HSUN/0000-0001-7671-9618; Chiu, Hsien-Yi/0000-0002-0493-9707	Cathay General Hospital [MR-A10324]; National Science Council of Taiwan [MOST-103-2221-E-009-117-]; Center forBioinformatics Research of Aiming for the Top University Program of the National Chiao Tung University; Center forBioinformatics Research of Aiming for the Top University Program of Ministry of Education, Taiwan, R.O.C. [104W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering - Ministry of Science and Technology with I-RiCE Program [MOST 103-2911-I-009-101. 2]	Cathay General Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Center forBioinformatics Research of Aiming for the Top University Program of the National Chiao Tung University; Center forBioinformatics Research of Aiming for the Top University Program of Ministry of Education, Taiwan, R.O.C.; UST-UCSD International Center of Excellence in Advanced Bioengineering - Ministry of Science and Technology with I-RiCE Program	This work was funded by the Cathay General Hospital (Grant number: MR-A10324; http://www.cgh.org.tw/index.html), the National Science Council of Taiwan under contract number MOST-103-2221-E-009-117-, and the Center forBioinformatics Research of Aiming for the Top University Program of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 104W962. This work was also supported in part by UST-UCSD International Center of Excellence in Advanced Bioengineering, sponsored by the Ministry of Science and Technology with I-RiCE Program under Grant Number: MOST 103-2911-I-009-101. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2011, CHEMOTHERAPY, V57, P327, DOI 10.1159/000330463; BOERS M, 1987, ANN RHEUM DIS, V46, P658, DOI 10.1136/ard.46.9.658; BOERS M, 1990, ARTHRITIS RHEUM, V33, P95, DOI 10.1002/art.1780330113; Chen YC, 2014, KIDNEY INT, V85, P1200, DOI 10.1038/ki.2013.455; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Chiu HY, 2012, DERMATOL SIN, V30, P136, DOI 10.1016/j.dsi.2012.08.002; Daoussis D, 2010, ANN RHEUM DIS, V69, P517, DOI 10.1136/ard.2008.105049; Daoussis D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2775; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dessein PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121693; DIJKMANS BAC, 1992, SEMIN ARTHRITIS RHEU, V22, P30, DOI 10.1016/0049-0172(92)90046-G; Fried L, 2004, J AM SOC NEPHROL, V15, P3184, DOI 10.1097/01.ASN.0000146422.45434.35; Goicoechea M, 2012, J NEPHROL, V25, P969, DOI 10.5301/jn.5000077; Haroon M, 2011, INT J RHEUM DIS, V14, P255, DOI 10.1111/j.1756-185X.2011.01594.x; HELIN HJ, 1995, ARTHRITIS RHEUM, V38, P242, DOI 10.1002/art.1780380213; Hickson LJ, 2014, AM J KIDNEY DIS, V63, P206, DOI 10.1053/j.ajkd.2013.08.010; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang HL, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-80; Karie S, 2008, RHEUMATOLOGY, V47, P350, DOI 10.1093/rheumatology/kem370; Karstila K, 2007, CLIN RHEUMATOL, V26, P2089, DOI 10.1007/s10067-007-0625-y; Kawada T, 2012, ANN RHEUM DIS, V71, pE3, DOI 10.1136/annrheumdis-2012-202595; Kim HW, 2015, RHEUMATOL INT, V35, P727, DOI 10.1007/s00296-014-3146-4; Koseki Y, 2001, ANN RHEUM DIS, V60, P327, DOI 10.1136/ard.60.4.327; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lai MN, 2010, AM J KIDNEY DIS, V55, P507, DOI 10.1053/j.ajkd.2009.10.055; Levy AR, 2014, ARTHRIT CARE RES, V66, P440, DOI 10.1002/acr.22176; Moller B, 2015, ANN RHEUM DIS, V74, P718, DOI 10.1136/annrheumdis-2013-204078; Nakano M, 1998, CLIN NEPHROL, V50, P154; National Health Insurance Database, 2014, LHID 2005; Sihvonen S, 2004, NEPHRON CLIN PRACT, V96, pC107, DOI 10.1159/000077372; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Sugumar E, 2007, CLIN CHIM ACTA, V376, P244, DOI 10.1016/j.cca.2006.04.006; Thomas E, 2003, J RHEUMATOL, V30, P958; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; van Sijl AM, 2012, ANN RHEUM DIS, V71, P341, DOI 10.1136/annrheumdis-2011-200051; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; YOCUM DE, 1988, ANN INTERN MED, V109, P863, DOI 10.7326/0003-4819-109-11-863; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	40	65	76	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136508	10.1371/journal.pone.0136508	http://dx.doi.org/10.1371/journal.pone.0136508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406879	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700012
J	Fogen, D; Wu, SC; Ng, KKS; Wong, SL				Fogen, Dawson; Wu, Sau-Ching; Ng, Kenneth Kai-Sing; Wong, Sui-Lam			Engineering Streptavidin and a Streptavidin-Binding Peptide with Infinite Binding Affinity and Reversible Binding Capability: Purification of a Tagged Recombinant Protein to High Purity via Affinity-Driven Thiol Coupling	PLOS ONE			English	Article							ONE-STEP PURIFICATION; MONOMERIC STREPTAVIDIN; BIOTIN DISSOCIATION; BACILLUS-SUBTILIS; STREP-TAG; DISULFIDE; SYSTEM; LIGAND; MODEL; DNA	To extend and improve the utility of the streptavidin-binding peptide tag (SBP-tag) in applications ranging from affinity purification to the reversible immobilization of recombinant proteins, a cysteine residue was introduced to the streptavidin mutein SAVSBPM18 and the SBP-tag to generate SAVSBPM32 and SBP(A18C), respectively. This pair of derivatives is capable of forming a disulfide bond through the newly introduced cysteine residues. SAVSBPM32 binds SBP-tag and biotin with binding affinities (K-d similar to 10(-8)M) that are similar to SAVSBPM18. Although SBP(A18C) binds to SAVSBPM32 more weakly than SBP-tag, the binding affinity is sufficient to bring the two binding partners together efficiently before they are locked together via disulfide bond formation-a phenomenon we have named affinity-driven thiol coupling. Under the condition with SBP(A18C) tags in excess, two SBP(A18C) tags can be captured by a tetrameric SAVSBPM32. The stoichiometry of the disulfide-bonded SAVSBPM32-SBP(A18C) complex was determined using a novel two-dimensional electrophoresis method which has general applications for analyzing the composition of disulfide-bonded protein complexes. To illustrate the application of this reversible immobilization technology, optimized conditions were established to use the SAVSBPM32-affinity matrix for the purification of a SBP(A18C)-tagged reporter protein to high purity. Furthermore, we show that the SAVSBPM32-affinity matrix can also be applied to purify a biotinylated protein and a reporter protein tagged with the unmodified SBP-tag. The dual (covalent and non-covalent) binding modes possible in this system offer great flexibility to many different applications which need reversible immobilization capability.	[Fogen, Dawson; Wu, Sau-Ching; Ng, Kenneth Kai-Sing; Wong, Sui-Lam] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Wong, SL (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	slwong@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445	Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC) [690573, 262089]	Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC)	This study was supported by Discovery grant (690573) from The Natural Sciences and Engineering Research Council of Canada (NSERC) to SLW,http://www.nserc-crsng.gc.ca/; Discovery grant (262089) from The Natural Sciences and Engineering Research Council of Canada (NSERC) to KKSN, http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Barrette-Ng IH, 2013, ACTA CRYSTALLOGR D, V69, P879, DOI 10.1107/S0907444913002576; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Creus M, 2007, ORG BIOMOL CHEM, V5, P1835, DOI 10.1039/b702068f; DeMonte D, 2013, PROTEINS, V81, P1621, DOI 10.1002/prot.24320; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Fairhead M, 2014, J MOL BIOL, V426, P199, DOI 10.1016/j.jmb.2013.09.016; Funabashi H, 2007, BIOTECHNOL LETT, V29, P785, DOI 10.1007/s10529-006-9301-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HALLING SM, 1977, BIOCHEMISTRY-US, V16, P2880, DOI 10.1021/bi00632a012; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Huang SC, 1996, ANAL BIOCHEM, V237, P115, DOI 10.1006/abio.1996.0208; HUTCHENS TW, 1987, BIOCHEMISTRY-US, V26, P7199, DOI 10.1021/bi00396a049; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim DM, 2011, SMALL, V7, P656, DOI 10.1002/smll.201002114; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Los GV, 2007, METH MOL B, V356, P195; Maraveyas A, 1998, INT J CANCER, V78, P610, DOI 10.1002/(SICI)1097-0215(19981123)78:5<610::AID-IJC14>3.3.CO;2-K; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Ovsejevi K, 2013, METHODS MOL BIOL, V1051, P89, DOI 10.1007/978-1-62703-550-7_7; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Sun X, 2014, BIOCONJUGATE CHEM, V25, P1375, DOI 10.1021/bc500296p; Swift JL, 2006, BIOPHYS J, V90, P1396, DOI 10.1529/biophysj.105.069526; Valadon P, 2010, J BIOL CHEM, V285, P713, DOI 10.1074/jbc.M109.061838; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; Wilson JL, 2010, BIOCHEM MOL BIOL EDU, V38, P400, DOI 10.1002/bmb.20442; Wu SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069530; Wu SC, 2009, PROTEINS, V77, P404, DOI 10.1002/prot.22446; Wu SC, 2006, PROTEIN EXPRES PURIF, V46, P268, DOI 10.1016/j.pep.2005.10.006; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Wu SC, 2002, APPL ENVIRON MICROB, V68, P3261, DOI 10.1128/AEM.68.7.3261-3269.2002; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P348, DOI 10.1006/prep.2001.1582; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P357, DOI 10.1006/prep.2001.1583; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhang XB, 2014, AICHE J, V60, P1245, DOI 10.1002/aic.14348	51	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139137	10.1371/journal.pone.0139137	http://dx.doi.org/10.1371/journal.pone.0139137			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406477	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700180
J	Ihwagi, FW; Wang, T; Wittemyer, G; Skidmore, AK; Toxopeus, AG; Ngene, S; King, J; Worden, J; Omondi, P; Douglas-Hamilton, I				Ihwagi, Festus W.; Wang, Tiejun; Wittemyer, George; Skidmore, Andrew K.; Toxopeus, Albertus G.; Ngene, Shadrack; King, Juliet; Worden, Jeffrey; Omondi, Patrick; Douglas-Hamilton, Iain			Using Poaching Levels and Elephant Distribution to Assess the Conservation Efficacy of Private, Communal and Government Land in Northern Kenya	PLOS ONE			English	Article							AFRICAN ELEPHANTS; WILDLIFE; LANDSCAPE; ATTITUDES; MOVEMENTS; LIVESTOCK; DYNAMICS; LAIKIPIA	Efforts to curb elephant poaching have focused on reducing demand, confiscating ivory and boosting security patrols in elephant range. Where land is under multiple uses and ownership, determining the local poaching dynamics is important for identifying successful conservation models. Using 2,403 verified elephant, Loxodonta africana, mortality records collected from 2002 to 2012 and the results of aerial total counts of elephants conducted in 2002, 2008 and 2012 for the Laikipia-Samburu ecosystem of northern Kenya, we sought to determine the influence of land ownership and use on diurnal elephant distribution and on poaching levels. We show that the annual proportions of illegally killed (i.e., poached) elephants increased over the 11 years of the study, peaking at 70% of all recorded deaths in 2012. The type of land use was more strongly related to levels of poaching than was the type of ownership. Private ranches, comprising only 13% of land area, hosted almost half of the elephant population and had significantly lower levels of poaching than other land use types except for the officially designated national reserves (covering only 1.6% of elephant range in the ecosystem). Communal grazing lands hosted significantly fewer elephants than expected, but community areas set aside for wildlife demonstrated significantly higher numbers of elephants and lower illegal killing levels relative to non-designated community lands. While private lands had lower illegal killing levels than community conservancies, the success of the latter relative to other community-held lands shows the importance of this model of land use for conservation. This work highlights the relationship between illegal killing and various land ownership and use models, which can help focus anti-poaching activities.	[Ihwagi, Festus W.; Wang, Tiejun; Skidmore, Andrew K.; Toxopeus, Albertus G.] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Ihwagi, Festus W.; Wittemyer, George; Douglas-Hamilton, Iain] Save Elephants, Nairobi, Kenya; [Wittemyer, George] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Ngene, Shadrack; Omondi, Patrick] Kenya Wildlife Serv, Nairobi, Kenya; [King, Juliet; Worden, Jeffrey] No Rangelands Trust, Isiolo, Kenya	University of Twente; Colorado State University	Ihwagi, FW (corresponding author), Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	f.w.ihwagi@utwente.nl	Toxopeus, Albertus/A-3650-2010; Wang, Tiejun/A-4671-2010; Skidmore, Andrew K/C-7441-2011; Wittemyer, George/AFQ-1840-2022	Wang, Tiejun/0000-0002-1138-8464; Skidmore, Andrew K/0000-0002-7446-8429; 	Nature Conservancy; Barrett Bateman Foundation; NUFFIC [NFP-PhD.14/44]	Nature Conservancy; Barrett Bateman Foundation; NUFFIC	Support for the study was provided by the Nature Conservancy, the Barrett Bateman Foundation and NUFFIC (NFP-PhD.14/44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekure S, 1990, STRUGGLE LAND INDIGE; Blom A, 2005, ORYX, V39, P381, DOI 10.1017/S0030605305001080; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caro T, 2011, TRENDS ECOL EVOL, V26, P111, DOI 10.1016/j.tree.2010.12.008; COLDHAM SFR, 1979, J MOD AFR STUD, V17, P615, DOI 10.1017/S0022278X00007473; Craig G. C., 2004, MONITORING ILLEGAL K; DIAMOND JM, 1984, EXTINCTIONS; Didier KA, 2009, BIODIVERS CONSERV, V18, P1979, DOI 10.1007/s10531-008-9568-0; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Douglas-Hamilton I, 1991, AFR WILDL RES MAN P; Douglas-Hamilton I., 2009, PACHYDERM, V45, P154; Douglas-Hamilton I, 2010, REPORT LEVELS ILLEGA, P1; Douglas-Hamilton Iain, 1996, P28; Fitzsimons JA, 2007, J ENVIRON MANAGE, V84, P38, DOI 10.1016/j.jenvman.2006.05.009; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Georgiadis NJ, 2011, INTRO CONSERVING WIL; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Greiner C, 2012, HUM ECOL, V40, P415, DOI 10.1007/s10745-012-9491-6; Hedges S, 2005, BIOL CONSERV, V124, P35, DOI 10.1016/j.biocon.2005.01.004; Jachmann H, 2013, PACHYDERM, V52, P72; Kahindi O, 2010, AFR J ECOL, V48, P972, DOI 10.1111/j.1365-2028.2009.01200.x; Maingi JK, 2012, WILDLIFE RES, V39, P234, DOI 10.1071/WR11017; Milliken T, 2012, 16 M C PART CITES CI; Murwira A, 2005, LANDSCAPE ECOL, V20, P217, DOI 10.1007/s10980-004-3159-6; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Ogutu JO, 2014, BIODIVERS CONSERV, V23, P573, DOI 10.1007/s10531-013-0617-y; Omondi P., 2012, GEORG WRIGHT FORUM, V29, P90; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Petrzelka P, 2011, AGR HUM VALUES, V28, P549, DOI 10.1007/s10460-011-9307-0; Pia MV, 2013, J ARID ENVIRON, V91, P31, DOI 10.1016/j.jaridenv.2012.11.004; R Core Team, 2012, LANG ENV STAT COMP; Raizman EA, 2013, PREV VET MED, V111, P76, DOI 10.1016/j.prevetmed.2013.04.007; Thouless CR, 1995, AFR J ECOL, V33, P321, DOI 10.1111/j.1365-2028.1995.tb01042.x; Thouless CR, 2008, REPORT STATUS KENYAS; UNEP CITES IUCN TRAFFIC, 2013, EL DUST AFR EL CRIS; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Waltert M, 2009, AFR J ECOL, V47, P737, DOI 10.1111/j.1365-2028.2009.01080.x; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wiederholt R, 2010, ECOL MODEL, V221, P2482, DOI 10.1016/j.ecolmodel.2010.06.026; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726; Woodroffe R., 2005, CONSERV BIOL	47	31	31	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139079	10.1371/journal.pone.0139079	http://dx.doi.org/10.1371/journal.pone.0139079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407001	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700163
J	Kim, HS; Seung, J; Lee, JH; Chung, BH; Yang, CW				Kim, Hyun Seon; Seung, Jaeho; Lee, Ju Hyun; Chung, Byung Ha; Yang, Chul Woo			Clinical Significance of Pre-Transplant Arterial Stiffness and the Impact of Kidney Transplantation on Arterial Stiffness	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; POSTTRANSPLANT RENAL-FUNCTION; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; SUBCLINICAL ATHEROSCLEROSIS; STRONG PREDICTOR; RISK-FACTOR; PROGRESSION; PRESSURE; DIALYSIS	Background Arterial stiffness is closely associated with cardiovascular disease (CVD) in end stage renal disease (ESRD) patients. However, the clinical significance of pre-transplant arterial stiffness and the impact of kidney transplantation (KT) on arterial stiffness have not yet been determined. Method We measured the brachial-ankle pulse wave velocity (baPWV) before KT and one year after KT. We evaluated the potential utility of pre-transplant baPWV as a screening test to predict CVD. The impact of KT on progression of arterial stiffness was evaluated according to changes in baPWV after KT. The factors that influence the change of baPWV after KT were also examined. Result The mean value of pre-transplant baPWV was 1508 +/- 300 cm/s in ESRD patients; 93.4% had a higher baPWV value than healthy controls. Pre-transplant baPWV was higher in patients with CVD than in those without CVD (1800 +/- 440 vs. 1491 +/- 265 cm/s, p<0.05), and was a strong predictive factor of CVD (OR 1.003, p<0.05). The optimal cut-off value of baPWV for the detection of CVD was 1591 cm/s, and this value was an independent predictor of CVD in KT recipients (OR 6.3, p<0.05). The post-transplant baPWV was significantly decreased compared to that of pre-transplant rates (1418 +/- 235 vs. 1517 +/- 293 cm/s, p<0.05), and progression of arterial stiffness was not observed in 86.9% patients. Logistic regression analysis revealed that higher body mass index and the degree of increase in calcium levels were independent risk factors that affected baPWV after KT. Conclusions Evaluation of arterial stiffness with baPWV is a useful screening test for predicting CVD after KT, and KT is effective in preventing the progression of arterial stiffness in ESRD patients.	[Kim, Hyun Seon; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Kim, Hyun Seon; Seung, Jaeho; Lee, Ju Hyun; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med,Div Nephrol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea.	yangch@catholic.ac.kr			Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C3417]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417).	Adamidis KN, 2013, RENAL FAILURE, V35, P1075, DOI 10.3109/0886022X.2013.815090; Adragao T, 2012, NEPHROL DIAL TRANSPL, V27, P318, DOI 10.1093/ndt/gfr233; Ai ZS, 2011, BRAZ J MED BIOL RES, V44, P1000; Avramovski P, 2014, RENAL FAILURE, V36, P176, DOI 10.3109/0886022X.2013.843359; Avramovski P, 2013, KOREAN J INTERN MED, V28, P464, DOI 10.3904/kjim.2013.28.4.464; Bachelet-Rousseau C, 2011, NEPHROL DIAL TRANSPL, V26, P3386, DOI 10.1093/ndt/gfr058; Brunner EJ, 2015, HYPERTENSION, V66, P294, DOI 10.1161/HYPERTENSIONAHA.115.05494; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Claes KJ, 2013, TRANSPL INT, V26, P973, DOI 10.1111/tri.12151; Clemente G, 2015, INT J FOOD SCI NUTR, V66, P466, DOI 10.3109/09637486.2015.1042845; Covic A, 2005, AM J KIDNEY DIS, V45, P965, DOI 10.1053/j.ajkd.2005.02.026; Dahle DO, 2015, TRANSPLANTATION, V99, P1730, DOI 10.1097/TP.0000000000000660; Deng XR, 2014, BIOMED ENVIRON SCI, V27, P594, DOI 10.3967/bes2014.091; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Elewa U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123903; Fernandez-Fresnedo G, 2003, TRANSPLANT P, V35, P1730, DOI 10.1016/S0041-1345(03)00605-5; Garcia-Donaire JA, 2010, CURR HYPERTENS REP, V12, P307, DOI 10.1007/s11906-010-0129-z; Gast KB, 2015, ATHEROSCLEROSIS, V241, P547, DOI 10.1016/j.atherosclerosis.2015.05.026; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hirai T, 2010, TRANSPL P, V42, P4061, DOI 10.1016/j.transproceed.2010.09.083; Hotta K, 2012, TRANSPL P, V44, P684, DOI 10.1016/j.transproceed.2011.11.016; Kovacs D, 2013, TRANSPL P, V45, P3682, DOI 10.1016/j.transproceed.2013.10.010; Ma YX, 2015, INT UROL NEPHROL, V47, P1157, DOI 10.1007/s11255-015-1009-x; Mansell H, 2014, SCI WORLD J, DOI 10.1155/2014/750579; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Nitta K, 2015, CONTRIB NEPHROL, V185, P156, DOI 10.1159/000380980; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Salvadori M, 2003, TRANSPL P, V35, P2863, DOI 10.1016/j.transproceed.2003.10.070; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Verbeke F, 2011, HYPERTENSION, V58, P833, DOI 10.1161/HYPERTENSIONAHA.111.176594	35	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139138	10.1371/journal.pone.0139138	http://dx.doi.org/10.1371/journal.pone.0139138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406607	Green Submitted, gold, Green Published			2022-12-26	WOS:000361800700181
J	Nguyen, KH; Smith, AC; Armfield, NR; Bensink, M; Scuffham, PA				Kim-Huong Nguyen; Smith, Anthony C.; Armfield, Nigel R.; Bensink, Mark; Scuffham, Paul A.			Cost-Effectiveness Analysis of a Mobile Ear Screening and Surveillance Service versus an Outreach Screening, Surveillance and Surgical Service for Indigenous Children in Australia	PLOS ONE			English	Article							ABORIGINAL CHILDREN; QUEENSLAND; OUTCOMES; DISEASE	Indigenous Australians experience a high rate of ear disease and hearing loss, yet they have a lower rate of service access and utilisation compared to their non-Indigenous counterparts. Screening, surveillance and timely access to specialist ear, nose and throat (ENT) services are key components in detecting and preventing the recurrence of ear diseases. To address the low access and utilisation rate by Indigenous Australians, a collaborative, community-based mobile telemedicine-enabled screening and surveillance (MTESS) service was trialled in Cherbourg, the third largest Indigenous community in Queensland, Australia. This paper aims to evaluate the cost-effectiveness of the MTESS service using a lifetime Markov model that compares two options: (i) the Deadly Ears Program alone (current practice involving an outreach ENT surgical service and screening program), and (ii) the Deadly Ears Program supplemented with the MTESS service. Data were obtained from the Deadly Ears Program, a feasibility study of the MTESS service and the literature. Incremental cost-utility ratios were calculated from a societal perspective with both costs (in 2013-14 Australian dollars) and quality-adjusted life years (QALYs) discounted at 5% annually. The model showed that compared with the Deadly Ears Program, the probability of an acceptable cost-utility ratio at a willingness-to-pay threshold of $ 50,000/QALY was 98% for the MTESS service. This cost effectiveness arises from preventing hearing loss in the Indigenous population and the subsequent reduction in associated costs. Deterministic and probability sensitivity analyses indicated that the model was robust to parameter changes. We concluded that the MTESS service is a cost-effective strategy. It presents an opportunity to resolve major issues confronting Australia's health system such as the inequitable provision and access to quality healthcare for rural and remotes communities, and for Indigenous Australians. Additionally, it may encourage effective health service delivery at a time when the healthcare funding and workforce capacity are limited.	[Kim-Huong Nguyen; Bensink, Mark; Scuffham, Paul A.] Griffith Univ, Ctr Appl Hlth Econ, Menzies Hlth Inst, Meadowbrook, Qld 4131, Australia; [Smith, Anthony C.; Armfield, Nigel R.; Bensink, Mark] Univ Queensland, Ctr Online Hlth, Brisbane, Qld, Australia; [Smith, Anthony C.; Armfield, Nigel R.; Bensink, Mark] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; University of Queensland	Nguyen, KH (corresponding author), Griffith Univ, Ctr Appl Hlth Econ, Menzies Hlth Inst, Meadowbrook, Qld 4131, Australia.	kim.nguyen@griffith.edu.au	Scuffham, Paul/AAS-8084-2021; Scuffham, Paul/B-3066-2014; Armfield, Nigel R./B-4896-2010; Smith, Anthony Carl/E-9538-2010; Nguyen, Kim-Huong/ABA-5902-2020; Nguyen, Kim-Huong/C-7260-2017	Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Armfield, Nigel R./0000-0003-4218-0030; Smith, Anthony Carl/0000-0002-7756-5136; Nguyen, Kim-Huong/0000-0002-2592-9372; Nguyen, Kim-Huong/0000-0002-2592-9372	Children's Hospital Foundation, Queensland; Centre of Research Excellence in Telehealth - National Health and Medical Research Council [APP1061183]; Darling Downs Hospital and Health Service (Queensland Department of Health)	Children's Hospital Foundation, Queensland; Centre of Research Excellence in Telehealth - National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Darling Downs Hospital and Health Service (Queensland Department of Health)	Start-up funding for this project was provided through the Children's Hospital Foundation, Queensland, by corporate and community sponsors. This research was conducted with the support of the Centre of Research Excellence in Telehealth funded by the National Health and Medical Research Council (grant ID: APP1061183). This service was funded by the Darling Downs Hospital and Health Service (Queensland Department of Health).	[ABS Australia Bureau of Statistics], 2012, AUSTR AB TORR STRAT; [ABS Australia Bureau of Statistics], 2013, LIF EXP MORT AUSTR; Access Economics, 2006, LIST HEAR EC IMPACT; [Anonymous], 2014, XE WORLDS FAVOURITE; Bamford J., 2007, CURRENT PRACTICE ACC; Barton Garry R, 2004, Appl Health Econ Health Policy, V3, P103, DOI 10.2165/00148365-200403020-00006; Barton GR, 2006, EAR HEARING, V27, P575, DOI 10.1097/01.aud.0000233967.11072.24; Burn J, 2013, REV EAR HLTH HEARING; Clemens S, 2014, QUAL LIFE RES, V23, P2375, DOI 10.1007/s11136-014-0676-x; Closing the Gap Clearinghouse (AIHW & AIFS ), 2014, EAR DIS AB TORR STRA; Eikelboom RH, 2005, INT J PEDIATR OTORHI, V69, P739, DOI 10.1016/j.ijporl.2004.12.008; Elliott G, 2010, TELEMED J E-HEALTH, V16, P250, DOI 10.1089/tmj.2010.0045; Howard D, 1993, ABORIG ISLANDER HEAL, V3, P1993; Howard D, 2004, AUST J TEACH ED, V29; Independent Hospital Pricing Authority (IHPA), 2014, NAT HOSP COST DAT CO; Kaplan RM, 1995, VALUING HLTH CARE CO, P31; Leach AJ, 1999, INT J PEDIATR OTORHI, V49, pS173; Mak D, 2004, CLIN OTOLARYNGOL, V29, P606, DOI 10.1111/j.1365-2273.2004.00896.x; Mak D, 2000, J LARYNGOL OTOL, V114, P26, DOI 10.1258/0022215001903843; Mbao MN, 2003, TELEMED J E-HEALTH, V9, P325, DOI 10.1089/153056203772744644; Morris P, 2010, REC CLIN CARE GUIDEL; Morris Peter, 2012, BMJ Clin Evid, V2012; Morris Peter S, 2005, BMC Pediatr, V5, P27, DOI 10.1186/1471-2431-5-27; Smith AC, 2003, J TELEMED TELECARE, V9, pS58; Smith AC, 2006, J TELEMED TELECARE, V12, P76, DOI 10.1258/135763306779380138; Smith AC, 2013, J TELEMED TELECARE, V19, P397, DOI 10.1177/1357633X13506526; Smith AC, 2012, J TELEMED TELECARE, V18, P485, DOI [10.1258/jtt.2012.GTH114, 10.1258/jtt.2012.CTH114]; Thorne J, 2004, CONTEMP NURSE, V16, P145, DOI DOI 10.5172/C0NU.16.1-2.145; World Health Organization, 2004, CHRON SUPP OT MED CS; World Health Organization, 1996, PREV HEAR IMP CHRON; Zubrick S., 2004, W AUSTR ABORIGINAL C	31	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138369	10.1371/journal.pone.0138369	http://dx.doi.org/10.1371/journal.pone.0138369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406592	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700041
J	Li, JY; Flick, F; Verheugd, P; Carloni, P; Lusher, B; Rossetti, G				Li, Jinyu; Flick, Franziska; Verheugd, Patricia; Carloni, Paolo; Luesher, Bernhard; Rossetti, Giulia			Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2)	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; FORCE-FIELD; ADP-RIBOSE; DYNAMICS; NICOTINAMIDE; DEACETYLASE; NAD(+); DEGENERATION	Sirtuin 2 (SIRT2) is a NAD(+)-dependent deacetylase that has been associated with neurodegeneration and cancer. SIRT2 is composed of a central catalytic domain, the structure of which has been solved, and N- and C-terminal extensions that are thought to control SIRT2 function. However structural information of these N- and C-terminal regions is missing. Here, we provide the first full-length molecular models of SIRT2 in the absence and presence of NAD+. We also predict the structural alterations associated with phosphorylation of SIRT2 at S331, a modification that inhibits catalytic activity. Bioinformatics tools and molecular dynamics simulations, complemented by in vitro deacetylation assays, provide a consistent picture based on which the C-terminal region of SIRT2 is suggested to function as an autoinhibitory region. This has the capacity to partially occlude the NAD(+) binding pocket or stabilize the NAD(+) in a non-productive state. Furthermore, our simulations suggest that the phosphorylation at S331 causes large conformational changes in the C-terminal region that enhance the autoinhibitory activity, consistent with our previous findings that phosphorylation of S331 by cyclin-dependent kinases inhibits SIRT2 catalytic activity. The molecular insight into the role of the C-terminal region in controlling SIRT2 function described in this study may be useful for future design of selective inhibitors targeting SIRT2 for therapeutic applications.	[Li, Jinyu; Carloni, Paolo; Rossetti, Giulia] Forschungszentrum Julich, Computat Biomed, Inst Adv Simulat IAS 5, D-52425 Julich, Germany; [Li, Jinyu; Carloni, Paolo; Rossetti, Giulia] Forschungszentrum Julich, Inst Neurosci & Med INM 9, D-52425 Julich, Germany; [Li, Jinyu; Flick, Franziska; Verheugd, Patricia; Luesher, Bernhard] Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, D-52057 Aachen, Germany; [Carloni, Paolo] Forschungszentrum Julich, German Res Sch Simulat Sci, Computat Biophys, D-52425 Julich, Germany; [Rossetti, Giulia] Forschungszentrum Julich, Julich Supercomp Ctr, D-52425 Julich, Germany; [Rossetti, Giulia] Rhein Westfal TH Aachen, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University	Rossetti, G (corresponding author), Forschungszentrum Julich, Computat Biomed, Inst Adv Simulat IAS 5, D-52425 Julich, Germany.	g.rossetti@fz-juelich.de	Rossetti, Giulia/U-2448-2019; Rossetti, Giulia/G-3473-2018; Korn, Patricia/AGZ-7000-2022; Luscher, Bernhard/A-7330-2011	Rossetti, Giulia/0000-0002-2032-4630; Rossetti, Giulia/0000-0002-2032-4630; Korn, Patricia/0000-0002-2434-1550; Carloni, Paolo/0000-0002-9010-0149; Luscher, Bernhard/0000-0002-9622-8709	Interdisciplinary Center for Clinical Research IZKF Aachen [N5-2]; Julich Supercomputing Centre	Interdisciplinary Center for Clinical Research IZKF Aachen; Julich Supercomputing Centre	This work was supported by funds from the Interdisciplinary Center for Clinical Research IZKF Aachen (http://www.rwth-aachen.de/cms/root/Forschung/Forschen-an-der-RWTH/Profilbereiche/Medical-Science-Technology-MedST-/similar to eerv/IZKF/lidx/1/) to BL (fund number: N5-2). The authors gratefully acknowledge the computing time granted by the JARA-HPC Vergabegremium (http://www.jara.org/en/research/jara-hpc/partition/details/details-useallocation/) to PC (jara0016) and provided on the JARA-HPC Partition part of the supercomputer RWTH Compute Cluster (RCC) at RWTH Aachen University. Julich Supercomputing Centre (http://www.fz-juelich.de/ias/jsc/EN/Home/home_node.html) provided support in the form of a salary for GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOWIE JU, 1994, P NATL ACAD SCI USA, V91, P4436, DOI 10.1073/pnas.91.10.4436; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cobucci-Ponzano B, 2009, CHEM BIOL, V16, P1097, DOI 10.1016/j.chembiol.2009.09.013; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Jong RM, 2003, EMBO J, V22, P4933, DOI 10.1093/emboj/cdg479; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dong XS, 2005, J BACTERIOL, V187, P2483, DOI 10.1128/JB.187.7.2483-2490.2005; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hasegawa T, 2010, NEUROCHEM INT, V57, P857, DOI 10.1016/j.neuint.2010.09.002; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hu L, 2011, J CHEM THEORY COMPUT, V7, P12; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ingvarsson H, 2010, FEBS J, V277, P3947, DOI 10.1111/j.1742-4658.2010.07784.x; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Jeyakanthan J, CRYSTAL STRUCTURE UR; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kunishima N., CRYSTAL STRUCTURE SO; Lahr SJ, 2005, J MOL BIOL, V346, P1441, DOI 10.1016/j.jmb.2004.12.016; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Murayama K, CRYSTAL STRUCTURE RI; Nair UB, CRYSTAL STRUCTURE RY; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Ohnishi S, SOLUTION STRUCTURE 3; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Ragunathan P, 2009, ACTA CRYSTALLOGR D, V65, P1262, DOI 10.1107/S0907444909038359; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rehse PH, 2004, ACTA CRYSTALLOGR D, V60, P1997, DOI 10.1107/S0907444904021146; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shrestha L, CRYSTAL STRUCTURE HU, V1; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Suzuki K, 2007, NEUROSCIENCE, V147, P599, DOI 10.1016/j.neuroscience.2007.04.059; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Yajima S, 2006, NUCLEIC ACIDS RES, V34, P6074, DOI 10.1093/nar/gkl729; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	84	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139095	10.1371/journal.pone.0139095	http://dx.doi.org/10.1371/journal.pone.0139095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407304	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700166
J	Liao, XH; Hu, ZB; Liu, WK; Lu, Y; Chen, DH; Chen, MX; Qiu, SY; Zeng, ZQ; Tian, XG; Cui, H; Zhou, R				Liao, Xiaohong; Hu, Zhengbo; Liu, Wenkuan; Lu, Yan; Chen, Dehui; Chen, Meixin; Qiu, Shuyan; Zeng, Zhiqi; Tian, Xingui; Cui, Hong; Zhou, Rong			New Epidemiological and Clinical Signatures of 18 Pathogens from Respiratory Tract Infections Based on a 5-Year Study	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTION; HUMAN BOCAVIRUS; STEM-CELL; TRANSPLANT RECIPIENTS; VIRUS-INFECTIONS; CHILDREN; POPULATION; GUANGZHOU; ETIOLOGY; ANTIBODY	Background Respiratory tract infections (RTIs) are a heavy burden on society. However, due to the complex etiology of RTIs, the clinical diagnosis, treatment, and prevention of these infections remain challenging, especially in developing countries. Methods To determine the epidemiological and clinical characteristics of 18 respiratory pathogens, we analyzed 12,502 patients with acute respiratory infections (ARIs) by performing polymerase chain reaction (PCR) on patient pharyngeal swabs. Results Samples positive for at least 1 pathogen were obtained from 48.42% of the total patients. Of these pathogen-positive patients, 17.99% were infected with more than 1 pathogen. Of the 18 pathogens analyzed, four were detected with a positive detection rate (PDR) > 5%: influenza A virus (IAV) > respiratory syncytial virus (RSV) > Mycoplasma pneumoniae (MP) > human coronavirus (HCoV). The pathogens with the 4 highest co-infection rates (CIRs) were as follows: HCoV > human bocavirus (HBoV) > enterovirus (EV) > parainfluenza virus (PIV). The overall positive detection rate (PDR) varied significantly according to patient age, the season and year of detection, and the disease subgroup, but not according to patient sex. The individual PDRs of the pathogens followed 3 types of distributions for patient sex, 4 types of distributions for patient age, 4 types of seasonal distributions, 2 types of seasonal epidemic trends, 4 types of yearly epidemic trends, and different susceptibility distributions in the disease subgroups. Additionally, the overall CIR showed significantly different distributions according to patient sex, patient age, and the disease subgroup, whereas the CIRs of individual pathogens suggested significant preference characteristics. Conclusion IAV remains the most common pathogen among the pathogens analyzed. More effort should be directed toward the prevention and control of pathogens that show a trend of increasing incidence such as HCoV, human adenovirus (ADV), and RSV. Although clinically distinguishing specific pathogens responsible for RTIs is difficult, the epidemiological and clinical characteristics of the various RTI-causing agents could provide clues for clinicians, thereby informing decisions regarding prevention and medication and guiding appropriate public health strategies.	[Liao, Xiaohong; Liu, Wenkuan; Lu, Yan; Chen, Meixin; Qiu, Shuyan; Zeng, Zhiqi; Tian, Xingui; Cui, Hong; Zhou, Rong] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Liao, Xiaohong; Liu, Wenkuan; Lu, Yan; Chen, Dehui; Chen, Meixin; Qiu, Shuyan; Zeng, Zhiqi; Tian, Xingui; Cui, Hong; Zhou, Rong] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Hu, Zhengbo] Southern Med Univ, Zhujiang Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Southern Medical University - China	Zhou, R (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	zhourong_gird@163.com	Tian, Xingui/AAC-3957-2021; Tian, Xingui/AAF-5709-2020	Tian, Xingui/0000-0001-9761-6677; Liu, Wen-Kuan/0000-0003-3020-9158	China Central Government [2012ZX10004-213]; National Science and Technology Support Program [2012BAI05B01]	China Central Government; National Science and Technology Support Program	This study was supported by The State Major Infectious Disease Research Program (China Central Government, 2012ZX10004-213), National Science and Technology Support Program (2012BAI05B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Ampuero JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046898; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Boeckh M, 2008, BRIT J HAEMATOL, V143, P455, DOI 10.1111/j.1365-2141.2008.07295.x; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; de Almeida MB, 2010, EMERG INFECT DIS, V16, P996, DOI 10.3201/eid1606.100063; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Esposito S, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/j.1750-2659.2012.00340.x; Everitt DE, 1996, J INFECT DIS, V174, P463, DOI 10.1093/infdis/174.3.463; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Ison MG, 2003, CLIN INFECT DIS, V36, P1139, DOI 10.1086/374340; Jokinen C, 2001, CLIN INFECT DIS, V32, P1141, DOI 10.1086/319746; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Kamboj M, 2008, J INFECTION, V57, P464, DOI 10.1016/j.jinf.2008.10.003; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kim YJ, 2007, SEMIN RESP CRIT CARE, V28, P222, DOI 10.1055/s-2007-976494; Lee MKP, 2013, J MED VIROL, V85, P1811, DOI 10.1002/jmv.23663; Lee MS, 2001, J INFECT DIS, V183, P1281, DOI 10.1086/319690; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Liu WK, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-345; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014; Reimer LG, 1998, CLIN INFECT DIS, V26, P742, DOI 10.1086/514583; Rojas LJ, 2012, EPIDEMIOL INFECT, V140, P818, DOI 10.1017/S0950268811001269; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Ryan MAK, 2002, CLIN INFECT DIS, V34, P577, DOI 10.1086/338471; Schmidt AC, 2011, EXPERT REV RESP MED, V5, P515, DOI [10.1586/ers.11.32, 10.1586/ERS.11.32]; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Signorelli SS, 2010, J CHEMOTHERAPY, V22, P392, DOI 10.1179/joc.2010.22.6.392; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Tran DN, 2015, EPIDEMIOL INFECT, V144, P1; Williams JV, 2010, J INFECT DIS, V201, P1890, DOI 10.1086/652782; Wu PS, 2008, EUR J PEDIATR, V167, P75, DOI 10.1007/s00431-007-0429-8; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	42	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138684	10.1371/journal.pone.0138684	http://dx.doi.org/10.1371/journal.pone.0138684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406339	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700069
J	Ojha, D; Das, R; Sobia, P; Dwivedi, V; Ghosh, S; Samanta, A; Chattopadhyay, D				Ojha, Durbadal; Das, Rashmi; Sobia, Parveen; Dwivedi, Vedprakash; Ghosh, Soma; Samanta, Amalesh; Chattopadhyay, Debprasad			Pedilanthus tithymaloides Inhibits HSV Infection by Modulating NF-kappa B Signaling	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; ANTIVIRAL ACTIVITY; GENE-EXPRESSION; ACTIVATION; PATHWAYS; APOPTOSIS; ETHNOMEDICINE; FLAVONOIDS	Pedilanthus tithymaloides (PT), a widely used ethnomedicinal plant, has been employed to treat a number of skin conditions. To extend its utility and to fully exploit its medicinal potential, we have evaluated the in vitro antiviral activity of a methanolic extract of PT leaves and its isolated compounds against Herpes Simplex Virus type 2 (HSV-2). Bioactivity-guided studies revealed that the extract and one of its constituents, luteolin, had potent antiviral activity against wild-type and clinical isolates of HSV-2 (EC50 48.5-52.6 and 22.4-27.5 mu g/ml, respectively), with nearly complete inhibition at 86.5-101.8 and 40.2-49.6 mu g/ml, respectively. The inhibitory effect was significant (p<0.001) when the drug was added 2 h prior to infection, and was effective up to 4 h post-infection. As viral replication requires NF-kappa B activation, we examined whether the observed extract-induced inhibition of HSV-2 was related to NF-kappa B inhibition. Interestingly, we observed that treatment of HSV-2-infected cells with extract or luteolin suppressed NF-kappa B activation. Although NF-kappa B, JNK and MAPK activation was compromised during HSV replication, neither the extract nor luteolin affected HSV-2-induced JNK1/2 and MAPK activation. Moreover, the PT leaf extract and luteolin potently down-regulated the expression of tumor necrosis factor (TNF)-alpha, Interleukin (IL)-1 beta, IL-6, NO and iNOS and the production of gamma interferon (IFN-gamma), which are directly involved in controlling the NF-kappa B signaling pathway. Thus, our results indicate that both PT leaf extract and luteolin modulate the NF-kappa B signaling pathway, resulting in the inhibition of HSV-2 replication.	[Ojha, Durbadal; Das, Rashmi; Ghosh, Soma; Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata 700010, India; [Sobia, Parveen; Dwivedi, Vedprakash] Univ KwaZulu Natal, Dept Microbiol, Coll Cell Sci, ZA-4001 Durban, South Africa; [Ghosh, Soma; Samanta, Amalesh] Jadavpur Univ, Dept Pharmaceut Technol, Kolkata 700032, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; University of Kwazulu Natal; Jadavpur University	Chattopadhyay, D (corresponding author), ID & BG Hosp, ICMR Virus Unit, Gen Block 4,57 Dr Suresh Chandra Banerjee Rd, Kolkata 700010, India.	debprasadc@gmail.com		Dwivedi, Ved Prakash/0000-0003-4321-2567; CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X	Science and Engineering Research Board, Department of Science and Technology, Govt. of India, New Delhi [SB/SO/HS-025/2013]	Science and Engineering Research Board, Department of Science and Technology, Govt. of India, New Delhi	The authors acknowledge financial support from the Science and Engineering Research Board, Department of Science and Technology, Govt. of India, New Delhi (SB/SO/HS-025/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici C, 2006, J BIOL CHEM, V281, P7110, DOI 10.1074/jbc.M512366200; Amici C, 2001, J BIOL CHEM, V276, P28759, DOI 10.1074/jbc.M103408200; Baba M, 2006, ANTIVIR RES, V71, P301, DOI 10.1016/j.antiviral.2006.01.002; Bag P, 2014, ANTIVIR RES, V105, P126, DOI 10.1016/j.antiviral.2014.02.007; Bag P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077937; Bag P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-98; Behbahani M, 2013, ANTIVIR RES, V97, P376, DOI 10.1016/j.antiviral.2013.01.001; Bhattacharjee S, 2009, J ANTIMICROB CHEMOTH, V63, P317, DOI 10.1093/jac/dkn479; Bunyapraphatsara N, 2000, MED PLANTS INDIGENOU, P691; Chattopadhyay D, 2008, BIOTECHNOL ANN REV, V14, P297, DOI 10.1016/S1387-2656(08)00012-4; Chen XQ, 2011, ANTIVIR RES, V92, P341, DOI 10.1016/j.antiviral.2011.09.005; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Dai X, 2008, INT IMMUNOL, V20, P901, DOI 10.1093/intimm/dxn048; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Du T, 2013, P NATL ACAD SCI USA, V110, pE2621, DOI 10.1073/pnas.1309906110; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Ghosh S, 2013, MED CHEM RES, V22, P4347, DOI 10.1007/s00044-012-0449-4; Ghosh S, 2012, J ETHNOPHARMACOL, V142, P714, DOI 10.1016/j.jep.2012.05.048; Gregory D, 2004, J VIROL, V78, P13582, DOI 10.1128/JVI.78.24.13582-13590.2004; Hargett D, 2005, J VIROL, V79, P8348, DOI 10.1128/JVI.79.13.8348-8360.2005; Hirobe C, 1997, PHYTOCHEMISTRY, V46, P521, DOI 10.1016/S0031-9422(97)00127-1; Huang WJ, 2012, J IMMUNOL, V188, P6247, DOI 10.4049/jimmunol.1103706; Karaca G, 2004, VIROLOGY, V329, P142, DOI 10.1016/j.virol.2004.08.020; Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002; Krylova N. V., 2011, Antibiotiki i Khimioterapiya, V56, P7; Kumar G.P., 2010, ETHNOBOT LEAFL, V2010, P4; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Lee JK, 2009, BIOCHEM PHARMACOL, V77, P1391, DOI 10.1016/j.bcp.2009.01.009; Liu AL, 2008, PLANTA MED, V74, P847, DOI 10.1055/s-2008-1074558; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; McLean TI, 1999, J VIROL, V73, P8415, DOI 10.1128/JVI.73.10.8415-8426.1999; Mehla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027915; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mukherjee H, 2013, MICROBIOL RES, V168, P238, DOI 10.1016/j.micres.2012.11.002; Patel A, 1998, VIROLOGY, V247, P212, DOI 10.1006/viro.1998.9243; Perkins D, 2002, J VIROL, V76, P1435, DOI 10.1128/JVI.76.3.1435-1449.2002; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Smith CC, 2000, J VIROL, V74, P10417, DOI 10.1128/JVI.74.22.10417-10429.2000; Song SW, 2014, ANTIMICROB AGENTS CH, V58, P5068, DOI 10.1128/AAC.02427-14; Swiecki M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003728; VRIJSEN R, 1988, J GEN VIROL, V69, P1749, DOI 10.1099/0022-1317-69-7-1749; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Xu L, 2014, VIRUSES-BASEL, V6, P2778, DOI 10.3390/v6072778; Yedowitz JC, 2005, VIROLOGY, V342, P297, DOI 10.1016/j.virol.2005.07.036; Zachos G, 1999, J BIOL CHEM, V274, P5097, DOI 10.1074/jbc.274.8.5097	47	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139338	10.1371/journal.pone.0139338	http://dx.doi.org/10.1371/journal.pone.0139338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405764	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700207
J	Davila, MP; Munoz, PM; Tapia, JA; Ferrusola, CO; da Silva, CB; Pena, FJ				Plaza Davila, Maria; Martin Munoz, Patricia; Tapia, Jose A.; Ortega Ferrusola, Cristina; da Silva C, Carolina Balao; Pena, Fernando J.			Inhibition of Mitochondrial Complex I Leads to Decreased Motility and Membrane Integrity Related to Increased Hydrogen Peroxide and Reduced ATP Production, while the Inhibition of Glycolysis Has Less Impact on Sperm Motility	PLOS ONE			English	Article							STALLION SPERMATOZOA; OXIDATIVE STRESS; CRYOPRESERVATION; APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; PRESERVATION; GENERATION; FORECAST; FROZEN	Mitochondria have been proposed as the major source of reactive oxygen species in somatic cells and human spermatozoa. However, no data regarding the role of mitochondrial ROS production in stallion spermatozoa are available. To shed light on the role of the mitochondrial electron transport chain in the origin of oxidative stress in stallion spermatozoa, specific inhibitors of complex I (rotenone) and III (antimycin-A) were used. Ejaculates from seven Andalusian stallions were collected and incubated in BWW media at 37 degrees C in the presence of rotenone, antimycin-A or control vehicle. Incubation in the presence of these inhibitors reduced sperm motility and velocity (CASA analysis) (p<0.01), but the effect was more evident in the presence of rotenone (a complex I inhibitor). These inhibitors also decreased ATP content. The inhibition of complexes I and III decreased the production of reactive oxygen species (p<0.01) as assessed by flow cytometry after staining with CellRox deep red. This observation suggests that the CellRox probe mainly identifies superoxide and that superoxide production may reflect intense mitochondrial activity rather than oxidative stress. The inhibition of complex I resulted in increased hydrogen peroxide production (p<0.01). The inhibition of glycolysis resulted in reduced sperm velocities (p<0.01) without an effect on the percentage of total motile sperm. Weak and moderate (but statistically significant) positive correlations were observed between sperm motility, velocity and membrane integrity and the production of reactive oxygen species. These results indicate that stallion sperm rely heavily on oxidative phosphorylation (OXPHOS) for the production of ATP for motility but also require glycolysis to maintain high velocities. These data also indicate that increased hydrogen peroxide originating in the mitochondria is a mechanism involved in stallion sperm senescence.	[Plaza Davila, Maria; Martin Munoz, Patricia; Ortega Ferrusola, Cristina; da Silva C, Carolina Balao; Pena, Fernando J.] Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain; [Tapia, Jose A.] Univ Extremadura, Dept Physiol, Fac Vet Med, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura	Davila, MP (corresponding author), Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain.	fjuanpvega@unex.es	Tapia, Jose A./C-5181-2008; Ortega-Ferrusola, Cristina/AGI-8478-2022; Peña, Fernando J/D-8450-2012	Tapia, Jose A./0000-0002-3614-6867; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Balao da Silva, Carolina Maria/0000-0002-9230-3919; PLAZA DAVILA, MARIA/0000-0002-8522-5879	Ministerio de Economia y Competitividad-FEDER in Madrid, Spain [AGL2013-43211-R]; Junta de Extremadura-FEDER [GR 10010, PCE1002]	Ministerio de Economia y Competitividad-FEDER in Madrid, Spain; Junta de Extremadura-FEDER(European Commission)	The authors received financial support for this study from Ministerio de Economia y Competitividad-FEDER in Madrid, Spain, grants AGL2013-43211-R and Junta de Extremadura-FEDER (GR 10010 and PCE1002).	Aitken RJ, 2014, ASIAN J ANDROL, V16, P31, DOI 10.4103/1008-682X.122203; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; da Silva CMB, 2013, ANIM REPROD SCI, V141, P68, DOI 10.1016/j.anireprosci.2013.07.008; Ball BA, 2001, AM J VET RES, V62, P508, DOI 10.2460/ajvr.2001.62.508; Ball BA, 2001, THERIOGENOLOGY, V56, P577, DOI 10.1016/S0093-691X(01)00590-8; Ball BA, 2000, AM J VET RES, V61, P1026, DOI 10.2460/ajvr.2000.61.1026; Ball BA, 2008, ANIM REPROD SCI, V107, P257, DOI 10.1016/j.anireprosci.2008.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caselles AB, 2014, REPROD DOMEST ANIM, V49, P254, DOI 10.1111/rda.12264; Bolanos JMG, 2014, REPROD DOMEST ANIM, V49, P657, DOI 10.1111/rda.12343; Bolanos JMG, 2014, REPRODUCTION, V148, P221, DOI 10.1530/REP-13-0191; Bolanos JMG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030688; Gibb Z, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118539; Gonzalez-Fernandez L, 2009, BIOL REPROD, V80, P1239, DOI 10.1095/biolreprod.108.073486; Gravance CG, 2000, THERIOGENOLOGY, V53, P1691, DOI 10.1016/S0093-691X(00)00308-3; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Koppers AJ, 2011, BIOCHEM J, V436, P687, DOI 10.1042/BJ20110114; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Garcia BM, 2011, REPROD DOMEST ANIM, V46, P141, DOI 10.1111/j.1439-0531.2010.01609.x; Garcia BM, 2011, J ANDROL, V33, P105, DOI 10.2164/jandrol.110.011957; Macias-Garcia B, 2012, ANIM REPROD SCI, V132, P74, DOI 10.1016/j.anireprosci.2012.03.017; Morillo-Rodriguez A, 2012, ANDROLOGIA, V44, P688, DOI 10.1111/j.1439-0272.2011.01251.x; Neagu VR, 2010, THERIOGENOLOGY, V73, P645, DOI 10.1016/j.theriogenology.2009.10.021; Nunez-Martinez I, 2007, INT J ANDROL, V30, P182, DOI 10.1111/j.1365-2605.2007.00743.x; O'Flaherty C, 2006, FREE RADICAL BIO MED, V41, P528, DOI 10.1016/j.freeradbiomed.2006.04.027; Ferrusola CO, 2010, THERIOGENOLOGY, V74, P458, DOI 10.1016/j.theriogenology.2010.02.029; Ferrusola CO, 2009, BIOL REPROD, V81, P1106, DOI 10.1095/biolreprod.109.078220; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Ortega-Ferrusola C, 2008, J ANDROL, V29, P213, DOI 10.2164/jandrol.107.003640; Ortega-Ferrusola C, 2009, ANIM REPROD SCI, V114, P393, DOI 10.1016/j.anireprosci.2008.10.005; Pena FJ, 2015, REPROD DOMEST ANIM, V50, P529, DOI 10.1111/rda.12551; Pena FJ, 2011, THERIOGENOLOGY, V76, P1177, DOI 10.1016/j.theriogenology.2011.06.023; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Pena FJ, 2005, INT J ANDROL, V28, P107, DOI 10.1111/j.1365-2605.2005.00512.x; Pena FJ, 2003, ANIM REPROD SCI, V78, P85, DOI 10.1016/S0378-4320(03)00049-6; Roca J, 2005, J ANDROL, V26, P15; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Xi Q, 2005, CIRC RES, V97, P354, DOI 10.1161/01.RES.0000177669.29525.78; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	42	82	83	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138777	10.1371/journal.pone.0138777	http://dx.doi.org/10.1371/journal.pone.0138777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407142	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700095
J	Ruggeri, C; Drinkwater, N; Sivaraman, KK; Bamert, RS; McGowan, S; Paiardini, A				Ruggeri, Chiara; Drinkwater, Nyssa; Sivaraman, Komagal Kannan; Bamert, Rebecca S.; McGowan, Sheena; Paiardini, Alessandro			Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MOLECULAR DOCKING; LIGANDS; DESIGN; INTERFACE; DATABASE; MODEL; ZINC	The Plasmodium falciparum PfA-M1 and PfA-M17 metalloaminopeptidases are validated drug targets for the discovery of antimalarial agents. In order to identify dual inhibitors of both proteins, we developed a hierarchical virtual screening approach, followed by in vitro evaluation of the highest scoring hits. Starting from the ZINC database of purchasable compounds, sequential 3D-pharmacophore and molecular docking steps were applied to filter the virtual 'hits'. At the end of virtual screening, 12 compounds were chosen and tested against the in vitro aminopeptidase activity of both PfA-M1 and PfA-M17. Two molecules showed significant inhibitory activity (low micromolar/nanomolar range) against both proteins. Finally, the crystal structure of the most potent compound in complex with both PfA-M1 and PfA-M17 was solved, revealing the binding mode and validating our computational approach.	[Ruggeri, Chiara] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Drinkwater, Nyssa; Sivaraman, Komagal Kannan; Bamert, Rebecca S.; McGowan, Sheena] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Drinkwater, Nyssa; Sivaraman, Komagal Kannan; Bamert, Rebecca S.; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Paiardini, Alessandro] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy	Sapienza University Rome; Monash University; Monash University; Sapienza University Rome	McGowan, S (corresponding author), Monash Univ, Dept Microbiol, Clayton Campus, Melbourne, Vic 3800, Australia.	sheena.mcgowan@monash.edu; alessandro.paiardini@uniroma1.it	McGowan, Sheena/C-4797-2014	McGowan, Sheena/0000-0001-6863-1106; Drinkwater, Nyssa/0000-0001-9165-7806; Paiardini, Alessandro/0000-0001-9078-7545	Australian Research Council [FT100100690]; Australia Endeavour Research Fellowship [4100-2014]; Sapienza University of Rome [C26A149EC4]; National Health and Medical Research [1063786]	Australian Research Council(Australian Research Council); Australia Endeavour Research Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); Sapienza University of Rome; National Health and Medical Research	Funding: SM acknowledges Future Fellowship support from the Australian Research Council (Grant FT100100690). CR was an Australia Endeavour Research Fellowship recipient (Grant 4100-2014). AP acknowledges Sapienza University of Rome (Grant C26A149EC4) for funding. This work was supported by the National Health and Medical Research (Grant 1063786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borbulevych OY, 2014, ACTA CRYSTALLOGR D, V70, P1233, DOI 10.1107/S1399004714002260; Chen YC, 2015, TRENDS PHARMACOL SCI, V36, P78, DOI 10.1016/j.tips.2014.12.001; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; Drinkwater N, 2015, PROTEINS, V83, P789, DOI 10.1002/prot.24771; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S28; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Krishnamoorthy M, 2013, BIOINFORMATION, V9, P293, DOI 10.6026/97320630009293; Kroon-Batenburg LMJ, 2014, ACTA CRYSTALLOGR D, V70, P2502, DOI 10.1107/S1399004713029817; Lahana R, 1999, DRUG DISCOV TODAY, V4, P447, DOI 10.1016/S1359-6446(99)01393-8; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mistry SN, 2014, J MED CHEM, V57, P9168, DOI 10.1021/jm501323a; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Paiardini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115859; Poreba M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031938; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schneider N, 2013, J COMPUT AID MOL DES, V27, P15, DOI 10.1007/s10822-012-9626-2; Seebeck B, 2008, PROTEINS, V71, P1237, DOI 10.1002/prot.21818; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Steffen A, 2006, J CHEM INF MODEL, V46, P1695, DOI 10.1021/ci060072v; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e	34	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138957	10.1371/journal.pone.0138957	http://dx.doi.org/10.1371/journal.pone.0138957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406322	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700129
J	Shu, JS; Liu, YM; Li, ZS; Zhang, LL; Fang, ZY; Yang, LM; Zhuang, M; Zhang, YY; Lv, HH				Shu, Jinshuai; Liu, Yumei; Li, Zhansheng; Zhang, Lili; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao			Organelle Simple Sequence Repeat Markers Help to Distinguish Carpelloid Stamen and Normal Cytoplasmic Male Sterile Sources in Broccoli	PLOS ONE			English	Article							BRASSICA-NAPUS L.; MADS-BOX GENES; MITOCHONDRIAL GENOME; MATERNAL INHERITANCE; CHLOROPLAST GENOME; OLERACEA L.; DNA; NUCLEAR; RAPESEED; CMS	We previously discovered carpelloid stamens when breeding cytoplasmic male sterile lines in broccoli (Brassica oleracea var. italica). In this study, hybrids and multiple backcrosses were produced from different cytoplasmic male sterile carpelloid stamen sources and maintainer lines. Carpelloid stamens caused dysplasia of the flower structure and led to hooked or coiled siliques with poor seed setting, which were inherited in a maternal fashion. Using four distinct carpelloid stamens and twelve distinct normal stamens from cytoplasmic male sterile sources and one maintainer, we used 21 mitochondrial simple sequence repeat (mtSSR) primers and 32 chloroplast SSR primers to identify a mitochondrial marker, mtSSR2, that can differentiate between the cytoplasm of carpelloid and normal stamens. Thereafter, mtSSR2 was used to identify another 34 broccoli accessions, with an accuracy rate of 100%. Analysis of the polymorphic sequences revealed that the mtSSR2 open reading frame of carpelloid stamen sterile sources had a deletion of 51 bases (encoding 18 amino acids) compared with normal stamen materials. The open reading frame is located in the coding region of orf125 and orf108 of the mitochondrial genomes in Brassica crops and had the highest similarity with Raphanus sativus and Brassica carinata. The current study has not only identified a useful molecular marker to detect the cytoplasm of carpelloid stamens during broccoli breeding, but it also provides evidence that the mitochondrial genome is maternally inherited and provides a basis for studying the effect of the cytoplasm on flower organ development in plants.	[Shu, Jinshuai; Liu, Yumei; Li, Zhansheng; Zhang, Lili; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Liu, YM (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, 12 Zhongguancun Nandajie St, Beijing 100081, Peoples R China.	liuyumei@caas.cn	Li, Zhansheng/M-9593-2019; Li, Zhansheng/L-8017-2019; Lv, Honghao/AFS-6332-2022	Li, Zhansheng/0000-0003-0132-2741; Shu, Jinshuai/0000-0001-8270-1879; Lv, Honghao/0000-0003-2635-3042; fang, zhi yuan/0000-0003-1664-759X	China Agriculture Research System [CARS-25-A]; National Natural Science Foundation of China [31372067]; National High Technology Research and Development Program (863 Program) of China [2012AA100105]; Key Projects in the National Science and Technology Pillar Program of China [2013BAD01B04]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P. R. China; Chinese Academy of Agricultural Sciences [CAAS-ASTIP-IVFCAAS]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program of China; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P. R. China; Chinese Academy of Agricultural Sciences	This work was supported by China Agriculture Research System (Grant No. CARS-25-A), National Natural Science Foundation of China (Grant No. 31372067), the National High Technology Research and Development Program (863 Program) of China (Grant No. 2012AA100105), the Key Projects in the National Science and Technology Pillar Program of China (Grant No. 2013BAD01B04), the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P. R. China, and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (Grant No. CAAS-ASTIP-IVFCAAS). YML received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2007, THEOR APPL GENET, V114, P609, DOI 10.1007/s00122-006-0461-5; Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Ashutosh, 2005, PLANT SCI, V168, P1083, DOI 10.1016/j.plantsci.2004.12.005; Avise John C., 1994, pi; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; Chen Z. J., 1993, Acta Agriculturae Zhejiangensis, V5, P172; Cheng YJ, 2003, ACTA BOT SIN, V45, P906; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Department for Environment Food and Rural Affairs (DEFRA), 2010, BAS HORT STAT UK; Dinkova-Kostova AT, 2007, CANCER EPIDEM BIOMAR, V16, P847, DOI 10.1158/1055-9965.EPI-06-0934; Fang Z. Y., 2001, WATER RESOURCES PROT, V1, P1; Fang ZhiYuan, 2004, Scientia Agricultura Sinica, V37, P717; Finley JW, 2003, NUTR REV, V61, P250, DOI [10.1301/nr.2003.jul.250-254, 10.1031/nr.2003.jul.250-254]; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Handa H, 2007, GENOME, V50, P234, DOI 10.1139/G06-150; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; Hu JB, 2009, ACTA PHYSIOL PLANT, V31, P1085, DOI 10.1007/s11738-009-0325-0; Hu ZY, 2011, GENET RESOUR CROP EV, V58, P875, DOI 10.1007/s10722-010-9626-9; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jeffery EH, 2009, PHYTOCHEM REV, V8, P283, DOI 10.1007/s11101-008-9106-4; Kaundun SS, 2002, GENOME, V45, P1041, DOI 10.1139/G02-070; Keck AS, 2003, J AGR FOOD CHEM, V51, P3320, DOI 10.1021/jf026189a; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Lampe JW, 2002, J NUTR, V132, P2991, DOI 10.1093/jn/131.10.2991; Lanner C, 1998, CAN J BOT, V76, P228, DOI 10.1139/cjb-76-2-228; Lehnebach CA, 2007, PLANT SYST EVOL, V264, P109, DOI 10.1007/s00606-006-0488-8; Leino M, 2003, THEOR APPL GENET, V106, P1156, DOI 10.1007/s00122-002-1167-y; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Linke B, 2003, PLANT J, V34, P27, DOI 10.1046/j.1365-313X.2003.01703.x; [陆光远 Liu Guangyuan], 2005, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V27, P28; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Malik M, 1999, PLANT BREEDING, V118, P75, DOI 10.1046/j.1439-0523.1999.118001075.x; Murashima M, 2004, BIOFACTORS, V22, P271, DOI 10.1002/biof.5520220154; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nishiyama T, 2004, MOL BIOL EVOL, V21, P1813, DOI 10.1093/molbev/msh203; PALMER JD, 1983, NATURE, V301, P725, DOI 10.1038/301725a0; PALMER JD, 1983, THEOR APPL GENET, V65, P181, DOI 10.1007/BF00308062; Panda S, 2003, THEOR APPL GENET, V106, P1122, DOI 10.1007/s00122-002-1134-7; Pinheiro F, 2009, CONSERV GENET RESOUR, V1, P505, DOI 10.1007/s12686-009-9121-9; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Skuza L, 2013, USE ORGANELLE MARKET, DOI [10.5772/52028, DOI 10.5772/52028]; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Soranzo N, 1999, GENOME, V42, P158, DOI 10.1139/gen-42-1-158; Sun Bo, 2010, Acta Horticulturae Sinica, V37, P59; Testolin R, 1997, THEOR APPL GENET, V94, P897, DOI 10.1007/s001220050493; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Walley PG, 2012, THEOR APPL GENET, V124, P467, DOI 10.1007/s00122-011-1721-6; [王道杰 Wang Daojie], 2014, [植物生理学报, Plant Physiology Journal], V50, P290; Wang QB, 2012, MOL BREEDING, V30, P709, DOI 10.1007/s11032-011-9656-9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Worth JRP, 2014, J PLANT RES, V127, P617, DOI 10.1007/s10265-014-0646-y; Zhang RJ, 2013, GENET RESOUR CROP EV, V60, P967, DOI 10.1007/s10722-012-9892-9; Zhang Y., 2011, THESIS BEIJING CHINE; Zhang Yan, 2010, Acta Horticulturae Sinica, V37, P915; Zhang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020930; [张彦锋 Zhang Yanfeng], 2005, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V14, P164; Zhang YY, 2012, J HERED, V103, P606, DOI 10.1093/jhered/ess006; Zhang YangYong, 2011, Scientia Agricultura Sinica, V44, P2959; Zhao HX, 2010, THEOR APPL GENET, V121, P643, DOI 10.1007/s00122-010-1336-3; Zhu YuYing, 1998, Acta Agriculturae Shanghai, V14, P19	72	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138750	10.1371/journal.pone.0138750	http://dx.doi.org/10.1371/journal.pone.0138750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407159	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700085
J	Wu, JQ; Kohno, N; Mano, S; Fukumoto, Y; Tanabe, H; Hasegawa, M; Yonezawa, T				Wu, Jiaqi; Kohno, Naoki; Mano, Shuhei; Fukumoto, Yukio; Tanabe, Hideyuki; Hasegawa, Masami; Yonezawa, Takahiro			Phylogeographic and Demographic Analysis of the Asian Black Bear (Ursus thibetanus) Based on Mitochondrial DNA	PLOS ONE			English	Article							COMPREHENSIVE ANALYSIS; GENETIC-STRUCTURE; PHYLOGENY; ORIGIN; DIVERGENCE; SEQUENCES; GENOMES; FAMILY; SUBSTITUTION; POLYMORPHISM	The Asian black bear Ursus thibetanus is widely distributed in Asia and is adapted to broad-leaved deciduous forests, playing an important ecological role in the natural environment. Several subspecies of U. thibetanus have been recognized, one of which, the Japanese black bear, is distributed in the Japanese archipelago. Recent molecular phylogeographic studies clarified that this subspecies is genetically distantly related to continental subspecies, suggesting an earlier origin. However, the evolutionary relationship between the Japanese and continental subspecies remained unclear. To understand the evolution of the Asian black bear in relation to geological events such as climatic and transgression-regression cycles, a reliable time estimation is also essential. To address these issues, we determined and analyzed the mt-genome of the Japanese subspecies. This indicates that the Japanese subspecies initially diverged from other Asian black bears in around 1.46Ma. The Northern continental population (northeast China, Russia, Korean peninsula) subsequently evolved, relatively recently, from the Southern continental population (southern China and Southeast Asia). While the Japanese black bear has an early origin, the tMRCAs and the dynamics of population sizes suggest that it dispersed relatively recently in the main Japanese islands: during the late Middle and Late Pleistocene, probably during or soon after the extinction of the brown bear in Honshu in the same period. Our estimation that the population size of the Japanese subspecies increased rapidly during the Late Pleistocene is the first evidential signal of a niche exchange between brown bears and black bears in the Japanese main islands. This interpretation seems plausible but was not corroborated by paleontological evidence that fossil record of the Japanese subspecies limited after the Late Pleistocene. We also report here a new fossil record of the oldest Japanese black bear from the Middle Pleistocene, and it supports our new evolutionary hypothesis of the Japanese black bear.	[Wu, Jiaqi; Hasegawa, Masami; Yonezawa, Takahiro] Fudan Univ, Sch Life Sci, Shanghai 200438, Peoples R China; [Kohno, Naoki] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Kohno, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Mano, Shuhei; Hasegawa, Masami; Yonezawa, Takahiro] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Fukumoto, Yukio] Hiroshima City Asa Zool Pk, Asakita Ku, Hiroshima 7313355, Japan; [Tanabe, Hideyuki; Yonezawa, Takahiro] Grad Univ Adv Studies, Sch Adv Sci, Hayama, Kanagawa 2400193, Japan	Fudan University; National Museum of Nature and Science; University of Tsukuba; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Graduate University for Advanced Studies - Japan	Kohno, N (corresponding author), Natl Museum Nat & Sci, Dept Geol & Paleontol, Amakubo 4-1-1, Tsukuba, Ibaraki 3050005, Japan.	kohno@kahaku.go.jp; cyclotis@gmail.com		Yonezawa, Takahiro/0000-0002-0012-1887	National Natural Foundation for the Foreign Young Scientist; Fudan University [EZH6281304/001/029]; JSPS [C25440219]; Grants-in-Aid for Scientific Research [25440219] Funding Source: KAKEN	National Natural Foundation for the Foreign Young Scientist; Fudan University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by National Natural Foundation for the Foreign Young Scientist to T.Y., Graduate innovation fund EZH6281304/001/029 of Fudan University to J.W., and a Grant in Aid for Scientific Research (C25440219) from JSPS to M.H.	Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Baryshnikov G. F., 2013, Trudy Zoologicheskogo Instituta, V317, P3; Baryshnikov G.F., 2010, Trudy Zoologicheskogo Instituta, V314, P67; Choi EH, 2010, MITOCHONDR DNA, V21, P105, DOI 10.3109/19401736.2010.491864; Davis CS, 2004, MOL PHYLOGENET EVOL, V33, P363, DOI 10.1016/j.ympev.2004.06.006; Dobson Mike, 1998, Quaternary Research (Tokyo), V37, P385; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Ginsburg Leonard, 1998, Annales de Paleontologie, V84, P71, DOI 10.1016/S0753-3969(98)80003-7; Griffiths RC, 1999, ANN APPL PROBAB, V9, P567; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hasegawa Y, 1979, HONYURUI KAGAKU, V38, P23; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Hou WR, 2007, INT J BIOL SCI, V3, P85; Hwang DS, 2008, MITOCHONDR DNA, V19, P418, DOI 10.1080/19401730802389525; IUCN, 2012, IUCN RED LIST THREAT; Kawamura Y., 2000, ACTA ANTHR SINICA S, V19, P264; Kawamura Y., 1982, HONYURUI KAGAKU, V43/44, P99; Kim YK, 2011, J HERED, V102, P165, DOI 10.1093/jhered/esq121; Kohno Naoki, 2005, Fossils (Tokyo), V77, P34; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Kurten B, 1980, PLEISTOCENE MAMMALS, P182; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; McLellan B, 1994, BEARS THEIR BIOL MAN, P85; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; Nikaido M, 2001, J MOL EVOL, V53, P508, DOI 10.1007/s002390010241; OHDACHI S. D., 2009, WILD MAMMALS JAPAN; Ohnishi N, 2009, HEREDITY, V102, P579, DOI 10.1038/hdy.2009.28; QIU Z, 2003, B AM MUS NAT HIST, V279, P18; Qiu Zhan-Xiang, 2014, Vertebrata Palasiatica, V52, P265; Qiu Zhanxiang, 1989, Vertebrata Palasiatica, V27, P153; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinmetz R, 2008, J WILDLIFE MANAGE, V72, P814, DOI 10.2193/2007-098; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi K, 2007, KYUSEKKI KENKYU, V3, P5; Takakuwa Yuji, 2007, Bulletin of Gunma Museum of Natural History, V11, P63; Taruno H, 2010, DAIYONKI KENKYU, V49, P315; Waits LP, 1999, MOL PHYLOGENET EVOL, V13, P82, DOI 10.1006/mpev.1999.0637; Walker EP., 1975, MAMMALS WORLD; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Woodburne MO, 2004, GLOBAL EVENTS N AM M, P331; Wu JQ, 2014, GENES GENET SYST, V89, P237, DOI 10.1266/ggs.89.237; Yamazaki H., 2001, ATLAS QUATERNARY MAR, P26; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yasukochi Y, 2009, J HERED, V100, P297, DOI 10.1093/jhered/esn097; Yoneda Masaaki, 2011, Honyurui Kagaku, V51, P79; Yonezawa T, 2007, GENE, V396, P1, DOI 10.1016/j.gene.2006.12.040; Yonezawa T, 2009, GENE, V441, P89, DOI 10.1016/j.gene.2009.01.022; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZHANG YP, 1993, P NATL ACAD SCI USA, V90, P9557, DOI 10.1073/pnas.90.20.9557	68	14	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136398	10.1371/journal.pone.0136398	http://dx.doi.org/10.1371/journal.pone.0136398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406587	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700011
J	Munoz, A; Bertuzzi, M; Bettgenhaeuser, J; Iakobachvili, N; Bignell, EM; Read, ND				Munoz, Alberto; Bertuzzi, Margherita; Bettgenhaeuser, Jan; Iakobachvili, Nino; Bignell, Elaine M.; Read, Nick D.			Different Stress-Induced Calcium Signatures Are Reported by Aequorin-Mediated Calcium Measurements in Living Cells of Aspergillus fumigatus	PLOS ONE			English	Article							CHRONIC PULMONARY ASPERGILLOSIS; COMPARATIVE GENOMIC ANALYSIS; INVASIVE FUNGAL-INFECTIONS; TRANSPLANT RECIPIENTS; ANTIFUNGAL ACTIVITY; WALL INTEGRITY; GLOBAL BURDEN; HYPHAL GROWTH; CALCINEURIN; HOMEOSTASIS	Aspergillus fumigatus is an inhaled fungal pathogen of human lungs, the developmental growth of which is reliant upon Ca2+-mediated signalling. Ca2+ signalling has regulatory significance in all eukaryotic cells but how A. fumigatus uses intracellular Ca2+ signals to respond to stresses imposed by the mammalian lung is poorly understood. In this work, A. fumigatus strains derived from the clinical isolate CEA10, and a non-homologous recombination mutant Delta akuB(KU80), were engineered to express the bioluminescent Ca2+-reporter aequorin. An aequorin-mediated method for routine Ca2+ measurements during the early stages of colony initiation was successfully developed and dynamic changes in cytosolic free calcium ([Ca2+](c)) in response to extracellular stimuli were measured. The response to extracellular challenges (hypo- and hyper-osmotic shock, mechanical perturbation, high extracellular Ca2+, oxidative stress or exposure to human serum) that the fungus might be exposed to during infection, were analysed in living conidial germlings. The 'signatures' of the transient [Ca2+](c) responses to extracellular stimuli were found to be dose-and age-dependent. Moreover, Ca2+-signatures associated with each physico-chemical treatment were found to be unique, suggesting the involvement of heterogeneous combinations of Ca2+-signalling components in each stress response. Concordant with the involvement of Ca2+-calmodulin complexes in these Ca2+-mediated responses, the calmodulin inhibitor trifluoperazine (TFP) induced changes in the Ca2+-signatures to all the challenges. The Ca2+-chelator BAPTA potently inhibited the initial responses to most stressors in accordance with a critical role for extracellular Ca2+ in initiating the stress responses.	[Munoz, Alberto; Bertuzzi, Margherita; Bignell, Elaine M.; Read, Nick D.] Univ Manchester, Inst Inflammat & Repair, Manchester Fungal Infect Grp, Manchester, Lancs, England; [Munoz, Alberto; Bettgenhaeuser, Jan; Read, Nick D.] Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland; [Bertuzzi, Margherita; Iakobachvili, Nino; Bignell, Elaine M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Mol Bacteriol & Infect, London, England	University of Manchester; University of Edinburgh; Imperial College London	Bignell, EM (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester Fungal Infect Grp, Manchester, Lancs, England.	Elaine.Bignell@manchester.ac.uk; Nick.Read@manchester.ac.uk	Bettgenhaeuser, Jan/I-2282-2019	Bettgenhaeuser, Jan/0000-0002-6901-1774; Bignell, Elaine/0000-0001-7748-1920; Bertuzzi, Margherita/0000-0002-5900-591X; Munoz, Alberto/0000-0002-1622-5074	Wellcome Trust [WT093596/A/10/Z, WT093596/C/10/Z]; Medical Research Council [G0501164]; BBSRC [BB/G009619/1]; MRC [MR/L000822/1, G0501164, MR/M02010X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009619/1] Funding Source: researchfish; Medical Research Council [MR/M02010X/1, MR/L000822/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to EMB and NDR from the Wellcome Trust (WT093596/A/10/Z and WT093596/C/10/Z, respectively), and in part by grants to EMB from the Medical Research Council (G0501164) and the BBSRC (BB/G009619/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Baddley JW, 2010, CLIN INFECT DIS, V50, P1559, DOI 10.1086/652768; Bagar T, 2012, FUNGAL GENET BIOL, V49, P779, DOI 10.1016/j.fgb.2012.07.007; Bains SN, 2012, CLIN CHEST MED, V33, P265, DOI 10.1016/j.ccm.2012.02.003; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Bencina M, 2005, MOL MICROBIOL, V56, P268, DOI 10.1111/j.1365-2958.2005.04541.x; Bencina M, 2009, FUNGAL GENET BIOL, V46, pS93, DOI 10.1016/j.fgb.2008.07.019; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Binder U, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-209; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Binder U, 2010, MOL MICROBIOL, V75, P294, DOI 10.1111/j.1365-2958.2009.06936.x; Bonora M, 2013, NAT PROTOC, V8, P2105, DOI 10.1038/nprot.2013.127; Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cavinder B, 2012, EUKARYOT CELL, V11, P978, DOI 10.1128/EC.00007-12; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; de Carvalho MJA, 2003, FUNGAL GENET BIOL, V39, P204, DOI 10.1016/S1087-1845(03)00044-6; Castro PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103957; Denning DW, 2013, EUR RESPIR J, V41, P621, DOI 10.1183/09031936.00226911; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Ding XH, 2014, BIOCHEM BIOPH RES CO, V446, P1073, DOI 10.1016/j.bbrc.2014.03.059; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Goncalves AP, 2014, J CELL SCI; Greene V, 2002, CELL SIGNAL, V14, P437, DOI 10.1016/S0898-6568(01)00266-2; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Juvvadi PR, 2014, FUNGAL BIOL REV, V28, P56, DOI 10.1016/j.fbr.2014.02.004; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kim HS, 2012, FUNGAL GENET BIOL, V49, P589, DOI 10.1016/j.fgb.2012.05.011; Kim YK, 1998, J BACTERIOL, V180, P5144, DOI 10.1128/JB.180.19.5144-5150.1998; Kleinkauf N, 2013, RISK ASSESSMENT ON T; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Kubodera T, 2000, BIOSCI BIOTECH BIOCH, V64, P1416, DOI 10.1271/bbb.64.1416; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Liu SY, 2015, EUKARYOT CELL, V14, P324, DOI 10.1128/EC.00271-14; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; MONOD M, 1993, FEMS MICROBIOL LETT, V106, P39, DOI 10.1111/j.1574-6968.1993.tb05932.x; Munoz A, 2014, MOL MICROBIOL, V92, P1357, DOI 10.1111/mmi.12634; Munoz A, 2012, MOL MICROBIOL, V85, P89, DOI 10.1111/j.1365-2958.2012.08091.x; Nelson G, 2004, MOL MICROBIOL, V52, P1437, DOI 10.1111/j.1365-2958.2004.04066.x; Ohba R, 2013, ANN HEMATOL, V92, P1, DOI 10.1007/s00277-012-1564-5; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Steinbach WJ, 2007, ANTIMICROB AGENTS CH, V51, P2979, DOI 10.1128/AAC.01394-06; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; Troppens DM, 2013, FUNGAL GENET BIOL, V56, P135, DOI 10.1016/j.fgb.2013.04.006; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Warwar V, 1996, APPL ENVIRON MICROB, V62, P74, DOI 10.1128/AEM.62.1.74-79.1996; Yu QL, 2014, MYCOPATHOLOGIA, V177, P167, DOI 10.1007/s11046-014-9735-7; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001	64	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138008	10.1371/journal.pone.0138008	http://dx.doi.org/10.1371/journal.pone.0138008			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402916	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100016
J	Repizo, GD; Gagne, S; Foucault-Grunenwald, ML; Borges, V; Charpentier, X; Limansky, AS; Gomes, JP; Viale, AM; Salcedo, SP				Repizo, Guillermo D.; Gagne, Stephanie; Foucault-Grunenwald, Marie-Laure; Borges, Vitor; Charpentier, Xavier; Limansky, Adriana S.; Gomes, Joao Paulo; Viale, Alejandro M.; Salcedo, Suzana P.			Differential Role of the T6SS in Acinetobacter baumannii Virulence	PLOS ONE			English	Article							VI SECRETION SYSTEM; BIOFILM FORMATION; GALLERIA-MELLONELLA; ABIOTIC SURFACES; PATHOGENESIS; PROTEINS; RECOMBINATION; RESISTANCE; BACTERIA; GENE	Gram-negative bacteria, such as Acinetobacter baumannii, are an increasing burden in hospitals worldwide with an alarming spread of multi-drug resistant (MDR) strains. Herein, we compared a type strain (ATCC17978), a non-clinical isolate (DSM30011) and MDR strains of A. baumannii implicated in hospital outbreaks (Ab242, Ab244 and Ab825), revealing distinct patterns of type VI secretion system (T6SS) functionality. The T6SS genomic locus is present and was actively transcribed in all of the above strains. However, only the A. baumannii DSM30011 strain was capable of killing Escherichia coli in a T6SS-dependent manner, unlike the clinical isolates, which failed to display an active T6SS in vitro. In addition, DSM30011 was able to outcompete ATCC17978 as well as Pseudomonas aeruginosa and Klebsiella pneumoniae, bacterial pathogens relevant in mixed nosocomial infections. Finally, we found that the T6SS of DSM30011 is required for host colonization of the model organism Galleria mellonella suggesting that this system could play an important role in A. baumannii virulence in a strain-specific manner.	[Repizo, Guillermo D.; Gagne, Stephanie; Salcedo, Suzana P.] Univ Lyon 1, Inst Biol & Chim Proteines, CNRS, Bases Mol & Struct Syst Infectieux,UMR 5086, F-69365 Lyon, France; [Foucault-Grunenwald, Marie-Laure; Charpentier, Xavier] Univ Lyon 1, CNRS, Unite Microbiol Adaptat & Pathogenie, UMR 5240, F-69622 Villeurbanne, France; [Borges, Vitor; Gomes, Joao Paulo] Natl Inst Hlth, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal; [Limansky, Adriana S.; Viale, Alejandro M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, Inst Biol Mol & Celular Rosario,IBR,CONICET, RA-2000 Rosario, Santa Fe, Argentina	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Salcedo, SP (corresponding author), Univ Lyon 1, Inst Biol & Chim Proteines, CNRS, Bases Mol & Struct Syst Infectieux,UMR 5086, F-69365 Lyon, France.	suzana.salcedo@ibcp.fr	Charpentier, Xavier/AAC-2379-2020; Charpentier, Xavier/M-1017-2014; salcedo, suzana/P-9830-2019; Salcedo, Suzana P/C-2853-2014	Charpentier, Xavier/0000-0001-9039-8021; Charpentier, Xavier/0000-0001-9039-8021; salcedo, suzana/0000-0001-5149-7756; Salcedo, Suzana P/0000-0001-5149-7756; Gomes, Joao Paulo/0000-0002-2697-2399; Borges, Vitor/0000-0003-3767-2209	FINOVI Young Researcher Grant; INSERM; Region Rhone-Alpes ARC1 Sante fellowship; CNRS-Inserm ATIP-Avenir program; Sanofi; ANPCyT; CONICET; Secretaria de Ciencia, Tecnologia e Innovacion, Provincia de Santa Fe, Argentina	FINOVI Young Researcher Grant; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Rhone-Alpes ARC1 Sante fellowship; CNRS-Inserm ATIP-Avenir program; Sanofi; ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia, Tecnologia e Innovacion, Provincia de Santa Fe, Argentina	This work was supported by a FINOVI Young Researcher Grant. SS is supported by an INSERM researcher contract and SG by Region Rhone-Alpes ARC1 Sante fellowship. XC and MLG are supported by grants from the CNRS-Inserm ATIP-Avenir program and Sanofi (awarded to XC). AV is a Staff Member of CONICET, Argentina, and AL a Staff Member of the Universidad Nacional de Rosario, Argentina. Both researchers are supported by grants from ANPCyT, CONICET, and Secretaria de Ciencia, Tecnologia e Innovacion, Provincia de Santa Fe, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Borgeaud S, 2015, SCIENCE, V347, P63, DOI 10.1126/science.1260064; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Harding CR, 2012, INFECT IMMUN, V80, P2780, DOI 10.1128/IAI.00510-12; Heindorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101033; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jones CL, 2015, CLIN INFECT DIS, V61, P145, DOI 10.1093/cid/civ225; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Lees-Miller RG, 2013, MOL MICROBIOL, V89, P816, DOI 10.1111/mmi.12300; Longo F, 2014, NEW MICROBIOL, V37, P119; Lopez-Rojas R, 2011, J INFECT DIS, V203, P545, DOI 10.1093/infdis/jiq086; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005; Mussi MA, 2007, FEBS LETT, V581, P5573, DOI 10.1016/j.febslet.2007.10.063; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Mussi MA, 2011, J BACTERIOL, V193, P4736, DOI 10.1128/JB.01533-10; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; PIECHAUD D, 1951, ANN I PASTEUR PARIS, V80, P97; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Salomon D, 2014, P NATL ACAD SCI USA, V111, P9271, DOI 10.1073/pnas.1406110111; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13; Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zhang LQ, 2014, MICROB PATHOGENESIS, V74, P1, DOI 10.1016/j.micpath.2014.06.006; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	42	60	62	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138265	10.1371/journal.pone.0138265	http://dx.doi.org/10.1371/journal.pone.0138265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401654	gold, Green Submitted, Green Published			2022-12-26	WOS:000361798100017
J	Ahmed, MS; Pelletier, J; Leumann, H; Gu, HF; Ostenson, CG				Ahmed, Mohammed Seed; Pelletier, Julien; Leumann, Hannes; Gu, Harvest F.; Ostenson, Claes-Goran			Expression of Protein Kinase C Isoforms in Pancreatic Islets and Liver of Male Goto-Kakizaki Rats, a Model of Type 2 Diabetes	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; BETA-CELL PROLIFERATION; GK RAT; IN-VIVO; INDUCED ACTIVATION; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; PKC-DELTA; SECRETION; TRANSLOCATION	Protein kinase C (PKC) is a family of protein kinases controlling protein phosphorylation and playing important roles in the regulation of metabolism. We have investigated expression levels of PKC isoforms in pancreatic islets and liver of diabetic Goto-Kakizaki (GK) rats with and without insulin treatment to evaluate their association with glucose homeostasis. mRNA and protein expression levels of PKC isoforms were assessed in pancreatic islets and liver of Wistar rats and GK rats with or without insulin treatment. PKC alpha and PKC zeta mRNA expressions were down-regulated in islets of GK compared with Wistar rats. PKC alpha and phosphorylated PKC alpha (p-PKC alpha) protein expressions were decreased in islets of GK compared with insulin-treated GK and Wistar rats. PKC zeta protein expression in islets was reduced in GK and insulin-treated GK compared with Wistar rats, but p-PKC zeta was decreased only in GK rats. Islet PKC epsilon mRNA and protein expressions were lower in GK compared with insulin-treated GK and Wistar rats. In liver, PKC delta and PKC zeta mRNA expressions were decreased in both GK and insulin-treated GK compared with Wistar rats. Hepatic PKC zeta protein expression was diminished in both GK rats with and without insulin treatment compared with Wistar rats. Hepatic PKC epsilon mRNA expression was down-regulated in insulin-treated GK compared with GK and Wistar rats. PKC alpha, PKC epsilon, and p-PKC zeta expressions were secondary to hyperglycaemia in GK rat islets. Hepatic PKC delta and PKC zeta mRNA expressions were primarily linked to hyperglycaemia. Additionally, hepatic PKC epsilon mRNA expression could be under control of insulin.	[Ahmed, Mohammed Seed; Pelletier, Julien; Leumann, Hannes; Gu, Harvest F.; Ostenson, Claes-Goran] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Ahmed, Mohammed Seed] Univ Khartoum, Fac Med, Dept Physiol, Khartoum, Sudan	Karolinska Institutet; Karolinska University Hospital; University of Khartoum	Ostenson, CG (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	claes-goran.ostenson@ki.se	Ahmed, Mohammed/T-5898-2019		Swedish Research Council; Swedish Diabetes Association; Karolinska Institutet Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Karolinska Institutet Fund(Karolinska Institutet)	Funding provided by Swedish Research Council (CGO), www.vr.se, Swedish Diabetes Association (CGO), www.sdf.se and Karolinska Institutet Fund (HFG, CGO), www.ki.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHALIM SM, 1994, DIABETES, V43, P281, DOI 10.2337/diabetes.43.2.281; Ahmed MS, 2012, ISLETS, V4, P343, DOI [10.4161/islets.22283, 10.4161/isl.22283]; Amed S, 2010, EXPERT REV CARDIOVAS, V8, P393, DOI [10.1586/ERC.10.15, 10.1586/erc.10.15]; AVIGNON A, 1995, BIOCHEM J, V308, P181, DOI 10.1042/bj3080181; Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Bergan HE, 2013, J MOL ENDOCRINOL, V51, P213, DOI 10.1530/JME-13-0039; Bergan HE, 2012, GEN COMP ENDOCR, V176, P367, DOI 10.1016/j.ygcen.2011.12.013; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; BISBIS S, 1993, AM J PHYSIOL, V265, pE807, DOI 10.1152/ajpendo.1993.265.5.E807; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; CALLE R, 1992, J BIOL CHEM, V267, P18723; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Kvezereli M, 2008, TRANSPL P, V40, P375, DOI 10.1016/j.transproceed.2008.01.014; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Matsumoto M, 2001, J BIOL CHEM, V276, P14400, DOI 10.1074/jbc.M011093200; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Nesher R, 2001, DIABETES, V50, P308, DOI 10.2337/diabetes.50.2.308; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Pereira S, 2015, METABOLISM, V64, P315, DOI 10.1016/j.metabol.2014.10.019; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Polakof Sergio, 2010, Recent Pat DNA Gene Seq, V4, P1; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; PUGAZHENTHI S, 1995, MOL CELL BIOCHEM, V149, P95, DOI 10.1007/BF01076568; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Standaert ML, 1996, BIOCHEM J, V313, P1039, DOI 10.1042/bj3131039; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Sun Miao-Kun, 2006, Recent Pat CNS Drug Discov, V1, P147, DOI 10.2174/157488906777452721; Thrush AB, 2012, HORM METAB RES, V44, P825, DOI 10.1055/s-0032-1316332; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Velazquez-Garcia S, 2011, DIABETES, V60, P2546, DOI 10.2337/db10-1783; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; YAMADA K, 1995, BIOCHEM J, V308, P177, DOI 10.1042/bj3080177; Yaney GC, 2002, AM J PHYSIOL-ENDOC M, V283, pE880, DOI 10.1152/ajpendo.00474.2001; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241	52	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0135781	10.1371/journal.pone.0135781	http://dx.doi.org/10.1371/journal.pone.0135781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398746	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500005
J	Chopin, J; Laga, H; Huang, CY; Heuer, S; Miklavcic, SJ				Chopin, Joshua; Laga, Hamid; Huang, Chun Yuan; Heuer, Sigrid; Miklavcic, Stanley J.			RootAnalyzer: A Cross-Section Image Analysis Tool for Automated Characterization of Root Cells and Tissues	PLOS ONE			English	Article							AERENCHYMA; TRANSPORT; ELONGATION; SOFTWARE; ANATOMY; PLANTS; CROPS; WHEAT; SHOOT	The morphology of plant root anatomical features is a key factor in effective water and nutrient uptake. Existing techniques for phenotyping root anatomical traits are often based on manual or semi-automatic segmentation and annotation of microscopic images of root cross sections. In this article, we propose a fully automated tool, hereinafter referred to as RootAnalyzer, for efficiently extracting and analyzing anatomical traits from root-cross section images. Using a range of image processing techniques such as local thresholding and nearest neighbor identification, RootAnalyzer segments the plant root from the image's background, classifies and characterizes the cortex, stele, endodermis and epidermis, and subsequently produces statistics about the morphological properties of the root cells and tissues. We use RootAnalyzer to analyze 15 images of wheat plants and one maize plant image and evaluate its performance against manually-obtained ground truth data. The comparison shows that RootAnalyzer can fully characterize most root tissue regions with over 90% accuracy.	[Chopin, Joshua; Laga, Hamid; Miklavcic, Stanley J.] Univ S Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia; [Huang, Chun Yuan; Heuer, Sigrid] Australian Ctr Plant Funct Genom, Urrbrae, SA, Australia	University of South Australia	Miklavcic, SJ (corresponding author), Univ S Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia.	stan.miklavcic@unisa.edu.au	Miklavcic, Stanley J/A-6244-2011		Grains Research and Development Corporation (GRDC) [GRS10512]; Australian Research Council; GRDC	Grains Research and Development Corporation (GRDC)(Grains R&D Corp); Australian Research Council(Australian Research Council); GRDC	The authors acknowledge funding from the Grains Research and Development Corporation (GRDC http://www.grdc.com.au/) under Grant Number #GRS10512 for a scholarship to Joshua Chopin. The authors also acknowledge the Australian Research Council and GRDC for funding to Hamid Laga, Chun Yuan Huang and Sigrid Heuer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell B.J., 1999, PLANTS IN ACTION; ATWELL BJ, 1993, ENVIRON EXP BOT, V33, P27, DOI 10.1016/0098-8472(93)90053-I; Berger Bettina, 2012, Methods Mol Biol, V918, P9, DOI 10.1007/978-1-61779-995-2_2; Burton AL, 2012, PLANT SOIL, V357, P189, DOI 10.1007/s11104-012-1138-2; Cai J, 2012, IET IMAGE PROCESS, V6, P687, DOI 10.1049/iet-ipr.2011.0281; Cai JH, 2013, IET IMAGE PROCESS, V7, P596, DOI 10.1049/iet-ipr.2012.0690; Chene Y, 2012, COMPUT ELECTRON AGR, V82, P122, DOI 10.1016/j.compag.2011.12.007; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; de Reuille PB, 2015, ELIFE, V4, DOI 10.7554/eLife.05864; Dyson RJ, 2014, NEW PHYTOL, V202, P1212, DOI 10.1111/nph.12764; Fan MS, 2003, FUNCT PLANT BIOL, V30, P493, DOI 10.1071/FP03046; Fernandez R, NATURE METHODS, P547; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Foster KJ, 2014, J THEOR BIOL, V340, P1, DOI 10.1016/j.jtbi.2013.09.004; Foster KJ, 2013, J THEOR BIOL, V336, P132, DOI 10.1016/j.jtbi.2013.07.025; Golzarian MR, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-2; Haque ME, 2010, PLANT ROOT, V4, P31, DOI 10.3117/plantroot.4.31; Hochholdinger F, 2004, TRENDS PLANT SCI, V9, P42, DOI 10.1016/j.tplants.2003.11.003; Hochholdinger F, 2010, ANNU PLANT REV, V37, P175, DOI 10.1002/9781444310023.ch7; Hu B, 2014, ANN BOT-LONDON, V113, P181, DOI 10.1093/aob/mct259; Kumar P., 2012, P 27 C IM VIS COMP N, P301; Kumar P, 2015, ADV EXP MED BIOL, V823, P249, DOI 10.1007/978-3-319-10984-8_14; Kumar P, 2014, PLANT SOIL, V380, P193, DOI 10.1007/s11104-014-2071-3; Laga H, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P524; Laga H, 2014, J THEOR BIOL, V363, P41, DOI 10.1016/j.jtbi.2014.07.036; Lipiec J, 2012, SOIL TILL RES, V121, P74, DOI 10.1016/j.still.2012.01.013; Maggio A, 2001, AUST J PLANT PHYSIOL, V28, P999, DOI 10.1071/PP01099; Morita S., 1995, Structure and function of roots. Proceedings of the Fourth International Symposium, Stara Lesna, Slovakia 20-26 June, 1993., P75; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PETERSON WR, 1981, AGRON J, V73, P316, DOI 10.2134/agronj1981.00021962007300020017x; Pound MP, PLANT CELL ONLINE, P1353; Rudall P. J., 2007, ANATOMY FLOWERING PL; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steinberg SR, 2015, CRIT NEW LITERACI, V1, P1; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; Watt M, 2009, FUNCT PLANT BIOL, V36, P960, DOI 10.1071/FP09214; WONG AKC, 1989, IEEE T SYST MAN CYB, V19, P866, DOI 10.1109/21.35351; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371	39	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137655	10.1371/journal.pone.0137655	http://dx.doi.org/10.1371/journal.pone.0137655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398501	Green Published, gold, Green Accepted			2022-12-26	WOS:000361797500044
J	Haenen, S; Vanoirbeek, JAJ; De Vooght, V; Schoofs, L; Nemery, B; Clynen, E; Hoet, PHM				Haenen, Steven; Vanoirbeek, Jeroen A. J.; De Vooght, Vanessa; Schoofs, Liliane; Nemery, Benoit; Clynen, Elke; Hoet, Peter H. M.			Proteomic Alterations in B Lymphocytes of Sensitized Mice in a Model of Chemical-Induced Asthma	PLOS ONE			English	Article							TOLUENE DIISOCYANATE; MOUSE MODEL; DERMAL SENSITIZATION; OCCUPATIONAL ASTHMA; IMMUNOLOGICAL DETERMINANTS; CYCLOPHILIN; RESPONSES; SERUM; ACTIVATION; DISEASE	Introduction and Aim The role of B-lymphocytes in chemical-induced asthma is largely unknown. Recent work demonstrated that transferring B lymphocytes from toluene diisocyanate (TDI)-sensitized mice into naive mice, B cell KO mice and SCID mice, triggered an asthma-like response in these mice after a subsequent TDI-challenge. We applied two-dimensional difference gel electrophoresis (2D-DIGE) to describe the "sensitized signature" of B lymphocytes comparing TDI-sensitized mice with control mice. Results Sixteen proteins were identified that were significantly up- or down-regulated in B lymphocytes of sensitized mice. Particularly differences in the expression of cyclophilin A, cofilin 1 and zinc finger containing CCHC domain protein 11 could be correlated to the function of B lymphocytes as initiators of T lymphocyte independent asthma-like responses. Conclusion This study revealed important alterations in the proteome of sensitized B cells in a mouse model of chemical-induced asthma, which will have an important impact on the B cell function.	[Haenen, Steven; Vanoirbeek, Jeroen A. J.; De Vooght, Vanessa; Nemery, Benoit; Hoet, Peter H. M.] Katholieke Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium; [Haenen, Steven; Schoofs, Liliane] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium; [Clynen, Elke] Hasselt Univ, Biomed Res Inst BIOMED, Hasselt, Belgium	KU Leuven; KU Leuven; Hasselt University	Vanoirbeek, JAJ (corresponding author), Katholieke Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium.	jeroen.vanoirbeek@kuleuven.be	schoofs, liliane/ABD-2943-2020; Vanoirbeek, Jeroen/D-5183-2016; Nemery, Benoit/N-3155-2019; Hoet, Peter/H-9987-2013; Schoofs, Liliane/F-2815-2010	Vanoirbeek, Jeroen/0000-0001-5508-3518; Nemery, Benoit/0000-0003-0571-4689; Hoet, Peter/0000-0002-0292-6603; Schoofs, Liliane/0000-0002-1673-432X	Interuniversity Attraction Pole Program (IUAP), Belgian State, Belgian Science Policy [P7/30]	Interuniversity Attraction Pole Program (IUAP), Belgian State, Belgian Science Policy	This work was supported by a grant of the Interuniversity Attraction Pole Program (IUAP), Belgian State, Belgian Science Policy [P7/30].	Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Billich A, 1997, J EXP MED, V185, P975, DOI 10.1084/jem.185.5.975; De Vooght V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083228; De Vooght V, 2011, TOXICOLOGY, V279, P85, DOI 10.1016/j.tox.2010.09.014; De Vooght V, 2010, THORAX, V65, P252, DOI 10.1136/thx.2009.121293; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Doody GM, 1996, CURR OPIN IMMUNOL, V8, P378, DOI 10.1016/S0952-7915(96)80128-2; Drolet JP, 2010, CLIN EXP ALLERGY, V40, P841, DOI 10.1111/j.1365-2222.2010.03512.x; Dykewicz MS, 2009, J ALLERGY CLIN IMMUN, V123, P519, DOI 10.1016/j.jaci.2009.01.061; Haenen S, 2012, PROTEOMICS, V12, P3548, DOI 10.1002/pmic.201200264; Haenen S, 2010, J PROTEOME RES, V9, P5868, DOI 10.1021/pr100638m; Heine SJ, 2011, J INFLAMM RES, V4, P93, DOI 10.2147/JIR.S20733; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; Lindell DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003129; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; Palikhe NS, 2011, ALLERGY ASTHMA IMMUN, V3, P21, DOI 10.4168/aair.2011.3.1.21; Park HS, 2002, CLIN EXP ALLERGY, V32, P551, DOI 10.1046/j.0954-7894.2002.01349.x; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Stemmy EJ, 2011, AM J RESP CELL MOL, V45, P991, DOI 10.1165/rcmb.2011-0007OC; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Tee RD, 1998, J ALLERGY CLIN IMMUN, V101, P709, DOI 10.1016/S0091-6749(98)70181-2; Tegeder I, 1997, J CLIN IMMUNOL, V17, P380, DOI 10.1023/A:1027364207544; Vanoirbeek JAJ, 2009, SCAND J IMMUNOL, V70, P25, DOI 10.1111/j.1365-3083.2009.02263.x; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027	29	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138791	10.1371/journal.pone.0138791	http://dx.doi.org/10.1371/journal.pone.0138791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398101	gold, Green Published			2022-12-26	WOS:000361797500109
J	Guo, ST; Chi, MN; Yang, RH; Guo, XY; Zan, LK; Wang, CY; Xi, YF; Jin, L; Croft, A; Tseng, HY; Yan, XG; Farrelly, M; Wang, FH; Lai, F; Wang, JF; Li, YP; Ackland, S; Scott, R; Agoulnik, IU; Hondermarck, H; Thorne, RF; Liu, T; Zhang, XD; Jiang, CC				Guo, S. T.; Chi, M. N.; Yang, R. H.; Guo, X. Y.; Zan, L. K.; Wang, C. Y.; Xi, Y. F.; Jin, L.; Croft, A.; Tseng, H-Y; Yan, X. G.; Farrelly, M.; Wang, F. H.; Lai, F.; Wang, J. F.; Li, Y. P.; Ackland, S.; Scott, R.; Agoulnik, I. U.; Hondermarck, H.; Thorne, R. F.; Liu, T.; Zhang, X. D.; Jiang, C. C.			INPP4B is an oncogenic regulator in human colon cancer	ONCOGENE			English	Article							LASER CAPTURE MICRODISSECTION; TUMOR-SUPPRESSOR; HUMAN-MELANOMA; BREAST-CANCER; PHOSPHORYLATION; PROTEIN; ACTIVATION; EXPRESSION; PATHWAY; ETS-1	Inositol polyphosphate 4-phosphatase type II (INPP4B) negatively regulates phosphatidylinositol 3-kinase signaling and is a tumor suppressor in some types of cancers. However, we have found that it is frequently upregulated in human colon cancer cells. Here we show that silencing of INPP4B blocks activation of Akt and serum-and glucocorticoid-regulated kinase 3 (SGK3), inhibits colon cancer cell proliferation and retards colon cancer xenograft growth. Conversely, overexpression of INPP4B increases proliferation and triggers anchorage-independent growth of normal colon epithelial cells. Moreover, we demonstrate that the effect of INPP4B on Akt and SGK3 is associated with inactivation of phosphate and tensin homolog through its protein phosphatase activity and that the increase in INPP4B is due to Ets-1-mediated transcriptional upregulation in colon cancer cells. Collectively, these results suggest that INPP4B may function as an oncogenic driver in colon cancer, with potential implications for targeting INPP4B as a novel approach to treat this disease.	[Guo, S. T.; Yang, R. H.; Guo, X. Y.; Wang, C. Y.; Wang, F. H.] Shanxi Med Univ, Affiliated Hosp, Shanxi Canc Hosp & Inst, Dept Mol Biol, Taiyuan, Shanxi, Peoples R China; [Chi, M. N.; Jin, L.; Yan, X. G.; Lai, F.; Jiang, C. C.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia; [Zan, L. K.; Xi, Y. F.; Wang, J. F.] Shanxi Canc Hosp & Inst, Dept Pathol, Taiyuan, Shanxi, Peoples R China; [Croft, A.; Ackland, S.] Calvary Mater Newcastle Hosp, Dept Med Oncol, Newcastle, NSW, Australia; [Tseng, H-Y; Farrelly, M.; Scott, R.; Hondermarck, H.; Zhang, X. D.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Li, Y. P.] Shanxi Canc Hosp & Inst, Dept Colorectal Surg, Taiyuan, Shanxi, Peoples R China; [Agoulnik, I. U.] Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL USA; [Thorne, R. F.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Liu, T.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia	Shanxi Medical University; University of Newcastle; Calvary Mater Newcastle Hospital; University of Newcastle; University of Newcastle; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney	Zhang, XD; Jiang, CC (corresponding author), Univ Newcastle, Prior Res Ctr Canc Res, Sch Med & Publ Hlth, LS3-49,Life Sci Bldg, Callaghan, NSW 2308, Australia.	Xu.Zhang@newcastle.edu.au; Chenchen.Jiang@newcastle.edu.au	Jin, Lei/K-2315-2019; Jin, Lei/J-1896-2019; Tseng, Cindy Hsin-Yi/AAB-8958-2022; Zhang, xiaoyu/GXA-3206-2022; Liu, Tao/A-3922-2015; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; Agoulnik, Irina/AAD-4687-2020; zhang, xu/GRX-9733-2022; Ackland, Stephen P./G-7460-2013; Scott, Rodney/B-2827-2013	Jin, Lei/0000-0001-7187-9671; Tseng, Cindy Hsin-Yi/0000-0002-7499-7515; Agoulnik, Irina/0000-0003-4889-0324; Ackland, Stephen P./0000-0001-5303-0017; Liu, Tao/0000-0001-6244-7316; Zhang, Xu Dong/0000-0001-9457-8003; Scott, Rodney/0000-0001-7724-3404	National Health and Medical Research Council (NHMRC) [APP1026458]; Cancer Council NSW, Australia [RG13-04, RG 13-15]; Shanxi Scholarship Council [2013-133]; Shanxi Natural Science Foundation, China [2013011043-3]; National Natural Science Foundation of China [81472837]; NATIONAL CANCER INSTITUTE [R15CA179287] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW, Australia(Cancer Council New South Wales); Shanxi Scholarship Council; Shanxi Natural Science Foundation, China(Natural Science Foundation of Shanxi Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council (NHMRC) (APP1026458), the Cancer Council NSW (RG13-04 and RG 13-15), Australia, the Shanxi Scholarship Council (2013-133), Shanxi Natural Science Foundation (2013011043-3), China and National Natural Science Foundation of China (81472837). We thank Professor James R Woodgett (Samuel Lunenfeld Research Institute, Canada) for providing the Flag-myristoylated SGK3-CMV construct.	Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dzneladze I, 2015, LEUKEMIA, V29, P1485, DOI 10.1038/leu.2015.51; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Ito Y, 2002, ANTICANCER RES, V22, P1581; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lopez SM, 2013, BIOCHEM BIOPH RES CO, V440, P277, DOI 10.1016/j.bbrc.2013.09.077; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Moniz Larissa S, 2013, Biochem J, V452, pe11, DOI 10.1042/BJ20130617; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ooms LM, 2006, MOL BIOL CELL, V17, P607, DOI 10.1091/mbc.E05-05-0469; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Rijal S, 2015, BLOOD, V125, P2815, DOI 10.1182/blood-2014-09-603555; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Scheid MP, 2002, J BIOL CHEM, V277, P9027, DOI 10.1074/jbc.M106755200; Scortegagna M, 2015, CANCER RES, V75, P1399, DOI 10.1158/0008-5472.CAN-14-2785; Struglics A, 2000, FEBS LETT, V475, P213, DOI 10.1016/S0014-5793(00)01680-X; Switzer CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3319; Ye Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2489	38	38	43	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 9	2016	35	23					3049	3061		10.1038/onc.2015.361	http://dx.doi.org/10.1038/onc.2015.361			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0NB	26411369	hybrid, Green Published			2022-12-26	WOS:000377474500010
J	Lineman, M; Do, Y; Kim, JY; Joo, GJ				Lineman, Maurice; Do, Yuno; Kim, Ji Yoon; Joo, Gea-Jae			Talking about Climate Change and Global Warming	PLOS ONE			English	Article							SEARCH BEHAVIOR; TRENDS	The increasing prevalence of social networks provides researchers greater opportunities to evaluate and assess changes in public opinion and public sentiment towards issues of social consequence. Using trend and sentiment analysis is one method whereby researchers can identify changes in public perception that can be used to enhance the development of a social consciousness towards a specific public interest. The following study assessed Relative search volume (RSV) patterns for global warming (GW) and Climate change (CC) to determine public knowledge and awareness of these terms. In conjunction with this, the researchers looked at the sentiment connected to these terms in social media networks. It was found that there was a relationship between the awareness of the information and the amount of publicity generated around the terminology. Furthermore, the primary driver for the increase in awareness was an increase in publicity in either a positive or a negative light. Sentiment analysis further confirmed that the primary emotive connections to the words were derived from the original context in which the word was framed. Thus having awareness or knowledge of a topic is strongly related to its public exposure in the media, and the emotional context of this relationship is dependent on the context in which the relationship was originally established. This has value in fields like conservation, law enforcement, or other fields where the practice can and often does have two very strong emotive responses based on the context of the problems being examined.	[Lineman, Maurice; Do, Yuno; Kim, Ji Yoon; Joo, Gea-Jae] Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Busan, South Korea	Pusan National University	Joo, GJ (corresponding author), Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Busan, South Korea.	gjjoo@pusan.ac.kr		Kim, Ji Yoon/0000-0001-5228-4939	Post-Doc Development Program of Pusan National University	Post-Doc Development Program of Pusan National University	This study was financially supported by the 2015 Post-Doc Development Program of Pusan National University.	Abeywardena IS., 2014, PUBLIC OPINION OER M; Aston N., 2014, J COMPUT COMMUN, V2, P11, DOI DOI 10.4236/JCC.2014.23002; Bollen J, 2011, P INT AAAI C WEB SOC, V5; Bossomaier T, 2003, ADV COMPLEX SYST, V6, P313, DOI 10.1142/S0219525903000992; BOSTROM A, 1994, RISK ANAL, V14, P959, DOI 10.1111/j.1539-6924.1994.tb00065.x; Bruns A, 2011, AUSVOTES TWITTER COV; Castle NG, 2005, HEALTH SERV RES, V40, P1996, DOI 10.1111/j.1475-6773.2005.00475.x; Cavnar W.B., 1994, P SDAIR 94 3 ANN S D, VVolume 161175, DOI DOI 10.1.1.53.9367; Chadwick A, 2011, INT J PRESS/POLIT, V16, P3, DOI 10.1177/1940161210384730; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Choi Yejin, 2008, P C EMP METH NAT LAN; Conway M, 2009, INT J MED INFORM, V78, pE47, DOI 10.1016/j.ijmedinf.2009.03.010; De Longueville Bertrand, 2009, P 2009 INT WORKSH LO; Do Y, 2015, CONSERV BIOL, V29, P271, DOI 10.1111/cobi.12419; Doherty TJ, 2011, PSYCHOL IMPACTS GLOB; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Fayyad U, 1996, AI MAG, V17, P37; Fayyad U, 1996, KNOWLEDGE DISCOVERY; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; GIDDENS A., 2009, POLITICS CLIMATE CHA; Granka L. A., 2009, UIIR SIGIR, P28; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Holscher C, 2000, COMPUT NETW, V33, P337, DOI 10.1016/S1389-1286(00)00031-1; Kim J. G., 2014, T MAT PROCESSING, V23, P23; Kouloumpis E, 2011, ICWSM, V11, P164; Lawrence L, 2014, RELIABILITY SENTIMEN; Lazarus R.S., 1991, EMOTION ADAPTATION; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; McCright AM, 2000, SOC PROBL, V47, P499, DOI 10.1525/sp.2000.47.4.03x0305s; Miksza P, 2010, J RES MUSIC EDUC, V57, P364, DOI 10.1177/0022429409351655; Mobley C, 2009, ENV BEHAV; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Motteux NMG., EVALUATING PEOPLE EN; Nasukawa T., 2003, SENTIMENT ANAL CAPTU, P1, DOI [10.1145/945645.945658, DOI 10.1145/945645.945658]; Neverla I, 2008, ICA C GLOB COMM SOC; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Phelan O, 2009, P 3 ACM C REC SYST A; Pinkerton B., 1994, P 2 WWW C CHIC IL US; Proulx R, 2014, CONSERV BIOL, V28, P44, DOI 10.1111/cobi.12131; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; Ripberger JT, 2011, POLICY STUD J, V39, P239, DOI 10.1111/j.1541-0072.2011.00406.x; ROBERTS ML, 1994, PUBLIC OPIN QUART, V58, P165, DOI 10.1086/269417; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Wang Xiaolong, 2011, P 20 ACM INT C INF K; Weingart P, 2000, PUBLIC UNDERST SCI, V9, P261, DOI 10.1088/0963-6625/9/3/304; Welch DD, 1997, SO CALIFORNIA INTERD, V6, P55; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Wiegand M., 2010, P WORKSH NEG SPEC NA; Zhao D., 2009, P ACM 2009 INT C SUP	52	50	50	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138996	10.1371/journal.pone.0138996	http://dx.doi.org/10.1371/journal.pone.0138996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418127	Green Submitted, gold, Green Published			2022-12-26	WOS:000362171400032
J	Pereira, JMC; Oom, D; Pereira, P; Turkman, AA; Turkman, KF				Pereira, Jose M. C.; Oom, Duarte; Pereira, Paula; Turkman, Antonia A.; Feridun Turkman, K.			Religious Affiliation Modulates Weekly Cycles of Cropland Burning in Sub-Saharan Africa	PLOS ONE			English	Article							FIRE; SAVANNA; AEROSOL; CLIMATE; IMPACT	Vegetation burning is a common land management practice in Africa, where fire is used for hunting, livestock husbandry, pest control, food gathering, cropland fertilization, and wildfire prevention. Given such strong anthropogenic control of fire, we tested the hypotheses that fire activity displays weekly cycles, and that the week day with the fewest fires depends on regionally predominant religious affiliation. We also analyzed the effect of land use (anthrome) on weekly fire cycle significance. Fire density (fire counts.km(-2)) observed per week day in each region was modeled using a negative binomial regression model, with fire counts as response variable, region area as offset and a structured random effect to account for spatial dependence. Anthrome (settled, cropland, natural, rangeland), religion (Christian, Muslim, mixed) week day, and their 2-way and 3-way interactions were used as independent variables. Models were also built separately for each anthrome, relating regional fire density with week day and religious affiliation. Analysis revealed a significant interaction between religion and week day, i.e. regions with different religious affiliation (Christian, Muslim) display distinct weekly cycles of burning. However, the religion vs. week day interaction only is significant for croplands, i.e. fire activity in African croplands is significantly lower on Sunday in Christian regions and on Friday in Muslim regions. Magnitude of fire activity does not differ significantly among week days in rangelands and in natural areas, where fire use is under less strict control than in croplands. These findings can contribute towards improved specification of ignition patterns in regional/global vegetation fire models, and may lead to more accurate meteorological and chemical weather forecasting.	[Pereira, Jose M. C.; Oom, Duarte] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal; [Pereira, Paula] Escola Super Tecnol Setubal, Inst Politecn Setubal, Setubal, Portugal; [Turkman, Antonia A.; Feridun Turkman, K.] Univ Lisbon, Fac Ciencias, Ctr Estat & Aplicacoes, Lisbon, Portugal	Universidade de Lisboa; Instituto Politecnico de Setubal; Universidade de Lisboa	Pereira, JMC (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal.	jmocpereira@gmail.com	Turkman, Maria Antónia Amaral/M-6010-2013; Oom, Duarte/B-5290-2008; Pereira, José/N-2829-2019; Pereira, Jose MC/I-1283-2014; Turkman, Kamil Feridun/M-3484-2015	Turkman, Maria Antónia Amaral/0000-0002-7564-7154; Oom, Duarte/0000-0002-9244-3487; Pereira, José/0000-0003-2583-3669; Pereira, Jose MC/0000-0003-2583-3669; Pereira, Paula/0000-0002-9326-1466; Turkman, Kamil Feridun/0000-0002-6864-8773	Fundacao para a Ciencia e a Tecnologia [PEst-OE/AGR/UI0239/2014, PEst-OE/MAT/UI0006/2014, PTDC/MAT/118335/2010, SFRH/BD/4752/2008]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding for this research was provided by Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/) research projects PEst-OE/AGR/UI0239/2014 (JMCP and DO), PEst-OE/MAT/UI0006/2014 (KFT, AT and PP), PTDC/MAT/118335/2010 (KFT, AT, PP and JMCP) and doctoral grant SFRH/BD/4752/2008 (DO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald S, 2010, INT J WILDLAND FIRE, V19, P774, DOI [10.1071/WF08207, 10.1071/WF10008]; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Balzter H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022526; Banerjee S., 2014, HIERARCHICAL MODELIN; Beirle S, 2003, ATMOS CHEM PHYS, V3, P2225, DOI 10.5194/acp-3-2225-2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird MI, 1998, NATURE, V394, P767, DOI 10.1038/29507; Bond W. J., 1997, P421; Box GE, 1992, BAYESIAN INFERENCE S; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; Dwyer E, 2000, J BIOGEOGR, V27, P57, DOI 10.1046/j.1365-2699.2000.00339.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; Goitein SD, 1959, MUSLIM WORLD, V49, P183; Hackett C., 2012, GLOBAL RELIG LANDSCA; Held L, 2004, J COMPUT GRAPH STAT, V13, P20, DOI 10.1198/1061860043083; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Johnson TM, 2012, WORLD RELIG DATABASE; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Kull Christian A., 2009, P171, DOI 10.1007/978-3-540-77381-8_7; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Laris P, 2002, HUM ECOL, V30, P155, DOI 10.1023/A:1015685529180; Le Page Y, 2008, ATMOS CHEM PHYS, V8, P1911, DOI 10.5194/acp-8-1911-2008; Le Page Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P575, DOI 10.1111/j.1466-8238.2010.00525.x; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Oom D, 2013, INT J APPL EARTH OBS, V21, P326, DOI 10.1016/j.jag.2012.07.018; PENNER JE, 1992, SCIENCE, V256, P1432, DOI 10.1126/science.256.5062.1432; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8493, DOI 10.5194/acp-9-8493-2009; Ringwald CD, 2007, DAY APART JEWS CHRIS; Roberts G, 2009, BIOGEOSCIENCES, V6, P849, DOI 10.5194/bg-6-849-2009; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sanchez-Lorenzo A, 2012, ATMOS CHEM PHYS, V12, P5755, DOI 10.5194/acp-12-5755-2012; Schultz MG, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003031; Shaffer LJ, 2010, FIRE ECOL, V6, P43, DOI 10.4996/fireecology.0602043; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Wooster MJ, 2012, BIOGEOSCIENCES, V9, P317, DOI 10.5194/bg-9-317-2012; Xia XG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009604	41	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139189	10.1371/journal.pone.0139189	http://dx.doi.org/10.1371/journal.pone.0139189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418002	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400060
J	Rios, L; Rosas, A; Estalrrich, A; Garcia-Tabernero, A; Bastir, M; Huguet, R; Pastor, F; Sanchis-Gimeno, JA; de la Rasilla, M				Rios, Luis; Rosas, Antonio; Estalrrich, Almudena; Garcia-Tabernero, Antonio; Bastir, Markus; Huguet, Rosa; Pastor, Francisco; Sanchis-Gimeno, Juan Alberto; de la Rasilla, Marco			Possible Further Evidence of Low Genetic Diversity in the El Sidron (Asturias, Spain) Neandertal Group: Congenital Clefts of the Atlas	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; KLIPPEL-FEIL-SYNDROME; POSTERIOR ARCH; ANTERIOR ARCH; BIPARTITE ATLAS; ANTEROPOSTERIOR SPONDYLOSCHISIS; OSSIFICATION PATTERNS; DEVELOPMENTAL ANATOMY; BRIEF COMMUNICATION; CERVICAL-VERTEBRAE	We present here the first cases in Neandertals of congenital clefts of the arch of the atlas. Two atlases from El Sidron, northern Spain, present respectively a defect of the posterior (frequency in extant modern human populations ranging from 0.73% to 3.84%), and anterior (frequency in extant modern human populations ranging from 0.087% to 0.1%) arch, a condition in most cases not associated with any clinical manifestation. The fact that two out of three observable atlases present a low frequency congenital condition, together with previously reported evidence of retained deciduous mandibular canine in two out of ten dentitions from El Sidron, supports the previous observation based on genetic evidence that these Neandertals constituted a group with close genetic relations. Some have proposed for humans and other species that the presence of skeletal congenital conditions, although without clinical significance, could be used as a signal of endogamy or inbreeding. In the present case this interpretation would fit the general scenario of high incidence of rare conditions among Pleistocene humans and the specific scenariothat emerges from Neandertal paleogenetics, which points to long-term small and decreasing population size with reduced and isolated groups. Adverse environmental factors affecting early pregnancies would constitute an alternative, non-exclusive, explanation for a high incidence of congenital conditions. Further support or rejection of these interpretations will come from new genetic and skeletal evidence from Neandertal remains.	[Rios, Luis; Rosas, Antonio; Estalrrich, Almudena; Garcia-Tabernero, Antonio; Bastir, Markus] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Grp Paleoanthropol, E-28006 Madrid, Spain; [Rios, Luis] Aranzadi Soc Sci, Dept Phys Anthropol, Donostia San Sebastian, Basque Country, Spain; [Huguet, Rosa] Univ Rovira & Virgili, Area Prehist, Inst Catala Palecol Humana & Evolucio Social IPHE, Unidad Asociada,CSIC, E-43007 Tarragona, Spain; [Pastor, Francisco] Univ Valladolid, Fac Med, Dept Anat & Radiol, Museo Anat, Valladolid, Spain; [Sanchis-Gimeno, Juan Alberto] Univ Valencia, Fac Med, Dept Anat & Human Embriol, Valencia, Spain; [de la Rasilla, Marco] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Rovira i Virgili; Universidad de Valladolid; University of Valencia; University of Oviedo	Rios, L (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Grp Paleoanthropol, E-28006 Madrid, Spain.	mertibea@yahoo.com; arosas@mncn.csic.es	Huguet, Rosa/H-5713-2015; García-Tabernero, Antonio/AAQ-8382-2020; Rios, Luis/G-3533-2015; Sanchis-Gimeno, Juan A/G-9976-2015; Rosas, Antonio/D-9742-2016; Estalrrich, Almudena/ABF-1891-2020; Bastir, Markus/G-8987-2013	García-Tabernero, Antonio/0000-0001-5400-5630; Rios, Luis/0000-0002-6720-2534; Sanchis-Gimeno, Juan A/0000-0002-2599-8474; Rosas, Antonio/0000-0002-5829-9952; Estalrrich, Almudena/0000-0003-2295-5396; Bastir, Markus/0000-0002-3141-3401	Ministerio de Economia y Competitividad, Spain [CGL2012-36682, CGL2012-37279]	Ministerio de Economia y Competitividad, Spain	Funding was provided by Ministerio de Economia y Competitividad, Spain, projects CGL2012-36682 and CGL2012-37279. Convenio Principado de Asturias-Universidad de Oviedo CN-09-084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Kaissi A, 2007, EUR SPINE J, V16, pS265, DOI 10.1007/s00586-006-0297-3; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Alt KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065649; Alt KW, 1997, AM J PHYS ANTHROPOL, V102, P123, DOI 10.1002/(SICI)1096-8644(199701)102:1<123::AID-AJPA10>3.0.CO;2-2; [Anonymous], 1912, TRAITE VARIATIONS CO; [Anonymous], 2005, NEW METHOD IDENIFYIN; Atasoy C, 2002, NEURORADIOLOGY, V44, P253, DOI 10.1007/s00234-001-0740-4; Barrett CK, 2012, AM J PHYS ANTHROPOL, V149, P193, DOI 10.1002/ajpa.22107; Bastir M, 2015, J HUM EVOL, V80, P64, DOI 10.1016/j.jhevol.2014.10.008; Bastir M, 2010, J HUM EVOL, V58, P68, DOI 10.1016/j.jhevol.2009.08.006; Bittles AH, 2010, ANNU REV ANTHROPOL, V39, P193, DOI 10.1146/annurev.anthro.012809.105051; Blanco-Perez E, 2015, SPINE J, V15, P198, DOI 10.1016/j.spinee.2014.08.450; Bocquet-Appel JP, 2013, CURR ANTHROPOL, V54, pS202, DOI 10.1086/673725; CALVY TM, 1987, AM J NEURORADIOL, V8, P489; Cardoso HFV, 2011, AM J PHYS ANTHROPOL, V144, P238, DOI 10.1002/ajpa.21394; Cardoso HFV, 2009, AM J PHYS ANTHROPOL, V138, P136, DOI 10.1002/ajpa.20910; Carmichael SL, 2007, J NUTR, V137, P2087, DOI 10.1093/jn/137.9.2087; Carmichael SL, 2012, ARCH PEDIAT ADOL MED, V166, P121, DOI 10.1001/archpediatrics.2011.185; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; CHALMERS AG, 1985, BRIT J RADIOL, V58, P761, DOI 10.1259/0007-1285-58-692-761; Chernoff N, 2004, J TOXICOL ENV HEAL B, V7, P437, DOI 10.1080/10937400490512447; CHILDERS JC, 1971, J BONE JOINT SURG AM, VA 53, P578, DOI 10.2106/00004623-197153030-00015; CURRARINO G, 1994, AM J NEURORADIOL, V15, P249; de la Rasilla M RA, 2011, UNA INVESTIGACION IN; Dean MC, 2013, J HUM EVOL, V64, P678, DOI 10.1016/j.jhevol.2013.03.004; Desgrez H, 1965, J Radiol Electrol Med Nucl, V46, P819; Dilettoso S, 2012, SPINE J, V12, P449, DOI 10.1016/j.spinee.2012.03.031; Eaves-Johnson KL, 2010, FASEB J, V24; Estalrrich A, 2015, J HUM EVOL, V80, P51, DOI 10.1016/j.jhevol.2014.07.007; Estalrrich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062797; Fabre V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005151; FARMAN AG, 1979, J ANAT, V128, P595; Galis F, 2006, EVOLUTION, V60, P2643; Ganau Mario, 2013, J Emerg Trauma Shock, V6, P47, DOI 10.4103/0974-2700.106325; Garg A, 2004, SPINE, V29, pE35, DOI 10.1097/01.BRS.0000106487.89648.88; GEHWEILER JA, 1976, SKELETAL RADIOL, V1, P97, DOI 10.1007/BF00347414; GEIPEL P, 1955, Zentralbl Allg Pathol, V94, P19; Gomez-Olivencia A., 2013, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V25, P19, DOI 10.1007/s13219-012-0064-4; Gomez-Olivencia A, 2007, J HUM EVOL, V53, P6, DOI 10.1016/j.jhevol.2006.12.006; Gomez-Olivencia A, 2013, J HUM EVOL, V64, P582, DOI 10.1016/j.jhevol.2013.02.006; Gomez-Olivencia A, 2013, J HUM EVOL, V64, P608, DOI 10.1016/j.jhevol.2013.02.008; Gonzalez-Reimers E, 2001, ANN RHEUM DIS, V60, P174; Guatelli-Steinberg D, 2004, J HUM EVOL, V47, P65, DOI 10.1016/j.jhevol.2004.05.004; Guenkel S, 2013, RADIOL RES PRACT, V2013, DOI 10.1155/2013/957280; HAAKONSEN M, 1995, ACTA ORTHOP SCAND, V66, P369, DOI 10.3109/17453679508995564; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Holliday TW, 2014, CURR ANTHROPOL, V55, P696, DOI 10.1086/679068; Hu Y, 2014, J SPINAL DISORD TECH, V27, pE219, DOI 10.1097/BSD.0b013e31829a36c5; Hu Y, 2009, SPINE, V34, pE418, DOI 10.1097/BRS.0b013e3181a0ff2f; Hummel E, 2013, SPINE J, V13, pE1, DOI 10.1016/j.spinee.2013.01.024; Jans Christophe, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.04.2009.1824; Jefferson G, 1920, BRIT J SURG, V7, P407; Jin M, 2014, SPINE J, V14, P1155, DOI 10.1016/j.spinee.2013.07.482; Junewick JJ, 2011, AM J ROENTGENOL, V197, P1229, DOI 10.2214/AJR.10.5403; Karwacki GM, 2012, AM J NEURORADIOL, V33, P1882, DOI 10.3174/ajnr.A3105; Klimo P, 2003, SPINE, V28, pE224, DOI 10.1097/00007632-200306150-00023; Kwon JK, 2009, J KOREAN NEUROSURG S, V46, P522, DOI 10.3340/jkns.2009.46.6.522; Lalueza-Fox C, 2012, QUATERN INT, V247, P10, DOI 10.1016/j.quaint.2010.10.012; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; LANDELLS CD, 1988, SPINE, V13, P450, DOI 10.1097/00007632-198805000-00002; Le Minor J. M., 1991, Archives d'Anatomie d'Histologie et d'Embryologie, V74, P11; LEE C, 1991, AM J NEURORADIOL, V12, P1105; Leonardi R, 2009, ANGLE ORTHOD, V79, P727, DOI 10.2319/082408-448.1; LEVINE AM, 1991, J BONE JOINT SURG AM, V73A, P680, DOI 10.2106/00004623-199173050-00006; LIPSON SJ, 1978, J BONE JOINT SURG AM, V60, P1104, DOI 10.2106/00004623-197860080-00016; MARTICH V, 1992, RADIOLOGY, V183, P125, DOI 10.1148/radiology.183.1.1532260; Martirosyan NL, 2011, NEUROSURGERY, V69, pE1317, DOI 10.1227/NEU.0b013e31822a9ab1; Menezes AH, 2008, CHILD NERV SYST, V24, P1109, DOI 10.1007/s00381-008-0600-1; Merbs CF, 2004, AM J PHYS ANTHROPOL, V123, P236, DOI 10.1002/ajpa.10264; Muthu SK, 2007, EMERG RADIOL, V13, P337, DOI 10.1007/s10140-006-0565-x; OGDEN JA, 1984, SKELETAL RADIOL, V12, P12, DOI 10.1007/BF00373169; Ogilvie MD, 1998, J HUM EVOL, V35, P597, DOI 10.1006/jhev.1998.0249; OGILVIE MD, 1989, AM J PHYS ANTHROPOL, V79, P25, DOI 10.1002/ajpa.1330790104; Osher SJ, 2004, BRIT J ORAL MAX SURG, V42, P270, DOI 10.1016/j.bjoms.2004.01.006; Osti Michael, 2006, Eur Spine J, V15 Suppl 5, P564, DOI 10.1007/s00586-005-0017-4; PALMA A, 1990, Archivio Italiano di Anatomia e di Embriologia, V95, P11; Pang D, 2014, PEDIATRIC CRANIOVERT, P19; Park JS, 2011, SPINE, V36, pE144, DOI 10.1097/BRS.0b013e3181efa320; Pascual-Gallego M, 2014, NEUROCIRUGIA, V25, P29, DOI 10.1016/j.neucir.2012.10.002; Pena-Melian A, 2011, ANAT REC, V294, P1370, DOI 10.1002/ar.21427; Petraglia Anthony L, 2012, Surg Neurol Int, V3, P126, DOI 10.4103/2152-7806.102351; Petre BM, 2012, ORTHOPEDICS, V35, pE1449, DOI 10.3928/01477447-20120822-39; Piatt JH, 2011, J NEUROSURG-PEDIATR, V8, P235, DOI 10.3171/2011.6.PEDS11187; Popat H, 2008, BRIT DENT J, V204, P303, DOI 10.1038/bdj.2008.199; Prempeh RC, 2002, SPINAL CORD, V40, P92, DOI 10.1038/sj.sc.3101230; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Radov~ci J., 1988, KRAPINA HOMINIDS ILL; Raikkonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067218; Rao RD, 2013, J BONE JOINT SURG AM, V95A, P1605, DOI 10.2106/JBJS.L.01035; Reumer JWF, 2014, PEERJ, V2, DOI 10.7717/peerj.318; Rios L, 2007, JORNADES ANTROPOLOGI, P12; Rios L, 2010, FORENSIC SCI INT, V199, pE27, DOI 10.1016/j.forsciint.2010.02.023; Rogers SA, 2011, ANGLE ORTHOD, V81, P350, DOI 10.2319/032210-165.1; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Rosas A, 2015, J HUM EVOL, V82, P51, DOI 10.1016/j.jhevol.2015.02.018; Rosas A, 2013, CR PALEVOL, V12, P279, DOI 10.1016/j.crpv.2013.06.003; Rosas A, 2012, ANTHROPOLOGIE, V116, P57, DOI 10.1016/j.anthro.2011.12.003; Sanchez-Quinto F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0374; Sanchis-Gimeno JA, 2014, FORENSIC SCI INT, V242, pE1, DOI 10.1016/j.forsciint.2014.06.016; Sanchis-Gimeno JA, 2011, EUR SPINE J, V20, P1574, DOI 10.1007/s00586-011-1715-8; SANDHAM A, 1986, CLEFT PALATE J, V23, P206; Sasaka KK, 2006, EMERG RADIOL, V12, P130, DOI 10.1007/s10140-005-0455-7; SAUNDERS SR, 1978, AM J PHYS ANTHROPOL, V49, P193, DOI 10.1002/ajpa.1330490207; Scheuer L., 2000, DEV JUVENIL OSTEOLOG; Schrodel MH, 2005, EMERG MED J, V22, P526, DOI 10.1136/emj.2003.006759; SEGAL LS, 1987, J BONE JOINT SURG AM, V69A, P1423; Selby S, 1955, AM J PHYS ANTHROP-NE, V13, P129, DOI 10.1002/ajpa.1330130110; Senoglu M, 2007, J NEUROSURG-SPINE, V7, P399, DOI 10.3171/SPI-07/10/399; Sholts SB, 2010, AM J PHYS ANTHROPOL, V143, P155, DOI 10.1002/ajpa.21343; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; Tyrrell AJ, 2004, INT J OSTEOARCHAEOL, V14, P52, DOI 10.1002/oa.712; Ugar DA, 2001, CLEFT PALATE-CRAN J, V38, P498, DOI 10.1597/1545-1569_2001_038_0498_tpoaot_2.0.co_2; WALKER J, 1995, ACTA RADIOL, V36, P152; Wang SL, 2010, EUR SPINE J, V19, P361, DOI 10.1007/s00586-009-1208-1; Wasterlain SN, 2016, INT J OSTEOARCHAEOL, V26, P621, DOI 10.1002/oa.2453; Wolf RFE, 1997, SURG RADIOL ANAT, V19, P339, DOI 10.1007/BF01637605; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x; Wu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059587; Yang J, 2008, AM J EPIDEMIOL, V167, P145, DOI 10.1093/aje/kwm283	119	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0136550	10.1371/journal.pone.0136550	http://dx.doi.org/10.1371/journal.pone.0136550			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418427	gold, Green Submitted, Green Published			2022-12-26	WOS:000362171400003
J	Welge, WA; Barton, JK				Welge, Weston A.; Barton, Jennifer K.			Expanding Functionality of Commercial Optical Coherence Tomography Systems by Integrating a Custom Endoscope	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; ULTRAHIGH-RESOLUTION; DISPERSION COMPENSATION; NEEDLE PROBE; HIGH-SPEED; ENDOMICROSCOPY; CATHETER; BIOPSY; CANCER; COLON	Optical coherence tomography (OCT) is a useful imaging modality for detecting and monitoring diseases of the gastrointestinal tract and other tubular structures. The non-destructiveness of OCT enables time-serial studies in animal models. While turnkey commercial research OCT systems are plenty, researchers often require custom imaging probes. We describe the integration of a custom endoscope with a commercial swept-source OCT system and generalize this description to any imaging probe and OCT system. A numerical dispersion compensation method is also described. Example images demonstrate that OCT can visualize the mouse colon crypt structure and detect adenoma in vivo.	[Welge, Weston A.; Barton, Jennifer K.] Univ Arizona, Ctr Opt Sci, Tucson, AZ 85721 USA; [Barton, Jennifer K.] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA	University of Arizona; University of Arizona	Welge, WA (corresponding author), Univ Arizona, Ctr Opt Sci, Tucson, AZ 85721 USA.	wwelge@email.arizona.edu; barton@email.arizona.edu			National Cancer Institute [R01CA109385]; National Heart, Lung, and Blood Institute of the National Institutes of Health [T32HL007955]; American Society for Laser Medicine and Surgery Student Research Grant; NATIONAL CANCER INSTITUTE [R01CA109385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007955] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society for Laser Medicine and Surgery Student Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Cancer Institute (cancer.gov) and the National Heart, Lung, and Blood Institute (nhlbi.nih.gov) of the National Institutes of Health under award numbers R01CA109385 (JKB) and T32HL007955 (WAW), respectively, and the American Society for Laser Medicine and Surgery (aslms.org) Student Research Grant (WAW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DC, 2007, NAT PHOTONICS, V1, P709, DOI 10.1038/nphoton.2007.228; Alrawi SJ, 2006, ANTICANCER RES, V26, P107; Bonnema GT, 2009, J BIOPHOTONICS, V2, P353, DOI 10.1002/jbio.200910024; Cense B, 2004, OPT EXPRESS, V12, P2435, DOI 10.1364/OPEX.12.002435; Choi HY, 2008, OPT LETT, V33, P34, DOI 10.1364/OL.33.000034; Drexler W, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071412; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Fercher AF, 2002, OPT COMMUN, V204, P67, DOI 10.1016/S0030-4018(02)01137-9; Hadri LP, 2007, CANCER BIOL THER, V6, P1753, DOI 10.4161/cbt.6.11.4852; Hatta W, 2012, GASTROINTEST ENDOSC, V76, P548, DOI 10.1016/j.gie.2012.05.012; Herz PR, 2004, OPT EXPRESS, V12, P3532, DOI 10.1364/OPEX.12.003532; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Keenan MR, 2015, LASER SURG MED, V47, P30, DOI 10.1002/lsm.22307; Lorenser D, 2011, OPT LETT, V36, P3894, DOI 10.1364/OL.36.003894; Marks DL, 2003, APPL OPTICS, V42, P204, DOI 10.1364/AO.42.000204; Quirk BC, 2014, OPT LETT, V39, P2888, DOI 10.1364/OL.39.002888; Reed WA, 2002, OPT LETT, V27, P1794, DOI 10.1364/OL.27.001794; Suter MJ, 2014, GASTROINTEST ENDOSC, V79, P886, DOI 10.1016/j.gie.2013.11.016; Swanson E, 2014, P SOC PHOTO-OPT INS, V8934, DOI [10.1117/12.2064185, DOI 10.1117/12.2064185]; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tearney GJ, 1996, OPT LETT, V21, P543, DOI 10.1364/OL.21.000543; Tsai TH, 2014, BIOMED OPT EXPRESS, V5, P4387, DOI 10.1364/BOE.5.004387; Tsai TH, 2013, BIOMED OPT EXPRESS, V4, P1119, DOI 10.1364/BOE.4.001119; Tumlinson AR, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2399454; Welge WA, 2013, PROC SPIE, V8575, DOI 10.1117/12.2002655; Winkler AM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3446674; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Xie Yijing, 2014, Front Neuroeng, V7, P34, DOI 10.3389/fneng.2014.00034; Zhang N, 2014, OPT LETT, V39, P186, DOI 10.1364/OL.39.000186; Zhao MT, 2012, OPT LETT, V37, P4835, DOI 10.1364/OL.37.004835; Zhou C, 2012, GASTROINTEST ENDOSC, V76, P32, DOI 10.1016/j.gie.2012.02.003	31	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139396	10.1371/journal.pone.0139396	http://dx.doi.org/10.1371/journal.pone.0139396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418811	gold, Green Submitted, Green Published			2022-12-26	WOS:000362171400087
J	Wallen, MC; Gaj, T; Barbas, CF				Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III			Redesigning Recombinase Specificity for Safe Harbor Sites in the Human Genome	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DNA-SEQUENCE SPECIFICITY; GAMMA-DELTA-RESOLVASE; HUMAN-CELLS; DIRECTED EVOLUTION; SERINE RECOMBINASE; STAPHYLOCOCCUS-AUREUS; CHIMERIC NUCLEASES; MAMMALIAN GENOMES; CRYSTAL-STRUCTURE	Site-specific recombinases (SSRs) are valuable tools for genetic engineering due to their ability to manipulate DNA in a highly specific manner. Engineered zinc-finger and TAL effector recombinases, in particular, are two classes of SSRs composed of custom-designed DNA-binding domains fused to a catalytic domain derived from the resolvase/invertase family of serine recombinases. While TAL effector and zinc-finger proteins can be assembled to recognize a wide range of possible DNA sequences, recombinase catalytic specificity has been constrained by inherent base requirements present within each enzyme. In order to further expand the targeted recombinase repertoire, we used a genetic screen to isolate enhanced mutants of the Bin and Tn21 recombinases that recognize target sites outside the scope of other engineered recombinases. We determined the specific base requirements for recombination by these enzymes and demonstrate their potential for genome engineering by selecting for variants capable of specifically recombining target sites present in the human CCR5 gene and the AAVS1 safe harbor locus. Taken together, these findings demonstrate that complementing functional characterization with protein engineering is a potentially powerful approach for generating recombinases with expanded targeting capabilities.	[Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wallen, MC (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	mcwallen@scripps.edu			National Institutes of Health [DP1 CA174426]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (Pioneer Award DP1 CA174426 to C.F.B.) and The Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100; Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2014, METHOD ENZYMOL, V546, P79, DOI 10.1016/B978-0-12-801185-0.00004-0; Gaj T, 2014, J AM CHEM SOC, V136, P5047, DOI 10.1021/ja4130059; Gaj T, 2014, BIOTECHNOL BIOENG, V111, P1, DOI 10.1002/bit.25096; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071; Gaj T, 2011, P NATL ACAD SCI USA, V108, P498, DOI 10.1073/pnas.1014214108; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Gersbach CA, 2010, NUCLEIC ACIDS RES, V38, P4198, DOI 10.1093/nar/gkq125; GLASGOW AC, 1989, J BIOL CHEM, V264, P10072; Gordley RM, 2007, J MOL BIOL, V367, P802, DOI 10.1016/j.jmb.2007.01.017; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAHMANN R, 1985, CELL, V41, P771, DOI 10.1016/S0092-8674(85)80058-1; Keenholtz RA, 2011, STRUCTURE, V19, P799, DOI 10.1016/j.str.2011.03.017; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Kolb AF, 2005, TRENDS BIOTECHNOL, V23, P399, DOI 10.1016/j.tibtech.2005.06.005; KRASNOW MA, 1983, CELL, V32, P1313, DOI 10.1016/0092-8674(83)90312-4; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; NEWMAN BJ, 1984, CELL, V38, P463, DOI 10.1016/0092-8674(84)90501-4; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Proudfoot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019537; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ritacco CJ, 2013, NUCLEIC ACIDS RES, V41, P2673, DOI 10.1093/nar/gks1303; ROGOWSKY P, 1985, EMBO J, V4, P2135, DOI 10.1002/j.1460-2075.1985.tb03904.x; ROJO F, 1995, NUCLEIC ACIDS RES, V23, P3181, DOI 10.1093/nar/23.16.3181; Rowland SJ, 2009, MOL MICROBIOL, V74, P282, DOI 10.1111/j.1365-2958.2009.06756.x; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; Rowland SJ, 2002, MOL MICROBIOL, V44, P607, DOI 10.1046/j.1365-2958.2002.02897.x; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Schneider F, 2000, J MOL BIOL, V295, P767, DOI 10.1006/jmbi.1999.3412; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Segal DJ, 2004, J BIOL CHEM, V279, P14509, DOI 10.1074/jbc.M400349200; Sirk SJ, 2014, NUCLEIC ACIDS RES, V42, P4755, DOI 10.1093/nar/gkt1389; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WELLS RG, 1984, J MOL BIOL, V179, P667, DOI 10.1016/0022-2836(84)90161-X; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	67	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139123	10.1371/journal.pone.0139123	http://dx.doi.org/10.1371/journal.pone.0139123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414179	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700044
J	Yakimovich, A; Andriasyan, V; Witte, R; Wang, IH; Prasad, V; Suomalainen, M; Greber, UF				Yakimovich, Artur; Andriasyan, Vardan; Witte, Robert; Wang, I-Hsuan; Prasad, Vibhu; Suomalainen, Maarit; Greber, Urs F.			Plaque2.0-A High-Throughput Analysis Framework to Score Virus-Cell Transmission and Clonal Cell Expansion	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN ADENOVIRUS; HUMAN RHINOVIRUS; IN-VITRO; RECEPTOR; SPREAD; ENTRY; INTEGRINS; MECHANISM; VIVO	Classical plaque assay measures the propagation of infectious agents across a monolayer of cells. It is dependent on cell lysis, and limited by user-specific settings and low throughput. Here, we developed Plaque2.0, a broadly applicable, fluorescence microscopy-based high-throughput method to mine patho-biological clonal cell features. Plaque2.0 is an open source framework to extract information from chemically fixed cells by immuno-histochemistry or RNA in situ hybridization, or from live cells expressing GFP transgene. Multi-parametric measurements include infection density, intensity, area, shape or location information at single plaque or population levels. Plaque2.0 distinguishes lytic and non-lytic spread of a variety of DNA and RNA viruses, including vaccinia virus, adenovirus and rhinovirus, and can be used to visualize simultaneous plaque formation from co-infecting viruses. Plaque2.0 also analyzes clonal growth of cancer cells, which is relevant for cell migration and metastatic invasion studies. Plaque2.0 is suitable to quantitatively analyze virus infections, vector properties, or cancer cell phenotypes.	[Yakimovich, Artur; Andriasyan, Vardan; Witte, Robert; Wang, I-Hsuan; Prasad, Vibhu; Suomalainen, Maarit; Greber, Urs F.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Greber, UF (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	urs.greber@imls.uzh.ch	Prasad, Vibhu/AAG-8493-2020; Prasad, Vibhu Ranjan/E-6107-2011; Wang, I-Hsuan/AAC-1200-2019; Yakimovich, Artur/AAA-5565-2020; Greber, Urs/G-9458-2015	Prasad, Vibhu/0000-0001-7450-607X; Wang, I-Hsuan/0000-0003-2159-7347; Yakimovich, Artur/0000-0003-2458-4904; Greber, Urs/0000-0003-2278-120X	Swiss National Science Foundation [31003A_141222/1, 310030B_160316]; Medical Research and Development project VirX from SystemsX.ch; Novartis Foundation; Kanton Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research and Development project VirX from SystemsX.ch; Novartis Foundation(Novartis); Kanton Zurich	Funding was obtained from the Swiss National Science Foundation (31003A_141222/1 and 310030B_160316 to UFG), the Medical Research and Development project VirX from SystemsX.ch (to UFG), the Novartis Foundation, and the Kanton Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigas M, 2006, MICROELECTRON J, V37, P433, DOI 10.1016/j.mejo.2005.07.002; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cordeiro JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008506; D'Herelle F., 1926, NATURE, V118, P183, DOI [10.1038/118183a0, DOI 10.1038/118183A0]; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Doronin K, 2003, VIROLOGY, V305, P378, DOI 10.1006/viro.2002.1772; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Dziedzic K, 2014, SEMIN CELL DEV BIOL, V36, P57, DOI 10.1016/j.semcdb.2014.08.003; Edlmayr J, 2011, EUR RESPIR J, V37, P44, DOI 10.1183/09031936.00149109; Flatt JW, 2015, CELLS-BASEL, V4, P277, DOI 10.3390/cells4030277; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Greber UF, 2007, CELL HOST MICROBE, V2, P143, DOI 10.1016/j.chom.2007.08.004; Helmuth JA, 2009, J STRUCT BIOL, V167, P1, DOI 10.1016/j.jsb.2009.03.017; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Jurgeit A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-264; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; LAUTER CB, 1974, ANTIMICROB AGENTS CH, V6, P598, DOI 10.1128/AAC.6.5.598; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Lutschg V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1391; Luisoni S, 2015, CELL HOST MICROBE, V18, P75, DOI 10.1016/j.chom.2015.06.006; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; Merilahti P, 2012, ADV VIROL, V2012, DOI 10.1155/2012/547530; Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nagel H, 2003, GENE THER, V10, P1643, DOI 10.1038/sj.gt.3302058; Nichol PF, 1996, J VIROL, V70, P5476, DOI 10.1128/JVI.70.8.5476-5486.1996; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Prasad V, 2014, J VIROL, V88, P13086, DOI 10.1128/JVI.02156-14; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Roulin PS, 2014, CELL HOST MICROBE, V16, P677, DOI 10.1016/j.chom.2014.10.003; Sanderson CM, 1998, J GEN VIROL, V79, P1415, DOI 10.1099/0022-1317-79-6-1415; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schumann M, 2006, CANCER RES, V66, P1282, DOI 10.1158/0008-5472.CAN-05-1484; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Suomalainen M, 2013, CURR OPIN VIROL, V3, P27, DOI 10.1016/j.coviro.2012.12.004; Wang XM, 2006, J IMMUNOL, V177, P6859, DOI 10.4049/jimmunol.177.10.6859; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Wolfrum N, 2013, CELL MICROBIOL, V15, P53, DOI 10.1111/cmi.12053; Yakimovich A, 2012, J VIROL, V86, P10123, DOI 10.1128/JVI.01102-12; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu YZ, 2014, WORLD J GASTROENTERO, V20, P3457, DOI 10.3748/wjg.v20.i13.3457	62	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138760	10.1371/journal.pone.0138760	http://dx.doi.org/10.1371/journal.pone.0138760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413745	gold, Green Published, Green Accepted			2022-12-26	WOS:000362170700021
J	Cha, SB; Jeon, BY; Kim, WS; Kim, JS; Kim, HM; Kwon, KW; Cho, SN; Shin, SJ; Koh, WJ				Cha, Seung Bin; Jeon, Bo Young; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hong Min; Kwon, Kee Woong; Cho, Sang-Nae; Shin, Sung Jae; Koh, Won-Jung			Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LATENT TUBERCULOSIS; TUBERCLE-BACILLI; THERAPY; DISEASE; DIFFERENTIATION; SUSCEPTIBILITY; PERSISTENCE; DIAGNOSIS; RISK	The latency and reactivation of Mycobacterium tuberculosis infection has been well studied. However, there have been few studies of the latency and reactivation of Mycobacterium avium complex (MAC), the most common etiological non-tuberculous Mycobacterium species next to M. tuberculosis in humans worldwide. We hypothesized that latent MAC infections can be reactivated following immunosuppression after combination chemotherapy with clarithromycin and rifampicin under experimental conditions. To this end, we employed a modified Cornell-like murine model of tuberculosis and investigated six strains consisting of two type strains and four clinical isolates of M. avium and M. intracellulare. After aerosol infection of each MAC strain, five to six mice per group were euthanized at 2, 4, 10, 18, 28 and 35 weeks post-infection, and lungs were sampled to analyze bacterial burden and histopathology. One strain of each species maintained a culture-negative state for 10 weeks after completion of 6 weeks of chemotherapy, but was reactivated after 5 weeks of immunosuppression in the lungs with dexamethasone (three out of six mice in M. avium infection) or sulfasalazine (four out of six mice in both M. avium and M. intracellulare infection). The four remaining MAC strains exhibited decreased bacterial loads in response to chemotherapy; however, they remained at detectable levels and underwent regrowth after immunosuppression. In addition, the exacerbated lung pathology demonstrated a correlation with bacterial burden after reactivation. In conclusion, our results suggest the possibility of MAC reactivation in an experimental mouse model, and experimentally demonstrate that a compromised immune status can induce reactivation and/or regrowth of MAC infection.	[Cha, Seung Bin; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hong Min; Kwon, Kee Woong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea; [Jeon, Bo Young] Yonsei Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Wonju, South Korea; [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea.	sjshin@yuhs.ac; wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011	Koh, Won-Jung/0000-0002-4756-3527; Shin, Sung Jae/0000-0003-0854-4582	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120647]; Basic Science Research Program through the Ministry of Science, ICT, and Future Planning [NRF-2013R1A2A1A01009932]; Samsung Medical Center	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; Basic Science Research Program through the Ministry of Science, ICT, and Future Planning; Samsung Medical Center(Samsung)	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A120647) and the Basic Science Research Program through the Ministry of Science, ICT, and Future Planning (NRF-2013R1A2A1A01009932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Samsung Medical Center provided support in the form of salary for the author Won-Jung Koh, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Bussone G, 2012, J INFECTION, V64, P613, DOI 10.1016/j.jinf.2011.12.020; Cardona PJ, 1999, SCAND J IMMUNOL, V49, P362; CLSI, 2011, CONTRACT NO CLSI DOC; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Fukunaga H, 2002, AM J RESP CRIT CARE, V166, P994, DOI 10.1164/rccm.2111028; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Guide SV, 2002, INFECT DIS CLIN N AM, V16, P163, DOI 10.1016/S0891-5520(03)00051-5; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kendall BA, 2013, SEMIN RESP CRIT CARE, V34, P87, DOI 10.1055/s-0033-1333567; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; LAMBRECHT RS, 1988, APPL ENVIRON MICROB, V54, P910, DOI 10.1128/AEM.54.4.910-916.1988; Lee SK, 2013, LUNG, V191, P565, DOI 10.1007/s00408-013-9481-5; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Maslow JN, 2003, J INFECT DIS, V187, P1748, DOI 10.1086/374985; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; Reed C, 2006, AM J EPIDEMIOL, V164, P32, DOI 10.1093/aje/kwj159; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Sexton P, 2008, EUR RESPIR J, V31, P1322, DOI 10.1183/09031936.00140007; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; Taga S., 2014, JMM CASE REP, V1, P1, DOI [10.1099/jmmcr.0.000935, DOI 10.1099/JMMCR.0.000935]; Torrelles JB, 2002, TUBERCULOSIS, V82, P293, DOI 10.1054/tube.2002.0373; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; van Ingen J, 2012, AM J RESP CRIT CARE, V186, P559, DOI 10.1164/rccm.201204-0682OC; Wallace RJ, 2014, CHEST, V146, P276, DOI 10.1378/chest.13-2538; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Yoo JW, 2014, EUR RESPIR J, V44, P1289, DOI 10.1183/09031936.00063514	35	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139251	10.1371/journal.pone.0139251	http://dx.doi.org/10.1371/journal.pone.0139251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406237	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700198
J	Cheng, C; MacIntyre, L; Abdelmohsen, UR; Horn, H; Polymenakou, PN; Edrada-Ebel, R; Hentschel, U				Cheng, Cheng; MacIntyre, Lynsey; Abdelmohsen, Usama Ramadan; Horn, Hannes; Polymenakou, Paraskevi N.; Edrada-Ebel, RuAngelie; Hentschel, Ute			Biodiversity, Anti-Trypanosomal Activity Screening, and Metabolomic Profiling of Actinomycetes Isolated from Mediterranean Sponges	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; MASS-SPECTROMETRY; NATURAL-PRODUCTS; POLY(ADP-RIBOSE) SYNTHETASE; ANTIMYCOBACTERIAL PEPTIDES; DEREPLICATION STRATEGIES; ANTIMICROBIAL ACTIVITIES; EPOXYDON GROUP; TERREIC ACID	Marine sponge-associated actinomycetes are considered as promising sources for the discovery of novel biologically active compounds. In the present study, a total of 64 actinomycetes were isolated from 12 different marine sponge species that had been collected offshore the islands of Milos and Crete, Greece, eastern Mediterranean. The isolates were affiliated to 23 genera representing 8 different suborders based on nearly full length 16S rRNA gene sequencing. Four putatively novel species belonging to genera Geodermatophilus, Microlunatus, Rhodococcus and Actinomycetospora were identified based on a 16S rRNA gene sequence similarity of < 98.5% to currently described strains. Eight actinomycete isolates showed bioactivities against Trypanosma brucei brucei TC221 with half maximal inhibitory concentration (IC50) values <20 mu g/mL. Thirty four isolates from the Milos collection and 12 isolates from the Crete collection were subjected to metabolomic analysis using high resolution LC-MS and NMR for dereplication purposes. Two isolates belonging to the genera Streptomyces (SBT348) and Micromonospora (SBT687) were prioritized based on their distinct chemistry profiles as well as their anti-trypanosomal activities. These findings demonstrated the feasibility and efficacy of utilizing metabolomics tools to prioritize chemically unique strains from microorganism collections and further highlight sponges as rich source for novel and bioactive actinomycetes.	[Cheng, Cheng; Abdelmohsen, Usama Ramadan; Horn, Hannes; Hentschel, Ute] Univ Wurzburg, Dept Bot 2, Julius von Sachs Inst Biol Sci, D-97070 Wurzburg, Germany; [MacIntyre, Lynsey; Edrada-Ebel, RuAngelie] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Polymenakou, Paraskevi N.] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece	University of Wurzburg; University of Strathclyde; Hellenic Centre for Marine Research	Edrada-Ebel, R (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	ruangelie.edrada-ebel@strath.ac.uk; ute.hentschel@uni-wuerzburg.de	Polymenakou, Paraskevi/AAW-5313-2020; Abdelmohsen, Usama Ramadan/AAX-9874-2020; Hentschel, Ute/H-8343-2013; Hentschel, Ute/ABD-6624-2021; Edrada-Ebel, RuAngelie/G-6127-2015	Abdelmohsen, Usama Ramadan/0000-0002-1014-6922; Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X; Edrada-Ebel, RuAngelie/0000-0003-2420-1117; Horn, Hannes/0000-0003-0324-5241	SeaBioTech - European Commission [KBBE.2012.3.2-01, 311932]	SeaBioTech - European Commission	This work was supported by SeaBioTech, funded by the European Commission within its FP7 Programme, under the thematic area KBBE.2012.3.2-01 with Grant Number 311932 (http://spider.science.strath.ac.uk/seabiotech/).	Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Abdelmohsen UR, 2012, MAR DRUGS, V10, P2208, DOI 10.3390/md10102208; Abdelmohsen UR, 2012, TETRAHEDRON LETT, V53, P23, DOI 10.1016/j.tetlet.2011.10.051; Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AOYAGI T, 1988, J ANTIBIOT, V41, P1009, DOI 10.7164/antibiotics.41.1009; Balskus EP, 2014, NAT CHEM BIOL, V10, P611, DOI 10.1038/nchembio.1588; Cain R B, 1968, Antonie Van Leeuwenhoek, V34, P17; Chagas-Paula DA, 2015, METABOLITES, V5, P404, DOI 10.3390/metabo5030404; DANDO PR, 1995, CONT SHELF RES, V15, P913, DOI 10.1016/0278-4343(95)80002-U; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELSTNER EF, 1973, BIOCHEMISTRY-US, V12, P4992, DOI 10.1021/bi00748a027; Eltamany EE, 2014, BIOORG MED CHEM LETT, V24, P4939, DOI 10.1016/j.bmcl.2014.09.040; Forner D, 2013, ANAL CHIM ACTA, V805, P70, DOI 10.1016/j.aca.2013.10.029; Gao SS, 2011, MAR DRUGS, V9, P59, DOI 10.3390/md9010059; GHIRINGHELLI D, 1981, BIOMED MASS SPECTROM, V8, P155, DOI 10.1002/bms.1200080405; Grkovic T, 2014, BIOORG MED CHEM LETT, V24, P5089, DOI 10.1016/j.bmcl.2014.08.068; Guo CJ, 2014, ORG LETT, V16, P5250, DOI 10.1021/ol502242a; Gutierrez-Lugo MT, 2005, NAT PROD RES, V19, P645, DOI 10.1080/14786410412331272040; Han HJ, 2010, BIOCHEMISTRY-US, V49, P4276, DOI 10.1021/bi100365b; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; HURLEY LH, 1979, ANTIMICROB AGENTS CH, V15, P42, DOI 10.1128/AAC.15.1.42; Igarashi Y, 2009, J NAT PROD, V72, P980, DOI 10.1021/np9000575; Iwatsuki M, 2007, J ANTIBIOT, V60, P357, DOI 10.1038/ja.2007.48; Iwatsuki M, 2006, J AM CHEM SOC, V128, P7486, DOI 10.1021/ja056780z; Kampfer P, 2015, INT J SYST EVOL MICR, V65, P879, DOI 10.1099/ijs.0.000031; Kampfer P, 2014, INT J SYST EVOL MICR, V64, P705, DOI 10.1099/ijs.0.055152-0; Kawakami Y, 1999, P NATL ACAD SCI USA, V96, P2227, DOI 10.1073/pnas.96.5.2227; Kunz AL, 2014, MAR DRUGS, V12, P1699, DOI 10.3390/md12041699; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li CS, 2013, MAR DRUGS, V11, P3068, DOI 10.3390/md11083068; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li K, 2011, MAR DRUGS, V9, P690, DOI 10.3390/md9050690; Li YF, 2000, TETRAHEDRON LETT, V41, P5181, DOI 10.1016/S0040-4039(00)00772-3; Macintyre L, 2014, MAR DRUGS, V12, P3416, DOI 10.3390/md12063416; Martens T, 2007, MICROB ECOL, V54, P31, DOI 10.1007/s00248-006-9165-2; Martinez-Luis S, 2012, MOLECULES, V17, P11146, DOI 10.3390/molecules170911146; Mincer TJ, 2005, APPL ENVIRON MICROB, V71, P7019, DOI 10.1128/AEM.71.11.7019-7028.2005; NOBLE M, 1977, J ANTIBIOT, V30, P455, DOI 10.7164/antibiotics.30.455; Olson JB, 2000, MICROBIAL ECOL, V40, P139; ORLOVA TI, 1973, ANTIBIOT MED BIOTEK, V18, P500; Pabel CT, 2003, MAR BIOTECHNOL, V5, P424, DOI 10.1007/s10126-002-0088-8; Polymenakou PN, 2009, SYST APPL MICROBIOL, V32, P17, DOI 10.1016/j.syapm.2008.09.006; Proksch P, 2002, APPL MICROBIOL BIOT, V59, P125, DOI 10.1007/s00253-002-1006-8; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; READ G, 1969, CAN J BIOCHEM CELL B, V47, P1071, DOI 10.1139/o69-171; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; REDDY GCS, 1984, J ANTIBIOT, V37, P1596, DOI 10.7164/antibiotics.37.1596; Roue M, 2012, NAT PROD REP, V29, P739, DOI 10.1039/c2np20040f; Santos-Gandelman JF, 2014, CURR PHARM BIOTECHNO, V15, P143, DOI 10.2174/1389201015666140711115033; SEKIGUCHI J, 1978, BIOCHEMISTRY-US, V17, P1785, DOI 10.1021/bi00602a033; SEKIGUCHI J, 1979, CAN J MICROBIOL, V25, P881, DOI 10.1139/m79-131; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stinchi S, 2003, FEMS MICROBIOL LETT, V225, P53, DOI 10.1016/S0378-1097(03)00490-7; Sugiyama Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2731, DOI 10.1271/bbb.90636; Tawfike AF, 2013, METHODS MOL BIOL, V1055, P227, DOI 10.1007/978-1-62703-577-4_17; Terui Y, 2008, BIOORG MED CHEM LETT, V18, P6321, DOI 10.1016/j.bmcl.2008.10.104; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Viegelmann C, 2014, MAR DRUGS, V12, P3323, DOI 10.3390/md12063323; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; YOSHIDA S, 1988, J ANTIBIOT, V41, P1015, DOI 10.7164/antibiotics.41.1015; Yuliana ND, 2011, PHYTOTHER RES, V25, P157, DOI 10.1002/ptr.3258; Zhang HT, 2006, INT J SYST EVOL MICR, V56, P2309, DOI 10.1099/ijs.0.64217-0; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	72	33	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138528	10.1371/journal.pone.0138528	http://dx.doi.org/10.1371/journal.pone.0138528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407167	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000361800700055
J	Chi, PC; Bulage, P; Urdal, H; Sundby, J				Chi, Primus Che; Bulage, Patience; Urdal, Henrik; Sundby, Johanne			Barriers in the Delivery of Emergency Obstetric and Neonatal Care in Post-Conflict Africa: Qualitative Case Studies of Burundi and Northern Uganda	PLOS ONE			English	Article							MATERNAL MORTALITY; HEALTH-SERVICES; ARMED CONFLICT; AVAILABILITY; IMPACT; DISTRICT; ACCESS; WOMEN; KENYA; WAR	Objectives Maternal and neonatal mortality and morbidity rates are particularly grim in conflict, post-conflict and other crisis settings, a situation partly blamed on non-availability and/or poor quality of emergency obstetric and neonatal care (EmONC) services. The aim of this study was to explore the barriers to effective delivery of EmONC services in post-conflict Burundi and Northern Uganda, in order to provide policy makers and other relevant stakeholders context-relevant data on improving the delivery of these lifesaving services. Methods This was a qualitative comparative case study that used 42 face-to-face semi-structured in-depth interviews and 4 focus group discussions for data collection. Participants were 32 local health providers and 37 staff of NGOs working in the area of maternal health. Data was analysed using the framework approach. Results The availability, quality and distribution of EmONC services were major challenges across the sites. The barriers in the delivery of quality EmONC services were categorised into two major themes; human resources-related challenges, and systemic and institutional failures. While some of the barriers were similar, others were unique to specific sites. The common barriers included shortage of qualified staff; lack of essential installations, supplies and medications; increasing workload, burn-out and turnover; and poor data collection and monitoring systems. Barriers unique to Northern Uganda were demoralised personnel and lack of recognition; poor referral system; inefficient drug supply system; staff absenteeism in rural areas; and poor coordination among key personnel. In Burundi, weak curriculum; poor harmonisation and coordination of training; and inefficient allocation of resources were the unique challenges. To improve the situation across the sites, efforts are ongoing to improve the training and recruitment of more staff; harmonise and strengthen the curriculum and training; increase the number of EmONC facilities; and improve staff supervision, monitoring and support. Conclusions Post-conflict health systems face different challenges in the delivery of EmONC services and as such require context-specific interventions to improve the delivery of these services.	[Chi, Primus Che; Urdal, Henrik] PRIO, Oslo, Norway; [Chi, Primus Che; Sundby, Johanne] Univ Oslo, Inst Hlth Soc, Oslo, Norway; [Bulage, Patience] Int Org Migrat, Kampala, Uganda	Peace Research Institute Oslo (PRIO); University of Oslo; International Organization for Migration	Chi, PC (corresponding author), PRIO, POB 9229, Oslo, Norway.	prichi@prio.org		Chi, Primus Che/0000-0002-2727-2693	Folke Bernadotte Academy, Sweden; Institute of Health and Society, University of Oslo, Norway; EU 7th Framework Marie Curie ITN 'Training and Mobility Network for Economic Analysis of Conflict' TAMNEAC [263905]; Peace Research Institute Oslo (PRIO)	Folke Bernadotte Academy, Sweden; Institute of Health and Society, University of Oslo, Norway; EU 7th Framework Marie Curie ITN 'Training and Mobility Network for Economic Analysis of Conflict' TAMNEAC; Peace Research Institute Oslo (PRIO)	This fieldwork received funding from Folke Bernadotte Academy, Sweden, and the Institute of Health and Society, University of Oslo, Norway. The entire work has been supported by the EU 7th Framework Marie Curie ITN 'Training and Mobility Network for the Economic Analysis of Conflict' TAMNEAC (Grant agreement 263905) and the Peace Research Institute Oslo (PRIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh C, 2012, INT J GYNECOL OBSTET, V117, P283, DOI 10.1016/j.ijgo.2012.01.015; Ameh CA, 2011, MATERN CHILD HLTH J, V15, P4, DOI 10.1007/s10995-009-0545-3; [Anonymous], 2011, MIN IN SERV PACK MIS; Apuuli Kasaija Phillip, 2006, J INT CRIM JUSTICE, V4, P179; Apuuli KP, 2003, WAR NO UGANDA WORLDS; Averting Maternal Death and Disability, 2013, EM OBST NEWB CAR LIF; Bundervoet T, 2009, J HUM RESOUR, V44, P536; Cabinet of the President Republic of Burundi, 2010, REP BUR TROIS REC GE; Chi PC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0449-8; Cho H, 2012, MONITORING MATERNAL; Chynoweth SK, 2008, REPROD HEALTH MATTER, V16, P93, DOI 10.1016/S0968-8080(08)31348-2; Devkota Bhimsen, 2010, Confl Health, V4, P20, DOI 10.1186/1752-1505-4-20; Echoka E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-113; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Inter-agency Working Group on Reproductive Health in Crisis, 2010, INT FIELD MAN REPR H; Jamieson DJ, 2000, JAMA-J AM MED ASSOC, V283, P397, DOI 10.1001/jama.283.3.397; Kim YM, 2012, INT J GYNECOL OBSTET, V116, P192, DOI 10.1016/j.ijgo.2011.10.017; Kongnyuy EJ, 2009, BJOG-INT J OBSTET GY, V116, P41, DOI 10.1111/j.1471-0528.2009.02332.x; Krause S K, 2006, Glob Public Health, V1, P205, DOI 10.1080/17441690600679939; Kruk ME, 2010, B WORLD HEALTH ORGAN, V88, P527, DOI 10.2471/BLT.09.071068; Kyotalengerire A, 2014, NEW VISION NEWS 1115; Lam Jennifer O, 2012, Confl Health, V6, P2, DOI 10.1186/1752-1505-6-2; Lee RB, 2008, REPROD HEALTH MATTER, V16, P65, DOI 10.1016/S0968-8080(08)31346-9; Mbonye AK, 2007, INT J GYNECOL OBSTET, V98, P285, DOI 10.1016/j.ijgo.2007.05.019; Medecins Sans Frontieres, 2012, SAF DEL RED MAT MORT; Mezie-Okoye Margaret M, 2012, Afr J Reprod Health, V16, P171; Ministry of Health Republic of Uganda, 2005, HLTH MORT SURV INT D; Morof Diane F, 2014, Confl Health, V8, P8, DOI 10.1186/1752-1505-8-8; New Deal for Building Peaceful States, NEW DEAL ENG FRAG ST; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Ocowun C, 2010, GULU NEEDS 316 HLTH; Orinda V, 2005, INT J GYNECOL OBSTET, V91, P285, DOI 10.1016/j.ijgo.2005.07.023; Otunnu O, 2002, CAUSES CONSEQUENCES; Oyerinde K, 2011, INT J GYNECOL OBSTET, V114, P168, DOI 10.1016/j.ijgo.2011.05.006; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Population Reference Bureau, 2014, 2014 WORLD POP SHEET; Reproductive Health Response in Conflict Consortium, 2004, EM OBST CAR CRIT NEE; Roberts B, 2008, REPROD HEALTH MATTER, V16, P57, DOI 10.1016/S0968-8080(08)31347-0; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; Turkmani S, 2013, MIDWIFERY, V29, P1166, DOI 10.1016/j.midw.2013.06.015; Uganda Medical & Dental Practitioners Council, REG; Uganda National Bureau of Statistics, 2010, UG NAT HOUS SURV 200; Uganda Nurses and Midwives Council, REG NURS MIDW HLTH W; UNFPA, 2012, WOM AR FABR REPR HLT; UNICEF, 2014, TRANSMONEE 2014 GUID; UNICEF WHO UN Population Fund, 1997, GUID MON AV US OBST; Urdal H, 2013, INT INTERACT, V39, P489, DOI 10.1080/03050629.2013.805133; Voors MJ, 2012, AM ECON REV, V102, P941, DOI 10.1257/aer.102.2.941; Wick L, 2012, REPROD HEALTH MATTER, V20, P7, DOI 10.1016/S0968-8080(12)40648-6; Women's Refugee Commission, 2009, REPR HLTH NO UG REP; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2011, BUR NAT PERF BAS FIN; World Health Organization, 2009, HLTH WORKF INFR ESS; World Health Organization: Burundi, 2014, COUNTR COOP STRAT; World Health Organization: Uganda, 2014, COUNTR COOP STRAT; World Health Organization (WHO), 2005, TECHNICAL REPORT; Zotti ME, 2013, MATERN CHILD HLTH J, V17, P783, DOI 10.1007/s10995-012-1068-x; Zuniga I, 2013, PUBLIC HEALTH ACTION, V3, P276, DOI 10.5588/pha.13.0050	62	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139120	10.1371/journal.pone.0139120	http://dx.doi.org/10.1371/journal.pone.0139120			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26405800	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700177
J	Chambault, P; Pinaud, D; Vantrepotte, V; Kelle, L; Entraygues, M; Guinet, C; Berzins, R; Bilo, K; Gaspar, P; de Thoisy, B; Le Maho, Y; Chevallier, D				Chambault, Philippine; Pinaud, David; Vantrepotte, Vincent; Kelle, Laurent; Entraygues, Mathieu; Guinet, Christophe; Berzins, Rachel; Bilo, Karin; Gaspar, Philippe; de Thoisy, Benoit; Le Maho, Yvon; Chevallier, Damien			Dispersal and Diving Adjustments of the Green Turtle Chelonia mydas in Response to Dynamic Environmental Conditions during Post- Nesting Migration	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; SATELLITE TELEMETRY; 1ST-PASSAGE TIME; ASCENSION ISLAND; MARINE TURTLES; AMAZON; TRACKING; BEHAVIOR; HABITAT; VARIABILITY	In response to seasonality and spatial segregation of resources, sea turtles undertake long journeys between their nesting sites and foraging grounds. While satellite tracking has made it possible to outline their migration routes, we still have little knowledge of how they select their foraging grounds and adapt their migration to dynamic environmental conditions. Here, we analyzed the trajectories and diving behavior of 19 adult green turtles (Chelonia mydas) during their post-nesting migration from French Guiana and Suriname to their foraging grounds off the coast of Brazil. First Passage Time analysis was used to identify foraging areas located off Ceara state of Brazil, where the associated habitat corresponds to favorable conditions for seagrass growth, i.e. clear and shallow waters. The dispersal and diving patterns of the turtles revealed several behavioral adaptations to the strong hydrodynamic processes induced by both the North Brazil current and the Amazon River plume. All green turtles migrated south-eastward after the nesting season, confirming that they coped with the strong counter North Brazil current by using a tight corridor close to the shore. The time spent within the Amazon plume also altered the location of their feeding habitats as the longer individuals stayed within the plume, the sooner they initiated foraging. The green turtles performed deeper and shorter dives while crossing the mouth of the Amazon, a strategy which would help turtles avoid the most turbulent upper surface layers of the plume. These adjustments reveal the remarkable plasticity of this green turtle population when reducing energy costs induced by migration.	[Chambault, Philippine; Le Maho, Yvon; Chevallier, Damien] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg 2, France; [Chambault, Philippine; Le Maho, Yvon; Chevallier, Damien] CNRS, UMR 7178, F-67087 Strasbourg 2, France; [Pinaud, David; Guinet, Christophe] Univ La Rochelle, UMR CNRS 7372, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Vantrepotte, Vincent] CNRS, UMR 8187, Lab Oceanol & Geosci, F-62930 Wimereux, France; [Vantrepotte, Vincent] CNRS Guyane, USR 3456, F-97300 Cayenne, France; [Kelle, Laurent] WWF Guyane, F-97300 Cayenne, France; [Entraygues, Mathieu; Berzins, Rachel] Off Natl Chasse & Faune Sauvage Cellule Tech Guya, F-97379 Kourou, France; [Bilo, Karin] WWF Guianas, Paramaribo, Suriname; [Gaspar, Philippe] Collecte Localisat Satellites, Direct Oceanog Spatiale, F-31520 Ramonville St Agne, France; [de Thoisy, Benoit] Assoc Kwata, F-97335 Cayenne, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Chambault, P (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, 23 Rue Becquerel, F-67087 Strasbourg 2, France.	philippine.chambault@gmail.fr	Chambault, Philippine/ABI-2110-2020; Guinet, Christophe/AAR-8457-2020; Pinaud, David/B-6326-2008; Chevallier, Damien/AAD-6754-2020; damien, chevallier/N-6532-2013	Pinaud, David/0000-0003-0815-9668; de thoisy, benoit/0000-0002-8420-5112; damien, chevallier/0000-0002-2232-6787	OP Amazonia; Ministry of Ecology, Sustainable Development and Energy; French National Centre for Space Studies (CNES); French Guiana Regional Council; Shell; CNES Guyane; project ANTIDOT (Pepiniere Interdisciplinaire Guyane, Mission pour l'Interdisciplinarite, CNRS); European Union's ERDF fund	OP Amazonia; Ministry of Ecology, Sustainable Development and Energy; French National Centre for Space Studies (CNES); French Guiana Regional Council; Shell(Royal Dutch Shell); CNES Guyane; project ANTIDOT (Pepiniere Interdisciplinaire Guyane, Mission pour l'Interdisciplinarite, CNRS); European Union's ERDF fund	The CARET2 program was co-financed by the OP Amazonia with the European Union's ERDF fund, the Ministry of Ecology, Sustainable Development and Energy and the French National Centre for Space Studies (CNES) and was also supported by the French Guiana Regional Council. PC's Phd Scholarship was supported by Shell (https://www.shell.fr/aboutshell/guyane.html) and CNES Guyane (http://www.cnes-csg.fr/). The authors also acknowledge the support of the project ANTIDOT (Pepiniere Interdisciplinaire Guyane, Mission pour l'Interdisciplinarite, CNRS). The funders had a role in the decision to publish but had no role in study design, data collection and analysis, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; [Anonymous], 2014, R LANG ENV STAT COMP; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Baudouin M, 2015, BIOL CONSERV, V184, P36, DOI 10.1016/j.biocon.2014.12.021; Bourret A, 2008, CONT SHELF RES, V28, P951, DOI 10.1016/j.csr.2008.01.008; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Copertino MS, 2013, SEAGRASS DISTRIBUTIO; Dagg M, 2004, CONT SHELF RES, V24, P833, DOI 10.1016/j.csr.2004.02.003; DeMaster DJ, 1996, CONT SHELF RES, V16, P617, DOI 10.1016/0278-4343(95)00048-8; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Endres CS, 2013, MAR BIOL, V160, P2951, DOI 10.1007/s00227-013-2285-6; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Feddersen F, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001293; Fossette S, 2014, J EXP MAR BIOL ECOL, V450, P6, DOI 10.1016/j.jembe.2013.10.014; Fossette S, 2010, J EXP BIOL, V213, P4074, DOI 10.1242/jeb.048207; Gallon S, 2013, DEEP-SEA RES PT II, V88-89, P14, DOI 10.1016/j.dsr2.2012.09.002; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2002, ECOGRAPHY, V25, P352, DOI 10.1034/j.1600-0587.2002.250312.x; Godley BJ, 2001, BIOL CONSERV, V97, P151, DOI 10.1016/S0006-3207(00)00107-5; Hansen JE, 2014, COAST ENG, V91, P251, DOI 10.1016/j.coastaleng.2014.05.010; Hays GC, 2002, CAN J ZOOL, V80, P1299, DOI 10.1139/Z02-110; Hays GC, 1999, MAR ECOL PROG SER, V189, P263, DOI 10.3354/meps189263; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Heerah K, 2013, DEEP-SEA RES PT II, V88-89, P23, DOI 10.1016/j.dsr2.2012.08.025; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hu CM, 2004, DEEP-SEA RES PT II, V51, P1151, DOI 10.1016/j.dsr2.2004.04.001; Johns WE, 1998, J PHYS OCEANOGR, V28, P103, DOI 10.1175/1520-0485(1998)028<0103:ACAVOT>2.0.CO;2; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Lee KS, 1997, J EXP MAR BIOL ECOL, V210, P53, DOI 10.1016/S0022-0981(96)02720-7; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Lopez R, 2014, IEEE T GEOSCI REMOTE, V52, P4744, DOI 10.1109/TGRS.2013.2284293; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Lutz PL, 1996, BIOL SEA TURTLES; McMahon CR, 2007, MAR ECOL PROG SER, V329, P239, DOI 10.3354/meps329239; Meade RH, 1996, SEA LEVEL RISE COAST, V2, P63, DOI DOI 10.1007/978-94-015-8719-8_4; Miller Jeffrey D., 1997, P51; Milliman J., 1983, J GEOL, V91; Molleri GSF, 2010, CONT SHELF RES, V30, P342, DOI 10.1016/j.csr.2009.11.015; Nikiema O, 2007, CONT SHELF RES, V27, P873, DOI 10.1016/j.csr.2006.12.004; Nittrouer CA, 1996, CONT SHELF RES, V16, P553, DOI 10.1016/0278-4343(95)00069-0; Oliveira EC, 1997, AQUAT BOT, V56, P25, DOI 10.1016/S0304-3770(96)01097-2; ONUF CP, 1994, ESTUAR COAST SHELF S, V39, P75, DOI 10.1006/ecss.1994.1050; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; PRITCHARD PCH, 1976, COPEIA, P749; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Robert J. Hijmans, 2012, RASTER GEOGRAPHIC AN; Scott R, 2014, ECOLOGY, V95, P2840, DOI 10.1890/13-2164.1; Seminoff JA, 2002, COPEIA, P610; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; van Ginneken VJT, 2000, NATURE, V403, P156, DOI 10.1038/35003110; Wallace BP, 2005, J EXP BIOL, V208, P3873, DOI 10.1242/jeb.01860; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Zuur Alain F., 2009, P1	66	20	21	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137340	10.1371/journal.pone.0137340	http://dx.doi.org/10.1371/journal.pone.0137340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398528	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500030
J	Gruppen, EG; Riphagen, IJ; Connelly, MA; Otvos, JD; Bakker, SJL; Dullaart, RPF				Gruppen, Eke G.; Riphagen, Ineke J.; Connelly, Margery A.; Otvos, James D.; Bakker, Stephan J. L.; Dullaart, Robin P. F.			GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; RISK; ALBUMINURIA; GLYCOSYLATION; CREATININE; PREDICTION; NUMBER	Objective GlycA is a novel nuclear magnetic resonance spectroscopy-measured biomarker of systemic inflammation. We determined whether GlycA is associated with incident cardiovascular disease (CVD) in men and women, examined whether this association with CVD is modified by renal function, and compared this association with high sensitivity C-reactive protein (hsCRP). Research design and methods A prospective cohort study was performed among 4,759 subjects (PREVEND study) without a history of CVD and cancer. Incident CVD was defined as the combined endpoint of cardiovascular morbidity and mortality. Cox regression analyses were used to examine associations of baseline GlycA and hsCRP with CVD. Results 298 first CVD events occurred during a median follow-up of 8.5 years. After adjustment for clinical and lipid measures the hazard ratio (HR) for CVD risk in the highest GlycA quartile was 1.58 (95% CI, 1.05-2.37, P for trend = 0.004). This association was similar after further adjustment for renal function (estimated glomerular filtration rate and urinary albumin excretion). After additional adjustment for hsCRP, GlycA was still associated with incident CVD (HR: 1.16 per SD change (95% CI, 1.01-1.33), P = 0.04). Similar results were obtained for hsCRP (HR per SD change after adjustment for GlycA: 1.17 (95% CI 1.17 (95% CI, 1.01-3.60), P = 0.04). CVD risk was highest in subjects with simultaneously higher GlycA and hsCRP (fully adjusted HR: 1.79 (95% CI, 1.31-2.46), P<0.001). Conclusion GlycA is associated with CVD risk in men and women, independent of renal function. The association of GlycA with incident CVD is as strong as that of hsCRP.	[Gruppen, Eke G.; Riphagen, Ineke J.; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Gruppen, Eke G.; Riphagen, Ineke J.; Bakker, Stephan J. L.; Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Gruppen, Eke G.; Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Connelly, Margery A.; Otvos, James D.] LabCorp, Raleigh, NC USA	University of Groningen; University of Groningen; University of Groningen	Gruppen, EG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	e.g.gruppen@umcg.nl			LabCorp	LabCorp	LabCorp provided support in the form of salaries for authors MAC and JDO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Akinkuolie AO, 2015, ARTERIOSCL THROM VAS, V35, P1544, DOI 10.1161/ATVBAHA.115.305635; Akinkuolie AO, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001221; Ala-Korpela M, 2015, CLIN CHEM, V61, P681, DOI 10.1373/clinchem.2015.238279; Axford J, 2001, TRENDS IMMUNOL, V22, P237, DOI 10.1016/S1471-4906(01)01890-7; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Chronic Kidney Disease Prognosis Consortium, 2010, ASS EST GLOM FILTR R, V375, P2073; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Corsetti JP, 2014, J AM SOC NEPHROL, V25, P2906, DOI 10.1681/ASN.2013121256; Corsetti JP, 2010, EUR J CLIN INVEST, V40, P483, DOI 10.1111/j.1365-2362.2010.02287.x; Dullaart RPF, 2015, CLIN BIOCHEM, V48, P811, DOI 10.1016/j.clinbiochem.2015.05.001; Fischer K, 2014, BIOMARKER PROFILING, V11; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jiang HJ, 2009, NEPHROLOGY, V14, P332, DOI 10.1111/j.1440-1797.2008.01053.x; Kappelle PJWH, 2011, J INTERN MED, V269, P232, DOI 10.1111/j.1365-2796.2010.02323.x; Kaysen GA, 2001, KIDNEY INT, V60, P2360, DOI 10.1046/j.1523-1755.2001.00052.x; Koning SH, 2015, KIDNEY INT, V87, P1009, DOI 10.1038/ki.2014.414; Kunutsor SK, 2015, ARTERIOSCL THROM VAS, V35, P716, DOI 10.1161/ATVBAHA.114.304929; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu XJ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-70; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matyus SP, 2014, CLIN BIOCHEM, V47, P203, DOI 10.1016/j.clinbiochem.2014.07.015; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ormseth MJ, 2015, UTILITY NOVEL INFLAM, V17, P117; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Tsai YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052775; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Yin XY, 2014, ARTERIOSCL THROM VAS, V34, P939, DOI 10.1161/ATVBAHA.113.302918; Zambrano-Galvan G, 2011, ARCH MED RES, V42, P451, DOI 10.1016/j.arcmed.2011.09.009	37	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0139057	10.1371/journal.pone.0139057	http://dx.doi.org/10.1371/journal.pone.0139057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398105	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500137
J	Filiponi, TC; Requiao-Moura, LR; Tonato, EJ; de Matos, ACC; Silva, APE; Durao, MD				Filiponi, Thiago Corsi; Requiao-Moura, Lucio Roberto; Tonato, Eduardo Jose; Carvalho de Matos, Ana Cristina; Pacheco e Silva-Filho, Alvaro; Durao Junior, Marcelino de Souza			Hospital Admission following Acute Kidney Injury in Kidney Transplant Recipients Is Associated with a Negative Impact on Graft Function after 1-Year	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HIGH-RISK; OUTCOMES; DISEASE; FAILURE	The incidence and outcomes of acute kidney injury (AKI) in kidney transplantation are poorly known. Retrospective cohort analysis was performed on the data of all patients (3 months after transplantation and >= 16 years of age) admitted to the hospital due to medical or surgical complications from 2007 to 2010. We analyzed 458 kidney transplant recipients, 55.2% men, median age 49 (IQR, 36-58) years, median of 12.5 (IQR, 3-35) months after kidney transplantation; admitted to the hospital due to medical or surgical complications. Most of the patients received a kidney from a deceased donor (62.2%), the primary cause for hospital admission was infection (60.7%) and 57 (12.4%) individuals were diagnosed with acute rejection (AR). The incidence of AKI was 82.3%: 31.9% stage 1, 29.3% stage 2 and 21.2% stage 3. Intensive care unit (ICU) admission (OR 8.90, 95% CI: 1.77-44.56 p = 0.008), infection (OR 5.73, 95% CI: 2.61-12.56, p<0.001) and the use of contrast media (OR 9.34, 95% CI: 2.04-42.70, p = 0.004) were the independent risk factors for AKI development. The mortality rate was 2.1% and all patients who died were diagnosed with AKI. Even after the exclusion of AR cases, at the end of 12 months, the individuals with AKI exhibited higher percent changes in creatinine values when compared with individuals without AKI (9.1% vs. -4.3%; p<0.001). According to KDIGO system, we found a high incidence of AKI among the complications of renal transplantation. As in other scenarios, AKI was associated with renal function loss at 1-year after the hospital discharge.	[Filiponi, Thiago Corsi; Requiao-Moura, Lucio Roberto; Tonato, Eduardo Jose; Carvalho de Matos, Ana Cristina; Pacheco e Silva-Filho, Alvaro; Durao Junior, Marcelino de Souza] Hosp Israelita Albert Einstein, Kidney Transplant Unit, Sao Paulo, Brazil; [Filiponi, Thiago Corsi; Pacheco e Silva-Filho, Alvaro; Durao Junior, Marcelino de Souza] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP)	Durao, MD (corresponding author), Hosp Israelita Albert Einstein, Kidney Transplant Unit, Sao Paulo, Brazil.	marcelino@einstein.br	silva, alvaro/HDO-6977-2022; Requião-Moura, Lúcio/X-1613-2019	Requião-Moura, Lúcio/0000-0001-8751-9048				Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cooper JE, 2013, CURR OPIN NEPHROL HY, V22, P698, DOI 10.1097/MNH.0b013e328365b388; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Durao MS, 2008, CRIT CARE MED, V36, P3024, DOI 10.1097/CCM.0b013e31818b9100; Elyasi S, EUR J CLINPHARMACOL, V68, P1243; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Golshahi Jafar, 2014, J Nephropathol, V3, P51, DOI 10.12860/jnp.2014.12; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Issa N, 2013, AM J NEPHROL, V37, P602, DOI 10.1159/000351648; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kotton CN, 2010, TRANSPLANTATION, V89, P779, DOI 10.1097/TP.0b013e3181cee42f; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mohammed Nazar M A, 2013, Heart Views, V14, P106, DOI 10.4103/1995-705X.125926; Nakamura M, 2012, CLIN TRANSPLANT, V26, P520, DOI 10.1111/j.1399-0012.2011.01546.x; Requiao-Moura LR, 2012, TRANSPL P, V44, P2428, DOI 10.1016/j.transproceed.2012.07.013; Salahudeen AK, 2013, CLIN J AM SOC NEPHRO, V8, P347, DOI 10.2215/CJN.03530412; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281, DOI 10.1177/039139880703000402; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138944	10.1371/journal.pone.0138944	http://dx.doi.org/10.1371/journal.pone.0138944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417949	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400029
J	Gabrielova, E; Zholobenko, AV; Bartosikova, L; Necas, J; Modriansky, M				Gabrielova, Eva; Zholobenko, Aleksey Vladimirovich; Bartosikova, Lenka; Necas, Jiri; Modriansky, Martin			Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart	PLOS ONE			English	Article							KINASE-C-EPSILON; INDUCED CARDIOTOXICITY; FCCP; OXIDATION; SILYBIN; ROS	2,3-dehydrosilybin (DHS) is a minor flavonolignan component of Silybum marianum seed extract known for its hepatoprotective activity. Recently we identified DHS as a potentially cardioprotective substance during hypoxia/reoxygenation in isolated neonatal rat cardiomyocytes. This is the first report of positive inotropic effect of DHS on perfused adult rat heart. When applied to perfused adult rat heart, DHS caused a dose-dependent inotropic effect resembling that of catecholamines. The effect was apparent with DHS concentration as low as 10 nM. Suspecting direct interaction with beta-adrenergic receptors, we tested whether DHS can trigger beta agonist-dependent gene transcription in a model cell line. While DHS alone was unable to trigger beta agonist-dependent gene transcription, it enhanced the effect of isoproterenol, a known unspecific beta agonist. Further tests confirmed that DHS could not induce cAMP accumulation in isolated neonatal rat cardiomyocytes even though high concentrations (>= 10 mu M) of DHS were capable of decreasing phosphodiesterase activity. Pre-treatment of rats with reserpine, an indole alkaloid which depletes catecholamines from peripheral sympathetic nerve endings, abolished the DHS inotropic effect in perfused hearts. Our data suggest that DHS causes the inotropic effect without acting as a beta agonist. Hence we identify DHS as a novel inotropic agent.	[Gabrielova, Eva; Zholobenko, Aleksey Vladimirovich; Modriansky, Martin] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic; [Bartosikova, Lenka; Necas, Jiri] Palacky Univ, Fac Med & Dent, Dept Physiol, CR-77147 Olomouc, Czech Republic; [Gabrielova, Eva; Modriansky, Martin] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Modriansky, M (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic.	martin.modriansky@upol.cz	GABRIELOVÁ, Eva/ABE-5387-2021; Modriansky, Martin/A-6338-2008; Gabrielová, Eva/E-2137-2018	Modriansky, Martin/0000-0001-7692-0338; Gabrielová, Eva/0000-0003-1460-0915	Ministry of Education, Youth and Sports (Czech Republic) [LO1403, CZ.1.07/2.3.00/30.0041]	Ministry of Education, Youth and Sports (Czech Republic)(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government)	This work was supported by grants LO1403 and CZ.1.07/2.3.00/30.0041 from the Ministry of Education, Youth and Sports (Czech Republic, www.msmt.cz). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2010, AGEING RES REV, V9, P153, DOI 10.1016/j.arr.2009.07.001; Bartosikova L, 2008, BIOMED PAP, V152, P79, DOI 10.5507/bp.2008.012; Bors W, 2002, ANN NY ACAD SCI, V957, P57, DOI 10.1111/j.1749-6632.2002.tb02905.x; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Chlopcikova A, 2004, PHYTOTHER RES, V18, P107, DOI 10.1002/ptr.1415; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; Comelli MC, 2007, INTEGR CANCER THER, V6, P120, DOI 10.1177/1534735407302349; El-Awady EE, 2011, EUR J PHARMACOL, V650, P335, DOI 10.1016/j.ejphar.2010.09.085; El-Shitany NA, 2008, FOOD CHEM TOXICOL, V46, P2422, DOI 10.1016/j.fct.2008.03.033; Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006; Frances C, 2003, J CARDIOVASC PHARM, V41, P396, DOI 10.1097/00005344-200303000-00008; FRIEL DD, 1994, J NEUROSCI, V14, P4007; Gabrielova E, 2015, PHYSIOL RES, V64, P79, DOI 10.33549/physiolres.932703; Gabrielova E, 2010, J BIOENERG BIOMEMBR, V42, P499, DOI 10.1007/s10863-010-9319-2; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Gazak R, 2013, TETRAHEDRON LETT, V54, P315, DOI 10.1016/j.tetlet.2012.11.049; Gazak R, 2011, J MED CHEM, V54, P7397, DOI 10.1021/jm201034h; Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816; Kozlovski VI, 2004, POL J PHARMACOL, V56, P767; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; Nabavi SM, 2012, AN ACAD BRAS CIENC, V84, P1121, DOI 10.1590/S0001-37652012005000056; Philipp S, 2006, CARDIOVASC RES, V70, P308, DOI 10.1016/j.cardiores.2006.02.014; Rambaldi A, 2005, AM J GASTROENTEROL, V100, P2583, DOI 10.1111/j.1572-0241.2005.00262.x; Rao Pragada Rajeswara, 2007, Exp Clin Cardiol, V12, P179; Raskovic A, 2011, MOLECULES, V16, P8601, DOI 10.3390/molecules16108601; Slim HB, 2011, AM J CARDIOL, V108, P308, DOI 10.1016/j.amjcard.2011.03.041; Taghiabadi E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/352091; Tang XL, 2014, J PHARMACOL SCI, V125, P176, DOI 10.1254/jphs.13247FP; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Xu TR, 2007, CELL SIGNAL, V19, P1986, DOI 10.1016/j.cellsig.2007.05.009; Zatta AJ, 2006, CARDIOVASC RES, V70, P315, DOI 10.1016/j.cardiores.2005.11.030; Zholobenko A, 2014, FITOTERAPIA, V97, P122, DOI 10.1016/j.fitote.2014.05.016; Zhou JJ, 2002, BRIT J PHARMACOL, V135, P1675, DOI 10.1038/sj.bjp.0704640	36	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139208	10.1371/journal.pone.0139208	http://dx.doi.org/10.1371/journal.pone.0139208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418338	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400063
J	Sugiyama, A; Fukuda, S; Takanashi, K; Yoshioka, M; Yoshioka, H; Narusaka, Y; Narusaka, M; Kojima, M; Sakakibara, H; Shitan, N; Sato, S; Tabata, S; Kawaguchi, M; Yazaki, K				Sugiyama, Akifumi; Fukuda, Shoju; Takanashi, Kojiro; Yoshioka, Miki; Yoshioka, Hirofumi; Narusaka, Yoshihiro; Narusaka, Mari; Kojima, Mikiko; Sakakibara, Hitoshi; Shitan, Nobukazu; Sato, Shusei; Tabata, Satoshi; Kawaguchi, Masayoshi; Yazaki, Kazufumi			Molecular Characterization of LjABCG1, an ATP-Binding Cassette Protein in Lotus japonicus	PLOS ONE			English	Article							MEMBRANE ABC TRANSPORTER; ARABIDOPSIS-THALIANA; MODEL LEGUME; CONFERS RESISTANCE; NONHOST RESISTANCE; PLANT; GENE; EXPRESSION; PATHOGEN; NODULATION	LjABCG1, a full-size ABCG subfamily of ATP-binding cassette proteins of a model legume, Lotus japonicus, was reported as a gene highly expressed during the early stages of nodulation, but have not been characterized in detail. In this study we showed that the induction of LjABCG1 expression was remarkable by methyl jasmonate treatment, and reporter gene experiments indicated that LjABCG1 was strongly expressed in the nodule parenchyma and cell layers adjacent to the root vascular tissue toward the nodule. LjABCG1 was suggested to be localized at the plasma membrane based on the fractionation of microsomal membranes as well as separation via aqueous two-phase partitioning. The physiological functions of LjABCG1 in symbiosis and pathogenesis were analyzed in homologous and heterologous systems. LjABCG1 knock-down L. japonicus plants did not show clear phenotypic differences in nodule formation, and not in defense against Pseudomonas syringae, either. In contrast, when LjABCG1 was expressed in the Arabidopsis pdr8-1 mutant, the penetration frequency of Phytophthora infestans, a potato late blight pathogen, was significantly reduced in LjABCG1/pdr8-1 than in pdr8-1 plants. This finding indicated that LjABCG1, at least partially, complemented the phenotype of pdr8 in Arabidopsis, suggesting the multiple roles of this protein in plant-microbe interactions.	[Sugiyama, Akifumi; Fukuda, Shoju; Takanashi, Kojiro; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Uji, Kyoto 6110011, Japan; [Yoshioka, Miki; Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Def Plant Pathogen Interact, Nagoya, Aichi 4648601, Japan; [Narusaka, Yoshihiro; Narusaka, Mari] Res Inst Biol Sci, Yoshikawa, Okayama 7161241, Japan; [Kojima, Mikiko; Sakakibara, Hitoshi] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Shitan, Nobukazu] Kobe Pharmaceut Univ, Lab Nat Med Chem, Kobe, Hyogo 6588558, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sato, Shusei; Tabata, Satoshi] Kazusa DNA Res Inst, Chiba 2920812, Japan; [Kawaguchi, Masayoshi] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Kyoto University; Nagoya University; RIKEN; Kobe Pharmaceutical University; Tohoku University; Kazusa DNA Research Institute; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Yazaki, K (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Uji, Kyoto 6110011, Japan.	yazaki@rish.kyoto-u.ac.jp	Kojima, Mikiko/D-1459-2017; Sakakibara, Hitoshi/A-6040-2010; Sato, Shusei/A-3616-2015	Sakakibara, Hitoshi/0000-0001-5449-6492; Sato, Shusei/0000-0002-0293-5366; Sugiyama, Akifumi/0000-0002-9643-6639; Shitan, Nobukazu/0000-0001-7760-2745; Kawaguchi, Masayoshi/0000-0002-1032-6261	Japan Society for the Promotion of Science [183051];  [20053009];  [23012024];  [23780066];  [26712013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (No. 20053009 and No. 23012024 to K.Y., No. 23780066 and 26712013 to A.S.); and by Research Fellowships for Young Scientists from the Japan Society for the Promotion of Science (No. 183051 to A.S.).	Akashi R, 2003, PLANT SOIL, V255, P27, DOI 10.1023/A:1026143606752; Banasiak J, 2013, J EXP BOT; BHUVANESWARI TV, 1980, PLANT PHYSIOL, V66, P1027, DOI 10.1104/pp.66.6.1027; Bordenave CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083199; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Carvalhais LC, 2015, MOL PLANT MICROBE IN, V28, P1049, DOI 10.1094/MPMI-01-15-0016-R; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; DeMichelis MI, 1996, PLANT PHYSIOL, V110, P957, DOI 10.1104/pp.110.3.957; Ding YL, 2008, PLANT CELL, V20, P2681, DOI 10.1105/tpc.108.061739; Eichhorn H, 2006, J EXP BOT, V57, P2193, DOI 10.1093/jxb/erj179; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Giovannetti M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00480; Hawes C., 2003, CURR PROTOC CELL BIO, V19, P1, DOI [DOI 10.1002/0471143030.CB0107S19, 10.1002/0471143030.cb0107s19]; Hirayama T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3247; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kato T, 2005, J BIOSCI BIOENG, V99, P165, DOI 10.1263/jbb.99.165; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Kumagai H, 2003, MOL PLANT MICROBE IN, V16, P663, DOI 10.1094/MPMI.2003.16.8.663; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Masai M, 2013, BIOSCI BIOTECH BIOCH, V77, P1773, DOI 10.1271/bbb.130209; Nagata M, 2008, MOL PLANT MICROBE IN, V21, P1175, DOI 10.1094/MPMI-21-9-1175; Nakagawa T, 2006, PLANT CELL PHYSIOL, V47, P176, DOI 10.1093/pcp/pci222; Narusaka M, 2011, J GEN PLANT PATHOL, V77, P75, DOI 10.1007/s10327-011-0298-x; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Sasabe M, 2002, FEBS LETT, V518, P164, DOI 10.1016/S0014-5793(02)02697-2; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shitan N, 2013, INT REV CEL MOL BIO, V305, P383, DOI 10.1016/B978-0-12-407695-2.00009-3; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Sugiyama A, 2007, PLANT PHYSIOL, V144, P2000, DOI 10.1104/pp.107.096727; Sugiyama A, 2006, DNA RES, V13, P205, DOI 10.1093/dnares/dsl013; Suzuki A, 2011, P NATL ACAD SCI USA, V108, P16837, DOI 10.1073/pnas.1105892108; Takanashi K, 2012, MOL PLANT MICROBE IN, V25, P869, DOI 10.1094/MPMI-01-12-0011-R; Takanashi K, 2012, J PLANT PHYSIOL, V169, P322, DOI 10.1016/j.jplph.2011.11.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; van den Brule S, 2002, PLANTA, V216, P95, DOI 10.1007/s00425-002-0889-z; van den Brule S, 2002, PLANT J, V30, P649, DOI 10.1046/j.1365-313X.2002.01321.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680	53	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139127	10.1371/journal.pone.0139127	http://dx.doi.org/10.1371/journal.pone.0139127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418593	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400047
J	Yamaguchi, M; Murakami, S; Yoneda, T; Nakamura, M; Zhang, L; Uezumi, A; Fukuda, S; Kokubo, H; Tsujikawa, K; Fukada, S				Yamaguchi, Masahiko; Murakami, Satoshi; Yoneda, Tomohiro; Nakamura, Miki; Zhang, Lidan; Uezumi, Akiyoshi; Fukuda, Sumiaki; Kokubo, Hiroki; Tsujikawa, Kazutake; Fukada, So-ichiro			Evidence of Notch-Hesr-Nrf2 Axis in Muscle Stem Cells, but Absence of Nrf2 Has No Effect on Their Quiescent and Undifferentiated State	PLOS ONE			English	Article							SKELETAL-MUSCLE; REDOX REGULATION; SATELLITE CELLS; REGENERATION; MAINTENANCE; DIFFERENTIATION; PROLIFERATION; EXPRESSION; MYOGENESIS; PATHWAYS	Nrf2 is a master regulator of oxidative stresses through the induction of anti-oxidative genes. Nrf2 plays roles in maintaining murine hematopoietic stem cells and fly intestinal stem cells. The canonical Notch signaling pathway is also crucial for maintaining several types of adult stem cells including muscle stem cells (satellite cells). Here, we show that Dll1 induced Nrf2 expression in myogenic cells. In addition, primary targets of Notch signaling, Hesr1 and Hesr3, were involved in the up-regulation of Nrf2 mRNA and expression of its target genes. In vitro, Nrf2 had anti-myogenic and anti-proliferative effects on primary myoblasts. In vivo, although Nrf2-knockout mice showed decreased expression of its target genes in muscle stem cells, adult muscle stem cells of Nrf2-knockout mice did not exhibit the phenotype. Taken together, in muscle stem cells, the Notch-Hesr-Nrf2 axis is a pathway potentially inducing anti-oxidative genes, but muscle stem cells either do not require Nrf2-mediated anti-oxidative gene expression or they have a complementary system compensating for the loss of Nrf2.	[Yamaguchi, Masahiko; Murakami, Satoshi; Yoneda, Tomohiro; Nakamura, Miki; Zhang, Lidan; Fukuda, Sumiaki; Tsujikawa, Kazutake; Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka 5650871, Japan; [Uezumi, Akiyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Toyoake, Aichi 4701192, Japan; [Kokubo, Hiroki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Minami Ku, Hiroshima 7348551, Japan	Osaka University; Fujita Health University; Hiroshima University	Fukada, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	fukada@phs.osaka-u.ac.jp	Uezumi, Akiyoshi/ABF-7359-2020; Fukada, So-ichiro/AAI-9151-2020	Uezumi, Akiyoshi/0000-0003-4294-0116; Fukada, So-ichiro/0000-0003-4051-5108	JSPS KAKENHI grant [25702044, 22-5, 25-5]; Nakatomi Foundation; Grants-in-Aid for Scientific Research [15K12675] Funding Source: KAKEN	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI grant, Grant-in Aid for Young Scientists (A) (25702044 to So-ichiro F), Intramural Research Grant (22-5 to So-ichiro F, 25-5 to So-ichiro F) for Neurological and Psychiatric Disorders of NCNP (NationalCenter of Neurology and Psychiatry), and The Nakatomi Foundation (to So-ichiro F).	Al-Sawaf O, 2014, J PATHOL, V234, P538, DOI 10.1002/path.4418; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00317; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gopinath SD, 2014, STEM CELL REP, V2, P414, DOI 10.1016/j.stemcr.2014.02.002; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kombairaju P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00057; L'honore A, 2014, DEV CELL, V29, P392, DOI 10.1016/j.devcel.2014.04.006; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Merchant AA, 2011, BLOOD, V118, P6572, DOI 10.1182/blood-2011-05-355362; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Satow T, 2001, J NEUROSCI, V21, P1265; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Wakabayashi N, 2014, MOL CELL BIOL, V34, P653, DOI 10.1128/MCB.01408-13; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Yamaguchi M., 2013, TUMOR DORMANCY QUIES, V1, P107; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138517	10.1371/journal.pone.0138517	http://dx.doi.org/10.1371/journal.pone.0138517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418810	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400017
J	Aziz, A; Ali, Y; Aziz, T; Siddique, JI				Aziz, Asim; Ali, Yasir; Aziz, Taha; Siddique, J. I.			Heat Transfer Analysis for Stationary Boundary Layer Slip Flow of a Power-Law Fluid in a Darcy Porous Medium with Plate Suction/Injection	PLOS ONE			English	Article							FLAT-PLATE; FORCED-CONVECTION; MASS-TRANSFER; THERMAL-CONDUCTIVITY; STRETCHING SHEET; SURFACE	In this paper, we investigate the slip effects on the boundary layer flow and heat transfer characteristics of a power-law fluid past a porous flat plate embedded in the Darcy type porous medium. The nonlinear coupled system of partial differential equations governing the flow and heat transfer of a power-law fluid is transformed into a system of nonlinear coupled ordinary differential equations by applying a suitable similarity transformation. The resulting system of ordinary differential equations is solved numerically using Matlab bvp4c solver. Numerical results are presented in the form of graphs and the effects of the power-law index, velocity and thermal slip parameters, permeability parameter, suction/injection parameter on the velocity and temperature profiles are examined.	[Aziz, Asim; Ali, Yasir] Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan; [Aziz, Taha] Univ Witwatersrand, DST NRF Ctr Excellence Math & Stat Sci, ZA-2050 Johannesburg, South Africa; [Siddique, J. I.] Penn State Univ, Dept Math, York, PA 17403 USA	National University of Sciences & Technology - Pakistan; University of Witwatersrand; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Aziz, A (corresponding author), Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan.	aaziz@ceme.nust.edu.pk	Aziz, Taha/AAD-5198-2020	Aziz, Taha/0000-0003-0519-1320; Aziz, Asim/0000-0002-2798-5191				ABUSITTA AMM, 1994, APPL MATH COMPUT, V64, P73, DOI 10.1016/0096-3003(94)90140-6; ACRIVOS A, 1960, AICHE J, V6, P312, DOI 10.1002/aic.690060227; ANDERSSON HI, 1992, INT J NONLINEAR MECH, V27, P929, DOI 10.1016/0020-7462(92)90045-9; Andersson HI, 2002, ACTA MECH, V158, P121, DOI 10.1007/BF01463174; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Aziz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114544; Baoku IG, 2013, INT J HEAT FLUID FL, V40, P81, DOI 10.1016/j.ijheatfluidflow.2013.01.016; BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375; Bhattacharyya K, 2011, J PETROL SCI ENG, V78, P304, DOI 10.1016/j.petrol.2011.06.009; Blasius H., 1908, GRENZSCHICHTEN FLUSS, V1256; Cheng CY, 2011, INT COMMUN HEAT MASS, V38, P615, DOI 10.1016/j.icheatmasstransfer.2010.12.034; Cheng CY, 2009, INT COMMUN HEAT MASS, V36, P351, DOI 10.1016/j.icheatmasstransfer.2009.01.003; Farhad A., 2011, EUR J SCI RES, V57, P293; GEBHART B, 1971, INT J HEAT MASS TRAN, V14, P2025, DOI 10.1016/0017-9310(71)90026-3; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hajmohammadi MR, 2014, HEAT TRANSFER ENG, V35, P863, DOI 10.1080/01457632.2014.852896; Hayat T, 2015, J APPL FLUID MECH, V8, P273; Howarth L, 1938, PROC R SOC LON SER-A, V164, P0547, DOI 10.1098/rspa.1938.0037; Ibrahim W, 2013, COMPUT FLUIDS, V75, P1, DOI 10.1016/j.compfluid.2013.01.014; Ingham D. B., 1998, TRANSPORT PHENOMENA; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; Khan ZH, 2009, HT2008: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 1, P301, DOI 10.1115/HT2008-56448; KUMARI M, 1990, ACTA MECH, V84, P201, DOI 10.1007/BF01176098; LEE SY, 1966, AICHE J, V12, P700, DOI 10.1002/aic.690120415; Loureiro JBR, 2013, J NON-NEWTON FLUID, V199, P20, DOI 10.1016/j.jnnfm.2013.05.003; Luna N, 2005, INT J THERM SCI, V44, P656, DOI 10.1016/j.ijthermalsci.2004.12.008; Magyari E, 2011, COMMUN NONLINEAR SCI, V16, P599, DOI 10.1016/j.cnsns.2010.03.020; Mahmoud MAA, 2006, ACTA MECH, V181, P83, DOI 10.1007/s00707-005-0268-5; Megahed AM, 2015, MECCANICA, V50, P1693, DOI 10.1007/s11012-015-0114-3; Mukhopadhyay S, 2009, MECCANICA, V44, P587, DOI 10.1007/s11012-009-9211-5; Nield D.A., 1998, CONVECTION POROUS ME; Noghrehabadi A, 2012, INT J THERM SCI, V54, P253, DOI 10.1016/j.ijthermalsci.2011.11.017; Pakdemirli M, 1996, INT J NONLINEAR MECH, V31, P267, DOI 10.1016/0020-7462(95)00071-2; Pal D, 2013, APPL MATH COMPUT, V219, P7556, DOI 10.1016/j.amc.2012.10.119; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1813, DOI 10.1016/j.cnsns.2009.07.011; Qasim M., 2014, PLOS ONE, V9; Sahoo B, 2010, CENT EUR J PHYS, V8, P498, DOI 10.2478/s11534-009-0105-x; SCHOWALTER WR, 1960, AICHE J, V6, P24, DOI 10.1002/aic.690060105; Shyam R, 2013, INT J HEAT MASS TRAN, V64, P1127, DOI 10.1016/j.ijheatmasstransfer.2013.05.052; Vafai K., 2000, HDB POROUS MEDIA, V1st; Wang CY, 2002, CHEM ENG SCI, V57, P3745, DOI 10.1016/S0009-2509(02)00267-1; WANG TY, 1995, INT J HEAT FLUID FL, V16, P56, DOI 10.1016/0142-727X(94)00008-Z; Xu H, 2006, J NON-NEWTON FLUID, V139, P31, DOI 10.1016/j.jnnfm.2006.06.003; Xu H, 2009, COMPUT MATH APPL, V57, P1425, DOI 10.1016/j.camwa.2009.01.029; Yazdi MH, 2014, INT REV MODELLING SI, V7	45	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138855	10.1371/journal.pone.0138855	http://dx.doi.org/10.1371/journal.pone.0138855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407162	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700105
J	Boyapalle, S; Xu, WD; Raulji, P; Mohapatra, S; Mohapatra, SS				Boyapalle, Sandhya; Xu, Weidong; Raulji, Payal; Mohapatra, Subhra; Mohapatra, Shyam S.			A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models	PLOS ONE			English	Article							VIRUS TYPE-1 REPLICATION; SMALL INTERFERING RNA; CHITOSAN NANOPARTICLES; VAGINAL MICROBICIDES; HIV-1 INFECTION; GENE DELIVERY; T-CELLS; INHIBITION; TRANSMISSION; EXPRESSION	Human immunodeficiency virus (HIV) types 1 and 2 (HIV-1 and HIV-2) are the etiologic agents of AIDS. Most HIV-1 infected individuals worldwide are women, who acquire HIV infections during sexual contact. Blocking HIV mucosal transmission and local spread in the female lower genital tract is important in preventing infection and ultimately eliminating the pandemic. Microbicides work by destroying the microbes or preventing them from establishing an infection. Thus, a number of different types of microbicides are under investigation, however, the lack of their solubility and bioavailability, and toxicity has been major hurdles. Herein, we report the development of multifunctional chitosan-lipid nanocomplexes that can effectively deliver plasmids encoding siRNA(s) as microbicides without adverse effects and provide significant protection against HIV in both in vitro and in vivo models. Chitosan or chitosan-lipid (chlipid) was complexed with a cocktail of plasmids encoding HIV-1-specific siRNAs (psiRNAs) and evaluated for their efficacy in HEK-293 cells, PBMCs derived from nonhuman primates, 3-dimensional human vaginal ectocervical tissue (3D-VEC) model and also in non-human primate model. Moreover, prophylactic administration of the chlipid to deliver a psiRNA cocktail intravaginally with a cream formulation in a non-human primate model showed substantial reduction of SHIV (simian/human immunodeficiency virus SF162) viral titers. Taken together, these studies demonstrate the potential of chlipid-siRNA nanocomplexes as a potential genetic microbicide against HIV infections.	[Boyapalle, Sandhya; Xu, Weidong; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Div Translat Med, Tampa, FL 33612 USA; [Boyapalle, Sandhya; Xu, Weidong; Mohapatra, Shyam S.] Univ S Florida, Nanomed Res Ctr, Tampa, FL USA; [Raulji, Payal; Mohapatra, Subhra] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley VA Hosp, Tampa, FL USA; [Boyapalle, Sandhya; Xu, Weidong; Raulji, Payal] Transgenex Nanobiotech Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mohapatra, SS (corresponding author), Univ S Florida, Dept Internal Med, Div Translat Med, Tampa, FL 33612 USA.	smohapat@health.usf.edu			National Institutes of Health [R43 AI080431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI080431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, R43 AI080431 awarded to Weidong Xu and Shyam S. Mohapatra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, CURR OPIN IMMUNOL, V25, P403, DOI 10.1016/j.coi.2013.03.009; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Artan M, 2010, CARBOHYD RES, V345, P656, DOI 10.1016/j.carres.2009.12.017; Arteaga HJ, 2003, NAT BIOTECHNOL, V21, P230, DOI 10.1038/nbt0303-230; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3; Boyapalle S, 2012, J GLOB INFECT DIS, V4, P62, DOI 10.4103/0974-777X.93764; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Coburn GA, 2002, J VIROL, V76, P9225, DOI 10.1128/JVI.76.18.9225-9231.2002; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Karagozlu MZ, 2014, INT J BIOL MACROMOL, V66, P260, DOI 10.1016/j.ijbiomac.2014.02.020; Khan AB, 2014, CURR DRUG DELIV, V11, P112, DOI 10.2174/156720181000131028120709; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Lavender KJ, 2013, BLOOD, V122, P4013, DOI 10.1182/blood-2013-06-506949; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Librelotto CS, 2015, REV SOC BRAS MED TRO, V48, P249, DOI 10.1590/0037-8682-0083-2015; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; Malhotra M, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S43683; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meng JN, 2014, NANOMEDICINE-UK, V9, P1595, DOI [10.2217/NNM.13.136, 10.2217/nnm.13.136]; Meng JN, 2011, EUR J PHARM SCI, V44, P57, DOI 10.1016/j.ejps.2011.06.007; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Nakagawa F, 2014, CURR HIV-AIDS REP, V11, P177, DOI 10.1007/s11904-014-0198-8; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289; Oshima K, 2003, CANCER RES, V63, P6809; Park SC, 2015, INT J MOL SCI, V16, P7995, DOI 10.3390/ijms16047995; Park S, 2013, CARBOHYD POLYM, V92, P57, DOI 10.1016/j.carbpol.2012.08.116; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Salgado M, 2014, J VIROL, V88, P3340, DOI 10.1128/JVI.03380-13; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Tager AM, 2013, J INFECT DIS, V208, pS121, DOI 10.1093/infdis/jit451; UNAIDS, 2013, REP GLOB AIDS EP; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Veselinovic M, 2012, VIROLOGY, V432, P505, DOI 10.1016/j.virol.2012.06.025; Walker PR, 2003, NATURE, V422, P679, DOI 10.1038/422679a; Wilkinson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109296; Wu CJ, 2005, ANTIVIR RES, V65, P45, DOI 10.1016/j.antiviral.2004.09.005; Zhang Weidong, 2004, Genet Vaccines Ther, V2, P8, DOI 10.1186/1479-0556-2-8; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	56	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135288	10.1371/journal.pone.0135288	http://dx.doi.org/10.1371/journal.pone.0135288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407080	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700004
J	Cheroni, C; Donnici, L; Aghemo, A; Balistreri, F; Bianco, A; Zanoni, V; Pagani, M; Soffredini, R; D'Ambrosio, R; Rumi, MG; Colombo, M; Abrignani, S; Neddermann, P; De Francesco, R				Cheroni, Cristina; Donnici, Lorena; Aghemo, Alessio; Balistreri, Francesca; Bianco, Annalisa; Zanoni, Valeria; Pagani, Massimiliano; Soffredini, Roberta; D'Ambrosio, Roberta; Rumi, Maria Grazia; Colombo, Massimo; Abrignani, Sergio; Neddermann, Petra; De Francesco, Raffaele			Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity	PLOS ONE			English	Article							DEFECTIVE INTERFERING PARTICLES; B-VIRUS; TRANSPLANT RECIPIENTS; PERSISTENT INFECTION; ENCEPHALITIS-VIRUS; VERO CELLS; IN-VITRO; RNA; IDENTIFICATION; DISEASE	Hepatitis C virus (HCV) variants characterized by genomic deletions in the structural protein region have been sporadically detected in liver and serum of hepatitis C patients. These defective genomes are capable of autonomous RNA replication and are packaged into infectious viral particles in cells co-infected with the wild-type virus. The prevalence of such forms in the chronically HCV-infected population and the impact on the severity of liver disease or treatment outcome are currently unknown. In order to determine the prevalence of HCV defective variants and to study their association with clinical characteristics, a screening campaign was performed on pre-therapy serum samples from a well-characterized cohort of previously untreated genotype 1 HCV-infected patients who received treatment with PEG-IFN alpha and RBV. 132 subjects were successfully analyzed for the presence of defective species exploiting a long-distance nested PCR assay. HCV forms with deletions predominantly affecting E1, E2 and p7 proteins were found in a surprising high fraction of the subjects (25/132, 19%). Their presence was associated with patient older age, higher viral load and increased necroinflammatory activity in the liver. While the presence of circulating HCV carrying deletions in the E1-p7 region did not appear to significantly influence sustained virological response rates to PEG-IFN alpha/RBV, our study indicates that the presence of these subgenomic HCV mutants could be associated with virological relapse in patients who did not have detectable viremia at the end of the treatment.	[Cheroni, Cristina; Donnici, Lorena; Balistreri, Francesca; Bianco, Annalisa; Zanoni, Valeria; Pagani, Massimiliano; Abrignani, Sergio; Neddermann, Petra; De Francesco, Raffaele] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, INGM, Milan, Italy; [Aghemo, Alessio; Soffredini, Roberta; D'Ambrosio, Roberta; Colombo, Massimo] Univ Milan, AM Migliavacca Ctr Liver Dis, Div Gastroenterol 1, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy; [Rumi, Maria Grazia] Univ Milan, Div Hepatol, Osped San Giuseppe IRCCS Multimed, Milan, Italy; [Abrignani, Sergio] Univ Milan, DISCCO, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of Milan	De Francesco, R (corresponding author), Ist Nazl Genet Mol Romeo & Enrica Invernizzi, INGM, Milan, Italy.	defrancesco@ingm.org	Aghemo, Alessio/ABE-5976-2021; D'Ambrosio, Roberta/K-3078-2016; Balistreri, Francesca/AAL-5608-2021; Cheroni, Cristina/AAO-2316-2020; De Francesco, Raffaele/J-6003-2012	Aghemo, Alessio/0000-0003-0941-3226; D'Ambrosio, Roberta/0000-0003-0019-1153; Balistreri, Francesca/0000-0001-9886-1228; De Francesco, Raffaele/0000-0001-8754-5123; RUMI, MARIAGRAZIA/0000-0002-5876-8528; Abrignani, Sergio/0000-0002-0794-3285; Cheroni, Cristina/0000-0002-0832-2333; Pagani, Massimiliano/0000-0002-7017-9304	Italian Ministry of Education, University and Research (MIUR) [RBAP10TPXK]; Italian Foundation for Research in Hepatology (FIRE, Fondazione Italiana per la Ricerca in Epatologia)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Foundation for Research in Hepatology (FIRE, Fondazione Italiana per la Ricerca in Epatologia)	This study was supported by a research grant from the Italian Ministry of Education, University and Research (MIUR; grant number RBAP10TPXK to INGM). Francesca Balistreri is the recipient of an annual fellowship of the Italian Foundation for Research in Hepatology (FIRE, Fondazione Italiana per la Ricerca in Epatologia). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Aghemo A, 2009, ANTIVIR THER, V14, P577; Aoki H, 2001, J VET MED SCI, V63, P751, DOI 10.1292/jvms.63.751; Asselah T, 2010, J PATHOL, V221, P264, DOI 10.1002/path.2703; Bernardin F, 2007, VIROLOGY, V365, P446, DOI 10.1016/j.virol.2007.04.003; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; DELATORRE JC, 1990, J VIROL, V64, P6278, DOI 10.1128/JVI.64.12.6278-6281.1990; Farinati F, 2007, J VIRAL HEPATITIS, V14, P821, DOI 10.1111/1365-2893.2007.00878.x; FERNHOLZ D, 1993, VIROLOGY, V194, P137, DOI 10.1006/viro.1993.1243; Fimia GM, 2003, CELL DEATH DIFFER, V10, pS16, DOI 10.1038/sj.cdd.4401114; Fricke J, 2001, VIROLOGY, V291, P77, DOI 10.1006/viro.2001.1170; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Iwai A, 2006, J VIRAL HEPATITIS, V13, P523, DOI 10.1111/j.1365-2893.2006.00760.x; Kupfermann H, 1996, J VIROL, V70, P8175, DOI 10.1128/JVI.70.11.8175-8181.1996; Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; MELEGARI M, 1994, VIROLOGY, V199, P292, DOI 10.1006/viro.1994.1127; MEYERS G, 1995, J VIROL, V69, P3683, DOI 10.1128/JVI.69.6.3683-3689.1995; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Ohtsuru S, 2013, J CLIN MICROBIOL, V51, P3645, DOI 10.1128/JCM.00676-13; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; R Development Core Team, R LANG ENV STAT COMP; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Venables WN., 2002, MODERN APPL STAT S 4; Yagi S, 2005, J MED VIROL, V77, P399, DOI 10.1002/jmv.20469; Yoon SW, 2006, MOL CELLS, V21, P112; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	32	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138546	10.1371/journal.pone.0138546	http://dx.doi.org/10.1371/journal.pone.0138546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405760	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700057
J	Lemic, D; Mikac, KM; Ivkosic, SA; Bazok, R				Lemic, Darija; Mikac, Katarina M.; Ivkosic, Stephanie A.; Bazok, Renata			The Temporal and Spatial Invasion Genetics of the Western Corn Rootworm (Coleoptera: Chrysomelidae) in Southern Europe	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; MULTIPLE TRANSATLANTIC INTRODUCTIONS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; REDUCTIONS; INFERENCE; AMERICAN; PROGRAM	This study describes the genetics of the western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte in southern Europe during the introduction (1996-2001) and establishment/spread (2002-2011) phases of its invasion. The Diabrotica microsatellite core-set was used to perform traditional population genetics analyses. Our results indicated that during the introduction phase genetic diversity and population genetic structure were lower overall as compared to the establishment/spread phase. Unusually high genetic differentiation was found between the Italy and southern Europe comparisons, including high differentiation between Italian populations separated by a short distance during the establishment/ spread phase. STRUCTURE analysis revealed two genetic clusters during the introduction phase and two genetic clusters during the establishment/spread phase. However, bottlenecked populations were only detected during the invasion phase. A small but significant isolation by distance effect was noted in both phases. Serbia was the geographic source of WCR to Croatia and Hungary in the introduction phase, while the United States of America was the possible source of WCR to Italy in 2001. These introductory populations were the subsequent source of individuals sampled during the establishment/spread phase. Repeated introductions and admixture events in southern Europe may have resulted in genetically diverse WCR populations that have attained 83% of all known alleles worldwide.	[Lemic, Darija; Bazok, Renata] Univ Zagreb, Fac Agr, Dept Agr Zool, Zagreb 41000, Croatia; [Mikac, Katarina M.; Ivkosic, Stephanie A.] Univ Wollongong, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia	University of Zagreb; University of Wollongong	Lemic, D (corresponding author), Univ Zagreb, Fac Agr, Dept Agr Zool, Zagreb 41000, Croatia.	dlemic@agr.hr	Bazok, Renata/G-8225-2012	Bazok, Renata/0000-0003-1655-8140; Mikac, Katarina/0000-0002-5779-7351	Ministry of Science, Education and Sports of the Republic of Croatia [178-1782066-2064, 178-1782066-2065]	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	Funding: This research was supported by the Ministry of Science, Education and Sports of the Republic of Croatia by projects: Risk estimation system-the basis for integrated control of corn pests, principal investigator: prof.dr.sc. Renata Bazok 178-1782066-2064. The spatial distribution of economically important pests with the use of GIS, Principal investigator: prof.dr.sc. Jasminka Igrc Barcic 178-1782066-2065.	Baca F, 1994, PFLANZENSCHUTZ, V1-2, P9; Barcic J. I., 2003, Entomologia Croatica, V7, P63; Baufeld P, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P285, DOI 10.1079/9780851998176.0285; Bermond G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050129; Boriani M., 2006, Bulletin OEPP, V36, P531; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Ciosi M, 2011, EVOL APPL, V4, P54, DOI 10.1111/j.1752-4571.2010.00133.x; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; (DEEDI) Department of Employment Economic Development and Innovation, 2011, AUSTR NAT RED IMP FI; Dobrincic Renata, 2002, Agriculturae Conspectus Scientificus, V67, P1; Earl DA, 2011, CONSERVATION GENETIC; (EPPO) European and Mediterranean Plant Protection Organisation, 2011, PRES SIT DIABR VIRG; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Frausin C, 2004, IWGO NEWSLETTER, V2, P8; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ivkosic SA, 2014, ENVIRON ENTOMOL, V43, P804, DOI 10.1603/EN13264; Johannesen J, 2013, ENTOMOL EXP APPL, V147, P61, DOI 10.1111/eea.12041; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kim KS, 2005, ENVIRON ENTOMOL, V34, P494, DOI 10.1603/0046-225X-34.2.494; Kim KS, 2005, MOL ECOL NOTES, V5, P115, DOI 10.1111/j.1471-8286.2004.00853.x; Kim KS, 2008, ENVIRON ENTOMOL, V37, P293, DOI 10.1603/0046-225X(2008)37[293:ACSOMM]2.0.CO;2; Kim KS, 2013, J ASIA-PAC ENTOMOL, V16, P87, DOI 10.1016/j.aspen.2012.11.004; Kiritani Keizi, 2003, P44; Kiss J, 2005, W CORN ROOTWORM ECOL, P285; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Krysan J.L., 1986, METHODS STUDY PEST D, P260; Lemic D, 2013, ENVIRON ENTOMOL, V42, P811, DOI 10.1603/EN12351; Lemic D, 2016, PEST MANAG SCI, V72, P405, DOI 10.1002/ps.4072; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2007, J APPL ENTOMOL, V131, P378, DOI 10.1111/j.1439-0418.2007.01190.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Park M, 2013, B ENTOMOL RES, V103, P414, DOI 10.1017/S0007485313000011; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sappington Thomas W., 2006, American Entomologist, V52, P90; Sivcev I, 2000, P 5 FAO TCP M 6 EPPO; SLATKIN M, 1995, GENETICS, V139, P457; Szalai M, 2011, J PEST SCI, V84, P133, DOI 10.1007/s10340-010-0336-z; Venette R. C., 1998, California Agriculture, V52, P13, DOI 10.3733/ca.v052n02p13; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034567	53	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138796	10.1371/journal.pone.0138796	http://dx.doi.org/10.1371/journal.pone.0138796			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406466	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700100
J	Safia; Kamil, M; Jadiya, P; Sheikh, S; Haque, E; Nazir, A; Lakshmi, V; Mir, SS				Safia; Kamil, Mohd; Jadiya, Pooja; Sheikh, Saba; Haque, Ejazul; Nazir, Aamir; Lakshmi, Vijai; Mir, Snober S.			The Chromone Alkaloid, Rohitukine, Affords Anti-Cancer Activity via Modulating Apoptosis Pathways in A549 Cell Line and Yeast Mitogen Activated Protein Kinase (MAPK) Pathway	PLOS ONE			English	Article							DYSOXYLUM-BINECTARIFERUM; SACCHAROMYCES-CEREVISIAE; CASPASE ACTIVATION; FLAVOPIRIDOL; STRESS; PROLIFERATION; INHIBITOR; CYCLIN; REPRESSION; PRODUCTS	The field of cancer research and treatment has made significant progress, yet we are far from having completely safe, efficient and specific therapies that target cancer cells and spare the healthy tissues. Natural compounds may reduce the problems related to cancer treatment. Currently, many plant products are being used to treat cancer. In this study, Rohitukine, a natural occurring chromone alkaloid extracted from Dysoxylum binectariferum, was investigated for cytotoxic properties against budding yeast as well as against lung cancer (A549) cells. We endeavored to specifically study Rohitukine in S. cerevisiae in the context of MAPK pathways as yeast probably represents the experimental model where the organization and regulation of MAPK pathways are best understood. MAPK are evolutionarily conserved protein kinases that transfer extracellular signals to the machinery controlling essential cellular processes like growth, migration, differentiation, cell division and apoptosis. We aimed at carrying out hypothesis driven studies towards targeting the important network of cellular communication, a critical process that gets awry in cancer. Employing mutant strains of genetic model system Saccharomyces cerevisiae. S. cerevisiae encodes five MAPKs involved in control of distinct cellular responses such as growth, differentiation, migration and apoptosis. Our study involves gene knockouts of Slt2 and Hog1 which are functional homologs of human ERK5 and mammalian p38 MAPK, respectively. We performed cytotoxicity assay to evaluate the effect of Rohitukine on cell viability and also determined the effects of drug on generation of reactive oxygen species, induction of apoptosis and expression of Slt2 and Hog1 gene at mRNA level in the presence of drug. The results of this study show a differential effect in the activity of drug between the WT, Slt2 and Hog1 gene deletion strain indicating involvement of MAPK pathway. Further, we investigated Rohitukine induced cytotoxic effects in lung cancer cells and stimulated the productions of ROS after exposure for 24 hrs. Results from western blotting suggest that Rohitukine triggered apoptosis in A549 cell line through upregulation of p53, caspase9 and down regulation of Bcl-2 protein. The scope of this study is to understand the mechanism of anticancer activity of Rohitukine to increase the repertoire of anticancer drugs, so that problem created by emergence of resistance towards standard anticancer compounds can be alleviated.	[Safia; Kamil, Mohd; Sheikh, Saba; Haque, Ejazul; Mir, Snober S.] Integral Univ, Dept Bioengn & Biosci, Lucknow, Uttar Pradesh, India; [Jadiya, Pooja; Nazir, Aamir] CSIR Cent Drug Res Inst, Lab Funct Genom & Mol Toxicol, Div Toxicol, Lucknow, Uttar Pradesh, India; [Lakshmi, Vijai] King Georges Med Univ, Dept Biochem, Lucknow, Uttar Pradesh, India	Integral University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Mir, SS (corresponding author), Integral Univ, Dept Bioengn & Biosci, Lucknow, Uttar Pradesh, India.	smir@iul.ac.in	Haque, Ejazul/AAS-9597-2020; Safia/AAU-4182-2020	Safia/0000-0002-5562-6460; Kamil, Mohd/0000-0001-9429-2662; Nazir, Aamir/0000-0002-2503-1335; Jadiya, Pooja/0000-0003-4807-9304	Integral University; University Grant Commission India; University Grants Commission (UGC), Government of India [F1-17.1/2011/MANF-MUS-UTT-5405]	Integral University; University Grant Commission India(University Grants Commission, India); University Grants Commission (UGC), Government of India(University Grants Commission, India)	The authors are funded by Integral University and University Grant Commission India. Ms. Safia is grateful to University Grants Commission (UGC), Government of India for Maulana Azad National Fellowship, (F1-17.1/2011/MANF-MUS-UTT-5405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenara J, 2002, LEUKEMIA, V16, P1331, DOI 10.1038/sj.leu.2402535; Azad GK, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0317-0; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Carlson B, 1999, CANCER RES, V59, P4634; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cui YX, 2012, MOL BIOL CELL, V23, P4373, DOI 10.1091/mbc.E12-04-0281; Decker RH, 2001, CELL DEATH DIFFER, V8, P715, DOI 10.1038/sj.cdd.4400868; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsuuw YD, 2005, J CELL PHYSIOL, V205, P379, DOI 10.1002/jcp.20408; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P976; Jiang SY, 2007, J EXP MICROBIOL IMMU, V11, P112; Kaba HEJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-16; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Karathia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016015; Keshri G, 2007, CONTRACEPTION, V76, P400, DOI 10.1016/j.contraception.2007.07.009; Kitada S, 2000, BLOOD, V96, P393; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kumara PM, 2013, ANTON LEEUW INT J G, V101, P323; Lakshmi V, 2007, PHYTOMEDICINE, V14, P36, DOI 10.1016/j.phymed.2005.10.002; Lane N, 2006, NATURE, V440, P600, DOI 10.1038/440600a; Lawrence CL, 2004, MOL CELL BIOL, V24, P3307, DOI 10.1128/MCB.24.8.3307-3323.2004; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Matuo R, 2012, CANCER CHEMOTH PHARM, V70, P491, DOI 10.1007/s00280-012-1937-4; Mitsui K, 2005, FEBS LETT, V579, P723, DOI 10.1016/j.febslet.2004.12.051; Mohanakumara P, 2010, FITOTERAPIA, V81, P145, DOI 10.1016/j.fitote.2009.08.010; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moye-Rowley WS, 2003, PROG NUCLEIC ACID RE, V73, P251, DOI 10.1016/S0079-6603(03)01008-0; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Queralt E, 2005, GENETICS, V171, P1485, DOI 10.1534/genetics.105.045005; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soriano-Carot M, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-1; Stepanov A, 2008, MOL PHARMACOL, V74, P423, DOI 10.1124/mol.107.044651; Stevens SK, 2013, MOL PHARMACOL, V83, P225, DOI 10.1124/mol.112.079657; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Takada Y, 2008, MOL PHARMACOL, V73, P1549, DOI 10.1124/mol.107.041350; Tong NN, 2012, ONCOL LETT, V3, P1263, DOI 10.3892/ol.2012.644; Tsuchiya T, 2008, HEPATO-GASTROENTEROL, V55, P930; Verma M, 2013, PLOS ONE, V7, DOI 10.1371-journal.pone.0042923; WAN CP, 1993, J IMMUNOL METHODS, V159, P131, DOI 10.1016/0022-1759(93)90150-6; WATTS C, 2009, MOL ENDOCRINOL, V9, P1804; Wen J, 2008, J HEALTH SCI, V54, P129, DOI 10.1248/jhs.54.129; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yu CR, 2002, CLIN CANCER RES, V8, P2976; Yuan L, 2013, FOOD CHEM TOXICOL, V53, P62, DOI [10.1016/j.fct.2013.02.003, 10.1016/j.fct.2012.11.048]; Zheng F, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-36	58	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137991	10.1371/journal.pone.0137991	http://dx.doi.org/10.1371/journal.pone.0137991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405812	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700027
J	van Driel, J; Sligte, IG; Linders, J; Elport, D; Cohen, MX				van Driel, Joram; Sligte, Ilja G.; Linders, Jara; Elport, Daniel; Cohen, Michael X.			Frequency Band-Specific Electrical Brain Stimulation Modulates Cognitive Control Processes	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; ANTERIOR CINGULATE CORTEX; INCREASES THETA ENERGY; MEDIAL-FRONTAL-CORTEX; HIGHER RESPONSE-TIME; INDIVIDUAL-DIFFERENCES; DYNAMICS; OSCILLATIONS; MECHANISMS; ADAPTATION	A large body of findings has tied midfrontal theta-band (4-8 Hz) oscillatory activity to adaptive control mechanisms during response conflict. Thus far, this evidence has been correlational. To evaluate whether theta oscillations are causally involved in conflict processing, we applied transcranial alternating current stimulation (tACS) in the theta band to a midfrontal scalp region, while human subjects performed a spatial response conflict task. Conflict was introduced by incongruency between the location of the target stimulus and the required response hand. As a control condition, we used alpha-band (8-12 Hz) tACS over the same location. The exact stimulation frequencies were determined empirically for each subject based on a pre-stimulation EEG session. Behavioral results showed general conflict effects of slower response times (RT) and lower accuracy for high conflict trials compared to low conflict trials. Importantly, this conflict effect was reduced specifically during theta tACS, which was driven by slower response times on low conflict trials. These results show how theta tACS can modulate adaptive cognitive control processes, which is in accordance with the view of midfrontal theta oscillations as an active mechanism for cognitive control.	[van Driel, Joram] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [van Driel, Joram; Sligte, Ilja G.; Linders, Jara; Elport, Daniel] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Sligte, Ilja G.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Sligte, Ilja G.] Univ Birmingham, Dept Psychol, Visual Experience Lab, Birmingham, W Midlands, England; [Cohen, Michael X.] Radboud Univ Nijmegen, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Cohen, Michael X.] Radboud Univ Nijmegen, Univ Med Ctr, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; University of Birmingham; Radboud University Nijmegen; Radboud University Nijmegen	van Driel, J (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	joramvandriel@gmail.com	Cohen, Michael/A-3092-2016	Cohen, Michael/0000-0002-1879-3593; van Driel, Joram/0000-0002-6950-2901	ERC StG [638589]; Netherlands Organization for Scientific Research; Newton International Fellowship from the Royal Academy	ERC StG; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Newton International Fellowship from the Royal Academy	This work was made possible by an ERC StG (project 638589) and a Vidi grant from the Netherlands Organization for Scientific Research (nwo.nl) awarded to MXC, and a Newton International Fellowship from the Royal Academy (raeng.org.uk) awarded to IGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Bestmann S, 2015, TRENDS COGN SCI, V19, P13, DOI 10.1016/j.tics.2014.10.003; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brignani D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056589; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2014, TRENDS NEUROSCI, V37, P480, DOI 10.1016/j.tins.2014.06.004; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2013, CLIN NEUROPHYSIOL, V124, P1479, DOI 10.1016/j.clinph.2013.03.013; Cohen MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057293; Cohen MX, 2013, CEREB CORTEX, V23, P1061, DOI 10.1093/cercor/bhs069; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Duthoo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110462; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Egner T, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00154; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Gulbinaite R, 2014, NEUROIMAGE, V99, P197, DOI 10.1016/j.neuroimage.2014.05.060; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Huster RJ, 2014, BRAIN STRUCT FUNCT, V219, P49, DOI 10.1007/s00429-012-0483-5; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Krause B, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00025; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Meiron O, 2014, CLIN NEUROPHYSIOL, V125, P77, DOI 10.1016/j.clinph.2013.06.013; Neuling T, 2015, NEUROIMAGE, V118, P406, DOI 10.1016/j.neuroimage.2015.06.026; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Pahor A, 2014, INT J PSYCHOPHYSIOL, V93, P322, DOI 10.1016/j.ijpsycho.2014.06.015; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Pastotter B, 2013, J COGNITIVE NEUROSCI, V25, P2167, DOI 10.1162/jocn_a_00474; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Reato D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00687; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P9448, DOI 10.1073/pnas.1504196112; Reinhart RMG, 2014, J NEUROSCI, V34, P4214, DOI 10.1523/JNEUROSCI.5421-13.2014; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Scherbaum S, 2013, CLIN NEUROPHYSIOL, V124, P1477, DOI 10.1016/j.clinph.2012.12.007; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Townsend J. T., 1983, STOCHASTIC MODELING; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; van Driel J, 2015, COGN AFFECT BEHAV NE; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; Vosskuhl J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00257; Weissman DH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00587	53	34	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138984	10.1371/journal.pone.0138984	http://dx.doi.org/10.1371/journal.pone.0138984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405801	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700137
J	Yeung, CY; Chan, WT; Jiang, CB; Cheng, ML; Liu, CY; Chang, SW; Chiau, JSC; Lee, HC				Yeung, Chun-Yan; Chan, Wai-Tao; Jiang, Chun-Bin; Cheng, Mei-Lien; Liu, Chia-Yuan; Chang, Szu-Wen; Chiau, Jen-Shiu Chiang; Lee, Hung-Chang			Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model	PLOS ONE			English	Article							LACTOBACILLUS-FERMENTUM BR11; CLINICAL-PRACTICE GUIDELINES; RECOMMENDED GUIDELINES; RAT MODEL; PREVENTION; 5-FLUOROURACIL; INFLAMMATION; MANAGEMENT; BACTERIA; SAFETY	Background and Aims Intestinal mucositis is a frequently encountered side effect in oncology patients undergoing chemotherapy. No well-established or up to date therapeutic strategies are available. To study a novel way to alleviate mucositis, we investigate the effects and safety of probiotic supplementation in ameliorating 5-FU-induced intestinal mucositis in a mouse model. Methods Seventy-two mice were injected saline or 5-Fluorouracil (5-FU) intraperitoneally daily. Mice were either orally administrated daily saline, probiotic suspension of Lactobacillus casei variety rhamnosus (Lcr35) or Lactobacillus acidophilus and Bifidobacterium bifidum (LaBi). Diarrhea score, pro-inflammatory cytokines serum levels, intestinal villus height and crypt depth and total RNA from tissue were assessed. Samples of blood, liver and spleen tissues were assessed for translocation. Results Marked diarrhea developed in the 5-FU groups but was attenuated after oral Lcr35 and LaBi administrations. Diarrhea scores decreased significantly from 2.64 to 1.45 and 0.80, respectively (P<0.001). Those mice in 5-FU groups had significantly higher proinflammatory cytokine levels (TNF-alpha: 234.80 vs. 29.10, P<0.001, IL-6: 25.13 vs. 7.43, P<0.001, IFN-.: 22.07 vs. 17.06, P = 0.137). A repairing of damage in jejunal villi was observed following probiotics administration. We also found TNF-alpha, IL-1 beta and IL-6 mRNA expressions were up-regulated in intestinal mucositis tissues following 5-FU treatment (TNF-alpha: 4.35 vs. 1.18, IL-1 beta: 2.29 vs. 1.07, IL-6: 1.49 vs. 1.02) and that probiotics treatment suppressed this up-regulation (P<0.05). No bacterial translocation was found in this study. Conclusions In conclusion, our results show that oral administration of probiotics Lcr35 and LaBi can ameliorate chemotherapy-induced intestinal mucositis in a mouse model. This suggests probiotics may serve as an alternative therapeutic strategy for the prevention or management of chemotherapy-induced mucositis in the future.	[Yeung, Chun-Yan; Chan, Wai-Tao; Jiang, Chun-Bin; Chang, Szu-Wen] MacKay Mem Hosp, Dept Pediat, Div Gastroenterol & Nutr, Taipei, Taiwan; [Yeung, Chun-Yan] MacKay Med Coll, Dept Med, New Taipei City, Taiwan; [Yeung, Chun-Yan] MacKay Junior Coll Med Nursing & Management, Taipei, Taiwan; [Yeung, Chun-Yan; Cheng, Mei-Lien; Liu, Chia-Yuan; Chiau, Jen-Shiu Chiang] MacKay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Liu, Chia-Yuan] MacKay Mem Hosp, Dept Hepatol & Gastroenterol, Taipei, Taiwan; [Lee, Hung-Chang] Hsinchu MacKay Mem Hosp, Dept Pediat, Div Gastroenterol & Nutr, Hsinchu, Taiwan; [Lee, Hung-Chang] Taipei Med Univ, Dept Pediat, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Taipei Medical University	Lee, HC (corresponding author), Hsinchu MacKay Mem Hosp, Dept Pediat, Div Gastroenterol & Nutr, Hsinchu, Taiwan.	8231boss@gmail.com			Hsinchu MacKay Memorial Hospital [MMH-10206]; Taipei MacKay Memorial Hospital [MMH-TT-9905]	Hsinchu MacKay Memorial Hospital; Taipei MacKay Memorial Hospital	The authors declare here that this research was supported by research grants from the Hsinchu MacKay Memorial Hospital (MMH-10206) and the Taipei MacKay Memorial Hospital (MMH-TT-9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimosleh SM, 2012, DIGEST DIS SCI, V57, P887, DOI 10.1007/s10620-011-1979-1; Arnold Renee J Goldberg, 2005, J Support Oncol, V3, P227; Bellavia M, 2014, J BIOL REG HOMEOS AG, V28, P251; Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132; Bhatt Valkal, 2010, J Oncol Pharm Pract, V16, P195, DOI 10.1177/1078155209348721; Bowen JM, 2007, CANCER BIOL THER, V6, P1449, DOI 10.4161/cbt.6.9.4622; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carasi P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/208974; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Gibson RJ, 2013, SUPPORT CARE CANCER, V21, P313, DOI 10.1007/s00520-012-1644-z; Gosselink MP, 2004, DIS COLON RECTUM, V47, P1519, DOI 10.1007/s10350-004-0623-y; Grem JL, 2000, INVEST NEW DRUG, V18, P299, DOI 10.1023/A:1006416410198; Haisan A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/286902; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Huang TY, 2009, BIOCHEM BIOPH RES CO, V389, P634, DOI 10.1016/j.bbrc.2009.09.041; Joint FAO/WHO Expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, 2001, FAO FOOD NUTR PAPER, P1; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Lalla RV, 2006, CANCER J, V12, P348, DOI 10.1097/00130404-200609000-00004; Leiper K, 2001, CLIN SCI, V101, P395, DOI 10.1042/CS20010078; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Maioli TU, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/1477-5751-13-6; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; Mauger CA, 2007, DIGEST DIS SCI, V52, P612, DOI 10.1007/s10620-006-9464-y; Llana MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082588; Prisciandaro LD, 2012, SUPPORT CARE CANCER, V20, P3205, DOI 10.1007/s00520-012-1446-3; Prisciandaro LD, 2011, CRIT REV FOOD SCI, V51, P239, DOI 10.1080/10408390903551747; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; Smith CL, 2008, NUTR CANCER, V60, P757, DOI 10.1080/01635580802192841; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Stringer AM, 2009, EXP BIOL MED, V234, P430, DOI 10.3181/0810-RM-301; Takiue S, 2013, ANAT REC, V296, P443, DOI 10.1002/ar.22652; Tazuke Y, 2011, PEDIATR SURG INT, V27, P151, DOI 10.1007/s00383-010-2798-8; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Wadler S, 1998, J CLIN ONCOL, V16, P3169, DOI 10.1200/JCO.1998.16.9.3169; Wagner AE, 2012, J CELL MOL MED, V16, P836, DOI 10.1111/j.1582-4934.2011.01367.x; Wang S, 2013, NUTR RES, V33, P1072, DOI 10.1016/j.nutres.2013.09.002; Wassenaar TM, 2008, J FOOD PROTECT, V71, P1734, DOI 10.4315/0362-028X-71.8.1734; Whitford EJ, 2009, CANCER BIOL THER, V8, P505, DOI 10.4161/cbt.8.6.7594; Yeung CY, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/973209	47	93	99	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138746	10.1371/journal.pone.0138746	http://dx.doi.org/10.1371/journal.pone.0138746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406888	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700082
J	Farr, JN; Roforth, MM; Fujita, K; Nicks, KM; Cunningham, JM; Atkinson, EJ; Therneau, TM; McCready, LK; Peterson, JM; Drake, MT; Monroe, DG; Khosla, S				Farr, Joshua N.; Roforth, Matthew M.; Fujita, Koji; Nicks, Kristy M.; Cunningham, Julie M.; Atkinson, Elizabeth J.; Therneau, Terry M.; McCready, Louise K.; Peterson, James M.; Drake, Matthew T.; Monroe, David G.; Khosla, Sundeep			Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; BONE-MINERAL DENSITY; VAN-BUCHEM-DISEASE; POSTMENOPAUSAL WOMEN; EMBRYONIC LETHALITY; CIRCULATING SCLEROSTIN; SOST GENE; MICE; TURNOVER; NOTCH	Precise delineation of the specific genes and pathways altered with aging and estrogen (E) therapy may lead to new skeletal biomarkers and the development of novel bone therapeutics. Previous human bone studies, however, have been limited by only examining prespecified genes and pathways. High-throughput RNA sequencing (RNAseq), on the other hand, offers an unbiased approach to examine the entire transcriptome. Here we present an RNAseq analysis of human bone samples, obtained from iliac crest needle biopsies, to yield the first in vivo interrogation of all genes and pathways that may be altered in bone with aging and E therapy in humans. 58 healthy women were studied, including 19 young women (mean age +/- SD, 30.3 +/- 5.4 years), 19 old women (73.1 +/- 6.6 years), and 20 old women treated with 3 weeks of E therapy (70.5 +/- 5.2 years). Using generally accepted criteria (false discovery rate [q] < 0.10), aging altered a total of 678 genes and 12 pathways, including a subset known to regulate bone metabolism (e.g., Notch). Interestingly, the LEF1 transcription factor, which is a classical downstream target of the Wnt/beta-catenin signaling pathway, was significantly downregulated in the bones from the old versus young women; consistent with this, LEF1 binding sites were significantly enriched in the promoter regions of the differentially expressed genes in the old versus young women, suggesting that aging was associated with alterations in Wnt signaling in bone. Further, of the 21 unique genes altered in bone by E therapy, the expression of INHBB (encoding for the inhibin, beta B polypeptide), which decreased with aging (by 0.6-fold), was restored to young adult levels in response to E therapy. In conclusion, our data demonstrate that aging alters a substantial portion of the skeletal transcriptome, whereas E therapy appears to have significant, albeit less wide-ranging effects. These data provide a valuable resource for the potential identification of novel biomarkers associated with age-related bone loss and also highlight potential pathways that could be targeted to treat osteoporosis.	[Farr, Joshua N.; Roforth, Matthew M.; Fujita, Koji; Nicks, Kristy M.; McCready, Louise K.; Peterson, James M.; Drake, Matthew T.; Monroe, David G.; Khosla, Sundeep] Mayo Clin, Div Endocrinol, Dept Med, Coll Med, Rochester, MN 55905 USA; [Farr, Joshua N.; Roforth, Matthew M.; Fujita, Koji; Nicks, Kristy M.; Drake, Matthew T.; Monroe, David G.; Khosla, Sundeep] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Coll Med, Rochester, MN 55905 USA; [Cunningham, Julie M.] Mayo Clin, Dept Expt Pathol & Lab Med, Coll Med, Rochester, MN 55905 USA; [Atkinson, Elizabeth J.; Therneau, Terry M.] Mayo Clin, Div Biomed Stat & Informat, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Khosla, S (corresponding author), Mayo Clin, Div Endocrinol, Dept Med, Coll Med, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020; Fujita, Koji/K-3905-2019	Khosla, Sundeep/0000-0002-2936-4372; Fujita, Koji/0000-0003-3733-0188	NIH [P01 AG004875, UL1TR000135]; Merck; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH Grant P01 AG004875, UL1TR000135, and an investigator-initiated grant from Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayturk UM, 2013, J BONE MINER RES, V28, P2081, DOI 10.1002/jbmr.1946; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Clarke Bart L, 2013, Bonekey Rep, V2, P361, DOI 10.1038/bonekey.2013.95; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Durosier C, 2013, J CLIN ENDOCR METAB, V98, P3873, DOI 10.1210/jc.2013-2113; Fajardo RJ, 2010, BONE, V46, P64, DOI 10.1016/j.bone.2009.09.018; Fatayerji D, 1999, J BONE MINER RES, V14, P1203, DOI 10.1359/jbmr.1999.14.7.1203; Fujita K, 2014, OSTEOPOROSIS INT, V25, P887, DOI 10.1007/s00198-013-2529-9; Fujita K, 2014, J CLIN ENDOCR METAB, V99, pE81, DOI 10.1210/jc.2013-3249; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Il Modder U, 2011, J BONE MINER RES, V26, P27, DOI 10.1002/jbmr.128; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosla S, 2013, J GERONTOL A-BIOL, V68, P1226, DOI 10.1093/gerona/gls163; Krebs LT, 2000, GENE DEV, V14, P1343; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Lotinun S., 2012, CURR MOL PHARMACOL, V5, P195, DOI DOI 10.2174/1874467211205020195; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Nicks KM, 2009, MOL CELL ENDOCRINOL, V310, P11, DOI 10.1016/j.mce.2009.07.001; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roforth MM, 2014, BONE, V59, P1, DOI 10.1016/j.bone.2013.10.019; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tseng YH, 2014, AUTOPHAGY, V10, P20, DOI 10.4161/auto.26126; Tu XL, 2015, P NATL ACAD SCI USA, V112, pE478, DOI 10.1073/pnas.1409857112; van Lierop AH, 2010, EUR J ENDOCRINOL, V163, P833, DOI 10.1530/EJE-10-0699; van Lierop AH, 2011, J BONE MINER RES, V26, P2804, DOI 10.1002/jbmr.474; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	67	45	46	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138347	10.1371/journal.pone.0138347	http://dx.doi.org/10.1371/journal.pone.0138347			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402159	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100021
J	Frederiksen, J; Buggert, M; Noyan, K; Nowak, P; Sonnerborg, A; Lund, O; Karlsson, AC				Frederiksen, Juliet; Buggert, Marcus; Noyan, Kajsa; Nowak, Piotr; Sonnerborg, Anders; Lund, Ole; Karlsson, Annika C.			Multidimensional Clusters of CD4+T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection	PLOS ONE			English	Article							FLOW-CYTOMETRY DATA; IMMUNE ACTIVATION; T-LYMPHOCYTES; ANTIRETROVIRAL THERAPY; GASTROINTESTINAL-TRACT; DISEASE PROGRESSION; LYMPH-NODES; VIRAL LOAD; IDENTIFICATION; POPULATION	HIV infection provokes a myriad of pathological effects on the immune system where many markers of CD4+ T cell dysfunction have been identified. However, most studies to date have focused on single/double measurements of immune dysfunction, while the identification of pathological CD4+ T cell clusters that is highly associated to a specific biomarker for HIV disease remain less studied. Here, multi-parametric flow cytometry was used to investigate immune activation, exhaustion, and senescence of diverse maturation phenotypes of CD4+ T cells. The traditional method of manual data analysis was compared to a multidimensional clustering tool, FLOw Clustering with K (FLOCK) in two cohorts of 47 untreated HIV-infected individuals and 21 age and sex matched healthy controls. In order to reduce the subjectivity of FLOCK, we developed an "artificial reference", using 2% of all CD4+ gated T cells from each of the HIV-infected individuals. Principle component analyses demonstrated that using an artificial reference lead to a better separation of the HIV-infected individuals from the healthy controls as compared to using a single HIV-infected subject as a reference or analyzing data manually. Multiple correlation analyses between laboratory parameters and pathological CD4+ clusters revealed that the CD4/CD8 ratio was the preeminent surrogate marker of CD4+ T cells dysfunction using all three methods. Increased frequencies of an early-differentiated CD4+ T cell cluster with high CD38, HLA-DR and PD-1 expression were best correlated (Rho = -0.80, P value = 1.96x10(-11)) with HIV disease progression as measured by the CD4/CD8 ratio. The novel approach described here can be used to identify cell clusters that distinguish healthy from HIV infected subjects and is biologically relevant for HIV disease progression. These results further emphasize that a simple measurement of the CD4/CD8 ratio is a useful biomarker for assessment of combined CD4+ T cell dysfunction in chronic HIV disease.	[Frederiksen, Juliet; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Buggert, Marcus; Noyan, Kajsa; Nowak, Piotr; Sonnerborg, Anders; Karlsson, Annika C.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Buggert, Marcus] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Nowak, Piotr; Sonnerborg, Anders] Karolinska Univ Hosp Huddinge, Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden	Technical University of Denmark; Karolinska Institutet; University of Pennsylvania; Karolinska Institutet; Karolinska University Hospital	Buggert, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	marcus.buggert@ki.se	Buggert, Marcus/F-4663-2018; Lund, Ole/F-4437-2014; Sönnerborg, Anders/W-2011-2019; Karlsson, Annika/R-2255-2016	Buggert, Marcus/0000-0003-0633-1719; Lund, Ole/0000-0003-1108-0491; Sönnerborg, Anders/0000-0001-8928-3374; Karlsson, Annika/0000-0002-2028-8393; Noyan, Kajsa/0000-0002-1053-6832; Nowak, Piotr/0000-0003-2747-0734	Swedish Research Council [K2010-56X-20345-04-3, K2014-57X-22451-01-5]; Swedish Physicians Against AIDS Research Foundation [Fob2013-0008]; Magnus Bergvalls foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Physicians Against AIDS Research Foundation; Magnus Bergvalls foundation; Karolinska Institutet(Karolinska Institutet)	This work was supported by The Swedish Research Council (Grants K2010-56X-20345-04-3 and K2014-57X-22451-01-5), http://www.vr.se/; The Swedish Physicians Against AIDS Research Foundation (Fob2013-0008), http://www.aidsfond.se/; Magnus Bergvalls foundation (2013), http://www.magnbergvallsstiftelse.nu/; Karolinska Institutet (Partial funding of new postgraduate student at Karolinska Institutet 2010-2013), https://internwebben.ki.se/en/grants-office.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; Amadori A, 1996, IMMUNOL TODAY, V17, P414, DOI 10.1016/0167-5699(96)10049-9; Anglaret X, 1997, J ACQ IMMUN DEF SYND, V14, P361, DOI 10.1097/00042560-199704010-00009; Anglaret X, 1998, INT J EPIDEMIOL, V27, P928, DOI 10.1093/ije/27.5.928; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Buggert M, 2014, J IMMUNOL, V192, P2099, DOI 10.4049/jimmunol.1302596; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Cossarizza A, 2013, CYTOM PART A, V83A, P680, DOI 10.1002/cyto.a.22318; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Freer G, 2013, METHODS, V61, P30, DOI 10.1016/j.ymeth.2013.03.035; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lelic A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003076; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; McArthur MA, 2013, CLIN IMMUNOL, V146, P140, DOI 10.1016/j.clim.2012.12.003; McArthur MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038408; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Norstrom MM, 2012, J VIROL, V86, P9802, DOI 10.1128/JVI.01165-12; O'Donnell Erika A, 2013, Immune Netw, V13, P43, DOI 10.4110/in.2013.13.2.43; O'Neill K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003365; Pedreira CE, 2013, TRENDS BIOTECHNOL, V31, P415, DOI 10.1016/j.tibtech.2013.04.008; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; R RDCT, 2011, R FDN STAT COMPUT, V1, P409; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Strindhall J, 2007, EXP GERONTOL, V42, P753, DOI 10.1016/j.exger.2007.05.001; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137635	10.1371/journal.pone.0137635	http://dx.doi.org/10.1371/journal.pone.0137635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402620	gold, Green Published, Green Submitted			2022-12-26	WOS:000361798100013
J	Seki, Y; Kikuchi, Y; Kimura, Y; Yoshimoto, R; Takahashi, M; Aburai, K; Kanai, Y; Ruike, T; Iwabata, K; Sugawara, F; Sakai, H; Abe, M; Sakaguchi, K				Seki, Yasutaka; Kikuchi, Yukiko; Kimura, Yoshihiro; Yoshimoto, Ryo; Takahashi, Masatoshi; Aburai, Kenichi; Kanai, Yoshihiro; Ruike, Tatsushi; Iwabata, Kazuki; Sugawara, Fumio; Sakai, Hideki; Abe, Masahiko; Sakaguchi, Kengo			Enhancement of Cellulose Degradation by Cattle Saliva	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; NONAQUEOUS SYSTEMS; FUEL ETHANOL; X-RAY; SURFACTANT; LIGNOCELLULOSE; DEACTIVATION; NEWSPAPER; MECHANISM; BSA	Saccharification of cellulose is a promising technique for producing alternative source of energy. However, the efficiency of conversion of cellulose into soluble sugar using any currently available methodology is too low for industrial application. Many additives, such as surfactants, have been shown to enhance the efficiency of cellulose-to-sugar conversion. In this study, we have examined first whether cattle saliva, as an additive, would enhance the cellulase-catalyzed hydrolysis of cellulose, and subsequently elucidated the mechanism by which cattle saliva enhanced this conversion. Although cattle saliva, by itself, did not degrade cellulose, it enhanced the cellulase-catalyzed degradation of cellulose. Thus, the amount of reducing sugar produced increased approximately 2.9-fold by the addition of cattle saliva. We also found that non-enzymatic proteins, which were present in cattle saliva, were responsible for causing the enhancement effect. Third, the mechanism of cattle saliva mediated enhancement of cellulase activity was probably similar to that of the canonical surfactants. Cattle saliva is available in large amounts easily and cheaply, and it can be used without further purification. Thus, cattle saliva could be a promising additive for efficient saccharification of cellulose on an industrial scale.	[Seki, Yasutaka; Kimura, Yoshihiro; Takahashi, Masatoshi; Kanai, Yoshihiro; Ruike, Tatsushi; Iwabata, Kazuki; Abe, Masahiko; Sakaguchi, Kengo] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 278, Japan; [Kikuchi, Yukiko; Yoshimoto, Ryo; Aburai, Kenichi; Sakai, Hideki] Tokyo Univ Sci, Dept Ind Chem, Noda, Chiba 278, Japan; [Sugawara, Fumio] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Science	Sakaguchi, K (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 278, Japan.	kengo@rs.noda.tus.ac.jp	Abe, Masahiko/F-3236-2017	Abe, Masahiko/0000-0001-6255-316X				Barry AJ, 1936, J AM CHEM SOC, V58, P333, DOI 10.1021/ja01293a043; Borjesson J, 2007, ENZYME MICROB TECH, V41, P186, DOI 10.1016/j.enzmictec.2007.01.003; CASTANON M, 1981, BIOTECHNOL BIOENG, V23, P1365, DOI 10.1002/bit.260230615; CHIQUETTE J, 1992, CAN J ANIM SCI, V72, P299, DOI 10.4141/cjas92-037; Davis WE, 1943, J AM CHEM SOC, V65, P1294, DOI 10.1021/ja01247a012; Duff SJB, 1996, BIORESOURCE TECHNOL, V55, P1, DOI 10.1016/0960-8524(95)00122-0; Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5; FAN LT, 1980, BIOTECHNOL BIOENG, V22, P177, DOI 10.1002/bit.260220113; Hattori K, 2004, POLYM J, V36, P123, DOI 10.1295/polymj.36.123; HELLE SS, 1993, BIOTECHNOL BIOENG, V42, P611, DOI 10.1002/bit.260420509; HOWELL JA, 1978, BIOTECHNOL BIOENG, V20, P847, DOI 10.1002/bit.260200607; Kaar WE, 1998, BIOTECHNOL BIOENG, V59, P419, DOI 10.1002/(SICI)1097-0290(19980820)59:4&lt;419::AID-BIT4&gt;3.0.CO;2-J; KAYA F, 1995, TAPPI J, V78, P150; KIM MH, 1982, ENZYME MICROB TECH, V4, P99, DOI 10.1016/0141-0229(82)90090-4; KLYOSOV AA, 1980, ENZYME ENG FUTURE DI, P83; Kristensen JB, 2007, ENZYME MICROB TECH, V40, P888, DOI 10.1016/j.enzmictec.2006.07.014; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; OOSHIMA H, 1986, BIOTECHNOL BIOENG, V28, P1727, DOI 10.1002/bit.260281117; PARK JW, 1992, BIOTECHNOL BIOENG, V39, P117, DOI 10.1002/bit.260390117; Wang H, 2013, APPL BIOCHEM BIOTECH, V170, P541, DOI 10.1007/s12010-013-0208-0; Yan LF, 2008, CELLULOSE, V15, P789, DOI 10.1007/s10570-008-9233-5; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Zhang YQ, 2011, BIOTECHNOL BIOPROC E, V16, P930, DOI 10.1007/s12257-011-0138-z	24	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138902	10.1371/journal.pone.0138902	http://dx.doi.org/10.1371/journal.pone.0138902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402242	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100041
J	Gutierrez-Gonzalez, CE; Gomez-Ramirez, MA; Lopez-Gonzalez, CA; Doherty, PF				Gutierrez-Gonzalez, Carmina E.; Gomez-Ramirez, Miguel A.; Lopez-Gonzalez, Carlos A.; Doherty, Paul F., Jr.			Are Private Reserves Effective for Jaguar Conservation?	PLOS ONE			English	Article							TAG-RECOVERY DATA; PANTHERA-ONCA; MARKED ANIMALS; RECAPTURE; SURVIVAL; MEXICO; POPULATION; MAMMALS; BRAZIL; MODEL	We present the first study of density and apparent survival for a jaguar (Panthera onca) population in northern Mexico using 13 years of camera trap data from 2000 to 2012. We used the Barker robust design model which combines data from closed sampling periods and resight data between these periods to estimate apparent survival and abundance. We identified 467 jaguar pictures that corresponded to 48 jaguar individuals. We included camera type and field technician as covariates for detection probabilities. We used three covariates to evaluate the effect of reserve on jaguar apparent survival: i) private reserve creation ii) later reserve expansions, and iii) cattle ranches' conservation activities. We found that the use of digital cameras in addition to film cameras increased detection probability by a factor of 6x compared with the use of only film cameras (p = 0.34 +/- 0.05 and p = 0.05 +/- 0.02 respectively) in the closed period and more than three times in the open period (R = 0.91 +/- 0.08 and R = 0.30 +/- 0.13 mixed and film cameras respectively). Our availability estimates showed no temporary emigration and a fidelity probability of 1. Despite an increase of apparent survival probability from 0.47 +/- 0.15 to 0.56 +/- 0.11 after 2007, no single covariate explained the change in these point estimates. Mean jaguar density was 1.87 +/- 0.47 jaguars/100 km(2). We found that 13 years of jaguar population monitoring with our sampling size were not enough for detecting changes in survival or density. Our results provide a baseline for studies evaluating the effectiveness of protected areas and the inclusion of ranch owners in jaguar conservation programs and long-term population viability.	[Gutierrez-Gonzalez, Carmina E.; Gomez-Ramirez, Miguel A.; Lopez-Gonzalez, Carlos A.] Univ Autonoma Queretaro, Fac Ciencias Nat, Zool Lab, Santiago De Queretaro, Queretaro, Mexico; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Universidad Autonoma de Queretaro; Colorado State University	Gutierrez-Gonzalez, CE (corresponding author), Univ Autonoma Queretaro, Fac Ciencias Nat, Zool Lab, Santiago De Queretaro, Queretaro, Mexico.	reservajaguar@gmail.com	Gonzalez, Carlos A Lopez/AEN-3112-2022		Defenders of Wildlife; Disney Worldwide Conservation Fund; Jeniam Foundation; Wendy P. McCaw Foundation; David & Lucile Packard Foundation; Patagonia; Shared Earth Foundation; CONACYT	Defenders of Wildlife; Disney Worldwide Conservation Fund; Jeniam Foundation; Wendy P. McCaw Foundation; David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Patagonia; Shared Earth Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Defenders of Wildlife, Disney Worldwide Conservation Fund, Jeniam Foundation, Wendy P. McCaw Foundation, David & Lucile Packard Foundation, Patagonia, Shared Earth Foundation, CONACYT provided a full scholarship for CEGG and MAGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker RJ, 2004, STAT SINICA, V14, P1037; Barker RJ, 1997, BIOMETRICS, V53, P666, DOI 10.2307/2533966; Brown D. E., 2001, BORDERLAND JAGUARS T; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; de Azevedo FCC, 2008, BIOTROPICA, V40, P494, DOI 10.1111/j.1744-7429.2008.00404.x; Caso A, 2008, IUCN 2014 IUCN RED L; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Collins CT, 2006, J FIELD ORNITHOL, V77, P310, DOI 10.1111/j.1557-9263.2006.00057.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Cooch E. G., 2014, PROGRAM MARK GENTLE; Cousins JA, 2008, ECOL SOC, V13; Cuervo-Robayo AP, 2012, REV BIOL TROP, V60, P1357; de la Torre JA, 2011, ORYX, V45, P546, DOI 10.1017/S0030605310001511; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Efford MG, 2014, ECOLOGY, V95, P1341, DOI 10.1890/13-1497.1; Felger RS, 2001, THE TREES OF SONORA; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gutierrez-Gonzalez CE, 2012, ORYX, V46, P431, DOI 10.1017/S003060531100041X; Hetem Robyn S, 2014, Temperature (Austin), V1, P115, DOI 10.4161/temp.29651; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kelly Marcella J., 2009, P187, DOI 10.1002/9781444312034.ch9; Kendall WL, 2013, METHODS ECOL EVOL, V4, P828, DOI 10.1111/2041-210X.12077; Kendall WL, 2014, PROGRAM MARK GENTLE, P566; Kotze DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040923; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Loery G, 1997, AUK, V114, P431, DOI 10.2307/4089244; Lukacs P, 2014, PROGRAM MARK GENTLE, P528; Maffei L, 2008, BIOTROPICA, V40, P71, DOI 10.1111/j.1744-7429.2007.00341.x; MILLER P, 2013, POPULATION VIABILITY; Moreno R, 2008, TECNOCIENCIA, V10, P115; Negroes N, 2012, ECOL RES, V27, P639, DOI 10.1007/s11284-012-0938-4; Nunez R, 2000, ENDANGERED ANIMALS, P159; OTIS DL, 1978, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Portillo Reyes H. O., 2011, Revista Latinoamericana de Conservacion, V2, P45; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; ROSAS-ROSAS Octavio C., 2012, Acta Zool. Mex, V28, P86; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; SEYMOUR KL, 1989, MAMMALIAN SPECIES, V340, P1, DOI DOI 10.2307/3504096; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Soto J, 2008, THESIS U FLORIDA; Trolle M, 2003, BIODIVERS CONSERV, V12, P823, DOI 10.1023/A:1022489426920; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 1982, LA8787NERP LOS AL NA; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	55	10	11	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137541	10.1371/journal.pone.0137541	http://dx.doi.org/10.1371/journal.pone.0137541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398115	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500039
J	Kuo, TL; Weng, CC; Kuo, KK; Chen, CY; Wu, DC; Hung, WC; Cheng, KH				Kuo, T-L; Weng, C-C; Kuo, K-K; Chen, C-Y; wu, D-C; Hung, W-C; Cheng, K-H			APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice	ONCOGENE			English	Article							SOLID-PSEUDOPAPILLARY TUMORS; POLYPOSIS-COLI PROTEIN; SOMATIC MUTATIONS; SIGNALING PATHWAY; WNT/BETA-CATENIN; MOUSE MODEL; CANCER; PROGRESSION; EXPRESSION; GENE	Adenomatous polyposis coli (APC), a tumor-suppressor gene critically involved in familial adenomatous polyposis, is integral in Wnt/beta-catenin signaling and is implicated in the development of sporadic tumors of the distal gastrointestinal tract including pancreatic cancer (PC). Here we report for the first time that functional APC is required for the growth and maintenance of pancreatic islets and maturation. Subsequently, a non-Kras mutation-induced premalignancy mouse model was developed; in this model, APC haploinsufficiency coupled with p53 deletion resulted in the development of a distinct type of pancreatic premalignant precursors, mucinous cystic neoplasms (MCNs), exhibiting pathomechanisms identical to those observed in human MCNs, including accumulation of cystic fluid secreted by neoplastic and ovarian-like stromal cells, with 100% penetrance and the presence of hepatic and gastric metastases in >30% of the mice. The major clinical implications of this study suggest targeting the Wnt signaling pathway as a novel strategy for managing MCN.	[Kuo, T-L; Weng, C-C; Cheng, K-H] Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan; [Kuo, K-K] Kaohsiung Med Univ Hosp, Div Hepatobiliopancreat Surg, Dept Surg, Kaohsiung, Taiwan; [Kuo, K-K; Chen, C-Y; wu, D-C; Cheng, K-H] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Chen, C-Y] Kaohsiung Med Univ Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [wu, D-C] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [wu, D-C] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Div Internal Med, Kaohsiung, Taiwan; [Hung, W-C] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Cheng, K-H] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University	Cheng, KH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.	khcheng@faculty.nsysu.edu.tw			National Science Council, Taiwan ROC [NSC 101-2314-B-110-001-MY2, 101-2628-B-110-001-MY2, MOST 103-2314-B-037-062]; Kaohsiung Medical University, Kaohsiung, Taiwan [KMU-TP103G00, KMU-TP103G01]	National Science Council, Taiwan ROC(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University, Kaohsiung, Taiwan	We gratefully thank Dr Sheau-Fang Yang, at Kaohsiung Medical University for helping us to confirm the histologic features and pathology of MCN mice. This work was supported by grants NSC 101-2314-B-110-001-MY2, 101-2628-B-110-001-MY2 (to KH Cheng) and MOST 103-2314-B-037-062 (to DC Wu and KH Cheng) from the National Science Council, Taiwan ROC, and grants KMU-TP103G00 and KMU-TP103G01 (to DC Wu and KH Cheng) from Kaohsiung Medical University, Kaohsiung, Taiwan.	Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Abraham SC, 2001, AM J PATHOL, V159, P1619, DOI 10.1016/S0002-9440(10)63008-8; Al-Haddad M, 2011, CLIN GASTROENTEROL H, V9, P635, DOI 10.1016/j.cgh.2011.03.005; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Bonk T, 2002, CLIN BIOCHEM, V35, P87, DOI 10.1016/S0009-9120(02)00279-5; Chiu CY, 2012, MOL CANCER RES, V10, P415, DOI 10.1158/1541-7786.MCR-11-0293; Dessimoz J, 2006, CELL CYCLE, V5, P7, DOI 10.4161/cc.5.1.2293; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Farrell JJ, 2013, GASTROENTEROLOGY, V144, P1303, DOI 10.1053/j.gastro.2013.01.073; Fazeli A, 1997, P NATL ACAD SCI USA, V94, P10199, DOI 10.1073/pnas.94.19.10199; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Guo MZ, 2014, DISCOV MED, V17, P67; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; HORII A, 1992, CANCER RES, V52, P6696; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ichii Shigetoshi, 1992, Human Molecular Genetics, V1, P387, DOI 10.1093/hmg/1.6.387; Ischenko I, 2013, P NATL ACAD SCI USA, V110, P3937, DOI 10.1073/pnas.1219592110; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jiang H, 2014, AM J PATHOL, V184, P1355, DOI 10.1016/j.ajpath.2014.01.037; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lang J, 2013, J NEUROSCI, V33, P3113, DOI 10.1523/JNEUROSCI.3467-12.2013; Le Borgne J, 1997, Chirurgie, V122, P31; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mavila N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050401; Milde-Langosch K, 2014, BREAST CANCER RES TR, V145, P295, DOI 10.1007/s10549-014-2949-z; Mimeault M, 2008, GUT, V57, P1456, DOI 10.1136/gut.2008.150052; Monti P, 2003, CANCER RES, V63, P7451; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Murakami Y, 2006, SURGERY, V140, P448, DOI 10.1016/j.surg.2006.03.017; Narayan S, 1997, J BIOL CHEM, V272, P30619, DOI 10.1074/jbc.272.49.30619; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; PELLEGATA NS, 1994, CANCER RES, V54, P1556; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Pujal J, 2006, BBA-MOL BASIS DIS, V1762, P73, DOI 10.1016/j.bbadis.2005.08.002; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sano M, 2014, GASTROENTEROLOGY, V146, P257, DOI 10.1053/j.gastro.2013.09.044; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Sekine H, 2012, BIOCHEM BIOPH RES CO, V429, P214, DOI 10.1016/j.bbrc.2012.10.048; Shimada M, 2002, J IMMUNOL, V168, P861, DOI 10.4049/jimmunol.168.2.861; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Strom A, 2007, DEVELOPMENT, V134, P2719, DOI 10.1242/dev.02875; Su HT, 2013, MOL CANCER RES, V11, P768, DOI 10.1158/1541-7786.MCR-12-0511; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tang LH, 2005, AM J SURG PATHOL, V29, P512, DOI 10.1097/01.pas.0000155159.28530.88; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007; Tsukamoto N, 2013, PANCREAS, V42, P1027, DOI 10.1097/MPA.0b013e31828804e7; Ueno K, 2011, INT J CANCER, V129, P2360, DOI 10.1002/ijc.25899; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	67	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2223	2234		10.1038/onc.2015.284	http://dx.doi.org/10.1038/onc.2015.284			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26411367				2022-12-26	WOS:000374986000008
J	Selzer, L; Kant, R; Wang, JCY; Bothner, B; Zlotnick, A				Selzer, Lisa; Kant, Ravi; Wang, Joseph C. -Y.; Bothner, Brian; Zlotnick, Adam			Hepatitis B Virus Core Protein Phosphorylation Sites Affect Capsid Stability and Transient Exposure of the C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH DOMAIN; ENCAPSIDATION; RNA	Hepatitis B virus core protein has 183 amino acids divided into an assembly domain and an arginine-rich C-terminal domain (CTD) that regulates essential functions including genome packaging, reverse transcription, and intracellular trafficking. Here, we investigated the CTD in empty hepatitis B virus (HBV) T = 4 capsids. We examined wild-type core protein (Cp183-WT) and a mutant core protein (Cp183-EEE), in which three CTD serines are replaced with glutamate to mimic phosphorylated protein. Wefound that Cp183-WT capsids were less stable than Cp183-EEE capsids. When we tested CTD sensitivity to trypsin, we detected two different populations of CTDs differentiated by their rate of trypsin cleavage. Interestingly, CTDs from Cp183-EEE capsids exhibited a much slower rate of proteolytic cleavage when compared with CTDs of Cp183-WT capsids. Cryo-electron microscopy studies of trypsin-digested capsids show that CTDs at five-fold symmetry vertices are most protected. We hypothesize that electrostatic interactions between glutamates and arginines in Cp183-EEE, particularly at five-fold, increase capsid stability and reduce CTD exposure. Our studies show that quasi-equivalent CTDs exhibit different rates of exposure and thus might perform distinct functions during the hepatitis B virus lifecycle. Our results demonstrate a structural role for CTD phosphorylation and indicate crosstalk between CTDs within a capsid particle.	[Selzer, Lisa; Wang, Joseph C. -Y.; Zlotnick, Adam] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Kant, Ravi; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Indiana University System; Indiana University Bloomington; Montana State University System; Montana State University Bozeman	Zlotnick, A (corresponding author), Dept Mol & Cellular Biochem, 212 S Hawthorne Dr, Bloomington, IN 47405 USA.	azlotnic@indiana.edu		Zlotnick, Adam/0000-0001-9945-6267; Wang, Joseph Che-Yen/0000-0001-6580-3531	Murdock Charitable Trust; National Institutes of Health of the CoBRE program [5P20RR02437]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077688] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health of the CoBRE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Michael Boersma and Dr. Malcom Winkler for their experimental contributions and Jonathan Hilmer for assistance with mass spectrometry instrumentation. The mass spectrometry facility at Montana State University receives funding from the Murdock Charitable Trust and National Institutes of Health 5P20RR02437 of the CoBRE program.	BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; Chen C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002388; Chu TH, 2014, J VIROL, V88, P2530, DOI 10.1128/JVI.03235-13; Cum X., 2013, J VIROL, V87, P11494; Dhason MS, 2012, VIROLOGY, V430, P20, DOI 10.1016/j.virol.2012.04.012; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Hilmer JK, 2008, J MOL BIOL, V375, P581, DOI 10.1016/j.jmb.2007.10.044; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Lewellyn EB, 2011, J VIROL, V85, P1298, DOI 10.1128/JVI.01957-10; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Rayaprolu V., 2014, BIOPROTOC, V4, P1199; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; STANNARD LM, 1979, J GEN VIROL, V45, P509, DOI 10.1099/0022-1317-45-2-509; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang JCY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002919; Wittkop L, 2010, CELL MICROBIOL, V12, P962, DOI 10.1111/j.1462-5822.2010.01444.x; Yan XD, 2007, J STRUCT BIOL, V157, P211, DOI 10.1016/j.jsb.2006.07.013; Yan X, 2007, J STRUCT BIOL, V157, P73, DOI 10.1016/j.jsb.2006.08.007; Yu XK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069729; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	37	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28584	+		10.1074/jbc.M115.678441	http://dx.doi.org/10.1074/jbc.M115.678441			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405031	hybrid, Green Published			2022-12-26	WOS:000365761900049
J	Remesh, SG; Santosh, V; Escalante, CR				Remesh, Soumya G.; Santosh, Vishaka; Escalante, Carlos R.			Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR FAMILY; SECONDARY STRUCTURE PREDICTION; PLASMA-CELL DIFFERENTIATION; ANGLE SCATTERING DATA; X-RAY-SCATTERING; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; FUNCTIONAL IMPLICATIONS; PROTEIN-PROTEIN	IRF4 is a unique member of the interferon regulatory factor (IRF) family playing critical regulatory roles in immune cell development, regulation of obesity-induced inflammation, and control of thermogenic gene expression. The ability of IRF4 to control diverse transcriptional programs arises from its proficiency to interact with numerous transcriptional partners. In this study, we present the structural characterization of full-length IRF4. Using a combination of x-ray and small angle x-ray scattering studies, we reveal unique features of the interferon activation domain, including a set of beta-sheets and loops that serve as the binding site for PU.1, and also show that unlike other IRF members, IRF4 has a flexible autoinhibitory region. In addition, we have determined the small angle x-ray scattering solution structure of full-length IRF4, which, together with circular dichroism studies, suggests that the linker region is not extended but folds into a domain structure.	[Remesh, Soumya G.; Santosh, Vishaka; Escalante, Carlos R.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Virginia Commonwealth University	Escalante, CR (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, 1220 E Broad St, Richmond, VA 23298 USA.	cescalante@vcu.edu	Regan, Clinton/E-6250-2012; Remesh, Soumya G/I-3558-2019		National Institutes of Health [R01-GM092854, R21-CA179008]; Virginia Commonwealth University PRQF award; NATIONAL CANCER INSTITUTE [R21CA179008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University PRQF award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health Grants R01-GM092854 and R21-CA179008 and a Virginia Commonwealth University PRQF award. The authors declare that they have no conflicts of interest with the contents of this article.	Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Guo S, 2014, CELL DEATH DIFFER, V21, P888, DOI 10.1038/cdd.2014.9; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hayes D, 1995, PROGRAM SEDNTERP SED; Jiang DS, 2013, HYPERTENSION, V61, P1193, DOI 10.1161/HYPERTENSIONAHA.111.00614; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meraro D, 1999, J IMMUNOL, V163, P6468; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perkel JM, 1998, J IMMUNOL, V160, P241; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shukla H, 2012, BIOCHEMISTRY-US, V51, P6320, DOI 10.1021/bi300260s; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wang JT, 2014, INNATE IMMUN-LONDON, V20, P78, DOI 10.1177/1753425913485307; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yee AA, 1998, J MOL BIOL, V279, P1075, DOI 10.1006/jmbi.1998.1838; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	65	16	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27779	27790		10.1074/jbc.M115.678789	http://dx.doi.org/10.1074/jbc.M115.678789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405037	Green Published, hybrid			2022-12-26	WOS:000365757500029
J	del Prado, A; Lazaro, JM; Longas, E; Villar, L; de Vega, M; Salas, M				del Prado, Alicia; Lazaro, Jose M.; Longas, Elisa; Villar, Laurentino; de Vega, Miguel; Salas, Margarita			Insights into the Determination of the Templating Nucleotide at the Initiation of phi 29 DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PRIMED INITIATION; SLIDING-BACK MECHANISM; STRAND-DISPLACEMENT CAPACITY; BACTERIOPHAGE PRD1 DNA; IN-VITRO REPLICATION; VACCINIA VIRUS-DNA; TERMINAL PROTEIN; PHAGE PHI-29; FUNCTIONAL-CHARACTERIZATION; LINEAR TEMPLATE	Bacteriophage phi 29 from Bacillus subtilis starts replication of its terminal protein (TP)-DNA by a protein-priming mechanism. To start replication, the DNA polymerase forms a heterodimer with a free TP that recognizes the replication origins, placed at both 5 ends of the linear chromosome, and initiates replication using as primer the OH-group of Ser-232 of the TP. The initiation of phi 29 TP-DNA replication mainly occurs opposite the second nucleotide at the 3 end of the template. Earlier analyses of the template position that directs the initiation reaction were performed using single-stranded and double-stranded oligonucleotides containing the replication origin sequence without the parental TP. Here, we show that the parental TP has no influence in the determination of the nucleotide used as template in the initiation reaction. Previous studies showed that the priming domain of the primer TP determines the template position used for initiation. The results obtained here using mutant TPs at the priming loop where Ser-232 is located indicate that the aromatic residue Phe-230 is one of the determinants that allows the positioning of the penultimate nucleotide at the polymerization active site to direct insertion of the initiator dAMP during the initiation reaction. The role of Phe-230 in limiting the internalization of the template strand in the polymerization active site is discussed.	[del Prado, Alicia; Lazaro, Jose M.; Longas, Elisa; Villar, Laurentino; de Vega, Miguel; Salas, Margarita] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Vega, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	mdevega@cbm.csic.es; msalas@cbm.csic.es	de Vega, Miguel/K-2878-2014; Salas, Margarita/J-9873-2014; del Prado, Alicia/K-4473-2017	de Vega, Miguel/0000-0003-1285-7549; Salas, Margarita/0000-0001-5939-3441; 	Spanish Ministry of Economy and Competitiveness [BFU2014-52656-P, BFU 2014-53791P]; Consolider-Ingenio from the Spanish Ministry of Science and Innovation [CSD2007-00015]; Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa"; Spanish Ministry of Education	Spanish Ministry of Economy and Competitiveness(Spanish Government); Consolider-Ingenio from the Spanish Ministry of Science and Innovation; Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa"; Spanish Ministry of Education(Spanish Government)	This work was supported in part by the Spanish Ministry of Economy and Competitiveness Grants BFU2014-52656-P (to M. S.) and BFU 2014-53791P (to M. V.), Consolider-Ingenio from the Spanish Ministry of Science and Innovation Grant CSD2007-00015 (to M. S.), and a Institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa." The authors declare that they have no conflicts of interest with the content of this article.; Supported by a predoctoral fellowship from the Spanish Ministry of Education.	BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1987, J VIROL, V61, P3983, DOI 10.1128/JVI.61.12.3983-3991.1987; BLASCO MA, 1990, NUCLEIC ACIDS RES, V18, P4763; CALDENTEY J, 1992, NUCLEIC ACIDS RES, V20, P3971, DOI 10.1093/nar/20.15.3971; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; de Vega M, 1998, J BIOL CHEM, V273, P28966, DOI 10.1074/jbc.273.44.28966; Dufour E, 2000, J MOL BIOL, V304, P289, DOI 10.1006/jmbi.2000.4216; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; GARON CF, 1978, P NATL ACAD SCI USA, V75, P4863, DOI 10.1073/pnas.75.10.4863; GESHELIN P, 1974, J MOL BIOL, V88, P785, DOI 10.1016/0022-2836(74)90399-4; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P14678, DOI 10.1074/jbc.M910058199; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P40547, DOI 10.1074/jbc.M007170200; GUTIERREZ J, 1986, VIROLOGY, V155, P474, DOI 10.1016/0042-6822(86)90209-6; GUTIERREZ J, 1986, GENE, V43, P1, DOI 10.1016/0378-1119(86)90002-8; Illana B, 1996, J MOL BIOL, V264, P453, DOI 10.1006/jmbi.1996.0653; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; Kornberg A., 1992, DNA REPLICATION; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Longas E, 2006, NUCLEIC ACIDS RES, V34, P6051, DOI 10.1093/nar/gkl769; Longas E, 2008, P NATL ACAD SCI USA, V105, P18290, DOI 10.1073/pnas.0809882105; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; Mencia M, 2011, P NATL ACAD SCI USA, V108, P18655, DOI 10.1073/pnas.1114397108; Mendez J, 1997, EMBO J, V16, P2519, DOI 10.1093/emboj/16.9.2519; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; Munoz-Espin D, 2010, P NATL ACAD SCI USA, V107, P16548, DOI 10.1073/pnas.1010530107; Perez-Arnaiz P, 2007, NUCLEIC ACIDS RES, V35, P7061, DOI 10.1093/nar/gkm749; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6407, DOI 10.1073/pnas.0500597102; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SCHLEGEL RA, 1972, J MOL BIOL, V68, P319, DOI 10.1016/0022-2836(72)90216-1; TAYLOR K, 1995, FEMS MICROBIOL REV, V17, P109	36	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27138	27145		10.1074/jbc.M115.682278	http://dx.doi.org/10.1074/jbc.M115.682278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26400085	Green Published, hybrid			2022-12-26	WOS:000364794000023
J	Jutla, A; Aldaach, H; Billian, H; Akanda, A; Huq, A; Colwell, R				Jutla, Antarpreet; Aldaach, Haidar; Billian, Hannah; Akanda, Ali; Huq, Anwar; Colwell, Rita			Satellite Based Assessment of Hydroclimatic Conditions Related to Cholera in Zimbabwe	PLOS ONE			English	Article							CLIMATE-CHANGE; ENVIRONMENTAL-FACTORS; VIBRIO-CHOLERAE; OUTBREAKS; AFRICA; DISEASE; HEALTH	Introduction Cholera, an infectious diarrheal disease, has been shown to be associated with large scale hydroclimatic processes. The sudden and sporadic occurrence of epidemic cholera is linked with high mortality rates, in part, due to uncertainty in timing and location of outbreaks. Improved understanding of the relationship between pathogenic abundance and climatic processes allows prediction of disease outbreak to be an achievable goal. In this study, we show association of large scale hydroclimatic processes with the cholera epidemic in Zimbabwe reported to have begun in Chitungwiza, a city in Mashonaland East province, in August, 2008. Principal Findings Climatic factors in the region were found to be associated with triggering cholera outbreak and are shown to be related to anomalies of temperature and precipitation, validating the hypothesis that poor conditions of sanitation, coupled with elevated temperatures, and followed by heavy rainfall can initiate outbreaks of cholera. Spatial estimation by satellite of precipitation and global gridded air temperature captured sensitivities in hydroclimatic conditions that permitted identification of the location in the region where the disease outbreak began. Discussion Satellite derived hydroclimatic processes can be used to capture environmental conditions related to epidemic cholera, as occurred in Zimbabwe, thereby providing an early warning system. Since cholera cannot be eradicated because the causative agent, Vibrio cholerae, is autochthonous to the aquatic environment, prediction of conditions favorable for its growth and estimation of risks of triggering the disease in a given population can be used to alert responders, potentially decreasing infection and saving lives.	[Jutla, Antarpreet; Aldaach, Haidar; Billian, Hannah] W Virginia Univ, Dept Civil & Environm Engn, Morgantown, WV 26506 USA; [Akanda, Ali] Univ Rhode Isl, Dept Civil & Environm Engn, Kingston, RI 02881 USA; [Huq, Anwar; Colwell, Rita] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Colwell, Rita] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Colwell, Rita] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	West Virginia University; University of Rhode Island; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jutla, A (corresponding author), W Virginia Univ, Dept Civil & Environm Engn, Morgantown, WV 26506 USA.	asjutla@mail.wvu.edu; rcolwell@mail.wvu.edu		Jutla, Antarpreet/0000-0002-8191-2348	NASA [NNX15AF71G]; WV NASA space grant	NASA(National Aeronautics & Space Administration (NASA)); WV NASA space grant	This research is funded in part from a NASA grant (NNX15AF71G) and WV NASA space grant.	Akanda AS, 2012, B WORLD HEALTH ORGAN, V90, P243, DOI 10.2471/BLT.11.092189; Akanda AS, 2014, LANCET GLOB HEALTH, V2, pE69, DOI 10.1016/S2214-109X(13)70155-4; Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Bompangue D, 2008, EMERG INFECT DIS, V14, P798, DOI 10.3201/eid1405.071260; Bompangue Didier, 2012, PLoS Curr, V4, pRRN1310; CDC Foundation, CHOL OUTBR INV CENTR, P20; Central African Republic, CENTR AFR REP SEV LO; Enserink M, 2010, NATURE, V330, P738, DOI [10.1126/science.330.6005.738, DOI 10.1126/SCIENCE.330.6005.738]; Fernandez MAL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-442; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; Hosmer DW, 1997, STAT MED, V16, P965; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; ISLAM MS, 1995, T ROY SOC TROP MED H, V89, P506, DOI 10.1016/0035-9203(95)90086-1; Jutla A, 2013, AM J TROP MED HYG, V89, P597, DOI 10.4269/ajtmh.12-0721; Jutla AS, 2011, AM J TROP MED HYG, V85, P303, DOI 10.4269/ajtmh.2011.11-0181; Jutla AS, 2010, J AM WATER RESOUR AS, V46, P651, DOI 10.1111/j.1752-1688.2010.00448.x; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Mendelsohn J, 2008, INT J HYG ENVIR HEAL, V211, P156, DOI 10.1016/j.ijheh.2006.12.002; MIH R, 2012, CHOL OUTBR KIN BIR H, P5; Mukandavire Z, 2011, P NATL ACAD SCI USA, V108, P8767, DOI 10.1073/pnas.1019712108; Rebaudet S, 2013, J INFECT DIS, V208, pS46, DOI 10.1093/infdis/jit195; Relief Web, 2013, 6 REL WEB; Reyburn R, 2011, AM J TROP MED HYG, V84, P862, DOI 10.4269/ajtmh.2011.10-0277; Thompson AA, 2012, INT J ENV RES PUB HE, V9, P831, DOI 10.3390/ijerph9030831; Traerup SLM, 2011, INT J ENV RES PUB HE, V8, P4386, DOI 10.3390/ijerph8124386; Turton A, 2008, CSIRNREWREXP20080160, P28; WHO, WHO RESP HLTH CRIS F; WHO, 2014, CHOL OUTBR JUB; WHO, CHOL ZIMB UPD; World Health Organization, GLOB TASK FORC CHOL, V2; World Health Organization, GLOB TASK FORC CHOL, P2	32	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137828	10.1371/journal.pone.0137828	http://dx.doi.org/10.1371/journal.pone.0137828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417994	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400009
J	Occhipinti, S; Chambers, SK; Lepore, S; Aitken, J; Dunn, J				Occhipinti, Stefano; Chambers, Suzanne K.; Lepore, Stephen; Aitken, Joanne; Dunn, Jeff			A Longitudinal Study of Post-Traumatic Growth and Psychological Distress in Colorectal Cancer Survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; PHYSICAL-ACTIVITY; DIAGNOSIS; ADJUSTMENT; PREVALENCE; BENEFITS; MODEL	The stability of post-traumatic growth over time and the relationship between post-traumatic growth and traditional distress outcomes remains unclear. We tracked post-traumatic growth in a population-based sample of colorectal cancer patients from soon after diagnosis to five years subsequently to assess the heterogeneity of a post-traumatic growth response to cancer over time and describe the simultaneous and longitudinal relationships between post-traumatic growth and psychological distress. 1966 colorectal patients who were five months post diagnosis were assessed six times over a five year period. There was considerable heterogeneity associated with both psychological distress and benefit finding scores over time. However, both for benefit finding and psychological distress, the variation in individual scores suggested an underlying positive linear trend and both lagged and lagged change components. Specifically, benefit finding and psychological distress are mutual leading indicators of each other. First, benefit finding served as a leading indicator of distress, in that increases in reported benefit finding from year to year predicted higher future increases in psychological distress. As well, in an inverse relationship, psychological distress served as a leading indicator of benefit finding, such that increases in reported distress from year to year predicted lower future increases in benefit finding. Post-traumatic growth may reflect patients coping efforts to enhance perceptions of wellbeing in response to escalating cancer-related threats, acting as harbinger of increasing trajectories of psychological distress. This explanation is consistent with a cognitive dissonance response in which threats to the integrity of the self then lead to a tendency to accentuate positive aspects of the self.	[Occhipinti, Stefano; Chambers, Suzanne K.; Aitken, Joanne; Dunn, Jeff] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [Chambers, Suzanne K.; Aitken, Joanne; Dunn, Jeff] Canc Council Queensland, Ctr Canc Res, Brisbane, Qld, Australia; [Chambers, Suzanne K.] Edith Cowan Univ, Hlth & Wellness Inst, Perth, WA, Australia; [Chambers, Suzanne K.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Lepore, Stephen] Temple Univ, Coll Publ Hlth, Dept Social & Behav Sci, Philadelphia, PA 19122 USA; [Aitken, Joanne] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Aitken, Joanne; Dunn, Jeff] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Cancer Council Queensland; Edith Cowan University; University of Queensland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Queensland University of Technology (QUT); University of Queensland	Chambers, SK (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.	suzanne.chambers@griffith.edu.au	Lepore, Stephen/AAE-3485-2020; Occhipinti, Stefano/G-3361-2015; Chambers, Suzanne K/H-5957-2012	Lepore, Stephen/0000-0001-7370-6280; Occhipinti, Stefano/0000-0002-2558-0609; Chambers, Suzanne K/0000-0003-2369-6111; Aitken, Joanne Frances/0000-0001-6859-2186; Dunn, Jeff/0000-0002-1180-3381	Cancer Council Queensland	Cancer Council Queensland(Cancer Council Queensland)	The original study was funded by Cancer Council Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck G, 1996, J PERS, V64, P899, DOI 10.1111/j.1467-6494.1996.tb00948.x; Chambers SK, 2012, QUAL LIFE RES, V21, P1551, DOI 10.1007/s11136-011-0067-5; Coyne JC, 2010, ANN BEHAV MED, V39, P16, DOI 10.1007/s12160-009-9154-z; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; Engelhard I. M., 2014, CLIN PSYCHOL SCI; Festinger L, 1956, PROPHECY FAILS, DOI 10.1037/10030-000; Frazier P, 2014, EUR J PERSONALITY, V28, P337; Frazier P, 2009, PSYCHOL SCI, V20, P912, DOI 10.1111/j.1467-9280.2009.02381.x; Grimm KJ, 2012, STRUCT EQU MODELING, V19, P268, DOI 10.1080/10705511.2012.659627; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Jansen L, 2011, BRIT J CANCER, V105, P1158, DOI 10.1038/bjc.2011.335; Jayawickreme E, 2014, EUR J PERSONALITY, V28, P312, DOI 10.1002/per.1963; Kernan WD, 2009, SOC SCI MED, V68, P1176, DOI 10.1016/j.socscimed.2008.12.038; Lynch BM, 2007, MED J AUSTRALIA, V186, P288, DOI 10.5694/j.1326-5377.2007.tb00902.x; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Park CL, 2009, MED ILLNESS POSITIVE; Rinaldis M, 2010, BRIT J PSYCHOL, V101, P259, DOI 10.1348/000712609X448676; Stone J, 2001, J EXP SOC PSYCHOL, V37, P228, DOI 10.1006/jesp.2000.1446; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tennen H., 2009, MEDICAL ILLNESS POSI, P31, DOI DOI 10.1037/11854-002; Tomich PL, 2004, HEALTH PSYCHOL, V23, P16, DOI 10.1037/0278-6133.23.1.16; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	29	26	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139119	10.1371/journal.pone.0139119	http://dx.doi.org/10.1371/journal.pone.0139119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418357	Green Published, Green Accepted, gold			2022-12-26	WOS:000362171400045
J	Yang, SY; Huh, IS; Baek, JH; Cho, EY; Choi, MJ; Ryu, S; Kim, JS; Park, T; Ha, K; Hong, KS				Yang, So Yung; Huh, Ik Soo; Baek, Ji Hyun; Cho, Eun-Young; Choi, Mi Ji; Ryu, Seunghyong; Kim, Ji Sun; Park, Taesung; Ha, Kyooseob; Hong, Kyung Sue			Association between ST8SIA2 and the Risk of Schizophrenia and Bipolar I Disorder across Diagnostic Boundaries	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; OLFACTORY-BULB; PSA-NCAM; LINKAGE; SCAN; GENE; PSYCHOSIS; FAMILIES; SPECTRUM	Background Findings from family studies and recent genome-wide association studies have indicated overlap in the risk genes between schizophrenia and bipolar disorder (BD). After finding a linkage between the ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2, 8-sicalyltransferase 2 gene) locus (15q26) and mixed families with schizophrenia and BD, several studies have reported a significant association between this gene and schizophrenia or BD. We investigated the genetic association between ST8SIA2 and both schizophrenia and BD in the Korean population. Methods A total of 582 patients with schizophrenia, 339 patients with BD, and 502 healthy controls were included. Thirty-one tag single nucleotide polymorphisms (SNPs) across the ST8SIA2 region and three other SNPs showing significant associations in previous studies were genotyped. The associations were evaluated by logistic regression analysis using additive, dominant, and recessive genetic models. Results Fourteen of 34 SNPs showed a nominally significant association (p < 0.05) with at least one diagnostic group. These association trends were strongest for the schizophrenia and combined schizophrenia and bipolar I disorder (BD-I) groups. The strongest association was observed in rs11637898 for schizophrenia (p = 0.0033) and BD-I (p = 0.0050) under the dominant model. The association between rs11637898 and the combined schizophrenia and BD-I group (p = 0.0006, under the dominant model) remained significant after correcting for multiple testing. Discussion We identified a possible role of ST8SIA2 in the common susceptibility of schizophrenia and BD-I. However, no association trend was observed for bipolar II disorder. Further efforts are needed to identify a specific phenotype associated with this gene crossing the current diagnostic categories.	[Yang, So Yung; Baek, Ji Hyun; Ryu, Seunghyong; Kim, Ji Sun; Hong, Kyung Sue] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea; [Huh, Ik Soo; Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Cho, Eun-Young; Choi, Mi Ji; Hong, Kyung Sue] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Ha, Kyooseob] Seoul Natl Hosp, Seoul, South Korea; [Ha, Kyooseob] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neuropsychiat, Kyunggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Hong, KS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea.	hongks@skku.edu		Ha, Kyooseob/0000-0001-5035-2950	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120887]; National Research Foundation (NRF) of Korea grant - Korea government (MSIP) [2012R1A3A2026438]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation (NRF) of Korea grant - Korea government (MSIP)	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120887). The work of T Park and IS H was supported by National Research Foundation (NRF) of Korea grant funded by the Korea government (MSIP) (No. 2012R1A3A2026438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDREASEN NC, 1987, ARCH GEN PSYCHIAT, V44, P461; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Baek JH, 2011, J AFFECT DISORDERS, V131, P59, DOI 10.1016/j.jad.2010.11.020; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Clayton D., 2014, SNPSTATS SNPMATRIX X; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Gilabert-Juan J, 2013, PSYCHIAT RES, V210, P1293, DOI 10.1016/j.psychres.2013.09.001; Gonzalez-Pinto A, 1998, J AFFECT DISORDERS, V50, P41, DOI 10.1016/S0165-0327(98)00032-9; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Keshavan MS, 2011, SCHIZOPHR RES, V133, P250, DOI 10.1016/j.schres.2011.09.005; Krabbendam L, 2005, SCHIZOPHR RES, V80, P137, DOI 10.1016/j.schres.2005.08.004; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McAuley EZ, 2009, MOL PSYCHIATR, V14, P492, DOI 10.1038/sj.mp.4002146; McAuley EZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038172; Merikangas KR, 2014, MOL PSYCHIATR, V19, P214, DOI 10.1038/mp.2013.116; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Ryu S, 2013, PSYCHIAT RES, V210, P756, DOI 10.1016/j.psychres.2013.08.015; Sadock BJ, 2014, SYNOPSIS PSYCHIAT BE, P23; Sanches M, 2008, PROG NEURO-PSYCHOPH, V32, P1617, DOI 10.1016/j.pnpbp.2008.04.017; Seki T, 1998, J NEUROSCI, V18, P3757; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Tamminga CA, 2013, AM J PSYCHIAT, V170, P1263, DOI 10.1176/appi.ajp.2013.12101339; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Valles V, 2000, SCHIZOPHR RES, V42, P83, DOI 10.1016/S0920-9964(99)00117-6; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Vieta E, 1997, COMPR PSYCHIAT, V38, P98, DOI 10.1016/S0010-440X(97)90088-2	46	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139413	10.1371/journal.pone.0139413	http://dx.doi.org/10.1371/journal.pone.0139413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418860	Green Published, gold, Green Submitted			2022-12-26	WOS:000362171400088
J	Nyri, K; Kohegyi, B; Micsonai, A; Kardos, J; Vertessy, BG				Nyri, Kinga; Kohegyi, Bianka; Micsonai, Andras; Kardos, Jozsef; Vertessy, Beata G.			Evidence-Based Structural Model of the Staphylococcal Repressor Protein: Separation of Functions into Different Domains	PLOS ONE			English	Article							PHOSPHATE ESTER HYDROLYSIS; CRYSTAL-STRUCTURE; LAMBDA-REPRESSOR; SECONDARY STRUCTURE; CATALYTIC MECHANISM; C1 REPRESSOR; STRUCTURE PREDICTION; ACTIVE-SITE; DUTPASE; OPERATOR	Horizontal transfer of mobile genetic elements within Staphylococci is of high biomedical significance as such elements are frequently responsible for virulence and toxic effects. Staphylococcus-encoded repressor proteins regulate the replication of these mobile genetic elements that are located within the so-called pathogenicity islands. Here, we report structural and functional characterization of one such repressor protein, namely the Stl protein encoded by the pathogenicity island SaPIbov1. We create a 3D structural model and based on this prediction, we investigate the different functionalities of truncated and point mutant constructs. Results suggest that a helix-turn-helix motif governs the interaction of the Stl protein with its cognate DNA site: point mutations within this motif drastically decrease DNA-binding ability, whereas the interaction with the Stl-binding partner protein dUTPase is unperturbed by these point mutations. The 3D model also suggested the potential independent folding of a carboxy-terminal domain. This suggestion was fully verified by independent experiments revealing that the carboxy-terminal domain does not bind to DNA but is still capable of binding to and inhibiting dUTPase. A general model is proposed, which suggests that among the several structurally different repressor superfamilies Stl-like Staphylococcal repressor proteins belong to the helix-turn-helix transcription factor group and the HTH motif is suggested to reside within N-terminal segment.	[Nyri, Kinga; Kohegyi, Bianka; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary; [Nyri, Kinga; Kohegyi, Bianka; Vertessy, Beata G.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary; [Micsonai, Andras; Kardos, Jozsef] Eotvos Lorand Univ, Inst Biol, Dept Biochem, H-1117 Budapest, Hungary; [Micsonai, Andras; Kardos, Jozsef] Eotvos Lorand Univ, Inst Biol, MTA ELTE NAP B Neuroimmunol Res Grp, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University	Nyri, K (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary.	nyiri.kinga@ttk.mta.hu; vertessy@mail.bme.hu	Kardos, József/J-1035-2017; Vertessy, Beata G/H-6202-2012	Kardos, József/0000-0002-2135-2932; Vertessy, Beata G./0000-0002-1288-2982	Hungarian Scientific Research Fund OTKA [NK 84008, K109486]; Baross Program of the New Hungary Development Plan [3DSTRUCT] [OMFB-00266/2010 REG-KM- 09-1-2009-0050]; Hungarian Academy of Sciences [TTK IF-28/2012]; Hungarian Academy of Sciences (MedinProt program); ICGEB Research Grant [CRP/HUN14-01]; European Commission FP7 Biostruct-X project [283570]; Hungarian Academy of Sciences;  [KTIA_NAP_13-2-2014-0017]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Baross Program of the New Hungary Development Plan [3DSTRUCT]; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Academy of Sciences (MedinProt program); ICGEB Research Grant(Department of Biotechnology (DBT) India); European Commission FP7 Biostruct-X project; Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This study was supported by the Hungarian Scientific Research Fund OTKA [NK 84008, K109486]; Baross Program of the New Hungary Development Plan [3DSTRUCT, OMFB-00266/2010 REG-KM- 09-1-2009-0050]; Hungarian Academy of Sciences ([TTK IF-28/2012]; MedinProt program); CRP/HUN14-01 ICGEB Research Grant to BGV and the European Commission FP7 Biostruct-X project [contract No. 283570]. Funding for open access charge: Hungarian Academy of Sciences. A. M. and J.K. were supported by the KTIA_NAP_13-2-2014-0017 program. SRCD experiments were supported by SOLEIL (Proposal No. 20140646).	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Albright RA, 1998, J MOL BIOL, V280, P137, DOI 10.1006/jmbi.1998.1848; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; Bell CE, 2001, J MOL BIOL, V314, P1127, DOI 10.1006/jmbi.2000.5196; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; CARLSON PA, 1994, J BACTERIOL, V176, P6907, DOI 10.1128/JB.176.22.6907-6914.1994; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Donner AL, 1997, J BACTERIOL, V179, P1253, DOI 10.1128/jb.179.4.1253-1261.1997; HEINZEL T, 1990, J BIOL CHEM, V265, P17928; HEINZEL T, 1992, J BIOL CHEM, V267, P4183; Hemsworth GR, 2013, BIOCHEM J, V456, P81, DOI 10.1042/BJ20130796; Hirmondo R, 2015, DNA REPAIR, V30, P21, DOI 10.1016/j.dnarep.2015.03.005; Hochschild A, 2009, CURR OPIN STRUC BIOL, V19, P79, DOI 10.1016/j.sbi.2008.12.008; Horvati K, 2015, TUBERCULOSIS, V95, pS207, DOI 10.1016/j.tube.2015.02.026; ISACKSON PJ, 1985, P NATL ACAD SCI USA, V82, P6226, DOI 10.1073/pnas.82.18.6226; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Leveles I, 2013, ACTA CRYSTALLOGR D, V69, P2298, DOI 10.1107/S0907444913021136; Leveles I, 2011, ACTA CRYSTALLOGR F, V67, P1411, DOI 10.1107/S1744309111034580; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nagy GN, 2014, FEBS J, V281, P4207, DOI 10.1111/febs.12941; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Orosz F, 1997, BRIT J PHARMACOL, V121, P947, DOI 10.1038/sj.bjp.0701189; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Pedersen M, 2008, J MOL BIOL, V376, P983, DOI 10.1016/j.jmb.2007.12.022; Persson R, 2001, CURR PROTEIN PEPT SC, V2, P287, DOI 10.2174/1389203013381035; Pinkett HW, 2006, MOL CELL, V21, P605, DOI 10.1016/j.molcel.2006.01.019; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; RIEDEL HD, 1993, FEBS LETT, V334, P165, DOI 10.1016/0014-5793(93)81705-5; ROBERTS JW, 1975, P NATL ACAD SCI USA, V72, P147, DOI 10.1073/pnas.72.1.147; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Shearwin KE, 1998, J BIOL CHEM, V273, P5708, DOI 10.1074/jbc.273.10.5708; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stayrook S, 2008, NATURE, V452, P1022, DOI 10.1038/nature06831; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Takacs E, 2004, FEBS LETT, V566, P48, DOI 10.1016/j.febslet.2004.04.039; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; VERTESSY BG, 1994, BBA-PROTEIN STRUCT M, V1205, P146, DOI 10.1016/0167-4838(94)90103-1; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wojciak JM, 2001, NAT STRUCT BIOL, V8, P84	64	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139086	10.1371/journal.pone.0139086	http://dx.doi.org/10.1371/journal.pone.0139086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414067	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000362170700041
J	Smith, M; Wilson, R; O'Brien, S; Tufarelli, C; Anderson, SI; O'Sullivan, SE				Smith, Marie; Wilson, Richard; O'Brien, Sally; Tufarelli, Cristina; Anderson, Susan I.; O'Sullivan, Saoirse Elizabeth			The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation	PLOS ONE			English	Article							TYPE-2 CANNABINOID RECEPTOR; MARROW STROMAL CELLS; REGULATES BONE MASS; FUNCTION IN-VITRO; OSTEOCLAST FUNCTION; KINASE; MICE; OSTEOPOROSIS; INVOLVEMENT; SYSTEM	The endocannabinoid system is expressed in bone, although its role in the regulation of bone growth is controversial. Many studies have examined the effect of endocannabinoids directly on osteoclast function, but few have examined their role in human osteoblast function, which was the aim of the present study. Human osteoblasts were treated from seeding with increasing concentrations of anandamide or 2-arachidonoylglycerol for between 1 and 21 days. Cell proliferation (DNA content) and differentiation (alkaline phosphatase (ALP), collagen and osteocalcin secretion and calcium deposition) were measured. Anandamide and 2-arachidonoylglycerol significantly decreased osteoblast proliferation after 4 days, associated with a concentration-dependent increase in ALP. Inhibition of endocannabinoid degradation enzymes to increase endocannabinoid tone resulted in similar increases in ALP production. 2-arachidonoylglycerol also decreased osteocalcin secretion. After prolonged (21 day) treatment with 2-arachidonoylglycerol, there was a decrease in collagen content, but no change in calcium deposition. Anandamide did not affect collagen or osteocalcin, but reduced calcium deposition. Anandamide increased levels of phosphorylated CREB, ERK 1/2 and JNK, while 2-arachidonoylglycerol increased phosphorylated CREB and Akt. RT-PCR demonstrated the expression of CB2 and TRPV1, but not CB1 in HOBs. Anandamide-induced changes in HOB differentiation were CB1 and CB2-independent and partially reduced by TRPV1 antagonism, and reduced by inhibition of ERK 1/2 and JNK. Our results have demonstrated a clear involvement of anandamide and 2-arachidonoylglycerol in modulating the activity of human osteoblasts, with anandamide increasing early cell differentiation and 2-AG increasing early, but decreasing late osteoblast-specific markers of differentiation.	[Smith, Marie; Wilson, Richard; O'Brien, Sally; Tufarelli, Cristina; Anderson, Susan I.; O'Sullivan, Saoirse Elizabeth] Univ Nottingham, Royal Derby Hosp, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England	University of Nottingham	O'Sullivan, SE (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England.	saoirse.osullivan@nottingham.ac.uk	Tufarelli, Cristina/AAD-3265-2019	Tufarelli, Cristina/0000-0002-1053-4618; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610; O'Brien, Sally/0000-0003-1269-8648; Kokolski, Marie/0000-0002-7779-4887; Smith, Marie/0000-0002-0874-4624				Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Bab I, 2009, ANN MED, V41, P560, DOI 10.1080/07853890903121025; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Di Silvio L, 1995, NOVEL APPL 2 BIOMATE; Doan TKP, 2012, TISSUE ENG REGEN MED, V9, P283, DOI 10.1007/s13770-012-0352-6; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Gui H, 2015, INT IMMUNOPHARMACOL, V26, P86, DOI 10.1016/j.intimp.2015.03.006; Henstock JR, 2014, J MATER SCI-MATER M, V25, P1087, DOI 10.1007/s10856-014-5140-5; Henstock JR, 2009, POROUS SILICON POLYC; Hind W.H., 2015, BR J PHARM; Hind WH, 2015, BRIT J PHARMACOL, V172, P3015, DOI 10.1111/bph.13106; Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Hutchins HL, 2011, J NUTR BIOCHEM, V22, P195, DOI 10.1016/j.jnutbio.2010.06.001; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Idris AI, 2008, ENDOCRINOLOGY, V149, P5619, DOI 10.1210/en.2008-0150; Idris AI, 2010, BONE, V46, P1089, DOI 10.1016/j.bone.2010.01.368; Idris AI, 2009, CELL METAB, V10, P139, DOI 10.1016/j.cmet.2009.07.006; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Karsak M, 2005, HUM MOL GENET, V14, P3389, DOI 10.1093/hmg/ddi370; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.95; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Rossi F, 2009, BONE, V44, P476, DOI 10.1016/j.bone.2008.10.056; Rossi F, 2011, BONE, V48, P997, DOI 10.1016/j.bone.2011.01.001; Scutt A, 2007, CALCIFIED TISSUE INT, V80, P50, DOI 10.1007/s00223-006-0171-7; Sophocleous A, 2011, ENDOCRINOLOGY, V152, P2141, DOI 10.1210/en.2010-0930; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Whyte LS, 2012, BRIT J PHARMACOL, V165, P2584, DOI 10.1111/j.1476-5381.2011.01519.x; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yamanouchi K, 1997, J BONE MINER METAB, V15, P23, DOI DOI 10.1007/BF02439451; Yang L, 2003, CHINESE MED J-PEKING, V116, P1357; Zhang RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020780; Zhang X, 2015, MOL CELL BIOCH; Zhao M, 2009, BONE, V44, pS27, DOI 10.1016/j.bone.2009.01.062; ZHOU H, 1994, J BONE MINER RES, V9, P1489	49	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0136546	10.1371/journal.pone.0136546	http://dx.doi.org/10.1371/journal.pone.0136546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414859	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700003
J	Aubry, F; Nougairede, A; de Fabritus, L; Piorkowski, G; Gould, EA; de Lamballerie, X				Aubry, Fabien; Nougairede, Antoine; de Fabritus, Lauriane; Piorkowski, Geraldine; Gould, Ernest A.; de Lamballerie, Xavier			"ISA-Lation" of Single-Stranded Positive-Sense RNA Viruses from Non-Infectious Clinical/Animal Samples	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; INFECTIOUS MOLECULAR CLONES; REAL-TIME PCR; DIAGNOSTIC VIROLOGY; AMPLIFICATION; CHIKUNGUNYA; GENERATION; SEQUENCES; GENOME	Isolation of viral pathogens from clinical and/or animal samples has traditionally relied on either cell cultures or laboratory animal model systems. However, virus viability is notoriously susceptible to adverse conditions that may include inappropriate procedures for sample collection, storage temperature, support media and transportation. Using our recently described ISA method, we have developed a novel procedure to isolate infectious single-stranded positive-sense RNA viruses from clinical or animal samples. This approach, that we have now called "ISA-lation", exploits the capacity of viral cDNA subgenomic fragments to re-assemble and produce infectious viral RNA in susceptible cells. Here, it was successfully used to rescue enterovirus, Chikungunya and Tick-borne encephalitis viruses from a variety of inactivated animal and human samples. ISA-lation represents an effective option to rescue infectious virus from clinical and/or animal samples that may have deteriorated during the collection and storage period, but also potentially overcomes logistic and administrative difficulties generated when complying with current health and safety and biosecurity guidelines associated with shipment of infectious viral material.	[Aubry, Fabien; Nougairede, Antoine; de Fabritus, Lauriane; Piorkowski, Geraldine; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13385 Marseille, France; [Nougairede, Antoine; de Lamballerie, Xavier] Univ Mediterranee Infect, Inst Hosp, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Aubry, F (corresponding author), Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13385 Marseille, France.	fab1.aubry@gmail.com		Piorkowski, Geraldine/0000-0001-5023-855X; de Fabritus, Lauriane/0000-0003-0668-4629; Aubry, Fabien/0000-0002-7733-7694	European Union [278433, 653316]; Agence Nationale de la Recherche [ANR-14-CE14-0001 RNA Vacci-Code]	European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the project Predemics, http://predemics.biomedtrain.eu/cms/default.aspx (European Union Seventh Framework Programme under grant no. 278433); the European Virus Archive goes Global, http://global.european-virus-archive.com/ (European Union's Horizon 2020 research and innovation programme under grant agreement no. 653316); and the Agence Nationale de la Recherche, http://www.agence-nationale-recherche.fr/ (grant ANR-14-CE14-0001 RNA Vacci-Code). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007; Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0; Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015; de Fabritus L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004738; Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Gunson RN, 2006, J CLIN VIROL, V35, P355, DOI 10.1016/j.jcv.2005.12.006; HSIUNG GD, 1984, YALE J BIOL MED, V57, P727; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Nougairede A, 2014, J CLIN VIROL, V61, P118, DOI 10.1016/j.jcv.2014.05.022; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Paul JR, 1940, J EXP MED, V71, P765, DOI 10.1084/jem.71.6.765; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; Santiago ML, 2003, J VIROL, V77, P2233, DOI 10.1128/JVI.77.3.2233-2242.2003; Schnepp BC, 2009, J VIROL, V83, P1456, DOI 10.1128/JVI.01686-08; Storch GA, 2000, CLIN INFECT DIS, V31, P739, DOI 10.1086/314015; Takehisa J, 2007, J VIROL, V81, P7463, DOI 10.1128/JVI.00551-07; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08	23	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138703	10.1371/journal.pone.0138703	http://dx.doi.org/10.1371/journal.pone.0138703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407018	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700073
J	Beltrame, CO; Cortes, MF; Bonelli, RR; Correa, ABD; Botelho, AMN; Americo, MA; Fracalanzza, SEL; Figueiredo, AMS				Beltrame, Cristiana Ossaille; Cortes, Marina Farrel; Bonelli, Raquel Regina; de Almeida Correa, Ana Beatriz; Nunes Botelho, Ana Maria; Americo, Marco Antonio; Longo Fracalanzza, Sergio Eduardo; Sa Figueiredo, Agnes Marie			Inactivation of the Autolysis-Related Genes lrgB and yycI in Staphylococcus aureus Increases Cell Lysis-Dependent eDNA Release and Enhances Biofilm Development In Vitro and In Vivo	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; MUREIN HYDROLASE ACTIVITY; EXTRACELLULAR DNA; BACTERIAL DEATH; RESISTANCE; PENICILLIN; EXPRESSION; REGULATOR; SYSTEM; SARA	Staphylococcus aureus ica-independent biofilms are multifactorial in nature, and various bacterial proteins have been associated with biofilm development, including fibronectin-binding proteins A and B, protein A, surface protein SasG, proteases, and some autolysins. The role of extracellular DNA (eDNA) has also been demonstrated in some S. aureus biofilms. Here, we constructed a Tn551 library, and the screening identified two genes that affected biofilm formation, lrgB and yycI. The repressive effect of both genes on the development of biofilm was also confirmed in knockout strains constructed by allelic recombination. In contrast, the superexpression of either lrgB or yycI by a cadmium-inducible promoter led to a decrease in biofilm accumulation. Indeed, a significant increase in the cell-lysis dependent eDNA release was detected when lrgB or yycI were inactivated, explaining the enhanced biofilm formed by these mutants. In fact, lrgB and yycI genes belong to distinct operons that repress bacterial autolysis through very different mechanisms. LrgB is associated with the synthesis of phage holin/anti-holin analogues, while YycI participates in the activation/repression of the two-component system YycGF (WalKR). Our in vivo data suggest that autolysins activation lead to increased bacterial virulence in the foreign body animal model since a higher number of attached cells was recovered from the implanted catheters inoculated with lrgB or yycI knockout mutants.	[Beltrame, Cristiana Ossaille; Cortes, Marina Farrel; Bonelli, Raquel Regina; de Almeida Correa, Ana Beatriz; Nunes Botelho, Ana Maria; Americo, Marco Antonio; Longo Fracalanzza, Sergio Eduardo; Sa Figueiredo, Agnes Marie] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Med, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Figueiredo, AMS (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Med, Rio De Janeiro, RJ, Brazil.	agnes@micro.ufrj.br	Figueiredo, Agnes/N-6836-2013; Bonelli, Raquel Regina/G-2494-2017; Figueiredo, Agnes Marie Sá/AAH-2084-2020; Côrtes, Marina Farrel/H-5255-2018	Bonelli, Raquel Regina/0000-0003-4537-5458; Figueiredo, Agnes Marie Sá/0000-0001-8229-6957; Ossaille Beltrame, Cristiana/0000-0002-5939-2585	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [302290/2011-7, 470534/2010-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR) [E-26/111.663/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR)	Funding: Funding was provided by: 1. AMSF, Grant Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR). Grant Number 302290/2011-7. URL: www.cnpq.br; 2. AMSF, Grant Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR). Grant Number 470534/2010-9. URL: www.cnpq.br; 3. AMSF, Grant Funder: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR). Grant Number: E-26/111.663/2013. URL: www.faperj.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Bayles KW, 2014, NAT REV MICROBIOL, V12, P63, DOI 10.1038/nrmicro3136; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chu XM, 2013, RES MICROBIOL, V164, P695, DOI 10.1016/j.resmic.2013.06.001; Cockfield JD, 2007, J MED MICROBIOL, V56, P614, DOI 10.1099/jmm.0.47074-0; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Cortes MF, 2015, INT J MED MICROBIOL, V305, P140, DOI 10.1016/j.ijmm.2014.11.011; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Das T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091935; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Dewey JS, 2010, P NATL ACAD SCI USA, V107, P2219, DOI 10.1073/pnas.0914030107; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Ferreira FA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-93; Ferreira FA, 2012, J MICROBIOL METH, V88, P393, DOI 10.1016/j.mimet.2012.01.007; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Hsueh PR, 1999, J CLIN MICROBIOL, V37, P504, DOI 10.1128/JCM.37.3.504-509.1999; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Ingavale SS, 2003, MOL MICROBIOL, V48, P1451, DOI 10.1046/j.1365-2958.2003.03503.x; JONES CL, 1986, J BACTERIOL, V166, P29, DOI 10.1128/jb.166.1.29-33.1986; KORNBLUM J, 1986, EUR J CLIN MICROBIOL, V5, P714, DOI 10.1007/BF02013311; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; MOREILLON P, 1990, ANTIMICROB AGENTS CH, V34, P33, DOI 10.1128/AAC.34.1.33; Morkel G, 2014, PAEDIATR INT CHILD H, V34, P108, DOI 10.1179/2046905513Y.0000000082; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Savva CG, 2008, MOL MICROBIOL, V69, P784, DOI 10.1111/j.1365-2958.2008.06298.x; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Verhasselt P, 1992, DNA Seq, V2, P281, DOI 10.3109/10425179209030960; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yamaguchi M, 2012, PLANT CELL PHYSIOL, V53, P125, DOI 10.1093/pcp/pcr180; Yang YJ, 2012, NEW PHYTOL, V193, P81, DOI 10.1111/j.1469-8137.2011.03867.x; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; Zielinska AK, 2012, MOL MICROBIOL, V86, P1183, DOI 10.1111/mmi.12048	60	22	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138924	10.1371/journal.pone.0138924	http://dx.doi.org/10.1371/journal.pone.0138924			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406329	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700119
J	Magnuszewski, P; Ostasiewicz, K; Chazdon, R; Salk, C; Pajak, M; Sendzimir, J; Andersson, K				Magnuszewski, Piotr; Ostasiewicz, Katarzyna; Chazdon, Robin; Salk, Carl; Pajak, Michal; Sendzimir, Jan; Andersson, Krister			Resilience and Alternative Stable States of Tropical Forest Landscapes under Shifting Cultivation Regimes	PLOS ONE			English	Article							SLASH-AND-BURN; AGRICULTURAL INTENSIFICATION; SOUTHEAST-ASIA; LINKING THEORY; LAND-USE; FIRE; DEFORESTATION; BIODIVERSITY; DEGRADATION; MANAGEMENT	Shifting cultivation is a traditional agricultural practice in most tropical regions of the world and has the potential to provide for human livelihoods while hosting substantial biodiversity. Little is known about the resilience of shifting cultivation to increasing agricultural demands on the landscape or to unexpected disturbances. To investigate these issues, we develop a simple social-ecological model and implement it with literature-derived ecological parameters for six shifting cultivation landscapes from three continents. Analyzing the model with the tools of dynamical systems analysis, we show that such landscapes exhibit two stable states, one characterized by high forest cover and agricultural productivity, and another with much lower values of these traits. For some combinations of agricultural pressure and ecological parameters both of these states can potentially exist, and the actual state of the forest depends critically on its historic state. In many cases, the landscapes' 'ecological resilience', or amount of forest that could be destroyed without shifting out of the forested stability domain, declined substantially at lower levels of agricultural pressure than would lead to maximum productivity. A measure of 'engineering resilience', the recovery time from standardized disturbances, was independent of ecological resilience. These findings suggest that maximization of short-term agricultural output may have counterproductive impacts on the long-term productivity of shifting cultivation landscapes and the persistence of forested areas.	[Magnuszewski, Piotr; Ostasiewicz, Katarzyna; Pajak, Michal; Sendzimir, Jan] Int Inst Appl Syst Anal, Risk Policy & Vulnerabil Program, A-2361 Laxenburg, Austria; [Magnuszewski, Piotr; Pajak, Michal] Ctr Syst Solut, Wroclaw, Poland; [Ostasiewicz, Katarzyna] Wroclaw Univ Econ, Dept Stat, Wroclaw, Poland; [Chazdon, Robin] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Salk, Carl; Andersson, Krister] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Salk, Carl] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Salk, Carl] Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Pajak, Michal] Wroclaw Univ Econ, Dept Math Econ, Wroclaw, Poland	International Institute for Applied Systems Analysis (IIASA); Wroclaw University of Economics & Business; University of Connecticut; University of Colorado System; University of Colorado Boulder; International Institute for Applied Systems Analysis (IIASA); Swedish University of Agricultural Sciences; Wroclaw University of Economics & Business	Magnuszewski, P (corresponding author), Int Inst Appl Syst Anal, Risk Policy & Vulnerabil Program, A-2361 Laxenburg, Austria.	piotr.magnuszewski@crs.org.pl	Pająk, Michał/AAH-4923-2019; andersson, krister/R-7554-2019; Chazdon, Robin/O-9766-2018	Pająk, Michał/0000-0002-4328-7123; andersson, krister/0000-0002-9320-8155; Magnuszewski, Piotr/0000-0003-1211-0672; Salk, Carl/0000-0003-2833-8292; Chazdon, Robin/0000-0002-7349-5687; Ostasiewicz, Katarzyna/0000-0002-0115-3696	National Science Foundation [DEB-1114984]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the National Science Foundation (http://www.nsf.gov/), grant number: DEB-1114984, KA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoellah O, 1993, 3 U CAL CTR SE AS ST; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barrera-Bassols N, 2005, J LAT AM GEOGR, V4, P9, DOI 10.1353/lag.2005.0021; Baumol W., 1996, ENVIRON DEV ECON, V3, P221, DOI 10.1017/S1355770X98240125; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Cairns M, 1999, AGROFOREST SYST, V47, P37, DOI 10.1023/A:1006248104991; Chazdon RL., 2013, J SUSTAIN FOREST, V32, P649, DOI DOI 10.1080/10549811.2013.817340; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Colfer Carol J. Pierce, 1997, ADV EC BOT, V11; CONKLIN HC, 1961, CURR ANTHROPOL, V2, P27, DOI 10.1086/200160; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; DUFOUR DL, 1990, BIOSCIENCE, V40, P652, DOI 10.2307/1311432; EHUI SK, 1989, AM J AGR ECON, V71, P703, DOI 10.2307/1242026; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fox J, 2000, BIOSCIENCE, V50, P521, DOI 10.1641/0006-3568(2000)050[0521:SCANOP]2.0.CO;2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilroy JJ, 2014, J APPL ECOL, V51, P1337, DOI 10.1111/1365-2664.12284; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holling C. S, 1996, ENG ECOLOGICAL CONST, P31, DOI DOI 10.17226/4919; Jakovac CC, 2015, J ECOL, V103, P67, DOI 10.1111/1365-2745.12298; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Lawrence D, 2010, BIOTROPICA, V42, P21, DOI 10.1111/j.1744-7429.2009.00599.x; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mertz O, 2009, HUM ECOL, V37, P259, DOI 10.1007/s10745-009-9245-2; Minang PA, 2014, PARTNERSHIP TROPICAL, P241; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; NYE P. H., 1960, The Soil under Shifting Cultivation.; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Pace ML, 2013, LIMNOL OCEANOGR, V58, P525, DOI 10.4319/lo.2013.58.2.0525; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Padoch C, 2010, BIOTROPICA, V42, P550, DOI 10.1111/j.1744-7429.2010.00681.x; Palm CA, 2005, SLASH AND BURN AGR S; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Phelps J, 2013, P NATL ACAD SCI USA, V110, P7601, DOI 10.1073/pnas.1220070110; Richards PW, 1952, TROPICAL RAIN FOREST; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schmidt-Vogt D, 2009, HUM ECOL, V37, P269, DOI 10.1007/s10745-009-9239-0; Schooler SS, 2011, NATURE, V470, P86, DOI 10.1038/nature09735; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Seekell DA, 2013, THEOR ECOL-NETH, V6, P385, DOI 10.1007/s12080-013-0183-7; Styger E, 2007, AGR ECOSYST ENVIRON, V119, P257, DOI 10.1016/j.agee.2006.07.012; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; van Nes EH, 2014, GLOBAL CHANGE BIOL, V20, P1016, DOI 10.1111/gcb.12398; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Veldman JW, 2011, BIOL CONSERV, V144, P1419, DOI 10.1016/j.biocon.2011.01.011	56	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137497	10.1371/journal.pone.0137497	http://dx.doi.org/10.1371/journal.pone.0137497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406907	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700022
J	Netikul, T; Kiratisin, P				Netikul, Thidarat; Kiratisin, Pattarachai			Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MODIFIED HODGE TEST; MOLECULAR EPIDEMIOLOGY; ESCHERICHIA-COLI; SEQUENCE TYPES; K.-PNEUMONIAE; EMERGENCE; PORIN; INFECTIONS; LACTAMASES	Carbapenem-resistant Enterobacteriaceae (CRE) has increasingly spread worldwide in the past decade. The prevalence and characteristics of CRE in Thailand are unknown. In this study, we conducted a 2-year surveillance of CRE among 12,741 clinical isolates of Enterobacteriaceae at the largest university hospital in Thailand with molecular characterization of beta-lactamase (bla) genes, including carbapenemase genes. The CRE prevalence was 1.4%. bla(KPC-13) and bla(IMP-14a) were the only carbapenemase genes detected among these CRE isolates. bla(KPC-13) gene was found in a single isolate of Escherichia coli, Enterobacter cloacae and Citrobacter freundii, and bla(IMP-14a) was found in four isolates of Klebsiella pneumoniae. Carbapenem-resistant K. pneumoniae (CRKP) isolates were resistant to multiple carbapenems at a higher ratio than other CRE species, and thus were further characterized for resistance phenotypes, bla genotypes and molecular epidemiology. Most CRKP isolates harboured multiple bla genes, especially those related to extended-spectrum beta-lactamases. Seven CRKP isolates were resistant to all tested carbapenems, and showed decreased ompK35 and/or ompK36 porin gene expression. Molecular typing of CRKP based on pulsed-field gel electrophoresis (PFGE) demonstrated several unrelated clones. Multilocus sequence typing (MLST) was partially concordant with PFGE results and revealed that ST340, a member of drug-resistant K. pneumoniae clonal complex 258, was the most predominant clone, followed by ST48, ST11 and ST273. The novel ST1645 was identified from this study. ST340 has neither been shown to be predominated among CRKP from other studies, nor been reported in Thailand. Therefore, it emphases a critical concern to monitor and control the spread of CRKP.	[Netikul, Thidarat; Kiratisin, Pattarachai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand	Mahidol University	Kiratisin, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.	pattarachai.kir@mahidol.ac.th			Thailand Research Fund through Royal Golden Jubilee Ph. D. Program [PHD/0232/2552]; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital	Thailand Research Fund through Royal Golden Jubilee Ph. D. Program; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital	This study was supported by the Thailand Research Fund through the Royal Golden Jubilee Ph. D. Program (Grant No. PHD/0232/2552 to PK and TN) (URL http://rgj.trf.or.th/eng/rgje11.asp) . PK was also supported by the Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital (URL http://www.si.mahidol.ac.th/en/) during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageevets VA, 2014, INT J ANTIMICROB AG, V44, P152, DOI 10.1016/j.ijantimicag.2014.05.004; Bushnell G, 2013, INT J INFECT DIS, V17, pE325, DOI 10.1016/j.ijid.2012.11.025; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Correa L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-80; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; Donati V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090564; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; European Committee on Antimicrobial Susceptibility Testing, 2014, BREAKP TABL INT MICS; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Geffen Y, 2013, J ANTIMICROB CHEMOTH, V68, P719, DOI 10.1093/jac/dks443; Giakkoupi P, 2011, J ANTIMICROB CHEMOTH, V66, P1510, DOI 10.1093/jac/dkr166; Girlich D, 2012, J CLIN MICROBIOL, V50, P477, DOI 10.1128/JCM.05247-11; Giske CG, 2012, ANTIMICROB AGENTS CH, V56, P2735, DOI 10.1128/AAC.06142-11; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Haeggman S, 2004, ANTIMICROB AGENTS CH, V48, P2400, DOI 10.1128/AAC.48.7.2400-2408.2004; Hernandez-Alles S, 2000, J ANTIMICROB CHEMOTH, V46, P273, DOI 10.1093/jac/46.2.273; Hsueah PR, 2010, INT J ANTIMICROB AG, V36, P408, DOI 10.1016/j.ijantimicag.2010.07.002; Kim SY, 2013, DIAGN MICR INFEC DIS, V76, P486, DOI 10.1016/j.diagmicrobio.2013.04.006; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Kiratisin P, 2012, INT J ANTIMICROB AG, V39, P311, DOI 10.1016/j.ijantimicag.2012.01.002; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P3002, DOI 10.1128/AAC.01818-09; Lubbert C, 2014, LIVER TRANSPLANT, V20, P736, DOI 10.1002/lt.23858; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Netikul T, 2014, INT J ANTIMICROB AG, V44, P568, DOI 10.1016/j.ijantimicag.2014.08.005; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Novais A, 2012, EUR J CLIN MICROBIOL, V31, P3057, DOI 10.1007/s10096-012-1665-z; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Pereira PS, 2013, J ANTIMICROB CHEMOTH, V68, P312, DOI 10.1093/jac/dks396; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, LANCET INFECT DIS, V10, P832, DOI 10.1016/S1473-3099(10)70279-6; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Zhang Y, 2014, ANTIMICROB AGENTS CH, V58, P1214, DOI 10.1128/AAC.02045-12	46	44	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139116	10.1371/journal.pone.0139116	http://dx.doi.org/10.1371/journal.pone.0139116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407326	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700176
J	Stros, M; Polanska, E; Kucirek, M; Pospisilova, S				Stros, Michal; Polanska, Eva; Kucirek, Martin; Pospisilova, Sarka			Histone H1 Differentially Inhibits DNA Bending by Reduced and Oxidized HMGB1 Protein	PLOS ONE			English	Article							GROUP BOX DOMAINS; LINKER HISTONES; CHROMATIN INTERACTIONS; 2 MUTATIONS; A-DOMAIN; BINDING; ASSOCIATION; HMG-1; LIGATION; TERMINUS	HMGB1 protein and linker histone H1 have overlapping binding sites in the nucleosome. HMGB1 has been implicated in many DNA-dependent processes in chromatin involving binding of specific proteins, including transcription factors, to DNA sites pre-bent by HMGB1. HMGB1 can also act as an extracellular signaling molecule by promoting inflammation, tumor growth a metastasis. Many of the intra-and extracellular functions of HMGB1 depend on redox-sensitive cysteine residues of the protein. Here we report that mild oxidization of HMGB1 (and much less mutation of cysteines involved in disulphide bond formation) can severely compromise the functioning of the protein as a DNA chaperone by inhibiting its ability to unwind or bend DNA. Histone H1 (via the highly basic C-terminal domain) significantly inhibits DNA bending by the full-length HMGB1, and the inhibition is further enhanced upon oxidization of HMGB1. Interestingly, DNA bending by HMGB1 lacking the acidic C-tail (HMGB1 Delta C) is much less affected by histone H1, but oxidization rendered DNA bending by HMGB1 Delta C and HMGB1 equally prone for inhibition by histone H1. Possible consequences of histone H1-mediated inhibition of DNA bending by HMGB1 of different redox state for the functioning of chromatin are discussed.	[Stros, Michal; Polanska, Eva; Kucirek, Martin] Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Proteins, Brno, Czech Republic; [Pospisilova, Sarka] Masaryk Univ, CEITEC, Ctr Mol Med, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno	Stros, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Proteins, Brno, Czech Republic.	michal.stros@email.cz	Pospisilova, Sarka/D-7200-2012	Pospisilova, Sarka/0000-0001-7136-2680; Kucirek, Martin/0000-0003-1297-8631	Grant Agency of the Czech Republic [P305/12/2475, P305-15-01354S]; CEITEC [MSMT CR CZ.1.05/1.1.00/02.0068]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); CEITEC	This work was supported by the Grant Agency of the Czech Republic (grants P305/12/2475 and P305-15-01354S awarded to MS). SP was also supported by research project MSMT CR CZ.1.05/1.1.00/02.0068 (CEITEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgrano FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079572; BILLINGS PC, 1992, BIOCHEM BIOPH RES CO, V188, P1286, DOI 10.1016/0006-291X(92)91371-V; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; JACKSON JB, 1979, BIOCHEMISTRY-US, V18, P3739, DOI 10.1021/bi00584a015; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; KOHLSTAEDT LA, 1994, BIOCHEMISTRY-US, V33, P570, DOI 10.1021/bi00168a023; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; Polanska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089070; Sanchez-Giraldo R, 2015, ACTA CRYSTALLOGR D, V71, P1423, DOI 10.1107/S1399004715007452; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SOBCZAK J, 1988, EUR J BIOCHEM, V175, P379, DOI 10.1111/j.1432-1033.1988.tb14207.x; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; STROS M, 1990, INT J BIOL MACROMOL, V12, P282, DOI 10.1016/0141-8130(90)90014-2; Stros M, 1998, J BIOL CHEM, V273, P10355; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; Stros M, 2001, BIOCHEMISTRY-US, V40, P4769, DOI 10.1021/bi002741i; Stros M, 2000, EUR J BIOCHEM, V267, P4088, DOI 10.1046/j.1432-1327.2000.01450.x; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tang DL, 2012, MOL MED, V18, P1360, DOI 10.2119/molmed.2012.00314; TEO SH, 1995, EUR J BIOCHEM, V230, P943, DOI 10.1111/j.1432-1033.1995.tb20640.x; TEO SH, 1995, EMBO J, V14, P3844, DOI 10.1002/j.1460-2075.1995.tb00054.x; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Travers A, 2000, CURR OPIN STRUC BIOL, V10, P102, DOI 10.1016/S0959-440X(99)00056-1; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang J, 2013, BIOCHEM BIOPH RES CO, V441, P701, DOI 10.1016/j.bbrc.2013.10.085; Yamanaka S, 2002, BIOCHEM BIOPH RES CO, V292, P268, DOI 10.1006/bbrc.2002.6647; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	41	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138774	10.1371/journal.pone.0138774	http://dx.doi.org/10.1371/journal.pone.0138774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406975	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700093
J	El Sadik, AO; El Ghamrawy, TA; El-Galil, TIA				El Sadik, Abir O.; El Ghamrawy, Tarek A.; El-Galil, Tarek I. Abd			The Effect of Mesenchymal Stem Cells and Chitosan Gel on Full Thickness Skin Wound Healing in Albino Rats: Histological, Immunohistochemical and Fluorescent Study	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW; IN-VIVO; STROMAL CELLS; GROWTH-FACTOR; ANIMAL-MODEL; REPAIR; DIFFERENTIATION; TISSUE; DEFECT	Background Wound healing involves the integration of complex biological processes. Several studies examined numerous approaches to enhance wound healing and to minimize its related morbidity. Both chitosan and mesenchymal stem cells (MSCs) were used in treating skin wounds. The aim of the current work was to compare MSCs versus chitosan in wound healing, evaluate the most efficient route of administration of MSCs, either intradermal or systemic injection, and elicit the mechanisms inducing epidermal and dermal cell regeneration using histological, immunohistochemical and fluorescent techniques. Material and Methods Forty adult male Sprague Dawley albino rats were divided into four equal groups (ten rats in each group): control group (Group I); full thickness surgical skin wound model, Group II: Wound and chitosan gel. Group III: Wound treated with systemic injection of MSCs and Group IV: Wound treated with intradermal injection of MSCs. The healing ulcer was examined on day 3, 5, 10 and 15 for gross morphological evaluation and on day 10 and 15 for histological, immunohistochemical and fluorescent studies. Results Chitosan was proved to promote wound healing more than the control group but none of their wound reached complete closure. Better and faster healing of wounds in MSCs treated groups were manifested more than the control or chitosan treated groups. It was found that the intradermal route of administration of stem cells enhanced the rate of healing of skin wounds better than the systemic administration to the extent that, by the end of the fifteenth day of the experiment, the wounds were completely healed in all rats of this group. Histologically, the wound areas of group IV were hardly demarcated from the adjacent normal skin and showed complete regeneration of the epidermis, dermis, hypodermis and underlying muscle fibers. Collagen fibers were arranged in many directions, with significant increase in their area percent, surrounding fully regenerated hair follicles and sebaceous glands in the dermis of the healed areas more than in other groups. Conclusion MSCs enhanced the healing process of wound closure more than chitosan gel treatment. Furthermore, MSCs injected intradermally, were more efficient in accelerating wound healing than any other mode of treatment.	[El Sadik, Abir O.; El Ghamrawy, Tarek A.; El-Galil, Tarek I. Abd] Cairo Univ, Fac Med, Dept Anat & Embryol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	El Ghamrawy, TA (corresponding author), Cairo Univ, Fac Med, Dept Anat & Embryol, Cairo, Egypt.	tarekabdelmoniem@gmail.com	Abd El-Galil, tarek Ibrahim/AGZ-3058-2022; Sadik, Abir El/AAE-4726-2021	Abd El-Galil, tarek Ibrahim/0000-0003-2217-7045; El Sadik, Abir/0000-0003-2098-2155				Akela A, 2012, INT WOUND J, V9, P505, DOI 10.1111/j.1742-481X.2011.00909.x; Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015; Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Alsarra IA, 2009, INT J BIOL MACROMOL, V45, P16, DOI 10.1016/j.ijbiomac.2009.03.010; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; [Anonymous], 2006, SCI PHARM; Augello A, 2010, EUR CELLS MATER, V20, P121; Bancroft J., 1994, MANUAL HISTOLOGICAL, P263; Bancroft JD, 2008, THEORY PRACTICE HIST, P150; Bohling MW, 2004, VET SURG, V33, P579, DOI 10.1111/j.1532-950X.2004.04081.x; Brissett Anthony E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P245, DOI 10.1097/00020840-200308000-00005; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen Ming, 2009, Critical Reviews in Biomedical Engineering, V37, P399, DOI 10.1615/CritRevBiomedEng.v37.i4-5.50; Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117; Dai YC, 2007, BURNS, V33, P418, DOI 10.1016/j.burns.2006.08.028; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x; Fukuoka H, 2015, EPLASTY, V15, P65; Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012; Hattori H, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0052-y; Hengartner NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116772; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Hsu SH, 2015, WOUND REPAIR REGEN, V23, P57, DOI 10.1111/wrr.12239; Huang SP, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-51; Huang SP, 2012, ANN PLAS SURG, V69, P656, DOI 10.1097/SAP.0b013e318273f909; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Ji KH, 2009, J DERMATOL, V36, P403, DOI 10.1111/j.1346-8138.2009.00666.x; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kawaguchi K, 2010, ARCH HISTOL CYTOL, V73, P65, DOI 10.1679/aohc.73.65; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Li HH, 2006, CELL TISSUE RES, V326, P725, DOI 10.1007/s00441-006-0270-9; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Luo GX, 2010, WOUND REPAIR REGEN, V18, P506, DOI 10.1111/j.1524-475X.2010.00616.x; Nishino Y, 2011, J CRANIOFAC SURG, V22, P438, DOI 10.1097/SCS.0b013e318207b507; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Park IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122776; Petrie A, 2005, MED STAT GLANCE, P55; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Raza K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109034; Sabapathy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093726; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012; Tario JD, 2011, METHODS MOL BIOL, V699, P119, DOI 10.1007/978-1-61737-950-5_7; Tark KC, 2010, ANN PLAS SURG, V65, P565, DOI 10.1097/SAP.0b013e3181d9aae2; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2; Wu Y, 2012, INT WOUND J, V9, P586, DOI 10.1111/j.1742-481X.2012.01076.x; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yamaguchi Y, 2005, BRIT J DERMATOL, V152, P616, DOI 10.1111/j.1365-2133.2005.06402.x; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhao FJ, 2011, HUM VACCINES, V7, P1083, DOI 10.4161/hv.7.10.16541; Zhao JJ, 2015, TISSUE ENG PT A, V21, P982, DOI [10.1089/ten.tea.2013.0726, 10.1089/ten.TEA.2013.0726]; Zohdi RM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/843025	59	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137544	10.1371/journal.pone.0137544	http://dx.doi.org/10.1371/journal.pone.0137544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402454	gold, Green Published			2022-12-26	WOS:000361798100012
J	Roussel, R; Chaignot, C; Weill, A; Travert, F; Hansel, B; Marre, M; Ricordeau, P; Alla, F; Allemand, H				Roussel, Ronan; Chaignot, Christophe; Weill, Alain; Travert, Florence; Hansel, Boris; Marre, Michel; Ricordeau, Philippe; Alla, Francois; Allemand, Hubert			Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; HYPERTENSIVE PATIENTS; EFFICACY; THERAPY; SAFETY; SIMVASTATIN; FENOFIBRATE; ATORVASTATIN; COMBINATION; BEZAFIBRATE	Background and Aim According to guidelines, diabetic patients with high cardiovascular risk should receive a statin. Despite this consensus, fibrate monotherapy is commonly used in this population. We assessed the frequency and clinical consequences of the use of fibrates for primary prevention in patients with diabetes and high cardiovascular risk. Design Retrospective cohort study based on nationwide data from the medical and administrative databases of French national health insurance systems (07/01/08-12/31/09) with a follow-up of up to 30 months. Methods Lipid-lowering drug-naive diabetic patients initiating fibrate or statin monotherapy were identified. Patients at high cardiovascular risk were then selected: patients with a diagnosis of diabetes and hypertension, and >50 (men) or 60 (women), but with no history of cardiovascular events. The composite endpoint comprised myocardial infarction, stroke, amputation, or death. Results Of the 31,652 patients enrolled, 4,058 (12.8%) received a fibrate. Age- and gender-adjusted annual event rates were 2.42% (fibrates) and 2.21%(statins). The proportionality assumption required for the Cox model was not met for the fibrate/statin variable. A multivariate model including all predictors was therefore calculated by dividing data into two time periods, allowing Hazard Ratios to be calculated before (HR<540) and after 540 days (HR>540) of follow-up. Multivariate analyses showed that fibrates were associated with an increased risk for the endpoint after 540 days: HR<540 = 0.95 (95% CI: 0.78-1.16) and HR>540 = 1.73 (1.28-2.32). Conclusion Fibrate monotherapy is commonly prescribed in diabetic patients with high cardiovascular risk and is associated with poorer outcomes compared to statin therapy.	[Roussel, Ronan; Travert, Florence; Hansel, Boris; Marre, Michel] INSERM, UMR 872, Ctr Rech Cordeliers, F-75006 Paris, France; [Roussel, Ronan; Travert, Florence; Hansel, Boris; Marre, Michel] Univ Paris 07, Fac Med, F-75018 Paris, France; [Roussel, Ronan; Travert, Florence; Hansel, Boris; Marre, Michel] Hop Bichat Claude Bernard, AP HP, Diabetol Endocrinol Nutr, F-75877 Paris, France; [Chaignot, Christophe; Weill, Alain; Ricordeau, Philippe] Natl Hlth Insurance, Strategy & Res Dept, F-75986 Paris 20, France; [Alla, Francois; Allemand, Hubert] Natl Hlth Insurance, Gen Div, F-75986 Paris 20, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Roussel, R (corresponding author), INSERM, UMR 872, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.	ronan.roussel@bch.aphp.fr	alla, francois/D-2295-2014	Chaignot, Christophe/0000-0002-1477-9401; Marre, Michel/0000-0002-3071-1837; alla, francois/0000-0002-5793-7190; Weill, Alain/0000-0001-8687-9092	Sanofi-Aventis; MSD Chibret; Servier; Novo Nordisk; Novartis; BMS; Janssen-Cilag; Novonordisk; Eli Lilly	Sanofi-Aventis(Sanofi-Aventis); MSD Chibret; Servier(Servier); Novo Nordisk(Novo Nordisk); Novartis(Novartis); BMS(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novonordisk(Novo Nordisk); Eli Lilly(Eli Lilly)	Prof. Roussel has received research grants, honoraria, or consulting fees from Sanofi-Aventis, MSD Chibret, Servier, Novo Nordisk, Novartis, BMS, and Janssen-Cilag. Mr. Chaignot, Dr. Weill, Dr. Ricordeau, Prof. Alla, and Prof. Allemand are employees of public institutions. Dr. Travert has received honoraria, or consulting fees from Novonordisk, BMS, MSD Chibret, and Eli Lilly. Dr. Hansel declared no financial conflict related to this work. Prof. Marre is a consultant for Association Diabete Risque Vasculaire and is a speaker or serves on boards for Merck, Sanofi-Aventis, Novo Nordisk, Servier, and Abbott Diagnostics. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BRUCKERT E, 1995, CLIN CARDIOL, V18, P621, DOI 10.1002/clc.4960181107; Bruckert E, 2011, ARCH CARDIOVASC DIS, V104, P381, DOI 10.1016/j.acvd.2011.04.007; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Eliasson B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018744; Empen K, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-17; Erqou S, 2014, DIABETOLOGIA, V57, P2444, DOI 10.1007/s00125-014-3374-x; Giral P, 2001, ATHEROSCLEROSIS, V154, P421, DOI 10.1016/S0021-9150(00)00474-3; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 1999, BIOMETRICS, V55, P1316; Hjerpe P, 2011, EUR J CLIN PHARMACOL, V67, P415, DOI 10.1007/s00228-010-0973-4; Jackevicius CA, 2011, JAMA-J AM MED ASSOC, V305, P1217, DOI 10.1001/jama.2011.353; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Klempfner R, 2014, AM J CARDIOL, V113, P12, DOI 10.1016/j.amjcard.2013.08.033; Leung WY, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-57; Li LL, 2011, AM J EPIDEMIOL, V174, P345, DOI 10.1093/aje/kwr096; Mancia G, 2004, J HYPERTENS, V22, P51, DOI 10.1097/00004872-200401000-00012; Meas T, 2009, EUR J INTERN MED, V20, P197, DOI 10.1016/j.ejim.2008.06.009; Montgomery AA, 2000, BRIT J GEN PRACT, V50, P127; Ooi TC, 1997, ARTERIOSCL THROM VAS, V17, P1793, DOI 10.1161/01.ATV.17.9.1793; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sacks FM, 2010, NEW ENGL J MED, V363, P692, DOI 10.1056/NEJMc1006407; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Sudchada P, 2012, J DIABETES COMPLICAT, V26, P102, DOI 10.1016/j.jdiacomp.2012.02.006; Tenenbaum A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0159-y; Teramoto T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-163; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; Weill A, 2010, PHARMACOEPIDEM DR S, V19, P1256, DOI 10.1002/pds.2044; ZIEGLER O, 1990, CARDIOLOGY, V77, P50, DOI 10.1159/000174683	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137733	10.1371/journal.pone.0137733	http://dx.doi.org/10.1371/journal.pone.0137733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398765	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500046
J	Sole, F; Amson, E; Borths, M; Vidalenc, D; Morlo, M; Bastl, K				Sole, Floreal; Amson, Eli; Borths, Matthew; Vidalenc, Dominique; Morlo, Michael; Bastl, Katharina			A New Large Hyainailourine from the Bartonian of Europe and Its Bearings on the Evolution and Ecology of Massive Hyaenodonts (Mammalia)	PLOS ONE			English	Article							EARLY EOCENE; POSTCRANIAL SKELETON; MIDDLE EOCENE; LATE MIOCENE; CREODONTA; CARNIVORA; FAUNA; OLIGOCENE; PROVIVERRINES; SYSTEMATICS	We describe a new large-sized species of hypercarnivorous hyainailourine-Kerberos langebadreae gen. & sp. nov.-from the Bartonian (MP16) locality of Montespieu (Tarn, France). These specimens consist of a skull, two hemimandibles and several hind limb elements (fibula, astragalus, calcaneum, metatarsals, and phalanges). Size estimates suggest K. langebadreae may have weighed up to 140 kg, revealing this species as the largest carnivorous mammal in Europe at that time. Besides its very large size, K. langebadreae possesses an interesting combination of primitive and derived features. The distinctive skull morphology of K. langebadreae reflects a powerful bite force. The postcranial elements, which are rarely associated with hyainailourine specimens, indicate an animal capable of a plantigrade stance and adapted for terrestrial locomotion. We performed the first phylogenetic analysis of hyainailourines to determine the systematic position of K. langebadreae and to understand the evolution of the group that includes other massive carnivores. The analysis demonstrates that Hemipsalodon, a North American taxon, is a hyainailourine and is closely related to European Paroxyaena. Based on this analysis we hypothesize the biogeographic history of the Hyainailourinae. The group appeared in Africa with a first migration to Europe during the Bartonian that likely included the ancestors of Kerberos, Paroxyaena and Hemipsalodon, which further dispersed into North America at this time. We propose that the hyainailourines dispersed into Europe also during the Priabonian. These migrants have no ecological equivalent in Europe during these intervals and likely did not conflict with the endemic hyaenodont proviverrines. The discovery of K. langebadreae shows that large body size appears early in the evolution of hyainailourines. Surprisingly, the late Miocene Hyainailouros shares a more recent common ancestor with small-bodied hyainailourines (below 15 kg). Finally, our study supports a close relationship between the Hyainailourinae and Apterodontinae and we propose the new clade: Hyainailouridae.	[Sole, Floreal] Royal Belgian Inst Nat Sci, Dept Paleontol, DO Earth & Hist Life, B-1000 Brussels, Belgium; [Sole, Floreal; Amson, Eli] Sorbonne Univ, Univ Paris 06, Ctr Rech Paleobiodiversite & Paleoenvironm, CR2P CNRS,MNHN,Dept Hist Terre, F-75005 Paris, France; [Borths, Matthew] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Morlo, Michael] Forschungsinst Senckenberg, D-60235 Frankfurt, Germany; [Bastl, Katharina] Univ Vienna, Inst Palaontol, A-1090 Vienna, Austria; [Bastl, Katharina] Med Univ Wien, HNO Klin, Forsch Grp Aerobiol & Polleninformat, A-1090 Vienna, Austria	Royal Belgian Institute of Natural Sciences; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Vienna; Medical University of Vienna	Sole, F (corresponding author), Royal Belgian Inst Nat Sci, Dept Paleontol, DO Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	floreal.sole@naturalsciences.be	Morlo, Michael/AAA-5943-2021; Amson, Eli/I-4619-2019	Morlo, Michael/0000-0003-3956-7912; Amson, Eli/0000-0003-1474-9613; Bastl, Katharina/0000-0002-8200-9708	National Science Foundation [DEB-1311354]; Belgian Science Policy Office [BR/121/A3/PALEURAFRICA]; Division Of Environmental Biology [1311354] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Belgian Science Policy Office(Belgian Federal Science Policy Office); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation Grant DEB-1311354 to MB (PhD Thesis). The Belgian Science Policy Office supports the project Paleurafrica BR/121/A3/PALEURAFRICA (Postdoctoral position of FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J-P., 1997, MEMOIRES TRAVAUX ECO, V21, P769; Andrews C. W., 1903, Geological Magazine, V(4), P337; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Argot C, 2004, ALCHERINGA, V28, P229, DOI 10.1080/03115510408619283; Astruc JG, 2003, GEOBIOS-LYON, V36, P629, DOI 10.1016/j.geobios.2003.01.001; Badiola A, 2009, GEOL ACTA, V7, P243, DOI 10.1344/105.000000281; BARNETT CH, 1953, J ANAT, V87, P11; Barry J.C., 1988, Journal of Vertebrate Paleontology, V8, P25; BARRY JC, 1980, J PALEONTOL, V54, P1128; Bastl K, 2012, THESIS U VIENNA; Bastl K, 2014, PALAEONTOGR ABT A, V303, P61; Bastl K, 2012, PALAEOGEOGR PALAEOCL, V348, P13, DOI 10.1016/j.palaeo.2012.05.026; Bastl K, 2011, J VERTEBR PALEONTOL, V31, P181, DOI 10.1080/02724634.2011.540052; Biedermann WGA., 1863, PETREFACTEN UMGEGEND; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Cardini A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3458; COLBERT EDWIN H., 1933, AMER MUS NOVITATES, V603, P1; Cope E. D., 1885, American Naturalist, Vxix, P163; Crochet J-Y, 1983, GEOL MEDITERR, V10, P49; CROCHET JY, 1988, CR ACAD SCI II, V307, P1795; De Blainville H., 1839, ANN FRANCAIS ETRANGE, V3, P17; DENISON ROBERT HOWLAND, 1938, ANN NEW YORK ACAD SCI, V37, P163; Egi N, 2007, J PALEONTOL, V81, P770, DOI 10.1666/pleo0022-3360(2007)081[0770:SSOAPA]2.0.CO;2; Egi N, 2005, J SYST PALAEONTOL, V3, P337, DOI 10.1017/S1477201905001707; Egi N, 2001, PALAEONTOLOGY, V44, P497, DOI 10.1111/1475-4983.00189; EMRY RJ, 1981, J PALEONTOL, V55, P563; Ewer, 1998, CARNIVORES; FILAN SL, 1990, AUST J ZOOL, V38, P617, DOI 10.1071/ZO9900617; Franzen Jens Lorenz, 2003, Geological Society of America Special Paper, V369, P455; Frey E., 2011, KAUPIA, V17, P107; Gebo Daniel L., 1993, Journal of Vertebrate Paleontology, V13, P125; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gheerbrant E, 2006, GEOL MAG, V143, P475, DOI 10.1017/S0016756806002032; Gheerbrant E, 2009, CR PALEVOL, V8, P281, DOI 10.1016/j.crpv.2008.08.003; Gheerbrant Emmanuel, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V237, P39; GINGERICH P D, 1990, Contributions from the Museum of Paleontology University of Michigan, V28, P79; GINGERICH P D, 1989, Contributions from the Museum of Paleontology University of Michigan, V27, P327; Ginsbuig L., 1961, Mammalia Paris, V2, P1; GINSBURG L, 1980, Annales de Paleontologie Vertebres, V66, P19; Ginsburg Leonard, 1999, P105; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; Godinot M., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P273; Godinot M., 1981, Palaeovertebrata (Montpellier), V10, P43; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gould FDH, 2014, J VERTEBR PALEONTOL, V34, P1180, DOI 10.1080/02724634.2014.841707; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; GREAVES WS, 1985, ZOOL J LINN SOC-LOND, V85, P267, DOI 10.1111/j.1096-3642.1985.tb01506.x; Grohe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049054; Gunnell Gregg F., 1998, P91; Gustafson E.P., 1986, TEXAS MEML MUSEUM B, V33, P1; Heinrich RE, 1997, PALAEONTOLOGY, V40, P279; Holroyd PA, 1994, THESIS DUKE U DURHAM; Holroyd Patricia A., 1999, Paleobios, V19, P1; Hooker J.J., 2010, MONOGRAPH PALAEONTOG, V165, P1; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; Koenigswald GHR von, 1947, SOC PALEONTOLOGIQUE, P292; Laborde C, 1987, ANN SCI NATURELLES S, V13, P25; Laison F, 2001, CR ACAD SCI III-VIE, V324, P855, DOI 10.1016/S0764-4469(01)01347-6; Lange-Badre B., 1979, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V114, P472; Lange-Badre B, 1979, MEMOIRES MUSEUM NA C; Lange-Badre Brigitte, 2005, Annales de Paleontologie, V91, P311, DOI 10.1016/j.annpal.2005.08.001; Laurent Y., 2010, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V146, P89; Lavrov AV, 2007, PALEONTOL J+, V41, P298, DOI 10.1134/S0031030107030094; Leidy J., 1869, J ACAD NATURAL SCI P, V2, P1, DOI DOI 10.5962/BHL.TITLE.20910; Lewis Margaret E., 2010, P543; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V2; Marandat B, 1997, NEWSL STRATIGR, V35, P63; Marandat B, 2012, SWISS J GEOSCI, V105, P417, DOI 10.1007/s00015-012-0113-5; MARTIN R, 1906, REV SUISSE ZOOL, V14, P405; MATHIS C, 1985, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V7, P305; Matthew W.D., 1909, MEMOIRS AM MUSEUM NA, V9, P289; Matthew WD, 1906, P US NATL MUS, V30, P203, DOI DOI 10.5479/SI.00963801.30-1449.203; Mellett J.S., 1977, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V1, P1; Mellett J.S., 1969, AM MUS NOVIT, P1; Meng Jin, 1998, Bulletin of Carnegie Museum of Natural History, V34, P148; Miller ME, 1965, ANATOMY DOG, P941; Morales Jorge, 2007, Paleontological Research, V11, P71, DOI 10.2517/1342-8144(2007)11[71:NCMCCA]2.0.CO;2; Morlo M., 2003, CONTRIBUTIONS MUSEUM, V31, P43; Morlo M., 1999, GEOBIOS, V32, P397, DOI DOI 10.1016/S0016-6995(99)80043-6; Morlo M, 2007, J VERTEBR PALEONTOL, V27, P145, DOI 10.1671/0272-4634(2007)27[145:CACFWM]2.0.CO;2; Morlo M, 2014, PALAEONTOLOGY, V57, P111, DOI 10.1111/pala.12052; Morlo Michael, 2010, P269; Morlo Michael, 1999, Courier Forschungsinstitut Senckenberg, V216, P31; Muizon C, 2007, LETHAIA, V30, P353; Nixon, 1999, WINCLADA BETA VER 09; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Ogg JG, 2013, TS CREATOR VISUALIZA; OLEARY MA, 1995, J VERTEBR PALEONTOL, V15, P401, DOI 10.1080/02724634.1995.10011238; Osborn HF, 1909, B AM MUS NAT HIST, V26, P415; Owen R., 1837, ENCY ANATOMY PHYSL, V4, P864; Pasitschniak-Arts Maria, 1993, Mammalian Species, V439, P1; Peigne S, 2007, GEODIVERSITAS, V29, P441; Pilgrim G. E., 1912, Mem Geol Surv India Pal Ind, V4; Pilgrim G. E., 1932, Palaeontologia Indica, V18, P1; Polly P. D., 1994, Journal of Vertebrate Paleontology, V14, p42A; Polly PD, 1996, J VERTEBR PALEONTOL, V16, P303, DOI 10.1080/02724634.1996.10011318; Rana RS, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.965308; Rasmussen DT, 2009, PALAEONTOGR ABT A, V288, P1; RASMUSSEN DT, 1989, J MAMMAL, V70, P442, DOI 10.2307/1381539; Remy J.A., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P169; Rose Kenneth D., 2001, Museum of Paleontology Papers on Paleontology, V33, P157; Sanders William J., 2010, P161; SAVAGE R J G, 1973, Bulletin of the British Museum (Natural History) Geology, V22, P483; Savage RJG, 1965, B BRIT MUS NAT HIST, V10, P242; Schlosser M., 1886, MORPHOLOGISCHES JB, V12, P287; SCOTT WILLIAM BERRYMAN, 1936, TRANS AMER PHIL SOC, V28, P1, DOI 10.2307/1005507; Shawn Z, 2014, J VERTEBR PALEONTOL, V2014, P259; Sinclair W. J., 1929, Proceedings of the American Philosophical Society, V68, P163; Smith Kathleen K., 1993, P150; Smith T, 2001, BELG J ZOOL, V131, P117; Sole F, 2013, J SYSTEMATIC PALAEON, V12, P303; Sole F, 2014, PALAEONTOLOGY, V57, P963, DOI 10.1111/pala.12097; Sole F, 2014, ZOOL J LINN SOC-LOND, V171, P878, DOI 10.1111/zoj.12155; Sole F, 2013, GEOBIOS-LYON, V46, P313, DOI 10.1016/j.geobios.2013.02.003; Sole F, 2013, J SYST PALAEONTOL, V11, P375, DOI 10.1080/14772019.2012.686927; Sole F, 2011, PALAEONTOL ELECTRON, V14; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stefen Clara, 1997, Palaeontologische Zeitschrift, V71, P291; Stehlin HG, 1904, MAMMIFEH SPECIAL REF, V4, P445; Sudre J., 1969, Palaeovertebrata, V2, P95; SZALAY FREDERICK S., 1967, AMER MUS NOVITATES, V2293, P1; Tsubamoto T, 2014, ACTA PALAEONTOL POL, V59, P259, DOI 10.4202/app.2011.0067; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; van der Made J., 2003, Deinsea, V9, P437; Van Valen L., 1967, Bulletin of the American Museum of Natural History, V135, P217; Van Valen L., 1966, B AM MUS NAT HIST, V132, P1; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Van Valkenburgh B, 1987, J VERT PALEONTOL, V7, P162, DOI DOI 10.1080/02724634.1987.10011651; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Wang XM, 1999, B AM MUS NAT HIST, P1; WERDELIN L, 1989, PALEOBIOLOGY, V15, P387, DOI 10.1017/S009483730000957X; Werdelin L, 1991, FOSSILS STRATA, V30, P1; Wortman JL, 1902, AM J SCI, V13, P197; Yans J, 2014, GONDWANA RES, V25, P257, DOI 10.1016/j.gr.2013.04.004	137	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0135698	10.1371/journal.pone.0135698	http://dx.doi.org/10.1371/journal.pone.0135698			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398622	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500004
J	Thein, HH; Campitelli, MA; Yeung, LT; Zaheen, A; Yoshida, EM; Earle, CC				Thein, Hla-Hla; Campitelli, Michael A.; Yeung, Latifa T.; Zaheen, Ahmad; Yoshida, Eric M.; Earle, Craig C.			Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; C VIRUS-INFECTIONS; RISK-FACTORS; CIRRHOTIC-PATIENTS; EARLY-DIAGNOSIS; EPIDEMIOLOGY; STAGE; METAANALYSIS; MANAGEMENT; TRIAL	The optimal schedule for ultrasonographic surveillance of patients with viral hepatitis for the detection of hepatocellular carcinoma (HCC) remains unclear owing to a lack of reliable studies. We examined the timing of ultrasonography in patients with viral hepatitis-induced HCC and its impact on survival and mortality risk while determining predictors of receiving surveillance before HCC diagnosis. A population-based retrospective cohort analysis of patients with viral hepatitis-induced HCC in Ontario between 2000 and 2010 was performed using data from the Ontario Cancer Registry linked health administrative data. HCC surveillance for 2 years preceding diagnosis was assigned as: i) >= 2 abdominal ultrasound screens annually; ii) 1 screen annually; iii) inconsistent screening; and iv) no screening. Survival rates were estimated using the Kaplan-Meier method and parametric models to correct for lead-time bias. Associations between HCC surveillance and the risk of mortality after diagnosis were examined using proportional-hazards regression adjusting for confounding factors. Overall, 1,483 patients with viral hepatitis-induced HCC were identified during the study period; 20.2% received >= 1 ultrasound screen annually (routine surveillance) for the 2 years preceding diagnosis. The 5-year survival of those receiving routine surveillance was 31.93% (95% CI: 25.77-38.24%) and 31.84% (95% CI: 25.69-38.14%) when corrected for lead-time bias (HCC sojourn time 70 days and 140 days, respectively). This is contrasted with 20.67% (95% CI: 16.86-24.74%) 5-year survival in those who did not undergo screening. In the fully adjusted model, compared to unscreened patients, routine surveillance was associated with a lower mortality risk and a hazard ratio of 0.76 (95% CI: 0.64-0.91) and 0.81 (95% CI: 0.68-0.97), corrected for the respective lead-time bias. Our findings suggest that routine ultrasonography in patients with viral hepatitis is associated with improved survival and reduced mortality risk in a population-based setting. The data emphasizes the importance of surveillance for timely intervention in HCC-diagnosed patients.	[Thein, Hla-Hla; Campitelli, Michael A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thein, Hla-Hla; Earle, Craig C.] Canc Care Ontario, Ontario Inst Canc Res, Toronto, ON, Canada; [Thein, Hla-Hla; Earle, Craig C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Yeung, Latifa T.] Rouge Valley Hlth Syst, Scarborough, ON, Canada; [Yeung, Latifa T.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Yeung, Latifa T.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Zaheen, Ahmad] Univ Toronto, Fac Med, Toronto, ON, Canada; [Yoshida, Eric M.] Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada	University of Toronto; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of British Columbia	Thein, HH (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	rosie.thein@utoronto.ca		Yeung, Latifa/0000-0002-2830-9929; Thein, Hla-Hla/0000-0003-4950-187X	Institute for Clinical Evaluative Sciences (ICES); Cancer Care Ontario (CCO); Ministry of Health and Long-Term Care (MOHLTC); Ontario Institute for Cancer Research (OICR); Ontario Institute for Cancer Research Health Services Research Program New Investigator Award at Dalla Lana School of Public Health, University of Toronto [IA-034]	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Cancer Care Ontario (CCO); Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Ontario Institute for Cancer Research (OICR); Ontario Institute for Cancer Research Health Services Research Program New Investigator Award at Dalla Lana School of Public Health, University of Toronto	This study was supported through provision of data by the Institute for Clinical Evaluative Sciences (ICES) and Cancer Care Ontario (CCO) and through funding support to ICES from an annual grant by the Ministry of Health and Long-Term Care (MOHLTC) and the Ontario Institute for Cancer Research (OICR). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, CCO, OICR or the Government of Ontario is intended or should be inferred. Hla-Hla Thein is supported by the Ontario Institute for Cancer Research Health Services Research Program New Investigator Award IA-034 at the Dalla Lana School of Public Health, University of Toronto.	Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Canadian Association for the Study of the Liver, 2000, CAN J GASTROENTEROL, V14, p5B; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2013, CAN CANC STAT 2013; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Clarke E A, 1991, IARC Sci Publ, P246; Davila JA, 2007, J CLIN GASTROENTEROL, V41, P777, DOI 10.1097/MCG.0b013e3180381560; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI 10.7326/0003-4819-154-2-201101180-00006; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Duffy SW, 2008, AM J EPIDEMIOL, V168, P98, DOI 10.1093/aje/kwn120; Dyer Z, 2005, ALIMENT PHARM THER, V22, P17, DOI 10.1111/j.1365-2036.2005.02504.x; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2011, GUT, V60, P992, DOI 10.1136/gut.2010.230508; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Jembere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040917; Kansagara D, 2014, ANN INTERN MED, V161, P261, DOI 10.7326/M14-0558; Khalili K, 2014, CAN J GASTROENTEROL, V28, P150, DOI 10.1155/2014/561732; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; MARRETT LD, 1986, CAN J PUBLIC HEALTH, V77, P79; Match Ware Technologies INC, 1998, AUTOMATCH GEN REC LI; Mourad A, 2014, HEPATOLOGY, V59, P1471, DOI 10.1002/hep.26944; OKA H, 1990, HEPATOLOGY, V12, P680, DOI 10.1002/hep.1840120411; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pocobelli G, 2008, LIVER INT, V28, P1272, DOI 10.1111/j.1478-3231.2008.01704.x; Richardson P, 2010, DIGEST DIS SCI, V55, P3241, DOI 10.1007/s10620-010-1387-y; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Santi V, 2010, J HEPATOL, V53, P291, DOI 10.1016/j.jhep.2010.03.010; SCHWARTZ M, 1961, CANCER, V14, P1272, DOI 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H; Sherman M, 2011, CURR ONCOL, V18, P228; SHEU JC, 1985, GASTROENTEROLOGY, V89, P259, DOI 10.1016/0016-5085(85)90324-5; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2012, CANCER EPIDEM BIOMAR, V21, P793, DOI 10.1158/1055-9965.EPI-11-1005; Statistics Canada Agriculture Division, 2002, 61 STAT CAN AGR DIV, V61; Thein Hla-Hla, 2015, CMAJ Open, V3, pE208, DOI 10.9778/cmajo.20140118; Thein HH, 2013, HEPATOLOGY, V58, P1375, DOI 10.1002/hep.26231; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; Trevisani F, 2007, AM J GASTROENTEROL, V102, P2448, DOI 10.1111/j.1572-0241.2007.01395.x; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Walter SR, 2011, J GASTROEN HEPATOL, V26, P1757, DOI 10.1111/j.1440-1746.2011.06785.x; Wilkins R., 2004, AUTOMATED GEOGRAPHIC; Wong LL, 2000, LIVER TRANSPLANT, V6, P320, DOI 10.1053/lv.2000.4875; Yeung LT, USING ADM DATA ASSEM; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	60	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138907	10.1371/journal.pone.0138907	http://dx.doi.org/10.1371/journal.pone.0138907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398404	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500127
J	Walsh, HJ; Richardson, DE; Marancik, KE; Hare, JA				Walsh, Harvey J.; Richardson, David E.; Marancik, Katrin E.; Hare, Jonathan A.			Long-Term Changes in the Distributions of Larval and Adult Fish in the Northeast US Shelf Ecosystem	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; EARLY-LIFE HISTORY; CLIMATE-CHANGE; CONTINENTAL-SHELF; MARINE FISHES; POPULATION CONNECTIVITY; DRIVEN CHANGES; COASTAL OCEAN; GEORGES BANK; ATLANTIC COD	Many studies have documented long-term changes in adult marine fish distributions and linked these changes to climate change and multi-decadal climate variability. Most marine fish, however, have complex life histories with morphologically distinct stages, which use different habitats. Shifts in distribution of one stage may affect the connectivity between life stages and thereby impact population processes including spawning and recruitment. Specifically, many marine fish species have a planktonic larval stage, which lasts from weeks to months. We compared the spatial distribution and seasonal occurrence of larval fish in the Northeast U.S. Shelf Ecosystem to test whether spatial and temporal distributions changed between two decades. Two large-scale ichthyoplankton programs sampled using similar methods and spatial domain each decade. Adult distributions from a long-term bottom trawl survey over the same time period and spatial area were also analyzed using the same analytical framework to compare changes in larval and adult distributions between the two decades. Changes in spatial distribution of larvae occurred for 43% of taxa, with shifts predominately northward (i.e., along-shelf). Timing of larval occurrence shifted for 49% of the larval taxa, with shifts evenly split between occurring earlier and later in the season. Where both larvae and adults of the same species were analyzed, 48% exhibited different shifts between larval and adult stages. Overall, these results demonstrate that larval fish distributions are changing in the ecosystem. The spatial changes are largely consistent with expectations from a changing climate. The temporal changes are more complex, indicating we need a better understanding of reproductive timing of fishes in the ecosystem. These changes may impact population productivity through changes in life history connectivity and recruitment, and add to the accumulating evidence for changes in the Northeast U.S. Shelf Ecosystem with potential to impact fisheries and other ecosystem services.	[Walsh, Harvey J.; Richardson, David E.; Hare, Jonathan A.] NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Narragansett, RI 02882 USA; [Marancik, Katrin E.] Integrated Stat, Narragansett, RI USA	National Oceanic Atmospheric Admin (NOAA) - USA	Walsh, HJ (corresponding author), NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Narragansett, RI 02882 USA.	Harvey.Walsh@noaa.gov						Able KW, 2010, ECOLOGY OF ESTUARINE; Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bell RJ, 2014, ICES J MAR SCI, V71, P2416, DOI 10.1093/icesjms/fsu069; Bi HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087720; Burton ML, 1998, P GULF CARIB FISH I, V50, P896; Center NFS, 2014, 58TH NORTHEAST REGIO; Center NFS, 2012, NORTHEAST REGIONAL S; Ciannelli L, 2015, ICES J MAR SCI, V72, P285, DOI 10.1093/icesjms/fsu145; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dagg MJ, 1996, MAR FRESHWATER RES, V47, P137, DOI 10.1071/MF9960137; Doubleday WG, 1981, BOTTOM TRAWL SURVEYS; Doyle MJ, 2012, CAN J FISH AQUAT SCI, V69, P2112, DOI 10.1139/cjfas-2012-0171; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Ecosystem Assessment Program, 2012, ECOSYSTEM STATUS REP; Edwards KP, 2007, MAR ECOL PROG SER, V352, P77, DOI 10.3354/meps07169; Ejsymont L, 2000, BULLETIN SEA FISHERI, V3; Fahay MP, 2007, EARLY STAGES OF FISH; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Forsyth JST, 2015, J GEOPHYS RES-OCEANS, V120, P2370, DOI 10.1002/2014JC010516; Friedland KD, 2007, CONT SHELF RES, V27, P2313, DOI 10.1016/j.csr.2007.06.001; Friedland KD, 2013, PROG OCEANOGR, V116, P1, DOI 10.1016/j.pocean.2013.05.011; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Gaichas SK, 2014, ICES J MAR SCI, V71, P2323, DOI 10.1093/icesjms/fsu048; Genner MJ, 2010, J PLANKTON RES, V32, P699, DOI 10.1093/plankt/fbp082; Greater Atlantic Regional Fisheries Office NOAA Fisheries, 2015, GREATER ATLANTIC REG; Hare JA, 2013, STOCK IDENTIFICATION; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hjort J., 1914, RAPPORTS DES PROCES, V19; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; Huret M, 2010, PROG OCEANOGR, V87, P6, DOI 10.1016/j.pocean.2010.09.023; Jossi JW, 1983, NOAA TECHNICAL MEMO; Jung S, 2014, REV FISH BIOL FISHER, V24, P443, DOI 10.1007/s11160-013-9310-1; Kleisner KM, 2015, SHIFTS IN MARINE FIS; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Llopiz JK, 2014, OCEANOGRAPHY, V27, P26, DOI 10.5670/oceanog.2014.84; Lloyd P, 2012, FISH OCEANOGR, V21, P78, DOI 10.1111/j.1365-2419.2011.00610.x; Manderson J, 2011, MAR ECOL PROG SER, V438, P1, DOI 10.3354/meps09308; MORSE WW, 1989, FISH B-NOAA, V87, P417; Mountain DG, 2010, MAR ECOL PROG SER, V398, P81, DOI 10.3354/meps08323; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Overholtz WJ, 2011, MAR COAST FISH, V3, P219, DOI 10.1080/19425120.2011.578485; Palamara L, 2012, MAR ECOL PROG SER, V447, P15, DOI 10.3354/meps09496; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Richardson DE, 2014, CAN J FISH AQUAT SCI, V71, P1349, DOI 10.1139/cjfas-2013-0489; Richardson DE, 2010, ICES J MAR SCI, V67, P617, DOI 10.1093/icesjms/fsp276; Rivoirard J, 2000, GEOSTATISTICS FOR ES; Robichaud D, 2001, CAN J FISH AQUAT SCI, V58, P2325, DOI 10.1139/cjfas-58-12-2325; Shackell NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090662; Shearman RK, 2010, J PHYS OCEANOGR, V40, P1004, DOI 10.1175/2009JPO4300.1; Shoji J, 2011, ICES J MAR SCI, V68, P1165, DOI 10.1093/icesjms/fsr059; Sibunka JD, 1989, ATLAS; Sibunka JD, 1984, NOAA TECHNICAL MEMO; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; SMITH WG, 1993, FISH B-NOAA, V91, P338; Sokal R. R, 1981, BIOMETRY; Sosebee KA, 2006, NORTHEAST FISHERIES, p[1963, 06]; Sullivan MC, 2005, FISH OCEANOGR, V14, P386, DOI 10.1111/j.1365-2419.2005.00343.x; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Voss R, 2012, J MARINE SYST, V100, P1, DOI 10.1016/j.jmarsys.2012.03.009; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435	72	64	65	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137382	10.1371/journal.pone.0137382	http://dx.doi.org/10.1371/journal.pone.0137382			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398900	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500033
J	Shi, P; Goodson, JM; Hartman, ML; Hasturk, H; Yaskell, T; Vargas, J; Cugini, M; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K; Welty, F				Shi, Ping; Goodson, J. Max; Hartman, Mor-Li; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Cugini, Maryann; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem; Welty, Francine			Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; NORMAL-WEIGHT; RISK SCORE; ADIPONECTIN; LEPTIN; YOUTH; ADOLESCENTS; PREVALENCE; PREDICTORS; OVERWEIGHT	Background Binary definitions of the metabolic syndrome based on the presence of a particular number of individual risk factors are limited, particularly in the pediatric population. To address this limitation, we aimed at constructing composite and continuous metabolic syndrome scores (cmetS) to represent an overall measure of metabolic syndrome (MetS) in a large cohort of metabolically at-risk children, focusing on the use of the usual clinical parameters (waist circumference (WC) and systolic blood pressure (SBP), supplemented with two salivary surrogate variables (glucose and high density lipoprotein cholesterol (HDLC). Two different approaches used to create the scores were evaluated in comparison. Methods Data from 8,112 Kuwaiti children (10.00 +/- 0.67 years) were used to construct two cmetS for each subject. The first cmetS (cmetS-Z) was created by summing standardized residuals of each variable regressed on age and gender; and the second cmetS (cmetS-PCA) was defined as the first principal component from gender-specific principal component analysis based on the four variables. Results There was a graded relationship between both scores and the number of adverse risk factors. The areas under the curve using cmetS-Z and cmetS-PCA as predictors for severe metabolic syndrome (defined as the presence of >= 3 metabolic risk factors) were 0.935 and 0.912, respectively. cmetS-Z was positively associated with WC, SBP, and glucose, but inversely associated with HDLC. Except for the lack of association with glucose, cmetS-PCA was similar to cmetS-Z in boys, but had minimum loading on HDLC in girls. Analysis using quantile regression showed an inverse association of fitness level with cmetS-PCA (p = 0.001 for boys; p = 0.002 for girls), and comparison of cmetS-Z and cmetS-PCA suggested that WC and SBP were main contributory components. Significant alterations in the relationship between cmetS and salivary adipocytokines were demonstrated in overweight and obese children as compared to underweight and normal-weight children. Conclusion We have derived continuous summary scores for MetS from a large-scale pediatric study using two different approaches, incorporating salivary measures as surrogate for plasma measures. The derived scores were viable expressions of metabolic risk, and can be utilized to study the relationships of MetS with various aspects of the metabolic disease process.	[Shi, Ping; Goodson, J. Max; Hartman, Mor-Li; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Cugini, Maryann; Soparkar, Pramod] Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA; [Barake, Roula; Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha; Ariga, Jitendra] Minist Hlth, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait; [Welty, Francine] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Forsyth Institute; Kuwait University; Harvard University; Beth Israel Deaconess Medical Center	Shi, P (corresponding author), Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA.	pscshi@gmail.com; mgoodson@forsyth.org		Barake, Roula/0000-0002-9461-2897	Dasman Diabetes Institute in Kuwait;  [P30 DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	Dasman Diabetes Institute in Kuwait; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the Dasman Diabetes Institute in Kuwait. The authors also received a consultation service from Boston Nutrition and Obesity Research Center, supported by grant P30 DK46200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/919425; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Batey LS, 1997, CIRCULATION, V96, P4319; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Brewer HB, 1999, AM J CARDIOL, V83, p3F; Chilibeck PD, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/597162; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DuBose KD, 2007, PEDIATRICS, V120, pE1262, DOI 10.1542/peds.2007-0443; Dubose KD, 2006, ACTA PAEDIATR, V95, P1005, DOI 10.1080/08035250600570553; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Gonzalez M, 2012, EUR J CLIN NUTR, V66, P1141, DOI 10.1038/ejcn.2012.112; Goodson J.M., 2014, DIABETES MANAGE, V4, P463; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Goodson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074461; Hartman ML, 2015, DIABET METAB SYND OB, V8, P9, DOI 10.2147/DMSO.S72744; Hillier TA, 2006, DIABETOLOGIA, V49, P1528, DOI 10.1007/s00125-006-0266-8; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2007, PEDIATR RES, V61, P640, DOI 10.1203/01.pdr.0000262638.48304.ef; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; Mascarenhas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101706; Miller M, 2007, INT J CARDIOL, V119, P192, DOI 10.1016/j.ijcard.2006.07.132; Mochizuki K, 2013, EUR J NUTR, V52, P67, DOI 10.1007/s00394-011-0287-z; Okosun IS, 2010, ANN EPIDEMIOL, V20, P843, DOI 10.1016/j.annepidem.2010.08.001; Pandit D, 2011, INT J OBESITY, V35, P1318, DOI 10.1038/ijo.2011.138; Peterson MD, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-146; Rizzo ACB, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-19; Singh S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/215748; Sovio U, 2013, J OBES, V2013, DOI 10.1155/2013/684782; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Thanakun S, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-19; Venner AA, 2006, CLIN BIOCHEM, V39, P1047, DOI 10.1016/j.clinbiochem.2006.07.010; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	40	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138979	10.1371/journal.pone.0138979	http://dx.doi.org/10.1371/journal.pone.0138979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418011	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400030
J	Hernandez-Camacho, CJ; Bakker, VJ; Aurioles-Gamboa, D; Laake, J; Gerber, LR				Hernandez-Camacho, Claudia J.; Bakker, Victoria. J.; Aurioles-Gamboa, David; Laake, Jeff; Gerber, Leah R.			The Use of Surrogate Data in Demographic Population Viability Analysis: A Case Study of California Sea Lions	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; ZALOPHUS-CALIFORNIANUS; TEMPORAL VARIATION; SURVIVAL; CONSERVATION; MANAGEMENT; MODELS; RATES; AGE; ACCURACY	Reliable data necessary to parameterize population models are seldom available for imperiled species. As an alternative, data from populations of the same species or from ecologically similar species have been used to construct models. In this study, we evaluated the use of demographic data collected at one California sea lion colony (Los Islotes) to predict the population dynamics of the same species from two other colonies (San Jorge and Granito) in the Gulf of California, Mexico, for which demographic data are lacking. To do so, we developed a stochastic demographic age-structured matrix model and conducted a population viability analysis for each colony. For the Los Islotes colony we used site-specific pup, juvenile, and adult survival probabilities, as well as birth rates for older females. For the other colonies, we used site-specific pup and juvenile survival probabilities, but used surrogate data from Los Islotes for adult survival probabilities and birth rates. We assessed these models by comparing simulated retrospective population trajectories to observed population trends based on count data. The projected population trajectories approximated the observed trends when surrogate data were used for one colony but failed to match for a second colony. Our results indicate that species-specific and even region-specific surrogate data may lead to erroneous conservation decisions. These results highlight the importance of using population-specific demographic data in assessing extinction risk. When vital rates are not available and immediate management actions must be taken, in particular for imperiled species, we recommend the use of surrogate data only when the populations appear to have similar population trends.	[Hernandez-Camacho, Claudia J.; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Bakker, Victoria. J.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Aurioles-Gamboa, David] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Pinnipedos Burney J Le Boeuf, La Paz, Baja California, Mexico; [Laake, Jeff] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA USA	Arizona State University; Arizona State University-Tempe; Montana State University System; Montana State University Bozeman; Instituto Politecnico Nacional - Mexico; National Oceanic Atmospheric Admin (NOAA) - USA	Hernandez-Camacho, CJ (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Pinnipedos Burney J Le Boeuf, La Paz, Baja California, Mexico.	jcamacho@ipn.mx	Camacho, Claudia J. Hernández/Q-8914-2018	Camacho, Claudia J. Hernández/0000-0002-6309-9728	Instituto Politecnico Nacional [SIP 20100911]; Consejo Nacional de Ciencia y Tecnologia [132415]; National Science Foundation [0347960]	Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF))	This work was funded by Instituto Politecnico Nacional (SIP 20100911) (http://www.sip.ipn.mx/Paginas/Principal.aspx) to CJHC, Consejo Nacional de Ciencia y Tecnologia (# 132415) (http://www.conacyt.mx/) to CJHC, and National Science Foundation (# 0347960) to LRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; Aurioles D., 1991, ECOL STUD, V88, P112; Bakker VJ, 2009, FRONT ECOL ENVIRON, V7, P158, DOI 10.1890/070220; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; CANCINO Jorge, 2010, Acta Zool. Mex, V26, P173; Caro T, 2005, CONSERV BIOL, V19, P1821, DOI 10.1111/j.1523-1739.2005.00251.x; Chilvers BL, 2010, J MAMMAL, V91, P758, DOI 10.1644/09-MAMM-A-285.1; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; Etterson MA, 2006, HUM ECOL RISK ASSESS, V12, P1074, DOI 10.1080/10807030600977277; Finkelstein ME, 2010, BIOL CONSERV, V143, P321, DOI 10.1016/j.biocon.2009.10.013; Fowler C.W., 1987, Current Mammalogy, V1, P401; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Garcia-Aguilar MC, CIENCIAS MARINAS, V29, P573; Githiru M, 2007, ORYX, V41, P239, DOI 10.1017/S0030605307001810; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Heath CB, 1989, THESIS U SAN CRUZ, P255; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hernandez-Camacho CJ, 2008, J MAMMAL, V89, P1059, DOI 10.1644/07-MAMM-A-404.1; Hernandez-Camacho CJ, 2008, MAR MAMMAL SCI, V24, P664, DOI 10.1111/j.1748-7692.2008.00199.x; Johnson HE, 2010, ECOL APPL, V20, P1753, DOI 10.1890/09-1107.1; Laake J., 2022, MARK, P109; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Melin SR, 2012, MAR MAMMAL SCI, V28, P751, DOI 10.1111/j.1748-7692.2011.00538.x; Melin SR, 2000, MAR MAMMAL SCI, V16, P169, DOI 10.1111/j.1748-7692.2000.tb00911.x; Miller DH, 2002, ECOL MODEL, V151, P271, DOI 10.1016/S0304-3800(01)00493-8; Morris W. F., 2002, QUANTITATIVE CONSERV; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Pistorius PA, 2001, POLAR BIOL, V24, P343, DOI 10.1007/s003000000217; Ralls K., 1980, REPORT INT WHALING C, V2, P233; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Schramm Y, 2009, MAR BIOL, V156, P1375, DOI 10.1007/s00227-009-1178-1; Schtickzelle N, 2005, OIKOS, V109, P89, DOI 10.1111/j.0030-1299.2005.13745.x; Schulz TM, 2005, ECOL MONOGR, V75, P159, DOI 10.1890/04-0319; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Sinclair ARE, 1996, FRONTIERS OF POPULATION ECOLOGY, P127; Soule M., 1987, VIABLE POPULATIONS C; Szteren D, 2011, CIENC MAR, V37, P349, DOI 10.7773/cm.v37i3.1818; Szteren D, 2006, LOW WAKE FI, P369; Underwood JG, 2008, CONSERV BIOL, V22, P701, DOI 10.1111/j.1523-1739.2008.00919.x; Ward EJ, 2010, J APPL ECOL, V47, P47, DOI 10.1111/j.1365-2664.2009.01745.x; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2000, METH C CONS, P288; Wielgus J, 2008, ECOL APPL, V18, P1287, DOI 10.1890/07-0892.1; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Young JK, 2007, MAR MAMMAL SCI, V23, P926, DOI 10.1111/j.1748-7692.2007.00138.x; ZavalaGonzalez A, 1997, FISH B-NOAA, V95, P180	54	11	11	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139158	10.1371/journal.pone.0139158	http://dx.doi.org/10.1371/journal.pone.0139158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413746	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700047
J	Lee, Y; Lee, M; Choi, SI				Lee, Yonggeol; Lee, Minsik; Choi, Sang-Il			Image Generation Using Bidirectional Integral Features for Face Recognition with a Single Sample per Person	PLOS ONE			English	Article							ONE TRAINING IMAGE; ILLUMINATION; CLASSIFICATION; EXTRACTION; SELECTION; VECTORS	In face recognition, most appearance-based methods require several images of each person to construct the feature space for recognition. However, in the real world it is difficult to collect multiple images per person, and in many cases there is only a single sample per person (SSPP). In this paper, we propose a method to generate new images with various illuminations from a single image taken under frontal illumination. Motivated by the integral image, which was developed for face detection, we extract the bidirectional integral feature (BIF) to obtain the characteristics of the illumination condition at the time of the picture being taken. The experimental results for various face databases show that the proposed method results in improved recognition performance under illumination variation.	[Lee, Yonggeol; Choi, Sang-Il] Dankook Univ, Dept Comp Sci & Engn, Yongin 448701, Gyeonggi Do, South Korea; [Lee, Minsik] Hanyang Univ, Div Elect Engn, Ansan 426791, Gyeonggi Do, South Korea	Dankook University; Hanyang University	Choi, SI (corresponding author), Dankook Univ, Dept Comp Sci & Engn, 126 Jukjeon Dong, Yongin 448701, Gyeonggi Do, South Korea.	choisi@dankook.ac.kr	Lee, Minsik/S-7959-2017	Lee, Minsik/0000-0003-4941-4311	Dankook University	Dankook University	The present research was conducted by the research fund of Dankook University in 2013.	[Anonymous], YALE FACE DATABASE; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Cevikalp H, 2005, IEEE T PATTERN ANAL, V27, P4, DOI 10.1109/TPAMI.2005.9; Chen SC, 2004, PATTERN RECOGN LETT, V25, P1173, DOI 10.1016/j.patrec.2004.03.012; Choi S.-I., 2010, FACE RECOGNITION BAS; Choi SI, 2012, SENSORS-BASEL, V12, P16182, DOI 10.3390/s121216182; Choi SI, 2012, PATTERN RECOGN LETT, V33, P1083, DOI 10.1016/j.patrec.2012.01.005; Choi SI, 2012, SIGNAL PROCESS, V92, P636, DOI 10.1016/j.sigpro.2011.08.023; De la Torre F, 2005, PROC CVPR IEEE, P266; Fukunaga K., 2013, INTRO STAT PATTERN R; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Jiang XD, 2008, IEEE T PATTERN ANAL, V30, P383, DOI 10.1109/TPAMI.2007.70708; Jung HC, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P272; Kim C, 2007, PATTERN RECOGN, V40, P1592, DOI 10.1016/j.patcog.2006.09.010; Kim C, 2012, IEEE T SYST MAN CY B, V42, P1095, DOI 10.1109/TSMCB.2012.2186798; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Lu JW, 2013, IEEE T PATTERN ANAL, V35, P39, DOI 10.1109/TPAMI.2012.70; Martinez AM, 2002, IEEE T PATTERN ANAL, V24, P748, DOI 10.1109/TPAMI.2002.1008382; Mian Ajmal S., 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P1833, DOI 10.1109/ICCVW.2009.5457505; Mian A, 2011, OPT EXPRESS, V19, P7491, DOI 10.1364/OE.19.007491; Oh J, 2013, PATTERN RECOGN LETT, V34, P1540, DOI 10.1016/j.patrec.2013.06.009; Sim T, 2003, IEEE T PATTERN ANAL, V25, P1615, DOI 10.1109/TPAMI.2003.1251154; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wu JX, 2002, PATTERN RECOGN LETT, V23, P1711, DOI 10.1016/S0167-8655(02)00134-4; Xu Y, 2013, PATTERN RECOGN, V46, P1151, DOI 10.1016/j.patcog.2012.11.003; Yan SC, 2007, IEEE T INF FOREN SEC, V2, P69, DOI 10.1109/TIFS.2006.890313; Yang Q, 2002, 2002 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P97; Yu H, 2001, PATTERN RECOGN, V34, P2067, DOI 10.1016/S0031-3203(00)00162-X; Zhang DQ, 2005, APPL MATH COMPUT, V163, P895, DOI 10.1016/j.amc.2004.04.016; Zhang T, 2014, OPTIK, V125, P5017, DOI 10.1016/j.ijleo.2014.01.171	32	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138859	10.1371/journal.pone.0138859	http://dx.doi.org/10.1371/journal.pone.0138859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414018	Green Submitted, gold, Green Published			2022-12-26	WOS:000362170700025
J	Qiu, X; Wu, S; Hilchey, SP; Thakar, J; Liu, ZP; Welle, SL; Henn, AD; Wu, HL; Zand, MS				Qiu, Xing; Wu, Shuang; Hilchey, Shannon P.; Thakar, Juilee; Liu, Zhi-Ping; Welle, Stephen L.; Henn, Alicia D.; Wu, Hulin; Zand, Martin S.			Diversity in Compartmental Dynamics of Gene Regulatory Networks: The Immune Response in Primary Influenza A Infection in Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; DIFFERENTIAL-EQUATION MODELS; TOLL-LIKE RECEPTOR; VIRUS-INFECTION; MEASUREMENT ERROR; EXPRESSION; IDENTIFICATION; ACTIVATION; MIGRATION; CD4(+)	Current approaches to study transcriptional profiles post influenza infection typically rely on tissue sampling from one or two sites at a few time points, such as spleen and lung in murine models. In this study, we infected female C57/BL6 mice intranasally with mouse-adapted H3N2/Hong Kong/X31 avian influenza A virus, and then analyzed the gene expression profiles in four different compartments (blood, lung, mediastinal lymph nodes, and spleen) over 11 consecutive days post infection. These data were analyzed by an advanced statistical procedure based on ordinary differential equation (ODE) modeling. Vastly different lists of significant genes were identified by the same statistical procedure in each compartment. Only 11 of them are significant in all four compartments. We classified significant genes in each compartment into co-expressed modules based on temporal expression patterns. We then performed functional enrichment analysis on these co-expression modules and identified significant pathway and functional motifs. Finally, we used an ODE based model to reconstruct gene regulatory network (GRN) for each compartment and studied their network properties.	[Qiu, Xing; Wu, Shuang; Thakar, Juilee; Liu, Zhi-Ping] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Hilchey, Shannon P.; Henn, Alicia D.; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Thakar, Juilee; Henn, Alicia D.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Liu, Zhi-Ping] Shandong Univ, Dept Biomed Engn, Jinan 250100, Shandong, Peoples R China; [Welle, Stephen L.] Univ Rochester, Funct Genom Ctr, Rochester, NY 14642 USA; [Wu, Hulin] Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA	University of Rochester; University of Rochester; University of Rochester; Shandong University; University of Rochester; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Wu, HL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA.	Hulin.Wu@uth.tmc.edu; martin_zand@urmc.rochester.edu	Liu, Zhi-Ping/C-9846-2010	Liu, Zhi-Ping/0000-0001-7742-9161; Ye, Guoyou/0000-0002-9943-4815; Zand, Martin/0000-0002-7095-8682	National Institutes of Health [NIH HHSN272201000055C, 5 R01 AI087135, R01-AI091461, R01-AI069351, 2 R01 HL062826-09A2]; University of Rochester CTSI pilot award from the National Center For Research Resources [UL1RR024160]; National Center for Advancing Translational Sciences of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069351, R01AI087135, R01AI098112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester CTSI pilot award from the National Center For Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is partially supported by NIH HHSN272201000055C, 5 R01 AI087135, R01-AI091461, R01-AI069351 and 2 R01 HL062826-09A2 from the National Institutes of Health; and the University of Rochester CTSI pilot award (UL1RR024160) from the National Center For Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almudevar A, 2010, EURASIP J BIOINFORM, DOI 10.1155/2010/947564; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Doherty PC, 2009, REV SCI TECH OIE, V28, P175, DOI 10.20506/rst.28.1.1857; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Gossner A, 2011, VET MICROBIOL, V153, P218, DOI 10.1016/j.vetmic.2011.05.036; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Henderson SC, 2002, J IMMUNOL, V168, P118, DOI 10.4049/jimmunol.168.1.118; Henn AD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KILBOURNE ED, 1968, SCIENCE, V160, P74, DOI 10.1126/science.160.3823.74; Klamp T, 2003, J IMMUNOL, V171, P1255, DOI 10.4049/jimmunol.171.3.1255; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Liang H, 2008, J AM STAT ASSOC, V103, P1570, DOI 10.1198/016214508000000797; Lines JL, 2010, J IMMUNOL, V185, P2980, DOI 10.4049/jimmunol.0903075; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Ludtke THW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003189; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mount AM, 2010, METHODS MOL BIOL, V595, P299, DOI 10.1007/978-1-60761-421-0_20; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Olson MR, 2010, FUTURE VIROL, V5, P175, DOI 10.2217/FVL.10.3; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Rahman N, 2010, IMMUNOL CELL BIOL, V88, P817, DOI 10.1038/icb.2010.57; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sandford EE, 2012, AVIAN DIS, V56, P732, DOI 10.1637/10261-060512-Reg.1; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Topham DJ, 1996, J VIROL, V70, P1288, DOI 10.1128/JVI.70.2.1288-1291.1996; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; Voit EO, 2004, BIOINFORMATICS, V20, P1670, DOI 10.1093/bioinformatics/bth140; Walters KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062412; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Wu S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-6; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340; Xue HQ, 2010, ANN STAT, V38, P2351, DOI 10.1214/09-AOS784; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453	52	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138110	10.1371/journal.pone.0138110	http://dx.doi.org/10.1371/journal.pone.0138110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413862	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700013
J	Liao, S; Yang, WQ; Tan, Y; Peng, Y; Li, J; Tan, B; Wu, FZ				Liao, Shu; Yang, Wanqin; Tan, Yu; Peng, Yan; Li, Jun; Tan, Bo; Wu, Fuzhong			Soil Fauna Affects Dissolved Carbon and Nitrogen in Foliar Litter in Alpine Forest and Alpine Meadow	PLOS ONE			English	Article							CLIMATE-CHANGE; FIELD DECOMPOSITION; ORGANIC NITROGEN; LEAF-LITTER; WINTER; MANIPULATION; MACROFAUNA; DIVERSITY; NUTRIENT; IMPACTS	Dissolved organic carbon (DOC) and total dissolved nitrogen (TDN) are generally considered important active biogeochemical pools of total carbon and nitrogen. Many studies have documented the contributions of soil fauna to litter decomposition, but the effects of the soil fauna on labile substances (i.e., DOC and TDN) in litter during early decomposition are not completely clear. Therefore, a field litterbag experiment was carried out from 13th November 2013 to 23rd October 2014 in an alpine forest and an alpine meadow located on the eastern Tibetan Plateau. Litterbags with different mesh sizes were used to provide access to or prohibit the access of the soil fauna, and the concentrations of DOC and TDN in the foliar litter were measured during the winter (the onset of freezing, deep freezing and thawing stage) and the growing season (early and late). After one year of field incubation, the concentration of DOC in the litter significantly decreased, whereas the TDN concentration in the litter increased. Similar dynamic patterns were detected under the effects of the soil fauna on both DOC and TDN in the litter between the alpine forest and the alpine meadow. The soil fauna showed greater positive effects on decreasing DOC concentration in the litter in the winter than in the growing season. In contrast, the dynamics of TND in the litter were related to seasonal changes in environmental factors, rather than the soil fauna. In addition, the soil fauna promoted a decrease in litter DOC/TDN ratio in both the alpine forest and the alpine meadow throughout the first year of decomposition, except for in the late growing season. These results suggest that the soil fauna can promote decreases in DOC and TDN concentrations in litter, contributing to early litter decomposition in these cold biomes.	[Liao, Shu; Yang, Wanqin; Tan, Yu; Peng, Yan; Li, Jun; Tan, Bo; Wu, Fuzhong] Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn Upper Reaches Yangtze, Inst Ecol & Forestry, Chengdu, Peoples R China; [Liao, Shu; Yang, Wanqin; Tan, Yu; Peng, Yan; Li, Jun; Tan, Bo; Wu, Fuzhong] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu, Peoples R China	Sichuan Agricultural University	Wu, FZ (corresponding author), Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn Upper Reaches Yangtze, Inst Ecol & Forestry, Chengdu, Peoples R China.	wufzchina@163.com	Li, Jun/GWR-0996-2022	Li, Jun/0000-0001-6459-4117	National Natural Science Foundation of China [31270498, 31170423]; Doctoral Scientific Fund Project of the Ministry of Education of China [20135103110002]; Postdoctoral Foundation of China [2012T50782]; Sichuan Youth Science & Technology Foundation [2012JQ0008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Fund Project of the Ministry of Education of China; Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Sichuan Youth Science & Technology Foundation	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) Grants 31270498 to FW, 31170423 to WY; the Doctoral Scientific Fund Project of the Ministry of Education of China (http://www.cutech.edu.cn) Grants 20135103110002 to FW; the Postdoctoral Foundation of China (http://res.chinapostdoctor.org.cn) Grants 2012T50782 to FW; and the Sichuan Youth Science & Technology Foundation (http://www.qnjj.sc.cn) Grants 2012JQ0008 to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert M, 2010, FOREST ECOL MANAG, V259, P563, DOI 10.1016/j.foreco.2009.11.014; Berg B, 2014, SOIL BIOL BIOCHEM, V78, P222, DOI 10.1016/j.soilbio.2014.08.005; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Berglund SL, 2012, OIKOS, V121, P1112, DOI 10.1111/j.1600-0706.2011.19787.x; Bo Tan, 2012, Biodiversity Science, V20, P215; Bo Tan, 2010, Acta Ecologica Sinica, V30, P93; Bokhorst S, 2012, GLOBAL CHANGE BIOL, V18, P1152, DOI 10.1111/j.1365-2486.2011.02565.x; Brussaard L, 2007, PEDOBIOLOGIA, V50, P447, DOI 10.1016/j.pedobi.2006.10.007; Chanpin FS, 2002, PRINCIPLES TERRESTRI; Chen H, 2013, GLOBAL CHANGE BIOL, V19, P2940, DOI 10.1111/gcb.12277; Coleman DC, 2005, PEDOBIOLOGIA, V49, P479, DOI 10.1016/j.pedobi.2005.05.006; Cornelissen JHC, 2014, ECOL RES, V29, P517, DOI 10.1007/s11284-013-1106-1; Cotrufo MF, 1998, SOIL BIOL BIOCHEM, V30, P1565, DOI 10.1016/S0038-0717(98)00032-7; Crutsinger GM, 2009, BASIC APPL ECOL, V10, P535, DOI 10.1016/j.baae.2008.10.011; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; FAO, 2020, SOILS PORTAL WORLD R; Frouz J, 2006, APPL SOIL ECOL, V33, P308, DOI 10.1016/j.apsoil.2005.11.001; Frouz J, 2015, EUR J SOIL BIOL, V68, P18, DOI 10.1016/j.ejsobi.2015.03.002; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Hafner SD, 2005, BIOGEOCHEMISTRY, V74, P257, DOI 10.1007/s10533-004-4722-6; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hawes TC, 2008, POLAR BIOL, V31, P681, DOI 10.1007/s00300-008-0406-3; Hawes TC, 2006, ECOL ENTOMOL, V31, P450, DOI 10.1111/j.1365-2311.2006.00796.x; Liu Ruilong, 2014, Chinese Journal of Applied and Environmental Biology, V20, P499, DOI 10.3724/SP.J.1145.2014.09045; McCay TS, 2013, FOREST ECOL MANAG, V304, P254, DOI 10.1016/j.foreco.2013.05.010; Megonigal JP., 2014, ANAEROBIC METABOLISM, V10; Ni XY, 2015, GEODERMA, V241, P136, DOI 10.1016/j.geoderma.2014.11.018; Ni XY, 2014, CAN J SOIL SCI, V94, P453, DOI 10.4141/CJSS2013-121; Sanchez FG, 2001, FOREST ECOL MANAG, V152, P85, DOI 10.1016/S0378-1127(00)00592-2; Scheu S, 2000, OECOLOGIA, V123, P285, DOI 10.1007/s004420051015; Silva JO, 2015, BASIC APPL ECOL, V16, P210, DOI 10.1016/j.baae.2015.02.005; Sinclair BJ, 2005, FUNCT ECOL, V19, P214, DOI 10.1111/j.1365-2435.2005.00962.x; Slade EM, 2012, BASIC APPL ECOL, V13, P423, DOI 10.1016/j.baae.2012.06.008; Tan B., 2013, ACTA ECOLOGICA SINIC, V33, P12, DOI 10.1016/j.chnaes.2012.12.003; Ullah S, 2006, BIOGEOCHEMISTRY, V81, P253, DOI 10.1007/s10533-006-9040-8; Versini A, 2014, GEODERMA, V232, P426, DOI 10.1016/j.geoderma.2014.05.018; Vestergard M, 2015, APPL SOIL ECOL, V92, P54, DOI 10.1016/j.apsoil.2015.03.002; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Wu QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097112; Xu ZF, 2015, GEODERMA, V239, P223, DOI 10.1016/j.geoderma.2014.10.018; Zwahlen C, 2007, PLANT SOIL, V300, P245, DOI 10.1007/s11104-007-9410-6	43	6	8	7	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139099	10.1371/journal.pone.0139099	http://dx.doi.org/10.1371/journal.pone.0139099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406249	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700168
J	McCarthy, MK; Procario, MC; Wilke, CA; Moore, BB; Weinberg, JB				McCarthy, Mary K.; Procario, Megan C.; Wilke, Carol A.; Moore, Bethany B.; Weinberg, Jason B.			Prostaglandin E-2 Production and T Cell Function in Mouse Adenovirus Type 1 Infection following Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							EXTENSIVE CROSS-REACTIVITY; RESPIRATORY-INFECTION; SELECTIVE INHIBITOR; ANTIVIRAL IMMUNITY; EARLY REGION-1; DNA-SEQUENCE; RESPONSES; CD4(+); CD8(+); IMMUNOSUPPRESSION	Adenovirus infections are important complications of bone marrow transplantation (BMT). We demonstrate delayed clearance of mouse adenovirus type 1 (MAV-1) from lungs of mice following allogeneic BMT. Virus-induced prostaglandin E-2 (PGE(2)) production was greater in BMT mice than in untransplanted controls, but BMT using PGE(2)-deficient donors or recipients failed to improve viral clearance, and treatment of untransplanted mice with the PGE(2) analog misoprostol did not affect virus clearance. Lymphocyte recruitment to the lungs was not significantly affected by BMT. Intracellular cytokine staining of lung lymphocytes demonstrated impaired production of INF-gamma and granzyme B by cells from BMT mice, and production of IFN-gamma, IL-2, IL-4, and IL-17 following ex vivo stimulation was impaired in lymphocytes obtained from lungs of BMT mice. Viral clearance was not delayed in untransplanted INF-gamma-deficient mice, suggesting that delayed viral clearance in BMT mice was not a direct consequence of impaired IFN-gamma production. However, lung viral loads were higher in untransplanted CD8-deficient mice than in controls, suggesting that delayed MAV-1 clearance in BMT mice is due to defective CD8 T cell function. We did not detect significant induction of IFN-beta expression in lungs of BMT mice or untransplanted controls, and viral clearance was not delayed in untransplanted type I IFN-unresponsive mice. We conclude that PGE(2) overproduction in BMT mice is not directly responsible for delayed viral clearance. PGE(2)-independent effects on CD8 T cell function likely contribute to the inability of BMT mice to clear MAV-1 from the lungs.	[McCarthy, Mary K.; Moore, Bethany B.; Weinberg, Jason B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Procario, Megan C.; Weinberg, Jason B.] Univ Michigan, Dept Pediat & Communicable Dis, Div Infect Dis, Ann Arbor, MI 48109 USA; [Wilke, Carol A.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weinberg, JB (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	jbwein@umich.edu		Moore, Bethany/0000-0003-3051-745X; Weinberg, Jason/0000-0002-4768-4361	National Institutes of Health [R01 AI083334, R01 HL115618]; University of Michigan Nancy Newton Loeb Pediatric Cancer Award; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117229, R01AI083334, T32AI007528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Nancy Newton Loeb Pediatric Cancer Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (www.nih.gov; R01 AI083334 to JBW and R01 HL115618 to BBM). This work was also supported by a University of Michigan Nancy Newton Loeb Pediatric Cancer Award (to JBW; http://www.med.umich.edu/pediatrics/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VE, 2009, VIROLOGY, V391, P25, DOI 10.1016/j.virol.2009.06.009; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Auner HW, 2002, ANN HEMATOL, V81, P374, DOI 10.1007/s00277-002-0484-1; Baldwin A, 2000, BONE MARROW TRANSPL, V26, P1333, DOI 10.1038/sj.bmt.1702716; BALL AO, 1991, VIROLOGY, V180, P257, DOI 10.1016/0042-6822(91)90030-F; BALL AO, 1988, J VIROL, V62, P3947, DOI 10.1128/JVI.62.11.3947-3957.1988; BALL AO, 1989, VIROLOGY, V170, P523, DOI 10.1016/0042-6822(89)90444-3; Ballinger MN, 2006, J IMMUNOL, V177, P5499, DOI 10.4049/jimmunol.177.8.5499; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; BETZ M, 1991, J IMMUNOL, V146, P108; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; Cauthen AN, 1996, GENE, V168, P183, DOI 10.1016/0378-1119(95)00715-6; Cauthen Angela N, 2007, Methods Mol Med, V130, P41; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chakupurakal G, 2013, J IMMUNOTHER, V36, P423, DOI 10.1097/CJI.0b013e3182a8029e; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Coomes SM, 2010, TRANSPLANTATION, V90, P1139, DOI 10.1097/TP.0b013e3181efd018; Coomes SM, 2010, J IMMUNOL, V184, P5130, DOI 10.4049/jimmunol.0901871; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Domingo-Gonzalez R, 2013, J IMMUNOL, V190, P5809, DOI 10.4049/jimmunol.1203274; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Feuchtinger T, 2004, EXP HEMATOL, V32, P282, DOI 10.1016/j.exphem.2003.12.009; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; Geyeregger R, 2014, J IMMUNOTHER, V37, P245, DOI 10.1097/CJI.0000000000000034; Gil L, 2007, INFECTION, V35, P421, DOI 10.1007/s15010-007-6350-2; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; Gowdy KM, 2015, TRANSPL IMMUNOL, V32, P51, DOI 10.1016/j.trim.2014.10.005; Heemskerk B, 2005, J INFECT DIS, V191, P520, DOI 10.1086/427513; Heemskerk B, 2003, J VIROL, V77, P6562, DOI 10.1128/JVI.77.11.6562-6566.2003; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Howard DS, 1999, CLIN INFECT DIS, V29, P1494, DOI 10.1086/313514; Hubbard LLN, 2008, EXP LUNG RES, V34, P263, DOI 10.1080/01902140802022518; Hubbard LLN, 2010, J IMMUNOL, V184, P6299, DOI 10.4049/jimmunol.0902828; Kajon AE, 2003, J MED VIROL, V71, P233, DOI 10.1002/jmv.10475; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; KLINGEMANN HG, 1986, BLOOD, V68, P102; Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386; KRING SC, 1990, NUCLEIC ACIDS RES, V18, P4003, DOI 10.1093/nar/18.13.4003; KRING SC, 1992, VIROLOGY, V190, P248, DOI 10.1016/0042-6822(92)91211-C; Leen AA, 2006, BIOL BLOOD MARROW TR, V12, P243, DOI 10.1016/j.bbmt.2005.10.024; Leen AM, 2004, BLOOD, V103, P1011, DOI 10.1182/blood-2003-07-2449; Leen AM, 2009, BLOOD, V114, P4283, DOI 10.1182/blood-2009-07-232454; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Martin-Pena A, 2011, CLIN TRANSPLANT, V25, P468, DOI 10.1111/j.1399-0012.2010.01286.x; McCarthy MK, 2014, VIROLOGY, V456, P259, DOI 10.1016/j.virol.2014.04.008; McCarthy MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077628; Meissner JD, 1997, VIRUS RES, V51, P53, DOI 10.1016/S0168-1702(97)00079-8; Nagayama Y, 2012, CLIN EXP IMMUNOL, V168, P268, DOI 10.1111/j.1365-2249.2012.04578.x; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Nguyen Y, 2011, VIRUS RES, V160, P351, DOI 10.1016/j.virusres.2011.07.012; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Procario MC, 2012, J VIROL, V86, P4194, DOI 10.1128/JVI.06967-11; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Runde V, 2001, BONE MARROW TRANSPL, V28, P51, DOI 10.1038/sj.bmt.1703083; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; SHIELDS AF, 1985, NEW ENGL J MED, V312, P529, DOI 10.1056/NEJM198502283120901; Smith CA, 1998, HUM GENE THER, V9, P1419, DOI 10.1089/hum.1998.9.10-1419; Smith CA, 1996, J VIROL, V70, P6733, DOI 10.1128/JVI.70.10.6733-6740.1996; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; van Tol MJD, 2005, BONE MARROW TRANSPL, V35, pS73, DOI 10.1038/sj.bmt.1704852; Walls T, 2003, LANCET INFECT DIS, V3, P79, DOI 10.1016/S1473-3099(03)00515-2; Weinberg JB, 2007, VIROLOGY, V357, P54, DOI 10.1016/j.virol.2006.08.013; Weinberg JB, 2005, VIROLOGY, V340, P245, DOI 10.1016/j.virol.2005.06.021; WIGAND R, 1977, ARCH VIROL, V54, P131, DOI 10.1007/BF01314385; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zandvliet ML, 2010, HAEMATOL-HEMATOL J, V95, P1943, DOI 10.3324/haematol.2010.022947	71	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139235	10.1371/journal.pone.0139235	http://dx.doi.org/10.1371/journal.pone.0139235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407316	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700196
J	Cecchetti, S; Bortolomai, I; Ferri, R; Mercurio, L; Canevari, S; Podo, F; Miotti, S; Iorio, E				Cecchetti, Serena; Bortolomai, Ileana; Ferri, Renata; Mercurio, Laura; Canevari, Silvana; Podo, Franca; Miotti, Silvia; Iorio, Egidio			Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; SPHINGOMYELIN SYNTHASE; DRUG-RESISTANCE; FUNCTIONAL-ROLE; GROWTH-FACTOR; IDENTIFICATION; ACTIVATION; EGFR; EXPRESSION; HEAD	Purpose The role of phosphatidylcholine-specific phospholipase C (PC-PLC), the enzyme involved in cell differentiation and proliferation, has not yet been explored in tumor initiating cells (TICs). We investigated PC-PLC expression and effects of PC-PLC inhibition in two adherent (AD) squamous carcinoma cell lines (A431 and CaSki), with different proliferative and stemness potential, and in TIC-enriched floating spheres (SPH) originated from them. Results Compared with immortalized non-tumoral keratinocytes (HaCaT) A431-AD cells showed 2.5-fold higher PC-PLC activity, nuclear localization of a 66-kDa PC-PLC isoform, but a similar distribution of the enzyme on plasma membrane and in cytoplasmic compartments. Compared with A431-AD, A431-SPH cells showed about 2.8-fold lower PC-PLC protein and activity levels, but similar nuclear content. Exposure of adherent cells to the PC-PLC inhibitor D609 (48h) induced a 50% reduction of cell proliferation at doses comprised between 33 and 50 mu g/ml, without inducing any relevant cytotoxic effect (cell viability 95 +/- 5%). In A431-SPH and CaSki-SPH D609 induced both cytostatic and cytotoxic effects at about 20 to 30-fold lower doses (IC50 ranging between 1.2 and 1.6 mu g/ml). Furthermore, D609 treatment of A431-AD and CaSki-AD cells affected the sphere-forming efficiency, which dropped in both cells, and induced down-modulation of stem-related markers mRNA levels (Oct4, Nestin, Nanog and ALDH1 in A431; Nestin and ALDH1 in CaSki cells). Conclusions These data suggest that the inhibition of PC-PLC activity may represent a new therapeutic approach to selectively target the most aggressive and tumor promoting sub-population of floating spheres originated from squamous cancer cells possessing different proliferative and stemness potential.	[Cecchetti, Serena; Mercurio, Laura; Podo, Franca; Iorio, Egidio] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Bortolomai, Ileana; Ferri, Renata; Canevari, Silvana; Miotti, Silvia] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy	Istituto Superiore di Sanita (ISS); Fondazione IRCCS Istituto Nazionale Tumori Milan	Canevari, S (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	silvana.canevari@istitutotumori.mi.it; franca.podo@alice.it	Iorio, Egidio/M-7077-2017; Mercurio, Laura/K-2750-2018; Cecchetti, Serena/N-1061-2015	Iorio, Egidio/0000-0001-6673-3838; Mercurio, Laura/0000-0003-0629-1729; Cecchetti, Serena/0000-0002-3601-176X; Ileana, Bortolomai/0000-0002-2592-1274	Fondazione CARIPLO [2007.5376]; AIRC; Italian Health Ministry-Progetto Oncologico di Medicina Molecolare: I Tumori Femminili; ISS Onco-Technology Program	Fondazione CARIPLO(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministry-Progetto Oncologico di Medicina Molecolare: I Tumori Femminili; ISS Onco-Technology Program	This work was partially supported by Fondazione CARIPLO 2007.5376, AIRC IG to Dr. Podo and Dr. Canevari, Italian Health Ministry-Progetto Oncologico di Medicina Molecolare: I Tumori Femminili to Dr. Canevari, ISS Onco-Technology Program to Dr. Iorio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Abe M, 2006, BRIT J PHARMACOL, V147, P402, DOI 10.1038/sj.bjp.0706634; AMTMANN E, 1990, INT J CANCER, V45, P1113, DOI 10.1002/ijc.2910450621; Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Bortolomai I, 2010, CELL CYCLE, V9, P1194, DOI 10.4161/cc.9.6.11108; Cascianelli G, 2008, MOL BIOL CELL, V19, P5289, DOI 10.1091/mbc.E08-05-0517; Cecchetti S, 2007, EUR J IMMUNOL, V37, P2912, DOI 10.1002/eji.200737266; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen D, 2015, MOL MED REP, V11, P4309, DOI 10.3892/mmr.2015.3279; Cichocki M, 2014, MOL CELL BIOCHEM, V396, P221, DOI 10.1007/s11010-014-2157-5; CLARK MA, 1986, BIOCHEM BIOPH RES CO, V140, P114, DOI 10.1016/0006-291X(86)91065-X; Cojoc M, 2015, SEMIN CANCER BIOL, V31, P16, DOI 10.1016/j.semcancer.2014.06.004; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Conesa-Zamora P, 2013, EXP MOL PATHOL, V95, P151, DOI 10.1016/j.yexmp.2013.06.011; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Duggal Rohit, 2013, J Stem Cells, V8, P135, DOI jsc.2014.8.3/4.135; Fantuzzi L, 2008, BLOOD, V111, P3355, DOI 10.1182/blood-2007-08-104901; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hashimoto N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-722; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jansen JFA, 2006, MAGN RESON MED, V56, P666, DOI 10.1002/mrm.20968; Kalluri HSG, 2013, MOL NEUROBIOL, V47, P782, DOI 10.1007/s12035-012-8390-6; Kalluri HSG, 2010, NEUROREPORT, V21, P700, DOI 10.1097/WNR.0b013e32833b46f6; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Liu SY, 2013, ONCOTARGET, V4, P2462, DOI 10.18632/oncotarget.1578; Liu X, 2006, ENDOTHELIUM-J ENDOTH, V13, P205, DOI 10.1080/10623320600760423; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Mao XG, 2010, CELL MOL NEUROBIOL, V30, P775, DOI 10.1007/s10571-010-9505-0; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; Mawn TM, 2011, BIOCONJUGATE CHEM, V22, P2434, DOI 10.1021/bc200242v; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Menendez JA, 2013, CELL CYCLE, V12, P1166, DOI 10.4161/cc.24479; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Paris L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2575; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pectasides D, 2008, CANCER TREAT REV, V34, P603, DOI 10.1016/j.ctrv.2008.05.006; Podo F, 1996, ANTICANCER RES, V16, P1399; Podo F, 2011, NMR BIOMED, V24, P648, DOI 10.1002/nbm.1658; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ramoni C, 2004, EXP CELL RES, V299, P370, DOI 10.1016/j.yexcr.2004.05.037; Ramoni C, 2001, J IMMUNOL, V167, P2642, DOI 10.4049/jimmunol.167.5.2642; Romanska HM, 2009, NEOPLASIA, V11, P1301, DOI 10.1593/neo.09850; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sebastian Carlos, 2014, Critical Reviews in Oncogenesis, V19, P363; Smith KM, 2010, EMBO MOL MED, V2, P371, DOI 10.1002/emmm.201000093; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Spadaro F, 2006, EUR J IMMUNOL, V36, P3277, DOI 10.1002/eji.200635927; Spadaro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059705; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Tomas A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8324; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang K, 2013, INT J NANOMED, V8, P899, DOI 10.2147/IJN.S38641; Wang N, 2008, INT J BIOCHEM CELL B, V40, P294, DOI 10.1016/j.biocel.2007.08.003; Wang N, 2006, BIOORG MED CHEM LETT, V16, P4780, DOI 10.1016/j.bmcl.2006.06.080; Wu JH, 2013, CURR CANCER DRUG TAR, V13, P143, DOI 10.2174/1568009611313020004; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	64	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0136120	10.1371/journal.pone.0136120	http://dx.doi.org/10.1371/journal.pone.0136120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402860	Green Submitted, gold, Green Published			2022-12-26	WOS:000361798100005
J	Kaur, G; Singh, HP; Batish, DR; Mahajan, P; Kohli, RK; Rishi, V				Kaur, Gurpreet; Singh, Harminder Pal; Batish, Daizy R.; Mahajan, Priyanka; Kohli, Ravinder Kumar; Rishi, Valbha			Exogenous Nitric Oxide (NO) Interferes with Lead (Pb)-Induced Toxicity by Detoxifying Reactive Oxygen Species in Hydroponically Grown Wheat (Triticum aestivum) Roots	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; CROSS-TALK; ACCUMULATION; ANTIOXIDANT; SENESCENCE; LEAVES; COUNTERACTS; GERMINATION; METABOLISM	Nitric Oxide (NO) is a bioactive signaling molecule that mediates a variety of biotic and abiotic stresses. The present study investigated the role of NO (as SNP [sodium nitroprusside]) in ameliorating lead (Pb)-toxicity in Triticum aestivum (wheat) roots. Pb (50 and 250 mu M) alone and in combination with SNP (100 mu M) was given to hydroponically grown wheat roots for a period of 0-8 h. NO supplementation reduced the accumulation of oxidative stress markers (malondialdehyde, conjugated dienes, hydroxyl ions and superoxide anion) and decreased the antioxidant enzyme activity in wheat roots particularly up to 6 h, thereby suggesting its role as an antioxidant. NO ameliorated Pb-induced membrane damage in wheat roots as evidenced by decreased ion-leakage and in situ histochemical localization. Pb-exposure significantly decreased in vivo NO level. The study concludes that exogenous NO partially ameliorates Pb-toxicity, but could not restore the plant growth on prolonged Pb-exposure.	[Kaur, Gurpreet; Singh, Harminder Pal] Panjab Univ, Dept Environm Studies, Chandigarh 160014, India; [Batish, Daizy R.; Mahajan, Priyanka; Kohli, Ravinder Kumar] Panjab Univ, Dept Bot, Chandigarh 160014, India; [Rishi, Valbha] Chandigarh Coll Engn & Technol, Chandigarh 160019, India	Panjab University; Panjab University	Singh, HP (corresponding author), Panjab Univ, Dept Environm Studies, Chandigarh 160014, India.	hpsingh_01@yahoo.com	Kohli, Ravinder/S-4061-2016; Singh, Harminder/E-1848-2012; Kohli, Ravinder/AAB-2281-2019	Kohli, Ravinder/0000-0002-4375-3390; Singh, Harminder/0000-0002-0024-5855; Kohli, Ravinder/0000-0002-4375-3390	University Grants Commission (UGC), India; Council for Scientific and Industrial Research (CSIR), India	University Grants Commission (UGC), India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Gurpreet Kaur and Priyanka Mahajan received funding from University Grants Commission (UGC), India, and Council for Scientific and Industrial Research (CSIR), India, respectively.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Bajji M, 2002, CAN J BOT, V80, P297, DOI [10.1139/B02-008, 10.1139/b02-008]; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beligni MV, 2002, PLANT PHYSIOL, V129, P1642, DOI 10.1104/pp.002337; Beligni MV, 2002, PLANT CELL ENVIRON, V25, P737, DOI 10.1046/j.1365-3040.2002.00857.x; BOVERIS A, 1980, PHOTOBIOCH PHOTOBIOP, V1, P175; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buet A, 2015, ANN NY ACAD SCI, V1340, P39, DOI 10.1111/nyas.12644; Correa-Aragunde N, 2015, J EXP BOT, V66, P2913, DOI 10.1093/jxb/erv073; Domingos P, 2015, MOL PLANT, V8, P506, DOI 10.1016/j.molp.2014.12.010; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gross F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00419; Guillas I, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00341, 10.3389/fpls.2013.00553]; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hermes VS, 2013, BIOL PLANTARUM, V57, P620, DOI 10.1007/s10535-013-0353-x; Hsu YT, 2004, PLANT GROWTH REGUL, V42, P227, DOI 10.1023/B:GROW.0000026514.98385.5c; Hung KT, 2005, BOT BULL ACAD SINICA, V46, P21; Kaur G, 2015, BIOLOGIA, V70, P190, DOI 10.1515/biolog-2015-0023; Kopyra M, 2003, PLANT PHYSIOL BIOCH, V41, P1011, DOI 10.1016/j.plaphy.2003.09.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Mishina TE, 2007, PLANT CELL ENVIRON, V30, P39, DOI 10.1111/j.1365-3040.2006.01604.x; MISRA HP, 1972, J BIOL CHEM, V247, P188; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Nriagu JO, 1996, SCIENCE, V272, P223, DOI 10.1126/science.272.5259.223; Phang IC, 2011, ECOTOX ENVIRON SAFE, V74, P1310, DOI 10.1016/j.ecoenv.2011.02.006; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Rubbo H, 2000, J BIOL CHEM, V275, P10812, DOI 10.1074/jbc.275.15.10812; Sang JR, 2008, J INTEGR PLANT BIOL, V50, P231, DOI 10.1111/j.1744-7909.2007.00594.x; Sanz L, 2015, J EXP BOT, V66, P2857, DOI 10.1093/jxb/erv213; Serrano I, 2015, J EXP BOT, V66, P2869, DOI 10.1093/jxb/erv083; Shi SY, 2005, NITRIC OXIDE-BIOL CH, V13, P1, DOI 10.1016/j.niox.2005.04.006; Singh HP, 2009, NITRIC OXIDE-BIOL CH, V20, P289, DOI 10.1016/j.niox.2009.02.004; Singh HP, 2008, ENVIRON EXP BOT, V63, P158, DOI 10.1016/j.envexpbot.2007.12.005; Singh HP, 2007, PLANT GROWTH REGUL, V53, P65, DOI 10.1007/s10725-007-9205-z; Sun BT, 2007, J PLANT PHYSIOL, V164, P536, DOI 10.1016/j.jplph.2006.02.011; Wang YQ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00314; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7; Xiong J, 2010, ARCH BIOCHEM BIOPHYS, V497, P13, DOI 10.1016/j.abb.2010.02.014; Yu CC, 2005, J PLANT PHYSIOL, V162, P1319, DOI 10.1016/j.jplph.2005.02.003; Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739; Zaninotto F, 2006, PLANT PHYSIOL, V141, P379, DOI 10.1104/pp.106.078857; Zhang H, 2008, RUSS J PLANT PHYSL+, V55, P469, DOI 10.1134/S1021443708040067	48	52	52	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138713	10.1371/journal.pone.0138713	http://dx.doi.org/10.1371/journal.pone.0138713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402793	Green Submitted, gold, Green Published			2022-12-26	WOS:000361798100034
J	Baker, AL; Ezzahir, J; Gardiner, C; Shipton, W; Warner, JM				Baker, Anthony L.; Ezzahir, Jessica; Gardiner, Christopher; Shipton, Warren; Warner, Jeffrey M.			Environmental Attributes Influencing the Distribution of Burkholderia pseudomallei in Northern Australia	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; SOIL; MELIOIDOSIS; SURVIVAL; WATER; DESICCATION; GROWTH; AGENT; PLANT	Factors responsible for the spatial and temporal clustering of Burkholderia pseudomallei in the environment remain to be elucidated. Whilst laboratory based experiments have been performed to analyse survival of the organism in various soil types, such approaches are strongly influenced by alterations to the soil micro ecology during soil sanitisation and translocation. During the monsoonal season in Townsville, Australia, B. pseudomallei is discharged from Castle Hill (an area with a very high soil prevalence of the organism) by groundwater seeps and is washed through a nearby area where intensive sampling in the dry season has been unable to detect the organism. We undertook environmental sampling and soil and plant characterisation in both areas to ascertain physiochemical and macro-floral differences between the two sites that may affect the prevalence of B. pseudomallei. In contrast to previous studies, the presence of B. pseudomallei was correlated with a low gravimetric water content and low nutrient availability (nitrogen and sulphur) and higher exchangeable potassium in soils favouring recovery. Relatively low levels of copper, iron and zinc favoured survival. The prevalence of the organism was found to be highest under the grasses Aristida sp. and Heteropogon contortus and to a lesser extent under Melinis repens. The findings of this study indicate that a greater variety of factors influence the endemicity of melioidosis than has previously been reported, and suggest that biogeographical boundaries to the organisms' distribution involve complex interactions.	[Baker, Anthony L.; Ezzahir, Jessica; Gardiner, Christopher; Warner, Jeffrey M.] James Cook Univ, Sch Vet & Biomed Sci, Environm & Publ Hlth Microbiol Res Grp, Townsville, Qld 4811, Australia; [Baker, Anthony L.] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia; [Shipton, Warren] Asia Pacific Int Univ, Fac Sci, Muaklek, Saraburi, Thailand	James Cook University; University of Tasmania	Baker, AL (corresponding author), James Cook Univ, Sch Vet & Biomed Sci, Environm & Publ Hlth Microbiol Res Grp, Townsville, Qld 4811, Australia.	anthony.baker@my.jcu.edu.au	; Baker, Anthony/C-2433-2014	Warner, Jeffrey/0000-0002-5869-8283; Baker, Anthony/0000-0001-5455-2271				[Anonymous], 2006, OPENEPI OPEN SOURCE; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; ASHDOWN LR, 1992, APPL ENVIRON MICROB, V58, P4011, DOI 10.1128/AEM.58.12.4011-4015.1992; Baker A, 2013, J CLIN MICROBIOL, V51, P2520, DOI 10.1128/JCM.00418-13; Baker A, 2011, APPL ENVIRON MICROB, V77, P7243, DOI 10.1128/AEM.05048-11; Baker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018343; Brennan FP, 2014, SCI TOTAL ENVIRON, V468, P302, DOI 10.1016/j.scitotenv.2013.08.037; Chen YS, 2003, FOLIA MICROBIOL, V48, P253, DOI 10.1007/BF02930965; Cheng AC, 2004, J CLIN MICROBIOL, V42, P5477, DOI 10.1128/JCM.42.12.5477-5483.2004; Corkeron ML, 2010, EPIDEMIOL INFECT, V138, P1346, DOI 10.1017/S0950268809991634; Currie BJ, 2004, TROP MED INT HEALTH, V9, P1167, DOI 10.1111/j.1365-3156.2004.01328.x; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Draper ADK, 2010, APPL ENVIRON MICROB, V76, P5305, DOI 10.1128/AEM.00287-10; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Hanna JN, 2010, COMMUN DIS INTELL, V34, P444; Inglis TJJ, 2000, EMERG INFECT DIS, V6, P56; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Kaestli M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003635; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Larsen E, 2013, APPL ENVIRON MICROB, V79, P2424, DOI 10.1128/AEM.03168-12; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Lin HH, 2011, MICROBIOL IMMUNOL, V55, P616, DOI 10.1111/j.1348-0421.2011.00365.x; MARSHALL KC, 1975, ANNU REV PHYTOPATHOL, V13, P357, DOI 10.1146/annurev.py.13.090175.002041; Marshall K, 2010, SE ASIAN J TROP MED, V41, P904; Morra MJ, 1998, SOIL SCI SOC AM J, V62, P663, DOI 10.2136/sssaj1998.03615995006200030017x; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; OSAAFIANA LO, 1982, SOIL SCI SOC AM J, V46, P285, DOI 10.2136/sssaj1982.03615995004600020014x; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; Pumpuang A, 2011, T ROY SOC TROP MED H, V105, P598, DOI 10.1016/j.trstmh.2011.06.004; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Suebrasri T., 2013, African Journal of Microbiology Research, V7, P1940; Taylor Clare M., 2005, V12, P55, DOI 10.1159/000081689; THOMAS AD, 1979, AM J EPIDEMIOL, V110, P515, DOI 10.1093/oxfordjournals.aje.a112832; Tong SD, 1996, MICROBIOL IMMUNOL, V40, P451, DOI 10.1111/j.1348-0421.1996.tb01092.x; Wang-Ngarm S, 2014, AM J TROP MED HYG, V90, P480, DOI 10.4269/ajtmh.13-0446; Warawa JM, 2009, INFECT IMMUN, V77, P5252, DOI 10.1128/IAI.00824-09; Warner JM, 2007, T ROY SOC TROP MED H, V101, P809, DOI 10.1016/j.trstmh.2007.02.024; YANG HM, 1991, INFECT IMMUN, V59, P776, DOI 10.1128/IAI.59.3.776-780.1991	38	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138953	10.1371/journal.pone.0138953	http://dx.doi.org/10.1371/journal.pone.0138953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398904	Green Published, gold, Green Accepted			2022-12-26	WOS:000361797500131
J	Giangarra, V; Igea, A; Castellazzi, CL; Bava, FA; Mendez, R				Giangarra, Valeria; Igea, Ana; Castellazzi, Chiara Lara; Bava, Felice-Alessio; Mendez, Raul			Global Analysis of CPEBs Reveals Sequential and Non-Redundant Functions in Mitotic Cell Cycle	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; POLY(A) TAIL LENGTH; PROTEINS; PROGRESSION; SENESCENCE; CANCER; P53	CPEB (Cytoplasmic Polyadenylation Element Binding) proteins are a family of four RNA-binding proteins that regulate the translation of maternal mRNAs controlling meiotic cell cycle progression. But CPEBs are not limited to the transcriptionally silent germline; they are also expressed, in various combinations, in somatic cells, yet their role in regulation of mitosis-related gene expression is largely unknown. Deregulation of CPEB1 and CPEB4 have been linked to tumor development. However, a systematic analysis addressing their requirements for the temporal regulation of mitotic gene expression has yet to be performed. This study addresses the requirements of each of the four CPEBs for mitotic phase transitions, with a particular focus on cytoplasmic polyadenylation and translational regulation. We demonstrate that CPEB3 is the only member dispensable for mitotic cell division, whereas the other three members, CPEB1, 2, and 4, are essential to successful mitotic cell division. Thus, CPEB1 is required for prophase entry, CPEB2 for metaphase and CPEB4 for cytokinesis. These three CPEBs have sequential non-redundant functions that promote the phase-specific polyadenylation and translational activation of CPE-regulated transcripts in the mitotic cell cycle.	[Giangarra, Valeria; Igea, Ana; Castellazzi, Chiara Lara; Bava, Felice-Alessio; Mendez, Raul] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Mendez, Raul] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Bava, FA (corresponding author), Stanford Univ, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	bava@stanford.edu; raul.mendez@irbbarcelona.org	Igea, Ana/K-8082-2017; bava, felice alessio/AAB-5212-2022	Igea, Ana/0000-0002-6658-4518; Mendez, Raul/0000-0002-1952-6905	Fundacion Botin and the Banco Santander through its Santander Universities Global Division; Spanish Ministerio de Economia y Competitividad [BFU2011-30121, Consolider RNAREG CSD2009-00080]; FPI fellowship from the Ministerio de Economia y Competitividad; Fundacio La Caixa; ICREA Funding Source: Custom	Fundacion Botin and the Banco Santander through its Santander Universities Global Division; Spanish Ministerio de Economia y Competitividad(Spanish Government); FPI fellowship from the Ministerio de Economia y Competitividad; Fundacio La Caixa(La Caixa FoundationEuropean Commission); ICREA(ICREA)	This project was supported by the Fundacion Botin and the Banco Santander through its Santander Universities Global Division, and by the Spanish Ministerio de Economia y Competitividad (BFU2011-30121 and Consolider RNAREG CSD2009-00080). VG was the recipient of an FPI fellowship from the Ministerio de Economia y Competitividad. F-AB was the recipient of predoctoral fellowship from "Fundacio La Caixa".	Afroz T, 2014, GENE DEV, V28, P1498, DOI 10.1101/gad.241133.114; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Ivshina M, 2014, ANNU REV CELL DEV BI; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; O'Connell ML, 2014, MOL REPROD DEV, V81, P376, DOI 10.1002/mrd.22306; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311	21	19	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138794	10.1371/journal.pone.0138794	http://dx.doi.org/10.1371/journal.pone.0138794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398195	Green Submitted, gold, Green Published			2022-12-26	WOS:000361797500110
J	Chen, Y; Guo, Y; Zhao, W; Ho, WTT; Fu, X; Zhao, ZJ				Chen, Y.; Guo, Y.; Zhao, W.; Ho, W-T Tina; Fu, X.; Zhao, Z. J.			Identification of an orally available compound with potent and broad FLT3 inhibition activity	ONCOGENE			English	Article							TYROSINE KINASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; EFFECTIVE PROTEIN SUBSTRATE; DRUG-RESISTANCE; MUTANT FLT3; AMG 925; MUTATIONS; EXPRESSION; GENERATION; CRENOLANIB	FLT3 internal tandem duplication (FLT3-ITD) is an activating mutation found in 20-30% of patients with acute myeloid leukemia (AML), which makes FLT3 an attractive target for the treatment of AML. Although FLT3-mutant patients respond to current FLT3 inhibitors, relapse usually happens because of the acquisition of resistant secondary mutations at the FLT3 catalytic domain, which is mainly on D835. In the search for compounds with broad FLT3 inhibition activities, we screened a kinase inhibitor library by using our unique FLT3 substrate and identified JAK3 inhibitor VI (designated JI6 hereafter) as a novel FLT3 inhibitor, which selectively targets FLT3 D835 mutants as well as FLT3-ITD. JI6 effectively inhibited FLT3-ITD-containing MV4-11 cells and HCD-57 cells transformed with FLT3-ITD and D835 mutants. Furthermore, administration of JI6 effectively targeted FLT3 signaling in vivo and suppressed the myeloproliferative phenotypes in FLT3-ITD knock-in mice, and significantly prolonged the survival of immunodeficient mice implanted with the transformed HCD-57 cells. Therefore, JI6 is a promising candidate for the development of next-generation anti-AML drugs.	[Chen, Y.; Zhao, W.; Ho, W-T Tina; Zhao, Z. J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, 940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA; [Guo, Y.; Fu, X.; Zhao, Z. J.] Jilin Univ, Coll Life Sci, Edmond H Fischer Signal Transduct Lab, Changchun 130023, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; Jilin University	Zhao, ZJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, 940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	joe-zhao@ouhsc.edu			National Institutes of Health [HL079441]; Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant HL079441 from the National Institutes of Health and a grant from Oklahoma Center for the Advancement of Science and Technology.	Adams C, 2003, BIOORG MED CHEM LETT, V13, P3105, DOI 10.1016/S0960-894X(03)00657-7; Annesley CE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00263; Bramson HN, 2001, J MED CHEM, V44, P4339, DOI 10.1021/jm010117d; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Chen Y, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-39; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Estey EH, 2014, AM J HEMATOL, V89, P1063, DOI 10.1002/ajh.23834; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; Gregory TK, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-23; Guo Y, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-72; Hofmann M, 2012, LEUKEMIA, V26, P1228, DOI 10.1038/leu.2011.372; Hsu FYY, 2006, CANCER RES, V66, P9002, DOI 10.1158/0008-5472.CAN-05-4101; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Lee HK, 2014, BLOOD, V123, P2209, DOI 10.1182/blood-2013-04-493916; Leung AYH, 2013, LEUKEMIA, V27, P260, DOI 10.1038/leu.2012.195; Levis M, 2014, FUTURE ONCOL, V10, P1571, DOI [10.2217/FON.14.105, 10.2217/fon.14.105]; Li C, 2015, MOL CANCER THER, V14, P375, DOI 10.1158/1535-7163.MCT-14-0388; Li Z, 2007, EXP HEMATOL, V35, P1624, DOI 10.1016/j.exphem.2007.07.003; Li Z, 2007, J BIOL CHEM, V282, P3428, DOI 10.1074/jbc.C600277200; Li ZH, 2014, J MED CHEM, V57, P3430, DOI 10.1021/jm500118j; Lockman JW, 2011, BIOORG MED CHEM LETT, V21, P1724, DOI 10.1016/j.bmcl.2011.01.077; Ma HS, 2014, CANCER RES, V74, P5206, DOI 10.1158/0008-5472.CAN-14-1028; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Moreno-Miralles I, 2005, J BIOL CHEM, V280, P40097, DOI 10.1074/jbc.M506855200; Papaetis GS, 2009, BIODRUGS, V23, P377, DOI 10.2165/11318860-000000000-00000; Schlenk RF, 2014, BLOOD, V124, P3441, DOI 10.1182/blood-2014-05-578070; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Smith CC, 2014, P NATL ACAD SCI USA, V111, P5319, DOI 10.1073/pnas.1320661111; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Swords R, 2012, LEUKEMIA, V26, P2176, DOI 10.1038/leu.2012.114; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-36; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; WEN DY, 1994, J BIOL CHEM, V269, P22839; Williams AB, 2013, LEUKEMIA, V27, P48, DOI 10.1038/leu.2012.191; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Xu MJ, 2003, BLOOD, V102, P4354, DOI 10.1182/blood-2003-04-1308; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328; Zhao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099017; Zhao WK, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-15; Zimmerman EI, 2013, BLOOD, V122, P3607, DOI 10.1182/blood-2013-07-513044	46	8	8	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 9	2016	35	23					2971	2978		10.1038/onc.2015.362	http://dx.doi.org/10.1038/onc.2015.362			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0NB	26411368	Green Accepted			2022-12-26	WOS:000377474500003
J	Zhang, HT; Unal, H; Desnoyer, R; Han, GW; Patel, N; Katritch, V; Karnik, SS; Cherezov, V; Stevens, RC				Zhang, Haitao; Unal, Hamiyet; Desnoyer, Russell; Han, Gye Won; Patel, Nilkanth; Katritch, Vsevolod; Karnik, Sadashiva S.; Cherezov, Vadim; Stevens, Raymond C.			Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPIDIC CUBIC PHASE; AT(1) RECEPTOR; BINDING; AGONIST; ACTIVATION; MUTATIONS; MECHANISM; SODIUM; ENERGY	Angiotensin II type 1 receptor (AT(1)R) is the primary blood pressure regulator. AT(1)R blockers (ARBs) have been widely used in clinical settings as anti-hypertensive drugs and share a similar chemical scaffold, although even minor variations can lead to distinct therapeutic efficacies toward cardiovascular etiologies. The structural basis for AT(1)R modulation by different peptide and non-peptide ligands has remained elusive. Here, we report the crystal structure of the human AT(1)R in complex with an inverse agonist olmesartan (Benicar (TM)), a highly potent anti-hypertensive drug. Olmesartan is anchored to the receptor primarily by the residues Tyr-35(1.39), Trp-84(2.60), and Arg-167(ECL2), similar to the antagonist ZD7155, corroborating a common binding mode of different ARBs. Using docking simulations and site-directed mutagenesis, we identified specific interactions between AT(1)R and different ARBs, including olmesartan derivatives with inverse agonist, neutral antagonist, or agonist activities. We further observed that the mutation N111(3.35)A in the putative sodium-binding site affects binding of the endogenous peptide agonist angiotensin II but not the beta-arrestin-biased peptide TRV120027.	[Zhang, Haitao; Patel, Nilkanth; Katritch, Vsevolod; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Zhang, Haitao; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Unal, Hamiyet; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	University of Southern California; University of Southern California; Cleveland Clinic Foundation	Karnik, SS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.	karniks@ccf.org; stevens@usc.edu	Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; Katritch, Vsevolod/Q-8357-2016; Patel, Nilkanth/S-2659-2019; Zhang, Haitao/L-7612-2015; Han, Gye Won/GLQ-8673-2022; Karnik, Sadashiva/Y-2477-2019	Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Patel, Nilkanth/0000-0002-9856-3041; Zhang, Haitao/0000-0003-4879-2951; Karnik, Sadashiva/0000-0003-0746-2753	Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NCI [ACB-12002]; NIGMS [AGM-12006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470, T32HL007914, R01HL115964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Velasquez for help with molecular biology, M. Chu for help with baculovirus expression, and A. Walker for assistance with manuscript preparation. We thank Dr. Shin-ichiro (Fukuoka University School of Medicine, Fukuoka, Japan) for help and Daiichi Sankyo Co., Ltd., Tokyo, Japan for generous supply of olmesartan and its derivatives. This research used resources of the Advanced Photon Source, a United States Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Parts of this research were carried out at the General Medical Sciences and NCI Structural Biology Facility at the Advanced Photon Source (GM/CA@APS), Argonne National Laboratory. GM/CA@APS has been funded in whole or in part by Grant ACB-12002 from NCI and Grant AGM-12006 from NIGMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Bursulaya BD, 2003, J COMPUT AID MOL DES, V17, P755, DOI 10.1023/B:JCAM.0000017496.76572.6f; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Feng YH, 2005, MOL PHARMACOL, V68, P347, DOI 10.1124/mol.105.011601; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Imaizumi S, 2013, CURR PHARM DESIGN, V19, P3002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miura S, 2004, HYPERTENS RES, V27, P765, DOI 10.1291/hypres.27.765; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Miura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079914; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; Miura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037974; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; PERLMAN S, 1995, J BIOL CHEM, V270, P1493, DOI 10.1074/jbc.270.4.1493; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Totrov M, 1997, PROTEINS, P215; Unal Hamiyet, 2014, Adv Pharmacol, V70, P155, DOI 10.1016/B978-0-12-417197-8.00006-7; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011	43	108	109	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29127	29139		10.1074/jbc.M115.689000	http://dx.doi.org/10.1074/jbc.M115.689000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26420482	hybrid, Green Published			2022-12-26	WOS:000366613400002
J	Capaldo, BJ; Roller, D; Axelrod, MJ; Koeppel, AF; Petricoin, EF; Slingluff, CL; Weber, MJ; Mackey, AJ; Gioeli, D; Bekiranov, S				Capaldo, Brian J.; Roller, Devin; Axelrod, Mark J.; Koeppel, Alex F.; Petricoin, Emanuel F.; Slingluff, Craig L., Jr.; Weber, Michael J.; Mackey, Aaron J.; Gioeli, Daniel; Bekiranov, Stefan			Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma	PLOS ONE			English	Article							IMPROVED SURVIVAL; RAF INHIBITION; IMMUNE ESCAPE; UP-REGULATION; CELL LINES; ACTIVATION; RESISTANCE; CANCER; GENE; PROLIFERATION	Fifty percent of cutaneous melanomas are driven by activated BRAF(V600E), but tumors treated with RAF inhibitors, even when they respond dramatically, rapidly adapt and develop resistance. Thus, there is a pressing need to identify the major mechanisms of intrinsic and adaptive resistance and develop drug combinations that target these resistance mechanisms. In a combinatorial drug screen on a panel of 12 treatment-naive BRAFV600E mutant melanoma cell lines of varying levels of resistance to mitogen-activated protein kinase (MAPK) pathway inhibition, we identified the combination of PLX4720, a targeted inhibitor of mutated BRaf, and lapatinib, an inhibitor of the ErbB family of receptor tyrosine kinases, as synergistically cytotoxic in the subset of cell lines that displayed the most resistance to PLX4720. To identify potential mechanisms of resistance to PLX4720 treatment and synergy with lapatinib treatment, we performed a multi-platform functional genomics analysis to profile the genome as well as the transcriptional and proteomic responses of these cell lines to treatment with PLX4720. We found modest levels of resistance correlated with the zygosity of the BRAF V600E allele and receptor tyrosine kinase (RTK) mutational status. Layered over base-line resistance was substantial upregulation of many ErbB pathway genes in response to BRaf inhibition, thus generating the vulnerability to combination with lapatinib. The transcriptional responses of ErbB pathway genes are associated with a number of transcription factors, including ETS2 and its associated cofactors that represent a convergent regulatory mechanism conferring synergistic drug susceptibility in the context of diverse mutational landscapes.	[Capaldo, Brian J.; Bekiranov, Stefan] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Roller, Devin; Axelrod, Mark J.; Weber, Michael J.; Gioeli, Daniel] Univ Virginia, Dept Microbiol Immunol & Canc, Charlottesville, VA USA; [Koeppel, Alex F.] Univ Virginia, Bioinfomat Core Facil, Charlottesville, VA USA; [Petricoin, Emanuel F.] George Mason Univ, Ctr Appl Prote & Mol Med, Sch Syst Biol, Coll Sci, Manassas, VA USA; [Slingluff, Craig L., Jr.] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Mackey, Aaron J.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; George Mason University; University of Virginia; University of Virginia	Bekiranov, S (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	sb3de@virginia.edu		Capaldo, Brian/0000-0003-1244-8884	Melanoma Research Alliance; UVA Cancer Center [DR01510 113573]; National Cancer Institute [R01 CA178338]; NATIONAL CANCER INSTITUTE [P30CA044579, R01CA178338] Funding Source: NIH RePORTER	Melanoma Research Alliance; UVA Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Young Investigator Award from the Melanoma Research Alliance (www.curemelanoma.org) to AJM, a UVA Cancer Center (http://cancer.uvahealth.com) Farrow Fellowship (DR01510 113573) to BJC, and R01 grant support: National Cancer Institute (R01 CA178338, DG).	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; DARROW TL, 1989, J IMMUNOL, V142, P3329; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Federici G, 2013, MOL CANCER RES, V11, P676, DOI 10.1158/1541-7786.MCR-12-0690; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Held MA, 2013, CANCER DISCOV, V3, P52, DOI 10.1158/2159-8290.CD-12-0408; Hertzman Johansson C, 2013, MELANOMA RES; Holderfield M, 2014, BRIT J CANCER, V111, P640, DOI 10.1038/bjc.2014.139; Improta G, 2011, J PROTEOME RES, V10, P3089, DOI 10.1021/pr200065t; Ji ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kugel CH, 2014, CANCER RES, V74, P4122, DOI 10.1158/0008-5472.CAN-14-0464; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Levin-Gromiko U, 2014, CARCINOGENESIS, V35, P2555, DOI 10.1093/carcin/bgu178; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Molhoek KR, 2011, MELANOMA RES, V21, P274, DOI 10.1097/CMR.0b013e328343a1d6; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Oike T, 2013, JPN J CLIN ONCOL, V43, P849, DOI 10.1093/jjco/hyt101; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sapkota B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22890; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Slingluff CL, 2000, CANCER IMMUNOL IMMUN, V48, P661, DOI 10.1007/s002620050015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Teven CM, 2014, GENES DIS, V1, P199, DOI 10.1016/j.gendis.2014.09.005; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Xu SX, 2015, DNA CELL BIOL, V34, P69, DOI 10.1089/dna.2014.2590; Yamshchikov GV, 2005, J IMMUNOL, V174, P6863, DOI 10.4049/jimmunol.174.11.6863; Zhang KM, 2013, PIGM CELL MELANOMA R, V26, P408, DOI 10.1111/pcmr.12089	66	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138210	10.1371/journal.pone.0138210	http://dx.doi.org/10.1371/journal.pone.0138210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405815	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700037
J	Ho, NF; Chong, JSX; Koh, HL; Koukouna, E; Lee, TS; Fung, D; Lim, CG; Zhou, J				Ho, New-Fei; Chong, Joanna S. X.; Koh, Hui Li; Koukouna, Eleni; Lee, Tih-Shih; Fung, Daniel; Lim, Choon Guan; Zhou, Juan			Intrinsic Affective Network Is Impaired in Children with Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY MRI; AUTISM SPECTRUM DISORDERS; MEDICATION-NAIVE CHILDREN; EMOTIONAL SELF-REGULATION; PREFRONTAL CORTEX; BEHAVIOR CHECKLIST; HUMAN AMYGDALA; HUMAN BRAIN; FOLLOW-UP	Deficits in impulsivity and affect dysregulation are key features of attention-deficit/hyperactivity disorder (ADHD) besides impairing levels of hyperactivity and/or inattention. However, the neural substrates underlying these traits are relatively under-investigated. In this study, we use resting-state functional magnetic resonance imaging to test the hypothesis of diminished functional integration within the affective/limbic network (which includes the amygdala, hippocampus, subgenual cingulate cortex, orbitofrontal cortex and nucleus accumbens) of children with ADHD, which is associated with their behavioral measures of emotional control deficits. Resting state-fMRI data were obtained from 12 healthy control subjects and 15 children with ADHD, all who had a minimum one-month washout period for medications and supplements. Children with ADHD demonstrated less integrated affective network, evidenced by increased bilateral amygdalar and decreased left orbitofrontal connectivity within the affective network compared to healthy controls. The hyper-connectivity at the left amygdalar within the affective network was associated with increased aggressiveness and conduct problems, as well as decline in functioning in children with ADHD. Similar findings in affective network dysconnectivity were replicated in a subset of children with ADHD three months later. Our findings of divergent changes in amygdala and orbitofrontal intrinsic connectivity support the hypothesis of an impaired functional integration within the affective network in childhood ADHD. Larger prospective studies of the intrinsic affective network in ADHD are required, which may provide further insight on the biological mechanisms of emotional control deficits observed in ADHD.	[Ho, New-Fei; Chong, Joanna S. X.; Koh, Hui Li; Lee, Tih-Shih; Zhou, Juan] Duke Natl Univ Singapore, Grad Sch Med, Ctr Cognit Neurosci, Neurosci & Behav Disorders Program, Singapore, Singapore; [Ho, New-Fei] Inst Mental Hlth, Div Res, Singapore, Singapore; [Koh, Hui Li; Koukouna, Eleni; Fung, Daniel; Lim, Choon Guan] Inst Mental Hlth, Dept Child & Adolescent Psychiat, Singapore, Singapore; [Zhou, Juan] Natl Univ Singapore, Agcy Sci Technol & Research, Clin Imaging Res Ctr, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); National University of Singapore	Zhou, J (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Ctr Cognit Neurosci, Neurosci & Behav Disorders Program, Singapore, Singapore.	helen.zhou@duke-nus.edu.sg	Fung, Daniel S S/W-6915-2019; Ho, NF/R-1144-2019; Sheng, Daniel Fung Shuen/AAN-9385-2021; Fung, Daniel/AAF-4775-2020	Sheng, Daniel Fung Shuen/0000-0003-0718-9363; , newfei/0000-0002-0456-3391; Zhou, Juan/0000-0002-0180-8648	National Medical Research Council (NMRC) [NIG11may025]; Duke-NUS Graduate Medical School Signature Research Program - Ministry of Health, Singapore	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Duke-NUS Graduate Medical School Signature Research Program - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore)	This research was supported by the National Medical Research Council (NMRC) Centre Grant (Institute of Mental Health [New-Fei Ho] and the NMRC New Investigator Grant NIG11may025 [Choon Guan Lim]). This research was also supported by Duke-NUS Graduate Medical School Signature Research Program funded by Ministry of Health, Singapore awarded to Juan Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Achenbach TM, 2014, ASEBA CHILD BEHAV CH; Althoff RR, 2010, J AM ACAD CHILD PSY, V49, P1105, DOI 10.1016/j.jaac.2010.08.006; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J., 2010, SPM8 MANUAL; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biederman J, 2012, NEUROPSYCH DIS TREAT, V8, P267, DOI 10.2147/NDT.S29670; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brotman MA, 2010, AM J PSYCHIAT, V167, P61, DOI 10.1176/appi.ajp.2009.09010043; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Castellanos FX, 2009, CAN J PSYCHIAT, V54, P665, DOI 10.1177/070674370905401003; Cha J, 2015, NEUROPSYCHOPHARMACOL, V40, P1717, DOI 10.1038/npp.2015.18; Chabernaud C, 2012, BIOL PSYCHIAT, V71, P434, DOI 10.1016/j.biopsych.2011.08.013; Choi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083516; CLEMENTS SD, 1966, J LANCET, V86, P121; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cortese S, 2013, BIOL PSYCHIAT, V74, P591, DOI 10.1016/j.biopsych.2013.02.025; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Gotham K, 2015, J AM ACAD CHILD PSY, V54, P369, DOI 10.1016/j.jaac.2015.02.005; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hulvershorn LA, 2014, J AM ACAD CHILD PSY, V53, P351, DOI 10.1016/j.jaac.2013.11.012; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Kucyi A, 2015, HUM BRAIN MAPP; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li F, 2014, RADIOLOGY, V272, P514, DOI 10.1148/radiol.14131622; MACLEAN PD, 1955, ARCH NEURO PSYCHIATR, V73, P130, DOI 10.1001/archneurpsyc.1955.02330080008004; Mazzone L, 2013, RES DEV DISABIL, V34, P3699, DOI 10.1016/j.ridd.2013.07.034; McCarthy H, 2013, JAMA PSYCHIAT, V70, P1329, DOI 10.1001/jamapsychiatry.2013.2174; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mueller S, 2014, HUM BRAIN MAPP, V35, P5379, DOI 10.1002/hbm.22557; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Posner J, 2013, PSYCHIAT RES-NEUROIM, V213, P24, DOI 10.1016/j.pscychresns.2013.01.004; Posner J, 2011, J AM ACAD CHILD PSY, V50, P828, DOI 10.1016/j.jaac.2011.05.010; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ray S, 2014, HUM BRAIN MAPP, V35, P6032, DOI 10.1002/hbm.22603; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Schulz KP, 2014, NEUROIMAGE-CLIN, V5, P1, DOI 10.1016/j.nicl.2014.05.016; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Spencer TJ, 2011, POSTGRAD MED, V123, P50, DOI 10.3810/pgm.2011.09.2459; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Surman CBH, 2013, ADHD-ATTEND DEFICIT, V5, P273, DOI 10.1007/s12402-012-0100-8; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanderwal T, 2013, J AM ACAD CHILD PSY, V52, P562, DOI 10.1016/j.jaac.2013.03.004; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; WIMBERGER HC, 1968, J AMER ACAD CHILD PS, V7, P677, DOI 10.1016/S0002-7138(09)62187-7; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	77	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139018	10.1371/journal.pone.0139018	http://dx.doi.org/10.1371/journal.pone.0139018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406311	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700149
J	Kaur, G; Leslie, EM; Tillman, H; Lee, WM; Swanlund, DP; Karvellas, CJ				Kaur, Gurnit; Leslie, Elaine M.; Tillman, Holly; Lee, William M.; Swanlund, Diane P.; Karvellas, Constantine J.		US Acute Liver Failure Study Grp	Detection of Ophthalmic Acid in Serum from Acetaminophen-Induced Acute Liver Failure Patients Is More Frequent in Non-Survivors	PLOS ONE			English	Article							GLUTATHIONE; ACETYLCYSTEINE	Background/Aim Acetaminophen (APAP) hepatotoxicity is related to the formation of N-acetyl-p-benzoquinone imine (NAPQI), which is detoxified through conjugation with reduced glutathione (GSH). Ophthalmic acid (OA) is an analogue of GSH in which cysteine is replaced with 2-aminobutyrate. Metabolomics studies of mice with APAP-induced acute liver failure (APAP-ALF) identified OA as a marker of oxidative stress and hepatic GSH consumption. The aim of the current study was to determine whether OA is detectable in APAP-ALF human patients either early (day 2) or late (day 4) and whether OA levels were associated with in-hospital survival in the absence of liver transplant. Methods Serum samples from 130 APAP-ALF patients (82 survivors, 48 non-survivors) were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and correlated with clinical data from the United States Acute Liver Failure Study Group (US ALFSG) Registry (2004-2011). Results Survivors had significantly lower admission bilirubin (4.2 vs. 5.7 mg/dl) and lactate levels (3.3 vs. 6.5 mu mol/l, p<0.05 for all). During the first 7 days of the study, survivors were less likely to require mechanical ventilation (55% vs. 88%), vasopressor support (9.8% vs. 67%) or renal replacement therapy (26% vs. 63%, p<0.001 for all). Non-survivors were more likely to have detectable OA levels early (31% vs. 15%, p = 0.034) and late (27% vs. 11%, p = 0.02). However there were no significant differences in mean OA levels between non-survivors and survivors (early 0.48 vs. 0.36, late 0.43 vs. 0.37, P > 0.5 for all). Conclusion OA was detectable more frequently in APAP-ALF non-survivors but mean OA levels were not associated with survival. The routine clinical administration of N-acetyl cysteine could replenish GSH levels and prevent OA production.	[Kaur, Gurnit; Leslie, Elaine M.] Univ Alberta, Dept Lab Med, Pathol, Edmonton, AB, Canada; [Leslie, Elaine M.; Swanlund, Diane P.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Tillman, Holly] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Lee, William M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Karvellas, Constantine J.] Univ Alberta, Div Hepatol, Edmonton, AB, Canada; [Karvellas, Constantine J.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alberta; University of Alberta	Karvellas, CJ (corresponding author), Univ Alberta, Div Hepatol, Edmonton, AB, Canada.	dean.karvellas@ualberta.ca		Hynan, Linda/0000-0002-4642-7769; Karvellas, Constantine/0000-0002-1555-1089; Leslie, Elaine/0000-0003-1825-348X	NIH from NIDDK [U01 58369]; Transplant Fund Value Added; Canadian Institutes of Health Research [MOP-272075]	NIH from NIDDK; Transplant Fund Value Added; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was sponsored by NIH grant U01 58369 (from NIDDK). It was also supported by a grant from the Transplant Fund Value Added and the Canadian Institutes of Health Research [Grant MOP-272075]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, HEPATIC COMA SYNDROM; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; Carretero A, 2014, ANAL BIOANAL CHEM, V406, P5465, DOI 10.1007/s00216-014-7983-5; DONALDSON BW, 1993, HEPATOLOGY, V18, P1370, DOI 10.1016/0270-9139(93)90226-D; Fagan E, 1996, BRIT MED J, V313, P1417, DOI 10.1136/bmj.313.7070.1417; Geenen S, 2011, J PHARMACEUT BIOMED, V54, P1128, DOI 10.1016/j.jpba.2010.11.038; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; New LS, 2008, J CHROMATOGR SCI, V46, P209, DOI 10.1093/chromsci/46.3.209; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1993, LANCET, V342, P743, DOI 10.1016/0140-6736(93)91736-6; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	17	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139299	10.1371/journal.pone.0139299	http://dx.doi.org/10.1371/journal.pone.0139299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407170	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700205
J	Leblond, AL; Klinkert, K; Martin, K; Turner, EC; Kumar, AH; Browne, T; Caplice, NM				Leblond, Anne-Laure; Klinkert, Kerstin; Martin, Kenneth; Turner, Elizebeth C.; Kumar, Arun H.; Browne, Tara; Caplice, Noel M.			Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction	PLOS ONE			English	Article							MONOCYTE SUBSETS; IN-VIVO; MICE; POLARIZATION; INFLAMMATION; IMPROVES; RUPTURE; GW2580; INJURY; REPAIR	The heart hosts tissue resident macrophages which are capable of modulating cardiac inflammation and function by multiple mechanisms. At present, the consequences of phenotypic diversity in macrophages in the heart are incompletely understood. The contribution of cardiac M2-polarized macrophages to the resolution of inflammation and repair response following myocardial infarction remains to be fully defined. In this study, the role of M2 macrophages was investigated utilising a specific CSF-1 receptor signalling inhibition strategy to achieve their depletion. In mice, oral administration of GW2580, a CSF-1R kinase inhibitor, induced significant decreases in Gr1(lo) and F4/80(hi) monocyte populations in the circulation and the spleen. GW2580 administration also induced a significant depletion of M2 macrophages in the heart after 1 week treatment as well as a reduction of cardiac arginase1 and CD206 gene expression indicative of M2 macrophage activity. In a murine myocardial infarction model, reduced M2 macrophage content was associated with increased M1-related gene expression (IL-6 and IL-1 beta), and decreased M2-related gene expression (Arginase1 and CD206) in the heart of GW2580-treated animals versus vehicle-treated controls. M2 depletion was also associated with a loss in left ventricular contractile function, infarct enlargement, decreased collagen staining and increased inflammatory cell infiltration into the infarct zone, specifically neutrophils and M1 macrophages. Taken together, these data indicate that CSF-1R signalling is critical for maintaining cardiac tissue resident M2-polarized macrophage population, which is required for the resolution of inflammation post myocardial infarction and, in turn, for preservation of ventricular function.	[Leblond, Anne-Laure; Klinkert, Kerstin; Martin, Kenneth; Turner, Elizebeth C.; Kumar, Arun H.; Browne, Tara; Caplice, Noel M.] Natl Univ Ireland Univ Coll Cork, Vasc Biol Res Ctr, Biosci Inst, Cork, Ireland	University College Cork	Caplice, NM (corresponding author), Natl Univ Ireland Univ Coll Cork, Vasc Biol Res Ctr, Biosci Inst, Coll Rd, Cork, Ireland.	n.caplice@ucc.ie	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219; Leblond, Anne-Laure/0000-0003-4080-3126; Caplice, Noel/0000-0001-5445-1016; Klinkert, Kerstin/0000-0001-5268-3710	Science Foundation Ireland [09/SRC/B1794, 07/RFP/BIMF816, 10/IN.1/B3034]; Health Research Board, Dublin, Ireland [R11831-NMC]; National Biophotonics and Imaging Platform, Ireland; Irish Government's Programme for Research in Third Level Institutions, Cycle 4; Ireland's EU Structural Funds Programmes [RCSI/NBIP/CEMP11]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board, Dublin, Ireland; National Biophotonics and Imaging Platform, Ireland; Irish Government's Programme for Research in Third Level Institutions, Cycle 4; Ireland's EU Structural Funds Programmes	Grants were provided by Science Foundation Ireland (09/SRC/B1794,07/RFP/BIMF816, 10/IN.1/B3034), and Health Research Board, Dublin, Ireland (R11831-NMC); National Biophotonics and Imaging Platform, Ireland; the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, and Ireland's EU Structural Funds Programmes 2007 to 2013 (RCSI/NBIP/CEMP11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2008, CARDIOVASC RES, V79, P395, DOI 10.1093/cvr/cvn097; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Conway JG, 2008, J PHARMACOL EXP THER, V326, P41, DOI 10.1124/jpet.107.129429; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Martin K, 2014, CURR PHARM DESIGN, V20, P1930, DOI 10.2174/13816128113199990450; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Sane DC, 2009, CARDIOL REV, V17, P293, DOI 10.1097/CRD.0b013e3181bf4ab4; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	26	61	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137515	10.1371/journal.pone.0137515	http://dx.doi.org/10.1371/journal.pone.0137515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407006	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700023
J	Paziewska, A; Cukrowska, B; Dabrowska, M; Goryca, K; Piatkowska, M; Kluska, A; Mikula, M; Karczmarski, J; Oralewska, B; Rybak, A; Socha, J; Balabas, A; Zeber-Lubecka, N; Ambrozkiewicz, F; Konopka, E; Trojanowska, I; Zagroba, M; Szperl, M; Ostrowski, J				Paziewska, Agnieszka; Cukrowska, Bozena; Dabrowska, Michalina; Goryca, Krzysztof; Piatkowska, Magdalena; Kluska, Anna; Mikula, Michal; Karczmarski, Jakub; Oralewska, Beata; Rybak, Anna; Socha, Jerzy; Balabas, Aneta; Zeber-Lubecka, Natalia; Ambrozkiewicz, Filip; Konopka, Ewa; Trojanowska, Ilona; Zagroba, Malgorzata; Szperl, Malgorzata; Ostrowski, Jerzy			Combination Testing Using a Single MSH5 Variant alongside HLA Haplotypes Improves the Sensitivity of Predicting Coeliac Disease Risk in the Polish Population	PLOS ONE			English	Article							EUROPEAN GENETICS CLUSTER; DQ; PREVALENCE; DIAGNOSIS; HMSH5	Assessment of non-HLA variants alongside standard HLA testing was previously shown to improve the identification of potential coeliac disease (CD) patients. We intended to identify new genetic variants associated with CD in the Polish population that would improve CD risk prediction when used alongside HLA haplotype analysis. DNA samples of 336 CD and 264 unrelated healthy controls were used to create DNA pools for a genome wide association study (GWAS). GWAS findings were validated with individual HLA tag single nucleotide polymorphism (SNP) typing of 473 patients and 714 healthy controls. Association analysis using four HLA-tagging SNPs showed that, as was found in other populations, positive predicting genotypes (HLA-DQ2.5/DQ2.5, HLA-DQ2.5/DQ2.2, and HLA-DQ2.5/DQ8) were found at higher frequencies in CD patients than in healthy control individuals in the Polish population. Both CD-associated SNPs discovered by GWAS were found in the CD susceptibility region, confirming the previously-determined association of the major histocompatibility (MHC) region with CD pathogenesis. The two most significant SNPs from the GWAS were rs9272346 (HLA-dependent; localized within 1 Kb of DQA1) and rs3130484 (HLA-independent; mapped to MSH5). Specificity of CD prediction using the four HLA-tagging SNPs achieved 92.9%, but sensitivity was only 45.5%. However, when a testing combination of the HLA-tagging SNPs and the MSH5 SNP was used, specificity decreased to 80%, and sensitivity increased to 74%. This study confirmed that improvement of CD risk prediction sensitivity could be achieved by including non-HLA SNPs alongside HLA SNPs in genetic testing.	[Paziewska, Agnieszka; Zeber-Lubecka, Natalia; Ambrozkiewicz, Filip; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland; [Cukrowska, Bozena; Konopka, Ewa; Trojanowska, Ilona] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Dabrowska, Michalina; Goryca, Krzysztof; Piatkowska, Magdalena; Kluska, Anna; Mikula, Michal; Karczmarski, Jakub; Balabas, Aneta] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Genet, Warsaw, Poland; [Oralewska, Beata; Rybak, Anna; Socha, Jerzy] Childrens Mem Hlth Inst, Dept Gastroenerol Hepatol Nutr Disorders & Pediat, Warsaw, Poland; [Zagroba, Malgorzata] State Higher Sch Vocat Educ, Fac Hlth Protect & Human Sci, Ciechanow, Poland; [Szperl, Malgorzata] Cardinal Stefan Wyszynski Inst Cardiol, Dept Mol Biol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Children's Memorial Health Institute; Maria Sklodowska-Curie National Research Institute of Oncology; Children's Memorial Health Institute	Ostrowski, J (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland.	jostrow@warman.com.pl	Rybak, Anna/HGB-1849-2022; Mikula, Michal/G-8276-2011; Żeber-Lubecka, Natalia/AAL-8834-2020	Mikula, Michal/0000-0003-3447-7328; Żeber-Lubecka, Natalia/0000-0003-4036-3191; Piatkowska, Magdalena/0000-0001-8372-8002; Kluska, Anna/0000-0002-5087-6575; Balabas, Aneta/0000-0001-6078-9232; Konopka, Ewa/0000-0002-5686-1112; Karczmarski, Jakub/0000-0002-7976-0365; Dabrowska, Michalina/0000-0002-7585-4946; Aneta, Balabas/0000-0003-0228-7650; Ambrozkiewicz, Filip/0000-0001-6850-780X; Cukrowska, Bozena/0000-0001-6887-0094; Ostrowski, Jerzy/0000-0003-1363-3766; Paziewska, Agnieszka/0000-0002-6644-1509	National Science Centre [2011/02/A/NZ5/00339]; Children's Memorial Health Institute [Z221/2012, S135/2013]	National Science Centre(National Science Centre, Poland); Children's Memorial Health Institute	Supported by 2011/02/A/NZ5/00339 grant from the National Science Centre (JO), and Z221/2012 and S135/2013 grants from the Children's Memorial Health Institute (BC).	Bao F, 2012, ARCH PATHOL LAB MED, V136, P735, DOI 10.5858/arpa.2011-0572-RA; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clark N, 2013, CURR GENOMICS, V14, P81, DOI 10.2174/1389202911314020002; Developer TJA, 2012, EP EP TOOLS; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Fernando MMA, 2012, ANN RHEUM DIS, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Gaj P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035307; Garampazzi A, 2007, J PEDIATR GASTR NUTR, V45, P611, DOI 10.1097/MPG.0b013e31814c3d79; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Hadithi M, 2007, ANN INTERN MED, V147, P294, DOI 10.7326/0003-4819-147-5-200709040-00003; Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Juyal G, 2014, GUT; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Lasky-Su J, 2012, CLIN EXP ALLERGY, V42, P1724, DOI 10.1111/cea.12000; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Megiorni F, 2008, AM J GASTROENTEROL, V103, P997, DOI 10.1111/j.1572-0241.2007.01716.x; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Pallav K, 2014, DIGEST DIS SCI, V59, P2199, DOI 10.1007/s10620-014-3143-1; Rampertab SD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.044; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Salardi S, 2008, J PEDIATR GASTR NUTR, V46, P612, DOI 10.1097/MPG.0b013e31815d697e; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; Uenishi RH, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-36; Ventura A, 2002, GUT, V51, P897, DOI 10.1136/gut.51.6.897; Wroblova K, 2014, ACTA BIOCHIM POL, V61, P191; Yi W, 2005, BIOCHEM BIOPH RES CO, V332, P524, DOI 10.1016/j.bbrc.2005.04.154	31	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139197	10.1371/journal.pone.0139197	http://dx.doi.org/10.1371/journal.pone.0139197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406233	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700188
J	Su, YB; Liu, YM; Li, ZS; Fang, ZY; Yang, LM; Zhuang, M; Zhang, YY				Su, Yanbin; Liu, Yumei; Li, Zhansheng; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong			QTL Analysis of Head Splitting Resistance in Cabbage (Brassica oleracea L. var. capitata) Using SSR and InDel Makers Based on Whole-Genome Re-Sequencing	PLOS ONE			English	Article							LINKAGE MAP; GENETIC-MAP; PLASMODIOPHORA-BRASSICAE; FLOWERING TIME; RFLP MARKERS; INHERITANCE; TRAITS; CONSTRUCTION; POPULATION; LOCI	Head splitting resistance (HSR) in cabbage is an important trait closely related to both quality and yield of head. However, the genetic control of this trait remains unclear. In this study, a doubled haploid (DH) population derived from an intra-cross between head splitting-susceptible inbred cabbage line 79-156 and resistant line 96-100 was obtained and used to analyze inheritance and detect quantitative trait loci (QTLs) for HSR using a mixed major gene/polygene inheritance analysis and QTL mapping. HSR can be attributed to additive-epistatic effects of three major gene pairs combined with those of polygenes. Negative and significant correlations were also detected between head Hsr and head vertical diameter (Hvd), head transverse diameter (Htd) and head weight (Hw). Using the DH population, a genetic map was constructed with simple sequence repeat (SSR) and insertion-deletion (InDel) markers, with a total length of 1065.9 cM and average interval length of 4.4 cM between adjacent markers. Nine QTLs for HSR were located on chromosomes C3, C4, C7, and C9 based on 2 years of phenotypic data using both multiple-QTL mapping and inclusive composite interval mapping. The identified QTLs collectively explained 39.4 to 59.1% of phenotypic variation. Three major QTLs (Hsr 3.2, 4.2, 9.2) showing a relatively larger effect were robustly detected in different years or with different mapping methods. The HSR trait was shown to have complex genetic mechanisms. Results from QTL mapping and classical genetic analysis were consistent. The QTLs obtained in this study should be useful for molecular marker-assisted selection in cabbage breeding and provide a foundation for further research on HSR genetic regulation.	[Su, Yanbin; Liu, Yumei; Li, Zhansheng; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [Su, Yanbin] Beijing Zhongnong Futong Hort Corp Ltd, Beijing 100083, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Liu, YM (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China.	liuyumei@caas.cn	Li, Zhansheng/L-8017-2019; Li, Zhansheng/M-9593-2019	Li, Zhansheng/0000-0003-0132-2741; fang, zhi yuan/0000-0003-1664-759X	National High Technology Research and Development Program (863 Program) of China [2012AA100104, 2012AA100105]; Key Projects in the National Science and Technology Pillar Program of China [2013BAD01B04]; China Agriculture Research System [CARS-25-A]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences [CAAS-ASTIP-IVFCAAS]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program of China; China Agriculture Research System; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences	This work was supported by the National High Technology Research and Development Program (863 Program) of China (2012AA100104, 2012AA100105), the Key Projects in the National Science and Technology Pillar Program of China (2013BAD01B04), the China Agriculture Research System (CARS-25-A), the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China, the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (Grant no. CAAS-ASTIP-IVFCAAS). YML received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, P S APPL STAT AMST N, P27; Anbessa Y, 2006, J HERED, V97, P55, DOI 10.1093/jhered/esj009; Brown AF, 2014, THEOR APPL GENET, V127, P2051, DOI 10.1007/s00122-014-2360-5; Budan S., 1999, EUR S FRUIT BREED GE, V538, P123; Camargo LEA, 1996, THEOR APPL GENET, V92, P610, DOI 10.1007/BF00224565; Chen Chen, 2010, Acta Horticulturae Sinica, V37, P221; Chen X, 2010, GENETICS, V186, P1053, DOI 10.1534/genetics.110.120311; Cheng LR, 2011, THEOR APPL GENET, V123, P421, DOI 10.1007/s00122-011-1594-8; CHIANG MS, 1972, EUPHYTICA, V21, P507, DOI 10.1007/BF00039347; CORTES C, 1983, SCI HORTIC-AMSTERDAM, V21, P323, DOI 10.1016/0304-4238(83)90122-X; Fahey JW, 1995, CUR TOP PL, V15, P87; Farinho M, 2004, THEOR APPL GENET, V109, P1392, DOI 10.1007/s00122-004-1747-0; Foisset N, 1996, THEOR APPL GENET, V93, P1017, DOI 10.1007/BF00230119; Gai J., 2003, GENETIC SYSTEM QUANT; Gai JY, 2000, EXPT METHOD; Gai JY, FRONT AGR CHINA, V1, P1; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Hao JJ, 2008, PLANT BREEDING, V127, P383, DOI 10.1111/j.1439-0523.2007.01474.x; HOLT JE, 1983, J TEXTURE STUD, V14, P99, DOI 10.1111/j.1745-4603.1983.tb00337.x; Junyi G, 2006, FRONT BIOL CHINA, V1, P85, DOI [10.1007/s11515-005-0001-8, DOI 10.1007/S11515-005-0001-8]; Kifuji Y, 2013, EUPHYTICA, V190, P289, DOI 10.1007/s10681-012-0847-1; Lan TH, 2001, THEOR APPL GENET, V103, P383, DOI 10.1007/s001220100615; LANDRY BS, 1992, GENOME, V35, P409, DOI 10.1139/g92-061; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li XX, 2007, DESCRIPTORS DATA STA; Liang HZ, 2014, THEOR APPL GENET, V127, P2127, DOI 10.1007/s00122-014-2366-z; Liu B, 2013, THEOR APPL GENET, V126, P231, DOI 10.1007/s00122-012-1976-6; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Lv HH, 2014, MOL BREEDING, V34, P87, DOI 10.1007/s11032-014-0019-1; Masarirambi M. T., 2011, African Journal of Plant Science, V5, P8; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Moriguchi K, 1999, BREEDING SCI, V49, P257, DOI 10.1270/jsbbs.49.257; Nagaoka T, 2010, THEOR APPL GENET, V120, P1335, DOI 10.1007/s00122-010-1259-z; Okazaki K, 2007, THEOR APPL GENET, V114, P595, DOI 10.1007/s00122-006-0460-6; Pang W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0318-1; Piepho HP, 2005, THEOR APPL GENET, V110, P561, DOI 10.1007/s00122-004-1872-9; Pink D, 2008, EUPHYTICA, V164, P509, DOI 10.1007/s10681-008-9742-1; Pu ZJ, 2012, MOL BREEDING, V30, P809, DOI 10.1007/s11032-011-9665-8; Qin Z. W., 1994, J NE AGR U, V25, P344; Rudolf K, 1999, PLANT BREEDING, V118, P237, DOI 10.1046/j.1439-0523.1999.118003237.x; Sabouri H, 2009, J GENET, V88, P81, DOI 10.1007/s12041-009-0011-4; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sebastian RL, 2000, THEOR APPL GENET, V100, P75, DOI 10.1007/s001220050011; SLOCUM MK, 1990, THEOR APPL GENET, V80, P57, DOI 10.1007/BF00224016; SOLLER M, 1990, THEOR APPL GENET, V80, P205, DOI 10.1007/BF00224388; Sotelo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091428; [苏成付 Su Chengfu], 2010, [作物学报, Acta Agronomica Sinica], V36, P1100; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; UZUNOVA M, 1995, THEOR APPL GENET, V90, P194, DOI 10.1007/BF00222202; Vali U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-8; van Eeuwijk FA, 2010, CURR OPIN PLANT BIOL, V13, P193, DOI 10.1016/j.pbi.2010.01.001; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VANOOIJEN JW, 2002, MAP QTL 4 0 SOFTWARE; Voorrips RE, 1997, THEOR APPL GENET, V94, P75, DOI 10.1007/s001220050384; Walley PG, 2012, THEOR APPL GENET, V124, P467, DOI 10.1007/s00122-011-1721-6; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Wang WY, 2012, SCI HORTIC-AMSTERDAM, V147, P29, DOI 10.1016/j.scienta.2012.08.033; Xing GN, 2012, THEOR APPL GENET, V125, P859, DOI 10.1007/s00122-012-1878-7; Yuan SX, 2011, PLANT BREEDING, V130, P80, DOI 10.1111/j.1439-0523.2009.01754.x; Yuan SX, 2012, PLANT CELL TISS ORG, V110, P69, DOI 10.1007/s11240-012-0131-z; Zeng A. S., 2009, ACTA AGR BOREALI S S, VS2, P41; Zhang F, 2011, EUPHYTICA, V177, P15, DOI 10.1007/s10681-010-0239-3; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhang YM, 2003, GENET RES, V81, P157, DOI 10.1017/S0016672303006141; Zhuang M, 2009, CHINA VEG, V1, P12	66	11	16	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138073	10.1371/journal.pone.0138073	http://dx.doi.org/10.1371/journal.pone.0138073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406606	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700031
J	Zhang, TJ; Yu, LX; Zheng, P; Li, YJ; Rivera, M; Main, D; Greene, SL				Zhang, Tiejun; Yu, Long-Xi; Zheng, Ping; Li, Yajun; Rivera, Martha; Main, Dorrie; Greene, Stephanie L.			Identification of Loci Associated with Drought Resistance Traits in Heterozygous Autotetraploid Alfalfa (Medicago sativa L.) Using Genome-Wide Association Studies with Genotyping by Sequencing	PLOS ONE			English	Article							ENVIRONMENTAL-STRESS; ENHANCED TOLERANCE; GENETIC DIVERSITY; ARABIDOPSIS; YIELD; TRANSCRIPTION; POPULATIONS; CULTIVARS; FAMILY; WHEAT	Drought resistance is an important breeding target for enhancing alfalfa productivity in arid and semi-arid regions. Identification of genes involved in drought tolerance will facilitate breeding for improving drought resistance and water use efficiency in alfalfa. Our objective was to use a diversity panel of alfalfa accessions comprised of 198 cultivars and landraces to identify genes involved in drought tolerance. The panel was selected from the USDA-ARS National Plant Germplasm System alfalfa collection and genotyped using genotyping by sequencing. A greenhouse procedure was used for phenotyping two important traits associated with drought tolerance: drought resistance index (DRI) and relative leaf water content (RWC). Marker-trait association identified nineteen and fifteen loci associated with DRI and RWC, respectively. Alignments of target sequences flanking to the resistance loci against the reference genome of M. truncatula revealed multiple chromosomal locations. Markers associated with DRI are located on all chromosomes while markers associated with RWC are located on chromosomes 1, 2, 3, 4, 5, 6 and 7. Co-localizations of significant markers between DRI and RWC were found on chromosomes 3, 5 and 7. Most loci associated with DRI in this work overlap with the reported QTLs associated with biomass under drought in alfalfa. Additional significant markers were targeted to several contigs with unknown chromosomal locations. BLAST search using their flanking sequences revealed homology to several annotated genes with functions in stress tolerance. With further validation, these markers may be used for marker-assisted breeding new alfalfa varieties with drought resistance and enhanced water use efficiency.	[Zhang, Tiejun; Yu, Long-Xi; Li, Yajun; Rivera, Martha] ARS, Plant & Germplasm Intro & Testing Res, USDA, Prosser, WA USA; [Zheng, Ping; Main, Dorrie] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Greene, Stephanie L.] ARS, Natl Ctr Genet Resource Preservat, USDA, Ft Collins, CO USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA)	Yu, LX (corresponding author), ARS, Plant & Germplasm Intro & Testing Res, USDA, Prosser, WA USA.	longxi.yu@ars.usda.gov	Zhang, Tiejun/HDM-7091-2022	Greene, Stephanie/0000-0002-3624-5021	USDA-ARS National Program Project [5354-21000-015-00D]; National Alfalfa and Forage Alliance; ARS [ARS-0425169] Funding Source: Federal RePORTER	USDA-ARS National Program Project; National Alfalfa and Forage Alliance; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was supported by USDA-ARS National Program Project No. 5354-21000-015-00D and by a partial grant from the National Alfalfa and Forage Alliance to L-X Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger D, 2000, GENE DEV, V14, P1119; Bouton J, 2007, EUPHYTICA, V154, P263, DOI 10.1007/s10681-006-9220-6; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen D, 2008, ACTA PHYSIOL PLANT, V30, P183, DOI 10.1007/s11738-007-0107-5; de Vasconcelos ES, 2008, ACTA SCI-AGRON, V30, P339, DOI 10.4025/actasciagron.v30i3.3511; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; FUERST PA, 1977, GENETICS, V86, P455; Garrison E, 2012, 12073907 ARXIV, V1207, P3907; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; Hamdy A, 2003, IRRIG DRAIN, V52, P3, DOI 10.1002/ird.73; Han SK, 2014, J EXP BOT, V65, P2785, DOI 10.1093/jxb/ert403; Kang Y, 2011, PLANT J, V68, P871, DOI 10.1111/j.1365-313X.2011.04738.x; LABERGE S, 1993, PLANT PHYSIOL, V101, P1411, DOI 10.1104/pp.101.4.1411; LENSSEN AW, 1991, CROP SCI, V31, P293, DOI 10.2135/cropsci1991.0011183X003100020012x; Li GD, 2010, CROP PASTURE SCI, V61, P645, DOI 10.1071/CP09360; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LUO M, 1992, J BIOL CHEM, V267, P15367; LUO M, 1991, PLANT MOL BIOL, V17, P1267, DOI 10.1007/BF00028745; Manabe Y, 2008, PLANT PHYSIOL, V146, P612, DOI 10.1104/pp.107.109009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKersie BD, 1996, PLANT PHYSIOL, V111, P1177, DOI 10.1104/pp.111.4.1177; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray IM, 2015, CROP SCI, V55, P2012, DOI 10.2135/cropsci2014.12.0840; Ray IM, 2004, CROP SCI, V44, P1970, DOI 10.2135/cropsci2004.1970; Ray IM, 1998, CROP SCI, V38, P1386, DOI 10.2135/cropsci1998.0011183X003800050038x; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Segovia-Lerma A, 2003, GENOME, V46, P51, DOI 10.1139/G02-100; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; SPOMER LA, 1985, HORTSCIENCE, V20, P1021; Suarez R, 2009, CROP SCI, V49, P1791, DOI 10.2135/cropsci2008.09.0573; Tan JJ, 2014, MOL PLANT, V7, P1329, DOI 10.1093/mp/ssu054; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	41	47	53	8	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138931	10.1371/journal.pone.0138931	http://dx.doi.org/10.1371/journal.pone.0138931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406473	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700120
J	Zulliger, R; Conley, SM; Mwoyosvi, ML; Stuck, MW; Azadi, S; Naash, MI				Zulliger, Rahel; Conley, Shannon M.; Mwoyosvi, Maggie L.; Stuck, Michael W.; Azadi, Seifollah; Naash, Muna I.			SNAREs Interact with Retinal Degeneration Slow and Rod Outer Segment Membrane Protein-1 during Conventional and Unconventional Outer Segment Targeting	PLOS ONE			English	Article							R172W MUTATION; INTRAFAMILIAL VARIABILITY; STATISTICAL-MODEL; CYSTEINE RESIDUES; SYNTAXIN 3B; PERIPHERIN/RDS; CONE; PHOTORECEPTORS; DYSTROPHY; FUSION	Mutations in the photoreceptor protein peripherin-2 (also known as RDS) cause severe retinal degeneration. RDS and its homolog ROM-1 (rod outer segment protein 1) are synthesized in the inner segment and then trafficked into the outer segment where they function in tetramers and covalently linked larger complexes. Our goal is to identify binding partners of RDS and ROM-1 that may be involved in their biosynthetic pathway or in their function in the photoreceptor outer segment (OS). Here we utilize several methods including mass spectrometry after affinity purification, in vitro co-expression followed by pull-down, in vivo pull-down from mouse retinas, and proximity ligation assay to identify and confirm the SNARE proteins Syntaxin 3B and SNAP-25 as novel binding partners of RDS and ROM-1. We show that both covalently linked and non-covalently linked RDS complexes interact with Syntaxin 3B. RDS in the mouse is trafficked from the inner segment to the outer segment by both conventional (i.e., Golgi dependent) and unconventional secretory pathways, and RDS from both pathways interacts with Syntaxin3B. Syntaxin 3B and SNAP-25 are enriched in the inner segment (compared to the outer segment) suggesting that the interaction with RDS/ROM-1 occurs in the inner segment. Syntaxin 3B and SNAP-25 are involved in mediating fusion of vesicles carrying other outer segment proteins during outer segment targeting, so could be involved in the trafficking of RDS/ROM-1.	[Zulliger, Rahel; Conley, Shannon M.; Mwoyosvi, Maggie L.; Stuck, Michael W.; Azadi, Seifollah; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77204 USA.	mnaash@central.uh.edu			National Eye Institute at the National Institutes of Health [R01EY10609]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology [HR14-150]; NATIONAL EYE INSTITUTE [R01EY010609] Funding Source: NIH RePORTER	National Eye Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute at the National Institutes of Health (R01EY10609, MIN, https://www.nei.nih.gov), the Foundation Fighting Blindness (MIN), and the Oklahoma Center for the Advancement of Science and Technology (HR14-150, SMC, http://www.ok.gov/ocast/).	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Bachnoff N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01620; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2002, EXP EYE RES, V75, P227, DOI 10.1006/exer.2002.2004; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Conley SM, 2012, CELL MOL LIFE SCI, V69, P1035, DOI 10.1007/s00018-011-0736-0; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Edrington TCV, 2007, BIOCHEMISTRY-US, V46, P3862, DOI 10.1021/bi061999r; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu XQ, 2014, MOL CELL NEUROSCI, V60, P53, DOI 10.1016/j.mcn.2014.03.002; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1592, DOI 10.1016/j.ophtha.2005.04.004; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Sherry DM, 2003, MOL VIS, V9, P673; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Teng FYH, 2001, GENOME BIOL, V2; Tian G, 2014, J NEUROSCI, V34, P992, DOI 10.1523/JNEUROSCI.3437-13.2014; Vaclavik V, 2012, RETINA-J RET VIT DIS, V32, P1942, DOI 10.1097/IAE.0b013e31824b32e4; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138508	10.1371/journal.pone.0138508	http://dx.doi.org/10.1371/journal.pone.0138508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406599	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700051
J	Cao, J; Dang, GH; Li, HF; Li, TT; Yue, ZG; Li, N; Liu, YJ; Liu, SG; Chen, LP				Cao, Jun; Dang, Guanghui; Li, Huafang; Li, Tiantian; Yue, Zhiguo; Li, Na; Liu, Yajun; Liu, Siguo; Chen, Liping			Identification and Characterization of Lipase Activity and Immunogenicity of LipL from Mycobacterium tuberculosis	PLOS ONE			English	Article							CELL-SURFACE; GENOME SEQUENCE; PROTEIN; EXPRESSION; PE; VIRULENCE; TRIACYLGLYCEROL; SMEGMATIS; ESTERASE; LIPIDS	Lipids and lipid-metabolizing esterases/lipases are highly important for the mycobacterial life cycle and, possibly, for mycobacterial virulence. In this study, we expressed 10 members of the Lip family of Mycobacterium tuberculosis. Among the 10 proteins, LipL displayed a significantly high enzymatic activity for the hydrolysis of long-chain lipids. The optimal temperature for the lipase activity of LipL was demonstrated to be 37 degrees C, and the optimal pH was 8.0. The lipase active center was not the conserved motif G-x-S-x-G, but rather the S-x-x-K and GGG motifs, and the key catalytic amino acid residues were identified as G50, S88, and K91, as demonstrated through site-directed mutagenesis experiments. A three-dimensional modeling structure of LipL was constructed, which showed that the GGG motif was located in the surface of a pocket structure. Furthermore, the subcellular localization of LipL was demonstrated to be on the mycobacterial surface by Western blot analysis. Our results revealed that the LipL protein could induce a strong humoral immune response in humans and activate a CD8(+) T cell-mediated response in mice. Overall, our study identified and characterized a novel lipase denoted LipL from M. tuberculosis, and demonstrated that LipL functions as an immunogen that activates both humoral and cell-mediated responses.	[Cao, Jun; Dang, Guanghui; Li, Huafang; Li, Tiantian; Liu, Siguo; Chen, Liping] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin, Peoples R China; [Yue, Zhiguo; Li, Na; Liu, Yajun] Heilongjiang Prov Hosp Prevent & Treatment TB, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Liu, SG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin, Peoples R China.	siguo_liu@hvri.ac.cn; clp@hvri.ac.cn			Major State Basic Research Development Program of China (973 program) [2012CB518800]; National Natural Science Foundation of China [31201920, 31272538]; State Key Laboratory of Veterinary Biotechnology Research Fund [SKLVBP201417]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnology Research Fund	This work was supported by the Major State Basic Research Development Program of China (973 program, No. 2012CB518800; http://www.973.gov.cn), the National Natural Science Foundation of China (No. 31201920; No. 31272538; http://www.nsfc.gov.cn/) and the State Key Laboratory of Veterinary Biotechnology Research Fund (No. SKLVBP201417; http://www.caas.net.cn/ky/kjpt/zdsys/gjzdsys/51601.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Delorme V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046493; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Dorhoi A, 2012, FUNDAMENTAL IMMUNOLO, P973, DOI 10.1002/eji.201141548; Ehrt S, 2007, NAT MED, V13, P284, DOI 10.1038/nm0307-284; Gardy JL, 2006, NAT REV MICROBIOL, V4, P741, DOI 10.1038/nrmicro1494; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Infanzon B, 2014, BIOCHIMIE, V104, P108, DOI 10.1016/j.biochi.2014.06.003; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kaufmann SHE, 2013, SEMIN IMMUNOL, V25, P172, DOI 10.1016/j.smim.2013.04.006; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Poulsen C, 2010, FEBS LETT, V584, P669, DOI 10.1016/j.febslet.2009.12.057; Rodriguez JG, 2014, MBIO, V5, DOI 10.1128/mBio.01125-14; Saxena AK, 2013, INT J ANTIMICROB AG, V42, P27, DOI 10.1016/j.ijantimicag.2013.03.007; Shen GM, 2012, INFECT IMMUN, V80, P243, DOI 10.1128/IAI.05541-11; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Singh VK, 2014, TUBERCULOSIS, V94, P252, DOI 10.1016/j.tube.2014.02.001; Singh VK, 2011, VACCINE, V29, P4754, DOI 10.1016/j.vaccine.2011.04.086; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Vizcaino C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000824; Vromman F, 2014, CURR OPIN MICROBIOL, V17, P38, DOI 10.1016/j.mib.2013.11.003; World Health Organization, 2014, GLOB TUB REP; Zhang M, 2005, PROTEIN EXPRES PURIF, V42, P59, DOI 10.1016/j.pep.2005.03.022	43	19	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138151	10.1371/journal.pone.0138151	http://dx.doi.org/10.1371/journal.pone.0138151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398213	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500055
J	ElFessi-Magouri, R; Peigneur, S; Othman, H; Srairi-Abid, N; ElAyeb, M; Tytgat, J; Kharrat, R				ElFessi-Magouri, Rym; Peigneur, Steve; Othman, Houcemeddine; Srairi-Abid, Najet; ElAyeb, Mohamed; Tytgat, Jan; Kharrat, Riadh			Characterization of Kbot21 Reveals Novel Side Chain Interactions of Scorpion Toxins Inhibiting Voltage-Gated Potassium Channels	PLOS ONE			English	Article							BUTHUS-OCCITANUS-TUNETANUS; K+-CHANNELS; 3-DIMENSIONAL STRUCTURE; MARTENSI KARSCH; ANIMAL TOXINS; VENOM; PURIFICATION; BMBKTX1; PREDICTION; MAUROTOXIN	Scorpion toxins are important pharmacological tools for probing the physiological roles of ion channels which are involved in many physiological processes and as such have significant therapeutic potential. The discovery of new scorpion toxins with different specificities and affinities is needed to further characterize the physiology of ion channels. In this regard, a new short polypeptide called Kbot21 has been purified to homogeneity from the venom of Buthus occitanus tunetanus scorpion. Kbot21 is structurally related to BmBKTx1 from the venom of the Asian scorpion Buthus martensii Karsch. These two toxins differ by only two residues at position 13 (R/V) and 24 (D/N). Despite their very similar sequences, Kbot21 and BmBKTx1 differ in their electrophysiological activities. Kbot21 targets KV channel sub-types whereas BmBKTx1 is active on both big conductance (BK) and small conductance (SK) Ca2+-activated K+ channel subtypes, but has no effects on Kv channel subtypes. The docking model of Kbot21 with the Kv1.2 channel shows that the D24 and R13 side-chain of Kbot21 are critical for its interaction with KV channels.	[ElFessi-Magouri, Rym; Othman, Houcemeddine; Srairi-Abid, Najet; ElAyeb, Mohamed; Kharrat, Riadh] Inst Pasteur Tunis, Lab Venins & Mol Therapeut, Tunis 1002, Tunisia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven KU Leuven, Lab Toxicol & Pharmacol, B-3000 Louvain, Belgium	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; KU Leuven	Kharrat, R (corresponding author), Inst Pasteur Tunis, Lab Venins & Mol Therapeut, 13 Pl Pasteur,BP-74, Tunis 1002, Tunisia.	riadh.kharrat@pasteur.rns.tn	Othman, Houcemeddine/AAF-6790-2019	Othman, Houcemeddine/0000-0002-1159-6482; Peigneur, Steve/0000-0003-0504-5702; Tytgat, Jan/0000-0003-1778-6022	Ministry of Research Tunisia (MRSTDC); Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [IUAP 7/10]; KU Leuven [OT/12/081]	Ministry of Research Tunisia (MRSTDC); Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); KU Leuven(KU Leuven)	This research was granted by Ministry of Research Tunisia (MRSTDC) and by IUAP 7/10 (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy) and OT/12/081 (KU Leuven).	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bergeron ZL, 2012, TOXINS, V4, P1082, DOI 10.3390/toxins4111082; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cai Z, 2004, BIOCHEMISTRY-US, V43, P3764, DOI 10.1021/bi035412+; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Darbon H, 1999, PERSPECT DRUG DISCOV, V16, P41; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Frenal K, 2004, PROTEINS, V56, P367, DOI 10.1002/prot.20102; Galeotti N, 2003, NEUROSCIENCE, V122, P471, DOI 10.1016/j.neuroscience.2003.08.005; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; Jouirou B, 2004, BIOCHEM J, V377, P37, DOI 10.1042/BJ20030977; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; KOBAYASHI Y, 1991, BIOPOLYMERS, V31, P1213, DOI 10.1002/bip.360311009; Korolkova YV, 2004, J MOL RECOGNIT, V17, P209, DOI 10.1002/jmr.667; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; Mahjoubi-Boubaker B, 2004, PEPTIDES, V25, P637, DOI 10.1016/j.peptides.2004.02.017; MARTIN MF, 1984, TOXICON, V22, P279, DOI 10.1016/0041-0101(84)90028-X; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; Pongs O., 2008, V44, P145, DOI 10.1007/400_2007_032; Pragl B, 2002, BIOCONJUGATE CHEM, V13, P416, DOI 10.1021/bc015543s; Rjeibi I, 2011, PEPTIDES, V32, P656, DOI 10.1016/j.peptides.2011.01.015; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schroeder N, 2002, FEBS LETT, V527, P298, DOI 10.1016/S0014-5793(02)03256-8; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Srairi-Abid N, 2000, EUR J BIOCHEM, V267, P5614, DOI 10.1046/j.1432-1327.2000.01632.x; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Visan V, 2004, MOL PHARMACOL, V66, P1103, DOI 10.1124/mol.104.002774; Wang SM, 2008, ACTA BIOCH BIOPH SIN, V40, P955, DOI 10.1111/j.1745-7270.2008.00479.x; Wu JJ, 2002, BIOCHEMISTRY-US, V41, P2844, DOI 10.1021/bi011367z; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu CQ, 2004, J BIOL CHEM, V279, P34562, DOI 10.1074/jbc.M312798200; Zhu SY, 2014, MOL BIOL EVOL, V31, P546, DOI 10.1093/molbev/msu038	42	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137611	10.1371/journal.pone.0137611	http://dx.doi.org/10.1371/journal.pone.0137611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398235	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500042
J	Li, Z; Hao, Q; Luo, J; Xiong, J; Zhang, S; Wang, T; Bai, L; Wang, W; Chen, M; Wang, W; Gu, L; Lv, K; Chen, J				Li, Z.; Hao, Q.; Luo, J.; Xiong, J.; Zhang, S.; Wang, T.; Bai, L.; Wang, W.; Chen, M.; Wang, W.; Gu, L.; Lv, K.; Chen, J.			USP4 inhibits p53 and NF-kappa B through deubiquitinating and stabilizing HDAC2	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; HISTONE DEACETYLASES; GENE-EXPRESSION; DNA-BINDING; ACETYLATION; ACTIVATION; APOPTOSIS; PHOSPHORYLATION; RECEPTOR; TARGETS	Histone deacetylases (HDACs) are major epigenetic modulators involved in a broad spectrum of human diseases including cancers. As HDACs are promising targets of cancer therapy, it is important to understand the mechanisms of HDAC regulation. In this study, we show that ubiquitin-specific peptidase 4 (USP4) interacts directly with and deubiquitinates HDAC2, leading to the stabilization of HDAC2. Accumulation of HDAC2 in USP4-overexpression cells leads to compromised p53 acetylation as well as crippled p53 transcriptional activation, accumulation and apoptotic response upon DNA damage. Moreover, USP4 targets HDAC2 to downregulate tumor necrosis factor TNF alpha-induced nuclear factor (NF)-kappa B activation. Taken together, our study provides a novel insight into the ubiquitination and stability of HDAC2 and uncovers a previously unknown function of USP4 in cancers.	[Li, Z.; Hao, Q.; Xiong, J.; Wang, T.] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Li, Z.; Hao, Q.; Xiong, J.; Wang, T.] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Li, Z.; Hao, Q.; Xiong, J.; Wang, W.; Chen, M.; Wang, W.; Gu, L.; Chen, J.] State Ocean Adm, Inst Oceanog 3, Key Lab Breeding Base Marine Genet Resources, Xiamen 361005, Fujian, Peoples R China; [Luo, J.] Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China; [Zhang, S.] Soochow Univ, Sch Radiat Med & Protect, Suzhou, Peoples R China; [Zhang, S.] Soochow Univ, Jiangsu Higher Educ Inst, Collaborat Innovat Ctr Radiat Med, Suzhou, Peoples R China; [Bai, L.] Xiamen Univ, Zhongshan Hosp, Xiamen, Peoples R China; [Lv, K.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Lv, K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Xiamen University; Xiamen University; State Oceanic Administration; Soochow University - China; Soochow University - China; Soochow University - China; Xiamen University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Chen, J (corresponding author), State Ocean Adm, Inst Oceanog 3, Key Lab Breeding Base Marine Genet Resources, Xiamen 361005, Fujian, Peoples R China.	chenjianming@tio.org.cn		Hao, Qiongyu/0000-0002-4720-767X	Scientific Research Foundation of Third Institute of Oceanography, SOA [2015011, 2014007]; China Ocean Mineral Resources RD Association [DY125-15-T-03, DY-125-15-T-08]; National Natural Science Foundation of China [81402518, 41201531, 31272684]; China Postdoctoral Science Foundation [2013M541853, 2014T70606]; Marine Public Welfare Project [201005022]; National Science Foundation [31171366]; special financial fund of innovative development of marine economic demonstration project [GD2012-D01-001]	Scientific Research Foundation of Third Institute of Oceanography, SOA; China Ocean Mineral Resources RD Association; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Marine Public Welfare Project; National Science Foundation(National Science Foundation (NSF)); special financial fund of innovative development of marine economic demonstration project	We thank all the members of the Jianming Chen laboratory for their help and assistance. This work was supported by the Scientific Research Foundation of Third Institute of Oceanography, SOA (No. 2015011), DY125-15-T-03 from China Ocean Mineral Resources R&D Association, the National Natural Science Foundation of China (81402518), grants from China Postdoctoral Science Foundation (No. 2013M541853), China Postdoctoral Science Foundation (No. 2014T70606), Marine Public Welfare Project 201005022, the National Science Foundation grant 31171366, the Scientific Research Foundation of Third Institute of Oceanography, SOA (No. 2014007), the National Natural Science Foundation of China (41201531), China Ocean Mineral Resources R&D Association (DY-125-15-T-08), the National Natural Science Foundation of China (31272684), special financial fund of innovative development of marine economic demonstration project, GD2012-D01-001.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang AA, 2005, ADV OTO-RHINO-LARYNG, V62, P92; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fan YH, 2011, CELL DEATH DIFFER, V18, P1547, DOI 10.1038/cdd.2011.11; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gong FD, 2013, MUTAT RES-FUND MOL M, V750, P23, DOI 10.1016/j.mrfmmm.2013.07.002; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Heideman MR, 2013, BLOOD, V121, P2038, DOI 10.1182/blood-2012-08-450916; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wagner T, 2014, BBA-REV CANCER, V1846, P524, DOI 10.1016/j.bbcan.2014.07.010; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	52	49	51	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2902	2912		10.1038/onc.2015.349	http://dx.doi.org/10.1038/onc.2015.349			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26411366	Green Published, hybrid			2022-12-26	WOS:000377473700010
J	Kodedova, M; Sychrova, H				Kodedova, Marie; Sychrova, Hana			Changes in the Sterol Composition of the Plasma Membrane Affect Membrane Potential, Salt Tolerance and the Activity of Multidrug Resistance Pumps in Saccharomyces cerevisiae	PLOS ONE			English	Article							ERGOSTEROL BIOSYNTHESIS; CANDIDA-ALBICANS; INTRACELLULAR PH; DRUG-RESISTANCE; ERG6 GENE; YEAST; CHOLESTEROL; EPIDEMIOLOGY; ORGANIZATION; TRANSPORTER	We investigated the impact of the deletions of genes from the final steps in the biosynthesis of ergosterol (ERG6, ERG2, ERG3, ERG5, ERG4) on the physiological function of the Saccharomyces cerevisiae plasma membrane by a combination of biological tests and the diSC3(3) fluorescence assay. Most of the erg mutants were more sensitive than the wild type to salt stress or cationic drugs, their susceptibilities were proportional to the hyperpolarization of their plasma membranes. The different sterol composition of the plasma membrane played an important role in the short-term and long-term processes that accompanied the exposure of erg strains to a hyperosmotic stress (effect on cell size, pH homeostasis and survival of yeasts), as well as in the resistance of cells to antifungal drugs. The pleiotropic drug-sensitive phenotypes of erg strains were, to a large extent, a result of the reduced efficiency of the Pdr5 efflux pump, which was shown to be more sensitive to the sterol content of the plasma membrane than Snq2p. In summary, the erg4 Delta and erg6 Delta mutants exhibited the most compromised phenotypes. As Erg6p is not involved in the cholesterol biosynthetic pathway, it may become a target for a new generation of antifungal drugs.	[Kodedova, Marie; Sychrova, Hana] Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Kodedova, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic.	Marie.Kodedova@fgu.cas.cz	Sychrova, Hana/B-1350-2012; Kodedova, Marie/B-7559-2012	Sychrova, Hana/0000-0001-5967-5019; Kodedova, Marie/0000-0003-3423-2363	Centre of Biomedical Research [CZ.1.07/2.3.00/30.0025]; European Social Fund; state budget of the Czech Republic; BIOCEV - Biotechnology and Biomedicine Centre of Academy of Sciences; Charles University [CZ.1.05/1.1.00.02.0109]; European Regional Development Fund	Centre of Biomedical Research; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; BIOCEV - Biotechnology and Biomedicine Centre of Academy of Sciences; Charles University; European Regional Development Fund(European Commission)	This work was supported within the project The Centre of Biomedical Research (CZ.1.07/2.3.00/30.0025). This project is co-funded by the European Social Fund and the state budget of the Czech Republic. This work was also supported by BIOCEV - Biotechnology and Biomedicine Centre of Academy of Sciences and Charles University (CZ.1.05/1.1.00.02.0109), the project from European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Anderson JB, 2003, GENETICS, V163, P1287; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Bard M, 2005, DIAGN MICR INFEC DIS, V52, P285, DOI 10.1016/j.diagmicrobio.2005.03.001; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Cadek R, 2004, BBA-BIOMEMBRANES, V1665, P111, DOI 10.1016/j.bbamem.2004.06.020; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Chung SK, 2000, BIOORGAN MED CHEM, V8, P2475, DOI 10.1016/S0968-0896(00)00177-2; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; Denksteinova B, 1997, FOLIA MICROBIOL, V42, P221, DOI 10.1007/BF02818983; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Dupont S, 2012, EVOLUTION, V66, P2961, DOI 10.1111/j.1558-5646.2012.01667.x; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; FROMTILING R A, 1988, Clinical Microbiology Reviews, V1, P187; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hazen KC, 2005, DIAGN MICR INFEC DIS, V52, P35, DOI 10.1016/j.diagmicrobio.2004.12.006; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hendrych T, 2009, BBA-BIOMEMBRANES, V1788, P717, DOI 10.1016/j.bbamem.2008.12.001; Herman P, 2015, FEBS J, V282, P419, DOI 10.1111/febs.13156; Herrera R, 2014, BBA-BIOMEMBRANES, V1838, P127, DOI 10.1016/j.bbamem.2013.08.022; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Jensen-Pergakes KL, 1998, ANTIMICROB AGENTS CH, V42, P1160, DOI 10.1128/AAC.42.5.1160; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; Kaur R, 1999, MICROBIOL-UK, V145, P809, DOI 10.1099/13500872-145-4-809; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; Kodedova M, 2011, BIOTECHNIQUES, V50, P58, DOI 10.2144/000113568; Kralli A, 1996, J BIOL CHEM, V271, P17152, DOI 10.1074/jbc.271.29.17152; Kristan K, 2012, J STEROID BIOCHEM, V129, P79, DOI 10.1016/j.jsbmb.2011.08.012; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Merzendorfer H, 2013, BIOL CHEM, V394, P189, DOI 10.1515/hsz-2012-0241; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mollinedo F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00140; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad R, 2013, CURR GENET, V59, P243, DOI 10.1007/s00294-013-0402-1; Ren B, 2014, APPL MICROBIOL BIOT, V98, P2609, DOI 10.1007/s00253-013-5425-5; Shalini K, 2011, BEILSTEIN J ORG CHEM, V7, P668, DOI 10.3762/bjoc.7.79; Spanova M, 2012, BBA-MOL CELL BIOL L, V1821, P647, DOI 10.1016/j.bbalip.2012.01.015; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Szopinska A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009589; Tiedje C, 2007, J CELL SCI, V120, P3613, DOI 10.1242/jcs.009860; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; WELIHINDA AA, 1994, BBA-BIOMEMBRANES, V1193, P107, DOI 10.1016/0005-2736(94)90339-5; WISEMAN H, 1993, FEBS LETT, V326, P285, DOI 10.1016/0014-5793(93)81809-E; Xiong QB, 2005, ANTIMICROB AGENTS CH, V49, P518, DOI 10.1128/AAC.49.2.518-524.2005	56	98	101	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139306	10.1371/journal.pone.0139306	http://dx.doi.org/10.1371/journal.pone.0139306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418026	Green Submitted, gold, Green Published			2022-12-26	WOS:000362171400072
J	Raupach, MJ; Barco, A; Steinke, D; Beermann, J; Laakmann, S; Mohrbeck, I; Neumann, H; Kihara, TC; Pointner, K; Radulovici, A; Segelken-Voigt, A; Wesse, C; Knebelsberger, T				Raupach, Michael J.; Barco, Andrea; Steinke, Dirk; Beermann, Jan; Laakmann, Silke; Mohrbeck, Inga; Neumann, Hermann; Kihara, Terue C.; Pointner, Karin; Radulovici, Adriana; Segelken-Voigt, Alexandra; Wesse, Christina; Knebelsberger, Thomas			The Application of DNA Barcodes for the Identification of Marine Crustaceans from the North Sea and Adjacent Regions	PLOS ONE			English	Article							MOLECULAR-SPECIES IDENTIFICATION; CALIGUS-ELONGATUS NORDMANN; OXIDASE SUBUNIT-I; BIOLOGICAL IDENTIFICATIONS; PARASITIC COPEPODS; DIVERSITY; TAXONOMY; POPULATION; PATTERNS; FISH	During the last years DNA barcoding has become a popular method of choice for molecular specimen identification. Here we present a comprehensive DNA barcode library of various crustacean taxa found in the North Sea, one of the most extensively studied marine regions of the world. Our data set includes 1,332 barcodes covering 205 species, including taxa of the Amphipoda, Copepoda, Decapoda, Isopoda, Thecostraca, and others. This dataset represents the most extensive DNA barcode library of the Crustacea in terms of species number to date. By using the Barcode of Life Data Systems (BOLD), unique BINs were identified for 198 (96.6%) of the analyzed species. Six species were characterized by two BINs (2.9%), and three BINs were found for the amphipod species Gammarus salinus Spooner, 1947 (0.4%). Intraspecific distances with values higher than 2.2% were revealed for 13 species (6.3%). Exceptionally high distances of up to 14.87% between two distinct but monophyletic clusters were found for the parasitic copepod Caligus elongatus Nordmann, 1832, supporting the results of previous studies that indicated the existence of an overlooked sea louse species. In contrast to these high distances, haplotype-sharing was observed for two decapod spider crab species, Macropodia parva Van Noort & Adema, 1985 and Macropodia rostrata (Linnaeus, 1761), underlining the need for a taxonomic revision of both species. Summarizing the results, our study confirms the application of DNA barcodes as highly effective identification system for the analyzed marine crustaceans of the North Sea and represents an important milestone for modern biodiversity assessment studies using barcode sequences.	[Raupach, Michael J.; Barco, Andrea; Laakmann, Silke; Mohrbeck, Inga; Kihara, Terue C.; Pointner, Karin; Wesse, Christina; Knebelsberger, Thomas] Senckenberg Meer, German Ctr Marine Biodivers DZMB, Wilhelmshaven, Niedersachsen, Germany; [Steinke, Dirk; Radulovici, Adriana] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Beermann, Jan] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Biol Anstalt Helgoland, Helgoland, Schleswig Holst, Germany; [Neumann, Hermann] Senckenberg Meer, Dept Marine Res, Niedersachsen, Germany; [Segelken-Voigt, Alexandra] Carl von Ossietzky Univ Oldenburg, Sch Math & Sci 5, Inst Biol & Environm Sci, Anim Biodivers & Evolutionary Biol, D-26111 Oldenburg, Niedersachsen, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); University of Guelph; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Senckenberg Gesellschaft fur Naturforschung (SGN); Carl von Ossietzky Universitat Oldenburg	Raupach, MJ (corresponding author), Senckenberg Meer, German Ctr Marine Biodivers DZMB, Wilhelmshaven, Niedersachsen, Germany.	mraupach@senckenberg.de	Raupach, Michael J./AAF-7566-2020	Raupach, Michael J./0000-0001-8299-6697; Segelken-Voigt, Alexandra/0000-0002-0825-4975; Beermann, Jan/0000-0001-5894-6817; Barco, Andrea/0000-0002-3963-1884; Steinke, Dirk/0000-0002-8992-575X; Laakmann, Silke/0000-0003-3273-7907; Wesse, Christina/0000-0001-7947-6922	Federal Ministry of Education and Research of Germany (Projekttrager Julich) [03F0664A]	Federal Ministry of Education and Research of Germany (Projekttrager Julich)	MJR received funding from Federal Ministry of Education and Research of Germany (Projekttrager Julich); https://www.ptj.de/index.php; grant no. 03F0664A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, DISTRIBUTION ATLAS B; Baeza JA, 2013, MAR ECOL-EVOL PERSP, V34, P381, DOI 10.1111/maec.12038; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barber BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037105; Barber P, 2006, P ROY SOC B-BIOL SCI, V273, P2053, DOI 10.1098/rspb.2006.3540; Beermann J., 2011, MAR BIODIVERS REC, V4, P1, DOI DOI 10.1017/S1755267211000388; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; BIRKY CW, 1983, GENETICS, V103, P513; BISHOP MWH, 1947, NATURE, V159, P501, DOI 10.1038/159501a0; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; BOXSHALL GA, 1974, J MAR BIOL ASSOC UK, V54, P355, DOI 10.1017/S0025315400058598; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Brusca RC, 2003, INVERTEBRATES; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Callaway R, 2002, ICES J MAR SCI, V59, P1199, DOI 10.1006/jmsc.2002.1288; Chen YY, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.214.3291; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Costa FO, 2009, SYST BIODIVERS, V7, P365, DOI 10.1017/S1477200009990120; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P483, DOI 10.1017/S0025315400023833; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; De Grave S, 2010, J CRUSTACEAN BIOL, V30, P521, DOI 10.1651/10-3278.1; DeWaard Jeremy R., 2008, V410, P275; Doublet V, 2013, J MOL EVOL, V77, P107, DOI 10.1007/s00239-013-9587-7; Doublet V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002938; DYER MF, 1983, J MAR BIOL ASSOC UK, V63, P683, DOI 10.1017/S0025315400070995; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fischnaller S, 2012, FLY, V6, P284, DOI 10.4161/fly.21535; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; FRANSZ HG, 1991, NETH J SEA RES, V28, P1, DOI 10.1016/0077-7579(91)90003-J; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gruner H-E, 1993, LEHRBUCH SPEZIELLEN, VI; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Harris R., 2000, ICES ZOOPLANKTON MET; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Haye PA, 2012, FOOD CONTROL, V25, P239, DOI 10.1016/j.foodcont.2011.10.034; Hayward PJ, 1990, HDB MARINE FAUNA N W; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEIP C, 1992, ICES J MAR SCI, V49, P13, DOI 10.1093/icesjms/49.1.13; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Holm ER, 2012, INTEGR COMP BIOL, V52, P348, DOI 10.1093/icb/ics042; HUYS R, 1992, ICES J MAR SCI, V49, P23, DOI 10.1093/icesjms/49.1.23; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kabata Z., 1979, Parasitic Copepoda of British fishes.; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khalaji-Pirbalouty V, 2014, ZOOTAXA, V3826, P230, DOI 10.11646/zootaxa.3826.1.7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koch W, 2014, J MAR BIOL ASSOC UK, V94, P547, DOI 10.1017/S0025315413001677; Krebes L, 2010, MOL PHYLOGENET EVOL, V54, P372, DOI 10.1016/j.ympev.2009.07.034; Krebes L, 2011, SYST BIODIVERS, V9, P259, DOI 10.1080/14772000.2011.604359; Kroncke I, 2013, ESTUAR COAST SHELF S, V119, P79, DOI 10.1016/j.ecss.2012.12.024; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lincoln RJ, 1979, BRIT MARINE AMPHIPOD; LUTHER G, 1987, HELGOLANDER MEERESUN, V41, P1, DOI 10.1007/BF02365098; Markert A, 2014, ORG DIVERS EVOL, V14, P369, DOI 10.1007/s13127-014-0176-4; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; McClain CR, 2015, PEERJ, V2, DOI 10.7717/peerj.715; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer R, 2013, SYST BIODIVERS, V11, P389, DOI 10.1080/14772000.2013.833143; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Moriniere J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109719; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Negri M, 2014, J CRUSTACEAN BIOL, V34, P848, DOI 10.1163/1937240X-00002277; Neumann H, 2008, HELGOLAND MAR RES, V62, P215, DOI 10.1007/s10152-008-0109-8; Nicole S, 2012, FOOD TECHNOL BIOTECH, V50, P387; Oines O, 2006, J FISH DIS, V29, P167, DOI 10.1111/j.1365-2761.2006.00702.x; Oines O, 2005, J MAR BIOL ASSOC UK, V85, P73, DOI 10.1017/S0025315405010854h; Oines O, 2008, ACTA PARASITOL, V53, P93, DOI 10.2478/s11686-008-0002-2; Ortea I, 2009, J AQUAT FOOD PROD T, V18, P146, DOI 10.1080/10498850802584280; Pante E, 2015, HEREDITY, V114, P450, DOI 10.1038/hdy.2014.105; Rachor E, 2013, ROTE LISTE GEFAHRDET, V2, P81; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Riccardi N, 2012, J PLANKTON RES, V34, P484, DOI 10.1093/plankt/fbs022; Riehl T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049354; Rock J, 2007, HEREDITY, V99, P102, DOI 10.1038/sj.hdy.6800971; Rodriguez-Fernandez JI, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2933.1.3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Sommer U, 2002, ECOL RES, V17, P161, DOI 10.1046/j.1440-1703.2002.00476.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stoeckle MY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02635; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; TAYLOR DJ, 1993, P ROY SOC B-BIOL SCI, V254, P163, DOI 10.1098/rspb.1993.0141; Trautner J, 2014, DISTRIBUTION ATLAS G; Turner JT, 2004, ZOOL STUD, V43, P255; van Noort GJ, 2011, ZOOL MED LEIDEN, V59, P363; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Woodcock TS, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-40; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1; Zuna-Kratky T, 2009, VERBREITUNGSATLAS HE	117	97	104	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139421	10.1371/journal.pone.0139421	http://dx.doi.org/10.1371/journal.pone.0139421			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417993	Green Published, Green Accepted, gold			2022-12-26	WOS:000362171400089
J	Schumann, M; Yli-Peltola, K; Abbiss, CR; Hakkinen, K				Schumann, Moritz; Yli-Peltola, Kaisu; Abbiss, Chris R.; Hakkinen, Keijo			Cardiorespiratory Adaptations during Concurrent Aerobic and Strength Training in Men and Women	PLOS ONE			English	Article							POSTEXERCISE OXYGEN-CONSUMPTION; INVERSE RELATIONSHIP; RESISTANCE EXERCISE; LACTATE THRESHOLD; RUNNING ECONOMY; ENDURANCE; MUSCLE; PERFORMANCE; EFFICIENCY; INCREASES	This study investigated the effects of endurance followed by strength training (ES, men n = 16; women n = 15), the reverse exercise order (SE, men n = 18, women n = 13) and concurrent endurance and strength training performed on alternating days (AD, men n = 21, women n = 18) on cardiorespiratory parameters. Peak oxygen consumption ((V) over dot O-2peak) and oxygen consumption at sub-maximal power outputs ((V) over dot O-2submax) of 50 to 175 Watts in men and 50 to 125 Watts in women were assessed during an incremental cycling test both before and after 24 weeks of training. Increases in (V) over dot O-2peak in both men and women were statistically larger in AD (18 +/- 9% and 25 +/- 11%) compared to ES (7 +/- 9% and 12 +/- 12%, p = 0.002 and 0.009, respectively) and SE (7 +/- 9% and 10 +/- 8%, p = 0.005 and 0.008, respectively). No statistical group interaction was observed for (V) over dot O-2submax in men, but in women (V) over dot O-2submax was statistically lower at week 24 in ES compared to AD at 75W(-2 +/- 6% vs. +3 +/- 6%, p = 0.027) and 125W(-4 +/- 5% vs. +2 +/- 5%, p = 0.010). These findings indicate that endurance and strength training performed on alternating days may optimize the adaptations in (V) over dot O-2peak in both sexes, while performing ES training in women may optimize cardiorespiratory fitness at sub-maximal power outputs.	[Schumann, Moritz; Yli-Peltola, Kaisu; Hakkinen, Keijo] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Abbiss, Chris R.] Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sports Sci Res, Perth, WA, Australia	University of Jyvaskyla; Edith Cowan University	Schumann, M (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	moritz.schumann@jyu.fi		Abbiss, Chris/0000-0003-3940-5542	Finnish Ministry of Education and Culture; Polar Electro Oy	Finnish Ministry of Education and Culture; Polar Electro Oy	The authors received funding from the following organisations: Finnish Ministry of Education and Culture, http://www.minedu.fi/OPM/?lang=en; Polar Electro Oy, http://www.polar.com/us-en?nogeo. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atkinson G, 2003, MED SCI SPORT EXER, V35, P1242, DOI 10.1249/01.MSS.0000074560.08128.5D; AUNOLA S, 1986, INT J SPORTS MED, V7, P161, DOI 10.1055/s-2008-1025755; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; BERGH U, 1991, MED SCI SPORT EXER, V23, P205; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BOND V, 1991, J SPORT MED PHYS FIT, V31, P357; Borsheim E, 2003, SPORTS MED, V33, P1037; Burt D, 2013, EUR J APPL PHYSIOL, V113, P285, DOI 10.1007/s00421-012-2437-2; Cadore EL, 2011, J STRENGTH COND RES, V25, P758, DOI 10.1519/JSC.0b013e318207ed66; Chtara M, 2005, BRIT J SPORT MED, V39, P555, DOI 10.1136/bjsm.2004.015248; Di Blasio A, 2012, J SPORT SCI MED, V11, P393; Doma K, 2014, EUR J SPORT SCI, V14, P107, DOI 10.1080/17461391.2012.726653; Drummond MJ, 2005, J STRENGTH COND RES, V19, P332; Eklund D, 2014, INT J SPORTS MED; Eklund D, 2015, J STRENGTH COND RES; Farrell SW, 2014, MED SCI SPORTS EXERC; Fonda B, 2012, SPORT SCI REV, V19, P187; Goreham C, 1999, AM J PHYSIOL-ENDOC M, V276, pE489; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824; Hickson RC., 1980, INTERFERENCE STRENGT, V45, P255; Hunter GR, 2005, EUR J APPL PHYSIOL, V94, P558, DOI 10.1007/s00421-005-1370-z; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Loveless DJ, 2005, MED SCI SPORT EXER, V37, P1231, DOI 10.1249/01.mss.0000170071.33880.f8; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; MARCINIK EJ, 1991, MED SCI SPORT EXER, V23, P739; Moseley L, 2001, MED SCI SPORT EXER, V33, P621; NELSON AG, 1990, PHYS THER, V70, P287, DOI 10.1093/ptj/70.5.287; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Palmer CD, 2001, J SCI MED SPORT, V4, P447, DOI 10.1016/S1440-2440(01)80053-0; PATE RR, 1992, MED SCI SPORT EXER, V24, P1128; Ratkevicius A, 2006, J SPORT SCI MED, V5, P440; Robineau J, 2014, J STRENGTH COND RES; Ronnestad BR, 2012, J STRENGTH COND RES, V26, P158, DOI 10.1519/JSC.0b013e318218dd94; Ruseski JE, 2011, EUR REV AGING PHYS A, V8, P57, DOI 10.1007/s11556-011-0084-y; SALE DG, 1990, MED SCI SPORT EXER, V22, P348; Schumann M, 2014, MED SCI SPORT EXER, V46, P1758, DOI 10.1249/MSS.0000000000000303; Thompson WR, 2010, ACSMS GUIDELINES EXE, V8th; Welsman JR, 1996, MED SCI SPORT EXER, V28, P259, DOI 10.1097/00005768-199602000-00016; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; ZHANG YY, 1991, MED SCI SPORT EXER, V23, P625	41	25	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139279	10.1371/journal.pone.0139279	http://dx.doi.org/10.1371/journal.pone.0139279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418015	gold, Green Published, Green Submitted			2022-12-26	WOS:000362171400071
J	Devapatla, B; Sharma, A; Woo, S				Devapatla, Bharat; Sharma, Ankur; Woo, Sukyung			CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HUMAN ENDOTHELIAL-CELLS; EPITHELIAL OVARIAN; GROWTH-FACTOR; TUMOR-GROWTH; LUNG-CANCER; ANGIOGENESIS; INTERLEUKIN-8; RESISTANCE; SUNITINIB	Antiangiogenic therapy is important for the treatment of gynecological cancer. However, the therapeutic benefit derived from these treatments is transient, predominantly due to the selective activation of compensatory proangiogenic pathways that lead to rapid development of resistance. We aimed to identify and target potential alternative signaling to antivascular endothelial growth factor (VEGF) therapy, with a view toward developing a combination of antiangiogenic agents to provide extended therapeutic benefits. We developed a preclinical in vivo phenotypic resistance model of ovarian cancer resistant to antiangiogenic therapy. We measured dynamic changes in secreted chemokines and angiogenic signaling in tumors and plasma in response to anti-VEGF treatment, as tumors advanced from the initial responsive phase to progressive disease. In tumors that progressed following sorafenib treatment, gene and protein expression levels of proangiogenic CXC chemokines and their receptors were significantly elevated, compared with responsive tumors. The chemokine (C-X-C motif) ligand 8 (CXCL8), also known as interleukin-8 (IL-8) increase was time-dependent and coincided with the dynamics of tumor progression. We used SB225002, a pharmacological inhibitor of chemokine (C-X-C motif) receptor 2 (CXCR2), to disrupt the CXC chemokine-mediated functions of ovarian cancer cells in in vitro assays of cell growth inhibition, spheroid formation, and cell migration. The combination of CXCR2 inhibitor with sorafenib led to a synergistic inhibition of cell growth in vitro, and further stabilized tumor progression following sorafenib in vivo. Our results suggest that CXCR2-mediated chemokines may represent an important compensatory pathway that promotes resistance to antiangiogenic therapy in ovarian cancer. Thus, simultaneous blockage of this proangiogenic cytokine pathway using CXCR2 inhibitors and the VEGF receptor (VEGFR) pathway could improve the outcomes of antiangiogenic therapy.	[Devapatla, Bharat; Sharma, Ankur; Woo, Sukyung] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Woo, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA.	sukyung-woo@ouhsc.edu			National Institutes of General Medical Sciences of the National Institutes of Health [P20GM103639]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103639] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institutes of General Medical Sciences of the National Institutes of Health under Award Number P20GM103639. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Alvarez AA, 1999, CLIN CANCER RES, V5, P587; Arthur D, 2006, INT J NURS STUD, V43, P107, DOI 10.1016/j.ijnurstu.2005.03.007; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brown MR, 2000, BEST PRACT RES CL OB, V14, P901, DOI 10.1053/beog.2000.0134; Chen AA, 2013, P NATL ACAD SCI USA, V110, P16820, DOI 10.1073/pnas.1309392110; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coward JIG, 2015, INT J WOMENS HEALTH, V7, P189, DOI 10.2147/IJWH.S52379; Danso-Abeam D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-79; Davidson BA, 2014, INT J WOMENS HEALTH, V6, P289, DOI 10.2147/IJWH.S49781; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Eskander RN, 2014, GYNECOL ONCOL, V132, P496, DOI 10.1016/j.ygyno.2013.11.029; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Garcia A, 2013, PARASITOLOGY INT; Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088234; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Gimeno-Santos E, 2014, COPD, V11, P190, DOI 10.3109/15412555.2013.831401; Gomez-Raposo C, 2009, CLIN TRANSL ONCOL, V11, P564, DOI 10.1007/s12094-009-0406-y; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Hazelton D, 1999, CLIN CANCER RES, V5, P823; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Huang YX, 2011, J CANCER RES CLIN, V137, P829, DOI 10.1007/s00432-010-0944-2; Hubscher D, 2010, J Stem Cells Regen Med, V6, P47; Ionescu M, 2013, J BACTERIOL, V195, P5273, DOI 10.1128/JB.00713-13; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kossaify A, 2013, BIOMARK INSIGHTS, V8, P115, DOI 10.4137/BMI.S12703; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Martinez L, 2013, ENVIRON TECHNOL, V34, P3137, DOI 10.1080/09593330.2013.808238; Matte I, 2012, AM J CANCER RES, V2, P566; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Ramakrishnan S., 2005, Angiogenesis, V8, P169, DOI 10.1007/s10456-005-9001-1; Rini BI, 2011, CANCER-AM CANCER SOC, V117, P758, DOI 10.1002/cncr.25639; Rodriguez GC, 2001, GYNECOL ONCOL, V80, P245, DOI 10.1006/gyno.2000.6042; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shaw D, 2013, CURR OPIN ONCOL, V25, P558, DOI 10.1097/CCO.0b013e328363e0da; Shekaran A, 2014, BIOMATERIALS, V35, P5453, DOI 10.1016/j.biomaterials.2014.03.055; Solana AB, 2014, MAGN RESON IMAGING, V32, P684, DOI 10.1016/j.mri.2014.03.008; STRIETER RM, 1995, J LEUKOCYTE BIOL, V57, P752, DOI 10.1002/jlb.57.5.752; Teoh DGK, 2011, CANCER CONTROL, V18, P31, DOI 10.1177/107327481101800105; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wang Y, 2012, CYTOKINE, V59, P145, DOI 10.1016/j.cyto.2012.04.013; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567	53	33	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139237	10.1371/journal.pone.0139237	http://dx.doi.org/10.1371/journal.pone.0139237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414070	gold, Green Submitted, Green Published			2022-12-26	WOS:000362170700052
J	Hao, MS; Jensen, AM; Boquist, AS; Liu, YJ; Rasmusson, AG				Hao, Meng-Shu; Jensen, Anna M.; Boquist, Ann-Sofie; Liu, Yun-Jun; Rasmusson, Allan G.			The Ca2+-Regulation of the Mitochondrial External NADPH Dehydrogenase in Plants Is Controlled by Cytosolic pH	PLOS ONE			English	Article							ALTERNATIVE NAD(P)H DEHYDROGENASES; ELECTRON-TRANSPORT CHAIN; REACTIVE OXYGEN; LEAF MITOCHONDRIA; RESPIRATORY-CHAIN; EXOGENOUS NADH; ARABIDOPSIS; METABOLISM; OXIDATION; CA2+	NADPH is a key reductant carrier that maintains internal redox and antioxidant status, and that links biosynthetic, catabolic and signalling pathways. Plants have a mitochondrial external NADPH oxidation pathway, which depends on Ca2+ and pH in vitro, but concentrations of Ca2+ needed are not known. We have determined the K-0.5(Ca2+) of the external NADPH dehydrogenase from Solanum tuberosum mitochondria and membranes of E. coli expressing Arabidopsis thaliana NDB1 over the physiological pH range using O-2 and decylubiquinone as electron acceptors. The K-0.5(Ca2+) of NADPH oxidation was generally higher than for NADH oxidation, and unlike the latter, it depended on pH. At pH 7.5, K-0.5(Ca2+) for NADPH oxidation was high (approximate to 100 mu M), yet 20-fold lower K-0.5(Ca2+) values were determined at pH 6.8. Lower K-0.5(Ca2+) values were observed with decylubiquinone than with O-2 as terminal electron acceptor. NADPH oxidation responded to changes in Ca2+ concentrations more rapidly than NADH oxidation did. Thus, cytosolic acidification is an important activator of external NADPH oxidation, by decreasing the Ca2+-requirements for NDB1. The results are discussed in relation to the present knowledge on how whole cell NADPH redox homeostasis is affected in plants modified for the NDB1 gene.	[Hao, Meng-Shu; Jensen, Anna M.; Boquist, Ann-Sofie; Liu, Yun-Jun; Rasmusson, Allan G.] Lund Univ, Dept Biol, Lund, Sweden; [Jensen, Anna M.] Linnaeus Univ, Dept Forestry & Wood Technol, Vaxjo, Sweden; [Liu, Yun-Jun] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Lund University; Linnaeus University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Rasmusson, AG (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	allan.rasmusson@biol.lu.se		Jensen, Anna Monrad/0000-0001-5113-5624	Carl Trygger Foundation for Scientific Research [10:318, 11:381, 12:397]; Faculty of Science at Lund University	Carl Trygger Foundation for Scientific Research; Faculty of Science at Lund University	This work was supported by The Carl Trygger Foundation for Scientific Research (10:318, 11:381, 12:397; http://www.carltryggersstiftelse.se/); Faculty of Science at Lund University (No grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WL, 2008, J EXP BOT, V59, P2555, DOI 10.1093/jxb/ern122; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Cardenas L, 2006, PLANT PHYSIOL, V142, P1460, DOI 10.1104/pp.106.087882; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; CORTESE JD, 1992, BIOCHIM BIOPHYS ACTA, V1100, P189; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; EDMAN K, 1985, BIOCHEM J, V232, P471, DOI 10.1042/bj2320471; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; Escobar MA, 2006, PLANT J, V45, P775, DOI 10.1111/j.1365-313X.2005.02640.x; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; FREDLUND KM, 1991, PLANT PHYSIOL, V97, P99, DOI 10.1104/pp.97.1.99; Geisler DA, 2007, J BIOL CHEM, V282, P28455, DOI 10.1074/jbc.M704674200; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; Gout E, 2011, NEW PHYTOL, V189, P135, DOI 10.1111/j.1469-8137.2010.03449.x; Iwata M, 2012, P NATL ACAD SCI USA, V109, P15247, DOI 10.1073/pnas.1210059109; Johansson FI, 2004, BIOCHEM J, V380, P193, DOI 10.1042/BJ20031969; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; KROMER S, 1995, ANNU REV PLANT PHYS, V46, P45, DOI 10.1146/annurev.pp.46.060195.000401; Liu YJ, 2008, PLANT CELL PHYSIOL, V49, P251, DOI 10.1093/pcp/pcn001; Liu YJ, 2009, PLANT PHYSIOL, V150, P1248, DOI 10.1104/pp.109.136242; Martins Teresa Vaz, 2013, Plants-Basel, V2, P541, DOI 10.3390/plants2040541; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Melo AMP, 1999, BBA-BIOENERGETICS, V1412, P282, DOI 10.1016/S0005-2728(99)00072-9; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Millar AH, 2007, METHOD CELL BIOL, V80, P65, DOI 10.1016/S0091-679X(06)80003-8; Millenaar FF, 2003, PLANT BIOLOGY, V5, P2, DOI 10.1055/s-2003-37974; Moller IM, 1997, PHYSIOL PLANTARUM, V100, P85, DOI 10.1034/j.1399-3054.1997.1000108.x; MOLLER IM, 1981, BIOCHEM J, V194, P487, DOI 10.1042/bj1940487; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; MOORE AL, 1982, BIOCHEM BIOPH RES CO, V109, P513, DOI 10.1016/0006-291X(82)91751-X; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; NASH D, 1983, PLANT PHYSIOL, V71, P627, DOI 10.1104/pp.71.3.627; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Nunes-Nesi A, 2011, PLANT PHYSIOL, V155, P101, DOI 10.1104/pp.110.163816; Pastore D, 2003, PLANT PHYSIOL, V133, P2029, DOI 10.1104/pp.103.028548; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Rasmusson AG, 2004, ANNU REV PLANT BIOL, V55, P23, DOI 10.1146/annurev.arplant.55.031903.141720; Rasmusson AG, 2001, PLANT PHYSIOL BIOCH, V39, P1057, DOI 10.1016/S0981-9428(01)01334-1; Rasmusson AG, 1999, PLANT J, V20, P79, DOI 10.1046/j.1365-313X.1999.00576.x; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Rasmusson AG, 2011, ADVAN PL BIO, V1, P357; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; ROBERTS TH, 1995, FEBS LETT, V373, P307, DOI 10.1016/0014-5793(95)01059-N; RUGOLO M, 1991, PLANT PHYSIOL, V95, P157, DOI 10.1104/pp.95.1.157; Sakano K, 2001, INT REV CYTOL, V206, P1; Shishova M, 2004, J PLANT PHYSIOL, V161, P937, DOI 10.1016/j.jplph.2003.12.005; Stael S, 2012, J EXP BOT, V63, P1525, DOI 10.1093/jxb/err394; STRUGLICS A, 1993, PHYSIOL PLANTARUM, V88, P19, DOI 10.1111/j.1399-3054.1993.tb01755.x; Szal B, 2012, PLANT CELL ENVIRON, V35, P1756, DOI 10.1111/j.1365-3040.2012.02559.x; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wallstrom SV, 2014, PLANT CELL PHYSIOL, V55, P881, DOI 10.1093/pcp/pcu021; Wallstrom SV, 2014, MOL PLANT, V7, P356, DOI 10.1093/mp/sst115; Zhou YB, 2013, METALLOMICS, V5, P29, DOI 10.1039/c2mt20009k	67	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139224	10.1371/journal.pone.0139224	http://dx.doi.org/10.1371/journal.pone.0139224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413894	Green Published, Green Submitted, gold			2022-12-26	WOS:000362170700050
J	Mondal, S; Haroun, NAH; Sibanda, P				Mondal, Sabyasachi; Haroun, Nageeb A. H.; Sibanda, Precious			The Effects of Thermal Radiation on an Unsteady MHD Axisymmetric Stagnation-Point Flow over a Shrinking Sheet in Presence of Temperature Dependent Thermal Conductivity with Navier Slip	PLOS ONE			English	Article							HEAT-TRANSFER; STRETCHING SHEET	In this paper, the magnetohydrodynamic (MHD) axisymmetric stagnation-point flow of an unsteady and electrically conducting incompressible viscous fluid in with temperature dependent thermal conductivity, thermal radiation and Navier slip is investigated. The flow is due to a shrinking surface that is shrunk axisymmetrically in its own plane with a linear velocity. The magnetic field is imposed normally to the sheet. The model equations that describe this fluid flow are solved by using the spectral relaxation method. Here, heat transfer processes are discussed for two different types of wall heating; (a) a prescribed surface temperature and (b) a prescribed surface heat flux. We discuss and evaluate how the various parameters affect the fluid flow, heat transfer and the temperature field with the aid of different graphical presentations and tabulated results.	[Mondal, Sabyasachi; Haroun, Nageeb A. H.; Sibanda, Precious] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, ZA-3209 Pietermaritzburg, South Africa	University of Kwazulu Natal	Mondal, S (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	sabya.mondal.2007@gmail.com	Sibanda, Precious/F-9616-2010; Mondal, Sabyasachi/C-9283-2015; Mondal, Sabyasachi/AAE-2837-2019	Sibanda, Precious/0000-0003-2115-4642; Mondal, Sabyasachi/0000-0003-4666-0568; Mondal, Sabyasachi/0000-0003-4666-0568; Haroun, Nageeb A.H/0000-0003-0044-267X	University of KwaZulu-Natal	University of KwaZulu-Natal	This work is funded by the University of KwaZulu-Natal through SM's postdoctoral fellowship.	ATTIA HA, 2007, TAMKANG J SCI ENG, V1, P11; Bansal JL., 1994, MAGNETOFLUIDDYNAMICS; CARRAGHER P, 1982, Z ANGEW MATH MECH, V62, P564, DOI 10.1002/zamm.19820621009; Chiam TC, 1998, ACTA MECH, V129, P63, DOI 10.1007/BF01379650; CHIAM TC, 1994, J PHYS SOC JPN, V63, P2443, DOI 10.1143/JPSJ.63.2443; Fang TG, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/1/014703; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Homann F, 1936, Z ANGEW MATH MECH, V16, P153, DOI 10.1002/zamm.19360160304; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Jat RN, 2014, THERMAL ENERGY POWER, V3, P234; Khalid A, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15057-9; Khan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090280; Khan JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107287; Mabood F, 2015, CHEM ENG J, V273, P430, DOI 10.1016/j.cej.2015.03.037; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Mabood F., 2015, FAR E J APPL MATH, V90, P21, DOI DOI 10.17654/FJAMJAN2015_; Mabood F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083581; Mahapatra TR, 2013, J APPL FLUID MECH, V6, P121; Mahapatra TR, 2003, CAN J CHEM ENG, V81, P258; Miklavcic M, 2006, Q APPL MATH, V64, P283, DOI 10.1090/S0033-569X-06-01002-5; Motsa SS, 2014, ADV MATH PHYS, V2014, DOI 10.1155/2014/341964; Motsa SS, 2013, CENT EUR J PHYS, V11, P363, DOI 10.2478/s11534-013-0182-8; Motsa SS, 2013, CHEM ENG COMMUN, V16, P23; Nandy SK, 2014, ALEX ENG J, V53, P929, DOI 10.1016/j.aej.2014.09.001; Pavlov K. B., 1974, MAGN GIDRODIN, V4, P146; Qayyum M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117368; Rahimpour M, 2008, INT J MECH, V2, P1; Rohni AM, 2013, INT COMMUN HEAT MASS, V43, P75, DOI 10.1016/j.icheatmasstransfer.2013.02.001; Samiulhaq, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088766; Shercliff JA., 1965, TXB MAGNETOHYDRODYNA; Wang CY, 2008, INT J NONLIN MECH, V43, P377, DOI 10.1016/j.ijnonlinmec.2007.12.021; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138355	10.1371/journal.pone.0138355	http://dx.doi.org/10.1371/journal.pone.0138355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414006	Green Published, gold, Green Submitted			2022-12-26	WOS:000362170700015
J	Nascimento-Brito, S; Zukurov, JP; Maricato, JT; Volpini, AC; Salim, ACM; Araujo, FMG; Coimbra, RS; Oliveira, GC; Antoneli, F; Janini, LMR				Nascimento-Brito, Sieberth; Zukurov, Jean Paulo; Maricato, Juliana T.; Volpini, Angela C.; Salim, Anna Christina M.; Araujo, Flavio M. G.; Coimbra, Roney S.; Oliveira, Guilherme C.; Antoneli, Fernando; Janini, Luiz Mario R.			HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA	PLOS ONE			English	Article							CD4(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; APOBEC3G RESTRICTS HIV-1; REVERSE TRANSCRIPTION; ENVELOPE GLYCOPROTEIN; PERIPHERAL-BLOOD; GENE-EXPRESSION; CORECEPTOR USE; INFECTION; PROTEINS	In order to establish new infections HIV-1 particles need to attach to receptors expressed on the cellular surface. HIV-1 particles interact with a cell membrane receptor known as CD4 and subsequently with another cell membrane molecule known as a co-receptor. Two major different co-receptors have been identified: C-C chemokine Receptor type 5 (CCR5) and C-X-C chemokine Receptor type 4 (CXCR4) Previous reports have demonstrated cellular modifications upon HIV-1 binding to its co-receptors including gene expression modulations. Here we investigated the effect of viral binding to either CCR5 or CXCR4 co-receptors on viral diversity after a single round of reverse transcription. CCR5 and CXCR4 pseudotyped viruses were used to infect non-stimulated and stimulated PBMCs and purified CD4 positive cells. We adopted the SOLiD methodology to sequence virtually the entire proviral DNA from all experimental infections. Infections with CCR5 and CXCR4 pseudotyped virus resulted in different patterns of genetic diversification. CCR5 virus infections produced extensive proviral diversity while in CXCR4 infections a more localized substitution process was observed. In addition, we present pioneering results of a recently developed method for the analysis of SOLiD generated sequencing data applicable to the study of viral quasi-species. Our findings demonstrate the feasibility of viral quasi-species evaluation by NGS methodologies. We presented for the first time strong evidence for a host cell driving mechanism acting on the HIV-1 genetic variability under the control of co-receptor stimulation. Additional investigations are needed to further clarify this question, which is relevant to viral diversification process and consequent disease progression.	[Nascimento-Brito, Sieberth] Univ Fed Rural Rio de Janeiro UFRRJ, Dept Microbiol & Imunol Vet, Rio De Janeiro, Brazil; [Nascimento-Brito, Sieberth; Maricato, Juliana T.; Janini, Luiz Mario R.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Zukurov, Jean Paulo; Janini, Luiz Mario R.] Univ Fed Sao Paulo, EPM, Dept Med, Sao Paulo, Brazil; [Volpini, Angela C.; Salim, Anna Christina M.; Araujo, Flavio M. G.; Oliveira, Guilherme C.] Fundacao Oswaldo Cruz FIOCRUZ, Res Ctr Rene Rachou CPqRR, Genom & Computat Biol Grp, Belo Horizonte, MG, Brazil; [Coimbra, Roney S.] Fiocruz MS, CPqRR, Biosyst Informat Grp, Belo Horizonte, MG, Brazil; [Antoneli, Fernando] Univ Fed Sao Paulo, EPM, Dept Informat Saude, Sao Paulo, Brazil; [Antoneli, Fernando] Univ Fed Sao Paulo, EPM, Lab Biocomplexidade & Genom Evolut, Sao Paulo, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Janini, LMR (corresponding author), Univ Fed Sao Paulo UNIFESP, EPM, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	janini@unifesp.br	Coimbra, Roney/ABA-0586-2022; Coimbra, Roney/B-3102-2013; Junior, Fernando Martins Antoneli/A-5155-2008	Junior, Fernando Martins Antoneli/0000-0001-9179-4632; Janini, Luiz Mario/0000-0002-6186-6284; Coimbra, Roney/0000-0002-9204-0573	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/14543-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [REDE-56/11, RED-00014-14]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309312/2012-4, 306362/2012-0]; Fogarty International Center National Institutes of Health [TW007012]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fogarty International Center National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support was provided to: LMRJ and SNB by 2009/14543-0 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [www.fapesp.br] (reagents/materials/analysis tools/fellowship); GCO by (REDE-56/11, RED-00014-14) Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [www.fapemig.br], (309312/2012-4, 306362/2012-0) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [www.cnpq.br], (TW007012) Fogarty International Center National Institutes of Health [www.fic.nih.gov]; ACV by (TW007012) Fogarty International Center National Institutes of Health [www.fic.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2009, BBA-BIOMEMBRANES, V1788, P2132, DOI 10.1016/j.bbamem.2009.07.008; Al-Sanabani S, 2005, THESIS UNIFESP; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Arrildt KT, 2012, CURR HIV-AIDS REP, V9, P52, DOI 10.1007/s11904-011-0107-3; Awong G, 2010, CURR OPIN HEMATOL, V17, P327, DOI 10.1097/MOH.0b013e3283395133; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bohl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069406; Cannavo G, 2001, BLOOD, V97, P1756, DOI 10.1182/blood.V97.6.1756; Card CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045911; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Choi WT, 2011, EXP BIOL MED, V236, P637, DOI 10.1258/ebm.2011.010389; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Etet PFS, 2012, CELL SIGNAL, V24, P1883, DOI 10.1016/j.cellsig.2012.05.015; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hill MS, 2007, J HISTOCHEM CYTOCHEM, V55, P63, DOI 10.1369/jhc.6A7054.2006; Holtz CM, 2013, J VIROL, V87, P5296, DOI 10.1128/JVI.03576-12; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jones KL, 2010, J BIOL CHEM, V285, P18603, DOI 10.1074/jbc.M109.090126; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Krueger RL, 2013, J VIROL, V87, P5916, DOI 10.1128/JVI.00398-13; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Loftin LM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S3; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mariani SA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S8; Mariani SA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S2-I19; Medjahed H, 2013, J VIROL, V87, P4103, DOI 10.1128/JVI.03124-12; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j; Ng KW, 2011, DIRICHLET RELATED DI, V889; Paiardini M, 2004, IMMUNOL RES, V29, P253, DOI 10.1385/IR:29:1-3:253; Piekna-Przybylska D, 2011, RNA BIOL, V8, P230, DOI 10.4161/rna.8.2.14802; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Ramakrishnan R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-42; Romani B, 2009, ARCH VIROL, V154, P1579, DOI 10.1007/s00705-009-0481-y; SALMINEN MO, 1995, VIROLOGY, V213, P80, DOI 10.1006/viro.1995.1548; Schopman NCT, 2012, VIRUS RES, V169, P438, DOI 10.1016/j.virusres.2012.06.017; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Sirois M, 2008, AIDS RES HUM RETROV, V24, P485, DOI 10.1089/aid.2007.0120; Sloan RD, 2011, RETROVIROLOGY, P8; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; St Gelais C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034521; Suspene R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036246; Verhofstede C, 2012, CURR OPIN HIV AIDS, V7, P432, DOI 10.1097/COH.0b013e328356f6f2; Vermeire J, 2011, CURR HIV RES, V9, P474, DOI 10.2174/157016211798842099; Voronin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000431; Wicker N, 2008, COMPUT STAT DATA AN, V52, P1315, DOI 10.1016/j.csda.2007.07.011; Wood N, 2009, PLOS PATHOG, P5; Wu L, 2012, RETROVIROLOGY, P9; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108; Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zukurov JP, 2014, ARXIV14052044	64	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139037	10.1371/journal.pone.0139037	http://dx.doi.org/10.1371/journal.pone.0139037			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413773	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700034
J	Nutter, FH; Haylor, JL; Khwaja, A				Nutter, Faith Hannah; Haylor, John L.; Khwaja, Arif			Inhibiting ERK Activation with CI-1040 Leads to Compensatory Upregulation of Alternate MAPKs and Plasminogen Activator Inhibitor-1 following Subtotal Nephrectomy with No Impact on Kidney Fibrosis	PLOS ONE			English	Article							PROTEIN-KINASE ACTIVATION; EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; MEDIATED ACTIVATION; MESANGIAL CELLS; RENAL FIBROSIS; MEK INHIBITOR; C-JUN; GROWTH; P38	Extracellular-signal regulated kinase (ERK) activation by MEK plays a key role in many of the cellular processes that underlie progressive kidney fibrosis including cell proliferation, apoptosis and transforming growth factor beta 1-mediated epithelial to mesenchymal transition. We therefore assessed the therapeutic impact of ERK1/2 inhibition using a MEK inhibitor in the rat 5/6 subtotal nephrectomy (SNx) model of kidney fibrosis. There was a twentyfold upregulation in phospho-ERK1/2 expression in the kidney after SNx in Male Wistar rats. Rats undergoing SNx became hypertensive, proteinuric and developed progressive kidney failure with reduced creatinine clearance. Treatment with the MEK inhibitor, CI-1040 abolished phospho-ERK1/2 expression in kidney tissue and prevented phospho-ERK1/2 expression in peripheral lymphocytes during the entire course of therapy. CI-1040 had no impact on creatinine clearance, proteinuria, glomerular and tubular fibrosis, and a-smooth muscle actin expression. However, inhibition of ERK1/2 activation led to significant compensatory upregulation of the MAP kinases, p38 and JNK in kidney tissue. CI-1040 also increased the expression of plasminogen activator inhibitor-1 (PAI-1), a key inhibitor of plasmin-dependent matrix metalloproteinases. Thus inhibition of ERK1/2 activation has no therapeutic effect on kidney fibrosis in SNx possibly due to increased compensatory activation of the p38 and JNK signalling pathways with subsequent upregulation of PAI-1.	[Nutter, Faith Hannah; Haylor, John L.] Univ Sheffield, Sch Med, Acad Unit Nephrol, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Khwaja, Arif] No Gen Hosp, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England	University of Sheffield; Northern General Hospital	Nutter, FH (corresponding author), Univ Sheffield, Sch Med, Acad Unit Nephrol, Dept Infect & Immun, Sheffield, S Yorkshire, England.	f.nutter@sheffield.ac.uk		Howard, Faith/0000-0001-9899-3079; Khwaja, Arif/0000-0002-4690-3649	Kidney Research UK	Kidney Research UK(Kidney Research UK (KRUK))	Support was provided by Kidney Research UK [www.kidneyresearchuk.org] and Sheffield Kidney Research Fund [http://www.sheffield-kidney-institute.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LF, 2003, SEMIN ONCOL, V30, P105, DOI 10.1053/j.seminoncol.2003.08.012; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Aoudjit L, 2003, AM J PHYSIOL-RENAL, V285, pF765, DOI 10.1152/ajprenal.00100.2003; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Chetram MA, 2012, J RECEPT SIG TRANSD, V32, P190, DOI 10.3109/10799893.2012.695798; Conway B, 2012, QJM-INT J MED, V105, P611, DOI 10.1093/qjmed/hcr235; D'Abaco GM, 2002, J CELL SCI, V115, P4607, DOI 10.1242/jcs.00161; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Borst MH, 2007, J PATHOL, V213, P219, DOI 10.1002/path.2228; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Feliers Denis, 2011, J Signal Transduct, V2011, P768512, DOI 10.1155/2011/768512; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Han YJ, 2008, NEPHROLOGY, V13, P411, DOI 10.1111/j.1440-1797.2008.00926.x; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Ishida T, 1999, DIABETES, V48, P595, DOI 10.2337/diabetes.48.3.595; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Ma FY, 2009, BRAZ J MED BIOL RES, V42, P29, DOI 10.1590/S0100-879X2008005000049; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Ma FY, 2009, LAB INVEST, V89, P470, DOI 10.1038/labinvest.2009.2; Masaki T, 2004, J AM SOC NEPHROL, V15, P1835, DOI 10.1097/01.ASN.0000130623.66271.67; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Ohashi R, 2004, AM J PATHOL, V164, P477, DOI 10.1016/S0002-9440(10)63138-0; Oldroyd SD, 2006, AM J PHYSIOL-RENAL, V290, pF695, DOI 10.1152/ajprenal.00058.2005; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sabbatini M, 2006, AM J PHYSIOL-RENAL, V290, pF1408, DOI 10.1152/ajprenal.00304.2005; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Wada T, 2001, AM J KIDNEY DIS, V38, P1169, DOI 10.1053/ajkd.2001.29206; Wang S, 2008, AM J PHYSIOL-RENAL, V295, pF672, DOI 10.1152/ajprenal.90285.2008; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; WOLF G, 1991, KIDNEY INT, V39, P401, DOI 10.1038/ki.1991.52; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137321	10.1371/journal.pone.0137321	http://dx.doi.org/10.1371/journal.pone.0137321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26415098	Green Accepted, Green Published, gold			2022-12-26	WOS:000362170700007
J	Gutierrez, L; House, MJ; Vasavda, N; Drasar, E; Marin, IGGY; Kulasekararaj, AG; St Pierre, TG; Thein, SL				Gutierrez, Lucia; House, Michael J.; Vasavda, Nisha; Drasar, Emma; Gonzalez-Gascon y Marin, Isabel; Kulasekararaj, Austin G.; St Pierre, Tim G.; Thein, Swee L.			Tissue Iron Distribution Assessed by MRI in Patients with Iron Loading Anemias	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; BETA-THALASSEMIA MAJOR; BONE-MARROW; MAGNETIC-RESONANCE; SERUM FERRITIN; LIVER-BIOPSY; OVERLOAD; STORES; RELAXOMETRY	Bone marrow, spleen, liver and kidney proton transverse relaxation rates (R2), together with cardiac R2* from patients with sickle cell disease (SCD), paroxysmal nocturnal hemoglobinuria (PNH) and non-transfusion dependent thalassemia (NTDT) have been compared with a control group. Increased liver and bone marrow R2 values for the three groups of patients in comparison with the controls have been found. SCD and PNH patients also present an increased spleen R2 in comparison with the controls. The simultaneous measurement of R2 values for several tissue types by magnetic resonance imaging (MRI) has allowed the identification of iron distribution patterns in diseases associated with iron imbalance. Preferential liver iron loading is found in the highly transfused SCD patients, while the low transfused ones present a preferential iron loading of the spleen. Similar to the highly transfused SCD group, PNH patients preferentially accumulate iron in the liver. A reduced spleen iron accumulation in comparison with the liver and bone marrow loading has been found in NTDT patients, presumably related to the differential increased intestinal iron absorption. The correlation between serum ferritin and tissue R2 is moderate to good for the liver, spleen and bone marrow in SCD and PNH patients. However, serum ferritin does not correlate with NTDT liver R2, spleen R2 or heart R2*. As opposed to serum ferritin measurements, tissue R2 values are a more direct measurement of each tissue's iron loading. This kind of determination will allow a better understanding of the different patterns of tissue iron biodistribution in diseases predisposed to tissue iron accumulation.	[Gutierrez, Lucia] ICMM CSIC, Inst Ciencia Mat Madrid, Madrid, Spain; [Gutierrez, Lucia; House, Michael J.; St Pierre, Tim G.] Univ Western Australia, Sch Phys, Crawley, WA, Australia; [Vasavda, Nisha; Drasar, Emma; Gonzalez-Gascon y Marin, Isabel; Kulasekararaj, Austin G.; Thein, Swee L.] Kings Coll London, Fac Life Sci & Med, Mol Haematol, London WC2R 2LS, England; [Drasar, Emma; Kulasekararaj, Austin G.; Thein, Swee L.] Kings Coll Hosp NHS Fdn Trust, Dept Haematol, London, England; [Gonzalez-Gascon y Marin, Isabel] Hosp Infanta Leonor, Dept Haematol, Madrid, Spain; [Thein, Swee L.] NHLB, NIH, Sickle Cell Branch, Bethesda, MD 20892 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); University of Western Australia; University of London; King's College London; King's College Hospital NHS Foundation Trust; Hospital Universitario Infanta Leonor; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gutierrez, L (corresponding author), ICMM CSIC, Inst Ciencia Mat Madrid, Madrid, Spain.	lucia@icmm.csic.es	Gutierrez, Lucia/A-4305-2008; St Pierre, Timothy G/A-5509-2008; House, Michael J/B-6477-2008	Gutierrez, Lucia/0000-0003-2366-3598; St Pierre, Timothy G/0000-0003-4682-4972; House, Michael J/0000-0002-1752-6274; Gonzalez-Gascon y Marin, Isabel/0000-0001-6329-1704	AXA Research Fund; Medical Research Council (UK) Development grant [G0001249 ID: 62593]	AXA Research Fund(AXA Research Fund); Medical Research Council (UK) Development grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LG is the beneficiary of a postdoctoral grant from the AXA Research Fund. SLT was funded by an Medical Research Council (UK) Development grant (G0001249 ID: 62593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757; Argyropoulou MI, 2007, EUR RADIOL, V17, P3025, DOI 10.1007/s00330-007-0683-1; Brewer CJ, 2009, J MAGN RESON IMAGING, V29, P357, DOI 10.1002/jmri.21666; BRITTENHAM GM, 1993, AM J HEMATOL, V42, P81, DOI 10.1002/ajh.2830420116; Drakonaki EE, 2007, EUR RADIOL, V17, P2079, DOI 10.1007/s00330-006-0504-y; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Hansbury EN, 2012, PEDIATR BLOOD CANCER, V58, P611, DOI 10.1002/pbc.23304; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HUTT MP, 1961, AM J MED, V31, P736, DOI 10.1016/0002-9343(61)90158-9; KANEKO K, 1993, PEDIATR RADIOL, V23, P435, DOI 10.1007/BF02012442; Kolnagou A, 2006, HEMOGLOBIN, V30, P219, DOI 10.1080/03630260600642542; Kontoyiannis DP, 2007, CANCER-AM CANCER SOC, V110, P1303, DOI 10.1002/cncr.22909; Krishnamurti Lakshmanan, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P6, DOI 10.1016/j.cppeds.2007.10.002; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LEVIN TL, 1995, PEDIATR RADIOL, V25, P614, DOI 10.1007/BF02011829; MAZZA P, 1995, HAEMATOLOGICA, V80, P398; Meloni A, 2010, MAGN RESON MED, V64, P211, DOI 10.1002/mrm.22410; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Papakonstantinou O, 2009, J MAGN RESON IMAGING, V29, P853, DOI 10.1002/jmri.21707; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; RATH CE, 1948, J LAB CLIN MED, V33, P81; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; ROUBIDOUX MA, 1994, ABDOM IMAGING, V19, P168, DOI 10.1007/BF00203497; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Siegelman ES, 1996, RADIOLOGY, V199, P13, DOI 10.1148/radiology.199.1.8633135; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; St Pierre TG, 2004, NMR BIOMED, V17, P446, DOI 10.1002/nbm.905; Taher A, 2008, HAEMATOL-HEMATOL J, V93, P1584, DOI 10.3324/haematol.13098; Taher A, 2006, BLOOD CELL MOL DIS, V37, P12, DOI 10.1016/j.bcmd.2006.04.005; Taher AT, 2011, BRIT J HAEMATOL, V152, P512, DOI 10.1111/j.1365-2141.2010.08486.x; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Vasavda N, 2012, BRIT J HAEMATOL, V157, P599, DOI 10.1111/j.1365-2141.2012.09093.x; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139220	10.1371/journal.pone.0139220	http://dx.doi.org/10.1371/journal.pone.0139220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406992	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700193
J	Kang, MH; Pengkit, A; Choi, K; Jeon, SS; Choi, HW; Shin, DB; Choi, EH; Uhm, HS; Park, G				Kang, Min Ho; Pengkit, Anchalee; Choi, Kihong; Jeon, Seong Sil; Choi, Hyo Won; Shin, Dong Bum; Choi, Eun Ha; Uhm, Han Sup; Park, Gyungsoon			Differential Inactivation of Fungal Spores in Water and on Seeds by Ozone and Arc Discharge Plasma	PLOS ONE			English	Article							OZONATED WATER; STERILIZATION; RICE; PATHOGENS; BACTERIA; SYSTEM	Seed sterilization is essential for preventing seed borne fungal diseases. Sterilization tools based on physical technologies have recently received much attention. However, available information is very limited in terms of efficiency, safety, and mode of action. In this study, we have examined antifungal activity of ozone and arc discharge plasma, potential tools for seed sterilization. In our results, ozone and arc discharge plasma have shown differential antifungal effects, depending on the environment associated with fungal spores (freely submerged in water or infected seeds). Ozone inactivates Fusarium fujikuroi (fungus causing rice bakanae disease) spores submerged in water more efficiently than arc discharge plasma. However, fungal spores associated with or infecting rice seeds are more effectively deactivated by arc discharge plasma. ROS generated in water by ozone may function as a powerful fungicidal factor. On the other hand, shockwave generated from arc discharge plasma may have greatly contributed to antifungal effects on fungus associated with rice seeds. In support of this notion, addition of ultrasonic wave in ozone generating water has greatly increased the efficiency of seed disinfection.	[Kang, Min Ho; Pengkit, Anchalee; Choi, Kihong; Jeon, Seong Sil; Choi, Eun Ha; Uhm, Han Sup; Park, Gyungsoon] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea; [Choi, Hyo Won] Natl Acad Agr Sci, Dept Crop Life Safety, Suwon 441707, South Korea; [Shin, Dong Bum] Natl Inst Crop Sci, Dept Crop Environm, Suwon 441857, South Korea	Kwangwoon University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Uhm, HS (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea.	hsuhm@kw.ac.kr; gyungp@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022	Choi, Eun Ha/0000-0001-5385-1878; Park, Gyungsoon/0000-0003-1592-3847	Rural Development Administration, Republic of Korea [PJ009891]; National Research Foundation of Korea (NRF) [NRF-2010-0027963]; R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) - Government funds	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) - Government funds	This work was supported by the Rural Development Administration, Republic of Korea (PJ009891), the National Research Foundation of Korea (NRF) (NRF-2010-0027963), and R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) funded by the Government funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIOS GN, 1997, PLANT PATHOLOGY; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bocci V, 2009, MED RES REV, V29, P646, DOI 10.1002/med.20150; Carter LLA, 2008, PHYTOPATHOLOGY, V98, P992, DOI 10.1094/PHYTO-98-9-0992; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fukumoto Y, 2010, HORTIC ENVIRON BIOTE, V51, P21; Gupta AK, 2014, J DERMATOL TREAT, V25, P251, DOI 10.3109/09546634.2012.714456; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jo YK, 2014, CROP SCI, V54, P796, DOI 10.2135/cropsci2013.05.0331; Kitazaki S, 2014, VACUUM, V110, P217, DOI 10.1016/j.vacuum.2014.06.014; Korachi M, 2010, J ELECTROSTAT, V68, P508, DOI 10.1016/j.elstat.2010.06.014; Korachi M, 2009, J ELECTROSTAT, V67, P678, DOI 10.1016/j.elstat.2009.03.002; Kwack Y, 2014, KOREAN J HORTIC SCI, V32, P901, DOI 10.7235/hort.2014.14129; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Lee HY, 2003, J KOREAN PHYS SOC, V42, pS880; Lee K, 2006, J MICROBIOL, V44, P269; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791; Li Bin, 2006, Zhongguo Shuidao Kexue, V20, P84; Mai-Prochnow A, 2014, INT J ANTIMICROB AG, V43, P508, DOI 10.1016/j.ijantimicag.2014.01.025; Mancini V, 2014, PEST MANAG SCI, V70, P860, DOI 10.1002/ps.3693; Mohan N, 2005, OZONE-SCI ENG, V27, P499, DOI 10.1080/01919510500351875; Munkvold GP, 2009, ANNU REV PHYTOPATHOL, V47, P285, DOI 10.1146/annurev-phyto-080508-081916; Oehmigen K, 2011, PLASMA PROCESS POLYM, V8, P904, DOI 10.1002/ppap.201000099; Ou SH, 1985, RICE DIS; Pak G, 2012, APPL PHYS LETT, V100; Panngom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099300; Pavlovich MJ, 2013, PLASMA PROCESS POLYM, V10, P69, DOI 10.1002/ppap.201200073; Rajkowski KT, 2004, J FOOD PROTECT, V67, P813, DOI 10.4315/0362-028X-67.4.813; Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Thirumdas R, 2015, FOOD BIOPHYS, V10, P1, DOI 10.1007/s11483-014-9382-z; Thobunluepop P, 2008, CHARACTERIZATION BOT; Trinetta V, 2011, INT J FOOD MICROBIOL, V146, P203, DOI 10.1016/j.ijfoodmicro.2011.02.014; Uhm HS, 2009, J HAZARD MATER, V168, P1595, DOI 10.1016/j.jhazmat.2009.03.056	35	40	41	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139263	10.1371/journal.pone.0139263	http://dx.doi.org/10.1371/journal.pone.0139263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406468	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700200
J	Mendis, N; McBride, P; Faucher, SP				Mendis, Nilmini; McBride, Peter; Faucher, Sebastien P.			Short-Term and Long-Term Survival and Virulence of Legionella pneumophila in the Defined Freshwater Medium Fraquil	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; GROWTH TEMPERATURE; PATHOGEN LEGIONELLA; IRON UPTAKE; TAP WATER; EXPRESSION; MODEL; IDENTIFICATION; SYSTEMS; AMEBAS	Legionella pneumophila (Lp) is the etiological agent responsible for Legionnaires' disease, a potentially fatal pulmonary infection. Lp lives and multiplies inside protozoa in a variety of natural and man-made water systems prior to human infection. Fraquil, a defined freshwater medium, was used as a highly reproducible medium to study the behaviour of Lp in water. Adopting a reductionist approach, Fraquil was used to study the impact of temperature, pH and trace metal levels on the survival and subsequent intracellular multiplication of Lp in Acanthamoeba castellanii, a freshwater protozoan and a natural host of Legionella. We show that temperature has a significant impact on the short-and long-term survival of Lp, but that the bacterium retains intracellular multiplication potential for over six months in Fraquil. Moreover, incubation in Fraquil at pH 4.0 resulted in a rapid decline in colony forming units, but was not detrimental to intracellular multiplication. In contrast, variations in trace metal concentrations had no impact on either survival or intracellular multiplication in amoeba. Our data show that Lp is a resilient bacterium in the water environment, remaining infectious to host cells after six months under the nutrient-deprived conditions of Fraquil.	[Mendis, Nilmini; McBride, Peter; Faucher, Sebastien P.] McGill Univ, Fac Agr & Environm Sci, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada	McGill University	Faucher, SP (corresponding author), McGill Univ, Fac Agr & Environm Sci, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	sebastien.faucher2@mcgill.ca		Faucher, Sebastien/0000-0002-2721-7715	Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant [418289-2012]; John R. Evans Leaders Fund from the Canadian Foundation for Innovation (CFI); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); NSERC Undergraduate Student Research Award	Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); John R. Evans Leaders Fund from the Canadian Foundation for Innovation (CFI); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council (NSERC, nserc-crsng.gc.ca) of Canada Discovery grant 418289-2012 and the John R. Evans Leaders Fund - Funding for research infrastructure from the Canadian Foundation for Innovation (CFI, innovation.ca/) to SPF. NM is supported by a PhD scholarship from Fonds de Recherche du Quebec - Nature et Technologies (FRQNT, frqnt.gouv.qc.ca/accueil). PM was supported by a NSERC Undergraduate Student Research Award (nserc-crsng.gc.ca).	AFNOR, 2010, NF T90 471 QUALITE D; Allard KA, 2006, J BACTERIOL, V188, P1351, DOI 10.1128/JB.188.4.1351-1363.2006; Allombert J, 2014, INFECT IMMUN, V82, P1222, DOI 10.1128/IAI.01077-13; [Anonymous], 1985, CAN MED ASSOC J, V132, P160; Azuma K, 2013, REGUL TOXICOL PHARM, V65, P1, DOI 10.1016/j.yrtph.2012.11.003; Bandyopadhyay P, 2004, INFECT IMMUN, V72, P4541, DOI 10.1128/IAI.72.8.4541-4551.2004; Bargellini A, 2011, WATER RES, V45, P2315, DOI 10.1016/j.watres.2011.01.009; Bartram J, 2007, LEGIONELLA AND THE P; BOPP CA, 1981, J CLIN MICROBIOL, V13, P714, DOI 10.1128/JCM.13.4.714-719.1981; Borella P, 2005, BIOTECHNOL ANN REV, V11, P355, DOI 10.1016/S1387-2656(05)11011-4; Borella P, 2004, EMERG INFECT DIS, V10, P457, DOI 10.3201/eid1003.020707; BUESCHING WJ, 1983, J CLIN MICROBIOL, V17, P1153, DOI 10.1128/JCM.17.6.1153-1155.1983; Cachafeiro SP, 2007, J HOSP INFECT, V67, P209, DOI 10.1016/j.jhin.2007.07.017; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; Cianciotto NP, 2007, BIOMETALS, V20, P323, DOI 10.1007/s10534-006-9057-4; DENNIS PJ, 1984, J APPL BACTERIOL, V56, P349, DOI 10.1111/j.1365-2672.1984.tb01359.x; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; Dufresne SF, 2012, EPIDEMIOL INFECT, V140, P172, DOI 10.1017/S0950268811000355; Edagawa A, 2008, J APPL MICROBIOL, V105, P2104, DOI 10.1111/j.1365-2672.2008.03932.x; EDELSTEIN PH, 1987, INFECT IMMUN, V55, P2701, DOI 10.1128/IAI.55.11.2701-2705.1987; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; GLICK TH, 1978, AM J EPIDEMIOL, V107, P149, DOI 10.1093/oxfordjournals.aje.a112517; Guerrieri E, 2008, CURR MICROBIOL, V57, P532, DOI 10.1007/s00284-008-9237-2; Guillemet TA, 2010, LETT APPL MICROBIOL, V51, P639, DOI 10.1111/j.1472-765X.2010.02947.x; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Heuner K, 2003, INT J MED MICROBIOL, V293, P133, DOI 10.1078/1438-4221-00259; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; HUSSONG D, 1987, BIO-TECHNOL, V5, P947, DOI 10.1038/nbt0987-947; KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x; Kuroki T, 2009, JPN J INFECT DIS, V62, P201; Kusnetsov JM, 1996, J APPL BACTERIOL, V81, P341; LANDEEN LK, 1989, APPL ENVIRON MICROB, V55, P3045, DOI 10.1128/AEM.55.12.3045-3050.1989; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lee G, 2002, APPL GEOCHEM, V17, P569, DOI 10.1016/S0883-2927(01)00125-1; Leoni E, 2005, J APPL MICROBIOL, V98, P373, DOI 10.1111/j.1365-2672.2004.02458.x; Li L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1869-6; Liles MR, 1998, INFECT IMMUN, V66, P1776, DOI 10.1128/IAI.66.4.1776-1782.1998; Loret J. F., 2005, Journal of Water and Health, V3, P423; Manske C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00125; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; MAUCHLINE WS, 1994, INFECT IMMUN, V62, P2995, DOI 10.1128/IAI.62.7.2995-2997.1994; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Messi P, 2011, BIOFOULING, V27, P165, DOI 10.1080/08927014.2010.551190; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Morel FMM, 1975, TECHNICAL NOTE; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; Mouchtouri VA, 2010, AM J INFECT CONTROL, V38, P50, DOI 10.1016/j.ajic.2009.04.285; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; Nishimori I, 2014, BIOORGAN MED CHEM, V22, P2939, DOI 10.1016/j.bmc.2014.04.006; PASZKOKOLVA C, 1992, FEMS MICROBIOL ECOL, V102, P45, DOI 10.1111/j.1574-6968.1992.tb05794.x; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Qin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059018; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Roig J, 2003, CURR OPIN INFECT DIS, V16, P145, DOI 10.1097/00001432-200304000-00011; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Serrano-Suarez A, 2013, ENVIRON SCI POLLUT R, V20, P5534, DOI 10.1007/s11356-013-1557-5; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P5583, DOI 10.1128/AEM.00067-08; Stewart CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050560; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Tachibana M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/514395; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; TISON DL, 1980, APPL ENVIRON MICROB, V39, P456, DOI 10.1128/AEM.39.2.456-459.1980; Trigui H, 2014, APPL ENVIRON MICROBI; Grosso-Becerraa MV, 2014, P NATL ACAD SCI USA, V111, P15562, DOI 10.1073/pnas.1402536111; Viswanathan VK, 2000, INFECT IMMUN, V68, P1069, DOI 10.1128/IAI.68.3.1069-1079.2000; WADOWSKY RM, 1982, APPL ENVIRON MICROB, V43, P1104, DOI 10.1128/AEM.43.5.1104-1110.1982; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677, DOI 10.1128/AEM.54.11.2677-2682.1988; WADOWSKY RM, 1985, APPL ENVIRON MICROB, V49, P1197, DOI 10.1128/AEM.49.5.1197-1205.1985; Walczak M, 2013, ANN AGR ENV MED, V20, P649; Walczak M, 2013, ENVIRON SCI-PROC IMP, V15, P2273, DOI 10.1039/c3em00452j; WANG WLL, 1979, ANN INTERN MED, V90, P614, DOI 10.7326/0003-4819-90-4-614; Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; YEE RB, 1982, APPL ENVIRON MICROB, V43, P1330, DOI 10.1128/AEM.43.6.1330-1334.1982; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Zheng HX, 2013, INFECT IMMUN, V81, P4182, DOI 10.1128/IAI.00858-13	85	22	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139277	10.1371/journal.pone.0139277	http://dx.doi.org/10.1371/journal.pone.0139277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406895	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700202
J	Mimche, PN; Brady, LM; Keeton, S; Fenne, DSJ; King, TP; Quicke, KM; Hudson, LE; Lamb, TJ				Mimche, Patrice N.; Brady, Lauren M.; Keeton, Shirley; Fenne, David S. J.; King, Thayer P.; Quicke, Kendra M.; Hudson, Lauren E.; Lamb, Tracey J.			Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation	PLOS ONE			English	Article							STIMULATES MIGRATION; ADHESION; MOUSE; DIFFERENTIATION; COSTIMULATION; INVOLVEMENT; LYMPHOCYTES; MONOCYTES; RESPONSES; EPHRINB1	The Eph receptor tyrosine kinases interact with their ephrin ligands on adjacent cells to facilitate contact-dependent cell communication. Ephrin B ligands are expressed on T cells and have been suggested to act as co-stimulatory molecules during T cell activation. There are no detailed reports of the expression and modulation of EphB receptors on dendritic cells, the main antigen presenting cells that interact with T cells. Here we show that mouse splenic dendritic cells (DC) and bone-marrow derived DCs (BMDC) express EphB2, a member of the EphB family. EphB2 expression is modulated by ligation of TLR4 and TLR9 and also by interaction with ephrin B ligands. Co-localization of EphB2 with MHC-II is also consistent with a potential role in T cell activation. However, BMDCs derived from EphB2 deficient mice were able to present antigen in the context of MHC-II and produce T cell activating cytokines to the same extent as intact DCs. Collectively our data suggest that EphB2 may contribute to DC responses, but that EphB2 is not required for T cell activation. This result may have arisen because DCs express other members of the EphB receptor family, EphB3, EphB4 and EphB6, all of which can interact with ephrin B ligands, or because EphB2 may be playing a role in another aspect of DC biology such as migration.	[Mimche, Patrice N.; Brady, Lauren M.; King, Thayer P.; Quicke, Kendra M.; Hudson, Lauren E.; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Keeton, Shirley; Fenne, David S. J.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England	Emory University; University of Reading	Lamb, TJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.	tracey.j.lamb@emory.edu	Mimche, Patrice/AHC-8116-2022	Lamb, Tracey/0000-0003-0620-3944	National Institute for Neurological Disorders and Strokes [1R21NS085382-01A1]; Children's Healthcare of Atlanta; Royal Society (UK); Emory Egleston Children's Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085382] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Strokes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Children's Healthcare of Atlanta; Royal Society (UK)(Royal Society of London); Emory Egleston Children's Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: Funding provided by National Institute for Neurological Disorders and Strokes (1R21NS085382-01A1), Children's Healthcare of Atlanta and the Royal Society (UK) and Emory Egleston Children's Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Alfaro D, 2007, EUR J IMMUNOL, V37, P2596, DOI 10.1002/eji.200737097; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedi B, 2012, PARASITE IMMUNOL, V34, P473, DOI 10.1111/j.1365-3024.2012.01382.x; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Braun J, 2011, ARTERIOSCL THROM VAS, V31, P297, DOI 10.1161/ATVBAHA.110.217646; Bush JO, 2012, SEMIN CELL DEV BIOL, V23, P26, DOI 10.1016/j.semcdb.2011.10.018; Dai DD, 2014, BBA-PROTEINS PROTEOM, V1844, P1729, DOI 10.1016/j.bbapap.2014.07.002; de Saint-Vis B, 2003, BLOOD, V102, P4431, DOI 10.1182/blood-2003-02-0500; Fernandes DM, 2000, EUR J IMMUNOL, V30, P2333, DOI 10.1002/1521-4141(2000)30:8<2333::AID-IMMU2333>3.0.CO;2-F; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gurniak CB, 1996, ONCOGENE, V13, P777; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hirai H, SCIENCE, V238, P1717; Holen HL, 2011, SCAND J IMMUNOL, V74, P144, DOI 10.1111/j.1365-3083.2011.02563.x; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Jellinghaus S, 2013, BBA-MOL CELL RES, V1833, P2201, DOI 10.1016/j.bbamcr.2013.05.017; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Mimche PN, 2015, HEPATOLOGY, V62, P900, DOI 10.1002/hep.27792; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Munthe Else, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-9; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Pfaff D, 2008, J CELL SCI, V121, P3842, DOI 10.1242/jcs.030627; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Sakamoto A, 2011, J INT MED RES, V39, P522, DOI 10.1177/147323001103900220; Shen ZH, 1997, J IMMUNOL, V158, P2723; Wohlfahrt JG, 2004, J IMMUNOL, V172, P843, DOI 10.4049/jimmunol.172.2.843; WYSSCORAY T, 1993, EUR J IMMUNOL, V23, P2175, DOI 10.1002/eji.1830230919; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Yu M, 2014, FASEB J, V28, P3609, DOI 10.1096/fj.13-247759	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138835	10.1371/journal.pone.0138835	http://dx.doi.org/10.1371/journal.pone.0138835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407069	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000361800700104
J	Richards, JA; Bucsaiova, M; Hesketh, EE; Ventre, C; Henderson, NC; Simpson, K; Bellamy, COC; Howie, SEM; Anderton, SM; Hughes, J; Wigmore, SJ				Richards, James A.; Bucsaiova, Martina; Hesketh, Emily E.; Ventre, Chiara; Henderson, Neil C.; Simpson, Kenneth; Bellamy, Christopher O. C.; Howie, Sarah E. M.; Anderton, Stephen M.; Hughes, Jeremy; Wigmore, Stephen J.			Acute Liver Injury Is Independent of B Cells or Immunoglobulin M	PLOS ONE			English	Article							CD4(+) T-LYMPHOCYTES; NATURAL IGM; REPERFUSION INJURY; IMMUNE-MECHANISMS; APOPTOTIC CELLS; MURINE MODEL; ISCHEMIA; INFLAMMATION; ACTIVATION; MOUSE	Background & Aims Acute liver injury is a clinically important pathology and results in the release of Danger Associated Molecular Patterns, which initiate an immune response. Withdrawal of the injurious agent and curtailing any pathogenic secondary immune response may allow spontaneous resolution of injury. The role B cells and Immunoglobulin M (IgM) play in acute liver injury is largely unknown and it was proposed that B cells and/or IgM would play a significant role in its pathogenesis. Methods Tissue from 3 models of experimental liver injury (ischemia-reperfusion injury, concanavalin A hepatitis and paracetamol-induced liver injury) and patients transplanted following paracetamol overdose were stained for evidence of IgM deposition. Mice deficient in B cells (and IgM) were used to dissect out the role B cells and/or IgM played in the development or resolution of injury. Serum transfer into mice lacking IgM was used to establish the role IgM plays in injury. Results Significant deposition of IgM was seen in the explanted livers of patients transplanted following paracetamol overdose as well as in 3 experimental models of acute liver injury (ischemia-reperfusion injury, concanavalin A hepatitis and paracetamol-induced liver injury). Serum transfer into IgM-deficient mice failed to reconstitute injury (p = 0.66), despite successful engraftment of IgM. Mice deficient in both T and B cells (RAG1-/-) mice (p<0.001), but not B cell deficient (mu MT) mice (p = 0.93), were significantly protected from injury. Further interrogation with T cell deficient (CD3 epsilon KO) mice confirmed that the T cell component is a key mediator of sterile liver injury. Mice deficient in B cells and IgM mice did not have a significant delay in resolution following acute liver injury. Discussion IgM deposition appears to be common feature of both human and murine sterile liver injury. However, neither IgM nor B cells, play a significant role in the development of or resolution from acute liver injury. T cells appear to be key mediators of injury. In conclusion, the therapeutic targeting of IgM or B cells (e.g. with Rituximab) would have limited benefit in protecting patients from acute liver injury.	[Richards, James A.; Bucsaiova, Martina; Hesketh, Emily E.; Ventre, Chiara; Henderson, Neil C.; Howie, Sarah E. M.; Anderton, Stephen M.; Hughes, Jeremy; Wigmore, Stephen J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Richards, James A.; Wigmore, Stephen J.] Univ Edinburgh, Surg Clin, Edinburgh, Midlothian, Scotland; [Henderson, Neil C.; Simpson, Kenneth] Univ Edinburgh, Sch Clin Sci, Div Hlth Sci, Hepatol, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Royal Infirm Edinburgh NHS Trust, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Richards, JA (corresponding author), Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	jamesrichards@doctors.net.uk	Wigmore, Stephen/AAF-3562-2019	Wigmore, Stephen/0000-0002-3614-8002; Hughes, Jeremy/0000-0002-3470-0422; Howie, Sarah/0000-0001-7291-3499; Aguiar Bucsai, Martina/0000-0002-9728-3902; Hesketh, Emily/0000-0001-6209-2295; Richards, James/0000-0001-9049-5745	Wellcome Trust [WT 092494/Z/10/Z]; Royal College of Surgeons of Edinburgh; Tenovus Scotland; Dowager Countess Eleanor Peel Trust; MRC [G0801924] Funding Source: UKRI; Kidney Research UK [ST4/2011] Funding Source: researchfish; Medical Research Council [G0801924] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Royal College of Surgeons of Edinburgh; Tenovus Scotland; Dowager Countess Eleanor Peel Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was made possible by the support of (JR): The Wellcome Trust (WT 092494/Z/10/Z), www.wellcome.ac.uk; The Royal College of Surgeons of Edinburgh (Maurice-Wohl Fellowship and Small Research Grant), www.rcsed.ac.uk; Tenovus Scotland, www.tenovus-scotland.org.uk; The Dowager Countess Eleanor Peel Trust, www.peeltrust.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bower WA, 2007, AM J GASTROENTEROL, V102, P2459, DOI 10.1111/j.1572-0241.2007.01388.x; Burne-Taney MJ, 2003, J IMMUNOL, V171, P3210, DOI 10.4049/jimmunol.171.6.3210; Caldwell CC, 2005, AM J PHYSIOL-GASTR L, V289, pG969, DOI 10.1152/ajpgi.00223.2005; Champe PC., 2005, BIOCHEMISTRY-US; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Devey L, 2008, LAB ANIM-UK, V42, P12, DOI 10.1258/la.2007.06009e; Devey LR, 2007, TRANSPLANTATION, V84, P70, DOI 10.1097/01.tp.0000268072.04260.69; Devey LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049647; Eggenhofer E, 2013, J IMMUNOL, V191, P480, DOI 10.4049/jimmunol.1202975; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Feng M, 2012, INT IMMUNOPHARMACOL, V13, P135, DOI 10.1016/j.intimp.2012.03.007; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Hochegger K, 2007, AM J PHYSIOL-RENAL, V293, pF741, DOI 10.1152/ajprenal.00486.2006; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 2003, BMJ-BRIT MED J, V327, P143, DOI 10.1136/bmj.327.7407.143; Jang HR, 2010, J AM SOC NEPHROL, V21, P654, DOI 10.1681/ASN.2009020182; Khandoga A, 2006, HEPATOLOGY, V43, P306, DOI 10.1002/hep.21017; Kimura K, 2006, AM J PATHOL, V168, P786, DOI 10.2353/ajpath.2006.050314; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kuboki S, 2009, AM J PHYSIOL-GASTR L, V296, pG1054, DOI 10.1152/ajpgi.90464.2008; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Lobo PI, 2012, J IMMUNOL, V188, P1675, DOI 10.4049/jimmunol.1101762; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Numata K, 2007, J IMMUNOL, V178, P3777, DOI 10.4049/jimmunol.178.6.3777; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Renner B, 2010, J IMMUNOL, V185, P4393, DOI 10.4049/jimmunol.0903239; Savransky V, 2006, KIDNEY INT, V69, P233, DOI 10.1038/sj.ki.5000038; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Strey CW, 2011, INT J MOL MED, V27, P447, DOI 10.3892/ijmm.2010.592; Tilney NL, 1997, TRANSPLANTATION, V64, P945, DOI 10.1097/00007890-199710150-00001; Vollmers HP, 2006, HISTOL HISTOPATHOL, V21, P1355, DOI 10.14670/HH-21.1355; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	45	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138688	10.1371/journal.pone.0138688	http://dx.doi.org/10.1371/journal.pone.0138688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406765	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700071
J	Bionaz, M; Monaco, E; Wheeler, MB				Bionaz, Massimo; Monaco, Elisa; Wheeler, Matthew B.			Transcription Adaptation during In Vitro Adipogenesis and Osteogenesis of Porcine Mesenchymal Stem Cells: Dynamics of Pathways, Biological Processes, Up-Stream Regulators, and Gene Networks	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; GREEN FLUORESCENT PROTEIN; FRESH BONE-MARROW; PPAR-GAMMA; STROMAL CELLS; ADIPOCYTE DIFFERENTIATION; IMMUNOLOGICAL-PROPERTIES; KEY REGULATOR; EXPRESSION; PEROXISOME	The importance of mesenchymal stem cells (MSC) for bone regeneration is growing. Among MSC the bone marrow-derived stem cells (BMSC) are considered the gold standard in tissue engineering and regenerative medicine; however, the adipose-derived stem cells (ASC) have very similar properties and some advantages to be considered a good alternative to BMSC. The molecular mechanisms driving adipogenesis are relatively well-known but mechanisms driving osteogenesis are poorly known, particularly in pig. In the present study we have used transcriptome analysis to unravel pathways and biological functions driving in vitro adipogenesis and osteogenesis in BMSC and ASC. The analysis was performed using the novel Dynamic Impact Approach and functional enrichment analysis. In addition, a k-mean cluster analysis in association with enrichment analysis, networks reconstruction, and transcription factors overlapping analysis were performed in order to uncover the coordination of biological functions underlining differentiations. Analysis indicated a larger and more coordinated transcriptomic adaptation during adipogenesis compared to osteogenesis, with a larger induction of metabolism, particularly lipid synthesis (mostly triglycerides), and a larger use of amino acids for synthesis of feed-forward adipogenic compounds, larger cell signaling, lower cell-to-cell interactions, particularly for the cytoskeleton organization and cell junctions, and lower cell proliferation. The coordination of adipogenesis was mostly driven by Peroxisome Proliferator-activated Receptors together with other known adipogenic transcription factors. Only a few pathways and functions were more induced during osteogenesis compared to adipogenesis and some were more inhibited during osteogenesis, such as cholesterol and protein synthesis. Up-stream transcription factor analysis indicated activation of several lipid-related transcription regulators (e.g., PPARs and CEBP alpha) during adipogenesis but osteogenesis was driven by inhibition of several up-stream regulators, such as MYC. Between MSCs the data indicated an 'adipocyte memory' in ASC with also an apparent lower immunogenicity compared to BMSC during differentiations. Overall the analysis allowed proposing a dynamic model for the adipogenic and osteogenic differentiation in porcine ASC and BMSC.	[Bionaz, Massimo; Monaco, Elisa; Wheeler, Matthew B.] Univ Illinois, Lab Stem Cell Biol & Engn, Dept Anim Sci, Urbana, IL 61801 USA; [Bionaz, Massimo; Monaco, Elisa; Wheeler, Matthew B.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wheeler, MB (corresponding author), Univ Illinois, Lab Stem Cell Biol & Engn, Dept Anim Sci, Urbana, IL 61801 USA.	mbwheele@illinois.edu	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892; Wheeler, Matthew/0000-0001-5589-357X	Illinois Regenerative Medicine Institute [63080017]	Illinois Regenerative Medicine Institute	Illinois Regenerative Medicine Institute provided the funding support of this project through grant #63080017 (MBW). The funding agency had no role in design, data collection, analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; Aubert J, 1999, CELL MOL LIFE SCI, V56, P538, DOI 10.1007/s000180050450; Ayala-Sumuano JT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00178; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Choi YA, 2010, J PROTEOME RES, V9, P2946, DOI 10.1021/pr901110q; Choi YS, 2012, BIOMATERIALS, V33, P2482, DOI 10.1016/j.biomaterials.2011.12.004; Christodoulides C, 2010, MOL CELL ENDOCRINOL, V318, P61, DOI 10.1016/j.mce.2009.09.014; Costa V, 2010, PPAR RES, V2010, DOI 10.1155/2010/409168; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; De Miguel MP, 2012, CURR MOL MED, V12, P574; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Ellero S, 2010, DRUG METAB DISPOS, V38, P679, DOI 10.1124/dmd.109.029249; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Fromm-Dornieden C, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-9; Fumoto T, 2014, BIOCHEM BIOPH RES CO, V447, P407, DOI 10.1016/j.bbrc.2014.03.149; Goff SA, 2011, NEW PHYTOL, V189, P923, DOI 10.1111/j.1469-8137.2010.03574.x; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Grontved L, 2010, MOL CELL BIOL, V30, P2155, DOI 10.1128/MCB.01238-09; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaffe IZ, 2007, ARTERIOSCL THROM VAS, V27, P799, DOI 10.1161/01.ATV.0000258414.59393.89; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Kapahi P, 2010, ADV EXP MED BIOL, V694, P30; KELLER JM, 1993, BIOL CELL, V77, P77, DOI 10.1016/S0248-4900(05)80177-7; Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9; Khatri P, 2012, PLOS COMPUTATIONAL B, V7, DOI [10.1371/journal.pone.0032455, DOI 10.1371/JOURNAL.PONE.0032455]; Kim DH, 2012, FASEB J, P26; Kim D, 2010, CELL TISSUE RES, V341, P359, DOI 10.1007/s00441-010-1015-3; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Kumarasuriyar A, 2009, J CELL PHYSIOL, V219, P572, DOI 10.1002/jcp.21700; Lai LX, 2002, MOL REPROD DEV, V62, P300, DOI 10.1002/mrd.10146; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lo T, 2012, J PROTEOME RES, V11, P586, DOI 10.1021/pr200868p; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; McGregor RA, 2011, CURR MOL MED, V11, P304; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020; Monaco E, 2009, OPEN TISSUE ENG REGE, V2, P20, DOI DOI 10.2174/1875043500902010020; Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Narsinh KH, 2011, MOL THER, V19, P635, DOI 10.1038/mt.2011.41; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nye C, 2008, TRENDS ENDOCRIN MET, V19, P356, DOI 10.1016/j.tem.2008.08.003; Oh IH, 2010, STEM CELLS, V28, P1243, DOI 10.1002/stem.453; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Olswang Y, 2003, J BIOL CHEM, V278, P12929, DOI 10.1074/jbc.M300263200; Pan WT, 2011, AM J PHYSIOL-ENDOC M, V301, pE901, DOI 10.1152/ajpendo.00087.2011; Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024; Park JG, 2014, BIOCHEM BIOPH RES CO, V446, P30, DOI 10.1016/j.bbrc.2014.02.036; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; SAMID D, 1992, CANCER RES, V52, P1988; Shi H, 2000, PHYSIOL GENOMICS, V3, P75, DOI 10.1152/physiolgenomics.2000.3.2.75; Slynarski K, 2006, TRANSPL P, V38, P318, DOI 10.1016/j.transproceed.2005.12.075; Spangenberg L, 2013, STEM CELL RES, V11, P902, DOI 10.1016/j.scr.2013.06.002; Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Tzaphlidou M, 2005, MICRON, V36, P593, DOI 10.1016/j.micron.2005.05.009; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Veyrat-Masson R, 2007, BRIT J HAEMATOL, V139, P312, DOI 10.1111/j.1365-2141.2007.06786.x; Vidal C, 2012, STEM CELLS, V30, P1042, DOI 10.1002/stem.1063; von der Heyde S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-381; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Wang CJ, 2011, J SURG RES, V171, P114, DOI 10.1016/j.jss.2010.01.045; Weber LW, 2004, WORLD J GASTROENTERO, V10, P3081, DOI 10.3748/wjg.v10.i21.3081; Xiang XX, 2011, ACTA BIOCH BIOPH SIN, V43, P501, DOI 10.1093/abbs/gmr041; Yamaguchi M, 2012, MOL CELL BIOCHEM, V366, P201, DOI 10.1007/s11010-012-1298-7; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Yin CY, 2014, J BIOSCIENCES, V39, P415, DOI 10.1007/s12038-014-9412-5; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181; Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	113	30	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137644	10.1371/journal.pone.0137644	http://dx.doi.org/10.1371/journal.pone.0137644			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398344	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500043
J	Sartorius, CA; Hanna, CT; Gril, B; Cruz, H; Serkova, NJ; Huber, KM; Kabos, P; Schedin, TB; Borges, VF; Steeg, PS; Cittelly, DM				Sartorius, C. A.; Hanna, C. T.; Gril, B.; Cruz, H.; Serkova, N. J.; Huber, K. M.; Kabos, P.; Schedin, T. B.; Borges, V. F.; Steeg, P. S.; Cittelly, D. M.			Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism	ONCOGENE			English	Article							RECEPTOR-ALPHA; AROMATASE EXPRESSION; PROGNOSTIC-FACTORS; TUMOR-GROWTH; SURVIVAL; S100A4; BETA; INVASION; ANGIOGENESIS; CARCINOMA	Brain metastases (BM) are a devastating consequence of breast cancer. BM occur more frequently in patients with estrogen receptor-negative (ER-) breast cancer subtypes; HER2 overexpressing (HER2+) tumors and triple-negative (TN) (ER-, progesterone receptor-negative (PR-) and normal HER2) tumors. Young age is an independent risk factor for the development of BM, thus we speculated that higher circulating estrogens in young, pre-menopausal women could exert paracrine effects through the highly estrogen-responsive brain microenvironment. Using a TN experimental metastases model, we demonstrate that ovariectomy decreased the frequency of magnetic resonance imaging-detectable lesions by 56% as compared with estrogen supplementation, and that the combination of ovariectomy and letrozole further reduced the frequency of large lesions to 14.4% of the estrogen control. Human BM expressed 4.2-48.4% ER+ stromal area, particularly ER+ astrocytes. In vitro, E2-treated astrocytes increased proliferation, migration and invasion of 231BR-EGFP cells in an ER-dependent manner. E2 upregulated epidermal growth factor receptor (EGFR) ligands Egf, Ereg and Tgfa mRNA and protein levels in astrocytes, and activated EGFR in brain metastatic cells. Co-culture of 231BR-EGFP cells with E2-treated astrocytes led to the upregulation of the metastatic mediator S100 Calcium-binding protein A4 (S100A4) (1.78-fold, P < 0.05). Exogenous EGF increased S100A4 mRNA levels in 231BR-EGFP cells (1.40 +/- 0.02-fold, P < 0.01 compared with vehicle control) and an EGFR/HER2 inhibitor blocked this effect, suggesting that S100A4 is a downstream effector of EGFR activation. Short hairpin RNA-mediated S100A4 silencing in 231BR-EGFP cells decreased their migration and invasion in response to E2-CM, abolished their increased proliferation in co-cultures with E2-treated astrocytes and decreased brain metastatic colonization. Thus, S100A4 is one effector of the paracrine action of E2 in brain metastatic cells. These studies provide a novel mechanism by which estrogens, acting through ER+ astrocytes in the brain microenvironment, can promote BM of TN breast cancers, and suggests existing endocrine agents may provide some clinical benefit towards reducing and managing BM.	[Sartorius, C. A.; Hanna, C. T.; Cruz, H.; Cittelly, D. M.] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Gril, B.; Steeg, P. S.] NCI, Womens Malignancies Branch, Bethesda, MD 20892 USA; [Serkova, N. J.; Huber, K. M.] Univ Colorado Denver, Dept Anesthesiol, Anschutz Med, Aurora, CO 80045 USA; [Kabos, P.; Schedin, T. B.; Borges, V. F.] Univ Colorado Denver, Div Med Oncol, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Cittelly, DM (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus,12801 E 17th Ave MS8104, Aurora, CO 80045 USA.	Diana.Cittelly@ucdenver.edu		Cittelly, Diana/0000-0002-8392-0800	NCI [P30CA046934, K22CA181250]; CTSA Center grant [UL1TR001082]; DOD BCRP [W81XWH-11-1-0101]; ACS IRG [57-001-53]; NIH [R01 CA140985]; NATIONAL CANCER INSTITUTE [K08CA164048, P30CA046934, K22CA181250, R01CA140985, ZIABC010538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA Center grant; DOD BCRP(United States Department of Defense); ACS IRG(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Colorado Cancer Center Animal Imaging Shared Resources, Tissue Culture Core, Cytometry and Cell Sorting Shared Resource and Functional Genomics Facility supported by NCI P30CA046934 and CTSA UL1TR001082 Center grants. Susan Edgerton provided de-identified tissue. This work was supported by DOD BCRP W81XWH-11-1-0101 (DMC), ACS IRG # 57-001-53 (DMC) and NCI K22CA181250 (DMC). CAS was supported by NIH R01 CA140985.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arnold S, 2005, NEUROBIOL DIS, V20, P82, DOI 10.1016/j.nbd.2005.02.002; Arnold S, 2012, J STEROID BIOCHEM, V131, P2, DOI 10.1016/j.jsbmb.2012.01.012; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; Barouk S, 2011, ENDOCRINOLOGY, V152, P1745, DOI 10.1210/en.2010-1290; BOOGERD W, 1993, J NEURO-ONCOL, V15, P165, DOI 10.1007/BF01053937; Braccini AL, 2013, BREAST, V22, P993, DOI 10.1016/j.breast.2013.05.011; Brufsky AM, 2011, CLIN CANCER RES, V17, P4834, DOI 10.1158/1078-0432.CCR-10-2962; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Dahlmann M, 2012, ONCOTARGET, V3, P783, DOI 10.18632/oncotarget.572; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Evans AJ, 2004, CLIN ONCOL-UK, V16, P345, DOI 10.1016/j.clon.2004.03.012; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; GARCIASEGURA LM, 1989, DEV BRAIN RES, V47, P298, DOI 10.1016/0165-3806(89)90186-7; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Gril B, 2013, AM J PATHOL, V182, P2368, DOI 10.1016/j.ajpath.2013.02.043; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Hung MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089389; Iyer V, 2012, CANCER RES, V72, P2705, DOI 10.1158/0008-5472.CAN-11-3287; Jenkinson SR, 2004, BRIT J CANCER, V90, P253, DOI 10.1038/sj.bjc.6601483; Kaal EC, 2005, LANCET NEUROL, V4, P289, DOI 10.1016/S1474-4422(05)70072-7; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Kodack DP, 2015, CANCER CELL, V27, P163, DOI 10.1016/j.ccell.2015.01.001; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee SS, 2008, BREAST CANCER RES TR, V111, P523, DOI 10.1007/s10549-007-9806-2; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; MA YJ, 1994, J NEUROSCI, V14, P5644; Montelli S, 2012, BRAIN RES, V1475, P11, DOI 10.1016/j.brainres.2012.08.010; Morissette M, 2008, J STEROID BIOCHEM, V108, P327, DOI 10.1016/j.jsbmb.2007.09.011; Neman J, 2013, CLIN EXP METASTAS, V30, P753, DOI 10.1007/s10585-013-9576-7; OSBORNE CK, 1985, CANCER RES, V45, P584; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Pequeux C, 2012, CANCER RES, V72, P3010, DOI 10.1158/0008-5472.CAN-11-3768; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Razmara A, 2008, J PHARMACOL EXP THER, V325, P782, DOI 10.1124/jpet.107.134072; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Stanczyk FZ, 2015, STEROIDS, V99, P91, DOI 10.1016/j.steroids.2014.12.011; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wang L, 2012, ACTA BIOCHIM POL, V59, P593; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080933; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yague JG, 2006, NEUROSCIENCE, V138, P389, DOI 10.1016/j.neuroscience.2005.11.054; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	54	46	47	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2881	2892		10.1038/onc.2015.353	http://dx.doi.org/10.1038/onc.2015.353			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26411365	Green Accepted			2022-12-26	WOS:000377473700008
J	Campos, LT; de Almeida, CEV				Campos, Luciana Tourinho; Veloso de Almeida, Carlos Eduardo			Monte Carlo Dosimetry of the Co-60 BEBIG High Dose Rate for Brachytherapy	PLOS ONE			English	Article								Introduction The use of high-dose-rate brachytherapy is currently a widespread practice worldwide. The most common isotope source is Ir-192, but Co-60 is also becoming available for HDR. One of main advantages of Co-60 compared to Ir-192 is the economic and practical benefit because of its longer half-live, which is 5.27 years. Recently, Eckert & Ziegler BEBIG, Germany, introduced a new afterloading brachytherapy machine (MultiSource (R)); it has the option to use either the Co-60 or Ir-192 HDR source. The source for the Monte Carlo calculations is the new Co-60 source (model Co0.A86), which is referred to as the new BEBIG Co-60 HDR source and is a modified version of the Co-60 source (model GK60M21), which is also from BEBIG. Objective and Methods The purpose of this work is to obtain the dosimetry parameters in accordance with the AAPM TG-43U1 formalism with Monte Carlo calculations regarding the BEBIG Co-60 high-dose-rate brachytherapy to investigate the required treatment-planning parameters. The geometric design and material details of the source was provided by the manufacturer and was used to define the Monte Carlo geometry. To validate the source geometry, a few dosimetry parameters had to be calculated according to the AAPM TG-43U1 formalism. The dosimetry studies included the calculation of the air kerma strength Sk, collision kerma in water along the transverse axis with an unbounded phantom, dose rate constant and radial dose function. The Monte Carlo code system that was used was EGSnrc with a new cavity code, which is a part of EGS++ that allows calculating the radial dose function around the source. The spectrum to simulate Co-60 was composed of two photon energies, 1.17 and 1.33 MeV. Only the gamma part of the spectrum was used; the contribution of the electrons to the dose is negligible because of the full absorption by the stainless-steel wall around the metallic Co-60. The XCOM photon cross-section library was used in subsequent simulations, and the photoelectric effect, pair production, Rayleigh scattering and bound Compton scattering were included in the simulation. Variance reduction techniques were used to speed up the calculation and to considerably reduce the computer time. The cut-off energy was 10 keV for electrons and photons. To obtain the dose rate distributions of the source in an unbounded liquid water phantom, the source was immersed at the center of a cube phantom of 100 cm(3). The liquid water density was 0.998 g/cm(3), and photon histories of up to 1010 were used to obtain the results with a standard deviation of less than 0.5% (k = 1). The obtained dose rate constant for the BEBIG Co-60 source was 1.1080.001 cGyh(-1)U(-1), which is consistent with the values in the literature. The radial dose functions were compared with the values of the consensus data set in the literature, and they are consistent with the published data for this energy range.	[Campos, Luciana Tourinho; Veloso de Almeida, Carlos Eduardo] Univ Estado Rio De Janeiro, DBB, LCR, BR-205550 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Campos, LT (corresponding author), Univ Estado Rio De Janeiro, DBB, LCR, Rua Sao Francisco Xavier,524 Maracana, BR-205550 Rio De Janeiro, Brazil.	tc_luciana@yahoo.com.br	Tourinho Campos, Luciana/O-1173-2017	Tourinho Campos, Luciana/0000-0003-4751-129X	Fundacao de Amparo a Pesquisa do Rio de janeiro [E-26/101.013/2011 LTC, E-26/101.016/2011 LTC]	Fundacao de Amparo a Pesquisa do Rio de janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding was provided by Fundacao de Amparo a Pesquisa do Rio de janeiro (http://www.faperj.br/), E-26/101.013/2011 LTC, E-26/101.016/2011 LTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester F, 2005, PHYS MED BIOL, V50, pN309, DOI 10.1088/0031-9155/50/21/N03; DeWerd LA, 2011, MED PHYS, V38, P782, DOI 10.1118/1.3533720; Granero D, 2007, MED PHYS, V34, P3485, DOI 10.1118/1.2759602; Guerrero R, 2014, PHYS MEDICA, V30, P960, DOI 10.1016/j.ejmp.2014.06.039; Kawrakow I., 2006, PIRS877 NRC; Kawrakow I., 2006, PIRS701 NRC; Kawrakow I., 2005, PIRS701 NRC; Medich DC, 2007, MED PHYS, V34, P1999, DOI 10.1118/1.2733809; Medich DC, 2006, MED PHYS, V33, P163, DOI 10.1118/1.2147767; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Nelson WR, 1985, EGS4 CODE SYSTEM; Palmer A., 2010, FUEL EN ABSTR, V78; Papagiannis P, 2003, MED PHYS, V30, P712, DOI 10.1118/1.1563662; Perez-Calatayud J, 2005, MED PHYS, V32, P28, DOI 10.1118/1.1834835; Perez-Calatayud J, 2012, DOSE CALCULATION PHO; Richter J, 2008, STRAHLENTHER ONKOL, V184, P187, DOI 10.1007/s00066-008-1684-y; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Selvam TP, 2010, MED PHYS, V37, P1365, DOI 10.1118/1.3326948; WILLIAMSON JF, 1995, MED PHYS, V22, P809, DOI 10.1118/1.597483	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139032	10.1371/journal.pone.0139032	http://dx.doi.org/10.1371/journal.pone.0139032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418559	Green Submitted, Green Published, gold			2022-12-26	WOS:000362171400036
J	Deng, YQ; Yang, YQ; Wang, SB; Li, F; Liu, MZ; Hua, QQ; Tao, ZZ				Deng, Yu-Qin; Yang, Ya-Qi; Wang, Shui-Bin; Li, Fen; Liu, Meng-Zhi; Hua, Qing-Quan; Tao, Ze-Zhang			Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3	PLOS ONE			English	Article							IMMUNE-SYSTEM; MICRORNA; EXPRESSION; RHINITIS; DIFFERENTIATION; DISEASE; LUNG	Mast cell (MC) degranulation is the foundation of the acute phase of allergic rhinitis (AR). Previously, downregulation of GATA binding protein 3 (GATA-3) was shown to suppressMC activation in an AR mouse model. Binding of microRNA-135a (miR-135a) to GATA-3 was also observed, and overexpression of this miRNA decreased GATA-3 mRNA and protein expression. However, the effects ofmiR-135a onMCs during AR are currently unknown. In the present study, we utilized a lentiviral (LV) vector to intranasally administer miR-135a to ovalbumin (OVA)-sensitized AR mice. Following miR-135a treatment, the total serumIgE concentration observed during AR was significantly reduced. In the nasal mucosa, the expression of T-box expressed in T cells (T-bet) was higher, whereas that of GATA-3 was lower in the AR mice following miRNA treatment. Notably, during AR, the ratio of type 1 T-helper cells (Th1) to type 2 (Th2) cells in the spleen is unbalanced, favoring Th2. However, administering miR-135a to the ARmice appeared to balance this ratio by increasing and decreasing the percentage of Th1 and Th2 cells, respectively. MiR-135a also appeared to strongly suppress the infiltration of eosinophils and MCs into the nasal mucosa, and it was specifically localized in the MCs, suggesting that its influence is modulated through regulation of GATA-3 in these cells. Additional work identifying the full therapeutic potential of miR-135a in the treatment of AR and diseases involving allergen-induced inflammation is warranted.	[Deng, Yu-Qin; Yang, Ya-Qi; Li, Fen; Liu, Meng-Zhi; Hua, Qing-Quan; Tao, Ze-Zhang] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430072, Hubei, Peoples R China; [Wang, Shui-Bin] Yichang Yiling Hosp, Dept Otolaryngol Head & Neck Surg, Yichang, Hubei, Peoples R China	Wuhan University	Tao, ZZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430072, Hubei, Peoples R China.	taozezhang@163.com		Wang, Shui/0000-0002-0307-7658	National Nature Science Foundation of China [81300813]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was suported by the National Nature Science Foundation of China grant 81300813 awarded to YQD.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baxter D, 2012, IMMUNOL CELL BIOL, V90, P288, DOI 10.1038/icb.2011.114; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; Chen RF, 2010, CLIN EXP ALLERGY, V40, P1482, DOI 10.1111/j.1365-2222.2010.03592.x; Deho' L, 2010, ARCH IMMUNOL THER EX, V58, P279, DOI 10.1007/s00005-010-0086-x; Hellings PW, 2010, CURR ALLERGY ASTHM R, V10, P143, DOI 10.1007/s11882-010-0107-1; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Kanasty RL, 2012, MOL THER, V20, P513, DOI 10.1038/mt.2011.294; Klein Jan A, 2014, J IMMUNOL, V192, P1385, DOI [10.4049/jimmunol.1301888, DOI 10.4049/JIMMUNOL.1301888]; Lampinen M, 1999, CLIN EXP ALLERGY, V29, P314; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Loewen N, 2005, ADV BIOCHEM ENG BIOT, V99, P169, DOI 10.1007/10_007; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Luo YY, 2014, EXP THER MED, V8, P1105, DOI 10.3892/etm.2014.1855; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pfeifer Alexander, 2009, V530, P391, DOI 10.1007/978-1-59745-471-1_21; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shin SH, 2014, BIOL PHARM BULL, V37, P1295, DOI 10.1248/bpb.b14-00102; Suojalehto H, 2014, INT ARCH ALLERGY IMM, V163, P168, DOI 10.1159/000358486; Temkin V, 2001, CYTOKINE, V15, P20, DOI 10.1006/cyto.2001.0890; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tiwari A, 2014, J BIOL CHEM, V289, P32276, DOI 10.1074/jbc.M114.584136; VUKELJA SJ, 1988, CANCER, V62, P1527, DOI 10.1002/1097-0142(19881015)62:8<1527::AID-CNCR2820620813>3.0.CO;2-X; Welker P, 2000, J INVEST DERMATOL, V114, P44, DOI 10.1046/j.1523-1747.2000.00827.x; Winandy S, 2007, NAT IMMUNOL, V8, P796, DOI 10.1038/ni0807-796; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Zhang XH, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0415-3; ZON LI, 1991, J BIOL CHEM, V266, P22948	38	39	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139322	10.1371/journal.pone.0139322	http://dx.doi.org/10.1371/journal.pone.0139322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418311	Green Published, Green Submitted, gold			2022-12-26	WOS:000362171400076
J	Han, F; Zhou, DY; Liu, XX; Cheng, J; Zhang, QW; Shelton, AM				Han, Fei; Zhou, Dingyang; Liu, Xiaoxia; Cheng, Jie; Zhang, Qingwen; Shelton, Anthony M.			Attitudes in China about Crops and Foods Developed by Biotechnology	PLOS ONE			English	Article							GENETICALLY-MODIFIED RICE; EXPERIMENTAL AUCTIONS; CONSUMER ACCEPTANCE; MULTIPLE CROPS; BT COTTON; GM CROPS; WILLINGNESS; ADOPTION; PLANT; SCIENTISTS	Transgenic Bt cotton has been planted in China since 1997 and, in 2009, biosafety certificates for the commercial production of Bt rice and phytase corn were issued by the Chinese government. The public attitude in China toward agricultural biotechnology and genetically modified (GM) crops and foods has received considerable attention worldwide. We investigated the attitudes of consumers, Bt cotton farmers and scientists in China regarding GM crops and foods and the factors influencing their attitudes. Data were collected using interview surveys of consumer households, farmer households and scientists. A discrete choice approach was used to elicit the purchase intentions of the respondents. Two separate probit models were developed to examine the effect of various factors on the choices of the respondents. Bt cotton farmers had a very positive attitude because Bt cotton provided them with significant economic benefits. Chinese consumers from developed regions had a higher acceptance and willingness to pay for GM foods than consumers in other regions. The positive attitude toward GM foods by the scientific community will help to promote biotechnology in China in the future. Our survey emphasized that educational efforts made by government officials, the media and scientists can facilitate the acceptance of GM technology in China. Further educational efforts will be critical for influencing consumer attitudes and decisions of government agencies in the future. More effective educational efforts by government agencies and public media concerning the scientific facts and safety of GM foods would enhance the acceptance of GM crops in China.	[Han, Fei; Liu, Xiaoxia; Zhang, Qingwen] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhou, Dingyang] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Han, Fei; Liu, Xiaoxia; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Cheng, Jie] Chinese Acad Social Sci, Inst Populat & Labor Econ, Beijing, Peoples R China	China Agricultural University; Beijing Normal University; Cornell University; Chinese Academy of Social Sciences	Zhang, QW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	zhangqingwen@263.net; ams5@cornell.edu			National Transgenic Special Program [2014ZX08011002-006]; 973 Project Grant from the Ministry of Science and Technology of China [2006CB102006]; National Key Technologies Research and Development Program of China [2008BADA5B06]	National Transgenic Special Program; 973 Project Grant from the Ministry of Science and Technology of China; National Key Technologies Research and Development Program of China(National Key Technology R&D Program)	This work was supported by National Transgenic Special Program (2014ZX08011002-006), the 973 Project Grant (2006CB102006) from the Ministry of Science and Technology of China and the National Key Technologies Research and Development Program of China (2008BADA5B06).	Amin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086174; Areal FJ, 2011, PLANT BIOTECHNOL J, V9, P945, DOI 10.1111/j.1467-7652.2011.00651.x; Brookes G, 2015, GM CROPS FOOD, V6, P13, DOI 10.1080/21645698.2015.1022310; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; De Steur H, 2010, APPETITE, V54, P118, DOI 10.1016/j.appet.2009.09.017; De Steur H, 2012, FOOD QUAL PREFER, V25, P87, DOI 10.1016/j.foodqual.2012.02.001; Finney D.J., 1971, PROBIT ANAL; Frewer LJ, 1997, SCI TECHNOL HUM VAL, V22, P98, DOI 10.1177/016224399702200105; Govindasamy R, 2008, AGRIBUSINESS, V24, P102, DOI 10.1002/agr.20149; Hall C, 2008, GEOFORUM, V39, P204, DOI 10.1016/j.geoforum.2007.06.003; Hoban TJ, 1997, NAT BIOTECHNOL, V15, P232, DOI 10.1038/nbt0397-232; Huang JK, 2006, APPETITE, V46, P144, DOI 10.1016/j.appet.2005.11.005; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Jia HP, 2010, NAT BIOTECHNOL, V28, P390, DOI 10.1038/nbt0510-390b; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041838; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kouser S, 2011, ECOL ECON, V70, P2105, DOI 10.1016/j.ecolecon.2011.06.008; Lu Changming, 2010, GM Crops, V1, P113, DOI 10.4161/gmcr.1.3.12377; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lusk JL, 2004, EUR REV AGRIC ECON, V31, P179, DOI 10.1093/erae/31.2.179; Macer D, 2000, NAT BIOTECHNOL, V18, P945, DOI 10.1038/79425; McGloughlin MN, 2010, NEW BIOTECHNOL, V27, P494, DOI 10.1016/j.nbt.2010.07.013; Okazaki Y, 2012, PLANT BIOTECHNOL REP, V6, P1, DOI 10.1007/s11816-011-0191-2; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; Pray C., 2007, AgBioForum, V10, P161; Shelton AM, 2010, CROP PROT, V29, P412, DOI 10.1016/j.cropro.2010.02.016; Stone R, 2008, SCIENCE, V321, P1279, DOI 10.1126/science.321.5894.1279; Stone R, 2011, SCIENCE, V331, P1000, DOI 10.1126/science.331.6020.1000; Wally Owen, 2010, GM Crops, V1, P199, DOI 10.4161/gmcr.1.4.13225; Wang Q, 2015, NATURE, V519, P7, DOI 10.1038/519007a; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang XY, 2010, FOOD POLICY, V35, P456, DOI 10.1016/j.foodpol.2010.04.008	36	19	19	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139114	10.1371/journal.pone.0139114	http://dx.doi.org/10.1371/journal.pone.0139114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418161	gold, Green Submitted, Green Published			2022-12-26	WOS:000362171400043
J	Zwakenberg, SR; Gundberg, CM; Spijkerman, AMW; van der A, DL; van der Schouw, YT; Beulens, JWJ				Zwakenberg, Sabine R.; Gundberg, Caren M.; Spijkerman, Annemieke M. W.; van der A, Daphne L.; van der Schouw, Yvonne T.; Beulens, Joline W. J.			Osteocalcin Is Not Associated with the Risk of Type 2 Diabetes: Findings from the EPIC-NL Study	PLOS ONE			English	Article							CARBOXYLASE GENE POLYMORPHISM; VITAMIN-K; GAMMA-CARBOXYLATION; OLDER MEN; METABOLISM; LEVEL	Objective To investigate whether total osteocalcin (tOC), uncarboxylated osteocalcin (ucOC) and percentage of uncarboxylated osteocalcin (%ucOC) are associated with the risk of type 2 diabetes. Methods This nested case control study included 1,635 participants, 833 incident diabetes cases and 802 non-diabetic control participants, aged 21-70 years from the EPIC-NL cohort. Baseline concentrations of tOC, ucOC and %ucOC were assessed. During 10 years of follow-up, diabetes cases were self-reported and verified against information from general practitioners or pharmacists. The association between the different forms of osteocalcin and diabetes risk was assessed with logistic regression adjusted for diabetes risk factors (waist circumference, age, sex, cohort, smoking status, family history of diabetes, hypertension, alcohol intake, physical activity and education) and dietary factors (total energy intake and energy adjusted intake of fat, fiber, protein and calcium). Results TOC concentration was not associated with diabetes risk, with an odds ratio (OR) of 0.97 (0.91-1.03) for each ng/ml increment after adjustment for diabetes risk factors and dietary factors. No association between ucOC and % ucOC and the risk of diabetes was observed either. In sex stratified analyses (P interaction = 0.07), higher % ucOC tended to be associated with an increased risk of type 2 diabetes in a multivariable model in women (OR 1.05 for each increment of 5% ucOC (1.00-1.11), P-trend = 0.08), but not in men (OR 0.96 for each increment of 5% ucOC (0.88-1.04)). When waist circumference was replaced by body mass index, none of the osteocalcin forms were associated with the risk of type 2 diabetes in the final model among both women and men. Conclusions Available evidence suggests that tOC, ucOC and %ucOC are each not associated with the risk of type 2 diabetes. However, more large-scale cohort studies are needed to clarify the presence of any association between the different forms of osteocalcin and the risk of type 2 diabetes.	[Zwakenberg, Sabine R.; van der Schouw, Yvonne T.; Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Gundberg, Caren M.] Yale Univ, Sch Med, Dept Orthopaed, New Haven, CT USA; [Spijkerman, Annemieke M. W.; van der A, Daphne L.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Yale University; Netherlands National Institute for Public Health & the Environment	Zwakenberg, SR (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	s.r.zwakenberg-3@umcutrecht.nl	van der Schouw, Yvonne T./F-8327-2014	van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937	"Europe against Cancer" program of the European Commission; Dutch Ministry of Public Health, Welfare and Sports; Dutch Cancer Society, ZonMW; Netherlands Organization for Health Research and Development; World Cancer Research Fund (WCRF); European Foundation for the Study of Diabetes (EFSD)/Janssen "Rising star" research fellowship; Dutch Heart Foundation [2013T120]	"Europe against Cancer" program of the European Commission; Dutch Ministry of Public Health, Welfare and Sports; Dutch Cancer Society, ZonMW(KWF KankerbestrijdingNetherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); European Foundation for the Study of Diabetes (EFSD)/Janssen "Rising star" research fellowship; Dutch Heart Foundation(Netherlands Heart Foundation)	The EPIC-NL study was funded by "Europe against Cancer" program of the European Commission, the Dutch Ministry of Public Health, Welfare and Sports, the Dutch Cancer Society, ZonMW, the Netherlands Organization for Health Research and Development and the World Cancer Research Fund (WCRF). Analyses of the vitamin K biomarkers were funded by a European Foundation for the Study of Diabetes (EFSD)/Janssen "Rising star" research fellowship (JWJ Beulens). J.W.J. Beulens and S.R. Zwakenberg are supported by the Senior Dr. Dekker grant (2013T120) from the Dutch Heart Foundation.	Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Booth SL, 2009, ANNU REV NUTR, V29, P89, DOI 10.1146/annurev-nutr-080508-141217; Bullo M, 2012, AM J CLIN NUTR, V95, P249, DOI 10.3945/ajcn.111.016642; Choi Hyung Jin, 2011, Diabetes Care, V34, pe147, DOI 10.2337/dc11-0551; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P4524, DOI 10.1210/jc.2013-2472; Fawzy T, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/876309; Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834; Haraikawa M, 2013, ASIA PAC J CLIN NUTR, V22, P646, DOI 10.6133/apjcn.2013.22.4.01; Hwang YC, 2012, DIABETES CARE, V35, P1919, DOI 10.2337/dc11-2471; Kunutsor SK, 2015, EUR J EPIDEMIOL; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liatis S, 2014, DIABETES METAB, V40, P198, DOI 10.1016/j.diabet.2014.01.001; Ngarmukos C, 2012, CLIN ENDOCRINOL, V77, P42, DOI 10.1111/j.1365-2265.2011.04215.x; Obrant KJ, 1999, J BONE MINER RES, V14, P555, DOI 10.1359/jbmr.1999.14.4.555; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schurgers LJ, 2001, PATHOPHYSIOL HAEMO T, V30, P298, DOI DOI 10.1159/000054147; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Shearer MJ, 1996, J NUTR, V126, pS1181, DOI 10.1093/jn/126.suppl_4.1181S; Sluijs I, 2010, NETH J MED, V68, P333; Sogabe N, 2007, J NUTR SCI VITAMINOL, V53, P419, DOI 10.3177/jnsv.53.419; Vermeer C., 2012, VITAMIN K EFFECT HLT; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yeap BB, 2014, J CLIN ENDOCR METAB, V99, pE9, DOI 10.1210/jc.2013-3272	26	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138693	10.1371/journal.pone.0138693	http://dx.doi.org/10.1371/journal.pone.0138693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418005	Green Published, gold			2022-12-26	WOS:000362171400020
J	Davies, JM; Santaolalla, R; von Furstenberg, RJ; Henning, SJ; Abreu, MT				Davies, Julie M.; Santaolalla, Rebeca; von Furstenberg, Richard J.; Henning, Susan J.; Abreu, Maria T.			The Viral Mimetic Polyinosinic: Polycytidylic Acid Alters the Growth Characteristics of Small Intestinal and Colonic Crypt Cultures	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INFLAMMATORY-BOWEL-DISEASE; STEM-CELL ORGANIZATION; TOLL-LIKE RECEPTOR-3; GERM-FREE MICE; EPITHELIAL-CELLS; IN-VITRO; MODEL; TLR3; RECOGNITION	Background & Aims The intestinal epithelium is the first line of defense against enteric pathogens. We investigated the response of small intestinal and colonic crypt cultures to a panel of toll-like receptor ligands to assess the impact of microbial pattern recognition on epithelial growth. Methods Primary murine jejunal enteroids and colonoids were cultured with lipopeptide Pam3CSK4, lipopolysaccharide (LPS) or polyinosinic: polycytidylic acid (Poly I: C) for 4 to 6 days. Surface area, budding and survival were assessed. Proliferation and numbers of lysozyme positive cells were quantified by flow cytometry. Gene expression was assessed by Nanostring and qRT-PCR. Results Exposure to Pam3CSK4 and LPS hadminimal impact on either enteroids or colonoids. In contrast, Poly I: C increased the surface area of enteroids, while colonoids demonstrated decreased budding. Survival was decreased by Poly I: C in enteroids but not in colonoids. Both enteroids and colonoids exhibited upregulated gene expression of chemokines, but these were increased in magnitude in enteroids. Decreases in gene expression associated with epithelial differentiation and lysozyme positive cells weremore apparent in enteroids than in colonoids. Baseline gene expression between enteroids and colonoids differed markedly in levels of stem cell and inflammatorymarkers. The changes inmorphology induced by Poly I: C were mediated by the toll-like receptor adaptor molecule 1 (Ticam1) in enteroids but not in colonoids. Conclusions Poly I: C alters the molecular program of epithelial cells and shifts from absorption and digestion towards defense and inflammation. Diversity of responses to microbial patterns inenteroids and colonoids may underlie differences in susceptibility to infection along the intestinal tract.	[Davies, Julie M.; Santaolalla, Rebeca; Abreu, Maria T.] Univ Miami, Miller Sch Med, Div Gastroenterol, Miami, FL 33136 USA; [von Furstenberg, Richard J.; Henning, Susan J.] Univ N Carolina, Dept Med & Cell Biol & Physiol, Chapel Hill, NC USA	University of Miami; University of North Carolina; University of North Carolina Chapel Hill	Abreu, MT (corresponding author), Univ Miami, Miller Sch Med, Div Gastroenterol, Miami, FL 33136 USA.	mabreu1@med.miami.edu	Davies, Julie/AAU-7129-2021	Davies, Julie/0000-0003-4035-6047; Abreu, Maria T./0000-0002-7294-0574	National Institute of Health, National Cancer Institute [5R01CA137869-05]; National Institute of Diabetes and Digestive and Kidney Diseases [2R01DK099076-06A1]; Crohn's and Colitis Foundation of America Senior Research Award [3786]; Crohn's and Colitis Foundation of America Research Fellowship Award [3591]; Micky AMP; Madeleine Arison Family Foundation Crohn's AMP; Colitis Discovery Laboratory; NATIONAL CANCER INSTITUTE [R01CA137869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099076] Funding Source: NIH RePORTER	National Institute of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America Senior Research Award; Crohn's and Colitis Foundation of America Research Fellowship Award; Micky AMP; Madeleine Arison Family Foundation Crohn's AMP; Colitis Discovery Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by grants to MTA (National Institute of Health, National Cancer Institute 5R01CA137869-05, National Institute of Diabetes and Digestive and Kidney Diseases 2R01DK099076-06A1; and Crohn's and Colitis Foundation of America Senior Research Award #3786), and to RS (Crohn's and Colitis Foundation of America Research Fellowship Award #3591). Additional funding was provided by The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Araya RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099236; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Borghan MA, 2007, J GEN VIROL, V88, P2064, DOI 10.1099/vir.0.82618-0; Brown M, 2014, CLIN EXP IMMUNOL, V178, P28, DOI 10.1111/cei.12381; Buske P, 2012, FEBS J, V279, P3475, DOI 10.1111/j.1742-4658.2012.08646.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cramer JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118792; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fuller MK, 2013, CELL TISSUE RES, V354, P441, DOI 10.1007/s00441-013-1674-y; Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037; Gourbeyre P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12225; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; HEYMAN M, 1987, PEDIATR RES, V22, P72, DOI 10.1203/00006450-198707000-00017; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; KHOURY KA, 1969, J EXP MED, V130, P659, DOI 10.1084/jem.130.3.659; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; McAllister CS, 2013, J IMMUNOL, V190, P418, DOI 10.4049/jimmunol.1202756; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Pin C, 2015, INTEGR BIOL-UK, V7, P213, DOI 10.1039/c4ib00236a; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Seya T, 2012, ONCOIMMUNOLOGY, V1, P917, DOI 10.4161/onci.21244; Sommer F, 2015, MUCOSAL IMMUNOL, V8, P372, DOI 10.1038/mi.2014.74; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Xu J, 2009, INFLAMM RES, V58, P585, DOI 10.1007/s00011-009-0022-x; Zhou Y, 2013, INNATE IMMUN-LONDON, V19, P184, DOI 10.1177/1753425912459975	45	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138531	10.1371/journal.pone.0138531	http://dx.doi.org/10.1371/journal.pone.0138531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414184	Green Submitted, Green Published, gold			2022-12-26	WOS:000362170700019
J	Ma, L; Wang, JT; Wu, TL; Siu, LK; Chuang, YC; Lin, JC; Lu, MC; Lu, PL				Ma, Ling; Wang, Jann-Tay; Wu, Tsu-Lan; Siu, L. Kristopher; Chuang, Yin-Ching; Lin, Jung-Chung; Lu, Min-Chi; Lu, Po-Liang			Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BETA-LACTAMASES; PLASMID; CARBAPENEMASES; RESISTANCE; OXA-48; IDENTIFICATION; SURVEILLANCE; CTX-M-15; IMIPENEM	The isolation of OXA-48-producing Enterobacteriaceae has increased dramatically in Mediterranean countries in the past 10 years, and has recently emerged in Asia. Between January 2012 and May 2014, a total of 760 carbapenem non-susceptible Klebsiella pneumoniae (CnSKP) isolates were collected during a Taiwan national surveillance. Carbapenemases were detected in 210 CnSKP isolates (27.6%), including 162 KPC-2 (n = 1), KPC-3, KPC17, and NDM-1 (n = 1 each), OXA-48 (n = 4), IMP-8 (n = 18), and VIM-1 (n = 24). The four blaOXA-48 CnSKP isolates were detected in late 2013. Herein we report the emergence OXA-48-producing K. pneumoniae isolates in Taiwan. PFGE analysis revealed that the four isolates belonged to three different pulsotypes. Three isolates harboured bla(CTX-M) genes and belonged to MLST type ST11. In addition, the plasmids belonged to the incompatibility group, IncA/C. One isolate belonged to ST116 and the plasmid incompatibility group was non-typeable. The sequence upstream of the bla(OXA-48) gene in all four isolates was identical to pKP(OXA)-48N1, a bla(OXA-48)-carrying plasmid. This is the first report of OXA-48-producing Enterobacteriaceae in Taiwan and the second report to identify bla(OXA-48) on an IncA/C plasmid in K. pneumoniae. Given that three isolates belong to the same pandemic clone (ST11) and possess the IncA/ C plasmid and similar plasmid digestion profile that indicated the role of clonal spread or plasmid for dissemination of bla(OXA-48) gene, the emergence of OXA-48-producing K. pneumoniae in Taiwan is of great concern.	[Ma, Ling; Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis, Miaoli, Taiwan; [Ma, Ling; Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Vaccinol, Miaoli, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Tsu-Lan] Linkou Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med & Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Jung-Chung] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lu, Min-Chi] Chung Shan Med Univ Hosp, Infect Dis Sect, Dept Med, Taichung 40201, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chi Mei Hospital; Chi Mei Hospital; National Defense Medical Center; Tri-Service General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Lu, MC (corresponding author), Chung Shan Med Univ Hosp, Infect Dis Sect, Dept Med, Taichung 40201, Taiwan.	luminchi@csmu.edu.tw; d830166@cc.kmu.edu.tw	Lu, Po-Liang/D-4499-2009	Lu, Po-Liang/0000-0002-7423-6783; WANG, JANN-TAY/0000-0002-0924-3469	Center for Diseases Control, Taiwan [MOHW103-CDC-C-114-134504]; Kaohsiung Medical University Research Foundation	Center for Diseases Control, Taiwan; Kaohsiung Medical University Research Foundation	This work was supported MOHW103-CDC-C-114-134504 from the Center for Diseases Control, Taiwan and by Kaohsiung Medical University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2004, ANTIMICROB AGENTS CH, V48, P533, DOI 10.1128/AAC.48.2.533-537.2004; [Anonymous], 2014, M100S24 CLIN LAB STA, P34; Berger S, 2013, ANTIMICROB AGENTS CH, V57, P4064, DOI 10.1128/AAC.02550-12; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Chouchani C, 2012, EUR J CLIN MICROBIOL, V31, P1081, DOI 10.1007/s10096-011-1410-z; Cockerill FR, 2012, METHODS DILUTION ANT; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Hrabak J, 2009, J CLIN MICROBIOL, V47, P3353, DOI 10.1128/JCM.00901-09; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Ko KS, 2010, J MED MICROBIOL, V59, P822, DOI 10.1099/jmm.0.018119-0; Ktari S, 2011, J ANTIMICROB CHEMOTH, V66, P1644, DOI 10.1093/jac/dkr181; Lascols C, 2013, ANTIMICROB AGENTS CH, V57, P130, DOI 10.1128/AAC.01686-12; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Liapis E, 2014, CLIN MICROBIOL INFEC, V20, pO1121, DOI 10.1111/1469-0691.12727; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Potron A, 2013, J ANTIMICROB CHEMOTH, V68, P476, DOI 10.1093/jac/dks397; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	26	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139152	10.1371/journal.pone.0139152	http://dx.doi.org/10.1371/journal.pone.0139152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414183	Green Submitted, gold, Green Published			2022-12-26	WOS:000362170700045
J	Deacon, NJ; Cavender-Bares, J				Deacon, Nicholas John; Cavender-Bares, Jeannine			Limited Pollen Dispersal Contributes to Population Genetic Structure but Not Local Adaptation in Quercus oleoides Forests of Costa Rica	PLOS ONE			English	Article							TROPICAL DRY FOREST; 2-GENERATION ANALYSIS; BUR OAK; PHENOTYPIC PLASTICITY; SEED DISPERSAL; CHAMAECRISTA-FASCICULATA; ENVIRONMENTAL GRADIENT; DIVERGENT SELECTION; LANDSCAPE GENETICS; PATERNITY ANALYSIS	Background 0pc?>Quercus oleoides Cham. and Schlect., tropical live oak, is a species of conservation importance in its southern range limit of northwestern Costa Rica. It occurs in high-density stands across a fragmented landscape spanning a contrasting elevation and precipitation gradient. We examined genetic diversity and spatial genetic structure in this geographically isolated and genetically distinct population. We characterized population genetic diversity at 11 nuclear microsatellite loci in 260 individuals from 13 sites. We monitored flowering time at 10 sites, and characterized the local environment in order to compare observed spatial genetic structure to hypotheses of isolation-by-distance and isolation-by-environment. Finally, we quantified pollen dispersal distances and tested for local adaptation through a reciprocal transplant experiment in order to experimentally address these hypotheses. Results High genetic diversity ismaintained in the population and the genetic variation is significantly structured among sampled sites. We identified 5 distinct genetic clusters and average pollen dispersal predominately occurred over short distances. Differences among sites in flowering phenology and environmental factors, however, were not strictly associated with genetic differentiation. Growth and survival of upland and lowland progeny in their native and foreign environments was expected to exhibit evidence of local adaptation due to the more extreme dry season in the lowlands. Seedlings planted in the lowland garden experienced much higher mortality than seedlings in the upland garden, but we did not identify evidence for local adaptation. Conclusion Overall, this study indicates that the Costa Rican Q. oleoides population has a rich population genetic history. Despite environmental heterogeneity and habitat fragmentation, isolation-by-distance and isolation-by-environment alone do not explain spatial genetic structure. These results add to studies of genetic structure by examining a common, tropical tree over multiple habitats and provide information for managers of a successional forest in a protected area.	[Deacon, Nicholas John; Cavender-Bares, Jeannine] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Deacon, Nicholas John] Univ Minnesota, Plant Biol Sci Grad Program, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Deacon, NJ (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	deac0004@umn.edu	Deacon, Nicholas/AAA-9150-2020; Cavender-Bares, Jeannine/K-5716-2013; Deacon, Nick/T-6347-2019	Deacon, Nicholas/0000-0002-6180-9888; Cavender-Bares, Jeannine/0000-0003-3375-9630	NSF [IOS-0843665]; University of Minnesota	NSF(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	Funding: The study was funded in part by NSF Grant IOS-0843665 to JCB and by The University of Minnesota to NJD including: Dayton-Wilkie Grant, Carolyn Crosby Fellowship, College of Food, Agriculture and Natural Resource Sciences Fellowship, Doctoral Dissertation International Research Grant, the Minnesota Center for Community Genetics, and the Plant Biological Sciences Graduate Program Travel and Summer Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Austerlitz F, 2002, GENETICS, V161, P355; Austerlitz F, 2001, GENET RES, V78, P271, DOI 10.1017/S0016672301005341; Austerlitz F, 2001, GENETICS, V157, P851; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; BECKER M, 1994, ANN SCI FOREST, V51, P477, DOI 10.1051/forest:19940504; Becknell JM, 2012, FOREST ECOL MANAG, V276, P88, DOI 10.1016/j.foreco.2012.03.033; BERG EE, 1995, EVOLUTION, V49, P110, DOI 10.1111/j.1558-5646.1995.tb05963.x; Bischoff A, 2006, BASIC APPL ECOL, V7, P347, DOI 10.1016/j.baae.2005.07.009; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BOUCHER DH, 1983, COSTA RICAN NATURAL, P319; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Cavender-Bares J, 2011, J BIOGEOGRAPHY; Cavender-Bares J, 2015, J BIOGEOGRAPHY; Cavender-Bares J, 2007, PHOTOSYNTH RES, V94, P437, DOI 10.1007/s11120-007-9215-8; Cavender-Bares J, 2011, J BIOGEOGR, V38, P962, DOI 10.1111/j.1365-2699.2010.02451.x; Cavender-Bares J, 2009, AM J BOT, V96, P1690, DOI 10.3732/ajb.0800315; Chapotin SM, 2003, PLANT CELL ENVIRON, V26, P623, DOI 10.1046/j.1365-3040.2003.00998.x; Clausen J, 1940, EXPT STUDIES NATURE; Craft KJ, 2007, FOREST ECOL MANAG, V239, P13, DOI 10.1016/j.foreco.2006.11.005; Craft KJ, 2006, CAN J FOREST RES, V36, P206, DOI 10.1139/x05-234; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; de Jong G, 2005, NEW PHYTOL, V166, P101, DOI 10.1111/j.1469-8137.2005.01322.x; Deacon NJ, 2010, POPULATION GENETIC S; Derory J, 2010, HEREDITY, V104, P438, DOI 10.1038/hdy.2009.134; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dow BD, 1998, NEW FOREST, V15, P161, DOI 10.1023/A:1006557904751; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Dutech C, 2005, AM J BOT, V92, P252, DOI 10.3732/ajb.92.2.252; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2004, HEREDITY, V92, P204, DOI 10.1038/sj.hdy.6800397; Epperson BK, 1997, EVOLUTION, V51, P275, DOI 10.1111/j.1558-5646.1997.tb02409.x; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Etterson JR, 2004, EVOLUTION, V58, P1459, DOI 10.1111/j.0014-3820.2004.tb01727.x; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2001, GENETICS AND BIOMETR; Fernandez JF, 2005, J HERED, V96, P635, DOI 10.1093/jhered/esi104; Gailing O, 2008, PLANT BIOLOGY, V10, P624, DOI 10.1111/j.1438-8677.2008.00063.x; Gao H, 2007, GENETICS; Gerber S, 2003, MOL ECOL NOTES, V3, P479, DOI 10.1046/j.1471-8286.2003.00439.x; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; Gonzalez-Rodriguez A, 2005, BOT J LINN SOC, V147, P427, DOI 10.1111/j.1095-8339.2004.00394.x; Gram WK, 2001, ECOLOGY, V82, P2012, DOI 10.1890/0012-9658(2001)082[2012:ABEAGH]2.0.CO;2; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; HALLWACHS W, 1994, CLUMSY DANCE AGOUTIS; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy OJ, 2003, GENETICS, V163, P1467; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Hereford J, 2008, NEW PHYTOL, V178, P888, DOI 10.1111/j.1469-8137.2008.02405.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Herrera W., 1986, CLIMA COSTA RICA, V2; HEYWOOD JS, 1991, ANNU REV ECOL SYST, V22, P335, DOI 10.1146/annurev.es.22.110191.002003; Hirao AS, 2004, HEREDITY, V93, P290, DOI 10.1038/sj.hdy.6800503; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; JACKSON MT, 1966, ECOLOGY, V47, P407, DOI 10.2307/1932980; Janzen D.H., 1986, GUANACASTE NATL PARK; JANZEN DH, 1988, ANN MO BOT GARD, V75, P105, DOI 10.2307/2399468; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kissing LB, 2010, J TROP ECOL, V26, P467, DOI 10.1017/S0266467410000131; Klemens J, 2011, SEASONALLY DRY TROPI; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; McClean CJ, 2005, ANN MO BOT GARD, V92, P139; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Nakanishi A, 2005, MOL ECOL, V14, P4469, DOI 10.1111/j.1365-294X.2005.02736.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ortego J, 2015, PLANT BIOLOGY, V17, P676, DOI 10.1111/plb.12272; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Pritchard JK, 2000, GENETICS, V155, P945; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Ramirez-Valiente JA, 2010, EVOL ECOL, V24, P1031, DOI 10.1007/s10682-010-9365-6; Ramirez-Valiente JA, 2009, FOREST ECOL MANAG, V257, P1676, DOI 10.1016/j.foreco.2009.01.024; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; RICE KJ, 1993, OECOLOGIA, V96, P537, DOI 10.1007/BF00320511; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; Slavov GT, 2009, MOL ECOL, V18, P357, DOI 10.1111/j.1365-294X.2008.04016.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2004, FOREST ECOL MANAG, V197, P21, DOI 10.1016/j.foreco.2004.05.049; Smouse PE, 2001, EVOLUTION, V55, P260; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; Steinkellner H, 1997, PLANT MOL BIOL, V33, P1093, DOI 10.1023/A:1005736722794; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; TONSOR SJ, 1985, OECOLOGIA, V67, P442, DOI 10.1007/BF00384953; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Volis S, 2004, AM NAT, V163, P312, DOI 10.1086/381406; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weis AE, 2005, EVOL ECOL RES, V7, P161; Wright S, 1943, GENETICS, V28, P114; Yamagishi H, 2005, ECOL RES, V20, P199, DOI 10.1007/s11284-004-0032-7; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; You FM, 2004, PLANT AN GEN 12 C SA	117	25	26	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138783	10.1371/journal.pone.0138783	http://dx.doi.org/10.1371/journal.pone.0138783			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407244	gold, Green Published, Green Submitted			2022-12-26	WOS:000361800700096
J	Maruyama, H; Yonemoto, N; Kono, Y; Kusuda, S; Fujimura, M				Maruyama, Hidehiko; Yonemoto, Naohiro; Kono, Yumi; Kusuda, Satoshi; Fujimura, Masanori		Neonatal Res Network Japan	Weight Growth Velocity and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; POSTNATAL-GROWTH; PREMATURE-INFANTS; JAPAN; BORN; AGE; GESTATION; MORBIDITY; NUTRITION; MORTALITY	Introduction This study aimed to assess whether weight growth velocity (WGV) predicts neurodevelopmental outcomes in extremely low birth weight infants (ELBWIs). Methods Subjects were infants who weighed 501-1000 g at birth and were included in the cohort of the Neonatal Research Network of Japan (2003-2007). Patel's exponential model (EM) method was used to calculate WGV between birth and discharge. Assessment of predictions of death or neurodevelopmental impairment (NDI) was performed at 3 years of age based on the WGV score, which was categorized by per one increase in WGV. Multivariate logistic regression analysis was used to calculate adjusted odds ratios and their 95% confidence intervals (95%CI). Results In the 2961 ELBWIs assessed, the median WGV was 10.5 g/kg/day (interquartile, 9.41-1.9). With the categorical approach, the adjusted odds ratios for death or NDI with WGV scores of 6 and 7 were 2.41 (95% CI, 1.60-3.62) and 1.81 (95% CI, 1.18-2.75), respectively, relative to the reference WGV score of 10. WGV scores >= 8 did not predict death or NDI. Conclusions WGV scores <8 were significant predictors suggesting that values of WGV during hospitalization in a NICU are associated with neurodevelopmental outcomes. Further investigations is necessary to determine whether additional nutritional support may improve low WGV in ELBWIs.	[Maruyama, Hidehiko] Kochi Hlth Sci Ctr, Dept Pediat, Kochi, Kochi, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Kodaira, Tokyo, Japan; [Kono, Yumi] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Kusuda, Satoshi] Tokyo Womens Med Univ, Maternal & Perinatal Ctr, Dept Neonatol, Tokyo, Japan; [Fujimura, Masanori] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Neonatol, Izumi, Osaka, Japan	National Center for Neurology & Psychiatry - Japan; Jichi Medical University; Tokyo Women's Medical University	Yonemoto, N (corresponding author), Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Kodaira, Tokyo, Japan.	nyonemoto@gmail.com	Naohiro, Yonemoto/Y-3761-2019	Hosono, Shigeharu/0000-0002-5319-6153; Kusuda, Satoshi/0000-0001-5318-8877; SOBAJIMA, HISANORI/0000-0002-7976-3945	Ministry of Health, Labour and Welfare, Japan [H25-IRYO-SHITEI-008]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported only by a grant from the Ministry of Health, Labour and Welfare, Japan, in 2013-2014 (H25-IRYO-SHITEI-008) (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchieta LM, 2003, BRAZ J MED BIOL RES, V36, P761, DOI 10.1590/S0100-879X2003000600012; [Anonymous], 2014, PROTOCOL MULTICENTER; BAUER K, 1991, J PEDIATR-US, V118, P615, DOI 10.1016/S0022-3476(05)83390-6; BAX MC, 1964, DEV MED CHILD NEUROL, V11, P295; Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bertino E, 2006, ARCH DIS CHILD-FETAL, V91, P349, DOI 10.1136/adc.2005.090993; Campos M, 2008, P R HEALTH SCI J, V27, P141; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Carpenter JR, 2013, MULTIPLE IMPUTATIONS; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ishii N, 2013, PEDIATRICS, V132, P62, DOI 10.1542/peds.2012-2857; Itabashi K., 2010, JAP J PEDIAT, V114, P1271; Kono Y, 2008, PEDIATR INT, V50, P23, DOI 10.1111/j.1442-200X.2007.02516.x; Kono Y, 2011, PEDIATR INT, V53, P930, DOI 10.1111/j.1442-200X.2011.03424.x; Kono Y, 2011, PEDIATR INT, V53, P1051, DOI 10.1111/j.1442-200X.2011.03480.x; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Mishina J., 2000, J PERINAT MED, P1263; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patel AL, 2009, J PERINATOL, V29, P618, DOI 10.1038/jp.2009.55; Patel AL, 2005, PEDIATRICS, V116, P1466, DOI 10.1542/peds.2004-1699; Pylipow M, 2009, J PEDIATR-US, V154, P201, DOI 10.1016/j.jpeds.2008.08.015; Roze JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000834; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Society for the Kyoto Scale of psychological Development Test, 2008, SHINP K SHIK HATT KE; Su BH, 2014, PEDIATR NEONATOL, V55, P5, DOI 10.1016/j.pedneo.2013.07.003	29	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139014	10.1371/journal.pone.0139014	http://dx.doi.org/10.1371/journal.pone.0139014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402326	gold, Green Published, Green Submitted			2022-12-26	WOS:000361798100051
J	Alonso, E; Lopez-Etxaniz, I; Hurtado, A; Liendo, P; Urbaneja, F; Aspiritxaga, I; Olaizola, JI; Pinero, A; Arrazola, I; Barandika, JF; Hernaez, S; Muniozguren, N; Garcia-Perez, AL				Alonso, Eva; Lopez-Etxaniz, Idoia; Hurtado, Ana; Liendo, Paloma; Urbaneja, Felix; Aspiritxaga, Inmaculada; Ignacio Olaizola, Jose; Pinero, Alvaro; Arrazola, Inaki; Barandika, Jesus F.; Hernaez, Silvia; Muniozguren, Nerea; Garcia-Perez, Ana L.			Q Fever Outbreak among Workers at a Waste-Sorting Plant	PLOS ONE			English	Article							COXIELLA-BURNETII; DOMESTIC RUMINANTS; DIVERSITY	An outbreak of Q fever occurred in February-April 2014 among workers at a waste-sorting plant in Bilbao (Spain). The outbreak affected 58.5% of investigated employees, 47.2% as confirmed cases (PCR and/or serology) and 11.3% as probable cases (symptoms without laboratory confirmation). Only employees who had no-access to the waste processing areas of the plant were not affected and incidence of infection was significantly higher among workers not using respiratory protection masks. Detection by qPCR of Coxiella burnetii in dust collected from surfaces of the plant facilities confirmed exposure of workers inside the plant. Animal remains sporadically detected among the residues received for waste-sorting were the most probable source of infection. After cleaning and disinfection, all environmental samples tested negative. Personal protection measures were reinforced and made compulsory for the staff and actions were taken to raise farmers' awareness of the biological risk of discharging animal carcasses as urban waste.	[Alonso, Eva; Aspiritxaga, Inmaculada; Muniozguren, Nerea] Subdirecc Salud Publ Bizkaia, Dept Epidemiol, Bilbao, Bizkaia, Spain; [Lopez-Etxaniz, Idoia; Urbaneja, Felix; Ignacio Olaizola, Jose] OSALAN Inst Vasco Seguridad & Salud Lab, Dept Epidemiol, Baracaldo, Bizkaia, Spain; [Hurtado, Ana; Pinero, Alvaro; Barandika, Jesus F.; Garcia-Perez, Ana L.] NEIKER, Inst Vasco Invest & Desarrollo Agr, Dept Anim Hlth, Derio, Bizkaia, Spain; [Liendo, Paloma; Hernaez, Silvia] Hosp Univ Basurto, Dept Microbiol, Bilbao, Bizkaia, Spain; [Arrazola, Inaki] Diputac Foral Bizkaia, Dept Agr, Bilbao, Bizkaia, Spain	Basurto Hospital	Garcia-Perez, AL (corresponding author), NEIKER, Inst Vasco Invest & Desarrollo Agr, Dept Anim Hlth, Derio, Bizkaia, Spain.	agarcia@neiker.net	Hurtado, Ana/AAB-2384-2019	Hurtado, Ana/0000-0001-7089-9670; Garcia-Perez, Ana L./0000-0001-7404-1380	Public Health Department of the Basque Government; Spanish National Institute for Agricultural and Food Research and Technology [RTA 2013-00051-C2-00]	Public Health Department of the Basque Government; Spanish National Institute for Agricultural and Food Research and Technology	This work was partially supported by the Public Health Department of the Basque Government (http://www.osasun.ejgv.euskadi.eus/r52-ghhome00/es/) and by the Spanish National Institute for Agricultural and Food Research and Technology (grant RTA 2013-00051-C2-00, http://www.inia.es/IniaPortal/verPresentacion.action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2013, MMWR RECOMM REP, V62, P1; Astobiza I, 2011, RES VET SCI, V91, pE58, DOI 10.1016/j.rvsc.2010.11.014; Astobiza I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-241; Astobiza I, 2011, APPL ENVIRON MICROB, V77, P7405, DOI 10.1128/AEM.05530-11; Astobiza I, 2010, VET J, V184, P172, DOI 10.1016/j.tvjl.2009.01.017; Botner A, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1595; Brooke RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-488; Cilla G, 2008, Euro Surveill, V13; Delgado Naranjo J, 2011, EPIDEMIOL RES INT, V2011; Denison AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-91; Forland F, 2012, EUROSURVEILLANCE, V17, P5; Guatteo R, 2007, VET RES, V38, P849, DOI 10.1051/vetres:2007038; Leone M, 2004, J INFECT DIS, V189, P339, DOI 10.1086/380798; MARRIE TJ, 1990, CAN VET J, V31, P555; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; OIE Terrestrial Manual, 2010, Q FEV; Pinero A, 2015, INFECT GENET EVOL, V31, P231, DOI 10.1016/j.meegid.2015.02.006; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Ruiz-Fons F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-3; Schets FM, 2013, INT J HYG ENVIR HEAL, V216, P698, DOI 10.1016/j.ijheh.2012.12.010; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; van Woerden HC, 2004, EMERG INFECT DIS, V10, P1282, DOI 10.3201/eid1007.030536; WELSH HH, 1951, PUBLIC HEALTH REP, V66, P1473, DOI 10.2307/4587909; Wilson LE, 2010, ZOONOSES PUBLIC HLTH, V57, P493, DOI 10.1111/j.1863-2378.2009.01251.x	27	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138817	10.1371/journal.pone.0138817	http://dx.doi.org/10.1371/journal.pone.0138817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398249	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500112
J	Okazaki, S; Hirotani, M; Koike, T; Bosch-Bayard, J; Takahashi, HK; Hashiguchi, M; Sadato, N				Okazaki, Shuntaro; Hirotani, Masako; Koike, Takahiko; Bosch-Bayard, Jorge; Takahashi, Haruka K.; Hashiguchi, Maho; Sadato, Norihiro			Unintentional Interpersonal Synchronization Represented as a Reciprocal Visuo-Postural Feedback System: A Multivariate Autoregressive Modeling Approach	PLOS ONE			English	Article							SOCIAL-INTERACTION; JOINT ACTION; DYNAMICS; COORDINATION; PERCEPTION; MOTION; STABILIZATION; CONVERSATION; BEHAVIOR; RAPPORT	People's behaviors synchronize. It is difficult, however, to determine whether synchronized behaviors occur in a mutual direction-two individuals influencing one another-or in one direction-one individual leading the other, and what the underlying mechanism for synchronization is. To answer these questions, we hypothesized a non-leader-follower postural sway synchronization, caused by a reciprocal visuo-postural feedback system operating on pairs of individuals, and tested that hypothesis both experimentally and via simulation. In the behavioral experiment, 22 participant pairs stood face to face either 20 or 70 cm away from each other wearing glasses with or without vision blocking lenses. The existence and direction of visual information exchanged between pairs of participants were systematically manipulated. The time series data for the postural sway of these pairs were recorded and analyzed with cross correlation and causality. Results of cross correlation showed that postural sway of paired participants was synchronized, with a shorter time lag when participant pairs could see one another's head motion than when one of the participants was blindfolded. In addition, there was less of a time lag in the observed synchronization when the distance between participant pairs was smaller. As for the causality analysis, noise contribution ratio (NCR), the measure of influence using a multivariate autoregressive model, was also computed to identify the degree to which one's postural sway is explained by that of the other's and how visual information (sighted vs. blindfolded) interacts with paired participants' postural sway. It was found that for synchronization to take place, it is crucial that paired participants be sighted and exert equal influence on one another by simultaneously exchanging visual information. Furthermore, a simulation for the proposed system with a wider range of visual input showed a pattern of results similar to the behavioral results.	[Okazaki, Shuntaro; Hirotani, Masako; Koike, Takahiko; Takahashi, Haruka K.; Hashiguchi, Maho; Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan; [Hirotani, Masako] Carleton Univ, Sch Linguist & Language Studies, Ottawa, ON K1S 5B6, Canada; [Hirotani, Masako] Carleton Univ, Inst Cognit Sci, Ottawa, ON K1S 5B6, Canada; [Bosch-Bayard, Jorge] UNAM, Inst Neurobiol, Unity Neurodev, Santiago De Queretaro, Queretaro, Mexico; [Takahashi, Haruka K.; Hashiguchi, Maho; Sadato, Norihiro] Grad Univ Adv Studies, Dept Physiol Sci, SOKENDAI, Hayama, Kanagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Carleton University; Carleton University; Universidad Nacional Autonoma de Mexico; Graduate University for Advanced Studies - Japan	Hirotani, M (corresponding author), Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan.	masako.hirotani@carleton.ca; sadato@nips.ac.jp	Koike, Takahiko/K-1039-2019; OKAZAKI, SHUNTARO/U-6813-2019; Bosch-Bayard, Jorge F/L-3295-2015	Koike, Takahiko/0000-0002-7778-2173; Bosch-Bayard, Jorge F/0000-0001-7168-5551; Takahashi, Haruka/0000-0002-6946-7982; Sadato, Norihiro/0000-0002-9786-3907; Hirotani, Masako/0000-0001-7069-2821	Japan Society for the Promotion of Science [15H01846]; Minister of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Minister of Education, Culture, Sports, Science and Technology of Japan	Funded by Grant-in-Aid for Scientific Research 15H01846 to NS from the Japan Society for the Promotion of Science. http://www.jsps.go.jp/english/. NS was also funded from the project "Development of biomarker candidates for social behavior", carried out under the Strategic Research Program for Brain Science by the Minister of Education, Culture, Sports, Science and Technology of Japan, http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1968, ANN I STAT MATH, V20, P425, DOI 10.1007/BF02911655; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bailenson JN, 2004, PRESENCE-VIRTUAL AUG, V13, P428, DOI 10.1162/1054746041944803; Bernieri FJ, 1991, FUNDAMENTALS NONVERB; BRONSTEIN AM, 1986, EXP BRAIN RES, V63, P655, DOI 10.1007/BF00237488; Bronstein AM, 1997, EXP BRAIN RES, V113, P243, DOI 10.1007/BF02450322; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Dichgans J, 1978, HDB SENSORY PHYSL, P755, DOI DOI 10.1007/978-3-642-46354-9_25; DIENER HC, 1984, EXP BRAIN RES, V56, P126; DIJKSTRA TMH, 1994, BIOL CYBERN, V71, P489, DOI 10.1007/BF00198467; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Frith C., 2007, MAKING MIND BRAIN CR; Gergely G, 2001, B MENNINGER CLIN, V65, P411, DOI 10.1521/bumc.65.3.411.19853; Haken H., 1983, ADV SYNERGETICS INST; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; LAFRANCE M, 1979, US SOC PSYCHOL, V42, P66, DOI 10.2307/3033875; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lee DN, 1975, J HUMAN MOVEMENT STU, V1, P87, DOI DOI 10.3758/BF03199297; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; Macrae CN, 2008, COGNITION, V109, P152, DOI 10.1016/j.cognition.2008.07.007; Marsh KL, 2006, ECOL PSYCHOL, V18, P1, DOI 10.1207/s15326969eco1801_1; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Nicolis G, 1977, SELF ORG NONEQUILIBR; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Okamoto Y, 2014, NEUROSCI RES, V87, P66, DOI 10.1016/j.neures.2014.06.012; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Ozaki T., 2012, TIME SERIES MODELING; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Todt D, 2000, ADV STUD BEHAV, V29, P247, DOI 10.1016/S0065-3454(08)60107-2; Wong KFK, 2007, BIOL CYBERN, V97, P151, DOI 10.1007/s00422-007-0165-1; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0137126	10.1371/journal.pone.0137126	http://dx.doi.org/10.1371/journal.pone.0137126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26398768	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500018
J	Yan, D; Wang, B; Sun, SQ; Feng, X; Jin, Y; Yao, XP; Cao, SZ; Guo, HC				Yan, Dan; Wang, Bin; Sun, Shiqi; Feng, Xia; Jin, Ye; Yao, Xueping; Cao, Suizhong; Guo, Huichen			Quantum Dots Encapsulated with Canine Parvovirus-Like Particles Improving the Cellular Targeted Labeling	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; DRUG-DELIVERY; NANOPARTICLES; SINGLE; CELLS; INDUCTION; STABILITY; VESICLES; TRACKING; LIGANDS	Quantum dots (QDs) have a promising prospect in live-cell imaging and sensing because of unique fluorescence features. QDs aroused significant interest in the bio-imaging field through integrating the fluorescence properties of QDs and the delivery function of biomaterial. The natural tropism of Canine Parvovirus (CPV) to the transferrin receptor can target specific cells to increase the targeting ability of QDs in cell imaging. CPV virus-like particles (VLPs) from the expression of the CPV-VP2 capsid protein in a prokaryotic expression system were examined to encapsulate the QDs and deliver to cells with an expressed transferrin receptor. CPV-VLPs were used to encapsulate QDs that were modified using 3-mercaptopropionic acid. Gel electrophoresis, fluorescence spectrum, particle size, and transmission electron microscopy verified the conformation of a complex, in which QDs were encapsulated in CPV-VLPs (CPV-VLPs-QDs). When incubated with different cell lines, CPV-VLPs-QDs significantly reduced the cytotoxicity of QDs and selectively labeled the cells with high-level transferrin receptors. Cell-targeted labeling was achieved by utilizing the specific binding between the CPV capsid protein VP2 of VLPs and cellular receptors. CPV-VLPs-QDs, which can mimic the native CPV infection, can recognize and attach to the transferrin receptors on cellular membrane. Therefore, CPV-VLPs can be used as carriers to facilitate the targeted delivery of encapsulated nanomaterials into cells via receptor-mediated pathways. This study confirmed that CPV-VLPs can significantly promote the biocompatibility of nanomaterials and could expand the application of CPV-VLPs in biological medicine.	[Yan, Dan; Wang, Bin; Sun, Shiqi; Feng, Xia; Jin, Ye; Guo, Huichen] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China; [Yan, Dan; Wang, Bin; Sun, Shiqi; Feng, Xia; Jin, Ye; Guo, Huichen] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, Lanzhou 730046, Gansu, Peoples R China; [Wang, Bin; Yao, Xueping; Cao, Suizhong] Sichuan Agr Univ, Coll Vet Med, Chengdu 611130, Sichuan, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Sichuan Agricultural University	Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Xujiaping 1, Lanzhou 730046, Gansu, Peoples R China.	sunshiqi@caas.cn; ghch-2004@hotmail.com			International Science & Technology Cooperation Program of China [2014DFA31890]; National Science and Technology Support Program [2013BAD12B00]; "Twelfth Five-Year" National Science and technology program [2011AA10A211]	International Science & Technology Cooperation Program of China; National Science and Technology Support Program; "Twelfth Five-Year" National Science and technology program	International Science & Technology Cooperation Program of China (No.2014DFA31890), the National Science and Technology Support Program (2013BAD12B00), and the "Twelfth Five-Year" National Science and technology program in rural areas (2011AA10A211).	Adamczak M, 2012, COLLOID SURFACE B, V90, P211, DOI 10.1016/j.colsurfb.2011.10.028; Anderson RE, 2008, ACS NANO, V2, P1341, DOI 10.1021/nn700450g; Bottrill M, 2011, CHEM COMMUN, V47, P7039, DOI 10.1039/c1cc10692a; Brasch M, 2011, J AM CHEM SOC, V133, P6878, DOI 10.1021/ja110752u; Byers RJ, 2011, PROG HISTOCHEM CYTO, V45, P201, DOI 10.1016/j.proghi.2010.11.001; Charoenphol P, 2014, ACTA BIOMATER, V10, P1683, DOI 10.1016/j.actbio.2013.07.021; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Delehanty JB, 2006, BIOCONJUGATE CHEM, V17, P920, DOI 10.1021/bc060044i; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Gao JH, 2010, CURR TOP MED CHEM, V10, P1147, DOI 10.2174/156802610791384162; Geszke-Moritz M, 2013, MAT SCI ENG C-MATER, V33, P1008, DOI 10.1016/j.msec.2013.01.003; He L, 2013, ACS NANO, V7, P8447, DOI 10.1021/nn4017839; Ho YP, 2010, NANOSCALE, V2, P60, DOI 10.1039/b9nr00178f; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Joo KI, 2008, ACS NANO, V2, P1553, DOI 10.1021/nn8002136; Kairdolf BA, 2013, ANNU REV ANAL CHEM, V6, P143, DOI 10.1146/annurev-anchem-060908-155136; Kaji N, 2007, ANAL SCI, V23, P21, DOI 10.2116/analsci.23.21; Lee YK, 2012, J NUCL MED, V53, P1462, DOI 10.2967/jnumed.111.092759; Li F, 2009, SMALL, V5, P718, DOI 10.1002/smll.200801303; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Lipin DI, 2008, ARCH VIROL, V153, P2027, DOI 10.1007/s00705-008-0220-9; Liu JH, 2012, CURR DRUG METAB, V13, P1046, DOI 10.2174/138920012802850083; Lockney DM, 2011, BIOCONJUGATE CHEM, V22, P67, DOI 10.1021/bc100361z; Lucon J, 2012, NAT CHEM, V4, P781, DOI [10.1038/NCHEM.1442, 10.1038/nchem.1442]; Mukthavaram R, 2011, BIOCONJUGATE CHEM, V22, P1638, DOI 10.1021/bc200201e; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Pokorski JK, 2011, CHEMBIOCHEM, V12, P2441, DOI 10.1002/cbic.201100469; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Ren SC, 2013, PROSTATE, V73, P1591, DOI 10.1002/pros.22709; Rzigalinski BA, 2009, TOXICOL APPL PHARM, V238, P280, DOI 10.1016/j.taap.2009.04.010; Sanchez-Rodriguez SP, 2012, BIOCHIMIE, V94, P870, DOI 10.1016/j.biochi.2011.12.006; Santra S, 2012, NANOMEDICINE-UK, V7, P623, DOI [10.2217/NNM.12.45, 10.2217/nnm.12.45]; Shao LJ, 2011, SENSORS-BASEL, V11, P11736, DOI 10.3390/s111211736; Shi YF, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-115; Singh P, 2009, CURR TOP MICROBIOL, V327, P123; Singh Pratik, 2006, J Nanobiotechnology, V4, P2, DOI 10.1186/1477-3155-4-2; Tan WB, 2005, J BIOMED MATER RES A, V75A, P56, DOI 10.1002/jbm.a.30410; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Valizadeh A, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-480; Veeranarayanan S, 2012, INT J NANOMED, V7, P3769, DOI 10.2147/IJN.S31310; Wang TJ, 2011, NANOSCALE, V3, P4275, DOI 10.1039/c1nr10568j; Wen L, 2014, BIOMATERIALS, V35, P2295, DOI 10.1016/j.biomaterials.2013.11.069; Xu JM, 2012, J PHYS CHEM B, V116, P11370, DOI 10.1021/jp306453y; Xu J, 2014, APPL MICROBIOL BIOT, V98, P3529, DOI 10.1007/s00253-013-5485-6; Ye F, 2014, BIOMATERIALS, V35, P3885, DOI 10.1016/j.biomaterials.2014.01.041; Yin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063500; Zhang Y, 2012, ACS NANO, V6, P3695, DOI 10.1021/nn301218z; Zhao QH, 2011, BIOCONJUGATE CHEM, V22, P346, DOI 10.1021/bc1002532; Zhou WB, 2011, ACS NANO, V5, P8013, DOI 10.1021/nn2024896; Zhu YQ, 2014, ACS NANO, V8, P6644, DOI 10.1021/nn502386j; Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g	51	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138883	10.1371/journal.pone.0138883	http://dx.doi.org/10.1371/journal.pone.0138883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398132	Green Submitted, Green Published, gold			2022-12-26	WOS:000361797500123
J	Li, SJ; Tan, M; Juillard, F; Ponnusamy, R; Correia, B; Simas, JP; Carrondo, MA; McVey, CE; Kaye, KM				Li, Shijun; Tan, Min; Juillard, Franceline; Ponnusamy, Rajesh; Correia, Bruno; Pedro Simas, J.; Carrondo, Maria A.; McVey, Colin E.; Kaye, Kenneth M.			The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICENTRIC CASTLEMANS-DISEASE; REVERSE-TRANSCRIPTASE PROMOTER; CELL-CYCLE ARREST; TERMINAL REPEAT; MITOTIC CHROMOSOMES; GENE-EXPRESSION; LANA RECRUITS; HIV-INFECTION; VIRAL GENOME; PROTEIN	Kaposi sarcoma-associated herpesvirus (KSHV) has a causative role in several human malignancies. KSHV latency-associated nuclear antigen (LANA) mediates persistence of viral episomes in latently infected cells. LANA mediates KSHV DNA replication and segregates episomes to progeny nuclei. The structure of the LANA DNA binding domain was recently solved, revealing a positive electrostatic patch opposite the DNA binding surface, which is the site of BET protein binding. Here we investigate the functional role of the positive patch in LANA mediated episome persistence. As expected, LANA mutants with alanine or glutamate substitutions in the central, peripheral, or lateral portions of the positive patch maintained the ability to bind DNA by EMSA. However, all of the substitution mutants were deficient for LANA DNA replication and episome maintenance. Mutation of the peripheral region generated the largest deficiencies. Despite these deficiencies, all positive patch mutants concentrated to dots along mitotic chromosomes in cells containing episomes, similar to LANA. The central and peripheral mutants, but not the lateral mutants, were reduced for BET protein interaction as assessed by co-immunoprecipitation. However, defects in BET protein binding were independent of episome maintenance function. Overall, the reductions in episome maintenance closely correlated with DNA replication deficiencies, suggesting that the replication defects account for the reduced episome persistence. Therefore, the electrostatic patch exerts a key role in LANA-mediated DNA replication and episome persistence and may act through a host cell partner(s) other than a BET protein or by inducing specific structures or complexes.	[Li, Shijun; Tan, Min; Juillard, Franceline; Kaye, Kenneth M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Li, Shijun; Tan, Min; Kaye, Kenneth M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ponnusamy, Rajesh; Correia, Bruno; Carrondo, Maria A.; McVey, Colin E.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade Nova de Lisboa; Universidade de Lisboa	Kaye, KM (corresponding author), Brigham & Womens Hosp, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	kkaye@bwh.harvard.edu	Tan, Min/K-1780-2016; Ponnusamy, Rajesh/K-3909-2012; McVey, Colin E/C-2110-2008; Simas, J Pedro/M-5157-2013; Juillard, Franceline/O-3246-2017	Ponnusamy, Rajesh/0000-0002-2828-061X; McVey, Colin E/0000-0001-7457-2130; Simas, J Pedro/0000-0001-6982-9253; Juillard, Franceline/0000-0003-1449-3603; Carrondo, Maria Armenia/0000-0002-1261-1162	National Institutes of Health (NCI) [CA082036]; National Institutes of Health (NIDCR) [DE025208]; Harvard Medical School-Portugal Program in Translational research and Information; Brigham and Women's Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA082036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025208] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harvard Medical School-Portugal Program in Translational research and Information; Brigham and Women's Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grants CA082036 (NCI) and DE025208 (NIDCR; both to K. M. K.), Harvard Medical School-Portugal Program in Translational research and Information (to J. P. S., M. A. C., C. E. M., and K. M. K.), and Brigham and Women's Hospital Research Institute (to K. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Barbera AJ, 2004, J VIROL, V78, P294, DOI 10.1128/JVI.78.1.294-301.2004; Campbell M, 2012, J BIOL CHEM, V287, P5806, DOI 10.1074/jbc.M111.289496; Canham M, 2004, J GEN VIROL, V85, P1363, DOI 10.1099/vir.0.79802-0; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Correia B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003673; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Cotter MA, 2001, VIROLOGY, V291, P241, DOI 10.1006/viro.2001.1202; Decker LL, 1996, J EXP MED, V184, P283, DOI 10.1084/jem.184.1.283; Di Bartolo DL, 2008, BLOOD, V111, P4731, DOI 10.1182/blood-2007-09-110544; Domsic JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003672; Dupin N, 2000, BLOOD, V95, P1406, DOI 10.1182/blood.V95.4.1406.004k26_1406_1412; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Fejer G, 2003, J GEN VIROL, V84, P1451, DOI 10.1099/vir.0.18940-0; Garber AC, 2002, J BIOL CHEM, V277, P27401, DOI 10.1074/jbc.M203489200; Garber AC, 2001, J VIROL, V75, P7882, DOI 10.1128/JVI.75.17.7882-7892.2001; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; Grundhoff A, 2003, J VIROL, V77, P2779, DOI 10.1128/JVI.77.4.2779-2783.2003; Habison AC, 2012, J VIROL, V86, P11863, DOI 10.1128/JVI.01656-12; Hellert J, 2015, P NATL ACAD SCI USA, V112, P6694, DOI 10.1073/pnas.1421804112; Hellert J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003640; Hu JH, 2002, J VIROL, V76, P11677, DOI 10.1128/JVI.76.22.11677-11687.2002; Hu JH, 2009, J VIROL, V83, P11051, DOI 10.1128/JVI.00907-09; Jager W, 2012, J VIROL, V86, P6745, DOI 10.1128/JVI.06840-11; Kedes DH, 1997, J CLIN INVEST, V100, P2606, DOI 10.1172/JCI119804; Kelley-Clarke B, 2007, J VIROL, V81, P4348, DOI 10.1128/JVI.01289-06; Kelley-Clarke B, 2007, VIROLOGY, V357, P149, DOI 10.1016/j.virol.2006.07.052; Kelley-Clarke B, 2009, J VIROL, V83, P4326, DOI 10.1128/JVI.02395-08; Kim KY, 2013, J VIROL, V87, P6782, DOI 10.1128/JVI.00011-13; Knight JS, 2001, J BIOL CHEM, V276, P22971, DOI 10.1074/jbc.M101890200; Komatsu T, 2004, VIROLOGY, V319, P225, DOI 10.1016/j.virol.2003.11.002; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Lagunoff M, 1997, VIROLOGY, V236, P147, DOI 10.1006/viro.1997.8713; Lim C, 2004, J VIROL, V78, P7248, DOI 10.1128/JVI.78.13.7248-7256.2004; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Ottinger M, 2009, J VIROL, V83, P4423, DOI 10.1128/JVI.02274-08; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Purushothaman P, 2012, J VIROL, V86, P9983, DOI 10.1128/JVI.00839-12; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; Shamay M, 2012, J VIROL, V86, P5179, DOI 10.1128/JVI.00169-12; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Srinivasan V, 2004, J VIROL, V78, P14033, DOI 10.1128/JVI.78.24.14033-14038.2004; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Sun QM, 2014, P NATL ACAD SCI USA, V111, P11816, DOI 10.1073/pnas.1404219111; Szekely L, 1999, J GEN VIROL, V80, P2889, DOI 10.1099/0022-1317-80-11-2889; Tang J, 2003, J VIROL, V77, P5975, DOI 10.1128/JVI.77.10.5975-5984.2003; Toptan T, 2013, J VIROL, V87, P2744, DOI 10.1128/JVI.03061-12; Vazquez Ede L., 2013, J VIROL, V87, P12270; Vazquez ED, 2014, VIROLOGY, V448, P344, DOI 10.1016/j.virol.2013.10.026; Vazquez ED, 2011, ARCH VIROL, V156, P1323, DOI 10.1007/s00705-011-0985-0; Vazquez ED, 2011, J VIROL, V85, P7622, DOI 10.1128/JVI.00304-11; Verma SC, 2006, J VIROL, V80, P2243, DOI 10.1128/JVI.80.5.2243-2256.2006; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06	67	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28084	28096		10.1074/jbc.M115.674622	http://dx.doi.org/10.1074/jbc.M115.674622			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26420481	hybrid, Green Published			2022-12-26	WOS:000365761900005
J	Rothan, HA; Ambikabothy, J; Abdulrahman, AY; Bahrani, H; Golpich, M; Amini, E; Rahman, NA; Teoh, TC; Mohamed, Z; Yusof, R				Rothan, Hussin A.; Ambikabothy, Jamunaa; Abdulrahman, Ammar Y.; Bahrani, Hirbod; Golpich, Mojtaba; Amini, Elham; Rahman, Noorsaadah A.; Teoh, Teow Chong; Mohamed, Zulqarnain; Yusof, Rohana			Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; CANCER-THERAPY; LATARCIN 2A; CELL LINES; IN-VITRO; EXPRESSION; PROTEIN; INHIBITION	The production of short anticancer peptides in recombinant form is an alternative method for costly chemical manufacturing. However, the limitations of host toxicity, bioactivity and column purification have impaired production in mass quantities. In this study, short cationic peptides were produced in aggregated inclusion bodies by double fusion with a central protein that has anti-cancer activity. The anticancer peptides Tachiplicin I (TACH) and Latarcin 1 (LATA) were fused with the N-and C-terminus of the MAP30 protein, respectively. We successfully produced the recombinant TACH-MAP30-LATA protein and MAP30 alone in E. coli that represented 59% and 68% of the inclusion bodies. The purified form of the inclusion bodies was prepared by eliminating host cell proteins through multiple washing steps and semi-solubilization in alkaline buffer. The purified active protein was recovered by inclusive solubilization at pH 12.5 in the presence of 2 M urea and refolded in alkaline buffer containing oxides and reduced glutathione. The peptide-fusion protein showed lower CC50 values against cancer cells (HepG2, 0.35 +/- 0.1 mu M and MCF-7, 0.58 +/- 0.1 mu M) compared with normal cells (WRL68, 1.83 +/- 0.2 mu M and ARPE19, 2.5 +/- 0.1 mu M) with outstanding activity compared with its individual components. The presence of the short peptides facilitated the entry of the peptide fusion protein into cancer cells (1.8 to 2.2-fold) compared with MAP30 alone through direct interaction with the cell membrane. The cancer chemotherapy agent doxorubicin showed higher efficiency and selectivity against cancer cells in combination with the peptide-fusion protein. This study provides new data on the mass production of short anticancer peptides as inclusion bodies in E. coli by fusion with a central protein that has similar activity. The product was biologically active against cancer cells compared with normal cells and enhanced the activity and selective delivery of an anticancer chemotherapy agent.	[Rothan, Hussin A.; Ambikabothy, Jamunaa; Abdulrahman, Ammar Y.; Bahrani, Hirbod; Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Golpich, Mojtaba; Amini, Elham] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Med, Kuala Lumpur 56000, Malaysia; [Rahman, Noorsaadah A.] Univ Malaya, Fac Med, Dept Chem, Kuala Lumpur 50603, Malaysia; [Teoh, Teow Chong; Mohamed, Zulqarnain] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia; Universiti Malaya; Universiti Malaya	Rothan, HA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.	rothan@um.edu.my	MOHAMED, ZULQARNAIN/C-1158-2010; YUSOF, ROHANA/B-9589-2010; Rahman, Noorsaadah Abd./B-9291-2010; Golpich, Mojtaba/K-8061-2014; ROTHAN, HUSSIN/D-5490-2016; TEOH, TEOW CHONG/B-9950-2010; Abdulrahman, Ammar Yasir/AAF-9133-2019	MOHAMED, ZULQARNAIN/0000-0001-7311-0356; YUSOF, ROHANA/0000-0002-6591-3236; Rahman, Noorsaadah Abd./0000-0001-5847-8961; Golpich, Mojtaba/0000-0002-7042-1201; Abdulrahman, Ammar Yasir/0000-0003-4839-6852; ROTHAN, HUSSIN/0000-0002-7300-6388	Ministry of Science, Technology and Innovation-Malaysia, University of Malaya-Malaysia (ERGS) [ER016-2013A, PG081-2014A]	Ministry of Science, Technology and Innovation-Malaysia, University of Malaya-Malaysia (ERGS)	This project was funded by the Ministry of Science, Technology and Innovation-Malaysia, University of Malaya-Malaysia (ERGS grant ER016-2013A and PG081-2014A).	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bommarius B, 2010, PEPTIDES, V31, P1957, DOI 10.1016/j.peptides.2010.08.008; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Brown JM, 1998, CANCER RES, V58, P1408; Chen JG, 2005, CANCER RES, V65, P4614, DOI 10.1158/0008-5472.CAN-04-2253; Chen YX, 2001, CANCER RES, V61, P2434; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Fang EF, 2012, CANCER LETT, V324, P66, DOI 10.1016/j.canlet.2012.05.005; Gaiser RA, 2011, SCI MICROBIAL PATHOG, V11, P992; Garcia M, 2007, GLOBAL CANC FACTS FI; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Kim SK, 2003, PEPTIDES, V24, P945, DOI 10.1016/S0196-9781(03)00194-3; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d; Lee-Huang S, 2000, ANTICANCER RES, V20, P653; Martin I, 2010, PHARMACEUTICALS, V3, P1456, DOI 10.3390/ph3051456; Puigbo P, 2008, NUCLEIC ACIDS RES, V36, pD524, DOI 10.1093/nar/gkm831; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rothan H.A., 2013, OMICS J INTEGR BIOL, V17; Rothan HA, 2014, ANTIVIR RES, V108, P173, DOI 10.1016/j.antiviral.2014.05.019; Rothan HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094561; Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Won A, 2012, BBA-BIOMEMBRANES, V1818, P3072, DOI 10.1016/j.bbamem.2012.07.030; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139248	10.1371/journal.pone.0139248	http://dx.doi.org/10.1371/journal.pone.0139248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418816	Green Submitted, Green Published, gold			2022-12-26	WOS:000362171400067
J	Ono, M; Yamada, K; Avolio, F; Afzal, V; Bensaddek, D; Lamond, AI				Ono, Motoharu; Yamada, Kayo; Avolio, Fabio; Afzal, Vackar; Bensaddek, Dalila; Lamond, Angus I.			Targeted Knock-Down of miR21 Primary Transcripts Using snoMEN Vectors Induces Apoptosis in Human Cancer Cell Lines	PLOS ONE			English	Article							MESSENGER-RNA SURVEILLANCE; NUCLEOLAR PROTEIN; IN-VIVO; MIRNA; MICRORNAS; REVEALS; SNORNA; GENE; IDENTIFICATION; MIR-21	We have previously reported an antisense technology, 'snoMEN vectors', for targeted knock-down of protein coding mRNAs using human snoRNAs manipulated to contain short regions of sequence complementarity with the mRNA target. Here we characterise the use of snoMEN vectors to target the knock-down of micro RNA primary transcripts. We document the specific knock-down of miR21 in HeLa cells using plasmid vectors expressing miR21-targeted snoMEN RNAs and show this induces apoptosis. Knock-down is dependent on the presence of complementary sequences in the snoMEN vector and the induction of apoptosis can be suppressed by over-expression of miR21. Furthermore, we have also developed lentiviral vectors for delivery of snoMEN RNAs and show this increases the efficiency of vector transduction in many human cell lines that are difficult to transfect with plasmid vectors. Transduction of lentiviral vectors expressing snoMEN targeted to pri-miR21 induces apoptosis in human lung adenocarcinoma cells, which express high levels of miR21, but not in human primary cells. We show that snoMEN-mediated suppression of miRNA expression is prevented by siRNA knock-down of Ago2, but not by knock-down of Ago1 or Upf1. snoMEN RNAs colocalise with Ago2 in cell nuclei and nucleoli and can be co-immunoprecipitated from nuclear extracts by antibodies specific for Ago2.	[Ono, Motoharu; Yamada, Kayo; Avolio, Fabio; Afzal, Vackar; Bensaddek, Dalila; Lamond, Angus I.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland.	angus@lifesci.dundee.ac.uk		Avolio, Fabio/0000-0003-2067-5315	Wellcome Trust [073980/Z/03/Z]; MRC [G0801738]; Medical Research Council [G0801738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this research was provided by a Wellcome Trust Programme Grant to A.I.L. (Ref: 073980/Z/03/Z)(http://www.wellcome.ac.uk/) and by an MRC Milstein Award to A.I.L. (Ref: G0801738) (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranat L, 2008, P NATL ACAD SCI USA, V105, P5028, DOI 10.1073/pnas.0710576105; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Ahmad Y., 2012, MOL CELL PROTEOMICS, V11, P1, DOI [10.1074/mcp.M111.013680, DOI 10.1074/mcp.M111.013680]; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bai BY, 2014, FEBS OPEN BIO, V4, P441, DOI 10.1016/j.fob.2014.04.010; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Coffin RS, 1996, GENE THER, V3, P560; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jung EJ, 2010, CANCER CELL, V18, P203, DOI 10.1016/j.ccr.2010.08.015; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Ono M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062305; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; Ono M, 2010, MOL BIOL CELL, V21, P1569, DOI 10.1091/mbc.E10-01-0078; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Scherr M, 2007, CELL CYCLE, V6, P444, DOI 10.4161/cc.6.4.3807; Scott MS, 2012, NUCLEIC ACIDS RES, V40, P3676, DOI 10.1093/nar/gkr1233; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; Yamada K, 2013, MOL CELL, V49, P922, DOI 10.1016/j.molcel.2012.12.023	53	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138668	10.1371/journal.pone.0138668	http://dx.doi.org/10.1371/journal.pone.0138668			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405811	gold, Green Submitted, Green Published			2022-12-26	WOS:000361800700067
J	Osathanunkul, M; Suwannapoom, C; Ounjai, S; Rora, JA; Madesis, P; de Boer, H				Osathanunkul, Maslin; Suwannapoom, Chatmongkon; Ounjai, Sarawut; Rora, Jantarika A.; Madesis, Panagiotis; de Boer, Hugo			Refining DNA Barcoding Coupled High Resolution Melting for Discrimination of 12 Closely Related Croton Species	PLOS ONE			English	Article							BAR-HRM ANALYSIS; FORENSIC USES; IDENTIFICATION; PLANTS; MICROSATELLITE; PROFILES; PRODUCTS; CURVES; TOOL	DNA barcoding coupled high resolution melting (Bar-HRM) is an emerging method for species discrimination based on DNA dissociation kinetics. The aim of this work was to evaluate the suitability of different primer sets, derived from selected DNA regions, for Bar-HRM analysis of species in Croton (Euphorbiaceae), one of the largest genera of plants with over 1,200 species. Seven primer pairs were evaluated (matK, rbcL1, rbcL2, rbcL3, rpoC, trnL and ITS1) from four plastid regions, matK, rbcL, rpoC, and trnL, and the nuclear ribosomal marker ITS1. The primer pair derived from the ITS1 region was the single most effective region for the identification of the tested species, whereas the rbcL1 primer pair gave the lowest resolution. It was observed that the ITS1 barcode was the most useful DNA barcoding region overall for species discrimination out of all of the regions and primers assessed. Our Bar-HRM results here also provide further support for the hypothesis that both sequence and base composition affect DNA duplex stability.	[Osathanunkul, Maslin; Ounjai, Sarawut; Rora, Jantarika A.] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50200, Thailand; [Suwannapoom, Chatmongkon] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Suwannapoom, Chatmongkon] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming 650223, Peoples R China; [Suwannapoom, Chatmongkon] Chiang Mai Univ, Sci & Technol Res Inst, Chiang Mai 50200, Thailand; [Madesis, Panagiotis] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece; [de Boer, Hugo] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, SE-75236 Uppsala, Sweden; [de Boer, Hugo] Univ Oslo, Nat Hist Museum, NO-0318 Oslo, Norway	Chiang Mai University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chiang Mai University; Centre for Research & Technology Hellas; Uppsala University; University of Oslo	Osathanunkul, M (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50200, Thailand.	omaslin@gmail.com	Madesis, Panagiotis/AAL-5980-2020; de Boer, Hugo Joris/AAS-7585-2020	Madesis, Panagiotis/0000-0003-1447-3514; de Boer, Hugo Joris/0000-0003-1985-7859	National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	Funding: This work received funding from the National Research Council of Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2002, J ETHNOPHARMACOL, V79, P313, DOI 10.1016/S0378-8741(01)00392-0; Berry PE, 2005, AM J BOT, V92, P1520, DOI 10.3732/ajb.92.9.1520; Bosmali I, 2012, FOOD RES INT, V46, P141, DOI 10.1016/j.foodres.2011.12.013; Chayamarit K, 2005, FLORA OF THAILAND 1, V8; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; De Boer HJ, DRUG SAF IN PRESS; de Boer HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084291; DEVOE H, 1962, J MOL BIOL, V4, P500; Dey S, 2015, EXP PARASITOL, V151, P84, DOI 10.1016/j.exppara.2015.01.012; Dumousseau M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-101; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; El-Mekkawy S, 2000, PHYTOCHEMISTRY, V53, P457, DOI 10.1016/S0031-9422(99)00556-7; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ganopoulos I, 2015, BIOCHEM SYST ECOL, V58, P64, DOI 10.1016/j.bse.2014.11.003; Ganopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060945; Ganopoulos I, 2013, J SCI FOOD AGR, V93, P2281, DOI 10.1002/jsfa.6040; Ganopoulos I, 2012, PLANT MOL BIOL REP, V30, P1322, DOI 10.1007/s11105-012-0453-3; Ganopoulos I, 2012, FOOD CHEM, V133, P505, DOI 10.1016/j.foodchem.2012.01.015; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; GOTOH O, 1981, BIOPOLYMERS, V20, P1033, DOI 10.1002/bip.1981.360200513; Govaerts R, 2000, WORLD CHECKLIST BIBL; GRAY DM, 1970, BIOPOLYMERS, V9, P223, DOI 10.1002/bip.1970.360090207; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kalivas A, 2014, MOL BIOL REP, V41, P5147, DOI 10.1007/s11033-014-3381-5; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Madesis P, 2014, FOOD RES INT, V60, P163, DOI 10.1016/j.foodres.2013.10.042; Madesis P, 2013, FOOD RES INT, V50, P351, DOI 10.1016/j.foodres.2012.10.038; Madesis P, 2012, FOOD CONTROL, V25, P576, DOI 10.1016/j.foodcont.2011.11.034; Minh PTH, 2004, FITOTERAPIA, V75, P552, DOI 10.1016/j.fitote.2004.04.009; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Osathanunkul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128476; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Rinthong PO, 2011, J NAT MED-TOKYO, V65, P641, DOI 10.1007/s11418-011-0536-8; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schmiderer C, 2010, PLANTA MED, V76, P1934, DOI 10.1055/s-0030-1249908; Skalli S, 2002, B SOC PATHOL EXOT, V95, P284; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; SUGIMOTO N, 1994, FEBS LETT, V354, P74, DOI 10.1016/0014-5793(94)01098-6; Sun L, 2014, NAT PROD RES, V28, P563, DOI 10.1080/14786419.2013.867856; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Thongtan J, 2003, J NAT PROD, V66, P868, DOI 10.1021/np030067a; Turner Douglas H, 2009, NUCLEIC ACIDS RES; Veldman S, 2014, NOVEL PLANT BIORESOURCES: APPLICATIONS IN FOOD, MEDICINE AND COSMETICS, P81; WEBSTER GL, 1993, TAXON, V42, P793, DOI 10.2307/1223265; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	61	28	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138888	10.1371/journal.pone.0138888	http://dx.doi.org/10.1371/journal.pone.0138888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406615	Green Published, gold, Green Submitted			2022-12-26	WOS:000361800700111
J	Schmidt-Burbach, J; Ronfot, D; Srisangiam, R				Schmidt-Burbach, Jan; Ronfot, Delphine; Srisangiam, Rossukon			Asian Elephant (Elephas maximus), Pig-Tailed Macaque (Macaca nemestrina) and Tiger (Panthera tigris) Populations at Tourism Venues in Thailand and Aspects of Their Welfare	PLOS ONE			English	Article								This study focused on determining the size and welfare aspects of Asian elephant, pig-tailed macaque and tiger populations at facilities open to tourists in Thailand. Data were gathered from 118 venues through direct observations and interviews with staff. A score sheet-based welfare assessment was used to calculate scores between 1 and 10, indicating each venue's welfare situation. Factors such as freedom of movement for the animals, access to veterinary care, environmental noise quality, hygiene standards and work intensity were included in the score sheet. 1688 elephants, 371 macaques and 621 tigers were found at the venues. 89 venues exclusively kept elephants, 9 designated 'Monkey schools' offered macaque shows, 4 venues kept primarily tigers, mostly for petting and photo opportunities, and the remaining venues kept a mix of these animals. A strong imbalance in female to male gender ratios was recorded with about 4: 1 for adult elephants and 1: 4 for adult macaques. Severely inadequate welfare conditions were common, with 75% of macaques and 99% of tigers being kept at venues with scores less than 5. 86% of elephants were kept in inadequate conditions at venues with scores between 3 and 5, but a significant number of venues with scores above 5 were found. 4.6% of elephants were provided commendable conditions, reaching assessment scores of 8 and above. 71% of venues did not offer any sort of education about animals to visitors. This study is the first to assess welfare aspects of captive wild animals at tourism venues across Thailand. It concludes that significant concerns exist about the welfare of wild animals in the tourism sector of Thailand. Urgent attention needs to be given to address these concerns and prevent further suffering. But also to ensure the demand for wild animals doesn't have a negative impact on wild populations.	[Schmidt-Burbach, Jan; Srisangiam, Rossukon] World Anim Protect, Thailand Off, Bangkok, Thailand; [Ronfot, Delphine] Univ Exeter, Exeter, Devon, England	University of Exeter	Schmidt-Burbach, J (corresponding author), World Anim Protect, Thailand Off, Bangkok, Thailand.	janschmidt-burbach@worldanimalprotection.org			Intrepid Foundation	Intrepid Foundation	This study's operational expenses were provided by the Intrepid Foundation (www.theintrepidfoundation.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2011, ECOL ECON, V70, P721, DOI 10.1016/j.ecolecon.2010.11.006; Agoramoorthy Govindasamy, 2005, J Appl Anim Welf Sci, V8, P141, DOI 10.1207/s15327604jaws0802_6; Ammann K, 2014, NATL GEOGRAPHIC 0415; [Anonymous], 2012, ABC NEWS; ASEAN Centre for Biodiversity, 2013, 2013 ANN REP; Association of Southeast Asian Nations-Wildlife Enforcement Network, 2011, INTR INT WILDL TRAD; Baker S, 2006, WILDLIFE TRADE E SE; Banks D, 2001, THAILANDS TIGER EC; Blokhuis H, WELF QUAL ASS PROT; Botreau IV R, 2007, ANIM WELFARE, V16, P2; Bulte EH, 2005, CONSERV BIOL, V19, P1222, DOI 10.1111/j.1523-1739.2005.00149.x; Care for the Wild, 2008, EXPL THE TIG; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; Chatkupt Thomas T., 1999, Journal of Applied Animal Welfare Science, V2, P187, DOI 10.1207/s15327604jaws0203_2; CLUTTONBROCK J, 1992, MAMMAL REV, V22, P79, DOI 10.1111/j.1365-2907.1992.tb00122.x; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Driscolla CA, 2009, PNAS, V106, P1; Eudey Ardith A., 2008, Primate Conservation, V23, P129, DOI 10.1896/052.023.0115; Fernando Prithiviraj, 2011, Gajah, V35, P15; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Godfrey A., 2009, GAJAH, V30, P13; Kleiman D.G., 2010, WILD MAMMALS CAPTIVI, P217; Kontogeorgopoulos N, 2009, J TOURISM, V10; Lair R.C., 1997, GONE ASTRAY CARE MAN; Lincoln GA, 1996, J REPROD FERTIL, V108, P107, DOI 10.1530/jrf.0.1080107; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Nijman V., 2014, ASSESSMENT LIVE ELEP; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; Rees PA, 2009, J APPL ANIM WELF SCI, V12, P44, DOI 10.1080/10888700802536699; RICHARD AF, 1989, INT J PRIMATOL, V10, P569, DOI 10.1007/BF02739365; Roots Clive, 2007, DOMESTICATION; Russell N, 2002, SOC ANIM, V10, P285, DOI 10.1163/156853002320770083; Sakamoto M, 2004, THAI ELEPHANT TRADE; Shepherd C. R., 2008, ELEPHANT IVORY TRADE; Stiles D., 2009, ELEPHANT IVORY TRADE; Sukumar R., 1993, ASIAN ELEPHANT ECOLO; Thailand Department of Tourism, 2011, TOUR ARR THAIL 2011; Thailand Elephant Conservation Center, 2012, THAIL EL; Webster J, 2005, REV SCI TECH OIE, V24, P723, DOI 10.20506/rst.24.2.1602	39	34	34	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139092	10.1371/journal.pone.0139092	http://dx.doi.org/10.1371/journal.pone.0139092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407173	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700165
J	Seo, MY; Jang, W; Rhee, K				Seo, Mi Young; Jang, Wonyul; Rhee, Kunsoo			Integrity of the Pericentriolar Material Is Essential for Maintaining Centriole Association during M Phase	PLOS ONE			English	Article							CENTROSOME REPLICATION; CHROMATID SEPARATION; DUPLICATION; CELLS; CLEAVAGE; CYCLE; DISENGAGEMENT; INHIBITOR; COHESION; NUMBERS	A procentriole is assembled next to the mother centriole during S phase and remains associated until M phase. After functioning as a spindle pole during mitosis, the mother centriole and procentriole are separated at the end of mitosis. A close association of the centriole pair is regarded as an intrinsic block to the centriole reduplication. Therefore, deregulation of this process may cause a problem in the centriole number control, resulting in increased genomic instability. Despite its importance for faithful centriole duplication, the mechanism of centriole separation is not fully understood yet. Here, we report that centriole pairs are prematurely separated in cells whose cell cycle is arrested at M phase by STLC. Dispersal of the pericentriolar material (PCM) was accompanied. This phenomenon was independent of the separase activity but needed the PLK1 activity. Nocodazole effectively inhibited centriole scattering in STLC-treated cells, possibly by reducing the microtubule pulling force around centrosomes. Inhibition of PLK1 also reduced the premature separation of centrioles and the PCM dispersal as well. These results revealed the importance of PCM integrity in centriole association. Therefore, we propose that PCM disassembly is one of the driving forces for centriole separation during mitotic exit.	[Seo, Mi Young; Jang, Wonyul; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr		Seo, Mi Young/0000-0002-6772-8077; Jang, Wonyul/0000-0003-0352-3862	Basic Research Laboratory [NRF-2014R1A4A1005259]; Marine Biotechnology Program [PJT200620]	Basic Research Laboratory; Marine Biotechnology Program	Funding: This study was supported by grants from the Basic Research Laboratory (NRF-2014R1A4A1005259) and Marine Biotechnology Program (PJT200620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cabral G, 2013, CURR BIOL, V23, P1380, DOI 10.1016/j.cub.2013.06.043; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Keryer G, 1984, J CELL SCI, V76, P35; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Kim K, 2008, EXP CELL RES, V314, P3692, DOI 10.1016/j.yexcr.2008.09.016; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; Lee K, 2012, CELL CYCLE, V11, P2476, DOI 10.4161/cc.20878; Lee S, 2010, CELL CYCLE, V9, P775, DOI 10.4161/cc.9.4.10667; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Maiato H, 2014, NAT CELL BIOL, V16, P386, DOI 10.1038/ncb2958; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Oliveira RA, 2013, CURR BIOL, V23, pR601, DOI 10.1016/j.cub.2013.04.003; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Prosser SL, 2012, J CELL SCI, V125, P5353, DOI 10.1242/jcs.106096; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; SELLITTO C, 1988, J CELL SCI, V89, P57; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sluder G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0455; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	37	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138905	10.1371/journal.pone.0138905	http://dx.doi.org/10.1371/journal.pone.0138905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407333	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700116
J	Wang, AL; Liu, L; Peng, YC; Islam, S; Applebee, M; Appels, R; Yan, YM; Ma, WJ				Wang, Aili; Liu, Li; Peng, Yanchun; Islam, Shahidul; Applebee, Marie; Appels, Rudi; Yan, Yueming; Ma, Wujun			Identification of Low Molecular Weight Glutenin Alleles by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF-MS) in Common Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SDS-PAGE; DOUGH PROPERTIES; LMW SUBUNITS; BREAD WHEAT; PAN BREAD; HMW; LANDRACES; GENETICS	Low molecular weight glutenin subunits (LMW-GS) play an important role in determining dough properties and breadmaking quality. However, resolution of the currently used methodologies for analyzing LMW-GS is rather low which prevents an efficient use of genetic variations associated with these alleles in wheat breeding. The aim of the current study is to evaluate and develop a rapid, simple, and accurate method to differentiate LMW-GS alleles using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A set of standard single LMW-GS allele lines as well as a suite of well documented wheat cultivars were collected from France, CIMMYT, and Canada. Method development and optimization were focused on protein extraction procedures and MALDI-TOF instrument settings to generate reproducible diagnostic spectrum peak profiles for each of the known wheat LMW-GS allele. Results revealed a total of 48 unique allele combinations among the studied genotypes. Characteristic MALDI-TOF peak patterns were obtained for 17 common LMW-GS alleles, including 5 (b, a or c, d, e, f), 7 (a, b, c, d or i, f, g, h) and 5 (a, b, c, d, f) patterns or alleles for the Glu-A3, Glu-B3, and Glu-D3 loci, respectively. In addition, some reproducible MALDI-TOF peak patterns were also obtained that did not match with any known alleles. The results demonstrated a high resolution and throughput nature of MALDI-TOF technology in analyzing LMW-GS alleles, which is suitable for application in wheat breeding programs in processing a large number of wheat lines with high accuracy in limited time. It also suggested that the variation of LMW-GS alleles is more abundant than what has been defined by the current nomenclature system that is mainly based on SDS-PAGE system. The MALDI-TOF technology is useful to differentiate these variations. An international joint effort may be needed to assign allele symbols to these newly identified alleles and determine their effects on end-product quality attributes.	[Wang, Aili; Liu, Li; Peng, Yanchun; Islam, Shahidul; Appels, Rudi; Ma, Wujun] Murdoch Univ, AEGIC, Sch Vet & Life Sci, State Agr Biotechnol Ctr, Perth, WA 6150, Australia; [Wang, Aili; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Key Lab Genet & Biotechnol, Beijing 100037, Peoples R China; [Liu, Li] Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, Beijing 100081, Peoples R China; [Peng, Yanchun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Applebee, Marie] South Australian Res & Dev Inst, Urrbrae, SA 5064, Australia	Murdoch University; Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Huazhong Agricultural University; South Australian Research & Development Institute (SARDI)	Ma, WJ (corresponding author), Murdoch Univ, AEGIC, Sch Vet & Life Sci, State Agr Biotechnol Ctr, Perth, WA 6150, Australia.	w.ma@murdoch.edu.au	Ma, Wujun/F-5957-2010	Ma, Wujun/0000-0002-1264-866X; Islam, Shahidul/0000-0001-5994-0521	Australian Grain Research & Development Corporation [UMU00028]	Australian Grain Research & Development Corporation(Grains R&D Corp)	This work is financially funded by Australian Grain Research & Development Corporation project: UMU00028. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbee MJ, 2009, J CEREAL SCI, V49, P254, DOI 10.1016/j.jcs.2008.10.011; BIETZ JA, 1975, CEREAL CHEM, V52, P513; Branlard G, 2003, GENET RESOUR CROP EV, V50, P669, DOI 10.1023/A:1025077005401; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; GUPTA RB, 1990, THEOR APPL GENET, V80, P65, DOI 10.1007/BF00224017; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Ikeda TM, 2014, INT GLUT WORKSH 11 P, P96; JACKSON EA, 1983, THEOR APPL GENET, V66, P29, DOI 10.1007/BF00281844; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Lan QX, 2013, GENET RESOUR CROP EV, V60, P799, DOI 10.1007/s10722-012-9877-8; Liu L, 2009, CEREAL RES COMMUN, V37, P57, DOI 10.1556/CRC.37.2009.1.7; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Liu L, 2009, J CEREAL SCI, V50, P295, DOI 10.1016/j.jcs.2009.05.006; Ma W, 2005, THEOR APPL GENET, V111, P410, DOI 10.1007/s00122-005-2001-0; MARGIOTTA B, 1993, J CEREAL SCI, V17, P221, DOI 10.1006/jcrs.1993.1021; MELAS V, 1994, CEREAL CHEM, V71, P234; Muccilli V, 2005, PROTEOMICS, V5, P719, DOI 10.1002/pmic.200401029; Nagamine T, 2000, J CEREAL SCI, V32, P129, DOI 10.1006/jcrs.2000.0323; NG PKW, 1987, CEREAL CHEM, V64, P324; PAYNE PI, 1984, PHILOS T R SOC B, V304, P359, DOI 10.1098/rstb.1984.0031; SINGH NK, 1991, J CEREAL SCI, V14, P203, DOI 10.1016/S0733-5210(09)80039-8; Skeritt J. H., 1998, AGBIOTECH NEWS INFOR, V10, P247; TATHAM AS, 1991, J CEREAL SCI, V14, P111, DOI 10.1016/S0733-5210(09)80131-8; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wrigley C.W., 2006, GLUTEN COMPOSITION W; Zhang XF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-243; Zhang XF, 2011, THEOR APPL GENET, V122, P1503, DOI 10.1007/s00122-011-1550-7; Zheng W, 2011, J CEREAL SCI, V54, P401, DOI 10.1016/j.jcs.2011.08.004	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138981	10.1371/journal.pone.0138981	http://dx.doi.org/10.1371/journal.pone.0138981			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407296	Green Submitted, Green Published, gold			2022-12-26	WOS:000361800700136
J	Hals, IK; Bruerberg, SG; Ma, ZH; Scholz, H; Bjorklund, A; Grill, V				Hals, Ingrid K.; Bruerberg, Simon Gustafson; Ma, Zuheng; Scholz, Hanne; Bjorklund, Anneli; Grill, Valdemar			Mitochondrial Respiration in Insulin-Producing beta-Cells: General Characteristics and Adaptive Effects of Hypoxia	PLOS ONE			English	Article							HIGH-RESOLUTION RESPIROMETRY; ISLET TRANSPLANTATION; INTERMITTENT HYPOXIA; IN-VITRO; SECRETION; RAT; GLUCOSE; LANGERHANS; DIAZOXIDE; SURVIVAL	Objective To provide novel insights on mitochondrial respiration in beta-cells and the adaptive effects of hypoxia. Methods and Design Insulin-producing INS-1 832/13 cells were exposed to 18 hours of hypoxia followed by 20-22 hours re-oxygenation. Mitochondrial respiration was measured by high-resolution respirometry in both intact and permeabilized cells, in the latter after establishing three functional substrate-uncoupler-inhibitor titration (SUIT) protocols. Concomitant measurements included proteins of mitochondrial complexes (Western blotting), ATP and insulin secretion. Results Intact cells exhibited a high degree of intrinsic uncoupling, comprising about 50% of oxygen consumption in the basal respiratory state. Hypoxia followed by re-oxygenation increased maximal overall respiration. Exploratory experiments in peremabilized cells could not show induction of respiration by malate or pyruvate as reducing substrates, thus glutamate and succinate were used as mitochondrial substrates in SUIT protocols. Permeabilized cells displayed a high capacity for oxidative phosphorylation for both complex I-and II-linked substrates in relation to maximum capacity of electron transfer. Previous hypoxia decreased phosphorylation control of complex I-linked respiration, but not in complex II-linked respiration. Coupling control ratios showed increased coupling efficiency for both complex I-and II-linked substrates in hypoxia-exposed cells. Respiratory rates overall were increased. Also previous hypoxia increased proteins of mitochondrial complexes I and II (Western blotting) in INS-1 cells as well as in rat and human islets. Mitochondrial effects were accompanied by unchanged levels of ATP, increased basal and preserved glucose-induced insulin secretion. Conclusions Exposure of INS-1832/13 cells to hypoxia, followed by a re-oxygenation period increases substrate-stimulated respiratory capacity and coupling efficiency. Such effects are accompanied by up-regulation of mitochondrial complexes also in pancreatic islets, highlighting adaptive capacities of possible importance in an islet transplantation setting. Results also indicate idiosyncrasies of beta-cells that do not respire in response to a standard inclusion of malate in SUIT protocols.	[Hals, Ingrid K.; Bruerberg, Simon Gustafson; Grill, Valdemar] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, Trondheim, Norway; [Ma, Zuheng; Bjorklund, Anneli] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Scholz, Hanne] Oslo Univ Hosp, Dept Transplantat Med, Oslo, Norway; [Scholz, Hanne] Oslo Univ Hosp, Inst Surg Res, Oslo, Norway; [Grill, Valdemar] St Olavs Univ Hosp, Dept Endocrinol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Karolinska Institutet; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Hals, IK (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, Trondheim, Norway.	Ingrid.hals@ntnu.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Ma, Zuheng/0000-0003-1186-9396	Norwegian Diabetes Association; Liaison Committee	Norwegian Diabetes Association; Liaison Committee	This study was supported by funds from the Norwegian Diabetes Association and the Liaison Committee between the Central Norwegian Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Almendros I, 2014, AM J PHYSIOL-LUNG C, V307, pL129, DOI 10.1152/ajplung.00089.2014; Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BJORKLUND A, 1993, ENDOCRINOLOGY, V132, P1319, DOI 10.1210/en.132.3.1319; Bloch K, 2012, HISTOCHEM CELL BIOL, V137, P801, DOI 10.1007/s00418-012-0925-4; Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x; Deters NA, 2011, ARCH IMMUNOL THER EX, V59, P421, DOI 10.1007/s00005-011-0143-0; DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E., 2012, AN INTRODUCTION TO O; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Hals IK, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/374925; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kim Chul, 2014, Bioenergetics, V3, P110; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Ma ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067498; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Rasmussen UF, 2000, MOL CELL BIOCHEM, V208, P37, DOI 10.1023/A:1007046028132; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Steurer W, 1999, TRANSPL P, V31, P650, DOI 10.1016/S0041-1345(98)01600-5; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023	30	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138558	10.1371/journal.pone.0138558	http://dx.doi.org/10.1371/journal.pone.0138558			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401848	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100028
J	Zhu, Z; Pan, GX; Zhou, SJ; Dai, JJ; Chen, X; Tang, JH; Chen, SP; Zheng, YL; Song, J; Xu, WB				Zhu, Zhen; Pan, Guixia; Zhou, Shujie; Dai, Jingjing; Chen, Xia; Tang, Jihai; Chen, Shuping; Zheng, Yilun; Song, Jie; Xu, Wenbo			Imported Genotype 2B Rubella Virus Caused the 2012 Outbreak in Anqing City, China	PLOS ONE			English	Article							1E	A rubella outbreak occurred in Anqing city of Anhui province, China, from February to July of 2012, and a total of 241 clinically diagnosed or lab-confirmed patients were reported. The highest number of rubella cases during this outbreak was recorded in teenagers between 10 and 19 years of age who had not previously received the rubella vaccine. Genotyping results indicated that the genotype 2B rubella virus (RV) was responsible for the outbreak. However, a phylogenetic analysis showed that the genotype 2B RVs isolated in Anqing City were not related to 2B RVs found in other cities of Anhui province and in other provinces of China, thus providing evidence for importation. After importation, the transmission of Anqing RVs was interrupted owing to an effective immunization campaign against rubella, suggesting the timeliness and effectiveness of contingency vaccination. Strengthening rubella surveillance, including the integration of epidemiologic information and laboratory data, is a vital strategy for rubella control and elimination. In addition, except for routine immunization, targeted supplementary immunization activities aimed at susceptible groups according to sero-epidemiological surveillance data also play a key role in stopping the continuous transmission of rubella viruses and in preventing further congenital rubella syndrome cases.	[Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Minist Hlth, Beijing, Peoples R China; [Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Pan, Guixia; Chen, Shuping; Zheng, Yilun] Anqing Prefecture Ctr Dis Control & Prevent, Anqing, Peoples R China; [Zhou, Shujie; Chen, Xia; Tang, Jihai] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Dai, Jingjing] Anhui Univ Sci & Technol, Sch Med, Huainan, Peoples R China; [Song, Jie] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Anhui University of Science & Technology; Jilin University	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Minist Hlth, Beijing, Peoples R China.	chenjing_fuchanke@163.com; wenbo_xu1@aliyun.com		dai, jingjing/0000-0001-8337-7281	National Natural Science Foundation of China [81101244]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003, 2012ZX10004215]; National Science and Technology Major Project for Creation of Major New Drugs [2013ZX09304101]; WHO Measles Regional Reference Laboratory [WPCHN1002802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science; National Science and Technology Major Project for Creation of Major New Drugs; WHO Measles Regional Reference Laboratory	This work was supported by the National Natural Science Foundation of China (project no. 81101244), Key Technologies R&D Program of National Ministry of Science (2013ZX10004-202, 2012ZX10004201-003, and 2012ZX10004215), National Science and Technology Major Project for Creation of Major New Drugs (2013ZX09304101), and WHO Measles Regional Reference Laboratory funding (WPCHN1002802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2011, EURO SURVEILL; Chen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-122; D'Agaro P, 2010, J MED VIROL, V82, P1976, DOI 10.1002/jmv.21874; Featherstone DA, 2011, J INFECT DIS, V204, pS491, DOI 10.1093/infdis/jir107; Figueiredo CA, 2012, J MED VIROL, V84, P1666, DOI 10.1002/jmv.23382; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Messedi E, 2014, J CLIN VIROL, V61, P248, DOI 10.1016/j.jcv.2014.07.003; Miyoshi M, 2014, JPN J INFECT DIS, V67, P479, DOI 10.7883/yoken.67.479; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tucker JD, 2014, LANCET, V383, P1460, DOI 10.1016/S0140-6736(14)60712-1; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042013; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07; Zhu Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07999; Zhu Z, 2014, J MED VIROL, V86, P2114, DOI 10.1002/jmv.23936; Zhu Z, 2012, J CLIN MICROBIOL, V50, P353, DOI 10.1128/JCM.01264-11; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	22	3	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139173	10.1371/journal.pone.0139173	http://dx.doi.org/10.1371/journal.pone.0139173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402467	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100063
J	Effenberger, KA; James, RC; Urabe, VK; Dickey, BJ; Linington, RG; Jurica, MS				Effenberger, Kerstin A.; James, Robert C.; Urabe, Veronica K.; Dickey, Bailey J.; Linington, Roger G.; Jurica, Melissa S.			The Natural Product N-Palmitoyl-L-leucine Selectively Inhibits Late Assembly of Human Spliceosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITRO SPLICING ASSAY; RNA; SPLICEOSTATIN; COMPLEXES; ACID	The spliceosome is a dynamic complex of five structural RNAs and dozens of proteins, which assemble together to remove introns from nascent eukaryotic gene transcripts in a process called splicing. Small molecules that target different components of the spliceosome represent valuable research tools to investigate this complicated macromolecular machine. However, the current collection of spliceosome inhibitors is very limited. To expand the toolkit we used a high-throughput in vitro splicing assay to screen a collection of pre-fractions of natural compounds derived from marine bacteria for splicing inhibition. Further fractionation of initial hits generated individual peaks of splicing inhibitors that interfere with different stages of spliceosome assembly. With additional characterization of individual peaks, we identified N-palmitoyl-L-leucine as a new splicing inhibitor that blocks a late stage of spliceosome assembly. Structure-activity relationship analysis of the compound revealed that length of carbon chain is important for activity in splicing, as well as for effects on the cytological profile of cells in culture. Together these results demonstrate that our combination of in vitro splicing analysis with complex natural product libraries is a powerful strategy for identifying new small molecule tools with which to probe different aspects of spliceosome assembly and function.	[Effenberger, Kerstin A.; Urabe, Veronica K.; Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Effenberger, Kerstin A.; Urabe, Veronica K.; Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [James, Robert C.; Dickey, Bailey J.; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Linington, RG (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St, Santa Cruz, CA 95064 USA.	rliningt@ucsc.edu; mjurica@ucsc.edu	Linington, Roger/ABD-5582-2021; Regan, Clinton/E-6250-2012	Linington, Roger/0000-0003-1818-4971; 	NIH [1S10RR022455]; California Institute for Quantitative Biosciences [QB3]; United States Department of State; NATIONAL CANCER INSTITUTE [R01CA136762] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Quantitative Biosciences; United States Department of State; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank R. S. Lokey, W. Bray, and the UCSC Chemical Screening Center, supported by NIH 1S10RR022455 and grants from the California Institute for Quantitative Biosciences (QB3) and the United States Department of State for assistance with cytological profiling measurements.	Beller M, 1997, ANGEW CHEM INT EDIT, V36, P1494, DOI 10.1002/anie.199714941; Berg MG, 2012, MOL CELL BIOL, V32, P1271, DOI 10.1128/MCB.05788-11; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Effenberger KA, 2014, J BIOL CHEM, V289, P1938, DOI 10.1074/jbc.M113.515536; Effenberger KA, 2013, J BIOMOL SCREEN, V18, P1110, DOI 10.1177/1087057113493117; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Jurica MS, 2008, NAT CHEM BIOL, V4, P3, DOI 10.1038/nchembio0108-3; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; PADGETT RA, 1983, P NATL ACAD SCI-BIOL, V80, P5230, DOI 10.1073/pnas.80.17.5230; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Samatov TR, 2012, CHEMBIOCHEM, V13, P640, DOI 10.1002/cbic.201100790; Schulze CJ, 2013, CHEM BIOL, V20, P285, DOI 10.1016/j.chembiol.2012.12.007; TAKEHARA M, 1972, J AM OIL CHEM SOC, V49, P157, DOI 10.1007/BF02633785; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woehrmann MH, 2013, MOL BIOSYST, V9, P2604, DOI 10.1039/c3mb70245f	21	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27524	27531		10.1074/jbc.M115.673210	http://dx.doi.org/10.1074/jbc.M115.673210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26408199	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000365757500008
J	Chang, YJ; Burton, T; Ha, L; Huang, Z; Olajubelo, A; Li, C				Chang, Yan-Jung; Burton, Tina; Ha, Lawrence; Huang, Zi; Olajubelo, Adewale; Li, Chris			Modulation of Locomotion and Reproduction by FLP Neuropeptides in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							FMRFAMIDE-LIKE PEPTIDES; GENE FAMILY; C-ELEGANS; BEHAVIORAL STATES; NERVOUS-SYSTEM; NEURONS; PROTEIN; INSULIN; EXPRESSION; SEROTONIN	Neuropeptides function in animals to modulate most, if not all, complex behaviors. In invertebrates, neuropeptides can function as the primary neurotransmitter of a neuron, but more generally they co-localize with a small molecule neurotransmitter, as is commonly seen in vertebrates. Because a single neuron can express multiple neuropeptides and because neuropeptides can bind to multiple G protein-coupled receptors, neuropeptide actions increase the complexity by which the neural connectome can be activated or inhibited. Humans are estimated to have 90 plus neuropeptide genes; by contrast, nematodes, a relatively simple organism, have a slightly larger complement of neuropeptide genes. For instance, the nematode Caenorhabditis elegans has over 100 neuropeptide-encoding genes, of which at least 31 genes encode peptides of the FMRFamide family. To understand the function of this large FMRFamide peptide family, we isolated knockouts of different FMRFamide-encoding genes and generated transgenic animals in which the peptides are overexpressed. We assayed these animals on two basic behaviors: locomotion and reproduction. Modulating levels of different neuropeptides have strong as well as subtle effects on these behaviors. These data suggest that neuropeptides play critical roles in C. elegans to fine tune neural circuits controlling locomotion and reproduction.	[Chang, Yan-Jung; Burton, Tina; Ha, Lawrence; Huang, Zi; Olajubelo, Adewale; Li, Chris] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Li, Chris] CUNY, Grad Ctr, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Li, C (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	cli@ccny.cuny.edu	LI, chris/HDO-6232-2022	Burton, Tina/0000-0001-9077-9238	National Science Foundation [IOS 0820748]; National Institutes of Health [R01 NS42459]; Research Centers in Minority Institutes grant from National Institute on Minority Health and Health Disparities [5G12MD007603]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042459] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820748] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutes grant from National Institute on Minority Health and Health Disparities; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS 0820748) - CL, National Institutes of Health (R01 NS42459) - CL, and Research Centers in Minority Institutes grant (5G12MD007603) from the National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; CHALFIE M, 1985, J NEUROSCI, V5, P956; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Davis RE, 1996, PARASITOLOGY, V113, pS97, DOI 10.1017/S0031182000077921; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Duret L, 1998, GENOME RES, V8, P348, DOI 10.1101/gr.8.4.348; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Gregoire FM, 1998, BIOCHEM BIOPH RES CO, V249, P385, DOI 10.1006/bbrc.1998.9164; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson SJ, 2007, FEBS LETT, V581, P4288, DOI 10.1016/j.febslet.2007.08.003; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Husson SJ, 2009, PEPTIDES, V30, P449, DOI 10.1016/j.peptides.2008.07.021; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kubiak TM, 2003, J BIOL CHEM, V278, P33724, DOI 10.1074/jbc.M304861200; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li C, 2013, LEARN MEMORY, V20, P103, DOI 10.1101/lm.028993.112; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Marks NJ, 1999, BIOCHEM BIOPH RES CO, V254, P222, DOI 10.1006/bbrc.1998.9920; Marks NJ, 1995, BIOCHEM BIOPH RES CO, V217, P845, DOI 10.1006/bbrc.1995.2849; Marks NJ, 1997, BIOCHEM BIOPH RES CO, V231, P591, DOI 10.1006/bbrc.1997.6155; Marks NJ, 2001, BIOCHEM BIOPH RES CO, V286, P1170, DOI 10.1006/bbrc.2001.5524; Marks NJ, 1998, BIOCHEM BIOPH RES CO, V248, P422, DOI 10.1006/bbrc.1998.8982; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; Nelson LS, 1998, MOL BRAIN RES, V58, P103, DOI 10.1016/S0169-328X(98)00106-5; OKKEMA PG, 1993, GENETICS, V135, P385; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; ROSOFF ML, 1992, J NEUROSCI, V12, P2356; ROSOFF ML, 1993, PEPTIDES, V14, P331, DOI 10.1016/0196-9781(93)90049-M; Schafer William R, 2005, WormBook, P1; SCHINKMANN K, 1992, J COMP NEUROL, V316, P251, DOI 10.1002/cne.903160209; Stawicki TM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003472; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Waggoner LF, 2000, GENETICS, V154, P1181; Wani KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037831; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	65	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135164	10.1371/journal.pone.0135164	http://dx.doi.org/10.1371/journal.pone.0135164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406995	Green Published, gold			2022-12-26	WOS:000361800700003
J	Fan, RY; Li, YJ; Li, CF; Zhang, YS				Fan, Rongyan; Li, Yuanjun; Li, Changfu; Zhang, Yansheng			Differential microRNA Analysis of Glandular Trichomes and Young Leaves in Xanthium strumarium L. Reveals Their Putative Roles in Regulating Terpenoid Biosynthesis	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; MEDICINAL-PLANTS; SMALL RNAS; IDENTIFICATION; ARABIDOPSIS; XANTHATIN; GENES; XANTHANOLIDES; GENOMICS; SYNTHASE	The medicinal plant Xanthium strumarium L. (X. strumarium) is covered with glandular trichomes, which are the sites for synthesizing pharmacologically active terpenoids such as xanthatin. MicroRNAs (miRNAs) are a class of 21-24 nucleotide (nt) non-coding RNAs, most of which are identified as regulators of plant growth development. Identification of miRNAs involved in the biosynthesis of plant secondary metabolites remains limited. In this study, high-throughput Illumina sequencing, combined with target gene prediction, was performed to discover novel and conserved miRNAs with potential roles in regulating terpenoid biosynthesis in X. strumarium glandular trichomes. Two small RNA libraries from leaves and glandular trichomes of X. strumarium were established. In total, 1,185 conserved miRNAs and 37 novel miRNAs were identified, with 494 conserved miRNAs and 18 novel miRNAs being differentially expressed between the two tissue sources. Based on the X. strumarium transcriptome data that we recently constructed, 3,307 annotated mRNA transcripts were identified as putative targets of the differentially expressed miRNAs. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis suggested that some of the differentially expressed miRNAs, including miR6435, miR5021 and miR1134, might be involved in terpenoid biosynthesis in the X. strumarium glandular trichomes. This study provides the first comprehensive analysis of miRNAs in X. strumarium, which forms the basis for further understanding of miRNA-based regulation on terpenoid biosynthesis.	[Fan, Rongyan; Li, Yuanjun; Li, Changfu; Zhang, Yansheng] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan 430074, Peoples R China; [Fan, Rongyan; Li, Yuanjun] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YS (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan 430074, Peoples R China.	zhangys@wbgcas.cn			National Natural Science Foundation of China [31370339]; Grant of One Hundred Talent Program of the CAS [29Y129441R0104444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grant of One Hundred Talent Program of the CAS	The funding sources are from the National Natural Science Foundation of China (grant number: 31370339) and the Grant of One Hundred Talent Program of the CAS (grant number: 29Y129441R0104444) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDEIMOGIB M, 1991, PHYTOCHEMISTRY, V30, P3461, DOI 10.1016/0031-9422(91)83230-I; AHMED AA, 1990, PHYTOCHEMISTRY, V29, P2211, DOI 10.1016/0031-9422(90)83040-8; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Anjoo Kamboj, 2010, International Journal of Green Pharmacy, V4, P129; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boke H, 2015, PLANT BIOTECHNOL J, V13, P409, DOI 10.1111/pbi.12346; Chandel S, 2012, PARASITOL RES, V110, P1179, DOI 10.1007/s00436-011-2611-1; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076621; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen Y, 2014, PLANT PHYSIOL, V166, P2028, DOI 10.1104/pp.114.247486; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; CHOI D, 1992, PLANT CELL, V4, P1333, DOI 10.1105/tpc.4.10.1333; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DUKE SO, 1994, INT J PLANT SCI, V155, P617, DOI 10.1086/297200; Eljounaidi K, 2014, PLANT SCI, V223, P59, DOI 10.1016/j.plantsci.2014.03.007; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Frazier TP, 2011, METHODS MOL BIOL, V678, P13, DOI 10.1007/978-1-60761-682-5_2; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hammerschmidt DE, 1998, J LAB CLIN MED, V132, P86, DOI 10.1016/S0022-2143(98)90030-0; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; HARADA A, 1985, AGR BIOL CHEM TOKYO, V49, P1887, DOI 10.1080/00021369.1985.10866999; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung JD, 2003, PLANT CELL REP, V22, P224, DOI 10.1007/s00299-003-0678-6; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KAWAZU K, 1979, EXPERIENTIA, V35, P1294, DOI 10.1007/BF01963966; KUPCHAN SM, 1971, J MED CHEM, V14, P1147, DOI 10.1021/jm00294a001; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011; Lavault M, 2005, FITOTERAPIA, V76, P363, DOI 10.1016/j.fitote.2005.03.019; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DM, 2009, PLANT CELL PHYSIOL, V50, P2146, DOI 10.1093/pcp/pcp149; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Ma YT, 1998, PHYTOCHEMISTRY, V48, P1083, DOI 10.1016/S0031-9422(98)00084-3; Mahmoud AA, 1998, PLANTA MED, V64, P724, DOI 10.1055/s-2006-957566; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Nibret E, 2011, PHYTOTHER RES, V25, P1883, DOI 10.1002/ptr.3651; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Prakash P, 2015, GENE, V554, P181, DOI 10.1016/j.gene.2014.10.046; Ramirez-Erosa I, 2007, CAN J PHYSIOL PHARM, V85, P1160, DOI 10.1139/Y07-104; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Robert-Seilaniantz A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P103, DOI 10.1007/978-90-481-3112-9_6; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; ROUSSAKIS C, 1994, PLANTA MED, V60, P473, DOI 10.1055/s-2006-959537; Sato Y, 1997, J PHARM PHARMACOL, V49, P1042, DOI 10.1111/j.2042-7158.1997.tb06038.x; SAXENA VK, 1994, PHYTOCHEMISTRY, V35, P1080, DOI 10.1016/S0031-9422(00)90678-2; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Soo Kim Hyun, 2003, Korean Society for Biotechnology and Bioengineering Journal, V18, P324; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Wang FD, 2013, GENE, V532, P222, DOI 10.1016/j.gene.2013.09.039; Wu B, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034588, 10.1371/journal.pone.0044385]; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin MH, 2005, J ETHNOPHARMACOL, V99, P113, DOI 10.1016/j.jep.2005.02.013; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X	70	34	42	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139002	10.1371/journal.pone.0139002	http://dx.doi.org/10.1371/journal.pone.0139002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406988	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700143
J	Williams, M; To, A; Bozhilov, K; Talbot, P				Williams, Monique; To, An; Bozhilov, Krassimir; Talbot, Prue			Strategies to Reduce Tin and Other Metals in Electronic Cigarette Aerosol	PLOS ONE			English	Article							IN-VITRO; NICOTINE; SMOKE	Background Metals are present in electronic cigarette (EC) fluid and aerosol and may present health risks to users. Objective The objective of this study was to measure the amounts of tin, copper, zinc, silver, nickel and chromium in the aerosol from four brands of EC and to identify the sources of these metals by examining the elemental composition of the atomizer components. Methods Four brands of popular EC were dissected and the cartomizers were examined microscopically. Elemental composition of cartomizer components was determined using integrated energy dispersive X-ray microanalysis, and the concentrations of the tin, copper, zinc silver, nickel, and chromium in the aerosol were determined for each brand using inductively coupled plasma optical emission spectroscopy. Results All filaments were made of nickel and chromium. Thick wires were copper coated with either tin or silver. Wires were joined to each other by tin solder, brazing, or by brass clamps. High concentrations of tin were detected in the aerosol when tin solder joints were friable. Tin coating on copper wires also contributed to tin in the aerosol. Conclusions Tin concentrations in EC aerosols varied both within and between brands. Tin in aerosol was reduced by coating the thick wire with silver rather than tin, placing stable tin solder joints outside the atomizing chamber, joining wires with brass clamps or by brazing rather than soldering wires. These data demonstrate the feasibility of removing tin and other unwanted metals from EC aerosol by altering designs and using materials of suitable quality.	[Williams, Monique; To, An; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bozhilov, Krassimir] Univ Calif Riverside, Cent Facil Adv Microscopy & Microanal, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021	To, An/0000-0003-3170-2999	National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: The work was supported by National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Brown CC, 2014, ARCH DIS CHILDHOOD-E, V99, P13, DOI 10.1136/archdischild-2013-304675; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; Davis B, 2015, NICOTINE TOB RES, V17, P134, DOI 10.1093/ntr/ntu080; Flouris AD, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c311; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Lee N-C, 2009, MAT ADV PACKAGING, P181, DOI DOI 10.1007/978-0-387-78219-5_5; Mansour SA, 2014, PRACTICAL FOOD SAFETY: CONTEMPORARY ISSUES AND FUTURE DIRECTIONS, P213; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Thota D, 2014, J EMERG MED, V47, P15, DOI 10.1016/j.jemermed.2013.09.034; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	26	42	45	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138933	10.1371/journal.pone.0138933	http://dx.doi.org/10.1371/journal.pone.0138933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406602	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700121
J	Kimura, Y; Okubo, Y; Hayashida, N; Takahashi, J; Gutevich, A; Chorniy, S; Kudo, T; Takamura, N				Kimura, Yuko; Okubo, Yuka; Hayashida, Naomi; Takahashi, Jumpei; Gutevich, Alexander; Chorniy, Sergiy; Kudo, Takashi; Takamura, Noboru			Evaluation of the Relationship between Current Internal Cs-137 Exposure in Residents and Soil Contamination West of Chernobyl in Northern Ukraine	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; THYROID-CANCER; RADIATION-EXPOSURE; BRYANSK OBLAST; BODY BURDEN; ACCIDENT; INHABITANTS; RUSSIA; CHILDHOOD	After the Chernobyl Nuclear Power Plant accident, the residents living around the Chernobyl were revealed to have been internally exposed to Cs-137 through the intake of contaminated local foods. To evaluate the current situation of internal Cs-137 exposure and the relationship between the Cs-137 soil contamination and internal exposure in residents, we investigated the Cs-137 body burden in residents who were living in 10 selected cities from the northern part of the Zhitomir region, Ukraine, and collected soil samples from three family farms and wild forests of each city to measured Cs-137 concentrations. The total number of study participants was 36,862, of which 68.9% of them were female. After 2010, the annual effective doses were less than 0.1 mSv in over 90% of the residents. The Cs-137 body burden was significantly higher in autumn than other seasons (p < 0.001) and in residents living in more contaminated areas (p < 0.001). We also found a significant correlation between the proportion of residents in each city with an estimated annual exposure dose exceeding 0.1 mSv and Cs-137 concentration of soil samples from family farms (r = 0.828, p = 0.003). In conclusion, more than 25 years after the Chernobyl accident, the internal exposure doses to residents living in contaminated areas of northern Ukraine is limited but still related to 137Cs soil contamination. Furthermore, the consumption of local foods is considered to be the cause of internal exposure.	[Kimura, Yuko; Okubo, Yuka; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Hayashida, Naomi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Div Strateg Collaborat Res, Nagasaki 852, Japan; [Hayashida, Naomi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Isotope Med 3Dept, Nagasaki 852, Japan; [Takahashi, Jumpei] Nagasaki Univ, Ctr Int Collaborat Res, Nagasaki 852, Japan; [Gutevich, Alexander; Chorniy, Sergiy] Zhitomir Interarea Med Diagnost Ctr, Korosten, Ukraine; [Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Isotope Med, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp		Takamura, Noboru/0000-0002-5552-3234	Japan Society for the Promotion of Science [26305025]; Grants-in-Aid for Scientific Research [26305025, 15K00540] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grant-in-Aid from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html, No. 26305025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardsson C, 2011, SCI TOTAL ENVIRON, V409, P4811, DOI 10.1016/j.scitotenv.2011.07.066; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Demidchik YE, 2007, ARQ BRAS ENDOCRINOL, V51, P748, DOI 10.1590/S0004-27302007000500012; Handl J, 2003, HEALTH PHYS, V84, P502, DOI 10.1097/00004032-200304000-00010; Hayashida N, 2011, J RADIAT RES, V52, P629, DOI 10.1269/jrr.11017; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; ICRP, 2007, 2007 REC INT COMM RA; International Atomic Energy Agency, 2006, CHERN LEG HLTH ENV S; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Ohnishi T, 2011, RADIAT RES, V177, P1, DOI DOI 10.1667/FTR2830.1; Orita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114407; Sekitani Y, 2010, RADIAT PROT DOSIM, V141, P36, DOI 10.1093/rpd/ncq137; Semioshkina N, 2006, J ENVIRON RADIOACTIV, V85, P84, DOI 10.1016/j.jenvrad.2005.06.001; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Taira Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057524; Takatsuji T, 2000, HEALTH PHYS, V78, P86, DOI 10.1097/00004032-200001000-00014; Travnikova IG, 2001, RADIAT PROT DOSIM, V93, P331, DOI 10.1093/oxfordjournals.rpd.a006445; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, UNSCEAR 2008 REP, VII	19	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139007	10.1371/journal.pone.0139007	http://dx.doi.org/10.1371/journal.pone.0139007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402065	Green Published, gold, Green Submitted			2022-12-26	WOS:000361798100049
J	Rai, A; Singh, R; Shirke, PA; Tripathi, RD; Trivedi, PK; Chakrabarty, D				Rai, Arti; Singh, Ruchi; Shirke, Pramod Arvind; Tripathi, Rudra Deo; Trivedi, Prabodh Kumar; Chakrabarty, Debasis			Expression of Rice CYP450-Like Gene (Os08g01480) in Arabidopsis Modulates Regulatory Network Leading to Heavy Metal and Other Abiotic Stress Tolerance	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; CHLOROPHYLL FLUORESCENCE; OXIDATIVE STRESS; PHOTOSYSTEM-II; CYTOCHROME-P450 GENE; SALT STRESS; PHOTOSYNTHESIS; TRANSCRIPTOME; P450; DETOXIFICATION	Heavy metal (HM) toxicity has become a grave problem in the world since it leads to hazardous effects on living organisms. Transcriptomic/proteomic studies in plants have identified a large number of metal-responsive gene families. Of these, cytochrome-P450 (CYPs) family members are composed of enzymes carrying out detoxification of exogenous molecules. Here, we report a CYP-like protein encoded by Os08g01480 locus in rice that helps the plant to combat HM and other abiotic stresses. To functionally characterize CYP-like gene, cDNA and promoter were isolated from rice to develop Arabidopsis transgenic lines. Heterologous expression of Os08g01480 in Arabidopsis provided significant tolerance towards abiotic stresses. In silico analysis reveals that Os08g01480 might help plants to combat environmental stress via modulating auxin metabolism. Transgenic lines expressing reporter gene under control of Os08g01480 promoter demonstrated differential promoter activity in different tissues during environmental stresses. These studies indicated that differential expression of Os08g01480 might be modulating response of plants towards environmental stresses as well as in different developmental stages.	[Rai, Arti; Singh, Ruchi; Shirke, Pramod Arvind; Tripathi, Rudra Deo; Trivedi, Prabodh Kumar; Chakrabarty, Debasis] CSIR, Natl Bot Res Inst, Lucknow 226001, Uttar Pradesh, India; [Rai, Arti; Shirke, Pramod Arvind; Tripathi, Rudra Deo; Trivedi, Prabodh Kumar; Chakrabarty, Debasis] Acad Sci & Innovat Res AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR)	Chakrabarty, D (corresponding author), CSIR, Natl Bot Res Inst, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India.	chakrabartyd@nbri.res.in	Chakrabarty, Debasis/H-4102-2017; Chakrabarty, Debasis/AAF-3680-2019	Chakrabarty, Debasis/0000-0003-4795-199X; Chakrabarty, Debasis/0000-0003-4795-199X; SINGH, RUCHI/0000-0003-4696-5150; Tripathi, Rudra Deo/0000-0002-1014-6762	CSIR, New Delhi [BSC-0107]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the research grant from the CSIR, New Delhi, as Network Project (BSC-0107). AR acknowledges CSIR for providing SRF.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Boyd RS, 2010, J CHEM ECOL, V36, P46, DOI 10.1007/s10886-009-9730-5; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Chakrabarty D, 2009, CHEMOSPHERE, V74, P688, DOI 10.1016/j.chemosphere.2008.09.082; Cui LJ, 2006, BOT STUD, V47, P61; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D; Dubey S, 2014, FUNCT INTEGR GENOMIC, V14, P401, DOI 10.1007/s10142-014-0361-8; Gomez K.A., 1984, STAT PROCEDURES AGR; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hossain MA, 2009, AUST J CROP SCI, V3, P53; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kim YC, 2006, BIOCHEM BIOPH RES CO, V345, P638, DOI 10.1016/j.bbrc.2006.04.124; Komura M, 2010, BBA-BIOENERGETICS, V1797, P331, DOI 10.1016/j.bbabio.2009.11.007; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar S, 2015, ENVIRON INT, V74, P221, DOI 10.1016/j.envint.2014.10.019; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu T, 2009, ENVIRON EXP BOT, V67, P377, DOI 10.1016/j.envexpbot.2009.03.016; Lu CM, 2002, PLANT SCI, V163, P1063, DOI 10.1016/S0168-9452(02)00281-9; Mallick N, 2003, ECOTOX ENVIRON SAFE, V55, P64, DOI 10.1016/S0147-6513(02)00122-7; Mathur S, 2011, PLANT BIOLOGY, V13, P1, DOI 10.1111/j.1438-8677.2009.00319.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Mosa KA, 2012, TRANSGENIC RES, V21, P1265, DOI 10.1007/s11248-012-9600-8; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Norton GJ, 2008, J EXP BOT, V59, P2267, DOI 10.1093/jxb/ern097; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Polle A, 1993, SIGNIFICANCE ANTIOXI; Rahman SH, 2012, APPL SCI-BASEL, V2, P584, DOI 10.3390/app2030584; Rai A, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0054; Rai A, 2011, CHEMOSPHERE, V82, P986, DOI 10.1016/j.chemosphere.2010.10.070; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Roychowdhury T, 2002, FOOD CHEM TOXICOL, V40, P1611, DOI 10.1016/S0278-6915(02)00104-7; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuler MA, 1996, CRIT REV PLANT SCI, V15, P235, DOI 10.1080/713608134; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Sharma P, 2007, PLANT CELL REP, V26, P2027, DOI 10.1007/s00299-007-0416-6; Shri M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05784; Shri M, 2009, ECOTOX ENVIRON SAFE, V72, P1102, DOI 10.1016/j.ecoenv.2008.09.022; Shukla D, 2012, PLANT CELL REP, V31, P1687, DOI 10.1007/s00299-012-1283-3; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Thomas Sterling, 2010, Human Genomics, V4, P353; Tiwari M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03964; Tiwari M, 2014, PLANT CELL ENVIRON, V37, P140, DOI 10.1111/pce.12138; Xiao FM, 2004, EMBO J, V23, P2903, DOI 10.1038/sj.emboj.7600290	57	28	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138574	10.1371/journal.pone.0138574	http://dx.doi.org/10.1371/journal.pone.0138574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401987	Green Submitted, Green Published, gold			2022-12-26	WOS:000361798100029
J	Rodriguez-Miguel, C; Moral, R; Escrich, R; Vela, E; Solanas, M; Escrich, E				Rodriguez-Miguel, Cristina; Moral, Raquel; Escrich, Raquel; Vela, Elena; Solanas, Montserrat; Escrich, Eduard			The Role of Dietary Extra Virgin Olive Oil and Corn Oil on the Alteration of Epigenetic Patterns in the Rat DMBA-Induced Breast Cancer Model	PLOS ONE			English	Article							INDUCED MAMMARY-CARCINOMA; TUMOR-SUPPRESSOR GENE; DNA METHYLTRANSFERASES; LIPID INFLUENCE; CPG ISLAND; METHYLATION; EXPRESSION; ESTROGEN; TRIMETHYLATION; INSTABILITY	Disruption of epigenetic patterns is a major change occurring in all types of cancers. Such alterations are characterized by global DNA hypomethylation, gene-promoter hypermethylation and aberrant histone modifications, and may be modified by environment. Nutritional factors, and especially dietary lipids, have a role in the etiology of breast cancer. Thus, we aimed to analyze the influence of different high fat diets on DNA methylation and histone modifications in the rat dimethylbenz(a) anthracene (DMBA)-induced breast cancer model. Female Sprague-Dawley rats were fed a low-fat, a high corn-oil or a high extra-virgin olive oil (EVOO) diet from weaning or from induction with DMBA. In mammary glands and tumors we analyzed global and gene specific (RASSF1A, TIMP3) DNA methylation by LUMA and bisulfite pyrosequencing assays, respectively. We also determined gene expression and enzymatic activity of DNA methyltransferases (DNMT1, DNMT3a and DNMT3b) and evaluated changes in histone modifications (H3K4me2, H3K27me3, H4K20me3 and H4K16ac) by western-blot. Our results showed variations along time in the global DNA methylation of the mammary gland displaying decreases at puberty and with aging. The olive oil-enriched diet, on the one hand, increased the levels of global DNA methylation in mammary gland and tumor, and on the other, changed histone modifications patterns. The corn oil-enriched diet increased DNA methyltransferase activity in both tissues, resulting in an increase in the promoter methylation of the tumor suppressor genes RASSF1A and TIMP3. These results suggest a differential effect of the high fat diets on epigenetic patterns with a relevant role in the neoplastic transformation, which could be one of the mechanisms of their differential promoter effect, clearly stimulating for the high corn-oil diet and with a weaker influence for the high EVOO diet, on breast cancer progression.	[Rodriguez-Miguel, Cristina; Moral, Raquel; Escrich, Raquel; Vela, Elena; Solanas, Montserrat; Escrich, Eduard] Univ Autonoma Barcelona, Fac Med, Dept Cell Biol Physiol & Immunol, Physiol Unit,Grp Multidisciplinari Estudi Canc Ma, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Moral, R (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Cell Biol Physiol & Immunol, Physiol Unit,Grp Multidisciplinari Estudi Canc Ma, E-08193 Barcelona, Spain.	Raquel.Moral@uab.cat	Moral, Raquel/H-2122-2015; Moral, Raquel/ABG-3355-2020; Solanas Garcia, Montserrat/O-4684-2016	Moral, Raquel/0000-0002-2738-6121; Solanas Garcia, Montserrat/0000-0003-2949-1344	Plan Nacional I+D+I [AGL2006-07691/ALI, AGL2011-24778]; Fundacion Patrimonio Comunal Olivarero [FPCO2008-165.396, FPCO2013-CF611.084]; Agencia para el Aceite de Oliva del Ministerio de Agricultura, Alimentacion y Medio Ambiente [AAO2008-165.471]; Organizacion Interprofesional del Aceite de Oliva Espanol [OIP2009-165.646]; Departament de Salut i d'Agricultura, Alimentacio i Accio Rural de la Generalitat de Catalunya [GC2010-165.000]	Plan Nacional I+D+I; Fundacion Patrimonio Comunal Olivarero; Agencia para el Aceite de Oliva del Ministerio de Agricultura, Alimentacion y Medio Ambiente; Organizacion Interprofesional del Aceite de Oliva Espanol; Departament de Salut i d'Agricultura, Alimentacio i Accio Rural de la Generalitat de Catalunya	This work was supported by "Plan Nacional I+D+I 2004-2007 & 2008-2011" (AGL2006-07691/ALI & AGL2011-24778) to EE; "Fundacion Patrimonio Comunal Olivarero" (FPCO2008-165.396; FPCO2013-CF611.084) to EE; "Agencia para el Aceite de Oliva del Ministerio de Agricultura, Alimentacion y Medio Ambiente" (AAO2008-165.471) to EE; "Organizacion Interprofesional del Aceite de Oliva Espanol" (OIP2009-165.646) to EE; and Departament de Salut i d'Agricultura, Alimentacio i Accio Rural de la Generalitat de Catalunya" (GC2010-165.000) to EE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Bachman KE, 1999, CANCER RES, V59, P798; Chodosh LA, 1998, J MAMMARY GLAND BIOL, V3, P389, DOI 10.1023/A:1018784031651; Costa I, 2004, BREAST CANCER RES TR, V86, P225, DOI 10.1023/B:BREA.0000036896.75548.0c; Costa I, 2002, ARCH PATHOL LAB MED, V126, P915; Dammann R, 2001, CANCER RES, V61, P3105; Di Francesco A, 2015, J NUTR BIOCHEM, V26, P250, DOI 10.1016/j.jnutbio.2014.10.013; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Escrich E, 2006, OLIVE OIL AND HEALTH, P317, DOI 10.1079/9781845930684.0317; Escrich E, 2014, CANCER TREAT RES, V159, P289, DOI 10.1007/978-3-642-38007-5_17; Escrich Eduard, 1994, In Vivo (Attiki), V8, P1107; Escrich Eduard, 1994, In Vivo (Attiki), V8, P1099; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2005, CELL CYCLE, V4, P1377, DOI 10.4161/cc.4.10.2113; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Girault I, 2003, CLIN CANCER RES, V9, P4415; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guthrie N, 1999, PROG LIPID RES, V38, P261, DOI 10.1016/S0163-7827(99)00006-5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardy TM, 2011, EPIGENOMICS-UK, V3, P503, DOI [10.2217/epi.11.71, 10.2217/EPI.11.71]; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kutanzi K, 2013, CANCER BIOL THER, V14, P564, DOI 10.4161/cbt.24599; Li JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106290; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Meeran SM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0011-5; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Moral R, 2011, NUTR CANCER, V63, P410, DOI 10.1080/01635581.2011.535956; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Russo J, 1997, ENDOCR-RELAT CANCER, V4, P7, DOI 10.1677/erc.0.0040007; Sant Karilyn E, 2012, Methods Mol Biol, V889, P385, DOI 10.1007/978-1-61779-867-2_24; Schwingshackl L, 2014, INT J CANCER, V135, P1884, DOI 10.1002/ijc.28824; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Solanas M, 2002, INT J ONCOL, V21, P745; Solanas M, 2010, CARCINOGENESIS, V31, P871, DOI 10.1093/carcin/bgp243; Starlard-Davenport A, 2010, CARCINOGENESIS, V31, P376, DOI 10.1093/carcin/bgp304; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTRITION PHYSI; Yenbutr P, 1998, MECH AGEING DEV, V106, P93, DOI 10.1016/S0047-6374(98)00093-1	44	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138980	10.1371/journal.pone.0138980	http://dx.doi.org/10.1371/journal.pone.0138980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26401660	Green Published, Green Submitted, gold			2022-12-26	WOS:000361798100047
J	Guthoff, M; Vosseler, D; Langanke, J; Nadalin, S; Konigsrainer, A; Haring, HU; Fritsche, A; Heyne, N				Guthoff, Martina; Vosseler, Dorothea; Langanke, Julia; Nadalin, Silvio; Koenigsrainer, Alfred; Haering, Hans-Ulrich; Fritsche, Andreas; Heyne, Nils			Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List-Prevalence, Metabolic Phenotyping and Risk Stratification Approach	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL DYSFUNCTION; INSULIN-RESISTANCE; GLYCEMIC CONTROL; RENAL-TRANSPLANTATION; RECIPIENTS; CYCLOSPORINE; SENSITIVITY; TACROLIMUS; CONVERSION	Background Despite a significant prognostic impact, little is known about disturbances in glucose metabolism among kidney transplant candidates. We assess the prevalence of diabetes mellitus (DM) and prediabetes on kidney transplant waiting list, its underlying pathophysiology and propose an approach for individual risk stratification. Methods All patients on active kidney transplant waiting list of a large European university hospital transplant center were metabolically phenotyped. Results Of 138 patients, 76 (55%) had disturbances in glucose metabolism. 22% of patients had known DM, 3% were newly diagnosed. 30% were detected to have prediabetes. Insulin sensitivity and-secretion indices allowed for identification of underlying pathophysiology and risk factors. Age independently affected insulin secretion, resulting in a relative risk for prediabetes of 2.95 (95% CI 1.38-4.83) with a cut-off at 48 years. Body mass index independently affected insulin sensitivity as a continuous variable. Conclusions The prevalence of DM or prediabetes on kidney transplant waiting list is as high as 55%, with more than one third of patients previously undiagnosed. Oral glucose tolerance test is mandatory to detect all patients at risk. Metabolic phenotyping allows for differentiation of underlying pathophysiology and provides a basis for early individual risk stratification and specific intervention to improve patient and allograft outcome.	[Guthoff, Martina; Vosseler, Dorothea; Langanke, Julia; Haering, Hans-Ulrich; Fritsche, Andreas; Heyne, Nils] Univ Tubingen, Dept Endocrinol & Diabetol, Angiol Nephrol & Clin Chem, D-72076 Tubingen, Germany; [Nadalin, Silvio; Koenigsrainer, Alfred] Univ Tubingen, Dept Gen Visceral & Transplant Surg, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Heyne, N (corresponding author), Univ Tubingen, Dept Endocrinol & Diabetol, Angiol Nephrol & Clin Chem, Otfried Muller Str 10, D-72076 Tubingen, Germany.	nils.heyne@med.uni-tuebingen.de	Guthoff, Martina/D-3960-2018	Guthoff, Martina/0000-0002-4294-980X	Novartis Pharma GmbH, Nurnberg, Germany; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	Novartis Pharma GmbH, Nurnberg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This work was funded by an unrestricted grant from Novartis Pharma GmbH, Nurnberg, Germany. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Al Ghofaili K, 2007, TRANSPLANTATION, V83, P24, DOI 10.1097/01.tp.0000251379.46596.2d; American Diabetes Association, 2010, DIABETES CARE S1, V3, pS62; [Anonymous], 2013, ANN REPORT; Bock G, 2007, DIABETES, V56, P1703, DOI 10.2337/db06-1776; Caillard S, 2011, TRANSPLANTATION, V91, P757, DOI 10.1097/TP.0b013e31820f0877; Chakkera HA, 2011, DIABETES CARE, V34, P2141, DOI 10.2337/dc11-0752; Cole EH, 2008, CLIN J AM SOC NEPHRO, V3, P814, DOI 10.2215/CJN.04681107; Cosio FG, 2002, KIDNEY INT, V62, P1440, DOI 10.1111/j.1523-1755.2002.kid582.x; Einollahi Behzad, 2008, Urol J, V5, P248; Gallwitz B, 2013, DIABETES CARE, V36, pS180, DOI 10.2337/dcS13-2012; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Garcia-Estevez DA, 2004, METABOLISM, V53, P1462, DOI 10.1016/j.metabol.2004.06.014; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Green JB, 2015, N ENGL J MED; Hagen M, 2003, NEPHROL DIAL TRANSPL, V18, P2154, DOI 10.1093/ndt/gfg338; Halpern H, 2004, TRANSPL P, V36, P984, DOI 10.1016/j.transproceed.2004.03.086; Hecking M, 2013, DIABETES CARE, V36, P2763, DOI 10.2337/dc12-2441; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hornum M, 2010, CLIN J AM SOC NEPHRO, V5, P709, DOI 10.2215/CJN.05360709; Joss N, 2007, CLIN TRANSPLANT, V21, P136, DOI 10.1111/j.1399-0012.2006.00580.x; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koh A, 2010, TRANSPLANTATION, V89, P465, DOI 10.1097/TP.0b013e3181c478fd; Kramer B, 2011, J AM SOC NEPHROL, V22, p838A; Kurzawski M, 2012, EUR J CLIN PHARMACOL, V68, P1587, DOI 10.1007/s00228-012-1292-8; Lane JT, 2011, TRANSPLANTATION, V92, pE56, DOI 10.1097/TP.0b013e3182347ea4; Lee YS, 2014, METABOLISM, V63, P9, DOI 10.1016/j.metabol.2013.09.010; Luan FL, 2011, TRANSPLANTATION, V91, P334, DOI 10.1097/TP.0b013e318203c25f; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCaughan JA, 2014, J AM SOC NEPHROL, V25, P1037, DOI 10.1681/ASN.2013040383; Midtvedt K, 1998, NEPHROL DIAL TRANSPL, V13, P427, DOI 10.1093/oxfordjournals.ndt.a027841; Montero N, 2015, CURR DIABETES REV, V11, P144, DOI 10.2174/1573399811666150331160846; Nam JH, 2001, TRANSPLANTATION, V71, P1417, DOI 10.1097/00007890-200105270-00011; Necking M, 2012, J AM SOC NEPHROL, V23, P739, DOI 10.1681/ASN.2011080835; Nijpels G, 1996, DIABETOLOGIA, V39, P113; Padmasekar M, 2013, ENDOCRINOLOGY, V154, P1424, DOI 10.1210/en.2012-1983; Pascual J, 2010, TRANSPLANTATION, V90, P343, DOI 10.1097/TP.0b013e3181e58912; Patibandla BK, 2012, CLIN TRANSPLANT, V26, pE307, DOI 10.1111/j.1399-0012.2012.01661.x; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Pham PTT, 2013, SEMIN DIALYSIS, V26, P568, DOI 10.1111/sdi.12109; Pinelli NR, 2013, DIABETES CARE, V36, pE171, DOI 10.2337/dc13-1066; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sharif A, 2014, AM J TRANSPLANT, V14, P1992, DOI 10.1111/ajt.12850; Sharif A, 2010, J AM SOC NEPHROL, V21, P383, DOI 10.1681/ASN.2010010031; Singh B, 2010, WORLD J DIABETES, V1, P36, DOI 10.4239/wjd.v1.i2.36; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Vos FE, 2012, NEPHROLOGY, V17, P182, DOI 10.1111/j.1440-1797.2011.01517.x; Wang JL, 2012, NEPHRON CLIN PRACT, V121, pC102, DOI 10.1159/000345159; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wissing K, 2014, AM J TRANSPLANT, V14, P95; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Zelle DM, 2013, DIABETES CARE, V36, P1926, DOI 10.2337/dc12-1894	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0134971	10.1371/journal.pone.0134971	http://dx.doi.org/10.1371/journal.pone.0134971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398489	Green Published, Green Submitted, gold			2022-12-26	WOS:000361797500003
J	Sanzogni, RL; Meekan, MG; Meeuwig, JJ				Sanzogni, R. L.; Meekan, M. G.; Meeuwig, J. J.			Multi-Year Impacts of Ecotourism on Whale Shark (Rhincodon typus) Visitation at Ningaloo Reef, Western Australia	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; POPULATION-SIZE; HUMPBACK WHALES; ECONOMIC VALUE; LARGEST FISH; LOS-ANGELES; MARINE-PARK; EAST-COAST; MOVEMENTS; TOURISM	In-water viewing of sharks by tourists has become a popular and lucrative industry. There is some concern that interactions with tourists with ecotourism operations might harm sharks through disruption of behaviours. Here, we analysed five years of whale shark (Rhincodon typus) encounter data by an ecotourism industry at Ningaloo Reef, Western Australia, to assess the impact of ecotourism interactions on shark visitation, within the context of the biological and physical oceanography of the region. Our data base consisted of 2823 encounter records for 951 individual whale sharks collected by ecotourism operators between 2007 and 2011. We found that total encounters per whale shark and encounters per boat trip increased through time. On average, whale sharks re-encountered in subsequent years were encountered earlier, stayed longer and tended to be encountered more often within a season than sharks that were only encountered in a single year. Sequential comparisons between years did not show any patterns consistent with disturbance and the rate of departure of whale sharks from the aggregation was negatively correlated to the number of operator trips. Overall, our analysis of this multi-year data base found no evidence that interactions with tourists affected the likelihood of whale shark re-encounters and that instead, physical and biological environmental factors had a far greater influence on whale shark visitation rates. Our approach provides a template for assessing the effects of ecotourism interactions and environmental factors on the visitation patterns of marine megafauna over multiple years.	[Sanzogni, R. L.; Meeuwig, J. J.] Univ Western Australia, Sch Anim Biol, Oceans Inst, Crawley, WA 6009, Australia; [Sanzogni, R. L.; Meekan, M. G.] UWA Oceans Inst, Australian Inst Marine Sci, Crawley, WA 6009, Australia; [Meeuwig, J. J.] Univ Western Australia, Ctr Marine Futures, Oceans Inst, Crawley, WA 6009, Australia	University of Western Australia; Australian Institute of Marine Science; University of Western Australia; University of Western Australia	Meekan, MG (corresponding author), UWA Oceans Inst, Australian Inst Marine Sci, 35 Stirling Highway, Crawley, WA 6009, Australia.	M.Meekan@aims.gov.au		Meeuwig, Jessica/0000-0003-1169-8785; Meekan, Mark/0000-0002-3067-9427	Apache Energy Ltd.	Apache Energy Ltd.	Funding for this project was provided by Apache Energy Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 1999, CASE STUDIES MANAGEM; [Anonymous], 2009, ECOTOURISM IMPACTS P; [Anonymous], WCPFC 9 REG SESS; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Cardenas-Torres N, 2007, FISH RES, V84, P114, DOI 10.1016/j.fishres.2006.11.019; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Catlin J, 2010, INT J TOUR RES, V12, P134, DOI 10.1002/jtr.742; Catlin J, 2010, TOURISM MANAGE, V31, P386, DOI 10.1016/j.tourman.2009.04.004; Chen VY, 2002, MANAGEMENT TRADE WHA; Cisneros-Montemayor AM, 2010, MAR POLICY, V34, P1273, DOI 10.1016/j.marpol.2010.05.005; Clua E, 2011, MAR FRESHWATER RES, V62, P764, DOI 10.1071/MF10163; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno L.J.V, 1984, HDB PALEOICHTHYOLO B, V4, P1; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Cummins G., 2010, THESIS U W AUSTR PER; Davis D, 1997, TOURISM MANAGE, V18, P259, DOI 10.1016/S0261-5177(97)00015-0; Defran RH, 1999, MAR MAMMAL SCI, V15, P366, DOI 10.1111/j.1748-7692.1999.tb00807.x; Fiedler PC, 1998, DEEP-SEA RES PT II, V45, P1781, DOI 10.1016/S0967-0645(98)80017-9; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Gende SM, 2006, DEEP-SEA RES PT II, V53, P432, DOI 10.1016/j.dsr2.2006.01.005; Gleiss AC, 2013, MAR BIOL, V160, P2981, DOI 10.1007/s00227-013-2288-3; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Holmberg J, 2008, ECOL APPL, V18, P222, DOI 10.1890/07-0315.1; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kideys AE, 2000, J MARINE SYST, V24, P355, DOI 10.1016/S0924-7963(99)00095-0; Marchal P, 2007, ICES J MAR SCI, V64, P192, DOI 10.1093/icesjms/fsl014; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Mau Roland, 2008, Journal of Ecotourism, V7, P213; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Norman BM, 1999, THESIS MURDOCH U W A; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; Orams MB, 2002, COAST MANAGE, V30, P361, DOI 10.1080/089207502900264; Palma L, 1999, J APPL ECOL, V36, P812, DOI 10.1046/j.1365-2664.1999.00436.x; Pauly D, 2000, ELASMOBRANC IN PRESS; Pauly D., 2010, WORKING PAPER SERIES; PEARCE AF, 1988, J CONSEIL, V45, P13; Pierce SJ, 2010, AQUAT CONSERV, V20, P782, DOI 10.1002/aqc.1149; Pravin P, 2000, CURR SCI INDIA, V79, P310; Quiros AL, 2007, FISH RES, V84, P102, DOI 10.1016/j.fishres.2006.11.017; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V382, P77, DOI 10.1016/j.jembe.2009.10.015; Sleeman JC, 2007, MAR FRESHWATER RES, V58, P608, DOI 10.1071/MF06213; Smith K, 2010, ENVIRON MANAGE, V46, P699, DOI 10.1007/s00267-010-9561-8; Speed CW, 2008, J FISH BIOL, V72, P1488, DOI 10.1111/j.1095-8649.2008.01810.x; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Sugimoto T, 1998, FISH OCEANOGR, V7, P289, DOI 10.1046/j.1365-2419.1998.00070.x; Taylor J. G., 1994, WHALE SHARKS GENTLE; Taylor JG, 2007, FISH RES, V84, P65, DOI 10.1016/j.fishres.2006.11.014; Taylor JG, 1999, J ROYAL SOC W AUSTR, V82, P9; Topelko Karen N., 2005, Journal of Ecotourism, V4, P108, DOI 10.1080/14724040409480343; Towner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071197; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wilson SG, 2002, J ROYAL SOC W AUSTR, V85, P2; Wintner SP, 2000, ENVIRON BIOL FISH, V59, P441, DOI 10.1023/A:1026564707027	70	12	13	1	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0127345	10.1371/journal.pone.0127345	http://dx.doi.org/10.1371/journal.pone.0127345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26398338	gold, Green Published, Green Submitted			2022-12-26	WOS:000361797500002
J	Snow-Lisy, DC; Diaz, EC; Bury, MI; Fuller, NJ; Hannick, JH; Ahmad, N; Sharma, AK				Snow-Lisy, Devon C.; Diaz, Edward C.; Bury, Matthew I.; Fuller, Natalie J.; Hannick, Jessica H.; Ahmad, Nida; Sharma, Arun K.			The Role of Genetically Modified Mesenchymal Stem Cells in Urinary Bladder Regeneration	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BLOOD-VESSELS; SELF-RENEWAL; WNT PROTEINS; SPINA-BIFIDA; PHASE-II; ANGIOGENESIS; CCN1; MUSCLE; TISSUE	Recent studies have demonstrated that mesenchymal stem cells (MSCs) combined with CD34(+) hematopoietic/stemprogenitor cells (HSPCs) can function as surrogate urinary bladder cells to synergistically promote multi-faceted bladder tissue regeneration. However, themolecular pathways governing these events are unknown. The pleiotropic effects of Wnt5a and Cyr61 are known to affect aspects of hematopoiesis, angiogenesis, and muscle and nerve regeneration. Within this study, the effects of Cyr61 and Wnt5a on bladder tissue regeneration were evaluated by grafting scaffolds containing modified human bone marrow derived MSCs. These cell lines were engineered to independently over-express Wnt5a or Cyr61, or to exhibit reduced expression of Cyr61 within the context of a nude rat bladder augmentation model. At 4 weeks post-surgery, data demonstrated increased vessel number (similar to 250 vs similar to 109 vessels/mm(2)) and bladder smooth muscle content (similar to 42% vs similar to 36%) in Cyr61OX (over-expressing) vs Cyr61KD (knock-down) groups. Muscle content decreased to similar to 25% at 10 weeks in Cyr61KD groups. Wnt5aOX resulted in high numbers of vessels and muscle content (similar to 206 vessels/mm(2) and similar to 51%, respectively) at 4 weeks. Over-expressing cell constructs resulted in peripheral nerve regeneration while Cyr61KD animals were devoid of peripheral nerve regeneration at 4 weeks. At 10 weeks post-grafting, peripheral nerve regeneration was at a minimal level for both Cyr61OX and Wnt5aOX cell lines. Blood vessel and bladder functionality were evident at both time-points in all animals. Results from this study indicate that MSC-based Cyr61OX and Wnt5aOX cell lines play pivotal roles with regards to increasing the levels of functional vasculature, influencing muscle regeneration, and the regeneration of peripheral nerves in a model of bladder augmentation. Wnt5aOX constructs closely approximated the outcomes previously observed with the co-transplantation of MSCs with CD34(+) HSPCs and may be specifically targeted as an alternate means to achieve functional bladder regeneration.	[Snow-Lisy, Devon C.; Diaz, Edward C.; Bury, Matthew I.; Fuller, Natalie J.; Ahmad, Nida; Sharma, Arun K.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Urol, Chicago, IL 60611 USA; [Hannick, Jessica H.] Loyola Univ Hlth Syst, Dept Urol, Maywood, IL USA; [Sharma, Arun K.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Sharma, Arun K.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA; [Sharma, Arun K.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Loyola University Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Sharma, AK (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Urol, Chicago, IL 60611 USA.	arun-sharma@northwestern.edu						Abdollah F, 2013, CANCER EPIDEMIOL, V37, P219, DOI 10.1016/j.canep.2013.02.002; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Arderiu G, 2014, J MOL CELL BIOL, V6, P380, DOI 10.1093/jmcb/mju036; Ascheim DD, 2014, CIRCULATION, V129, P2287, DOI 10.1161/CIRCULATIONAHA.113.007412; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Austin JC, 2007, J UROLOGY, V178, P798, DOI 10.1016/j.juro.2007.05.055; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bury MI, 2014, BIOMATERIALS, V35, P9311, DOI 10.1016/j.biomaterials.2014.07.057; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Cheng EY, 2014, J UROLOGY, V191, P1395, DOI 10.1016/j.juro.2013.10.157; Cully Megan, 2013, Nat Rev Rheumatol, V9, P136, DOI 10.1038/nrrheum.2013.22; Dahms SE, 1998, BRIT J UROL, V82, P411; Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154; Deng KL, 2015, AM J PHYSIOL-RENAL, V308, pF92, DOI 10.1152/ajprenal.00510.2014; Diez-Tejedor E, 2014, J STROKE CEREBROVASC, V23, P2694, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.011; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Farhat WA, 2014, J UROLOGY, V191, P1394, DOI 10.1016/j.juro.2013.10.156; Frey SP, 2012, INT ORTHOP, V36, P2387, DOI 10.1007/s00264-012-1659-6; GILMOUR RF, 1993, J UROLOGY, V150, P1200, DOI 10.1016/S0022-5347(17)35727-0; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; Hoke A, 2001, EXP NEUROL, V172, P398, DOI 10.1006/exnr.2001.7808; HOULE AM, 1993, J UROLOGY, V149, P561, DOI 10.1016/S0022-5347(17)36148-7; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Jung YS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.48; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lazzeri M, 2006, UROL INT, V76, P289, DOI 10.1159/000092049; Li XR, 2010, ONCOTARGET, V1, P309, DOI 10.18632/oncotarget.141; MacNeily AL, 2007, J UROLOGY, V178, P1752, DOI 10.1016/j.juro.2007.03.157; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Osborn DJ, 2014, UROLOGY, V83, P1433, DOI 10.1016/j.urology.2014.02.030; Park YS, 2015, J CELL PHYSIOL, V230, P140, DOI 10.1002/jcp.24690; Planutis K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-12; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Prager GW, 2012, TRANSL LUNG CANCER R, V1, P14, DOI 10.3978/j.issn.2218-6751.2011.11.02; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Schlomer BJ, 2014, J PEDIATR UROL, V10, P1043, DOI 10.1016/j.jpurol.2014.03.007; Sharma AK, 2014, ADV DRUG DE IN PRESS; Sharma AK, 2013, P NATL ACAD SCI USA, V110, P4003, DOI 10.1073/pnas.1220764110; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sloff M, 2014, J UROLOGY, V192, P1035, DOI 10.1016/j.juro.2014.03.116; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tran C, 2014, ADV DRUG DELIV REV; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Vaegler M, 2012, EUR UROL, V61, P1263, DOI 10.1016/j.eururo.2012.03.025; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004	72	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138643	10.1371/journal.pone.0138643	http://dx.doi.org/10.1371/journal.pone.0138643			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BM	26398705	gold, Green Submitted, Green Published			2022-12-26	WOS:000361797500087
J	Yang, TC; Matthews, SA				Yang, Tse-Chuan; Matthews, Stephen A.			Death by Segregation: Does the Dimension of Racial Segregation Matter?	PLOS ONE			English	Article							RESIDENTIAL SEGREGATION; INCOME INEQUALITY; IMMIGRANT ENCLAVES; HEALTH RESEARCH; UNITED-STATES; MORTALITY; REGRESSION; DISPARITIES; MULTILEVEL; BLACK	The county-level geographic mortality differentials have persisted in the past four decades in the United States (US). Though several socioeconomic factors (e.g., inequality) partially explain this phenomenon, the role of race/ethnic segregation, in general, and the different dimensions of segregation, more specifically, has been underexplored. Focusing on allcause age-sex standardized US county-level mortality (2004-2008), this study has two substantive goals: (1) to understand whether segregation is a determinant of mortality and if yes, how the relationship between segregation and mortality varies by racial/ethnic dyads (e.g., white/black), and (2) to explore whether different dimensions of segregation (i.e., evenness, exposure, concentration, centralization, and clustering) are associated with mortality. A third goal is methodological: to assess whether spatial autocorrelation influences our understanding of the associations between the dimensions of segregation and mortality. Race/ethnic segregation was found to contribute to the geographic mortality disparities. Moreover, the relationship with mortality differed by both race/ethnic group and the dimension of segregation. Specifically, white/black segregation is positively related to mortality, whereas the segregation between whites and non-black minorities is negatively associated with mortality. Among the five dimensions of segregation, evenness and exposure are more strongly related to mortality than other dimensions. Spatial filtering approaches also identified six unique spatial patterns that significantly affect the spatial distribution of mortality. These patterns offer possible insights that help identify omitted variables related to the persistent patterning of mortality in the US.	[Yang, Tse-Chuan] SUNY Albany, Dept Sociol, Ctr Social & Demog Anal, Albany, NY 12222 USA; [Matthews, Stephen A.] Penn State Univ, Populat Res Inst, Dept Sociol, University Pk, PA 16802 USA; [Matthews, Stephen A.] Penn State Univ, Populat Res Inst, Dept Anthropol, University Pk, PA 16802 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yang, TC (corresponding author), 315 Arts & Sci Bldg,1400 Washington Ave, Albany, NY 12222 USA.	tyang3@albany.edu	Matthews, Stephen/AAO-6173-2020; Matthews, Stephen/GPS-9884-2022	Matthews, Stephen/0000-0002-1645-4854; Matthews, Stephen/0000-0002-1645-4854; Yang, Tse-Chuan/0000-0002-4271-4584	Center for Social and Demographic Analysis at the University at Albany, SUNY; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R24-HD04494309, R24-HD041025]; Population Research Institute at Penn State; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044943, R24HD041025] Funding Source: NIH RePORTER	Center for Social and Demographic Analysis at the University at Albany, SUNY; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Population Research Institute at Penn State; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge the support from the Center for Social and Demographic Analysis at the University at Albany, SUNY, which receives core funding from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (http://www.nichd.nih.gov/Pages/index.aspx) [R24-HD04494309] and from the Population Research Institute at Penn State, which receives core funding from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (http://www.nichd.nih.gov/Pages/index.aspx) [R24-HD041025].	Acevedo-Garcia D, 2003, AM J PUBLIC HEALTH, V93, P215, DOI 10.2105/AJPH.93.2.215; [Anonymous], 2011, COUNTY HLTH RANKINGS; Becares L, 2009, HEALTH PLACE, V15, P700, DOI 10.1016/j.healthplace.2008.10.008; Blanchard TC, 2008, SOC FORCES, V86, P1591, DOI 10.1353/sof.0.0045; Brulle RJ, 2006, ANNU REV PUBL HEALTH, V27, P103, DOI 10.1146/annurev.publhealth.27.021405.102124; CDC, 2012, OV OB CAUS CONS 2012; Center for Disease Control, 2013, BEH RISK FACT SURV S; Centers for Disease Control Prevention, 2000, MEAS HLTH DAYS POP A; Chun Y., 2013, SPATIAL STAT GEOSTAT; Collins CA, 1999, SOCIOLOGICAL FORUM; Cossman JS, 2007, AM J PUBLIC HEALTH, V97, P2148, DOI 10.2105/AJPH.2006.093112; Cossman RE, 2008, POPUL RES POLICY REV, V27, P459, DOI 10.1007/s11113-008-9069-6; Cressie N, 1991, STAT SPATIAL DATA; Cressie N., 2011, STAT SPATIO TEMPORAL; DeNavas-Walt C., 2009, INCOME POVERTY HLTH; Dinwiddie GY, 2013, SOC SCI MED, V80, P67, DOI 10.1016/j.socscimed.2012.11.024; DUNCAN OD, 1961, STAT GEOGRAPHY PROBL; Eschbach K, 2004, AM J PUBLIC HEALTH, V94, P1807, DOI 10.2105/AJPH.94.10.1807; Fischer MJ, 2003, URBAN AFF REV, V38, P669, DOI 10.1177/1078087403038005003; Fuguitt GV, 1994, POPULATION CHANGE NO; Gaskin DJ, 2012, HEALTH SERV RES, V47, P2353, DOI 10.1111/j.1475-6773.2012.01417.x; Getis A, 2002, GEOGR ANAL, V34, P130, DOI 10.1111/j.1538-4632.2002.tb01080.x; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; Glaeser Edward, 2012, END SEGREGATED CENTU; GREENBERG M, 1994, SOC SCI MED, V39, P179, DOI 10.1016/0277-9536(94)90326-3; Griffith DA, 2000, LINEAR ALGEBRA APPL, V321, P95, DOI 10.1016/S0024-3795(00)00031-8; GRIFFITH DA, 2003, ADV SPAT SCI, pR7, DOI 10.1007/978-3-540-24806-4; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hobbs F., 2002, DEMOGRAPHIC TRENDS 2; Hoyert DL, 2011, NATL VITAL STAT REP, V61, P1; Iceland J, 2002, BUREAU CENSUS; Jass G., 2004, IFS WORKING PAPERS; Johnson KM, 2010, POPUL DEV REV, V36, P151, DOI 10.1111/j.1728-4457.2010.00322.x; Kandula NR, 2004, ANNU REV PUBL HEALTH, V25, P357, DOI 10.1146/annurev.publhealth.25.101802.123107; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Kershaw KN, 2014, CIRCULATION; Kindig DA, 2013, HLTH AFF MILLWOOD, V32, P451, DOI DOI 10.1377/HLTHAFF; Kramer MR, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-29; Kramer MR, 2009, EPIDEMIOL REV, V31, P178, DOI 10.1093/epirev/mxp001; LeClere FB, 1997, SOC FORCES, V76, P169, DOI 10.2307/2580322; Lee BA, 2008, AM SOCIOL REV, V73, P766, DOI 10.1177/000312240807300504; Lee MA, 2007, J HEALTH SOC BEHAV, V48, P131, DOI 10.1177/002214650704800203; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lobao L. M., 2007, SOCIOLOGY SPATIAL IN; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Logan JR, 2004, DEMOGRAPHY, V41, P1, DOI 10.1353/dem.2004.0007; LOGAN JR, 1978, AM J SOCIOL, V84, P404, DOI 10.1086/226790; Logan JR, 2002, AM SOCIOL REV, V67, P299, DOI 10.2307/3088897; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; MASSEY DS, 1989, DEMOGRAPHY, V26, P373, DOI 10.2307/2061599; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; MATTHEWS SA, 1990, COMPUT ENVIRON URBAN, V14, P213, DOI 10.1016/0198-9715(90)90010-Q; Matthews SA, 2013, DEMOGR RES, P28; McLaughlin D.K., 2007, SOCIOLOGY SPATIAL IN, P141; McLaughlin DK, 2002, AM J PUBLIC HEALTH, V92, P99, DOI 10.2105/AJPH.92.1.99; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MURDOCK SH, 1994, RURAL SOCIOL, V59, P236; NCHS, 2010, NCHS SER, V20; NCHS, 2012, SPEC FEAT SOC STAT H; OPENSHAW S, 1984, ENVIRON PLANN A, V16, P17, DOI 10.1068/a160017; Osypuk TL, 2008, AM J EPIDEMIOL, V167, P1295, DOI 10.1093/aje/kwn043; Osypuk TL, 2009, SOC SCI MED, V69, P110, DOI 10.1016/j.socscimed.2009.04.010; Parisi D, 2011, SOC FORCES, V89, P829, DOI 10.1353/sof.2011.0013; Putnam R. D., 2001, BOWLING ALONE COLLAP; R Core Development Team, 2013, R LANG ENV STAT COMP; Reardon SF, 2008, DEMOGRAPHY, V45, P489, DOI 10.1353/dem.0.0019; Reardon SF, 2002, SOCIOL METHODOL, V32, P33, DOI 10.1111/1467-9531.00110; RUPASINGHA A, 2006, J SOCIOECONOMICS, V0035; Rupasingha A., 2008, US COUNTY LEVEL SOCI; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sethi R, 2004, J POLIT ECON, V112, P1296, DOI 10.1086/424742; Song L., 2016, NEW COMPANION MED SO, P184; Sparks PJ, 2013, GEOJOURNAL, V78, P389, DOI 10.1007/s10708-011-9445-3; Sparks PJ, 2010, POPUL SPACE PLACE, V16, P465, DOI 10.1002/psp.564; Thayn JB, 2013, ANN ASSOC AM GEOGR, V103, P47, DOI 10.1080/00045608.2012.685048; Theil H., 1972, STAT DECOMPOSITION A; Tiefelsdorf M, 2007, ENVIRON PLANN A, V39, P1193, DOI 10.1068/a37378; Voss PR, 2007, POPUL RES POLICY REV, V26, P457, DOI 10.1007/s11113-007-9047-4; Voss PR, 2006, POPUL RES POLICY REV, V25, P369, DOI 10.1007/s11113-006-9007-4; Walton E, 2009, J HEALTH SOC BEHAV, V50, P427, DOI 10.1177/002214650905000404; White K, 2011, HEALTH PLACE, V17, P438, DOI 10.1016/j.healthplace.2010.12.002; WHITE MJ, 1986, POPUL INDEX, V52, P198, DOI 10.2307/3644339; Whitley R, 2006, INT J SOC PSYCHIATR, V52, P376, DOI 10.1177/0020764006067239; Wilkes R, 2004, DEMOGRAPHY, V41, P23, DOI 10.1353/dem.2004.0009; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Yang T-C, 2009, APPL SPAT ANAL POLIC, V2, P211, DOI DOI 10.1007/S12061-009-9025-9; Yang TC, 2015, POPUL SPACE PLACE, V21, P18, DOI 10.1002/psp.1809; Yang TC, 2014, SOC SCI MED, V107, P26, DOI 10.1016/j.socscimed.2014.01.030; Yang TC, 2012, SOC SCI MED, V74, P1900, DOI 10.1016/j.socscimed.2012.02.029; Yang TC, 2011, RURAL SOCIOL, V76, P347, DOI 10.1111/j.1549-0831.2011.00055.x	91	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2015	10	9							e0138489	10.1371/journal.pone.0138489	http://dx.doi.org/10.1371/journal.pone.0138489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BM	26398346	Green Published, gold, Green Submitted			2022-12-26	WOS:000361797500071
J	Labree, W; Van de Mheen, D; Rutten, F; Rodenburg, G; Koopmans, G; Foets, M				Labree, Wim; Van de Mheen, Dike; Rutten, Frans; Rodenburg, Gerda; Koopmans, Gerrit; Foets, Marleen			Differences in Overweight and Obesity among Children from Migrant and Native Origin: The Role of Physical Activity, Dietary Intake, and Sleep Duration	PLOS ONE			English	Article							CHILDHOOD OBESITY; VEGETABLE INTAKE; ADOLESCENTS; PREVENTION; WEIGHT; REPRODUCIBILITY; ACCULTURATION; QUESTIONNAIRE; ASSOCIATION; ENVIRONMENT	A cross-sectional survey was performed to examine to what degree differences in overweight and obesity between native Dutch and migrant primary school children could be explained by differences in physical activity, dietary intake, and sleep duration among these children. Subjects (n= 1943) were primary school children around the age of 8-9 years old and their primary caregivers: native Dutch children (n = 1546), Turkish children (n = 93), Moroccan children (n = 66), other non-western children (n = 105), and other western children (n = 133). Multivariate regressions and logistic regressions were used to examine the relationship between migrant status, child's behavior, and BMI or prevalence of overweight, including obesity (logistic). Main explanatory variables were physical activity, dietary intake, and sleep duration. We controlled for age, sex, parental educational level, and parental BMI. Although sleep duration, dietary intake of fruit, and dietary intake of energy-dense snacks were associated with BMI, ethnic differences in sleep duration and dietary intake did not have a large impact on ethnic differences in overweight and obesity among children from migrant and native origin. It is suggested that future preventive strategies to reduce overweight and obesity, in general, consider the role of sleep duration. Also, cross-cultural variation in preparation of food among specific migrant groups, focusing on fat, sugar, and salt, deserves more attention. In order to examine which other variables may clarify ethnic differences in overweight and obesity, future research is needed.	[Labree, Wim; Rutten, Frans; Koopmans, Gerrit; Foets, Marleen] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Van de Mheen, Dike; Rodenburg, Gerda] Res Inst Addict, Rotterdam, Netherlands; [Van de Mheen, Dike; Rodenburg, Gerda] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Van de Mheen, Dike] Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Maastricht University	Labree, W (corresponding author), POB 1738, NL-3000 DR Rotterdam, Netherlands.	labree@bmg.eur.nl	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900; Rutten, Gemma/0000-0001-9552-4605	Netherlands Organization for Health Research and Development [115100004]; Institute of Health Policy and Management, a department of the Erasmus University Rotterdam	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Institute of Health Policy and Management, a department of the Erasmus University Rotterdam	This research was made possible by a grant of the Netherlands Organization for Health Research and Development (115100004) and financial support from the Institute of Health Policy and Management, a department of the Erasmus University Rotterdam.	Aranceta J, 2009, NUTR REV, V67, pS83, DOI 10.1111/j.1753-4887.2009.00166.x; Beccuti G, 2011, CURR OPIN CLIN NUTR, V14, P402, DOI 10.1097/MCO.0b013e3283479109; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Burrows TL, 2013, CLIN NUTR, V32, P613, DOI 10.1016/j.clnu.2012.11.006; Cattaneo A, 2010, OBES REV, V11, P389, DOI 10.1111/j.1467-789X.2009.00639.x; CBS (Statistics Netherlands), 2000, STAND ALL; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; de Wilde JA, 2014, ARCH DIS CHILD, V99, P46, DOI 10.1136/archdischild-2013-304222; de Wilde JA, 2009, ARCH DIS CHILD, V94, P795, DOI 10.1136/adc.2009.163709; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; GGD (Municipal Health Services), 2009, STANDD BEW MON JEUGD; Gilbert PA, 2008, NUTR REV, V66, P203, DOI 10.1111/j.1753-4887.2008.00025.x; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Guo XF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-120; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; John J, 2010, CURR OPIN CLIN NUTR, V13, P305, DOI 10.1097/MCO.0b013e328337fe18; Knutson KL, 2012, AM J HUM BIOL, V24, P361, DOI 10.1002/ajhb.22219; Labree LJW, 2011, OBES REV, V12, pe535, DOI 10.1111/j.1467-789X.2010.00839.x; Labree LJW, 2014, J PUBLIC HEALTH-HEID, V22, P415, DOI 10.1007/s10389-014-0637-4; Liu JH, 2012, J SPEC PEDIATR NURS, V17, P193, DOI 10.1111/j.1744-6155.2012.00332.x; Lytle LA, 2009, AM J COMMUN PSYCHOL, V44, P338, DOI 10.1007/s10464-009-9269-1; Mejean C, 2009, PUBLIC HEALTH NUTR, V12, P832, DOI 10.1017/S1368980008003285; Meng LP, 2012, BIOMED ENVIRON SCI, V25, P133, DOI 10.3967/0895-3988.2012.02.002; Nicolaou M, 2009, J NUTR EDUC BEHAV, V41, P232, DOI 10.1016/j.jneb.2008.05.011; Rauner A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-19; Renzaho AMN, 2010, PUBLIC HEALTH NUTR, V13, P438, DOI 10.1017/S136898000999111X; SALLIS JF, 1991, J SCHOOL HEALTH, V61, P215, DOI 10.1111/j.1746-1561.1991.tb06017.x; Steinbeck K S, 2001, Obes Rev, V2, P117, DOI 10.1046/j.1467-789x.2001.00033.x; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Toselli S, 2014, ENDOCRINE, V24, pE1; van der Horst K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-142; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	37	54	54	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0123672	10.1371/journal.pone.0123672	http://dx.doi.org/10.1371/journal.pone.0123672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26406985	Green Published, Green Submitted, gold			2022-12-26	WOS:000356630900009
J	Rutten, G; Ensslin, A; Hemp, A; Fischer, M				Rutten, Gemma; Ensslin, Andreas; Hemp, Andreas; Fischer, Markus			Vertical and Horizontal Vegetation Structure across Natural and Modified Habitat Types at Mount Kilimanjaro	PLOS ONE			English	Article							SPECIES-DIVERSITY; TROPICAL FOREST; CLIMATE-CHANGE; LAND-USE; MONTANE FORESTS; TREE DIVERSITY; BIOMASS; CONSERVATION; BIODIVERSITY; GRADIENTS	In most habitats, vegetation provides the main structure of the environment. This complexity can facilitate biodiversity and ecosystem services. Therefore, measures of vegetation structure can serve as indicators in ecosystem management. However, many structural measures are laborious and require expert knowledge. Here, we used consistent and convenient measures to assess vegetation structure over an exceptionally broad elevation gradient of 866-4550m above sea level at Mount Kilimanjaro, Tanzania. Additionally, we compared (human)-modified habitats, including maize fields, traditionally managed home gardens, grasslands, commercial coffee farms and logged and burned forests with natural habitats along this elevation gradient. We distinguished vertical and horizontal vegetation structure to account for habitat complexity and heterogeneity. Vertical vegetation structure (assessed as number, width and density of vegetation layers, maximum canopy height, leaf area index and vegetation cover) displayed a unimodal elevation pattern, peaking at intermediate elevations in montane forests, whereas horizontal structure (assessed as coefficient of variation of number, width and density of vegetation layers, maximum canopy height, leaf area index and vegetation cover) was lowest at intermediate altitudes. Overall, vertical structure was consistently lower in modified than in natural habitat types, whereas horizontal structure was inconsistently different in modified than in natural habitat types, depending on the specific structural measure and habitat type. Our study shows how vertical and horizontal vegetation structure can be assessed efficiently in various habitat types in tropical mountain regions, and we suggest to apply this as a tool for informing future biodiversity and ecosystem service studies.	[Rutten, Gemma; Ensslin, Andreas; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Rutten, Gemma] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Rutten, Gemma; Ensslin, Andreas; Fischer, Markus] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Hemp, Andreas] Univ Bayreuth, Dept Plant Systemat, Bayreuth, Germany; [Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Fischer, Markus] Biodivers & Climate Res Ctr BiK F, Senckenberg Gesell Naturforschung, Frankfurt, Germany	University of Bern; University of Bern; University of Bayreuth; University of Bern; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Rutten, G (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	ggpmrutten@gmail.com	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900; Rutten, Gemma/0000-0001-9552-4605	Swiss National Science Foundation (SNSF) of Research-Unit of the German Research Foundation (DFG) [1246]	Swiss National Science Foundation (SNSF) of Research-Unit of the German Research Foundation (DFG)	Funding: This study was supported by the Swiss National Science Foundation (SNSF) in the context of Research-Unit 1246 of the German Research Foundation (DFG). Prof. Dr. Markus Fischer, Dr. Andreas Hemp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawala S, 2003, DEV CLIMATE CHANGE T; Appelhans T, 2014, MONTHLY ANN CLIMATE; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; BELSKY AJ, 1994, BIOSCIENCE, V44, P77, DOI 10.2307/1312205; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Dean WRJ, 1999, J ARID ENVIRON, V41, P61, DOI 10.1006/jare.1998.0455; Dickinson MB, 2000, FOREST ECOL MANAG, V134, P137, DOI 10.1016/S0378-1127(99)00252-2; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; HATLEY CL, 1980, ENVIRON ENTOMOL, V9, P632, DOI 10.1093/ee/9.5.632; Helbig-Bonitz M, 2013, AFRICAN J ECOLOGY; Hemp A, 2005, GLOBAL CHANGE BIOL, V11, P1013, DOI 10.1111/j.1365-2486.2005.00968.x; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; Herve BD, 2008, BIODIVERS CONSERV, V17, P1821, DOI 10.1007/s10531-007-9276-1; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; JENSEN M, 1993, AGROFOREST SYST, V24, P171, DOI 10.1007/BF00706890; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lambrechts C., 2002, AERIAL SURVEY THREAT; Lopez-Gomez AA, 2008, AGR ECOSYST ENVIRON, V124, P160, DOI 10.1016/j.agee.2007.09.008; Lovett JC, 2006, AFR J ECOL, V44, P478, DOI 10.1111/j.1365-2028.2006.00660.x; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Moser G, 2007, ECOSYSTEMS, V10, P924, DOI 10.1007/s10021-007-9063-6; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Reich RM, 2010, PLANT ECOL, V210, P67, DOI 10.1007/s11258-010-9738-5; Rhoades CC, 1996, AGROFOREST SYST, V35, P71, DOI 10.1007/BF02345330; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Ruiz-Jaen MC, 2005, FOREST ECOL MANAG, V218, P159, DOI 10.1016/j.foreco.2005.07.008; Rutten G, 2015, FOREST ECOL MANAG, V337, P61, DOI 10.1016/j.foreco.2014.10.036; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Stumpf K., 1993, SOC AM FOR NAT CONV; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Van Gemerden BS, 2003, BIODIVERS CONSERV, V12, P1553, DOI 10.1023/A:1023603813163; Williams-Linera G, 2013, PLANT ECOL, P1; Wilson JB, 2011, J VEG SCI, V22, P197, DOI 10.1111/j.1654-1103.2010.01238.x	53	54	54	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138822	10.1371/journal.pone.0138822	http://dx.doi.org/10.1371/journal.pone.0138822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406985	Green Published, Green Submitted, gold			2022-12-26	WOS:000361800700103
